Citrus Sinensis ID: 011380

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------
Protein Sequence
MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHcHHHHHHHHHHHHcccHHHHHHHHHHHHHHcccccccEEHHHHHHHHHHHccccccHHHHHHHHHHHcccccccEEcccccHHHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEHHHHccccccEEEEEEEEcccccEEEEHHHHHHHcccHHHHHHHHHHHHHHHHHcccccEEEEEccccccHHEEEEEEEccccHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccEcccccccHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHcccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHcccccccccccccccEcHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHcccccccEEEHHHHHHHHHHHccccccHHHHHHHHHHHccccccEEEccccHHHHHHHHHHccccHHHHHHHHcc
Coil and Loop (DISEMBL)
mgiclsttkvsgsnsgsnnnnanhhrnANKEEAKRRhnhharndtthkhqHQHQERAKNYQQLKTkqhqktnsrrqtgvipcgkrtdfgydkdfdrRYTIGKLlghgqfgytyvatdkangdrVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHlhglvhrdmkpenflfksakedsslkatdfglsdfikpgkkfqDIVGSAYYvapevlkrksgpesdvwsIGVITYILLcgrrpfwdktedGIFKEVlrnkpdfrrkpwpsisnSAKDFVKKLLVKDPRARLTAAQalshpwvreggdaseipiDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRdqfdaidvdkngsiSLEEMRQALAKDLPWKLKESRVLEILQAvntpflglflpchekgekfsylLLFPVDMVYNLLYLTV
Flexible Loop (DISEMBL)
mgiclsttkvsgsnsgsnnnnanhhRNANKEEAKRRHNHHARndtthkhqhqHQERAKNYQQLktkqhqktnsrrqtgvipcgkrtdfgydkdFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVkkieknkmilpiaveDVKREVKILQAlaghenvvKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLhglvhrdmKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEvlkrksgpesdvwsiGVITYILLCGRRPFWDKTEDGIFKevlrnkpdfrrkpwpsisnsaKDFVKKLLVKDPRARLTaaqalshpwvreggdaSEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Low Complexity Region (SEG)
MGICLSTTKVsgsnsgsnnnnanhhrnanKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Disordered region (IsUnstruct)
*****************************************************************************GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK********KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI**SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYL**
Disordered Region (DISOPRED)
*******************************************************************************************KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD****PI**SVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Disordered Region (DISEMBL)
*********************ANHHRNAN************************************************GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Disordered Region (DISPRO)
************************************************************************************RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMVYNLLYLTV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	487	2.2.26 [Sep-21-2011]
Q7XJR9	571	Calcium-dependent protein	yes	no	0.921	0.786	0.763	0.0
Q9FKW4	523	Calcium-dependent protein	no	no	0.864	0.804	0.730	0.0
Q1PE17	534	Calcium-dependent protein	no	no	0.882	0.805	0.724	0.0
Q9SCS2	601	CDPK-related kinase 5 OS=	no	no	0.903	0.732	0.479	1e-115
P53681	602	CDPK-related protein kina	N/A	no	0.757	0.612	0.556	1e-115
Q9FX86	606	CDPK-related kinase 8 OS=	no	no	0.852	0.684	0.498	1e-115
Q9LJL9	599	CDPK-related kinase 2 OS=	no	no	0.743	0.604	0.539	1e-110
Q10KY3	600	Calcium/calmodulin-depend	no	no	0.743	0.603	0.542	1e-110
O49717	554	Calcium-dependent protein	no	no	0.821	0.722	0.476	1e-108
O80673	576	CDPK-related kinase 1 OS=	no	no	0.759	0.642	0.524	1e-108

>sp|Q7XJR9|CDPKG_ARATH Calcium-dependent protein kinase 16 OS=Arabidopsis thaliana GN=CPK16 PE=1 SV=1

 Score =  713 bits (1841), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/465 (76%), Positives = 385/465 (82%), Gaps = 16/465 (3%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARN------DTTHKHQHQHQ 54
           MG+C S+   +  +SG N ++ N H +      K R      +         H+ Q +  
Sbjct: 1   MGLCFSS---AAKSSGHNRSSRNPHPHPPLTVVKSRPPRSPCSFMAVTIQKDHRTQPRRN 57

Query: 55  ERAKNYQQLKTKQHQKT-------NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
             AK      T  H K        N RR    IP GKR DFGY KDFD RYTIGKLLGHG
Sbjct: 58  ATAKKTPTRHTPPHGKVREKVISNNGRRHGETIPYGKRVDFGYAKDFDHRYTIGKLLGHG 117

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE 167
           QFGYTYVATDK  GDRVAVKKI+K KM +PIAVEDVKREVKILQAL GHENVV+FYNAFE
Sbjct: 118 QFGYTYVATDKKTGDRVAVKKIDKAKMTIPIAVEDVKREVKILQALTGHENVVRFYNAFE 177

Query: 168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP 227
           D N VYI MELCEGGELLDRILA+KDSRY+E+DAAVVVRQML+VAAECHL GLVHRDMKP
Sbjct: 178 DKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVVVRQMLKVAAECHLRGLVHRDMKP 237

Query: 228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG 287
           ENFLFKS +EDS LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKR+SGPESDVWSIG
Sbjct: 238 ENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRRSGPESDVWSIG 297

Query: 288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
           VI+YILLCGRRPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISNSAKDFVKKLLVKDPRARL
Sbjct: 298 VISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNSAKDFVKKLLVKDPRARL 357

Query: 348 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLR 407
           TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK+SRLKQFALRALA+TLD+EELADLR
Sbjct: 358 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFSRLKQFALRALATTLDEEELADLR 417

Query: 408 DQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           DQFDAIDVDKNG ISLEEMRQALAKD PWKLK++RV EILQA+++
Sbjct: 418 DQFDAIDVDKNGVISLEEMRQALAKDHPWKLKDARVAEILQAIDS 462

May play a role in signal transduction pathways that involve calcium as a second messenger.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FKW4|CDPKS_ARATH Calcium-dependent protein kinase 28 OS=Arabidopsis thaliana GN=CPK28 PE=1 SV=1

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/457 (73%), Positives = 383/457 (83%), Gaps = 36/457 (7%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S  +V+G++S          R +++ ++K                          
Sbjct: 1   MGVCFSAIRVTGASSS---------RRSSQTKSK-------------------------- 25

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
               T    K +++R+TG IPCGKRTDFGY KDF   YTIGKLLGHGQFGYTYVA  + N
Sbjct: 26  -AAPTPIDTKASTKRRTGSIPCGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPN 84

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVK+++K+KM+LPIAVEDVKREV+IL AL+GHENVV+F+NAFEDD+YVYI MELCE
Sbjct: 85  GDRVAVKRLDKSKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCE 144

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL+KK +RY+EKDAAVVVRQML+VA ECHLHGLVHRDMKPENFLFKSA+ DS 
Sbjct: 145 GGELLDRILSKKGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSP 204

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGK+F DIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPF
Sbjct: 205 LKATDFGLSDFIKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPF 264

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WD+TEDGIFKEVLRNKPDF RKPW +IS+SAKDFVKKLLVKDPRARLTAAQALSH WVRE
Sbjct: 265 WDRTEDGIFKEVLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVRE 324

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGS 420
           GG+A++IP+DISVLNN+RQFV+YSRLKQFALRALASTLD+ E++DLRDQFDAIDVDKNG 
Sbjct: 325 GGNATDIPVDISVLNNLRQFVRYSRLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGV 384

Query: 421 ISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           ISLEEMRQALAKDLPWKLK+SRV EIL+A+++   GL
Sbjct: 385 ISLEEMRQALAKDLPWKLKDSRVAEILEAIDSNTDGL 421

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PE17|CDPKI_ARATH Calcium-dependent protein kinase 18 OS=Arabidopsis thaliana GN=CPK18 PE=2 SV=1

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/457 (72%), Positives = 365/457 (79%), Gaps = 27/457 (5%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S+ K +   +GS N N +        E     N         +HQ          
Sbjct: 1   MGLCFSSPKATRRGTGSRNPNPDSPTQGKASEKVSNKNKKNTKKIQLRHQ---------- 50

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
                            G IP GKR DFGY KDFD RYTIGKLLGHGQFG+TYVATD  N
Sbjct: 51  -----------------GGIPYGKRIDFGYAKDFDNRYTIGKLLGHGQFGFTYVATDNNN 93

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           G+RVAVK+I+K KM  PI VEDVKREVKILQAL GHENVV F+NAFED  Y+YI MELC+
Sbjct: 94  GNRVAVKRIDKAKMTQPIEVEDVKREVKILQALGGHENVVGFHNAFEDKTYIYIVMELCD 153

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHL GLVHRDMKPENFLFKS +E SS
Sbjct: 154 GGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEGSS 213

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPG KFQDIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPF
Sbjct: 214 LKATDFGLSDFIKPGVKFQDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPF 273

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKT+DGIF EV+R KPDFR  PWP+ISN AKDFVKKLLVK+PRARLTAAQALSH WV+E
Sbjct: 274 WDKTQDGIFNEVMRKKPDFREVPWPTISNGAKDFVKKLLVKEPRARLTAAQALSHSWVKE 333

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGS 420
           GG+ASE+PIDISVLNNMRQFVK+SRLKQ ALRALA T++++EL DLRDQFDAID+DKNGS
Sbjct: 334 GGEASEVPIDISVLNNMRQFVKFSRLKQIALRALAKTINEDELDDLRDQFDAIDIDKNGS 393

Query: 421 ISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           ISLEEMRQALAKD+PWKLK++RV EILQA ++   GL
Sbjct: 394 ISLEEMRQALAKDVPWKLKDARVAEILQANDSNTDGL 430

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  416 bits (1070), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 221/461 (47%), Positives = 297/461 (64%), Gaps = 21/461 (4%)

Query: 4   CLSTTKVSGSNSG--SNNNNANHHRNANKEEAKRRHNHHARNDTT---HKHQHQHQERAK 58
           C++TT   G  S      + +  H   +K+   R    ++ N T     K        AK
Sbjct: 42  CVTTTNNEGKKSPFFPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAK 101

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTD---------FGYDKDFDRRYTIGKLLGHGQF 109
           + + +  ++H     +  +  IP G   +         FG+ K F  +Y +G  +G G F
Sbjct: 102 HIRAVLARRHGSV--KPNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHF 159

Query: 110 GYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           GYT  A  K     G +VAVK I K KM   IA+EDV+REVKIL+AL+GH N+  FY+A+
Sbjct: 160 GYTCAAKFKKGDNKGQQVAVKVIPKAKMTTAIAIEDVRREVKILRALSGHNNLPHFYDAY 219

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           ED + VYI MELCEGGELLDRIL++   +YTE+DA  V+ Q+L V A CHL G+VHRD+K
Sbjct: 220 EDHDNVYIVMELCEGGELLDRILSR-GGKYTEEDAKTVMIQILNVVAFCHLQGVVHRDLK 278

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSI 286
           PENFLF S ++ S LKA DFGLSD+++P ++  DIVGSAYYVAPEVL R    E+D+WS+
Sbjct: 279 PENFLFTSKEDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRSYSTEADIWSV 338

Query: 287 GVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
           GVI YILLCG RPFW +TE GIF+ VL+  P F   PWP +S+ A+DFVK+LL KDPR R
Sbjct: 339 GVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVKRLLNKDPRKR 398

Query: 347 LTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADL 406
           LTAAQALSHPW+++  DA ++P+DI V   MR +++ S L++ ALRAL+ TL  +EL  L
Sbjct: 399 LTAAQALSHPWIKDSNDA-KVPMDILVFKLMRAYLRSSSLRKAALRALSKTLTVDELFYL 457

Query: 407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEIL 447
           R+QF  ++  KNG+ISLE ++ AL K     +K+SR+ E L
Sbjct: 458 REQFALLEPSKNGTISLENIKSALMKMATDAMKDSRIPEFL 498

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 208/374 (55%), Positives = 268/374 (71%), Gaps = 5/374 (1%)

Query: 82  CGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPI 138
            G    FG+ K F  ++ +G+ +G G FGYT  A  K     G  VAVK I K KM   I
Sbjct: 132 AGLDKSFGFSKKFGSKFEVGEEVGRGHFGYTCRAKFKKGEFKGQDVAVKVIPKAKMTTAI 191

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           A+EDV+REVKIL+AL GH N+V+FY+AFED   VY+ MELCEGGELLDRIL++   +YTE
Sbjct: 192 AIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVMELCEGGELLDRILSR-GGKYTE 250

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
            DA  V+ Q+L V A CHL G+VHRD+KPENFLFKS  EDS LKA DFGLSD++KP ++ 
Sbjct: 251 DDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDEDSQLKAIDFGLSDYVKPDERL 310

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            DIVGSAYYVAPEVL R    E+DVWSIGVI+YILLCG RPFW +TE GIF+ VL+    
Sbjct: 311 NDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSRPFWARTESGIFRAVLKANLS 370

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           F   PWPS+S+ AKDFVK+LL KDPR R+TAAQAL H W++   D  + P+DI V   M+
Sbjct: 371 FDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWIKNSNDI-KFPLDILVFKLMK 429

Query: 379 QFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKL 438
            +++ S L++ ALRAL+ TL  +EL  L++QF  ++  KNG+ISLE ++QAL ++    +
Sbjct: 430 VYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNGTISLENIKQALMRNSTDAM 489

Query: 439 KESRVLEILQAVNT 452
           K+SRVL++L ++N 
Sbjct: 490 KDSRVLDLLVSLNA 503

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 209/419 (49%), Positives = 275/419 (65%), Gaps = 4/419 (0%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
           R   H  +   H      + + K    L       T   ++      G    FG+ K+F 
Sbjct: 88  RRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKRFGFSKEFH 147

Query: 96  RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            R  +G+ +G G FGYT  A  K     G  VAVK I K+KM   IA+EDV+REVKILQA
Sbjct: 148 SRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKILQA 207

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L+GH+N+V+FY+AFED+  VYIAMELCEGGELLDRILA+   +Y+E DA  V+ Q+L V 
Sbjct: 208 LSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILAR-GGKYSENDAKPVIIQILNVV 266

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           A CH  G+VHRD+KPENFL+ S +E+S LKA DFGLSDF++P ++  DIVGSAYYVAPEV
Sbjct: 267 AFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEV 326

Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           L R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWP +S+ AK
Sbjct: 327 LHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAK 386

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           DFVK+LL KDPR R++A+QAL HPW+R       IP DI +   M+ +++ S L++ ALR
Sbjct: 387 DFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALR 446

Query: 393 ALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
           AL+ TL  +E+  L+ QF  +  +K+G I+++ +R ALA +    +KESR+ E L  +N
Sbjct: 447 ALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALLN 505

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1

 Score =  399 bits (1025), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 198/367 (53%), Positives = 259/367 (70%), Gaps = 5/367 (1%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVK 144
           FG+ K+   R  +G+ +G G FGYT  A  K        VAVK I K+KM   I++EDV+
Sbjct: 134 FGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVR 193

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           REVKIL+AL+GH+N+V+FY+AFED+  VYI MELC GGELLDRILA+   +Y+E DA  V
Sbjct: 194 REVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILAR-GGKYSEDDAKAV 252

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           + Q+L V A CHL G+VHRD+KPENFL+ S +E+S LK  DFGLSDF++P ++  DIVGS
Sbjct: 253 LIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGS 312

Query: 265 AYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           AYYVAPEVL R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PW
Sbjct: 313 AYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPW 372

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
           PS+S  AKDFVK+LL KDPR R+TA+QAL HPW+  G    +IP DI +   ++ +++ S
Sbjct: 373 PSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWI-AGYKKIDIPFDILIFKQIKAYLRSS 431

Query: 385 RLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVL 444
            L++ AL AL+ TL  +EL  L+ QF  +  +KNG I+L+ +R ALA +    +KESR+ 
Sbjct: 432 SLRKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIP 491

Query: 445 EILQAVN 451
           + L  +N
Sbjct: 492 DFLALLN 498

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 199/367 (54%), Positives = 270/367 (73%), Gaps = 5/367 (1%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVK 144
           FG+ + F  +Y +G+ +G G FGYT  AT K     GD VAVK I K KM   IA+EDV+
Sbjct: 137 FGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDVAVKVIPKAKMTTAIAIEDVR 196

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           REV+IL +LAGH N+V+FY+A+ED+  VYI MELC+GGELLDRILA+   +Y+E+DA VV
Sbjct: 197 REVRILSSLAGHSNLVQFYDAYEDEENVYIVMELCKGGELLDRILAR-GGKYSEEDAKVV 255

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +RQ+L VA+ CHL G+VHRD+KPENFLF S  E+S++K  DFGLSDF+KP ++  DIVGS
Sbjct: 256 MRQILSVASFCHLQGVVHRDLKPENFLFSSKDENSAMKVIDFGLSDFVKPDERLNDIVGS 315

Query: 265 AYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           AYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PW
Sbjct: 316 AYYVAPEVLHRSYGTEADMWSIGVIVYILLCGSRPFWARTESGIFRAVLKADPSFEEAPW 375

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
           P++S  AKDFV++LL KD R R+TAAQAL HPW+R G +  ++P+D+ +   MR ++  S
Sbjct: 376 PTLSAEAKDFVRRLLNKDYRKRMTAAQALCHPWIR-GTEEVKLPLDMIIYRLMRAYISSS 434

Query: 385 RLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVL 444
            L++ ALRALA TL  +++  LR+QF+ I  +K+  I+L+ ++ AL K+    +K+SRV+
Sbjct: 435 SLRRAALRALAKTLTTDQIYYLREQFELIGPNKSDLITLQNLKTALMKNSTNAMKDSRVV 494

Query: 445 EILQAVN 451
           + +  ++
Sbjct: 495 DFVNTIS 501

Possesses kinase activity in vitro.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O49717|CDPKF_ARATH Calcium-dependent protein kinase 15 OS=Arabidopsis thaliana GN=CPK15 PE=2 SV=1

 Score =  393 bits (1010), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 196/411 (47%), Positives = 275/411 (66%), Gaps = 11/411 (2%)

Query: 45  TTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD---RRYTIG 101
           TT +  H HQ+ +K   Q   K+H  T   +        + T+    K F+   + YT+G
Sbjct: 50  TTTQSNHHHQQESKPVNQQIEKKHVLTQPLKPI----VFRETETILGKPFEEIRKLYTLG 105

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG TY   + + G+  A K I K K+     ++DVKRE++I+Q L+G EN+V+
Sbjct: 106 KELGRGQFGITYTCKENSTGNTYACKSILKRKLTRKQDIDDVKREIQIMQYLSGQENIVE 165

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+ED   +++ MELC G EL DRI+A+    Y+EK AA V+R +L V   CH  G++
Sbjct: 166 IKGAYEDRQSIHLVMELCGGSELFDRIIAQ--GHYSEKAAAGVIRSVLNVVQICHFMGVI 223

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           HRD+KPENFL  S  E++ LKATDFGLS FI+ GK ++DIVGSAYYVAPEVL+R  G E 
Sbjct: 224 HRDLKPENFLLASTDENAMLKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLRRSYGKEI 283

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS G+I YILLCG  PFW +TE GIF E+++ + DF  +PWPSIS SAKD V+KLL K
Sbjct: 284 DIWSAGIILYILLCGVPPFWSETEKGIFNEIIKGEIDFDSQPWPSISESAKDLVRKLLTK 343

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDE 401
           DP+ R++AAQAL HPW+R GG+A + PID +VL+ M+QF   ++LK+ AL+ +A +L +E
Sbjct: 344 DPKQRISAAQALEHPWIR-GGEAPDKPIDSAVLSRMKQFRAMNKLKKLALKVIAESLSEE 402

Query: 402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           E+  L+  F  +D DK+G+I+ EE++  LAK L  KL E+ V ++++A + 
Sbjct: 403 EIKGLKTMFANMDTDKSGTITYEELKNGLAK-LGSKLTEAEVKQLMEAADV 452

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1

 Score =  392 bits (1008), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 200/381 (52%), Positives = 259/381 (67%), Gaps = 11/381 (2%)

Query: 80  IPCGKRTD------FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIE 130
           IP GK  +      FG+ K F   Y I   +G G FGYT  A  K     G  VAVK I 
Sbjct: 99  IPEGKECEIGLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIP 158

Query: 131 KNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA 190
           K+KM   IA+EDV REVK+L+AL GH+N+V+FY+AFEDD  VYI MELC+GGELLD+IL 
Sbjct: 159 KSKMTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKIL- 217

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           ++  +Y+E DA  V+ Q+L V A CHL G+VHRD+KPENFLF +  E S LKA DFGLSD
Sbjct: 218 QRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSD 277

Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK 310
           ++KP ++  DIVGSAYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+
Sbjct: 278 YVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 337

Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
            VL+ +P+F   PWPS+S  A DFVK+LL KD R RLTAAQAL HPW+  G    +IP D
Sbjct: 338 AVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLV-GSHELKIPSD 396

Query: 371 ISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQAL 430
           + +   ++ ++  + L++ AL ALA TL   +LA LR+QF  +   KNG IS++  + A+
Sbjct: 397 MIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKTAI 456

Query: 431 AKDLPWKLKESRVLEILQAVN 451
            K     +K+SRV + +  ++
Sbjct: 457 LKSSTDAMKDSRVFDFVHMIS 477

May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
225431134	558	PREDICTED: calcium-dependent protein kin	0.917	0.801	0.814	0.0
449434158	543	PREDICTED: calcium-dependent protein kin	0.924	0.828	0.833	0.0
224134094	556	calcium dependent protein kinase 18 [Pop	0.924	0.809	0.803	0.0
350538611	565	calcium-dependent protein kinase [Solanu	0.852	0.734	0.85	0.0
255561295	575	calcium-dependent protein kinase, putati	0.788	0.667	0.924	0.0
395863620	550	CDPK1 [Fragaria vesca]	0.854	0.756	0.858	0.0
16904224	572	calcium-dependent protein kinase CPK4 [N	0.897	0.763	0.813	0.0
224074263	557	calcium dependent protein kinase 16 [Pop	0.926	0.809	0.808	0.0
325683724	552	calcium-dependent protein kinase [Fragar	0.919	0.811	0.807	0.0
179399369	563	putative calcium dependent protein kinas	0.895	0.774	0.788	0.0

>gi|225431134|ref|XP_002267099.1| PREDICTED: calcium-dependent protein kinase 16 [Vitis vinifera] gi|297735013|emb|CBI17375.3| unnamed protein product [Vitis vinifera]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/464 (81%), Positives = 406/464 (87%), Gaps = 17/464 (3%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQH---QHQERA 57
           MG CLS TKV  SNS +  N A          A +       + T++K+Q    Q  +R 
Sbjct: 1   MGACLSATKVRSSNSNTTANAA----------ATKNTRPRGSSKTSNKNQQKKPQEGDRN 50

Query: 58  KNYQQLKTKQHQKT----NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTY 113
           ++ QQ +  Q QK     N RR TG+IPCGKRTDFGY KDFD RYTIGKLLGHGQFGYTY
Sbjct: 51  RSNQQHRNPQPQKVKDRANGRRGTGIIPCGKRTDFGYAKDFDARYTIGKLLGHGQFGYTY 110

Query: 114 VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
           VATDKANGDRVAVK+IEKNKMILPIAVEDVKREVKIL+AL GHENVV+F+NAFEDD+YVY
Sbjct: 111 VATDKANGDRVAVKRIEKNKMILPIAVEDVKREVKILEALTGHENVVQFHNAFEDDSYVY 170

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK 233
           I MELCEGGELLDRILAKKDSRY+EKDAA VVRQML+VAAECHLHGLVHRDMKPENFLFK
Sbjct: 171 IVMELCEGGELLDRILAKKDSRYSEKDAAKVVRQMLKVAAECHLHGLVHRDMKPENFLFK 230

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYIL 293
           S KEDS LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSGPESDVWSIGVITYIL
Sbjct: 231 STKEDSPLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGPESDVWSIGVITYIL 290

Query: 294 LCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           LCG+RPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISN AKDFVKKLLVKDPRARLTAAQAL
Sbjct: 291 LCGKRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNGAKDFVKKLLVKDPRARLTAAQAL 350

Query: 354 SHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAI 413
           SHPWVREGGDASEIPIDISVL+NMR+FVKYS LKQFALRALASTLDDEELADLRDQFDAI
Sbjct: 351 SHPWVREGGDASEIPIDISVLSNMREFVKYSHLKQFALRALASTLDDEELADLRDQFDAI 410

Query: 414 DVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           DVDKNGSISLEEMRQALAKDLPWK+KESRVLEILQA+++   GL
Sbjct: 411 DVDKNGSISLEEMRQALAKDLPWKMKESRVLEILQAIDSNTDGL 454

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449434158|ref|XP_004134863.1| PREDICTED: calcium-dependent protein kinase 28-like [Cucumis sativus] gi|449491358|ref|XP_004158870.1| PREDICTED: calcium-dependent protein kinase 28-like [Cucumis sativus]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/457 (83%), Positives = 406/457 (88%), Gaps = 7/457 (1%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG+C S +KVSGSNS +NN   NHHR  +    +      +  DT+   +  +    +N 
Sbjct: 1   MGVCFSASKVSGSNSNTNNTVVNHHRRGSTANPQ-----PSTTDTSQNQKRPNDNPKRNS 55

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           QQLK K+  K  SRRQ+GVIPCGKRTDFGY K+FD RYTIGKLLGHGQFGYTYVA DK N
Sbjct: 56  QQLKIKE--KNVSRRQSGVIPCGKRTDFGYHKNFDERYTIGKLLGHGQFGYTYVAIDKGN 113

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVKKIEKNKMILPIAVEDVKREVKILQ L GHENVV+F+NAFEDD+YVYI MELCE
Sbjct: 114 GDRVAVKKIEKNKMILPIAVEDVKREVKILQELTGHENVVQFHNAFEDDSYVYIVMELCE 173

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL+KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRD+KPENFLFKSAKEDS 
Sbjct: 174 GGELLDRILSKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDLKPENFLFKSAKEDSH 233

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF
Sbjct: 234 LKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 293

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKTEDGIFKEVLRNKPDFRRKPWPSIS SAKDF+KKLLVKDPRARLTAAQALSH WVRE
Sbjct: 294 WDKTEDGIFKEVLRNKPDFRRKPWPSISPSAKDFIKKLLVKDPRARLTAAQALSHRWVRE 353

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGS 420
           GGDASEIPIDISVL+NMRQFVKYSRLKQFALRALAST+ +EELADLRDQFDAIDVDKNGS
Sbjct: 354 GGDASEIPIDISVLSNMRQFVKYSRLKQFALRALASTIGEEELADLRDQFDAIDVDKNGS 413

Query: 421 ISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           ISLEEMRQALAKDLPWKLKESRVLEILQA++    GL
Sbjct: 414 ISLEEMRQALAKDLPWKLKESRVLEILQAIDVNTDGL 450

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224134094|ref|XP_002327754.1| calcium dependent protein kinase 18 [Populus trichocarpa] gi|222836839|gb|EEE75232.1| calcium dependent protein kinase 18 [Populus trichocarpa]

 Score =  750 bits (1937), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/459 (80%), Positives = 397/459 (86%), Gaps = 9/459 (1%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHK--HQHQHQERAK 58
           MG C ST KVSGSNS   NNN  H R    +   +            +  H HQ+ +   
Sbjct: 1   MGACFSTIKVSGSNS---NNNVIHSRKEPTKPQTKTTKATTATRKKQEVVHHHQNNKNVN 57

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N  + K K  +K +S+     IPCGKRTDFGYDKDFD RYTIGKLLGHGQFGYTYVA DK
Sbjct: 58  NEAEKKLKVKEKQSSK----AIPCGKRTDFGYDKDFDMRYTIGKLLGHGQFGYTYVAIDK 113

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
           ANGDRVAVK+IEKNKM+LPIAVEDVKREVKIL+ L GHENVV+FYNA EDD+YVYI MEL
Sbjct: 114 ANGDRVAVKRIEKNKMVLPIAVEDVKREVKILRELTGHENVVQFYNALEDDSYVYIVMEL 173

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
           CEGGELLDRIL+KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS K D
Sbjct: 174 CEGGELLDRILSKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKGD 233

Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 298
           S LKATDFGLSDFIKPG+KFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR
Sbjct: 234 SPLKATDFGLSDFIKPGRKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 293

Query: 299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           PFWDKTEDGIFKEVL+NKPDFRRKPWP+IS SAKDFV KLLVKDPRARLTAAQALSHPWV
Sbjct: 294 PFWDKTEDGIFKEVLKNKPDFRRKPWPTISTSAKDFVNKLLVKDPRARLTAAQALSHPWV 353

Query: 359 REGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKN 418
           REGG ASEIPIDISVL+NMRQFVKYSRLKQFALRALAST+D+EELADL+DQFDAIDVDKN
Sbjct: 354 REGGVASEIPIDISVLSNMRQFVKYSRLKQFALRALASTIDEEELADLKDQFDAIDVDKN 413

Query: 419 GSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           G+ISLEEMRQALAKDLPWKLKESRVLEI+QA+++   GL
Sbjct: 414 GAISLEEMRQALAKDLPWKLKESRVLEIVQAIDSNTDGL 452

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350538611|ref|NP_001234607.1| calcium-dependent protein kinase [Solanum lycopersicum] gi|241994912|gb|ACS74732.1| calcium-dependent protein kinase [Solanum lycopersicum]

 Score =  745 bits (1924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/420 (85%), Positives = 388/420 (92%), Gaps = 5/420 (1%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           N     D  + +Q   Q++ +N QQ     + K +SRRQ GVIPCGKRTDFGY KDF++R
Sbjct: 53  NQEGCRDKGNINQKNQQKQPRNSQQ-----NVKPSSRRQGGVIPCGKRTDFGYHKDFEKR 107

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           YTIGKLLGHGQFGYTYVATDK++GDRVAVK+IEKNKM+LPIAVEDVKREVKIL+AL GHE
Sbjct: 108 YTIGKLLGHGQFGYTYVATDKSSGDRVAVKRIEKNKMVLPIAVEDVKREVKILKALGGHE 167

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NVV+FYN+FEDDNYVYI MELCEGGELLDRIL+KKDSRYTEKDAA+VVRQML+VAAECHL
Sbjct: 168 NVVQFYNSFEDDNYVYIVMELCEGGELLDRILSKKDSRYTEKDAAIVVRQMLKVAAECHL 227

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           HGLVHRDMKPENFLFKS KEDS LKATDFGLSDFI+PGKKFQDIVGSAYYVAPEVLKR+S
Sbjct: 228 HGLVHRDMKPENFLFKSTKEDSPLKATDFGLSDFIRPGKKFQDIVGSAYYVAPEVLKRRS 287

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW +ISNSAKDFVKK
Sbjct: 288 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWSNISNSAKDFVKK 347

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAST 397
           +LVKDPRARLTAAQALSHPWVREGGDASEIP+DISVL+NMRQFVKYSRLKQFALRALAST
Sbjct: 348 ILVKDPRARLTAAQALSHPWVREGGDASEIPLDISVLSNMRQFVKYSRLKQFALRALAST 407

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           LD+EE+ADLRDQF AIDVDKNG ISLEEMRQALAKDLPWK+KESRVLEILQA+++   GL
Sbjct: 408 LDEEEIADLRDQFSAIDVDKNGVISLEEMRQALAKDLPWKMKESRVLEILQAIDSNTDGL 467

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255561295|ref|XP_002521658.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223539049|gb|EEF40645.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  743 bits (1917), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/384 (92%), Positives = 370/384 (96%)

Query: 74  RRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 133
           RR  GVIPCGKRTDFGY KDFD+RY+IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK
Sbjct: 88  RRPGGVIPCGKRTDFGYAKDFDKRYSIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 147

Query: 134 MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
           M+LPIAVEDVKREVKILQ LAGHENVV FYNAFEDD++VYI MELCEGGELLDRIL KKD
Sbjct: 148 MVLPIAVEDVKREVKILQELAGHENVVHFYNAFEDDSFVYIVMELCEGGELLDRILLKKD 207

Query: 194 SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
           SRYTEKDAAV+VRQML+VAAECHLHGLVHRDMKPENFLFKS K+DS LKATDFGLSDFIK
Sbjct: 208 SRYTEKDAAVIVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKDDSPLKATDFGLSDFIK 267

Query: 254 PGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           PGKKFQDIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL
Sbjct: 268 PGKKFQDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 327

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 373
           RNKPDFRRKPWPSIS+SAKDFVKKLLVKDPR RLTAAQALSHPWVREGG+ASEIPIDISV
Sbjct: 328 RNKPDFRRKPWPSISSSAKDFVKKLLVKDPRVRLTAAQALSHPWVREGGNASEIPIDISV 387

Query: 374 LNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD 433
           LNNMRQFVKYSR KQFALRALASTLDDEEL+DLRDQFDAIDVDKNGSISLEEMRQALAKD
Sbjct: 388 LNNMRQFVKYSRFKQFALRALASTLDDEELSDLRDQFDAIDVDKNGSISLEEMRQALAKD 447

Query: 434 LPWKLKESRVLEILQAVNTPFLGL 457
           LPWKLKESRVLEILQA+++   GL
Sbjct: 448 LPWKLKESRVLEILQAIDSNTDGL 471

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|395863620|gb|AFN80337.1| CDPK1 [Fragaria vesca]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/416 (85%), Positives = 382/416 (91%)

Query: 42  RNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG 101
           R  TT     Q      N  Q K K   K +SR++TGVIPCGKRTDFGYDK+FDRRYTIG
Sbjct: 31  RKQTTRPQPAQTNHHRPNEAQKKNKHKSKQSSRQKTGVIPCGKRTDFGYDKNFDRRYTIG 90

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLGHGQFGYTYVATD++NGDRVAVK I+KNKMILPIAVEDVKREV+ILQALAGHENVV+
Sbjct: 91  KLLGHGQFGYTYVATDRSNGDRVAVKGIDKNKMILPIAVEDVKREVEILQALAGHENVVQ 150

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           F+NA EDD YVYI MELCEGGELLDRIL KKDSRYTEKDAAVVVRQML+VAAECHLHGLV
Sbjct: 151 FFNACEDDTYVYIVMELCEGGELLDRILEKKDSRYTEKDAAVVVRQMLKVAAECHLHGLV 210

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           HRDMKPENFLFKS   DS LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSGPES
Sbjct: 211 HRDMKPENFLFKSKALDSPLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGPES 270

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           DVWSIGVI+YILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDFVKKLLVK
Sbjct: 271 DVWSIGVISYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFVKKLLVK 330

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDE 401
           DPRARLTAAQALSHPWVREGGDAS+IPIDISVLNNMRQFV+YSRLKQFALRALASTL+ E
Sbjct: 331 DPRARLTAAQALSHPWVREGGDASDIPIDISVLNNMRQFVRYSRLKQFALRALASTLNAE 390

Query: 402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           ELADL+DQFDAIDVDKNGSISLEEMRQALAKD+PWKLK+SRV+EIL+A+++   GL
Sbjct: 391 ELADLKDQFDAIDVDKNGSISLEEMRQALAKDIPWKLKDSRVVEILEAIDSNTDGL 446

Source: Fragaria vesca

Species: Fragaria vesca

Genus: Fragaria

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16904224|gb|AAL30819.1|AF435451_1 calcium-dependent protein kinase CPK4 [Nicotiana tabacum]

 Score =  740 bits (1911), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/440 (81%), Positives = 391/440 (88%), Gaps = 3/440 (0%)

Query: 20  NNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQ-TG 78
           N AN    +     K+  +H  +      H+ QHQ++     Q   K+H   N RRQ +G
Sbjct: 33  NKANPPSTSTITSTKQEGSHCNKQKVKDNHKSQHQKQQPRNSQQNVKKH--NNGRRQKSG 90

Query: 79  VIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI 138
           VI CGKRTDFGYDKDFD+R+TIGKLLGHGQFGYTYVAT K+NGDRVAVK+IEKNKM+LPI
Sbjct: 91  VIACGKRTDFGYDKDFDKRFTIGKLLGHGQFGYTYVATHKSNGDRVAVKRIEKNKMVLPI 150

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           AVEDVKREVKIL+AL+GHENVV+F NAFEDDNYVYI MELCEGGELLDRILAKKDSRY E
Sbjct: 151 AVEDVKREVKILKALSGHENVVQFNNAFEDDNYVYIVMELCEGGELLDRILAKKDSRYAE 210

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           KDAA+VVRQML+ AA+CHLHGLVHRDMKPENFLFKS+KEDS LKATDFGLSDFI+PGKKF
Sbjct: 211 KDAAIVVRQMLKEAAQCHLHGLVHRDMKPENFLFKSSKEDSPLKATDFGLSDFIRPGKKF 270

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
           QDIVGSAYYVAPEVLKR+SGPESD WSIGVITYILLCGRR FWDKTEDGIFKEVLRNKPD
Sbjct: 271 QDIVGSAYYVAPEVLKRRSGPESDEWSIGVITYILLCGRRRFWDKTEDGIFKEVLRNKPD 330

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           FRRKPWP+ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP+DISVL+NMR
Sbjct: 331 FRRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPLDISVLSNMR 390

Query: 379 QFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKL 438
           QFVKYSRLKQFALRALAST+D+EELAD+RDQF AIDVDKNG ISLEEMRQALAKDLPWK+
Sbjct: 391 QFVKYSRLKQFALRALASTVDEEELADVRDQFSAIDVDKNGVISLEEMRQALAKDLPWKM 450

Query: 439 KESRVLEILQAVNTPFLGLF 458
           KESRVLEILQA+++   GL 
Sbjct: 451 KESRVLEILQAIDSNSDGLL 470

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074263|ref|XP_002304327.1| calcium dependent protein kinase 16 [Populus trichocarpa] gi|222841759|gb|EEE79306.1| calcium dependent protein kinase 16 [Populus trichocarpa]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/459 (80%), Positives = 402/459 (87%), Gaps = 8/459 (1%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHAR--NDTTHKHQHQHQERAK 58
           MG C ST  +SGSNS +NN  ANH+R    +   R      R   +  H H HQ  +   
Sbjct: 1   MGACFSTINISGSNS-NNNTKANHNRKEPTKPQTRTTKAATRKKQEVVH-HHHQINKNVN 58

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N  + K K  +K +S+     IPCGKRTDFGYDKDFD RYTIGKLLGHGQFGYTYVATDK
Sbjct: 59  NEAEKKLKVKEKQSSK----AIPCGKRTDFGYDKDFDIRYTIGKLLGHGQFGYTYVATDK 114

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
            NGDRVAVK+I+KNKM+LPIAVEDVKREV+ILQ L GHENVV+F+NAFEDD+YVYI MEL
Sbjct: 115 GNGDRVAVKRIDKNKMVLPIAVEDVKREVRILQELTGHENVVQFHNAFEDDSYVYIVMEL 174

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
           CEGGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS KED
Sbjct: 175 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSTKED 234

Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR 298
           S LKATDFGLSDFIKPG+KF+DIVGSAYYVAPEVLKR SGPESDVWSIGVITYILLCGRR
Sbjct: 235 SPLKATDFGLSDFIKPGRKFKDIVGSAYYVAPEVLKRNSGPESDVWSIGVITYILLCGRR 294

Query: 299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           PFWDKTEDGIFKEVLRNKPDFRRKPWP+IS SAKDFV+KLLVKDPRARLTAAQALSHPWV
Sbjct: 295 PFWDKTEDGIFKEVLRNKPDFRRKPWPTISTSAKDFVQKLLVKDPRARLTAAQALSHPWV 354

Query: 359 REGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKN 418
           REGGDASEIPIDISVL+NMRQFVKYSRLKQFALRALAST+D+EELADL+DQFDAIDVDKN
Sbjct: 355 REGGDASEIPIDISVLSNMRQFVKYSRLKQFALRALASTIDEEELADLKDQFDAIDVDKN 414

Query: 419 GSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           G+ISLEEMRQALAKDLPWKLKES VLEI+QA+++   GL
Sbjct: 415 GAISLEEMRQALAKDLPWKLKESLVLEIVQAIDSNTDGL 453

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|325683724|gb|ADZ44603.1| calcium-dependent protein kinase [Fragaria x ananassa]

 Score =  731 bits (1888), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/457 (80%), Positives = 396/457 (86%), Gaps = 9/457 (1%)

Query: 1   MGICLSTTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNY 60
           MG CL+T KV+GSNS +N NN                    R  TT     Q      N 
Sbjct: 1   MGGCLTTAKVTGSNSNTNTNNNPATTTTAVVN---------RKQTTRPPPAQTNHHRANE 51

Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
            Q K K   K +SR++TG+IPCGKRTDFGYDK+FDRRY IGKLLGHGQFGYTYV TD++N
Sbjct: 52  AQKKHKHKPKQSSRQKTGMIPCGKRTDFGYDKNFDRRYMIGKLLGHGQFGYTYVVTDRSN 111

Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           GDRVAVK+I+KNKMILPIAVEDVKREVKILQALAGHENVV+FYNA EDD YVYI MELCE
Sbjct: 112 GDRVAVKRIDKNKMILPIAVEDVKREVKILQALAGHENVVQFYNACEDDTYVYIVMELCE 171

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           GGELLDRIL KKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS   DS 
Sbjct: 172 GGELLDRILEKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSKALDSP 231

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPF 300
           LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL+RKSG ESDVWSIGVITYILLCGRRPF
Sbjct: 232 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLRRKSGRESDVWSIGVITYILLCGRRPF 291

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           WDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDF KKLLVKDPRARLTAAQALSHPWVRE
Sbjct: 292 WDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFAKKLLVKDPRARLTAAQALSHPWVRE 351

Query: 361 GGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGS 420
           GGDAS+IPIDISVLNNMRQFV+YSRLKQFALRALASTL+ EELADL+DQFDAIDVDKNGS
Sbjct: 352 GGDASDIPIDISVLNNMRQFVRYSRLKQFALRALASTLNAEELADLKDQFDAIDVDKNGS 411

Query: 421 ISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL 457
           ISLEEMRQALAKD+PWKLK+SRV+EIL+A+++   GL
Sbjct: 412 ISLEEMRQALAKDIPWKLKDSRVVEILEAIDSNTDGL 448

Source: Fragaria x ananassa

Species: Fragaria x ananassa

Genus: Fragaria

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|179399369|gb|ACB86621.1| putative calcium dependent protein kinase [Silene vulgaris]

 Score =  729 bits (1882), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/453 (78%), Positives = 393/453 (86%), Gaps = 17/453 (3%)

Query: 15  SGSNNNNANHHRNANKEEAKRRHNHHARNDT---------------THKHQHQHQERAKN 59
           SGSN+NN      A K +  RR        T               TH H  +H++ +KN
Sbjct: 4   SGSNSNNTASTSTAGKTKRNRRKPPSMPYTTSGVPSRTSGVPTTTITHYHNDKHRKTSKN 63

Query: 60  YQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKA 119
              +  K  +KT+SRRQ+  IPCGKRTDFGYDKDFD+RY IGKLLGHGQFGYTYVAT+K+
Sbjct: 64  NSNI-IKLREKTSSRRQSS-IPCGKRTDFGYDKDFDKRYIIGKLLGHGQFGYTYVATNKS 121

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
           NGDRVAVKKI+KNKM LPIAVEDVKREVKIL+AL GHENVV+FYNAFEDDNYVYI MELC
Sbjct: 122 NGDRVAVKKIDKNKMKLPIAVEDVKREVKILKALTGHENVVQFYNAFEDDNYVYIVMELC 181

Query: 180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
           EGGELLDRILAKKDSRYTEKDAAVVVRQML+VAAECHLHGLVHRDMKPENFLFKS KEDS
Sbjct: 182 EGGELLDRILAKKDSRYTEKDAAVVVRQMLKVAAECHLHGLVHRDMKPENFLFKSPKEDS 241

Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 299
            LKATDFGLSDFI P +KF DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP
Sbjct: 242 PLKATDFGLSDFINPSRKFTDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 301

Query: 300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           FWDKTEDGIFKEVLRNKPDFRRKPWP+ISNSAKDFV+KLLVKDP  RLTAAQALSH WVR
Sbjct: 302 FWDKTEDGIFKEVLRNKPDFRRKPWPTISNSAKDFVRKLLVKDPLVRLTAAQALSHQWVR 361

Query: 360 EGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNG 419
           EGG A +IPIDISVL+NMRQFVKYSR+KQFALRALASTL+D+ELA+LRDQFDAIDVDK+G
Sbjct: 362 EGGSALDIPIDISVLHNMRQFVKYSRMKQFALRALASTLNDDELANLRDQFDAIDVDKSG 421

Query: 420 SISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           +ISL+EMRQALAKDLPWKLK+SRV+EI++A+++
Sbjct: 422 TISLDEMRQALAKDLPWKLKDSRVMEIVEAIDS 454

Source: Silene vulgaris

Species: Silene vulgaris

Genus: Silene

Family: Caryophyllaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
TAIR|locus:2827826	571	CPK16 "AT2G17890" [Arabidopsis	0.833	0.711	0.832	1.2e-184
TAIR|locus:2156947	523	CPK28 "calcium-dependent prote	0.796	0.741	0.835	1.1e-176
TAIR|locus:2012232	606	AT1G49580 [Arabidopsis thalian	0.848	0.681	0.501	3.2e-104
TAIR|locus:2094053	599	AT3G19100 [Arabidopsis thalian	0.833	0.677	0.498	2.3e-101
TAIR|locus:2062764	595	CRK3 "AT2G46700" [Arabidopsis	0.741	0.606	0.533	7.1e-100
TAIR|locus:2063197	576	CRK1 "AT2G41140" [Arabidopsis	0.753	0.637	0.529	1.7e-98
TAIR|locus:2103655	577	AT3G56760 [Arabidopsis thalian	0.802	0.677	0.5	3.5e-98
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.733	0.676	0.505	4.5e-98
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.733	0.682	0.5	1.1e-96
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.720	0.673	0.514	2.2e-96

TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)]

 Score = 1763 (625.7 bits), Expect = 1.2e-184, Sum P(2) = 1.2e-184
 Identities = 344/413 (83%), Positives = 366/413 (88%)

Query:    47 HKHQHQHQERAKNYQQLKTKQHQKT-------NSRRQTGVIPCGKRTDFGYDKDFDRRYT 99
             H+ Q +    AK      T  H K        N RR    IP GKR DFGY KDFD RYT
Sbjct:    50 HRTQPRRNATAKKTPTRHTPPHGKVREKVISNNGRRHGETIPYGKRVDFGYAKDFDHRYT 109

Query:   100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
             IGKLLGHGQFGYTYVATDK  GDRVAVKKI+K KM +PIAVEDVKREVKILQAL GHENV
Sbjct:   110 IGKLLGHGQFGYTYVATDKKTGDRVAVKKIDKAKMTIPIAVEDVKREVKILQALTGHENV 169

Query:   160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
             V+FYNAFED N VYI MELCEGGELLDRILA+KDSRY+E+DAAVVVRQML+VAAECHL G
Sbjct:   170 VRFYNAFEDKNSVYIVMELCEGGELLDRILARKDSRYSERDAAVVVRQMLKVAAECHLRG 229

Query:   220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGP 279
             LVHRDMKPENFLFKS +EDS LKATDFGLSDFIKPGKKF DIVGSAYYVAPEVLKR+SGP
Sbjct:   230 LVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIKPGKKFHDIVGSAYYVAPEVLKRRSGP 289

Query:   280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             ESDVWSIGVI+YILLCGRRPFWDKTEDGIFKEVL+NKPDFRRKPWP+ISNSAKDFVKKLL
Sbjct:   290 ESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVLKNKPDFRRKPWPTISNSAKDFVKKLL 349

Query:   340 VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLD 399
             VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK+SRLKQFALRALA+TLD
Sbjct:   350 VKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKFSRLKQFALRALATTLD 409

Query:   400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
             +EELADLRDQFDAIDVDKNG ISLEEMRQALAKD PWKLK++RV EILQA+++
Sbjct:   410 EEELADLRDQFDAIDVDKNGVISLEEMRQALAKDHPWKLKDARVAEILQAIDS 462

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0005886 "plasma membrane" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)]

 Score = 1716 (609.1 bits), Expect = 1.1e-176, P = 1.1e-176
 Identities = 324/388 (83%), Positives = 363/388 (93%)

Query:    70 KTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI 129
             K +++R+TG IPCGKRTDFGY KDF   YTIGKLLGHGQFGYTYVA  + NGDRVAVK++
Sbjct:    34 KASTKRRTGSIPCGKRTDFGYSKDFHDHYTIGKLLGHGQFGYTYVAIHRPNGDRVAVKRL 93

Query:   130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
             +K+KM+LPIAVEDVKREV+IL AL+GHENVV+F+NAFEDD+YVYI MELCEGGELLDRIL
Sbjct:    94 DKSKMVLPIAVEDVKREVQILIALSGHENVVQFHNAFEDDDYVYIVMELCEGGELLDRIL 153

Query:   190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
             +KK +RY+EKDAAVVVRQML+VA ECHLHGLVHRDMKPENFLFKSA+ DS LKATDFGLS
Sbjct:   154 SKKGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMKPENFLFKSAQLDSPLKATDFGLS 213

Query:   250 DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
             DFIKPGK+F DIVGSAYYVAPEVLKR+SGPESDVWSIGVITYILLCGRRPFWD+TEDGIF
Sbjct:   214 DFIKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVITYILLCGRRPFWDRTEDGIF 273

Query:   310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             KEVLRNKPDF RKPW +IS+SAKDFVKKLLVKDPRARLTAAQALSH WVREGG+A++IP+
Sbjct:   274 KEVLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRARLTAAQALSHAWVREGGNATDIPV 333

Query:   370 DISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQA 429
             DISVLNN+RQFV+YSRLKQFALRALASTLD+ E++DLRDQFDAIDVDKNG ISLEEMRQA
Sbjct:   334 DISVLNNLRQFVRYSRLKQFALRALASTLDEAEISDLRDQFDAIDVDKNGVISLEEMRQA 393

Query:   430 LAKDLPWKLKESRVLEILQAVNTPFLGL 457
             LAKDLPWKLK+SRV EIL+A+++   GL
Sbjct:   394 LAKDLPWKLKDSRVAEILEAIDSNTDGL 421

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1032 (368.3 bits), Expect = 3.2e-104, P = 3.2e-104
 Identities = 211/421 (50%), Positives = 279/421 (66%)

Query:    36 RHNHHARNDTTHKHQHQHQERAKNYQQLK--TKQHQKTNSRRQTGVIPCGKRTDFGYDKD 93
             R   H  +   H      + + K    L   T+   +   R +   +   KR  FG+ K+
Sbjct:    88 RRAFHPPSPAKHIRAALRRRKGKKEAALSGVTQLTTEVPQREEEEEVGLDKR--FGFSKE 145

Query:    94 FDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             F  R  +G+ +G G FGYT  A  K     G  VAVK I K+KM   IA+EDV+REVKIL
Sbjct:   146 FHSRVELGEEIGRGHFGYTCSAKFKKGELKGQVVAVKIIPKSKMTTAIAIEDVRREVKIL 205

Query:   151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
             QAL+GH+N+V+FY+AFED+  VYIAMELCEGGELLDRILA+   +Y+E DA  V+ Q+L 
Sbjct:   206 QALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILAR-GGKYSENDAKPVIIQILN 264

Query:   211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             V A CH  G+VHRD+KPENFL+ S +E+S LKA DFGLSDF++P ++  DIVGSAYYVAP
Sbjct:   265 VVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAP 324

Query:   271 EVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             EVL R    E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWP +S+ 
Sbjct:   325 EVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSD 384

Query:   331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
             AKDFVK+LL KDPR R++A+QAL HPW+R       IP DI +   M+ +++ S L++ A
Sbjct:   385 AKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAA 444

Query:   391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
             LRAL+ TL  +E+  L+ QF  +  +K+G I+++ +R ALA +    +KESR+ E L  +
Sbjct:   445 LRALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRMALASNATEAMKESRIPEFLALL 504

Query:   451 N 451
             N
Sbjct:   505 N 505

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
 Identities = 207/415 (49%), Positives = 274/415 (66%)

Query:    40 HARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYT 99
             H  +   H      + + K    L   + QK    R+   +   KR  FG+ K+   R  
Sbjct:    90 HPPSPARHIRDVLRRRKEKKEAALPAARQQKEEEEREE--VGLDKR--FGFSKELQSRIE 145

Query:   100 IGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             +G+ +G G FGYT  A  K        VAVK I K+KM   I++EDV+REVKIL+AL+GH
Sbjct:   146 LGEEIGRGHFGYTCSAKFKKGELKDQEVAVKVIPKSKMTSAISIEDVRREVKILRALSGH 205

Query:   157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +N+V+FY+AFED+  VYI MELC GGELLDRILA+   +Y+E DA  V+ Q+L V A CH
Sbjct:   206 QNLVQFYDAFEDNANVYIVMELCGGGELLDRILAR-GGKYSEDDAKAVLIQILNVVAFCH 264

Query:   217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
             L G+VHRD+KPENFL+ S +E+S LK  DFGLSDF++P ++  DIVGSAYYVAPEVL R 
Sbjct:   265 LQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRS 324

Query:   277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
                E+DVWSIGVI YILLCG RPFW +TE GIF+ VL+  P F   PWPS+S  AKDFVK
Sbjct:   325 YTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVK 384

Query:   337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAS 396
             +LL KDPR R+TA+QAL HPW+  G    +IP DI +   ++ +++ S L++ AL AL+ 
Sbjct:   385 RLLYKDPRKRMTASQALMHPWIA-GYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSK 443

Query:   397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
             TL  +EL  L+ QF  +  +KNG I+L+ +R ALA +    +KESR+ + L  +N
Sbjct:   444 TLTTDELLYLKAQFAHLAPNKNGLITLDSIRLALATNATEAMKESRIPDFLALLN 498

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)]

 Score = 991 (353.9 bits), Expect = 7.1e-100, P = 7.1e-100
 Identities = 197/369 (53%), Positives = 264/369 (71%)

Query:    88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDV 143
             FGY K+F  +Y +GK +G G FG+T     K  GD     +AVK I K KM   IA+EDV
Sbjct:   133 FGYGKNFGAKYELGKEVGRGHFGHTCSGRGK-KGDIKDHPIAVKIISKAKMTTAIAIEDV 191

Query:   144 KREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
             +REVK+L++L+GH+ ++K+Y+A ED N VYI MELC+GGELLDRILA+   +Y E DA  
Sbjct:   192 RREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLDRILAR-GGKYPEDDAKA 250

Query:   204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
             +V Q+L V + CHL G+VHRD+KPENFLF S++EDS LK  DFGLSDFI+P ++  DIVG
Sbjct:   251 IVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVG 310

Query:   264 SAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             SAYYVAPEVL R    E+D+WSIGVITYILLCG RPFW +TE GIF+ VLR +P++   P
Sbjct:   311 SAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVP 370

Query:   324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKY 383
             WPS S+  KDFVK+LL KD R R++A QAL+HPW+R+  D+  IP+DI +   ++ ++  
Sbjct:   371 WPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRD--DSRVIPLDILIYKLVKAYLHA 428

Query:   384 SRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRV 443
             + L++ AL+ALA  L + EL  LR QF  +  +K+GS+SLE  + AL ++    ++ESRV
Sbjct:   429 TPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFKTALMQNATDAMRESRV 488

Query:   444 LEILQAVNT 452
              EIL  + +
Sbjct:   489 PEILHTMES 497

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010150 "leaf senescence" evidence=IEP

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)]

 Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
 Identities = 197/372 (52%), Positives = 255/372 (68%)

Query:    83 GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIA 139
             G    FG+ K F   Y I   +G G FGYT  A  K     G  VAVK I K+KM   IA
Sbjct:   108 GLDKSFGFSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSKMTTAIA 167

Query:   140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
             +EDV REVK+L+AL GH+N+V+FY+AFEDD  VYI MELC+GGELLD+IL ++  +Y+E 
Sbjct:   168 IEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKIL-QRGGKYSED 226

Query:   200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
             DA  V+ Q+L V A CHL G+VHRD+KPENFLF +  E S LKA DFGLSD++KP ++  
Sbjct:   227 DAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKPDERLN 286

Query:   260 DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
             DIVGSAYYVAPEVL R  G E+D+WSIGVI YILLCG RPFW +TE GIF+ VL+ +P+F
Sbjct:   287 DIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAEPNF 346

Query:   320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
                PWPS+S  A DFVK+LL KD R RLTAAQAL HPW+  G    +IP D+ +   ++ 
Sbjct:   347 EEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWL-VGSHELKIPSDMIIYKLVKV 405

Query:   380 FVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLK 439
             ++  + L++ AL ALA TL   +LA LR+QF  +   KNG IS++  + A+ K     +K
Sbjct:   406 YIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYKTAILKSSTDAMK 465

Query:   440 ESRVLEILQAVN 451
             +SRV + +  ++
Sbjct:   466 DSRVFDFVHMIS 477

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010286 "heat acclimation" evidence=IMP

TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)]

 Score = 975 (348.3 bits), Expect = 3.5e-98, P = 3.5e-98
 Identities = 202/404 (50%), Positives = 268/404 (66%)

Query:    57 AKNYQQLKTKQHQKTNSRRQTGVIPCGKRTD------FGYDKDFDRRYTIGKLLGHGQFG 110
             AK+ + L  ++H        +  IP G   +      FG+ K F   Y I   +G G FG
Sbjct:    79 AKHIRALLARRHGSVKPNEAS--IPEGSECEVGLDKKFGFSKQFASHYEIDGEVGRGHFG 136

Query:   111 YTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE 167
             YT  A  K     G  VAVK I K+KM   IA+EDV+REVKIL+AL GH+N+V+FY+AFE
Sbjct:   137 YTCSAKGKKGSLKGQDVAVKVIPKSKMTTAIAIEDVRREVKILRALTGHKNLVQFYDAFE 196

Query:   168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP 227
             DD  VYI MELC+GGELLD+IL ++  +Y+E DA  V+ Q+L V A CHL G+VHRD+KP
Sbjct:   197 DDENVYIVMELCQGGELLDKIL-QRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKP 255

Query:   228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIG 287
             ENFLF +  E S LKA DFGLSD+++P ++  DIVGSAYYVAPEVL R  G E+D+WSIG
Sbjct:   256 ENFLFTTKDESSPLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIG 315

Query:   288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
             VI YILLCG RPFW ++E GIF+ VL+ +P+F   PWPS+S  A DFVK+LL KD R RL
Sbjct:   316 VIAYILLCGSRPFWARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRL 375

Query:   348 TAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLR 407
             TAAQAL HPW+  G    +IP D+ +   ++ ++  S L++ AL ALA TL   +L  L+
Sbjct:   376 TAAQALCHPWL-VGSHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQ 434

Query:   408 DQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
             +QF+ +   KNG IS++  + A+ K      K+SRVL+ +  ++
Sbjct:   435 EQFNLLGPSKNGYISMQNYKTAILKSSTEATKDSRVLDFVHMIS 478

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004723 "calcium-dependent protein serine/threonine phosphatase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 974 (347.9 bits), Expect = 4.5e-98, P = 4.5e-98
 Identities = 182/360 (50%), Positives = 256/360 (71%)

Query:    92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             +D    Y++GK LG GQFG T++ T KA G + A K I K K++    +EDV+REV+I+ 
Sbjct:    67 EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMH 126

Query:   152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
              L G  N+V+   A+ED + V++ MELC GGEL DRI+AK    Y+E+ AA ++R ++++
Sbjct:   127 HLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAK--GHYSERAAASLLRTIVQI 184

Query:   212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
                CH  G++HRD+KPENFL  +  E+S LKATDFGLS F KPG+ F+DIVGSAYY+APE
Sbjct:   185 VHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPE 244

Query:   272 VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
             VLKRK GPE+D+WSIGV+ YILLCG  PFW ++E+GIF  +LR   DF   PWPSIS  A
Sbjct:   245 VLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQA 304

Query:   332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
             KD VKK+L  DP+ RLTAAQ L+HPW++E G+A ++P+D +V++ ++QF   +  K+ AL
Sbjct:   305 KDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVAL 364

Query:   392 RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
             R +A  L +EE+  L++ F  +D D +G+I+LEE+RQ LAK    +L E  V ++++A +
Sbjct:   365 RVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQ-GTRLSEYEVQQLMEAAD 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
 Identities = 180/360 (50%), Positives = 255/360 (70%)

Query:    92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             +D    YT+GK LG GQFG T++ T KA G + A K I K K++    +EDV+REV+I+ 
Sbjct:    62 EDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRREVQIMH 121

Query:   152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
              L G  N+V+   A+ED + V++ MELC GGEL DRI+AK    Y+E+ AA ++R ++++
Sbjct:   122 HLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAK--GHYSERAAASLLRTIVQI 179

Query:   212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
                CH  G++HRD+KPENFL  S  E+S LKATDFGLS F KPG+ F+DIVGSAYY+APE
Sbjct:   180 IHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPE 239

Query:   272 VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
             VL+RK GPE+D+WSIGV+ YILLCG  PFW ++E+GIF  +L  + DF   PWP IS  A
Sbjct:   240 VLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVISPQA 299

Query:   332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
             KD V+K+L  DP+ RLTAAQ L+HPW++E G+A ++P+D +V++ ++QF   +  K+ AL
Sbjct:   300 KDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKKVAL 359

Query:   392 RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
             R +A  L +EE+  L++ F  +D D +G+I+LEE+RQ LAK    +L E  V ++++A +
Sbjct:   360 RVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQ-GTRLSEYEVQQLMEAAD 418

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
 Identities = 182/354 (51%), Positives = 253/354 (71%)

Query:    98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
             YT+ K LG GQFG TY+ T+K+ G R A K I K K++     ED++RE++I+Q L+G  
Sbjct:    73 YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query:   158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             N+V+F  A+ED+  V + MELC GGEL DRILAK    Y+E+ AA V RQ++ V   CH 
Sbjct:   133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAK--GHYSERAAASVCRQIVNVVNICHF 190

Query:   218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
              G++HRD+KPENFL  S  E + +KATDFGLS FI+ G+ ++DIVGSAYYVAPEVLKR+ 
Sbjct:   191 MGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRY 250

Query:   278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             G E D+WS G+I YILL G  PFW +TE GIF  +L  + DF  +PWPSISNSAKD V++
Sbjct:   251 GKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRR 310

Query:   338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAST 397
             +L +DP+ R++AA+ L HPW+REGG+AS+ PID +VL+ M+QF   ++LK+ AL+ +A  
Sbjct:   311 MLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKLALKVIAEN 370

Query:   398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
             +D EE+  L+  F  ID D +G+I+ EE+++ LAK L  +L E+ V +++ A +
Sbjct:   371 IDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAK-LGSRLTEAEVKQLMDAAD 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FKW4	CDPKS_ARATH	2, ., 7, ., 1, 1, ., 1	0.7308	0.8644	0.8049	no	no
Q1PE17	CDPKI_ARATH	2, ., 7, ., 1, 1, ., 1	0.7242	0.8829	0.8052	no	no
Q7XJR9	CDPKG_ARATH	2, ., 7, ., 1, 1, ., 1	0.7634	0.9219	0.7863	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	487
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-96
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-82
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-59
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-58
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-57
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-55
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-55
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-53
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-51
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-47
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-45
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-44
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-44
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-43
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-41
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-41
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-41
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-40
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-40
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-39
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-39
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-38
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-38
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-38
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-37
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-36
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-35
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-35
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-35
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-33
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-32
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-31
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-31
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-31
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-31
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-31
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-30
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-30
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-30
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-29
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-29
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-29
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-29
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-29
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-29
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-28
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-28
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-28
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-28
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-28
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-28
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-27
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-27
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-27
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-27
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-27
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-26
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-26
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-26
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-26
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-26
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-26
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-26
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-25
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-25
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-25
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-25
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-25
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-25
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-24
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-24
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-24
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-24
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-24
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-24
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-23
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-23
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-23
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-23
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-23
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-23
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-23
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-22
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-22
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-22
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-22
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-22
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-21
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-21
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-20
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-20
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-19
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-19
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-19
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-19
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-18
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-18
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-17
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-13
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	6e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	3e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-04
pfam13405	30	pfam13405, EF_hand_4, EF-hand domain	5e-04
pfam13202	25	pfam13202, EF_hand_3, EF hand	6e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.001
pfam00036	29	pfam00036, efhand, EF hand	0.001
pfam13499	60	pfam13499, EF_hand_5, EF-hand domain pair	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.001
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd00051	63	cd00051, EFh, EF-hand, calcium binding motif; A di	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  290 bits (744), Expect = 5e-96
 Identities = 119/263 (45%), Positives = 159/263 (60%), Gaps = 11/263 (4%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  Y+A DK  G  VA+K I+K K+      E + RE+KIL+ L  H 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKL-KHP 57

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V+ Y+ FED++ +Y+ ME CEGG+L D +  KK  R +E +A   +RQ+L      H 
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L     ED  +K  DFGL+  + PG+K    VG+  Y+APEVL  K 
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 278 -GPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
            G   D+WS+GVI Y LL G+ PF  D     +FK++ + KP F    W  IS  AKD +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLI 231

Query: 336 KKLLVKDPRARLTAAQALSHPWV 358
           +KLLVKDP  RLTA +AL HP+ 
Sbjct: 232 RKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  256 bits (656), Expect = 1e-82
 Identities = 102/267 (38%), Positives = 145/267 (54%), Gaps = 13/267 (4%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G FG  Y A  K  G  VAVK ++K         +  +RE++IL+ L  H 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRL-SHP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V+  +AFED +++Y+ ME CEGG+L D +        +E +A  +  Q+LR     H 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHS 116

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK-- 274
           +G++HRD+KPEN L     E+  +K  DFGL+   +K        VG+ +Y+APEVL   
Sbjct: 117 NGIIHRDLKPENILLD---ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRRKPWPSISNSA 331
              GP+ DVWS+GVI Y LL G+ PF  +       + + +L    +F    W S S  A
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           KD +KK L KDP  R TA + L HPW 
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  197 bits (502), Expect = 1e-59
 Identities = 91/292 (31%), Positives = 141/292 (48%), Gaps = 39/292 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
            DF      GK++G G F    +A +K      A+K ++K ++I    V+ VK E ++L 
Sbjct: 1   DDFK----FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L GH  ++K Y  F+D+  +Y  +E    GELL  I  +K     EK       ++L  
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---------- 261
               H  G++HRD+KPEN L     +D  +K TDFG +  + P    +            
Sbjct: 115 LEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 262 -----------VGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
                      VG+A YV+PE+L  K +G  SD+W++G I Y +L G+ PF    E   F
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231

Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA----AQALSHPW 357
           +++L+ +  F     P+    AKD ++KLLV DP+ RL       +  +HP+
Sbjct: 232 QKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  190 bits (486), Expect = 5e-58
 Identities = 91/256 (35%), Positives = 134/256 (52%), Gaps = 44/256 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y+A DK  G +VA+K I+K        +E++ RE++IL+ L  H N+VK Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             FED+N++Y+ ME CEGG L D +L + + + +E +   ++ Q+L      H +G++HR
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVLKRKS--GPE 280
           D+KPEN L  S  ++  +K  DFGLS  +   K   + IVG+  Y+APEVL  K     +
Sbjct: 117 DLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
           SD+WS+GVI Y L                                      KD ++K+L 
Sbjct: 175 SDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199

Query: 341 KDPRARLTAAQALSHP 356
           KDP  R +A + L H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  190 bits (486), Expect = 2e-57
 Identities = 92/264 (34%), Positives = 138/264 (52%), Gaps = 16/264 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + +G G FG  Y A  K  G  VA+K I+          E +  E++IL+    H 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE---KKEKIINEIQILKKCK-HP 57

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK+Y ++   + ++I ME C GG L D +L   +   TE   A V +++L+     +L
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLK--GLEYL 114

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H  G++HRD+K  N L  S   D  +K  DFGLS  +   K    +VG+ Y++APEV+  
Sbjct: 115 HSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING 171

Query: 276 KS-GPESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           K    ++D+WS+G IT I L  G+ P+ +        ++  N P   R P    S+  KD
Sbjct: 172 KPYDYKADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW-SDEFKD 229

Query: 334 FVKKLLVKDPRARLTAAQALSHPW 357
           F+KK L K+P  R TA Q L HP+
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  190 bits (484), Expect = 3e-57
 Identities = 87/260 (33%), Positives = 137/260 (52%), Gaps = 17/260 (6%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG   +   K  G   A+K ++K K+I    VE    E  IL  +  H  +VK +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
            AF+ +  +Y+ +E   GGEL   +   K+ R++E+ A     +++ +A E  H  G+++
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIV-LALEYLHSLGIIY 116

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+KPEN L      D  +K TDFGL+ +    G +     G+  Y+APEVL  K  G  
Sbjct: 117 RDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D WS+GV+ Y +L G+ PF+ +    I++++L++   F   P   +S  A+D +  LL 
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQ 229

Query: 341 KDPRARLTAAQA---LSHPW 357
           KDP  RL +  A    +HP+
Sbjct: 230 KDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  183 bits (468), Expect = 8e-55
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 20/271 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +T G+LLG G FG  Y+A DK  G+ +AVK +E +       +E ++RE++IL +L  H
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-H 58

Query: 157 ENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            N+V++Y +   E+ N + I +E   GG L   +  KK  +  E       RQ+L   A 
Sbjct: 59  PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAY 116

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H +G+VHRD+K  N L  S   D  +K  DFG +     I+ G+    + G+ Y++APE
Sbjct: 117 LHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 272 VLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG--IFKEVLRNKPDFRRKPWPS-I 327
           V++  + G  +D+WS+G     +  G+ P+ +       ++K     +P       P  +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP----EIPEHL 229

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S  AKDF++K L +DP+ R TA + L HP++
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  183 bits (467), Expect = 9e-55
 Identities = 97/268 (36%), Positives = 139/268 (51%), Gaps = 20/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G L+G G FG  Y   +   GD VA+K+I   K I   A++ + +E+ +L+ L  H
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK+  + E  + +YI +E  E G L   I  KK   + E   AV V Q+L+  A  H
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
             G++HRD+K  N L     +D  +K  DFG++       K    +VG+ Y++APEV+  
Sbjct: 117 EQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-E 172

Query: 276 KSGP--ESDVWSIGVITYI-LLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPS-ISNS 330
            SG    SD+WS+G  T I LL G  P++D       F+ V  + P     P P  IS  
Sbjct: 173 MSGASTASDIWSLG-CTVIELLTGNPPYYDLNPMAALFRIVQDDHP-----PLPEGISPE 226

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            KDF+ +   KDP  R TA Q L HPW+
Sbjct: 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  182 bits (464), Expect = 3e-54
 Identities = 86/274 (31%), Positives = 138/274 (50%), Gaps = 32/274 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y I K +G G FG  Y+   K++G    +K+I+ + M      ED   EVKIL+ L  H
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLN-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
            N++K+Y +FE+   + I ME  +GG+L  +I  +K     + E+       Q+    A 
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL--CLAL 116

Query: 215 CHLHG--LVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-------IVGS 264
            +LH   ++HRD+KP+N FL      +  +K  DFG+S      K           +VG+
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTS----NGLVKLGDFGIS------KVLSSTVDLAKTVVGT 166

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE+ + K    +SD+WS+G + Y L   + PF  +    +  ++L+ +      P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PP 222

Query: 324 WPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            PS  S+  ++ V  LL KDP  R + AQ L  P
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  183 bits (464), Expect = 4e-53
 Identities = 99/366 (27%), Positives = 155/366 (42%), Gaps = 27/366 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  Y+A D+     VA+K + K        VE   RE++IL +L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECH 216
           N+VK Y+ F+D+  +Y+ ME  +GG L D +         +E +A  ++ Q+L      H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------KFQDIVGSAYYVA 269
             G++HRD+KPEN L     +   +K  DFGL+  +                VG+  Y+A
Sbjct: 119 SKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 270 PEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN---------K 316
           PEVL       +   SD+WS+G+  Y LL G  PF  +       + L+           
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNN 376
                     IS +A D +KKLL KDP+ RL+++  LSH  +           D+   ++
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 377 -MRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP 435
                +      +  + +L S         L D   + ++  NG  S      +L     
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTA 356

Query: 436 WKLKES 441
              + S
Sbjct: 357 SSKRSS 362

Length = 384

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  174 bits (444), Expect = 2e-51
 Identities = 90/267 (33%), Positives = 130/267 (48%), Gaps = 27/267 (10%)

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G +G  ++A  K+ GD  A+K I+K  MI    V+ V  E  IL   A    VVK Y +F
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS-QAQSPYVVKLYYSF 62

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           +    +Y+ ME   GG+L    L +      E  A + + +++      H +G++HRD+K
Sbjct: 63  QGKKNLYLVMEYLPGGDL--ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 227 PENFLFKSAKEDSSLKATDFGLSDF---------IKPGKKFQDIVGSAYYVAPEVLKRKS 277
           P+N L  S   +  LK TDFGLS               K+ + IVG+  Y+APEV+  + 
Sbjct: 121 PDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177

Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS---ISNSAKD 333
                D WS+G I Y  L G  PF  +T + IF+ +L  K       WP    +S+ A D
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-----IEWPEDVEVSDEAID 232

Query: 334 FVKKLLVKDPRARLTAAQA---LSHPW 357
            + KLLV DP  RL A       +HP+
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPF 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  163 bits (415), Expect = 5e-47
 Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 28/273 (10%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-----EVKILQALA 154
             K+LG G  G  Y    K  G   A+KKI        +  ++  R     E+K L++  
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKI-------HVDGDEEFRKQLLRELKTLRS-C 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               VVK Y AF  +  + I +E  +GG L D  L KK  +  E   A + RQ+L+    
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILKGLD- 113

Query: 215 CHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAP 270
            +LH    ++HRD+KP N L  S  E   +K  DFG+S  ++    +    VG+  Y++P
Sbjct: 114 -YLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--I 327
           E ++ +S    +D+WS+G+       G+ PF        F E+++   D      P+   
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEF 228

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S   +DF+   L KDP+ R +AA+ L HP++++
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  159 bits (404), Expect = 4e-45
 Identities = 85/270 (31%), Positives = 138/270 (51%), Gaps = 18/270 (6%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G  G  Y ATD+A G  VA+KK+   K         E +  E+ I++    H N+V 
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCK-HPNIVD 79

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +Y+++   + +++ ME  +GG L D I+ +   R  E   A V R++L+     H   ++
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS-GP 279
           HRD+K +N L      D S+K  DFG +  +   K K   +VG+ Y++APEV+KRK  GP
Sbjct: 139 HRDIKSDNILLSK---DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195

Query: 280 ESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
           + D+WS+G++   +  G  P+  +     +F    +  P  +       S   KDF+ K 
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP--EKWSPEFKDFLNKC 253

Query: 339 LVKDPRARLTAAQALSHPWVREGGDASEIP 368
           LVKDP  R +A + L HP++++     E  
Sbjct: 254 LVKDPEKRPSAEELLQHPFLKKACPKEEFA 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  158 bits (401), Expect = 1e-44
 Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 24/272 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +   K LG G FG   +   K +G   A+K + K K++    VE V  E +ILQ++  H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  Y +F+DD+ +Y+ ME   GGEL   +  +K  R+ E  A     Q++ +A E +L
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVV-LALE-YL 117

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H   +V+RD+KPEN L  S   D  +K TDFG +  +K       + G+  Y+APE++  
Sbjct: 118 HSLDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILS 172

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKD 333
           K  G   D W++G++ Y +L G  PF+D     I++++L  K  F     PS  S  AKD
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF-----PSFFSPDAKD 227

Query: 334 FVKKLLVKDPRARL-----TAAQALSHPWVRE 360
            ++ LL  D   RL           +HPW   
Sbjct: 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  157 bits (398), Expect = 2e-44
 Identities = 90/292 (30%), Positives = 132/292 (45%), Gaps = 39/292 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   +G G  G  + A D+  G+ VA+KK+   ++   I      RE+K LQA   H
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             VVK  + F   +   + ME       L  +L  ++    E      +R +L+  A  H
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVL- 273
            +G++HRD+KP N L  +   D  LK  DFGL+      +       V + +Y APE+L 
Sbjct: 117 ANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 274 -KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV----------LRNKP 317
             RK  P  D+W++G I   LL G  P +    D      +F+ +          L + P
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 318 DF--------RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           D+        +  P     P  S  A D +K LLV DP  RL+AA+AL HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  156 bits (397), Expect = 4e-44
 Identities = 95/296 (32%), Positives = 134/296 (45%), Gaps = 47/296 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM------ILPIAVEDVKREVKIL 150
           RY  GK LG G +   Y A DK  G  VA+KKI+  +       I   A+    RE+K+L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLL 56

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           Q L  H N++   + F   + + +  E  E    L++++  K    T  D    +   LR
Sbjct: 57  QELK-HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H + ++HRD+KP N L  S   D  LK  DFGL+  F  P +K    V + +Y A
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRA 170

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----GIFKEVL-----RNKP 317
           PE+L   R  G   D+WS+G I +  L  R PF     D      IF E L      N P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCI-FAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWP 228

Query: 318 DFRRKP----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                P                +P+ S+ A D +++LL  +P  R+TA QAL HP+
Sbjct: 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  153 bits (389), Expect = 3e-43
 Identities = 90/283 (31%), Positives = 141/283 (49%), Gaps = 40/283 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           R+  G  +G G FG  Y A +   G+ +AVK  +I+ N    P  ++++  E+K+L+ L 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QMLR 210
            H N+VK+Y        VYI ME C GG L + +L      +       V+R    Q+L 
Sbjct: 58  -HPNLVKYYGVEVHREKVYIFMEYCSGGTL-EELL-----EHGRILDEHVIRVYTLQLLE 110

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-----GKKFQDIVGSA 265
             A  H HG+VHRD+KP N        +  +K  DFG +  +K      G++ Q + G+ 
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 266 YYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPD 318
            Y+APEV+        G  +D+WS+G +   +  G+RP W + ++    +F     +KP 
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGHKP- 225

Query: 319 FRRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               P P    +S   KDF+ + L  DP+ R TA++ L HP+V
Sbjct: 226 ----PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 3e-42
 Identities = 88/266 (33%), Positives = 132/266 (49%), Gaps = 20/266 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +  G FG  Y+A  ++ GD  A+K ++K+ MI    V +VK E  I+        V K
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 162 FYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
            Y +F+  +Y+Y+ ME   GG+   L + L      + ++  A VV     +  E  LH 
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVV-----LGVE-DLHQ 115

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G++HRD+KPEN L     +   LK TDFGLS      KKF   VG+  Y+APE +    
Sbjct: 116 RGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVG 169

Query: 278 GPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             + SD WS+G + +  L G  PF  +T D +F  +L  + ++  +     S  A D + 
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229

Query: 337 KLLVKDPRARLTA---AQALSHPWVR 359
           +LL  DP  RL A    +  SHP+ +
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  148 bits (375), Expect = 2e-41
 Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 22/265 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG   +   K+     A+K ++K  ++     E +  E +IL+    H  +VK Y
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             F+D  Y+Y+ ME C GGEL   IL  +   + E  A   +  ++      H  G+++R
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWT-ILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 224 DMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           D+KPEN L      DS+  +K  DFG +  +K G+K     G+  YVAPE++  K     
Sbjct: 118 DLKPENLLL-----DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 281 SDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKK 337
            D WS+G++ Y LL GR PF +  ED   I+ ++L+         +P+ I  +AKD +K+
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQ 229

Query: 338 LLVKDPRARLTAAQA-----LSHPW 357
           LL ++P  RL   +        H W
Sbjct: 230 LLRRNPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 3e-41
 Identities = 89/293 (30%), Positives = 138/293 (47%), Gaps = 39/293 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K++G G FG  ++  DK  G   A+K + K+ MI    +  V+ E  IL A A  
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-ADADS 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +VK Y +F+D+ ++Y+ ME   GG+L+  +L +KD  + E+ A   + +++      H
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKD-VFPEETARFYIAELVLALDSVH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQD--------------- 260
             G +HRD+KP+N L      D  +K  DFGL     K   +                  
Sbjct: 119 KLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 261 --------------IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE 305
                          VG+  Y+APEVL+    G E D WS+GVI Y +L G  PF+  T 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA-QALSHPW 357
              + +++  K   R  P P +S  A D + +LL  DP  RL +  +  SHP+
Sbjct: 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 8e-41
 Identities = 97/295 (32%), Positives = 143/295 (48%), Gaps = 48/295 (16%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK-------MILPIAVEDVKREVKIL 150
           Y + K LG G FG  Y+A +K  G+ VA+KK+ K K       M L        REVK L
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNL--------REVKSL 51

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+VK    F +++ +Y   E  E G L   +  +K   ++E     ++ Q+L+
Sbjct: 52  RKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             A  H HG  HRD+KPEN L    +    +K  DFGL+  I+    + D V + +Y AP
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAP 167

Query: 271 EVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL-----RNKPD-- 318
           E+L R +   S  D+W++G I   L   R  F   +E D ++K   VL     ++ P+  
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227

Query: 319 -------FR---------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  FR          +  P+ S  A D +K +L  DP+ R TA+QAL HP+
Sbjct: 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  146 bits (372), Expect = 1e-40
 Identities = 86/291 (29%), Positives = 136/291 (46%), Gaps = 41/291 (14%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPI-AVEDVKREVKILQALA 154
           Y   + LG G +G  Y A DK  G+ VA+KKI  +     +P  A+    RE+ +L+ L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+VK  +    +  +Y+  E C+    L + L K+    +      ++ Q+LR  A 
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCD--MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      D  LK  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 114 CHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL--------------- 313
              +      D+WS+G I   ++ G+  F   +E D +FK  ++L               
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 314 ---RNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                 P F  K      P +     D + K+L  +P  R++A +AL HP+
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  144 bits (365), Expect = 7e-40
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 24/273 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G     Y A    N ++VA+K+I+  K     +V+++++EV+ +     H 
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECH 216
           NVVK+Y +F   + +++ M    GG LLD + +        E   A V++++L+     H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPG----KKFQDIVGSAYYVAPE 271
            +G +HRD+K  N L     ED S+K  DFG+S  +   G    K  +  VG+  ++APE
Sbjct: 120 SNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 272 VLKRKSG--PESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKP-----DFRRKP 323
           V+++  G   ++D+WS G IT I L  G  P+       +    L+N P         K 
Sbjct: 177 VMEQVHGYDFKADIWSFG-ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +   S S +  +   L KDP  R TA + L H 
Sbjct: 236 Y---SKSFRKMISLCLQKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  145 bits (368), Expect = 2e-39
 Identities = 95/321 (29%), Positives = 148/321 (46%), Gaps = 66/321 (20%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK-------NKMILPIAVEDVKREVKI 149
           RY + K +G G +G    A DK  G +VA+KKI          K IL        RE+K+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL--------REIKL 52

Query: 150 LQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L+ L  HEN++   +       ED N VYI  EL E    L +++ K     T+      
Sbjct: 53  LRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVI-KSPQPLTDDHIQYF 108

Query: 205 VRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI- 261
           + Q+LR     +LH   ++HRD+KP N L      +  LK  DFGL+  + P +  +   
Sbjct: 109 LYQILR--GLKYLHSANVIHRDLKPSNIL---VNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 262 ---VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF---------WDK---- 303
              V + +Y APE+L    +     D+WS+G I   LL  R+P           +     
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDYIDQLNLIVEV 222

Query: 304 ----TEDGI-------FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLT 348
               +E+ +        +  L++ P   +KP     P  S  A D ++K+LV DP+ R+T
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282

Query: 349 AAQALSHPWVREGGDASEIPI 369
           A +AL+HP++ +  D  + P+
Sbjct: 283 ADEALAHPYLAQLHDPEDEPV 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 4e-39
 Identities = 90/292 (30%), Positives = 136/292 (46%), Gaps = 42/292 (14%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALA 154
           Y     +G G +G  Y A DK  G+ VA+KKI    +++ I   A+    RE+K+L+ L 
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++K  + F     +Y+  E  +    L +++  +     E      + Q+L+  A 
Sbjct: 57  -HPNIIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
           CH HG++HRD+KPEN L      +  LK  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 114 CHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 274 KRKS--GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL--------------- 313
                     D+WS+G I   LL  R  F  K+E D +FK    L               
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 314 ----RNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                + P     P     P+ S  A D + ++L  DP  R+TA QAL+HP+
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  142 bits (359), Expect = 8e-39
 Identities = 85/269 (31%), Positives = 147/269 (54%), Gaps = 19/269 (7%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +ATDK+ G +VAVKK++  K       E +  EV I++    H N+V+ Y
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HPNIVEMY 82

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 224 DMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           D+K ++ L  S   D  +K +DFG    +S  + P +K   +VG+ Y++APEV+ R   G
Sbjct: 140 DIKSDSILLTS---DGRVKLSDFGFCAQVSKEV-PRRK--SLVGTPYWMAPEVISRLPYG 193

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
            E D+WS+G++   ++ G  P++++      K +  N P   +     +S   + F+ ++
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDRM 252

Query: 339 LVKDPRARLTAAQALSHPWVREGGDASEI 367
           LV+DP  R TAA+ L+HP++ + G  S I
Sbjct: 253 LVRDPAQRATAAELLNHPFLAKAGPPSSI 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 3e-38
 Identities = 89/298 (29%), Positives = 132/298 (44%), Gaps = 49/298 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKK---IEKNKMILPIAVEDVKREVKILQAL 153
           +Y +  ++G G +G      +KA G+ VA+KK    E ++ +   A+    REVK+L+ L
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
             HEN+V    AF     +Y+  E  E    ELL+                  + Q+L+ 
Sbjct: 58  R-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS----YIWQLLQA 112

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPGKKFQDIVGSAYYVA 269
            A CH H ++HRD+KPEN L     E   LK  DFG +  +  +P     D V + +Y A
Sbjct: 113 IAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK-------------EVL 313
           PE+L      G   DVW+IG I   LL G   F   ++ D ++              E+ 
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229

Query: 314 RNKPDFRRKPWPSI--------------SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            + P F    +P                S+ A DF+K  L  DP+ RLT  + L HP+
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  139 bits (352), Expect = 3e-38
 Identities = 87/272 (31%), Positives = 138/272 (50%), Gaps = 24/272 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           R+  G+LLG G FG  Y   +  +GD  AVK   +  +      AV+ +++E+ +L  L 
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V++     +++ +YI +EL  GG L  ++L K  S + E    +  RQ+L     
Sbjct: 61  -HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGS-FPEPVIRLYTRQILLGLEY 117

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H    VHRD+K  N L  +   +  +K  DFG++  +      +   GS Y++APEV+ 
Sbjct: 118 LHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSI--- 327
           ++   G  +D+WS+G  T + +   +P W + E    +FK         R K  P I   
Sbjct: 175 QQGGYGLAADIWSLGC-TVLEMATGKPPWSQLEGVAAVFKIG-------RSKELPPIPDH 226

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S+ AKDF+ K L +DP  R TAA+ L HP+V
Sbjct: 227 LSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 4e-38
 Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 15/285 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +T+ + +G G FG  Y A DK     VA+K I+  +    I  ED+++E++ L      
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRS- 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
             + K+Y +F   + ++I ME C GG  LD +   K  +  E   A ++R++L    E  
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLL-GLEYL 114

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H  G +HRD+K  N L     E+  +K  DFG+S  +     K    VG+ +++APEV+K
Sbjct: 115 HEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 275 RKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +    E +D+WS+G+    L  G  P  D     +   + +N P          S   KD
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKD 229

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           FV   L KDP+ R +A + L H ++++    S + + I  +   +
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  139 bits (352), Expect = 4e-38
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 20/270 (7%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F+    IGK    G FG   +   +      A+K + K K +   +V +V  E +ILQ L
Sbjct: 2   FELLRVIGK----GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  + +F+D+  +Y+ ++L  GG+L   +  K   +++E+     + +++    
Sbjct: 58  N-HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALE 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H  G++HRD+KP+N L     E   +  TDF ++  + P        G+  Y+APEVL
Sbjct: 115 YLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171

Query: 274 KRK-SGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPSISN 329
            R+      D WS+GV  Y  L G+RP+   +    D I  +       +      + S 
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWST 227

Query: 330 SAKDFVKKLLVKDPRARL--TAAQALSHPW 357
            A D + KLL +DP+ RL        +HP+
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 7e-37
 Identities = 92/299 (30%), Positives = 138/299 (46%), Gaps = 53/299 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G  G  ++   K  G   A+K ++K +MI    V+ V  E +IL  L  H  +  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD----AAVVVRQMLRVAAE-CH 216
            Y +F+ + Y+ + M+ C GGEL   +  +     +E+     AA V+     +A E  H
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL-----LALEYLH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS--------------------------- 249
           L G+V+RD+KPEN L     E   +  +DF LS                           
Sbjct: 121 LLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 250 -DFIK--PGKKFQDIVGSAYYVAPEVLKRKSGPESDV--WSIGVITYILLCGRRPFWDKT 304
            +     P  +    VG+  Y+APEV+    G  S V  W++G++ Y +L G  PF    
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL----TAAQALSHPWVR 359
            D  F  +L+ +  F     P +S+SA+D ++KLLVKDP  RL     AA+   HP+ R
Sbjct: 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 5e-36
 Identities = 96/275 (34%), Positives = 138/275 (50%), Gaps = 24/275 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A  K  G   A K I+         +ED   E+ IL +   H N+V  Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDIL-SECKHPNIVGLY 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A+  +N ++I +E C+GG L D I+ + +   TE     V RQML      H H ++HR
Sbjct: 69  EAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-IVGSAYYVAPEVL---KRKSGP 279
           D+K  N L      D  +K  DFG+S   K   + +D  +G+ Y++APEV+     K  P
Sbjct: 128 DLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 280 ---ESDVWSIGVITYILLCGRRPFWDKTEDG--IFKEVLRNKPDFRRKP--WPSISNSAK 332
              ++D+WS+G IT I L    P   +      + K +L+++P    +P  W   S+S  
Sbjct: 185 YDYKADIWSLG-ITLIELAQMEPPHHELNPMRVLLK-ILKSEPPTLDQPSKW---SSSFN 239

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           DF+K  LVKDP  R TAA+ L HP+V +  D   I
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAI 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 1e-35
 Identities = 87/263 (33%), Positives = 132/263 (50%), Gaps = 15/263 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  ++A  K  G+ VA+K+++K+ +     V  V  E  IL      E +VK  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDIL-TTTKSEWLVKLL 67

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            AF+DD Y+Y+AME   GG+   R L       +E  A   + +M       H  G +HR
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDF--RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHR 125

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESD 282
           D+KPENFL  +      +K TDFGLS  I        +VGS  Y+APEVL+ +      D
Sbjct: 126 DLKPENFLIDA---SGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR----KPWPSISNSAKDFVKKL 338
            WS+G + Y  LCG  PF   T +  ++ +   K   +R     P  ++S+ A D + KL
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL 240

Query: 339 LVKDPRARLTAAQAL-SHPWVRE 360
           +  DP  R  + + + +HP+ +E
Sbjct: 241 I-NDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  133 bits (337), Expect = 1e-35
 Identities = 91/277 (32%), Positives = 151/277 (54%), Gaps = 14/277 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT K++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 83

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 141 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  + K    +S S K F+ +LLV+
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDRLLVR 256

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR 378
           DP  R TAA+ L HP++ + G  S I + +   N MR
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPSCI-VPLMRQNRMR 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 1e-35
 Identities = 86/280 (30%), Positives = 141/280 (50%), Gaps = 29/280 (10%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + +++G G +G  Y A  K  G  VA+K ++    I+    E++K E  IL+  + H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNH 62

Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLD--RILAKKDSRYTEKDAAVVVRQM 208
            N+  FY AF       +D+ +++ MELC GG + D  + L KK  R  E+  A ++R+ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
           LR  A  H + ++HRD+K +N L     +++ +K  DFG+S        +    +G+ Y+
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179

Query: 268 VAPEVLKRKSGPE------SDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR 320
           +APEV+     P+      SDVWS+G IT I L  G+ P  D        ++ RN P   
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238

Query: 321 RKP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + P  W   S    DF+ + L+K+   R    + L HP++
Sbjct: 239 KSPENW---SKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  132 bits (334), Expect = 2e-35
 Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 41/277 (14%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G +G  Y A  K  G  VA+K +   +      ++++ +E+ IL+      
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQ-CDSP 58

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +VK+Y ++  +  ++I ME C  G + D I+   +   TE++ A ++ Q L+     H 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHS 117

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
           +  +HRD+K  N L     E+   K  DFG+S        K   ++G+ +++APEV++ +
Sbjct: 118 NKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ-E 173

Query: 277 SGPES--DVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR------RKPWPSI 327
            G  +  D+WS+G IT I +  G+ P               +    R       KP P++
Sbjct: 174 IGYNNKADIWSLG-ITAIEMAEGKPP-------------YSDIHPMRAIFMIPNKPPPTL 219

Query: 328 SNSAK------DFVKKLLVKDPRARLTAAQALSHPWV 358
           S+  K      DFVKK LVKDP  R +A Q L HP++
Sbjct: 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 4e-35
 Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 44/289 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  Y A +K  G+ VA+KKI  E  K   PI      RE+K+LQ L  H N+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA---IREIKLLQKL-RHPNIVR 62

Query: 162 FYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
                  +    +Y+  E  +    L  +L   + ++TE      ++Q+L      H +G
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHD--LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--FQDIVGSAYYVAPEVL--KR 275
           ++HRD+K  N L  +   D  LK  DFGL+          + + V + +Y  PE+L    
Sbjct: 121 ILHRDIKGSNILINN---DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNKPDFR- 320
           + GPE D+WS+G I   L  G+  F   TE    + IF+            +   P F  
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237

Query: 321 ---RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              +KP+           I  SA D + KLL  DP+ R++A QAL H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 2e-34
 Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 30/277 (10%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +R  T+G     G FG  ++  D+ +    A+K +   ++I     + V  E ++L+ 
Sbjct: 2   DLERIKTVGT----GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           ++ H  +++ +    D  ++Y+ ME   GGEL   +      R++         +++   
Sbjct: 58  VS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCAL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYV 268
              H   +V+RD+KPEN L      +  +K TDFG +      KK +D    + G+  Y+
Sbjct: 115 EYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFA------KKLRDRTWTLCGTPEYL 165

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           APEV++ K      D W++G++ Y +L G  PF+D    GI++++L  K +F R     +
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HL 221

Query: 328 SNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVR 359
              AKD +KKLLV D   RL      A    +H W +
Sbjct: 222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-33
 Identities = 87/272 (31%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + + +G G +G  Y A D A G+ VA+K I   K+      E +++E+ +L+    H
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKE-CRH 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V ++ ++   + ++I ME C GG L D I        +E   A V R+ L+  A  H
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEVL-- 273
             G +HRD+K  N L     ED  +K  DFG+S  +     K +  +G+ Y++APEV   
Sbjct: 119 ETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 274 KRKSGPES--DVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           +RK G +   D+W++G IT I L   + P +D          L         P P + + 
Sbjct: 176 ERKGGYDGKCDIWALG-ITAIELAELQPPMFDLHP----MRALFLISKSNFPP-PKLKDK 229

Query: 331 AK------DFVKKLLVKDPRARLTAAQALSHP 356
            K      DF+KK L KDP+ R TA + L HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  128 bits (322), Expect = 1e-33
 Identities = 86/266 (32%), Positives = 143/266 (53%), Gaps = 13/266 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT+K  G +VAVKK++  K       E +  EV I++    HENVV  Y
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYH-HENVVDMY 85

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +LR  +  H  G++HR
Sbjct: 86  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L  S   D  +K +DFG  +   K   K + +VG+ Y++APEV+ R   G E 
Sbjct: 143 DIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      + +  N P  R K    +S+  + F+  +LV+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVLRGFLDLMLVR 258

Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           +P  R TA + L HP+++  G  S I
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPPSCI 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  128 bits (322), Expect = 3e-33
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 30/297 (10%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           KDFD +  +G+    G FG   V  +KA GD  A+K ++K+ ++    V   + E  IL 
Sbjct: 1   KDFDVKSLVGR----GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL- 55

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +++    + +   AF+D + +Y+ ME   GG+LL  +L + + ++ E  A   + +++  
Sbjct: 56  SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--VGSAYYVA 269
               H  G VHRD+KPEN L         +K  DFG +  +   K       VG+  Y+A
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRT---GHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171

Query: 270 PEVL-------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           PEVL       K   G E D WS+GVI Y ++ GR PF + T    +  ++  +   +  
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP 231

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
             P +S+   D ++ LL    + RL       HP+       S+I       NN+R 
Sbjct: 232 EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF------SKID-----WNNIRN 276

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  123 bits (311), Expect = 4e-32
 Identities = 89/275 (32%), Positives = 129/275 (46%), Gaps = 43/275 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAGHE 157
           LG G  G       +  G  +AVK I         K IL        RE+ IL       
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL--------RELDILHK-CNSP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH- 216
            +V FY AF ++  + I ME  +GG  LD+IL +   R  E+    +   +L+     H 
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGS-LDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEV 272
            H ++HRD+KP N L  S  +   +K  DFG+S     G+      +  VG++ Y+APE 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPE- 169

Query: 273 LKRKSGP----ESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLR---NKPDFRRKP 323
             R  G     +SD+WS+G+    L  GR P+   +   DGIF E+L+   N+P   R P
Sbjct: 170 --RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPP-PRLP 225

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               S   +DFV   L+KDPR R +  + L HP++
Sbjct: 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  123 bits (309), Expect = 5e-32
 Identities = 87/286 (30%), Positives = 145/286 (50%), Gaps = 43/286 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE-----------KNKMILPIAVEDVKR 145
           ++  G L+G G FG  Y+  + ++G+ +AVK++E           K  M+     + + R
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSML-----DALAR 55

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE---LLDRILAKKDSRYTEKDAA 202
           E+ +L+ L  HEN+V++  +  D +++ I +E   GG    LL+   A     + E    
Sbjct: 56  EIALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-----FEETLVR 109

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPG 255
             VRQ+L+     H  G++HRD+K  N L  +      +K +DFG+S  +       K  
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKLEANSLSTKTN 166

Query: 256 KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVL 313
                + GS +++APEV+K+ S   ++D+WS+G +   +L G+ PF D T+   IFK   
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226

Query: 314 RNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
              P+      PS IS+ A DF++K    D   R TAA+ L HP++
Sbjct: 227 NASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  121 bits (306), Expect = 1e-31
 Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 16/267 (5%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+    IGK    G FG  +    KA+    A+K+I+ +KM      E +  E ++L  
Sbjct: 1   DFEILNKIGK----GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAK 55

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L     ++++Y +F D   + I ME  E G+L   +  ++     E        Q+L   
Sbjct: 56  L-DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPE 271
           A  H   ++HRD+K  N          ++K  D G++  +     F   IVG+ YY++PE
Sbjct: 115 AHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171

Query: 272 VLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISN 329
           + + K   E SDVW++GV+ Y    G+ PF    +  +  +++R        P     S 
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG----VFPPVSQMYSQ 227

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHP 356
                + + L KD R R    Q L +P
Sbjct: 228 QLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 2e-31
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 19/267 (7%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAVEDVKREVKILQALAGHEN 158
           GKLLG G FG  Y+  D   G  +AVK++    +       V  ++ E+++L+ L  HE 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HER 65

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V++Y    DD  + I ME   GG + D++  K     TE       RQ+L      H +
Sbjct: 66  IVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP----GKKFQDIVGSAYYVAPEVLK 274
            +VHRD+K  N L  SA    ++K  DFG S  ++     G   + + G+ Y+++PEV+ 
Sbjct: 124 MIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISNSA 331
            +  G ++DVWS+G  T + +   +P W + E    IFK  +  +P   + P   +S  A
Sbjct: 181 GEGYGRKADVWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLP-SHVSPDA 236

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           ++F+++  V++ + R +A + L H +V
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  122 bits (307), Expect = 4e-31
 Identities = 95/318 (29%), Positives = 150/318 (47%), Gaps = 30/318 (9%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           +G+ LG G FG   +A  K  G+  A+K ++K +++    V+ V +E  IL  L+ H  +
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
           V    +F+D+N VY  +E   GGEL   +  +K  R+   D A      L +A E +LH 
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFP-NDVAKFYHAELVLAFE-YLHS 136

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             +++RD+KPEN L  +      +K TDFG +  + P + F  + G+  Y+APEV++ K 
Sbjct: 137 KDIIYRDLKPENLLLDN---KGHVKVTDFGFAKKV-PDRTFT-LCGTPEYLAPEVIQSKG 191

Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
            G   D W++GV+ Y  + G  PF+D T   I++++L  +  F    W      A+D VK
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVK 247

Query: 337 KLLVKDPRARLTA-----AQALSHPWVREG--------GDASEIPIDISVLNNMRQFVKY 383
            LL  D   RL       A   +HP+               + IP+ +    +   F KY
Sbjct: 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKY 307

Query: 384 SRLKQFALRALASTLDDE 401
                  L  L +    E
Sbjct: 308 PDSPVDRLPPLTAAQQAE 325

Length = 329

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  121 bits (304), Expect = 5e-31
 Identities = 80/273 (29%), Positives = 139/273 (50%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKI 149
           D  ++YT  + +G G  G  Y A D A G  VA+K++   ++ K  L I    V RE K 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK- 74

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
                 H N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L
Sbjct: 75  ------HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECL 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYV 268
           +     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPS 326
           APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++     ++       P+ +      
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EK 240

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L HP+++
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  119 bits (301), Expect = 8e-31
 Identities = 82/276 (29%), Positives = 136/276 (49%), Gaps = 31/276 (11%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-----EVKILQA 152
           Y + + +G G FG       K++G  +  K+I+   M       + ++     EV IL+ 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRE 55

Query: 153 LAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAV-VVRQM 208
           L  H N+V++Y+   D  +  +YI ME CEGG+L   I   KK+ +Y E++    ++ Q+
Sbjct: 56  LK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 209 LRVAAECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIV 262
           L    ECH      + ++HRD+KP N +F  A    ++K  DFGL+  +     F +  V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPAN-IFLDANN--NVKLGDFGLAKILGHDSSFAKTYV 171

Query: 263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           G+ YY++PE L       +SD+WS+G + Y L     PF  + +  +  ++   K  FRR
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FRR 229

Query: 322 KPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHP 356
              P   S+   + +K +L  DP  R +  + L  P
Sbjct: 230 --IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  120 bits (302), Expect = 1e-30
 Identities = 80/261 (30%), Positives = 139/261 (53%), Gaps = 13/261 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +A +K +G +VAVK ++  K       E +  EV I++    H+NVV+ Y
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HQNVVEMY 84

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     +++ ME  +GG L D +     +R  E+  A V   +L+     H  G++HR
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRKS-GPES 281
           D+K ++ L      D  +K +DFG    I K   K + +VG+ Y++APEV+ R   G E 
Sbjct: 142 DIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++  +     K  LR+ P  + K    IS   +DF++++L +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERMLTR 257

Query: 342 DPRARLTAAQALSHPWVREGG 362
           +P+ R TA + L HP++ + G
Sbjct: 258 EPQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  119 bits (300), Expect = 3e-30
 Identities = 88/287 (30%), Positives = 138/287 (48%), Gaps = 46/287 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+   TI KL+ +G +G  Y+   K    R A+KKI K  +IL   ++ V  E  IL  
Sbjct: 2   DFE---TI-KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDIL-T 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGE---LLDRI--LAKKDSRYTEKDAAVVVRQ 207
            A +  VV  + +FE   ++ + ME  EGG+   LL  I  L    +R    +  + +  
Sbjct: 57  FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEY 116

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF--------------IK 253
           +       H +G+VHRD+KP+N L  S      +K TDFGLS                 K
Sbjct: 117 L-------HNYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 254 PGKKFQD--IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK 310
             ++F D  + G+  Y+APEV+ R+  G   D W++G+I Y  L G  PF+  T + +F 
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226

Query: 311 EVLRNKPDFRRKPWP----SISNSAKDFVKKLLVKDPRARLTAAQAL 353
           +V+ +  +     WP    ++   A+D + +LL ++P  RL    A 
Sbjct: 227 QVISDDIE-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAF 268

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  119 bits (300), Expect = 3e-30
 Identities = 102/316 (32%), Positives = 150/316 (47%), Gaps = 49/316 (15%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           FG   +   RY   + +G G FG    A D+  G  VA+KKI K     P+  +   RE+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYREL 60

Query: 148 KILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AA 202
           K+L+ L  HEN++     F +  ED   +Y   EL   G  L R+L    SR  EK    
Sbjct: 61  KLLKHLR-HENIISLSDIFISPLED---IYFVTELL--GTDLHRLL---TSRPLEKQFIQ 111

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
             + Q+LR     H  G+VHRD+KP N L     E+  LK  DFGL+    P  +    V
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQDP--QMTGYV 166

Query: 263 GSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDK---TEDGIFKEVLRNKP 317
            + YY APE++   +K   E D+WS G I   +L G+  F  K    +  I  ++L   P
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226

Query: 318 DF------------------RRKPWP------SISNSAKDFVKKLLVKDPRARLTAAQAL 353
           D                   +R+P P      +   SA D ++K+LV DP+ R++AA+AL
Sbjct: 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286

Query: 354 SHPWVREGGDASEIPI 369
           +HP++    D ++ P+
Sbjct: 287 AHPYLAPYHDPTDEPV 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  117 bits (296), Expect = 4e-30
 Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 20/267 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y   ++LG G FG   +     +   V  K++   ++       D   E+ IL  L  H
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQ-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++ +YN F DDN + I ME   GG L D+I+ +K   + E+     + Q++   +  H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEV 272
             G++HRD+K  N FL K       +K  DFG+S     G ++   + +VG+ YY++PE+
Sbjct: 119 KAGILHRDIKTLNIFLTK----AGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPEL 172

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
            +      +SD+W++G + Y LL  +R F      + + K V  N       P  S+ +S
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-----YTPVVSVYSS 227

Query: 331 A-KDFVKKLLVKDPRARLTAAQALSHP 356
                V  LL +DP  R TA + L  P
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  117 bits (295), Expect = 5e-30
 Identities = 76/266 (28%), Positives = 128/266 (48%), Gaps = 14/266 (5%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             + I K +G GQF   Y A    +G  VA+KK++  +M+   A +D  +E+ +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAA 213
           H NV+K+  +F ++N + I +EL + G+L   I    K+     E+       Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEV 272
             H   ++HRD+KP N +F +A     +K  D GL  F          +VG+ YY++PE 
Sbjct: 121 HMHSKRIMHRDIKPAN-VFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 273 LKRKSGPE--SDVWSIGVITYILLCGRRPFW-DKTE-DGIFKEVLRNKPDFRRKPWPSIS 328
           +  ++G    SD+WS+G + Y +   + PF+ DK     + K++   K D+   P    S
Sbjct: 178 I-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EKCDYPPLPADHYS 234

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALS 354
              +D V + +  DP  R   +  L 
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  116 bits (293), Expect = 2e-29
 Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 23/278 (8%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
              D ++ +T  + +GHG FG  Y A D    + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   SKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQ 207
           LQ L  H N +++   +  ++  ++ ME C G   ++L+  + KK  +  E + A +   
Sbjct: 69  LQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQ--EVEIAAICHG 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
            L+  A  H H  +HRD+K  N L     E  ++K  DFG +  + P   F   VG+ Y+
Sbjct: 124 ALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPANSF---VGTPYW 177

Query: 268 VAPEV-LKRKSGP---ESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRR 321
           +APEV L    G    + DVWS+G IT I L  R+P  F       ++     + P    
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
             W   S+  ++FV   L K P+ R ++ + L H +V 
Sbjct: 237 NDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 2e-29
 Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 15/267 (5%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AG 155
           Y   +L+G G +G  Y       G  VA+K I  N       V D++REV +L  L  + 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKII--NLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
             N+ K+Y ++     ++I ME  EGG +  R L K      EK  +V++R++L      
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKA-GPIAEKYISVIIREVLVALKYI 117

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G++HRD+K  N L  +     ++K  DFG++    +   K    VG+ Y++APEV+ 
Sbjct: 118 HKVGVIHRDIKAANILVTNT---GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 275 --RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +    ++D+WS+G+  Y +  G  P+ D         + ++KP   R      S   +
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP--RLEDNGYSKLLR 232

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           +FV   L ++P+ RL+A + L   W++
Sbjct: 233 EFVAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  116 bits (293), Expect = 3e-29
 Identities = 84/270 (31%), Positives = 137/270 (50%), Gaps = 24/270 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVV 160
           K+LG G FG   +A  K   +  AVK ++K+ ++    VE    E ++L ALAG H  + 
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL-ALAGKHPFLT 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDA---AVVVRQMLRVAAECHL 217
           + ++ F+  + ++  ME   GG+L+  I   +  R+ E  A   A  +   L+     H 
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQF---LHE 114

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            G+++RD+K +N L  S   +  +K  DFG+  + I  G       G+  Y+APE+L  +
Sbjct: 115 RGIIYRDLKLDNVLLDS---EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GP  D W++GV+ Y +L G+ PF    ED +F+ +L ++  + R     +S  AK  +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSIL 227

Query: 336 KKLLVKDPRARL----TAAQAL-SHPWVRE 360
           K  L K+P  RL    T  Q +  HP+ RE
Sbjct: 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  115 bits (290), Expect = 4e-29
 Identities = 87/267 (32%), Positives = 131/267 (49%), Gaps = 22/267 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE-KNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  Y A +K  G   A K IE K++  L    ED   E++IL A   H  +VK 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEIL-ATCNHPYIVKL 74

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
             AF  D  ++I +E C GG + D I+ + D   TE    V+ RQML      H   ++H
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL---KRKSG 278
           RD+K  N L      D  +K  DFG+S   +K  ++    +G+ Y++APEV+     K  
Sbjct: 134 RDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 279 P---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAKD 333
           P   ++D+WS+G+    +     P  +     +  ++ +++P    +P  W   S   +D
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW---SMEFRD 247

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVRE 360
           F+K  L K P  R +AAQ L HP+V  
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (288), Expect = 4e-29
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 47/230 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           T+GK LG G FG                 VAVK ++++       +E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NVVK      ++  +YI ME  EGG+LL  +   +          + +  +L  A +
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--------KLSLSDLLSFALQ 110

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     +HRD+   N L     E+  +K +DFGLS  +             YY
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YY 158

Query: 268 V-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK  K   +SDVWS GV+ + I   G +P+   +
Sbjct: 159 RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  116 bits (293), Expect = 5e-29
 Identities = 94/327 (28%), Positives = 136/327 (41%), Gaps = 85/327 (25%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------ 144
           DK   R+Y I + LG G +G  + A D+   + VA+KKI         A  +        
Sbjct: 2   DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTF 54

Query: 145 REVKILQALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           RE+  LQ L  H N+VK  N    E+D  +Y+  E                  Y E D  
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE------------------YMETDLH 96

Query: 203 VVVR--------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL 248
            V+R              Q+L+     H   ++HRD+KP N L  S   D  +K  DFGL
Sbjct: 97  AVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGL 153

Query: 249 SDFIKPGKKFQ------DIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF 300
           +  +   ++        D V + +Y APE+L    +     D+WS+G I   +L G+  F
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Query: 301 ----------------WDKTEDGI------FKE-VLRNKPDFRRKP----WPSISNSAKD 333
                              + + I      F   +L + P   RKP     P  S+ A D
Sbjct: 214 PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALD 273

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVRE 360
            +KKLLV +P  RLTA +AL HP+V +
Sbjct: 274 LLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 5e-29
 Identities = 83/299 (27%), Positives = 126/299 (42%), Gaps = 52/299 (17%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVKREVKILQA 152
           Y     +G G +G  Y A D   G  VA+KK+   ++ L     P++     RE+ +L+ 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLST---LREIALLKQ 54

Query: 153 L--AGHENVVKFYNAF---EDDNY--VYIAMELCEG--GELLDRILAKKDSRYTEKDAAV 203
           L    H N+V+  +       D    + +  E  +      L +         T KD   
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD--- 111

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           ++RQ+LR     H H +VHRD+KP+N L  S   D  +K  DFGL+           +V 
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLARIYSFEMALTSVVV 168

Query: 264 SAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IF-------- 309
           + +Y APEVL + S     D+WS+G I   L   RRP +  T +      IF        
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDKIFDVIGLPSE 227

Query: 310 ----KEVLRNKPDFRRKP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               + V   +  F            P I     D +KK+L  +P  R++A +AL HP+
Sbjct: 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  114 bits (288), Expect = 8e-29
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 32/269 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHE 157
           ++LG G +G  ++       D  ++   K+ K   I+  A   E  + E ++L+A+    
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ D  +++ ++   GGEL   +  ++   +TE +  V + ++  V A  HL
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEI--VLALDHL 121

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVL 273
           H  G+++RD+K EN L  S   +  +  TDFGLS      ++ +     G+  Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 274 KRKSGPESDV---WSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRRKP 323
           +  SG        WS+GV+T+ LL G  PF   T DG       I + +L++KP F    
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPF---TVDGEQNSQSEISRRILKSKPPFP--- 232

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQA 352
             ++S  A+DF++KLL KDP+ RL A  A
Sbjct: 233 -KTMSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  116 bits (292), Expect = 8e-29
 Identities = 85/317 (26%), Positives = 139/317 (43%), Gaps = 54/317 (17%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-AVEDVK---REVK 148
           +   RY     +G G +G    A D   G +VA+KK+ +     P  +    K   RE++
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-----PFQSAIHAKRTYRELR 66

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +L+ +  HENV+   + F      ED   VY+   L   G  L+ I+  K  + ++    
Sbjct: 67  LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIV--KCQKLSDDHIQ 121

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +V Q+LR     H  G++HRD+KP N    +  ED  LK  DFGL+       +    V
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLAR--HTDDEMTGYV 176

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR----------------------- 297
            + +Y APE++          D+WS+G I   LL G+                       
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236

Query: 298 RPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQAL 353
                K      +  +++ P   +K +  +    +  A D ++K+LV DP  R+TAA+AL
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 354 SHPWVREGGDASEIPID 370
           +HP++ E  D  + P+ 
Sbjct: 297 AHPYLAEYHDPEDEPVA 313

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  114 bits (288), Expect = 9e-29
 Identities = 89/294 (30%), Positives = 130/294 (44%), Gaps = 33/294 (11%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G  G       K  G   A+K I       P   + + RE++I ++      +VK+Y
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCK-SPYIVKYY 65

Query: 164 NAF--EDDNYVYIAMELCEGGELLDRI---LAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
            AF  E  + + IAME CEGG L D I   + K+  R  EK    +   +L+  +  H  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            ++HRD+KP N L         +K  DFG+S + +          G+++Y+APE ++ K 
Sbjct: 125 KIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179

Query: 278 -GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLR---NKPDFRRKPWPSI----S 328
               SDVWS+G+    +   R PF  +        E+L    N P+   K  P      S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
              KDF+K+ L KDP  R T    L HPW++    A           NM +FV 
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK----AQMKKK-----VNMAKFVA 284

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  115 bits (289), Expect = 1e-28
 Identities = 79/267 (29%), Positives = 131/267 (49%), Gaps = 17/267 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K +G   AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y  F+  + ++  ME   GG+L+  I  +K  R+ E  A     ++       H  G++
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K +N L      +   K  DFG+  + I  GK      G+  Y+APE+L+    GP
Sbjct: 119 YRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +    W  +S  A D +K  +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFM 231

Query: 340 VKDPRARLTA------AQALSHPWVRE 360
            K+P  RL +         L HP+ +E
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 35/279 (12%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-------LPIAVEDVKREVKILQAL 153
           G+L+G G +G  Y+A +   G+ +AVK++E    I           V+ ++ E++ L+ L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V++      + Y+ I +E   GG  +   L +   R+ E+       Q+L   A
Sbjct: 66  D-HLNIVQYLGFETTEEYLSIFLEYVPGGS-IGSCL-RTYGRFEEQLVRFFTEQVLEGLA 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV---------GS 264
             H  G++HRD+K +N L  +   D   K +DFG+S      KK  DI          GS
Sbjct: 123 YLHSKGILHRDLKADNLLVDA---DGICKISDFGIS------KKSDDIYDNDQNMSMQGS 173

Query: 265 AYYVAPEVLKRKSGPES---DVWSIGVITYILLCGRRPFWDKTE--DGIFK-EVLRNKPD 318
            +++APEV+   S   S   D+WS+G +   +  GRRP W   E    +FK    R+ P 
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPP 232

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  ++S  A DF+      +P  R TA + L HP+
Sbjct: 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 1e-28
 Identities = 92/293 (31%), Positives = 140/293 (47%), Gaps = 56/293 (19%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           +G G +G  Y A DK  G+ VA+KKI      L    E V     RE+ +L+ L  H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELN-HPNI 60

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRY-TEKDAAVV---VRQMLRVAAE 214
           V+  +    +N +Y+  E       LD  L K  DS   T  D  ++   + Q+L+  A 
Sbjct: 61  VRLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      + +LK  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 115 CHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 274 ---KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL-----------RN 315
              ++ S P  D+WSIG I +  +  RRP +  D   D +F+    L            +
Sbjct: 172 LGSRQYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 316 KPDF-------RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            PD+        R+      P++     D + K+LV DP  R++A  AL HP+
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  113 bits (284), Expect = 3e-28
 Identities = 79/269 (29%), Positives = 138/269 (51%), Gaps = 13/269 (4%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  + A D A G  VA+K+I   K       E +  E+ +++ 
Sbjct: 16  DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKE 72

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  + N+V F ++F   + +++ ME   GG L D +    ++   E   A V R+ L+  
Sbjct: 73  LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQAL 128

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++APE
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   +S  
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPI 244

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +DF+ + L  D   R +A + L HP+++
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  112 bits (282), Expect = 3e-28
 Identities = 73/266 (27%), Positives = 132/266 (49%), Gaps = 13/266 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I K +G G FG  Y+A  K++ +   +K+I+  KM  P+  ++  ++  IL A   H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V F+ +F+++  ++I ME C+GG+L+ RI  ++   ++E        Q+       H
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K+       K  DFG++  +    +     VG+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGM---VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-PSISNSAK 332
            R    ++D+WS+G + Y L   + PF    E     +++         P  P+ S   +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAPISPNFSRDLR 231

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
             + +L    PR R +    L  P++
Sbjct: 232 SLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  112 bits (282), Expect = 3e-28
 Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 46/230 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           T+GK LG G FG     T           VAVK ++++       +E+  RE +I++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS--EQQIEEFLREARIMRKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+VK      ++  + I ME   GG+LLD +   +    +       +  +L  A +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-------LSDLLSFALQ 111

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     +HRD+   N L     E+  +K +DFGLS  +             YY
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDD---------YY 159

Query: 268 V-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK  K   +SDVWS GV+ + I   G  P+   +
Sbjct: 160 KVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  113 bits (285), Expect = 4e-28
 Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 17/265 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  +I    V     E ++LQ    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+  + +   ME   GGEL   +   ++  ++E  A     +++      H   +V
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALGYLHSCDVV 117

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 118 YRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R     +S  AK  +  LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLL 230

Query: 340 VKDPRARL-----TAAQALSHPWVR 359
            KDP+ RL      A + + H +  
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  111 bits (280), Expect = 4e-28
 Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 19/264 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALA 154
           +Y + +++G G FG   +     +  + A+K+I      LP +   V+  R+  +L A  
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-----LPKSSSAVEDSRKEAVLLAKM 55

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V F  +FE D ++YI ME C+GG+L+ +I  ++   + E        QM      
Sbjct: 56  KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115

Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEV 272
            H   ++HRD+K +N FL ++ K    +K  DFG +  +  PG      VG+ YYV PE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNS 330
            +      +SD+WS+G I Y L   + PF    +   +K ++        KP PS  S  
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPSHYSYE 227

Query: 331 AKDFVKKLLVKDPRARLTAAQALS 354
            +  +K++  ++PR+R +A   LS
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 5e-28
 Identities = 86/301 (28%), Positives = 137/301 (45%), Gaps = 50/301 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+KK+ K++M+    V  V+ E  IL A A +  VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL-AEADNPWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D+NY+Y+ ME   GG+++  +L KKD+ +TE++    + + +      H  G +
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDT-FTEEETRFYIAETILAIDSIHKLGYI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL---------SDF------IKPGKKFQDI----- 261
           HRD+KP+N L  +      +K +DFGL         ++F        P      I     
Sbjct: 124 HRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 262 -------------------VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
                              VG+  Y+APEV  +     E D WS+GVI Y +L G  PF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 302 DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQA---LSHPWV 358
                  +++++  K   +      +S  AKD +K+L   +   RL         SHP+ 
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299

Query: 359 R 359
           +
Sbjct: 300 K 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  113 bits (284), Expect = 6e-28
 Identities = 87/316 (27%), Positives = 139/316 (43%), Gaps = 53/316 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQA 152
           RY + K LG G +G    A +   +  + VA+KKI    +K IL    +   RE+K+L+ 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL---AKRALRELKLLRH 57

Query: 153 LAGHENVVKFY---NAFEDD-NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
             GH+N+   Y     F  + N +Y+  EL E    L +I+ +     T+      + Q+
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQII-RSGQPLTDAHFQSFIYQI 114

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-----IVG 263
           L      H   ++HRD+KP N L  +   D  LK  DFGL+                 V 
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 264 SAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWD-----------------KT 304
           + +Y APE++          DVWS+G I   LL GR+P +                    
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230

Query: 305 EDGIFK-------EVLRNKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQAL 353
           E+ + +         +R+ P+  +KP+ SI    +  A D ++KLL  DP  R++  +AL
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 354 SHPWVREGGDASEIPI 369
            HP++    D  + P+
Sbjct: 291 EHPYLAIWHDPDDEPV 306

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  110 bits (277), Expect = 1e-27
 Identities = 74/275 (26%), Positives = 133/275 (48%), Gaps = 24/275 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + +L+G+G +G  Y       G   A+K ++    +     E++K+E+ +L+  + H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 158 NVVKFYNAFED------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           N+  +Y AF        D+ +++ ME C  G + D I   K +   E+  A + R++LR 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +  H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++AP
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 271 EVLKRKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKP 323
           EV+     P+      SD+WS+G+    +  G  P  D         + RN  P  + K 
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   + F++  LVK+   R T  Q + HP++
Sbjct: 241 W---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  111 bits (279), Expect = 2e-27
 Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 44/286 (15%)

Query: 107 GQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVKFYN 164
           G +G  Y A DK  G+ VA+KK+  EK K   PI      RE+ IL  L  H N+V    
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS---LREINILLKL-QHPNIVTVKE 71

Query: 165 AF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
                + + +Y+ ME  E  +L   ++      + + +   ++ Q+L   A  H + ++H
Sbjct: 72  VVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGP 279
           RD+K  N L  +      LK  DFGL+ ++  P K +  +V + +Y APE+L   ++   
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----LRNKPDF------------ 319
             D+WS+G I   LL  +  F  K+E    + IFK +     +  P F            
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246

Query: 320 -------RRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                  R+K P  S+S++  D + +LL  DP  R++A  AL HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 3e-27
 Identities = 87/318 (27%), Positives = 138/318 (43%), Gaps = 54/318 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKI 149
           D   RY     +G G +G    AT K  G +VA+KKI   E              RE+KI
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-----RTLREIKI 56

Query: 150 LQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L+    HEN++   +     +FE  N VYI  EL E    L +++  K    +       
Sbjct: 57  LRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLI--KTQHLSNDHIQYF 111

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP----GKKFQD 260
           + Q+LR     H   ++HRD+KP N L  +      LK  DFGL+    P         +
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTE 168

Query: 261 IVGSAYYVAPEV-LKRKSGPES-DVWSIGVITYILLCGRRPFWDK--------------- 303
            V + +Y APE+ L  K   ++ D+WS+G I   +L  R  F  K               
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228

Query: 304 -TEDGIF-------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQ 351
            +++ +        +  +++ P   + PW    P+    A D + K+L  +P  R+T  +
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288

Query: 352 ALSHPWVREGGDASEIPI 369
           AL+HP++ +  D S+ P+
Sbjct: 289 ALAHPYLEQYHDPSDEPV 306

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  110 bits (277), Expect = 4e-27
 Identities = 78/248 (31%), Positives = 124/248 (50%), Gaps = 12/248 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 118 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 230

Query: 340 VKDPRARL 347
            KDP+ RL
Sbjct: 231 KKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  110 bits (276), Expect = 5e-27
 Identities = 92/325 (28%), Positives = 134/325 (41%), Gaps = 73/325 (22%)

Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVK 144
           +F +  +  +   + K+ G G FG  + A  K     VA+KK+  E  K   PI      
Sbjct: 4   EFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---L 59

Query: 145 REVKILQALAGHENVVKF----------YNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
           RE+KILQ L  HENVV            YN ++     Y+  E CE    L  +L+ K+ 
Sbjct: 60  REIKILQLLK-HENVVNLIEICRTKATPYNRYKGS--FYLVFEFCEHD--LAGLLSNKNV 114

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIK 253
           ++T  +   V++ +L      H + ++HRDMK  N L     +D  LK  DFGL+  F  
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSL 171

Query: 254 P----GKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVI------------------ 289
                  ++ + V + +Y  PE+L  +R  GP  D+W  G I                  
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231

Query: 290 --TYIL-LCG-----------RRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSISNSAK 332
             T I  LCG           +   + K E       K   R KP  +          A 
Sbjct: 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK-------DPHAL 284

Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
           D + KLLV DP  R+ A  AL+H +
Sbjct: 285 DLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  109 bits (274), Expect = 6e-27
 Identities = 78/273 (28%), Positives = 137/273 (50%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA+K++           +  K+E+ I + 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--------QQPKKELIINEI 67

Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 124

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 125 LQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ER 240

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L HP+++
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  110 bits (275), Expect = 6e-27
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 19/288 (6%)

Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           GV+   +  D  Y  D +  +     +GHG FG  Y AT+    + VAVKK+  +     
Sbjct: 3   GVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN 62

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
              +D+ +EVK LQ L  H N +++   +  ++  ++ ME C G      +L        
Sbjct: 63  EKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQ 119

Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E + A +    L+  A  H H ++HRD+K  N L     E   +K  DFG +    P   
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSPANS 176

Query: 258 FQDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKE 311
           F   VG+ Y++APEV+    + +   + DVWS+G IT I L  R+P  F       ++  
Sbjct: 177 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 232

Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              + P  +   W   ++S + FV   L K P+ R  +A+ L H +VR
Sbjct: 233 AQNDSPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  109 bits (274), Expect = 7e-27
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 50/299 (16%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQ 151
           ++   + K+ G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+
Sbjct: 1   EKYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLK 55

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQML 209
            L  H N+V     F     +++  E C+   L  L++          +K    ++ Q L
Sbjct: 56  QLK-HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK----IIWQTL 110

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYV 268
           +    CH H  +HRD+KPEN L     +   +K  DFG +  +  PG  + D V + +Y 
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYR 167

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------GIF----KE 311
           APE+L    + GP  DVW+IG +   LL G +P W    D           G      ++
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226

Query: 312 VLRNKPDFR---------RKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           +      F+         R+P    +P+IS+ A  F+K  L  DP  RL+  + L HP+
Sbjct: 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  108 bits (272), Expect = 7e-27
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 20/269 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED----VKREVKILQA 152
           +Y   +++G G FG  ++   KA+   V +K+I   +M      +D     + E ++L+ 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-----TKDERLAAQNECQVLKL 55

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L+ H N++++Y  F +D  + I ME   GG L + I  + +S   E        Q+L   
Sbjct: 56  LS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H   ++HRD+K +N L    K    +K  DFG+S  +    K   +VG+  Y++PE+
Sbjct: 115 HHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--PDFRRKPWPSISN 329
            + K    +SD+W++G + Y L   +R F       +  +++     P   R      S 
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDR-----YSP 227

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             +  +  +L  DP  R   +Q ++ P  
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  109 bits (274), Expect = 1e-26
 Identities = 78/253 (30%), Positives = 130/253 (51%), Gaps = 21/253 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 114

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 115 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSL 226

Query: 335 VKKLLVKDPRARL 347
           +  LL KDP+ RL
Sbjct: 227 LSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  108 bits (271), Expect = 1e-26
 Identities = 84/264 (31%), Positives = 131/264 (49%), Gaps = 20/264 (7%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A +K  G   A K I+         +ED   E+ IL A   H N+VK  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNIVKLL 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + ++HR
Sbjct: 69  DAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL---KRKSGP 279
           D+K  N LF     D  +K  DFG+S    +  ++    +G+ Y++APEV+     K  P
Sbjct: 128 DLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 280 ---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAKDF 334
              ++DVWS+G+    +     P  +     +  ++ +++P    +P  W   S+  KDF
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSEFKDF 241

Query: 335 VKKLLVKDPRARLTAAQALSHPWV 358
           +KK L K+  AR T  Q L HP+V
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  109 bits (274), Expect = 1e-26
 Identities = 73/268 (27%), Positives = 131/268 (48%), Gaps = 18/268 (6%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K   +  A+K ++K+ ++    V+    E +IL   A H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+  + ++  ME   GG+L+ +I  ++  ++ E  +     ++       H HG++
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGP 279
           +RD+K +N L  +   +   K  DFG+  + I  G       G+  Y+APE+L+  + GP
Sbjct: 119 YRDLKLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y ++ G+ PF    ED +F+ +L +  D     W  +S  A   +K  +
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFM 231

Query: 340 VKDPRARL--TAAQALS-----HPWVRE 360
            K+P  RL   A+Q        HP+ +E
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  108 bits (270), Expect = 1e-26
 Identities = 82/276 (29%), Positives = 141/276 (51%), Gaps = 30/276 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------EVKILQ 151
           + +GKLLG G FG  Y+  D   G  +AVK+++ +    P + E  K       E+++L+
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD----PESPETSKEVNALECEIQLLK 59

Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
            L  HE +V++Y    D  +  + I ME   GG + D++  K     TE       RQ+L
Sbjct: 60  NLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQIL 116

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSA 265
              +  H + +VHRD+K  N L  S     ++K  DFG S  ++     G   + + G+ 
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRK 322
           Y+++PEV+  +  G ++D+WS+G  T + +   +P W + E    IFK  +  +P     
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGC-TVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVL 230

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           P P +S+  +DF+K++ V + + R +A + L H +V
Sbjct: 231 P-PHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  108 bits (270), Expect = 2e-26
 Identities = 84/292 (28%), Positives = 141/292 (48%), Gaps = 26/292 (8%)

Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           GK   F    D    + I + +G G +G  +   +K NG + AVK ++    I     E+
Sbjct: 5   GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEE 60

Query: 143 VKREVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRI--LAKKDSR 195
           ++ E  IL+AL+ H NVVKFY  +     ++ + +++ +ELC GG + D +    K+  R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
             E   A ++ + L      H++  +HRD+K  N L  +   +  +K  DFG+S  +   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 177

Query: 256 KKFQDI-VGSAYYVAPEVLKRKSGPES------DVWSIGVITYILLCGRRPFWDKTEDGI 308
           +  ++  VG+ +++APEV+  +   +S      DVWS+G+    L  G  P  D      
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237

Query: 309 FKEVLRNKPDFRRKP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             ++ RN P    +P  W   SN   DF++K L KD   R T +  L H ++
Sbjct: 238 LFKIPRNPPPTLHQPELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  107 bits (269), Expect = 2e-26
 Identities = 74/271 (27%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G+G +G  Y       G   A+K ++    +     E++K E+ +L+  + H N+  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 162 FYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +Y AF        D+ +++ ME C  G + D +   K +   E   A + R++LR  A  
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
           H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++APEV+ 
Sbjct: 138 HAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194

Query: 275 RKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKPWPSI 327
               P+      SD+WS+G+    +  G  P  D         + RN  P  + K W   
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW--- 251

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S    DF++  LVK+  +R +  Q L HP++
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  107 bits (269), Expect = 3e-26
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68

Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  109 bits (273), Expect = 4e-26
 Identities = 80/266 (30%), Positives = 122/266 (45%), Gaps = 40/266 (15%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------ 145
           +DFD      K++G G FG   +   K++    A+K + K +MI        KR      
Sbjct: 43  EDFDVI----KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--------KRSDSAFF 90

Query: 146 -EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAA 202
            E + + A A  E +V+ + AF+DD Y+Y+ ME   GG+L++ +     S Y   EK A 
Sbjct: 91  WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDIPEKWAR 145

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--- 259
               +++      H  G +HRD+KP+N L         LK  DFG    +K         
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTC--MKMDANGMVRC 200

Query: 260 -DIVGSAYYVAPEVLKRKS-----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
              VG+  Y++PEVLK +      G E D WS+GV  Y +L G  PF+  +  G + +++
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLL 339
            +K          IS  AKD +   L
Sbjct: 261 DHKNSLTFPDDIEISKQAKDLICAFL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  107 bits (267), Expect = 5e-26
 Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 30/280 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV--EDVKREVKILQALAG 155
           + I + +G G +G  Y  T+K +G   AVK ++      PI+   E+++ E  ILQ+L  
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD------PISDVDEEIEAEYNILQSLPN 77

Query: 156 HENVVKFYNAF-EDDNYV----YIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQM 208
           H NVVKFY  F + D  V    ++ +ELC GG + + +  L     R  E   + ++   
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-VGSAYY 267
           L      H + ++HRD+K  N L  +   +  +K  DFG+S  +   +  ++  VG+ ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 268 VAPEVLKRKSGPES------DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           +APEV+  +   +       DVWS+G+    L  G  P +D        ++ RN P    
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 322 KP--WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            P  W     S   F+ + L+KD  AR +    L HP+++
Sbjct: 255 HPEKW---CRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  107 bits (269), Expect = 8e-26
 Identities = 80/264 (30%), Positives = 128/264 (48%), Gaps = 21/264 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           + LG G FG   +AT K N D   VA+K+ EK+K+I    V+ V  E KIL  +  H   
Sbjct: 36  RTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFC 93

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V  Y +F+D++Y+Y+ +E   GGE       +++ R+          Q++ +        
Sbjct: 94  VNLYGSFKDESYLYLVLEFVIGGEFF--TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSG 278
           +V+RD+KPEN L     +D  +K TDFG +  +    +   + G+  Y+APE+ L    G
Sbjct: 152 IVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGHG 206

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
             +D W++G+  Y +L G  PF+      I++++L     F +     + N+ K  +KKL
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKL 262

Query: 339 LVKDPRARL-----TAAQALSHPW 357
           L  D   R       A     HPW
Sbjct: 263 LSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  106 bits (265), Expect = 8e-26
 Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 19/218 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIE-------KNKMILPIAVEDVKREVKI 149
           Y + + LG G FG  Y    K NG   +A+K+I        K+K     ++ D+  EV I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQ 207
           ++    H N+V++Y  F +++ +YI M+L EG  L +    L +K  R+TE+    +  Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 208 MLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           M  V A  +LH    +VHRD+ P N +     ED  +  TDFGL+   +P  K   +VG+
Sbjct: 122 M--VLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGT 176

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
             Y  PE++K +  G ++DVW+ G I Y +   + PF+
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  107 bits (267), Expect = 1e-25
 Identities = 77/255 (30%), Positives = 127/255 (49%), Gaps = 26/255 (10%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA+G   A+K ++K  +I    V     E ++L+    H  +  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+   +          V+A  +
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI---------VSALDY 110

Query: 217 LHG--LVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVL 273
           LH   +V+RD+K EN +     +D  +K TDFGL  + I      +   G+  Y+APEVL
Sbjct: 111 LHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           +    G   D W +GV+ Y ++CGR PF+++  + +F+ +L     F R    ++S  AK
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAK 223

Query: 333 DFVKKLLVKDPRARL 347
             +  LL+KDP  RL
Sbjct: 224 SLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  107 bits (268), Expect = 1e-25
 Identities = 91/320 (28%), Positives = 143/320 (44%), Gaps = 63/320 (19%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
           D +Y   K +G G +G    A +    ++VA+KKI     N++       D K   RE+K
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-------DAKRTLREIK 56

Query: 149 ILQALAGHENVVKF--------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           +L+ L  HENV+            AF D   VYI  EL +    L +I+ +     ++  
Sbjct: 57  LLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD--LHQII-RSSQTLSDDH 109

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ- 259
               + Q+LR     H   ++HRD+KP N L  +   +  LK  DFGL+        F  
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARTTSEKGDFMT 166

Query: 260 DIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFW---------------- 301
           + V + +Y APE+L   S      DVWS+G I   LL GR+P +                
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLKLITELL 225

Query: 302 ---DKTEDGIF-----KEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTA 349
               + + G       +  +R+ P   R+     +P  +  A D ++K+LV DP  R+T 
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285

Query: 350 AQALSHPWVREGGDASEIPI 369
            +AL+HP++    D S+ P+
Sbjct: 286 EEALAHPYLASLHDPSDEPV 305

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 48/231 (20%)

Query: 99  TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            +GK LG G FG     T     +    +VAVK +++         E+   E  I++ L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS--EEEREEFLEEASIMKKL- 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+          +YI  E   GG+LLD +    +         + ++ +L++A +
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--------LTLKDLLQMALQ 110

Query: 215 -----CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L     VHRD+   N L     E+  +K +DFGLS          DI    YY
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSR---------DIYEDDYY 158

Query: 268 V------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                        APE LK  K   +SDVWS GV+ + I   G +P+   +
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209

Length = 258

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  105 bits (263), Expect = 2e-25
 Identities = 85/300 (28%), Positives = 146/300 (48%), Gaps = 55/300 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D+   + +A+KKI   ++++ +   A+    RE+ +L+ +  H N+V
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI----REISLLKEMQ-HGNIV 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVV---VRQMLRVAAEC 215
           +  +    +  +Y+  E       LD  L K    S    K+  ++   + Q+LR  A C
Sbjct: 65  RLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL- 273
           H H ++HRD+KP+N L    +  ++LK  DFGL+  F  P + F   V + +Y APE+L 
Sbjct: 119 HSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFKEVLR--------------N 315
             +  S P  D+WS+G I +  +  ++P +  D   D +FK + R              +
Sbjct: 177 GSRHYSTP-VDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTS 233

Query: 316 KPDFRRK--PW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
            PD++     W         P++  +  D + K+L  DP  R+TA  AL H + ++ GDA
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293

Length = 294

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 4e-25
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 13/251 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN--VVK 161
           +G G FG  Y    K      A+K + K +++    V     E  IL      E+  +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+ D+ +Y+  +   GGEL   +  +K+ R++E  A   + +++      H + +V
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSG-- 278
           +RD+KPEN L  +      +   DFGLS   +   K      G+  Y+APEVL  + G  
Sbjct: 119 YRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D WS+GV+ + + CG  PF+ +    +++ +   K  F   P   +S+  + FVK L
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGL 232

Query: 339 LVKDPRARLTA 349
           L ++P+ RL A
Sbjct: 233 LNRNPQHRLGA 243

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  103 bits (259), Expect = 4e-25
 Identities = 85/275 (30%), Positives = 138/275 (50%), Gaps = 32/275 (11%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR------EVKILQALA 154
           GKLLG G FG  Y+  D   G  +A K+++ +    P + E  K       E+++L+ L 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFD----PESPETSKEVSALECEIQLLKNLQ 62

Query: 155 GHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
            HE +V++Y    D  +  + I ME   GG + D++  K     TE       RQ+L   
Sbjct: 63  -HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGM 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSAYYV 268
           +  H + +VHRD+K  N L  SA    ++K  DFG S  ++     G   + + G+ Y++
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWP 325
           +PEV+  +  G ++DVWS+G  T + +   +P W + E    IFK  +  +P       P
Sbjct: 177 SPEVISGEGYGRKADVWSLGC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPT--NPQLP 231

Query: 326 S-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           S IS  A+DF+  + V + R R +A + L HP+ +
Sbjct: 232 SHISEHARDFLGCIFV-EARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  105 bits (263), Expect = 4e-25
 Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 32/262 (12%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALAG 155
           K+LG G FG  ++    T    G   A+K ++K  +     V D    K E  IL A   
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL----KVRDRVRTKMERDIL-AEVN 56

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    + + L +A + 
Sbjct: 57  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-LALALD- 112

Query: 216 HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           HLH  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+  Y+APEV
Sbjct: 113 HLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169

Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSIS 328
           + R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F       +S
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-------LS 222

Query: 329 NSAKDFVKKLLVKDPRARLTAA 350
             A+  ++ L  ++P  RL A 
Sbjct: 223 PEAQSLLRALFKRNPANRLGAG 244

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  103 bits (259), Expect = 6e-25
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK-----REVKILQALAGHEN 158
           LG G +G  Y    +  G  +A+K+I        + +++ K      E+ IL        
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR-------LELDESKFNQIIMELDILHKAVSPY- 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILA------KKDSRYTEKDAAVVVRQMLRVA 212
           +V FY AF  +  VY+ ME  + G L D++ A              +    VV+ +  + 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
            E   H ++HRD+KP N L     +   +K  DFG+S + +    K    +G   Y+APE
Sbjct: 120 EE---HNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVASLAKTN--IGCQSYMAPE 171

Query: 272 VLKRKSGP--------ESDVWSIGVITYILLCGRRPFWDKTEDGIFKE---VLRNKPDFR 320
            +K   GP        +SDVWS+G+    +  GR P+  +T   IF +   ++   P   
Sbjct: 172 RIK-SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-- 228

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
             P    S+ A+DFV K L K P  R T AQ L HPW+ +  +A
Sbjct: 229 TLP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  104 bits (260), Expect = 8e-25
 Identities = 80/266 (30%), Positives = 129/266 (48%), Gaps = 20/266 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILA--KKD-SRYTEKDAAVVV-RQMLRVAAECHL 217
            Y  F+    ++  ME   GG+L+  I +  K D  R T   A ++   Q L      H 
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL------HS 114

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L  +   D  +K  DFG+  + +    K     G+  Y+APE+ L +
Sbjct: 115 KGIVYRDLKLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF    E+ +F+ +  + P + R  W  ++  AKD +
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDIL 227

Query: 336 KKLLVKDPRARL-TAAQALSHPWVRE 360
            KL V++P  RL        HP+ RE
Sbjct: 228 VKLFVREPERRLGVKGDIRQHPFFRE 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  103 bits (257), Expect = 8e-25
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 31/280 (11%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALA 154
           +  G+ LG G F   Y A D   G  +AVK++             VE +++E++++  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL- 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H ++++   A  +D++  + +E   GG +    L  K   + E        Q+LR  + 
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSV--SHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQ-DIVGSAYYVA 269
            H + ++HRD+K  N L  S  +   L+  DFG    L+       +FQ  ++G+  ++A
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEVLRNKPDFRRKP 323
           PEVL+ +  G   DVWS+G +   +   + P W+  +       IFK             
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTA------ 229

Query: 324 WPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            PSI    S   +D   + L   P  R  + + L HP  R
Sbjct: 230 -PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  102 bits (258), Expect = 8e-25
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 39/235 (16%)

Query: 102 KLLGHGQFG--YTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K LG G FG  Y      K      VAVK ++++        +D  +E ++++ L GH N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKL-GHPN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           VV+      ++  +Y+ +E  EGG+LLD +   +    + + + + ++ +L  A +    
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 216 --HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L     VHRD+   N L     ED  +K +DFGLS  +             YY    
Sbjct: 118 MEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDD---------YYRKKT 165

Query: 269 ---------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
                    APE LK      +SDVWS GV+ + I   G  P+   + + + + +
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 9e-25
 Identities = 82/272 (30%), Positives = 142/272 (52%), Gaps = 22/272 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAG 155
           + +GKLLG G FG  Y+  D   G  +AVK++  + +       V  ++ E+++L+ L  
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR- 62

Query: 156 HENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           H+ +V++Y    D  +  + I +E   GG + D++  K     TE       RQ+L+  +
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK----PGKKFQDIVGSAYYVA 269
             H + +VHRD+K  N L  SA    ++K  DFG S  I+     G   + + G+ Y+++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPS 326
           PEV+  +  G ++DVWS+   T + +   +P W + E    IFK  +  +P     P   
Sbjct: 178 PEVISGEGYGRKADVWSVAC-TVVEMLTEKPPWAEYEAMAAIFK--IATQPTKPMLP-DG 233

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           +S++ +DF+K++ V++ R R TA   L HP+V
Sbjct: 234 VSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  102 bits (257), Expect = 1e-24
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 56/293 (19%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           +G G +G  Y A +K  G+ VA+KKI      L    E V     RE+ +L+ L  H N+
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKEL-NHPNI 61

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVR----QMLRVAAE 214
           VK  +    +N +Y+  E       L + L K  D+         +++    Q+L+  A 
Sbjct: 62  VKLLDVIHTENKLYLVFEF------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-FIKPGKKFQDIVGSAYYVAPEVL 273
           CH H ++HRD+KP+N L      + ++K  DFGL+  F  P + +   V + +Y APE+L
Sbjct: 116 CHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 274 ---KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRN-------------- 315
              K  S    D+WS+G I   ++  R  F   +E D +F+ + R               
Sbjct: 173 LGCKYYSTA-VDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTS 230

Query: 316 ----KPDF---RRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               KP F    R+ +    P +    +D + ++L  DP  R++A  AL+HP+
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  103 bits (259), Expect = 1e-24
 Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 12/262 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K   +  A+K ++K+ ++    VE    E ++L     H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+   +++  ME   GG+L+  I +    R+ E  A     +++      H  G++
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+K +N L     +D  +K  DFG+    +    K     G+  Y+APE+LK +   E
Sbjct: 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           S D WS GV+ Y +L G+ PF  + ED +F  +L ++P F R  W  IS  AKD + KL 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLF 231

Query: 340 VKDPRARL-TAAQALSHPWVRE 360
            +DP  RL        HP+ R 
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRG 253

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  102 bits (257), Expect = 2e-24
 Identities = 88/275 (32%), Positives = 135/275 (49%), Gaps = 33/275 (12%)

Query: 102 KLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIAVED--VKREVKILQALAGHE 157
           K+LG G +G  +       A+  ++   K+ K   I+    +    K E  IL+A+  H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V    AF+    +Y+ +E   GGEL   +  +++  + E  A   + ++  +A E HL
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEIS-LALE-HL 116

Query: 218 H--GLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G+++RD+KPEN L  +      +K TDFGL  + I  G       G+  Y+APE+L 
Sbjct: 117 HQQGIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           R   G   D WS+G + Y +L G  PF      KT D I K  L N P       P ++ 
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLP-------PYLTP 225

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQALSHPWVR 359
            A+D +KKLL ++P +RL      AA+  SHP+ R
Sbjct: 226 EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  101 bits (252), Expect = 4e-24
 Identities = 74/270 (27%), Positives = 136/270 (50%), Gaps = 22/270 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   K +G G FG   +   K +G +  +K+I  +KM  P   E+ ++EV +L  +  H
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-H 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V++  +FE++  +YI M+ CEGG+L  +I A++   + E        Q+       H
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K    D ++K  DFG++  +    +  +  +G+ YY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTK----DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE-VLRNKPDFRRKPWPSI----S 328
            R    +SD+W++G + Y +   +  F    E G  K  VL+      R  +P +    S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAF----EAGNMKNLVLK----IIRGSYPPVSSHYS 226

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
              ++ V +L  ++PR R +    L   ++
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  101 bits (254), Expect = 4e-24
 Identities = 77/290 (26%), Positives = 139/290 (47%), Gaps = 50/290 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  + A ++   + VA+K++   + ++ +   A+    RE+ +L+ L  H+N+V
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELK-HKNIV 62

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECH 216
           + Y+    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+  A CH
Sbjct: 63  RLYDVLHSDKKLTLVFEYC------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
            H ++HRD+KP+N L     ++  LK  DFGL+  F  P + +   V + +Y  P+VL  
Sbjct: 117 SHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 276 KSGPES--DVWSIGVITYILLCGRRPFWDKTE-----DGIFKEV----------LRNKPD 318
                +  D+WS G I   L    RP +   +       IF+ +          +   PD
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233

Query: 319 FRRKP-------W----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           ++  P            P ++++ +D ++ LLV +P  R++A +AL HP+
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  101 bits (253), Expect = 4e-24
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 54/292 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G +   Y   ++  G+ VA+K+I    E+      I      RE+ +++ L  HEN+
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI------REISLMKELK-HENI 60

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK---DAAVV---VRQMLRVAA 213
           V+ ++    +N + +  E  +        L K    +  +   D   V     Q+L+  A
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKD------LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH + ++HRD+KP+N L         LK  DFGL+  F  P   F + V + +Y AP+V
Sbjct: 115 FCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV 171

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------------- 314
           L   R      D+WS+G I   ++ GR  F     +    ++ R                
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231

Query: 315 --NKPDFRRKP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              KP F R P       +P       D + +LL  +P  R++A  AL HPW
Sbjct: 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  101 bits (253), Expect = 6e-24
 Identities = 84/309 (27%), Positives = 145/309 (46%), Gaps = 22/309 (7%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           + +D ++ +T  + +GHG FG  Y A D    + VA+KK+  +        +D+ +EVK 
Sbjct: 19  FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ +  H N +++   +  ++  ++ ME C G      +L        E + A +    L
Sbjct: 79  LQRIK-HPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGAL 135

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +    P   F   VG+ Y++A
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPANSF---VGTPYWMA 189

Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV-REGGDASEIPIDISVLNNMRQF-- 380
           W   S+  ++FV   L K P+ R T+ + L H +V RE  +   I +     + +R+   
Sbjct: 249 W---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDN 305

Query: 381 VKYSRLKQF 389
           ++Y ++K+ 
Sbjct: 306 LQYRKMKKL 314

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  102 bits (256), Expect = 6e-24
 Identities = 91/328 (27%), Positives = 138/328 (42%), Gaps = 76/328 (23%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVK--ILQA 152
           +RY   K +G G  G    A D   G  VA+KK+ +     P   V   KR  +  +L  
Sbjct: 16  KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSR-----PFQNVTHAKRAYRELVLMK 70

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVV 204
           L  H+N++   N F      E+   VY+ MEL +    +++   L  +   Y       +
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-------L 123

Query: 205 VRQMLRVAAEC---HLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           + QML     C   HLH  G++HRD+KP N + KS   D +LK  DFGL+          
Sbjct: 124 LYQML-----CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMT 175

Query: 260 DIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDK------T 304
             V + YY APEV+      E+ D+WS+G I   ++ G   F        W+K      T
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235

Query: 305 EDGIFKEVL--------RNKPDFRRKPWPSI-----------------SNSAKDFVKKLL 339
               F   L         N+P +    +  +                 ++ A+D + K+L
Sbjct: 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295

Query: 340 VKDPRARLTAAQALSHPWVREGGDASEI 367
           V DP  R++   AL HP++    D SE+
Sbjct: 296 VIDPEKRISVDDALQHPYINVWYDPSEV 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  102 bits (256), Expect = 8e-24
 Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 55/306 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +          A+K + K  +++      VK E  IL A A +E VVK
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL-AEADNEWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++   L  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMS--LLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL---------SDFIKPGKKF-QD----------- 260
           HRD+KP+N L      D  +K TDFGL         S + + G    QD           
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180

Query: 261 -----------------------IVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCG 296
                                  +VG+  Y+APEVL R    +  D WS+GVI Y +L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQAL 353
           + PF   T      +V+  +          +S  A D + + L      RL    A +  
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIK 299

Query: 354 SHPWVR 359
           +HP+ +
Sbjct: 300 AHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  101 bits (252), Expect = 8e-24
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 43/291 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A DK  G  VA+KK       + I P A+    RE+ +LQ L+    +V
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIYIV 64

Query: 161 KFYNA--FEDDN---YVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           +  +    E+ N    +Y+  E  +    + +D            K     + Q+L+  A
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH HG++HRD+KP+N L    K    LK  D GL   F  P K +   + + +Y APEV
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV-------------L 313
           L          D+WS+G I   +   +  F   +E      IFK +             L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242

Query: 314 RN-------KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           R+       KP    +  P +S    D ++K+L  DP  R++A  AL+HP+
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  100 bits (252), Expect = 9e-24
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 42/290 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  Y A D  +G+ VA+KK+  +  +  +PI+     RE+ +L  L  H N+V+
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLR-HPNIVE 70

Query: 162 FYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
                     + +++ ME CE  + L  +L    + ++E     ++ Q+LR     H + 
Sbjct: 71  LKEVVVGKHLDSIFLVMEYCE--QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRK 276
           ++HRD+K  N L         LK  DFGL+  +  P K     V + +Y APE+L     
Sbjct: 129 IIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTE---------------DGIF----------KE 311
                D+W++G I   LL  +     K+E               + I+          K 
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245

Query: 312 VLRNKP-DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            L  +P +  +  +P +S +    +  LL+ DP+ R TA +AL   + +E
Sbjct: 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 78/275 (28%), Positives = 127/275 (46%), Gaps = 19/275 (6%)

Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +  +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           V+ LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V  
Sbjct: 66  VRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTH 122

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
             L+  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPY 176

Query: 267 YVAPEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFR 320
           ++APEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
              W   S   ++FV   L K P+ R T+   L H
Sbjct: 236 SGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 74/263 (28%), Positives = 136/263 (51%), Gaps = 30/263 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHE 157
           K+LG G +G  ++    +  D  ++   K+ K   I+  A   E  + E ++L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ D  +++ ++   GGEL   +  ++  R+ E++  +   +++      H 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPG-KKFQDIVGSAYYVAPEVLKR 275
            G+++RD+K EN L  S   +  +  TDFGLS +F +   ++     G+  Y+AP++++ 
Sbjct: 124 LGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 276 KSGPES---DVWSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRRKPWP 325
             G      D WS+GV+ Y LL G  PF   T DG       I + +L+++P     P+P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKNSQAEISRRILKSEP-----PYP 232

Query: 326 S-ISNSAKDFVKKLLVKDPRARL 347
             +S  AKD +++LL+KDP+ RL
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 14/266 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K LG G +G  Y     ++    A+K+++   M      ED   E++IL A   H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRIL-ASVNH 58

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
            N++ +  AF D N + I ME    G+L   I  +K  R    E++   +  Q+LR    
Sbjct: 59  PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   ++HRD+K  N +   A +   +K  D G+S  +K       I G+ +Y+APEV K
Sbjct: 119 LHEQKILHRDLKSAN-ILLVANDL--VKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK 174

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI-SNSAK 332
            +    +SD+WS+G + Y +     PF  ++   +  +V R K      P P I S   +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP----PIPPIYSQDLQ 230

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           +F++ +L   P+ R    + L+ P V
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  100 bits (249), Expect = 3e-23
 Identities = 74/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K + +R+   KI     +L  A     RE + +      +
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+NY+Y+ M+   GG+LL  +L+K + R  E  A   + +M+      H 
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 121 LHYVHRDIKPDNVLLDM---NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHIT 234

Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 235 DVSEEAKDLIQRLICSRER 253

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 71/248 (28%), Positives = 122/248 (49%), Gaps = 11/248 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG   +A  K  G+  AVK ++K+ +++   VE    E ++L     +  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y  F+   +++  ME   GG+L+  I  K   R+    A     +++      H  G++
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGP 279
           +RD+K +N +      D  +K  DFG+  + +    +     G+  Y+APE+L+  K   
Sbjct: 119 YRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D WS GV+ Y +L G+ PF    ED +F+ +  + P + R  W  I+  +KD ++KL 
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLF 231

Query: 340 VKDPRARL 347
            +DP  RL
Sbjct: 232 ERDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 99.8 bits (248), Expect = 4e-23
 Identities = 75/254 (29%), Positives = 126/254 (49%), Gaps = 20/254 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N D+V   KI     +L  A     RE + +     ++
Sbjct: 3   FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N +Y+ M+   GG+LL  +L+K + R  E  A   + +M+      H 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVL-- 273
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L  
Sbjct: 121 LHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 274 ----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
               K K GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+   +P+   
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVT 234

Query: 327 -ISNSAKDFVKKLL 339
            +S  AKD +++L+
Sbjct: 235 DVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 99.6 bits (248), Expect = 5e-23
 Identities = 75/276 (27%), Positives = 136/276 (49%), Gaps = 28/276 (10%)

Query: 102 KLLGHGQFGYTYV---ATDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           K+LG G +G  ++    T    G   A+K ++K  ++     VE  + E  +L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ +  +++ ++   GGE+   +  + +  ++E +      +++      H 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHK 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGK-KFQDIVGSAYYVAPEVLKR 275
            G+V+RD+K EN L  S   +  +  TDFGLS +F+   K +     G+  Y+APE+++ 
Sbjct: 124 LGIVYRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 276 KSG--PESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPWPS-IS 328
           K G     D WS+G++ + LL G  PF       T+  + + +L+  P     P+PS I 
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-----PFPSFIG 235

Query: 329 NSAKDFVKKLLVKDPRARLTAA-----QALSHPWVR 359
             A+D + KLL KDP+ RL A      +   HP+ +
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 13/270 (4%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R+Y   ++LG G FG       +A G   A K++EK ++           E +IL+ +  
Sbjct: 3   RQY---RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-N 58

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
            + VV    A+E  + + + + +  GG+L   I    +  + E+ A     ++L    + 
Sbjct: 59  SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK- 274
           H    V+RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEVL  
Sbjct: 119 HRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN 175

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           ++     D W +G + Y ++ G+ PF  + E    +EV R   +         S  AK  
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI 235

Query: 335 VKKLLVKDPRARL-----TAAQALSHPWVR 359
            K LL KDP+ RL      A +   HP+ R
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 67/252 (26%), Positives = 121/252 (48%), Gaps = 14/252 (5%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AGHENVVK 161
           LG G FG   +A  K  G+  A+K ++K  +I    VE +  E +I +      H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+ +++V   ME   GG+L+  I       ++E  A      ++      H + +V
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAACVVLGLQYLHENKIV 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+K +N L  +   +  +K  DFGL  + +  G +     G+  ++APEVL   S   
Sbjct: 124 YRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +GV+ Y +L G  PF    E+ +F  ++ ++  + R     +S  A   +++LL
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLL 236

Query: 340 VKDPRARLTAAQ 351
            ++P  RL + +
Sbjct: 237 RRNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 22/277 (7%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF+    I K++G G FG   V   K  G   A+K + K +M L  A     RE + +  
Sbjct: 2   DFE----ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLV 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 +   + AF+D+N +Y+ M+   GG+LL  +L+K + R  E  A   + +M+   
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAP 270
              H  G VHRD+KP+N L     ++  ++  DFG    +      Q    VG+  Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172

Query: 271 EVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           E+L      K + GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+  P 
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232

Query: 325 -PSISNSAKDFVKKLLVKDPRARL---TAAQALSHPW 357
              +S  AKD +++L+   P  RL          HP+
Sbjct: 233 VTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 99.3 bits (247), Expect = 9e-23
 Identities = 81/264 (30%), Positives = 124/264 (46%), Gaps = 29/264 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-------EVKIL 150
           Y + K++G G FG   +   K+     A+K + K +MI        KR       E + +
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--------KRSDSAFFWEERDI 96

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A A    VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++ 
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD--VPEKWARFYTAEVVL 153

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYV 268
                H  G +HRD+KP+N L   +     LK  DFG      K G    D  VG+  Y+
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210

Query: 269 APEVLKRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           +PEVLK + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K       
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270

Query: 324 WPSISNSAKDFVKKLLVKDPRARL 347
              IS  AK+ +   L  D   RL
Sbjct: 271 DNDISKEAKNLICAFLT-DREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 89/311 (28%), Positives = 133/311 (42%), Gaps = 53/311 (17%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            RYT  K +G G +G    A DK  G++VA+KK+ +      I  +   RE+ +L+ +  
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQ- 72

Query: 156 HENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           HENV+            + F+D    Y+ M   +    L +I+       +E     +V 
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQD---FYLVMPYMQTD--LQKIMGHP---LSEDKVQYLVY 124

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 179

Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239

Query: 302 DKTEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K ED   K  +++ P + RK     +P  S  A D ++K+L  D   RLTA +AL HP+
Sbjct: 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 358 VREGGDASEIP 368
                DA E  
Sbjct: 300 FDSFRDADEET 310

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 98.6 bits (245), Expect = 1e-22
 Identities = 90/326 (27%), Positives = 143/326 (43%), Gaps = 55/326 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K  M+    V  ++ E  IL    G   VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+D   +Y+ ME   GG+++  +L KKD+   E     +   +L + A  H  G +
Sbjct: 66  MFYSFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEATQFYIAETVLAIDA-IHQLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----------------FQDI---- 261
           HRD+KP+N L  +      +K +DFGL   +K   +                FQ++    
Sbjct: 124 HRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 262 ----------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKT 304
                           VG+  Y+APEV  +    +  D WS+GVI Y +L G  PF  +T
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREG 361
               +++V+  K      P   IS  AKD + +    D   R+ +    +  SHP+  EG
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF-EG 298

Query: 362 GD-------ASEIPIDISVLNNMRQF 380
            D        + IPI+I  +++   F
Sbjct: 299 VDWGHIRERPAAIPIEIKSIDDTSNF 324

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 94/317 (29%), Positives = 140/317 (44%), Gaps = 52/317 (16%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   + +G G +G    A D  +G +VA+KKI     +  +A   + RE+KIL+ 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRH 60

Query: 153 LAGHENVVKFYNAF----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
              H+N++   +       D   VY+ M+L E    L  I+   D   TE+     + Q+
Sbjct: 61  FK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHII-HSDQPLTEEHIRYFLYQL 116

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFIKPGKKFQ-DIVG 263
           LR     H   ++HRD+KP N L     ED  L+  DFG    LS      K F  + V 
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 264 SAYYVAPEVLKRKSGPES----DVWSIGVITYILLCGRRP-FWDKT-------------- 304
           + +Y APE+L   S PE     D+WS+G I   +L GRR  F  K               
Sbjct: 174 TRWYRAPELL--LSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGS 230

Query: 305 -EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQ 351
             + +   +        ++N P  +  PW    P  S  A D + ++L  DP  R+T  Q
Sbjct: 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290

Query: 352 ALSHPWVREGGDASEIP 368
           AL HP++ +  D  + P
Sbjct: 291 ALQHPFLAQYHDPDDEP 307

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 65/299 (21%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENV 159
           L+G G +G       K  G  VA+KK    E +KM+  IA+    RE+++L+ L  HEN+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLR-HENL 62

Query: 160 V----------KFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           V          + Y  FE  D+ V   +E    G  LD    +K            + Q+
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRK-----------YLFQI 109

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYY 267
           LR    CH H ++HRD+KPEN L   +     +K  DFG +  +  PG+ + D V + +Y
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYTDYVATRWY 166

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVL-------RNKP 317
            APE+L    K G   D+W++G +   +L G   F  D   D ++  +        R++ 
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226

Query: 318 DFRRKP-------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            F++ P                   +P +S    D  K+ L  DP  R +++Q L H +
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 74/272 (27%), Positives = 130/272 (47%), Gaps = 22/272 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  Y   D    + VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 + ++Y ++     ++I ME   GG  LD +   K     E   A ++R++L+  
Sbjct: 59  -CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+K+ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQ 224

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S   K+FV+  L KDPR R TA + L H ++
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 77/262 (29%), Positives = 120/262 (45%), Gaps = 10/262 (3%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       KA G   A KK++K ++      +    E KIL        +V   
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            AFE  + + + M L  GG+L   I    +  + E  A     Q++      H   +V+R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES-D 282
           D+KPEN L     +  +++ +D GL+  +K GKK +   G+  Y+APEVL+ +    S D
Sbjct: 120 DLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
            +++G   Y ++ GR PF  + E    +E+ R   +   +     S  AKD  + LL KD
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 343 PRARL-----TAAQALSHPWVR 359
           P  RL     +A +   HP  +
Sbjct: 237 PEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 76/289 (26%), Positives = 133/289 (46%), Gaps = 37/289 (12%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
             ++ YD++ +R      +LG G +G  Y A D +   R+A+K+I +        V+ + 
Sbjct: 2   EYEYEYDENGER-----VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLH 53

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E+ +   L  H N+V++  +  ++ +  I ME   GG L   +L  K     + +  ++
Sbjct: 54  EEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTII 111

Query: 205 --VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQ 259
              +Q+L      H + +VHRD+K +N L  +      +K +DFG S     I P    +
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINPCT--E 167

Query: 260 DIVGSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTED-------GIF 309
              G+  Y+APEV+    R  G  +D+WS+G     +  G+ PF +  E        G+F
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227

Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           K +    P+       S+S  AK+F+ +    DP  R +A   L  P++
Sbjct: 228 K-IHPEIPE-------SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 89/312 (28%), Positives = 135/312 (43%), Gaps = 58/312 (18%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   + LG G  G  + A D     RVAVKKI    +  P +V+   RE+KI++ 
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRR 58

Query: 153 LAGHENVVKFYNAFEDDNY--------------VYIAMELCEGGELLDRILAKKDSRYTE 198
           L  H+N+VK Y                      VYI  E  E    L  +L  +    +E
Sbjct: 59  LD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVL--EQGPLSE 113

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---- 254
           + A + + Q+LR     H   ++HRD+KP N    +  ED  LK  DFGL+  + P    
Sbjct: 114 EHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPHYSH 171

Query: 255 -GKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE------ 305
            G   + +V + +Y +P +L          D+W+ G I   +L G+  F    E      
Sbjct: 172 KGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Query: 306 --DGI-------FKEVLRNKPDF-------RRKPW----PSISNSAKDFVKKLLVKDPRA 345
             + +         E+L   P F        R+P     P ++  A DF++++L  +P  
Sbjct: 231 ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290

Query: 346 RLTAAQALSHPW 357
           RLTA +AL HP+
Sbjct: 291 RLTAEEALMHPY 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 96.6 bits (240), Expect = 5e-22
 Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I+         G+  Y+APEVL ++    
Sbjct: 119 YRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L NKP  + K  P+I+NSA+  ++ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKP-LQLK--PNITNSARHLLEGLL 231

Query: 340 VKDPRARLTA 349
            KD   RL A
Sbjct: 232 QKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 96.4 bits (240), Expect = 5e-22
 Identities = 90/315 (28%), Positives = 136/315 (43%), Gaps = 55/315 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I +++G G +G    A D   G++VA+KKI      +  A   + RE+K+L+ L  H
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLR-H 58

Query: 157 ENVVKFY--------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
            ++V+            F+D   +Y+  EL E  +L   I A  D   T +     + Q+
Sbjct: 59  PDIVEIKHIMLPPSRREFKD---IYVVFELME-SDLHQVIKANDD--LTPEHHQFFLYQL 112

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---KPGKKF-QDIVGS 264
           LR     H   + HRD+KP+N L   A  D  LK  DFGL+       P   F  D V +
Sbjct: 113 LRALKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 265 AYYVAPEV---LKRKSGPESDVWSIGVITYILLCGRRPFWDK------------------ 303
            +Y APE+      K  P  D+WSIG I   +L G+  F  K                  
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Query: 304 -TEDGI-------FKEVLRNKP--DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            T   +       +   +R K    F +K +P+    A   +++LL  DP+ R TA +AL
Sbjct: 230 ETISRVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Query: 354 SHPWVREGGDASEIP 368
           + P+ +        P
Sbjct: 289 ADPYFKGLAKVEREP 303

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 46/292 (15%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDV 143
           Y  D +    +G  +G G  G  Y    K  G  +AVK++      E+NK IL       
Sbjct: 10  YPADLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL------- 61

Query: 144 KREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL----CEGGELLDRILAKKDSRYTEK 199
             ++ ++        +VK Y  F  D+ V+I MEL     +  +LL RI          K
Sbjct: 62  -MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLD--KLLKRIQGPIPEDILGK 118

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
               +V+ +  +  +   HG++HRD+KP N L        ++K  DFG+S  +   K   
Sbjct: 119 MTVAIVKALHYLKEK---HGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVDSKAKT 172

Query: 260 DIVGSAYYVAPEVLK-RKSGPE----SDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVL 313
              G A Y+APE +      P+    +DVWS+G+    L  G+ P+ + KTE  +  ++L
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 314 RNKPDFRRKPWPSISNSA------KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           + +P       PS+  +         FV   L KD R R    + L HP++R
Sbjct: 233 QEEP-------PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 96.2 bits (239), Expect = 9e-22
 Identities = 80/264 (30%), Positives = 126/264 (47%), Gaps = 29/264 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR-------EVKIL 150
           Y + K++G G FG   +   K++    A+K + K +MI        KR       E + +
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI--------KRSDSAFFWEERDI 96

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A A    VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++ 
Sbjct: 97  MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD--VPEKWAKFYTAEVVL 153

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYV 268
                H  GL+HRD+KP+N L     +   LK  DFG      + G    D  VG+  Y+
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210

Query: 269 APEVLKRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           +PEVLK + G      E D WS+GV  + +L G  PF+  +  G + +++ +K       
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270

Query: 324 WPSISNSAKDFVKKLLVKDPRARL 347
              IS  AK+ +   L  D   RL
Sbjct: 271 DVEISKHAKNLICAFLT-DREVRL 293

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 13/271 (4%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R+Y   ++LG G FG       +A G   A KK+EK ++           E +IL+ +  
Sbjct: 3   RQY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-N 58

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
              VV    A+E  + + + + L  GG+L   I    ++ + E  A     ++     + 
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H   +V+RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K 
Sbjct: 119 HQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 276 KSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           +    S D W++G + Y ++ G+ PF  + +    +EV R   + + +     S  A+  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 335 VKKLLVKDPRARL-----TAAQALSHPWVRE 360
            K LL KDP+ RL      A +   HP  ++
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 32/282 (11%)

Query: 93  DFDRR-----YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  RR     + + + +G G +G  Y A +   G+  A+K I+    + P     V ++ 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQE 56

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            I+     H N+V ++ ++   + ++I ME C GG L D  +       +E   A V R+
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRE 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAY 266
            L+     H  G +HRD+K  N L     ++  +K  DFG+S  I     K +  +G+ Y
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171

Query: 267 YVAPEV--LKRKSGPES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFR- 320
           ++APEV  ++RK G     D+W++G+    L   + P +D      +F   L  K +F+ 
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP 228

Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                +  W   SNS   FVK  L K+P+ R TA + L HP+
Sbjct: 229 PKLKDKMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 85/314 (27%), Positives = 119/314 (37%), Gaps = 63/314 (20%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQ 151
           R Y I   LG G FG  Y A     G  VA+KKI    EK+    PI      RE+KIL+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL---REIKILK 62

Query: 152 ALAGHENVVKFYNAF--------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            L  H NVV   +               VY+     +    L  +L     + TE     
Sbjct: 63  KLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD--LSGLLENPSVKLTESQIKC 119

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-----KPGK-- 256
            + Q+L      H + ++HRD+K  N L  +      LK  DFGL+         P    
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDN---QGILKIADFGLARPYDGPPPNPKGGG 176

Query: 257 -----KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE---- 305
                K+ ++V + +Y  PE+L  +R+     D+W IG +   +   R     K++    
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 306 DGIFK-------------EVLRNKPDFR-RKPWPSI--SNSAK------DFVKKLLVKDP 343
             IFK               L           +P        K      D + KLL  DP
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 344 RARLTAAQALSHPW 357
             RLTA+ AL HP+
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 36/279 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--------REVK 148
           RY + + LG G FG  Y+  DK           E+ K++  I V ++         +E +
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQ 54

Query: 149 ILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVV 205
           +L  L  H  +VKF+ +F E D +  I  E CEG +L  ++  L       +E       
Sbjct: 55  LLSKLD-HPAIVKFHASFLERDAFCIIT-EYCEGRDLDCKLEELKHTGKTLSENQVCEWF 112

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGS 264
            Q+L      H   ++HRD+K +N   K    ++ LK  DFG+S  +           G+
Sbjct: 113 IQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGT 168

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE LK +    +SD+WS+G I Y + C    F  +    +   ++         P
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG-------P 221

Query: 324 WPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            PS+    S      ++ +L KDP  R +AA+ L +P++
Sbjct: 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 69/249 (27%), Positives = 123/249 (49%), Gaps = 13/249 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VV 160
            +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L AL G    + 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVL-ALPGKPPFLT 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPE-VLKRKSG 278
           ++RD+K +N +  +   +  +K  DFG+  + I  GK  +   G+  Y+APE +  +  G
Sbjct: 123 IYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGL 235

Query: 339 LVKDPRARL 347
           L K P  RL
Sbjct: 236 LTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 87/327 (26%), Positives = 142/327 (43%), Gaps = 51/327 (15%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K  M+    V  ++ E  IL   A    VVK
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEADSLWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+D   +Y+ ME   GG+++  +L KKD+  TE++    + + +      H  G +
Sbjct: 66  MFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDT-LTEEETQFYIAETVLAIDSIHQLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----------------FQDI---- 261
           HRD+KP+N L  S      +K +DFGL   +K   +                FQ++    
Sbjct: 124 HRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 262 ----------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKT 304
                           VG+  Y+APEV  +    +  D WS+GVI Y +L G  PF  +T
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK-DPRARLTAAQALSHPWVREGGD 363
               +K+V+  K      P   IS  AKD + +   + + R      + +      EG D
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300

Query: 364 -------ASEIPIDISVLNNMRQFVKY 383
                   + IPI+I  +++   F ++
Sbjct: 301 WEHIRERPAAIPIEIKSIDDTSNFDEF 327

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 80/298 (26%), Positives = 131/298 (43%), Gaps = 65/298 (21%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILP-IAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y   +K  G  VA+KKI  E  +  +P  A+    RE+ +L+ L  H N+V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI----REISLLKELQ-HPNIV 62

Query: 161 KFYNAFEDDNYVYIAMELCE-----------GGELLDRILAKKDSRYTEKDAAVVVRQML 209
              +    ++ +Y+  E               G+ +D  L K    Y          Q+L
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS---YL--------YQIL 111

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +    CH   ++HRD+KP+N L  +      +K  DFGL+  F  P + +   V + +Y 
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDN---KGVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168

Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK------------- 310
           APEVL    R S P  D+WSIG I +  +  ++P +  D   D +F+             
Sbjct: 169 APEVLLGSPRYSTP-VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 311 ---EVLRN--------KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                L +        K    R    ++     D ++K+L+ DP  R++A +AL+HP+
Sbjct: 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.7 bits (230), Expect = 3e-21
 Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 47/286 (16%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALA 154
           +T G++LG G +G  Y       G  +AVK++E    N +      E ++ EV +L++L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGG---ELLDRILAKKD---SRYTEKDAAVVVRQM 208
            H N+V++     DDN + I ME   GG    +L+R     +    +YT        +Q+
Sbjct: 61  -HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT--------KQI 111

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDI 261
           L   A  H + +VHRD+K  N +      +  +K  DFG +  +             + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 262 VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF- 319
            G+ Y++APEV+     G +SD+WSIG   + +  G+ P            + R    F 
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL---------ASMDRLAAMFY 219

Query: 320 ---RRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               R   P +    S +A DFV   L +D   R +A Q L H ++
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +G GQF   Y AT   +   VA+KK++  +M+   A +D  +E+ +L+ L  H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           NV+K+ ++F +DN + I +EL + G+L   I    K+     E+       Q+       
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAYYVAPEVLK 274
           H   ++HRD+KP N    +      +K  D GL  F          +VG+ YY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW 301
                 +SD+WS+G + Y +   + PF+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 55/305 (18%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQALA 154
           + I   +G G +G  Y A DK  G+ VA+KK+  +  K   PI A+    RE+KIL+ L 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI----REIKILRQLN 64

Query: 155 GHENVVKFYNAFEDDNYV----------YIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            H N+V       D              Y+  E  +    L  +L      ++E      
Sbjct: 65  -HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD--LMGLLESGLVHFSEDHIKSF 121

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--FQDIV 262
           ++Q+L     CH    +HRD+K  N L  +  +   +K  DFGL+      +   + + V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKV 178

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF-------------------- 300
            + +Y  PE+L  + + GP  DVWS G I   L   ++P                     
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRLCGSP 237

Query: 301 ----WDKTEDGIFKEVLRNKPDFRRK---PWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
               W       +   ++ K  +RR+    +  I   A D +  +L  DP  R TA +AL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 354 SHPWV 358
           + PW+
Sbjct: 298 NSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 93.6 bits (232), Expect = 7e-21
 Identities = 88/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 75

Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 131

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 186

Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKPD---FRRKP 323
           E++          D+WS+G I   LL GR  F         K +LR    P     ++  
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246

Query: 324 WPSISN----------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
             S  N                       A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306

Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 307 HDPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 94.7 bits (235), Expect = 9e-21
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 28/216 (12%)

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQML 209
           A   H  +VK ++ F+ D+ + + ME   GG+L  +I  +      + E +  ++  Q++
Sbjct: 120 AACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIV 179

Query: 210 RVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV------ 262
               E H   ++HRD+K  N FL  +      +K  DFG S      K++ D V      
Sbjct: 180 LALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFS------KQYSDSVSLDVAS 229

Query: 263 ---GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
              G+ YY+APE+ +RK    ++D+WS+GVI Y LL   RPF   ++  I ++VL  K D
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289

Query: 319 FRRKPWP-SISNSAKDFVKKLLVKDPRARLTAAQAL 353
               P+P  +S+  K  +  LL K+P  R T  Q L
Sbjct: 290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 77/252 (30%), Positives = 129/252 (51%), Gaps = 15/252 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA+G   AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL- 220
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++   +A  +LH L 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEI--ASALGYLHSLN 116

Query: 221 -VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
            ++RD+KPEN L  S      +  TDFGL  + I+  K      G+  Y+APEVL+++  
Sbjct: 117 IIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 279 PES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             + D W +G + Y +L G  PF+ +    ++  +L NKP  R KP  +IS SA+  ++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-NKP-LRLKP--NISVSARHLLEG 229

Query: 338 LLVKDPRARLTA 349
           LL KD   RL A
Sbjct: 230 LLQKDRTKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 86/311 (27%), Positives = 141/311 (45%), Gaps = 54/311 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE----DVKREVKILQA 152
           RY   K +G G +G    A D+  G +VA+KK+ +     P   E       RE+++L+ 
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-----PFQSELFAKRAYRELRLLKH 70

Query: 153 LAGHENVVKFYNAFEDD------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F  D      +  Y+ M     G  L +++  K  + +E     +V 
Sbjct: 71  MK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLM--KHEKLSEDRIQFLVY 125

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G++HRD+KP N    +  ED  LK  DFGL+   +   +    V + +
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QTDSEMTGYVVTRW 180

Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGR-----------------------RPFW 301
           Y APEV+          D+WS+G I   +L G+                       + F 
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240

Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K +    K  ++  P FR+K +    P+ +  A + ++K+LV D  +R+TAA+AL+HP+
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Query: 358 VREGGDASEIP 368
             E  D  +  
Sbjct: 301 FEEFHDPEDET 311

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 8/208 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +G GQF   Y AT   +G  VA+KK++   ++   A  D  +E+ +L+ L  H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           NV+K+Y +F +DN + I +EL + G+L  + +   K+     EK       Q+       
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVLK 274
           H   ++HRD+KP N    +      +K  D GL  F          +VG+ YY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFW 301
                 +SD+WS+G + Y +   + PF+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 59  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P      +   S  
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKP 228

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 85/310 (27%), Positives = 132/310 (42%), Gaps = 59/310 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +A         A+K + K  ++L   V  VK E  IL A A +E VV+
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL-AEADNEWVVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++  ++  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYIAELTCAVESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL--------------------------------- 248
           HRD+KP+N L      D  +K TDFGL                                 
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 249 -----SDFIKP-----GKKFQ-----DIVGSAYYVAPEVLKRKSGPE-SDVWSIGVITYI 292
                 D +KP      ++ Q      +VG+  Y+APEVL R    +  D WS+GVI Y 
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TA 349
           +L G+ PF  +T      +V+  +      P   +S  A D + K L + P  RL    A
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGA 299

Query: 350 AQALSHPWVR 359
            +  +HP+ +
Sbjct: 300 DEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 64/251 (25%), Positives = 120/251 (47%), Gaps = 11/251 (4%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L        + + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+++
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + +  G   +   G+  Y+APE++  +  G  
Sbjct: 125 RDLKLDNVMLDS---EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMT 237

Query: 341 KDPRARLTAAQ 351
           K P  RL    
Sbjct: 238 KHPSKRLGCGP 248

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 68/249 (27%), Positives = 125/249 (50%), Gaps = 13/249 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VV 160
            +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L AL+G    + 
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVL-ALSGKPPFLT 64

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + ++ F+  + +Y  ME   GG+L+ +I  ++  R+ E  A     ++       H  G+
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N +  S   +  +K  DFG+  + +  G   +   G+  Y+APE++  +  G
Sbjct: 123 IYRDLKLDNVMLDS---EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGL 235

Query: 339 LVKDPRARL 347
           + K P  RL
Sbjct: 236 MTKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 89.7 bits (222), Expect = 9e-20
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  K +G   AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+    +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIV 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I          G+  Y+APEV++++    
Sbjct: 119 YRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L      R    P  S +A   +++LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELL 231

Query: 340 VKDPRARLTA 349
            KD + RL A
Sbjct: 232 EKDRQRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 92.1 bits (229), Expect = 1e-19
 Identities = 82/290 (28%), Positives = 126/290 (43%), Gaps = 42/290 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I +L+G G  G  Y+A D     RVA+KKI ++    P+  +   RE KI   L  H
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-H 61

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRV--- 211
             +V  Y+   D + VY  M   EG  L  L + + +K+S   E      V   L +   
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 212 ----AAECHLHGLVHRDMKPENFL----------------FKSAKED--SSLKATDFGL- 248
                   H  G++HRD+KP+N L                FK  +E+    +   +  + 
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 249 -SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTED 306
            S    PGK    IVG+  Y+APE L      ES D++++GVI Y +L    P+  + + 
Sbjct: 182 YSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKK 235

Query: 307 G---IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           G    +++V+ +  +    P+  I         K L  DP  R ++ Q L
Sbjct: 236 GRKISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 43/274 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKREVKILQALAGHEN 158
           +G G  G  Y    +  G   A+K I  N        ED     + RE++IL+    H N
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRD-VNHPN 133

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           VVK ++ F+ +  + + +E  +GG L    +A       E+  A V RQ+L   A  H  
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD------EQFLADVARQILSGIAYLHRR 187

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLK--- 274
            +VHRD+KP N L  SAK   ++K  DFG+S  + +        VG+  Y++PE +    
Sbjct: 188 HIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 275 ---RKSGPESDVWSIGVITYILLCGRRPF-------WDKTEDGIFKEVLRNKPDFRRKPW 324
                 G   D+WS+GV       GR PF       W      I    +   P+      
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMSQPPE----AP 297

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            + S   + F+   L ++P  R +A Q L HP++
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 67/281 (23%), Positives = 135/281 (48%), Gaps = 38/281 (13%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKILQALAGHENVV 160
           +++G G +    +   K   +R+   K+ K +++     ++ V+ E  + +  + H  +V
Sbjct: 1   RVIGRGSYAKVLLVRLKKT-ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
             ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +  +       
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL------- 112

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK 274
           H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+
Sbjct: 113 HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLRNKPDFRRKPW 324
            +  G   D W++GV+ + ++ GR PF            TED +F+ +L  +    R   
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 226

Query: 325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 227 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 10/261 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + +  GG+L   I    +  + E+ A     ++     +     +V
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEV+  +    S
Sbjct: 125 YRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W +G + Y ++ G+ PF  + E    +EV R   + + +     S  AK   + LL 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 341 KDPRARL-----TAAQALSHP 356
           K+P+ RL      AA    HP
Sbjct: 242 KNPKERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 76/334 (22%), Positives = 137/334 (41%), Gaps = 63/334 (18%)

Query: 93  DFDRRYT-IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------- 144
               RY   G  LG G +G    A D   G  VA+KK++  ++   +  +          
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 145 ----REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
               RE+KI+  +  HEN++   + + + +++ + M++      L +++ +K  R TE  
Sbjct: 65  FTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRK-IRLTESQ 120

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS----------- 249
              ++ Q+L      H    +HRD+ P N    S       K  DFGL+           
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDT 177

Query: 250 ----DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--- 300
               + ++  ++    V + +Y APE+L    K     D+WS+G I   LL G+  F   
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237

Query: 301 --------------------W-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
                               W    +  ++ E    KP   +  +P+ S+ A D ++ LL
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297

Query: 340 VKDPRARLTAAQALSHPWVREGG---DASEIPID 370
             +P  R++A +AL H + +      D S++P +
Sbjct: 298 KLNPLERISAKEALKHEYFKSDPLPCDPSQLPFN 331

Length = 335

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 80/310 (25%), Positives = 133/310 (42%), Gaps = 59/310 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +   K  G   A+K + K++M     +  VK E  +L A +    VV 
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-AESDSPWVVS 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D  Y+Y+ ME   GG+L+  +L K D+ ++E      + + +      H  G +
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-------------------------------- 249
           HRD+KP+N L         +K +DFGLS                                
Sbjct: 124 HRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 250 -----------DFIKPGKKFQDI-----VGSAYYVAPEV-LKRKSGPESDVWSIGVITYI 292
                      D I   KK + +     VG+  Y+APE+ L++  G E D WS+G I + 
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TA 349
            L G  PF  +     +++++  +          +S  A+D +++L+  +   RL    A
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299

Query: 350 AQALSHPWVR 359
            +  SHP+ R
Sbjct: 300 HEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 22/272 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQ 58

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++     ++I ME   GG  LD + A     + E   A +++++L+  
Sbjct: 59  -CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGL 114

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 115 DYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+++ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLTGE 224

Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S   K+F+   L KDP  R TA + L H ++
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 84/285 (29%), Positives = 134/285 (47%), Gaps = 32/285 (11%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            K+  ++Y I ++LG G  G    A   ++G+  AVK ++   M         + EV  L
Sbjct: 27  AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCL 85

Query: 151 ------QALAGHENVVKFYNAFEDDNYVYIAMEL--CEGGELLDRI--LAKKDSRYTEKD 200
                   +  HE+  K  +    +N + IA+ L     G+L   I   AK +  + E +
Sbjct: 86  LNCDFFSIVKCHEDFAK-KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP------ 254
           A ++  Q+L      H   ++HRD+K  N L  S   +  +K  DFG S           
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDV 201

Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEV 312
           G+ F    G+ YYVAPE+ +RK    ++D++S+GV+ Y LL  +RPF     DG   +EV
Sbjct: 202 GRTF---CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEEV 253

Query: 313 LRNKPDFRRKPWP-SISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +      R  P P SIS   ++ V  LL  DP+ R ++++ L+ P
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 85/317 (26%), Positives = 132/317 (41%), Gaps = 57/317 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +A         A+K + K  ++    V  VK E  IL A A +E VVK
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDIL-AEADNEWVVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y +F+D + +Y  M+   GG+++  ++  +   + E  A   + ++       H  G +
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL--------------------SDFIKPGKKFQDI 261
           HRD+KP+N L      D  +K TDFGL                     D ++P   + D+
Sbjct: 124 HRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 262 ----------------------------VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYI 292
                                       VG+  Y+APEVL RK   +  D WS+GVI + 
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL--VKDPRARLTAA 350
           +L G+ PF   T      +V+  +      P   +S  A D + KL    ++   R  A 
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300

Query: 351 QALSHPWVREGGDASEI 367
              +HP+  E   +S+I
Sbjct: 301 DIKAHPFFSEVDFSSDI 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 88/304 (28%), Positives = 136/304 (44%), Gaps = 63/304 (20%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G+G FG  +  TD  +G RVA+KK+      L ++ + V RE+K+L     H+NV+   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL-VSCKRVFRELKMLCFFK-HDNVLSAL 65

Query: 164 NA--------FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +         FE+   +Y+  EL +    L +I+       +     V + Q+LR     
Sbjct: 66  DILQPPHIDPFEE---IYVVTELMQSD--LHKIIVSP-QPLSSDHVKVFLYQILRGLKYL 119

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEV 272
           H  G++HRD+KP N L  S   +  LK  DFGL+   +P +     Q++V + YY APE+
Sbjct: 120 HSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEI 175

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPF-----------------------WDKTEDG 307
           L   R      D+WS+G I   LL  R  F                            +G
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235

Query: 308 IFKEVLRNKPDFRRKPWPSIS----------NSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               +LR       KP PS+           + A   + ++LV DP  R++AA AL+HP+
Sbjct: 236 ARAHILRGPH----KP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Query: 358 VREG 361
           + EG
Sbjct: 291 LDEG 294

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 11/250 (4%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  K++G   AVK ++K  ++       +  E  +L     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+    +Y  ++   GGEL   +  +++  + E  A     ++       H   ++
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + ++P +      G+  Y+APEVL+++    
Sbjct: 119 YRDLKPENILLDS---QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L              + +A D +  LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLL 231

Query: 340 VKDPRARLTA 349
            KD R RL A
Sbjct: 232 HKDQRRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 10/264 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I    +  + E+ A     ++     + H   +V
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPE 280
           +RD+KPEN L     +   ++ +D GL+  I  G+  +  VG+  Y+APEV+K  +    
Sbjct: 125 YRDLKPENILLD---DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W +G + Y ++ G+ PF  + E    +EV R   + + +     S +A+   ++LL 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 341 KDPRARL-----TAAQALSHPWVR 359
           KDP  RL      A +  +HP+ R
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 90/319 (28%), Positives = 138/319 (43%), Gaps = 61/319 (19%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 76

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 77  V-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELD----HERMSYLLY 130

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 187

Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV L        D+WS+G I   L+ G   F        W+K  + +         
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247

Query: 309 -FKEVLR----NKPD---------FRRKPWPSIS-------NSAKDFVKKLLVKDPRARL 347
             +  +R    N+P          F    +PS S       + A+D + K+LV DP  R+
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307

Query: 348 TAAQALSHPWVREGGDASE 366
           +  +AL HP++    D +E
Sbjct: 308 SVDEALRHPYITVWYDPAE 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 86.3 bits (213), Expect = 2e-18
 Identities = 87/324 (26%), Positives = 136/324 (41%), Gaps = 69/324 (21%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELD----HERMSYLLY 126

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183

Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239

Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++  +AL HP++    D +E+
Sbjct: 300 AKRISVDEALQHPYINVWYDPAEV 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 46/308 (14%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            RY     +G G +G    A D     +VAVKK+ +    L I      RE+++L+ +  
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMK- 72

Query: 156 HENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           HENV+   + F      E+ N VY+   L   G  L+ I+  K  + +++    ++ Q+L
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV--KCQKLSDEHVQFLIYQLL 128

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           R     H  G++HRD+KP N    +  ED  L+  DFGL+   +   +    V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMTGYVATRWYRA 183

Query: 270 PEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----NKPDFRRK- 322
           PE++          D+WS+G I   LL G+  F         K ++       P+  +K 
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243

Query: 323 -------------PWPSISNS---------AKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                          P              A D ++K+LV D   R++A++AL+HP+  +
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Query: 361 GGDASEIP 368
             D  + P
Sbjct: 304 YHDPEDEP 311

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 46/295 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQA 152
           ++ +  ++G G +G       K   + VA+KK + ++       E+VK    RE+K+L+ 
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-----ENEEVKETTLRELKMLRT 56

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L   EN+V+   AF     +Y+  E  E   L   +L +  +    +     + Q+++  
Sbjct: 57  LK-QENIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYIYQLIKAI 113

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAP 270
             CH + +VHRD+KPEN L      +  LK  DFG +  +  G    + + V + +Y +P
Sbjct: 114 HWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 271 E-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK-------------EVLRN 315
           E +L    G   D+WS+G I   L  G+  F  ++E D +F              ++  +
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230

Query: 316 KPDFRRKPWPSISNSAK--------------DFVKKLLVKDPRARLTAAQALSHP 356
            P F    +P++++                 D +K LL  +P  R    Q L+HP
Sbjct: 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 13/266 (4%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       +A G   A KK+ K ++      E    E +IL A      +V   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRIL-AKVHSRFIVSLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            AF+    + + M +  GG+L   I  + +++  + E  A     Q++      H   ++
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L      D +++ +D GL+  +K G+ K +   G+  ++APE+L+ +    
Sbjct: 120 YRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           S D +++GV  Y ++  R PF  + E    KE+ +   +         S ++K F + LL
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 340 VKDPRARL-----TAAQALSHPWVRE 360
            KDP  RL           +HP  R+
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 46/291 (15%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALAGHE 157
           +GK+ G G F     A  +  G   A+K ++K+      ++E V   RE++ L+ L+ H 
Sbjct: 4   LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFK----SLEQVNNLREIQALRRLSPHP 58

Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAA 213
           N+++      D     + +  EL +   L + I   K  +    EK     + Q+L+   
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMDM-NLYELI---KGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +G+ HRD+KPEN L K    D  LK  DFG    I     + + + + +Y APE L
Sbjct: 115 HMHRNGIFHRDIKPENILIK----DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 274 KRKS--GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVL---RNKPDFRRKPW- 324
                 GP+ D+W++G + + +L     F    E D I K  +VL     +   + +   
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 325 ------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                             P+ S    D +KKLL  DP  R+TA QAL HP+
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 85/319 (26%), Positives = 135/319 (42%), Gaps = 61/319 (19%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78

Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD----HERMSYLLY 133

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190

Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K  + +         
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250

Query: 309 -----FKEVLRNKPDFR----RKPWPSI------------SNSAKDFVKKLLVKDPRARL 347
                 +  + N+P +      K +P +            ++ A+D + K+LV D   R+
Sbjct: 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310

Query: 348 TAAQALSHPWVREGGDASE 366
           +  +AL HP++    D SE
Sbjct: 311 SVDEALQHPYINVWYDPSE 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 63/261 (24%), Positives = 125/261 (47%), Gaps = 30/261 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K N    A+K ++K  +     ++ V+ E  + +  + +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++ F+  + +++ +E   GG+L+      R L ++ +R+   +  + +  +       H
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL-------H 113

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLK- 274
             G+++RD+K +N L      D  +K TD+G+  + + PG       G+  Y+APE+L+ 
Sbjct: 114 ERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWD--------KTEDGIFKEVLRNKPDFRRKPWPS 326
            + G   D W++GV+ + ++ GR PF D         TED +F+ +L       R     
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVILEKPIRIPR----F 225

Query: 327 ISNSAKDFVKKLLVKDPRARL 347
           +S  A   +K  L KDP+ RL
Sbjct: 226 LSVKASHVLKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 65/302 (21%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE----NV 159
           LG G  G       + +G  +A K I     I P     + RE+K+L     HE     +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVL-----HECNSPYI 61

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-- 217
           V FY AF  D  + I ME  +GG  LD++L KK  R  E     +   +LR     +L  
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPENILGKISIAVLR--GLTYLRE 117

Query: 218 -HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
            H ++HRD+KP N L  S  E   +K  DFG+S     G+    +    VG+  Y++PE 
Sbjct: 118 KHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 169

Query: 273 LK-RKSGPESDVWSIGVITYILLCGRRP------------FWDKTEDGIFKEVLR----N 315
           L+      +SD+WS+G+    +  GR P            F     +G  KE  R    +
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229

Query: 316 KPDFRR-------------KPWPSI-----SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            PD  R             +P P +     S+  +DFV K L K+P+ R    +   HP+
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289

Query: 358 VR 359
           ++
Sbjct: 290 IK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 54/255 (21%)

Query: 145 REVKILQALAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           RE++I+     HE     +V FY AF ++N + + ME  + G L DRI          K 
Sbjct: 52  RELQIM-----HECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY---------KK 96

Query: 201 AAVVVRQMLRVAAECHLHGL---------VHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
              +  ++L   A   + GL         +HRD+KP N L  S  +   +K  DFG+S  
Sbjct: 97  GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS-- 151

Query: 252 IKPGKKFQDI----VGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTED 306
              G+    I    VG++ Y++PE ++  K   +SDVWS+G+    L  G+ PF     D
Sbjct: 152 ---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208

Query: 307 --------GIFKEVLR--NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
                   GI   + +   +P   R P        +DFV   L+KDP  R T  Q  + P
Sbjct: 209 DDGQDDPMGILDLLQQIVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267

Query: 357 WVREGGDASEIPIDI 371
              +        +D+
Sbjct: 268 PFIQA--LRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 17/225 (7%)

Query: 126 VKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL 185
           V+KI K K    I       E  + Q +  + N +K Y +        + M+  + G+L 
Sbjct: 45  VQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
           D  L KK+ + +E +   ++RQ++    + H H ++H D+K EN L+  AK+   +   D
Sbjct: 98  D--LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCD 153

Query: 246 FGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDK 303
           +GL   I  P     D  G+  Y +PE +K  +   S D W++GV+TY LL G+ PF + 
Sbjct: 154 YGLCKIIGTPSC--YD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
            ++ +  E L  +   +     ++S +A DFV+ +L  +   RLT
Sbjct: 210 EDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 21/267 (7%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + +G G +G  Y A +   G+  AVK I   K+        +++E+ +++    H 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HC 66

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V ++ ++     ++I ME C GG L D  +       +E   A V R+ L+  A  H 
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEV--LK 274
            G +HRD+K  N L     ++  +K  DFG++  I     K +  +G+ Y++APEV  ++
Sbjct: 125 KGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 275 RKSGPES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF---RRKPWPSIS 328
           +  G     D+W++G+    L   + P +D      +F   L +K +F   + K     S
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKDKTKWS 238

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSH 355
           ++  +FVK  L K+P+ R TA + L+H
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 26/265 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG       K  G   A KK++K ++      +    E +IL+ +     +V   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-----HLH 218
            AFE   ++ + M L  GG+L   I       Y   +  + + +++  +A+      HLH
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHI-------YNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 219 --GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              +V+RDMKPEN L     +  + + +D GL+  +K GK      G+  Y+APE+LK +
Sbjct: 113 SMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169

Query: 277 SGPES-DVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSISNSA 331
                 D +++G   Y ++ GR PF D  E    + + +  L ++  F  +   + +  +
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEES 226

Query: 332 KDFVKKLLVKDPRARLTAAQALSHP 356
           KD  +  L K P  RL + +    P
Sbjct: 227 KDICRLFLAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 84.0 bits (207), Expect = 5e-17
 Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 45/299 (15%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQ 151
           Y + K +G+G+FG  ++   K   +    K I      E+ K  L I V +V RE+K   
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV-NVMRELK--- 70

Query: 152 ALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQ 207
               H+N+V++ + F  + +  +YI ME C+ G+L   I    K   +  E     + RQ
Sbjct: 71  ----HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126

Query: 208 MLRVAAECHL-------HGLVHRDMKPENFLF--------KSAKEDSSL------KATDF 246
           +L   A CH          ++HRD+KP+N           K   + ++L      K  DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGP---ESDVWSIGVITYILLCGRRPFWDK 303
           GLS  I         VG+ YY +PE+L  ++     +SD+W++G I Y L  G+ PF   
Sbjct: 187 GLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG 362
                    L+  PD    P    S      +K LL    + R +A Q L +  ++  G
Sbjct: 247 NNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 87/326 (26%), Positives = 127/326 (38%), Gaps = 76/326 (23%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKM----ILPIAVEDVKREVKIL 150
           +Y I   +G G +G  Y A  K    G   A+KK + +K     I   A     RE+ +L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALL 56

Query: 151 QALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           + L  HENVV     F +     VY+  +  E  +L   I   K  R  +     +   M
Sbjct: 57  RELK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII---KFHR--QAKRVSIPPSM 109

Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKS-AKEDSSLKATDFGLSD-FIKPGKKF 258
           ++      L+G+        +HRD+KP N L      E   +K  D GL+  F  P K  
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 259 QD---IVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED------- 306
            D   +V + +Y APE+L   R      D+W+IG I   LL     F  +          
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229

Query: 307 ------GIFK-----------------EVLRNKPDFRRKPWPS----------ISNSAK- 332
                  IF+                 E      DF+ K +PS              ++ 
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289

Query: 333 -DFVKKLLVKDPRARLTAAQALSHPW 357
            D ++KLL  DP  R+TA +AL HP+
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 23/263 (8%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG       +      A+K I K  ++    V     E  +L A      +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVL-AQVNCPFIVPLK 59

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
            +F+    +Y+ +    GGEL   +  +++ R+    A     ++L  A E  H   +++
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELL-CALENLHKFNVIY 116

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDF-IKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           RD+KPEN L         +   DFGL    +K   K     G+  Y+APE+L      ++
Sbjct: 117 RDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKK 337
            D W++GV+ Y +L G  PF+D+  + +++++L+     PD            AKD +  
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD-------GFDRDAKDLLIG 226

Query: 338 LLVKDPRARL---TAAQALSHPW 357
           LL +DP  RL    A +  +HP+
Sbjct: 227 LLSRDPTRRLGYNGAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 67/275 (24%), Positives = 130/275 (47%), Gaps = 26/275 (9%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K      A+K I+K  +     ++ V+ E  + +  + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++ F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++       H  G++
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGII 118

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K +N L  +   +  +K TD+G+  + I+PG       G+  Y+APE+L+ +  G 
Sbjct: 119 YRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 280 ESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S  
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVK 231

Query: 331 AKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
           A   +K  L KDP+ RL            SHP+ R
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 46/290 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAG--HENV 159
           +G G +G  Y A D  +G  VA+K  +++ N+  LP++     REV +L+ L    H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST---VREVALLKRLEAFDHPNI 64

Query: 160 VKFYNA-----FEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           V+  +       + +  V +  E  +      LD++        T KD   ++RQ LR  
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD---LMRQFLRGL 121

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H + +VHRD+KPEN L  S      +K  DFGL+           +V + +Y APEV
Sbjct: 122 DFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFW------DK-----------TEDGIFKEVLR 314
           L + +     D+WS+G I +  +  R+P +      D+            ED   ++V  
Sbjct: 179 LLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237

Query: 315 NKPDFR-RKPW------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            +  F  R P       P I  S    + ++L  +P  R++A +AL HP+
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 62/270 (22%), Positives = 122/270 (45%), Gaps = 23/270 (8%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQAL 153
           Y   +++G G +G   +   + +G +  +KK+      L  A    ++    E ++L  L
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN-----LRNASRRERKAAEQEAQLLSQL 56

Query: 154 AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             H N+V +  ++E +D  +YI M  CEGG+L  ++  +K     E        Q+    
Sbjct: 57  K-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 213 AECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-IVGSAYYVAP 270
              H   ++HRD+K +N FL ++    + +K  D G++  ++        ++G+ YY++P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRT----NIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-PDFRRKPWPSIS 328
           E+   K    +SDVW++G   Y +   +  F  K  + +   ++  K P   +   P + 
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
               + +  +L K P  R +    L  P++
Sbjct: 232 ----ELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 71/286 (24%), Positives = 120/286 (41%), Gaps = 43/286 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   +    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVSLLKNLK-HANIVT 67

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +    L + L    +  +  +  + + Q+LR  + CH   ++
Sbjct: 68  LHDIIHTERCLTLVFEYLDSD--LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL---KRKS 277
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P+VL      S
Sbjct: 126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------N 315
            P  D+W +G I Y +  GR  F   T       + R                       
Sbjct: 183 TP-IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241

Query: 316 KPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            P +R +P     P +     D +  LL+ + ++R++A  AL H +
Sbjct: 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 78/301 (25%), Positives = 119/301 (39%), Gaps = 70/301 (23%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHENV 159
           LG G +   Y    K  G  VA+K+I           E       RE  +L+ L  H N+
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLE------HEEGAPFTAIREASLLKDLK-HANI 65

Query: 160 VKFYNAFEDD---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV----VR----QM 208
           V  ++          V+         E LD  L     +Y +     +    VR    Q+
Sbjct: 66  VTLHDIIHTKKTLTLVF---------EYLDTDL----KQYMDDCGGGLSMHNVRLFLFQL 112

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYY 267
           LR  A CH   ++HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVVTLWY 169

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-----DGIFK---------- 310
             P+VL    +     D+W +G I Y +  GR  F   T+       IF+          
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229

Query: 311 -EVLRNK-------PDFRRKP----WPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHP 356
             V  N        P +  +P     P +      ++   K L  +P+ R++AA+A+ HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289

Query: 357 W 357
           +
Sbjct: 290 Y 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 41/291 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 68

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +    L + L    +     +  + + Q+LR    CH   ++
Sbjct: 69  LHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL--KRKSG 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L       
Sbjct: 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I Y +  GR  F   T +     + R                      N 
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243

Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
           P +R        P + +   + + KLL  + R R++A +A+ HP+    G+
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 78/278 (28%), Positives = 116/278 (41%), Gaps = 41/278 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G          G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQKRLLMDLDISMRSVDCPYTV 63

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDA----AVVVRQMLRVAAE 214
            FY A   +  V+I ME+ +    LD+   K         +D     AV + + L     
Sbjct: 64  TFYGALFREGDVWICMEVMDTS--LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE---- 117

Query: 215 CHLH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +LH    ++HRD+KP N L      +  +K  DFG+S   +    K  D  G   Y+AP
Sbjct: 118 -YLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLVDSVAKTIDA-GCKPYMAP 172

Query: 271 EVLKRKSGPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRK 322
           E +  +   +     SDVWS+G IT I L  GR P+  W KT     K+V+       + 
Sbjct: 173 ERINPELNQKGYDVKSDVWSLG-ITMIELATGRFPYDSW-KTPFQQLKQVVEEPSP--QL 228

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P    S   +DFV K L K+ + R    + L HP+   
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           T  K LG GQFG   V   K  G   VA+K I +  M    + +D   E K++  L+ H 
Sbjct: 7   TFLKELGSGQFGV--VHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HP 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK--DAAVVVRQMLRVAAEC 215
           N+V+ Y        ++I  E    G LL+ +  +K    TE   D    V + +      
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES- 118

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYV 268
             +G +HRD+   N L     ED+ +K +DFGL+ ++         G KF        + 
Sbjct: 119 --NGFIHRDLAARNCL---VGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-----PVKWA 168

Query: 269 APEVLKR-KSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
            PEV    +   +SDVWS GV+ + +   G+ P+   +   + + V  
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 64/231 (27%), Positives = 95/231 (41%), Gaps = 46/231 (19%)

Query: 95  DRRYTIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            R     K LG G FG      Y       G++VAVK +  N         D +RE++IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEIL 60

Query: 151 QALAGHENVVKFYNAFEDD--NYVYIAMELCEGGELLD-------RILAKKDSRYTEKDA 201
           + L  HEN+VK+    E      + + ME    G L D       +I  K+   ++ +  
Sbjct: 61  RTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ-- 117

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             + + M  + ++      +HRD+   N L +S   +  +K +DFGL+  +   K +   
Sbjct: 118 --ICKGMDYLGSQ----RYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDY--- 165

Query: 262 VGSAYYV-----------APEVLK-RKSGPESDVWSIGVITYILLCGRRPF 300
               YYV           APE L+  K    SDVWS GV  Y L     P 
Sbjct: 166 ----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 77/280 (27%), Positives = 115/280 (41%), Gaps = 43/280 (15%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---DVKREVKILQALAGHENVV 160
           LGHG  G  Y A        +AVK I      L I VE    +  E++IL        ++
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP-----LDITVELQKQIMSELEILYKCDS-PYII 62

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
            FY AF  +N + I  E  +GG L   +  K       + A  VV+ +       +L  L
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGRIAVAVVKGL------TYLWSL 114

Query: 221 --VHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--KPGKKFQDIVGSAYYVAPE-VLKR 275
             +HRD+KP N L  +  +   +K  DFG+S  +     K +   VG+  Y+APE +   
Sbjct: 115 KILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGE 168

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP----------DFRRKPWP 325
           + G  SDVWS+G+    L  GR P+       I K      P          D    P  
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQ-----IQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
             S     F+ + + K P+ R      + HP++ +  D +
Sbjct: 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 47/291 (16%)

Query: 104 LGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQALAG--HEN 158
           +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+ L    H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHPN 65

Query: 159 VVKFYNA-----FEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           VV+ ++       + +  + +  E  +      LD++        T KD   ++ Q+LR 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---MMFQLLRG 122

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V + +Y APE
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED-----GIF------------KEVL 313
           VL + S     D+WS+G I +  +  R+P +  + D      I             ++V 
Sbjct: 180 VLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 314 RNKPDFRRKPW-------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             +  F  K           I    KD + K L  +P  R++A  ALSHP+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 42/304 (13%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   +    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 68

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    D  + +  E  +    L + +    +  +  +  + + Q+LR  A CH   ++
Sbjct: 69  LHDIVHTDKSLTLVFEYLDKD--LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS--G 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P+VL   S   
Sbjct: 127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I + +  GR  F   T +     + R                      N 
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243

Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE-GGDASEIPIDI 371
           P ++ +P     P +     + + K L  + + R++A +A+ H + R  G     +P  I
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESI 303

Query: 372 SVLN 375
           S+ +
Sbjct: 304 SIFS 307

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 69/230 (30%), Positives = 95/230 (41%), Gaps = 47/230 (20%)

Query: 102 KLLGHGQFGYTYVAT------DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             LG G FG  Y  T        +   RVAVK + K       A +  K+E      L  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG------ATDQEKKEFLKEAHLMS 54

Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM-LR 210
              H N+VK       +   YI MEL EGG+LL  +  A+ +           +  + L 
Sbjct: 55  NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 211 VAAECH----LHGLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGS 264
           VA  C     +H  +HRD+   N L      D+   +K  DFGL+         +DI  S
Sbjct: 115 VAKGCVYLEQMH-FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKS 164

Query: 265 AYY------------VAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
            YY            +APE L   K   +SDVWS GV+ + IL  G++P+
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 62/323 (19%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 4   DDDFEKISE----LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 57

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK---DAAVVVRQ 207
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E+     ++ V +
Sbjct: 58  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
            L    E   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSY 168

Query: 268 VAPEVLK-RKSGPESDVWSIGVITYILLCGRRP------------FWDKTEDGIFKEVLR 314
           ++PE L+      +SD+WS+G+    +  GR P            F    E    +    
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228

Query: 315 NKPDFRRKP----------------------------WPSISNSA--KDFVKKLLVKDPR 344
            +P    +P                             PS    A  +DFV K L+K+P 
Sbjct: 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288

Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   +A E+
Sbjct: 289 ERADLKQLMVHAFIKR-SEAEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K +  G FG  Y+   K N    AVK ++K  MI    V  V+ E   L AL+   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSP 64

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  Y + +  N VY+ ME   GG++  + L      + E+ A   + ++       H 
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDV--KSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
           HG++HRD+KP+N L  +   +  +K TDFGLS
Sbjct: 123 HGIIHRDLKPDNMLISN---EGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 69/241 (28%), Positives = 103/241 (42%), Gaps = 41/241 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG GQFG  +      N   VAVK ++   M      +D   E +I++ L  H  +++
Sbjct: 12  RKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQ 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC------ 215
            Y     +  +YI  EL + G LL+  L     R      A+ + Q++ +AA+       
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLE-YLQGGAGR------ALKLPQLIDMAAQVASGMAY 118

Query: 216 -HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-------PGKKFQDIVGSAYY 267
                 +HRD+   N L     E++  K  DFGL+  IK        G KF        +
Sbjct: 119 LEAQNYIHRDLAARNVL---VGENNICKVADFGLARVIKEDIYEAREGAKF-----PIKW 170

Query: 268 VAPE-VLKRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            APE  L  +   +SDVWS G+ +T I+  GR P+   T      EVL+      R P P
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMPCP 226

Query: 326 S 326
            
Sbjct: 227 P 227

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++        +VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 12  IGSGQFGLVWLGY-WLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLY 65

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               + + + +  E  E G L D + A++     E    +   V   M  + +      +
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN----V 121

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---APEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ + V   +PEV    K
Sbjct: 122 IHRDLAARNCL---VGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 15/211 (7%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF+R       LG G  G       K +G  +A K I     I P     + RE+++L
Sbjct: 4   DDDFERISE----LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 57

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   +V FY AF  D  + I ME  +GG  LD++L K+  R  E+    V   +LR
Sbjct: 58  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KEAKRIPEEILGKVSIAVLR 114

Query: 211 -VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
            +A     H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y++
Sbjct: 115 GLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMS 170

Query: 270 PEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           PE L+      +SD+WS+G+    L  GR P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 33/231 (14%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKIL 150
           TI K++G G+FG       K  G +   VA+K +     +K ++       D   E  I+
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIM 59

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N+++          V I  E  E G L D+ L + D ++T       +  MLR
Sbjct: 60  GQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFT----VGQLVGMLR 113

Query: 211 -VAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--- 263
            +A+          VHRD+   N L  S   +   K +DFGLS  ++  +      G   
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKI 170

Query: 264 SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
              + APE +  RK    SDVWS G++ + ++  G RP+WD +   + K V
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F +RY    ++LG G FG    Y Y   +   G+ VAVK +++            K+E+ 
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEIN 58

Query: 149 ILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HEN+VK+     +     + + ME    G L D         Y  K    + +
Sbjct: 59  ILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD---------YLPKHKLNLAQ 108

Query: 207 QMLRVAAEC----HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-- 258
            +L     C    +LH    +HRD+   N L  +   D  +K  DFGL+  +  G ++  
Sbjct: 109 LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYR 165

Query: 259 --QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
             +D     ++ A E LK  K    SDVWS GV  Y LL
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 38/278 (13%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAGHE 157
            +G G FG       K +G  +AVK+I     EK +  L + ++ V R            
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-------P 63

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTE----KDAAVVVRQMLRV 211
            +VKFY A   +   +I MEL +    +    +     S   E    K A   V+     
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK----- 118

Query: 212 AAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
            A  +L     ++HRD+KP N L      + ++K  DFG+S   +    K +D  G   Y
Sbjct: 119 -ALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRD-AGCRPY 173

Query: 268 VAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRR 321
           +APE +   +       SDVWS+G+  Y +  G+ P+  W+   D + + V  + P    
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                 S S  +F+   L+KD   R    + L HP+++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 72/312 (23%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA----- 152
             IGK        +  +A  K     VAVKKI  +           K ++K+LQ      
Sbjct: 4   TLIGKCFEDLMIVH--LAKHKPTNTLVAVKKINLDSC--------SKEDLKLLQQEIITS 53

Query: 153 -LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR- 210
               H N++ +  +F  D+ +Y+   L   G   D +     + + E    + +  +L+ 
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKD 109

Query: 211 -VAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGS 264
            + A  ++H  G +HR +K  + L          K    GL      IK GK+ + +   
Sbjct: 110 VLNALDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 265 A-------YYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR 314
                    +++PEVL+   +    +SD++S+G+    L  G  PF D     +  E +R
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224

Query: 315 -----------------NKPDFRRK---PWPSISNSAK----------DFVKKLLVKDPR 344
                            +    R     P    S               FV+  L +DP 
Sbjct: 225 GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284

Query: 345 ARLTAAQALSHP 356
           +R +A+Q L+H 
Sbjct: 285 SRPSASQLLNHS 296

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 48/221 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG--- 155
            +G  +G G+FG   +   +  G +VAVK +              K +    QA      
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCL--------------KDDSTAAQAFLAEAS 52

Query: 156 ------HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
                 H N+V+        N +YI  E    G L+D +        +   A + + Q L
Sbjct: 53  VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-------RSRGRAVITLAQQL 105

Query: 210 RVA-----AECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
             A        +L     VHRD+   N L     ED   K +DFGL+   K   + QD  
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLA---KEASQGQDSG 159

Query: 263 G-SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
                + APE L+ +K   +SDVWS G++ + I   GR P+
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 54/233 (23%)

Query: 104 LGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++        + + + VAVK +++       A +D +RE ++L     HEN
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--TASNDARKDFEREAELLTNF-QHEN 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLD---------RILAKKDSRYTEKDAAVVVRQML 209
           +VKFY    + +   +  E  E G+L             L   DS   E    + + Q+L
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE----LTLSQLL 125

Query: 210 RVAAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
           ++A +      +L     VHRD+   N L      D  +K  DFG+S         +D+ 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCL---VGYDLVVKIGDFGMS---------RDVY 173

Query: 263 GSAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            + YY            + PE ++ RK   ESDVWS GV+ + I   G++P++
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 20/222 (9%)

Query: 99  TIGKLLGHGQFGYTYVAT-DKANGDRVAVK-KIEKNKMILPIAVEDVKREVKILQALAGH 156
           T+G+ +G GQFG  Y         +++AV  K  KN     +  E   +E  I++    H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQF-DH 66

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AEC 215
            ++VK      ++  V+I MEL   GEL   +   K S     D A ++    +++ A  
Sbjct: 67  PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSL----DLASLILYSYQLSTALA 121

Query: 216 HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS--AYYVAPE 271
           +L     VHRD+   N L  S      +K  DFGLS +++    ++   G     ++APE
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 272 VLK-RKSGPESDVWSIGVITY-ILLCGRRPF-WDKTEDGIFK 310
            +  R+    SDVW  GV  + IL+ G +PF   K  D I +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 79/285 (27%), Positives = 118/285 (41%), Gaps = 32/285 (11%)

Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           T   YD   +F R   + GK LG G FG    AT        AV K+   KM+ P A   
Sbjct: 22  TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAV-KMLKPTAHSS 80

Query: 143 VKR----EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            +     E+KI+  L  HEN+V    A      + +  E C  G+LL+ +  K++S  T 
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           +D      Q+ +  A       +HRD+   N L    K    +K  DFGL+  I     +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNY 197

Query: 259 QDIV-GSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
             +V G+A     ++APE +       ESDVWS G++ + I   G  P+     D  F +
Sbjct: 198 --VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255

Query: 312 VLRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
           +++      +P+        I  +  D        DP  R T  Q
Sbjct: 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDA-------DPLKRPTFKQ 293

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 73/293 (24%), Positives = 124/293 (42%), Gaps = 54/293 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K NG  VA+K  ++++ +     A+    RE  +L+ L  H N+V 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLK-HANIVL 67

Query: 162 FYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++           + Y+  +LC+        + K       ++  + + Q+LR  +  H
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQ-------YMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKR 275
              ++HRD+KP+N L     E   LK  DFGL+     P   + + V + +Y  P+VL  
Sbjct: 121 QRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177

Query: 276 KSGPES--DVWSIGVITYILLCGRRPF--WDKTEDGIFKEVL-------------RNKPD 318
            +   +  D+W +G I   ++ G   F      +D + +  L              + P 
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237

Query: 319 FR------------RKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           F+            R+ W  +S  N A+D   KLL   P+ RL+A  ALSH +
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 27/219 (12%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKR 145
           ++K F +R    + LG G FG   +      GD     VAVK ++       IA  D+K+
Sbjct: 1   FEKRFLKRI---RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKK 55

Query: 146 EVKILQALAGHENVVKFYNAFEDD--NYVYIAMELCEGG---ELLDRILAKKDSRYTEKD 200
           E++IL+ L  HEN+VK+     +D  N + + ME    G   E L R   K + +   K 
Sbjct: 56  EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-- 258
           A  + + M  + +  +    VHRD+   N L +S   +  +K  DFGL+  I+  K++  
Sbjct: 115 AVQICKGMDYLGSRQY----VHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYT 167

Query: 259 --QDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
              D+    ++ APE L + K    SDVWS GV  Y LL
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 67/240 (27%), Positives = 99/240 (41%), Gaps = 46/240 (19%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVK 148
              I K++G G+FG       K  G R   VA+K +     EK +        D   E  
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-------RDFLSEAS 57

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           I+     H N++           V I  E  E G L D  L K D ++T     + +  M
Sbjct: 58  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFT----VIQLVGM 111

Query: 209 LRVAAECHLH----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           LR  A    +    G VHRD+   N L  S   +   K +DFGLS      +  +D   +
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLS------RVLEDDPEA 162

Query: 265 AY----------YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           AY          + APE +  RK    SDVWS G++ + ++  G RP+W+ +   + K +
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +  T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMKLS- 57

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           HE +V+ Y        +YI  E    G LL+  L +   R+       + + +    A  
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN-YLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---APEV 272
                +HRD+   N L         +K +DFGLS ++    ++   VGS + V    PEV
Sbjct: 117 ESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEV 172

Query: 273 LKR-KSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + +   G+ P+
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 33/272 (12%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQ 61

Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM---LR 210
             H N++           V I  E  E G L D  L + D ++T      ++R +   ++
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS------ 264
             +E +    VHRD+   N L  S   +   K +DFGLS F++          S      
Sbjct: 121 YLSEMNY---VHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 265 AYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             + APE +  RK    SDVWS G++ + ++  G RP+WD +   +   +   + D+R  
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---EQDYRLP 231

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           P      +    +     KD  AR    Q +S
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 40/208 (19%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHE 157
           + +G G FG  Y    K N + VAVK     +  LP    D+KR    E +IL+    H 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTE-VAVKTC---RSTLP---PDLKRKFLQEAEILKQYD-HP 52

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK-------DAAVVVRQMLR 210
           N+VK          +YI MEL  GG LL   L KK +R T K       DAA     M  
Sbjct: 53  NIVKLIGVCVQKQPIYIVMELVPGGSLLT-FLRKKKNRLTVKKLLQMSLDAAA---GMEY 108

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD------FIKPGKKFQDIVGS 264
           + ++      +HRD+   N L     E++ LK +DFG+S       +       Q  +  
Sbjct: 109 LESKN----CIHRDLAARNCL---VGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK- 160

Query: 265 AYYVAPEVLKR-KSGPESDVWSIGVITY 291
             + APE L   +   ESDVWS G++ +
Sbjct: 161 --WTAPEALNYGRYTSESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 70/248 (28%), Positives = 107/248 (43%), Gaps = 38/248 (15%)

Query: 102 KLLGHGQFGYTYVATDKANGDR---VAVKKI-----EKNKMILPIAVEDVKREVKILQAL 153
           K++G G+FG  +    K  G +   VA+K +     EK +       +D   E  I+   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-------QDFLSEASIMGQF 63

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR--V 211
           + H N+++            I  E  E G L D+ L   D  ++    +  +  MLR   
Sbjct: 64  S-HHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFS----SYQLVGMLRGIA 117

Query: 212 AAECHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVGSA-- 265
           A   +L  +  VHRD+   N L  S  E    K +DFGLS  ++  P   +    G    
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            + APE +  RK    SDVWS G++ + ++  G RP+WD +      EV++   D  R P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGFRLP 230

Query: 324 WPSISNSA 331
            P    SA
Sbjct: 231 APMDCPSA 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+G+++G G+FG   V   +  G +VAVK I+ +     +  +    E  ++  L  H+N
Sbjct: 9   TLGEIIGEGEFGA--VLQGEYTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKN 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V+        N +YI MEL   G L++ +        T   A V V Q+L+ + +    
Sbjct: 61  LVRLLGVILH-NGLYIVMELMSKGNLVNFL-------RTRGRALVSVIQLLQFSLDVAEG 112

Query: 216 --HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAP 270
             +L    LVHRD+   N L     ED   K +DFGL+   + G    D       + AP
Sbjct: 113 MEYLESKKLVHRDLAARNIL---VSEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAP 166

Query: 271 EVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           E LK +K   +SDVWS GV+ + +   GR P+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 50/231 (21%)

Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +   K     A +D +RE ++L  L  H++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQ-HQH 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--DSRYTE--KDAA---VVVRQMLRV 211
           +V+FY    +   + +  E    G+L +R L     D++     +D A   + + QML +
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 212 AAE-----CHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A++      +L  L  VHRD+   N L     +   +K  DFG+S         +DI  +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCL---VGQGLVVKIGDFGMS---------RDIYST 175

Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            YY            + PE +L RK   ESD+WS GV+ + I   G++P++
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 68

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLH--GL 220
                +   YI  E    G LLD +   ++    E +A V++    +++ A  +L     
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   K
Sbjct: 126 IHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 277 SGPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 29/202 (14%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHE 157
           +LLG G FG  +  T K +   VAVK  +++   LP   +++K     E +IL+    H 
Sbjct: 1   ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LP---QELKIKFLSEARILKQY-DHP 52

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA---AE 214
           N+VK          +YI MEL  GG+ L  +  KKD   T++    +V+  L  A   A 
Sbjct: 53  NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ----LVKFALDAAAGMAY 108

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS----DFIKPGKKFQDIVGSAYYVAP 270
                 +HRD+   N L     E++ LK +DFG+S    D I      + I     + AP
Sbjct: 109 LESKNCIHRDLAARNCL---VGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAP 163

Query: 271 EVLKR-KSGPESDVWSIGVITY 291
           E L   +   ESDVWS G++ +
Sbjct: 164 EALNYGRYSSESDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.9 bits (166), Expect = 7e-12
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 17/221 (7%)

Query: 144 KREVKILQALAGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +RE  +   L  H N+V   ++ E     ++   E   G  L + + A  D      +  
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA--DGALPAGETG 82

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-- 260
            ++ Q+L   A  H  G+VHRD+KP+N +          K  DFG+   + PG +  D  
Sbjct: 83  RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVA 141

Query: 261 -------IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  ++G+  Y APE L+ +   P SD+++ G+I    L G+R     +   I  + 
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQ 201

Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           L +  D    PW +  +     ++K L KDPR R  +A AL
Sbjct: 202 L-SPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 94  FDRRYTIG-KLLGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+    + LG G FG      Y       G+ VAVKK++ +       + D +RE++
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIE 57

Query: 149 ILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDA 201
           IL++L  H+N+VK+    Y+A      + + ME    G L D +   +   D R     A
Sbjct: 58  ILKSLQ-HDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           + + + M  + ++ +    VHRD+   N L +S   ++ +K  DFGL+  +   K++  +
Sbjct: 115 SQICKGMEYLGSKRY----VHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 262 V----GSAYYVAPEVL-KRKSGPESDVWSIGVITYIL 293
                   ++ APE L + K    SDVWS GV+ Y L
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 37/206 (17%)

Query: 102 KLLGHGQFGYTYVAT-DKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K LG G FG         + G    VAVK ++ +K  L   ++D  +E  I+ +L  HEN
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDDFLKEAAIMHSLD-HEN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA---AEC 215
           +++ Y        + +  EL   G LLDR+   +         + +    +++A      
Sbjct: 58  LIRLYGVVLTHPLMMVT-ELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                +HRD+   N L  S  +   +K  DFGL   +   +         +YV       
Sbjct: 114 ESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNED--------HYVMEEHLKV 162

Query: 269 -----APEVLK-RKSGPESDVWSIGV 288
                APE L+ R     SDVW  GV
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGV 188

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 80/363 (22%), Positives = 157/363 (43%), Gaps = 61/363 (16%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR 123
           K  + +++++          K  D   ++  ++ Y +G ++G+G FG  Y A      ++
Sbjct: 34  KLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEK 93

Query: 124 VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF--------EDDNYVYIA 175
           VA+KK+ ++        +   RE+ I++ L  H N++   + +        E + ++ + 
Sbjct: 94  VAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAV---VVR----QMLRVAAECHLHGLVHRDMKPE 228
           M      E + + + K    Y   + A+   +V+    Q+ R  A  H   + HRD+KP+
Sbjct: 146 M------EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQ 199

Query: 229 NFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES--DVWSI 286
           N L        +LK  DFG +  +  G++    + S +Y APE++   +   +  D+WS+
Sbjct: 200 NLLIDP--NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257

Query: 287 GVITYILLCGRRPFWDK----------------TEDGIFKEVLRNKPDFR---------R 321
           G I   ++ G   F  +                TED + KE+  N  D +         +
Sbjct: 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL-KEMNPNYADIKFPDVKPKDLK 316

Query: 322 KPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS-EIPIDISVLNNMRQ 379
           K +P    + A +F+ + L  +P  RL   +AL+ P+  +  D   ++P  I  L ++  
Sbjct: 317 KVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFN 376

Query: 380 FVK 382
           F  
Sbjct: 377 FCD 379

Length = 440

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 39/244 (15%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +T+ + LG G FG  +    K N  RVA+K ++ + ++     +D ++EV+ L+ L  H+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLL---KQQDFQKEVQALKRLR-HK 62

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE--- 214
           +++  +        VYI  EL E G LL   L   + +       + V  ++ +A +   
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLA-FLRSPEGQ------VLPVASLIDMACQVAE 115

Query: 215 --CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----- 265
              +L     +HRD+   N L     ED   K  DFGL+  IK     +D+  S+     
Sbjct: 116 GMAYLEEQNSIHRDLAARNIL---VGEDLVCKVADFGLARLIK-----EDVYLSSDKKIP 167

Query: 266 -YYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             + APE         +SDVWS G++ Y +   G+ P+       ++ ++        R 
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG----YRM 223

Query: 323 PWPS 326
           P P+
Sbjct: 224 PCPA 227

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 12  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
             +A      +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 66  L-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 125 HRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 176

Query: 275 RKSGP-ESDVWSIGV-ITYILLCGRRPF 300
             S   +SDVWS G+ +  I+  GR P+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 35/216 (16%)

Query: 100 IGKLLGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           + + LG GQFG  ++ T   NG  +VAVK ++   M    + E   +E +I++ L  H+ 
Sbjct: 10  LERKLGAGQFGEVWMGT--WNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDK 62

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-----AAVVVRQMLRVAA 213
           +V+ Y    ++  +YI  E    G LLD  L   + +          AA +   M  + +
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-------GKKFQDIVGSAY 266
                  +HRD+   N L     E+   K  DFGL+  I+        G KF        
Sbjct: 122 R----NYIHRDLAARNIL---VGENLVCKIADFGLARLIEDDEYTAREGAKF-----PIK 169

Query: 267 YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + APE     +   +SDVWS G++   I+  GR P+
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 26/234 (11%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG  ++   +A   +VA+K I +  M    + ED   E K++  L+ H  
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPK 60

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-CHL 217
           +V+ Y        +YI  E  E G LL+  L ++  + + KD  + + Q +    E    
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLN-YLRQRQGKLS-KDMLLSMCQDVCEGMEYLER 118

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAP 270
           +  +HRD+   N L  S      +K +DFG++ ++         G KF        +  P
Sbjct: 119 NSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDEYTSSSGAKF-----PVKWSPP 170

Query: 271 EVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           EV    K   +SDVWS GV+ + +   G+ PF  K+   + + + R    +R K
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 61/238 (25%), Positives = 90/238 (37%), Gaps = 52/238 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKA-NGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           T+ + LGHG FG  Y    +  +GD V   V      +        D   E  I+     
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN- 67

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLR 210
           H+N+V+      +    +I +EL  GG+L      +R   ++ S  T KD     R    
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD--- 124

Query: 211 VAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           VA  C     +  +HRD+   N L          K  DFG++         +DI  ++YY
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYY 175

Query: 268 VAPEVLKRKSG----------PE----------SDVWSIGVITY-ILLCGRRPFWDKT 304
                  RK G          PE          +DVWS GV+ + I   G  P+  +T
Sbjct: 176 -------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 50/293 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK----REVKILQALAGHE 157
           + LG G +   Y    + NG  VA+K I           E V     RE  +L+ L  H 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMK------TEEGVPFTAIREASLLKGLK-HA 63

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V  ++       +    E       L + + +        +  + + Q+LR  A  H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK 276
             ++HRD+KP+N L     E   LK  DFGL+     P + +   V + +Y  P+VL   
Sbjct: 122 QHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 277 S--GPESDVWSIGVITYILLCGRRPF-------------WD----KTED---GIFKEVLR 314
           +      D+W  G I   +L G+  F             W      TED   G+ K +  
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK-LPN 237

Query: 315 NKPDFRRKP--------WPSISN--SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            KP++            W  +S    A+D   ++L+  P+ R++A  AL HP+
Sbjct: 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 12  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 126 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 177

Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++ Y I+  G+ P+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 17/210 (8%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             K+LG G FG  Y       G++    VA+K + +     P A +++  E  ++ A   
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVM-ASVD 67

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H +VV+            I  +L   G LLD +   KD     +       Q+ +  +  
Sbjct: 68  HPHVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYL 125

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPE- 271
               LVHRD+   N L K+      +K TDFGL+  +   +K     G      ++A E 
Sbjct: 126 EEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 272 VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
           +L R    +SDVWS GV  + L+  G +P+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 22/201 (10%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK-NKMILPIAVEDVKRE--VKILQALA 154
           YT+ K L  G  G  +VAT     D V +K  +K   +I  + +++V     +++   L 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLV 127

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
                      +  D Y Y               L K+        A ++ +Q+L     
Sbjct: 128 SGAITCMVLPHYSSDLYTY---------------LTKRSRPLPIDQALIIEKQILEGLRY 172

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   ++HRD+K EN           +   D G + F      F  + G+    APEVL 
Sbjct: 173 LHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA 229

Query: 275 R-KSGPESDVWSIGVITYILL 294
           R K   ++D+WS G++ + +L
Sbjct: 230 RDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 28/233 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++        +VA+K +++  M    + E    E  +++ L  H  +V+
Sbjct: 12  KKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVR 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y A      +YI  E  E G L+D +   +  + T      +  Q+    A       +
Sbjct: 66  LY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-------GKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I+        G KF        + APE + 
Sbjct: 125 HRDLRAANIL---VSETLCCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAIN 176

Query: 275 RKS-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             +   +SDVWS G+ +T I+  GR P+   T      EV++N     R P P
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLERGYRMPRP 225

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 68/252 (26%), Positives = 118/252 (46%), Gaps = 17/252 (6%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN---V 159
           ++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    +   +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFI 59

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V    AF   + +   ++L  GG+L   +   +   ++EK+      +++      H   
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
           +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL++ + 
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTA 172

Query: 279 PES--DVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
            +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S   K  +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTVNVELPDSFSPELKSLL 230

Query: 336 KKLLVKDPRARL 347
           + LL +D   RL
Sbjct: 231 EGLLQRDVSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 62.8 bits (152), Expect = 9e-11
 Identities = 82/318 (25%), Positives = 127/318 (39%), Gaps = 68/318 (21%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC-----REIALLRELK-HPN 59

Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR-------------RPFWDKTEDGIF 309
            +Y APE+L   R      D+W+IG I   LL                 PF     D IF
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 310 K----------EVLRNKP-------DFRRKPWPS-----------ISNSAKDFV--KKLL 339
                      E +R  P       DFRR  + +           +   +K F+  +KLL
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298

Query: 340 VKDPRARLTAAQALSHPW 357
             DP  R+T+ QAL  P+
Sbjct: 299 TMDPTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 68/257 (26%), Positives = 112/257 (43%), Gaps = 36/257 (14%)

Query: 80  IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVA----TDKANGDR---VAVKKIEKN 132
           +P   R +F  DK      T+GK LG G FG   +A     DK        VAVK ++ +
Sbjct: 4   LPEDPRWEFSRDK-----LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD 58

Query: 133 KMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK 192
                ++  D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++
Sbjct: 59  ATEKDLS--DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 116

Query: 193 --------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
                         D + T KD      Q+ R          +HRD+   N L     E+
Sbjct: 117 PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL---VTEN 173

Query: 239 SSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-IL 293
           + +K  DFGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I 
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233

Query: 294 LCGRRPFWDKTEDGIFK 310
             G  P+     + +FK
Sbjct: 234 TLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 33/241 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVE----DVKREVK 148
           R  +GK LG G FG   +A     DK   +RV    +   KM+   A E    D+  E++
Sbjct: 19  RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV---KMLKSDATEKDLSDLISEME 75

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DS 194
           +++ +  H+N++    A   D  +Y+ +E    G L + + A++              + 
Sbjct: 76  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DF 251
           + + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHH 192

Query: 252 IKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +F
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252

Query: 310 K 310
           K
Sbjct: 253 K 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 56/254 (22%), Positives = 103/254 (40%), Gaps = 60/254 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV-------KR-----E 146
           T+ + LG G FG  Y             K + K +    +A++ V       +R     E
Sbjct: 9   TLIRELGQGSFGMVYEGL---------AKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVV 205
             +++    H +VV+            + MEL   G+L   + +++ ++          +
Sbjct: 60  ASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 206 RQMLRVAAE-----CHLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           ++ +++AAE      +L     VHRD+   N +     ED ++K  DFG++         
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM---VAEDLTVKIGDFGMT--------- 166

Query: 259 QDIVGSAYY------------VAPEVLKRKSG---PESDVWSIGVITY-ILLCGRRPFWD 302
           +DI  + YY            +APE LK   G    +SDVWS GV+ + +     +P+  
Sbjct: 167 RDIYETDYYRKGGKGLLPVRWMAPESLK--DGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224

Query: 303 KTEDGIFKEVLRNK 316
            + + + K V+   
Sbjct: 225 LSNEEVLKFVIDGG 238

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 39/206 (18%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVKF 162
           +G G FG  +    +A+   VAVK   +    LP  ++    +E +IL+  + H N+V+ 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYS-HPNIVRL 58

Query: 163 YNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
                    +YI MEL +GG+ L        R+  K+  +  E  AA     M  + ++ 
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA----GMEYLESKH 114

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY--------- 266
                +HRD+   N L     E + LK +DFG+S      ++ +D V ++          
Sbjct: 115 ----CIHRDLAARNCL---VTEKNVLKISDFGMS------REEEDGVYASTGGMKQIPVK 161

Query: 267 YVAPEVLKR-KSGPESDVWSIGVITY 291
           + APE L   +   ESDVWS G++ +
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 31/258 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG+GQFG  ++ T   N  +VAVK ++   M    + E    E +I++ L  H+ +V+
Sbjct: 12  KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQ 65

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGL 220
            Y A   +  +YI  E    G LLD  L   + R  +    V +  Q+    A       
Sbjct: 66  LY-AVVSEEPIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV- 272
           +HRD++  N L     +    K  DFGL+  I       + G KF        + APE  
Sbjct: 124 IHRDLRSANIL---VGDGLVCKIADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAA 175

Query: 273 LKRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN-S 330
           L  +   +SDVWS G+ +T ++  GR P+       + ++V R      R P P     S
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPIS 231

Query: 331 AKDFVKKLLVKDPRARLT 348
             + + +   KDP  R T
Sbjct: 232 LHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 23/255 (9%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN---V 159
           ++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    +   +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFI 59

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V    AF   + +   ++L  GG+L   +   +   ++E +      +++      H   
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSG 278
           +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL++   
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVA 172

Query: 279 PES--DVWSIGVITYILLCGRRPFWD-KTEDG--IFKEVLRNKPDFRRKPWP-SISNSAK 332
            +S  D +S+G + + LL G  PF   KT+D   I +  L    +      P S S   +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-----LPDSFSPELR 227

Query: 333 DFVKKLLVKDPRARL 347
             ++ LL +D   RL
Sbjct: 228 SLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 43/248 (17%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHEN 158
           ++G G FG    A  K +G    ++     K +   A +D  R    E+++L  L  H N
Sbjct: 2   VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA----------VVVRQM 208
           ++    A E   Y+Y+A+E    G LLD +   + SR  E D A          +  +Q+
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           L  AA+    G+        +HRD+   N L     E+   K  DFGLS   +   K   
Sbjct: 115 LHFAADV-ARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKTM 170

Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF--------WDKTEDGIFK 310
                 ++A E L        SDVWS GV+ + I+  G  P+        ++K   G   
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230

Query: 311 EVLRNKPD 318
           E   N  D
Sbjct: 231 EKPLNCDD 238

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 61/274 (22%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAGHEN 158
           ++G G FG    A  K +G ++        KM+   A E+  R    E+++L  L  H N
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA----------VVVRQM 208
           ++    A E+  Y+YIA+E    G LLD +   + SR  E D A          +  +Q+
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 209 LRVAAECH--LHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLS--DFIKPGKKFQ 259
           L+ A++    +  L     +HRD+   N L     E+ + K  DFGLS  + +   K   
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVL---VGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF--------WDKTEDG-- 307
            +     ++A E L       +SDVWS GV+ + I+  G  P+        ++K   G  
Sbjct: 179 RL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236

Query: 308 -------------IFKEVLRNKPDFRRKPWPSIS 328
                        + ++  R++P + R P+  IS
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRP-YERPPFAQIS 269

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 49/239 (20%)

Query: 96  RRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           R   + + LG G FG  ++A     +   +   VAVK ++   +    A +D +RE ++L
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELL 61

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAV 203
             L  HE++VKFY    D + + +  E  + G+L   + A         D +  +    +
Sbjct: 62  TNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120

Query: 204 VVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            + QML +A++      +L     VHRD+   N L  +   +  +K  DFG+S       
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS------- 170

Query: 257 KFQDIVGSAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
             +D+  + YY            + PE ++ RK   ESDVWS GVI + I   G++P++
Sbjct: 171 --RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 31/230 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVA------TDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKI 149
           R T+GK LG G FG   +A       DK N    VAVK ++ +     ++  D+  E+++
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS--DLVSEMEM 70

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
            T KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+  +   
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL---VTEDNVMKIADFGLARDVHNI 187

Query: 256 KKFQDIVGS---AYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
             ++          ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 32/235 (13%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVA----TDKANGDR---VAVKKIEKNKMILPIAVEDVK 144
           +F R R  +GK LG G FG    A     DK+  D+   VAVK ++ N     +A  D+ 
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA--DLI 65

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------------ 192
            E+++++ +  H+N++        +  +Y+ +E    G L + + A++            
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 193 --DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS- 249
             + + + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+ 
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL---VTEDNVMKIADFGLAR 182

Query: 250 --DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
               I   KK  +      ++APE L  R    +SDVWS G++ + I   G  P+
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 33/257 (12%)

Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  +VA+K ++   M      E   +E +I++ L  H+ +V  
Sbjct: 14  LGQGCFGEVWMGT--WNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y A   +  +YI  E    G LLD  L + D +Y +    V +  Q+    A       +
Sbjct: 67  Y-AVVSEEPIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     ++   K  DFGL+  I       + G KF        + APE  L
Sbjct: 125 HRDLRAANIL---VGDNLVCKIADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 176

Query: 274 KRKSGPESDVWSIGVI-TYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G++ T ++  GR P+       + ++V R      R P P     S 
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG----YRMPCPQGCPESL 232

Query: 332 KDFVKKLLVKDPRARLT 348
            + +K    KDP  R T
Sbjct: 233 HELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 79/318 (24%), Positives = 126/318 (39%), Gaps = 68/318 (21%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELK-HPN 59

Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR-------------RPFWDKTEDGIF 309
            +Y APE+L   R      D+W+IG I   LL                 P+     D IF
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 310 K----------EVLRNKP-------DFRRKPWPSIS-------------NSAKDFVKKLL 339
                      E ++  P       DFRR  + + S             + A   ++KLL
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 340 VKDPRARLTAAQALSHPW 357
             DP  R+T+ QA+  P+
Sbjct: 299 TMDPIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 74/257 (28%), Positives = 110/257 (42%), Gaps = 33/257 (12%)

Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 14  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 66

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y A   +  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 67  Y-AVVSEEPIYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 125 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 176

Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G+ +T +   GR P+       +  +V R      R P P     S 
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----YRMPCPPECPESL 232

Query: 332 KDFVKKLLVKDPRARLT 348
            D + +   K+P  R T
Sbjct: 233 HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 58/247 (23%)

Query: 93  DFDR-RYTIGKLLGHGQFGY----TYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKRE 146
           +  R R T+GK LG G FG       V  D  N    VAVK ++ +     ++  D+  E
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS--DLVSE 65

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------------- 192
           +++++ +  H+N++        +  +Y+ +E    G L D + A++              
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 193 DSRYTEKD----AAVVVRQMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG 247
           +   T+KD    A  V R M  +A++ C     +HRD+   N L     ED  +K  DFG
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKC-----IHRDLAARNVL---VTEDHVMKIADFG 177

Query: 248 LSDFIKPGKKFQDIVGSAYY------------VAPEVL-KRKSGPESDVWSIGVITY-IL 293
           L+         +DI    YY            +APE L  R    +SDVWS GV+ + I 
Sbjct: 178 LA---------RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Query: 294 LCGRRPF 300
             G  P+
Sbjct: 229 TLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 52/201 (25%), Positives = 76/201 (37%), Gaps = 33/201 (16%)

Query: 104 LGHGQFGYT---YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LGHG FG                VAVK +++  +      ++  RE  ++  L  H  +V
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQL-DHPCIV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           +     + +  + + MEL   G LL  +  KK       D   +  Q+    A       
Sbjct: 60  RLIGVCKGEPLMLV-MELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY------------V 268
           VHRD+   N L  +       K +DFG+S  +  G        S YY             
Sbjct: 117 VHRDLAARNVLLVN---RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPLKWY 165

Query: 269 APEVLK-RKSGPESDVWSIGV 288
           APE +   K   +SDVWS GV
Sbjct: 166 APECINYGKFSSKSDVWSYGV 186

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 59/246 (23%), Positives = 107/246 (43%), Gaps = 46/246 (18%)

Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVK--REVKI 149
           + T+ + LG G FG  Y   A D   G+   RVAVK + ++  +     E ++   E  +
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEASV 62

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQM 208
           ++    H +VV+            + MEL   G+L   + + + ++          +++M
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 209 LRVAAE-----CHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +++AAE      +L+    VHRD+   N +      D ++K  DFG++         +DI
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCM---VAHDFTVKIGDFGMT---------RDI 169

Query: 262 VGSAYY------------VAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDG 307
             + YY            +APE LK       SD+WS GV+ + I     +P+   + + 
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229

Query: 308 IFKEVL 313
           + K V+
Sbjct: 230 VLKFVM 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 54/256 (21%)

Query: 104 LGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK ++        A +D  RE ++L  L  HE+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEH 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGEL--------LDRILAKKDSRYTEKDAAVVVRQMLR 210
           +VKFY    + + + +  E  + G+L         D +L  + +R  E    +   QML 
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE----LTQSQMLH 124

Query: 211 VAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           +A +             VHRD+   N L     E+  +K  DFG+S         +D+  
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCL---VGENLLVKIGDFGMS---------RDVYS 172

Query: 264 SAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           + YY            + PE ++ RK   ESDVWS+GV+ + I   G++P++  + + + 
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232

Query: 310 KEVLRNKPDFRRKPWP 325
           + + + +   R +  P
Sbjct: 233 ECITQGRVLQRPRTCP 248

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 10/101 (9%)

Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           I+G+  Y+APE+L  K  GP  D W++GV  +  L G  PF D+T   +F+ +L      
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594

Query: 320 RRKPWP----SISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           R  PWP     +S +A++ ++ LL  DP  R    +   HP
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 27/232 (11%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPI 138
           PC   +          +Y I   L  G  G  +V T   +  R  V VK +   K     
Sbjct: 77  PCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----- 131

Query: 139 AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL--CEGGELLDRILAKKDSRY 196
                 RE+ IL+ ++ H  ++   +A+   + V + M    C+    +DR         
Sbjct: 132 ---TPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-----GPL 182

Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG----LSDFI 252
             + A  + R++L   A  H  G++HRD+K EN +F    E++ L   DFG    L    
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHP 239

Query: 253 KPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDK 303
              + +    G+    +PE+L       ++D+WS G++ + +       + K
Sbjct: 240 DTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290

Length = 392

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)

Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 124

Query: 207 QMLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           Q+L  AA+             +HRD+   N L     E+   K  DFGLS   +   K  
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKT 181

Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKP 317
                  ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +   
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 239

Query: 318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            +R +   +  +   D +++   + P  R + AQ L
Sbjct: 240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 40/230 (17%)

Query: 102 KLLGHGQFGYTYVATDKANGDR-----VAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             LG G+FG  ++A  K   +      V VK ++K K        + +RE+ + + L+ H
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLS-H 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
           +NVV+      +    Y+ +E  + G+L   + A K      K   +  +Q + +  +  
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 216 ----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY-- 267
               HL     VHRD+   N L  S      +K +   LS         +D+  S YY  
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSS---QREVKVSLLSLS---------KDVYNSEYYKL 175

Query: 268 ---------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTED 306
                    +APE V +     +SDVWS GV+ + +   G  PF+  +++
Sbjct: 176 RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+     TIGK    G+FG   +   +  G++VAVK I+ +        +    E  ++ 
Sbjct: 6   KELKLLQTIGK----GEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT 54

Query: 152 ALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            L  H N+V+      E+   +YI  E    G L+D + ++  S         +++  L 
Sbjct: 55  QLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLD 110

Query: 211 VA-AECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAY 266
           V  A  +L     VHRD+   N L     ED+  K +DFGL+   K     QD       
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVK 164

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPF 300
           + APE L+ K    +SDVWS G++ + I   GR P+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 40/234 (17%)

Query: 100 IGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +GK LG G+FG    AT      +A    VAVK +++N       + D+  E  +L+ + 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVN 61

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI----------LAKKDSRYTEKDAAVV 204
            H +V+K Y A   D  + + +E  + G L   +          L    +R +       
Sbjct: 62  -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 205 VR------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI 252
            R            Q+ R         LVHRD+   N L    ++   +K +DFGLS  +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDV 177

Query: 253 KPG----KKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
                  K+ +  +    ++A E L       +SDVWS GV+ + I+  G  P+
Sbjct: 178 YEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 17/196 (8%)

Query: 104 LGHGQFGYT---YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG          K   ++    KI KN    P   +++ RE  ++Q L  +  +V
Sbjct: 3   LGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIV 59

Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           +     E ++++ + MEL E G L ++ L K +   TEK+   +V Q+            
Sbjct: 60  RMIGICEAESWMLV-MELAELGPL-NKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNF 116

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY----VAPEVLK-R 275
           VHRD+   N L  +       K +DFGLS  +   + +        +     APE +   
Sbjct: 117 VHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 276 KSGPESDVWSIGVITY 291
           K   +SDVWS GV+ +
Sbjct: 174 KFSSKSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 43/222 (19%)

Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV--KILQALAGHEN 158
            KLLG G FG  +       GD + +          P+A++ ++     +  Q +  H  
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKI----------PVAIKTIQDRSGRQTFQEITDHML 61

Query: 159 VVKFYNAFEDDNYVYIAMELCEG------------GELLDRILAKKDSRYTEKDAAVVVR 206
            +       D  Y+   + +C G            G LLD +   +DS     D   ++ 
Sbjct: 62  AMGSL----DHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSL----DPQRLLN 113

Query: 207 QMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQD 260
             +++A   +    H +VHR++   N L KS   DS ++  DFG++D + P  K   + +
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
                 ++A E +L  +   +SDVWS GV  + ++  G  P+
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 62/249 (24%), Positives = 97/249 (38%), Gaps = 56/249 (22%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVAT---------------DKANGDR-VAVKKIEKNKMI 135
           +F R      + LG GQFG  ++                 D A+    VAVK +  +   
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE----LLDRILAK 191
              A ED  +EVKIL  L+   N+ +       D  + + ME  E G+    L   +   
Sbjct: 61  --NAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117

Query: 192 KDSRYTEK--DAAVVVRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDF 246
                  K    + ++    ++A+   +L     VHRD+   N L      + ++K  DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADF 174

Query: 247 GLSDFIKPGKKFQDIVGSAYY------VAP-------EVLKRKSGPESDVWSIGVITY-I 292
           G+S         +++  S YY        P        VL  K   +SDVW+ GV  + I
Sbjct: 175 GMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 293 L-LCGRRPF 300
           L LC  +P+
Sbjct: 226 LTLCREQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 40/250 (16%)

Query: 97  RYTIGKLLGHGQFGYTY------VATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVK 148
           + T+ + LG G FG  Y      V  D+    RVA+K + +   +     E ++   E  
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMR----ERIEFLNEAS 61

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQ 207
           +++    H +VV+            + MEL   G+L   + + + +       A   +++
Sbjct: 62  VMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 208 MLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKP 254
           M+++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + 
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRK 177

Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           G K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V
Sbjct: 178 GGKG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Query: 313 ----LRNKPD 318
               L +KPD
Sbjct: 235 MEGGLLDKPD 244

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 104 LGHGQFGYTYVA--TDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  Y    T          VA+K +++N    P   ++ ++E +++  L  H N
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPN 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK---KDSRYTEKDAAVV----VRQMLRV 211
           +V        +    +  E    G+L + ++      D      D  V         L +
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 212 AAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A +      +L  H  VHRD+   N L     E  ++K +DFGLS         +DI  +
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCL---VGEGLTVKISDFGLS---------RDIYSA 177

Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            YY            + PE +L  K   ESD+WS GV+ + I   G +P++
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 38/143 (26%), Positives = 52/143 (36%), Gaps = 24/143 (16%)

Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
             KLL  G     Y+       +   +K              D +REV ILQ LA     
Sbjct: 2   SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSR-----EKGADREREVAILQLLARKGLP 54

Query: 160 V-KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           V K   + E D + Y+ ME  EG  L       + S   ++D A  + ++L       LH
Sbjct: 55  VPKVLASGESDGWSYLLMEWIEGETL------DEVSEEEKEDIAEQLAELLA-----KLH 103

Query: 219 -----GLVHRDMKPENFLFKSAK 236
                 L H D+ P N L    K
Sbjct: 104 QLPLLVLCHGDLHPGNILVDDGK 126

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 21/206 (10%)

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V  +     ++ V++ ++  EGG+L   I   K     E+       +M+      H 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS--KFLNIPEECVKRWAAEMVVALDALHR 103

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+V RD+ P N L         ++ T F     ++     + +     Y APEV     
Sbjct: 104 EGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDSCDGEAV--ENMYCAPEVGGISE 158

Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             E+ D WS+G I + LL G +   +    GI      N P++       +S  A+  ++
Sbjct: 159 ETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEW-------VSEEARSLLQ 210

Query: 337 KLLVKDPRARLTAAQA-----LSHPW 357
           +LL  +P  RL A  A      SHP+
Sbjct: 211 QLLQFNPTERLGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 17/208 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y      +G+     VA+K + +N    P A +++  E  ++ A  G  
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVM-AGVGSP 69

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V +          V +  +L   G LLD +   KD R   +D      Q+ +  +    
Sbjct: 70  YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEE 127

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEVL 273
             LVHRD+   N L KS    + +K TDFGL+  +   +      G      +     +L
Sbjct: 128 VRLVHRDLAARNVLVKSP---NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 274 KRKSGPESDVWSIGVITYILLC-GRRPF 300
            R+   +SDVWS GV  + L+  G +P+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.8 bits (113), Expect = 7e-06
 Identities = 67/236 (28%), Positives = 101/236 (42%), Gaps = 23/236 (9%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 71

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LLD +   KD+  ++      V Q+ +         
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 129

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 130 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSI 327
           K   +SDVWS GV  + L+     F  K  DGI     R  PD      R P P I
Sbjct: 187 KFTHQSDVWSYGVTIWELMT----FGGKPYDGI---PTREIPDLLEKGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 29/223 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +GK+LG G+FG         +     +VAVK + K  +     +E+   E   ++    
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 156 HENVVKFYN-AFEDDNYVYIAMELC-----EGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           H NV+K     FE  +   I   +      + G+L   +L    SR       + ++ +L
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY---SRLGGLPEKLPLQTLL 116

Query: 210 RVAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
           +   +  L          +HRD+   N +    +ED ++   DFGLS  I  G  ++   
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 263 GSAY---YVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
            +     ++A E L  R    +SDVW+ GV  + I   G+ P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 14/170 (8%)

Query: 126 VKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE---GG 182
           + K  K      I +E+   E+  L  L  HEN++K       +   Y+  +  +     
Sbjct: 196 IAKRVKAGSRAAIQLEN---EILALGRL-NHENILKIEEILRSEANTYMITQKYDFDLYS 251

Query: 183 ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK 242
            + D     KD    ++  A++ +Q+L      H   L+HRD+K EN        D  + 
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIM-KQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIV 307

Query: 243 ATDFG-LSDFIKPGKKFQ-DIVGSAYYVAPEVLKRKSGPE-SDVWSIGVI 289
             DFG    F K  + F    VG+    +PE+L      E +D+WS G+I
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLI 357

Length = 501

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 76/327 (23%), Positives = 128/327 (39%), Gaps = 49/327 (14%)

Query: 10  VSGSNSGSNNNNANH--HRNANKEEAKR------RHNHHARNDTTHKHQHQHQERAKNYQ 61
               NS   NN+A+     + +   A+R      R    + +    K         +   
Sbjct: 26  ALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATT 85

Query: 62  QLKTKQHQKTNSRRQ--TGVIPCGKRTD------FGYDKDFD-RRYTIGKLLGHGQFGYT 112
              T        +++  T  +P   R +       G D D   +R+ I  LLG G FG  
Sbjct: 86  TPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145

Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-----AGHENVVKFYNAFE 167
             A D+   +  AVK I +N   +P    D K E++ ++ +     A    ++K    F+
Sbjct: 146 VEAWDRKRKEYCAVK-IVRN---VPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201

Query: 168 DDN-YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRD 224
           ++  ++ I M    G  LLD I+  K   ++ +  A ++ Q        H  LH L+H D
Sbjct: 202 NETGHMCIVMPK-YGPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELH-LMHTD 257

Query: 225 MKPENFLFKSAK-------------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
           +KPEN L +++              +   ++  D G             IV + +Y +PE
Sbjct: 258 LKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPE 315

Query: 272 V-LKRKSGPESDVWSIGVITYILLCGR 297
           V L       +D+WS+G I Y L  G+
Sbjct: 316 VVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 56/229 (24%), Positives = 86/229 (37%), Gaps = 30/229 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALA- 154
            I ++LG G+FG       K    R   VA+         L     D +R   + +AL  
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIH-------TLRAGCSDKQRRGFLAEALTL 60

Query: 155 ---GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N+V+        N + I  E    G  LD  L K + +      A  +  ML  
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNG-ALDSFLRKHEGQLV----AGQLMGMLPG 115

Query: 212 AAECHLH----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS--A 265
            A    +    G VH+ +     L  S   D   K + F      K    +  + G    
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
            + APE ++       SDVWS G++ + ++  G RP+WD +   + K V
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 29/239 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ A   + 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 69

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y   +  V + + +    E
Sbjct: 70  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEE 127

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPE 271
             L   VHRD+   N L K+ +    +K TDFGL+  +   +K     G      ++A E
Sbjct: 128 RRL---VHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 272 -VLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSI 327
            +L R    +SDVWS GV  + L+  G +P+     DGI   E+        R P P I
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEISSILEKGERLPQPPI 235

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---F 258
             V RQ+L      H  G++HRD+K EN +  +  ED  L   DFG + F +        
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 259 QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY 291
             I G+    APEVL      P  D+WS G++ +
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 40.6 bits (96), Expect = 6e-05
 Identities = 17/46 (36%), Positives = 28/46 (60%), Gaps = 1/46 (2%)

Query: 405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           +LR+ F   D D +G+IS +E++ AL K L   L E  + E+++ V
Sbjct: 1   ELREAFRLFDKDGDGTISADELKAAL-KSLGEGLSEEEIDEMIREV 45

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 20/118 (16%)

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           D   + R +LR     H + ++HRD+K EN +F +   D  L   DFG + F  P     
Sbjct: 183 DILAIERSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACF--P----V 233

Query: 260 DIVGSAYY--------VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
           DI  + YY         APE+L R   GP  D+WS G++ + +       ++K  DG+
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK--DGL 289

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 31/92 (33%), Positives = 42/92 (45%), Gaps = 7/92 (7%)

Query: 100 IGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            GK LG G FG    AT      + N  RVAVK ++ +        E +  E+KIL  L 
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLG 99

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLD 186
            H+N+V    A      V +  E C  G+LL+
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 33/217 (15%)

Query: 80  IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA 139
           +P   R +F  D        +G++LG G FG     T         V K+   KM+ P A
Sbjct: 26  LPYDSRWEFPRD-----GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAV-KMLKPTA 79

Query: 140 VEDVKR----EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-- 193
               K+    E+KI+  L  H N+V    A      +YI  E C  G+L++ +   +D  
Sbjct: 80  RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Query: 194 -SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL---FKSAKEDSSLKATD---F 246
            SR+ EK              +  + G+   D    +++   F++  +   +K  D   +
Sbjct: 140 LSRHPEKP-----------KKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188

Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDV 283
                IK   K+ DI  S Y         K   +S+V
Sbjct: 189 VPMLEIKEASKYSDIQRSNYDRPAS---YKGSNDSEV 222

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 10/104 (9%)

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           V R +    A  H HG V  D+   +FL     +   + +  F ++     G      VG
Sbjct: 122 VARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA---NGTLHLCPVG 178

Query: 264 SAYYVAPEVLKRKS------GPESDVWSIGVITY-ILLCGRRPF 300
            + +  PE+    S          D + + V+ + +L  GR P+
Sbjct: 179 VSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222

Length = 637

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 38/216 (17%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV----------EDVKREVKILQAL 153
           LG G FG            +  V K+ K ++ + I V          +++ RE +I+  L
Sbjct: 3   LGSGNFGCV----------KKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL 52

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             +  +V+     E +  + + ME+  GG L   +  KKD          VV  M +V+ 
Sbjct: 53  D-NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN----VVELMHQVSM 106

Query: 214 EC-HLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY--- 267
              +L G   VHRD+   N L  +       K +DFGLS  +     +     +  +   
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 268 -VAPE-VLKRKSGPESDVWSIGVITYILLC-GRRPF 300
             APE +  RK    SDVWS G+  +     G++P+
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 49/238 (20%), Positives = 100/238 (42%), Gaps = 35/238 (14%)

Query: 102 KLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQALAGHE 157
           K +G+G FG   +          +V VK++  +  +     E +K   E +  ++L  H 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ----EQMKFLEEAQPYRSLQ-HS 55

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA---E 214
           N+++      +     + ME C  G+L   + + + +     D   + R    +A     
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD-------FIKPGKKFQDIVGSAYY 267
            H +  +H D+   N L  +   D ++K  D+GLS        ++ P + +  +     +
Sbjct: 116 LHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RW 168

Query: 268 VAPEVLKRKSG--------PESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNK 316
           +APE++    G         ES+VWS+GV  + L   G +P+   +++ +    +R +
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain

 Score = 37.2 bits (87), Expect = 5e-04
 Identities = 13/28 (46%), Positives = 18/28 (64%)

Query: 405 DLRDQFDAIDVDKNGSISLEEMRQALAK 432
           +LR+ F   D D +G IS EE+R+AL  
Sbjct: 1   ELREAFKLFDKDGDGYISAEELRKALRS 28

Length = 30

>gnl|CDD|205383 pfam13202, EF_hand_3, EF hand

 Score = 36.9 bits (87), Expect = 6e-04
 Identities = 10/25 (40%), Positives = 16/25 (64%)

Query: 406 LRDQFDAIDVDKNGSISLEEMRQAL 430
           L+D F   D + +G IS EE+++ L
Sbjct: 1   LKDLFRQFDTNGDGKISKEELKRLL 25

Length = 25

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 33/226 (14%)

Query: 98  YTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +T+G++LG G+FG    A   ++  +  +VAVK + K  +     +E+  RE   ++   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58

Query: 155 GHENVVKFYNAF---EDDNYVYIAM---ELCEGGELLDRILAKKDSRYTEKDAAV----V 204
            H NV+K             + I M      + G+L   +L    SR  E+   +    +
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM---SRIGEEPFTLPLQTL 115

Query: 205 VRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           VR M+ +A+          +HRD+   N +     E+ ++   DFGLS  I  G  ++  
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQ- 171

Query: 262 VGSAYYVAPEVLKRKS------GPESDVWSIGVITY-ILLCGRRPF 300
            G A  +  + L  +S         SDVW+ GV  + I+  G+ P+
Sbjct: 172 -GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 26/106 (24%)

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE--------- 271
           VHRD+   N L     E+  +K  DFGLS         ++I  + YY A E         
Sbjct: 152 VHRDLATRNCL---VGENMVVKIADFGLS---------RNIYSADYYKASENDAIPIRWM 199

Query: 272 ----VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
               +   +   ESDVW+ GV+ + I   G +P++    + +   V
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|200946 pfam00036, efhand, EF hand

 Score = 36.3 bits (85), Expect = 0.001
 Identities = 11/28 (39%), Positives = 17/28 (60%)

Query: 405 DLRDQFDAIDVDKNGSISLEEMRQALAK 432
           +L++ F   D D +G IS EE ++ L K
Sbjct: 1   ELKEAFKEFDKDGDGKISFEEFKELLKK 28

The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29

>gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair

 Score = 37.0 bits (86), Expect = 0.001
 Identities = 13/51 (25%), Positives = 23/51 (45%)

Query: 380 FVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQAL 430
           ++    L++          D+E    +   F+ ID D +G IS EE  +A+
Sbjct: 10  YIDVEELRKLLKALGLKLTDEEVEELIEADFNEIDKDGDGRISFEEFLEAM 60

Length = 60

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 53/192 (27%), Positives = 72/192 (37%), Gaps = 45/192 (23%)

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           V+RQ+L    + H  G+VHRD+KPEN L      D  +K  DFG +  +  G  F  + G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYG 370

Query: 264 --SAYYVAPEVL-KRKSGPESDVWSIGVI--TYILLCGRRPFWDKTEDGI---------- 308
                Y  PE L   +S P +   ++  +   +  L GR   +D    G+          
Sbjct: 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL 430

Query: 309 --------FKEVLRN-KPDFRRKPWPSISNSAKDF-------------VKKLLVKDP--- 343
                   F   LR    D  R  W        DF               KL+ K     
Sbjct: 431 RPVANIRLFNTELRQYDNDLNR--WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQAN 488

Query: 344 RARLTAAQALSH 355
           R RL+  QALSH
Sbjct: 489 RGRLSVGQALSH 500

Length = 507

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 29/127 (22%)

Query: 158 NVVKFYNAFEDDNYVYIA-------------MELCEGGELLDRILAKKDSRYTEKDAAVV 204
           N  +F   F+DD  VY+              ME  +G ++ D    K      ++ A ++
Sbjct: 214 NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELL 273

Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           VR    Q+LR        G  H D  P N L    + D  +   DFG+   + P  KF+ 
Sbjct: 274 VRAFLRQLLR-------DGFFHADPHPGNIL---VRSDGRIVLLDFGIVGRLDP--KFRR 321

Query: 261 IVGSAYY 267
            +     
Sbjct: 322 YLAELLL 328

Length = 517

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 18/198 (9%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           ++  G+ G +Y      NG +  VK+I     I    + D+ +    LQ    H N+VK 
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----LQ----HPNIVKL 748

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
                 +   Y+  E  EG   L  +L         K A  + + +  +   C    +V 
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKN-LSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE-S 281
            ++ PE  +    K++  L+ +  GL       K F     S+ YVAPE  + K   E S
Sbjct: 808 -NLSPEKIII-DGKDEPHLRLSLPGL--LCTDTKCFI----SSAYVAPETRETKDITEKS 859

Query: 282 DVWSIGVITYILLCGRRP 299
           D++  G+I   LL G+ P
Sbjct: 860 DIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 45/185 (24%), Positives = 70/185 (37%), Gaps = 42/185 (22%)

Query: 89  GYD----KDFDRR---YTIGKLLGHGQFGYTYVATDKANGDRVAVK----------KIEK 131
           GYD        +R     IG  +G G+    YVA D   G +VAVK          K+++
Sbjct: 77  GYDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKR 135

Query: 132 NKMILP---------IAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIAMELCEG 181
           N+  L          ++    +RE + LQ L      V K        N   + ME  EG
Sbjct: 136 NRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI----AWNRHAVVMEYIEG 191

Query: 182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
            EL          R   ++   ++ ++L    + +  G+VH D+   N L     ED  +
Sbjct: 192 VEL-------YRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNIL---VTEDGDI 241

Query: 242 KATDF 246
              D+
Sbjct: 242 VVIDW 246

Length = 304

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 40/118 (33%), Positives = 60/118 (50%), Gaps = 15/118 (12%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVAT----DKANG-DRVAVKKIEKNKMILPIAVED--VK 144
           +F R R  +GK+LGHG FG    A+    DK +  + VAVK +++       A E   + 
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT----ASEHKALM 58

Query: 145 REVKILQALAGHENVVKFYNAFEDDN-YVYIAMELCEGGELLDRILAKKD--SRYTEK 199
            E+KIL  +  H NVV    A    N  + + +E C+ G L + + AK++  S Y EK
Sbjct: 59  SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

 Score = 35.6 bits (83), Expect = 0.003
 Identities = 13/42 (30%), Positives = 23/42 (54%), Gaps = 3/42 (7%)

Query: 390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALA 431
           AL++L   L +EE+ ++      +D D +G I  EE  + +A
Sbjct: 25  ALKSLGEGLSEEEIDEM---IREVDKDGDGKIDFEEFLELMA 63

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 22/203 (10%)

Query: 114 VATDKANGDRVAVKKIE----KNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD 169
           +A  K  G+ V V++I      N+M     V  ++ E+ +   L  H N+V +   F  D
Sbjct: 18  LARYKPTGEYVTVRRINLEACTNEM-----VTFLQGELHV-SKLFNHPNIVPYRATFIAD 71

Query: 170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN 229
           N +++       G   D I        +E   A +++ +L+     H  G VHR +K  +
Sbjct: 72  NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-------VGSAYYVAPEVLKRK---SGP 279
            L  S      L      LS  I  G++ + +       V    +++PEVL++       
Sbjct: 132 ILI-SVDGKVYLSGLRSNLS-MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189

Query: 280 ESDVWSIGVITYILLCGRRPFWD 302
           +SD++S+G+    L  G  PF D
Sbjct: 190 KSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 17/44 (38%), Positives = 26/44 (59%), Gaps = 2/44 (4%)

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG 247
           ++RQ+L      H  G+VHRD+KP+N +F  ++   S K  D G
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGSFKIIDLG 301

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	487
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.88
PRK10345	210	hypothetical protein; Provisional	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.17
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.07
cd05022	89	S-100A13 S-100A13: S-100A13 domain found in protei	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.0
cd05027	88	S-100B S-100B: S-100B domain found in proteins sim	98.93
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	98.93
PF13499	66	EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A	98.91
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.84
KOG0027	151	consensus Calmodulin and related proteins (EF-Hand	98.81
smart00027	96	EH Eps15 homology domain. Pair of EF hand motifs t	98.79
cd05029	88	S-100A6 S-100A6: S-100A6 domain found in proteins	98.78
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	98.78
cd05026	93	S-100Z S-100Z: S-100Z domain found in proteins sim	98.73
COG5126	160	FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S	98.73
cd05025	92	S-100A1 S-100A1: S-100A1 domain found in proteins	98.7
PRK09902	216	hypothetical protein; Provisional	98.69
cd00213	88	S-100 S-100: S-100 domain, which represents the la	98.67
cd05031	94	S-100A10_like S-100A10_like: S-100A10 domain found	98.64
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.64
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.61
cd00052	67	EH Eps15 homology domain; found in proteins implic	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
PF14658	66	EF-hand_9: EF-hand domain	98.58
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.56
cd05023	89	S-100A11 S-100A11: S-100A11 domain found in protei	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
KOG0041	244	consensus Predicted Ca2+-binding protein, EF-Hand	98.51
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.48
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	98.48
KOG0028	172	consensus Ca2+-binding protein (centrin/caltractin	98.43
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.42
PF13833	54	EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A	98.4
KOG0031	171	consensus Myosin regulatory light chain, EF-Hand p	98.37
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
cd00051	63	EFh EF-hand, calcium binding motif; A diverse supe	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
PTZ00184	149	calmodulin; Provisional	98.31
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.3
cd05030	88	calgranulins Calgranulins: S-100 domain found in p	98.3
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	98.27
PTZ00183	158	centrin; Provisional	98.27
PLN02876	822	acyl-CoA dehydrogenase	98.26
KOG0034	187	consensus Ca2+/calmodulin-dependent protein phosph	98.23
PTZ00184	149	calmodulin; Provisional	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.17
PTZ00183	158	centrin; Provisional	98.16
cd00252	116	SPARC_EC SPARC_EC; extracellular Ca2+ binding doma	98.16
KOG0037	221	consensus Ca2+-binding protein, EF-Hand protein su	98.15
KOG0030	152	consensus Myosin essential light chain, EF-Hand pr	98.13
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-65  Score=479.79  Aligned_cols=273  Identities=36%  Similarity=0.631  Sum_probs=248.0

Q ss_pred             CCCcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh----HhHHHHHHHHHHHHhccCCCCccEE
Q 011380           87 DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP----IAVEDVKREVKILQALAGHENVVKF  162 (487)
Q Consensus        87 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~~E~~~l~~l~~hpnIv~~  162 (487)
                      .....+.+.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+......    .....+.+|++||++|. |||||++
T Consensus       163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~  241 (475)
T KOG0615|consen  163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRI  241 (475)
T ss_pred             ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEE
Confidence            344556688899999999999999999999999999999999988665431    13345789999999995 9999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      +++|+.....||||||++||+|++.+..+  +.+.+...+.+++||+.||.|||++||+||||||+|||+..+.++..+|
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEE
Confidence            99999999999999999999999999766  6788999999999999999999999999999999999999776778999


Q ss_pred             EeecccccccCCCCccccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCC
Q 011380          243 ATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~  317 (487)
                      |+|||+|++......+.+.||||.|.|||++.++    +..++||||+||+||-+++|.+||.+...+. ..+.|.++..
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            9999999999888889999999999999999653    2458999999999999999999998876665 8899999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .|....|..+|+++.+||.+||..||++|||++|+|+||||+...
T Consensus       400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            999999999999999999999999999999999999999998754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5e-62  Score=426.82  Aligned_cols=300  Identities=31%  Similarity=0.638  Sum_probs=272.2

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .|.+.|++.+.||+|.|+.||++.+..+|+.+|+|+|...++.. ...+.+.+|++|.+.|+ |||||++.+.+...+..
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            46678999999999999999999999999999999998766543 36788999999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||+|++.|++|..-|.++  ..++|..+-.+++||+++|.|+|.+||||||+||+|+|+.+.....-+||+|||+|..+
T Consensus        86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999999999888665  56899999999999999999999999999999999999998777889999999999998


Q ss_pred             CCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..+......+|||.|||||++.. .|+..+|||+.|||||.|+.|++||++.+...+++.|..+..+++.+.|+.+++++
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            87777778999999999999975 57999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAS  396 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~  396 (487)
                      ++||++||..||.+|+|+.|+|+|||+.+........-....+..|++|....+||.+++..+..
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s  308 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA  308 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999987544333333346788999999999999998887654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-60  Score=464.25  Aligned_cols=260  Identities=35%  Similarity=0.636  Sum_probs=241.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|..++.||+|||+.||.+++..+|+.||+|+|.+..+..+...+.+.+||+|.+.|+ |||||+++++|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            67999999999999999999999999999999999988888888999999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +|+|+.++|.+++.  +.+.++|.+++.+++||+.||.|||+++|+|||||..|+|++   ++.+|||+|||||..++..
T Consensus        97 LELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   97 LELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeecCc
Confidence            99999999998885  457899999999999999999999999999999999999999   5789999999999998744


Q ss_pred             -CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 -KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                       ....+.||||.|+|||++... .+..+||||+|||||.||.|++||......+.+..|......++.    .+|.++++
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~d  247 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKD  247 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHH
Confidence             667889999999999999754 699999999999999999999999999999999999988776654    68999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                      ||.+||+.||.+|||++++|+|+||+......
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence            99999999999999999999999996654433

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-58  Score=452.31  Aligned_cols=323  Identities=53%  Similarity=0.907  Sum_probs=292.4

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ....+...|.+.+.||+|.||.||+|+++.+|+.+|+|++.+.........+.+.+|+.+|+++.+|||||.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            44667788999999999999999999999999999999999887655556789999999999997799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC-CCcEEEeeccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-DSSLKATDFGL  248 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG~  248 (487)
                      ..+++|||+|.||+|++.+...   .+++..+..+++|++.++.|||+.||+||||||+|+|+....+ .+.+|++|||+
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999999999776   3999999999999999999999999999999999999987543 45899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      +............+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+......++..+...|...+|+.+
T Consensus       186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            99988877788999999999999998 67899999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccCChHHHHHHH
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLR  407 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~~~~~~~~l~  407 (487)
                      |..+++||++||..||.+|+|+.++|+|||++........+........++++...+++++..+........   ...++
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  342 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLK  342 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHH
Confidence            999999999999999999999999999999998766666666666667777888888887776666665555   67788


Q ss_pred             HhhcccCCCCC
Q 011380          408 DQFDAIDVDKN  418 (487)
Q Consensus       408 ~~F~~~D~d~~  418 (487)
                      ..|..+|.+.+
T Consensus       343 ~~~~~~~~~~~  353 (382)
T KOG0032|consen  343 EMFKLMDTDNN  353 (382)
T ss_pred             HHHHhhccccc
Confidence            88999988877

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-57  Score=421.38  Aligned_cols=258  Identities=31%  Similarity=0.581  Sum_probs=235.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||.++.+.+++.||+|++.+.........+....|..||..+. ||+||+++..|++...+|+|
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence            57999999999999999999999999999999999988777777889999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-CC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~  254 (487)
                      +||+.||+|+.+|.  +.+.++|..++.++..|+.||.|||++|||||||||+|||++   .+|+|+|+|||+++.. ..
T Consensus       104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcccC
Confidence            99999999999984  447899999999999999999999999999999999999999   6899999999999854 44


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      +....+.|||+.|||||++.+ .|+..+|+||||+++|+|++|.+||.+.+...++++|..++.....   .-++.++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ard  255 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARD  255 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHH
Confidence            455667899999999999865 5799999999999999999999999999999999999998733222   238899999


Q ss_pred             HHHHccccCccCCc----CHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARL----TAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rp----t~~e~L~h~~~~~~~  362 (487)
                      +|+++|..||++|.    ++.++-+||||....
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            99999999999996    789999999998754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-56  Score=415.52  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=224.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-EEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYIA  175 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-~~~lv  175 (487)
                      +.+.++.||+|+.|+||+|+++.|++.+|+|+|...  ..+....++.+|+++++.. +||+||++|++|...+ .++|+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEee
Confidence            466778999999999999999999999999999433  3466788999999999999 5999999999999999 59999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+||+|.+.+...  +.++|.....++.++++||.|||. ++||||||||+|||++   ..|.|||||||.+..+..
T Consensus       157 mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN---skGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN---SKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec---cCCCEEeccccccHHhhh
Confidence            9999999999887443  779999999999999999999995 9999999999999999   488999999999988765


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK-----TEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      + ...+++||..|||||.+.+ .|+.++||||||+.++||++|+.||...     ..-+++..|..+.++-...  ..+|
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS  308 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFS  308 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCC
Confidence            5 5578999999999999987 5899999999999999999999999774     4456677777654332221  2489


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +++++||..||++||.+|||+.|+++|||+++..
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            9999999999999999999999999999998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-56  Score=402.08  Aligned_cols=255  Identities=31%  Similarity=0.590  Sum_probs=236.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||.|+||+|.+++++.+|..+|+|++++.....-...+...+|.++|+.+. ||+++++++.|.+.+.+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence            46899999999999999999999999999999999988777777889999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||.|+.++  ++.+++++..++.++.||+.||+|||+++|++|||||+|||++   .+|.+||+|||+|+.....
T Consensus       123 meyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccceEEecCc
Confidence            9999999999998  4457899999999999999999999999999999999999999   5899999999999987643


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                        ..+.||||.|+|||++..+ |+.++|+|||||++|||+.|.+||.+.+...++.+|+.++..|+.    .+++++++|
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdL  271 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDL  271 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHH
Confidence              5688999999999998765 688999999999999999999999999999999999999988774    589999999


Q ss_pred             HHHccccCccCCc-----CHHHHhcCccccccC
Q 011380          335 VKKLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       335 i~~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                      |+++|+.|-.+|.     ...++..||||+...
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            9999999999993     678999999999753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-56  Score=431.94  Aligned_cols=258  Identities=36%  Similarity=0.658  Sum_probs=236.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|.+++.||.|+|++|++|+++.+++.||||++.+..+.....+..+..|-.+|.+|.+||.|+++|-.|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            46999999999999999999999999999999999877766666778889999999998899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||+++|+|+++|.+.  +.|++..++.++.||+.||+|||++|||||||||+|||++   .++++||+|||.|+.+.+.
T Consensus       153 Le~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeeccccccCChh
Confidence            9999999999999554  7899999999999999999999999999999999999999   6899999999999876532


Q ss_pred             Cc--------------cccccCCccccchhhhccCC-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          256 KK--------------FQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       256 ~~--------------~~~~~gt~~y~aPE~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ..              ..+++||..|.+||++...+ ++.+|||+||||+|.|+.|.+||.+.++--++++|+.-...|+
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11              14589999999999998765 8899999999999999999999999999999999998877665


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                          +.+++.+++||+++|..||++|+|+.+|.+||||....
T Consensus       308 ----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  308 ----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             ----CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                46889999999999999999999999999999998754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9e-56  Score=414.81  Aligned_cols=263  Identities=32%  Similarity=0.613  Sum_probs=235.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..+|.+.+.||+|+||+||+|+++.++..||||.|.+... .+..++.+..||++|+.++ |||||.+++++...+.+|+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEE
Confidence            3579999999999999999999999999999999988764 4567888999999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCC---CcEEEeecccccc
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED---SSLKATDFGLSDF  251 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~---~~vkl~DfG~a~~  251 (487)
                      |||||.||+|.+++...  +.++|..++.++.||+.||++||+++||||||||+|||++.....   ..+||+|||+|+.
T Consensus        87 VMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999999554  689999999999999999999999999999999999999864222   6799999999999


Q ss_pred             cCCCCccccccCCccccchhhh-ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ..++....+.||+|.|||||++ ..+|+.|+|+||+|+|+|+|++|+.||...+..+++..+.++....+..+ ..+++.
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~  243 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNP  243 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCc
Confidence            9988888899999999999998 67899999999999999999999999999999998887766654333222 346667


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..+++...|+.+|.+|.+..+-+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999998654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-55  Score=432.23  Aligned_cols=258  Identities=33%  Similarity=0.619  Sum_probs=238.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +-|++++.||.|+-|.|.+|++..||+.+|||+|.+...........+.+||-||+-+. ||||+++|++|+...++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence            45899999999999999999999999999999998875444445678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      .||++||.|++++..+  +++++.+++.+++||+.|+.|||..+|+||||||+|+|++.   .+.|||+|||+|..-.++
T Consensus        91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~---~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV---KNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc---ccCEeeeccceeecccCC
Confidence            9999999999999766  78999999999999999999999999999999999999994   455999999999988888


Q ss_pred             CccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .-+.+.||+|+|.|||++.|. | +.++||||+|||||.||+|++||.+.+...++.++.++....+    ..+|.++++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQd  241 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQD  241 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHH
Confidence            888999999999999999886 4 8999999999999999999999999999999999999987655    479999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ||.+||..||++|+|..||++|||+..+..
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999999999987654

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-56  Score=398.00  Aligned_cols=265  Identities=32%  Similarity=0.623  Sum_probs=242.5

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-----ChHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      +.+-..|.-.+.||+|..++|.++.++.+|+.+|+|+|......     .....+.-.+|+.||+++.+||+|+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34555688889999999999999999999999999998643221     1234566778999999999999999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +.+..+++|+|+|+.|.|+|++...  -.++|...+.+++||++|++|||.++|+||||||+|||++   ++..+||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld---dn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD---DNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec---cccceEEecc
Confidence            9999999999999999999999544  5799999999999999999999999999999999999999   5788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK-------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |++..+.++......||||+|.|||.+.       .+|+..+|+||+|||+|.|+.|.+|||.....-+++.|+.++..|
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            9999999999999999999999999874       356889999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ..+.|.++|...++||.+||+.||.+|+|++|+|.||||...
T Consensus       248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            999999999999999999999999999999999999999653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.3e-56  Score=399.72  Aligned_cols=258  Identities=29%  Similarity=0.530  Sum_probs=224.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|+...++|+|+||+||+|+++.||+.||||++.... ..+...+-..+||++|++|+ |||+|.++++|.....+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            46888889999999999999999999999999986543 34556677889999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-C
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~  254 (487)
                      +|||+. ++++.+.+. ...+++..+..+++|++.|+.|+|++++|||||||+||||+   .++.+||||||+|+.+. +
T Consensus        80 FE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCC
Confidence            999976 666666544 35689999999999999999999999999999999999999   68999999999999887 7


Q ss_pred             CCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--------------cCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------------NKPD  318 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------~~~~  318 (487)
                      +..++.++.|.||+|||.+-+  +|++.+||||+||++.||++|.+.|.+.++-+.+..|..              ..+.
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            778899999999999999876  689999999999999999999999999988776655432              2222


Q ss_pred             CC-------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          319 FR-------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       319 ~~-------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      |.             ...+|.++..+.+|+++||..||.+|++.+|+|.||||..
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            11             1225678888999999999999999999999999999954

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-54  Score=426.44  Aligned_cols=259  Identities=38%  Similarity=0.719  Sum_probs=232.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-Ch-HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-LP-IAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.|.+++.||+|+||+|+.|.+..+|..||+|++.+.... .. ...+.+.+|+.+++++..||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            446799999999999999999999999999999988765322 11 2456677999999999669999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+|||||.||+|++++..  .+++.|..++.+++||+.||+|||++||+||||||+|||++.+  .+.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~--~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGN--EGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCC--CCCEEEeccccccc
Confidence            9999999999999999966  4789999999999999999999999999999999999999942  28999999999998


Q ss_pred             c-CCCCccccccCCccccchhhhccC--C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 I-KPGKKFQDIVGSAYYVAPEVLKRK--S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~-~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      . .......+.|||+.|+|||++.+.  | +.++||||+||+||.|++|+.||.+.....++..|..+...++.    .+
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~  246 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YL  246 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----Cc
Confidence            8 466678899999999999999874  4 68999999999999999999999999888899998888766554    24


Q ss_pred             -CHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       328 -s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                       |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             999999999999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.3e-55  Score=421.78  Aligned_cols=262  Identities=32%  Similarity=0.556  Sum_probs=234.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++++.||+|+||.||+|+.+.||..+|+|++.+..+.....++.++.|-.+|... ++|+||++|-.|++..++||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence            35799999999999999999999999999999999998887777889999999999996 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||++..+|...  ..|++..++.++.+++.|++.||+.|+|||||||+|+||+   ..|++||+||||+.-+..
T Consensus       219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeeccccccchhhh
Confidence            99999999999988554  7899999999999999999999999999999999999999   689999999999742210


Q ss_pred             ----------------------CC-c-------------------------cccccCCccccchhhhccC-CCCcchHHH
Q 011380          255 ----------------------GK-K-------------------------FQDIVGSAYYVAPEVLKRK-SGPESDVWS  285 (487)
Q Consensus       255 ----------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~~-~~~~~DiwS  285 (487)
                                            .. .                         ....+|||.|||||++.++ |+..+|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                  00 0                         0136899999999998764 799999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCc---CHHHHhcCccccccC
Q 011380          286 IGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREGG  362 (487)
Q Consensus       286 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~L~h~~~~~~~  362 (487)
                      ||||+||||.|.+||.+.+..+.+.+|......+..+.-..++++++|||.+||+ ||.+|.   ++.||.+||||+...
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence            9999999999999999999999999999887666555556788999999999999 999998   599999999999864


Q ss_pred             C
Q 011380          363 D  363 (487)
Q Consensus       363 ~  363 (487)
                      .
T Consensus       453 W  453 (550)
T KOG0605|consen  453 W  453 (550)
T ss_pred             c
Confidence            3

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-56  Score=422.16  Aligned_cols=263  Identities=32%  Similarity=0.513  Sum_probs=228.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-E
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-Y  171 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-~  171 (487)
                      .+.++|.++++||.|+||.||+|+.+.+|..||||++++.-....  .-.-.||+..|++|..|||||++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            355789999999999999999999999999999999977544322  2233689999999956999999999998887 9


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+|||||+ .+|++.+..+ +..+++..++.|+.||+.||+|+|.+|+.||||||+|||+..   ...|||+|||+|+.
T Consensus        85 L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEecccccccc
Confidence            999999995 5899988665 788999999999999999999999999999999999999983   67899999999999


Q ss_pred             cCCCCccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC------------
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP------------  317 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------  317 (487)
                      +.....++.++.|.||+|||++.  +-|+.++||||+|||++|+++-++.|.|.++-+.+.+|..--.            
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            99889999999999999999985  4579999999999999999999999999998887777653111            


Q ss_pred             -------CCCCC-------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 -------DFRRK-------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 -------~~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                             .++..       ..++.+.++.++|.+||.+||.+||||.++|+||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                   11110       1355788999999999999999999999999999998643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-53  Score=405.71  Aligned_cols=265  Identities=28%  Similarity=0.470  Sum_probs=229.1

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      +.....+.|+.+++||+|+||.||+|++..+|+.||+|++...... +....-..+||.||++| +||||+++.+...+.
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRL-DHPNIIKLEEIVTSK  188 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhc-CCCcccceeeEEEec
Confidence            3344556799999999999999999999999999999999876533 33445667999999999 599999999988765


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        +.+|||+|||+. +|.-++ ...+-.|++.++..+++||+.||+|||.+||+|||||.+||||+   ++|.+||+|||
T Consensus       189 ~~~siYlVFeYMdh-DL~GLl-~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid---n~G~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMDH-DLSGLL-SSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID---NNGVLKIADFG  263 (560)
T ss_pred             CCceEEEEEecccc-hhhhhh-cCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc---CCCCEEecccc
Confidence              789999999976 666654 44566899999999999999999999999999999999999999   68999999999


Q ss_pred             cccccCCCC--ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          248 LSDFIKPGK--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       248 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      +|+++....  .++..+-|.||+|||.+.|  .|+.++|+||+||||.||+.|++.|.+.++-+.+..|.+-........
T Consensus       264 LAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  264 LARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             ceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence            999776543  5778899999999999976  589999999999999999999999999999999999876544444444


Q ss_pred             CC-------------------------CCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          324 WP-------------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       324 ~~-------------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |+                         .++..+.+|+..||+.||.+|.||.++|+|+||...
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            43                         257789999999999999999999999999999653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-52  Score=372.88  Aligned_cols=259  Identities=31%  Similarity=0.499  Sum_probs=224.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|...+.||+|.||.||+|++..||+.||||+|........ ......+||+.|+.++ ||||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            468889999999999999999999999999999987654332 2345679999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||++. +|...+ +.+...++..++..++.+++.||+|||++.|+||||||+|+|++   .+|.+||+|||+|+.+.+.
T Consensus        80 fEfm~t-dLe~vI-kd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   80 FEFMPT-DLEVVI-KDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             EEeccc-cHHHHh-cccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCC
Confidence            999974 776655 44567899999999999999999999999999999999999999   5889999999999988654


Q ss_pred             Cc-cccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC------
Q 011380          256 KK-FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS------  326 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------  326 (487)
                      .. ....+-|.||+|||.+.|  .|+..+||||.|||+.||+.|.+-|.+.++-+.+..|++.-.......||+      
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            33 344588999999999876  589999999999999999999999999999888888876544444444433      


Q ss_pred             ------------------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ------------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                        .+.++.||+.+||.+||.+|+|+.|+|+|+||+..
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                              46678999999999999999999999999999974

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-53  Score=369.26  Aligned_cols=257  Identities=32%  Similarity=0.621  Sum_probs=237.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|.||.||.|+.+.++-.||+|++.+..........++.+|++|-..|+ ||||+++|++|.+...+|++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            46999999999999999999999999999999998887665666788999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||.+.|+|+..+...+..++++..++.+++|++.||.|+|.++||||||||+|+|++.   .+.+||+|||.+.... .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~---~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS---AGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC---CCCeeccCCCceeecC-C
Confidence            99999999999998777888999999999999999999999999999999999999984   7789999999997765 4


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ....+.|||..|.|||...+. ++..+|+|++|++.||++.|.+||...+..+.+.+|.+....++    ..++..+.|+
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            556789999999999999875 58899999999999999999999999999999999998876665    5789999999


Q ss_pred             HHHccccCccCCcCHHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |.+||.++|.+|.+..|++.|||+...
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-52  Score=412.30  Aligned_cols=257  Identities=26%  Similarity=0.493  Sum_probs=236.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.++||+|+||+|+++..+.+++.+|||++++..+.....++....|.+|+....+||.++.++.+|+...++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            57999999999999999999999999999999999998888888999999999999887899999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-C
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~  254 (487)
                      |||+.||++..+   .....+++..++.++..++.||.|||++||||||||.+|||++   ..|.+||+|||+++... .
T Consensus       448 mey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  448 MEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEecccccccccCCC
Confidence            999999995433   3447899999999999999999999999999999999999999   58999999999998654 5


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      +....++||||.|||||++.+ .|+..+|+|||||+||||+.|..||.+.++++++..|+...+.|+.    .+|.++.+
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~  597 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIA  597 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHH
Confidence            566788999999999999976 5899999999999999999999999999999999999998877764    58999999


Q ss_pred             HHHHccccCccCCcC-----HHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLT-----AAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~~  362 (487)
                      +++++|.++|++|..     +.+|..||||+...
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            999999999999985     57899999999754

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-52  Score=406.33  Aligned_cols=254  Identities=30%  Similarity=0.566  Sum_probs=230.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||+||+|+.+.+.+.||+|.+++... .......+.+|++|++.|+ |||||.++++|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            468899999999999999999999999999999988764 3456778999999999996 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +|||.| +|+..+..  .+.++|+.+..++.+++.||.|||+++|+|||+||.|||+.   .++.+|+||||+|+....+
T Consensus        80 te~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             ehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccC
Confidence            999977 99998844  47899999999999999999999999999999999999998   5899999999999987765


Q ss_pred             Cc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      +. ...+.|||.|||||++.+. |+..+|+||||||+|||+.|++||...+...+.+.|+.....++    +.+|..+..
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~n  229 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVN  229 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHH
Confidence            54 4567899999999999765 68999999999999999999999999998888888887755443    378999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |++.+|.+||.+|+|+.+++.|||.+..
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence            9999999999999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-53  Score=380.34  Aligned_cols=254  Identities=30%  Similarity=0.522  Sum_probs=219.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEE-EEEeCCE-E
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-AFEDDNY-V  172 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~-~~~~~~~-~  172 (487)
                      ..+|++.++||+|+||+||++.+..+|..+|.|.|....+ .....+....|+.+|++|. |||||++++ -|..++. +
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence            3569999999999999999999999999999999985544 4567788999999999995 999999998 4555554 9


Q ss_pred             EEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH--cC--ceeecCCCCceEeccCCCCCcEEEeec
Q 011380          173 YIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHL--HG--LVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~--~~--iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +||||||.+|+|...+...  ....++|..++.++.|++.||..+|+  ..  |+||||||.||+++   .+|.|||+||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvKLGDf  172 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVKLGDF  172 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCceeeccc
Confidence            9999999999999888543  44679999999999999999999999  45  99999999999999   6889999999


Q ss_pred             ccccccCCCCc-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          247 GLSDFIKPGKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       247 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |+++++..... ..+.+|||+||+||.+.+ .|+.++||||+||++|||+.-.+||.+.+-.++..+|.++..  +.-+-
T Consensus       173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--~~~p~  250 (375)
T KOG0591|consen  173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--PPLPD  250 (375)
T ss_pred             hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--CCCcH
Confidence            99999876554 356899999999999865 589999999999999999999999999988888888888742  22222


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ..+|.++..+|..|+..||..||+.     +|++..
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence            3578999999999999999999987     555544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-52  Score=406.03  Aligned_cols=261  Identities=31%  Similarity=0.541  Sum_probs=229.4

Q ss_pred             CcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ....+....|...++||+|+-|.||.|+...+++.||||++...+.   ...+.+.+|+.+|+.++ |+|||.+++.|..
T Consensus       266 ~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  266 VSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLV  341 (550)
T ss_pred             ccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhcc
Confidence            3345667789999999999999999999999999999999987653   35578899999999996 9999999999998


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      .+.+|+||||++||+|.+.+..   ..++|.+++.+++.+|.||+|||.+||+|||||.+|||++   .++.+||+|||+
T Consensus       342 ~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGF  415 (550)
T KOG0578|consen  342 GDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGF  415 (550)
T ss_pred             cceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeee
Confidence            8999999999999999987733   4699999999999999999999999999999999999999   578899999999


Q ss_pred             ccccCCCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCCCCCCCCC
Q 011380          249 SDFIKPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKPWP  325 (487)
Q Consensus       249 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  325 (487)
                      +..+.... ...+.+|||+|||||++.. .|++++||||||++++||+-|.+||..+..-..+..|..+ .+.+  ..+.
T Consensus       416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l--k~~~  493 (550)
T KOG0578|consen  416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL--KNPE  493 (550)
T ss_pred             eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc--CCcc
Confidence            98776544 5678899999999999875 6899999999999999999999999987765555555443 3333  3446


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+|+++++||.+||+.|+.+|++|.|+|+||||+..
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            899999999999999999999999999999999654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-52  Score=389.37  Aligned_cols=258  Identities=32%  Similarity=0.606  Sum_probs=239.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+...+|++.+.||+|+||+|-+|++...|+.||||.|.+.+....+..-.+++||+||..| +||||+.+|++|+..+.
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDK  127 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCce
Confidence            45567899999999999999999999999999999999999998888899999999999999 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +.|||||..+|+|++++..  .+.+++.+++.+++||.+|+.|+|.++++|||||.+|||++   .++++||+|||++..
T Consensus       128 IvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD---~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD---QNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec---CCCCeeeeccchhhh
Confidence            9999999999999999944  47899999999999999999999999999999999999999   588899999999999


Q ss_pred             cCCCCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      +.....++++||+|.|.+||+++|.+  ++.+|-|||||+||.|+.|..||.+.+-..++++|.++...-+     .-+.
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PS  277 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPS  277 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCc
Confidence            88888899999999999999999874  8999999999999999999999999999999999988764332     3456


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      .+.-||+.||-.||++|.|+.++-.|=|+.-
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            7999999999999999999999999999863

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=382.73  Aligned_cols=269  Identities=32%  Similarity=0.546  Sum_probs=224.9

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED---  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~---  168 (487)
                      -.+..+|...+.||+|+||.|+.|.++.+|+.||||++... +......+...+|+++|+.++ |+||+.+++++..   
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR   95 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence            34556788789999999999999999999999999998632 223446677889999999996 9999999998865   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                        -+.+|+|+|+| +.+|...+..  +..+++.++..+++||+.||+|+|+.+|+||||||.|+|++   .+..+||+||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DF  169 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDF  169 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccc
Confidence              45799999999 4577776633  34599999999999999999999999999999999999998   5788999999


Q ss_pred             ccccccCC---CCccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH--------
Q 011380          247 GLSDFIKP---GKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL--------  313 (487)
Q Consensus       247 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~--------  313 (487)
                      |+|+....   ...++.++-|.||+|||++.  ..|+.++||||+|||+.||++|++.|.+.+.-..+..|+        
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99998753   44567889999999999874  468999999999999999999999998876554444332        


Q ss_pred             ---------------hcCCCCCCCC----CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCC
Q 011380          314 ---------------RNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (487)
Q Consensus       314 ---------------~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~  368 (487)
                                     +..+..+..+    +|+.++.+.+|+.+||..||.+|+|++|+|.|||+.........|
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                           2233333333    578899999999999999999999999999999999877655544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-52  Score=391.46  Aligned_cols=258  Identities=34%  Similarity=0.565  Sum_probs=215.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--EEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--YVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~~~  173 (487)
                      ..|..++.||+|+||.||++.++.+|...|||.+.....  + ..+.+.+|+.+|.+|+ |||||+++|......  .++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence            357888999999999999999999999999999876531  1 2577899999999997 999999999754444  699


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |+|||++||+|.+.+....+ .+++..++.+.+||++||+|||++||+||||||+|||++.  .++.+||+|||++....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~--~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP--SNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC--CCCeEEeccCccccccc
Confidence            99999999999999976655 8999999999999999999999999999999999999993  15799999999998765


Q ss_pred             C----CCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 P----GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 ~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .    ........||+.|||||++....  .+++|||||||++.||+||+.||.. ......+..+...... + .....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~-P-~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL-P-EIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC-C-CCCcc
Confidence            3    12234578999999999998543  3499999999999999999999987 3333444444444311 1 22246


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|+++++||.+||..||++||||.++|+|||.+...
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            999999999999999999999999999999998754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-51  Score=384.57  Aligned_cols=262  Identities=31%  Similarity=0.553  Sum_probs=237.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.|++++.||.|.-|+||+|..+.++..+|+|++++..+.......++..|-+||+.+ +||.++.+|..|+.+...|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence            3588999999999999999999999999999999998776666777888999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC--
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~--  253 (487)
                      ||||+||+|...+.++.+..+++..++.++..++.||+|||..|||+|||||+||||.   ++|+|-|+||.|+....  
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccccCCCC
Confidence            9999999999999888999999999999999999999999999999999999999999   68999999999863210  


Q ss_pred             --------------------------------CCC-----------------------ccccccCCccccchhhhccCC-
Q 011380          254 --------------------------------PGK-----------------------KFQDIVGSAYYVAPEVLKRKS-  277 (487)
Q Consensus       254 --------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~-  277 (487)
                                                      ...                       .....+||-.|.|||++.|.. 
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                       012368999999999999864 


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcC----HHHHh
Q 011380          278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT----AAQAL  353 (487)
Q Consensus       278 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~e~L  353 (487)
                      +.++|+|+|||++|||+.|..||.+.+..+.+.+|+...+.|+..+  .+|..++|||+++|.+||++|..    |.||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            8999999999999999999999999999999999999998888764  78899999999999999999998    99999


Q ss_pred             cCccccccCC
Q 011380          354 SHPWVREGGD  363 (487)
Q Consensus       354 ~h~~~~~~~~  363 (487)
                      +||||+..+.
T Consensus       391 ~HpFF~gVnW  400 (459)
T KOG0610|consen  391 RHPFFEGVNW  400 (459)
T ss_pred             cCccccCCCh
Confidence            9999998654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-51  Score=374.85  Aligned_cols=259  Identities=28%  Similarity=0.421  Sum_probs=220.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~  173 (487)
                      +.|+.+..|++|+||.||+|+++.|++.||+|+++...-... .--...+||.+|.+++ |||||.+-++...  -+.+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence            468999999999999999999999999999999976542211 1123469999999996 9999999998764  35799


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+. +|...+. ....++...++..++.|++.|++|||.+.|+||||||+|+|+.   +.|.+||+|||+|+.+.
T Consensus       154 ~VMe~~Eh-DLksl~d-~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLME-TMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHHh-hHHHHHH-hccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhc
Confidence            99999976 7766553 4447899999999999999999999999999999999999998   68999999999999876


Q ss_pred             CC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC----
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS----  326 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----  326 (487)
                      .. ..++..+-|.||+|||.+.+  .|+.++|+||+|||+.||+++++.|.+.++.+.+..|+..-.......||.    
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            54 45778889999999999876  479999999999999999999999999999988888876322222222222    


Q ss_pred             ------------------------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ------------------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                              +++...+|+..+|.+||.+|.||.|+|+|+||.+.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                                    45788999999999999999999999999999984

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-52  Score=373.88  Aligned_cols=267  Identities=33%  Similarity=0.627  Sum_probs=239.1

Q ss_pred             cCCCeeEe-eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE----e
Q 011380           94 FDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----D  168 (487)
Q Consensus        94 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~----~  168 (487)
                      +.++|.+. ++||-|-.|.|..+.++.||+.+|+|++...        ...++|+++.-....|||||.++++|+    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            55678875 5899999999999999999999999987543        445778887666668999999999886    4


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ...+.+|||.++||+|+..+..+....++|.++..|++||+.|+.|||+.+|.||||||+|+|+.....+..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            56789999999999999999888888899999999999999999999999999999999999999888889999999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhcCCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~  323 (487)
                      |+.......+.+.|-||+|.|||++.. +|+..+|+||+|||+|.|++|.+||+...    ..++...|..+...|+.+.
T Consensus       211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE  290 (400)
T KOG0604|consen  211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE  290 (400)
T ss_pred             ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence            988776677888999999999999965 58889999999999999999999998764    3567888999999999999


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~  368 (487)
                      |..+|+.++++|+++|..+|++|.|+.++++|||+.........+
T Consensus       291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp  335 (400)
T KOG0604|consen  291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP  335 (400)
T ss_pred             HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence            999999999999999999999999999999999998765444333

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-51  Score=389.87  Aligned_cols=259  Identities=34%  Similarity=0.643  Sum_probs=224.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----------HhHHHHHHHHHHHHhccCCCCccEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----------IAVEDVKREVKILQALAGHENVVKFY  163 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~E~~~l~~l~~hpnIv~~~  163 (487)
                      -+.|++++.||+|.||.|-+|++..+++.||||++.+......           ...+.+.+||.||++|. |||||+++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEE
Confidence            3579999999999999999999999999999999976433211           12368999999999996 99999999


Q ss_pred             EEEEeC--CEEEEEEeccCCCCHHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          164 NAFEDD--NYVYIAMELCEGGELLDRILAKKDSR-YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       164 ~~~~~~--~~~~lv~e~~~gg~L~~~l~~~~~~~-l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      ++..+.  +.+|||+|||..|.+...   ..... +++.+++.++++++.||+|||.+|||||||||+|+||+   .++.
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence            999764  689999999999986432   23344 89999999999999999999999999999999999999   4799


Q ss_pred             EEEeecccccccCCC------CccccccCCccccchhhhccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHH
Q 011380          241 LKATDFGLSDFIKPG------KKFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIF  309 (487)
Q Consensus       241 vkl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  309 (487)
                      |||+|||.+.....+      ..+...+|||.|+|||.+.+.     .+.+.||||+||+||+|+.|..||.+....+++
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999998766222      224457999999999987652     277899999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+|......|+..  +.+.+.+++||.+||++||.+|+++.++..|||.....
T Consensus       329 ~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  329 DKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            9999988777664  46889999999999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-50  Score=379.31  Aligned_cols=262  Identities=28%  Similarity=0.479  Sum_probs=231.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.|++.+.||.|..++||+|+...++..||||++...+..  ...+.+.+|+..|+.+ +||||++++..|..+..+|+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEe
Confidence            4799999999999999999999999999999999877643  3478899999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |.||.+|++++.+...-...++|..++.+++++++||.|||.+|.||||||+.||||+   .+|.|||+|||.+..+..+
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---SDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---CCCcEEEcCceeeeeeccc
Confidence            9999999999999887777799999999999999999999999999999999999999   5899999999987554322


Q ss_pred             -C----ccccccCCccccchhhhc---cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC------C
Q 011380          256 -K----KFQDIVGSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR------R  321 (487)
Q Consensus       256 -~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------~  321 (487)
                       .    .+.+.+|||+|||||++.   .+|+.|+||||||++..||.+|..||.......++-.-+++.+...      .
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence             1    125679999999999964   3689999999999999999999999999888888877777776432      2


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .....++..++.+|..||.+||++||||.++|+|+||+....
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            223457788999999999999999999999999999998654

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=388.03  Aligned_cols=265  Identities=32%  Similarity=0.636  Sum_probs=242.7

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ++..+..-|.+.+.||+|.|+.|-+|++..||..||||+|++.++.. .....++.|++.|+.++ |||||++|++....
T Consensus        12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQ   89 (864)
T ss_pred             cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhc-CcCeeeeeehhccc
Confidence            45667778999999999999999999999999999999999988643 45678889999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ..+|+|+|+-++|+|+++|++.. ..+.|..+..++.||+.|+.|+|+..+|||||||+||.+..  +-|.|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeecccc
Confidence            99999999999999999998764 67999999999999999999999999999999999998874  6899999999999


Q ss_pred             cccCCCCccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..+.++..+.+.||+..|-|||++.|. | .+++||||||||||.|++|.+||...+..+.+-.|+..+...+    ..+
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shv  242 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHV  242 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhh
Confidence            999999999999999999999998875 4 6889999999999999999999999999999999988765544    358


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      |.++++||..||..||++|.+.++|..|+|++....
T Consensus       243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  243 SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             hHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999999999999997644

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-49  Score=383.82  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=219.3

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |++.+.||+|+||+||+|.++.+|+.||+|.+.+...........+.+|+.+++.+. ||||+++++++.+.+.+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            788999999999999999999999999999987654333334456788999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  257 (487)
                      |+++|+|.+.+.......+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887655455789999999999999999999999999999999999998   477899999999987655444


Q ss_pred             cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          258 FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+..............++.++.+||+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            556789999999999865 5689999999999999999999999876554333333222222222233468999999999


Q ss_pred             HccccCccCCcC-----HHHHhcCcccccc
Q 011380          337 KLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       337 ~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +||+.||.+||+     ++++++||||...
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999997     8999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-49  Score=384.84  Aligned_cols=253  Identities=28%  Similarity=0.528  Sum_probs=222.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence            6899999999999999999999999999999997644323334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcchhccCC-
Confidence            999999999988543  5789999999999999999999999999999999999998   4778999999999766432 


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                       ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+..+...++    ..+++.+++||
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li  229 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLI  229 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHH
Confidence             2346799999999998764 58899999999999999999999999888888888887765543    24688999999


Q ss_pred             HHccccCccCCcC-----HHHHhcCcccccc
Q 011380          336 KKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       336 ~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      ++||+.||.+||+     +.++++||||+..
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            9999999999995     9999999999763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-51  Score=368.28  Aligned_cols=268  Identities=36%  Similarity=0.624  Sum_probs=237.3

Q ss_pred             cccCCCeeE-eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           92 KDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        92 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ..|.+-|++ .+.||+|+||.|--+....+|..||||+|++..   ......+.+|++++...++|+||++++++|+++.
T Consensus        73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            345566776 468999999999999999999999999998874   4567889999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+|||-+.||+|+.+|.++  ..++|.++..+.++|+.||.|||.+||.||||||+|||....+.-.-||||||.+..
T Consensus       150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence            999999999999999999655  679999999999999999999999999999999999999876666789999999975


Q ss_pred             ccCCC--------CccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCC------------
Q 011380          251 FIKPG--------KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKT------------  304 (487)
Q Consensus       251 ~~~~~--------~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~------------  304 (487)
                      -+...        ..+.+.+|+..|||||+..      ..|+.++|.||||||+|.|++|++||.+..            
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            54322        2245678999999999863      247899999999999999999999996532            


Q ss_pred             ---hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          305 ---EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       305 ---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                         ...++..|..++..|+...|-.+|.+++++|..+|..|+.+|.++.++++|||++.....
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence               246788899999999999999999999999999999999999999999999999976544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-49  Score=389.52  Aligned_cols=254  Identities=31%  Similarity=0.566  Sum_probs=223.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997654333344567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        97 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCceEcCCC
Confidence            9999999999988543  5789999999999999999999999999999999999998   4788999999999766432


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                        ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+..+...++    ..++..+++|
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  245 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDL  245 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHH
Confidence              2346899999999998764 58899999999999999999999998888778888877654433    2478899999


Q ss_pred             HHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      |.+||+.||.+||+     +.+++.||||+..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999999997     7999999999863

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.9e-49  Score=392.45  Aligned_cols=259  Identities=28%  Similarity=0.469  Sum_probs=220.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++..+. ||||+++++.+.+...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence            36899999999999999999999999999999997654333344567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        80 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          80 MEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             EcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCccccccc
Confidence            9999999999988543  6799999999999999999999999999999999999998   4778999999998754321


Q ss_pred             C------------------------------------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCC
Q 011380          256 K------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRR  298 (487)
Q Consensus       256 ~------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~  298 (487)
                      .                                    .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            0                                    0124589999999999865 46899999999999999999999


Q ss_pred             CCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccC---CcCHHHHhcCcccccc
Q 011380          299 PFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA---RLTAAQALSHPWVREG  361 (487)
Q Consensus       299 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~---Rpt~~e~L~h~~~~~~  361 (487)
                      ||.+....+.+..+.........+....++++++++|.+|+. +|.+   ||++.|+++||||+..
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            999888888888887654444334444689999999999876 4554   5899999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-49  Score=367.90  Aligned_cols=262  Identities=30%  Similarity=0.472  Sum_probs=221.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCC----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VVKFYNAFEDDN----  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-Iv~~~~~~~~~~----  170 (487)
                      ..|..+++||+|+||+||+|+.+.+|+.||+|++...... +..-....+|+.+|+.|+ |+| |+.+++++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            4577888899999999999999999999999999765431 112245579999999996 999 999999998877    


Q ss_pred             --EEEEEEeccCCCCHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          171 --YVYIAMELCEGGELLDRILAKKD--SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                        .+++|+||++ -+|..++.....  ..++...++.+++||+.||+|||+++|+||||||+||||+   ..+.+||+||
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeecc
Confidence              8999999995 488888865432  3678899999999999999999999999999999999999   4889999999


Q ss_pred             ccccccC-CCCccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          247 GLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       247 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      |+|+... +...+...++|.+|+|||++.+.  |+...||||+|||++||+++++.|.+.++.+.+..|..--.......
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9998776 44457788999999999998764  78999999999999999999999999999888888765332222222


Q ss_pred             CC--------------------------CCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          324 WP--------------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       324 ~~--------------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ||                          ..++...+++.+||+++|.+|.|+..+|.||||.....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            22                          23457899999999999999999999999999988643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.7e-49  Score=387.38  Aligned_cols=250  Identities=30%  Similarity=0.537  Sum_probs=217.8

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333345567789999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~~  260 (487)
                      |+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccCCCcccc
Confidence            999988854  35789999999999999999999999999999999999998   47789999999987532 2233445


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......++    ..+++++.+||.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLL  230 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence            689999999999865 468999999999999999999999998887777777776655443    358899999999999


Q ss_pred             ccCccCCc-----CHHHHhcCcccccc
Q 011380          340 VKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ..||++||     ++.++++||||...
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.2e-50  Score=371.20  Aligned_cols=258  Identities=30%  Similarity=0.524  Sum_probs=219.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--C---
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--N---  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~---  170 (487)
                      -.|.-.+++|+|+||.||.|....+++.||||++-.....       -.+|+.+|+.+. |||||++.-+|...  +   
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLD-HPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcC-CcCeeeEEEEEEecCCCchh
Confidence            3588899999999999999999999999999988655422       247999999995 99999999888532  2   


Q ss_pred             EEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      +..+||||++. +|.+.+...  .+..++.-.++-+.+||++||.|||+.||+||||||.|+|++.  +.+.+||||||.
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKicDFGS  172 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEeccCCc
Confidence            45689999975 888877532  3567899999999999999999999999999999999999996  679999999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh------------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------  314 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~------------  314 (487)
                      |+.+..++...++..|..|+|||.+.|  .|+.+.||||.||++.||+-|++.|.+.+..+++..|.+            
T Consensus       173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            999988888888999999999999876  589999999999999999999999999988877777654            


Q ss_pred             cCCC--------CCCCCC-----CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          315 NKPD--------FRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       315 ~~~~--------~~~~~~-----~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                      .++.        +....|     ...++++.+|+.++|.++|.+|.++.|+|.||||.+....
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            1111        112222     3478899999999999999999999999999999986654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-48  Score=391.46  Aligned_cols=258  Identities=31%  Similarity=0.553  Sum_probs=222.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence            6999999999999999999999999999999997654333344567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccceeccccc
Confidence            999999999988543  5799999999999999999999999999999999999998   57889999999986542211


Q ss_pred             ---------------------------------------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhC
Q 011380          257 ---------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG  296 (487)
Q Consensus       257 ---------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g  296 (487)
                                                             .....+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                   0113479999999999865 468999999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcC---HHHHhcCcccccc
Q 011380          297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (487)
Q Consensus       297 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~L~h~~~~~~  361 (487)
                      ..||.+......+..+......+..+....+++++++||.+||. +|.+|++   +.++|.||||+..
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999888887777777655444444444689999999999997 9999998   9999999999874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-48  Score=385.70  Aligned_cols=257  Identities=32%  Similarity=0.525  Sum_probs=222.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence            6999999999999999999999999999999997654333334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCCccccc--
Confidence            99999999998844  35789999999999999999999999999999999999998   478899999999976543  


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC----CCCCHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW----PSISNSA  331 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~  331 (487)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+.+..+......+..+.+    ..+++++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            3345689999999999865 4689999999999999999999999988887777776654433322222    2578999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+||.+||..+|.+||++.++++||||+..
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-48  Score=390.70  Aligned_cols=259  Identities=29%  Similarity=0.481  Sum_probs=224.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEE
Confidence            46999999999999999999999999999999997643323334456788999999994 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccceeeccCC
Confidence            999999999987743   3589999999999999999999999999999999999998   5788999999999765433


Q ss_pred             C--ccccccCCccccchhhhcc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .  .....+||+.|+|||++.+     .++.++|||||||++|+|++|+.||.+......+..+.........+....+|
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS  275 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence            2  2235689999999999854     25789999999999999999999999988888888888765554444455689


Q ss_pred             HHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      .++++||++||+.+|.+  |+|+.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999999999998  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-48  Score=385.49  Aligned_cols=254  Identities=31%  Similarity=0.554  Sum_probs=221.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ++|.+.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEE
Confidence            46999999999999999999876655 689999987654333345567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCCCeecCC
Confidence            99999999999988543  5789999999999999999999999999999999999998   578899999999987643


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .  ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+..+...++    +.+++.+.+
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  257 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKH  257 (340)
T ss_pred             C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHH
Confidence            2  3456899999999998654 68899999999999999999999998888778888877654433    357889999


Q ss_pred             HHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      +|++||+.||.+|+     ++.++++||||+..
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999995     89999999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-48  Score=389.61  Aligned_cols=259  Identities=30%  Similarity=0.463  Sum_probs=218.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|.+++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999997654433445677889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          81 DYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCccccccc
Confidence            999999999988543  5689999999999999999999999999999999999998   47789999999875321000


Q ss_pred             ------------------------------------------------ccccccCCccccchhhhcc-CCCCcchHHHHH
Q 011380          257 ------------------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIG  287 (487)
Q Consensus       257 ------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG  287 (487)
                                                                      .....+||+.|+|||++.+ .++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                            0123579999999999865 468999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccc--cCccCCcCHHHHhcCcccccc
Q 011380          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV--KDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       288 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~--~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |++|+|++|..||...........+.........+.+..+++++++||.+||.  .+|..|+++.++++||||+..
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999999998887766666666544334444445689999999999665  455559999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.6e-48  Score=374.24  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=211.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||.|+||+||+|.++.+++.||+|++.....  ......+.+|+.+++++. ||||+++++++...+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            469999999999999999999999999999999865432  123356778999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        82 ~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          82 FEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVP  156 (288)
T ss_pred             EeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeeccCC
Confidence            999975 888877543 34688999999999999999999999999999999999998   4778999999998764322


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (487)
                       .......||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+..+.+..+.........           
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             22345678999999998864  4688999999999999999999999887766655554332111000           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          322 ---------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       322 ---------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                     ...+.++.++++||++||++||.+|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                           0123568899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-48  Score=390.32  Aligned_cols=258  Identities=31%  Similarity=0.503  Sum_probs=221.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++++. ||||+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            5899999999999999999999999999999997654333345567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      |||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCccccccc
Confidence            999999999988543  5689999999999999999999999999999999999998   4788999999997432100 


Q ss_pred             -----------------------------------------------CccccccCCccccchhhhcc-CCCCcchHHHHH
Q 011380          256 -----------------------------------------------KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIG  287 (487)
Q Consensus       256 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG  287 (487)
                                                                     ......+||+.|+|||++.+ .++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           00123579999999999865 578999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcC---HHHHhcCcccccc
Q 011380          288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (487)
Q Consensus       288 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~L~h~~~~~~  361 (487)
                      |++|+|++|+.||.+....+....+.........+....+++++.++|.+|+ .+|.+|++   +.++++||||+..
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999999988877777777765555555555678999999999987 59999997   9999999999874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-48  Score=390.18  Aligned_cols=259  Identities=27%  Similarity=0.490  Sum_probs=218.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+++.||+|+||+||+|.++.+|+.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence            36999999999999999999999999999999987644333345567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++..  ...+++..++.++.||+.||+|||+.||+||||||+|||++   .++.+||+|||+++.....
T Consensus        80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeecccccccccc
Confidence            999999999998854  36789999999999999999999999999999999999998   4788999999998532110


Q ss_pred             C------------------------------------------------ccccccCCccccchhhhcc-CCCCcchHHHH
Q 011380          256 K------------------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSI  286 (487)
Q Consensus       256 ~------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSl  286 (487)
                      .                                                .....+||+.|+|||++.+ .++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            0                                                0012579999999999865 46899999999


Q ss_pred             HHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCC---cCHHHHhcCcccccc
Q 011380          287 GVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVREG  361 (487)
Q Consensus       287 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---pt~~e~L~h~~~~~~  361 (487)
                      ||++|+|++|..||.+....+.+..+.........+....++.++++||.+||. +|.+|   +++.+++.||||+..
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999999998888777777776543333333334588999999999998 77775   599999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.1e-48  Score=387.83  Aligned_cols=259  Identities=29%  Similarity=0.484  Sum_probs=222.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+++.+|+|
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997643333334556788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccceecccC
Confidence            999999999998743   3589999999999999999999999999999999999998   5788999999999876432


Q ss_pred             C--ccccccCCccccchhhhccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .  .....+||+.|+|||++.+.     ++.++|||||||++|+|++|+.||.+.+....+..+......+..+....++
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  275 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS  275 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence            2  22456899999999998642     5789999999999999999999999888888888887765444443444689


Q ss_pred             HHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      ..++++|.+||..+|.+  |+|+.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999866554  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=380.28  Aligned_cols=255  Identities=29%  Similarity=0.508  Sum_probs=224.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|...+.||+|+||.||+|.+..+++.||+|++.....  ....+++..|+.+|.++. +|||.++|+.|..+..++++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence            457778999999999999999999999999999987654  345688999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||.||++.+.+  ..+..+.+..+..++++++.||.|||..+.+|||||+.|||+.   ..+.+||+|||.+......
T Consensus        90 Mey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   90 MEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeech
Confidence            9999999999988  3445569999999999999999999999999999999999998   4689999999999877654


Q ss_pred             Cc-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .. ..+++|||.|||||++.+ .|+.++||||||++.+||++|.+|+........+..|-+..|+...   ..+|+.+++
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kE  241 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKE  241 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHH
Confidence            33 378899999999999987 6899999999999999999999999888776555555544433322   268899999


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ||..||.+||+.||+|.++|+|+|++..
T Consensus       242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  242 FVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999999884

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-48  Score=378.97  Aligned_cols=248  Identities=26%  Similarity=0.489  Sum_probs=216.1

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++...+.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999997654333445567789999999995 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccccc
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIV  262 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~~~  262 (487)
                      |.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... .......+
T Consensus        80 L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          80 LFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCCcccccc
Confidence            9998854  35789999999999999999999999999999999999998   477899999999875432 22334568


Q ss_pred             CCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcccc
Q 011380          263 GSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (487)
Q Consensus       263 gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (487)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+......++    ..+++++.++|.+||..
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~  230 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCC
Confidence            99999999998664 68899999999999999999999998888888888877654443    45889999999999999


Q ss_pred             CccCCc---CHHHHhcCcccccc
Q 011380          342 DPRARL---TAAQALSHPWVREG  361 (487)
Q Consensus       342 dp~~Rp---t~~e~L~h~~~~~~  361 (487)
                      ||.+||   ++.++|.||||...
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCC
Confidence            999997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-48  Score=390.00  Aligned_cols=258  Identities=28%  Similarity=0.469  Sum_probs=219.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+++. ||||+++++.+.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence            6999999999999999999999999999999987643322334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      |||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+... 
T Consensus        81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCCccccccc
Confidence            999999999988543  5689999999999999999999999999999999999998   4788999999997432100 


Q ss_pred             -------------------------------------------CccccccCCccccchhhhccC-CCCcchHHHHHHHHH
Q 011380          256 -------------------------------------------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITY  291 (487)
Q Consensus       256 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~  291 (487)
                                                                 ......+||+.|+|||++.+. ++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       001235799999999998654 688999999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCc---CHHHHhcCcccccc
Q 011380          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREG  361 (487)
Q Consensus       292 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~L~h~~~~~~  361 (487)
                      +|++|+.||.+....+....+...........+..+++++.++|.+|+ .+|.+|+   ++.++++||||+..
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999999988877776666655544444445678999999999987 5999999   99999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=376.17  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=212.3

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCE-EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-EEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYIA  175 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-~~~lv  175 (487)
                      ..+.+.||+|+||+||+|.++  |+. ||+|++......... .+.+.+|+.+|.+|+ |||||+++|++.... .++||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence            445566999999999999875  556 999999876544333 779999999999995 999999999999887 79999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeecCCCCceEeccCCCCC-cEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG-LVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~-iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~~~  253 (487)
                      |||+++|+|.+++.......++...+..++.||+.|++|||+++ ||||||||+|||++   .+. ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccceeec
Confidence            99999999999986644578999999999999999999999999 99999999999999   454 99999999998766


Q ss_pred             CC-CccccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .. .......||+.|||||++.+.   |+.++||||||+++|||+||+.||.+.........+..+......+  ...++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCH
Confidence            54 344557899999999999854   8999999999999999999999999888866666665544332222  13788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+..+|.+||..||.+||+..+++.
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999988764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.2e-48  Score=379.40  Aligned_cols=251  Identities=30%  Similarity=0.550  Sum_probs=217.3

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|+++.+++.||+|++.+.........+.+..|+.++..+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654333345567788999998876799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~~  260 (487)
                      |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcCCCcccc
Confidence            9999887543  5799999999999999999999999999999999999998   47789999999987532 2223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......++    +.++.++.++|++||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L  231 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFM  231 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHc
Confidence            689999999999875 468899999999999999999999999888888888877654433    347899999999999


Q ss_pred             ccCccCCcCH------HHHhcCcccccc
Q 011380          340 VKDPRARLTA------AQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~------~e~L~h~~~~~~  361 (487)
                      +.||.+||++      .+++.||||+..
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-48  Score=386.40  Aligned_cols=262  Identities=31%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-----CCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-----ENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-----pnIv~~~~~~  166 (487)
                      +.+..+|.+.+.||+|+||.|.+|.+..|++.||||+|+...    ....+...|+.+|..|..|     -|||+++++|
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            445568999999999999999999999999999999998764    3456677899999999633     4899999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ...+++|||+|++ +-+|+++++.++...++...++.++.||+.||.+||+.||||+|||||||||...+ ...|||+||
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDF  335 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDF  335 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEec
Confidence            9999999999999 56999999999888999999999999999999999999999999999999998654 458999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc----------
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN----------  315 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------  315 (487)
                      |+|.+....  ..+++.+..|+|||++.| .|+.++||||||||++||++|.+.|.+.++.+.+..|..-          
T Consensus       336 GSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  336 GSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            999876532  337889999999999876 6899999999999999999999999999888777665420          


Q ss_pred             -----CCCCCC--------------------------------CCCC------------CCCHHHHHHHHHccccCccCC
Q 011380          316 -----KPDFRR--------------------------------KPWP------------SISNSAKDFVKKLLVKDPRAR  346 (487)
Q Consensus       316 -----~~~~~~--------------------------------~~~~------------~~s~~~~~li~~~L~~dp~~R  346 (487)
                           ...|..                                ...|            .-...+.+||++||.+||.+|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                 000000                                0001            012357899999999999999


Q ss_pred             cCHHHHhcCcccccc
Q 011380          347 LTAAQALSHPWVREG  361 (487)
Q Consensus       347 pt~~e~L~h~~~~~~  361 (487)
                      +|+.++|+||||...
T Consensus       494 ~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGT  508 (586)
T ss_pred             CCHHHHhcCcccccc
Confidence            999999999999853

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-48  Score=385.80  Aligned_cols=259  Identities=33%  Similarity=0.607  Sum_probs=224.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            36999999999999999999999999999999997654333345567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCCccCccc
Confidence            9999999999988554  6799999999999999999999999999999999999998   5788999999998765433


Q ss_pred             C------------------------------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 011380          256 K------------------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT  304 (487)
Q Consensus       256 ~------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~  304 (487)
                      .                              ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                              22346799999999998764 6899999999999999999999999888


Q ss_pred             hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcC-HHHHhcCcccccc
Q 011380          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT-AAQALSHPWVREG  361 (487)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-~~e~L~h~~~~~~  361 (487)
                      .......+.........+..+.+++++.+||.+||. ||.+||+ +.++|+||||+..
T Consensus       235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            777777777643333344445589999999999998 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8e-48  Score=379.29  Aligned_cols=250  Identities=29%  Similarity=0.532  Sum_probs=216.6

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333445567889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  260 (487)
                      |+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        80 g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          80 GELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCccccccc
Confidence            999888744  35789999999999999999999999999999999999998   477899999999875322 223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......++    ..+++++.+||.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLL  230 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHc
Confidence            689999999999865 468999999999999999999999988877777777766554433    358899999999999


Q ss_pred             ccCccCCc-----CHHHHhcCcccccc
Q 011380          340 VKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ..||++||     ++.++++||||...
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9e-48  Score=378.21  Aligned_cols=250  Identities=31%  Similarity=0.538  Sum_probs=216.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333344566778999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~~  260 (487)
                      |+|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          80 GELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCCCCcccc
Confidence            9998877443  5789999999999999999999999999999999999998   47789999999987532 2233345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+......++    ..+++++.++|.+||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L  230 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLL  230 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHc
Confidence            689999999999865 468999999999999999999999988888777777776654433    357899999999999


Q ss_pred             ccCccCCc-----CHHHHhcCcccccc
Q 011380          340 VKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ..||++||     ++.++++||||...
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            99999998     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-47  Score=376.69  Aligned_cols=256  Identities=26%  Similarity=0.462  Sum_probs=220.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+.++..+..|++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            48899999999999999999999999999999976543333455677889999999964567899999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~  255 (487)
                      ||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ..
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCCCC
Confidence            999999999888543  5789999999999999999999999999999999999998   47789999999986432 22


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+......++    ..++.++.++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~l  231 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSI  231 (324)
T ss_pred             CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence            333456899999999998764 68899999999999999999999998888888888877655443    3578999999


Q ss_pred             HHHccccCccCCcCH-----HHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLTA-----AQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~-----~e~L~h~~~~~~  361 (487)
                      |.+||..||.+|+++     .++++||||+..
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999976     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.8e-48  Score=380.99  Aligned_cols=259  Identities=29%  Similarity=0.499  Sum_probs=223.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEE
Confidence            699999999999999999999999999999999865433334556788999999998 5999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCCeECCCCC
Confidence            999999999988544 35799999999999999999999999999999999999998   57889999999997765433


Q ss_pred             c--cccccCCccccchhhhc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          257 K--FQDIVGSAYYVAPEVLK-------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       257 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      .  .....||+.|+|||++.       ..++.++|||||||++|+|++|+.||........+..+.........+..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            2  22357999999999985       23578999999999999999999999888887777777765443333344578


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +.++.+||.+||. +|.+|||+.+++.||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=368.95  Aligned_cols=261  Identities=28%  Similarity=0.450  Sum_probs=219.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++...+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence            3889999999999999999999999999999997654333333456778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   +++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCceecCCCC
Confidence            999999999887655455799999999999999999999999999999999999998   47889999999998765444


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      .....+|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+............+.++..+.+||
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            4455689999999999865 468899999999999999999999987665443333322211112222346889999999


Q ss_pred             HHccccCccCCc-----CHHHHhcCcccccc
Q 011380          336 KKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       336 ~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      .+||..||++||     ++.++++||||...
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-47  Score=389.45  Aligned_cols=257  Identities=23%  Similarity=0.435  Sum_probs=210.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----  169 (487)
                      ..+|++++.||+|+||.||+|.+..+++.||||++....       ....+|+.+|+.+. ||||+++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence            457999999999999999999999999999999886432       23357999999995 99999999887432     


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          170 ---NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                         ..+++||||+++ +|.+++..  .....+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL~  213 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKLC  213 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceeee
Confidence               257799999975 67776643  23467999999999999999999999999999999999999984  34579999


Q ss_pred             ecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC------
Q 011380          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK------  316 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------  316 (487)
                      |||+++...........+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+.+..+....      
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9999987765555556789999999998865  47899999999999999999999998887666555554311      


Q ss_pred             ------CCCCCCC------------C-CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 ------PDFRRKP------------W-PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 ------~~~~~~~------------~-~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                            +.+....            + ...|+++.+||.+||++||.+|||+.|+|+||||....
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                  1111000            1 13678999999999999999999999999999998754

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-47  Score=370.92  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=208.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.....  ......+.+|+.+++.+. ||||+++++++.+....|+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999875432  122345678999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-  254 (487)
                      |||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          82 FEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCcceeccCC
Confidence            99995 6888877543 35689999999999999999999999999999999999998   477899999999875432 


Q ss_pred             CCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhc--CC------------
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRN--KP------------  317 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~--~~------------  317 (487)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+... ...+..+...  .+            
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            223345678999999999864  368899999999999999999999976543 2223222211  00            


Q ss_pred             CCCCCC------------C--CCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          318 DFRRKP------------W--PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       318 ~~~~~~------------~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+....            |  ..+++.+.+||.+||+.||++|||+.++|+||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            000000            1  1245789999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-47  Score=382.56  Aligned_cols=259  Identities=28%  Similarity=0.474  Sum_probs=221.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999987543333334556788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcCcC
Confidence            999999999988743   3589999999999999999999999999999999999998   4788999999999766432


Q ss_pred             C--ccccccCCccccchhhhccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .  .....+||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+....+..+.........+..+.++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence            2  22356899999999998642     6789999999999999999999999988888888888765544444456789


Q ss_pred             HHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      .+++++|.+||..++.+  |+++.++++||||+..
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999844443  7899999999999774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.7e-47  Score=368.27  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEE-----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFE-----  167 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~-----  167 (487)
                      ++|++.+.||+|+||+||+|.+.. +|+.||+|++....... .......+|+.+++.+.  +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            369999999999999999999854 46889999886543221 12344567888877763  4999999999885     


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      ....+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEcccc
Confidence            3456899999996 5898888665556789999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC----
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK----  322 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  322 (487)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|++||.+....+.+..+..........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9987655444456789999999999854 56889999999999999999999999888777776665432111100    


Q ss_pred             -------------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          323 -------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       323 -------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                         ..+.++..+++||.+||+.||++|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-48  Score=378.14  Aligned_cols=258  Identities=28%  Similarity=0.478  Sum_probs=234.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE-EEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY-VYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~-~~l  174 (487)
                      +.|..++.+|+|+||.++.++++..++.+++|.|.......+. .+...+|+.+++++. |||||.+.+.|..++. ++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            4699999999999999999999999999999999887765553 447889999999996 9999999999998887 999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||+||+||+|.+.+...++..++++.+..|+.||+.|+.|||+++|+|||||+.|||++   .++.|||+|||+|+...+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCC
Confidence            99999999999999988888899999999999999999999999999999999999999   477789999999999887


Q ss_pred             CC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .. ...+++|||.||+||++.+ .|+.|+|||||||++|||++-+++|.+.+...++.+|.........   ..+|.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence            76 5677899999999999987 4799999999999999999999999999999999999988733222   35789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+|+.||..+|..||++.++|.+|.+..+
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            99999999999999999999999998743

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-47  Score=375.80  Aligned_cols=251  Identities=27%  Similarity=0.493  Sum_probs=217.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|.+++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999999999999999997654333345566778999998776799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  260 (487)
                      |+|...+...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccCCccccc
Confidence            9999888543  5789999999999999999999999999999999999998   478899999999875432 223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......++    ..++.++.++|.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L  231 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFM  231 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence            679999999999865 468899999999999999999999999888888888887654433    247899999999999


Q ss_pred             ccCccCCc-------CHHHHhcCcccccc
Q 011380          340 VKDPRARL-------TAAQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rp-------t~~e~L~h~~~~~~  361 (487)
                      +.||++||       ++.++++||||...
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            99999999       99999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-47  Score=382.62  Aligned_cols=258  Identities=29%  Similarity=0.503  Sum_probs=219.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++..+. ||||+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence            6899999999999999999999999999999997543333345567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCCccccccc
Confidence            999999999988543  5789999999999999999999999999999999999998   47889999999986542110


Q ss_pred             ------------------------------------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCC
Q 011380          257 ------------------------------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP  299 (487)
Q Consensus       257 ------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~p  299 (487)
                                                          .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence                                                0123579999999999865 468999999999999999999999


Q ss_pred             CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCc---CHHHHhcCcccccc
Q 011380          300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREG  361 (487)
Q Consensus       300 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~L~h~~~~~~  361 (487)
                      |.+......+..+.........+....++++++++|.+|+. ||.+|+   ++.++++||||+..
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            99888888888777644333333334588999999999874 999998   58999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-47  Score=375.50  Aligned_cols=251  Identities=25%  Similarity=0.463  Sum_probs=210.6

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998654433445567889999999997799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-CCCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~~~~~~~  260 (487)
                      |+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++... ........
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccCCCcccc
Confidence            9998887543  6799999999999999999999999999999999999998   4778999999998652 22333456


Q ss_pred             ccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---------EDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||....         .......+......++    ..++.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~  231 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHH
Confidence            7899999999998764 6889999999999999999999995321         1223333444333222    357899


Q ss_pred             HHHHHHHccccCccCCcC------HHHHhcCcccccc
Q 011380          331 AKDFVKKLLVKDPRARLT------AAQALSHPWVREG  361 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt------~~e~L~h~~~~~~  361 (487)
                      +.++|.+||+.||.+|||      +.++++||||...
T Consensus       232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999999999997      7899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.9e-47  Score=373.85  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=221.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+....|..++..+..||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999976543333345567788888888866899999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-C
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-G  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~  255 (487)
                      ||+++|+|.+.+...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... .
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCceecCCCC
Confidence            999999999888543  5689999999999999999999999999999999999998   478899999999875432 2


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......++    ..++.++.++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  231 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI  231 (323)
T ss_pred             CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence            23345689999999999875 468999999999999999999999999888888888887665443    3588999999


Q ss_pred             HHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +.+||+.||.+|++     ..++++||||+..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            99999999999997     4899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.1e-47  Score=373.83  Aligned_cols=253  Identities=27%  Similarity=0.484  Sum_probs=217.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHH---hccCCCCccEEEEEEEeCCEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ---ALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~---~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|++++.   .+ +||||+++++++...+.+|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence            678999999999999999999999999999997654333334566777877664   45 49999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|...+.   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        80 v~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          80 VMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCccCCC
Confidence            999999999987763   25699999999999999999999999999999999999998   478899999999865332


Q ss_pred             -CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 -GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                       .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......++    +.++.++.
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  229 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAI  229 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence             223345789999999999865 468899999999999999999999998888888888877665433    35789999


Q ss_pred             HHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ++|.+||..||.+||     ++.++++||||+..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999999999999     79999999999764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.5e-47  Score=367.85  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=209.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence            69999999999999999999999999999999876432 2234567789999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++++.+.. +.. ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++.......
T Consensus        80 e~~~~~~l~~-~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          80 EYVEKNMLEL-LEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             ecCCCCHHHH-HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccccc
Confidence            9998876543 332 335789999999999999999999999999999999999998   57789999999998764322


Q ss_pred             --ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--------------CCCC
Q 011380          257 --KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--------------KPDF  319 (487)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------~~~~  319 (487)
                        ......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+...              .+.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence              2334679999999999865 4688999999999999999999999877654443332221              1111


Q ss_pred             CCC--------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          320 RRK--------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       320 ~~~--------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ...              .+..+|.++.+||++||++||++|||+.++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000              012368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.2e-47  Score=372.31  Aligned_cols=251  Identities=28%  Similarity=0.501  Sum_probs=214.0

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+|+.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997643222234456678888888765799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  260 (487)
                      |+|..++..  ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccCCCceec
Confidence            999988854  35789999999999999999999999999999999999998   467899999999865322 223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....+.++    ..++.+++++|.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l  231 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLF  231 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHc
Confidence            789999999999875 468899999999999999999999998888777777766554433    247899999999999


Q ss_pred             ccCccCCcCH-HHHhcCcccccc
Q 011380          340 VKDPRARLTA-AQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~-~e~L~h~~~~~~  361 (487)
                      ..||++||++ .++++||||+..
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCC
Confidence            9999999998 588899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-47  Score=372.07  Aligned_cols=251  Identities=31%  Similarity=0.532  Sum_probs=213.9

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.+..+++.||+|++.+.........+....|..++..+.+||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333334455667888887665799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-Ccccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~~~  260 (487)
                      |+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... .....
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCCCCcccc
Confidence            9999888543  5799999999999999999999999999999999999998   4778999999999764322 23345


Q ss_pred             ccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+....+.++    ..++.++.++|.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l  231 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLF  231 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence            6899999999998754 68999999999999999999999998888888877766544333    357889999999999


Q ss_pred             ccCccCCcCH-HHHhcCcccccc
Q 011380          340 VKDPRARLTA-AQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~-~e~L~h~~~~~~  361 (487)
                      ..||++||++ .++++||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCC
Confidence            9999999986 488899999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-47  Score=376.23  Aligned_cols=250  Identities=30%  Similarity=0.534  Sum_probs=215.8

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+++++.+. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654333344567788999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~  259 (487)
                      |+|..++..  ...+++..+..++.||+.||.|||+ .||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          80 GELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCCCCcccc
Confidence            999887744  3578999999999999999999997 7999999999999998   47789999999987532 223334


Q ss_pred             cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++    ..+++++.+||.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  230 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGL  230 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence            5679999999999865 468999999999999999999999988887777777766554433    35789999999999


Q ss_pred             cccCccCCc-----CHHHHhcCcccccc
Q 011380          339 LVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      |+.||++|+     ++.++++||||...
T Consensus       231 L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         231 LKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            999999997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-49  Score=376.21  Aligned_cols=266  Identities=34%  Similarity=0.583  Sum_probs=241.3

Q ss_pred             cccCCCeeE--eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           92 KDFDRRYTI--GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        92 ~~~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .+|..-|++  .+.||+|.||+||-|+++.+|+.||||+|++.++... ....+++|+.||+++. ||.||.+--.|+..
T Consensus       558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~  635 (888)
T KOG4236|consen  558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETP  635 (888)
T ss_pred             hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCC
Confidence            445566777  4789999999999999999999999999998876443 4478999999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +.+++|||.+ .|+.++.|+....+++++.....++.||+.||.|||.++|+|+||||+|||+.+.+.-..+||||||+|
T Consensus       636 ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  636 ERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             ceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccce
Confidence            9999999999 568889998888899999999999999999999999999999999999999998777789999999999


Q ss_pred             cccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      +.+.+.....+++|||.|+|||++..+ |...-|+||.|||+|--++|..||..  .+++-.+|.+....|+..+|..++
T Consensus       715 RiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis  792 (888)
T KOG4236|consen  715 RIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEIS  792 (888)
T ss_pred             eecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcC
Confidence            999887777889999999999999765 67778999999999999999999954  345667788888899999999999


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +++.|||..+|+..-.+|.|.+..|.|||++++.
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            9999999999999999999999999999999863

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.6e-47  Score=375.61  Aligned_cols=256  Identities=27%  Similarity=0.515  Sum_probs=212.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .....+.+.+|+.+++.+.+||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999999864   47899999998754321 1234456788999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCccc
Confidence            9999999999999988543  5689999999999999999999999999999999999998   4678999999998764


Q ss_pred             CCCC--ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCCCC
Q 011380          253 KPGK--KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       253 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~  324 (487)
                      ....  .....+||+.|+|||++.+.  ++.++|||||||++|+|++|..||.....    ......+....+.+    .
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~  231 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF----P  231 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC----C
Confidence            3322  22346799999999998753  57899999999999999999999964322    23333444433322    2


Q ss_pred             CCCCHHHHHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      +.+++.+.++|.+||..||++||     ++.++++||||+..
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            45889999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.4e-47  Score=371.93  Aligned_cols=251  Identities=29%  Similarity=0.516  Sum_probs=216.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333344566778999998886799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~~  260 (487)
                      |+|..++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcCCCcccc
Confidence            9999887543  5799999999999999999999999999999999999998   47789999999986532 2223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......++    ..++.++.+||++||
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  231 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFL  231 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence            679999999999875 468899999999999999999999988888777777776654433    357899999999999


Q ss_pred             ccCccCCcCH-----HHHhcCcccccc
Q 011380          340 VKDPRARLTA-----AQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~-----~e~L~h~~~~~~  361 (487)
                      ..||++|||+     .++++||||+..
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.5e-47  Score=373.53  Aligned_cols=259  Identities=30%  Similarity=0.482  Sum_probs=209.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----CE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----NY  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~  171 (487)
                      +|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            58999999999999999999999999999999864321 1223456789999999995 99999999987543     35


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+|||||. ++|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        79 ~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg~~~~  152 (338)
T cd07859          79 IYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCccccc
Confidence            899999995 688888744  35689999999999999999999999999999999999998   578899999999875


Q ss_pred             cCCCC----ccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH-----------
Q 011380          252 IKPGK----KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL-----------  313 (487)
Q Consensus       252 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-----------  313 (487)
                      .....    .....+||+.|+|||++.+   .++.++|||||||++|+|++|++||.+.........+.           
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            43211    1245689999999999754   56889999999999999999999997765433222111           


Q ss_pred             ----------------hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          314 ----------------RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       314 ----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                      ...+......++.+++.+.++|.+||..||++|||+.++|+||||+....
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                            01111111224567889999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-46  Score=370.35  Aligned_cols=261  Identities=27%  Similarity=0.485  Sum_probs=218.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence            3699999999999999999999999999999999754332333456678899999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCceeecCCC
Confidence            9999999999988542 45789999999999999999999999999999999999998   5788999999998765433


Q ss_pred             Ccc--ccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCC
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPS  326 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  326 (487)
                      ...  ...+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+....+.+..+......+.. ...+.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  235 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTD  235 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCC
Confidence            222  23579999999999862      3578999999999999999999999888777777777654433322 22345


Q ss_pred             CCHHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      +|++++++|++||..++++  |+++.++++||||...
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            8999999999999764444  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-46  Score=371.43  Aligned_cols=251  Identities=25%  Similarity=0.464  Sum_probs=210.0

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998754444445667889999998886799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~~  260 (487)
                      |+|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .......
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCCCCcccc
Confidence            9998877443  5799999999999999999999999999999999999998   47889999999987532 2233345


Q ss_pred             ccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          261 IVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDK---------TEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...         ........+......++    ..++..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~  231 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHH
Confidence            6899999999998764 688999999999999999999999521         11223334444433322    357899


Q ss_pred             HHHHHHHccccCccCCcC------HHHHhcCcccccc
Q 011380          331 AKDFVKKLLVKDPRARLT------AAQALSHPWVREG  361 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt------~~e~L~h~~~~~~  361 (487)
                      +.++|++||..||++||+      +.++++||||+..
T Consensus       232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-46  Score=368.96  Aligned_cols=251  Identities=29%  Similarity=0.503  Sum_probs=213.6

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.+..+++.||+|++................|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997653222233456677888888765699999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  260 (487)
                      |+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCCceee
Confidence            999998854  35689999999999999999999999999999999999998   467899999999875322 223345


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+....+.+..+....+.++    ..++.+++++|.+||
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  231 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLF  231 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHh
Confidence            679999999999865 468999999999999999999999988887777777765554332    247889999999999


Q ss_pred             ccCccCCcCHH-HHhcCcccccc
Q 011380          340 VKDPRARLTAA-QALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~~-e~L~h~~~~~~  361 (487)
                      +.||++||++. ++++||||+..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCC
Confidence            99999999996 89999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-46  Score=368.99  Aligned_cols=256  Identities=25%  Similarity=0.444  Sum_probs=220.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.+.+||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            37888999999999999999999999999999976543333345667789999988876788999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      ||++||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeccccccccCCCC
Confidence            999999999888443  5799999999999999999999999999999999999998   4778999999998754322 


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+......++    ..++.++.++
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSI  231 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence            223456799999999998654 68899999999999999999999998888888888877655433    3578999999


Q ss_pred             HHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +.+||..+|.+|++     ..++++||||+..
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999999999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-46  Score=363.06  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=210.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe-----C
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFED-----D  169 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~-----~  169 (487)
                      +|++.+.||+|+||+||+|.++.+|+.||+|.+...... ......+.+|+.+++.+.  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            489999999999999999999999999999998754321 112234567887777663  59999999998864     3


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ..++++|||+++ +|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccCcc
Confidence            568999999974 888888665555689999999999999999999999999999999999998   4778999999999


Q ss_pred             cccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC----------
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----------  318 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  318 (487)
                      .............||+.|+|||++.+ .++.++|||||||++|+|++|++||.+......+.++......          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            87654444456688999999998854 4689999999999999999999999887776665555431100          


Q ss_pred             ------CC-------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 ------FR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 ------~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                            +.       ....+.++..+.++|.+||++||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00       01124578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.8e-46  Score=361.16  Aligned_cols=258  Identities=26%  Similarity=0.458  Sum_probs=216.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++. |++|+.+++.+.+.+.+|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence            3778899999999999999999999999999987654433334456778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCCCc
Confidence            999999999888655556799999999999999999999999999999999999998   46789999999997665444


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......   .....+....   .......+++++.
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDAR  233 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHH
Confidence            4455689999999999865 4688999999999999999999999765432   2222222211   1122346788999


Q ss_pred             HHHHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +||.+||+.||++|||     +.++++||||++.
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999999     9999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-46  Score=370.80  Aligned_cols=250  Identities=27%  Similarity=0.484  Sum_probs=211.9

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHH-HHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI-LQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      +.||+|+||+||+|.++.+|+.||+|++.+...........+..|..+ ++.+ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999976543222333455566554 5667 59999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQ  259 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~  259 (487)
                      ||+|..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... .....
T Consensus        80 ~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCcccccCCCccc
Confidence            9999988854  35789999999999999999999999999999999999998   478899999999875322 22334


Q ss_pred             cccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+.......    .+.++.++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~  230 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLEGL  230 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHH
Confidence            56799999999998654 6889999999999999999999999888888888887665433    246799999999999


Q ss_pred             cccCccCCcCH----HHHhcCcccccc
Q 011380          339 LVKDPRARLTA----AQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rpt~----~e~L~h~~~~~~  361 (487)
                      |+.||.+||++    .++++||||...
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            99999999988    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-46  Score=360.96  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=208.2

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.+. ||||+++++++.....+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999987654333334456778999999994 9999999999999999999999999999


Q ss_pred             HHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc-ccc
Q 011380          184 LLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQD  260 (487)
Q Consensus       184 L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-~~~  260 (487)
                      |...+...  ....+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++........ ...
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCccccc
Confidence            98776432  335689999999999999999999999999999999999998   477899999999976544322 334


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+............+.++..+.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            679999999999865 4688999999999999999999999765432222222221111111222468899999999999


Q ss_pred             ccCccCCc-----CHHHHhcCcccccc
Q 011380          340 VKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      +.||++||     +++++++||||+..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            99999999     88999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-47  Score=374.01  Aligned_cols=250  Identities=28%  Similarity=0.506  Sum_probs=213.2

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      ||+|+||+||+|+++.+|+.||+|++.+..............|..++..+.  +||||+++++++...+.+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997644332333445566777777664  699999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~~  260 (487)
                      |+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCCCccC
Confidence            999988754  36799999999999999999999999999999999999998   477899999999875422 223345


Q ss_pred             ccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          261 IVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      .+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+..+...++.   ..+++++.+||++|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~  232 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGL  232 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHH
Confidence            789999999999864  3688999999999999999999999988888888887766554432   34789999999999


Q ss_pred             cccCccCCc----CHHHHhcCcccccc
Q 011380          339 LVKDPRARL----TAAQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rp----t~~e~L~h~~~~~~  361 (487)
                      |..||.+||    ++.++++||||+..
T Consensus       233 L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         233 LNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             cCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-46  Score=368.38  Aligned_cols=250  Identities=31%  Similarity=0.557  Sum_probs=213.3

Q ss_pred             eeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380          102 KLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      +.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+|+.+. ||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            57999999999999864   47889999998754321 1223456778999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~  256 (487)
                      |++||+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... ..
T Consensus        81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCeecccCCC
Confidence            9999999998854  35788999999999999999999999999999999999998   478899999999875332 22


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+..+...++    +.+++++.+||
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  231 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL  231 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            23456799999999998654 68899999999999999999999998888777778777654432    45789999999


Q ss_pred             HHccccCccCCc-----CHHHHhcCcccccc
Q 011380          336 KKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       336 ~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      .+||..||++||     ++.++++||||+..
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=350.98  Aligned_cols=258  Identities=31%  Similarity=0.543  Sum_probs=236.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      -++|...++||+|.||+|.+++.+.+|+.||+|++++.-......+..-..|-++|+..+ ||.+..+.-.|+..+.+|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            357888999999999999999999999999999999887766667788889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc-cC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~-~~  253 (487)
                      ||||..||+|+-++.+  ...+++..++.+-..|+.||.|||+++||+||||.+|.|++   .+|++||+|||+++. +.
T Consensus       246 VMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecccchhccc
Confidence            9999999999988844  46799999999999999999999999999999999999999   689999999999965 45


Q ss_pred             CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .+....++||||.|+|||++.. .|+.++|+|.+||++|||++|+.||+....+.++.-|+.....|+.    .+|++++
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAk  396 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAK  396 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHH
Confidence            5667789999999999999965 6899999999999999999999999999999999999988877775    5899999


Q ss_pred             HHHHHccccCccCCc-----CHHHHhcCccccccC
Q 011380          333 DFVKKLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       333 ~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                      .|+..+|.+||.+|.     .+.|+.+|+||....
T Consensus       397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            999999999999997     689999999998754

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-45  Score=356.94  Aligned_cols=260  Identities=28%  Similarity=0.451  Sum_probs=220.2

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |+..+.||.|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+. |+||+.+++++..++.++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            778899999999999999999999999999987654433334456788999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  257 (487)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCCCCc
Confidence            99999998888655555799999999999999999999999999999999999998   467899999999876554444


Q ss_pred             cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          258 FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      .....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+............+.++.++.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            455689999999999864 4688999999999999999999999877655444444333322222334568899999999


Q ss_pred             HccccCccCCcC-----HHHHhcCcccccc
Q 011380          337 KLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       337 ~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +||+.||++||+     +.+++.|+||+..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-45  Score=364.38  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||++.+..+|..+|+|.+....  .+.....+.+|+++++++. ||||+++++++...+.+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            367999999999999999999999999999999987542  2345577899999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||++||+|.+++...  ..+++..+..++.|++.||.|||+. +|+||||||+|||++   .++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccccc
Confidence            99999999999988543  5689999999999999999999986 699999999999998   47789999999987654


Q ss_pred             CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----------------
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------------  316 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  316 (487)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....+....                
T Consensus       156 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             cc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            32 23456799999999998754 6889999999999999999999997655433322111000                


Q ss_pred             ----------------------------CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          317 ----------------------------PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       317 ----------------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                                  ...+......+++++++||.+||..||++|||+.++|+||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                        000011122478899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-46  Score=366.08  Aligned_cols=251  Identities=25%  Similarity=0.439  Sum_probs=210.0

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999998754433445667889999999987799999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-CCCCcccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQD  260 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~~~~~~~  260 (487)
                      |+|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++... ........
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCceec
Confidence            9998887443  5799999999999999999999999999999999999998   4778999999998753 22333455


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT-------EDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||....       .......+......+    ...++..+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~  231 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI----PRFLSVKAS  231 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC----CCCCCHHHH
Confidence            789999999999865 46889999999999999999999995321       122333333332222    235789999


Q ss_pred             HHHHHccccCccCCcC------HHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLT------AAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt------~~e~L~h~~~~~~  361 (487)
                      ++|.+||..||++|++      +.++++||||+..
T Consensus       232 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999999999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.1e-46  Score=366.72  Aligned_cols=261  Identities=26%  Similarity=0.456  Sum_probs=219.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||++.++.+++.+|+|++.+...........+..|+.++..+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence            36999999999999999999999999999999986543222334456788999999984 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchheecccC
Confidence            9999999999988543 35689999999999999999999999999999999999998   5778999999998765332


Q ss_pred             Cc--cccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CCCC
Q 011380          256 KK--FQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PWPS  326 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~  326 (487)
                      ..  ....+||+.|+|||++.      +.++.++|||||||++|+|++|+.||......+.+..+......+..+ .+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD  235 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence            22  23457999999999985      246889999999999999999999999888888888877655433222 2346


Q ss_pred             CCHHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      +++++++||++||..++.+  |+++.++++||||...
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            8999999999999765554  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-46  Score=357.06  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=209.5

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||+|+||.||++.++.+|+.||+|.+.............+..|+++++++ +||||+++++++.....+|+||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            79999999999999999999999998754432222334556799999999 59999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccC
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~g  263 (487)
                      |.+++.......+++..+..++.||+.||.|||+.||+||||||+|||++   .++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCceeeccCC
Confidence            99888665556689999999999999999999999999999999999998   477899999999987665444455679


Q ss_pred             Cccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      |+.|+|||++.+ .++.++|||||||++|+|++|+.||......    ............+   ....+++++.++|.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence            999999999865 4688999999999999999999999764332    2333333332222   2246889999999999


Q ss_pred             cccCccCCcCH----HHHhcCcccccc
Q 011380          339 LVKDPRARLTA----AQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rpt~----~e~L~h~~~~~~  361 (487)
                      |+.||.+||++    .+++.||||+..
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999    778899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-46  Score=372.43  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.++++|. ||||+++++++......++|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEEE
Confidence            579999999999999999999999999999996532         34578999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +|++. ++|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   ..+.+||+|||++......
T Consensus       162 ~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        162 LPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccccc
Confidence            99995 6888887543  5689999999999999999999999999999999999998   4678999999998653221


Q ss_pred             --CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHhcC---------
Q 011380          256 --KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT-------EDGIFKEVLRNK---------  316 (487)
Q Consensus       256 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~---------  316 (487)
                        ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||....       ....+..+....         
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence              22345689999999999865 46899999999999999999998876432       111122111100         


Q ss_pred             -----------------CC--CCCCCC---CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 -----------------PD--FRRKPW---PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 -----------------~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                       ..  .....|   ..++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                             00  000111   13567899999999999999999999999999998754

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.3e-46  Score=370.94  Aligned_cols=255  Identities=27%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|++++.||+|+||+||+|++..+|+.||||++....  .......+.+|+++++.+. ||||+++++++...+.+|+|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence            46888999999999999999999999999999986543  2344567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+.      ....+..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecccc
Confidence            999999988542      2456788899999999999999999999999999999998   4788999999999776432


Q ss_pred             C-ccccccCCccccchhhhcc-----C-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 K-KFQDIVGSAYYVAPEVLKR-----K-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~-----~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      . .....+||..|+|||++..     . .+.++|||||||++|+|++|+.||...........+..............++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence            2 2345689999999998743     2 2568999999999999999999997443322222111111111122234688


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .++++||.+||..||++|||+.|+|+||||....
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999999998754

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.2e-46  Score=365.96  Aligned_cols=261  Identities=26%  Similarity=0.461  Sum_probs=219.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            36999999999999999999999999999999987543222334456788999999985 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccceeeccCC
Confidence            9999999999988543 35789999999999999999999999999999999999998   4778999999999765433


Q ss_pred             Ccc--ccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCC
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPS  326 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  326 (487)
                      ...  ...+||+.|+|||++.+      .++.++|||||||++|+|++|+.||......+.+..+......+.. ..+..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  235 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD  235 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence            222  23579999999999864      4678999999999999999999999888877777777665433322 22356


Q ss_pred             CCHHHHHHHHHccccCccC--CcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~  361 (487)
                      ++.+++++|.+||..++.+  |++++++++||||+..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            7899999999999976655  5699999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-46  Score=361.73  Aligned_cols=259  Identities=25%  Similarity=0.432  Sum_probs=213.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|.+.....  ......+.+|+.+++++. ||||+++++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            569999999999999999999999999999999875432  122345678999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        83 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          83 FEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVP  157 (309)
T ss_pred             EeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceecCCC
Confidence            999975 888777543 34589999999999999999999999999999999999998   4778999999998764322


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  318 (487)
                       .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+......              
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             22334578999999998864  4688999999999999999999999887765554444321110              


Q ss_pred             -----CCC-------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          319 -----FRR-------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       319 -----~~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                           ++.       ...+.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                 000       11245788999999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.4e-46  Score=367.46  Aligned_cols=250  Identities=26%  Similarity=0.463  Sum_probs=211.5

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHH-HHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI-LQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~-l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      +.||+|+||+||+|.++.+|+.||+|++.+...........+..|..+ ++.+ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976533223334555666654 5667 59999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-CCccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQ  259 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-~~~~~  259 (487)
                      ||+|..++..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... .....
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          80 GGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCCCCCCcc
Confidence            9999888743  36799999999999999999999999999999999999998   477899999999875322 22334


Q ss_pred             cccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||......+.+..+.......    .+.++..+.++|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~l  230 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEEL  230 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHH
Confidence            56899999999998654 6889999999999999999999999888888888877654332    246889999999999


Q ss_pred             cccCccCCcCH----HHHhcCcccccc
Q 011380          339 LVKDPRARLTA----AQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rpt~----~e~L~h~~~~~~  361 (487)
                      |..+|.+||++    .+++.||||...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            99999999977    599999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=397.78  Aligned_cols=260  Identities=28%  Similarity=0.478  Sum_probs=229.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+++.||+|+||.|.+++++.+++.||+|++.+-.+.......-|+.|-.+|..- +.+-|+.++-.|.+++++|+|
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEE
Confidence            5799999999999999999999999999999999874443334557788888898776 589999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|...+...  .++++..++.++..|+.||.-||+.|+|||||||+|||++   ..|+|||+|||.+-.+..+
T Consensus       154 MdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchhHHhcCCC
Confidence            9999999999988433  4899999999999999999999999999999999999999   5899999999998766533


Q ss_pred             -C-ccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          256 -K-KFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       256 -~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                       . .....+|||.|++||++.      +.|++.||+||+||++|||++|..||+..+.-+.+.+|+.-+-.+..+.-..+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence             2 245678999999999984      45799999999999999999999999999999999999988655555555679


Q ss_pred             CHHHHHHHHHccccCccCCcC---HHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt---~~e~L~h~~~~~~~  362 (487)
                      |.++++||+++|+ +|+.|..   +.++..||||.+..
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            9999999999998 7999998   99999999999754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-47  Score=370.96  Aligned_cols=256  Identities=35%  Similarity=0.600  Sum_probs=233.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .-|.+.+.||+|.|++|.+|++..+|..||||.|++...... ..+.+.+|+++|+.| +|||||+++.+.+.+..+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEE
Confidence            469999999999999999999999999999999998776443 455689999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.+|++++++.+.  +.+.+..+..++.|+.+|++|||+++|+|||||++|||++   .+..+||+|||++.++..+
T Consensus       134 ~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---ENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---cccceeeeccccceeeccc
Confidence            9999999999999654  6788899999999999999999999999999999999999   4677999999999999988


Q ss_pred             CccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      ....+.||++.|.|||++.+. | ++++|+||+|+++|.|++|.+||.+.+-.++-..++.++...+.    .++.++.+
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~  284 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCED  284 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHH
Confidence            888999999999999999875 3 89999999999999999999999999888888888887765544    47889999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|+++|..+|.+|++.+++..|.|.....
T Consensus       285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             HHHHhhccCccccCCHHHhhhhcccchhh
Confidence            99999999999999999999999987543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.8e-46  Score=365.31  Aligned_cols=250  Identities=27%  Similarity=0.468  Sum_probs=210.3

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      +.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997643222223344455554 45667 59999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~  259 (487)
                      ||+|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          80 GGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCcccccCCCCcc
Confidence            9999988854  35688999999999999999999999999999999999998   47789999999987532 222344


Q ss_pred             cccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          260 DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......+    .+.+++.+.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~  230 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGL  230 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHH
Confidence            56899999999998764 6889999999999999999999999888888877777654332    357899999999999


Q ss_pred             cccCccCCcCHH----HHhcCcccccc
Q 011380          339 LVKDPRARLTAA----QALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rpt~~----e~L~h~~~~~~  361 (487)
                      |+.||.+||++.    ++++|+||...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            999999999876    89999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-45  Score=379.07  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-----CCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~~~~~~~  169 (487)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....    ........|+.+++.+.     +|++|+++++++...
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            468999999999999999999999999999999986432    23345567888887774     245688999988754


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCC-----------
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAK-----------  236 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~-----------  236 (487)
                       +++|+|||++ |++|.+++...  ..+++..++.++.||+.||.|||+ .|||||||||+|||++..+           
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence             5789999998 77899888543  579999999999999999999998 5999999999999998532           


Q ss_pred             --CCCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 011380          237 --EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       237 --~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  313 (487)
                        +...+||+|||++....  ......+||+.|+|||++.+ .++.++|||||||++|||++|++||.+....+.+..+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              12259999999875432  23346789999999999866 47899999999999999999999998776554443332


Q ss_pred             hcCCCCCC---------------------------C---------CCC--CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          314 RNKPDFRR---------------------------K---------PWP--SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       314 ~~~~~~~~---------------------------~---------~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .....++.                           .         .+.  ..++.+.+||.+||++||++|||+.|+|+|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            21110000                           0         000  013457899999999999999999999999


Q ss_pred             ccccccC
Q 011380          356 PWVREGG  362 (487)
Q Consensus       356 ~~~~~~~  362 (487)
                      |||....
T Consensus       439 p~~~~~~  445 (467)
T PTZ00284        439 PYVLKYY  445 (467)
T ss_pred             ccccccC
Confidence            9998753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.5e-46  Score=364.89  Aligned_cols=249  Identities=29%  Similarity=0.514  Sum_probs=213.5

Q ss_pred             eeeeecCceEEEEEEE---cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          102 KLLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +.||+|+||.||++++   ..+|+.||+|++.+.... ......+.+|+++++++. ||||+++++++.+.+.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999976   357899999999764321 223455678999999995 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-Cc
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KK  257 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~  257 (487)
                      +++|+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... ..
T Consensus        80 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          80 LRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccCCCCCc
Confidence            999999998844  35789999999999999999999999999999999999998   4778999999998765433 23


Q ss_pred             cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          258 FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+......++    +.+++.+.++|+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  230 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR  230 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            345689999999999875 468899999999999999999999998888777777776654433    357899999999


Q ss_pred             HccccCccCCcC-----HHHHhcCcccccc
Q 011380          337 KLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       337 ~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +||+.||++||+     +.+++.||||+..
T Consensus       231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999999999     7889999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-45  Score=362.92  Aligned_cols=250  Identities=26%  Similarity=0.462  Sum_probs=210.0

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+..|.. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999999999999999997654322333445566655 56777 59999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-CCCccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQ  259 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~~~~~~  259 (487)
                      ||+|...+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... ......
T Consensus        80 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          80 GGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCCCCCccc
Confidence            9999887744  35789999999999999999999999999999999999998   47789999999987532 222334


Q ss_pred             cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++    +..+.++.++|.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~  230 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGL  230 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHH
Confidence            5689999999999865 468899999999999999999999998887777777776543322    35788999999999


Q ss_pred             cccCccCCcCH----HHHhcCcccccc
Q 011380          339 LVKDPRARLTA----AQALSHPWVREG  361 (487)
Q Consensus       339 L~~dp~~Rpt~----~e~L~h~~~~~~  361 (487)
                      |+.||.+||++    .++++||||...
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            99999999976    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-45  Score=367.76  Aligned_cols=258  Identities=30%  Similarity=0.459  Sum_probs=208.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++...+   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence            45689999999999999999999999999999999865432 2334567789999999995 999999999986543   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                         .+|+||||+++ +|...+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~Dfg  168 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  168 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEecCC
Confidence               57999999965 5666552    3488999999999999999999999999999999999998   47889999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH-------------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL-------------  313 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-------------  313 (487)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.             
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9976654444556789999999999865 46889999999999999999999998765433332221             


Q ss_pred             ---------hcCCCCCCCC----------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          314 ---------RNKPDFRRKP----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       314 ---------~~~~~~~~~~----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                               ...+.+....                ....++++++||.+||..||++|||+.|+|+||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                     1111111100                01245779999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.7e-45  Score=387.73  Aligned_cols=266  Identities=27%  Similarity=0.473  Sum_probs=219.9

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--  168 (487)
                      ...+..+|.+++.||.|+||+||+|.++.++..||+|++...... ......+..|+.+|+.|. |||||+++++|.+  
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecC
Confidence            445557899999999999999999999999999999998765432 334567889999999995 9999999998854  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-------CceeecCCCCceEeccC----
Q 011380          169 DNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLH-------GLVHRDMKPENFLFKSA----  235 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~-------~iiHrDlkp~NIll~~~----  235 (487)
                      ...+||||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+.       +||||||||+||||+..    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            46799999999999999988543  235799999999999999999999985       49999999999999642    


Q ss_pred             ----------CCCCcEEEeecccccccCCCCccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 011380          236 ----------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWD  302 (487)
Q Consensus       236 ----------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~  302 (487)
                                +....+||+|||++............+||+.|+|||++.+   .++.++||||||||||+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      1234699999999987654444455689999999999853   368899999999999999999999977


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ......+...+...+.+   +.+..+.++.+||.+||..+|.+||++.++|.|||++..
T Consensus       246 ~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            65544444444443322   234578999999999999999999999999999999854

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-45  Score=351.10  Aligned_cols=254  Identities=40%  Similarity=0.692  Sum_probs=210.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |++++.||+|+||+||++.+..+++.||+|++....... .......+|+.+++++ .||||+++++++.+....++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence            889999999999999999999999999999998765321 1222345699999999 59999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-CCCC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~~~  256 (487)
                      ++++++|.+++.  ....+++..+..++.||+.||.+||+.||+||||||+||+++   .++.++|+|||.+... ....
T Consensus        79 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   79 YCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccc--cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence            999999999886  336789999999999999999999999999999999999999   5788999999998753 3334


Q ss_pred             ccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          257 KFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ......||+.|+|||++.  ...+.++||||||+++|+|++|..||....   ....+..................+..+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL  233 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence            456678999999999987  456899999999999999999999998773   233333333222111111112234789


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .++|.+||+.||++|||+.++++||||
T Consensus       234 ~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  234 RDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.6e-45  Score=374.80  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=220.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC-CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN-GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...|.+.+.||+|+||.||+|.+..+ ++.||+|.+....   ......+.+|+.+|+.+. ||||+++++++...+.+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEE
Confidence            34599999999999999999998877 7889999775432   334466788999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      |||||++||+|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCcee
Confidence            999999999999877542  345689999999999999999999999999999999999998   477899999999987


Q ss_pred             cCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ......   ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+..+....   ....+
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~  295 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV  295 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence            643321   3456799999999998654 6889999999999999999999998888888888877664331   12357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +.++.++|.+||..||++||++.+++.|||++..
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            8999999999999999999999999999999753

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-44  Score=374.57  Aligned_cols=261  Identities=27%  Similarity=0.460  Sum_probs=221.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      ....+|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++..+. |+||+++++.+....  
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceeccccc
Confidence            345689999999999999999999999999999999976543 2345567889999999995 999999988775332  


Q ss_pred             ------EEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          171 ------YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ------~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                            .+++||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEE
Confidence                  478999999999999988543  235689999999999999999999999999999999999998   477899


Q ss_pred             EeecccccccCCC---CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 011380          243 ATDFGLSDFIKPG---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       243 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      |+|||+++.....   ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+..+...
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~  263 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD  263 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            9999998765432   223456899999999998754 789999999999999999999999988887777777765433


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .   ..+.+++++.++|.+||+.||.+||++.++++|||++..
T Consensus       264 ~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            2   225688999999999999999999999999999998763

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.2e-45  Score=353.48  Aligned_cols=259  Identities=25%  Similarity=0.415  Sum_probs=213.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||.|+||.||+|.++.+++.||+|.+.....  ......+.+|+.+++.+. ||||+++++++...+.+++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            469999999999999999999999999999999865432  122345678999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++ ++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus        83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIP  157 (301)
T ss_pred             Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhccCCC
Confidence            99997 5888877543 35689999999999999999999999999999999999998   4678999999998754322


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (487)
                       .......+++.|+|||++.+  .++.++|||||||++|+|++|++||...+..+....+.........           
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             22334567999999999865  3578999999999999999999999877765555443321111000           


Q ss_pred             ---------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          322 ---------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       322 ---------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                     ...+.+++.+++||.+||+.||.+|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                           01235788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=371.29  Aligned_cols=260  Identities=31%  Similarity=0.478  Sum_probs=225.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..+.|.|+..||.|+||+||+|.++.++-..|.|+|....   ....+++.-||+||..+. ||+||++++.|..++.++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence            3456788899999999999999999999888999986543   567889999999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |+.|||.||-+-..+.. -+..+.+.++..+++|+|.||.|||+++|||||||+.|||++   -+|.|+|+|||.+....
T Consensus       106 iliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccch
Confidence            99999999987665543 457899999999999999999999999999999999999999   47889999999875432


Q ss_pred             -CCCccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 -PGKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 -~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                       .-....+++|||+|||||++.      ..|+.++||||||+.|.||..+.+|-..-+...++-+|.+..|+-...+ ..
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~  260 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SH  260 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-ch
Confidence             223456789999999999863      3578999999999999999999999888888888888887766544332 35


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+..+.||+++||.+||..||+++++|+||||+...
T Consensus       261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            678899999999999999999999999999998653

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5e-45  Score=365.89  Aligned_cols=257  Identities=30%  Similarity=0.460  Sum_probs=211.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----E
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----Y  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----~  171 (487)
                      +|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++ ||||+++++++....     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence            3788999999999999999999999999999986532 12234567889999999995 999999999998776     8


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||+. ++|.+.+..  ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        79 ~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~a~~  152 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFGLARV  152 (372)
T ss_pred             EEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEeccccceee
Confidence            999999996 578887743  35799999999999999999999999999999999999998   478899999999976


Q ss_pred             cCCC--CccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc------------
Q 011380          252 IKPG--KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN------------  315 (487)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  315 (487)
                      ....  .......+|+.|+|||++.+.  ++.++|||||||++|+|++|+.||.+......+..+...            
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            5432  223445789999999998763  688999999999999999999999887765554444321            


Q ss_pred             -----------CCCCCC-----CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          316 -----------KPDFRR-----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       316 -----------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                 ....+.     ...+..++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                       000000     1123467899999999999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-44  Score=362.68  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=210.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcC-CCCccccceeeccccccc
Confidence            44689999999999999999999999999999999875432 2234466789999999995 99999999987543    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|+||||+++ +|.+.+.    ..+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG  171 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  171 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEeCC
Confidence              468999999965 6777663    2478999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  316 (487)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..++...          
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9987655444456789999999999866 46889999999999999999999998877666555544311          


Q ss_pred             ------------CCCCCC----------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          317 ------------PDFRRK----------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       317 ------------~~~~~~----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                  +.+...                .....+.++++||.+||+.||.+|||+.++|+||||..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                        111100                01123567899999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-44  Score=357.24  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=211.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+..+|..+|+|.+....  .......+.+|+++++.+. ||||+++++++.+.+.+|+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            367999999999999999999999999999999887542  2334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||++||+|.+++..  ...+++..+..++.|++.||.|||+. +|+||||||+|||++   .++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhhh
Confidence            9999999999998854  35689999999999999999999975 799999999999998   46789999999987653


Q ss_pred             CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHH--------------------
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV--------------------  312 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i--------------------  312 (487)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+                    
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         156 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             hh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            22 22446799999999998764 688999999999999999999999765433221111                    


Q ss_pred             ------------------------HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          313 ------------------------LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       313 ------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                              .....  +......++.++++||.+||++||++|||+.|++.||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                    00000  000012367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5e-45  Score=357.97  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=194.7

Q ss_pred             eeeeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEEEEEE
Q 011380          101 GKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYIAM  176 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~lv~  176 (487)
                      +++||+|+||+||+|+++  .+++.||+|.+.....     ...+.+|+.+++++. ||||+++++++..  ...+|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            467999999999999975  4678999999875432     245678999999995 9999999998854  56789999


Q ss_pred             eccCCCCHHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC-CCCCcEEEeeccc
Q 011380          177 ELCEGGELLDRILAK-------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (487)
Q Consensus       177 e~~~gg~L~~~l~~~-------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG~  248 (487)
                      ||+. ++|.+.+...       ....+++..++.++.||+.||.|||++||+||||||+|||+... ...+.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            9995 5888776432       12358999999999999999999999999999999999999642 2467899999999


Q ss_pred             ccccCCC----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHHH
Q 011380          249 SDFIKPG----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED---------GIFKEVL  313 (487)
Q Consensus       249 a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~  313 (487)
                      +......    ......+||+.|+|||++.+  .++.++||||+||++|+|++|++||......         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            9765432    12345688999999999865  3688999999999999999999999654321         1122221


Q ss_pred             hcCCCC---------------------C-------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          314 RNKPDF---------------------R-------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       314 ~~~~~~---------------------~-------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ......                     .             .......+.++.+||++||++||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            110000                     0             00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.7e-45  Score=361.62  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=209.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence            44689999999999999999999999999999999875432 2334567788999999995 99999999988643    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|+||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~Dfg  164 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  164 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEeeCc
Confidence              357999999965 6666653    3488999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh------------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------  314 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~------------  314 (487)
                      +++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+..            
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9987655444556789999999999866 468899999999999999999999987665443332221            


Q ss_pred             ----------cCCCCCC----------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          315 ----------NKPDFRR----------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       315 ----------~~~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                ..+.+..                ......+.++++||.+||..||++|||+.|+|+||||...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                      1111100                0012245678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-46  Score=358.16  Aligned_cols=257  Identities=28%  Similarity=0.484  Sum_probs=204.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      +..|++.+.||+||.+.||++... +.+.||+|++.... .+.....-+.+|+.+|.+|++|.+||++|+|-..++.+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            456999999999999999999854 34567777665433 3456778899999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||-+ .+|-.+|.. +...++.-.++.+.+|||.|+.++|.+||||.||||.|+|+.    .|.+||+|||+|..+..
T Consensus       438 vmE~Gd-~DL~kiL~k-~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKK-KKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             Eeeccc-ccHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCc
Confidence            999863 577776644 344455558899999999999999999999999999999998    68999999999988875


Q ss_pred             CCc---cccccCCccccchhhhcc------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCC
Q 011380          255 GKK---FQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPD  318 (487)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~  318 (487)
                      ...   ..+.+||+.||+||.+..            +.++++||||||||||+|+.|++||..-.. -.-+..|......
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE  591 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence            543   346799999999998732            136789999999999999999999954432 1222333332222


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ...+..+. ..++.++++.||..||++|||+.++|+|||++-
T Consensus       592 Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            22222221 234999999999999999999999999999875

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-45  Score=363.57  Aligned_cols=259  Identities=29%  Similarity=0.483  Sum_probs=210.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccc
Confidence            34679999999999999999999999999999999875432 1223456778999999995 99999999887543    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|++++++ +++|.+.+.   ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg  163 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFG  163 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcCCc
Confidence              4579999998 778877663   35699999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC---------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  316 (487)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+....         
T Consensus       164 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         164 LARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             cceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9976543  3345689999999999865  46889999999999999999999998765544443332211         


Q ss_pred             --------------CCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          317 --------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       317 --------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                    +..+..    .+...++.+.+||.+||..||.+|||+.++|.||||.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                          001100    12345677899999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=365.03  Aligned_cols=262  Identities=27%  Similarity=0.460  Sum_probs=229.5

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      +.++....|.-.+.||.|+||.||-|++..+.+.||||++............++.+|++.|++|. |||++.+.+||..+
T Consensus        20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre   98 (948)
T KOG0577|consen   20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLRE   98 (948)
T ss_pred             ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeecc
Confidence            44555667888899999999999999999999999999998766555556688999999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ...|+|||||-| +-.|.+.- ..+++.+.+++.|..+.+.||.|||+++.||||||+.|||++   +.+.|||+|||.|
T Consensus        99 ~TaWLVMEYClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSA  173 (948)
T KOG0577|consen   99 HTAWLVMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSA  173 (948)
T ss_pred             chHHHHHHHHhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccch
Confidence            999999999964 65555533 346899999999999999999999999999999999999999   6899999999999


Q ss_pred             cccCCCCccccccCCccccchhhh----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ....+   ..+++|||+|||||++    .|.|+-++||||||++..||...++|++..+....+..|..+.++...  -+
T Consensus       174 si~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~  248 (948)
T KOG0577|consen  174 SIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SN  248 (948)
T ss_pred             hhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--Cc
Confidence            87654   3567999999999987    468999999999999999999999999999988888888877654333  24


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..|..+..|+..||++-|.+|||++++|.|+|+....
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            5688999999999999999999999999999997653

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-44  Score=345.56  Aligned_cols=256  Identities=27%  Similarity=0.496  Sum_probs=213.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      ..+.|.+.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++++.+||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4567999999999999999999999999999999986543    23456789999999986699999999998753    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|++|||+++++|.+++.......+++..+..++.|++.||.|||+++|+||||+|+||+++   +++.+||+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccCC
Confidence              4689999999999999988765556789999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCC-CccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPG-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ++...... .......|++.|+|||++.+      .++.++|||||||++|+|++|..||...........+....  ..
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~  234 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP  234 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence            98765432 22345679999999999842      35778999999999999999999997665544443333221  22


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ......++.++.+||.+||..+|.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            22234678899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=352.36  Aligned_cols=260  Identities=33%  Similarity=0.588  Sum_probs=223.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.............+..|+++++.+. ||||+++++.+.+....|+||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence            6999999999999999999999999999999998765433345567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+.|++|.+++.......+++..+..++.||+.||.|||+.|++||||||+||+++   .++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhcccccc
Confidence            999999999988665567799999999999999999999999999999999999998   46789999999986543211


Q ss_pred             ------------------------------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 011380          257 ------------------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE  305 (487)
Q Consensus       257 ------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~  305 (487)
                                                    ......||..|+|||++.+. ++.++||||||+++|+|++|..||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          11234789999999998654 58899999999999999999999988887


Q ss_pred             hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcC----HHHHhcCccccccC
Q 011380          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT----AAQALSHPWVREGG  362 (487)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt----~~e~L~h~~~~~~~  362 (487)
                      ...+..+......+..  ...++..+.++|.+||..||++|||    +.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         238 DETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            7777777655444332  2237899999999999999999999    99999999998753

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-44  Score=347.35  Aligned_cols=253  Identities=33%  Similarity=0.578  Sum_probs=220.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+++++++. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence            6999999999999999999999999999999987654433445677889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+||||+|.|||++   .++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCccccCCC-
Confidence            999999999988544  6799999999999999999999999999999999999998   4678999999999876543 


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                       .....|++.|+|||.+.+. .+.++||||||+++|+|++|..||...........+..+...++    +.++..++++|
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li  229 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLI  229 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHH
Confidence             3445789999999988654 57889999999999999999999988776666677765544333    34688999999


Q ss_pred             HHccccCccCCc-----CHHHHhcCcccccc
Q 011380          336 KKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       336 ~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      .+||..||.+|+     +++++++||||+..
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            999999999999     99999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=352.02  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=228.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|+.-++||+||||.||-+.-+.||+.||+|.+.+............++|-.||.++. .|.||.+--+|+..+.+++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            35777889999999999999999999999999998877665666677889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +..|.||+|.-+|.......+++..++.++.+|+.||++||+.+||+|||||+|||+|   +.|+|+|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD---d~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD---DHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec---cCCCeEeeccceEEecCCC
Confidence            9999999998888776667899999999999999999999999999999999999999   6899999999999999988


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHhcCCCCCCCCCCCCCHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG----IFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ......+||.+|||||++.+ .|+...|+|||||++|+|+.|+.||....+..    +-+.++.....++    ..+|++
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~----~kFS~e  416 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS----DKFSEE  416 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc----cccCHH
Confidence            88888899999999999865 58999999999999999999999997654433    3333333333332    579999


Q ss_pred             HHHHHHHccccCccCCc-----CHHHHhcCccccccC
Q 011380          331 AKDFVKKLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                      ++++++.+|++||++|.     ++.++.+||||+...
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            99999999999999997     677999999999754

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.1e-44  Score=345.87  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||+|+++.+|+.||+|++...... ......+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            488999999999999999999999999999998654321 223456788999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||+|+|||++   .++.+||+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeecCCC
Confidence            9997 58888775433 35689999999999999999999999999999999999998   4788999999998755332


Q ss_pred             C-ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-------------
Q 011380          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------------  319 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  319 (487)
                      . ......+++.|+|||++.+  .++.++|||||||++|+|++|++||.+.........+.......             
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 2234467899999998865  35889999999999999999999998765543333222111000             


Q ss_pred             ------------CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          320 ------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       320 ------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                  ....+..+++++.++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                        011134578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=354.80  Aligned_cols=244  Identities=28%  Similarity=0.431  Sum_probs=211.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .+.+++.||+|.||.||.|.+.. ...||+|.+.....    ..+.+.+|+.+|++|+ |+|||++++++..+..+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEE
Confidence            45678899999999999998753 33799999876543    3467789999999996 999999999999988999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++.|+|.++|....+..+...+.+.++.||++|++||.++++|||||-+.||||+   ++..+||+|||+|+.+.++ 
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~-  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDD-  356 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCC-
Confidence            999999999999876678899999999999999999999999999999999999999   5789999999999955433 


Q ss_pred             ccccccC---Cccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          257 KFQDIVG---SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       257 ~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .+....|   -..|.|||++. +.++.+||||||||+||||+| |+.||.+.+..+.++.+-++..-..   .+..|+++
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~~CP~~v  433 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PEGCPDEV  433 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CCCCCHHH
Confidence            2333233   33599999986 568999999999999999999 9999999999999999988864433   35688999


Q ss_pred             HHHHHHccccCccCCcCHHHHh
Q 011380          332 KDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      .+++..||..+|++|||...+.
T Consensus       434 Y~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  434 YELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHHHHHhhCCcccCCCHHHHH
Confidence            9999999999999999998554

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-44  Score=363.83  Aligned_cols=254  Identities=22%  Similarity=0.355  Sum_probs=205.1

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+..+|.+++.||+|+||.||+|...  .+++.||+|.+....        ...+|+++|+.+. ||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            34568999999999999999999764  356789999886532        3458999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|++||++. ++|.+++  .....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       160 ~~~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~  233 (392)
T PHA03207        160 TVCMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAAC  233 (392)
T ss_pred             EEEEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCcccc
Confidence            9999999995 6888888  3346799999999999999999999999999999999999998   57889999999987


Q ss_pred             ccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcC----CCC
Q 011380          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNK----PDF  319 (487)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~----~~~  319 (487)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...   ...+..+....    ..+
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~  313 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF  313 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence            6543221   234679999999999875 468899999999999999999999976542   22222222210    000


Q ss_pred             CC------------------C--CC------CCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          320 RR------------------K--PW------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       320 ~~------------------~--~~------~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +.                  .  .+      ..++.++.++|++||..||.+|||+.++|.||||++.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            00                  0  00      1346788999999999999999999999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=343.16  Aligned_cols=262  Identities=26%  Similarity=0.471  Sum_probs=222.7

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ..+...+.|.++.+||+|+||.||+|.++.+|+.+|||.+....     ..+.+.+||.|++++. .|++|++|+.|-..
T Consensus        27 L~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~-S~yVVKYYGSYFK~  100 (502)
T KOG0574|consen   27 LNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCK-SKYVVKYYGSYFKH  100 (502)
T ss_pred             hcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcC-CchhhhhhhhhccC
Confidence            34455567999999999999999999999999999999987653     6788899999999995 99999999999988


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ..+|||||||..|++.+.+.. +++.+++.++..+++..+.||+|||...-||||||+.|||++   .+|..||+|||.+
T Consensus       101 sDLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVA  176 (502)
T KOG0574|consen  101 SDLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVA  176 (502)
T ss_pred             CceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhcccc
Confidence            999999999999999887754 457899999999999999999999999999999999999998   5889999999999


Q ss_pred             cccCCC-CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          250 DFIKPG-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       250 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..+.+. ....++.|||.|||||++.. .|..++||||||+...||..|++||.+-.....+-.|-.+.+. ........
T Consensus       177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP-TF~KPE~W  255 (502)
T KOG0574|consen  177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP-TFKKPEEW  255 (502)
T ss_pred             chhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC-CCCChHhh
Confidence            776432 23467899999999999976 6899999999999999999999999766554333223222221 11122346


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      |.++.|||++||-++|++|-||.++++|||++...
T Consensus       256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            88999999999999999999999999999998754

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.3e-44  Score=339.75  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=218.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||.|+||+||+|....++..+|+|++......  .....+.+|+.+++.+. ||||+++++.+...+.+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            3699999999999999999999889999999998754432  25577899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||+++|++|.+++..... ..+++..+..++.||+.||.|||+.||+||||+|+||+++   +++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhcc
Confidence            999999999998865433 5689999999999999999999999999999999999998   467899999999876554


Q ss_pred             CCcc-----ccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CC
Q 011380          255 GKKF-----QDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WP  325 (487)
Q Consensus       255 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~  325 (487)
                      ....     ....|+..|+|||++...  .+.++|+|||||++|+|++|+.||........+..+....+......  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            3221     345789999999988654  68899999999999999999999987776666666655543222211  24


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .+++.+.+++.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            688999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-44  Score=339.41  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=212.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC--hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .|.+.+.||+|++|.||+|.+..+++.||+|.+.......  ......+.+|+.+++++. ||||+++++++.....+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence            5889999999999999999999999999999986543221  123457889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+||++|++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceeccc
Confidence            99999999999988543  5689999999999999999999999999999999999998   477899999999876543


Q ss_pred             CCc----cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          255 GKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       255 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...    .....|++.|+|||++.+. ++.++||||||+++|+|++|+.||...........+.......  .....++.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  234 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSP  234 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCH
Confidence            211    1345688999999998664 5889999999999999999999997765555544444332221  12246789


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .+.++|.+||..+|.+|||+.++|+||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.4e-44  Score=354.53  Aligned_cols=252  Identities=26%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-  169 (487)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+.+||||+++++++... 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            57999999999999999999752     345789999986532  2234567889999999996699999999988754 


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc---------------------------------------------------------
Q 011380          170 NYVYIAMELCEGGELLDRILAKK---------------------------------------------------------  192 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------  192 (487)
                      +.+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999886432                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc---cccccCCcc
Q 011380          193 ---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY  266 (487)
Q Consensus       193 ---~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~  266 (487)
                         ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+++.......   .....+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               12477888999999999999999999999999999999998   477899999999976533221   123346788


Q ss_pred             ccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcc
Q 011380          267 YVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR  344 (487)
Q Consensus       267 y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  344 (487)
                      |+|||++.+ .++.++|||||||++|+|++ |..||.+......+...+.......  ....+++++.++|.+||..||.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR--APENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHccCChh
Confidence            999998865 46899999999999999997 9999987655444434333322211  1245788999999999999999


Q ss_pred             CCcCHHHHhc
Q 011380          345 ARLTAAQALS  354 (487)
Q Consensus       345 ~Rpt~~e~L~  354 (487)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.6e-44  Score=351.57  Aligned_cols=257  Identities=22%  Similarity=0.306  Sum_probs=206.4

Q ss_pred             Eeeeeeec--CceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380          100 IGKLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus       100 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      ++++||+|  +||+||++.++.+|+.||+|++..... .......+.+|+.+++.+. ||||+++++++..++..|+|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            46789999  789999999999999999999876532 2334567788999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-C
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-K  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~  256 (487)
                      |+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.++++|||.+...... .
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhccccccc
Confidence            99999999988665455689999999999999999999999999999999999998   4678999999865432111 0


Q ss_pred             -------ccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC------
Q 011380          257 -------KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR------  320 (487)
Q Consensus       257 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------  320 (487)
                             ......++..|+|||++.+   .++.++|||||||++|+|++|+.||..............+.....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   0122356788999999864   468899999999999999999999976655443333322211100      


Q ss_pred             ------------------------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          321 ------------------------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       321 ------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                                          ......+++++.+||.+||+.||++|||+.++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                00011356789999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-44  Score=357.47  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|++.+.||+|+||.||+|.+..+++.||+|+.....         ...|+.+++++. ||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            35999999999999999999999999999999754432         246999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||++. ++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   ..+.+||+|||++......
T Consensus       136 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCccccccccC
Confidence            99995 5888877543 45789999999999999999999999999999999999998   4778999999999765433


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh----------HHHHHHHhcC----CCCC
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----------GIFKEVLRNK----PDFR  320 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----------~~~~~i~~~~----~~~~  320 (487)
                      .......||+.|+|||++.+ .++.++|||||||++|+|+++..|+......          ..+..+....    ..+.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            34455679999999999865 5689999999999999999865554332111          1111111110    0011


Q ss_pred             ------------------C--------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          321 ------------------R--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       321 ------------------~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                        .        .....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                              0        001245677889999999999999999999999999975

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-45  Score=361.13  Aligned_cols=261  Identities=25%  Similarity=0.438  Sum_probs=222.9

Q ss_pred             ccCCCe-eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc-CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           93 DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        93 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +...+| +...+||+|+|-+||+|.|..+|..||.-.++...+ ..+...+.+..|+.+|+.|+ ||||+++|+.|.+..
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTD  114 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCC
Confidence            344555 456789999999999999999999999765543322 23556789999999999995 999999999998765


Q ss_pred             E--EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--CceeecCCCCceEeccCCCCCcEEEeec
Q 011380          171 Y--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       171 ~--~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      .  +.+|+|++..|+|..|+.+.  +.++...+..|++||+.||.|||++  .|||||||.+||||+.  ..|.|||+|+
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG--~~G~VKIGDL  190 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG--NLGEVKIGDL  190 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC--CcCceeecch
Confidence            4  88999999999999988554  6788999999999999999999988  5999999999999985  7899999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      |||.....+. ....+|||.|||||++...|.+.+||||||+++.||+|+..||... +...+++++..+..+-..... 
T Consensus       191 GLAtl~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV-  268 (632)
T KOG0584|consen  191 GLATLLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV-  268 (632)
T ss_pred             hHHHHhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc-
Confidence            9998876543 3558999999999999999999999999999999999999999765 556788888888754332222 


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                       -.+++++||.+||.. .+.|||+.|+|.||||....
T Consensus       269 -~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  269 -KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             -CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence             257899999999999 99999999999999999863

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-43  Score=335.00  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=218.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||+|.++.+|+.|++|.+...... ......+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence            478889999999999999999999999999998754332 345677889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++.......+++..++.++.|++.||.|||+.||+||||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence            999999999988765557799999999999999999999999999999999999998   46789999999987665432


Q ss_pred             c-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      . .....|++.|+|||++.+. ++.++|||||||++|+|++|+.||...........+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL  232 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence            2 2345789999999988654 588999999999999999999999888776666666654422111   2578899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      |.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-43  Score=334.74  Aligned_cols=254  Identities=22%  Similarity=0.467  Sum_probs=215.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYIA  175 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~lv  175 (487)
                      .|++.+.||.|++|.||++.++.+++.||+|.+..... .....+.+.+|+.+++++. ||||+++++.+.. ...+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence            48999999999999999999999999999999865432 2234566889999999995 9999999998764 4578999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..++.++.|++.||.+||+.||+||||||+||+++   .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEeccc
Confidence            9999999999998765566799999999999999999999999999999999999998   5788999999998766432


Q ss_pred             C-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      . ......|++.|+|||++.+. ++.++||||||+++|+|++|+.||...........+..+...   .....+++++.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence            2 23345789999999988654 588999999999999999999999877766666666554432   122468899999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +|.+||+.||.+|||+.+++.||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-43  Score=342.61  Aligned_cols=256  Identities=28%  Similarity=0.506  Sum_probs=212.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE------
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE------  167 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~------  167 (487)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++.+||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4467999999999999999999999999999999986542    234567889999999977999999999885      


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      ....+|++|||+++|+|.+++.......+++..+..++.||+.||.|||+.||+||||+|+||+++   +++.++|+|||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~dfg  166 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFG  166 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCc
Confidence            356789999999999999988766666789999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCC-CccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ++...... .......|++.|+|||.+.      ..++.++|||||||++|+|++|..||...........+.....  .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~  244 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P  244 (282)
T ss_pred             chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence            98765322 2234467899999999874      2457789999999999999999999977655444433333221  1


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ......++.++.+||.+||..||.+|||+.++|+||||
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-43  Score=334.51  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=220.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++. ||||+++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            489999999999999999999999999999999765432 334577889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++.......+++..+..++.|++.+|.|||++||+||||+|+||+++.  ++..+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence            9999999999987655566899999999999999999999999999999999999974  35578999999998765544


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      ......|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...........+.......   ....++.++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence            44456789999999998754 5889999999999999999999998877766666665543221   1235788999999


Q ss_pred             HHccccCccCCcCHHHHhcCccc
Q 011380          336 KKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       336 ~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .+||..+|.+|||+.++++||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=369.92  Aligned_cols=249  Identities=30%  Similarity=0.510  Sum_probs=209.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEE-EE---e---C
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA-FE---D---D  169 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~-~~---~---~  169 (487)
                      +++|.+.|.+|||+.||+|.+...|..||+|++-..   .....+.+.+||++|+.|++|||||.+++. ..   .   .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            688899999999999999999888899999988654   356889999999999999999999999993 22   1   2


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      -.++|+||||.||.|.+++..+....|+|.+++.|++|+++||.+||..+  |||||||-|||||.   .++..||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCccc
Confidence            35789999999999999998777777999999999999999999999997  99999999999999   57899999999


Q ss_pred             cccccCCCC-ccc---------cccCCccccchhhhc---c-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 011380          248 LSDFIKPGK-KFQ---------DIVGSAYYVAPEVLK---R-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       248 ~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~---~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  313 (487)
                      .+...-... ...         ...-|+.|+|||++.   + ..++|+|||||||+||-|+....||......    .|+
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIl  267 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AIL  267 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEE
Confidence            986432211 100         124699999999874   3 3499999999999999999999999765332    455


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      .++..|  ++.+.+|..+++||+.||+.||.+||++.+++.+-+
T Consensus       268 ng~Y~~--P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  268 NGNYSF--PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             eccccC--CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            555444  445789999999999999999999999999987544

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-43  Score=341.77  Aligned_cols=259  Identities=27%  Similarity=0.479  Sum_probs=216.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++.+......|
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEE
Confidence            44689999999999999999999999999999999876542   23467889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++|++|.+++..   ..+++..+..++.|++.||.|||+.||+||||||+|||++   .++.+||+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhcc
Confidence            99999999999998743   4588999999999999999999999999999999999998   47789999999987654


Q ss_pred             CCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .... .....|++.|+|||.+.+. ++.++|||||||++|+|++|+.||...........+...... .....+.++..+
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  246 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHH
Confidence            3322 2345789999999988654 588999999999999999999999877664444333332211 111224578899


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .++|.+||..+|.+|||+.++++||||.....
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            99999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.3e-43  Score=341.19  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=211.0

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++++. ||||+++++++...+.+|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999987644332334456678999999995 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccC
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~g  263 (487)
                      |.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++   +++.+||+|||++.............|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCccccccC
Confidence            99988766555799999999999999999999999999999999999998   477899999999877654444455678


Q ss_pred             Cccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccC
Q 011380          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD  342 (487)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  342 (487)
                      +..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+............+.+++.+.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            899999998765 4688999999999999999999999765442222222222222222233467899999999999999


Q ss_pred             ccCCc-----CHHHHhcCcccccc
Q 011380          343 PRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       343 p~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      |.+||     ++.+++.||||+..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhcC
Confidence            99999     99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.1e-44  Score=344.59  Aligned_cols=255  Identities=27%  Similarity=0.504  Sum_probs=206.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++++. ||||+++++++.+.+.+|+|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            58899999999999999999999999999999865432 1223356778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          79 EYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             ecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCCCC
Confidence            9996 5788876543 35689999999999999999999999999999999999998   46789999999987654322


Q ss_pred             -ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcC--------------CC
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNK--------------PD  318 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~--------------~~  318 (487)
                       ......+++.|+|||++.+.  ++.++|||||||++|+|++|..||... +....+..+....              +.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             23345688999999998653  588999999999999999998886443 3333333332210              00


Q ss_pred             CC-----------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 FR-----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 ~~-----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +.           ....+.+++++.++|.+||..||.+|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00           01124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-43  Score=341.56  Aligned_cols=260  Identities=30%  Similarity=0.458  Sum_probs=217.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   ......+.+|+.+++.+. ||||+++++.+..++.+|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            4467999999999999999999999999999999986542   345677889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++|++|...+... ...+++..+..++.||+.+|.|||+.||+||||||+||+++   .++.+||+|||++....
T Consensus        86 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          86 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceecc
Confidence            999999999987766443 35689999999999999999999999999999999999998   47789999999886543


Q ss_pred             CC-CccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .. .......|++.|+|||.+.+      .++.++|||||||++|+|++|..||..........++....... ......
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSK  240 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCcc
Confidence            22 22344578999999998742      34778999999999999999999998776665555554433221 111235


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++.++.++|.+||..+|++||++.++++||||....
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            788999999999999999999999999999997653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-43  Score=340.42  Aligned_cols=256  Identities=28%  Similarity=0.512  Sum_probs=210.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.....+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            369999999999999999999999999999998865432 1223356789999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++++.|...+.  ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++......
T Consensus        79 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          79 FEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             EeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCCC
Confidence            99999877766543  235689999999999999999999999999999999999998   4678999999999876543


Q ss_pred             C-ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------------
Q 011380          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  318 (487)
                      . ......++..|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+......              
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            3 2334568899999999864  3588999999999999999999999877654444333221000              


Q ss_pred             -----CCC--------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 -----FRR--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 -----~~~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                           .+.        ..++.++..+.+||.+||..+|++|||+.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                 000        0134578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-43  Score=342.80  Aligned_cols=263  Identities=28%  Similarity=0.488  Sum_probs=218.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +...+|.+.+.||+|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++...+.+
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEE
Confidence            445689999999999999999999999999999999875432   23466789999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+++++|.+++..   ..+++..+..++.|++.||.|||+.||+||||||+|||++   .++.++|+|||++...
T Consensus        92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceEc
Confidence            999999999999998743   4588999999999999999999999999999999999998   4788999999998765


Q ss_pred             CCCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ..... .....|++.|+|||.+.+. ++.++|||||||++|+|++|..||...........+...... .......++..
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  244 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPERLSAV  244 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC-CCCCccccCHH
Confidence            43322 2345789999999988654 688999999999999999999999776554333222222111 11122457888


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCCCCC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE  366 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~  366 (487)
                      +.+||.+||..+|++||++.++++||||+.......
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            999999999999999999999999999987655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=319.36  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=223.3

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      .+++..||.|+.|.|++++.+.+|...|||.+.+..  .......++..+.++....+.|+||+.+|+|..+..++|.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            455677999999999999999999999999998764  344567788888888777668999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      .|.  .-.+.++..-.++++|..+-.+...++.||.||-+ +||+|||+||+|||++   +.|.+||||||++..+-++.
T Consensus       172 lMs--~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMS--TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHH--HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccceeeccc
Confidence            984  33666666666789999999999999999999975 6999999999999999   68999999999998888777


Q ss_pred             ccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          257 KFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..+...|.+.|||||.+.    .+|+-++||||||+.++||.||..||.+. .+-+.+.++++..+.... .-..+|+.+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-~~~gFSp~F  325 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-GHMGFSPDF  325 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-cccCcCHHH
Confidence            778889999999999985    35788999999999999999999999875 566788888887663332 224599999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .+|+..||++|+.+||...++|+|||+..+..
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            99999999999999999999999999988753

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-43  Score=339.30  Aligned_cols=253  Identities=28%  Similarity=0.463  Sum_probs=209.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.+. ||||+++++.+...+.+|+|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999986543   223456788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++..  ...+++..++.++.|++.||.|||+.||+|+||||+||+++   .++.+||+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          85 MEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEccCc
Confidence            999999999998744  35789999999999999999999999999999999999998   4778999999998655322


Q ss_pred             C-ccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCCCCH
Q 011380          256 K-KFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSISN  329 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~  329 (487)
                      . ......|++.|+|||++.    +.++.++|||||||++|+|++|..||..................... .....++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            1 223457999999999873    34688999999999999999999999766544433333222221111 11124678


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      .+.++|.+||..+|++|||+.++++|||
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-43  Score=343.51  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=210.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||++.+..+|..+|+|.+....  .......+.+|+++++++. ||||+++++++..++.+|+||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence            5899999999999999999999999999999886532  2334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||+ .+++||||||+|||++   .++.+||+|||++......
T Consensus        79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccc
Confidence            999999999988543  678999999999999999999997 6999999999999998   4678999999998765332


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC----------------
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----------------  318 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  318 (487)
                       .....+|++.|+|||++.+. ++.++|||||||++|+|++|+.||.......... +......                
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA-MFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH-hhcCccccccccCCcccccCCCC
Confidence             23456789999999998654 5889999999999999999999996554332221 1111000                


Q ss_pred             -------------------CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 -------------------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 -------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                         .+..+...++.++++||.+||..+|++|||+.++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                               0011112367889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=341.91  Aligned_cols=258  Identities=33%  Similarity=0.508  Sum_probs=217.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+...   .....+.+.+|+.+++++. ||||+++++.+.....+|+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            45799999999999999999999889999999998643   2345567889999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          80 LIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchhhcc
Confidence            99999999998877543 35699999999999999999999999999999999999998   478899999998865432


Q ss_pred             C-CccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          255 G-KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       255 ~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      . .......|++.|+|||.+..      .++.++||||||+++|+|++|+.||...........+........ ...+.+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  234 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKW  234 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccC
Confidence            2 22234578999999998742      246789999999999999999999988776666666655433211 112357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +.++.++|.+||..+|.+||++.++|+||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            8899999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-43  Score=340.09  Aligned_cols=263  Identities=29%  Similarity=0.490  Sum_probs=212.1

Q ss_pred             CCcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      +..-....++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++.+||||+++++++.
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3344456778999999999999999999999999999999876532    123567789999999966999999999873


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          168 -----DDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       168 -----~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                           ..+.+++||||++|++|.+.+...  ....+++..+..++.|++.||.|||+.+|+||||||+||+++   .++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCC
Confidence                 456799999999999998877432  335688999999999999999999999999999999999998   4677


Q ss_pred             EEEeecccccccCCCC-ccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 011380          241 LKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       241 vkl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  313 (487)
                      +||+|||++....... ......|++.|+|||++.      ..++.++||||+||++|+|++|..||........+..+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            9999999987654322 223457999999999874      236789999999999999999999998765544433332


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..... .......++..+.++|.+||+.||++|||+.++++|+||
T Consensus       243 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         243 RNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22111 111112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.7e-45  Score=330.31  Aligned_cols=264  Identities=29%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNY  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~  171 (487)
                      .|+++..||+|+||.||+|..+.++.    .+|||+++..+-... .....-+|+.+++.|+ |||++.+..+|.. +..
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccCce
Confidence            58999999999999999997665543    689999876532221 2244568999999996 9999999998876 889


Q ss_pred             EEEEEeccCCCCHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC-CCCCcEEEeecc
Q 011380          172 VYIAMELCEGGELLDRILAK---KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFG  247 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG  247 (487)
                      +++++||.+. +|++.|...   +...++...+..+++||+.|+.|||++-|+||||||.|||+..+ .+.|.|||+|||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999999976 888877433   33569999999999999999999999999999999999999853 345899999999


Q ss_pred             cccccCCC----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHH
Q 011380          248 LSDFIKPG----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED---------GIFKEV  312 (487)
Q Consensus       248 ~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i  312 (487)
                      +++.+...    .....++-|.+|+|||.+.|  .|++++||||+|||+.||++-.+.|.+....         +.+..|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99887543    23455778999999999876  4799999999999999999999988664321         233344


Q ss_pred             HhcCCCCCCCCCCC---------------------------------CCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          313 LRNKPDFRRKPWPS---------------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       313 ~~~~~~~~~~~~~~---------------------------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      +.--.......||.                                 -++.+.+|+.+||++||.+|+|+.++|+|+||.
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            33211112222221                                 244588999999999999999999999999999


Q ss_pred             ccCC
Q 011380          360 EGGD  363 (487)
Q Consensus       360 ~~~~  363 (487)
                      +...
T Consensus       342 ~d~l  345 (438)
T KOG0666|consen  342 EDPL  345 (438)
T ss_pred             cCCC
Confidence            8643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.3e-43  Score=342.33  Aligned_cols=258  Identities=29%  Similarity=0.478  Sum_probs=218.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+++++.+. ||||+++++.+...+.+|+||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999987654333344567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++   ..+.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCcCc
Confidence            999999999988443  5689999999999999999999999999999999999998   57889999999886321000


Q ss_pred             ----------------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          257 ----------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       257 ----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                                      ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||.+....+....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                            0112467889999998754 56899999999999999999999999888777777777665444


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcC---HHHHhcCcccccc
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~L~h~~~~~~  361 (487)
                      +... +.++.++.++|.+||..||++||+   +.++|+||||...
T Consensus       236 ~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         236 PEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            4332 257899999999999999999997   7999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7e-43  Score=331.86  Aligned_cols=254  Identities=28%  Similarity=0.475  Sum_probs=220.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.+++++. ||||+++++++.+.+.++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            589999999999999999999999999999998755432 334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence            999999999998766556789999999999999999999999999999999999998   47789999999987664333


Q ss_pred             -ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......|++.|+|||.+.+. ++.++||||||+++|+|++|..||......+....+..+.....   .+.++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence             23456789999999988654 68899999999999999999999988777777777766543322   15678999999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      |.+||..+|.+||++.++|+|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.2e-43  Score=338.39  Aligned_cols=259  Identities=29%  Similarity=0.488  Sum_probs=213.5

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~---  169 (487)
                      ...++|.+.+.||+|+||.||+|.+..+|+.+|+|++....    .....+.+|+.+++++.+||||+++++++...   
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            45678999999999999999999999999999999986542    13356778999999996699999999998643   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          170 --NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                        +.+|+||||++|++|.+++..  .....+++..++.++.|++.||.|||+.||+||||||+||+++   .++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEee
Confidence              468999999999999987743  2345789999999999999999999999999999999999998   467899999


Q ss_pred             cccccccCCCC-ccccccCCccccchhhhccC------CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 011380          246 FGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRK------SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       246 fG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      ||++....... ......|+..|+|||++...      ++.++|||||||++|+|++|+.||........+..+......
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  251 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP  251 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence            99987654322 22345789999999987532      478999999999999999999999877665555555444322


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      .. .....++..+.++|.+||..+|++||++.++++||||+
T Consensus       252 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            11 11234677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-43  Score=340.92  Aligned_cols=256  Identities=32%  Similarity=0.504  Sum_probs=213.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++++. ||||+++++++.....+|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            489999999999999999999999999999998765422 234567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++   .++.++|+|||++.......
T Consensus        79 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          79 EYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             ccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCC
Confidence            999 999998875443 6799999999999999999999999999999999999998   47789999999987664432


Q ss_pred             --ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-------------
Q 011380          257 --KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------------  319 (487)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  319 (487)
                        ......|+..|+|||.+.+.  ++.++||||+||++|+|++|.+||.+......+..+.......             
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence              23456789999999987543  4889999999999999999988887776655555544321110             


Q ss_pred             ------CC-------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          320 ------RR-------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       320 ------~~-------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                            ..       ..++..+..+.++|.+||..+|.+|||+.++|+||||.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                  00       01245678899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-43  Score=335.60  Aligned_cols=252  Identities=32%  Similarity=0.532  Sum_probs=211.8

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+||||+++++++...+.+|+|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999999999999999987654322223334556666555544699999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI  261 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  261 (487)
                      ++|.+++...  ..+++..+..++.||+.||.|||+.+++||||+|+||+++   .++.+||+|||++.....   ....
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc---cccC
Confidence            9999987443  5789999999999999999999999999999999999998   467899999999875432   2345


Q ss_pred             cCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccc
Q 011380          262 VGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (487)
Q Consensus       262 ~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (487)
                      .|++.|+|||.+.+. ++.++||||||+++|+|++|..||........+..+......+.....+.++.++.++|.+||+
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            689999999998664 5889999999999999999999998888777777777666555554445689999999999999


Q ss_pred             cCccCCcC---HHHHhcCcccccc
Q 011380          341 KDPRARLT---AAQALSHPWVREG  361 (487)
Q Consensus       341 ~dp~~Rpt---~~e~L~h~~~~~~  361 (487)
                      .+|++||+   +.|+|.||||+..
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhcC
Confidence            99999994   5799999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.2e-43  Score=339.96  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+++++++ +||||+++++.+...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEE
Confidence            5888999999999999999999999999999986542  233456788999999999 4999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|..+      ..+++..+..++.|++.||.|||+.||+|+||||+|||++   .++.+||+|||++...... 
T Consensus        79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceecccc-
Confidence            99999988543      3578999999999999999999999999999999999998   4788999999999765432 


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-------HHHHHHHhcCCCCCCCCCCCCC
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-------GIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......       .....+....  ........++
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFS  226 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCC
Confidence            2345689999999998865 4688999999999999999999999653211       1222222221  1222234578


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +++.++|.+||+.+|.+||++.++++||||+...
T Consensus       227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            8999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.3e-43  Score=340.17  Aligned_cols=258  Identities=29%  Similarity=0.508  Sum_probs=218.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++.....+|+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence            3579999999999999999999999999999999865432   23467889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+||+++++|.+++..   ..+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhccc
Confidence            9999999999987743   3589999999999999999999999999999999999998   477899999999876543


Q ss_pred             CCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ... .....|++.|+|||.+.+. ++.++|||||||++|+|++|+.||...........+....... ......+++.+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSPIFR  246 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCHHHH
Confidence            322 2345789999999988654 6889999999999999999999998877655554444332211 122346889999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ++|.+||..||.+|||+.+++.||||+....
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            9999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-43  Score=346.22  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=193.3

Q ss_pred             eeeeeecCceEEEEEEEcC--CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCCEEEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYVYIAM  176 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~~~~lv~  176 (487)
                      +.+||+|+||+||+|+++.  ++..||+|.+.....     ...+.+|+.+++.+. ||||+++++++.  ....+++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            4679999999999999654  568899999875432     245678999999995 999999999885  456789999


Q ss_pred             eccCCCCHHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC-CCCCcEEEeeccc
Q 011380          177 ELCEGGELLDRILAK-------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGL  248 (487)
Q Consensus       177 e~~~gg~L~~~l~~~-------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG~  248 (487)
                      ||+. ++|.+.+...       ....+++..+..++.||+.||.|||+.||+||||||+|||+... ..++.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9986 5787776422       12358899999999999999999999999999999999999543 2467899999999


Q ss_pred             ccccCCCC----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---------HHHHHHH
Q 011380          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED---------GIFKEVL  313 (487)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~  313 (487)
                      ++......    ......||+.|+|||++.+  .++.++|||||||++|+|++|++||.....+         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            97654322    2334678999999999865  3688999999999999999999999654321         1111111


Q ss_pred             hc--------------CCCCCC--------------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          314 RN--------------KPDFRR--------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       314 ~~--------------~~~~~~--------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..              .+.+..                    ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            10              000000                    0011235568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=338.14  Aligned_cols=256  Identities=30%  Similarity=0.526  Sum_probs=217.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|+||.||+|.+..+|+.||+|.+.....  ......+.+|+.+++.+. ||||+++++++.++..+|+|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEE
Confidence            68899999999999999999999999999999875431  234466789999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      ||+++++|.+++..   ..+++..++.++.|++.||.|||+.+++||||+|+||+++   .++.++|+|||++...... 
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          79 EYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             EeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEcccccceeecccc
Confidence            99999999998843   2789999999999999999999999999999999999998   4788999999999776543 


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      .......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+....+...  ....++.++.++
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  230 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL--EGNKFSKPFKDF  230 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC--cccccCHHHHHH
Confidence            22345678999999998865 468999999999999999999999987665555555544432211  112278899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccCC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +.+||..+|++|||+.++++||||+....
T Consensus       231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            99999999999999999999999988644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.6e-43  Score=341.14  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=210.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE-----
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY-----  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~-----  171 (487)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            68999999999999999999999999999998865432 112335678899999999767999999999887665     


Q ss_pred             EEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          172 VYIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      +|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||++||+||||+|+||+++.  .++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeeccc
Confidence            8999999985 7888876543   246899999999999999999999999999999999999984  367899999999


Q ss_pred             ccccCCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011380          249 SDFIKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----  320 (487)
Q Consensus       249 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  320 (487)
                      +...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.+.......+........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8754322 22233467899999998854  358899999999999999999999988766555544433211000     


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          321 -------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       321 -------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                                         ....+.++.++.+||.+||.+||.+||++.++|.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                               011245788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.2e-43  Score=332.75  Aligned_cols=254  Identities=25%  Similarity=0.533  Sum_probs=218.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++++. ||||+++++++...+..|+|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            589999999999999999999999999999998754322 234567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+.+.......+++..+..++.|++.||.|||++|++|+||+|+|||++   .++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecCcch
Confidence            999999999988665555789999999999999999999999999999999999998   46789999999987654322


Q ss_pred             c-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      . .....|++.|+|||++.+. .+.++|+|||||++|+|++|+.||......+....+..+.....   ...++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence            2 2235688999999998654 57899999999999999999999988877777777766543221   23578899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      |.+||+.+|.+||++.+++.||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-43  Score=337.40  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=208.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+|++.+.||+|+||.||+|+++.+|+.||+|++.....   .....+.+|+.+++++. ||||+++++++...+.+|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence            34579999999999999999999999999999999865421   23456788999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+||||+|+||+++   .++.+||+|||++....
T Consensus        83 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCccceeec
Confidence            99999999999988743  35789999999999999999999999999999999999998   46789999999987654


Q ss_pred             CCC-ccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCCC
Q 011380          254 PGK-KFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSI  327 (487)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  327 (487)
                      ... ......|++.|+|||.+.    ..++.++||||+||++|+|++|..||...........+......... .....+
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW  237 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence            322 223457899999999874    23577899999999999999999999655443322222222111111 111346


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      +..+.+||++||..+|++|||++++|+|+|
T Consensus       238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.1e-43  Score=337.87  Aligned_cols=257  Identities=31%  Similarity=0.477  Sum_probs=215.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.+. ||||+++++++...+..|+|+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEEE
Confidence            4788899999999999999999999999999986543   334567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      ||+++++|...+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++...... 
T Consensus        82 e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          82 EFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccccccc
Confidence            99999999877643 235789999999999999999999999999999999999998   4778999999998654322 


Q ss_pred             CccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .......|++.|+|||++..      .++.++||||+||++|+|++|.+||...........+......... ....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence            22344678999999998742      3467899999999999999999999887766666666554332111 1235788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++.+||.+||..||.+||++.++++||||+...
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-43  Score=358.10  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|+++|++|. |||||++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            4479999999999999999999999999999996422         23468999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       238 v~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        238 VLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceeccc
Confidence            999995 6888887543 34699999999999999999999999999999999999998   467899999999976543


Q ss_pred             CCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHHHHhcCC---C-
Q 011380          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT--------EDGIFKEVLRNKP---D-  318 (487)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~---~-  318 (487)
                      ...   ....+||+.|+|||++.+. ++.++|||||||++|||++|..|+....        ...+...+.....   . 
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            221   2245799999999998654 6889999999999999999887664322        1222222221110   0 


Q ss_pred             -----------------------CCCCCCC---CCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          319 -----------------------FRRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       319 -----------------------~~~~~~~---~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                             +....|.   .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                   1111222   45678999999999999999999999999999964

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-43  Score=336.52  Aligned_cols=257  Identities=30%  Similarity=0.521  Sum_probs=213.2

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      ..++|++.+.||+|+||.||+|.++.+++.+++|++....    ...+.+.+|+.+++++.+||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            3468999999999999999999999999999999987543    234678899999999966999999999997644   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          171 ---YVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                         .+|+||||+++++|.+.+....  ...+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECC
Confidence               5899999999999998875433  46789999999999999999999999999999999999998   467899999


Q ss_pred             cccccccCCCC-ccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 011380          246 FGLSDFIKPGK-KFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       246 fG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      ||++....... ......|++.|+|||++..      .++.++|||||||++|+|++|..||...........+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            99987654322 2234678999999998743      3467899999999999999999999876655555555544322


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ... ....++.++.+||.+||..||++|||+.++++|||+
T Consensus       237 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         237 TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            111 112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.6e-43  Score=340.92  Aligned_cols=263  Identities=30%  Similarity=0.438  Sum_probs=215.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|.+......  .......+..|+.+++++. ||||+++++++.+.+.+++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            488899999999999999999999999999999765432  1223355678999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+|||++   .++.+||+|||++.....
T Consensus        80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGS  154 (298)
T ss_pred             EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccC
Confidence            99999 889999885432 3699999999999999999999999999999999999998   478899999999977654


Q ss_pred             C-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC----------
Q 011380          255 G-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR----------  321 (487)
Q Consensus       255 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----------  321 (487)
                      . .......+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+....+.+..+.........          
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            3 22334467889999998854  3578999999999999999998888776665555554432111000          


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                                    ..++..+.++.++|.+||..||++|||+.++|.||||++.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                          01234578899999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.7e-43  Score=338.16  Aligned_cols=241  Identities=17%  Similarity=0.226  Sum_probs=205.2

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCEEEEEEe
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNYVYIAME  177 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----~~~~~lv~e  177 (487)
                      ..||+|++|.||+|..  +|+.||+|++.+.........+.+.+|+.+|+++. ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            4699999999999986  68999999997654433444577889999999995 9999999999876    457899999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |++||+|.+++..  ...+++.....++.|++.||.|||+. +++||||||+|||++   +++.+||+|||++...... 
T Consensus       103 y~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhccc-
Confidence            9999999998854  35788999999999999999999984 999999999999998   4788999999998765432 


Q ss_pred             ccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                       .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+.+..+.+..+......+..+  ...++++++
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~  253 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKC  253 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHH
Confidence             234578999999999864   57899999999999999999999999888877777776655443321  257899999


Q ss_pred             HHHHccccCccCCcCHHHHhc
Q 011380          334 FVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ||.+||+.||++|||+.++++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999975

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-43  Score=336.93  Aligned_cols=253  Identities=28%  Similarity=0.503  Sum_probs=216.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.....+++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            4899999999999999999999999999999998765444456678899999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+.|++|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++   +++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          80 DLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             eCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCCCc
Confidence            999999999888543  5789999999999999999999999999999999999998   57889999999987765544


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      ......|+..|+|||.+.+. ++.++|+||||+++|+|++|..||.....  ...+......   ......+.++..+.+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  231 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTEAID  231 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHHHHH
Confidence            44556789999999998654 58899999999999999999999987764  2222222221   111222457899999


Q ss_pred             HHHHccccCccCCcCH--HHHhcCccc
Q 011380          334 FVKKLLVKDPRARLTA--AQALSHPWV  358 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~--~e~L~h~~~  358 (487)
                      +|.+||..||.+||++  .|+++||||
T Consensus       232 ~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         232 AINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.9e-43  Score=339.04  Aligned_cols=262  Identities=26%  Similarity=0.446  Sum_probs=214.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|++|+||+|.++.+|+.||+|.+...... ......+.+|+++++++. ||||+++++++.+...+|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            4699999999999999999999999999999998654321 123456788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++ ++|.+.+.......+++..+..++.||+.||.|||++||+||||+|+||+++.  .++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence            99996 58888876555555788999999999999999999999999999999999984  3467999999999765332


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (487)
                       .......|++.|+|||++.+  .++.++|||||||++|+|++|..||......+.+.++.........           
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22344578899999998865  3578999999999999999999999877665555554331111000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                    ...+.+++++.++|.+||+.+|++||++.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence                          01245788999999999999999999999999999998753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=340.30  Aligned_cols=267  Identities=29%  Similarity=0.426  Sum_probs=219.2

Q ss_pred             CCcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-C----CccEE
Q 011380           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-E----NVVKF  162 (487)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-p----nIv~~  162 (487)
                      +...+.+..+|.+.+.||+|+||.|..+.+..++..||||+++.-    ....+..+-|+++|+++..+ |    -+|++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            445566789999999999999999999999999999999998753    23567778899999999423 3    37888


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC------
Q 011380          163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK------  236 (487)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~------  236 (487)
                      .++|+..++++||+|.+ |-++++++..+...+++...++.+++||+.++++||+.+++|.||||+|||+.+..      
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence            99999999999999998 67999999888888899999999999999999999999999999999999996411      


Q ss_pred             -----------CCCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 011380          237 -----------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT  304 (487)
Q Consensus       237 -----------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~  304 (487)
                                 ++..|+|+|||.|++...  .....+.|..|+|||++.+ .++.++||||+||||+|+++|...|....
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                       245799999999987543  3467899999999999876 68999999999999999999999998776


Q ss_pred             hhH---HHHHHHhcCCCCC-------------CCCCCCC--------------------------CHHHHHHHHHccccC
Q 011380          305 EDG---IFKEVLRNKPDFR-------------RKPWPSI--------------------------SNSAKDFVKKLLVKD  342 (487)
Q Consensus       305 ~~~---~~~~i~~~~~~~~-------------~~~~~~~--------------------------s~~~~~li~~~L~~d  342 (487)
                      +.+   +.+.|+...|...             ...|++.                          -.++.|||++||.+|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            544   3333332111000             0112211                          124789999999999


Q ss_pred             ccCCcCHHHHhcCcccccc
Q 011380          343 PRARLTAAQALSHPWVREG  361 (487)
Q Consensus       343 p~~Rpt~~e~L~h~~~~~~  361 (487)
                      |.+|+|+.|+|.||||+..
T Consensus       394 P~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARL  412 (415)
T ss_pred             ccccccHHHHhcCHHhhcC
Confidence            9999999999999999864

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.5e-43  Score=342.28  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=212.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~  172 (487)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++++. ||||+++++++.+.  +.+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            357999999999999999999999999999999986543211 12234568999999995 99999999998755  578


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+.+ +|.+.+... ...+++..+..++.||+.||.|||+.|++||||||+||+++   .++.+||+|||++...
T Consensus        84 ~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~~  158 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeeec
Confidence            999999964 788777543 35689999999999999999999999999999999999998   4778999999999776


Q ss_pred             CCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC--------
Q 011380          253 KPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR--------  321 (487)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--------  321 (487)
                      ... .......+++.|+|||++.+  .++.++|||||||++|+|++|++||.+.+..+.+..+.........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            533 22333456888999999864  3588999999999999999999999888877776666542211100        


Q ss_pred             -----------CC-------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          322 -----------KP-------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       322 -----------~~-------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                 ..       .+.+++++.++|.+||..||++|||+.++|.||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                       00       123588899999999999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.9e-43  Score=339.82  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=210.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||.|+||.||+|+++.+|+.||||++..... .......+.+|+++++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence            38899999999999999999999999999998865432 1223356889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+. ++|.+++.......+++..++.++.|++.||.|||+.|++||||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhcccCc
Confidence            9996 5888888666567799999999999999999999999999999999999998   47789999999987654322


Q ss_pred             -ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-------------
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-------------  320 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  320 (487)
                       ......+++.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.........+........             
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             22344678999999987653  47889999999999999999999987766544443332111100             


Q ss_pred             ------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 ------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 ------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                  ....+.++++++++|.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                        01124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.9e-43  Score=337.17  Aligned_cols=253  Identities=30%  Similarity=0.472  Sum_probs=207.8

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYIA  175 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~lv  175 (487)
                      |++.+.||+|+||.||+|.+..+++.||+|++.+....  .......+|+.+++++.+||||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            67889999999999999999999999999998654321  12234457999999997799999999999987  899999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++ ++|.+.+.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++   . +.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccC
Confidence            99996 58888775432 5689999999999999999999999999999999999998   3 88999999999876555


Q ss_pred             CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC----------------
Q 011380          256 KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP----------------  317 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  317 (487)
                      .......+++.|+|||.+..  .++.++|||||||++|+|++|..||.+.+..+.+..+.....                
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            44455678999999997643  358899999999999999999999987766554444332110                


Q ss_pred             C--CCCC-------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          318 D--FRRK-------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       318 ~--~~~~-------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .  ++..       ..+.+|.++.++|.+||.++|++|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0  0000       013568899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-42  Score=332.86  Aligned_cols=253  Identities=30%  Similarity=0.517  Sum_probs=211.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh------HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP------IAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~------~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +|.++..||.|+||.||+|.+..+++.+|+|.+........      ...+.+.+|+.+++++. ||||+++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            47788999999999999999998999999998865432211      23356889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ..+++|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||+|+||+++   .++.+||+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~dfg~~~  154 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISK  154 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEecccCCCc
Confidence            999999999999999988543  5689999999999999999999999999999999999998   57889999999987


Q ss_pred             ccCCCC-------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011380          251 FIKPGK-------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       251 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  322 (487)
                      ......       ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+..+....   ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~  231 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPE  231 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCc
Confidence            664211       1123568899999998865 45789999999999999999999998766554444443321   111


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ....++..+.++|++||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.2e-43  Score=333.04  Aligned_cols=250  Identities=31%  Similarity=0.550  Sum_probs=213.1

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||.|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.+. ||||+++++.+.++..+|+++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999999999999999997665443445578899999999995 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccC
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG  263 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~g  263 (487)
                      |.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++   .++.++|+|||++.............|
T Consensus        80 L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          80 LWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             HHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccccccccC
Confidence            99988543  4689999999999999999999999999999999999998   477899999999987655433345678


Q ss_pred             Cccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccc
Q 011380          264 SAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT--EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (487)
Q Consensus       264 t~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (487)
                      ++.|+|||.+.+ .++.++|+||+|+++|+|++|..||....  .......+..+......+  +..++++.++|.+||.
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~  232 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLR  232 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHcc
Confidence            999999998754 46889999999999999999999998776  555566665322222111  2357899999999999


Q ss_pred             cCccCCcC-----HHHHhcCcccccc
Q 011380          341 KDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       341 ~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      .+|.+||+     +.|+++||||+..
T Consensus       233 ~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CChhhCcCCcccCHHHHhcChhhhCC
Confidence            99999999     9999999999865

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-43  Score=339.01  Aligned_cols=261  Identities=28%  Similarity=0.394  Sum_probs=213.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.+++++. ||||+++++.+...+.+|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence            36889999999999999999999999999999886532  2334567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||++|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++   .++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccccc
Confidence            99999999987774321 2368999999999999999999997 5999999999999998   47789999999987654


Q ss_pred             CCCccccccCCccccchhhhccC-------CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .. ......|++.|+|||.+.+.       ++.++|||||||++|+|++|+.||...........+............+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            32 23345788999999987532       37789999999999999999999976655444433222111111222345


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ++.++.+||.+||..+|++||++.+++.||||.....
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            8899999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.9e-43  Score=340.63  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=209.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|...+.||+|+||.||++.+..+|+.||+|.+.....  ......+.+|+.++.++.+||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            46677889999999999999999999999999876432  2345678899999999966999999999999999999999


Q ss_pred             eccCCCCHHH---HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          177 ELCEGGELLD---RILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       177 e~~~gg~L~~---~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ||+.+ ++.+   .+.......+++..+..++.|++.||+|||+. +|+||||||+||+++   .++.+||+|||++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHh
Confidence            99864 5443   33333446799999999999999999999974 999999999999998   4678999999999766


Q ss_pred             CCCCccccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcC-CCCCCCCCCC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNK-PDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~  326 (487)
                      ..........|++.|+|||++.+.    ++.++|||||||++|+|++|+.||..... .+...++..+. +......+..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            544433455789999999998654    68899999999999999999999965542 12222222222 2222222345


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++.++.+||.+||+.+|++|||+.+++.||||+..
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            88999999999999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=330.22  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=214.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++.....   .....+.+|+.+++++. ||||+++++++.+.+.+|+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            3579999999999999999999999999999999875432   24578889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      +|||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++   .++.+||+|||++.....
T Consensus        78 ~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhhh
Confidence            99999999998877543 35789999999999999999999999999999999999998   477899999999876543


Q ss_pred             CC-ccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-CCCCCCC
Q 011380          255 GK-KFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-KPWPSIS  328 (487)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s  328 (487)
                      .. ......|+..|+|||.+.+    .++.++|||||||++|+|++|..||...........+......... ...+.++
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence            22 2344678999999998854    4578999999999999999999999877665555444443211111 1123467


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      .++.++|.+||..+|.+|||+.+++.|||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            88999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-42  Score=335.23  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=200.3

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhc--cCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL--AGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l--~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .||+|+||.||++.+..+|+.+|+|.+.+.............+|..+++.+  .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998765433222233344555444433  259999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD  260 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~  260 (487)
                      ||+|.+++...  ..+++..+..++.||+.||.|||+.+|+||||||+|||++   .++.++|+|||++....... ...
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~-~~~  154 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK-PHA  154 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccC-ccC
Confidence            99998887543  5699999999999999999999999999999999999998   47789999999986554322 234


Q ss_pred             ccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          261 IVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      ..||+.|+|||.+..  .++.++||||+||++|+|++|..||......  .......   ........+.+++++.++|.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCccccCHHHHHHHH
Confidence            579999999998853  3688999999999999999999999754321  1222221   11122223468899999999


Q ss_pred             HccccCccCCc-----CHHHHhcCccccccC
Q 011380          337 KLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       337 ~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                      +||..||++||     |+.++++||||+...
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999999999     699999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-42  Score=334.80  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=207.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.....  ......+..|+.++.+..+||||+++++++...+.+|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            68999999999999999999999999999999876432  1223455667776444446999999999999999999999


Q ss_pred             eccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          177 ELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       177 e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||++ |+|.+.+...  ....+++..++.++.||+.||.|||++ +++||||||+|||++   .++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecccccccc
Confidence            9996 5777766432  335689999999999999999999997 999999999999998   47789999999987664


Q ss_pred             CCCccccccCCccccchhhhcc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCCC
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      .........|+..|+|||.+.+     .++.++|+|||||++|+|++|+.||.... ..+.+..+.....  ...+...+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCcccc
Confidence            4333334578999999998753     34789999999999999999999996532 2233334433221  11112357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      |.++.++|.+||..+|.+||++.+++.||||+...
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            89999999999999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-42  Score=332.89  Aligned_cols=256  Identities=28%  Similarity=0.494  Sum_probs=211.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-------hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+.......       ....+.+.+|+.+++.+. ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            5889999999999999999999999999999885422111       112356788999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +.+++||||++|++|.+++...  ..+++..+..++.||+.||.|||+++++||||+|+||+++   .++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l~d~~~~  155 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKISDFGIS  155 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEEeecccc
Confidence            9999999999999999988543  5789999999999999999999999999999999999998   4788999999998


Q ss_pred             cccCCCC---ccccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--CCCCCC
Q 011380          250 DFIKPGK---KFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRR  321 (487)
Q Consensus       250 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~  321 (487)
                      .......   ......|+..|+|||.+...   ++.++|+||||+++|+|++|..||...........+...  ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP  235 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence            7543211   12345688999999987643   588999999999999999999999765554444443322  222333


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ...+.++.++.++|.+||..+|.+|||+.++|+||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            3345678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-42  Score=331.28  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=209.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC---ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +|++++.||.|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.+. ||||+++++++.+.+.++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            478899999999999999986 57889999988654221   1223456889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +++||++|++|.+++...  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++   .++.+||+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          79 IFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccchhhHhhh
Confidence            999999999999988543  5689999999999999999999999999999999999998   47789999999987542


Q ss_pred             C-------CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          254 P-------GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       254 ~-------~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      .       ........|++.|+|||.+.+. ++.++|||||||++|+|++|..||...........+.......+ ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  232 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPD  232 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCC
Confidence            1       1112345789999999998654 58899999999999999999999977655444433333221111 1224


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .++.++.++|++||..+|.+||++.++|+||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.8e-43  Score=338.03  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=210.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+++++.+. ||||+++++++...+..|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence            3689999999999999999999989999999988654322 234456789999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||++++.|.++...  ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          79 FEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             EecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeeeccCC
Confidence            999998887765532  34589999999999999999999999999999999999998   4778999999998765433


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-------------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-------------  319 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  319 (487)
                       .......|+..|+|||++.+  .++.++||||||+++|+|++|++||......+....+......+             
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             22344678999999998864  35788999999999999999999997666544433333211100             


Q ss_pred             ------C--------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          320 ------R--------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       320 ------~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                            +        ...++.++..+.+|+.+||..+|.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                  0        01135678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-44  Score=298.61  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=217.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|.-.++||+|.||+||+|+++.+++.||+|.+....-. +..-....+||-+|+.|+ |.|||+++++...++.+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            466678899999999999999999999999998765422 223356789999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |||.. +|..+.. .-++.+..+.++.++.|++.||.++|++++.||||||.|.||+   .+|.+||+|||+++.+.-..
T Consensus        81 e~cdq-dlkkyfd-slng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HHhhH-HHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCCce
Confidence            99954 6666553 3457899999999999999999999999999999999999998   58999999999998776443


Q ss_pred             -ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC------
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS------  326 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------  326 (487)
                       -+...+-|.+|++|.++.+.  |+...|+||.|||+.|+.. |++.|.+...++.+..|...-.......||.      
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence             23445779999999998774  6889999999999999987 8888999998888888876444434444433      


Q ss_pred             -------------------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 -------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 -------------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                         ++...+++++++|.-+|.+|++++.+|+||||...
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                               33457899999999999999999999999999764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.7e-43  Score=339.49  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=210.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~  173 (487)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++. ||||+++++++...  +.+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            3689999999999999999999999999999999755432 222345678999999996 99999999998877  8999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++....
T Consensus        83 lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLAREYG  157 (293)
T ss_pred             EEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCceeecc
Confidence            99999974 8888775433 4689999999999999999999999999999999999998   46889999999987665


Q ss_pred             CC-CccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-----------
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF-----------  319 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------  319 (487)
                      .. .......+++.|+|||.+.+.  .+.++||||||+++|+|++|..||........+..+.......           
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            43 333445688999999998653  4789999999999999999999998777665555543321100           


Q ss_pred             ---------------CCCCCCC--CCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          320 ---------------RRKPWPS--ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       320 ---------------~~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                     ....++.  +++.+.++|++||+.||++|||+.|+|.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                           0011222  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=335.38  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=204.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+......  .....+.+|+.+++++. ||||+++++++.+.+..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            5799999999999999999999999999999998654321  12244668999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus        82 ~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          82 FEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVP  156 (291)
T ss_pred             EecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECccccccccCCC
Confidence            999975 8988775443 4789999999999999999999999999999999999998   4678999999998654321


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhcCCC-------------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPD-------------  318 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~-------------  318 (487)
                       .......++..|+|||++.+  .++.++||||+|+++|+|++|+.||.+.. ..+.+..+......             
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             12233457889999998864  36889999999999999999999997654 22222222110000             


Q ss_pred             -CC------------CCCCCCCC--HHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 -FR------------RKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 -~~------------~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                       +.            ...++.++  .++.++|.+||+.+|++|||+.++|.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00            00112344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-42  Score=327.73  Aligned_cols=250  Identities=28%  Similarity=0.508  Sum_probs=214.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+.....  ....+.+.+|+.+++.+. ||||+++++.+.+.+.+|++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            48899999999999999999999999999999865432  234577889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceeecccc
Confidence            999999999988765666789999999999999999999999999999999999998   47789999999987654322


Q ss_pred             -ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......|++.|+|||++.+. ++.++|+||||+++|+|++|..||...........+..+.....   ...++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHH
Confidence             22346789999999998654 68899999999999999999999988776666666655443221   23578899999


Q ss_pred             HHHccccCccCCcCHHHHhcC
Q 011380          335 VKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      |.+||+.||.+|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=353.52  Aligned_cols=250  Identities=27%  Similarity=0.450  Sum_probs=210.3

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCC
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGG  182 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg  182 (487)
                      +||+|+||+||-|+++.+....|||-|....   ....+.+..||.+.+.|+ |.|||+++|.+...+.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            6999999999999999999999999986543   345677889999999997 999999999999999999999999999


Q ss_pred             CHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc-cc
Q 011380          183 ELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQ  259 (487)
Q Consensus       183 ~L~~~l~~~~~~~l--~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-~~  259 (487)
                      +|.+.+. .+.+++  .|..+..+.+||++||.|||++.|||||||-+|||++.  -.|.+||+|||.++.+..-.. ..
T Consensus       658 SLSsLLr-skWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  658 SLSSLLR-SKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             cHHHHHH-hccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEEecccccchhhccCCcccc
Confidence            9988764 455677  88999999999999999999999999999999999985  578999999999877654333 45


Q ss_pred             cccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          260 DIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      ++.||..|||||++..   +|+.++|||||||.+.||.||++||...... ...-++  +....-.+....+|.+++.||
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceecCCCCcHHHHHHHHHHH
Confidence            6889999999999964   5799999999999999999999999654332 111111  111111111235788999999


Q ss_pred             HHccccCccCCcCHHHHhcCcccccc
Q 011380          336 KKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       336 ~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+|+.+||.+||+|.++|..||++..
T Consensus       813 lrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHcCCCcccCccHHHhccCcccccC
Confidence            99999999999999999999999875

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=343.82  Aligned_cols=261  Identities=30%  Similarity=0.478  Sum_probs=208.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.+++++. ||||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            4568999999999999999999999999999999986422  2234466788999999996 99999999887543    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+|+++||+. ++|.+.+.   ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~  152 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDFGL  152 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcccc
Confidence             35899999996 47877663   35689999999999999999999999999999999999998   578899999999


Q ss_pred             ccccCCCC----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--------
Q 011380          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------  314 (487)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------  314 (487)
                      +.......    ......||+.|+|||.+.+  .++.++||||+||++|+|++|+.||.+.........+..        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            87654322    1234578999999998643  468899999999999999999999976654332222211        


Q ss_pred             ---------------cCCCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          315 ---------------NKPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       315 ---------------~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                     ..+.....    ..+.+++++.++|.+||+.+|++|||+.++++||||+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                           00000011    124578889999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-42  Score=329.60  Aligned_cols=252  Identities=29%  Similarity=0.515  Sum_probs=212.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|.+....     ..+.+.+|+++++++ +||||+++++++.....+|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence            57999999999999999999999889999999986542     257889999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++   .++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          77 MEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccC
Confidence            999999999988743 345789999999999999999999999999999999999998   4678999999998876543


Q ss_pred             C-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      . ......|+..|+|||++.+. ++.++||||||+++|+|++|+.||...........+...... .....+.++.++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFND  231 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHH
Confidence            3 23345689999999998654 588999999999999999999999776554443333222111 11112357789999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +|.+||+.||++|||+.++|.||||
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-42  Score=331.93  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             CeeEeeee--eecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLL--GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .|.+.+.+  |+|+||.||++.++.+|..+|+|.+.......        .|+.+...+.+||||+++++.+...+.+|+
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            45565555  99999999999999999999999987543211        133333333369999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC-cEEEeecccccccC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~~~  253 (487)
                      ||||++|++|.+++...  ..+++..+..++.||+.||.|||+.|++||||||+||+++.   ++ .++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---AKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---CCCeEEEecCccceecC
Confidence            99999999999988544  48999999999999999999999999999999999999984   44 89999999987654


Q ss_pred             CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..   ....|++.|+|||++.+ .++.++||||+|+++|+|++|+.||.......................++.+|+.+.
T Consensus       162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN  238 (267)
T ss_pred             CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence            32   23468999999999865 468899999999999999999999976544332111111111222233456899999


Q ss_pred             HHHHHccccCccCCcC-HHHHhcCccccc
Q 011380          333 DFVKKLLVKDPRARLT-AAQALSHPWVRE  360 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt-~~e~L~h~~~~~  360 (487)
                      +||.+||+.+|.+||+ ++++|+||||+.
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 599999999963

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.3e-42  Score=327.77  Aligned_cols=255  Identities=32%  Similarity=0.534  Sum_probs=212.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+. ||||+++++.+...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            589999999999999999999889999999998765432 346678999999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+.||+|+||+|+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          79 EYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             ecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCC
Confidence            99999999998854  34588999999999999999999999999999999999998   47889999999987654332


Q ss_pred             c-----cccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          257 K-----FQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       257 ~-----~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      .     .....+++.|+|||.+.+.    .+.++||||||+++|+|++|+.||.....................+.+..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccccc
Confidence            2     1235688999999998653    578999999999999999999999765333222222222222223334456


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.7e-42  Score=329.02  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=206.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~  172 (487)
                      .|++.+.||+|+||.||+|.+..+|+.||+|++......  .......+.+|+.++++++ ||||+++++++..  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            588899999999999999999999999999988654321  1234467889999999995 9999999998875  4678


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++++||+++++|.+++...  ..+++...+.++.|++.||.|||+.+|+||||+|+||+++   .++.+||+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCCCcccc
Confidence            9999999999999988543  4689999999999999999999999999999999999998   4678999999998754


Q ss_pred             CCC----CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          253 KPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       253 ~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ...    .......|+..|+|||.+.+. ++.++||||+||++|+|++|+.||...................  .....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~  234 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP--QLPSHI  234 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC--CCchhc
Confidence            321    112335689999999998654 5889999999999999999999997765544444433222111  111346


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ++.++++| +||..+|++||+++++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78889999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-42  Score=331.40  Aligned_cols=258  Identities=23%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      .|+..+.||+|+||.||+|.+..+|+.||+|++.......   ......+.+|+.++++++ ||||+++++++.+.+.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            3788899999999999999999999999999986543211   124567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +|+||++|++|.+++...  ..+++..+..++.||+.||.|||++|++||||+|+||+++.  .+..+||+|||++....
T Consensus        80 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccc
Confidence            999999999999988543  57899999999999999999999999999999999999974  33469999999987654


Q ss_pred             CCCc-----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCCCC
Q 011380          254 PGKK-----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-DFRRKPWPS  326 (487)
Q Consensus       254 ~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~  326 (487)
                      ....     .....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+..... .......+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence            3211     123468899999998865 458899999999999999999999965543322222222111 111112235


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      +++++.+++.+||..+|.+|||+.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            788999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-42  Score=347.94  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++.+.||+|+||.||+|++..+|     ..||+|++.....  ......+.+|+.+++.+.+||||+++++++...+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            47999999999999999999865443     5799999875432  2345678899999999955999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc----------------------------------------------------------
Q 011380          171 YVYIAMELCEGGELLDRILAKK----------------------------------------------------------  192 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------------  192 (487)
                      .+++|||||++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999885421                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcc---c
Q 011380          193 ----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---Q  259 (487)
Q Consensus       193 ----------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~---~  259 (487)
                                ...+++..++.++.||+.||.|||++||+||||||+|||++   +++.+||+|||++.........   .
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcceeecc
Confidence                      12478889999999999999999999999999999999998   4778999999998765433221   1


Q ss_pred             cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011380          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK  337 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  337 (487)
                      ...+++.|+|||++.+ .++.++|||||||++|+|++ |+.||........+............  ...+++++.++|.+
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~  350 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKM  350 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHH
Confidence            2335667999998754 57999999999999999997 99999876655444444443322221  12468999999999


Q ss_pred             ccccCccCCcCHHHHhc
Q 011380          338 LLVKDPRARLTAAQALS  354 (487)
Q Consensus       338 ~L~~dp~~Rpt~~e~L~  354 (487)
                      ||+.||.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.4e-42  Score=335.55  Aligned_cols=260  Identities=27%  Similarity=0.459  Sum_probs=216.0

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+..+|.+.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence            344567999999999999999999999999999999987554334445567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+|+||+. |+|.+.+... ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.+||+|||++..
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCccee
Confidence            999999997 5777766433 35689999999999999999999999999999999999998   477899999999876


Q ss_pred             cCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ....   ....|++.|+|||++.    +.++.++||||||+++|+|++|..||.+.........+....+.  ......+
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  239 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDW  239 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhh
Confidence            5432   3457889999999873    34688999999999999999999999877665555444433221  1111246


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +..+.++|.+||..+|++||++.+++.||||....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            78899999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-42  Score=332.54  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=215.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence            458888999999999999999999999999999875432  234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++|++|.+++..   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++   .++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCC
Confidence            999999999998743   4689999999999999999999999999999999999998   4678999999998765433


Q ss_pred             Cc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .. .....++..|+|||.+.+. .+.++|+|||||++|+|++|..||...........+....+   ......++..+.+
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  231 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKE  231 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHH
Confidence            22 2335688999999998654 58899999999999999999999987766555444433222   1122356788999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|.+||..+|++||++.+++.||||....
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         232 FIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.9e-43  Score=332.49  Aligned_cols=255  Identities=28%  Similarity=0.450  Sum_probs=212.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+.....  ......+.+|+.+++++. ||||+++++.+...+.+++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence            57888999999999999999999999999999876532  245567889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++||||||+||+++   .++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHH
Confidence            9999999998875433 678999999999999999999999 9999999999999998   4778999999998765432


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT-----EDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .. ....|+..|+|||.+.+. ++.++||||||+++|+|++|..||....     .......+......  ..+...++.
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP--RLPSGKFSP  231 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC--CCChhhcCH
Confidence            22 226789999999998654 6889999999999999999999996542     22233333332211  111112788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++.++|.+||..||++|||+.+++.||||+.+
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            99999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.9e-42  Score=327.34  Aligned_cols=255  Identities=27%  Similarity=0.505  Sum_probs=208.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc--CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~  171 (487)
                      ..|++.+.||+|+||.||+|.+..+|+.||+|.+.....  ........+.+|+.+++++. ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            368999999999999999999999999999998864321  12234567889999999995 9999999998876  357


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ++++|||++|++|.+++...  ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++   .++.+||+|||++..
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~~  155 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCccccc
Confidence            88999999999999987543  4688999999999999999999999999999999999998   477899999999875


Q ss_pred             cCCC----CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPG----KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ....    .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||........+..+......  ....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  233 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPH  233 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchh
Confidence            4321    12234568999999998865 4688999999999999999999999776555444444332211  111235


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ++..+.++|.+||. +|++||+++++++|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            77889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-42  Score=347.44  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=204.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEE-----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++++.||+|+||+||+|++     ..++..||+|++.....  ....+.+.+|+.+++.+.+||||+++++++.+.+
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            4799999999999999999974     34577899999864432  2345678899999999956999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc----------------------------------------------------------
Q 011380          171 YVYIAMELCEGGELLDRILAKK----------------------------------------------------------  192 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------------------------------------------------  192 (487)
                      ..++|||||+||+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999885432                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc
Q 011380          193 ---------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (487)
Q Consensus       193 ---------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  257 (487)
                                     ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCccc
Confidence                           12477888999999999999999999999999999999998   467899999999976543322


Q ss_pred             c---ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          258 F---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       258 ~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .   ....++..|+|||++.+ .++.++|||||||++|+|++ |..||........+...+.......  .....+.++.
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  347 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMY  347 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHH
Confidence            1   12334667999999865 46899999999999999998 8999977655544444444322111  1234678999


Q ss_pred             HHHHHccccCccCCcCHHHHhcC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +||.+||+.||++|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-42  Score=337.26  Aligned_cols=261  Identities=32%  Similarity=0.560  Sum_probs=216.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.+.|.....||.|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.+. ||||+++++.+...+..|
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence            3345666778999999999999999999999999986533   234567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++   +++.+||+|||++....
T Consensus        96 lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          96 VVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcc
Confidence            99999999999887632   4689999999999999999999999999999999999998   46789999999987543


Q ss_pred             CCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........+..+....+. .......++..+
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  248 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVL  248 (292)
T ss_pred             cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHHH
Confidence            222 2234578999999998865 4688999999999999999999999877666555554433221 111223578899


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                      .++|.+||..||.+|||+.++++||||+.....+
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999999999999765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-42  Score=327.33  Aligned_cols=255  Identities=27%  Similarity=0.520  Sum_probs=216.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||+|.++.+|..+|+|.+...... ....+.+.+|+.+++.++ ||||+++++.+.....+|+|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            488999999999999999999999999999998764321 224467789999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.  ++..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence            9999999999987665556899999999999999999999999999999999999984  33467999999987665433


Q ss_pred             c-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 K-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      . .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......   ...+.++.++.++
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  233 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL  233 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence            2 223468999999998764 4688999999999999999999999877666666555544322   1224678899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      |.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-42  Score=344.11  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=207.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +..+|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++++. ||||+++++++...    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence            45689999999999999999999999999999999865322 2234456778999999995 99999999988643    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~Dfg  163 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  163 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEccCc
Confidence              35799999996 588877632    288999999999999999999999999999999999998   46789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-----------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-----------  315 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------  315 (487)
                      ++.............|++.|+|||.+.+ .++.++|||||||++|+|++|+.||........+..+...           
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9987654444445678999999998865 4689999999999999999999999876654444333221           


Q ss_pred             -----------CCCCCCCC-----------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          316 -----------KPDFRRKP-----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       316 -----------~~~~~~~~-----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                 .+......                 ....++.+.++|.+||+.||++|||+.|+|.||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                       11000000                 1124567899999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.8e-42  Score=336.18  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----  170 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++++. ||||+++++++....     
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCC-CCCccceEEEEecccccccC
Confidence            4699999999999999999999999999999988654321 112345568999999995 999999999886543     


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                         ..++||||+. ++|.+.+... ...+++..++.++.||+.||.|||++|++||||||+||+++   .++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEECcCC
Confidence               4699999996 4787776433 34689999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCC-----ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPGK-----KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ++.......     ......++..|+|||.+.+.  ++.++||||||+++|+|++|+.||.+.........+......++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            987653321     12345678899999988653  57899999999999999999999987765544333322111111


Q ss_pred             CCCC----------------------------CCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 RKPW----------------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 ~~~~----------------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ...+                            ...+..+.+||.+||..||.+|||++++|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1000                            0135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.2e-42  Score=324.98  Aligned_cols=254  Identities=31%  Similarity=0.496  Sum_probs=213.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc--CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+.....  ........+.+|+.+++.+. ||||+++++++.....+|+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            47788999999999999999988999999998865432  12234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ++||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||+|+||+++   .++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          80 FLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceeccc
Confidence            99999999999988543  5689999999999999999999999999999999999998   477899999999877654


Q ss_pred             CCccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ........|++.|+|||.+...  ++.++|+||||+++|+|++|..||...........+.... . .....+.+++.+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~  232 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-E-LPPIPDHLSDEAK  232 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-c-CCCcCCCcCHHHH
Confidence            4434556789999999987543  6889999999999999999999997766544444433311 1 1112346789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +++.+||+.+|.+||++.+++.|||+
T Consensus       233 ~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         233 DFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=338.30  Aligned_cols=260  Identities=29%  Similarity=0.478  Sum_probs=205.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcC--CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~  172 (487)
                      +|++.+.||+|+||.||+|.++.  +++.||+|.+.............+.+|+.+++.+. ||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48899999999999999999988  89999999987643222223466788999999995 99999999999988  889


Q ss_pred             EEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc-CCCCCcEEEeeccc
Q 011380          173 YIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGL  248 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~-~~~~~~vkl~DfG~  248 (487)
                      ++||||+++ +|.+.+....   ...+++..++.++.||+.||.|||+.+|+||||||+||+++. ...++.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999964 7777664332   236899999999999999999999999999999999999984 12278899999999


Q ss_pred             ccccCCCC----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhH---------HHHHHH
Q 011380          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------IFKEVL  313 (487)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---------~~~~i~  313 (487)
                      +.......    ......+|+.|+|||++.+  .++.++|||||||++|+|++|++||.+.....         .+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            87654322    1234578999999998765  36889999999999999999999997654322         111111


Q ss_pred             hc--------------CC-------CCCCCCCC------------CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          314 RN--------------KP-------DFRRKPWP------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       314 ~~--------------~~-------~~~~~~~~------------~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..              .+       .......+            ..+..+.++|.+||..||++|||+.++++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            10              00       00111112            466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.9e-42  Score=365.22  Aligned_cols=255  Identities=28%  Similarity=0.410  Sum_probs=206.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.......+.....+.+|+++++++. ||||+++++++.+.+..|+|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            47999999999999999999999999999999997654333445677899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          176 MELCEGGELLDRILAKK---------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      |||++||+|.+++....         ...++...+..++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEEEec
Confidence            99999999998875321         12355677889999999999999999999999999999998   4778999999


Q ss_pred             ccccccCCCC-------------------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          247 GLSDFIKPGK-------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       247 G~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                      |++.......                   .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   11235799999999998654 688999999999999999999999775544


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       307 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..........+ ....++..+++.+.+++.+||..||++||+..+.+.+
T Consensus       238 ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        238 KISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33222111111 1112345688999999999999999999987776654

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.5e-42  Score=325.56  Aligned_cols=254  Identities=28%  Similarity=0.494  Sum_probs=215.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~~~~l  174 (487)
                      +|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++.  ....+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            48899999999999999999999999999999875443 2345567889999999995 999999999775  3567899


Q ss_pred             EEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHH-----HcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          175 AMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECH-----LHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH-----~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      +|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.+|+||||+|+||+++   .++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccc
Confidence            99999999999888543  2457899999999999999999999     99999999999999998   47889999999


Q ss_pred             cccccCCCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          248 LSDFIKPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       248 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ++........ .....|++.|+|||.+.+. ++.++|+||||+++|+|++|..||...........+..+....   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence            9987654433 3456789999999998654 5888999999999999999999998877666666665543221   123


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .++..+.+++.+||..+|++|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.5e-42  Score=331.48  Aligned_cols=255  Identities=25%  Similarity=0.465  Sum_probs=210.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|++|.||+|++..+|+.||+|++.....  ......+.+|+.+++++. ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            48899999999999999999999999999999876432  223456778999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||+++ +|.+++.... ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhhcCC
Confidence            99975 8888775432 24689999999999999999999999999999999999998   4778999999998765432


Q ss_pred             C-ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC----------
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK----------  322 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------  322 (487)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|+.||.+.+..+....+..........          
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            1 22345678999999988653  5789999999999999999999998877666555544321100000          


Q ss_pred             ---------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          323 ---------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       323 ---------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                     ..+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-42  Score=341.49  Aligned_cols=263  Identities=30%  Similarity=0.458  Sum_probs=210.9

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +..+|.+.+.||+|+||+||+|.+..+|+.||||.+..... .......+.+|+.+++.+. ||||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            34679999999999999999999999999999999875422 2223456778999999995 99999999987644    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+|+|+||+. ++|.+++..  ...+++..+..++.||+.||.|||+++++||||||+||+++   .++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~  154 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGL  154 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcCcc
Confidence             35899999995 688887743  36799999999999999999999999999999999999998   467899999999


Q ss_pred             ccccCCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-----------
Q 011380          249 SDFIKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-----------  314 (487)
Q Consensus       249 a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-----------  314 (487)
                      +...... .......|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+..           
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9765433 22345578999999998753  468899999999999999999999976543322222211           


Q ss_pred             ------------cCCCCC----CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          315 ------------NKPDFR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       315 ------------~~~~~~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                  ..+...    ...++.+++++.++|++||+.+|++|||+.++|+||||......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                        000000    01235688999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.4e-42  Score=341.42  Aligned_cols=260  Identities=32%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +..+|.+.+.||.|+||.||+|.++.+|+.||+|++.....   ...+.+.+|++++++++ ||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            45789999999999999999999999999999999865542   34567889999999995 99999999876543    


Q ss_pred             ----------CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          170 ----------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       170 ----------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                                ..+|+||||++ ++|.+.+.   ...+++..++.++.||+.||.|||+.||+||||||+||+++.  .++
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~  152 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDL  152 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCc
Confidence                      36899999996 58887763   246899999999999999999999999999999999999974  456


Q ss_pred             cEEEeecccccccCCCCc----cccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 011380          240 SLKATDFGLSDFIKPGKK----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  313 (487)
                      .+||+|||++........    .....|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+.........+.
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            799999999876532211    123468899999998753  35789999999999999999999998776655544443


Q ss_pred             hcCCCC----------------------CC----CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          314 RNKPDF----------------------RR----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       314 ~~~~~~----------------------~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ...+..                      ..    ...+.++.++.+||.+||+.||.+|||+.++|.||||+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            321110                      00    012457889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.5e-42  Score=326.88  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=209.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|+++.+|+.||||.+.............+.+|+.+++.+. ||||+++++++.+.+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            46999999999999999999999999999999887644444455667889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||+++|+|.+++...  ....+++..+..++.||+.||.|||++||+||||||+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence            9999999998877432  234589999999999999999999999999999999999998   46789999999987664


Q ss_pred             CCCc-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .... .....|++.|+|||.+.+ ..+.++||||+|+++|+|++|+.||.....  ......+....  ++......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            3221 234578999999998865 468899999999999999999999966533  23333333222  22222335778


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.++|.+||..+|++||++.++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            8999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=332.84  Aligned_cols=255  Identities=33%  Similarity=0.532  Sum_probs=208.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++++. ||||+++++++...+..+++|
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            69999999999999999999999999999998865432 2234567889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++++.+.... .+ ...+++..+..++.||+.||.|||+.|++||||+|+||+++   +++.+||+|||++.......
T Consensus        80 e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          80 EYVERTLLELLE-AS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             ecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCCCc
Confidence            999876554433 32 35689999999999999999999999999999999999998   47889999999988765443


Q ss_pred             --ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------------CC
Q 011380          257 --KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--------------PD  318 (487)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------~~  318 (487)
                        ......|+..|+|||++.+.  ++.++||||||+++|+|++|+.||.+....+.+..+....              ..
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence              33456789999999998654  5789999999999999999999998765544333322110              00


Q ss_pred             CCC-----C--------CCC-CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 FRR-----K--------PWP-SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 ~~~-----~--------~~~-~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +..     .        .++ .++.++.+||++||..+|++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000     0        012 248889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.5e-42  Score=333.07  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=201.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC----------------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA----------------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN  158 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn  158 (487)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++.++. |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            3579999999999999999997532                34579999886542  2334567889999999995 999


Q ss_pred             ccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCce
Q 011380          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-----------------DSRYTEKDAAVVVRQMLRVAAECHLHGLV  221 (487)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~~~~qil~~l~~lH~~~ii  221 (487)
                      |+++++++.+.+..++||||+++|+|.+++....                 ...+++..+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999885431                 12467788999999999999999999999


Q ss_pred             eecCCCCceEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh--
Q 011380          222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--  295 (487)
Q Consensus       222 HrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~--  295 (487)
                      ||||||+|||++   .++.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|+|++  
T Consensus       161 H~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999998   478899999999976543321   12345678899999875 457899999999999999986  


Q ss_pred             CCCCCCCCChhHHHHHHHh---cC-CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          296 GRRPFWDKTEDGIFKEVLR---NK-PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       296 g~~pf~~~~~~~~~~~i~~---~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      +..||........+..+..   .. ........+.++..+.+||.+||..||++|||+.++.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            6678877666555544322   11 1111112245788999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=349.22  Aligned_cols=246  Identities=33%  Similarity=0.504  Sum_probs=212.5

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+..       .+..+|+.++....+||||+++.+++.+..+.
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~  391 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI  391 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence            45678999999999999999999999999999999998763       23357888888888899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||++.|+.+++.+...+   .....+..|+.+|+.|+.|||++|+|||||||+|||++  +..++++|+|||.++..
T Consensus       392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhC
Confidence            99999999999999886553   23378888999999999999999999999999999996  25788999999999877


Q ss_pred             CCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  +.+.+-|..|.|||++.. .|+++|||||||++||+||+|+.||.....+ ++...+..+...      ..+|.+
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~  538 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDE  538 (612)
T ss_pred             chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHH
Confidence            654  445577899999999875 5799999999999999999999999877666 344444333222      469999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +++||..||+.||.+||++.+++.||||
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCcch
Confidence            9999999999999999999999999999

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=344.91  Aligned_cols=237  Identities=26%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      ++-||+|+.|.||+|+.  .++.||||++..-          -..+|+-|++|+ ||||+.|.++|.....++||||||.
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            45699999999999964  5889999987532          246888899996 9999999999999999999999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD  260 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~  260 (487)
                      .|.|++.|.  .+..+.......|..+|+.|+.|||.+.|||||||.-||||.   .+..|||+|||.++........-.
T Consensus       196 ~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  196 QGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             cccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhh
Confidence            999999884  457899999999999999999999999999999999999999   477899999999987765544556


Q ss_pred             ccCCccccchhhhccCC-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      ++||..|||||++...+ ++|+|||||||+|||||||..||.+-....++.-+-.+....+.  ....++-++=||+.||
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL~Kqcw  348 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLLLKQCW  348 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHHHHHHH
Confidence            89999999999998765 89999999999999999999999877666665555444333322  1356778999999999


Q ss_pred             ccCccCCcCHHHHhcCcc
Q 011380          340 VKDPRARLTAAQALSHPW  357 (487)
Q Consensus       340 ~~dp~~Rpt~~e~L~h~~  357 (487)
                      +-.|..||+..++|.|-=
T Consensus       349 ~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             hcCCCCCccHHHHHHHHh
Confidence            999999999999999843

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=331.91  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=209.4

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |++.+.||.|++|.||+|.++.+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+.+..|++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            67788999999999999999999999999998754321 223356788999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-C
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-K  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~  256 (487)
                      |++ ++|.+++.......+++..+..++.|++.||.|||+++++||||+|+||+++   .++.++|+|||++...... .
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence            995 6899888655445789999999999999999999999999999999999998   4788999999998755322 2


Q ss_pred             ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-----------------
Q 011380          257 KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-----------------  317 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  317 (487)
                      ......+++.|+|||++.+.  ++.++||||||+++|+|++|+.||...........+.....                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22334678999999987653  57899999999999999999999987765544443332110                 


Q ss_pred             ----CC----CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          318 ----DF----RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       318 ----~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                          ..    .....+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                00    011135678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.6e-42  Score=329.04  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHH---HHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI---LQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~---l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      .||+|+||.||+|.+..+|+.||+|.+.+..............|..+   ++.. +||+|+++++++...+.+|+||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence            48999999999999999999999999876543322222233344433   3344 5999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccc
Q 011380          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ  259 (487)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~  259 (487)
                      +||+|.+++..  ...+++..+..++.|++.||.|||+.+|+||||||+||+++   .++.+||+|||++...... ...
T Consensus        80 ~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~-~~~  153 (278)
T cd05606          80 NGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPH  153 (278)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCcc-CCc
Confidence            99999887743  35799999999999999999999999999999999999998   4678999999998765432 223


Q ss_pred             cccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          260 DIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ...|+..|+|||++.+  .++.++||||+||++|+|++|+.||.....   ......+....+    .....+|.++.++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~l  229 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFSPELRSL  229 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC----CCCCcCCHHHHHH
Confidence            4579999999999864  468899999999999999999999976532   222222222211    1223578999999


Q ss_pred             HHHccccCccCCc-----CHHHHhcCccccccC
Q 011380          335 VKKLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       335 i~~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                      +.+||..+|.+||     ++.++++||||+...
T Consensus       230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             HHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            9999999999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-41  Score=327.67  Aligned_cols=256  Identities=31%  Similarity=0.567  Sum_probs=215.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|...+.||+|++|.||++.+..+++.+|+|++....   ....+.+.+|+.+++.+. ||||+++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEE
Confidence            4555678999999999999999999999999886432   233456789999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++..   ..+++..+..++.||+.||.|||++||+||||+|+||+++   .++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhccCC
Confidence            99999999988744   4689999999999999999999999999999999999998   47889999999886554322


Q ss_pred             -ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 -KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+....+.... ....++..+.++
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l  248 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSF  248 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHH
Confidence             2234568999999999865 4688999999999999999999999887766666666554322221 223478899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccCC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      |.+||..+|++|||+.++++||||+....
T Consensus       249 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         249 LDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHHcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999999988654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-41  Score=330.30  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|.+.+.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+.+++.+. ||||+++++++......|+|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence            579999999999999999999999999999999865432  122345678999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+. ++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus        82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          82 FEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKSIP  156 (291)
T ss_pred             Eeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccCCC
Confidence            99995 6887776543 34678889999999999999999999999999999999998   4778999999998754322


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHh--------------cCC
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLR--------------NKP  317 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~--------------~~~  317 (487)
                       .......+++.|+|||.+.+  .++.++|||||||++|+|++|..||.+.... +.+.++..              ..+
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             22334567999999999865  3578899999999999999999999765432 22222211              000


Q ss_pred             CCCCC------------CCC--CCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          318 DFRRK------------PWP--SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       318 ~~~~~------------~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .+...            .|.  ..+..+.+++.+||..||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            10000            011  125678999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-42  Score=328.18  Aligned_cols=256  Identities=29%  Similarity=0.511  Sum_probs=212.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.+++++.  .||||+++++++.....+|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            4788899999999999999999999999999986542  2234567889999999985  49999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++|++|.+++..   ..+++..++.++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCC
Confidence            9999999999987733   3789999999999999999999999999999999999998   478899999999877654


Q ss_pred             CC-ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          255 GK-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .. ......|++.|+|||.+.+.  ++.++|+|||||++|+|++|..||.+.........+....  .+......++.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK--PPRLEDNGYSKLL  231 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC--CCCCCcccCCHHH
Confidence            32 23345789999999988643  4789999999999999999999997765544433332221  1111122378899


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+++.+||..||++||++.+++.||||++..
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            9999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=311.78  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE-----eC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-----DD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-----~~  169 (487)
                      ++||++.+.||+|||+.||+++...+++.||+|+|....   ....+..++|++..+++ +|||+++++++..     ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence            368999999999999999999999999999999997765   34678889999999999 4999999987653     33


Q ss_pred             CEEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEee
Q 011380          170 NYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                      ...||++.|...|+|.+.+...  ++..++|.++..++.+|++||++||+..  ++||||||.|||+.   +.+.++|+|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEe
Confidence            4599999999999999988543  4456999999999999999999999998  99999999999998   478899999


Q ss_pred             cccccccCCCC----------ccccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHH
Q 011380          246 FGLSDFIKPGK----------KFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTE--DGIF  309 (487)
Q Consensus       246 fG~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~  309 (487)
                      ||.++...-..          ....-..|..|+|||.+.-+    .++++|||||||+||.|+.|..||...-.  ..+-
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            99986543111          11223568999999998643    38899999999999999999999943211  1112


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      -.+..+...++..  +.+|..+.++|+.||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            2233444444443  3489999999999999999999999999864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-41  Score=325.71  Aligned_cols=249  Identities=19%  Similarity=0.265  Sum_probs=206.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+....  .......+.+|+.+++++. ||||+++++++...+.+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence            46999999999999999999865   346689999987643  2334567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++   .++.+|++|||.+...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~~~~~  157 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCcccccc
Confidence            9999999999999887543 35789999999999999999999999999999999999998   4778999999987654


Q ss_pred             CCCCccc--cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          253 KPGKKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       253 ~~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .......  ...++..|+|||.+.+ .++.++|||||||++|++++ |..||++....+....+..+...   ...+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCC
Confidence            3222111  2345678999998764 56889999999999999775 99999988877777766544321   2234678


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.3e-42  Score=329.88  Aligned_cols=251  Identities=20%  Similarity=0.301  Sum_probs=210.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence            36889999999999999999876555     679999886443  2344567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          171 YVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      ..+++|||+++++|.+++.....              ..+++..+..++.||+.||.|||++|++||||||+||+++   
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---
Confidence            99999999999999998865321              4578899999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCC---ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  311 (487)
                      +++.+||+|||++.......   ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            46789999999987653322   123446788999999875 457899999999999999998 9999998887777776


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +.......   ....+|+++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            66544322   124688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-41  Score=324.19  Aligned_cols=248  Identities=22%  Similarity=0.317  Sum_probs=209.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|.+.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+++++++. ||||+++++++...+.++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEE
Confidence            35889999999999999999999999999999986543    23567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++   +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccc
Confidence            9999999999988665556789999999999999999999999999999999999998   5788999999998766433


Q ss_pred             Ccc--ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ...  ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+.....   ......++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKV  234 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHH
Confidence            211  12234668999998765 46889999999999999998 9999988777766666654321   12224678999


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .++|.+||..||++|||+.++++
T Consensus       235 ~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         235 YELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-41  Score=323.93  Aligned_cols=254  Identities=28%  Similarity=0.462  Sum_probs=215.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|++.+.||.|++|.||+|.+..+|+.||+|++.....  +.....+.+|+.++.++. ||||+++++++...+.+++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            58899999999999999999999999999999876542  145678899999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||+|+||+++   .++.++|+|||++......
T Consensus        79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENT  153 (264)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCccceecccC
Confidence            999999999988544  678999999999999999999999 9999999999999998   4788999999998776543


Q ss_pred             Ccc-ccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCC-CCH
Q 011380          256 KKF-QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPS-ISN  329 (487)
Q Consensus       256 ~~~-~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-~s~  329 (487)
                      ... ....|+..|+|||.+.+. ++.++||||||+++|+|++|..||....   ..+....+......   ..... ++.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEEFSP  230 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCcccCCH
Confidence            332 255789999999988654 5789999999999999999999997763   33444444432211   11123 788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+.++|.+||..+|++||++.++++||||+..
T Consensus       231 ~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         231 EFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-42  Score=329.68  Aligned_cols=258  Identities=25%  Similarity=0.372  Sum_probs=212.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||++.+..+|+.||+|++....  .......+.+|+++++.+. ||||+++++++...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            46899999999999999999999999999999886542  2334577889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||+++++|.+++..  .+.+++..+..++.+++.||.|||+ .+++||||+|+||+++   +++.++|+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          82 MEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccchhh
Confidence            999999999887744  3568999999999999999999997 6999999999999998   477899999999865432


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHHHHhcCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-----------GIFKEVLRNKPDFRRK  322 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~  322 (487)
                      . .....+|+..|+|||++.+ .++.++|||||||++|+|++|..||......           +....+.....  ...
T Consensus       157 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (284)
T cd06620         157 S-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--PRL  233 (284)
T ss_pred             h-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC--CCC
Confidence            2 2234679999999998754 5688999999999999999999999765432           22233332211  111


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                      ....++.++.+|+.+||..||.+|||+.++++||||......
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~  275 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA  275 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            122377889999999999999999999999999999775443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-42  Score=357.18  Aligned_cols=265  Identities=21%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCC-CEEEEE--------------EecccCcCChHhHHHHHHHHHHHHhccCC
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANG-DRVAVK--------------KIEKNKMILPIAVEDVKREVKILQALAGH  156 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK--------------~i~~~~~~~~~~~~~~~~E~~~l~~l~~h  156 (487)
                      ..+..+|++++.||+|+||+||+|..+... ...+.|              .+.+...........+.+|+.+|+++. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            345678999999999999999998765432 222222              111111111224456789999999995 9


Q ss_pred             CCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       157 pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      |||+++++++...+..|+|++++. ++|++++....   ........++.++.||+.||.|||++||+||||||+|||++
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            999999999999999999999994 57887774432   12234677889999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hhH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT---EDG  307 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~  307 (487)
                         .++.+||+|||++..+.....  ....+||+.|+|||++.+ .++.++|||||||++|+|++|..|+....   ...
T Consensus       302 ---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        302 ---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence               478899999999987654322  234689999999999865 46899999999999999999876544322   222


Q ss_pred             HHHHHHhcCC----CCCC----------------C--C------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          308 IFKEVLRNKP----DFRR----------------K--P------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       308 ~~~~i~~~~~----~~~~----------------~--~------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      .+.+++....    .++.                .  .      ...++.++.++|.+||++||.+|||+.|+|.||||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            2222222110    0000                0  0      013566788899999999999999999999999997


Q ss_pred             cc
Q 011380          360 EG  361 (487)
Q Consensus       360 ~~  361 (487)
                      ..
T Consensus       459 ~~  460 (501)
T PHA03210        459 AE  460 (501)
T ss_pred             cC
Confidence            64

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=327.69  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=210.3

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCE----
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFEDDNY----  171 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~~~~----  171 (487)
                      |++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++++.  +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6788999999999999999998999999999875432 1222345667888887764  49999999999988776    


Q ss_pred             -EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          172 -VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       172 -~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                       ++++|||+.+ +|.+++.......+++..++.++.||+.||.|||+.+++|+||+|+||+++.   ++.+||+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~---~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS---DGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc---CCCEEEeccCcce
Confidence             9999999974 8888876554456999999999999999999999999999999999999984   6889999999987


Q ss_pred             ccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-----------
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-----------  318 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  318 (487)
                      ............+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7654444445568999999998865 4588999999999999999999999888877766666542110           


Q ss_pred             -----CC-------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          319 -----FR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       319 -----~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                           +.       ....+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 00       00123456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.9e-42  Score=339.94  Aligned_cols=262  Identities=32%  Similarity=0.512  Sum_probs=210.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE----eCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~----~~~  170 (487)
                      .++|.+.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            4679999999999999999999999999999999875432 2234566778999999995 999999998875    345


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||+. ++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~~~  155 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMAR  155 (334)
T ss_pred             eEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccccce
Confidence            7899999995 588887743  35699999999999999999999999999999999999998   57889999999987


Q ss_pred             ccCCCCc-----cccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh---------
Q 011380          251 FIKPGKK-----FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------  314 (487)
Q Consensus       251 ~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---------  314 (487)
                      .......     .....|+..|+|||.+.+  .++.++|||||||++|+|++|+.||.+......+..+..         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6532211     134578999999998754  468899999999999999999999977654333322211         


Q ss_pred             --------------cCCCCCCCC----CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          315 --------------NKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       315 --------------~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                    ..+......    ++.++.++.++|++||+.+|.+|||+.+++.||||......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                          111111111    24578999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.2e-42  Score=331.96  Aligned_cols=255  Identities=30%  Similarity=0.533  Sum_probs=214.2

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |.....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.+. ||||+++++++..++..|+|+|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEEe
Confidence            4555679999999999999999999999999865432   23466889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-  256 (487)
                      |+++++|...+..   ..+++..++.++.|++.||.|||+.||+||||+|+||+++   .++.+||+|||++....... 
T Consensus        99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcccccc
Confidence            9999999886632   4689999999999999999999999999999999999998   57889999999987554322 


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||......+....+.... ......+..++..+.++|
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHH
Confidence            2234678999999999865 46889999999999999999999998776665555544332 222233456888999999


Q ss_pred             HHccccCccCCcCHHHHhcCccccccCC
Q 011380          336 KKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       336 ~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .+||+.+|.+||++.++++||||.+...
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-41  Score=326.09  Aligned_cols=259  Identities=29%  Similarity=0.440  Sum_probs=208.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~l  174 (487)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|+++++++. ||||+++++++..  .+.+|+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence            58899999999999999999999999999999875432  234577889999999995 9999999998864  447899


Q ss_pred             EEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          175 AMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ||||++|++|.+++..  .....+++..+..++.||+.||.|||+.|++|+||+|+||+++   .++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeeccccccc
Confidence            9999999999887643  2345689999999999999999999999999999999999998   4678999999998655


Q ss_pred             CCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHhcCCC-CCCCCC-
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT-----EDGIFKEVLRNKPD-FRRKPW-  324 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~-~~~~~~-  324 (487)
                      .... .....++..|+|||.+.+ .++.++|||||||++|+|++|..||....     ..+....+...... ...... 
T Consensus       156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            4322 234567889999998865 46889999999999999999999997652     22333333332211 111111 


Q ss_pred             -CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          325 -PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       325 -~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                       ...++.+.+||.+||..+|++|||+.|++.||||+...
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence             13467899999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=331.41  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=229.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|..+.+||+|+||+|.+|..+.+.+.||||++++.-.......+--..|-++|.....-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999999999999999998876655556666678888887766678999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc-cCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~-~~~  254 (487)
                      |||+.||+|...|.+  -+.+.|..+..++..|+-||-+||++|||+||||.+||+++   ..|+|||+|||+++. +-.
T Consensus       429 MEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---cCCceEeeecccccccccC
Confidence            999999999988844  47899999999999999999999999999999999999999   488999999999864 334


Q ss_pred             CCccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      +....+.||||.|+|||++. ..|+..+|+||+||+||||+.|.+||.+..+++++..|...+..++.    .+|.++.+
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~  579 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVA  579 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHH
Confidence            45567899999999999876 45789999999999999999999999999999999999998877764    68999999


Q ss_pred             HHHHccccCccCCcCH-----HHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTA-----AQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~-----~e~L~h~~~~~~~  362 (487)
                      +++.+|.+.|.+|..+     .++-.||||+...
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            9999999999999743     5788999998753

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-41  Score=332.15  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCE--EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++|++.+.||+|+||.||+|.++.+|..  +|+|.+...  ........+.+|+.++.++.+||||+++++++...+.+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            3689999999999999999999888765  466665432  223445678899999999956999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      +||||+++++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---CCC
Confidence            9999999999999885432              23578999999999999999999999999999999999998   477


Q ss_pred             cEEEeecccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      .+||+|||++.............++..|+|||.+.+. ++.++|||||||++|+|++ |..||......+....+.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-  240 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-  240 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence            8999999998643221111122346679999988654 5889999999999999998 999998777766665553321 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                        .......+++++.+||.+||..+|++||++.++|.+
T Consensus       241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              111223478899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-42  Score=329.57  Aligned_cols=253  Identities=35%  Similarity=0.663  Sum_probs=217.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++++.+||||+++++++.+.+.+++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            69999999999999999999999999999999877544444455778899999999955999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |++++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence            999999999988543  4799999999999999999999999999999999999998   47789999999987654322


Q ss_pred             ---------------------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 011380          257 ---------------------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       257 ---------------------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  314 (487)
                                           ......|+..|+|||++.+. ++.++||||||++++++++|..||........+..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                 11234678999999987654 58899999999999999999999988776666666654


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCH----HHHhcCccc
Q 011380          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA----AQALSHPWV  358 (487)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~----~e~L~h~~~  358 (487)
                      ....++    +.+++.+.++|.+||+.+|.+|||+    .++++||||
T Consensus       237 ~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         237 LEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             cCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            433322    3568899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.7e-41  Score=323.30  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=201.5

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      ..||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++ ||||+++++++..++.+++|+||+++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCCC
Confidence            47999999999999999999999999886543   234567889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-cc
Q 011380          182 GELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KF  258 (487)
Q Consensus       182 g~L~~~l~~~~~~~l--~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~~  258 (487)
                      ++|.+++.... ..+  ++..+..++.||+.||.|||+.||+||||||+||+++.  ..+.++|+|||++....... ..
T Consensus        90 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          90 GSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCcc
Confidence            99999886432 334  78889999999999999999999999999999999974  35689999999987654322 22


Q ss_pred             ccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          259 QDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       259 ~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ....|++.|+|||.+.+   .++.++||||+|+++|+|++|+.||....... ........  .........+++++.++
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--KIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--ccCCCCCcccCHHHHHH
Confidence            34568999999999854   25789999999999999999999996543321 11111100  01111123578899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +.+||..+|.+|||+.+++.||||
T Consensus       245 i~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-41  Score=330.54  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=215.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..+|.+.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.+. ||||+++++.+...+..|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence            468999999999999999999998899999999986433   223467889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+||+++++|.+++..   ..+++..+..++.|++.||.|||++|++||||+|+||+++   .++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecccc
Confidence            9999999999988743   3578999999999999999999999999999999999998   467899999998865543


Q ss_pred             CC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .. ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+..... ........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~  246 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR  246 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHH
Confidence            32 2234578999999998764 468899999999999999999999977655443333322211 11112335778899


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                      ++|.+||..+|.+||++.+++.||||+......
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~  279 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS  279 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence            999999999999999999999999998765433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-42  Score=332.10  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=212.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.|++.+.||+|+||.||+|.+..+|+.||+|.+.....  ......+.+|+.+++++. ||||+++++++...+.+|+|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEE
Confidence            457888999999999999999999999999999875432  234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.   ...+++..+..++.||+.||.|||++|++|+||+|+||+++   +++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          81 MEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCc
Confidence            99999999988773   24689999999999999999999999999999999999998   4778999999998765433


Q ss_pred             Cc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .. .....|+..|+|||.+.+. ++.++|||||||++|+|++|..||...........+......   .....++.++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKE  231 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHH
Confidence            21 2234688999999998664 588999999999999999999999765554444433332211   111346788999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|.+||..+|.+||++.++++||||....
T Consensus       232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         232 FVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            99999999999999999999999997753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-41  Score=335.83  Aligned_cols=259  Identities=31%  Similarity=0.509  Sum_probs=212.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++++. ||||+++++++....   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccc
Confidence            5678999999999999999999999999999999986532 22334456789999999995 999999999987553   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                         .+++||||+ |++|.+++.   ...+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence               468999999 778887763   25689999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-------  318 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------  318 (487)
                      ++.....  ......+++.|+|||.+.+  .++.++|+|||||++|+|++|+.||.+......+..+......       
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         164 LARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876543  2234578999999998864  3688999999999999999999999876655444443332111       


Q ss_pred             ----------------CC----CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          319 ----------------FR----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       319 ----------------~~----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                      +.    ...++.+++++.++|.+||..||++|||+.+++.||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                            10    0123567888999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=328.01  Aligned_cols=254  Identities=31%  Similarity=0.501  Sum_probs=210.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYIA  175 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~lv  175 (487)
                      |++.+.||.|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.+. |||++++++++.+.  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            678899999999999999999999999999997653 12234466788999999995 99999999999988  899999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +||+++ +|.+.+... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++   +++.+||+|||++......
T Consensus        79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          79 FEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             eccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeeccCC
Confidence            999975 888777443 25789999999999999999999999999999999999998   4788999999999776543


Q ss_pred             C--ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC-------
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-------  324 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------  324 (487)
                      .  ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||........+..+...........|       
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            2  2344567889999998754  3588999999999999999999999887776666655543221111111       


Q ss_pred             -------------------CC-CCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          325 -------------------PS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       325 -------------------~~-~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                         .. ++..+.++|++||..+|.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                               12 27889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.2e-42  Score=336.78  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=204.3

Q ss_pred             eeeeec--CceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          102 KLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       102 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      ..||+|  +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+. ||||+++++++...+..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            356666  9999999999999999999998754322 334578889999999995 999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-Cc-
Q 011380          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KK-  257 (487)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~-  257 (487)
                      .+++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++   .++.+|++|||.+...... .. 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence            999999988665555689999999999999999999999999999999999998   4678999999865332111 00 


Q ss_pred             ------cccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--------
Q 011380          258 ------FQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--------  320 (487)
Q Consensus       258 ------~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  320 (487)
                            .....++..|+|||++.+.   ++.++|||||||++|+|++|+.||............+...+..+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0112356679999998653   57899999999999999999999987665544444433221100        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 -----------------------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 -----------------------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                                         ......+++.+.+||++||+.||++|||+.++|+||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                                               001123567899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=336.24  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=211.9

Q ss_pred             ccCCCeeE-eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH-----------hHHHHHHHHHHHHhccCCCCcc
Q 011380           93 DFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----------AVEDVKREVKILQALAGHENVV  160 (487)
Q Consensus        93 ~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hpnIv  160 (487)
                      .+.++|.. .+.||.|+||+||+|.++.+|+.||+|++.........           ....+.+|+.+++.+. ||||+
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv   83 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM   83 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence            45567864 57799999999999999999999999998654321100           1124678999999995 99999


Q ss_pred             EEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      ++++++...+..++||||+. |+|.+++..  ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~~  157 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGI  157 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCCC
Confidence            99999999999999999996 588888743  35689999999999999999999999999999999999998   4778


Q ss_pred             EEEeecccccccCC---------------CCccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 011380          241 LKATDFGLSDFIKP---------------GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDK  303 (487)
Q Consensus       241 vkl~DfG~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~  303 (487)
                      +||+|||++.....               ........+++.|+|||.+.+.  ++.++|||||||++|+|++|..||.+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876541               1112234578899999988653  588999999999999999999999888


Q ss_pred             ChhHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          304 TEDGIFKEVLRNKPDFRRK------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       304 ~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ...+.+..+..........                        ..+..+.++.++|.+||..+|++|||++++|.||||+
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            7766655554321111110                        1234578899999999999999999999999999998


Q ss_pred             ccC
Q 011380          360 EGG  362 (487)
Q Consensus       360 ~~~  362 (487)
                      ...
T Consensus       318 ~~~  320 (335)
T PTZ00024        318 SDP  320 (335)
T ss_pred             CCC
Confidence            754

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-41  Score=325.87  Aligned_cols=255  Identities=27%  Similarity=0.469  Sum_probs=213.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +-|++.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++++. ||||+++++++.....+|+|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            347888999999999999999999999999998865432  234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++..   ..+++..+..++.|++.++.|||+.|++|+||+|+||+++   .++.++|+|||++......
T Consensus        81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceecccc
Confidence            999999999988732   4689999999999999999999999999999999999998   4678999999998765432


Q ss_pred             C-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      . ......|+..|+|||.+.+. .+.++|+|||||++|+|++|..||...........+......   .....++.++.+
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (277)
T cd06641         155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKE  231 (277)
T ss_pred             hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHH
Confidence            2 12335689999999988653 578999999999999999999999776655555544333221   112357889999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|.+||..+|.+||++.++++||||.+..
T Consensus       232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         232 FVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            99999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.5e-41  Score=319.11  Aligned_cols=254  Identities=31%  Similarity=0.538  Sum_probs=218.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+++++.+. |||++++++.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            48899999999999999999999999999999876543 2345567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          177 ELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |++++++|.+.+....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeeccc
Confidence            9999999999886543  46799999999999999999999999999999999999998   468899999999876644


Q ss_pred             CC-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .. ......|++.|+|||.+.+. ++.++|+||+|+++|+|++|..||....................   ...++..+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence            32 23345789999999987654 58899999999999999999999987776666666655442221   135788999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +++.+||..+|++|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.6e-41  Score=328.58  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=216.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+..+.|...+.||+|+||+||+|++..+|+.||+|++.............+.+|+.+++.+. ||||+++++++.+...
T Consensus        17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   95 (313)
T cd06633          17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHT   95 (313)
T ss_pred             CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence            334456788889999999999999999999999999987654434445567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||+. |+|.+.+... ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.+||+|||++..
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcc
Confidence            999999996 5777766443 35689999999999999999999999999999999999998   467899999999864


Q ss_pred             cCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..   ......|+..|+|||++.    +.++.++|||||||++|+|++|..||...........+.....  +....+.+
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  245 (313)
T cd06633         171 SS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEW  245 (313)
T ss_pred             cC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCcccc
Confidence            32   223567899999999874    3468899999999999999999999988766555555544332  22223456


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +..+++||.+||+.+|.+||++.+++.||||+...
T Consensus       246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            78899999999999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-41  Score=324.68  Aligned_cols=250  Identities=34%  Similarity=0.574  Sum_probs=213.1

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||.|+||.||+|.+..+|+.+|+|.+...........+.+.+|+.+++++. ||||+++++.+...+..|+++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999999999999987654433345678899999999995 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-------
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------  256 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-------  256 (487)
                      |.+++...  ..+++..+..++.||+.||.|||+.|++||||+|+||+++   .++.++|+|||++.......       
T Consensus        80 L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          80 LASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcccccccc
Confidence            99888543  4789999999999999999999999999999999999998   47789999999987543321       


Q ss_pred             --ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          257 --KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       257 --~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                        ......+++.|+|||.+... .+.++||||||+++|+|++|..||......+....+..+...++..  ..++..+.+
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAID  232 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHH
Confidence              22345688999999987554 6889999999999999999999998888877777776644333221  235899999


Q ss_pred             HHHHccccCccCCcCH---HHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTA---AQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~---~e~L~h~~~~~~  361 (487)
                      ++.+||+.+|++|||+   .++|+||||+..
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            9999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.2e-42  Score=359.88  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=200.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----  169 (487)
                      ..+|+..+.||+||||.||+++++-+|+.||||+|....  .......+.+|+..|.+| +|||||++|..|...     
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccc
Confidence            345777889999999999999999999999999997664  344567889999999999 599999998655110     


Q ss_pred             --------------------------------------------------------------------------------
Q 011380          170 --------------------------------------------------------------------------------  169 (487)
Q Consensus       170 --------------------------------------------------------------------------------  169 (487)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011380          170 ----------------------------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC  215 (487)
Q Consensus       170 ----------------------------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~l  215 (487)
                                                        ..+||-||||+...+.+.+.++.... ....+++++++|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                              12789999998866666554432211 4778999999999999999


Q ss_pred             HHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-------------------CCCccccccCCccccchhhhcc-
Q 011380          216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-------------------PGKKFQDIVGSAYYVAPEVLKR-  275 (487)
Q Consensus       216 H~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-  275 (487)
                      |+.|||||||||.|||++   .+..|||+|||+|+...                   .....+..+||..|+|||++.+ 
T Consensus       714 H~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999999999999999999   57889999999997621                   0113456789999999999854 


Q ss_pred             ---CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHH
Q 011380          276 ---KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ  351 (487)
Q Consensus       276 ---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e  351 (487)
                         .|+.|+|+||||||||||+.   ||....+. .++.++..+..+++...+-.--+.-..+|++||+.||++||||.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               47899999999999999985   56554333 344444444443332222223345789999999999999999999


Q ss_pred             HhcCccccc
Q 011380          352 ALSHPWVRE  360 (487)
Q Consensus       352 ~L~h~~~~~  360 (487)
                      +|++.||--
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999963

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-41  Score=340.14  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=204.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC-----CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|.+++.||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+++++++..||||+++++++...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            45799999999999999999987543     3469999986543  2334567899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc---------------------------------------------------------
Q 011380          170 NYVYIAMELCEGGELLDRILAKK---------------------------------------------------------  192 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~---------------------------------------------------------  192 (487)
                      +.+|||||||++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999998875431                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC
Q 011380          193 -------------------------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (487)
Q Consensus       193 -------------------------------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~  235 (487)
                                                           ...+++..+..++.||+.||.|||+.+|+||||||+|||++  
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe--
Confidence                                                 12477888899999999999999999999999999999998  


Q ss_pred             CCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 011380          236 KEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFK  310 (487)
Q Consensus       236 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  310 (487)
                       .++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||........+.
T Consensus       272 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 -QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             -CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence             467899999999876543221   223456788999998865 46899999999999999997 999998765544443


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..........  ....++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3333322221  22467889999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-41  Score=328.09  Aligned_cols=257  Identities=27%  Similarity=0.528  Sum_probs=211.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++...... .....+.+.+|+.+++++.+||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3889999999999999999874   47899999998654321 1223466788999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++||||+|+|||++   .++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceec
Confidence            9999999999999988543  5689999999999999999999999999999999999998   4788999999998765


Q ss_pred             CCCC--ccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCCC
Q 011380          253 KPGK--KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       253 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~  323 (487)
                      ....  ......|+..|+|||.+.+   .++.++||||||+++|+|++|..||.....    ......+....+.++   
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---  232 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC---
Confidence            4322  2234578999999999864   357889999999999999999999964332    223333333332221   


Q ss_pred             CCCCCHHHHHHHHHccccCccCCc-----CHHHHhcCccccccC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREGG  362 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~~  362 (487)
                       +.+++.+.+++.+||..||++||     ++.+++.||||+...
T Consensus       233 -~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         233 -QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             -ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence             35788999999999999999997     899999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.7e-41  Score=324.37  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=208.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||.||+|.+..+|+.+|+|.+.............+.+|+.+++.+. ||||+++++++...+.++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence            35888999999999999999999999999999887654433445567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||++|++|.+++...  ....+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhhccc
Confidence            9999999999887532  235689999999999999999999999999999999999998   46789999999987654


Q ss_pred             CCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.+....  .....+...  .++...+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence            3322 2345789999999998654 588999999999999999999999765432  233333222  222223345788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.++|.+||..||.+|||+.++++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.4e-41  Score=324.35  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=208.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            468999999999999999999977     77889999886432  2334567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          171 YVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                      ..++||||++|++|.+++.....     ..+++..+..++.||+.||.|||+++++||||||+|||++..+....+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999998865432     2588999999999999999999999999999999999998654456799999


Q ss_pred             cccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          246 FGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       246 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||...........+......  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence            999976532211   112233567999999854 57999999999999999997 99999887777666555443221  


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                       ...+.++..+.+++.+||+.+|++|||+.++++|
T Consensus       241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             1124578999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.5e-41  Score=321.21  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.++||+|+||.||+|.+. ++..||+|.+....    ...+.+.+|+.+++.+. ||||+++++++...+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence            46999999999999999999864 56789999876533    23567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||+++   .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceecCCC
Confidence            9999999999998766667789999999999999999999999999999999999998   4778999999999776432


Q ss_pred             Cc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+.....   ......++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHH
Confidence            21  122345678999998864 46889999999999999998 9999988777666666654422   22334688999


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+||..+|++||+++++++
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-40  Score=327.42  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=218.1

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++...|...+.||+|+||.||+|++..+|..+|+|.+.............+.+|+.+++.+. |||++++++++.+...
T Consensus        21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   99 (317)
T cd06635          21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT   99 (317)
T ss_pred             CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence            445556888999999999999999999999999999987654444445567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||+.| +|.+.+... ...+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.+||+|||++..
T Consensus       100 ~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCccc
Confidence            9999999975 777766433 45689999999999999999999999999999999999998   477899999999865


Q ss_pred             cCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ...   .....|++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+.......  .....+
T Consensus       175 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~  249 (317)
T cd06635         175 ASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEW  249 (317)
T ss_pred             cCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--CCCccc
Confidence            432   23457899999999873    346889999999999999999999998877666666665543221  122357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++.+.++|.+||+.+|.+||++.++++|+|+....
T Consensus       250 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             cHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            78899999999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=338.74  Aligned_cols=249  Identities=26%  Similarity=0.393  Sum_probs=210.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +...+++.||+|.||+||+|.+..   .||||++..... .+...+.|++|+.++++-+ |.||+-+.|++..... .||
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AII  465 (678)
T ss_pred             HHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eee
Confidence            346678899999999999998764   599999977654 3457889999999999996 9999999999998887 999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc---
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---  252 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~---  252 (487)
                      +.+|+|-+|+.++...+ ..|.....+.|++||+.|+.|||.++|||||||..|||+.   +++.|||+|||++...   
T Consensus       466 TqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~---~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH---EDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             ehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---cCCcEEEecccceeeeeee
Confidence            99999999999885543 6788999999999999999999999999999999999998   5689999999998643   


Q ss_pred             CCCCccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CCCCC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PWPSI  327 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~  327 (487)
                      ..........|...|||||++..    .|++.+|||||||++|||++|..||.....+.++..+-++....+.. ...+.
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence            22334455678889999999853    46899999999999999999999999777777776666663322221 22356


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.++++|+..||.+++++||...+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            679999999999999999999999887

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-41  Score=325.88  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=209.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+.+.||+|+||.||+|.+..     +++.||+|++.....  ......+.+|+++++.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            458899999999999999998753     467899999865432  234578899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~  238 (487)
                      ..++||||++|++|.+++....            ...+++..+..++.||+.||.|||++|++||||||+||+++   .+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CC
Confidence            9999999999999999886432            24578899999999999999999999999999999999998   47


Q ss_pred             CcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 011380          239 SSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  313 (487)
                      +.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||......+....+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            8999999999875432221   123456788999998865 46889999999999999998 999998888777777777


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.....   ...++..+.+++.+||..||.+||++.|+++
T Consensus       239 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5543322   2457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=341.04  Aligned_cols=258  Identities=28%  Similarity=0.479  Sum_probs=233.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +.+++..||-||||.|-++........+|+|++++.........+.+..|-+||..++ .|.||++|-.|.+..++|++|
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhH
Confidence            4667788999999999999876655569999999988877778899999999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |-|-||+|+..+.  ..+.+.+..++.++..+++|++|||++|||+|||||+|.+++   .+|.+||.|||+|+.+..+.
T Consensus       500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd---~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD---NRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---cCCceEEeehhhHHHhccCC
Confidence            9999999998874  447899999999999999999999999999999999999999   68999999999999999999


Q ss_pred             ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV  335 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  335 (487)
                      ...++||||.|.|||++.. ..+.++|.||||+++|||++|.+||.+.+....+..|+++.-....+  ..++..+.+||
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Li  652 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLI  652 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHH
Confidence            9999999999999998754 56899999999999999999999999999999999999986443322  35888999999


Q ss_pred             HHccccCccCCcC-----HHHHhcCccccccC
Q 011380          336 KKLLVKDPRARLT-----AAQALSHPWVREGG  362 (487)
Q Consensus       336 ~~~L~~dp~~Rpt-----~~e~L~h~~~~~~~  362 (487)
                      +++...+|.+|..     +.+|-+|.||....
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            9999999999985     89999999998654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.2e-41  Score=326.92  Aligned_cols=259  Identities=25%  Similarity=0.361  Sum_probs=210.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.|++.+.||+|+||.||+|.+..+|+.||+|.+.....  ......+..|+.++.++.+||||+++++++.+....|++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            468999999999999999999998999999999875432  223455667888777776799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||+. +.|.+.+... ...+++..+..++.||+.||.|||+ .||+||||+|+||+++   .++.+||+|||++.....
T Consensus        93 ~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          93 MELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchhccC
Confidence            99985 4666655432 3578999999999999999999997 6999999999999998   478899999999876654


Q ss_pred             CCccccccCCccccchhhhccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      ........|++.|+|||.+.+.     ++.++||||||+++|+|++|+.||..... .+.+..+........ .....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCC
Confidence            4444445688899999998643     57899999999999999999999966432 344444444432211 1112478


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .++.+||.+||..||.+||++.+++.||||+...
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            8999999999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.5e-41  Score=332.12  Aligned_cols=260  Identities=30%  Similarity=0.432  Sum_probs=207.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCC--CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CC
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DN  170 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----~~  170 (487)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|++.... ........+.+|+.+++++.+||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            488999999999999999999888  8999999986432 1222345678899999999779999999986532    35


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+++||+. ++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCce
Confidence            6889999985 688888743  46789999999999999999999999999999999999998   46789999999997


Q ss_pred             ccCCCC-----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC------
Q 011380          251 FIKPGK-----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP------  317 (487)
Q Consensus       251 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------  317 (487)
                      ......     ......||+.|+|||.+.+  .++.++||||+||++|+|++|.+||........+..++....      
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            654221     1234578999999998754  468899999999999999999999977654443333222100      


Q ss_pred             -----------------CC----CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          318 -----------------DF----RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       318 -----------------~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                       ..    ....++..+..+.+|+.+||+.||++|||+.+++.||||++..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                             00    01123457889999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-41  Score=337.01  Aligned_cols=260  Identities=30%  Similarity=0.506  Sum_probs=213.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE--
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY--  171 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~--  171 (487)
                      +.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++. ||||+++++++.....  
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccccc
Confidence            45689999999999999999999999999999998865422 2233456778999999995 9999999988766554  


Q ss_pred             ----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          172 ----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       172 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                          +++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg  163 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFG  163 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcccc
Confidence                89999999 6799887743   4689999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----  320 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  320 (487)
                      ++......  .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+......+..+........     
T Consensus       164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         164 LARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             cccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            99765432  345678999999998854  458899999999999999999999987766655555443211100     


Q ss_pred             ------------------C----CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          321 ------------------R----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       321 ------------------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                        .    ..++.++..+.++|.+||+.||++|||+.+++.||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                              0    0123468899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-40  Score=316.59  Aligned_cols=253  Identities=32%  Similarity=0.545  Sum_probs=213.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~l  174 (487)
                      +|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.+++++. ||||+++++.+...  ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence            478889999999999999999999999999998765422 345678899999999995 99999999999988  89999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ++||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++   .++.++|+|||.+.....
T Consensus        79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccc
Confidence            99999999999988554  3889999999999999999999999999999999999998   478899999999987765


Q ss_pred             CCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...   .....++..|+|||.+.+. .+.++||||||+++|+|++|..||..... ......+.... . .......++.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~  231 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-E-PPEIPEHLSE  231 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccC-C-CcCCCcccCH
Confidence            442   3456789999999998765 68899999999999999999999977652 22222222111 1 1112235688


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .+.++|.+||..||.+||++.+++.||||
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.6e-41  Score=319.36  Aligned_cols=253  Identities=27%  Similarity=0.470  Sum_probs=209.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++++. ||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            46999999999999999999999999999999987544444445678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||+++++|.+++...  ....+++..+..++.||+.||.|||+.||+||||+|+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceeeecc
Confidence            9999999999887542  235589999999999999999999999999999999999998   47789999999987654


Q ss_pred             CCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||.....  ......+..+.  +...+.+.++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence            332 2234578999999998865 468899999999999999999999965432  22333333322  22222336788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-41  Score=318.78  Aligned_cols=246  Identities=24%  Similarity=0.395  Sum_probs=205.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|++.+.||+|+||.||++..+ .+..+|+|.+.....    ....+.+|+.+++++. ||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence            35889999999999999999875 456899998865432    3467889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCCC
Confidence            99999999999875433 4689999999999999999999999999999999999998   4778999999998765332


Q ss_pred             Ccc--ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ...  ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||......+....+..+......   ...+.++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~  230 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTV  230 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHH
Confidence            221  12335668999999864 46889999999999999999 99999888877777777665432221   2367889


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+||..+|.+||++.++++
T Consensus       231 ~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         231 YEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-41  Score=328.54  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      ..++|++.+.||.|+||.||+|.++.+|+.||+|++...... ......+.+|+.++++++ ||||+++++++.+..   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhh
Confidence            345799999999999999999999999999999998654321 123356678999999995 999999999887654   


Q ss_pred             -------EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          171 -------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       171 -------~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                             .+++|+||+++ ++...+... ...+++..+..++.||+.||.|||+.||+||||||+||+++   +++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~kl  157 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKL  157 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcEEe
Confidence                   89999999976 777766433 35689999999999999999999999999999999999998   5788999


Q ss_pred             eecccccccCCCC--ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          244 TDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       244 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      +|||++.......  ......+++.|+|||.+.+  ..+.++|||||||++|+|++|++||......+.+..+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999987654332  2233456888999998864  35789999999999999999999998766655554443321110


Q ss_pred             CC--------------------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          320 RR--------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       320 ~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..                          ..+..+|..+.++|.+||..||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                          1133578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.9e-41  Score=324.07  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ..|.+.+.||+|+||+||++.+.     .++..+|+|.+....   ......+.+|+.+++++. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            46899999999999999999853     345679999886532   334567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK-----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-----------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      .+++||||+++++|.+++....           ...+++..+..++.||+.||+|||++|++||||||+|||++   .++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCC
Confidence            9999999999999999885432           13489999999999999999999999999999999999998   478


Q ss_pred             cEEEeecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 011380          240 SLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  314 (487)
                      .+||+|||++........   .....+++.|+|||.+.+. ++.++|||||||++|+|++ |..||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            899999999876533221   1234467889999988754 6889999999999999998 9999988877777777766


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.....   ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            543221   1357889999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-41  Score=326.18  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=205.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC--EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.+....  .....+.+.+|+.++.++.+||||+++++++...+.+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            469999999999999999999887775  46888775321  23345678899999999966999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      +++||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++   .++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CCC
Confidence            9999999999999885432              13588999999999999999999999999999999999998   477


Q ss_pred             cEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      .+||+|||++.............++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            899999999864322111111223557999998865 46889999999999999997 9999988887777776655421


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                         ......++.++.+||.+||..+|.+|||++++++.
T Consensus       237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               11224578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-41  Score=326.27  Aligned_cols=255  Identities=33%  Similarity=0.519  Sum_probs=211.1

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |.+.+.||+|+||+||+|....+++.||+|.+......  .......+|+..++++.+||||+++++++.+.+..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999989999999998654321  1223445799999999669999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  257 (487)
                      |+ +|+|.+.+.......+++..+..++.|++.+|.|||++|++|+||+|+||+++   .++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccCCCC
Confidence            99 78999888665545789999999999999999999999999999999999998   478899999999987665445


Q ss_pred             cccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC---------------
Q 011380          258 FQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR---------------  320 (487)
Q Consensus       258 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  320 (487)
                      .....|+..|+|||++..  .++.++|+||||+++|+|++|++||......+.+..+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            556678999999998743  358899999999999999999999987766555444332111100               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 -----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                 ....+..+..+.++|++||+.+|.+|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00122346789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=317.89  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=209.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccC--cCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK--MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~  171 (487)
                      .+|++.+.||+|+||.||+|.++.+|+.||+|.+....  .........+.+|+.++++++ ||||+++++++.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            46999999999999999999999999999999875421  112345568889999999995 99999999998763  56


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++++||+++++|.+++...  ..+++..+..++.||+.||.|||+.|++||||+|+||+++   .++.++|+|||++..
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~  155 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECccccccc
Confidence            89999999999999888543  4688999999999999999999999999999999999998   467899999999876


Q ss_pred             cCCC----CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ....    .......|+..|+|||.+.+. .+.++|||||||++|+|++|+.||...........+.....  .....+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~  233 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDG  233 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcc
Confidence            5321    122345789999999998654 58899999999999999999999987665555544443221  1122356


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +++++.++|.+||. +|.+||++.+++.|||.
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            88999999999999 58999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-40  Score=314.58  Aligned_cols=251  Identities=33%  Similarity=0.553  Sum_probs=212.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+.+++.+. ||||+++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence            48889999999999999999998999999999876542   34578889999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+.+.... ..+++..+..++.|++.||.+||.+|++||||+|+||+++   .++.++|+|||.+.......
T Consensus        77 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          77 EFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             ecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeeccccccccccc
Confidence            9999999998875442 5789999999999999999999999999999999999998   47889999999998766543


Q ss_pred             ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC-CCCCHHHHHH
Q 011380          257 KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW-PSISNSAKDF  334 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~s~~~~~l  334 (487)
                      ......|+..|+|||.+.+. ++.++||||||+++|+|++|..||...+............  ...... ..++..+.++
T Consensus       153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG--PPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC--CCCcCcccccCHHHHHH
Confidence            23456789999999998654 5889999999999999999999998775544444433321  111111 2247899999


Q ss_pred             HHHccccCccCCcCHHHHhcCcc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      |.+||+.||++|||+.++|.|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-41  Score=335.03  Aligned_cols=260  Identities=32%  Similarity=0.483  Sum_probs=216.1

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----E
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----Y  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----~  171 (487)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            5899999999999999999999999999999987542 12334567889999999995 999999999988765     7


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|++|||++ ++|.+.+..  ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.++|+|||++..
T Consensus        79 ~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~~~  152 (330)
T cd07834          79 VYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLARG  152 (330)
T ss_pred             eEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCceEe
Confidence            999999997 478887743  34799999999999999999999999999999999999998   468899999999987


Q ss_pred             cCCCC----ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC---
Q 011380          252 IKPGK----KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK---  322 (487)
Q Consensus       252 ~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  322 (487)
                      .....    ......+++.|+|||.+.+.  ++.++||||||+++|+|++|++||.+....+.+..+..........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65432    23456789999999998654  5889999999999999999999998887766665554422111100   


Q ss_pred             ------------------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          323 ------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       323 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                              ..+.++.++.++|.+||+.+|.+|||+.+++.||||+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                                    123478889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-41  Score=334.31  Aligned_cols=258  Identities=33%  Similarity=0.523  Sum_probs=209.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----  169 (487)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.+. ||||+++++++...     
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccCCC
Confidence            4579999999999999999999999999999999875422 2223456789999999995 99999999998754     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+|+|+||+. .+|...+    ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~dfg~  163 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGL  163 (342)
T ss_pred             CceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCCC
Confidence             35699999996 4665543    24689999999999999999999999999999999999998   478899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  316 (487)
                      +.....  ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+......+..+....          
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            876432  2344578999999998865  46889999999999999999999998776554444433211          


Q ss_pred             -------------CCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          317 -------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       317 -------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                   +.+...    .++..+..+.+||.+||+.||.+||++.+++.||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence                         111111    134678889999999999999999999999999999887543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.3e-41  Score=357.30  Aligned_cols=149  Identities=31%  Similarity=0.497  Sum_probs=135.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||.|+||+||+|.+..+++.||||++.............+..|+.+++.++ ||||+++++++.....+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999997665544555678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      |||+.|++|.+++..  ...+++..++.++.||+.||.|||.+||+||||||+|||++   .++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence            999999999998844  35689999999999999999999999999999999999998   46789999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-41  Score=333.20  Aligned_cols=260  Identities=31%  Similarity=0.487  Sum_probs=209.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++...    
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   92 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccc
Confidence            45789999999999999999999999999999999875422 2223466788999999995 99999999988643    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|++++++ |++|.+.+..   ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~dfg  165 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFG  165 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEeccc
Confidence              3578888887 7888776632   4689999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP--------  317 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------  317 (487)
                      ++.....  ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||........+..+.....        
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T cd07877         166 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  243 (345)
T ss_pred             ccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            9876432  2345678999999998765  358899999999999999999999977665444443322110        


Q ss_pred             ---------------CCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          318 ---------------DFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       318 ---------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                     ..+..    .+...++++.+||.+||+.||.+||++.++++||||+.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                           00110    112457889999999999999999999999999999975543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-41  Score=333.30  Aligned_cols=254  Identities=25%  Similarity=0.332  Sum_probs=202.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  168 (487)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|++....  .......+.+|+.+++++.+||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3579999999999999999997543     45789999986432  123445678899999999669999999998764 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcC-------------------------------------------------------
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKD-------------------------------------------------------  193 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~-------------------------------------------------------  193 (487)
                      ...++++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4678999999999999988854321                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc---cccccCCcc
Q 011380          194 ----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY  266 (487)
Q Consensus       194 ----~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~  266 (487)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..+.....   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                2678899999999999999999999999999999999998   467899999999976533221   223456778


Q ss_pred             ccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCcc
Q 011380          267 YVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR  344 (487)
Q Consensus       267 y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  344 (487)
                      |+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+...+........  ....++++.+++.+||+.+|+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence            999998754 57899999999999999998 99999876554444444433222111  135678999999999999999


Q ss_pred             CCcCHHHHhcC
Q 011380          345 ARLTAAQALSH  355 (487)
Q Consensus       345 ~Rpt~~e~L~h  355 (487)
                      +||++.++++|
T Consensus       319 ~RPs~~ell~~  329 (337)
T cd05054         319 DRPTFSELVEI  329 (337)
T ss_pred             hCcCHHHHHHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.3e-41  Score=317.86  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||+||+|.+.. +..+|+|.+.....    ..+.+.+|+.+++++. ||||+++++++.....++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            468999999999999999998654 45699998875432    2466889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+|||++   .++.+||+|||++......
T Consensus        78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecCCC
Confidence            99999999999885433 3689999999999999999999999999999999999998   4778999999998765433


Q ss_pred             Ccc--ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ...  ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+..+...+..   ...+..+
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKV  230 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHH
Confidence            211  12335678999999864 56889999999999999998 99999877777777777665433222   2467899


Q ss_pred             HHHHHHccccCccCCcCHHHHhcC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+++.+||..+|.+|||+.+++.+
T Consensus       231 ~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         231 YAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-41  Score=334.15  Aligned_cols=265  Identities=31%  Similarity=0.472  Sum_probs=212.7

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--C
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--D  169 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~  169 (487)
                      ..+.++|.+.+.||+|+||.||+|.+..+|+.+|+|++..... .......+.+|+.+++++.+||||+++++++..  .
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            3456789999999999999999999998999999998865322 223345677899999999459999999998864  3


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ..+|+||||++ ++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccch
Confidence            46899999997 588887743   2688999999999999999999999999999999999998   5789999999998


Q ss_pred             cccCCCC------ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC---
Q 011380          250 DFIKPGK------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD---  318 (487)
Q Consensus       250 ~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---  318 (487)
                      .......      ......||+.|+|||.+.+  .++.++||||||+++|+|++|+.||.+.........+......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7654322      2234678999999998754  3578999999999999999999999776654443333222110   


Q ss_pred             ------------------------CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          319 ------------------------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       319 ------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                              ......+.++.++.++|.+||+.||++|||+.++++||||+.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                                    0111234578899999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-40  Score=325.89  Aligned_cols=259  Identities=28%  Similarity=0.455  Sum_probs=215.2

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .....|...+.||.|+||.||+|+++.+++.+|+|.+.............+.+|+.+++.+. |||++++++++......
T Consensus        12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCee
Confidence            34556888899999999999999999999999999987543333344567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+. |+|.+.+... ...+++..+..++.|++.||.|||+.+++||||+|+|||++   .++.+||+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccceee
Confidence            99999996 5777766433 35689999999999999999999999999999999999998   4678999999998765


Q ss_pred             CCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      ...   ....|++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+......  ......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~  240 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWS  240 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCccccc
Confidence            432   3457899999999874    34688999999999999999999999876655555555443321  11123578


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..+.++|.+||..+|.+||++.+++.|||+....
T Consensus       241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            8899999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-42  Score=336.42  Aligned_cols=260  Identities=29%  Similarity=0.493  Sum_probs=223.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .-|..++.||-|+||.|.++....|...||+|.+.+...........+..|-.||... +.+-||++|-.|.+.+.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEE
Confidence            3478889999999999999998899999999999887766666778889999999998 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC--
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~--  253 (487)
                      |||++||++..+|.+.  +-|+|..++.++..+..|+++.|..|+|||||||+|||||   .+|+|||+||||++-+.  
T Consensus       708 MdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID---rdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             EeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---cCCceeeeeccccccceec
Confidence            9999999999988765  6799999999999999999999999999999999999999   58999999999985321  


Q ss_pred             -------CCCc----------------------------------cccccCCccccchhhhcc-CCCCcchHHHHHHHHH
Q 011380          254 -------PGKK----------------------------------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITY  291 (487)
Q Consensus       254 -------~~~~----------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~  291 (487)
                             .+..                                  ....+||+.|+|||++.. .|+.-||+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   1100                                  012579999999999854 6789999999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCc---CHHHHhcCccccccC
Q 011380          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREGG  362 (487)
Q Consensus       292 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~L~h~~~~~~~  362 (487)
                      ||+.|+.||...+..+...++++-.........-++|.++.++|.++.+ +++.|.   .++++..||||+...
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence            9999999999988877766665544444445556899999999998776 789997   567899999998753

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=324.59  Aligned_cols=252  Identities=26%  Similarity=0.342  Sum_probs=207.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEE-----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+.+.||+|+||.||+|.+     ..++..||+|.+....  .....+.+.+|+.+++++.+||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            4799999999999999999975     2345689999886543  23345678899999999955999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|++|||+++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++   .++.+||+|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCcccc
Confidence            999999999999999988655445589999999999999999999999999999999999998   47789999999987


Q ss_pred             ccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      .......   .....+++.|+|||.+.+ .++.++||||+||++|+|++ |..||........+..........  ....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  267 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQPE  267 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCCC
Confidence            6543221   122346788999998765 46889999999999999998 999998776665555544433221  1223


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..++++.+++.+||..+|++|||+.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.3e-41  Score=324.91  Aligned_cols=256  Identities=33%  Similarity=0.575  Sum_probs=213.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|.....||+|+||.||++..+.+|+.||+|++....   ......+.+|+.+++.+. ||||+++++.+...+..++||
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEE
Confidence            3444578999999999999999999999999885432   234567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++..   ..+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.++|+|||++.......
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceeccccc
Confidence            99999999886632   4689999999999999999999999999999999999998   46789999999886554322


Q ss_pred             -ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 -KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+....+.. ......++..+.++
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  249 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKGF  249 (292)
T ss_pred             ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHHH
Confidence             2234578999999998754 46889999999999999999999998776665555544333222 11234678899999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccCC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +.+||..+|.+||++.+++.||||.....
T Consensus       250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         250 LDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-40  Score=322.50  Aligned_cols=261  Identities=33%  Similarity=0.535  Sum_probs=218.7

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +....|.+.+.||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.+. ||||+++++++......
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence            345668899999999999999999998999999999876432    4567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+++||++|++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++   .++.++|+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~  166 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhhhh
Confidence            99999999999999886543 4799999999999999999999999999999999999998   4678999999988654


Q ss_pred             CCCC-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .... ......|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...........+...... .....+.++..
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPE  245 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHH
Confidence            3321 22345688999999987654 588999999999999999999999877665555544433221 11222347889


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +.++|.+||+.+|.+|||+.+++.||||+....
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            999999999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-41  Score=320.65  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=211.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|++.+.||.|+||.||+|.+.. ++.+|+|++....   ......+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEE
Confidence            469999999999999999999877 8899999987643   224567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.||+.||.|||+.||+||||+|+||+++   +++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhcCCc
Confidence            9999999999999766666789999999999999999999999999999999999998   5778999999999765432


Q ss_pred             Cc-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          256 KK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .. .....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||......+.+..+.....   ....+..++.+.
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCPQEIY  234 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCCHHHH
Confidence            21 123345678999998764 46889999999999999998 8999988777777777664322   222356789999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +++.+||+.||.+|||+.++++
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=324.52  Aligned_cols=254  Identities=33%  Similarity=0.518  Sum_probs=210.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |.+.+.||+|++|.||+|.+..+|+.+|+|.+..... .+.....+.+|+.+++++. ||||+++++++.+...+++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            5678899999999999999999999999999875442 2234567889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-  256 (487)
                      |+++ +|.+.+.... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++   .++.+||+|||.+....... 
T Consensus        79 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          79 FMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             ccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCCcc
Confidence            9975 8888775533 5789999999999999999999999999999999999998   46789999999987765443 


Q ss_pred             ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--------------
Q 011380          257 KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--------------  320 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  320 (487)
                      ......++..|+|||.+.+.  ++.++||||||+++|+|++|+.||...+..+.+..+........              
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            33445788999999988653  58899999999999999999999987776555544432211100              


Q ss_pred             ------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          321 ------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       321 ------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                                  ...++.++.++.++|.+||..||.+||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                        01123577899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=313.44  Aligned_cols=252  Identities=34%  Similarity=0.584  Sum_probs=214.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|.+.+.||+|++|.||++.+..+++.||+|.+...... ......+.+|+++++++. |||++++++++.+.+.++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            488999999999999999999999999999999765432 245678899999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||+|+||+++   .++.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          79 EYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             ecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCc
Confidence            999999999988544  6789999999999999999999999999999999999998   46789999999998765433


Q ss_pred             c-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          257 K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       257 ~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      . .....|+..|+|||.+.+. ++.++||||+|+++|+|++|..||.................   ....+.++..+.++
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  230 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDF  230 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHH
Confidence            2 2345789999999987654 57889999999999999999999987665444444432221   12224678999999


Q ss_pred             HHHccccCccCCcCHHHHhcCccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +.+||..+|++|||+.+++.||||
T Consensus       231 i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         231 LMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHHhCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=372.12  Aligned_cols=259  Identities=32%  Similarity=0.569  Sum_probs=218.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++.-+++-+..||.|.||.||.|.+..+|...|+|-|.-.... ......+.+|..+|..+ +|||+|++||+-.+...+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHH
Confidence            3445677788999999999999999999999999988654433 33456788999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +|.||||+||+|.+.+  ..+...+|.....+..|++.|+.|||++|||||||||+|||++   .+|.+|++|||.|..+
T Consensus      1310 ~IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeecccceeEe
Confidence            9999999999999977  4445678888888999999999999999999999999999999   4789999999999887


Q ss_pred             CCCC-----ccccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcC-CCCCC
Q 011380          253 KPGK-----KFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNK-PDFRR  321 (487)
Q Consensus       253 ~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~-~~~~~  321 (487)
                      .++.     ..+..+|||.|||||++.+.    .+.+.|||||||++.||+||+.||...+.+ .+...+-.+. |.++ 
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P- 1463 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP- 1463 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-
Confidence            6543     34568999999999999764    367899999999999999999999655443 3444444443 3333 


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                         ..+|.+.++||.+||..||++|+++.|+|+|.|-+...
T Consensus      1464 ---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1464 ---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             ---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence               24899999999999999999999999999999976543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-40  Score=320.54  Aligned_cols=252  Identities=20%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++.+.||+|+||.||+|.++.     ++..||+|++....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~   81 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG   81 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            4679999999999999999998642     35679999885432  1234456889999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcE
Q 011380          170 NYVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~v  241 (487)
                      ...++||||+++|+|.+++....        ...++...+..++.|++.||.|||+.|++||||||+|||++   .++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence            99999999999999999885432        12357788999999999999999999999999999999998   47789


Q ss_pred             EEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 011380          242 KATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNK  316 (487)
Q Consensus       242 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  316 (487)
                      ||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........+....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999875533221   112345788999999865 46889999999999999999 789998877766666665543


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ....   ....+..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 LLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2211   13577899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=314.34  Aligned_cols=257  Identities=24%  Similarity=0.456  Sum_probs=225.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|++...||+|+|++|..++.+.|.+.||+|++++.-.........+..|-.+..+..+||.+|.++.+|+.+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            46999999999999999999999999999999999988777778889999999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc-cCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~-~~~  254 (487)
                      .||++||+|.-++.++  ..++++.++.+...|+.||.|||+.|||+||||.+|+|++   ..+.+||+|+|.++. +.+
T Consensus       330 ieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld---aeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---cCCceeecccchhhcCCCC
Confidence            9999999998777444  6799999999999999999999999999999999999999   478999999999865 456


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCC--------CChhHHHHHHHhcCCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWD--------KTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      +....++||||.|+|||++.+. |+..+|+|+|||++|||+.|+.||.-        ++++-+++-|+......+    .
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----r  480 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----R  480 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----c
Confidence            6777889999999999999875 89999999999999999999999941        223334455555443333    3


Q ss_pred             CCCHHHHHHHHHccccCccCCc------CHHHHhcCcccccc
Q 011380          326 SISNSAKDFVKKLLVKDPRARL------TAAQALSHPWVREG  361 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rp------t~~e~L~h~~~~~~  361 (487)
                      .+|-.+..+++..|++||++|.      ...++..|+||+..
T Consensus       481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence            5777889999999999999996      56899999999854

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-41  Score=328.28  Aligned_cols=257  Identities=28%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----  169 (487)
                      .++|.+.+.||+|+||.||+|.++.+++.+|+|++...... ......+.+|+++++.++ ||||+++++++...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            36799999999999999999999999999999998654321 112245678999999995 99999999887543     


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                         ..+++|+||+.+ +|...+.. ....+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+||
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~l~df  159 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADF  159 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECcC
Confidence               357999999964 67766643 345799999999999999999999999999999999999998   4788999999


Q ss_pred             ccccccCCCC------------ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 011380          247 GLSDFIKPGK------------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       247 G~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  312 (487)
                      |++.......            ......|++.|+|||.+.+  .++.++|||||||++|+|++|++||.+.+.......+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9987543221            1223467889999998754  3688999999999999999999999887766555554


Q ss_pred             HhcCCCCCC--------------------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          313 LRNKPDFRR--------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       313 ~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      .........                          ..+..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            432111000                          0123455778999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-40  Score=321.51  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=208.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            3579999999999999999997652     34589999876443  2233456788999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcE
Q 011380          170 NYVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~v  241 (487)
                      ...|+||||+++|+|.+++....        ...++...+..++.||+.||.|||+++|+||||||+|||++   .++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence            99999999999999999986432        12346678899999999999999999999999999999998   47789


Q ss_pred             EEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 011380          242 KATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNK  316 (487)
Q Consensus       242 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  316 (487)
                      ||+|||+++.......   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+..+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999875432221   112345678999998864 56899999999999999998 789998877766666665443


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc------Ccccccc
Q 011380          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVREG  361 (487)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~------h~~~~~~  361 (487)
                      ....   ....++.+.+++.+||+.||++|||+.++++      ||||+..
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            2111   1346789999999999999999999999987      9998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-40  Score=321.44  Aligned_cols=251  Identities=19%  Similarity=0.294  Sum_probs=206.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++.+.||+|+||+||+|...    .+++.+|+|.+....  .......+.+|+.+++++. ||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            45899999999999999999853    456789999986532  2334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          172 VYIAMELCEGGELLDRILAKK---------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~---------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      .|+||||+++++|.+++....               ...+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---
Confidence            999999999999999885332               13478889999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  311 (487)
                      .++.+||+|||++.......   ......++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.........
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            46789999999997653322   1233456778999998864 46899999999999999998 9999988766655555


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +......   .....+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5443321   1234578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-40  Score=327.40  Aligned_cols=262  Identities=33%  Similarity=0.513  Sum_probs=210.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNY  171 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~  171 (487)
                      .+.++|++.+.||.|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.+. ||||+++++++.. ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence            356789999999999999999999999999999998865432 2234467789999999995 9999999999865 567


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+++||+ +++|.+.+.   ...+++..+..++.||+.||.|||+.||+||||+|.|||++   .++.+||+|||++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCccccccc
Confidence            89999998 568877663   24688899999999999999999999999999999999998   478899999999875


Q ss_pred             cCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh---------------
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---------------  314 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---------------  314 (487)
                      ...  ......+++.|+|||.+.+  .++.++|||||||++|+|++|+.||...........+..               
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  2344578899999998754  468899999999999999999999976654322211111               


Q ss_pred             --------cC----CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          315 --------NK----PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       315 --------~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                              ..    +.......+.++.++.++|.+||+.+|++|||+.+++.||||.......
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                    00    0000111245788999999999999999999999999999998765443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=326.88  Aligned_cols=274  Identities=29%  Similarity=0.475  Sum_probs=223.8

Q ss_pred             CCCCCCcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH----hHHHHHHHHHHHHhccCCCCc
Q 011380           84 KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI----AVEDVKREVKILQALAGHENV  159 (487)
Q Consensus        84 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~~E~~~l~~l~~hpnI  159 (487)
                      ....|.....+.++|.+..+||+|||+.||+|.+....+.||||+-..++-+...    ......+|.+|.+.| +||.|
T Consensus       451 dnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRI  529 (775)
T KOG1151|consen  451 DNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRI  529 (775)
T ss_pred             chhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Cccee
Confidence            3344555566788999999999999999999999999999999987655443322    344567899999999 59999


Q ss_pred             cEEEEEEE-eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--CceeecCCCCceEeccCC
Q 011380          160 VKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       160 v~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--~iiHrDlkp~NIll~~~~  236 (487)
                      |++|++|. +.+.+|-|+|||+|.+|--++...  ..+++.+++.|+.||+.||.||...  .|||-||||.|||+....
T Consensus       530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            99999996 566788999999999987777444  6799999999999999999999876  699999999999998767


Q ss_pred             CCCcEEEeecccccccCCCCc--------cccccCCccccchhhhc-c----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 011380          237 EDSSLKATDFGLSDFIKPGKK--------FQDIVGSAYYVAPEVLK-R----KSGPESDVWSIGVITYILLCGRRPFWDK  303 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwSlG~il~ell~g~~pf~~~  303 (487)
                      ..|.+||+|||+++.+.....        .....||.||++||+|- +    +.+.++||||+|||+|.++.|+.||...
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            778999999999988754321        12367999999999873 2    3488999999999999999999999766


Q ss_pred             Chh-HHHHH--HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          304 TED-GIFKE--VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       304 ~~~-~~~~~--i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ... +++..  |++ ......++-|.++.++++||++||++--++|....++-.||||.-.
T Consensus       688 qsQQdILqeNTIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  688 QSQQDILQENTILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhHHHHHhhhchhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            443 33322  222 2233344457899999999999999999999999999999999753

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-40  Score=317.15  Aligned_cols=246  Identities=26%  Similarity=0.361  Sum_probs=203.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+ ..||+|++.....    ..+.+.+|+.+++.+. ||||+++++.+.. ...|+|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEEE
Confidence            5799999999999999999988655 4699999875432    2356889999999995 9999999998754 568999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||+++   +++.+||+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecccc
Confidence            9999999999998655555689999999999999999999999999999999999998   4778999999999765433


Q ss_pred             Cc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+....+......   ...+.++..+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  232 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESL  232 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCccccCHHH
Confidence            21  123346678999998754 56889999999999999999 88899877777766666544321   1124578899


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+||+.||++||++.+++.
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         233 HDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-40  Score=315.32  Aligned_cols=243  Identities=23%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|.++.+|+.+|+|.+....  .......+.+|+++++.+. ||||+++++++.....+|+||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36999999999999999999999999876432  2345577899999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcc---
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---  258 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~---  258 (487)
                      ++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||++.........   
T Consensus        78 ~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          78 GDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             CcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccccC
Confidence            9999887533 35689999999999999999999999999999999999998   4678999999998754432111   


Q ss_pred             ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          259 QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       259 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+......   ......+..+.+++.
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~  230 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLME  230 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHH
Confidence            11122456999998865 46889999999999999998 89999776665555555443221   122457889999999


Q ss_pred             HccccCccCCcCHHHHhc
Q 011380          337 KLLVKDPRARLTAAQALS  354 (487)
Q Consensus       337 ~~L~~dp~~Rpt~~e~L~  354 (487)
                      +||+.+|++|||+.++++
T Consensus       231 ~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         231 RCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=323.34  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=207.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++.+.||+|+||.||++.++..+     ..+|+|.+....  .......+.+|+.+++++.+||||+++++++...+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            57999999999999999999876443     689999887543  23344668899999999955999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          171 YVYIAMELCEGGELLDRILAK--------------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      .++++|||+++|+|.+++...              ....+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---
Confidence            999999999999999988542              235689999999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  311 (487)
                      .++.+||+|||++........   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            578899999999976543221   122335678999998755 46889999999999999997 9999988777666666


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +......   ......+..+.+|+.+||..||++|||+.+++++
T Consensus       247 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5544321   1223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-40  Score=326.89  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=202.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCE----EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++.+.||+|+||.||+|.+..+|+.    ||+|++....  .....+.+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            4699999999999999999998766654    8999886432  2345567889999999995 99999999998765 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++++||+++|+|.+++... ...+++..+..++.||+.||+|||+.||+||||||+|||++   .++.+||+|||++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~  158 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  158 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEcccccccc
Confidence            67999999999999988654 34688999999999999999999999999999999999998   467899999999987


Q ss_pred             cCCCCcc---ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .......   ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+....+.. .+.......+.  .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~--~~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQ--PPI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCCC--CCC
Confidence            6543321   22334678999998865 56899999999999999997 99999776655443 34433322222  245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+.++.+++.+||..+|.+||++.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=311.54  Aligned_cols=260  Identities=28%  Similarity=0.480  Sum_probs=214.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--------
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--------  167 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--------  167 (487)
                      ..|.-..+||+|.||.||+|+.+.+|+.||+|++-...... ..-....+|+++|..|+ |+|++.+++.|.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            45777789999999999999999999999999765422111 12245579999999996 999999988764        


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      +...+|+|+.+|+. +|...+ .+...+++..++..++++++.||.|+|...|+|||+||+|+||+   .++.+||+|||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlL-sn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLL-SNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHh-cCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeeccc
Confidence            23469999999975 777655 34446799999999999999999999999999999999999999   58999999999


Q ss_pred             cccccCCC-----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      +++.+...     ..++..+-|.+|++||.+.|  .|+++.|||..|||+.+|.++.+.+.+.++...+..|..-...+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99765322     23455677999999999866  579999999999999999999999999999888777765555555


Q ss_pred             CCCCCCC-------------------------------CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 RKPWPSI-------------------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 ~~~~~~~-------------------------------s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ...||++                               .+++.+|+.+||..||.+|++++++|+|.||....
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            5555542                               23678999999999999999999999999998754

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=315.45  Aligned_cols=245  Identities=33%  Similarity=0.605  Sum_probs=211.7

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||.|+||.||++.+..+++.+|+|.+.+...........+.+|+.+++++. ||||+++++.+...+.+|+||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999999899999999998765544445678899999999995 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-Ccccccc
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIV  262 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~  262 (487)
                      |.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++   .++.++|+|||++...... .......
T Consensus        80 L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          80 LFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCc
Confidence            99988544  4689999999999999999999999999999999999998   4678999999998776443 2334567


Q ss_pred             CCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcccc
Q 011380          263 GSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (487)
Q Consensus       263 gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (487)
                      |+..|+|||.+.+. .+.++|+||||+++|+|++|..||...........+......++    ..++..+.++|++||..
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQK  230 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcC
Confidence            89999999988654 57889999999999999999999987776666666665433222    34588999999999999


Q ss_pred             CccCCcCH---HHHhcCccc
Q 011380          342 DPRARLTA---AQALSHPWV  358 (487)
Q Consensus       342 dp~~Rpt~---~e~L~h~~~  358 (487)
                      ||++||++   .++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.3e-41  Score=318.77  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             eEeeeeeecCceEEEEEEEc----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           99 TIGKLLGHGQFGYTYVATDK----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...  ......+.+.+|+++++++ +||||+++++++...+.+++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence            46788999999999999987    44678999999542  2344578899999999999 59999999999998888999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+||+++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||+|+|||++   .++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence            99999999999999776567899999999999999999999999999999999999999   478999999999977632


Q ss_pred             CCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          255 GKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...   .....+...|+|||.+... ++.++||||||+++|||++ |+.||...........+..+....   ..+.++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            211   2234567789999998655 6899999999999999999 789998887777777775544321   1235789


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.++|.+||..||.+|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=315.43  Aligned_cols=247  Identities=24%  Similarity=0.321  Sum_probs=206.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+.....    ..+.+.+|+.+++++. ||||+++++++...+..|++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeee
Confidence            56999999999999999999875 457899999875432    3466889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   .++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEccCC
Confidence            9999999999998665555789999999999999999999999999999999999998   4778999999999876532


Q ss_pred             Ccc--ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ...  ....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+.........+......   ...+..+..+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---PCPPGCPKEL  233 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHH
Confidence            211  11223457999998765 46889999999999999999 99999887777666666544321   1224578899


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+||+.+|.+||++.+++.
T Consensus       234 ~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         234 YDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.9e-41  Score=327.72  Aligned_cols=257  Identities=23%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      .+++.+|.|  |.||++++..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++...+..+++|||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence            344444444  5556666677999999999876532 2345678999999999995 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC--
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--  256 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~--  256 (487)
                      +++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++   .++.+||+|||.+.......  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccc
Confidence            9999999988765556789999999999999999999999999999999999998   46789999999886543211  


Q ss_pred             ------ccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-------
Q 011380          257 ------KFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-------  320 (487)
Q Consensus       257 ------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------  320 (487)
                            ......++..|+|||++..   .++.++||||+||++|+|++|+.||..........+...+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                  1233457888999999865   368899999999999999999999987654433322222110000       


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 -----------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 -----------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                             ......++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                                   000012346788999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=316.15  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++.+.||+|+||+||+|.++.+   ...||+|.+....  .......+.+|+.+++++. ||||+++++.+...+.+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            4689999999999999999998654   4579999886543  2344567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++   .++.+||+|||++...
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~  156 (266)
T cd05033          81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhcc
Confidence            99999999999999885543 4789999999999999999999999999999999999998   4778999999999876


Q ss_pred             CCC-Cccc--cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          253 KPG-KKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       253 ~~~-~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ... ....  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+......   ......
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDC  233 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            421 1111  2234678999998864 46889999999999999998 99999887777666666544221   122357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         234 PSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=318.60  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=206.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCC-----CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.+. ||||+++++++....
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   82 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTGQ   82 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCCC
Confidence            5799999999999999999988654     3789999986443  2234467889999999994 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      ..++||||+++|+|.+++....        ...+++..+..++.||+.||.|||+.+|+||||||+|||++   .++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence            9999999999999999885432        22467889999999999999999999999999999999998   478899


Q ss_pred             EeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |+|||+++.......   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+.......+..+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            999999876543221   223456789999998754 56889999999999999998 9999988777777666653322


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      . . . ....+.++.++|.+||+.+|++|||+.++++
T Consensus       240 ~-~-~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         240 L-D-L-PENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-C-C-CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1 1 1 1346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.1e-40  Score=323.69  Aligned_cols=253  Identities=24%  Similarity=0.360  Sum_probs=206.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      .++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3579999999999999999998643       23579999987542  23345678889999999966999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      ..+.+|+||||+++|+|.+++.....              ..++...++.++.||+.||.|||++|++||||||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence            99999999999999999999865421              3478899999999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  308 (487)
                         .++.+||+|||++........   .....+++.|+|||++.+. ++.++|||||||++|+|++ |..||.+....+.
T Consensus       175 ---~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         175 ---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             ---CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence               467899999999876543211   1122345789999988654 6889999999999999998 8999977766666


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...+.....   ......++.++.+++.+||..+|.+|||+.+++++
T Consensus       252 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            655544331   12234678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=315.01  Aligned_cols=245  Identities=26%  Similarity=0.384  Sum_probs=208.5

Q ss_pred             eeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          102 KLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +.||+|+||.||+|.+...   +..||+|.+......  .....+.+|+++++.+. ||||+++++++.....+++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999999866   889999998765421  24678899999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          179 CEGGELLDRILAKK-------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       179 ~~gg~L~~~l~~~~-------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++++|.+++....       ...+++..++.++.||+.||.|||++||+||||+|+||+++   .++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccc
Confidence            99999999885532       36799999999999999999999999999999999999998   468899999999987


Q ss_pred             cCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....   ......+++.|+|||.+.. .++.++||||||+++|+|++ |..||...........+..+...   ...+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            65432   2334567889999998865 56889999999999999999 69999888777777777653321   12245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +|.++.+++.+||..+|++|||+.+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.5e-40  Score=321.27  Aligned_cols=253  Identities=21%  Similarity=0.249  Sum_probs=206.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC----------------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCc
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG----------------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV  159 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI  159 (487)
                      .+|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|+++++++. ||||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcC-CCCE
Confidence            57999999999999999999876544                4689998875432  245677889999999995 9999


Q ss_pred             cEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCce
Q 011380          160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (487)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NI  230 (487)
                      +++++++...+.++++||++++++|.+++....         ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999885542         12689999999999999999999999999999999999


Q ss_pred             EeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 011380          231 LFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC--GRRPFWDKT  304 (487)
Q Consensus       231 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~--g~~pf~~~~  304 (487)
                      +++   .++.++|+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++  |..||....
T Consensus       162 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            998   468899999999876543221   223456788999998765 57899999999999999998  788887766


Q ss_pred             hhHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          305 EDGIFKEVLRN----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       305 ~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ....+..+...    .........+.+|.++.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66666555432    111111122356789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-40  Score=314.89  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|+++++||+|+||.||+|..+ +++.||+|.+.....    ....+.+|+.+++++. ||||+++++++. .+.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            3467999999999999999999864 578899999875542    3467889999999995 999999999874 45689


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ++|||+++++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+||+++   .++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecC
Confidence            999999999999988766667799999999999999999999999999999999999998   47789999999987654


Q ss_pred             CCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ....  .....++..|+|||++.. .++.++||||||+++|+|++ |++||.+....+....+.....   .......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCH
Confidence            2221  123345678999998865 45889999999999999999 9999988777666665544322   122245788


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.++|.+||..+|++|||+++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-40  Score=314.93  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=204.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.+++++. ||||+++++++. ....|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcEE
Confidence            457999999999999999999865 566799999876443    2356889999999995 999999999875 456899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      +|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++   +++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccC
Confidence            99999999999988665556689999999999999999999999999999999999998   477899999999976543


Q ss_pred             CCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+......   ......+..
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPIS  231 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHH
Confidence            221  122345668999998754 46889999999999999999 89999887776666666543221   122357889


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.+++.+||..+|++|||+.+++.
T Consensus       232 ~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         232 LHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=314.79  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=204.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.++ ++..+|+|++.....    ....+.+|+.+++++. ||||+++++++...+..|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            5889999999999999999876 466899998865432    2356788999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||++|++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.+||+|||+++......
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccccc
Confidence            9999999999886543 4689999999999999999999999999999999999998   47789999999987654322


Q ss_pred             cc--ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          257 KF--QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       257 ~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..  ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+....+......   ......+.++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHH
Confidence            11  11223457999998864 56889999999999999999 89999877776666666544221   12235789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +++.+||..+|++|||+.++++.
T Consensus       232 ~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         232 TIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-40  Score=321.76  Aligned_cols=256  Identities=29%  Similarity=0.525  Sum_probs=208.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .|++.+.||+|+||.||++.+.   .+++.||+|++.+.... .......+.+|+.++.++.+||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3889999999999999999864   46789999998754321 1223456788999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+++|+|.+++...  ..+++..++.++.|++.+|.|||+.|++||||+|.||+++   .++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECcccccc
Confidence            9999999999999988543  5689999999999999999999999999999999999998   4678999999998765


Q ss_pred             CCCCc--cccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCCC
Q 011380          253 KPGKK--FQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       253 ~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~  323 (487)
                      .....  .....|++.|+|||.+.+.   .+.++||||||+++|+|++|..||.....    ......+....+.    .
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~  231 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP----F  231 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----C
Confidence            43321  1235689999999998653   57899999999999999999999964322    2233333333222    2


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcC---HHHHhcCcccccc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLT---AAQALSHPWVREG  361 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~L~h~~~~~~  361 (487)
                      ...++..+.++|.+||+.||++|||   +.++|+||||+..
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            2357889999999999999999998   5678999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-40  Score=313.13  Aligned_cols=253  Identities=28%  Similarity=0.446  Sum_probs=215.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||.|+||.||++.+..+|+.+|+|.+...... ......+.+|+.+++.+. ||||+++++++.+....|+|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            488999999999999999999999999999998764432 334567788999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          177 ELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       177 e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||+.|++||||+|+||+++   .++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence            999999999887552  235689999999999999999999999999999999999998   467899999999977654


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      . ......|++.|+|||.+.+. ++.++|+||||+++|+|++|+.||...........+........   ...++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHH
Confidence            4 33345789999999998654 57899999999999999999999988777666655554432211   1357889999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ++.+||..+|.+|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-40  Score=318.01  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=205.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+....   ......+.+|+++++.+. ||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            46888999999999999999743     356789999876542   345578899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          171 YVYIAMELCEGGELLDRILAKKD-------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      ..+++|||+++++|.+++.....             ..+++..+..++.||+.||.|||++||+||||||+|||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence            99999999999999998864321             3588999999999999999999999999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 011380          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  312 (487)
                      ++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||...........+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            78899999999875533221   122345778999998765 46889999999999999998 99999877777666666


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+....   ....+++.+.++|.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5554321   12357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.3e-40  Score=321.89  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=205.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ++|.+++.||+|+||.||+|.+..       .+..+|+|.+....  .......+.+|+.+++++.+||||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            579999999999999999998632       34579999886542  233456788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      .+.+|++|||+++|+|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  168 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-  168 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-
Confidence            999999999999999999986532              23588899999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        .++.+||+|||+++.......   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.+
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         169 --EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             --CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              477899999999976543211   112234567999998765 46889999999999999999 89999887777666


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+......   .....++.++++++.+||..+|++|||+.++++
T Consensus       247 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 KLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            666544321   112467889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=316.07  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=203.4

Q ss_pred             eeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE---
Q 011380           98 YTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY---  171 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~---  171 (487)
                      |++++.||+|+||.||+|....+   +..||+|++..... .......+.+|+.+++.+. ||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            56789999999999999987653   47899999875432 2334567889999999995 9999999998865443   


Q ss_pred             ---EEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          172 ---VYIAMELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       172 ---~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                         .++++||+++|+|..++....    ...+++..+..++.|++.||.|||+.+|+||||||+||+++   +++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCCeEEEC
Confidence               799999999999988875432    24689999999999999999999999999999999999998   47789999


Q ss_pred             ecccccccCCCCcc---ccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 011380          245 DFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       245 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |||+++........   ....++..|+|||.+.+. ++.++|||||||++|||++ |..||.+....+.+..+..+....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999765433221   122356789999988654 6889999999999999999 899998877777776665543221


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                         ....++.++.+++.+||+.||++|||+.+++++
T Consensus       236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.1e-40  Score=312.30  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEE-EeCCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF-EDDNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~~~~~~~l  174 (487)
                      .+|++.+.||+|+||.||++..  .|..+|+|.+....     ....+.+|+.+++++. ||||+++++++ ...+..|+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            3689999999999999999975  47889999886432     3456889999999995 99999999975 45567999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      +|||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++   +++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceeccc
Confidence            99999999999998765555689999999999999999999999999999999999998   578899999999875433


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..  ....++..|+|||++.+. ++.++|||||||++|+|++ |+.||...........+..+..   ....+.+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  233456789999988654 6889999999999999997 9999987776666666654422   122346789999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +++.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-40  Score=320.09  Aligned_cols=249  Identities=18%  Similarity=0.260  Sum_probs=206.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCC-----CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +|++.+.||.|+||.||+|.+..+     ++.||+|++....  .....+.+.+|+.++..+. ||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence            588899999999999999987543     5789999987543  2234567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          172 VYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||++||+||||||+|||++   +
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---D  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---C
Confidence            999999999999998874321              23478889999999999999999999999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCCc---cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 011380          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  312 (487)
                      ++.+||+|||+++.......   .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            67899999999876543221   22345678999999875 457889999999999999998 88899887777777777


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ........   ...++..+.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         240 RNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            66543221   2457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.7e-40  Score=312.75  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++++. ||||+++++++. .+..+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEE
Confidence            5799999999999999999987655 4699998765432    3456788999999995 999999999875 4568899


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++   +++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEccCC
Confidence            9999999999998665555689999999999999999999999999999999999998   4778999999999765432


Q ss_pred             Cc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+....+....+.....   ......++..+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPESL  232 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHH
Confidence            21  122346678999998764 46889999999999999999 9999988777766666654422   12234678899


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+||..||.+||++.++++
T Consensus       233 ~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         233 HELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.8e-40  Score=318.66  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=205.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....   ......+.+|+.+++++. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence            46899999999999999999854     345668999876433   234467889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      ..++||||+++++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++   
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---
Confidence            9999999999999999886432              23488999999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  311 (487)
                      .++.+||+|||++........   .....|++.|+|||.+.+ .++.++|||||||++|+|++ |..||...........
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            477899999999876543221   233456889999998765 46889999999999999998 9999988777766666


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +..+....   .....|..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            65543322   12346889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=320.33  Aligned_cols=254  Identities=30%  Similarity=0.508  Sum_probs=209.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.+.+.+++|+|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            5677889999999999999999999999999876531 2223466778999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-  256 (487)
                      |++ ++|.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+||+++   +++.+||+|||++....... 
T Consensus        79 ~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          79 YCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             CcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCCcc
Confidence            997 58998886542 4689999999999999999999999999999999999998   47889999999987664332 


Q ss_pred             ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-----------------
Q 011380          257 KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-----------------  317 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  317 (487)
                      ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||......+.+..+.....                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            2334566888999998854  458899999999999999999999988766555544432110                 


Q ss_pred             -CCC-------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          318 -DFR-------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       318 -~~~-------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                       .+.       ...++.++..+.++|.+||..||++||++.+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             000       01234567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-40  Score=328.65  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=200.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEE-----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-C
Q 011380           96 RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-D  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~  169 (487)
                      ++|++++.||+|+||+||+|.+     ..+++.||||++.....  ......+.+|+.++.++.+||||+++++++.. .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            5799999999999999999985     34678999999865432  23456788999999999768999999998764 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcC--------------------------------------------------------
Q 011380          170 NYVYIAMELCEGGELLDRILAKKD--------------------------------------------------------  193 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~--------------------------------------------------------  193 (487)
                      ..++++||||++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            568999999999999998854321                                                        


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc---cccc
Q 011380          194 ---------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDI  261 (487)
Q Consensus       194 ---------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~  261 (487)
                               ..++...+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........   ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchhhcCCC
Confidence                     2367788899999999999999999999999999999998   477899999999876532211   1223


Q ss_pred             cCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          262 VGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       262 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                      .+++.|+|||.+.+ .++.++||||||+++|+|++ |..||........+............+  ...++++.+++.+||
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl  319 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHc
Confidence            45678999998754 46889999999999999997 999997765443333333332222221  236788999999999


Q ss_pred             ccCccCCcCHHHHhcC
Q 011380          340 VKDPRARLTAAQALSH  355 (487)
Q Consensus       340 ~~dp~~Rpt~~e~L~h  355 (487)
                      ..||++|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.9e-40  Score=315.19  Aligned_cols=249  Identities=20%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCC--EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe------CC
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------DN  170 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------~~  170 (487)
                      .+++.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+.+|+.+++.+. ||||+++++++..      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCC
Confidence            467889999999999999877775  68999886542 22345677889999999995 9999999997642      23


Q ss_pred             EEEEEEeccCCCCHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          171 YVYIAMELCEGGELLDRILAK----KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ..+++|||+++|+|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCEEECCC
Confidence            578999999999998887432    224588999999999999999999999999999999999998   5788999999


Q ss_pred             ccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 011380          247 GLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR  321 (487)
Q Consensus       247 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  321 (487)
                      |++........   .....+++.|+|||.+.+. ++.++|||||||++|+|++ |..||.+.........+..+...   
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---  233 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL---  233 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99987643321   1223456789999998654 6889999999999999999 89999877776666666554321   


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...+.++..+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1224678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=314.73  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=198.5

Q ss_pred             eeeeecCceEEEEEEEcCCCCE--EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          102 KLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      +.||+|+||.||+|.++.+|..  +|+|.+....  .......+.+|+.++.++.+||||+++++++...+.+|++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            3589999999999999888764  6888776422  23345678899999999966999999999999999999999999


Q ss_pred             CCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          180 EGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       180 ~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                      ++|+|.+++....              ...+++..+..++.|++.||+|||++|++||||||+|||++   .++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEEECC
Confidence            9999999886532              13478999999999999999999999999999999999998   578899999


Q ss_pred             cccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      ||++..............++.|+|||++.. .++.++|||||||++|+|++ |..||.+....+....+....   ....
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence            999853321111112234567999998855 46889999999999999997 999998877766666664432   1112


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ...++.++.+++.+||..||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2357789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.8e-40  Score=312.17  Aligned_cols=241  Identities=24%  Similarity=0.299  Sum_probs=197.4

Q ss_pred             eeeecCceEEEEEEE--cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .||+|+||.||+|.+  +.+++.+|+|++.... ......+.+.+|+.+++.+. ||||+++++++.. ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecCC
Confidence            589999999999965  4567899999886543 23345677889999999995 9999999998764 46789999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc---
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---  257 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---  257 (487)
                      +|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||.||+++   .++.+||+|||++........   
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          79 LGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCeee
Confidence            99999988443  5689999999999999999999999999999999999998   467899999999976543322   


Q ss_pred             -cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          258 -FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       258 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+++.|+|||.+.. .++.++|||||||++|+|++ |..||......+....+..+.. .  ...+.+++++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~l  230 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M--ECPQRCPPEMYDL  230 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C--CCCCCCCHHHHHH
Confidence             122234678999998864 46889999999999999998 9999988777666666654432 1  1224588999999


Q ss_pred             HHHccccCccCCcCHHHHhc
Q 011380          335 VKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~  354 (487)
                      |.+||+.||++||++.++..
T Consensus       231 i~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         231 MKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHhccCchhCcCHHHHHH
Confidence            99999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.6e-40  Score=314.88  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=202.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|++....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence            468999999999999999999877776    48999886543  2344567889999999995 99999999988754 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++++||+++|+|.+.+... ...+++..+..++.||+.||.|||+++|+||||||+|||++   +++.+||+|||+++.
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~  158 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCceee
Confidence            78999999999999987543 35689999999999999999999999999999999999997   467899999999977


Q ss_pred             cCCCCcc---ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .......   ....+++.|+|||.+.+ .++.++|||||||++|||++ |..||...........+..+.. .  ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-L--PQPPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C--CCCcc
Confidence            6433221   12335678999998754 46889999999999999998 8999876665555544443322 1  12346


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.++.+++.+||..||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-40  Score=315.73  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=208.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      +|.+.+.||+|+||.||++.+..++..+++|++......  .......+..|+.+++.+. ||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            589999999999999999999888777777766542211  1223345678999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          175 AMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||+++++|.+.+..  .....+++..++.++.|++.||.|||+.|++|+||+|+||+++    ++.+||+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            9999999999887754  2345689999999999999999999999999999999999997    356999999998765


Q ss_pred             CCCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..+.....   ...++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence            4332 2234568999999998765 457889999999999999999999977666555555554332211   1357789


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      +.++|.+||..+|++||++.++++||||
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-40  Score=311.71  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=208.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|.+.+.||+|+||.||+|.+. .++.+|+|.+.....    ....+.+|+.+++++. ||||+++++++......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEE
Confidence            457999999999999999999875 457899999875432    3467889999999995 9999999999999899999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++   .++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceeccc
Confidence            99999999999998766556789999999999999999999999999999999999998   478899999999876543


Q ss_pred             CCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  .....++..|+|||.+.+ .++.++||||||+++|+|++ |+.||.+......+..+..+...   ......+.+
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNCPEE  232 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence            211  112234568999998865 46889999999999999998 99999887777777777654321   112346889


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.+++.+||..+|.+||++.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         233 LYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.3e-40  Score=319.44  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=207.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-------CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      ..+|.+.+.||+|+||.||+|.+.       .++..||+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            357999999999999999999753       234579999886432  23345678899999999956999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      ....+|++|||+++|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+|||++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            9999999999999999999886532              23577888999999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  308 (487)
                         .++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+.
T Consensus       172 ---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         172 ---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             ---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence               477899999999976543221   122345678999998865 46889999999999999998 8899988877777


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...+.......   ....++.++.+|+.+||..+|.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            77665443221   124578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-40  Score=310.91  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=205.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||.|+||.||+|...  |+.||+|.+.....    ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            46899999999999999999764  88999999875532    4567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++   .++.+||+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccccc
Confidence            9999999999988665545799999999999999999999999999999999999998   5788999999999776322


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .  ....++..|+|||.+.. .++.++||||||+++|+|++ |..||...........+.....   ......+++.+.+
T Consensus       156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (256)
T cd05039         156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK  230 (256)
T ss_pred             c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence            2  23345667999998754 56889999999999999997 9999987776666555544321   1122457899999


Q ss_pred             HHHHccccCccCCcCHHHHhc
Q 011380          334 FVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +|.+||..+|++|||+.+++.
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.9e-42  Score=297.40  Aligned_cols=254  Identities=28%  Similarity=0.549  Sum_probs=213.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYV  172 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~  172 (487)
                      .++|++.+++|+|.|+.||.|.+..+++.++||+++.-      ....+.+|+.||+.|++||||++++++..+.  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            35799999999999999999999999999999998643      4578899999999999999999999998764  467


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      .+|+||+.+.+.....     ..++...++.++.+|+.||.|||+.||+|||+||.|++|+.  +...++|+|+|+|.+.
T Consensus       111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh--~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech--hhceeeeeecchHhhc
Confidence            8999999887754433     46888999999999999999999999999999999999996  5678999999999999


Q ss_pred             CCCCccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHh-------------c-
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLR-------------N-  315 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~-------------~-  315 (487)
                      .++..+...+.+..|.-||.+-  ..|+..-|+|||||++..|+..+.||... +..+.+.+|.+             - 
T Consensus       184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            9998888889999999999885  35788899999999999999999998654 33333333211             0 


Q ss_pred             ---CC-------CCCCCCCCC---------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          316 ---KP-------DFRRKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       316 ---~~-------~~~~~~~~~---------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                         .+       .....+|..         +++++.||+.++|.+|..+|+||.|++.||||...
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence               01       111222321         57899999999999999999999999999999753

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.3e-40  Score=312.55  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+|++.+.||+|+||.||+|.++.++.   .+|+|.+....  .......+.+|+.+++++. ||||+++++++...+.+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            468999999999999999999865543   79999886543  2334567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||++   .++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~  156 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCccccc
Confidence            9999999999999988543 35689999999999999999999999999999999999998   4778999999998765


Q ss_pred             CCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....    .....++..|+|||.+.+ .++.++|+|||||++|++++ |..||......+....+.....   .+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~  233 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---LPAPMD  233 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---CCCCCC
Confidence            43221    111233568999999875 56899999999999999886 9999988777666666654421   122245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +++.+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         234 CPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.1e-41  Score=342.48  Aligned_cols=249  Identities=22%  Similarity=0.379  Sum_probs=212.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+-...+.||+|+||+||+|....     ....||||.++...  ..+...+|++|++++..|+ |||||+++|+|..++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence            345667899999999999997532     34579999987654  4557899999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------CC----CCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------DS----RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~----~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~  238 (487)
                      .+|+|+|||..|||-++|....        +.    +++..+.+.|+.||+.|+.||-++.+|||||-+.|+||.   ++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---EN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cc
Confidence            9999999999999999996542        22    288999999999999999999999999999999999998   68


Q ss_pred             CcEEEeecccccccCCCCccc---cccCCccccchhhh-ccCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 011380          239 SSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~  313 (487)
                      ..|||+|||+++.+-..+-+.   ...--.+|||||.+ .++++.+|||||+||+|||+++ |+.||.+.+.+++++.|.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            899999999998764332222   11224579999965 6889999999999999999998 999999999999999999


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      .+.. ...  ....|.++.+|+..||+.+|++||++.||=
T Consensus       720 ~g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            8875 222  246889999999999999999999999973

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=336.58  Aligned_cols=266  Identities=29%  Similarity=0.495  Sum_probs=228.6

Q ss_pred             CCcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           88 FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        88 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      +..-.+..+.|++.+.||.|.+|.||+++++.+|+..|+|+.....    ...+.+..|.++|+.+.+|||++.+|++|.
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            3334455677999999999999999999999999999999886543    234677889999999999999999999985


Q ss_pred             -----eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          168 -----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       168 -----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                           .++.+|||||||.||+..|++..-.+..+.|..+++|++.++.||.+||.+.++|||||-.|||++   .++.||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEE
Confidence                 357899999999999999999877788999999999999999999999999999999999999999   588999


Q ss_pred             EeecccccccCCCC-ccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 011380          243 ATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN  315 (487)
Q Consensus       243 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  315 (487)
                      |+|||.+..+.... ...+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+.+......+-.|-++
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            99999987765432 3457899999999999843      3567899999999999999999999888776665555444


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+ .....|.+.+.++.+||..||.+|-.+||+..++|+|||+++.
T Consensus       244 PP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  244 PP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             CC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            32 2333456788999999999999999999999999999999853

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.1e-40  Score=330.03  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=204.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+++.||+|+||.||+|++.     .+++.||+|++.....  ....+.+.+|+.+|.++..||||+++++++...+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            46888999999999999999864     3456899999975432  2334568899999999955999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC---------------------------------------------------------
Q 011380          171 YVYIAMELCEGGELLDRILAKKD---------------------------------------------------------  193 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~---------------------------------------------------------  193 (487)
                      .+++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999998854321                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          194 ---------------------------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       194 ---------------------------------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                                                             ..+++..++.++.||+.||.|||+.+|+||||||+|||++ 
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~-  273 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC-  273 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-
Confidence                                                   2356778889999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        ..+.+||+|||++........   .....|++.|+|||.+.+ .++.++|||||||++|||++ |..||......+..
T Consensus       274 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         274 --EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             --CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence              477899999999976432211   223457889999998865 46889999999999999998 89999776555555


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...+......  .....++.++.+++.+||..+|.+||++.++++.
T Consensus       352 ~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4444433221  1224578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-39  Score=315.91  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=201.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence            47888999999999999998753     23568888876543  2334567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCc
Q 011380          172 VYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~N  229 (487)
                      .++++||+.+++|.+++....                      ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            999999999999998875321                      1347889999999999999999999999999999999


Q ss_pred             eEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 011380          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKT  304 (487)
Q Consensus       230 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~  304 (487)
                      ||++   +++.+||+|||++........   .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+..
T Consensus       158 ill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9998   477899999999876532221   122345778999998755 46889999999999999998 999998777


Q ss_pred             hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .......+....   .......++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHhCCC---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            666555444322   11122457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=329.09  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=208.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCC---E-EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGD---R-VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +-.+.++||+|+||.||+|..+..+.   . ||+|...............+.+|.++++++ +|||||++||+...+..+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCcc
Confidence            44566899999999999999876533   3 899988754434556788999999999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +||||+|+||+|.++|.... ..++..+...++.+.+.||+|||++++|||||-.+|+|+.   .+..+||+|||+++.-
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence            99999999999999996654 3699999999999999999999999999999999999998   4566899999998764


Q ss_pred             CCCCcccccc-CCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          253 KPGKKFQDIV-GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       253 ~~~~~~~~~~-gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .........+ --..|+|||.+.. .++.++|||||||++||+++ |..||.+....++...|.......+.  .+..+.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--~~~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--PSKTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC--CCCCHH
Confidence            3111111111 2357999999864 57999999999999999999 89999999999999888654432222  235678


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++..++.+|+..+|++|||+.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            8999999999999999999998865

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-39  Score=311.82  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+|++.+.||+|+||.||+|.++.+++   .||+|.+....  .......+..|+.+++.+. ||||+++++++.....+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence            358999999999999999999887765   59999886532  3445678899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++   .++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~~~~~  156 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcccccc
Confidence            9999999999998887543 45689999999999999999999999999999999999998   4778999999998765


Q ss_pred             CCCCcc---cccc---CCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          253 KPGKKF---QDIV---GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       253 ~~~~~~---~~~~---gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      ......   ....   ++..|+|||.+.+ .++.++|||||||++|||++ |..||+..........+....   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~  233 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPP  233 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCCCc
Confidence            432211   1111   2457999999864 56889999999999999886 999998887776666664332   22223


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.++..+.+++.+||..+|.+||++.+++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=316.99  Aligned_cols=253  Identities=20%  Similarity=0.266  Sum_probs=201.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC--------------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG--------------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK  161 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~  161 (487)
                      ++|++.+.||+|+||.||+|.+..++              ..||+|.+....  .......+.+|+++++++. ||||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            57999999999999999999875432              358999886542  2345567899999999995 999999


Q ss_pred             EEEEEEeCCEEEEEEeccCCCCHHHHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceE
Q 011380          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK----------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL  231 (487)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIl  231 (487)
                      +++++...+..++||||+++++|.+++....          ...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999885431          123678899999999999999999999999999999999


Q ss_pred             eccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh--CCCCCCCCCh
Q 011380          232 FKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--GRRPFWDKTE  305 (487)
Q Consensus       232 l~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~  305 (487)
                      ++   .++.+||+|||++........   .....+++.|+|||++. +.++.++|||||||++|+|++  |..||.....
T Consensus       162 l~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 VG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             Ec---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            98   467899999999876533221   12234567899999875 457899999999999999988  6788877666


Q ss_pred             hHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          306 DGIFKEVLRNK----PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       306 ~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ...+..+....    ........+.+++.+.+|+.+||..||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            65555443211    11111123457889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-39  Score=308.56  Aligned_cols=247  Identities=27%  Similarity=0.415  Sum_probs=207.9

Q ss_pred             eEeeeeeecCceEEEEEEEcCCC----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           99 TIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .+.+.||.|+||.||+|.+...+    ..||+|++.....  ......+..|+.+++.+ +||||+++++++.+.+..++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEE
Confidence            46788999999999999998766    8999999865432  22457888999999999 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      +|||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||+|+||+++   .++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceeccc
Confidence            99999999999988655433389999999999999999999999999999999999998   467899999999977654


Q ss_pred             CCccc--cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .....  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |.+||...........+........   ...++.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence            32222  1336789999998854 46899999999999999998 8899988777777777766543222   2347899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.+++.+||..||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-39  Score=321.66  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=206.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCC-------CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKAN-------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      .+|.+++.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++++.+||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            4699999999999999999986432       2368999876432  233456788999999999569999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      .+.+++++||+++|+|.+++....              ...++...+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-  168 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-  168 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-
Confidence            999999999999999999886532              23477888999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        .++.+||+|||+++.......   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+..
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         169 --EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             --CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence              467899999999876543221   122334567999998865 46889999999999999998 89999888777776


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..+......   ......+.++.+++.+||..+|.+|||+.+++.+
T Consensus       247 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            666544321   1223578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=308.80  Aligned_cols=241  Identities=22%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             eeeeecCceEEEEEEEcCCC---CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          102 KLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +.||+|+||.||+|.+..++   ..+|+|.+......  .....+.+|+.+++.+. ||||+++++++.. ..+++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCKG-EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEcC-CceEEEEEe
Confidence            46999999999999876655   78999998765432  34567889999999995 9999999998764 468999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcc
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF  258 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~  258 (487)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||..+++||||||+|||++   .++.+||+|||++.........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCcc
Confidence            9999999988544  4789999999999999999999999999999999999998   4778999999998766433221


Q ss_pred             ----ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          259 ----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       259 ----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                          ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+......   .....++..+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  228 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIY  228 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHH
Confidence                11123467999998864 46889999999999999998 99999877766666655544321   22245788999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++|.+||..+|++||++.++++
T Consensus       229 ~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         229 SIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-39  Score=308.75  Aligned_cols=244  Identities=24%  Similarity=0.365  Sum_probs=203.0

Q ss_pred             eeeeecCceEEEEEEEcC-CCC--EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          102 KLLGHGQFGYTYVATDKA-NGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +.||+|++|.||+|.+.. .++  .||+|.+......  ...+.+.+|+.+++++. ||||+++++.+.. ..+++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999998865 333  6999998776532  45678899999999995 9999999999988 889999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc-
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-  257 (487)
                      +++++|.+++.......+++..++.++.|++.||.|||++|++||||+|+||+++   .++.+||+|||++........ 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence            9999999998665435689999999999999999999999999999999999998   468899999999877643211 


Q ss_pred             ---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          258 ---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                         .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+.........  ...+|..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence               113457788999998865 56889999999999999998 99999877777766666543222221  135788999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +++.+||..+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-39  Score=308.01  Aligned_cols=241  Identities=21%  Similarity=0.276  Sum_probs=196.3

Q ss_pred             eeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++++. ||||+++++++.. ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence            3899999999999775  345679999886542  2334567889999999995 9999999998864 56899999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc---
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---  257 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---  257 (487)
                      +++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++   .++.+||+|||++........   
T Consensus        78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCcccee
Confidence            99999887543 35789999999999999999999999999999999999998   477899999999876543321   


Q ss_pred             -cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          258 -FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       258 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+++.|+|||.+.. .++.++|||||||++|+|++ |..||......+....+..+....   ..+..++++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  230 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYAL  230 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence             111233578999998865 46889999999999999996 999998887777666665544221   124578999999


Q ss_pred             HHHccccCccCCcCHHHHhc
Q 011380          335 VKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~  354 (487)
                      |.+||..+|++||++.++++
T Consensus       231 i~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         231 MKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-39  Score=308.17  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=205.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++++. |+||+++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            3468999999999999999999854 45679999886532    24567889999999995 9999999999887 7789


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ++|||+++++|.+++.......+++..+..++.||+.||.|||+.|++||||+|+||+++   ..+.+||+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeecc
Confidence            999999999999998765566788999999999999999999999999999999999998   47889999999987654


Q ss_pred             CCCc--cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGKK--FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ....  .....++..|+|||.+... ++.++|||||||++|++++ |+.||.+.+.......+.....   .......+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCCH
Confidence            3221  1223456779999988654 5889999999999999998 9999988776666655544322   222356888


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+++.+||..+|++||++.+++.
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.6e-39  Score=338.84  Aligned_cols=334  Identities=21%  Similarity=0.243  Sum_probs=209.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC----CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEE-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA-----  165 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~-----  165 (487)
                      .++|.+.+.||+|+||.||+|++..+    +..||+|++.....     .+....|  .++... +.+++.++..     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            35799999999999999999999988    89999998764321     1111111  112221 2333322221     


Q ss_pred             -EEeCCEEEEEEeccCCCCHHHHHHhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCceeecCC
Q 011380          166 -FEDDNYVYIAMELCEGGELLDRILAKKDS------------------RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK  226 (487)
Q Consensus       166 -~~~~~~~~lv~e~~~gg~L~~~l~~~~~~------------------~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlk  226 (487)
                       ......+++|+||+.+++|.+++......                  ...+..+..++.||+.||.|||+++|+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             24566899999999999999887543210                  11234567899999999999999999999999


Q ss_pred             CCceEeccCCCCCcEEEeecccccccCCCC--ccccccCCccccchhhhcc-----------------------CCCCcc
Q 011380          227 PENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR-----------------------KSGPES  281 (487)
Q Consensus       227 p~NIll~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~  281 (487)
                      |+|||++.  ..+.+||+|||++.......  .....+||+.|+|||.+..                       .++.++
T Consensus       283 P~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            99999984  35789999999997654322  2345789999999996532                       123456


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-CCC----------CCCC-------CCCCCCHHHHHHHHHccccCc
Q 011380          282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPD----------FRRK-------PWPSISNSAKDFVKKLLVKDP  343 (487)
Q Consensus       282 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~----------~~~~-------~~~~~s~~~~~li~~~L~~dp  343 (487)
                      |||||||++|||+++..|+..  ....+...+.. ...          ....       .+...+...++||.+||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766432  21122221111 000          0000       001122345699999999999


Q ss_pred             cCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCH
Q 011380          344 RARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISL  423 (487)
Q Consensus       344 ~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~  423 (487)
                      ++|||+.++|+||||+.........     +.++..-..  .-..        ....+-...+...+..-+.+.+|-.+.
T Consensus       439 ~kR~ta~e~L~Hpff~~~~~~~~~~-----~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~e  503 (566)
T PLN03225        439 RQRISAKAALAHPYFDREGLLGLSV-----MQNLRLQLF--RATQ--------QDYGEAAAWVVFLMAKSGTEKEGGFTE  503 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCCcccccc-----ccccccccc--hhhH--------HHHHHHHHHHHHHHHhcCCCCCCCccH
Confidence            9999999999999998754321110     010000000  0000        000001123333444456666777888


Q ss_pred             HHHHHHHHhhCCCcccHHHH--HHHHHhcCCCCCcee
Q 011380          424 EEMRQALAKDLPWKLKESRV--LEILQAVNTPFLGLF  458 (487)
Q Consensus       424 ~el~~~l~~~~~~~~~~~e~--~~~~~~~d~~~~g~i  458 (487)
                      .+|+.+...  +. -.+.+.  ..+....|.+..|..
T Consensus       504 ~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~  537 (566)
T PLN03225        504 AQLQELREK--EP-KKKGSAQRNALASALRLQRKGVK  537 (566)
T ss_pred             HHHHHhhhh--cC-cchhhhhhhhHHHHHhhhhhhhh
Confidence            887775554  31 122222  347777777777766

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-39  Score=311.74  Aligned_cols=248  Identities=21%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCE----EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++.+.||+|+||+||+|.+..+|+.    +++|.+....  .......+..|+.+++++. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~~-~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-HAYIVRLLGICPG-AS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCC-CCCcceEEEEECC-Cc
Confidence            4688999999999999999998877764    6777764321  1233456778888999994 9999999998764 45


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++++||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++||||||+|||++   .++.+||+|||+++.
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg~~~~  158 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADL  158 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCcccee
Confidence            78899999999999988543 35689999999999999999999999999999999999998   578899999999976


Q ss_pred             cCCCC---ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....   ......|+..|+|||.+. +.++.++|||||||++|||++ |..||.+.........+..+.. ...  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~  235 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LAQ--PQI  235 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CCC--CCC
Confidence            54322   123345777899999885 457899999999999999998 9999987766554444433322 111  123


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+..+.+++.+||..||.+|||+.++++
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5678999999999999999999999866

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-39  Score=313.68  Aligned_cols=250  Identities=20%  Similarity=0.270  Sum_probs=205.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|++....  .......+.+|+.+++.+. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCC
Confidence            469999999999999999998753     67889999886543  2344567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCce
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NI  230 (487)
                      .++++|||+++|+|.+++....                    ...+++..+..++.||+.||.|||+.+++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999886432                    12478889999999999999999999999999999999


Q ss_pred             EeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCh
Q 011380          231 LFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTE  305 (487)
Q Consensus       231 ll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  305 (487)
                      |++   .++.+||+|||++........   .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+...
T Consensus       162 l~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Eec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            998   478899999999875432211   122345677999998764 56889999999999999997 8899988777


Q ss_pred             hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+....+..+....   ..+.++.++.+||.+||+.+|.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77776665543221   12357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-39  Score=313.17  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             CCe-eEeeeeeecCceEEEEEE----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 011380           96 RRY-TIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (487)
Q Consensus        96 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--  168 (487)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+++++.+. ||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            455 899999999999998765    34578899999987542  2234567889999999995 9999999998765  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ...++++|||+++++|.+++..   ..+++..++.++.|++.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~  153 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGL  153 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeeccc
Confidence            3468999999999999998843   3589999999999999999999999999999999999998   467899999999


Q ss_pred             ccccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh--H------------HH
Q 011380          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--G------------IF  309 (487)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~------------~~  309 (487)
                      +........    .....++..|+|||.+.+ .++.++||||||+++|+|++|..||......  .            ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            876543221    122345677999998864 4689999999999999999999998543221  0            01


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..........  .....++.++.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111111111  112356789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-39  Score=307.61  Aligned_cols=242  Identities=25%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||++.  .+++.||+|.+....     ....+.+|+.+++++. ||||+++++++.... .+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLH-HKNLVRLLGVILHNG-LYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCC-cEEE
Confidence            469999999999999999985  578899999886432     3467889999999995 999999999987654 7999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceecccc
Confidence            9999999999998765555689999999999999999999999999999999999998   4678999999998754322


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                        ......+..|+|||.+.+ .++.++|||||||++|+|++ |+.||......+....+..+.   .....+.++..+.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHHHHH
Confidence              223344678999998864 56889999999999999997 999998877766666555432   22223567899999


Q ss_pred             HHHHccccCccCCcCHHHHhc
Q 011380          334 FVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+||+.+|.+||++.+++.
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.6e-39  Score=308.60  Aligned_cols=248  Identities=21%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +|+..+.||+|+||.||+|.++.++.   .+|+|.+....  .....+.+.+|+.+++.+. ||||+++++++...+.+|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCcE
Confidence            58889999999999999999876665   79999886542  2334567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++....
T Consensus        83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          83 IITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence            999999999998887543 35789999999999999999999999999999999999998   47789999999987654


Q ss_pred             CCCc--cc--cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          254 PGKK--FQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       254 ~~~~--~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ....  ..  ....++.|+|||++.. .++.++|||||||++|+|++ |+.||......+....+.....   .+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCCC
Confidence            3221  11  1223457999998864 56889999999999999997 9999988877777766654321   1122357


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.++.+++.+||..+|++||++.++++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-39  Score=310.41  Aligned_cols=248  Identities=23%  Similarity=0.284  Sum_probs=204.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++.+.||+|+||.||+|.++.+|.    .+|+|.+.....  ......+.+|+.+++++. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            569999999999999999999877665    589998765532  345577889999999995 9999999999887 78


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++..
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg~~~~  158 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  158 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCccccc
Confidence            89999999999999988543 34589999999999999999999999999999999999998   467899999999976


Q ss_pred             cCCCCccc---cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGKKFQ---DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ........   ...++..|+|||.+.. .++.++||||||+++|++++ |..||.+....+....+..+... ..  .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQ--PPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CC--CCC
Confidence            65332211   1223567999998754 56889999999999999998 99999888777766666544321 11  134


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+..+.+++.+||..+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.8e-39  Score=305.51  Aligned_cols=246  Identities=22%  Similarity=0.400  Sum_probs=204.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ....+.+|+++++++. ||||+++++++......++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence            6889999999999999999875 477899998865432    2356789999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ||+++++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||+++   .++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCc
Confidence            999999998887543 34688999999999999999999999999999999999998   47789999999987653321


Q ss_pred             c--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          257 K--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       257 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .  .....++..|+|||.+.+ .++.++||||||+++|+|++ |..||...........+..+...+..   ...+..+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence            1  112335678999998864 56889999999999999998 99999887777777666554322221   23678999


Q ss_pred             HHHHHccccCccCCcCHHHHhcC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +|+.+||..+|++|||+.++++.
T Consensus       232 ~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         232 ELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHcccChhhCCCHHHHHHh
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.1e-40  Score=312.24  Aligned_cols=241  Identities=17%  Similarity=0.253  Sum_probs=191.6

Q ss_pred             eeeeecCceEEEEEEEcCCCC-------EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGD-------RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      +.||+|+||.||+|.++..+.       .+|+|.+....   ....+.+..|+.+++.+. ||||+++++++......++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            369999999999999866544       38888775432   234567788999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC-----CCcEEEeecccc
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-----DSSLKATDFGLS  249 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~-----~~~vkl~DfG~a  249 (487)
                      ||||+++|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+.     .+.++++|||++
T Consensus        77 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          77 VQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             EEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999999887543 346899999999999999999999999999999999999985321     234899999998


Q ss_pred             cccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGR-RPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ......   ....+++.|+|||++.+  .++.++|||||||++|+|++|. .||....... ...+......++    +.
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~----~~  227 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQFYEDRHQLP----AP  227 (258)
T ss_pred             cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHHHHHccccCC----CC
Confidence            655432   33568899999999875  3688999999999999999985 5554443332 233333333222    23


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+.++.++|.+||+.||++|||+.++++.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            55789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.8e-39  Score=308.71  Aligned_cols=246  Identities=19%  Similarity=0.291  Sum_probs=193.2

Q ss_pred             eeeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          102 KLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++++. ||||+++++++.+...+++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            35899999999999754  3556799998865432  233457888999999995 999999999999999999999999


Q ss_pred             CCCCHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          180 EGGELLDRILAKK---DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       180 ~gg~L~~~l~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      ++|+|.+++....   ....++..+..++.|++.||.|||+.|++||||||+||+++   .++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcc
Confidence            9999999886432   22456778889999999999999999999999999999998   47789999999986543221


Q ss_pred             c---cccccCCccccchhhhcc--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc-CCCCCCCC
Q 011380          257 K---FQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRN-KPDFRRKP  323 (487)
Q Consensus       257 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  323 (487)
                      .   .....|++.|+|||++.+        .++.++||||||+++|+|++ |..||......+........ ...+..+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123467888999998853        24779999999999999996 99999776655544333322 22222222


Q ss_pred             C-CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          324 W-PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       324 ~-~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      . ...++.+.+++.+|+ .+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1 246788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-39  Score=312.63  Aligned_cols=254  Identities=19%  Similarity=0.275  Sum_probs=200.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC----------------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA----------------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN  158 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn  158 (487)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|++....  .......+.+|+.+++.+. |||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3579999999999999999986432                34468999886542  2334567889999999995 999


Q ss_pred             ccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCc
Q 011380          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (487)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~N  229 (487)
                      |+++++++...+..+++|||+++++|.+++.....         ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            99999999999999999999999999998865321         246778999999999999999999999999999999


Q ss_pred             eEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 011380          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC--GRRPFWDK  303 (487)
Q Consensus       230 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~--g~~pf~~~  303 (487)
                      ||++   .++.++|+|||++........   .....+++.|+|||+.. +.++.++|||||||++|+|++  |..||...
T Consensus       161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9998   477899999999876533221   12234467899999764 557899999999999999998  78899776


Q ss_pred             ChhHHHHHHHh---cC-CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          304 TEDGIFKEVLR---NK-PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       304 ~~~~~~~~i~~---~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +..+.+.....   .. .....+..+.+++.+.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66555443321   10 01111112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.6e-39  Score=309.75  Aligned_cols=252  Identities=21%  Similarity=0.363  Sum_probs=207.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++.+.||.|+||.||+|+.+.     +.+.+|+|.+....  .......+.+|+++++++. ||||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            468999999999999999999754     34679999876543  1224567899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          171 YVYIAMELCEGGELLDRILAKKD-------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                      ..|+||||+++|+|.+++.....       ..+++..+..++.||+.||.|||+.||+||||||+||+++   .++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEE
Confidence            99999999999999998865431       2689999999999999999999999999999999999998   4778999


Q ss_pred             eecccccccCCC--CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 011380          244 TDFGLSDFIKPG--KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       244 ~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      +|||++......  .......+++.|+|||.+.+ ..+.++||||||+++|+|++ |..||...........+..+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            999998654321  12334466788999998754 46888999999999999998 889997776666666665444332


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..  ...++..+.+++.+||+.+|.+|||+.+++..
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            22  24578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-39  Score=307.96  Aligned_cols=245  Identities=20%  Similarity=0.302  Sum_probs=192.6

Q ss_pred             eeeecCceEEEEEEEcC--CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+.....+|+||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCC
Confidence            59999999999996432  34578888775432  2334567789999999995 9999999999999999999999999


Q ss_pred             CCCHHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc
Q 011380          181 GGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK  257 (487)
Q Consensus       181 gg~L~~~l~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~  257 (487)
                      +|+|.+++.....   ...++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccccchh
Confidence            9999998865432   2346788899999999999999999999999999999998   477899999999865332211


Q ss_pred             ---cccccCCccccchhhhcc--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC-CCCCCCC-
Q 011380          258 ---FQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNK-PDFRRKP-  323 (487)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~-  323 (487)
                         .....+++.|+|||++..        .++.++|||||||++|+|++ |..||......+.+..+.... ...+... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence               123346778999998742        34778999999999999999 788887776666655554432 2222222 


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ...++..+.+++..|+ .||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2357788999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.8e-39  Score=309.21  Aligned_cols=250  Identities=20%  Similarity=0.251  Sum_probs=204.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~  170 (487)
                      ++|++.+.||+|+||.||+|.+..    ++..||+|++....  .......+.+|+.+++++ +||||+++++++.. ..
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGE   82 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCC
Confidence            579999999999999999999876    35789999876432  344567788999999999 59999999998765 56


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          171 YVYIAMELCEGGELLDRILAKKD------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                      ..++++||+++++|.+++.....      ..+++..+..++.||+.||.|||+++++||||||+||+++   .++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence            78999999999999998855422      4589999999999999999999999999999999999998   46889999


Q ss_pred             ecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 011380          245 DFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       245 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |||+++.......   .....++..|+|||++.+. ++.++|||||||++|++++ |+.||......+....+..+. ..
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~  238 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL  238 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC
Confidence            9999976543221   1223457789999988654 6889999999999999998 999998776655554444332 21


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                        .....+++++.+++.+||..||++|||+.++++
T Consensus       239 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         239 --AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              122457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.4e-39  Score=307.73  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=203.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.+++++. ||||+++++++.+ ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence            4688999999999999999987644   3468999876442  1345567889999999995 9999999998876 457


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.|++||||||+|||++   ..+.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~  157 (270)
T cd05056          82 WIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence            8999999999999988543 34689999999999999999999999999999999999998   4678999999998765


Q ss_pred             CCCCccc--cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          253 KPGKKFQ--DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       253 ~~~~~~~--~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .......  ...+++.|+|||.+.. .++.++||||||+++|+|++ |..||.+....+....+..+...   ...+.++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence            4432221  2234567999998764 46889999999999999986 99999888776666666544322   2235678


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++.++|.+||..+|.+|||+.+++..
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-39  Score=302.79  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=199.2

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      +.||+|+||.||+|... +++.+|+|.+....  .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999864 68899999886542  2334457889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcc--c
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--Q  259 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~--~  259 (487)
                      ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++   .++.+||+|||++.........  .
T Consensus        77 ~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          77 GDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceeccccccccCC
Confidence            9999987543 34688999999999999999999999999999999999998   4778999999998754332211  1


Q ss_pred             cccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011380          260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK  337 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  337 (487)
                      ...+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+....   .......++..+.+++.+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~  229 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHH
Confidence            1234567999998864 46889999999999999998 999998877666665554432   112234578999999999


Q ss_pred             ccccCccCCcCHHHHhc
Q 011380          338 LLVKDPRARLTAAQALS  354 (487)
Q Consensus       338 ~L~~dp~~Rpt~~e~L~  354 (487)
                      ||..+|++||++.++++
T Consensus       230 ~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         230 CWDYKPENRPKFSELQK  246 (250)
T ss_pred             HcccCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8e-41  Score=333.46  Aligned_cols=248  Identities=29%  Similarity=0.487  Sum_probs=199.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC------
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN------  170 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~------  170 (487)
                      -+...+.||+||||.||+++++.+|+.||||.+.+...  ....+..-+|+++|++|. |||||++++.-++..      
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccc
Confidence            35667889999999999999999999999999877543  234577889999999995 999999998765433      


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~  248 (487)
                      ...+|||||.||+|+..+.+.. ...+++.+.+.++..+..||.|||++||+||||||.||++.... ....-||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            5689999999999999885432 34699999999999999999999999999999999999987533 345689999999


Q ss_pred             ccccCCCCccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  322 (487)
                      |+.+..+..+.+.+||+.|.+||++.  ..|+..+|.|||||++|+++||..||.....    .++...+...++.-...
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            99999998999999999999999997  4578889999999999999999999954322    23444444333221100


Q ss_pred             ----------CC----C---CCCH----HHHHHHHHccccCccCCc
Q 011380          323 ----------PW----P---SISN----SAKDFVKKLLVKDPRARL  347 (487)
Q Consensus       323 ----------~~----~---~~s~----~~~~li~~~L~~dp~~Rp  347 (487)
                                .|    |   .++.    .+..++..+|..+|.+|.
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      01    1   1222    355778899999999998

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-39  Score=311.28  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             CeeEeeeeeecCceEEEEEEE----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--C
Q 011380           97 RYTIGKLLGHGQFGYTYVATD----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--N  170 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~  170 (487)
                      -|++.+.||+|+||.||+|..    +.++..||+|.+....  .......+.+|+.+++++. ||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            378899999999999999974    4578899999986442  2334567899999999995 99999999998775  6


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+++||||++|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~  157 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK  157 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccc
Confidence            789999999999999987543 24689999999999999999999999999999999999998   46789999999997


Q ss_pred             ccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--------------hHHHHH
Q 011380          251 FIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--------------DGIFKE  311 (487)
Q Consensus       251 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------------~~~~~~  311 (487)
                      .......    .....|+..|+|||++.+ .++.++|||||||++|+|++++.|+.....              ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            6643321    123557778999998764 468899999999999999998776532211              011111


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ......  ....+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         238 VLEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111111  112235688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=318.07  Aligned_cols=251  Identities=27%  Similarity=0.361  Sum_probs=196.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-EEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-~~~l  174 (487)
                      +.|.-...||+|+||.||+|.-. +|+.||||++.......   ..+|.+|+.++.+++ |||+|+++|||.+.+ ..+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEE
Confidence            45666678999999999999864 45899999887654211   355999999999996 999999999999988 5999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      |+||+++|+|.+++.......+++.....|+.+++.||+|||...   ||||||||+|||+|   ++...||+|||+|+.
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD---~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD---EDFNAKLSDFGLAKL  226 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---CCCCEEccCccCccc
Confidence            999999999999996554338899999999999999999999864   99999999999999   688999999999976


Q ss_pred             cCC-CCccccc-cCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCC---hh---HHHHHHHhcC--CCCC
Q 011380          252 IKP-GKKFQDI-VGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKT---ED---GIFKEVLRNK--PDFR  320 (487)
Q Consensus       252 ~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~---~~~~~i~~~~--~~~~  320 (487)
                      ... ....... .||..|+|||.+. +..+.++|||||||+|.||++|+.|.....   ..   +.....+...  ....
T Consensus       227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii  306 (361)
T KOG1187|consen  227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV  306 (361)
T ss_pred             CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence            654 3333333 8999999999885 567999999999999999999998876432   11   1111122211  1111


Q ss_pred             CCCC--CCCC--HH---HHHHHHHccccCccCCcCHHHHhc
Q 011380          321 RKPW--PSIS--NS---AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       321 ~~~~--~~~s--~~---~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+..  ...+  .+   +..+..+|++.+|.+||++.++++
T Consensus       307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1111  1223  22   557788999999999999999743

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-39  Score=302.46  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~g  181 (487)
                      ++||.|+||.||+|.+.. ++.||+|.+.....  ......+.+|+++++++. ||||+++++++......++||||++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            369999999999999877 99999998876542  235567889999999995 99999999999999999999999999


Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcc---
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---  258 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~---  258 (487)
                      ++|.+++... ...+++..+..++.+++.||.|||+++++||||+|+|||++   .++.+||+|||++.........   
T Consensus        77 ~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          77 GSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCcceecc
Confidence            9999988543 34688999999999999999999999999999999999998   4778999999998765422111   


Q ss_pred             ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Q 011380          259 QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK  336 (487)
Q Consensus       259 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  336 (487)
                      ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||...........+.... .  ......++.++.+++.
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~  229 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-R--MPAPQLCPEEIYRLML  229 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-C--CCCCccCCHHHHHHHH
Confidence            11233567999998764 46889999999999999999 899987776655555554332 1  1122357889999999


Q ss_pred             HccccCccCCcCHHHHhc
Q 011380          337 KLLVKDPRARLTAAQALS  354 (487)
Q Consensus       337 ~~L~~dp~~Rpt~~e~L~  354 (487)
                      +||..+|.+|||+.++++
T Consensus       230 ~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         230 QCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-39  Score=304.26  Aligned_cols=228  Identities=22%  Similarity=0.326  Sum_probs=187.0

Q ss_pred             cCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCCHHH
Q 011380          107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD  186 (487)
Q Consensus       107 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~  186 (487)
                      |.||.||+|.++.+|+.||+|.+....        ...+|...+... .||||+++++++.....+++||||++||+|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            889999999999999999999997643        123444445555 49999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCcc
Q 011380          187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY  266 (487)
Q Consensus       187 ~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~  266 (487)
                      ++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++   .++.++|+|||.+......  .....++..
T Consensus        75 ~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~--~~~~~~~~~  147 (237)
T cd05576          75 HISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDS--CDGEAVENM  147 (237)
T ss_pred             HHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccc--cccCCcCcc
Confidence            88554  4689999999999999999999999999999999999998   4678999999987655432  234566788


Q ss_pred             ccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccC
Q 011380          267 YVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA  345 (487)
Q Consensus       267 y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  345 (487)
                      |+|||.+.+ .++.++||||+|+++|+|++|+.||......     + .......  ..+.+++.++++|.+||+.||++
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~  219 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLN--IPEWVSEEARSLLQQLLQFNPTE  219 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccC--CcccCCHHHHHHHHHHccCCHHH
Confidence            999998864 4688999999999999999999987543221     0 0011111  11357889999999999999999


Q ss_pred             CcCH-----HHHhcCccc
Q 011380          346 RLTA-----AQALSHPWV  358 (487)
Q Consensus       346 Rpt~-----~e~L~h~~~  358 (487)
                      ||++     .++++||||
T Consensus       220 R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         220 RLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hcCCCccchHHHHcCCCC
Confidence            9986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.6e-39  Score=305.77  Aligned_cols=253  Identities=28%  Similarity=0.503  Sum_probs=208.2

Q ss_pred             eeEeeeeeecCceEEEEEEEcC-CCCEEEEEEecccCc-------CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           98 YTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKM-------ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      |++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.+..+||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7888999999999999999987 688999998753221       12334566778999887644699999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          170 NYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +..+++|||++|++|.+.+..  .....+++..++.++.|++.||.|||+ .+++||||+|+|||++   .++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEecc
Confidence            999999999999999887743  234568999999999999999999996 7899999999999998   4778999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      |++.............|+..|+|||.+.+. ++.++||||||+++|+|++|+.||...........+......  .....
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLPEG  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCCcc
Confidence            999776544444566789999999998654 688999999999999999999999777666555555544322  11223


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+++++.++|.+||+.||++||++.|+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            578899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-38  Score=306.82  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEE----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--C
Q 011380           96 RRYTIGKLLGHGQFGYTYVATD----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--D  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~  169 (487)
                      .+|++.+.||+|+||.||+|..    ..+++.||+|.+....   ......+.+|+++++++. ||||+++++++..  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence            4689999999999999999973    4578899999986543   334567889999999995 9999999998653  4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ..+++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++   .++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~  155 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDFGLT  155 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCCccc
Confidence            5689999999999999988543 34689999999999999999999999999999999999998   4778999999999


Q ss_pred             cccCCCCcc----ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---------------HHH
Q 011380          250 DFIKPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---------------GIF  309 (487)
Q Consensus       250 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------------~~~  309 (487)
                      .........    ....++..|+|||++.+ .++.++|||||||++|+|++|..|+......               ..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            876433221    11223456999999865 4688999999999999999987775433211               001


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..++.....+  ...+.++.++.+||.+||..+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         236 IELLKNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHhcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1222222111  122467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-38  Score=304.50  Aligned_cols=241  Identities=18%  Similarity=0.194  Sum_probs=188.7

Q ss_pred             eeeeecCceEEEEEEEcC------------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380          102 KLLGHGQFGYTYVATDKA------------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~------------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      +.||+|+||.||+|+...            ....+|+|.+....   ......+..|+.+++.+. ||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            358999999999997532            22358888876532   234456788999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC----CCcEEEee
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE----DSSLKATD  245 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~----~~~vkl~D  245 (487)
                      ...++||||+++|+|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++..+.    ...+|++|
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999998776643 3456899999999999999999999999999999999999974221    12489999


Q ss_pred             cccccccCCCCccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHH-hCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~  322 (487)
                      ||++.....   .....|+..|+|||++.  ..++.++|||||||++|+|+ +|..||......+.. ........    
T Consensus       156 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----  227 (262)
T cd05077         156 PGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----  227 (262)
T ss_pred             CCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----
Confidence            999865432   23456888999999885  34688999999999999997 588888665443322 22222211    


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .....++++.+||.+||+.||.+||++.+++++
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.8e-39  Score=306.76  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=198.3

Q ss_pred             eeeecCceEEEEEEEcCCC------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380          103 LLGHGQFGYTYVATDKANG------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .||+|+||.||+|+++..+      +.+|+|.+.+..  .......+.+|+.+++.+. ||||+++++++......++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEE
Confidence            5899999999999876543      689999886532  1234567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--CCCcEEEeecccc
Q 011380          177 ELCEGGELLDRILAKK-----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLS  249 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a  249 (487)
                      ||+++++|.+++....     ...+++..+..++.||+.||.|||+.+++|+||||+||+++..+  ....+||+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999999986532     23478899999999999999999999999999999999998532  2237999999998


Q ss_pred             cccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          250 DFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       250 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      ........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||......+....+..+..   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~  235 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR---LQKP  235 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---cCCc
Confidence            76533221   122345788999998864 46899999999999999998 9999987766665555543321   1223


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+|..+.++|.+||..+|.+||++.++++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            467889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-39  Score=307.12  Aligned_cols=240  Identities=17%  Similarity=0.191  Sum_probs=189.8

Q ss_pred             eeeecCceEEEEEEEcCC------------------------CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC
Q 011380          103 LLGHGQFGYTYVATDKAN------------------------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN  158 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn  158 (487)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.+. |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence            599999999999975322                        2358888886432   223456788999999995 999


Q ss_pred             ccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--
Q 011380          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--  236 (487)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--  236 (487)
                      |+++++++......++||||+++|+|..++.. ....+++..+..++.||+.||.|||+.||+||||||+|||++..+  
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999999877643 345789999999999999999999999999999999999997421  


Q ss_pred             --CCCcEEEeecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHH-hCCCCCCCCChhHHHHH
Q 011380          237 --EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 --~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~  311 (487)
                        ....+|++|||++......   ....++..|+|||.+.+  .++.++|||||||++|+|+ +|..||......+... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-  232 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-  232 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence              2335899999987543221   23467889999998864  4688999999999999984 6999997765544332 


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ........+    +..++.+.++|.+||+.+|++|||+.++|++
T Consensus       233 ~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FYEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            222222222    2345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=298.63  Aligned_cols=260  Identities=24%  Similarity=0.317  Sum_probs=216.9

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +-...||.|+||+|++-.++.+|+..|||+|.....  .....+++.|.+...+-.+.||||++||..-.++..||.||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            345679999999999999999999999999987653  456788899999888877899999999999999999999999


Q ss_pred             cCCCCH---HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          179 CEGGEL---LDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       179 ~~gg~L---~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+ .+|   +.++.......++|..+..+....+.||.||-. ..|||||+||+|||++   ..|.|||||||.+..+..
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---r~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---RHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe---cCCCEeeecccchHhHHH
Confidence            95 343   223333345679999999999999999999975 5999999999999999   588999999999987766


Q ss_pred             CCccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcCCCCCCCCC--CCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPW--PSIS  328 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~--~~~s  328 (487)
                      +...+.-.|...|||||.+..   .|+-++||||||++|||+.||+.|+.+- +..+.+..+..+.++......  -.+|
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            655566689999999999853   4788999999999999999999999654 345566667777655443332  2478


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                      ..+..+|..||.+|-+.||...+++.+||++.+...
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence            999999999999999999999999999999987543

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-38  Score=303.09  Aligned_cols=238  Identities=17%  Similarity=0.196  Sum_probs=189.4

Q ss_pred             eeeeecCceEEEEEEEcCCC----------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380          102 KLLGHGQFGYTYVATDKANG----------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +.||+|+||.||+|.++.++          ..+++|.+.....    ....+.+|+.+++.+. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            36999999999999998776          3577887654321    1577889999999995 9999999999888 77


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC----CCCcEEEeecc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK----EDSSLKATDFG  247 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~----~~~~vkl~DfG  247 (487)
                      .++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++..+    ....+||+|||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            899999999999999886543 3789999999999999999999999999999999999998532    11279999999


Q ss_pred             cccccCCCCccccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      ++.....   .....++..|+|||.+.+.   ++.++|||||||++|+|++ |..||............. .....+.  
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--  227 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--  227 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC--
Confidence            9876543   2234677889999998654   6889999999999999999 588886665433332222 1111111  


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                        ..+..+.++|.+||..+|.+|||+.++++
T Consensus       228 --~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         228 --PDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence              12378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.4e-38  Score=308.60  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ++|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            468889999999999999999887776    46888876443  2333456889999999995 99999999988754 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++++||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~  158 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARL  158 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccccc
Confidence            67899999999999987543 34688999999999999999999999999999999999997   467899999999976


Q ss_pred             cCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ......   .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+........ +......+.  ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--~~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGERLP--QPPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCCCC--CCCC
Confidence            543222   123345778999998865 46889999999999999997 999997765544443 333332222  2245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+..+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-38  Score=301.27  Aligned_cols=243  Identities=23%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             eeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE-eCCEEEEEEe
Q 011380          102 KLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DDNYVYIAME  177 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~~~~lv~e  177 (487)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .....+.+.+|+.+++.+. ||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998654   34579999875432  2334567889999999995 999999999765 5667899999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-  256 (487)
                      |+.+|+|.+++... ....++..+..++.||+.||.|||+.+|+||||||+|||++   .++.+||+|||++....... 
T Consensus        78 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          78 YMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCcc
Confidence            99999999988543 34567788899999999999999999999999999999998   47789999999987543211 


Q ss_pred             ----ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          257 ----KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       257 ----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                          ......+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||...........+..+.....   ...++..
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDP  230 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence                1123356778999998754 56889999999999999999 4666766665555555544322111   1246789


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.+++.+||..+|++||++.+++.
T Consensus       231 ~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         231 LYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=337.79  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=212.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCC-----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ...-.+.+.||+|+||.||.|......-     .||+|.+.+..  ..+...+|.+|..+|+.+ +|||||+++|++.+.
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCC
Confidence            3456788899999999999998764322     48999887543  467788999999999999 599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          170 NYVYIAMELCEGGELLDRILAKK-----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                      ...+|++|||+||+|..+|...+     ...++..+.+.++.||+.|++||+++++|||||-+.|+|++   ....|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEc
Confidence            99999999999999999996542     34588999999999999999999999999999999999999   56899999


Q ss_pred             ecccccccCCCCcccccc--C--Cccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCC
Q 011380          245 DFGLSDFIKPGKKFQDIV--G--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~--g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      |||+|+.+.... +...-  +  -..|||||.+. +.++.++|||||||++||+++ |..||.+.+..+++..++.+.  
T Consensus       845 DFGlArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            999998543222 11111  2  24799999987 567999999999999999999 999999999999988788776  


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                       +..+.+..+..+.++|..||+.+|++||+...+++
T Consensus       922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence             23333568889999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5e-38  Score=300.81  Aligned_cols=245  Identities=18%  Similarity=0.283  Sum_probs=192.5

Q ss_pred             eeeecCceEEEEEEEcCC--CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .||+|+||+||+|.....  ...+++|.+....  .....+.+.+|+.+++.+. ||||+++++.+.+....|+||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence            599999999999975433  2356677665432  2234578899999999995 9999999999999999999999999


Q ss_pred             CCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC--
Q 011380          181 GGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--  256 (487)
Q Consensus       181 gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~--  256 (487)
                      +|+|.+++....  ....++..+..++.||+.||.|||+.+|+||||||+|||++   .++.+||+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCcchhh
Confidence            999999886542  23467778889999999999999999999999999999998   47789999999975432211  


Q ss_pred             -ccccccCCccccchhhhcc--------CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC-CCCCCC-C
Q 011380          257 -KFQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP-DFRRKP-W  324 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~-~  324 (487)
                       .....+|++.|+|||++..        .++.++|||||||++|+|++ |..||......+.+..+..... ....+. .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1234578899999998742        23678999999999999997 5778877777677766655432 222222 2


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+++.+.+++..|| .+|.+||++.++++
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            357888999999999 68999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.9e-38  Score=305.72  Aligned_cols=250  Identities=17%  Similarity=0.210  Sum_probs=185.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHh--------HHHHHHHHHHHHhccCCCCccE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIA--------VEDVKREVKILQALAGHENVVK  161 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~--------~~~~~~E~~~l~~l~~hpnIv~  161 (487)
                      ....+|++.+.||+|+||+||+|.+..+   +..+|+|+...........        ......+...+..+ +|+||++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCc
Confidence            3456899999999999999999998877   6677887643322110000        01112233344556 5999999


Q ss_pred             EEEEEEeCC----EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          162 FYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       162 ~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      +++++....    ..++++|++. .++.+.+..  ....++..++.++.|++.||.|||+.+|+||||||+|||++   .
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~  161 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G  161 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence            998765443    4578888874 456555432  23467888999999999999999999999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh-hH
Q 011380          238 DSSLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE-DG  307 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~  307 (487)
                      ++.+||+|||+|+......        ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+... ..
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            6789999999997653221        11234799999999998764 68999999999999999999999977633 22


Q ss_pred             H--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          308 I--------FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       308 ~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .        +..+..+.     ...+..++++.++++.|+..+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHhHHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1        12222222     123456789999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.8e-38  Score=302.23  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=200.2

Q ss_pred             eeEeeeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 011380           98 YTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----  170 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~----  170 (487)
                      |.+.+.||+|+||.||+|..+.   +++.||||++..... .....+.+.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            5678899999999999998643   578999999865432 3345667889999999995 999999999886432    


Q ss_pred             --EEEEEEeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          171 --YVYIAMELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                        ..+++++|+.+|+|.+++....    ...+++..+..++.||+.||+|||+.||+||||||+||+++   .++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEEC
Confidence              3478999999999988774332    22578999999999999999999999999999999999997   47789999


Q ss_pred             ecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 011380          245 DFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       245 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |||++........   .....+++.|++||.+... ++.++|||||||++|+|++ |++||.+.........+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999876543221   1233456789999988654 5889999999999999999 899998777666666555443211


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                         ..+..+..+.+++.+||..+|++|||+.+++.+
T Consensus       236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               114577899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-38  Score=303.69  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--C
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--D  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~  169 (487)
                      ++|++.+.||+|+||.||+|....    +++.+|+|++......  .....+.+|+++++.+. ||||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            457888999999999999998643    4789999998765431  34578899999999995 9999999999887  6


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      ...+++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++   .++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~  156 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLA  156 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccccc
Confidence            68999999999999999885442 3589999999999999999999999999999999999998   4688999999999


Q ss_pred             cccCCCCcc----ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhH--------------HHH
Q 011380          250 DFIKPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG--------------IFK  310 (487)
Q Consensus       250 ~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------------~~~  310 (487)
                      .........    ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.......              .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876532221    12344567999998754 46889999999999999999999986543221              122


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+.....+.  .....+.++.+++.+||..+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         237 ELLKEGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHcCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2233222222  12356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=9.1e-40  Score=313.77  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=218.1

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-----CCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~~~~  166 (487)
                      +.+..+|.+....|+|-|++|..|.+...|..||||+|..+..    ....=+.|++||++|.     +--++++++..|
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            4567789999999999999999999999999999999987642    3445578999999996     235899999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                      ...+++|||+|-+ ..+|.+.+... ..-.|....+..++.||+.||..|-..||+|.||||+|||++.  ....+||||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iLKLCD  580 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNILKLCD  580 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Ccceeeecc
Confidence            9999999999988 46888888554 2345888999999999999999999999999999999999984  567899999


Q ss_pred             cccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC-
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP-  323 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-  323 (487)
                      ||.|..+..+. .+.+.-+..|+|||++.| .|+...|+||+||+||||+||+..|.+.+...++.-.+.-+..|+... 
T Consensus       581 fGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  581 FGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             Ccccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            99998876543 455667788999999877 579999999999999999999999999998888776654443333211 


Q ss_pred             ------------------------------------------------CCCCC-------HHHHHHHHHccccCccCCcC
Q 011380          324 ------------------------------------------------WPSIS-------NSAKDFVKKLLVKDPRARLT  348 (487)
Q Consensus       324 ------------------------------------------------~~~~s-------~~~~~li~~~L~~dp~~Rpt  348 (487)
                                                                      .+.++       ..+++||.+||..||++|+|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                                                            00112       24789999999999999999


Q ss_pred             HHHHhcCccccc
Q 011380          349 AAQALSHPWVRE  360 (487)
Q Consensus       349 ~~e~L~h~~~~~  360 (487)
                      ..++|.||||++
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999975

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=311.25  Aligned_cols=243  Identities=25%  Similarity=0.401  Sum_probs=206.0

Q ss_pred             EeeeeeecCceEEEEEEEcCC--C--CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380          100 IGKLLGHGQFGYTYVATDKAN--G--DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~--~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.+.||.|.||.||+|....-  |  -.||||..+...  .+...+.|..|..+|+++. ||||++++|++.+. ..|||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-ceeEE
Confidence            356899999999999986432  3  358899887654  3556899999999999995 99999999998765 48999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||+++.|.|..++..++ ..++......++.||+.||.|||+..+|||||-..|||+.+   ...|||+|||+++.+...
T Consensus       469 mEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhcccc
Confidence            99999999999997654 57899999999999999999999999999999999999984   678999999999998876


Q ss_pred             CccccccCCc--cccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKFQDIVGSA--YYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~~~~~gt~--~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .-+....|..  -|||||.++ ...+.++|||.|||++||++. |..||.+-...+++-.+-++...   +..|+.|+.+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl---P~P~nCPp~L  621 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL---PCPPNCPPAL  621 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC---CCCCCCChHH
Confidence            6555545543  599999886 567999999999999999887 99999998888777777666532   2236788999


Q ss_pred             HHHHHHccccCccCCcCHHHHh
Q 011380          332 KDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      ..|+.+||.++|.+||...++.
T Consensus       622 YslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHH
Confidence            9999999999999999887764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.2e-37  Score=311.72  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=188.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc----------------CCCCEEEEEEecccCcCCh-----------HhHHHHHHHH
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK----------------ANGDRVAVKKIEKNKMILP-----------IAVEDVKREV  147 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~i~~~~~~~~-----------~~~~~~~~E~  147 (487)
                      .++|.+.++||+|+||+||+|...                ..++.||||++........           ...+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            467999999999999999999742                3456899999864321100           0112234577


Q ss_pred             HHHHhccCCCC-----ccEEEEEEEe--------CCEEEEEEeccCCCCHHHHHHhhcC---------------------
Q 011380          148 KILQALAGHEN-----VVKFYNAFED--------DNYVYIAMELCEGGELLDRILAKKD---------------------  193 (487)
Q Consensus       148 ~~l~~l~~hpn-----Iv~~~~~~~~--------~~~~~lv~e~~~gg~L~~~l~~~~~---------------------  193 (487)
                      .++.++. |.+     +++++++|..        .+..++|+||+++++|.+++.....                     
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7777775 544     3667776642        3568999999999999988753211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCcccc--ccCCccccch
Q 011380          194 -SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAP  270 (487)
Q Consensus       194 -~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~--~~gt~~y~aP  270 (487)
                       ..+++..++.++.|++.+|.|||+.+|+||||||+|||++   .++.+||+|||++...........  ..+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             1235677889999999999999999999999999999998   467899999999976544333222  2348999999


Q ss_pred             hhhccC---------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCChh-----------HHHHHHHhc
Q 011380          271 EVLKRK---------------------S--GPESDVWSIGVITYILLCGRR-PFWDKTED-----------GIFKEVLRN  315 (487)
Q Consensus       271 E~~~~~---------------------~--~~~~DiwSlG~il~ell~g~~-pf~~~~~~-----------~~~~~i~~~  315 (487)
                      |.+...                     +  ..+.||||+||++|+|++|.. ||.+....           ..+..+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            987421                     1  134799999999999999876 66432110           111112222


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHccccCc---cCCcCHHHHhcCccccc
Q 011380          316 KPDFRRKPWPSISNSAKDFVKKLLVKDP---RARLTAAQALSHPWVRE  360 (487)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp---~~Rpt~~e~L~h~~~~~  360 (487)
                      .  +....+...++.+++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       460 ~--~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 K--YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             C--CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2  2333567789999999999999866   78999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=296.12  Aligned_cols=267  Identities=30%  Similarity=0.481  Sum_probs=208.8

Q ss_pred             cccccC-CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-------CCccE
Q 011380           90 YDKDFD-RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-------ENVVK  161 (487)
Q Consensus        90 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-------pnIv~  161 (487)
                      ..+.|. .+|.+.++||-|.|++||+|.|..+.+.||+|+++...    ...+....||++|++++.+       ..||+
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            445676 89999999999999999999999999999999987653    4567788999999998733       36999


Q ss_pred             EEEEEEe----CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCC
Q 011380          162 FYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       162 ~~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~  236 (487)
                      +++.|..    +.+++||+|++ |.+|+.+|.......++...++.|++|||.||.|||. .||||.||||+|||+....
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e  225 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE  225 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence            9999974    55899999999 8899999999888899999999999999999999996 5999999999999992210


Q ss_pred             --------------------------------------------------------------------------------
Q 011380          237 --------------------------------------------------------------------------------  236 (487)
Q Consensus       237 --------------------------------------------------------------------------------  236 (487)
                                                                                                      
T Consensus       226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~  305 (590)
T KOG1290|consen  226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN  305 (590)
T ss_pred             cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------C------------------------------------------------
Q 011380          237 -------------------------------E------------------------------------------------  237 (487)
Q Consensus       237 -------------------------------~------------------------------------------------  237 (487)
                                                     .                                                
T Consensus       306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~  385 (590)
T KOG1290|consen  306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP  385 (590)
T ss_pred             ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence                                           0                                                


Q ss_pred             ----CCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC------hh
Q 011380          238 ----DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT------ED  306 (487)
Q Consensus       238 ----~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~  306 (487)
                          .-.|||+|||-|....  ..++.-+.|..|+|||++.+ .|++.+||||++|++|||+||-..|...+      ++
T Consensus       386 ~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  386 LPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             CCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence                0025677777666543  33455567999999999876 68999999999999999999999985432      11


Q ss_pred             HHHHHH---Hh---------cCC--CCC-----------CCCCCC---------C----CHHHHHHHHHccccCccCCcC
Q 011380          307 GIFKEV---LR---------NKP--DFR-----------RKPWPS---------I----SNSAKDFVKKLLVKDPRARLT  348 (487)
Q Consensus       307 ~~~~~i---~~---------~~~--~~~-----------~~~~~~---------~----s~~~~~li~~~L~~dp~~Rpt  348 (487)
                      +-+..|   +.         ++.  +|.           ..+||-         +    ..++.+||.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            222211   11         110  000           112321         2    235789999999999999999


Q ss_pred             HHHHhcCccccccCC
Q 011380          349 AAQALSHPWVREGGD  363 (487)
Q Consensus       349 ~~e~L~h~~~~~~~~  363 (487)
                      |.++|+|||+.....
T Consensus       544 A~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  544 AAQCLKHPWLNPVAG  558 (590)
T ss_pred             HHHHhcCccccCCCC
Confidence            999999999986544

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=308.79  Aligned_cols=245  Identities=23%  Similarity=0.360  Sum_probs=210.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +..+..+||-|.||.||.|.++.-.-.||||.++...+    .++.|+.|..+|+.++ |||+|+++++|..+..+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEE
Confidence            34556789999999999999999888999999876543    6789999999999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |||..|+|+++|..-....++.-..++++.||..|++||..+++|||||-..|+|+.   ++..||++|||+++.+..+ 
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgD-  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGD-  418 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCC-
Confidence            999999999999777666788888899999999999999999999999999999998   6889999999999987643 


Q ss_pred             ccccccC---Cccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          257 KFQDIVG---SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       257 ~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .++.-.|   ..-|.|||-+. ...+.++|||+|||+|||+.| |-.||.+-....++.-+-++   |.......+++.+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg---yRM~~PeGCPpkV  495 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG---YRMDGPEGCPPKV  495 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---ccccCCCCCCHHH
Confidence            3333334   34599999875 557899999999999999988 88999888777666555443   3333445789999


Q ss_pred             HHHHHHccccCccCCcCHHHHh
Q 011380          332 KDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      .+|++.||++.|.+||+.+|+-
T Consensus       496 YeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  496 YELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHHhcCCcccCccHHHHH
Confidence            9999999999999999999873

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-36  Score=284.59  Aligned_cols=242  Identities=43%  Similarity=0.742  Sum_probs=203.6

Q ss_pred             CceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCCHHHH
Q 011380          108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDR  187 (487)
Q Consensus       108 ~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~  187 (487)
                      +||.||+|.+..+|+.+|+|++.......  ....+.+|+..++++ +|+||+++++.+......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999999899999999987654321  157889999999999 599999999999999999999999999999998


Q ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccc
Q 011380          188 ILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY  267 (487)
Q Consensus       188 l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y  267 (487)
                      +...  ..++...+..++.+++.++.+||+.+++|+||+|.||+++.   ++.++|+|||.+.............|+..|
T Consensus        78 ~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       78 LKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE---DGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             HHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC---CCcEEEccccceeeeccccccccccCCcCC
Confidence            8543  23899999999999999999999999999999999999984   588999999999877655455667889999


Q ss_pred             cchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccC
Q 011380          268 VAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA  345 (487)
Q Consensus       268 ~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  345 (487)
                      +|||.+.+ ..+.++||||||+++|+|++|..||.. .........+...... ....+..++.++.+++.+||..+|++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCCchh
Confidence            99998864 568899999999999999999999977 3444444433333322 22222237889999999999999999


Q ss_pred             CcCHHHHhcCccc
Q 011380          346 RLTAAQALSHPWV  358 (487)
Q Consensus       346 Rpt~~e~L~h~~~  358 (487)
                      ||++.++++||||
T Consensus       232 Rp~~~~~~~~~~~  244 (244)
T smart00220      232 RLTAEEALQHPFF  244 (244)
T ss_pred             ccCHHHHhhCCCC
Confidence            9999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=286.91  Aligned_cols=254  Identities=30%  Similarity=0.510  Sum_probs=206.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-----  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----  169 (487)
                      ..+|.-.+.+|.|+- .|..|.|..++++||+|++..... .........+|..++..+ +|+||++++.+|...     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            357888999999998 788899999999999998866532 233445677999999999 599999999999644     


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+|+|||++. .+|...+.    ..+.-..+..++.|++.|++|||+.||+||||||+||++.   .+..+||.|||+
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg~  164 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFGL  164 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccchh
Confidence             35899999995 58877764    3467789999999999999999999999999999999998   578999999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-------------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------  314 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-------------  314 (487)
                      |+.....-.++.++.|..|+|||++.+ .+.+.+||||+|||+.||++|+..|.+..--+.+.++..             
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            987766656788999999999998765 578889999999999999999999987665443333321             


Q ss_pred             ---------cCCCC---------CCCCCCC-------CCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          315 ---------NKPDF---------RRKPWPS-------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       315 ---------~~~~~---------~~~~~~~-------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                               ..+.+         +...|+.       -+..+++++.+||..||++|.+++++|+||||+
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                     11111         1111211       234589999999999999999999999999997

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=315.86  Aligned_cols=250  Identities=30%  Similarity=0.499  Sum_probs=199.6

Q ss_pred             EeeeeeecCceE-EEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          100 IGKLLGHGQFGY-TYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       100 ~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      -.+.+|.|+-|+ ||+|..  .|+.||||++-..      ......+||..|+.-.+|||||++|+.-.+....||..|+
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            346789998875 699974  5889999988544      3356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--CCCcEEEeecccccccCC
Q 011380          179 CEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       179 ~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a~~~~~  254 (487)
                      |. .+|.+++...  ..........+.++.|+++||++||+.+||||||||.||||...+  ....++|+|||+++.+..
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            95 5999988653  111122245688999999999999999999999999999998642  345799999999988765


Q ss_pred             CCc----cccccCCccccchhhhccCC-CCcchHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          255 GKK----FQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~~~----~~~~~gt~~y~aPE~~~~~~-~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      +..    ..+..||-+|+|||++.... ..++||||+||++|+.++| .+||.+....  -.+|+.+........ +.-.
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~~d  740 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PLPD  740 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cCch
Confidence            432    45678999999999997654 6789999999999998885 9999655432  345666654443322 1112


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .++.+||.+||.++|..||+|.++|.||+|...
T Consensus       741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            289999999999999999999999999999874

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=305.28  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=215.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCC-CC--EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKAN-GD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++..+.++||+|+||.|++|.++.. |+  .||||.+.....  .....+|.+|+.+|.+|. |||++++||+..+ ..+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l--~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL--NAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc--chhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            3456788999999999999998753 33  589999876553  236789999999999996 9999999999988 668


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      .||+|++++|+|++.|.+.....|.......++.||+.|+.||.++++|||||-..|+|+..   ...|||+|||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence            89999999999999997756677889999999999999999999999999999999999984   678999999999988


Q ss_pred             CCCCccccccC----Cccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKKFQDIVG----SAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~~~~~~g----t~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ..+..+....+    -..|+|||.++. +.+.++|||++||++|||++ |..||.+.....++++|-.+..-..   .+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCC
Confidence            77665443222    336999999975 67999999999999999998 8999999999988888874432222   245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      .|..+.++++.||..+|.+|||...|...-+..+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            7889999999999999999999999876666554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=310.17  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=217.7

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..|.++||.|.||.||+|+.+..|+   .||||.++...  .+....+|+.|..||-++. ||||+++-|+....+.+.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEE
Confidence            4678899999999999999887774   59999997653  3556788999999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |+|||++|+|-.+|..+. +.++..+..-+++-|+.|++||-+.++|||||-+.|||++   .+..+|++|||+++.+++
T Consensus       708 iTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccceeeccc
Confidence            999999999988876554 6699999999999999999999999999999999999999   478999999999998865


Q ss_pred             CC--ccccccC--Cccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          255 GK--KFQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      +.  .+++.-|  -.+|.|||.+. ++.+.++||||+|++|||.++ |..|||+.+++++++.|..+.   ..++....|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCCc
Confidence            43  2233333  35799999885 567999999999999998665 999999999999999998764   444446788


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhc--Cccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~--h~~~~~  360 (487)
                      ..+..|+..||++|-.+||...||+.  +..+++
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            99999999999999999999999876  344443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=294.31  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=207.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ......++++||+|-||.|.+|.- ..+..||+|+++....  ......+.+||++|.+|+ ||||++++++|..++.++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence            445678889999999999999974 3468999999976543  345688999999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +|+||++.|+|.+++.++.-..+.-.....++.||+.|++||.+.++|||||.+.|+|++   .+.++||+|||.++.+-
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccccccc
Confidence            999999999999999776433445566778999999999999999999999999999999   68899999999998765


Q ss_pred             CCCccc---cccCCccccchhhh-ccCCCCcchHHHHHHHHHHHH--hCCCCCCCCChhHHHHHHHhcCCCCCCC----C
Q 011380          254 PGKKFQ---DIVGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL--CGRRPFWDKTEDGIFKEVLRNKPDFRRK----P  323 (487)
Q Consensus       254 ~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~  323 (487)
                      .+.-+.   ..+-..+|||||.+ .++.+.++|+|+||+++||++  +...||...+.++..++.-.-.......    .
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            443221   23445789999964 788999999999999999975  4789998888877776653322111111    1


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      .+-++..+.++|.+||..|.++||+.+++-
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            234678899999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=278.20  Aligned_cols=254  Identities=30%  Similarity=0.450  Sum_probs=201.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----EEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----YVYIA  175 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----~~~lv  175 (487)
                      .+.||-|+||.||.++|..+|+.||+|++..-. ..-.....+.+|+++|..++ |.|++..++......     .+|++
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHH
Confidence            357999999999999999999999999886432 12235578899999999996 999999888765443     46788


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +|++.. +|...|..  ...++...+.-+++||+.||+|||+.+|.||||||.|.|++   .+..+||||||+++..+..
T Consensus       136 TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccchh
Confidence            898854 66555532  36799999999999999999999999999999999999998   4889999999999876543


Q ss_pred             C--ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH------------------
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL------------------  313 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~------------------  313 (487)
                      .  .++..+-|.+|+|||++.|  .|+.++||||.|||+.||+..+..|...+.-+.++.|.                  
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            3  3555677999999999976  47999999999999999999999997776655444332                  


Q ss_pred             -----hcCCCCCCCC-CCC------CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          314 -----RNKPDFRRKP-WPS------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       314 -----~~~~~~~~~~-~~~------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                           ++.+..+... +-.      -..+...++.+||..||.+|++..+++.|++..+..
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                 2221111110 011      223678999999999999999999999999988743

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.2e-36  Score=287.26  Aligned_cols=256  Identities=30%  Similarity=0.508  Sum_probs=203.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +...|.++++||.|+|++||++.+..   .++.||+|.+....     ....+.+|+++|..+.++.||+++.+++..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            34568999999999999999999887   78899999986543     33678999999999999999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ...+|+||++..+..+++     ..++...+..+++.++.||.++|.+|||||||||.|+|++.  ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhHH
Confidence            999999999998877766     34678999999999999999999999999999999999986  56677999999986


Q ss_pred             ccC-----------------C--CC--------------------------ccccccCCccccchhhhccC--CCCcchH
Q 011380          251 FIK-----------------P--GK--------------------------KFQDIVGSAYYVAPEVLKRK--SGPESDV  283 (487)
Q Consensus       251 ~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~~--~~~~~Di  283 (487)
                      ...                 +  +.                          ......||++|+|||++..-  .++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            210                 0  00                          00125699999999998653  4889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChh-HHHHHHH--------------hcC-------------------CCC----------
Q 011380          284 WSIGVITYILLCGRRPFWDKTED-GIFKEVL--------------RNK-------------------PDF----------  319 (487)
Q Consensus       284 wSlG~il~ell~g~~pf~~~~~~-~~~~~i~--------------~~~-------------------~~~----------  319 (487)
                      ||.|||+..+++++.||.....+ ..+.++.              -+.                   ...          
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999999544321 1111100              000                   000          


Q ss_pred             ---CCCCCC-CCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          320 ---RRKPWP-SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       320 ---~~~~~~-~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                         ....|. ..+..+.+|+.+||..||.+|+||+++|.||||.+.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence               001111 245578999999999999999999999999999854

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=298.28  Aligned_cols=260  Identities=28%  Similarity=0.455  Sum_probs=219.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +..++|.+...+|+|+||.||+++++.+++..|+|+++....   ....-+..|+-+++..+ |||||.+++-|.....+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            566789999999999999999999999999999999976542   34456778999999985 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +|.||||.||+|.+..  .-.+++++.++....+..+.||+|||+.|=+|||||-.|||++   +.+.+|+.|||.+..+
T Consensus        88 wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhh
Confidence            9999999999998854  4457899999999999999999999999999999999999999   5788999999998665


Q ss_pred             CCC-CccccccCCccccchhhh----ccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CCCC
Q 011380          253 KPG-KKFQDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PWPS  326 (487)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~  326 (487)
                      ... ....++.|||+|||||+-    .+.|...||||++|+...|+-.-.+|..+......+.-..+..+..+.. .-..
T Consensus       163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCcc
Confidence            432 234678999999999984    5678999999999999999998888877766655544444433332222 2235


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .++.+.+|++.+|.++|++|||+..+|.|||+...
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            67889999999999999999999999999998753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=288.91  Aligned_cols=208  Identities=34%  Similarity=0.639  Sum_probs=180.7

Q ss_pred             CcccccCC--CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHH-----HHHHHHHHHHhcc--CCCCc
Q 011380           89 GYDKDFDR--RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVKREVKILQALA--GHENV  159 (487)
Q Consensus        89 ~~~~~~~~--~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~-----~~~~E~~~l~~l~--~hpnI  159 (487)
                      ++.+.+..  +|...+.||.|+||.|++|.++.....|+||.|.+.+.....+.+     .+-.||.||..|.  .|+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            34444433  499999999999999999999999999999999887764433332     3567999999994  39999


Q ss_pred             cEEEEEEEeCCEEEEEEecc-CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCC
Q 011380          160 VKFYNAFEDDNYVYIAMELC-EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (487)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~-~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~  238 (487)
                      ++++++|++++++||+||-. +|.+|+++|..+  ..++|.++..|++|+..|+++||+.||||||||-+|+.++   .+
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~  706 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SN  706 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cC
Confidence            99999999999999999975 567999999554  6799999999999999999999999999999999999999   48


Q ss_pred             CcEEEeecccccccCCCCccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCC
Q 011380          239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWD  302 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~  302 (487)
                      |.+||+|||.+...+. ..+..++||..|.|||++.|. | +.+-|||+||++||.++....||+.
T Consensus       707 g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999987764 457889999999999999885 4 8889999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=250.84  Aligned_cols=213  Identities=25%  Similarity=0.334  Sum_probs=179.1

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      ...+..||+|++|.|-+.++..+|+..|+|.+...-  ..+...++.+|+.+..+..++|.+|.+|+.+..+..++|.||
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            344567999999999999999999999999997543  345677888999998888789999999999999999999999


Q ss_pred             ccCCCCHHHHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          178 LCEGGELLDRIL--AKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       178 ~~~gg~L~~~l~--~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      .|. .+|..+..  -.++..++|..+-+++..++.||.|||++ .+||||+||+|||++   ..|.||+||||.+..+.+
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccceeehh
Confidence            995 35433221  23578899999999999999999999976 899999999999999   589999999999988776


Q ss_pred             CCccccccCCccccchhhhcc-----CCCCcchHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNK  316 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~  316 (487)
                      +...+--.|...|||||.+..     .|+-++||||||+.++||.+++.||.. .++-+.+.++....
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            554444578899999998853     568899999999999999999999954 46667777776654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.9e-35  Score=326.51  Aligned_cols=240  Identities=20%  Similarity=0.266  Sum_probs=183.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ..|...+.||+|+||.||+|.++.+|..||+|++.....       ....|++++++++ |||||++++++.+.+..|+|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence            346667789999999999999999999999999865331       1135688999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||+++|+|.+++.     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.   +...++. ||.....
T Consensus       762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~---~~~~~~~-~~~~~~~  832 (968)
T PLN00113        762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG---KDEPHLR-LSLPGLL  832 (968)
T ss_pred             EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC---CCceEEE-ecccccc
Confidence            99999999999883     3789999999999999999999   669999999999999984   4555554 6654433


Q ss_pred             CCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHHH---HHHhcC-------CCC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFK---EVLRNK-------PDF  319 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~---~i~~~~-------~~~  319 (487)
                      ..   .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....  .....   ......       +..
T Consensus       833 ~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        833 CT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             cc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence            21   123478999999998865 478999999999999999999999854321  11111   000000       000


Q ss_pred             CCC-C-CCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          320 RRK-P-WPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       320 ~~~-~-~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ... . .+....++.+++.+||+.||++|||+.|+++.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000 0 00112246789999999999999999999874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=266.82  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=191.0

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHh--ccCCCCccEEEEEEE
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFE  167 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~hpnIv~~~~~~~  167 (487)
                      ....+.+...+.+.||+|-||.||+|.++  |+.||||++....      ...+.+|.+|.+.  | +|+||+.+++.-.
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmL-RHENILgFIaaD~  275 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVML-RHENILGFIAADN  275 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHh-ccchhhhhhhccc
Confidence            34557778899999999999999999765  8899999997543      3567788887764  5 4999999998764


Q ss_pred             eC----CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCceEeccC
Q 011380          168 DD----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSA  235 (487)
Q Consensus       168 ~~----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--------~iiHrDlkp~NIll~~~  235 (487)
                      .+    .++|||++|.+.|+|+|+|.+   ..++...+..++..++.||++||..        .|.|||||..|||+.  
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK--  350 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK--  350 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc--
Confidence            33    379999999999999999955   5789999999999999999999953        599999999999998  


Q ss_pred             CCCCcEEEeecccccccCCCC-----ccccccCCccccchhhhccCC-------CCcchHHHHHHHHHHHHhC-------
Q 011380          236 KEDSSLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCG-------  296 (487)
Q Consensus       236 ~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~DiwSlG~il~ell~g-------  296 (487)
                       .++.+-|+|+|||.......     ..+..+||.+|||||++....       ...+||||||.++||+...       
T Consensus       351 -kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~  429 (513)
T KOG2052|consen  351 -KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV  429 (513)
T ss_pred             -cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence             58999999999997654332     245679999999999997543       3458999999999999763       


Q ss_pred             ---CCCCCCCCh----hHHHHHHHhcCC-CC-CCCCCCCCC--HHHHHHHHHccccCccCCcCHHHHh
Q 011380          297 ---RRPFWDKTE----DGIFKEVLRNKP-DF-RRKPWPSIS--NSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       297 ---~~pf~~~~~----~~~~~~i~~~~~-~~-~~~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                         .+||.+-..    .+...++..-.. .. ....|...+  ..+-.+++.||..||.-|.||-.+.
T Consensus       430 eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  430 EEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             hhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence               578865422    233333332211 11 112233222  1356789999999999999986553

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=269.82  Aligned_cols=240  Identities=27%  Similarity=0.390  Sum_probs=186.3

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-CCCCccEEEEEEEeCC----E
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-GHENVVKFYNAFEDDN----Y  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~~~~----~  171 (487)
                      ..++.+.+|+|.||.||+|.  .+++.||||++...      ..+.+.+|-+|.+-.. .|+||++++++-+...    .
T Consensus       211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             chhhHHHhhcCccceeehhh--ccCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            35677899999999999996  45799999998643      4577788877765431 4999999998876554    8


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---------cCceeecCCCCceEeccCCCCCcEE
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---------HGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~---------~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      ++||++|.+.|+|.++|..   ..+++....+++..+++||+|||+         ..|+|||||..||||.   ++.+.-
T Consensus       283 ywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlTcc  356 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLTCC  356 (534)
T ss_pred             eeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCcEE
Confidence            9999999999999999955   468999999999999999999996         3699999999999998   589999


Q ss_pred             EeecccccccCCCCc---cccccCCccccchhhhccCCC-------CcchHHHHHHHHHHHHhCCCC------------C
Q 011380          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRKSG-------PESDVWSIGVITYILLCGRRP------------F  300 (487)
Q Consensus       243 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~DiwSlG~il~ell~g~~p------------f  300 (487)
                      |+|||+|..+.++..   .-..+||.+|||||++.+...       .+.||||+|.+||||++...-            |
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            999999988765433   234789999999999977532       358999999999999986433            2


Q ss_pred             C-----CCChhHHHHHHHhcCCCCC-CCCCCC--CCHHHHHHHHHccccCccCCcCHH
Q 011380          301 W-----DKTEDGIFKEVLRNKPDFR-RKPWPS--ISNSAKDFVKKLLVKDPRARLTAA  350 (487)
Q Consensus       301 ~-----~~~~~~~~~~i~~~~~~~~-~~~~~~--~s~~~~~li~~~L~~dp~~Rpt~~  350 (487)
                      .     ..+.+++...+...+.... ...|..  -...+++.+..||..||+.|.||.
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            1     1223344444444332211 112322  223578999999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-33  Score=291.28  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=203.2

Q ss_pred             eeEeeeeeecCceEEEEEEEcC-------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           98 YTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ..+.+.||+|+||.|++|.-..       ....||||.+.....  ....+.+..|+++|+.+..||||+.+++++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3566799999999999997431       145799998876543  2567889999999999988999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc------C--------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK------D--------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~------~--------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      .+++|+||+..|+|.+++...+      .        ..++..+...++.||+.|++||++.+++||||-+.|||+.   
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence            9999999999999999997654      0        1388999999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCCccc--cccCCc--cccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCC-hhHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGKKFQ--DIVGSA--YYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKT-EDGIF  309 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~~~~--~~~gt~--~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~-~~~~~  309 (487)
                      .+..+||+|||+|+.......+.  ...|+.  .|||||.+.. .++.++||||+||+|||+++ |..||.+-. ..+++
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            57899999999998655443332  222323  4999999876 57999999999999999999 899998755 45555


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+..+.....   ....++++.++++.||..+|++||+..++..
T Consensus       533 ~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 EFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            54444432211   1346899999999999999999999988754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=253.67  Aligned_cols=258  Identities=27%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEE-EEEeCCE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-AFEDDNY  171 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~-~~~~~~~  171 (487)
                      .+.+.|.|.+.||+|.||.+-+|.++.+++.+++|.+.+...    ...++.+|...--.|..|.||+..|+ .|+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            355779999999999999999999999999999999987653    56889999988777888999999886 4778888


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++++||++.|+|...+-   ...+-|.....++.|+++|+.|+|++++||||||.+||||-.. +...|||||||+.+.
T Consensus        97 YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccc
Confidence            999999999999988763   3568899999999999999999999999999999999999753 456899999999875


Q ss_pred             cCCCCccccccCCccccchhhhc----cCC--CCcchHHHHHHHHHHHHhCCCCCCCCCh-hH---HHHHHHhcCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK----RKS--GPESDVWSIGVITYILLCGRRPFWDKTE-DG---IFKEVLRNKPDFRR  321 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~-~~---~~~~i~~~~~~~~~  321 (487)
                      .....  ...--+..|.|||+..    +.+  .+.+|||.||+|+|.++||++||..... +.   -+.+...++..-..
T Consensus       173 ~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  173 VGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             cCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            43221  1223356799999763    232  6778999999999999999999974322 22   23334444333333


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCC---cCHHHHhcCccccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVRE  360 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~R---pt~~e~L~h~~~~~  360 (487)
                      ..+..+|+.+..+.++-|..+|++|   .+++.-....|...
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            3456689999999999999999999   56666666777543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-33  Score=279.68  Aligned_cols=246  Identities=25%  Similarity=0.351  Sum_probs=203.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      .+..++||+|+||+||+|.+--.|+    +||||++....  .+.....+..|+-+|.+|. |||++++++++.... +-
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence            3446789999999999999866554    68999876543  3445678899999999995 999999999998766 88


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||++|+++|.|.+++...+ ..+-....+.|..||++|+.|||.++++||||-+.|||+.   ....+||.|||+++...
T Consensus       774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccC
Confidence            9999999999999987654 6788999999999999999999999999999999999998   47789999999998876


Q ss_pred             CCCc-cccccC--Cccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          254 PGKK-FQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       254 ~~~~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .... +....|  .+-|||-|.+. +.++.++||||+||.+||++| |..|+.+....++-.-+..+.. ...  .|..+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCt  926 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICT  926 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCcc
Confidence            5433 222222  34588989774 568999999999999999998 9999999888877666655543 222  25677


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      -++.-++.+||..|+..||+++++-.
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHHH
Confidence            88999999999999999999988643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8.4e-31  Score=239.83  Aligned_cols=212  Identities=42%  Similarity=0.739  Sum_probs=183.9

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCCC
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE  183 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  183 (487)
                      ||+|++|.||++....+|+.+++|++.......  ....+.+|+.+++.+. |++|+++++++......++++|++.|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999998889999999987654211  3467899999999996 9999999999999999999999999999


Q ss_pred             HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-cccccc
Q 011380          184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIV  262 (487)
Q Consensus       184 L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~  262 (487)
                      |.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.  ..+.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--CCCcEEEecCCceEEccCCcchhhccc
Confidence            999875432 46899999999999999999999999999999999999983  15789999999987664432 133456


Q ss_pred             CCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccc
Q 011380          263 GSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV  340 (487)
Q Consensus       263 gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  340 (487)
                      +...|++||.+..  .++.+.|+|++|+++++|                                   ..+.+++.+||.
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            7889999999876  568899999999999999                                   468999999999


Q ss_pred             cCccCCcCHHHHhcCc
Q 011380          341 KDPRARLTAAQALSHP  356 (487)
Q Consensus       341 ~dp~~Rpt~~e~L~h~  356 (487)
                      .+|++||++.++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=6e-30  Score=237.46  Aligned_cols=212  Identities=41%  Similarity=0.696  Sum_probs=178.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+......  .....+.+|++.++++. |+|++++++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            56788999999999999999988999999998765422  24578889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-  256 (487)
                      ++++++|.+++..... .+++..+..++.+++.++.+||+.+++|+||+|.||+++.   ++.++|+|||++....... 
T Consensus        78 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~---~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       78 YCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM---DGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             ccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEeeCceeeEecCccc
Confidence            9999999998854421 2889999999999999999999999999999999999984   5889999999988765442 


Q ss_pred             -ccccccCCccccchhhhc-c-CCCCcchHHHHHHHHHHHHhCCCCCCC-CC-hhHHHHHHHhcC
Q 011380          257 -KFQDIVGSAYYVAPEVLK-R-KSGPESDVWSIGVITYILLCGRRPFWD-KT-EDGIFKEVLRNK  316 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlG~il~ell~g~~pf~~-~~-~~~~~~~i~~~~  316 (487)
                       ......++..|++||.+. . .++.++||||||+++++|++|+.||.. .. ...+.+.+..+.
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence             334567889999999873 2 346799999999999999999999977 33 335555565554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.2e-31  Score=293.20  Aligned_cols=198  Identities=21%  Similarity=0.262  Sum_probs=146.8

Q ss_pred             CCccEEEEEE-------EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCc
Q 011380          157 ENVVKFYNAF-------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (487)
Q Consensus       157 pnIv~~~~~~-------~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~N  229 (487)
                      +||+.++++|       .....++.++|++ +++|.+++... ...+++..++.+++||+.||.|||++||+||||||+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N  110 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC  110 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence            5777777766       2334677889987 66999988532 3569999999999999999999999999999999999


Q ss_pred             eEeccC----------------CCCCcEEEeecccccccCCC-----------------CccccccCCccccchhhhcc-
Q 011380          230 FLFKSA----------------KEDSSLKATDFGLSDFIKPG-----------------KKFQDIVGSAYYVAPEVLKR-  275 (487)
Q Consensus       230 Ill~~~----------------~~~~~vkl~DfG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-  275 (487)
                      |||+..                +.++.+||+|||+++.....                 ......+||++|||||++.+ 
T Consensus       111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  190 (793)
T PLN00181        111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS  190 (793)
T ss_pred             EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence            999631                23456888888887642210                 00112468999999998765 


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       276 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++.++|||||||+||||++|.+|+....  ..+..+.....  +. .+..-.+...+++.+||.++|.+||++.|+|+|
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            57999999999999999999998875322  12222222111  11 111123567899999999999999999999999


Q ss_pred             cccccc
Q 011380          356 PWVREG  361 (487)
Q Consensus       356 ~~~~~~  361 (487)
                      |||.+.
T Consensus       266 ~~~~~~  271 (793)
T PLN00181        266 EFINEP  271 (793)
T ss_pred             hhhhhh
Confidence            999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-28  Score=227.41  Aligned_cols=250  Identities=20%  Similarity=0.249  Sum_probs=198.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE-eC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DD  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~  169 (487)
                      .|+++...+-+|.||.||.|.++...     +.|.+|.++...  .+.....+..|--.+..+. |||+..+.++.. +.
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY  360 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence            35777788999999999999776533     346777776543  3456677888988999996 999999998875 45


Q ss_pred             CEEEEEEeccCCCCHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          170 NYVYIAMELCEGGELLDRILAK------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                      ...++++.+..-|+|..++..-      ....++..+...++.|+..|++|||++||||.||-..|++|+   +...|||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---d~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---DQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---hheeEEe
Confidence            6678888998889998888521      223477788899999999999999999999999999999999   5789999


Q ss_pred             eecccccccCCCCcc---ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCC
Q 011380          244 TDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       244 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      +|=.+++.+-+..-.   ........||+||.+.. .|+.++|+|||||+||||+| |+.|+..-++.++..-+..+.. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-  516 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-  516 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-
Confidence            999998765433211   01112346999998865 58999999999999999998 9999988788777766666642 


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                        ....-+.|+++..++.-||...|++||+..|+..
T Consensus       517 --laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  517 --LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             --ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence              2222478999999999999999999999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.8e-30  Score=267.64  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=197.4

Q ss_pred             CCCe-eEeeeeeecCceEEEEEEEcCCCCEEEEEEeccc---CcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN---KMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+.| .....+|.|++|.|+.+......+.++.|.....   ..........+..|.-+-..|. ||||+..+..+.+..
T Consensus       316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEID  394 (601)
T ss_pred             ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcc
Confidence            3446 4567899999998888888777776777655421   1111112222566777777885 999988877766666


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ..+-+||||++ +|+..+...  ..+...++-.+++||+.||.|+|+.||.||||||+|+++.   .++.+||+|||.+.
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAAS  468 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcce
Confidence            66666999999 999988543  5788999999999999999999999999999999999999   57799999999987


Q ss_pred             ccCCC-----CccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHH--HHHHhcC---CC
Q 011380          251 FIKPG-----KKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIF--KEVLRNK---PD  318 (487)
Q Consensus       251 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~i~~~~---~~  318 (487)
                      .....     ......+|+..|+|||++.+. | ....||||.|++++.|++|+.||......+..  ...-...   ..
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE  548 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc
Confidence            65432     224568899999999998764 5 45689999999999999999999655433221  1111111   11


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      -+...+..++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            1112244578889999999999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=6.5e-28  Score=215.62  Aligned_cols=163  Identities=26%  Similarity=0.336  Sum_probs=128.2

Q ss_pred             CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccc
Q 011380          182 GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI  261 (487)
Q Consensus       182 g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~  261 (487)
                      |+|.+.+... ...+++..++.++.||+.||.|||+.+      ||+|||++   .++.+|+  ||++......    ..
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~----~~   64 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPE----QS   64 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeeccc----cC
Confidence            6888887543 456999999999999999999999999      99999998   5778888  9998775432    23


Q ss_pred             cCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCC---CCCCCCH--HHHHH
Q 011380          262 VGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKPDFRRK---PWPSISN--SAKDF  334 (487)
Q Consensus       262 ~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~s~--~~~~l  334 (487)
                      .||+.|||||++.+ .++.++|||||||++|+|++|+.||..... ...+..+..........   ....++.  ++.++
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            68999999999865 468999999999999999999999976543 23344444332222111   1122333  69999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      |.+||..+|.+||++.+++.|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-26  Score=226.27  Aligned_cols=255  Identities=23%  Similarity=0.293  Sum_probs=193.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCC-CEEEEEEecccCcCChHhHHHHHHHHHHHHhcc---CCCCccEEEEEE-EeCCE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALA---GHENVVKFYNAF-EDDNY  171 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~---~hpnIv~~~~~~-~~~~~  171 (487)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|.........  . ..+..|+.++..+.   +-+++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            7999999999999999999987775 678888776542211  1 15678899988886   236999999999 58888


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--CCCcEEEeecccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLS  249 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a  249 (487)
                      .||||+++ |.+|.+.........++...+..++.|++.+|++||+.|++||||||+|+++...+  +...+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 88999876555567899999999999999999999999999999999999998643  1257999999999


Q ss_pred             cccC---CCC-------c-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 011380          250 DFIK---PGK-------K-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       250 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      +...   ...       . .....||..|+++.+..+. .+++.|+||++.++.+|+.|..||.+........++.....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322   111       1 1235599999999988765 58999999999999999999999966554333333332222


Q ss_pred             CCCCC-CCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..... .....+.++..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22221 223345667777777777788888877665443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=5.6e-26  Score=222.43  Aligned_cols=257  Identities=36%  Similarity=0.581  Sum_probs=206.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCC-CccEEEEEEEeCCEEEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~~~~~~~~~~~~~lv~  176 (487)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.+++.+. |+ +|+++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            788899999999999999887   789999987765443335678899999999996 66 7999999998888899999


Q ss_pred             eccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC-cEEEeecccccccCC
Q 011380          177 ELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIKP  254 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~~~~  254 (487)
                      +++.++++.+.+..... ..+++..+..++.|++.++.|+|+.+++|||+||+||+++.   .+ .++++|||++.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~---~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR---DGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC---CCCeEEEeccCcceecCC
Confidence            99999999965533211 26899999999999999999999999999999999999984   44 699999999875543


Q ss_pred             CC-------ccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCC-
Q 011380          255 GK-------KFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPD-  318 (487)
Q Consensus       255 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~-  318 (487)
                      ..       .....+||..|+|||.+.+    .+....|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       2467789999999999875    468889999999999999999999876653    3444444433322 


Q ss_pred             CCCCCCCCC----CHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 FRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 ~~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ......+..    ...+.+++.+++..+|..|.+..+...++|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            222111111    2578999999999999999999999999777654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=8.1e-27  Score=228.12  Aligned_cols=166  Identities=20%  Similarity=0.258  Sum_probs=129.9

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcC-CCCEEEEEEecccCc--CChHhHHHHHHHHHHHHhccCCCCccE-EEEEEEe
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKM--ILPIAVEDVKREVKILQALAGHENVVK-FYNAFED  168 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~-~~~~~~~  168 (487)
                      .+..+|.+.+.||+|+||+||+|.++. +++.+|||++.....  ......+.+.+|+++|+++. |+||+. ++++   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc---
Confidence            355679999999999999999999876 678889998753311  12334567899999999995 999985 5432   


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecC-CCCceEeccCCCCCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDM-KPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDl-kp~NIll~~~~~~~~vkl~DfG  247 (487)
                       +..|+||||++|++|.. +  ..   ..   ...++.|++.+|.|||++||+|||| ||+|||++   .++.+||+|||
T Consensus        91 -~~~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFG  157 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQ  157 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECc
Confidence             45899999999999862 2  11   11   1467899999999999999999999 99999997   45789999999


Q ss_pred             cccccCCCC---------ccccccCCccccchhhhcc
Q 011380          248 LSDFIKPGK---------KFQDIVGSAYYVAPEVLKR  275 (487)
Q Consensus       248 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~  275 (487)
                      +|+......         .....+|++.|+|||.+..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            998654322         1235678999999999854

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=9.1e-27  Score=204.77  Aligned_cols=240  Identities=21%  Similarity=0.314  Sum_probs=189.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ...|+++++||+|+||.+|.|....+|..||||+-.... ..    -.+..|..+.+.|++-+.|+.+.-+..+..+-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            457999999999999999999999999999999765432 22    3466899999999877899999988999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||+++ |-+|.+.+ .--...++...++-++-|++.-++|+|.+++|||||||+|+|..-......+.|+|||+|+...+
T Consensus        89 VMdLL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             eeecc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            99998 77877755 33346789999999999999999999999999999999999998655667899999999987654


Q ss_pred             CC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcCCCCCCC
Q 011380          255 GK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       255 ~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~  322 (487)
                      ..        .-....||..|.+-....+. .+..-|+-|+|.+|..+..|..||.+-..   .+.+++|...+...+..
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence            32        22346799999987766543 47788999999999999999999987644   34555666555433322


Q ss_pred             -CCCCCCHHHHHHHHHcccc
Q 011380          323 -PWPSISNSAKDFVKKLLVK  341 (487)
Q Consensus       323 -~~~~~s~~~~~li~~~L~~  341 (487)
                       .+..+|.++.-.+.-|=..
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L  266 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGL  266 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhc
Confidence             2455677776666555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-28  Score=242.42  Aligned_cols=241  Identities=28%  Similarity=0.483  Sum_probs=203.3

Q ss_pred             eeeecCceEEEEEEE---cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          103 LLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      .+|.|+||.|+++..   ...|..+|+|+..+......... ....|-.++...++||.+|++...++.++..++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999997753   34567899998876544332222 45568888888877999999999999999999999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccc
Q 011380          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ  259 (487)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~  259 (487)
                      .||+|+..+  .....+.+.....+...++.+++++|+.+|+|||+|++||+++   .+|.+++.|||+++..-..+.. 
T Consensus        80 rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   80 RGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             ccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHhhhhc-
Confidence            999998877  4446788889999999999999999999999999999999999   5889999999999876443322 


Q ss_pred             cccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcc
Q 011380          260 DIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL  339 (487)
Q Consensus       260 ~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  339 (487)
                        |||..|||||+++ .....+|.||+|+++|+|++|..||..    ++...|++.++.++.    .++..+++++..++
T Consensus       154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLF  222 (612)
T ss_pred             --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHH
Confidence              9999999999998 567889999999999999999999977    677778877666554    46788999999999


Q ss_pred             ccCccCCcCH-----HHHhcCcccccc
Q 011380          340 VKDPRARLTA-----AQALSHPWVREG  361 (487)
Q Consensus       340 ~~dp~~Rpt~-----~e~L~h~~~~~~  361 (487)
                      ..+|..|..+     .++++|+||+..
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheee
Confidence            9999999744     799999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-25  Score=205.93  Aligned_cols=202  Identities=24%  Similarity=0.446  Sum_probs=169.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|+++++||+|+||.++.|++..++++||||.-....     ..-++..|.+..+.|.+.++|...|-+...+.+-.||+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            5999999999999999999999999999999654332     12356788888888888899999998888888999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC--CCCCcEEEeecccccccCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DfG~a~~~~~  254 (487)
                      |++ |-+|.|++ .-.+..|+...++.++.|++.-++|+|++.+|+|||||+|+||...  .+...|.|+|||+|+...+
T Consensus       104 dLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  104 DLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            998 77877654 3456789999999999999999999999999999999999999753  2446799999999987654


Q ss_pred             CC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 011380          255 GK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE  305 (487)
Q Consensus       255 ~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~  305 (487)
                      ..        ...+..||.+||+=....|. .+.+-|+-|||-+++.+|-|.+||.+-..
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            33        34567899999997654443 48889999999999999999999977543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=4.4e-26  Score=236.95  Aligned_cols=224  Identities=29%  Similarity=0.508  Sum_probs=176.2

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+|..++.+..|+||.||.++++.+.+++|+| +.+...        +.+-  ++... +.|.+|             
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv-------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV-------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--ccccc-CCccee-------------
Confidence            4467899999999999999999999999999994 554432        1111  33333 355554             


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                              |+-...+  +.-+.++...        +.+++|||+.||+|||+||+|.+|+.   -|.+|++|||+++..-
T Consensus       136 --------gDc~tll--k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~---mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 --------GDCATLL--KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             --------chhhhhc--ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee---cccccccchhhhhhhh
Confidence                    2323333  1223444433        77999999999999999999999994   7889999999975421


Q ss_pred             C--------CC--------ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 011380          254 P--------GK--------KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK  316 (487)
Q Consensus       254 ~--------~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~  316 (487)
                      .        +.        .-..+||||.|+|||++. ..|+..+|+|++|+|+|+.+-|+.||.+++.++++..++...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            1        00        013469999999999875 569999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHccccCccCCc---CHHHHhcCccccccCCC
Q 011380          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARL---TAAQALSHPWVREGGDA  364 (487)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~L~h~~~~~~~~~  364 (487)
                      ..++... ..++++++++|.++|..+|..|.   .+.++.+|+||+.....
T Consensus       275 i~wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  275 IEWPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            8888774 45889999999999999999995   67889999999976543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=5.2e-24  Score=199.68  Aligned_cols=236  Identities=23%  Similarity=0.368  Sum_probs=149.9

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccC---------CCCccEEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG---------HENVVKFYNAFE  167 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---------hpnIv~~~~~~~  167 (487)
                      .+..+..||.|+++.||.+++..||+.+|+|+............+.+.+|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678899999999999999999999999998865543333355666666544433221         222333333221


Q ss_pred             ------------eCC-----EEEEEEeccCCCCHHHHHH---hhcCCC--CCHHHHHHHHHHHHHHHHHHHHcCceeecC
Q 011380          168 ------------DDN-----YVYIAMELCEGGELLDRIL---AKKDSR--YTEKDAAVVVRQMLRVAAECHLHGLVHRDM  225 (487)
Q Consensus       168 ------------~~~-----~~~lv~e~~~gg~L~~~l~---~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~iiHrDl  225 (487)
                                  +..     +.+++|+-+. ++|.+.+.   ......  +.......+..|++..+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                        111     2367788774 57766542   222111  222233455689999999999999999999


Q ss_pred             CCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhcc---------CCCCcchHHHHHHHHHHHHhC
Q 011380          226 KPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCG  296 (487)
Q Consensus       226 kp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwSlG~il~ell~g  296 (487)
                      +|+|+|++   .+|.++|+||+.......  .......+..|.|||....         .++.+.|.|+||+++|.|.||
T Consensus       172 ~~~nfll~---~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLD---QDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEc---CCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999   589999999997765432  2222345678999997633         247788999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCC
Q 011380          297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR  346 (487)
Q Consensus       297 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R  346 (487)
                      ..||...........        ....+..+|+.++.||..||+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999975543211111        222344788999999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.8e-24  Score=194.83  Aligned_cols=175  Identities=15%  Similarity=0.129  Sum_probs=133.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHH------HHHHHHHHHhccCCCCccEEEEEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED------VKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~------~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      -+..+|++.+.||.|+||.||++.+  ++..+|+|++.......+.....      +.+|+..+.++. ||+|..+.+++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~  104 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY  104 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence            3567999999999999999999754  47789999987554333333333      579999999995 99999999886


Q ss_pred             EeC--------CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCC
Q 011380          167 EDD--------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED  238 (487)
Q Consensus       167 ~~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~  238 (487)
                      ...        +..+|+|||++|.+|.+..      .+++    ..+.+++.+|..+|+.|++|||++|+||+++.   +
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~---~  171 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK---N  171 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC---C
Confidence            643        3588999999999987753      2333    34669999999999999999999999999984   4


Q ss_pred             CcEEEeecccccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHH
Q 011380          239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILL  294 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell  294 (487)
                      + ++|+|||.............      |    ++...+..++||||||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d~------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKDR------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHHH------H----HHHhHhcccccccceeEeehHHH
Confidence            5 99999998765432211110      0    22344667899999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.4e-23  Score=186.87  Aligned_cols=189  Identities=18%  Similarity=0.264  Sum_probs=143.2

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      .+...|++|+||+||.+..  .+.+++.+.+........ .....+.+|+++|++|.+|++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999998854  677888777765543211 1223578999999999767899999986    34699999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecC-CCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDM-KPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDl-kp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |+.|.+|...+.        .. ...++.|++.+|.++|++||+|||| ||+|||++   .++.++|+|||++.......
T Consensus        79 yI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         79 YLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence            999988865331        11 2357889999999999999999999 79999998   46789999999998654332


Q ss_pred             cc----c----------cccCCccccchhhhc--cCCC-CcchHHHHHHHHHHHHhCCCCCCCCCh
Q 011380          257 KF----Q----------DIVGSAYYVAPEVLK--RKSG-PESDVWSIGVITYILLCGRRPFWDKTE  305 (487)
Q Consensus       257 ~~----~----------~~~gt~~y~aPE~~~--~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~  305 (487)
                      ..    .          -...++.|++|+.-.  ...+ ...++++.|+-+|.++|+..|+++..+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0          123678888888532  2333 567888999999999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=7.8e-24  Score=190.66  Aligned_cols=142  Identities=20%  Similarity=0.207  Sum_probs=109.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH-----------------------hHHHHHHHHHHHHhccCCC
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----------------------AVEDVKREVKILQALAGHE  157 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~~hp  157 (487)
                      ...||+|+||.||+|.+. +|+.||+|++.........                       ......+|+.++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            457999999999999986 8999999999754321100                       0123346999999995 77


Q ss_pred             CccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeecCCCCceEeccCC
Q 011380          158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       158 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~l-H~~~iiHrDlkp~NIll~~~~  236 (487)
                      ++.....+....  .+|||||++|+++...+..  ...+++..+..++.|++.+|.++ |+.||+||||||+|||++   
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---  152 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---  152 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE---
Confidence            765443332222  3899999998876554332  35789999999999999999999 799999999999999997   


Q ss_pred             CCCcEEEeeccccccc
Q 011380          237 EDSSLKATDFGLSDFI  252 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~  252 (487)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             357999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-23  Score=197.01  Aligned_cols=190  Identities=25%  Similarity=0.415  Sum_probs=141.2

Q ss_pred             cCCCCccEEEEEEEe---------------------------CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHH
Q 011380          154 AGHENVVKFYNAFED---------------------------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR  206 (487)
Q Consensus       154 ~~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~  206 (487)
                      ..|||||++..+|.+                           ...+|+||...+ .+|.+++..+   ..+....+-++.
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~la  348 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILA  348 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHH
Confidence            369999999887743                           235899999885 4888888543   467788889999


Q ss_pred             HHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeecccccccCC-------CCccccccCCccccchhhhccCC-
Q 011380          207 QMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKP-------GKKFQDIVGSAYYVAPEVLKRKS-  277 (487)
Q Consensus       207 qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~-  277 (487)
                      |+++|+.|||.+||.|||||.+|||+.-++ .-..+.|+|||++---+.       ....-..-|...-||||+....+ 
T Consensus       349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            999999999999999999999999997542 335689999998632211       11223456788899999986533 


Q ss_pred             ------CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHH-HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHH
Q 011380          278 ------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK-EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA  350 (487)
Q Consensus       278 ------~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~  350 (487)
                            ..++|.|+.|.+.||++....||++..+..+-. ......  . ......+++.+++++..+|+.||++|+++.
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--L-Palp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--L-PALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--C-CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                  457999999999999999999998743321111 111111  0 111135788899999999999999999864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.2e-22  Score=181.82  Aligned_cols=143  Identities=19%  Similarity=0.214  Sum_probs=112.0

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----------------------HhHHHHHHHHHHHHhccCCC
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----------------------IAVEDVKREVKILQALAGHE  157 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~hp  157 (487)
                      ...||+|+||.||+|.+. +|+.||||++........                       ........|.+.+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            467999999999999987 899999999876421100                       01233468999999996 89


Q ss_pred             CccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCC
Q 011380          158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       158 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~  236 (487)
                      +|.....+....  .||||||++|+++......  ...+++..+..++.|++.+|.++|. .||+||||||+|||++   
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---  152 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---  152 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence            885544443333  4899999998865443322  2467889999999999999999999 9999999999999997   


Q ss_pred             CCCcEEEeecccccccC
Q 011380          237 EDSSLKATDFGLSDFIK  253 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~  253 (487)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             4679999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=9.5e-24  Score=206.06  Aligned_cols=175  Identities=24%  Similarity=0.404  Sum_probs=133.9

Q ss_pred             EEEEEeccCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          172 VYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      +||.|++|...+|.+||..+ .....+...++.++.|+..|++|   +|.+|||+||.||++.   .+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhee
Confidence            58899999999999999643 33456778899999999999999   9999999999999998   46689999999987


Q ss_pred             ccCCCC-------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 011380          251 FIKPGK-------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR  321 (487)
Q Consensus       251 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  321 (487)
                      ......       ..+..+||.+||+||.+.+ .|+.++||||||+||+|++. -..+|..   ...+..+..+..  +.
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~i--p~  479 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGII--PP  479 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCC--Ch
Confidence            665443       4567899999999999985 58999999999999999997 2333211   112222222221  11


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..+.+. ++-.+|+.+||...|.+||++.+.--|+|.
T Consensus       480 ~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  480 EFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            112222 345699999999999999988887777775

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=9.5e-22  Score=178.71  Aligned_cols=138  Identities=21%  Similarity=0.314  Sum_probs=108.3

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc----CCCCccEEEEEEEeCC---EEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----GHENVVKFYNAFEDDN---YVY  173 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~~~~~~---~~~  173 (487)
                      .+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+.    +||||+++++++++..   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46799999999995  6777666 6998865432   23467899999999994    3799999999998863   444


Q ss_pred             -EEEec--cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCceeecCCCCceEeccCC-CCCcEEEeeccc
Q 011380          174 -IAMEL--CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGL  248 (487)
Q Consensus       174 -lv~e~--~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l-~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~  248 (487)
                       +|+||  +.+|+|.+++..   ..+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+||+.
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             78999  557999999843   246655  45688888888 999999999999999999998543 345899999443


Q ss_pred             c
Q 011380          249 S  249 (487)
Q Consensus       249 a  249 (487)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=3.4e-23  Score=215.74  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=172.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc-CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .|...+.||++-|=+|.+|++. .| .|+||++-+..- ..-....+...|++ .... .+||++.+.-+....+..|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            5778899999999999999865 34 499999866541 11112223334555 3333 699999998888888889999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc--cC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF--IK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~--~~  253 (487)
                      -+|.. -+|+|++..+  .-+..-+.+-|+.||+.||.-+|..||+|||||.+||||++   -..+.|+||..-+.  +.
T Consensus       100 Rqyvk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHHHh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCccCC
Confidence            99985 4899988433  45777788889999999999999999999999999999995   56799999985432  11


Q ss_pred             CCC--c----cccccCCccccchhhhccC------------CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 011380          254 PGK--K----FQDIVGSAYYVAPEVLKRK------------SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       254 ~~~--~----~~~~~gt~~y~aPE~~~~~------------~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  314 (487)
                      .+.  .    +.+...-..|+|||.|...            .+++.||||+||+++||++ |++||.-    ..+-+...
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~  249 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS  249 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc
Confidence            111  1    1222234469999987421            2567899999999999988 7888821    11111111


Q ss_pred             cCCCCCCCCCCCC-CHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          315 NKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       315 ~~~~~~~~~~~~~-s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +....+...+..+ +..++.+|..|++.||++|.+|++.|+.
T Consensus       250 ~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111110000111 2358999999999999999999999875

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.1e-21  Score=208.27  Aligned_cols=197  Identities=25%  Similarity=0.347  Sum_probs=161.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .+.|.|.+.||+|+||+||+|.+.. |+.||+|+=.....+.-....+++.-++ ++   --+-|..+..++...+.-++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~---~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ---MLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh---hhcchHHHHHHHccCCccee
Confidence            4679999999999999999999876 9999999876655443333333333333 11   23567777777777888899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC----CCCCcEEEeeccccc
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----KEDSSLKATDFGLSD  250 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~----~~~~~vkl~DfG~a~  250 (487)
                      |+||.+.|+|++++.  ..+.+++..+..+..|+|..|+.||..+|||+||||+|+||...    .+..-++|+|||.+.
T Consensus       772 v~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999999884  56789999999999999999999999999999999999999642    234579999999885


Q ss_pred             c---cCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCC
Q 011380          251 F---IKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRR  298 (487)
Q Consensus       251 ~---~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~  298 (487)
                      .   +.++..+...++|-.+-.+|+..|. ++..+|.|.|..+++.||.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            4   4455677888999999999999886 5999999999999999999854

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.8e-22  Score=176.27  Aligned_cols=242  Identities=16%  Similarity=0.172  Sum_probs=185.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      ..+.-+|.....|..|+|++.  |..+++|++..... .+....++..|.-.|+-+. ||||+.+++.|....++.++..
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            344567888999999999765  56677787765443 2233467888888888885 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |++.|+|+..+....+-.....++.+++.+++.|+.|||+..  |.---|....++++. +-...+-.+|-.++..    
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfsfq----  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFSFQ----  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceeeee----
Confidence            999999999986665556788899999999999999999874  444568888899983 1223344445433321    


Q ss_pred             CccccccCCccccchhhhccCC----CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~~----~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                        .....-.|.||+||.+..+.    -.++|+|||.+++|||.|...||.+-+..+.-.+|.-....  ....|.+|..+
T Consensus       343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~hm  418 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRHM  418 (448)
T ss_pred             --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHHH
Confidence              11234478999999997654    35789999999999999999999887776655555433322  22336899999


Q ss_pred             HHHHHHccccCccCCcCHHHH
Q 011380          332 KDFVKKLLVKDPRARLTAAQA  352 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~  352 (487)
                      ..|+.-|+..||.+||..+.+
T Consensus       419 ~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             HHHHHHHhcCCCCcCCCccee
Confidence            999999999999999987665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.9e-22  Score=208.77  Aligned_cols=261  Identities=27%  Similarity=0.469  Sum_probs=210.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ........+..|..+-..+.+|+|++.+++........++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            458888999999999998887643 33456777665433 2223445566788887788669999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCceEeccCCCCC-cEEEeeccccccc
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFI  252 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH-~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~~  252 (487)
                      +++|..|+++++.+........+...+..++.|+..++.|+| ..++.||||||+|.+++.   .+ .+|+.|||+|...
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~---s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE---SGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc---CCCcccCCCchhhccc
Confidence            999999999988774232236788889999999999999999 999999999999999984   55 8999999999876


Q ss_pred             CC-C---CccccccC-Cccccchhhhcc-CC-CCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCC
Q 011380          253 KP-G---KKFQDIVG-SAYYVAPEVLKR-KS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       253 ~~-~---~~~~~~~g-t~~y~aPE~~~~-~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  324 (487)
                      .. .   ......+| ++.|+|||...+ .+ .+..|+||+|+++..+++|..||....... .+.........+...+|
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            54 2   22445788 999999999877 34 788999999999999999999986554332 22333344444456778


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ..++....+++.++|..+|..|.+..++-.+||+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            899999999999999999999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.6e-20  Score=172.56  Aligned_cols=146  Identities=23%  Similarity=0.223  Sum_probs=113.1

Q ss_pred             CeeEeeeeeecCceEEEEEE-EcCCCCEEEEEEecccCcCC-------------------h--HhHHHHHHHHHHHHhcc
Q 011380           97 RYTIGKLLGHGQFGYTYVAT-DKANGDRVAVKKIEKNKMIL-------------------P--IAVEDVKREVKILQALA  154 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~i~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~  154 (487)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|++.......                   +  .....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67799999999987543110                   0  01234678999999995


Q ss_pred             CC--CCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-ceeecCCCCceE
Q 011380          155 GH--ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG-LVHRDMKPENFL  231 (487)
Q Consensus       155 ~h--pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~-iiHrDlkp~NIl  231 (487)
                       +  ..+++++++   . ..++||||++|++|......  ...+....+..++.||+.+|.+||+.| |+||||||+||+
T Consensus       109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             -hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence             4  334455543   2 35899999999887654422  234667778899999999999999999 999999999999


Q ss_pred             eccCCCCCcEEEeecccccccC
Q 011380          232 FKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       232 l~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ++    ++.++|+|||.+....
T Consensus       182 i~----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE----CCCEEEEEChhhhccC
Confidence            97    4679999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8e-19  Score=161.63  Aligned_cols=137  Identities=26%  Similarity=0.365  Sum_probs=112.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      +.||+|++|.||+|.+  .|..+++|+........+     .....+.+|+.++..+. |++|+....++.+....+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999986  678899997654332211     12346788999999996 999887777777778889999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ||++|++|.+.+...     .. ....++.+++.+|.++|+.|++|||++|.|||++    ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            999999999887432     12 7889999999999999999999999999999997    46799999998865

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.9e-19  Score=178.12  Aligned_cols=199  Identities=26%  Similarity=0.345  Sum_probs=157.0

Q ss_pred             HhccCCCCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-eeecCCCCc
Q 011380          151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL-VHRDMKPEN  229 (487)
Q Consensus       151 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i-iHrDlkp~N  229 (487)
                      +.+. |.|+.++++.+.++..+++|.+||.-|+|.+.+.. ....++......++++|+.||.|||.-.| .|+.|++.|
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            4564 99999999999999999999999999999998854 45678888999999999999999998876 999999999


Q ss_pred             eEeccCCCCCcEEEeecccccccCCC---CccccccCCccccchhhhccC--------CCCcchHHHHHHHHHHHHhCCC
Q 011380          230 FLFKSAKEDSSLKATDFGLSDFIKPG---KKFQDIVGSAYYVAPEVLKRK--------SGPESDVWSIGVITYILLCGRR  298 (487)
Q Consensus       230 Ill~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwSlG~il~ell~g~~  298 (487)
                      ++++   ....+||+|||+.......   .......-...|.|||.+...        .+.+.||||+|++++|+++...
T Consensus        80 Clvd---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   80 CLVD---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ceee---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999   5889999999998766421   111112234569999998653        3667999999999999999999


Q ss_pred             CCCCCC----hhHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          299 PFWDKT----EDGIFKEVLR-NKPDFRRKPW--PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       299 pf~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ||....    ..+++..+.. +...+....+  ..+++++..++..||..+|.+||++.++-.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            996532    2345555555 2222222222  145567999999999999999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.9e-18  Score=157.66  Aligned_cols=134  Identities=25%  Similarity=0.356  Sum_probs=105.8

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      .||+|+||.||+|.  .+|..+++|+........+     .....+.+|++++..+. |+++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            38999999999997  4678899998654322111     12356778999999996 7776555555556667789999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |++|++|.+.+....      .   .++.+++.+|.+||+.|++|||++|.||+++    ++.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcH------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            999999988763321      0   7899999999999999999999999999997    567999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.5e-18  Score=158.12  Aligned_cols=139  Identities=24%  Similarity=0.318  Sum_probs=107.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-------------------HhHHHHHHHHHHHHhccCCC-
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-------------------IAVEDVKREVKILQALAGHE-  157 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~hp-  157 (487)
                      |.+.+.||+|+||.||++... +|+.||||++........                   ........|+.++..+. |+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            777889999999999999874 799999998765321000                   11223678999999995 76 


Q ss_pred             -CccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          158 -NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       158 -nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                       .++..++    ....++||||++|++|.....        ......++.+++.++.++|..||+||||+|+||+++   
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---  159 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---  159 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---
Confidence             4455443    244689999999998865331        134677899999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccC
Q 011380          237 EDSSLKATDFGLSDFIK  253 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~  253 (487)
                      +++.++|+|||.+....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            47889999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=5.4e-18  Score=177.38  Aligned_cols=142  Identities=24%  Similarity=0.305  Sum_probs=112.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-----ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ....|...+.||+|+||+||++.+.  +..+++|+.......     .....+.+.+|+++++.+. |++|+....++.+
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~  407 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD  407 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe
Confidence            3445667889999999999999764  344555543221111     1123456889999999996 9999988877777


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ....++||||++|++|.+.+.          ....++.+++.+|.+||+.||+||||||+|||++    ++.++|+|||+
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGl  473 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGL  473 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcc
Confidence            777899999999999988773          3567899999999999999999999999999994    56799999999


Q ss_pred             cccc
Q 011380          249 SDFI  252 (487)
Q Consensus       249 a~~~  252 (487)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            8753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.1e-17  Score=151.01  Aligned_cols=141  Identities=25%  Similarity=0.276  Sum_probs=100.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHH---------------------HHHHHHHHHHhccCC-CC
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------------------DVKREVKILQALAGH-EN  158 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h-pn  158 (487)
                      .+.||+|+||+||+|.+. +|+.||||++............                     ....|...+..+..+ ..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999876 8999999998654321111111                     114567777776422 23


Q ss_pred             ccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCC
Q 011380          159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       159 Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~  237 (487)
                      +++.+++    ...++||||++|+.+........  .. ...+..++.+++.++.++|. .||+||||||+||+++    
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence            5555543    23589999999864432111111  01 16788999999999999999 9999999999999998    


Q ss_pred             CCcEEEeecccccccC
Q 011380          238 DSSLKATDFGLSDFIK  253 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~  253 (487)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            5679999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=3.4e-16  Score=146.13  Aligned_cols=138  Identities=17%  Similarity=0.252  Sum_probs=102.5

Q ss_pred             eeee-ecCceEEEEEEEcCCCCEEEEEEecccCc----------CChHhHHHHHHHHHHHHhccCCCCc--cEEEEEEEe
Q 011380          102 KLLG-HGQFGYTYVATDKANGDRVAVKKIEKNKM----------ILPIAVEDVKREVKILQALAGHENV--VKFYNAFED  168 (487)
Q Consensus       102 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~i~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpnI--v~~~~~~~~  168 (487)
                      ..|| .||.|+||.+..  .+..+++|.+.....          ........+.+|++++..|. |++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4577 788888888865  377899998754221          01123456788999999996 8775  677766443


Q ss_pred             C-C---EEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          169 D-N---YVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       169 ~-~---~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                      . .   ..++|||+++| .+|.+.+..   ..+++.    .+.||+.+|.+||++||+||||||+|||++.   ++.++|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~---~~~v~L  183 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP---DGKFWL  183 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC---CCCEEE
Confidence            2 2   23599999997 588777632   345554    3678999999999999999999999999984   568999


Q ss_pred             eeccccccc
Q 011380          244 TDFGLSDFI  252 (487)
Q Consensus       244 ~DfG~a~~~  252 (487)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=2.9e-17  Score=163.96  Aligned_cols=261  Identities=25%  Similarity=0.305  Sum_probs=201.3

Q ss_pred             cccCCCeeEeeeeee--cCceEEEEEEE--cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           92 KDFDRRYTIGKLLGH--GQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      ..+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.. ...+.....-.+|+...+.+..|+|.++.+..++
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccc
Confidence            335567788899999  99999999988  888999999973221 1122233344578888888888999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR----VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~----~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                      ..+..|+-+|+| |.+|..+.. .....+++..++..+.+...    ||..+|+.+++|-|+||.||+...  +...+++
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~-~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~--~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCH-TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS--DWTSCKL  264 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhh-cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc--ccceeec
Confidence            999999999999 567776653 33455889999999999999    999999999999999999999984  2278999


Q ss_pred             eecccccccCCCCcc------ccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 011380          244 TDFGLSDFIKPGKKF------QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       244 ~DfG~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      +|||+...+.++...      ....|...|++||..++-++...||||+|.++.+-.++..++........ ..+-... 
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~-  342 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGY-  342 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-ccccccc-
Confidence            999999877655421      22357888999999999999999999999999998887666533311111 0000000 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                       .+...+...+.++...+..|+..+|..|+++..++.|+++..
T Consensus       343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             -CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence             122223345667777999999999999999999999999875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2e-16  Score=136.96  Aligned_cols=133  Identities=29%  Similarity=0.355  Sum_probs=110.6

Q ss_pred             EeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCEEEEEEec
Q 011380          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +.+.||.|+++.||++...  +..+++|.+.....     ...+.+|+.+++.+..+ +++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3567999999999999864  37899998865431     35688999999999733 6899999988888899999999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ++|+.+...         +......++.+++.+|.++|..   +++|+||+|+||+++.   .+.++++|||.+..
T Consensus        75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence            988766432         5566778899999999999985   7999999999999983   67899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=2.6e-17  Score=172.14  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=201.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.+.+.+.+-+|++|.++.+.-..+|...++|+............+....+-.++-.. .+|.++...-.+......+++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence            4567778999999999999988888877777765443322222233334444333322 256666655445567789999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-  254 (487)
                      ++|..|++|...+.  ..+..+++.++..+..+..+++|||...+.|||++|.|+|..   ..+..+++|||....... 
T Consensus       883 ~~~~~~~~~~Skl~--~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLH--NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hHHhccCCchhhhh--cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccccc
Confidence            99999999988773  345678888899999999999999999999999999999988   588899999984321100 


Q ss_pred             ---------C----------------------CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q 011380          255 ---------G----------------------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWD  302 (487)
Q Consensus       255 ---------~----------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~  302 (487)
                               .                      .......||+.|.+||.+.+. .+..+|+|++|+++++.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                     0                      001235799999999988764 58899999999999999999999999


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHH---HHhcCccccccCC
Q 011380          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREGGD  363 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---e~L~h~~~~~~~~  363 (487)
                      ...+.+++++..+....+..+ ...+.++++++.++|..+|.+|..+.   ++-.|+||+....
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            999999999988776554433 35788999999999999999999888   8899999997643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.8e-15  Score=139.71  Aligned_cols=240  Identities=17%  Similarity=0.183  Sum_probs=156.6

Q ss_pred             EEEEEEEcCCCCEEEEEEecccCcCChHhHHH-HHHHHHHHHhccCCCCccEEEEEEEeCC-----EEEEEEeccCCCCH
Q 011380          111 YTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVKFYNAFEDDN-----YVYIAMELCEGGEL  184 (487)
Q Consensus       111 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~-~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----~~~lv~e~~~gg~L  184 (487)
                      .||++.+...|..|+.--+.......+...+. ...-..-|.++. |.|||+++.+|.+.+     ...+++||+..|++
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            46666666667666544332221111111111 112233344564 999999999986544     47889999999999


Q ss_pred             HHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHc--CceeecCCCCceEeccCCCCCcEEEeecccccccC---CC--
Q 011380          185 LDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---PG--  255 (487)
Q Consensus       185 ~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~--~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~---~~--  255 (487)
                      ..+|.+.  ....+......+|+.||+.||.|||+.  -|+|+++..+-|++.   .++-||+.---......   ..  
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~  236 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTRE  236 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEecccCccccchhhhhhhH
Confidence            9988654  345688899999999999999999987  599999999999998   47777765322111100   00  


Q ss_pred             CccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......|-++|.|||.=. .+.+-++|||++|+...+|..+..-- .+.+.-..-..+.+......       ...-++
T Consensus       237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~  309 (458)
T KOG1266|consen  237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG  309 (458)
T ss_pred             hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence            0111234678899998532 23456899999999999998876542 22222222222222111111       122467


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++.+||+..|..||++.++|.||.+-+.
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeeec
Confidence            8999999999999999999999987553

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=9.9e-14  Score=140.69  Aligned_cols=145  Identities=20%  Similarity=0.219  Sum_probs=95.6

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---------------------------hH----hH------HHH
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---------------------------PI----AV------EDV  143 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---------------------------~~----~~------~~~  143 (487)
                      .+.||+|++|.||+|+.+ +|+.||||+....-...                           ..    ..      -++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            357999999999999864 79999999875421000                           00    00      023


Q ss_pred             HHHHHHHHhcc----CCCCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHHHc
Q 011380          144 KREVKILQALA----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR-VAAECHLH  218 (487)
Q Consensus       144 ~~E~~~l~~l~----~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~-~l~~lH~~  218 (487)
                      .+|.+.+.++.    ++|+|.-..-++...+..++||||++|++|.+....... ...   ...++.+++. .+..+|..
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhC
Confidence            44555444442    344433222222334456899999999998876533211 122   3345555555 46788999


Q ss_pred             CceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       219 ~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |++|+|++|.||+++   .++.++|+|||++..+.
T Consensus       277 g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVL---KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence            999999999999997   46789999999986543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=4.5e-13  Score=119.70  Aligned_cols=142  Identities=13%  Similarity=0.103  Sum_probs=102.3

Q ss_pred             eeeeecCceEEEEEEEcC------CCCEEEEEEecccC---------------c----CChHhHH----HHHHHHHHHHh
Q 011380          102 KLLGHGQFGYTYVATDKA------NGDRVAVKKIEKNK---------------M----ILPIAVE----DVKREVKILQA  152 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~---------------~----~~~~~~~----~~~~E~~~l~~  152 (487)
                      ..||.|.-+.||.|....      .+..+|||+.....               +    .......    ...+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543      35799999863210               0    0011122    33489999999


Q ss_pred             ccCC-CCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCceeecCCCCce
Q 011380          153 LAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVHRDMKPENF  230 (487)
Q Consensus       153 l~~h-pnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~l-H~~~iiHrDlkp~NI  230 (487)
                      +... -++++++++    ..-+|||||+.++.+.......  ..+++..+..++.+++.+|..+ |..||+|+||+|.||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8633 567777764    4467999999765443222221  3456667788899999999999 899999999999999


Q ss_pred             EeccCCCCCcEEEeecccccccC
Q 011380          231 LFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       231 ll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |+.    ++.+.|+|||.+....
T Consensus       157 L~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE----CCcEEEEECCCceeCC
Confidence            997    4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=1.7e-14  Score=147.84  Aligned_cols=149  Identities=20%  Similarity=0.266  Sum_probs=95.2

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc--------------------------CC-h----HhHHHHHH
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--------------------------IL-P----IAVEDVKR  145 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--------------------------~~-~----~~~~~~~~  145 (487)
                      .|+. +.||+|++|.||+|+.+.+|+.||||++.+.-.                          .. .    ...+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 789999999999999988899999999864310                          00 0    11222333


Q ss_pred             ------HHHHHHhcc---CCCCccEEEEEE-EeCCEEEEEEeccCCCCHHHHHHhhcCC----CCCHHHHHHHHHHHHHH
Q 011380          146 ------EVKILQALA---GHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDS----RYTEKDAAVVVRQMLRV  211 (487)
Q Consensus       146 ------E~~~l~~l~---~hpnIv~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~~~~qil~~  211 (487)
                            |+..+.++.   .+.+.+.+-.+| +..+..+|||||++|+.+.+.-.....+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                  333333332   123333333333 2345678999999999987642111111    244444555555554  


Q ss_pred             HHHHHHcCceeecCCCCceEeccCC-CCCcEEEeecccccccC
Q 011380          212 AAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIK  253 (487)
Q Consensus       212 l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a~~~~  253 (487)
                           ..|++|+|+||.||+++.++ ..+.++++|||++..+.
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 58999999999999998421 22489999999987664

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.47  E-value=1.8e-12  Score=111.10  Aligned_cols=150  Identities=20%  Similarity=0.259  Sum_probs=115.3

Q ss_pred             EeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ....|-+|+-+.|+++.  ..|+...||.=....+..|     .......+|+++|.++. --.|.-..-++.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            45678899999999996  4688888885433333333     24456788999999985 5566555555667677789


Q ss_pred             EEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          175 AMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       175 v~e~~~g-g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +|||++| -++.+++...............++++|-..+.-||.++|||+||..+||++.+.+....+.|+|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999987 36677776655444555555899999999999999999999999999999998777777899999998653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=1.3e-12  Score=132.05  Aligned_cols=182  Identities=19%  Similarity=0.258  Sum_probs=134.6

Q ss_pred             eeEeeeeeecCceEEE-EEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           98 YTIGKLLGHGQFGYTY-VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~-~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      |.+ ...+-++.+ +| .|..+.++.+|.|...+....   ...+.+.+.++-|+.++ ||||+++++.++.++.+|||+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence            555 333444444 34 466678899999998876542   34566788899999996 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH-~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |-+.  .|..++..     +........+.||+.||.||| +.+++|++|....|+|+   ..|..||++|-++......
T Consensus        89 ErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~  158 (690)
T KOG1243|consen   89 ERVR--PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGF  158 (690)
T ss_pred             eccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccC
Confidence            9984  55555532     347778888999999999997 67899999999999999   6889999999987554322


Q ss_pred             Cc-cccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhC
Q 011380          256 KK-FQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG  296 (487)
Q Consensus       256 ~~-~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g  296 (487)
                      .. .....---.|..|+.+... .-..|.|-|||++++++.|
T Consensus       159 ~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  159 NAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence            21 1111112235666543222 1346999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=5.6e-13  Score=118.07  Aligned_cols=129  Identities=19%  Similarity=0.207  Sum_probs=95.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccC
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      ++.|+.|.++.||++...  |..|++|.......    ......+|+.+++.+.+...+++++.+..  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999854  78899998754321    12345789999999863333455665443  23579999999


Q ss_pred             CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       181 gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i-----iHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      |.++...          .......+.+++.+|..||..++     +|+|++|.||+++    ++.++++|||.+..
T Consensus        75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence            9876532          01123457899999999999985     9999999999998    34699999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=8.4e-14  Score=139.34  Aligned_cols=252  Identities=17%  Similarity=0.170  Sum_probs=184.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEc-CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ...+|..+..||.|.|+.|+.+... .++..|++|.+.+...... ....-..|+-+...+.-|.+++.++..|......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            4457888999999999999988755 6778899998765443222 2233356777777776799999999988888888


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+-.|||+++++...+.  -...+.+...+.+..|++.++.++|+..++|+|++|+||++...  .+..++.|||....+
T Consensus       342 ~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhcccccccccc
Confidence            89999999998765542  22457888999999999999999999999999999999999842  278899999988642


Q ss_pred             CCCCccccccCCcccc-chhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          253 KPGKKFQDIVGSAYYV-APEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~-aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .-  ......++-++. .+|++...  +..+.|++|||.-+.+.++|...-+....   ...+..+.    ....+..+.
T Consensus       418 ~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~----~p~~~~~~~  488 (524)
T KOG0601|consen  418 AF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD----TPNLPGLKL  488 (524)
T ss_pred             ce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc----ccCCCchHH
Confidence            11  111223344555 36666554  47899999999999999998654322211   11122221    112234457


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ++..+.+.++..++..||.+.++..|.=|-
T Consensus       489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  489 QLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            788999999999999999999988877553

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=8.6e-12  Score=107.55  Aligned_cols=135  Identities=25%  Similarity=0.331  Sum_probs=100.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      ..+++|+-+.+|.+..  -|..+++|.=.+..+..+     ...+...+|.+++.++. --.|.-.+=+..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            3578999999999965  355677774333333222     23456678999999886 445555555556677778999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ||++|..|.+.+...         ...+++.+-.-+.-||..||+|+||.++||++.    ++.+.++|||++.+.
T Consensus        79 e~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~s  141 (204)
T COG3642          79 EYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEFS  141 (204)
T ss_pred             EEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccccc
Confidence            999988877777433         256788888889999999999999999999998    445999999998753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.31  E-value=2.3e-10  Score=112.51  Aligned_cols=290  Identities=17%  Similarity=0.235  Sum_probs=190.5

Q ss_pred             ceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE----eCCEEEEEEeccCC-CC
Q 011380          109 FGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDNYVYIAMELCEG-GE  183 (487)
Q Consensus       109 ~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~----~~~~~~lv~e~~~g-g~  183 (487)
                      -.+.|++....+|..|++|++.-.+...+   ...-.-+++++++. |+|||++.++|.    .+..+++|++|.++ ++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            35789999999999999999943322111   22234577889995 999999999886    45679999999986 46


Q ss_pred             HHHHHHhh-------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          184 LLDRILAK-------------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       184 L~~~l~~~-------------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      |+++....             .+...+|..+|.++.||..||.++|+.|+..+-|.|.+||++.   ...++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G---~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG---KMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC---cceEEEeccccee
Confidence            77765432             1234788999999999999999999999999999999999983   4479999888776


Q ss_pred             ccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hhHH-HHHHHhcCCCCCCCCCCCCC
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKT-EDGI-FKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .+..+.      +     +|  +.+  -.+-|.=.||.+++.|.||..--+..+ ..+. +..|.           +.+|
T Consensus       442 vl~~d~------~-----~~--le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS  495 (655)
T KOG3741|consen  442 VLQEDP------T-----EP--LES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYS  495 (655)
T ss_pred             eecCCC------C-----cc--hhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhh
Confidence            654332      0     01  111  235688899999999999965422222 2222 22222           3578


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCc---cccccCCCCCCCcCHHHHH-HHHHhhhhhHHHHHHHHHHh--ccC--C-
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHP---WVREGGDASEIPIDISVLN-NMRQFVKYSRLKQFALRALA--STL--D-  399 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~k~~~l~~m~--~~~--~-  399 (487)
                      .+++++|.-+...++.+ -++.+++.+-   ||....   ......+.+. .+..-....||-+.++.+..  .+.  . 
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vme---s~q~~~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~~  571 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVME---SVQLKTDVMETELSREMENGRLFRLLLKLNFIDDRPEYVD  571 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHHHHHHhcchHHHHHHHHhhhccCccccc
Confidence            88999999999988887 6788887653   232211   1111111111 12222223455444443322  111  0 


Q ss_pred             ------hHH---HHHHH-HhhcccCCCCCCCCCHHHHHHHHHhhCCC
Q 011380          400 ------DEE---LADLR-DQFDAIDVDKNGSISLEEMRQALAKDLPW  436 (487)
Q Consensus       400 ------~~~---~~~l~-~~F~~~D~d~~G~i~~~el~~~l~~~~~~  436 (487)
                            ..+   +.-+| -+|...|.|+...++...+.++|.+ |..
T Consensus       572 D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNK-LDA  617 (655)
T KOG3741|consen  572 DPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNK-LDA  617 (655)
T ss_pred             CCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhh-ccc
Confidence                  011   11122 2477789999988999999999988 653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.17  E-value=1.5e-10  Score=107.14  Aligned_cols=143  Identities=29%  Similarity=0.450  Sum_probs=103.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccC-CCCccEEEEEEEeC---CEEEEEEe
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDD---NYVYIAME  177 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~~---~~~~lv~e  177 (487)
                      +.||.|..+.||++... +|+.+++|........  .....+.+|..+++.+.. +.++++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56899999999999864 3688999987654321  123567899999999963 24567777776653   36789999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL----------------------------------------  217 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~----------------------------------------  217 (487)
                      |++|.++.+.+..   ..+++.....++.+++.+|..||+                                        
T Consensus        81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9999877654311   245666677777777777777773                                        


Q ss_pred             ----------------cCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          218 ----------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       218 ----------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                                      ..++|+|+.|.||+++.. ..+.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence                            246999999999999842 145689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=99.14  E-value=8.5e-11  Score=99.77  Aligned_cols=81  Identities=23%  Similarity=0.347  Sum_probs=70.5

Q ss_pred             HHHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccc
Q 011380          388 QFALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       388 ~~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~  466 (487)
                      ..|+..|.... ..+..++++++|+.||+|++|+|+..||+.+++. +|..+++++++++++.+|.|++|.|        
T Consensus        75 ~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~-lge~~~deev~~ll~~~d~d~dG~i--------  145 (160)
T COG5126          75 PEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKS-LGERLSDEEVEKLLKEYDEDGDGEI--------  145 (160)
T ss_pred             HHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHh-hcccCCHHHHHHHHHhcCCCCCceE--------
Confidence            34666666655 3344678999999999999999999999999999 9999999999999999999999999        


Q ss_pred             cchhhhccccc
Q 011380          467 KFSYLLLFPVD  477 (487)
Q Consensus       467 ~f~~f~~~~~~  477 (487)
                      +|++|......
T Consensus       146 ~~~eF~~~~~~  156 (160)
T COG5126         146 DYEEFKKLIKD  156 (160)
T ss_pred             eHHHHHHHHhc
Confidence            89999876543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=2.8e-09  Score=102.48  Aligned_cols=240  Identities=19%  Similarity=0.215  Sum_probs=158.3

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEE------E-EeCCE
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA------F-EDDNY  171 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~------~-~~~~~  171 (487)
                      ..++.||+|+-+.+|-.-.-  + ..+.|+..+...   ....   ..+..|....+||-+..-+.+      . .....
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Ppp---a~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPP---AAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh--h-chhheeecCCCc---hHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            34678999999999966322  2 235577765432   2222   223334444456654431111      0 11223


Q ss_pred             EEEEEeccCCCCHHHHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          172 VYIAMELCEGGELLDRILA-----KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~-----~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +.+.|..++|..-...+..     +......+..+.+.++.|+.+...||..|.+-+|+.++|+|+.   +++.|.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcc
Confidence            7788888877533222221     2223466788999999999999999999999999999999998   5788999986


Q ss_pred             ccccccCCCCccccccCCccccchhhhc-c-----CCCCcchHHHHHHHHHHHHhC-CCCCCCCC----hhHHHH-HHHh
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK-R-----KSGPESDVWSIGVITYILLCG-RRPFWDKT----EDGIFK-EVLR  314 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwSlG~il~ell~g-~~pf~~~~----~~~~~~-~i~~  314 (487)
                      ..-.....+..+...+|.+.|.+||.-. +     .-+...|-|.||+++|+++.| +.||.+-.    ....++ .|..
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            5444434455666778999999999754 2     236779999999999999886 99996421    111111 2222


Q ss_pred             c------------CCCCCCCCCCCCCHHHHHHHHHcccc--CccCCcCHH
Q 011380          315 N------------KPDFRRKPWPSISNSAKDFVKKLLVK--DPRARLTAA  350 (487)
Q Consensus       315 ~------------~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~Rpt~~  350 (487)
                      +            ++.....+|.-+++.+..+..+|+..  ++.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            1            12223334566889999999999985  356899875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=6.9e-11  Score=120.26  Aligned_cols=150  Identities=22%  Similarity=0.287  Sum_probs=109.3

Q ss_pred             HHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccc-----c-----ccCCccccchhhhccC
Q 011380          208 MLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ-----D-----IVGSAYYVAPEVLKRK  276 (487)
Q Consensus       208 il~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~-----~-----~~gt~~y~aPE~~~~~  276 (487)
                      ...|+.|+|.. ++||++|.|++|.++   ..+.+||+.|+++.....+..+.     .     ..-...|.|||.+.+.
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34899999965 899999999999998   58899999999987665432211     0     1234569999998775


Q ss_pred             -CCCcchHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          277 -SGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRK-PWPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       277 -~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                       .+.++|+||+||++|.+..| +.-+...... .......+....... .-.+++.++++=|.++|..++.-||++.+++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence             47899999999999999854 4444333222 222221111111111 1146899999999999999999999999999


Q ss_pred             cCcccccc
Q 011380          354 SHPWVREG  361 (487)
Q Consensus       354 ~h~~~~~~  361 (487)
                      ..|||...
T Consensus       264 ~~~ff~D~  271 (700)
T KOG2137|consen  264 SIPFFSDP  271 (700)
T ss_pred             cccccCCc
Confidence            99999874

>cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13

Probab=99.06  E-value=1.5e-10  Score=89.31  Aligned_cols=67  Identities=18%  Similarity=0.266  Sum_probs=60.7

Q ss_pred             HHHHHHHhhcccCC-CCCCCCCHHHHHHHHHhhCCCcccH-HHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDV-DKNGSISLEEMRQALAKDLPWKLKE-SRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~-d~~G~i~~~el~~~l~~~~~~~~~~-~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+..++++|..||. +++|+|+.+||+.+|++.+|..+++ ++++++|+.+|.|+||.|        +|+||+.++.
T Consensus         6 ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I--------~F~EF~~l~~   74 (89)
T cd05022           6 AIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKL--------SFEEFWELIG   74 (89)
T ss_pred             HHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHH
Confidence            45678999999999 9999999999999998757877888 999999999999999999        9999987653

S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=6.8e-09  Score=98.12  Aligned_cols=139  Identities=17%  Similarity=0.127  Sum_probs=94.7

Q ss_pred             eEEEEEEEcCCCCEEEEEEecccCcCC---h-----HhHHHHHHHHHHHHhccCCCCc--cEEEEEEEe-----CCEEEE
Q 011380          110 GYTYVATDKANGDRVAVKKIEKNKMIL---P-----IAVEDVKREVKILQALAGHENV--VKFYNAFED-----DNYVYI  174 (487)
Q Consensus       110 g~V~~~~~~~~~~~vaiK~i~~~~~~~---~-----~~~~~~~~E~~~l~~l~~hpnI--v~~~~~~~~-----~~~~~l  174 (487)
                      ..|+++.  ..|+.|.||.........   .     .-...+.+|...+.+|. .-+|  +..+.+.+.     ...-++
T Consensus        36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence            3455553  357788888663322100   0     01113678888888774 2232  333444432     235789


Q ss_pred             EEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC----CCCCcEEEeecccc
Q 011380          175 AMELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----KEDSSLKATDFGLS  249 (487)
Q Consensus       175 v~e~~~gg-~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~----~~~~~vkl~DfG~a  249 (487)
                      |||++++. +|.+++........++.....++.+++..+.-||..||+|+||+|.|||++..    ++...+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999876 78777643223455677888999999999999999999999999999999841    34578999999987


Q ss_pred             cc
Q 011380          250 DF  251 (487)
Q Consensus       250 ~~  251 (487)
                      ..
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            53

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=1.6e-09  Score=96.47  Aligned_cols=130  Identities=25%  Similarity=0.284  Sum_probs=82.9

Q ss_pred             EEEEEEEcCCCCEEEEEEecccC-----------------------cCChHhHHHHHHHHHHHHhccCC-CCccEEEEEE
Q 011380          111 YTYVATDKANGDRVAVKKIEKNK-----------------------MILPIAVEDVKREVKILQALAGH-ENVVKFYNAF  166 (487)
Q Consensus       111 ~V~~~~~~~~~~~vaiK~i~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~  166 (487)
                      .||.|.. ..|..+|+|+.....                       ...........+|.+.|.++... -++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888976 467799999863210                       01122345678999999999632 2577777553


Q ss_pred             EeCCEEEEEEeccC--CCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          167 EDDNYVYIAMELCE--GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       167 ~~~~~~~lv~e~~~--gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~-lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                        .  -+|||||++  |..+.. +...   .++......++.+++..+.. +|..||+|+||.+.|||++    .+.+.|
T Consensus        80 --~--~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~i  147 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYI  147 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE
T ss_pred             --C--CEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEE
Confidence              2  369999998  544433 3221   12245567788888885555 5899999999999999998    338999


Q ss_pred             eecccccccC
Q 011380          244 TDFGLSDFIK  253 (487)
Q Consensus       244 ~DfG~a~~~~  253 (487)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.00  E-value=3.2e-09  Score=97.23  Aligned_cols=138  Identities=28%  Similarity=0.322  Sum_probs=103.4

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecc-------------------cCcCChHhHHHHHHHHHHHHhccCC-C
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK-------------------NKMILPIAVEDVKREVKILQALAGH-E  157 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~-------------------~~~~~~~~~~~~~~E~~~l~~l~~h-p  157 (487)
                      +.++.+||-|.-|.||.|.+. .|.++|||.=..                   ...+.-.......+|.++|.+|.++ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            567889999999999999875 688999995311                   0001123445678999999999633 3


Q ss_pred             CccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       158 nIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      .+++.+++    +.-.+|||+++|-.|...       ++..+.+..++..|+.-+.-+-..||||+|+.+-||+++   +
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~  237 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---E  237 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---c
Confidence            57776653    456799999999766432       224556667777888877777799999999999999999   5


Q ss_pred             CCcEEEeeccccc
Q 011380          238 DSSLKATDFGLSD  250 (487)
Q Consensus       238 ~~~vkl~DfG~a~  250 (487)
                      ++.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            7889999997554

>cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B

Probab=98.93  E-value=1.5e-09  Score=84.03  Aligned_cols=67  Identities=13%  Similarity=0.211  Sum_probs=59.5

Q ss_pred             HHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHh----hCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAID-VDKNG-SISLEEMRQALAK----DLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~----~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+..++++|+.|| .|++| +|+.+||+.+|+.    .+|...++++++++++.+|.|++|.|        +|++|+.+.
T Consensus         6 ~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v--------~f~eF~~li   77 (88)
T cd05027           6 AMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGEC--------DFQEFMAFV   77 (88)
T ss_pred             HHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            3567899999998 89999 5999999999986    46888889999999999999999999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        78 ~   78 (88)
T cd05027          78 A   78 (88)
T ss_pred             H
Confidence            3

S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=98.93  E-value=1.6e-09  Score=93.81  Aligned_cols=65  Identities=25%  Similarity=0.377  Sum_probs=61.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+++++|+.||.|++|+|+.+||+.+|.. +|...+.++++.+++.+|.|+||.|        +|.+|+.++.
T Consensus        84 ~~el~eaF~~fD~d~~G~Is~~el~~~l~~-lg~~~~~~e~~~mi~~~d~d~dg~i--------~f~ef~~~m~  148 (151)
T KOG0027|consen   84 SEELKEAFRVFDKDGDGFISASELKKVLTS-LGEKLTDEECKEMIREVDVDGDGKV--------NFEEFVKMMS  148 (151)
T ss_pred             HHHHHHHHHHHccCCCCcCcHHHHHHHHHH-hCCcCCHHHHHHHHHhcCCCCCCeE--------eHHHHHHHHh
Confidence            468999999999999999999999999999 9999999999999999999999999        8999988654

>PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E

Probab=98.91  E-value=1.1e-09  Score=80.32  Aligned_cols=61  Identities=31%  Similarity=0.473  Sum_probs=53.0

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCccc----HHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLK----ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~----~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +++++|+.+|.|++|+|+.+||+.+++. ++...+    ++.++.+++.+|.|+||.|        +|+||+.+
T Consensus         1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~-~~~~~~~~~~~~~~~~~~~~~D~d~dG~i--------~~~Ef~~~   65 (66)
T PF13499_consen    1 RLKEAFKKFDKDGDGYISKEELRRALKH-LGRDMSDEESDEMIDQIFREFDTDGDGRI--------SFDEFLNF   65 (66)
T ss_dssp             HHHHHHHHHSTTSSSEEEHHHHHHHHHH-TTSHSTHHHHHHHHHHHHHHHTTTSSSSE--------EHHHHHHH
T ss_pred             CHHHHHHHHcCCccCCCCHHHHHHHHHH-hcccccHHHHHHHHHHHHHHhCCCCcCCC--------cHHHHhcc
Confidence            4788999999999999999999999999 885544    4556667999999999999        99999864

...

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=6.4e-08  Score=88.44  Aligned_cols=111  Identities=22%  Similarity=0.239  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHHHhccC-CCCccEEEEEEEeC----CEEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Q 011380          140 VEDVKREVKILQALAG-HENVVKFYNAFEDD----NYVYIAMELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAA  213 (487)
Q Consensus       140 ~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~~----~~~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~  213 (487)
                      .....+|...+..|.. .-..++.+.+.+..    ...++|+|+++|. +|.+.+....  ..+......++.++...+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            3456788887777751 12344555555432    2458999999885 6777764422  2667788899999999999


Q ss_pred             HHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       214 ~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      -||.+||+|+|++|.|||++..+....+.|+||+-+...
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999996544568999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms]

Probab=98.81  E-value=8.9e-09  Score=89.10  Aligned_cols=70  Identities=23%  Similarity=0.397  Sum_probs=65.1

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...+..+++++|..||+|++|+|+..||..+|+. +|..+++.++..++..+|.|++|.|        +|++|+.++..
T Consensus         3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~-lg~~~t~~el~~~~~~~D~dg~g~I--------~~~eF~~l~~~   72 (151)
T KOG0027|consen    3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRS-LGQNPTEEELRDLIKEIDLDGDGTI--------DFEEFLDLMEK   72 (151)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHHHh
Confidence            3456788999999999999999999999999999 9999999999999999999999999        99999987653

>smart00027 EH Eps15 homology domain

Probab=98.79  E-value=1e-08  Score=81.23  Aligned_cols=67  Identities=16%  Similarity=0.229  Sum_probs=61.0

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++...++++|..+|.|++|.|+.+|++.+|+. .|  ++.+++++++..+|.+++|.|        +|++|+.+.
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~-~~--~~~~ev~~i~~~~d~~~~g~I--------~~~eF~~~~   70 (96)
T smart00027        4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLK-SG--LPQTLLAKIWNLADIDNDGEL--------DKDEFALAM   70 (96)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH-cC--CCHHHHHHHHHHhcCCCCCCc--------CHHHHHHHH
Confidence            45678889999999999999999999999999998 76  578899999999999999999        899998754

Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences.

>cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6

Probab=98.78  E-value=8.8e-09  Score=79.68  Aligned_cols=67  Identities=13%  Similarity=0.233  Sum_probs=58.9

Q ss_pred             HHHHHHHhhcccCC-CC-CCCCCHHHHHHHHHh--hCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDV-DK-NGSISLEEMRQALAK--DLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~-d~-~G~i~~~el~~~l~~--~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+..+-.+|..+|. |+ +|+|+.+||+.+|++  .+|..+++++++++++.+|.|++|.|        +|++|+.++.
T Consensus         8 ~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~I--------df~EFv~lm~   78 (88)
T cd05029           8 AIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEV--------NFQEYVTFLG   78 (88)
T ss_pred             HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCC--------cHHHHHHHHH
Confidence            45677889999998 77 899999999999973  17999999999999999999999999        9999987553

S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=98.78  E-value=1.1e-08  Score=84.85  Aligned_cols=69  Identities=16%  Similarity=0.276  Sum_probs=63.1

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      .+..++++.+|+.+|.|++|+|+..+|+.+.+. ||..++++|+.+|+.++|.|+||.|        +-++|+.++.+
T Consensus       102 ~dt~eEi~~afrl~D~D~~Gkis~~~lkrvake-LgenltD~El~eMIeEAd~d~dgev--------neeEF~~imk~  170 (172)
T KOG0028|consen  102 RDTKEEIKKAFRLFDDDKTGKISQRNLKRVAKE-LGENLTDEELMEMIEEADRDGDGEV--------NEEEFIRIMKK  170 (172)
T ss_pred             cCcHHHHHHHHHcccccCCCCcCHHHHHHHHHH-hCccccHHHHHHHHHHhcccccccc--------cHHHHHHHHhc
Confidence            335678899999999999999999999999999 9999999999999999999999999        88888876643

>cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z

Probab=98.73  E-value=1.5e-08  Score=79.52  Aligned_cols=66  Identities=14%  Similarity=0.215  Sum_probs=56.0

Q ss_pred             HHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAID-VDKNG-SISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++++|..|| .|++| +|+.+||+.+|+..+    +...+..+++++++.+|.|+||.|        +|+||+.++.
T Consensus         9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~I--------df~EF~~l~~   80 (93)
T cd05026           9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEV--------DFNEFVVLVA   80 (93)
T ss_pred             HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH
Confidence            467888999999 78999 599999999997633    334477899999999999999999        9999988654

S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac

>COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]

Probab=98.73  E-value=2.3e-08  Score=85.08  Aligned_cols=72  Identities=19%  Similarity=0.373  Sum_probs=67.2

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ...+..+++++++++|..+|.|++|.|+..||..+|+. +|..++++++.+|+..+|. +.|.|        +|.+|+.+
T Consensus        11 ~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~-lg~~~s~~ei~~l~~~~d~-~~~~i--------df~~Fl~~   80 (160)
T COG5126          11 FTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRS-LGFNPSEAEINKLFEEIDA-GNETV--------DFPEFLTV   80 (160)
T ss_pred             cccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHH-cCCCCcHHHHHHHHHhccC-CCCcc--------CHHHHHHH
Confidence            35568899999999999999999999999999999998 9999999999999999999 99999        99999987


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +-
T Consensus        81 ms   82 (160)
T COG5126          81 MS   82 (160)
T ss_pred             HH
Confidence            64

>cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1

Probab=98.70  E-value=1.8e-08  Score=79.13  Aligned_cols=66  Identities=17%  Similarity=0.246  Sum_probs=56.8

Q ss_pred             HHHHHHhhcccC-CCCCCC-CCHHHHHHHHHhhCCC----cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAID-VDKNGS-ISLEEMRQALAKDLPW----KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D-~d~~G~-i~~~el~~~l~~~~~~----~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++++|+.|| .|++|+ |+.+||+.+|+..+|.    .++.++++++++.+|.|++|.|        +|++|+.++.
T Consensus         8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I--------~f~eF~~l~~   79 (92)
T cd05025           8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEV--------DFQEFVVLVA   79 (92)
T ss_pred             HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcC--------cHHHHHHHHH
Confidence            467899999997 999995 9999999999742443    4578999999999999999999        9999987653

S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins.

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=3.7e-07  Score=81.99  Aligned_cols=143  Identities=15%  Similarity=0.134  Sum_probs=100.2

Q ss_pred             eeecCceEEEEEEEcCCCCEEEEEEecccC---cCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEE---e--CCEEEE
Q 011380          104 LGHGQFGYTYVATDKANGDRVAVKKIEKNK---MILPIAVEDVKREVKILQALAGH-ENVVKFYNAFE---D--DNYVYI  174 (487)
Q Consensus       104 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~---~--~~~~~l  174 (487)
                      -|+||-+-|+....  .|+.+-+|.-...-   ...|.....+.+|+..|.+|... -.+++.. ++.   .  .-.-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            35688888888753  35578888764211   11144567789999999888521 1244444 222   1  224679


Q ss_pred             EEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          175 AMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       175 v~e~~~g-g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      |+|-++| -+|.+++....-.+.++.....++.++...+.-||+.|+.|+|+-+.|||++..+ ...++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence            9997754 4777776444344567888889999999999999999999999999999998432 3459999998654

>cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif

Probab=98.67  E-value=3.1e-08  Score=77.18  Aligned_cols=70  Identities=19%  Similarity=0.306  Sum_probs=59.9

Q ss_pred             hHHHHHHHHhhcccCC--CCCCCCCHHHHHHHHHhhCCCcc----cHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          400 DEELADLRDQFDAIDV--DKNGSISLEEMRQALAKDLPWKL----KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~--d~~G~i~~~el~~~l~~~~~~~~----~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      +++++.++++|..+|.  |++|.|+.+||+.+++..+|..+    +.+++..++..+|.+++|.|        +|++|+.
T Consensus         4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I--------~f~eF~~   75 (88)
T cd00213           4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKV--------DFQEFLV   75 (88)
T ss_pred             HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcC--------cHHHHHH
Confidence            3466789999999999  89999999999999975345444    58999999999999999999        9999988


Q ss_pred             cccc
Q 011380          474 FPVD  477 (487)
Q Consensus       474 ~~~~  477 (487)
                      +...
T Consensus        76 ~~~~   79 (88)
T cd00213          76 LIGK   79 (88)
T ss_pred             HHHH
Confidence            6543

Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th

>cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10

Probab=98.64  E-value=3.5e-08  Score=77.83  Aligned_cols=66  Identities=17%  Similarity=0.231  Sum_probs=57.4

Q ss_pred             HHHHHHhhcccCC-CC-CCCCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDV-DK-NGSISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~-d~-~G~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++++|..||. |+ +|+|+.+||+.+|+..    +|..++.++++.+++.+|.+++|.|        +|++|+.++.
T Consensus         7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I--------~f~eF~~l~~   78 (94)
T cd05031           7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKV--------NFEEFVSLVA   78 (94)
T ss_pred             HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            4678999999997 97 6999999999999752    3567789999999999999999999        9999986553

S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.64  E-value=5.2e-07  Score=81.28  Aligned_cols=141  Identities=21%  Similarity=0.289  Sum_probs=89.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhH------HHHHHHHHHHHhcc--CCCCccEEEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV------EDVKREVKILQALA--GHENVVKFYNA  165 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~------~~~~~E~~~l~~l~--~hpnIv~~~~~  165 (487)
                      +...|.+.+.+-......|.+..  ..|+.+++|.............      ....+++..+.++.  +--.++.++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45678888888887777666664  5688999997654321111000      11233444444442  12233333322


Q ss_pred             EE-----eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          166 FE-----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       166 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      .+     .....+++|||++|..|.+..      .+++    .+...|..++.-||+.|++|+|..|.|++++    ++.
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCc
Confidence            22     234567899999998775532      1333    2446677889999999999999999999998    345


Q ss_pred             EEEeeccccc
Q 011380          241 LKATDFGLSD  250 (487)
Q Consensus       241 vkl~DfG~a~  250 (487)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.61  E-value=2e-09  Score=108.47  Aligned_cols=242  Identities=18%  Similarity=0.223  Sum_probs=166.9

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCCEEEEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-Iv~~~~~~~~~~~~~lv~  176 (487)
                      |.....+++|+++++++.+...+...+ .+.+...        ....-++++|.++ +||| .+..++-++.+.+.++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhh
Confidence            555667899999999999766554444 5555432        3445689999999 5999 777788888889999999


Q ss_pred             eccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          177 ELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       177 e~~~gg-~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      +++.++ +....+. ...-.+.+.+...+.+.-+++++++|+--=+|||    ||+..    .+..|..||+....+...
T Consensus       314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCcc
Confidence            999887 2211110 1112344556667778888999999998778999    88876    467899999988776655


Q ss_pred             CccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--CCCCC-CCCCCCCHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--PDFRR-KPWPSISNSA  331 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~s~~~  331 (487)
                      ....+..+|+.++|||+.. +.+....|.|++|+-..+|.-|-+|-.....  ....+-.+.  +.... ..|...  .-
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~--~~  460 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPV--FH  460 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcc--cc
Confidence            4556788999999999765 4567888999999877788777776422100  000000000  00000 111111  11


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .++...|+...|..|+....++-|.+|....
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            2577889999999999999999999998754

>cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction

Probab=98.59  E-value=6.8e-08  Score=70.94  Aligned_cols=58  Identities=24%  Similarity=0.218  Sum_probs=52.9

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +++|..+|.|++|.|+.+|++.+|+. +|.  +.+++.++++.+|.+++|.|        +|++|+.+.
T Consensus         2 ~~~F~~~D~~~~G~i~~~el~~~l~~-~g~--~~~~~~~i~~~~d~~~~g~i--------~~~ef~~~~   59 (67)
T cd00052           2 DQIFRSLDPDGDGLISGDEARPFLGK-SGL--PRSVLAQIWDLADTDKDGKL--------DKEEFAIAM   59 (67)
T ss_pred             hHHHHHhCCCCCCcCcHHHHHHHHHH-cCC--CHHHHHHHHHHhcCCCCCcC--------CHHHHHHHH
Confidence            56899999999999999999999998 774  78899999999999999999        899997654

The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=4.8e-07  Score=92.71  Aligned_cols=146  Identities=22%  Similarity=0.266  Sum_probs=93.8

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccC---------------------------cCChHhH----H------HHH
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNK---------------------------MILPIAV----E------DVK  144 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---------------------------~~~~~~~----~------~~~  144 (487)
                      +.|+.++-|.||+|+.+ +|+.||||+....-                           .......    +      ++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57999999999999975 59999999864310                           1111111    1      123


Q ss_pred             HHHHHHHhc----cCCCCccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 011380          145 REVKILQAL----AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL  220 (487)
Q Consensus       145 ~E~~~l~~l----~~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i  220 (487)
                      +|..-+.++    ++.|++.-..-+++..+.-.|+|||++|-.+.+...... ..++...+...+.++.  +.-+-..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            444444433    345665444445565667789999999988877643232 3445333333322221  223335899


Q ss_pred             eeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       221 iHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      +|.|..|.||++.   .++.+.+.|||+...+.+
T Consensus       287 fHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         287 FHADPHPGNILVR---SDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cccCCCccceEEe---cCCcEEEEcCcceecCCH
Confidence            9999999999999   468999999999876543

>PF14658 EF-hand_9: EF-hand domain

Probab=98.58  E-value=6.6e-08  Score=68.67  Aligned_cols=62  Identities=21%  Similarity=0.365  Sum_probs=57.6

Q ss_pred             hhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCC-ceeecCccccccchhhhcccccce
Q 011380          409 QFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFL-GLFLPCHEKGEKFSYLLLFPVDMV  479 (487)
Q Consensus       409 ~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~-g~i~~~~~~~~~f~~f~~~~~~~~  479 (487)
                      +|..||.++.|.|...+|+..|+. ++. .+++++++.+..++|.++. |.|        +|++|+.++.+.|
T Consensus         3 ~F~~fD~~~tG~V~v~~l~~~Lra-~~~~~p~e~~Lq~l~~elDP~g~~~~v--------~~d~F~~iM~~wi   66 (66)
T PF14658_consen    3 AFDAFDTQKTGRVPVSDLITYLRA-VTGRSPEESELQDLINELDPEGRDGSV--------NFDTFLAIMRDWI   66 (66)
T ss_pred             chhhcCCcCCceEeHHHHHHHHHH-HcCCCCcHHHHHHHHHHhCCCCCCceE--------eHHHHHHHHHHhC
Confidence            799999999999999999999999 887 8899999999999999998 999        9999999887643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.56  E-value=1.1e-06  Score=94.95  Aligned_cols=205  Identities=20%  Similarity=0.235  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHhccCCCCccEEEEEEEeCCE----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011380          141 EDVKREVKILQALAGHENVVKFYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH  216 (487)
Q Consensus       141 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH  216 (487)
                      .....|+..+..+. |+|++.++.|-.....    +.+..++|.+.++...+.  .-...+....+.+..+++.||.|+|
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHH
Confidence            44456777788886 9999999988754332    334567888888887763  3467889999999999999999999


Q ss_pred             HcCceeecCCCCceEeccCCCCCcEEEe--ecccccccCCCCccccccCCccccchhhhccCCC---CcchHHHHHHHHH
Q 011380          217 LHGLVHRDMKPENFLFKSAKEDSSLKAT--DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSG---PESDVWSIGVITY  291 (487)
Q Consensus       217 ~~~iiHrDlkp~NIll~~~~~~~~vkl~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~DiwSlG~il~  291 (487)
                      +....|.-|...-..-......+.+.++  ||+.+.............-+..+.+||.......   ...|+|.+|..+.
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            9977666665553222222245566666  8888776654443333344566788887765543   3469999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH-HHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN-SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       292 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~-~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+..|..+-...   .....++           +..+. +..+.+.+|+..++++|+++.+++.|+|.+...
T Consensus       384 ~~~~~~~i~~~~---~~~~~~l-----------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  384 QLSQGEDISEKS---AVPVSLL-----------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhhhcCcccccc---cchhhhh-----------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            998875542111   1111111           11111 578899999999999999999999999988654

>cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11

Probab=98.56  E-value=1.1e-07  Score=73.64  Aligned_cols=67  Identities=13%  Similarity=0.146  Sum_probs=56.9

Q ss_pred             HHHHHHHhhcc-cCCCCCC-CCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDA-IDVDKNG-SISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~-~D~d~~G-~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+..+..+|.. +|.|++| +|+.+||+.+|...+    +...+..+++++++.+|.|+||.|        +|+||+.++
T Consensus         7 ~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I--------~f~EF~~l~   78 (89)
T cd05023           7 CIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQL--------DFQEFLNLI   78 (89)
T ss_pred             HHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcC--------cHHHHHHHH
Confidence            45678899999 8899986 999999999998732    334567899999999999999999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        79 ~   79 (89)
T cd05023          79 G   79 (89)
T ss_pred             H
Confidence            4

S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=2e-06  Score=79.67  Aligned_cols=73  Identities=19%  Similarity=0.210  Sum_probs=55.4

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCEEEEEEeccC
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      ..||.|..+.||+.    .|..+++|......     ....+.+|.++++.+... -.+++.+.+....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999984    25567888775432     235578999999998633 236788888888888899999999


Q ss_pred             CCC
Q 011380          181 GGE  183 (487)
Q Consensus       181 gg~  183 (487)
                      |.+
T Consensus        78 G~~   80 (226)
T TIGR02172        78 GKR   80 (226)
T ss_pred             Ccc
Confidence            864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only]

Probab=98.51  E-value=1.1e-07  Score=81.67  Aligned_cols=69  Identities=23%  Similarity=0.403  Sum_probs=63.8

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++..+++.+..+|+.+|.+.||+|+..||+.+|.+ +|.+-|.--++.||+++|.|.||+|        +|.+|+++.
T Consensus        93 FsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEK-LgapQTHL~lK~mikeVded~dgkl--------SfreflLIf  161 (244)
T KOG0041|consen   93 FSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEK-LGAPQTHLGLKNMIKEVDEDFDGKL--------SFREFLLIF  161 (244)
T ss_pred             HHHHHHHHHHHHHHHhcccccccccHHHHHHHHHH-hCCchhhHHHHHHHHHhhcccccch--------hHHHHHHHH
Confidence            35567888899999999999999999999999999 9999999999999999999999999        999998764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.48  E-value=2.2e-06  Score=78.17  Aligned_cols=139  Identities=20%  Similarity=0.210  Sum_probs=95.4

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---------------------hHhHHHHHHHHHHHHhccC-CCCcc
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---------------------PIAVEDVKREVKILQALAG-HENVV  160 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---------------------~~~~~~~~~E~~~l~~l~~-hpnIv  160 (487)
                      .|++|.-+.||+|.. .++..+|+|+........                     ........+|..-|+++.+ +-.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677888889999974 568899999874321110                     0112345678888877752 34556


Q ss_pred             EEEEEEEeCCEEEEEEeccCCCCH-HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCC
Q 011380          161 KFYNAFEDDNYVYIAMELCEGGEL-LDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKED  238 (487)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L-~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~  238 (487)
                      +.+.+..    -.|||||+...-. .-.|   +.-.+....+..+..+++..+.-|-. .++||+||+.=|||+.    .
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~  202 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----D  202 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----C
Confidence            6665443    4699999954311 0011   11233444788889999999988876 9999999999999997    5


Q ss_pred             CcEEEeecccccccC
Q 011380          239 SSLKATDFGLSDFIK  253 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~  253 (487)
                      +.+.|+|||-|....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            779999999886554

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=98.48  E-value=3.9e-07  Score=75.17  Aligned_cols=81  Identities=15%  Similarity=0.243  Sum_probs=71.4

Q ss_pred             HHHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccc
Q 011380          388 QFALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       388 ~~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~  466 (487)
                      ..||.+++..+ ..+..+.+..+|+.||.+++|.|..+.|+.+|.. .|.+++++||+.|++.+-.|..|.|        
T Consensus        84 t~FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt-~gDr~~~eEV~~m~r~~p~d~~G~~--------  154 (171)
T KOG0031|consen   84 TVFLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTT-MGDRFTDEEVDEMYREAPIDKKGNF--------  154 (171)
T ss_pred             HHHHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHH-hcccCCHHHHHHHHHhCCcccCCce--------
Confidence            45777777777 3345578899999999999999999999999999 9999999999999999999999999        


Q ss_pred             cchhhhccccc
Q 011380          467 KFSYLLLFPVD  477 (487)
Q Consensus       467 ~f~~f~~~~~~  477 (487)
                      +|..|..++.+
T Consensus       155 dy~~~~~~ith  165 (171)
T KOG0031|consen  155 DYKAFTYIITH  165 (171)
T ss_pred             eHHHHHHHHHc
Confidence            89999887653

>KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning]

Probab=98.43  E-value=3.9e-07  Score=75.78  Aligned_cols=70  Identities=24%  Similarity=0.438  Sum_probs=64.4

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+.+++..+++.+|..||.+++|+|+.+||+.+++. +|..+..+|+.+++..+|.++.|.|        .|++|...+
T Consensus        26 ~l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmra-lGFE~~k~ei~kll~d~dk~~~g~i--------~fe~f~~~m   95 (172)
T KOG0028|consen   26 ELTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRA-LGFEPKKEEILKLLADVDKEGSGKI--------TFEDFRRVM   95 (172)
T ss_pred             cccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHH-cCCCcchHHHHHHHHhhhhccCcee--------chHHHHHHH
Confidence            345667789999999999999999999999999999 9999999999999999999999999        899998864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.42  E-value=8.1e-06  Score=72.83  Aligned_cols=129  Identities=25%  Similarity=0.292  Sum_probs=92.1

Q ss_pred             CCeeEeeeeeecCc-eEEEEEEEcCCCCEEEEEEecccCcCC------------------hHhHHHHHHHHHHHHhcc--
Q 011380           96 RRYTIGKLLGHGQF-GYTYVATDKANGDRVAVKKIEKNKMIL------------------PIAVEDVKREVKILQALA--  154 (487)
Q Consensus        96 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~------------------~~~~~~~~~E~~~l~~l~--  154 (487)
                      .+++.++.||.|+- |.||++.  ..|+.||+|++..-....                  ......+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67899999999999 9999996  468899999932100000                  022346778888877776  


Q ss_pred             CCCCc--cEEEEEEEeC------------------CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Q 011380          155 GHENV--VKFYNAFEDD------------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE  214 (487)
Q Consensus       155 ~hpnI--v~~~~~~~~~------------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~  214 (487)
                      ++.++  |+++||..-.                  ....||.||++...           .+    ...-+.+|++-+..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHH
Confidence            34455  9999987321                  12467888876543           12    22345677888889


Q ss_pred             HHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       215 lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +|..||+-+|+++.|..      +  -||+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~------~--G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYR------G--GKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCcccccc------C--CEEEecccC
Confidence            99999999999999997      2  289999964

>PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A

Probab=98.40  E-value=2.3e-07  Score=64.84  Aligned_cols=51  Identities=33%  Similarity=0.440  Sum_probs=47.1

Q ss_pred             CCCCCCHHHHHHHHHhhCCCc-ccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          417 KNGSISLEEMRQALAKDLPWK-LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       417 ~~G~i~~~el~~~l~~~~~~~-~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+|.|+.++|+.+|.. +|.. ++++++..+|..+|.|++|.|        +|+||+.+..
T Consensus         1 ~~G~i~~~~~~~~l~~-~g~~~~s~~e~~~l~~~~D~~~~G~I--------~~~EF~~~~~   52 (54)
T PF13833_consen    1 KDGKITREEFRRALSK-LGIKDLSEEEVDRLFREFDTDGDGYI--------SFDEFISMMQ   52 (54)
T ss_dssp             SSSEEEHHHHHHHHHH-TTSSSSCHHHHHHHHHHHTTSSSSSE--------EHHHHHHHHH
T ss_pred             CcCEECHHHHHHHHHH-hCCCCCCHHHHHHHHHhcccCCCCCC--------CHHHHHHHHH
Confidence            4799999999999977 8999 999999999999999999999        9999987654

...

>KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=98.37  E-value=5.9e-07  Score=74.11  Aligned_cols=70  Identities=19%  Similarity=0.408  Sum_probs=62.7

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+.+.|+.+++++|..+|.|+||.|..++|+..|.+ +|...++++++.|++++    .|.|        +|.-|+.+.
T Consensus        24 amf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aS-lGk~~~d~elDaM~~Ea----~gPI--------Nft~FLTmf   90 (171)
T KOG0031|consen   24 AMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLAS-LGKIASDEELDAMMKEA----PGPI--------NFTVFLTMF   90 (171)
T ss_pred             HHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHhC----CCCe--------eHHHHHHHH
Confidence            4457889999999999999999999999999999999 99999999999999985    5789        999998876


Q ss_pred             ccc
Q 011380          476 VDM  478 (487)
Q Consensus       476 ~~~  478 (487)
                      -+.
T Consensus        91 Gek   93 (171)
T KOG0031|consen   91 GEK   93 (171)
T ss_pred             HHH
Confidence            543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=5.5e-06  Score=77.88  Aligned_cols=75  Identities=19%  Similarity=0.191  Sum_probs=55.3

Q ss_pred             eeecCc-eEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCC
Q 011380          104 LGHGQF-GYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGG  182 (487)
Q Consensus       104 lG~G~~-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg  182 (487)
                      |-.|.. +.||++..  .+..+++|+.....      ...+.+|+++++.+..+--+++++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            445555 78999964  34678888765432      2356789999999876666778888887777789999999997


Q ss_pred             CHHH
Q 011380          183 ELLD  186 (487)
Q Consensus       183 ~L~~  186 (487)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd00051 EFh EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands

Probab=98.35  E-value=9.9e-07  Score=63.12  Aligned_cols=60  Identities=32%  Similarity=0.465  Sum_probs=55.7

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++.+|..+|.+++|.|+.+|+..+++. ++...+.+++..++..+|.+++|.|        +|++|+..
T Consensus         2 ~~~~f~~~d~~~~g~l~~~e~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~l--------~~~ef~~~   61 (63)
T cd00051           2 LREAFRLFDKDGDGTISADELKAALKS-LGEGLSEEEIDEMIREVDKDGDGKI--------DFEEFLEL   61 (63)
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHH
Confidence            567899999999999999999999999 8999999999999999999999999        89998764

Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=1e-05  Score=75.24  Aligned_cols=79  Identities=27%  Similarity=0.280  Sum_probs=57.2

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEE---eCCEEEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFE---DDNYVYIAM  176 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~---~~~~~~lv~  176 (487)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.|..+ ..+++++....   .....+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            4679999999999998654  58999986543     2456788999999888634 23667776443   344679999


Q ss_pred             eccCCCCHHH
Q 011380          177 ELCEGGELLD  186 (487)
Q Consensus       177 e~~~gg~L~~  186 (487)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PTZ00184 calmodulin; Provisional

Probab=98.31  E-value=1.1e-06  Score=75.63  Aligned_cols=71  Identities=21%  Similarity=0.426  Sum_probs=57.6

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+++++...++..|..+|.+++|.|+.+|+..++.. ++..++.+++..++..+|.+++|.|        +|++|+.+.
T Consensus         3 ~~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~l   73 (149)
T PTZ00184          3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLTLM   73 (149)
T ss_pred             CccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHhcCcCCCCcC--------cHHHHHHHH
Confidence            3456667778888888888888888888888888887 7777777888888888888888888        788887654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.30  E-value=4.4e-06  Score=72.03  Aligned_cols=131  Identities=26%  Similarity=0.358  Sum_probs=90.3

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      +..+.||+|++|.||+|.+.  |..+|+|+-....     ....+..|.++|..+.+----.++|.+..+    ++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            45678999999999999754  6799999765433     457788999999998633333566655443    456999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC--CceEeccCCCCCcEEEeecccccccC
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP--ENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp--~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +.|-.|.+.-..     ..    ..-+..+++.---|-..||-|+.|.-  .||++.    +..+.|+||..|+...
T Consensus        94 i~G~~L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~  157 (201)
T COG2112          94 IDGRPLGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKK  157 (201)
T ss_pred             hcCcchhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhcc
Confidence            999887664311     01    22333445554456678999999864  455554    4589999999987544

>cd05030 calgranulins Calgranulins: S-100 domain found in proteins belonging to the Calgranulin subgroup of the S100 family of EF-hand calcium-modulated proteins, including S100A8, S100A9, and S100A12

Probab=98.30  E-value=1e-06  Score=68.36  Aligned_cols=66  Identities=21%  Similarity=0.380  Sum_probs=56.6

Q ss_pred             HHHHHHhhcccCCC--CCCCCCHHHHHHHHHhhCCCccc----HHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVD--KNGSISLEEMRQALAKDLPWKLK----ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d--~~G~i~~~el~~~l~~~~~~~~~----~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...+...|..++..  ++|+|+.+||+.+|...+|..++    +++++.+++.+|.|++|.|        +|++|+.++.
T Consensus         7 i~~~~~~f~~y~~~~~~~~~Is~~El~~ll~~~~g~~~t~~~~~~~v~~i~~~~D~d~dG~I--------~f~eF~~~~~   78 (88)
T cd05030           7 IETIINVFHQYSVRKGHPDTLYKKEFKQLVEKELPNFLKKEKNQKAIDKIFEDLDTNQDGQL--------SFEEFLVLVI   78 (88)
T ss_pred             HHHHHHHHHHHhccCCCcccCCHHHHHHHHHHHhhHhhccCCCHHHHHHHHHHcCCCCCCcC--------cHHHHHHHHH
Confidence            45677899999865  48999999999999743777777    8999999999999999999        9999987654

Note that the S-100 hierarchy, to which this Calgranulin group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. These proteins are expressed mainly in granulocytes, and are involved in inflammation, allergy, and neuritogenesis, as well as in host-parasite response. Calgranulins are modulated not only by calcium, but also by other metals such as zinc and copper. Structural data suggested that calgranulins may exist in multiple structural forms, homodimers, as well as hetero-oligomers. For example, the S100A8/S100A9 complex called calprotectin plays important roles in the regulation of inflammatory processes, wound repair, and regulating zinc-dependent enzymes as well as microbial growth.

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=98.27  E-value=1.1e-06  Score=71.26  Aligned_cols=71  Identities=24%  Similarity=0.319  Sum_probs=60.4

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +.-.+...++.-+-++.||++++|.|...|||.+|.. +|..++++|++.++.-. .|.+|.|        +|++|++.+
T Consensus        80 knk~q~t~edfvegLrvFDkeg~G~i~~aeLRhvLtt-lGekl~eeEVe~Llag~-eD~nG~i--------~YE~fVk~i  149 (152)
T KOG0030|consen   80 KNKDQGTYEDFVEGLRVFDKEGNGTIMGAELRHVLTT-LGEKLTEEEVEELLAGQ-EDSNGCI--------NYEAFVKHI  149 (152)
T ss_pred             hccccCcHHHHHHHHHhhcccCCcceeHHHHHHHHHH-HHhhccHHHHHHHHccc-cccCCcC--------cHHHHHHHH
Confidence            3334445567777889999999999999999999999 99999999999999875 4789999        999998755


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      +
T Consensus       150 ~  150 (152)
T KOG0030|consen  150 M  150 (152)
T ss_pred             h
Confidence            3

>PTZ00183 centrin; Provisional

Probab=98.27  E-value=1.5e-06  Score=75.70  Aligned_cols=70  Identities=23%  Similarity=0.434  Sum_probs=57.7

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++++..++..+|..+|.+++|.|+.+|+..+++. +|..++..++..++..+|.+++|.|        +|++|+.+.
T Consensus        10 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~-~g~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~~~   79 (158)
T PTZ00183         10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRS-LGFEPKKEEIKQMIADVDKDGSGKI--------DFEEFLDIM   79 (158)
T ss_pred             CCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            456677778888888888888888888888888887 7877778888888888888888888        888887654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.4e-05  Score=88.29  Aligned_cols=81  Identities=30%  Similarity=0.438  Sum_probs=58.0

Q ss_pred             eeeeeecCceEEEEEEEcCCC--CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCc--cEEEEEEEeC---CEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANG--DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV--VKFYNAFEDD---NYVY  173 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI--v~~~~~~~~~---~~~~  173 (487)
                      .+.|+.|.++.+|+......+  ..+++|+.......  .....+.+|.++|+.|.+|+++  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            466899999999998764432  46788876543211  1235678999999999646654  7888877664   4688


Q ss_pred             EEEeccCCCC
Q 011380          174 IAMELCEGGE  183 (487)
Q Consensus       174 lv~e~~~gg~  183 (487)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998864

>KOG0034 consensus Ca2+/calmodulin-dependent protein phosphatase (calcineurin subunit B), EF-Hand superfamily protein [Signal transduction mechanisms]

Probab=98.23  E-value=2.3e-06  Score=75.55  Aligned_cols=64  Identities=25%  Similarity=0.228  Sum_probs=54.0

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCccc--HH----HHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLK--ES----RVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~--~~----e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +.++=+|+.+|.+++|+|+.+|+.+++...+|...+  ++    -++.+|.++|.|+||.|        +|+||..+.
T Consensus       104 ~Kl~faF~vYD~~~~G~I~reel~~iv~~~~~~~~~~~~e~~~~i~d~t~~e~D~d~DG~I--------sfeEf~~~v  173 (187)
T KOG0034|consen  104 EKLRFAFRVYDLDGDGFISREELKQILRMMVGENDDMSDEQLEDIVDKTFEEADTDGDGKI--------SFEEFCKVV  173 (187)
T ss_pred             HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHccCCcchHHHHHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            578889999999999999999999999986664444  33    35778999999999999        899988754

>PTZ00184 calmodulin; Provisional

Probab=98.20  E-value=3.2e-06  Score=72.70  Aligned_cols=64  Identities=23%  Similarity=0.405  Sum_probs=59.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.+++|+|+.+|++.++.. .|..++.+++..++..+|.+++|.|        +|++|+.++.
T Consensus        84 ~~~~~~F~~~D~~~~g~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~~  147 (149)
T PTZ00184         84 EEIKEAFKVFDRDGNGFISAAELRHVMTN-LGEKLTDEEVDEMIREADVDGDGQI--------NYEEFVKMMM  147 (149)
T ss_pred             HHHHHHHHhhCCCCCCeEeHHHHHHHHHH-HCCCCCHHHHHHHHHhcCCCCCCcC--------cHHHHHHHHh
Confidence            46788999999999999999999999998 8988999999999999999999999        9999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.17  E-value=6.4e-05  Score=67.68  Aligned_cols=137  Identities=18%  Similarity=0.261  Sum_probs=94.6

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCc-------------CChHhHHHHHHHHHHHHhcc-----CCCCccEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-------------ILPIAVEDVKREVKILQALA-----GHENVVKFY  163 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~  163 (487)
                      ..||+|+.=.||.-   .......||++.....             ..........+|+.....+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46999999888865   3345678888866540             00112355667777666553     378899999


Q ss_pred             EEEEeCCEEEEEEeccCC------CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          164 NAFEDDNYVYIAMELCEG------GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       164 ~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      |+.++...+.+|+|.+..      -+|.+++..   ..+++    .+...+-+-..||-+++|+.+||+|.||++...++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999999999999998643      256666622   34554    33334445557889999999999999999987555


Q ss_pred             CC-cEEEee-ccc
Q 011380          238 DS-SLKATD-FGL  248 (487)
Q Consensus       238 ~~-~vkl~D-fG~  248 (487)
                      .. .+.|+| ||.
T Consensus       157 ~~~~lvlIDG~G~  169 (199)
T PF10707_consen  157 GEFRLVLIDGLGE  169 (199)
T ss_pred             CceEEEEEeCCCC
Confidence            44 678887 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PTZ00183 centrin; Provisional

Probab=98.16  E-value=4e-06  Score=73.01  Aligned_cols=64  Identities=17%  Similarity=0.250  Sum_probs=59.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|+.+|.+++|.|+.+|++.++.. +|..++..++..++..+|.|++|.|        +|++|..++.
T Consensus        90 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~-~~~~l~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~~  153 (158)
T PTZ00183         90 EEILKAFRLFDDDKTGKISLKNLKRVAKE-LGETITDEELQEMIDEADRNGDGEI--------SEEEFYRIMK  153 (158)
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHh
Confidence            56889999999999999999999999998 8999999999999999999999999        8999977653

>cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP)

Probab=98.16  E-value=3.7e-06  Score=68.32  Aligned_cols=62  Identities=13%  Similarity=0.093  Sum_probs=52.3

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .....+..+|..+|.|+||+|+.+||..++   +  ...+..+..+|..+|.|+||.|        +++||....
T Consensus        45 ~~~~~l~w~F~~lD~d~DG~Ls~~EL~~~~---l--~~~e~~~~~f~~~~D~n~Dg~I--------S~~Ef~~cl  106 (116)
T cd00252          45 MCKDPVGWMFNQLDGNYDGKLSHHELAPIR---L--DPNEHCIKPFFESCDLDKDGSI--------SLDEWCYCF  106 (116)
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCHHHHHHHH---c--cchHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence            345678899999999999999999999865   1  2336778999999999999999        899988754

SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules.

>KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=98.15  E-value=5.5e-06  Score=72.99  Aligned_cols=64  Identities=23%  Similarity=0.338  Sum_probs=59.1

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +...+.+|..+|+|++|.|+..||+++|.. +|..++.+-.+-+++.+|.-++|.|        .|++|+...
T Consensus       123 i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~-~Gy~Lspq~~~~lv~kyd~~~~g~i--------~FD~FI~cc  186 (221)
T KOG0037|consen  123 INQWRNVFRTYDRDRSGTIDSSELRQALTQ-LGYRLSPQFYNLLVRKYDRFGGGRI--------DFDDFIQCC  186 (221)
T ss_pred             HHHHHHHHHhcccCCCCcccHHHHHHHHHH-cCcCCCHHHHHHHHHHhccccCCce--------eHHHHHHHH
Confidence            467889999999999999999999999999 9999999999999999998889999        899998643

>KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton]

Probab=98.13  E-value=2.3e-06  Score=69.44  Aligned_cols=70  Identities=17%  Similarity=0.269  Sum_probs=62.4

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCC--CCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP--FLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~--~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +.+++..+++++|..||..+||+|+..++..+|+. +|.++|+.++.+.+...+.+  +--.|        +|++|+.+.
T Consensus         5 ~~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRa-lG~nPT~aeV~k~l~~~~~~~~~~~rl--------~FE~fLpm~   75 (152)
T KOG0030|consen    5 FTPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRA-LGQNPTNAEVLKVLGQPKRREMNVKRL--------DFEEFLPMY   75 (152)
T ss_pred             cCcchHHHHHHHHHHHhccCcccccHHHHHHHHHH-hcCCCcHHHHHHHHcCcccchhhhhhh--------hHHHHHHHH
Confidence            35567789999999999999999999999999999 99999999999999999987  44678        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        76 q   76 (152)
T KOG0030|consen   76 Q   76 (152)
T ss_pred             H
Confidence            3

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=4.6e-05  Score=78.13  Aligned_cols=144  Identities=19%  Similarity=0.233  Sum_probs=88.2

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-----------------------------hHhHHHHHHHHHHH--
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----------------------------PIAVEDVKREVKIL--  150 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------------------------~~~~~~~~~E~~~l--  150 (487)
                      +.||..+.|.|++|+-+. |+.||||+-... ...                             .+..+.+..|++.+  
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            579999999999999765 999999974321 100                             00111222222222  


Q ss_pred             --------HhccCCCC------ccEEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011380          151 --------QALAGHEN------VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH  216 (487)
Q Consensus       151 --------~~l~~hpn------Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH  216 (487)
                              +.+. |-+      |+++|  +.....-.|+||||+|..+.+.-.- ....++...+..-+.+...  +-|=
T Consensus       245 A~Nae~~~~~f~-~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf  318 (538)
T KOG1235|consen  245 AKNAERFRENFK-DFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIF  318 (538)
T ss_pred             HHhHHHHHHHHH-hcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHH
Confidence                    2232 444      44444  2334456899999999876543221 2234555544433333221  2233


Q ss_pred             HcCceeecCCCCceEeccC-CCCCcEEEeecccccccC
Q 011380          217 LHGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       217 ~~~iiHrDlkp~NIll~~~-~~~~~vkl~DfG~a~~~~  253 (487)
                      ..|++|+|=.|.||++.++ ..+..+.+-|||+...+.
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            5789999999999999954 256789999999987654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	487
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-60
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-59
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-59
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-59
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-59
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-59
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-57
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-55
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-55
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-54
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-54
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-54
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-53
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-53
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-53
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-52
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-52
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-52
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-52
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-51
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-49
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-45
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-43
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-43
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-43
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-43
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-43
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-43
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-43
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-43
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-43
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-43
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-43
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-43
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-42
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-42
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-42
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-42
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-42
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-42
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-42
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-42
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-42
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-42
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-42
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-42
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-42
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-42
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-42
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-42
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-42
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-42
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-41
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-41
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-41
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-41
3soa_A	444	Full-Length Human Camkii Length = 444		1e-41
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-41
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-41
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-41
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-41
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-41
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-41
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-41
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-40
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-40
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-40
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-39
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-39
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-39
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-38
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-38
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-38
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-37
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-37
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-37
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-37
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-37
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-36
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-36
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-36
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-36
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-36
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-36
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-36
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-36
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-36
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-36
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-36
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-36
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-35
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-35
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-34
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-34
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-34
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-34
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-34
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-33
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-33
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-33
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-33
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-33
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-33
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-33
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-33
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-33
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-33
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-33
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-33
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-33
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-33
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-33
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-33
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-33
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-33
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-32
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-32
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-32
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-32
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-32
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-32
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-32
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-32
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-32
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-32
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-32
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-32
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-32
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-32
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-32
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-32
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-32
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-32
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-32
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-32
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-32
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-32
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-32
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-32
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-32
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-32
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-31
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-31
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-31
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-31
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-31
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-31
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-31
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-31
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-31
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-31
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-31
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-31
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-31
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-31
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-31
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-31
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-31
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-31
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-31
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-31
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-31
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-31
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-31
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-31
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-31
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-31
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-31
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-31
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-31
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-31
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-31
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-31
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-31
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-31
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-31
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-31
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-31
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-31
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-31
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-31
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-30
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-30
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-30
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-30
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-30
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-29
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-29
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-29
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-29
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-29
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-29
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-29
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-28
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-27
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-27
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-27
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-26
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-26
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-26
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-26
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-25
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-25
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-25
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-25
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-25
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-24
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-24
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-24
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-24
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-24
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-24
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-24
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-24
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-24
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-24
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-24
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-24
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-23
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-23
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-23
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-23
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-22
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-22
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-22
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-22
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-22
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-22
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-22
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-22
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-22
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-22
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-22
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-22
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-22
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-22
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-22
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-22
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-22
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-22
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-22
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-22
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-22
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-22
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-22
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-22
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-22
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-22
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-22
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-22
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-22
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-22
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-22
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-22
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-22
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-22
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-22
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-22
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-22
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-21
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-21
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-21
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-21
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-21
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-21
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-21
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-21
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-21
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-21
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-20
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-20
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-20
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-20
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-20
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-20
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-20
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-20
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-20
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-20
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-20
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-20
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-20
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-20
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-20
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-20
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-20
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-20
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-19
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-19
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-19
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-19
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-19
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-19
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-19
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-19
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-19
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-19
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-19
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-19
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-19
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-19
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-19
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-19
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-19
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-19
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-19
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-19
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-19
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-19
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-19
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-19
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-19
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-19
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-19
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-19
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-19
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-19
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-19
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-19
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-19
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-19
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-19
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-19
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-19
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-19
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-19
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-19
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-19
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-19
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-19
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-19
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-19
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-19
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-19
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-19
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-19
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-19
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-19
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-19
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-19
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-19
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-19
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-19
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-19
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-19
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-19
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-19
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-19
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-19
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-19
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-19
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-19
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-19
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-19
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-19
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-19
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-19
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-19
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-19
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-18
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-18
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-18
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-18
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-18
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-18
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-18
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-18
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-18
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-18
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-18
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-18
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-18
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-18
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-18
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-18
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-18
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-18
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-18
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-18
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-18
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-18
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-18
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-18
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-18
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-18
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-18
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-17
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-17
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-17
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-17
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-17
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-17
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-17
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-17
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-17
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-17
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-15
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-15
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-15
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-15
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-15
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-15
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-15
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-15
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-15
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-13
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-12
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		5e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-12
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		5e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-12
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-11
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-10
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
2aao_A	166	Regulatory Apparatus Of Calcium Dependent Protein K		1e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-09
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		7e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		8e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-08
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-08
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		1e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-05
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-05

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  228 bits (582), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 134/351 (38%), Positives = 190/351 (54%), Gaps = 17/351 (4%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR----EGGDASEIPIDISVLNN 376
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++    E    S++P   S + N
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302
Query: 377 MRQFVKYSRLKQFALRALASTLDD-EELADLRDQFDAIDVDKNGSISLEEM 426
           +RQF    +L Q AL  +AS L   +E   L + F  +D + +G +  +E+
Sbjct: 303 IRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDEL 353

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 133/370 (35%), Positives = 201/370 (54%), Gaps = 18/370 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K LG G +G   +  DK  G   A+K I+K+ +        +  EV +L+ L  H
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL-DH 63
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++K Y  FED    Y+ ME+  GGEL D I+ ++  +++E DAAV+++Q+L      H
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTTYLH 121
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L +S   D+ +K  DFGLS   + G K ++ +G+AYY+APEVL++K
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS GVI YILLCG  PF  +T+  I K V + K  F    W  +S+ AK  VK
Sbjct: 182 YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 241
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPID----ISVLNNMRQFVKYSRLKQFALR 392
            +L  +P  R++A +AL+HPW+ +        +        L NM++F    +L Q A+ 
Sbjct: 242 LMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGKHALTGALGNMKKFQSSQKLAQAAML 301
Query: 393 ALASTLDD-EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLK----------ES 441
            + S L   EE  +L   F  +D + +G +  +E+ +   K + WK            E+
Sbjct: 302 FMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIEA 361
Query: 442 RVLEILQAVN 451
            V  ILQ+V+
Sbjct: 362 EVDHILQSVD 371

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 132/357 (36%), Positives = 200/357 (56%), Gaps = 9/357 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 108 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 164
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 165 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 224
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 225 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 284
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W++      +I +D+  L+    N+RQF    +L Q 
Sbjct: 285 LIRKMLTYVPSMRISARDALDHEWIQT-YTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 343
Query: 390 ALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLE 445
           AL  + S L   +E  +L   F  +D + +G +   E+ +   + +  K +++ +L+
Sbjct: 344 ALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLD 400

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 132/357 (36%), Positives = 200/357 (56%), Gaps = 9/357 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 107 -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 163
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 164 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 223
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 224 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 283
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W++      +I +D+  L+    N+RQF    +L Q 
Sbjct: 284 LIRKMLTYVPSMRISARDALDHEWIQT-YTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 342
Query: 390 ALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLE 445
           AL  + S L   +E  +L   F  +D + +G +   E+ +   + +  K +++ +L+
Sbjct: 343 ALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLD 399

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  227 bits (579), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 132/357 (36%), Positives = 200/357 (56%), Gaps = 9/357 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 84  -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 140
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K+L   P  R++A  AL H W+ +     +I +D+  L+    N+RQF    +L Q 
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWI-QTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 319
Query: 390 ALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLE 445
           AL  + S L   +E  +L   F  +D + +G +   E+ +   + +  K +++ +L+
Sbjct: 320 ALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLD 376

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  226 bits (576), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 137/364 (37%), Positives = 205/364 (56%), Gaps = 20/364 (5%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G +G   +  DK      A+K I K   +   +   +  EV +L+ L  H N++K
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLL-DHPNIMK 100
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y+ FED    Y+ ME  +GGEL D I+ +   ++ E DAAV+++Q+L      H H +V
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           HRD+KPEN L +S ++D+ +K  DFGLS   +  KK ++ +G+AYY+APEVL++K   + 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKC 218
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           DVWSIGVI +ILL G  PF  +T+  I ++V + K  F    W ++S  AKD +K++L  
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDI----SVLNNMRQFVKYSRLKQFALRALAST 397
           D + R++A QAL HPW++E     E  I++    + + NMR+F    +L Q AL  +AS 
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASK 338
Query: 398 L-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAK---------DLPWKLKESRVLEIL 447
           L   EE  +L D F  ID + +G +  +E+    +K         DLP    ES V  IL
Sbjct: 339 LTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQ--IESEVDAIL 396
Query: 448 QAVN 451
            A +
Sbjct: 397 GAAD 400

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  220 bits (561), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 130/338 (38%), Positives = 186/338 (55%), Gaps = 9/338 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+ K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 84  -DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 140
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 141 YXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL 200
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN----NMRQFVKYSRLKQF 389
            ++K L   P  R++A  AL H W+ +     +I +D+  L+    N+RQF    +L Q 
Sbjct: 261 LIRKXLTYVPSXRISARDALDHEWI-QTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQA 319
Query: 390 ALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEM 426
           AL    S L   +E  +L   F   D + +G +   E+
Sbjct: 320 ALLYXGSKLTSQDETKELTAIFHKXDKNGDGQLDRAEL 357

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV---KREVKI 149
           D ++ YT+   +G G +G   +A  K    R A KKI K        VEDV   K+E++I
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK------YFVEDVDRFKQEIEI 76
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           +++L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+  R  E DAA +++ +L
Sbjct: 77  MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 133
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
              A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           P+VL+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S 
Sbjct: 194 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 253
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            A+  +++LL K P+ R+T+ QAL H W
Sbjct: 254 QAESLIRRLLTKSPKQRITSLQALEHEW 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 110/268 (41%), Positives = 160/268 (59%), Gaps = 12/268 (4%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV---KREVKI 149
           D ++ YT+   +G G +G   +A  K    R A KKI K        VEDV   K+E++I
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK------YFVEDVDRFKQEIEI 59
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           +++L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+  R  E DAA +++ +L
Sbjct: 60  MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFR--ESDAARIMKDVL 116
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
              A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           P+VL+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPW 357
            A+  +++LL K P+ R+T+ QAL H W
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEW 264

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  211 bits (536), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 111/266 (41%), Positives = 157/266 (59%), Gaps = 3/266 (1%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+ L
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L    
Sbjct: 90  -DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGIT 146
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APEVL
Sbjct: 147 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 206
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                 + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SAKD
Sbjct: 207 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 266
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVR 359
            ++K+L   P  R++A  AL H W++
Sbjct: 267 LIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  210 bits (534), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 121/305 (39%), Positives = 174/305 (57%), Gaps = 8/305 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D  + +   + LG G F    +A +KA G   AVK I K    L      ++ E+ +L+
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKA--LKGKESSIENEIAVLR 75
Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            +  HEN+V   + +E  N++Y+ M+L  GGEL DRI+ K    YTEKDA+ ++RQ+L  
Sbjct: 76  KIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIRQVLDA 132
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H  G+VHRD+KPEN L+ S  E+S +  +DFGLS     G       G+  YVAPE
Sbjct: 133 VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 272 VLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VL +K   ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+S
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
           AKDF++ L+ KDP  R T  QA  HPW+  G  A    I  SV   +R+    S+ +Q A
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQAARHPWI-AGDTALNKNIHESVSAQIRKNFAKSKWRQ-A 310
Query: 391 LRALA 395
             A A
Sbjct: 311 FNATA 315

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 109/269 (40%), Positives = 159/269 (59%), Gaps = 3/269 (1%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           Y +    RY   K LG G +G   +  DK  G   A+K I+K+ +        +  EV +
Sbjct: 15  YFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L+ L  H N++K Y  FED    Y+ ME+  GGEL D I+ ++  +++E DAAV+++Q+L
Sbjct: 75  LKQL-DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVL 131
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H H +VHRD+KPEN L +S   D+ +K  DFGLS   + G K ++ +G+AYY+A
Sbjct: 132 SGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 191
Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           PEVL++K   + DVWS GVI YILLCG  PF  +T+  I K V + K  F    W  +S+
Sbjct: 192 PEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSD 251
Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            AK  VK +L  +P  R++A +AL+HPW+
Sbjct: 252 EAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 113/280 (40%), Positives = 156/280 (55%), Gaps = 12/280 (4%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W +IS+ AKD ++K+L   P  R+TA Q L HPW+++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 113/280 (40%), Positives = 156/280 (55%), Gaps = 12/280 (4%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK----NKMILPIAV 140
           R +  +   F  RY I  +LG G FG      D+      AVK I K    NK       
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DT 65
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W +IS+ AKD ++K+L   P  R+TA Q L HPW+++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  205 bits (522), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 121/341 (35%), Positives = 188/341 (55%), Gaps = 19/341 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEK-----------NKMILPIAVEDVKREVKILQA 152
           LG G +G   +  +K      A+K I+K           NK I     E++  E+ +L++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH-EEIYNEISLLKS 102
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H N++K ++ FED  Y Y+  E  EGGEL ++I+ +   ++ E DAA +++Q+L   
Sbjct: 103 L-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGI 159
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
              H H +VHRD+KPEN L ++     ++K  DFGLS F     K +D +G+AYY+APEV
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           LK+K   + DVWS GVI YILLCG  PF  + +  I K+V + K  F    W +IS+ AK
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGG---DASEIPIDISVLNNMRQFVKYSRLKQF 389
           + +K +L  D   R TA +AL+  W+++     + S+       L+NMR+F    +L Q 
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQA 339
Query: 390 ALRALASTLDD-EELADLRDQFDAIDVDKNGSISLEEMRQA 429
           A+  + S L   EE  +L D F  +D + +G +  +E+ + 
Sbjct: 340 AILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEG 380

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  202 bits (514), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 107/264 (40%), Positives = 160/264 (60%), Gaps = 8/264 (3%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           + +   ++LG G F   ++   +  G   A+K I+K+      ++E+   E+ +L+ +  
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIK- 64
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           HEN+V   + +E   + Y+ M+L  GGEL DRIL +    YTEKDA++V++Q+L      
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYL 122
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H +G+VHRD+KPEN L+ + +E+S +  TDFGLS   + G       G+  YVAPEVL +
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 276 KSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           K   ++ D WSIGVITYILLCG  PF+++TE  +F+++     +F    W  IS SAKDF
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 335 VKKLLVKDPRARLTAAQALSHPWV 358
           +  LL KDP  R T  +ALSHPW+
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWI 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  202 bits (514), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 166/292 (56%), Gaps = 7/292 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
            L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  202 bits (513), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 116/292 (39%), Positives = 166/292 (56%), Gaps = 7/292 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
            L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 119/299 (39%), Positives = 169/299 (56%), Gaps = 8/299 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALA 395
            L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ A  A A
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI-AGDTALDKNIHQSVSEQIKKNFAKSKWKQ-AFNATA 311

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 110/269 (40%), Positives = 156/269 (57%), Gaps = 8/269 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y    +LG G F    +A DK     VA+K I K    L      ++ E+ +L  +  H 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEA--LEGKEGSMENEIAVLHKIK-HP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+V   + +E   ++Y+ M+L  GGEL DRI+ K    YTE+DA+ ++ Q+L      H 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPEVL +K 
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             ++ D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+SAKDF++
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDAS 365
            L+ KDP  R T  QAL HPW+   GD +
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI--AGDTA 281

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  191 bits (486), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 169/296 (57%), Gaps = 12/296 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G     Y    K      A+K ++K      +  + V+ E+ +L  L+ H N++K  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLS-HPNIIKLK 114
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             FE    + + +EL  GGEL DRI+ K    Y+E+DAA  V+Q+L   A  H +G+VHR
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESD 282
           D+KPEN L+ +   D+ LK  DFGLS  ++     + + G+  Y APE+L+  + GPE D
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVD 232
Query: 283 VWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           +WS+G+ITYILLCG  PF+D+  D  +F+ +L  +  F    W  +S +AKD V+KL+V 
Sbjct: 233 MWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 342 DPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAST 397
           DP+ RLT  QAL HPWV  G  A+ + +D +    +++F    +LK      +AS+
Sbjct: 293 DPKKRLTTFQALQHPWV-TGKAANFVHMD-TAQKKLQEFNARRKLKAAVKAVVASS 346

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 160/279 (57%), Gaps = 6/279 (2%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           R +  +    D  +   + LG G FG  ++  ++++G    +K I K++  +P+  E ++
Sbjct: 11  RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIE 68
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAA 202
            E+++L++L  H N++K +  FED + +YI ME CEGGELL+RI++   +    +E   A
Sbjct: 69  AEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +++QM+   A  H   +VH+D+KPEN LF+     S +K  DFGL++  K  +   +  
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA 187
Query: 263 GSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
           G+A Y+APEV KR    + D+WS GV+ Y LL G  PF   + + + ++    +P++  +
Sbjct: 188 GTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
             P ++  A D +K++L KDP  R +AAQ L H W ++ 
Sbjct: 248 CRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 70  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 125
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 126 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 245
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 246 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 286

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 63  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 118
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 238
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 239 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 279

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A E     +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 94/305 (30%), Positives = 169/305 (55%), Gaps = 12/305 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + LG G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CHL+G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           D + K+L  +P  R+TA++AL HPW+ +    + +      ++ +++F    +LK   L 
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILT 298
Query: 393 ALAST 397
            + +T
Sbjct: 299 TMLAT 303

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 155/267 (58%), Gaps = 8/267 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV IL+ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+L     
Sbjct: 67  -HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQILDGVHY 123
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +VAPE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + S  AK
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           DF+++LLVKDP+ R+T AQ+L H W++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           +D +  Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+
Sbjct: 68  ILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQI 124
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +
Sbjct: 125 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 184
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 244
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+  AQ+L H W++
Sbjct: 245 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 167/302 (55%), Gaps = 12/302 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + LG G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILESVNH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CHL+G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
           D + K+L  +P  R+TA++AL HPW+ +    + +      ++ +++F    +LK   L 
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGAILT 298
Query: 393 AL 394
            +
Sbjct: 299 TM 300

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  172 bits (435), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 154/267 (57%), Gaps = 8/267 (2%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV IL+ + 
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ FE+   V + +EL  GGEL D  LA+K+S  TE +A   ++Q+L     
Sbjct: 88  -HPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKES-LTEDEATQFLKQILDGVHY 144
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L      +  +K  DFG++  I+ G +F++I G+  +VAPE++
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + S  AK
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 264
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
           DF+++LLVKDP+ R+  AQ+L H W++
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +  A E     +V+
Sbjct: 143 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 202
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 203 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 258
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 419

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  171 bits (433), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 171/309 (55%), Gaps = 11/309 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN--NMR-QFVKYSRLKQF 389
           DF++KLLVK+ R RLT  +AL HPW+    +   +    SV+N  N R Q+V+      F
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLAF 310
Query: 390 ALRALASTL 398
           ++ +L + L
Sbjct: 311 SIVSLCNHL 319

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  171 bits (433), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 171/309 (55%), Gaps = 11/309 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN--NMR-QFVKYSRLKQF 389
           DF++KLLVK+ R RLT  +AL HPW+    +   +    SV+N  N R Q+V+      F
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRSKLAF 310
Query: 390 ALRALASTL 398
           ++ +L + L
Sbjct: 311 SIVSLCNHL 319

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/281 (36%), Positives = 152/281 (54%), Gaps = 14/281 (4%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE-----DVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +  A E     +V+
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 244
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 265 AYYVAPEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 171/309 (55%), Gaps = 11/309 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN--NMR-QFVKYSRLKQF 389
           DF++KLLVK+ R RLT  +AL HPW+    +   +    SV+N  N R Q+V+      F
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSF 310
Query: 390 ALRALASTL 398
           ++ +L + L
Sbjct: 311 SIVSLCNHL 319

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 106/298 (35%), Positives = 165/298 (55%), Gaps = 9/298 (3%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
            S  AKDF+++LLVKDP+ R+T   +L HPW++       +    S + NM +F K++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV-NMEKFKKFA 300

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/286 (32%), Positives = 159/286 (55%), Gaps = 9/286 (3%)
Query: 77  TGVIPCGKRTDFGYDKD--FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM 134
           TG    G+ ++F  +    F   Y + + LG G F        K  G   A K I   K+
Sbjct: 8   TGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL 67
Query: 135 ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
                 + ++RE +I + L  H N+V+ +++ +++++ Y+  +L  GGEL + I+A++  
Sbjct: 68  SAR-DFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-- 123
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
            Y+E DA+  ++Q+L   A CH +G+VHR++KPEN L  S  + +++K  DFGL+  +  
Sbjct: 124 FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 255 GKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
            + +    G+  Y++PEVLK+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++
Sbjct: 184 SEAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                D+    W +++  AK  +  +L  +P+ R+TA QAL  PW+
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 111/309 (35%), Positives = 171/309 (55%), Gaps = 11/309 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLN--NMR-QFVKYSRLKQF 389
           DF++KLLVK+ R RLT  +AL HPW+    +   +    SV+N  N R Q+V+      F
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLDF 310
Query: 390 ALRALASTL 398
           ++ +L + L
Sbjct: 311 SIVSLCNHL 319

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  169 bits (428), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 152/266 (57%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H NV+  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 122
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 122
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 100/266 (37%), Positives = 151/266 (56%), Gaps = 8/266 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA 154
           Y IG+ LG GQF       +K+ G   A K I+K +       +  E+++REV IL+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++  ++ +E+   V + +EL  GGEL D  LA+K+S  +E++A   ++Q+L     
Sbjct: 74  -HPNIITLHDVYENRTDVVLILELVSGGELFD-FLAQKES-LSEEEATSFIKQILDGVNY 130
Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            H   + H D+KPEN  L         +K  DFGL+  I+ G +F++I G+  +VAPE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + +   S  AK
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF++KLLVK+ R RLT  +AL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  168 bits (426), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 93/299 (31%), Positives = 162/299 (54%), Gaps = 12/299 (4%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F           G   A K I   K+    +  D   ++RE +I 
Sbjct: 20  FQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL----SARDHQKLEREARIC 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L 
Sbjct: 76  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILE 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
               CH  G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 252
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLK 387
             AKD + K+L  +P  R+TAA+AL HPW+      +        ++ +++F    +LK
Sbjct: 253 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 311

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  167 bits (424), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 63  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 180 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 62  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 179 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 237
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 238 KSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 154/279 (55%), Gaps = 18/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQAL 153
           Y I + LG G FG  +  T++A G+  A K +    E +K       E V++E++ +  L
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-------ETVRKEIQTMSVL 105
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +   
Sbjct: 106 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV 
Sbjct: 164 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 222
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           + K  G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   K
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           DF++KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 321

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 151/267 (56%), Gaps = 7/267 (2%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + LG G F        K  G   A K I   K+      + ++RE +I + L
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L   A
Sbjct: 63  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIA 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           K+   S P  D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  A
Sbjct: 180 KKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWV 358
           K  +  +L  +P+ R+TA QAL  PW+
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 93/309 (30%), Positives = 165/309 (53%), Gaps = 17/309 (5%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L   Q + T +     + P  +  D+   K+F ++Y    ++G G          +A 
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 121 GDRVAVKKIEKN-KMILPIAVEDVK----REVKILQALAGHENVVKFYNAFEDDNYVYIA 175
           G   AVK +E   + + P  +E+V+    RE  IL+ +AGH +++   +++E  +++++ 
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            +L   GEL D +  K     +EK+   ++R +L   +  H + +VHRD+KPEN L    
Sbjct: 179 FDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-- 234
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGV 288
            ++  ++ +DFG S  ++PG+K +++ G+  Y+APE+LK          G E D+W+ GV
Sbjct: 235 -DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 289 ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
           I + LL G  PFW + +  + + ++  +  F    W   S++ KD + +LL  DP ARLT
Sbjct: 294 ILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT 353
Query: 349 AAQALSHPW 357
           A QAL HP+
Sbjct: 354 AEQALQHPF 362

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 98/335 (29%), Positives = 176/335 (52%), Gaps = 18/335 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F           G   A   I   K+    +  D   ++RE +I 
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL----SARDHQKLEREARIC 64
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L 
Sbjct: 65  RLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILE 121
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
               CH  G+VHR++KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
             AKD + K+L  +P  R+TAA+AL HPW+      +        ++ +++F    +LK 
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKG 301
Query: 389 FALRALAST----LDDEELADLRDQFDAIDVDKNG 419
             L  + +T    +  +E+  + +Q   I+   NG
Sbjct: 302 AILTVMLATRNFSVRKQEIIKVTEQL--IEAISNG 334

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/279 (35%), Positives = 154/279 (55%), Gaps = 18/279 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQAL 153
           Y I + LG G FG  +  T++A G+  A K +    E +K       E V++E++ +  L
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-------ETVRKEIQTMSVL 211
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +   
Sbjct: 212 R-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV 
Sbjct: 270 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           + K  G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   K
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           DF++KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 155/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG G+F       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V +  EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 163/295 (55%), Gaps = 12/295 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA 154
           Y + + +G G F           G   A K I   K+    +  D   ++RE +I + L 
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL----SARDHQKLEREARICRLLK 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L     
Sbjct: 62  -HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLH 118
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPEVL 273
           CH  G+VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           ++++ G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLK 387
           + + ++L  +P  R+TA +AL HPWV +    + +      +  +++F    +LK
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK 293

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 100/273 (36%), Positives = 154/273 (56%), Gaps = 8/273 (2%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVK 148
           ++ D  Y  G+ LG G F       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D  LA+K+S  TE++A   ++Q+
Sbjct: 67  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKES-LTEEEATEFLKQI 123
Query: 209 LRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN  L         +K  DFGL+  I  G +F++I G+  +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            S  AKDF+++LLVKDP+ R+T   +L HPW++
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 102/318 (32%), Positives = 172/318 (54%), Gaps = 20/318 (6%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP--IAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL------SDFIKPGKKFQD 260
           Q+L     CH + ++HRD+KPEN L  S +  + +K  DFG+      S  +  G+    
Sbjct: 138 QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR---- 193
Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
            VG+ +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K   
Sbjct: 194 -VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKM 251
Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI-SVLNNMR 378
             + W  IS SAKD V+++L+ DP  R+T  +AL+HPW++E  D     I +   +  +R
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYKIHLPETVEQLR 310
Query: 379 QFVKYSRLKQFALRALAS 396
           +F    +LK   L A++S
Sbjct: 311 KFNARRKLKGAVLAAVSS 328

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 162/306 (52%), Gaps = 12/306 (3%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F   Y + + LG G F        K      A K I   K+    +  D   ++RE +I 
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL----SARDHQKLEREARIC 84
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  + Q+L 
Sbjct: 85  RLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE--YYSEADASHCIHQILE 141
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVA 269
                H H +VHRD+KPEN L  S  + +++K  DFGL+  ++  ++ +    G+  Y++
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++
Sbjct: 202 PEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 261
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
             AK+ + ++L  +P  R+TA QAL HPWV +    + +      +  +R+F    +LK 
Sbjct: 262 PEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKG 321
Query: 389 FALRAL 394
             L  +
Sbjct: 322 AILTTM 327

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 105/288 (36%), Positives = 157/288 (54%), Gaps = 11/288 (3%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG  +   +KA G RV V K        P+    VK E+ I+  L  H 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATG-RVFVAKFINTP--YPLDKYTVKNEISIMNQLH-HP 108
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            ++  ++AFED   + + +E   GGEL DRI A +D + +E +    +RQ        H 
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H +VH D+KPEN + ++ K+ SS+K  DFGL+  + P +  +    +A + APE++ R+ 
Sbjct: 168 HSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 278 -GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
            G  +D+W+IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+K
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP--IDISVLNNMRQFVK 382
            LL K+PR RLT   AL HPW++  GD S +   I  S  N +RQ +K
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLK--GDHSNLTSRIPSSRYNKIRQKIK 332

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 102/328 (31%), Positives = 175/328 (53%), Gaps = 12/328 (3%)
Query: 76  QTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI 135
            +G++P G   D   D  F+  Y + +++G G F       ++  G + AVK ++  K  
Sbjct: 8   SSGLVPRGSMAD--DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 65
Query: 136 LP--IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
               ++ ED+KRE  I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D
Sbjct: 66  SSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 124
Query: 194 SR--YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-D 250
           +   Y+E  A+  +RQ+L     CH + ++HRD+KP   L  S +  + +K   FG++  
Sbjct: 125 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 184
Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
             + G      VG+ +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F
Sbjct: 185 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 243
Query: 310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           + +++ K     + W  IS SAKD V+++L+ DP  R+T  +AL+HPW++E  D     I
Sbjct: 244 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYKI 302
Query: 370 DI-SVLNNMRQFVKYSRLKQFALRALAS 396
            +   +  +R+F    +LK   L A++S
Sbjct: 303 HLPETVEQLRKFNARRKLKGAVLAAVSS 330

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 147/264 (55%), Gaps = 13/264 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +G LLG G F   Y A     G  VA+K I+K  M     V+ V+ EVKI   L  H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           ++++ YN FED NYVY+ +E+C  GE ++R L  +   ++E +A   + Q++      H 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGE-MNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRK 276
           HG++HRD+   N L      + ++K  DFGL+  +K P +K   + G+  Y++PE+  R 
Sbjct: 131 HGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 277 S-GPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           + G ESDVWS+G + Y LL GR PF  D  ++ + K VL    D+    + SI   AKD 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADYEMPSFLSI--EAKDL 242
Query: 335 VKKLLVKDPRARLTAAQALSHPWV 358
           + +LL ++P  RL+ +  L HP++
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 106/303 (34%), Positives = 154/303 (50%), Gaps = 37/303 (12%)
Query: 94  FDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           F+  Y +  +LLG G +     A    NG   AVK IEK       +   V REV+ L  
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSRVFREVETLYQ 66
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             G++N+++    FEDD   Y+  E  +GG +L  I  +K   + E++A+ VVR +    
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVAAAL 124
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGS 264
              H  G+ HRD+KPEN L +S ++ S +K  DF L   +K       I         GS
Sbjct: 125 DFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 265 AYYVAPEVLKRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE---- 305
           A Y+APEV++  +   +      D+WS+GV+ YI+L G  PF         WD+ E    
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRV 244
Query: 306 --DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
             + +F+ +   K +F  K W  IS+ AKD + KLLV+D + RL+AAQ L HPWV+  G 
Sbjct: 245 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GQ 302
Query: 364 ASE 366
           A E
Sbjct: 303 APE 305

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 98/313 (31%), Positives = 168/313 (53%), Gaps = 10/313 (3%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP--IAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSA 265
           Q+L     CH + ++HRD+KP   L  S +  + +K   FG++    + G      VG+ 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K     + W
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256
Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI-SVLNNMRQFVKY 383
             IS SAKD V+++L+ DP  R+T  +AL+HPW++E  D     I +   +  +R+F   
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE-RDRYAYKIHLPETVEQLRKFNAR 315
Query: 384 SRLKQFALRALAS 396
            +LK   L A++S
Sbjct: 316 RKLKGAVLAAVSS 328

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 151/269 (56%), Gaps = 15/269 (5%)
Query: 98  YTIGK--LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           YT+ K  +LG G+FG  +   + A G ++A K I+   M      E+VK E+ ++  L  
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-D 144
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAA 213
           H N+++ Y+AFE  N + + ME  +GGEL DRI+   D  Y  TE D  + ++Q+     
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIR 201
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H   ++H D+KPEN L  + ++   +K  DFGL+   KP +K +   G+  ++APEV+
Sbjct: 202 HMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV 260
Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
                S P +D+WS+GVI Y+LL G  PF    +      +L  + D   + +  IS  A
Sbjct: 261 NYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           K+F+ KLL+K+   R++A++AL HPW+ +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 145/289 (50%), Gaps = 19/289 (6%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           G++P G   +      F   Y + + +G G +        KA     AVK I+K+K    
Sbjct: 13  GLVPRGSHMNL----VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---- 64
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
               D   E++IL     H N++   + ++D  +VY+  EL  GGELLD+IL +K   ++
Sbjct: 65  ---RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFS 119
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGK 256
           E++A+ V+  + +     H  G+VHRD+KP N L+   +     L+  DFG +  ++   
Sbjct: 120 EREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179
Query: 257 KF-QDIVGSAYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDG---IFKE 311
                   +A +VAPEVLKR+   E  D+WS+G++ Y +L G  PF +   D    I   
Sbjct: 180 GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +   K       W ++S +AKD V K+L  DP  RLTA Q L HPWV +
Sbjct: 240 IGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  154 bits (390), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 141/271 (52%), Gaps = 15/271 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRY 72
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVE 130
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGKK-FQDIVGSAYYVAPE 271
             H  G+VHRD+KP N L+   +    S++  DFG +  ++           +A +VAPE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPWPSI 327
           VL+R+      D+WS+GV+ Y +L G  PF    D T + I   +   K       W S+
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S++AKD V K+L  DP  RLTAA  L HPW+
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 139/273 (50%), Gaps = 15/273 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRY 77
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  +VY+  EL  GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 78  GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVE 135
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPE 271
             H  G+VHRD+KP N L+   +     L+  DFG +  ++           +A +VAPE
Sbjct: 136 YLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE 195
Query: 272 VLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRRKPWPSI 327
           VLKR+   E  D+WS+G++ Y +L G  PF +   D    I   +   K       W ++
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S +AKD V K+L  DP  RLTA Q L HPWV +
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 128/227 (56%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 112
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K ++
Sbjct: 113 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 229
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 230 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 128/227 (56%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 125
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K ++
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 76/227 (33%), Positives = 127/227 (55%), Gaps = 12/227 (5%)
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K     +EK+
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKE 125
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K + 
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 261 IVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL 313
           + G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + +  + + ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VA+K I+K ++  P +++ + REV+I++ L  H 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 130 KRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 242
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           K+ LV +P  R T  Q +   W+  G +  E+
Sbjct: 243 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 274

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 144/291 (49%), Gaps = 20/291 (6%)
Query: 91  DKDFDRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  F + Y +    K LG G F        K +    AVK I K          + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEI 56
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             L+   GH N+VK +  F D  + ++ MEL  GGEL +RI  KK   ++E +A+ ++R+
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRK 114
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAY 266
           ++   +  H  G+VHRD+KPEN LF    ++  +K  DFG +    P  +  +    + +
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTED-------GIFKEVLRNKPD 318
           Y APE+L +    ES D+WS+GVI Y +L G+ PF              I K++ +    
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           F  + W ++S  AKD ++ LL  DP  RL  +    + W+++G   S  P+
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 139/271 (51%), Gaps = 15/271 (5%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   Y + + +G G +        KA     AVK I+K+K        D   E++IL   
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRY 72
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +   
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVE 130
Query: 214 ECHLHGLVHRDMKPENFLF-KSAKEDSSLKATDFGLSDFIKPGKKFQDI-VGSAYYVAPE 271
             H  G+VHRD+KP N L+   +    S++  DFG +  ++           +A +VAPE
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPWPSI 327
           VL+R+      D+WS+GV+ Y  L G  PF    D T + I   +   K       W S+
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           S++AKD V K L  DP  RLTAA  L HPW+
Sbjct: 251 SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VA+K I+K ++  P +++ + REV+I++ L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 133 KRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 245
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           K+ LV +P  R T  Q +   W+  G +  E+
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 94/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 142/285 (49%), Gaps = 18/285 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   V   +  G +VAVK + + K+     V  ++RE++ L+ L  H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y      + +++ ME   GGEL D I   K+ R  EK++  + +Q+L     CH 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +   GS  Y APEV+  + 
Sbjct: 135 HMVVHRDLKPENVLLDAHM---NAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRL 191
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN---KPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D     +FK++       P +       ++ S  
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY-------LNPSVI 244
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNM 377
             +K +L  DP  R T      H W ++       P D S  + M
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTM 289

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAV+ I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K  +  GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  149 bits (376), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 140/281 (49%), Gaps = 26/281 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G       +  G + A+K +  +           ++EV      +G  ++V 
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVC 67
Query: 162 FYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+ ++    + I ME  EGGEL  RI  + D  +TE++AA ++R +       H 
Sbjct: 68  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YYVAPEVL    
Sbjct: 128 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL---- 182
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F    W  +S
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 242
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+
Sbjct: 243 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 140/281 (49%), Gaps = 26/281 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G       +  G + A+K +  +           ++EV      +G  ++V 
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVC 86
Query: 162 FYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+ ++    + I ME  EGGEL  RI  + D  +TE++AA ++R +       H 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YYVAPEVL    
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVL---- 201
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F    W  +S
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  149 bits (375), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAV+ I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  148 bits (374), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 140/265 (52%), Gaps = 19/265 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I + LG G FG   +AT      +VA+K I +  +        V+RE+  L+ L  H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+       + + +E   GGEL D I+ KK  R TE +     +Q++     CH 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     ++ ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 127 HKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS G++ Y++L GR PF D+    +FK+V   +   PDF       +S  A+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQ 236
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             +++++V DP  R+T  +    PW
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 100/320 (31%), Positives = 148/320 (46%), Gaps = 52/320 (16%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--ILPIAVEDVKREVKIL 150
           +  ++Y +   +G G +G   VA +       A+K + KNK+  I P  VE +K EV+++
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           + L  H N+ + Y  +ED+ Y+ + MELC GG LLD++    D   T K A  VV+  + 
Sbjct: 83  KKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS-TGKCAMDVVKTQIC 140
Query: 211 VAAEC---------------------------------------HLHGLVHRDMKPENFL 231
              EC                                       H  G+ HRD+KPENFL
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 232 FKSAKEDSSLKATDFGLS-DFIKPGKK----FQDIVGSAYYVAPEVLKRKS---GPESDV 283
           F S  +   +K  DFGLS +F K             G+ Y+VAPEVL   +   GP+ D 
Sbjct: 201 F-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDP 343
           WS GV+ ++LL G  PF    +     +VL  K  F    +  +S  A+D +  LL ++ 
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
Query: 344 RARLTAAQALSHPWVREGGD 363
             R  A +AL HPW+ +  D
Sbjct: 320 DERFDAMRALQHPWISQFSD 339

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 142/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 276

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 91/268 (33%), Positives = 136/268 (50%), Gaps = 18/268 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+ L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y         ++ ME   GGEL D I   K  R  E +A  + +Q+L     CH 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +D  GS  Y APEV+  + 
Sbjct: 130 HMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRL 186
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D+    +FK++   +   P++       ++ S  
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-------LNRSVA 239
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
             +  +L  DP  R T      H W ++
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 141/272 (51%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I++ L  H 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIMKVL-NHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A       EK+A    RQ++     CH 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 125 KFIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 237
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q +   W+  G +  E+
Sbjct: 238 KKFLILNPSKRGTLEQIMKDRWMNVGHEDDEL 269

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/268 (33%), Positives = 135/268 (50%), Gaps = 18/268 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+ L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y         ++ ME   GGEL D I   K  R  E +A  + +Q+L     CH 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L  +     + K  DFGLS+ +  G+  +   GS  Y APEV+  + 
Sbjct: 130 HMVVHRDLKPENVLLDA---HMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRL 186
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE D+WS GVI Y LLCG  PF D+    +FK++   +   P++       ++ S  
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY-------LNRSVA 239
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
             +  +L  DP  R T      H W ++
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 104/296 (35%), Positives = 145/296 (48%), Gaps = 36/296 (12%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVK 161
           +LG G         +       AVK IEK     P  +   V REV++L    GH NV++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
               FE+++  Y+  E   GG +L  I   K   + E +A+VVV+ +       H  G+ 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGSAYYVAPEVL 273
           HRD+KPEN L +   + S +K  DFGL   IK       I         GSA Y+APEV+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 274 KRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE------DGIFKEV 312
           +  S   S      D+WS+GVI YILL G  PF         WD+ E      + +F+ +
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+     + +P
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 132 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 241
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 242 GLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 131 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 240
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 241 GLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 64
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 121
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 122 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 231
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 232 GLIKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/267 (32%), Positives = 140/267 (52%), Gaps = 19/267 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I K LG G FG   +A     G +VA+K I K  +        ++RE+  L+ L  H 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           +++K Y+  +  + + + +E   G EL D I+ +   + +E++A    +Q++     CH 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK- 276
           H +VHRD+KPEN L     E  ++K  DFGLS+ +  G   +   GS  Y APEV+  K 
Sbjct: 126 HKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 277 -SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV---LRNKPDFRRKPWPSISNSAK 332
            +GPE DVWS GVI Y++LC R PF D++   +FK +   +   P F       +S  A 
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF-------LSPGAA 235
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVR 359
             +K++L+ +P  R++  + +   W +
Sbjct: 236 GLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 103/296 (34%), Positives = 144/296 (48%), Gaps = 36/296 (12%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVKILQALAGHENVVK 161
           +LG G         +       AVK IEK     P  +   V REV++L    GH NV++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
               FE+++  Y+  E   GG +L  I   K   + E +A+VVV+ +       H  G+ 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKGIA 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--------VGSAYYVAPEVL 273
           HRD+KPEN L +   + S +K  DF L   IK       I         GSA Y+APEV+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 274 KRKSGPES------DVWSIGVITYILLCGRRPF---------WDKTE------DGIFKEV 312
           +  S   S      D+WS+GVI YILL G  PF         WD+ E      + +F+ +
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+     + +P
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/272 (33%), Positives = 137/272 (50%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++    +++ + REV+I + L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN-SSSLQKLFREVRIXKVL-NHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+  E   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH--GRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L  +   D ++K  DFG S+    G K     G+  Y APE+   K+
Sbjct: 132 KFIVHRDLKAENLLLDA---DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+   S   ++ +
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YXSTDCENLL 244
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KK L+ +P  R T  Q     W   G +  E+
Sbjct: 245 KKFLILNPSKRGTLEQIXKDRWXNVGHEDDEL 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 143/272 (52%), Gaps = 13/272 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K +G G F    +A     G  VAVK I+K ++  P +++ + REV+I++ L  H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLN-PTSLQKLFREVRIMKIL-NHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--GRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KR 275
             +VHRD+K EN L      D ++K  DFG S+    G K     GS  Y APE+   K+
Sbjct: 133 KYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             GPE DVWS+GVI Y L+ G  PF  +    + + VLR K    R P+  +S   ++ +
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---YRIPF-YMSTDCENLL 245
Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           KKLLV +P  R +  Q +   W+  G +  E+
Sbjct: 246 KKLLVLNPIKRGSLEQIMKDRWMNVGHEEEEL 277

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 91/326 (27%), Positives = 156/326 (47%), Gaps = 28/326 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 191
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 192 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFVKYSRL 386
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S VL   ++  ++  +
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE--RWEDV 308
Query: 387 KQFALRALASTLDDEELADLRDQFDA 412
           K+    ALA+   D E   ++   DA
Sbjct: 309 KEEMTSALATMRVDYEQIKIKKIEDA 334

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 144/272 (52%), Gaps = 12/272 (4%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKI 149
           K+   +Y I + LG G+FG  +   + ++      K  K++    +L      VK+E+ I
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISI 54
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L  +A H N++  + +FE    + +  E   G ++ +RI         E++    V Q+ 
Sbjct: 55  LN-IARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC 112
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H H + H D++PEN ++++ +  S++K  +FG +  +KPG  F+ +  +  Y A
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PEV +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             A DFV +LLVK+ ++R+TA++AL HPW+++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/326 (27%), Positives = 156/326 (47%), Gaps = 28/326 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 124
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 241
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 242 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFVKYSRL 386
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S VL   ++  ++  +
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE--RWEDV 358
Query: 387 KQFALRALASTLDDEELADLRDQFDA 412
           K+    ALA+   D E   ++   DA
Sbjct: 359 KEEMTSALATMRVDYEQIKIKKIEDA 384

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/326 (27%), Positives = 156/326 (47%), Gaps = 28/326 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 118
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 235
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 236 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFVKYSRL 386
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S VL   ++  ++  +
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE--RWEDV 352
Query: 387 KQFALRALASTLDDEELADLRDQFDA 412
           K+    ALA+   D E   ++   DA
Sbjct: 353 KEEMTSALATMRVDYEQIKIKKIEDA 378

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 138/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +          +   + YYVAPEVL   
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL--- 189
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 190 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 89/316 (28%), Positives = 152/316 (48%), Gaps = 28/316 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 191
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 192 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFVKYSRL 386
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S VL   ++  ++  +
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE--RWEDV 308
Query: 387 KQFALRALASTLDDEE 402
           K+    ALA+   D E
Sbjct: 309 KEEMTSALATMRVDYE 324

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 79
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 196
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 197 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 300

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 80
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 197
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 198 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 189
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 190 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 73
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 190
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 191 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 294

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 25/285 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 78
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 195
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +
Sbjct: 196 -GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 25/284 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V+
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVR 89
Query: 162 FYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H 
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL    
Sbjct: 150 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL---- 205
Query: 278 GPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSIS 328
           GPE      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 265
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
              K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 266 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 309

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 87
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 145 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 260
Query: 342 DPRARLTAAQALSHPWVREGG-DASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 261 DPAQRATAAELLKHPFLAKAGPPASIVPL 289

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 14/269 (5%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 83
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 141 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 256
Query: 342 DPRARLTAAQALSHPWV-REGGDASEIPI 369
           DP  R TAA+ L HP++ + G  AS +P+
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPASIVPL 285

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 13/266 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 92
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 150 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 265
Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           DP  R TAA+ L HP++ + G  + I
Sbjct: 266 DPAQRATAAELLKHPFLAKAGPPASI 291

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 13/266 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 94
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 152 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 267
Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           DP  R TAA+ L HP++ + G  + I
Sbjct: 268 DPAQRATAAELLKHPFLAKAGPPASI 293

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 13/266 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 137
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 194
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 195 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 310
Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           DP  R TAA+ L HP++ + G  + I
Sbjct: 311 DPAQRATAAELLKHPFLAKAGPPASI 336

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 146/266 (54%), Gaps = 13/266 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +AT +++G  VAVKK++  K       E +  EV I++    HENVV+ Y
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMY 214
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           N++   + +++ ME  EGG L D +     +R  E+  A V   +L+  +  H  G++HR
Sbjct: 215 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 271
Query: 224 DMKPENFLFKSAKEDSSLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPES 281
           D+K ++ L      D  +K +DFG  +   K   + + +VG+ Y++APE++ R   GPE 
Sbjct: 272 DIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++++      K +  N P  R K    +S S K F+ +LLV+
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKNLHKVSPSLKGFLDRLLVR 387
Query: 342 DPRARLTAAQALSHPWVREGGDASEI 367
           DP  R TAA+ L HP++ + G  + I
Sbjct: 388 DPAQRATAAELLKHPFLAKAGPPASI 413

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 3/275 (1%)
Query: 88  FGYDKDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           F   ++F+  Y +  K LG G+F        K+ G   A K ++K +       E +  E
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHE 78
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           + +L+       V+  +  +E+ + + + +E   GGE+    L +     +E D   +++
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           Q+L      H + +VH D+KP+N L  S      +K  DFG+S  I    + ++I+G+  
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           Y+APE+L        +D+W+IG+I Y+LL    PF  +     +  + +   D+  + + 
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S+S  A DF++ LLVK+P  R TA   LSH W+++
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 154/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 15  EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 58
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 59  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 117
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 118 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 172
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +  D+ G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 173 LKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 232 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 284
Query: 357 WV 358
           W+
Sbjct: 285 WI 286

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I  A+
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NAM 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    GE+   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    GE+   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 23/283 (8%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G +  +  + DFD    IG+ LG G+FG  Y+A ++ +   +A+K + K ++      
Sbjct: 2   PLGSKRQWTLE-DFD----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE 56
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             ++REV+I Q+   H N+++ Y  F D   VY+ +E    G +   +  +K SR+ E+ 
Sbjct: 57  HQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            A  + ++    + CH   ++HRD+KPEN L  S  E   LK  DFG S    P  +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWS-VHAPSSRRTT 169
Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--- 316
           + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G  PF   T    ++ + R +   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           PDF       ++  A+D + +LL  +   RLT A+ L HPW++
Sbjct: 230 PDF-------VTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 89/254 (35%), Positives = 130/254 (51%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F  T +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  135 bits (340), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 146/283 (51%), Gaps = 23/283 (8%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G +  +  + DFD    IG+ LG G+FG  Y+A ++ +   +A+K + K ++      
Sbjct: 2   PLGSKRQWTLE-DFD----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE 56
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             ++REV+I Q+   H N+++ Y  F D   VY+ +E    G +   +  +K SR+ E+ 
Sbjct: 57  HQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQR 113
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            A  + ++    + CH   ++HRD+KPEN L  S  E   LK  DFG S    P  +   
Sbjct: 114 TATYITELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWS-VHAPSSRRDT 169
Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--- 316
           + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G  PF   T    ++ + R +   
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTF 229
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           PDF       ++  A+D + +LL  +   RLT A+ L HPW++
Sbjct: 230 PDF-------VTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  D+ G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  135 bits (339), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 61  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 117
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 118 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 228
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 229 WKKIDSAPLALLHKILVENPSARIT 253

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 148 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 260
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 261 LVEKLLVLDATKRL 274

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 62
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 63  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 120 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 230
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 231 WKKIDSAPLALLHKILVENPSARIT 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  134 bits (338), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 153/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 6   EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 49
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 50  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 108
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 109 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 163
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +   + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 164 LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 223 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 275
Query: 357 WV 358
           W+
Sbjct: 276 WI 277

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 153/302 (50%), Gaps = 34/302 (11%)
Query: 61  QQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKAN 120
           ++L +KQ  + + +RQ  +            +DF+    IG+ LG G+FG  Y+A +K +
Sbjct: 15  EELASKQKNEESKKRQWAL------------EDFE----IGRPLGKGKFGNVYLAREKQS 58
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
              +A+K + K ++        ++REV+I Q+   H N+++ Y  F D   VY+ +E   
Sbjct: 59  KFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHPNILRLYGYFHDATRVYLILEYAP 117
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            G +   +  +K S++ E+  A  + ++    + CH   ++HRD+KPEN L  SA E   
Sbjct: 118 LGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--- 172
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRP 299
           LK  DFG S    P  +   + G+  Y+ PE+++ R    + D+WS+GV+ Y  L G+ P
Sbjct: 173 LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231
Query: 300 FWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           F   T    +K + R +   PDF       ++  A+D + +LL  +P  R    + L HP
Sbjct: 232 FEANTYQETYKRISRVEFTFPDF-------VTEGARDLISRLLKHNPSQRPMLREVLEHP 284
Query: 357 WV 358
           W+
Sbjct: 285 WI 286

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +  ++ G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 148 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 260
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 261 LVEKLLVLDATKRL 274

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDS-----XQEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 152 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 264
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 265 LVEKLLVLDATKRL 278

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 74
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 133 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 245
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 246 LVEKLLVLDATKRL 259

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS  +S D+W++G I Y L+ G  PF    E  IF ++++ + DF  K +P     A+D
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/326 (27%), Positives = 150/326 (46%), Gaps = 28/326 (8%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHIV 118
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I  E  +GGEL  RI  + D  +TE++A+ + + +       H
Sbjct: 119 RIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH 178
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL   
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--- 235
Query: 277 SGPE-----SDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSI 327
            GPE      D WS+GVI YILLCG  PF+         G    +   + +F    W  +
Sbjct: 236 -GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV 294
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFVKYSRL 386
           S   K  ++ LL  +P  R T  +  +HPW+ +     + P+  S VL   ++  ++  +
Sbjct: 295 SEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKE--RWEDV 352
Query: 387 KQFALRALASTLDDEELADLRDQFDA 412
           K+    ALA+   D E   ++   DA
Sbjct: 353 KEEXTSALATMRVDYEQIKIKKIEDA 378

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF ++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 149 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 261
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 262 LVEKLLVLDATKRL 275

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KKVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 152 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 264
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 265 LVEKLLVLDATKRL 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 239
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 240 LVEKLLVLDATKRL 253

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 128 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 240
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 241 LVEKLLVLDATKRL 254

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 97
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 156 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 268
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 269 LVEKLLVLDATKRL 282

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 67
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 126 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 182 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 234
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 235 LISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 133/265 (50%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 73
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 74  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 131
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 132 AMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 251 HLISRIFVADPAKRISIPEIRNHEW 275

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 67
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 126 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 238
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 239 LVEKLLVLDATKRL 252

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 184
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 237
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 129 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 241
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 242 LVEKLLVLDATKRL 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 72
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 130
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 131 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 187 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 239
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 240 LISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 127
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 236
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 131
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE ++ R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 188 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 240
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 241 LISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 127 KRVIHRDIKPENLLLGSAGE---LKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 235
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  132 bits (333), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/265 (33%), Positives = 135/265 (50%), Gaps = 24/265 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G  G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 61
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 62  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 118
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L     E  +LK +DFGL+   +   +      + G+  YVAP
Sbjct: 119 YLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 271 EVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-----P 323
           E+LKR+       DVWS G++   +L G  P WD+  D       +   D++ K     P
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSC-----QEYSDWKEKKTYLNP 229
Query: 324 WPSISNSAKDFVKKLLVKDPRARLT 348
           W  I ++    + K+LV++P AR+T
Sbjct: 230 WKKIDSAPLALLHKILVENPSARIT 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K     +A+K + K ++        ++REV+I Q+   H 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 123
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  DFG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 124 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 180 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 232
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 233 LISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 133/265 (50%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK   FG S       + +D VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 137/268 (51%), Gaps = 16/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DFD    IG+ LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I Q+
Sbjct: 16  DFD----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-QS 70
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++    
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADAL 128
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH   ++HRD+KPEN L     E   LK  DFG S    P  + + + G+  Y+ PE+
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWS-VHAPSLRRRXMCGTLDYLPPEM 184
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           ++ K+  E  D+W  GV+ Y  L G  PF   +     + ++     F     P +S+ +
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 240
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           KD + KLL   P  RL     + HPWV+
Sbjct: 241 KDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I      +VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----AANVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 70
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 128
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  +FG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 129 KRVIHRDIKPENLLLGSAGE---LKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 185 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 237
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 238 LISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 18/265 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I Q+   H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI-QSHLRHP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS 129
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN L  SA E   LK  +FG S    P  +   + G+  Y+ PE+++ R 
Sbjct: 130 KRVIHRDIKPENLLLGSAGE---LKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFRRKPWPSISNSAKD 333
              + D+WS+GV+ Y  L G+ PF   T    +K + R +   PDF       ++  A+D
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------VTEGARD 238
Query: 334 FVKKLLVKDPRARLTAAQALSHPWV 358
            + +LL  +P  R    + L HPW+
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 137/263 (52%), Gaps = 12/263 (4%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + IG+ LG G+FG  Y+A +K +   VA+K + K+++        ++RE++I QA   H 
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEI-QAHLHHP 83
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+++ YN F D   +Y+ +E    GEL   +  +K   + E+  A ++ ++      CH 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             ++HRD+KPEN           LK  DFG S    P  + + + G+  Y+ PE+++ R 
Sbjct: 142 KKVIHRDIKPEN---LLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRM 197
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + D+W IGV+ Y LL G  PF   + +  ++ +++    F      S+   A+D + 
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP----ASVPTGAQDLIS 253
Query: 337 KLLVKDPRARLTAAQALSHPWVR 359
           KLL  +P  RL  AQ  +HPWVR
Sbjct: 254 KLLRHNPSERLPLAQVSAHPWVR 276

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  131 bits (329), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 129/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + G LL  I  +K   + E        +++      H 
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 151 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 275 RKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS  +S D+W++G I Y L+ G  PF    E  IF+++++ + DF  K +P     A+D
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARD 263
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 264 LVEKLLVLDATKRL 277

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 128/254 (50%), Gaps = 14/254 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 95
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
             VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK 274
            G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L 
Sbjct: 154 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 275 RKSG-PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF    +P     A+D
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARD 266
Query: 334 FVKKLLVKDPRARL 347
            V+KLLV D   RL
Sbjct: 267 LVEKLLVLDATKRL 280

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK + + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   + CH
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK   FG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVCHRDLKLENTLLDGSPA-PRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 142/275 (51%), Gaps = 12/275 (4%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   E +  E+ I ++L  
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-D 84
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +A   +RQ ++     
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +D+ G+  Y+APEVL 
Sbjct: 143 HNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 199
Query: 275 RKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +K    E D+WS+G I Y LL G+ PF        +  + +N+    R     I+  A  
Sbjct: 200 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASA 255
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 290

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 142/275 (51%), Gaps = 12/275 (4%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   E +  E+ I ++L  
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-D 100
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +A   +RQ ++     
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ +D+ G+  Y+APEVL 
Sbjct: 159 HNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLC 215
Query: 275 RKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +K    E D+WS+G I Y LL G+ PF        +  + +N+    R     I+  A  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASA 271
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/323 (28%), Positives = 163/323 (50%), Gaps = 29/323 (8%)
Query: 60  YQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKA 119
           +Q +    H++  +  Q  V P   R    Y  +F +       +G G  G   +AT+K 
Sbjct: 19  FQSMSRVSHEQFRAALQLVVSPGDPRE---YLANFIK-------IGEGSTGIVCIATEKH 68
Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
            G +VAVKK++  K       E +  EV I++    H+NVV  Y+++   + +++ ME  
Sbjct: 69  TGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYH-HDNVVDMYSSYLVGDELWVVMEFL 124
Query: 180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
           EGG L D +     +R  E+  A V   +LR  +  H  G++HRD+K ++ L  S   D 
Sbjct: 125 EGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS---DG 178
Query: 240 SLKATDFGL-SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGR 297
            +K +DFG  +   K   K + +VG+ Y++APEV+ R   G E D+WS+G++   ++ G 
Sbjct: 179 RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238
Query: 298 RPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            P++++      + +  + P  R K    +S+  + F+  +LV++P  R TA + L HP+
Sbjct: 239 PPYFNEPPLQAMRRIRDSLPP-RVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPF 297
Query: 358 VREGGDASEIPIDISVLNNMRQF 380
           ++  G  S       ++  MRQ+
Sbjct: 298 LKLAGPPS------CIVPLMRQY 314

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DFD    I + LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I Q+
Sbjct: 15  DFD----IVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI-QS 69
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++    
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADAL 127
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH   ++HRD+KPEN L     E   LK  DFG S    P  + + + G+  Y+ PE+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWS-VHAPSLRRRXMCGTLDYLPPEM 183
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           ++ K+  E  D+W  GV+ Y  L G  PF   +     + ++     F     P +S+ +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239
Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
           KD + KLL   P  RL     + HPWV+
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K +G G FG   +  DK   + VAVK IE+   I     E+V+RE+   ++L  H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-H 75
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q+L   + CH
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERIC--NAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL R+
Sbjct: 134 SMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------NKPDFRRKPWPSI 327
              G  +DVWS GV  Y++L G  PF D  E   +++ ++       + PD  R     I
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-----I 247
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           S      + ++ V DP  R++  +  +H W
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSW 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 131/265 (49%), Gaps = 12/265 (4%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY + K +G G FG   +  DK   + VAVK IE+ + I     E+VKRE+   ++L  H
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKI----DENVKREIINHRSLR-H 74
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q++   +  H
Sbjct: 75  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYAH 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L   +     LK  DFG S       + +  VG+  Y+APEVL +K
Sbjct: 133 AMQVAHRDLKLENTLLDGSPA-PRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKK 191
Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   F++ +       +    +  IS   +
Sbjct: 192 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 251
Query: 333 DFVKKLLVKDPRARLTAAQALSHPW 357
             + ++ V DP  R++  +  +H W
Sbjct: 252 HLISRIFVADPAKRISIPEIRNHEW 276

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 82
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 141 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 252
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 253 QTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 86
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 144
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 145 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 202 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 256
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 257 QTDPTARPTINELLNDEFFTSGYIPARLPI 286

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 82
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 140
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 141 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 198 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 252
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 253 QTDPTARPTINELLNDEFFTSGYIPARLPI 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 12/275 (4%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   E +  E+ I ++L  
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-D 100
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +A   +RQ ++     
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ + + G+  Y+APEVL 
Sbjct: 159 HNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLC 215
Query: 275 RKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +K    E D+WS+G I Y LL G+ PF        +  + +N+    R     I+  A  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASA 271
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 80
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 139 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 250
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYIPARLPI 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 12/275 (4%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY  G+ LG G F   Y  TD    +  A K + K+ ++ P   E +  E+ I ++L  
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL-D 100
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +VV F+  FEDD++VY+ +E+C    LL+  L K+    TE +A   +RQ ++     
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLE--LHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLK 274
           H + ++HRD+K  N       +D  +K  DFGL+  I+  G++ + + G+  Y+APEVL 
Sbjct: 159 HNNRVIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLC 215
Query: 275 RKSGP-ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
           +K    E D+WS+G I Y LL G+ PF        +  + +N+    R     I+  A  
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPR----HINPVASA 271
Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            ++++L  DP  R + A+ L+  +   G     +P
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFFTSGYAPMRLP 306

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 106
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 165 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 276
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYIPARLPI 306

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 142/270 (52%), Gaps = 14/270 (5%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I ++LA H++VV F
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGF 104
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +  FED+++V++ +ELC    LL+  L K+    TE +A   +RQ++      H + ++H
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIH 162
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           RD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+APEVL +K    E
Sbjct: 163 RDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEV-LRNKPDFRRKPWPSISNSAKDFVKKLL 339
            DVWSIG I Y LL G+ PF    E    KE  LR K +    P   I+  A   ++K+L
Sbjct: 220 VDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSIPK-HINPVAASLIQKML 274
Query: 340 VKDPRARLTAAQALSHPWVREGGDASEIPI 369
             DP AR T  + L+  +   G   + +PI
Sbjct: 275 QTDPTARPTINELLNDEFFTSGYIPARLPI 304

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 81/261 (31%), Positives = 138/261 (52%), Gaps = 13/261 (4%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G  G   +A +K +G +VAVK ++  K       E +  EV I++    H NVV+ Y
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ-HFNVVEMY 108
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     +++ ME  +GG L D +      R  E+  A V   +L+  A  H  G++HR
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRK-SGPES 281
           D+K ++ L      D  +K +DFG    I K   K + +VG+ Y++APEV+ R     E 
Sbjct: 166 DIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
           D+WS+G++   ++ G  P++  +     K  LR+ P  + K    +S   +DF++++LV+
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 342 DPRARLTAAQALSHPWVREGG 362
           DP+ R TA + L HP++ + G
Sbjct: 282 DPQERATAQELLDHPFLLQTG 302

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
            ++LG G  G      +K   ++ A+K ++             +REV++    +   ++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +       H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+KPEN L+ S + ++ LK TDFG                     A E    K
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK 174
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
                D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S   K
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 234
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
             ++ LL  +P  R+T  + ++HPW+ +     + P+  S
Sbjct: 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKR 145
           + ++ ++Y+    LG G FG+ + A DK     V VK I+K K++    +ED     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-LAKKDSRYTEKDAAVV 204
           E+ IL  +  H N++K  + FE+  +  + ME  + G  LD      +  R  E  A+ +
Sbjct: 79  EIAILSRVE-HANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYI 135
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
            RQ++       L  ++HRD+K EN +     ED ++K  DFG + +++ GK F    G+
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGT 192
Query: 265 AYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             Y APEVL      GPE ++WS+GV  Y L+    PF +          L    +    
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIH 242
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P   +S      V  LL   P  R T  + ++ PWV +
Sbjct: 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQALAGHENVVK 161
           LG G +G  Y A  K  G  VA+K++       P+   ++++ +E+ I+Q      +VVK
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV-------PVESDLQEIIKEISIMQQ-CDSPHVVK 88
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +Y ++  +  ++I ME C  G + D I+  ++   TE + A +++  L+     H    +
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           HRD+K  N L  +   +   K  DFG++        K   ++G+ +++APEV++      
Sbjct: 148 HRDIKAGNILLNT---EGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAKDFVKK 337
            +D+WS+G+    +  G+ P+ D         +  N P   RKP  W   S++  DFVK+
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SDNFTDFVKQ 261
Query: 338 LLVKDPRARLTAAQALSHPWVREGGDAS 365
            LVK P  R TA Q L HP+VR     S
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 139/288 (48%), Gaps = 24/288 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + +L+G+G +G  Y       G   A+K ++    +     E++K+E+ +L+  + H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 158 NVVKFYNAFED------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           N+  +Y AF        D+ +++ ME C  G + D I   K +   E+  A + R++LR 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAP 270
            +  H H ++HRD+K +N L     E++ +K  DFG+S    +   +    +G+ Y++AP
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 271 EVLKRKSGPE------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-KPDFRRKP 323
           EV+     P+      SD+WS+G+    +  G  P  D         + RN  P  + K 
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 258
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
           W   S   + F++  LVK+   R    Q + HP++R+  +  ++ I +
Sbjct: 259 W---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 18/269 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G FG  ++   + NG   A+K ++K  ++    VE    E +++ ++  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +++ +  F+D   +++ M+  EGGEL    L +K  R+    A     ++       H 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             +++RD+KPEN L     ++  +K TDFG + ++ P   +  + G+  Y+APEV+  K 
Sbjct: 125 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYV-PDVTYX-LCGTPDYIAPEVVSTKP 179
Query: 278 GPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
             +S D WS G++ Y +L G  PF+D      ++++L  +  F     P  +   KD + 
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 235
Query: 337 KLLVKDPRARLTAAQ-----ALSHPWVRE 360
           +L+ +D   RL   Q       +HPW +E
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  115 bits (287), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 17/267 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K  GD  AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +  F+  + ++  ME   GG+L+  I  +K  R+ E  A     +++      H  G++
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGII 146
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK-SGP 279
           +RD+K +N L      +   K  DFG+  + I  G       G+  Y+APE+L+    GP
Sbjct: 147 YRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +    W  +   A   +K  +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LHEDATGILKSFM 259
Query: 340 VKDPRARLTAAQ------ALSHPWVRE 360
            K+P  RL +         L HP+ +E
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 130
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 131 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 187
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 243
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 244 KKDPKQRLGGGPS 256

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 132
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 133 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 189
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 245
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 246 KKDPKQRLGGGPS 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 125/253 (49%), Gaps = 12/253 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H   +V
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GP 279
           +RD+K EN +     +D  +K TDFGL  + I  G   +   G+  Y+APEVL+    G 
Sbjct: 128 YRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGR 184
Query: 280 ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
             D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  LL
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLL 240
Query: 340 VKDPRARLTAAQA 352
            KDP+ RL    +
Sbjct: 241 KKDPKQRLGGGPS 253

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 6   DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 62
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A   H  +VK   A+  D  ++I +E C GG + D I+ + D   TE    VV RQML 
Sbjct: 63  -ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 120
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S   +K  +K    +G+ Y++A
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 270 PEVL---KRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+     K  P   ++D+WS+G+    +     P  +     +  ++ ++ P     P
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 237
Query: 324 --WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             W   S   +DF+K  L K+P  R +AAQ L HP+V
Sbjct: 238 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 87/277 (31%), Positives = 132/277 (47%), Gaps = 20/277 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 70
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            A   H  +VK   A+  D  ++I +E C GG + D I+ + D   TE    VV RQML 
Sbjct: 71  -ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S   +K  +K    +G+ Y++A
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 270 PEVL---KRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+     K  P   ++D+WS+G+    +     P  +     +  ++ ++ P     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245
Query: 324 --WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             W   S   +DF+K  L K+P  R +AAQ L HP+V
Sbjct: 246 SKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 137/273 (50%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K  ++VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A +K      A K I+         +ED   E+ IL A   H N+VK  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNIVKLL 100
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + ++HR
Sbjct: 101 DAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRKSGPE 280
           D+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  ++  +
Sbjct: 160 DLKAGNILFTL---DGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 281 ------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAK 332
                 +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S++ K
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSNFK 271
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF+KK L K+  AR T +Q L HP+V
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A +K      A K I+         +ED   E+ IL A   H N+VK  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNIVKLL 100
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + ++HR
Sbjct: 101 DAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRKSGPE 280
           D+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  ++  +
Sbjct: 160 DLKAGNILFTL---DGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 281 ------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAK 332
                 +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S++ K
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSNFK 271
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF+KK L K+  AR T +Q L HP+V
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 68
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 125
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 241
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + L H +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 95/332 (28%), Positives = 147/332 (44%), Gaps = 62/332 (18%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           KR  +    DF     +  LLG G +G    AT K  G+ VA+KKIE      P+     
Sbjct: 3   KRIVYNISSDFQ----LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRT 56
Query: 144 KREVKILQALAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
            RE+KIL+    HEN++  +N     +FE+ N VYI  EL +    L R+++ +    ++
Sbjct: 57  LREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ--MLSD 111
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------ 252
                 + Q LR     H   ++HRD+KP N L  S   +  LK  DFGL+  I      
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAAD 168
Query: 253 --KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDK-- 303
             +P  +     + V + +Y APEV+    K     DVWS G I   L   RRP +    
Sbjct: 169 NSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227
Query: 304 -----------------------TEDGIFKEVLRNKPDFRRKP----WPSISNSAKDFVK 336
                                   E    +E +++ P +   P    +P ++    D ++
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 337 KLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           ++LV DP  R+TA +AL HP+++   D ++ P
Sbjct: 288 RMLVFDPAKRITAKEALEHPYLQTYHDPNDEP 319

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  Y A +K      A K I+         +ED   E+ IL A   H N+VK  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL-ASCDHPNIVKLL 100
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +AF  +N ++I +E C GG + D ++ + +   TE    VV +Q L      H + ++HR
Sbjct: 101 DAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRKSGPE 280
           D+K  N LF     D  +K  DFG+S   K  +  Q     +G+ Y++APEV+  ++  +
Sbjct: 160 DLKAGNILFTL---DGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 281 ------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP--WPSISNSAK 332
                 +DVWS+G+    +     P  +     +  ++ +++P    +P  W   S++ K
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSNFK 271
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWV 358
           DF+KK L K+  AR T +Q L HP+V
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 69
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 126
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 127 LQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + + H +++
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 212
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 267
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 268 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 379
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 380 LSGLLKKDPKQRLGGG 395

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D + G  VA+K+I    +++ I   A+    RE+ +L+ L  H N+V
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELH-HPNIV 82
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
              +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A CH H +
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKS 277
           +HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+VL   +K 
Sbjct: 141 LHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL--------RNKPD----------- 318
               D+WSIG I   ++ G+  F   T+D    ++         R  P            
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 319 ---FRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              F +KPW    P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 215
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 270
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 271 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 326
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 327 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 382
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 383 LSGLLKKDPKQRLGGG 398

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 127
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 128 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 183
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 184 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 239
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 240 LSGLLKKDPKQRLGGG 255

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 129
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 130 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 185
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 186 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 241
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 242 LSGLLKKDPKQRLGGG 257

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 135/289 (46%), Gaps = 43/289 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIE---KNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G +G  Y A D + G  VA+K+I    +++ I   A+    RE+ +L+ L  H N+V
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELH-HPNIV 82
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
              +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A CH H +
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKS 277
           +HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+VL   +K 
Sbjct: 141 LHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL--------RNKPD----------- 318
               D+WSIG I   ++ G+  F   T+D    ++         R  P            
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 319 ---FRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              F +KPW    P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 129/256 (50%), Gaps = 21/256 (8%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  +  
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              +F+  + +   ME   GGEL      +R+ ++  +R+     A +V  +  + +E  
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSALDYLHSE-- 128
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
              +V+RD+K EN +     +D  +K TDFGL  + IK G   +   G+  Y+APEVL+ 
Sbjct: 129 -KNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLED 184
Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK  
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSL 240
Query: 335 VKKLLVKDPRARLTAA 350
           +  LL KDP+ RL   
Sbjct: 241 LSGLLKKDPKQRLGGG 256

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 136/273 (49%), Gaps = 21/273 (7%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++           +  K+E+ I + 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--------QQPKKELIINEI 69
Query: 153 LAGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L   E    N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ 
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCREC 126
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYY 267
           L+     H + ++HR++K +N L      D S+K TDFG    I P + K   +VG+ Y+
Sbjct: 127 LQALEFLHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APEV+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N     + P   
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EK 242
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +S   +DF+ + L  D   R +A + + H +++
Sbjct: 243 LSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/319 (27%), Positives = 147/319 (46%), Gaps = 28/319 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H 
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L     +D  +K  DFG+      G  K  +  G+  Y+APE+ L +
Sbjct: 138 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R  W  +   AKD +
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLL 250
Query: 336 KKLLVKDPRARLTAAQAL-SHPWVREGG----DASEI----------PIDISVLNNMRQF 380
            KL V++P  RL     +  HP  RE      +  EI          P D S  N  ++F
Sbjct: 251 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS--NFDKEF 308
Query: 381 VKYSRLKQFALRALASTLD 399
           +       FA RAL +++D
Sbjct: 309 LNEKPRLXFADRALINSMD 327

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 76  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 249 ------LSPEAQSLLRMLFKRNPANRLGAG 272

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 18  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 76
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 77  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 133
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 190
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 249
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 250 ------LSPEAQSLLRMLFKRNPANRLGAG 273

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/319 (27%), Positives = 146/319 (45%), Gaps = 28/319 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H 
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-KKFQDIVGSAYYVAPEV-LKR 275
            G+V+RD+K +N L     +D  +K  DFG+      G  K     G+  Y+APE+ L +
Sbjct: 137 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           K     D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R  W  +   AKD +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--W--LEKEAKDLL 249
Query: 336 KKLLVKDPRARLTAAQAL-SHPWVREGG----DASEI----------PIDISVLNNMRQF 380
            KL V++P  RL     +  HP  RE      +  EI          P D S  N  ++F
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS--NFDKEF 307
Query: 381 VKYSRLKQFALRALASTLD 399
           +       FA RAL +++D
Sbjct: 308 LNEKPRLSFADRALINSMD 326

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           G++K    ++ + K+LG G FG  ++    +  D     A+K ++K  + +   V   K 
Sbjct: 17  GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKM 75
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL  +  H  +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 76  ERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 132
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+   +S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF- 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL A 
Sbjct: 249 ------LSPEAQSLLRMLFKRNPANRLGAG 272

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 39/292 (13%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA----------------- 139
           +YT+   +G G +G   +A ++ +    A+K + K K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 140 ------VEDVKREVKILQALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK 191
                 +E V +E+ IL+ L  H NVVK     +D N  ++Y+  EL   G +++    K
Sbjct: 74  IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +E  A    + +++     H   ++HRD+KP N L     ED  +K  DFG+S+ 
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNE 186
Query: 252 IKPGKKF-QDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKTED 306
            K       + VG+  ++APE L       SG   DVW++GV  Y  + G+ PF D+   
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            +  ++     +F  +P   I+   KD + ++L K+P +R+   +   HPWV
Sbjct: 247 CLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 92
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 150
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     E   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 151 YRDLKPENLLI---DEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 205
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 260
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 261 QVDLTKRF 268

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 22/270 (8%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           G +K     + + K+LG G FG  ++    T   +G   A+K ++K  + +   V   K 
Sbjct: 21  GSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKM 79
Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  IL A   H  VVK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    +
Sbjct: 80  ERDIL-ADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL 136
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
            ++       H  G+++RD+KPEN L     E+  +K TDFGLS + I   KK     G+
Sbjct: 137 AELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGT 193
Query: 265 AYYVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---PDFR 320
             Y+APEV+ R+    S D WS GV+ + +L G  PF  K        +L+ K   P F 
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF- 252
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA 350
                 +S  A+  ++ L  ++P  RL + 
Sbjct: 253 ------LSTEAQSLLRALFKRNPANRLGSG 276

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 157 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 266
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 267 QVDLTKRF 274

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K       + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGAT--WTLCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFAEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 100
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 158
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 159 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 213
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 268
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 269 QVDLTKRF 276

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFGL+  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 128/243 (52%), Gaps = 15/243 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKD 342
             D
Sbjct: 274 QVD 276

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 184
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 185 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 294
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 295 QVDLTKRF 302

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K  G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 98
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 99  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 156
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 157 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 266
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 267 QVDLTKRF 274

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 64
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I   +    +L D I  +      E+ A     Q
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITER--GALQEELARSFFWQ 122
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 179
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 230
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 231 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 129/248 (52%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLII---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 19/275 (6%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V    L
Sbjct: 69  LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGAL 125
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMA 179
Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   ++FV   L K P+ R T+   L H +V
Sbjct: 239 W---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 19/275 (6%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 48  FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G      +L        E + A V    L
Sbjct: 108 LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGAL 164
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMA 218
Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRP--FWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+    + +   + DVWS+G IT I L  R+P  F       ++       P  +   
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           W   S   ++FV   L K P+ R T+   L H +V
Sbjct: 278 W---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPFEHD------EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 142/267 (53%), Gaps = 30/267 (11%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGD--RVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + K+LG G +G  ++    +  D  ++   K+ K   I+  A   E  + E ++L+ +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
                +V  + AF+ +  +++ ++   GGEL   +  ++  R+TE +  + V +++    
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALE 173
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIK-PGKKFQDIVGSAYYVAPE 271
             H  G+++RD+K EN L  S   +  +  TDFGLS +F+    ++  D  G+  Y+AP+
Sbjct: 174 HLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 272 VLK-RKSGPES--DVWSIGVITYILLCGRRPFWDKTEDG-------IFKEVLRNKPDFRR 321
           +++   SG +   D WS+GV+ Y LL G  PF   T DG       I + +L+++P    
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPF---TVDGEKNSQAEISRRILKSEP---- 283
Query: 322 KPWP-SISNSAKDFVKKLLVKDPRARL 347
            P+P  +S  AKD +++LL+KDP+ RL
Sbjct: 284 -PYPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 144/280 (51%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVA-AECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +   + F ++ 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDEDFAKEF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFGL+  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 21/273 (7%)
Query: 98  YTIGKLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + ++LG G +G  +       AN  ++   K+ K  MI+  A      K E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++     
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALG 135
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
             H  G+++RD+KPEN +         +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R     + D WS+G + Y +L G  PF  +       ++L+ K +      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 332 KDFVKKLLVKDPRARLT-----AAQALSHPWVR 359
           +D +KKLL ++  +RL      A +  +HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 40/285 (14%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H 
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-CHHP 73
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLD---RILAK---KDSRYTEKDAAVVVRQMLRV 211
           N+V +Y +F   + +++ M+L  GG +LD    I+AK   K     E   A ++R++L  
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG------KKFQDIVGSA 265
               H +G +HRD+K  N L     ED S++  DFG+S F+  G      K  +  VG+ 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 266 YYVAPEVLKRKSGPE--SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            ++APEV+++  G +  +D+WS G+    L  G  P+       +    L+N P      
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP------ 244
Query: 324 WPSISNSAKD-------------FVKKLLVKDPRARLTAAQALSH 355
            PS+    +D              +   L KDP  R TAA+ L H
Sbjct: 245 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 21/273 (7%)
Query: 98  YTIGKLLGHGQFGYTYVA--TDKANGDRVAVKKIEKNKMILPIA--VEDVKREVKILQAL 153
           + + ++LG G +G  +       AN  ++   K+ K  MI+  A      K E  IL+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H  +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++     
Sbjct: 79  K-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALG 135
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
             H  G+++RD+KPEN +         +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192
Query: 273 LKRKSGPES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R     + D WS+G + Y +L G  PF  +       ++L+ K +      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 332 KDFVKKLLVKDPRARLT-----AAQALSHPWVR 359
           +D +KKLL ++  +RL      A +  +HP+ R
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 133/285 (46%), Gaps = 40/285 (14%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H 
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-CHHP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLD---RILAK---KDSRYTEKDAAVVVRQMLRV 211
           N+V +Y +F   + +++ M+L  GG +LD    I+AK   K     E   A ++R++L  
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG------KKFQDIVGSA 265
               H +G +HRD+K  N L     ED S++  DFG+S F+  G      K  +  VG+ 
Sbjct: 129 LEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 266 YYVAPEVLKRKSGPE--SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            ++APEV+++  G +  +D+WS G+    L  G  P+       +    L+N P      
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP------ 239
Query: 324 WPSISNSAKD-------------FVKKLLVKDPRARLTAAQALSH 355
            PS+    +D              +   L KDP  R TAA+ L H
Sbjct: 240 -PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 283

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 92  LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 149
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 150 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKA 204
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 259
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 260 QVDLTKRF 267

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 25  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 84
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 85  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 143
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 144 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 199
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 200 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 259 DIPFEHD------EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 308
Query: 357 WVRE 360
           W+++
Sbjct: 309 WMQD 312

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 233
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 234 -----EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 142/280 (50%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVA-AECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +     F +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKTF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+AP ++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 99
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 157
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 214
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF         +E++R +  FR++   
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR--- 265
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 266 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 63
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 64  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 121
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 178
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 229
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 230 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 263

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 64
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 65  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 122
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 179
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 230
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 231 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 264

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 20/256 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N D+V   KI     +L  A     RE + +      +
Sbjct: 76  FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+DDN +Y+ M+   GG+LL  +L+K + R  E+ A   + +M+      H 
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVL-- 273
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L  
Sbjct: 194 LHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 274 ----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
               K + GPE D WS+GV  Y +L G  PF+ ++    + +++ +K  F+   +P+   
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPTQVT 307
Query: 327 -ISNSAKDFVKKLLVK 341
            +S +AKD +++L+  
Sbjct: 308 DVSENAKDLIRRLICS 323

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 118
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 175
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 226
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 79
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 194
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF         +E++R +  FR++   
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR--- 245
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 246 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 142/280 (50%), Gaps = 23/280 (8%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D++  YTIG     G +G       K++G  +  K+++   M      + +  EV +L+
Sbjct: 6   EDYEVLYTIGT----GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLR 60
Query: 152 ALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQM 208
            L  H N+V++Y+   D  +  +YI ME CEGG+L   I    K+ +Y +++  + V   
Sbjct: 61  ELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 209 LRVA-AECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDI 261
           L +A  ECH      H ++HRD+KP N +F   K++  +K  DFGL+  +     F +  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQN--VKLGDFGLARILNHDTSFAKAF 176
Query: 262 VGSAYYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           VG+ YY++PE + R S  E SD+WS+G + Y L     PF   ++  +  ++   K  FR
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FR 234
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           R P+   S+   + + ++L      R +  + L +P + E
Sbjct: 235 RIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDV--PEKWARFYTAEVVLALDAIHS 191
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 192 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 307 KEAKNLICAFLT-DREVRL 324

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMID---QQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDV--PEKWARFYTAEVVLALDAIHS 191
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 192 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 307 KEAKNLICAFLT-DREVRL 324

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           L+ + +G   V++  + FE  +   + +E  E  + L   + ++ +   E+ A     Q+
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQV 119
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
           L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y 
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVYS 176
Query: 269 APEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
            PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++    
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR---- 226
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 65
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 66  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 123
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 124 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 180
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 231
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 232 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 265

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 233
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                +E++R +  FR++    +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 234 -----EEIIRGQVFFRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 123/259 (47%), Gaps = 19/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   K+     A+K + K +MI          E  I+ A A   
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 129
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDV--PEKWARFYTAEVVLALDAIHS 186
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVGSAYYVAPEVL 273
            G +HRD+KP+N L   +     LK  DFG    +K  K    +    VG+  Y++PEVL
Sbjct: 187 MGFIHRDVKPDNMLLDKS---GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 274 KRKSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           K + G      E D WS+GV  Y +L G  PF+  +  G + +++ +K          IS
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 329 NSAKDFVKKLLVKDPRARL 347
             AK+ +   L  D   RL
Sbjct: 302 KEAKNLICAFLT-DREVRL 319

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 127/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLMI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 29/296 (9%)
Query: 78  GVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKN 132
           G  PC      +   G +K+  + +Y +G LLG G FG  Y     ++   VA+K +EK+
Sbjct: 1   GAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 60
Query: 133 KMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLD 186
           ++     LP     V  EV +L+ + +G   V++  + FE  D++V I        +L D
Sbjct: 61  RISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 119
Query: 187 RILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            I  +      E+ A     Q+L     CH  G++HRD+K EN L    +    LK  DF
Sbjct: 120 FITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDF 175
Query: 247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKT 304
           G    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG  PF    
Sbjct: 176 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 233
Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                +E++R +  FR++    +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 234 -----EEIIRGQVFFRQR----VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQD 280

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 79
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 80  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 138 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 194
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF         +E++R +  FR++   
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR--- 245
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 246 -VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 279

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 87
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 88  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 145
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 146 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 202
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF     D   +E++R +  FR++   
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHD---EEIIRGQVFFRQR--- 253
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S   +  ++  L   P  R T  +  +HPW+++
Sbjct: 254 -VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 287

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 128/248 (51%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ TDFG +  +K G+ +  + G+   +APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 92/315 (29%), Positives = 134/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL A
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLA 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +    S LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---SDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDK-----------------T 304
           + +Y APE++    G     D+WS+G I   +L  R  F  K                  
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 305 ED---GI---FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           ED   GI    +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLAQYYDPSDEPI 326

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 142/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/304 (28%), Positives = 135/304 (44%), Gaps = 49/304 (16%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGH 156
           IGK+ G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+ L  H
Sbjct: 8   IGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLK-H 61
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V     F     +++  E C+   L +  L +      E     +  Q L+    CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVL-- 273
            H  +HRD+KPEN L     + S +K  DFG +  +  P   + D V + +Y +PE+L  
Sbjct: 120 KHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVL-----RNKPDFRRKPW 324
             + GP  DVW+IG +   LL G  P W    D     + ++ L     R++  F    +
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 325 -------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW---VREGG 362
                              P+IS  A   +K  L  DP  RLT  Q L HP+   +RE  
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295
Query: 363 DASE 366
           D ++
Sbjct: 296 DLAK 299

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 125/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG G FG   +      G+  A+K ++K K++    +E    E +ILQA+     + K
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLTK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GGE+   +  ++  R+ E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN +     +   +K TDFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLMID---QQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/257 (31%), Positives = 124/257 (48%), Gaps = 15/257 (5%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + K++G G FG   +   KA+    A+K + K +MI          E  I+ A A   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSP 135
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            VV+ + AF+DD Y+Y+ ME   GG+L++ +++  D    EK A     +++      H 
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD--VPEKWAKFYTAEVVLALDAIHS 192
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDI-VGSAYYVAPEVLKR 275
            GL+HRD+KP+N L     +   LK  DFG      + G    D  VG+  Y++PEVLK 
Sbjct: 193 MGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 276 KSGP-----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           + G      E D WS+GV  + +L G  PF+  +  G + +++ +K          IS  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKH 309
Query: 331 AKDFVKKLLVKDPRARL 347
           AK+ +   L  D   RL
Sbjct: 310 AKNLICAFLT-DREVRL 325

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 96/350 (27%), Positives = 139/350 (39%), Gaps = 83/350 (23%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D+   R+Y + K LG G +G  + + D+  G+ VAVKKI  +        +   RE+ IL
Sbjct: 4   DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMIL 62
Query: 151 QALAGHENVVKFYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
             L+GHEN+V   N    DN      V+  ME      +   IL     +Y       VV
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-------VV 115
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---------------- 249
            Q+++V    H  GL+HRDMKP N L  +   +  +K  DFGLS                
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 250 ------DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF- 300
                 +F        D V + +Y APE+L    K     D+WS+G I   +LCG+  F 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 301 ----------------WDKTED---------GIFKEVLRNKPDFRR-------------- 321
                           +   ED             E L+ K + R+              
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292
Query: 322 ---KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
               P    +  A D + KLL  +P  R++A  AL HP+V    + +E P
Sbjct: 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 5   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 64
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 65  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 123
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 124 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 179
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 180 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 239 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 357 WVRE 360
           W+++
Sbjct: 289 WMQD 292

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G FG  Y     ++   V
Sbjct: 6   KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 65
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQAL-AGHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ + +G   V++  + FE  D++V I    
Sbjct: 66  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 124
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 125 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 180
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 181 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF +  E+ I  +V      FR++    +S   +  ++  L   P  R T  +  +HP
Sbjct: 240 DIPF-EHDEEIIGGQVF-----FRQR----VSXECQHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 357 WVRE 360
           W+++
Sbjct: 290 WMQD 293

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 24/275 (8%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPIAVEDVKREVKI 149
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     LP     V  EV +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVL 60
Query: 150 LQAL-AGHENVVKFYNAFE-DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L+ + +G   V++  + FE  D++V I        +L D I  +      E+ A     Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQ 118
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L     CH  G++HRD+K EN L    +    LK  DFG    +K    + D  G+  Y
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLK-DTVYTDFDGTRVY 175
Query: 268 VAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
             PE ++  R  G  + VWS+G++ Y ++CG  PF +  E+ I  +V      FR++   
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIGGQVF-----FRQR--- 226
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 227 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GG++   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG G FG   +   K  G+  A+K ++K K++    +E    E +I QA+     +VK
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-NFPFLVK 106
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ +E   GGE+   +  ++  R++E  A     Q++      H   L+
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 164
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 165 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 274
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 275 QVDLTKRF 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K +G G FG   +      G+  A+K ++K K++    +E    E +ILQA+     +VK
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              +F+D++ +Y+ ME   GG++   +  ++  R++E  A     Q++      H   L+
Sbjct: 106 LEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   +K  DFG +  +K G+ +  + G+  Y+APE++  K   ++
Sbjct: 164 YRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLL 339
            D W++GV+ Y +  G  PF+      I+++++  K  F     PS  S+  KD ++ LL
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF-----PSHFSSDLKDLLRNLL 273
Query: 340 VKDPRARL 347
             D   R 
Sbjct: 274 QVDLTKRF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N +R+   KI     +L  A     RE + +      +
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMK-NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N++Y+ M+   GG+LL  +L+K + +  E  A   + +M+      H 
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 210 LHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 323
Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 324 DVSEEAKDLIQRLICSRER 342

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G FG   V   K N +R+   KI     +L  A     RE + +      +
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMK-NTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +   + AF+D+N++Y+ M+   GG+LL  +L+K + +  E  A   + +M+      H 
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLL-TLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKR 275
              VHRD+KP+N L      +  ++  DFG    +      Q    VG+  Y++PE+L+ 
Sbjct: 194 LHYVHRDIKPDNVLLDV---NGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 276 ------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS--- 326
                 K GPE D WS+GV  Y +L G  PF+ ++    + +++ ++  F+   +PS   
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHVT 307
Query: 327 -ISNSAKDFVKKLLVKDPR 344
            +S  AKD +++L+    R
Sbjct: 308 DVSEEAKDLIQRLICSRER 326

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 126/261 (48%), Gaps = 18/261 (6%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG   +     +G +  +K+I  ++M      E+ +REV +L  +  H N+V++ 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMK-HPNIVQYR 89
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            +FE++  +YI M+ CEGG+L  RI A+K   + E        Q+       H   ++HR
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLKRKS-GPES 281
           D+K +N       +D +++  DFG++  +    +  +  +G+ YY++PE+ + K    +S
Sbjct: 150 DIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKS 206
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKK 337
           D+W++G + Y L   +  F   +   +  +++          +P +    S   +  V +
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-------FPPVSLHYSYDLRSLVSQ 259
Query: 338 LLVKDPRARLTAAQALSHPWV 358
           L  ++PR R +    L   ++
Sbjct: 260 LFKRNPRDRPSVNSILEKGFI 280

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 131/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL A
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLA 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTE-------DGIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F  K          GI      
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLAQYYDPSDEPI 326

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 131/299 (43%), Gaps = 54/299 (18%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG+G +   Y   +K  G  VA+K  K++  +     A+    RE+ +++ L  HEN+V+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELK-HENIVR 67
Query: 162 FYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVR-QMLRVAAECHLH 218
            Y+    +N + +  E  +    + +D        R  E +     + Q+L+  A CH +
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KR 275
            ++HRD+KP+N L     +   LK  DFGL+  F  P   F   V + +Y AP+VL   R
Sbjct: 128 KILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR 184
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP----WPSISNSA 331
                 D+WS G I   ++ G +P +  T D   +E L+   D    P    WPS++   
Sbjct: 185 TYSTSIDIWSCGCILAEMITG-KPLFPGTND---EEQLKLIFDIMGTPNESLWPSVTKLP 240
Query: 332 K------------------------------DFVKKLLVKDPRARLTAAQALSHPWVRE 360
           K                              DF+  LL  +P  RL+A QAL HPW  E
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   V + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEVVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +  + Y     +G G +G    A DK +G++VA+KK+ +      I  +   RE+ +L+ 
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKH 79
Query: 153 LAGHENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F   + +      Y+ M   +    L +I+  K   ++E+    +V 
Sbjct: 80  MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGLK---FSEEKIQYLVY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G+VHRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 188
Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K  D   K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL+HP+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 358 VREGGDASE 366
                D  E
Sbjct: 309 FEPFRDPEE 317

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 58/296 (19%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +   G+  A+KKI   K    I    + RE+ IL+ L  H N+VK Y
Sbjct: 10  IGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTI-REISILKELK-HSNIVKLY 66
Query: 164 NAFEDDNYVYIAME-----------LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +       + +  E           +CEGG  L+ + AK             + Q+L   
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS-----------FLLQLLNGI 113
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
           A CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   + + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 272 VL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           VL   +K     D+WS+G I   ++ G   F   +E      + R       K WP+++ 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 330 -------------------------SAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                    S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 57/301 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N ++V VK      ++ P+    +KRE+KIL+ L G  
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKNKIKREIKILENLRGGP 92
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAVVVRQMLRVA 212
           N++   +  +D         +     L+   +   D +      T+ D    + ++L+  
Sbjct: 93  NIITLADIVKD--------PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKAL 144
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             CH  G++HRD+KP N +     E   L+  D+GL++F  PG+++   V S Y+  PE+
Sbjct: 145 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW------------------DKTEDGIFKEV 312
           L   +      D+WS+G +   ++  + PF+                  +   D I K  
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 313 LRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +   P F        RK W           +S  A DF+ KLL  D ++RLTA +A+ HP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 357 W 357
           +
Sbjct: 323 Y 323

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KSQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL        +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 122/250 (48%), Gaps = 11/250 (4%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++       H   +V
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE 280
           +RD+KPEN L  S      +  TDFGL  + I+         G+  Y+APEVL ++    
Sbjct: 162 YRDLKPENILLDS---QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 281 S-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLL 339
           + D W +G + Y +L G  PF+ +    ++  +L NKP  + K  P+I+NSA+  ++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKP-LQLK--PNITNSARHLLEGLL 274
Query: 340 VKDPRARLTA 349
            KD   RL A
Sbjct: 275 QKDRTKRLGA 284

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 136/309 (44%), Gaps = 47/309 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +  + Y     +G G +G    A DK +G++VA+KK+ +      I  +   RE+ +L+ 
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKH 97
Query: 153 LAGHENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  HENV+   + F   + +      Y+ M   +    L +I+  +   ++E+    +V 
Sbjct: 98  MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGME---FSEEKIQYLVY 151
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML+     H  G+VHRD+KP N    +  ED  LK  DFGL+       +    V + +
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKILDFGLAR--HADAEMTGYVVTRW 206
Query: 267 YVAPEVLKR--KSGPESDVWSIGVITYILLCGRR-----------------------PFW 301
           Y APEV+          D+WS+G I   +L G+                         F 
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266
Query: 302 DKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            K  D   K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL+HP+
Sbjct: 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326
Query: 358 VREGGDASE 366
                D  E
Sbjct: 327 FEPFRDPEE 335

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 28  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 85
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 86  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 140
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 257
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 258 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 317
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 318 HPYLEQYYDPSDEPI 332

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 20  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 77
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 78  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 132
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 310 HPYLEQYYDPSDEPI 324

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  EDS LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 22  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 79
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 80  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 134
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 312 HPYLEQYYDPSDEPI 326

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 122/250 (48%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   +A  K   +  A+K ++K+ +I    VE    E ++L  L     + + 
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  ++ E  A     ++       H  G+++
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLHKRGIIY 143
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + +  G   ++  G+  Y+APE++  +  G  
Sbjct: 144 RDLKLDNVMLDS---EGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMT 256
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 257 KHPAKRLGCG 266

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 75
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 76  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 130
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQ 247
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 308 HPYLEQYYDPSDEPI 322

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 18  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 75
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 76  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 130
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 247
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 308 HPYLEQYYDPSDEPI 322

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/315 (27%), Positives = 130/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 97
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 98  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 152
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTE-------DGIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F  K          GI      
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 270 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 330 HPYLEQYYDPSDEPI 344

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYXQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 14  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 66
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 67  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 124
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 125 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 303 AHSFFDELRDPN 314

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 82
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 83  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 315 HPYLEQYYDPSDEPI 329

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 26  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 83
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 84  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 138
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 255
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 256 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 315
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 316 HPYLEQYYDPSDEPI 330

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 17  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 74
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 75  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 129
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 246
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 247 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 306
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 307 HPYLEQYYDPSDEPI 321

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 25  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 82
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 83  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 137
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 315 HPYLEQYYDPSDEPI 329

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ K    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 32  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 84
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 85  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 142
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 143 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 200
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 260
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 261 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 321 AHSFFDELRDPN 332

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 14/268 (5%)
Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           R D GY+   + R  I K +G GQF   Y A    +G  VA+KK++   ++   A  D  
Sbjct: 23  RPDMGYNTLANFR--IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAA 202
           +E+ +L+ L  H NV+K+Y +F +DN + I +EL + G+L   I    K+     E+   
Sbjct: 81  KEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDI 261
               Q+       H   ++HRD+KP N    +      +K  D GL  F          +
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 262 VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPD 318
           VG+ YY++PE +       +SD+WS+G + Y +   + PF+    +   + K++   + D
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI--EQCD 254
Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRAR 346
           +   P    S   +  V   +  DP  R
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 136/308 (44%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K ++ T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCAKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 25  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 77
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 78  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 135
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 314 AHSFFDELRDPN 325

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 25  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 77
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 78  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 135
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 193
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 253
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 314 AHSFFDELRDPN 325

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 26  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 78
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 79  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 136
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 137 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 194
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 195 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 254
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 255 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 315 AHSFFDELRDPN 326

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 17  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 69
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 70  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 127
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 128 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 306 AHSFFDELRDPN 317

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KXQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 21  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 73
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 74  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 131
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 132 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 189
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 249
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 250 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 310 AHSFFDELRDPN 321

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KXQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L D + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 18  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 70
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 71  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 128
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 129 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 307 AHSFFDE 313

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 99
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 100 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 157
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 336 AHSFFDE 342

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 141/312 (45%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 90
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 146
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 147 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 201
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 261
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 262 SESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 322 HDPDDEPV 329

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KCQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 41  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 93
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 94  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 151
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 152 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 209
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---- 314
            + S YY APE++   +   S  DVWS G +   LL G+  F   +      E+++    
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 269
Query: 315 ----------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
                             P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 330 AHSFFDE 336

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 99
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 100 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 157
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 336 AHSFFDE 342

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 103
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 159
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 160 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAP 214
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 335 HDPDDEPV 342

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 49  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 101
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 102 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 159
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 160 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 217
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 218 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 277
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 278 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 338 AHSFFDE 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 92  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 144
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 145 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 202
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 203 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 260
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 261 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 320
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 321 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 381 AHSFFDE 387

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 134/313 (42%), Gaps = 58/313 (18%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RY   K LG G  G  + A D     RVA+KKI       P +V+   RE+KI++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRR 64
Query: 153 LAGHENVVKFY-------NAFEDD-------NYVYIAMELCEGGELLDRILAKKDSRYTE 198
           L  H+N+VK +       +   DD       N VYI  E  E     D     +     E
Sbjct: 65  L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLE 119
Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---- 254
           + A + + Q+LR     H   ++HRD+KP N    +  ED  LK  DFGL+  + P    
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPHYSH 177
Query: 255 -GKKFQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
            G   + +V + +Y +P +L   +      D+W+ G I   +L G+  F    E    + 
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236
Query: 312 VLRNKPDFR----------------------RKP----WPSISNSAKDFVKKLLVKDPRA 345
           +L + P                          KP     P IS  A DF++++L   P  
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 346 RLTAAQALSHPWV 358
           RLTA +ALSHP++
Sbjct: 297 RLTAEEALSHPYM 309

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 86
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 142
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 197
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 257
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 258 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 318 HDPDDEPV 325

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E       +D       S  T     ++   + Q+L+  A CH H +
Sbjct: 70  DVIHTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 126 LHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 132/315 (41%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA++KI   +       +   RE+KIL  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEH--QTYCQRTLREIKILLR 81
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VYI  +L E    L ++L  K    +       + Q
Sbjct: 82  FR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETD--LYKLL--KTQHLSNDHICYFLYQ 136
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +      LK  DFGL+    P         + V 
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGR-----RPFWDKTED--GIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R     + + D+     GI      
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 314 HPYLEQYYDPSDEPI 328

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 85
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 141
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 196
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 256
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 257 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 317 HDPDDEPV 324

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 82
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 138
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 193
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 253
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 254 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 314 HDPDDEPV 321

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 79
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 135
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 136 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 190
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 250
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 251 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 311 HDPDDEPV 318

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 92
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 148
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 203
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 263
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 264 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 324 HDPDDEPV 331

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 77
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 133
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 309 HDPDDEPV 316

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 103
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 159
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 160 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 214
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 274
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 275 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 335 HDPDDEPV 342

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 91
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 147
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 323 HDPDDEPV 330

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 40/288 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGL 220
           +    +N +Y+  E       +D       S  T     ++   + Q+L+  A CH H +
Sbjct: 72  DVIHTENKLYLVFEFLS----MDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKS 277
           +HRD+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +  
Sbjct: 128 LHRDLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR--- 320
               D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++   
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 91
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 147
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 202
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 262
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 263 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 323 HDPDDEPV 330

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 51  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQ 103
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L    E + R+ A+  SR  +    + 
Sbjct: 104 IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIY 161
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 162 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 219
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 279
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 354 SHPWVRE 360
           +H +  E
Sbjct: 340 AHSFFDE 346

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 127/263 (48%), Gaps = 14/263 (5%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D +FD  + I + +G G FG   +          A+K + K K +    V +V +E++I+
Sbjct: 11  DVNFDH-FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           Q L  H  +V  + +F+D+  +++ ++L  GG+L  R   +++  + E+   + + +++ 
Sbjct: 70  QGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVM 126
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                    ++HRDMKP+N L     E   +  TDF ++  +    +   + G+  Y+AP
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 271 EVLKRKSGP----ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           E+   + G       D WS+GV  Y LL GRRP+  ++     KE++    +     +PS
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTF-ETTVVTYPS 241
Query: 327 I-SNSAKDFVKKLLVKDPRARLT 348
             S      +KKLL  +P  R +
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRFS 264

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 76
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 132
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 187
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 308 HDPDDEPV 315

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 77
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 133
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 188
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 248
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 249 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 309 HDPDDEPV 316

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           D+ YD++ DR      +LG G +G  Y   D +N  R+A+K+I +         + +  E
Sbjct: 18  DYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEE 69
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-RYTEKDAAVVV 205
           + + + L  H+N+V++  +F ++ ++ I ME   GG L   + +K    +  E+      
Sbjct: 70  IALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD---FIKPGKKFQDIV 262
           +Q+L      H + +VHRD+K +N L  +      LK +DFG S     I P    +   
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCT--ETFT 184
Query: 263 GSAYYVAPEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFK-EVLRNK 316
           G+  Y+APE++    R  G  +D+WS+G     +  G+ PF++  E    +FK  + +  
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           P+       S+S  AK F+ K    DP  R  A   L
Sbjct: 245 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLL 277

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 129/315 (40%), Gaps = 48/315 (15%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 40  DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 97
Query: 153 LAGHENVVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +       E    VY+   L  G +L   +   K    +       + Q
Sbjct: 98  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL---KTQHLSNDHICYFLYQ 152
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG 263
           +LR     H   ++HRD+KP N L  +  +   LK  DFGL+    P         + V 
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 264 SAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTE-------DGIF----- 309
           + +Y APE++    G     D+WS+G I   +L  R  F  K          GI      
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 310 -----------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                      +  L + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 270 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329
Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 330 HPYLEQYYDPSDEPI 344

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 78
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 134
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 135 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 189
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 249
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 250 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 310 HDPDDEPV 317

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KPEN L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPENLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 27/277 (9%)
Query: 87  DFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           D+ YD++ DR      +LG G +G  Y   D +N  R+A+K+I +         + +  E
Sbjct: 4   DYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEE 55
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-RYTEKDAAVVV 205
           + + + L  H+N+V++  +F ++ ++ I ME   GG L   + +K    +  E+      
Sbjct: 56  IALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD---FIKPGKKFQDIV 262
           +Q+L      H + +VHRD+K +N L  +      LK +DFG S     I P    +   
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGINPCT--ETFT 170
Query: 263 GSAYYVAPEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFK-EVLRNK 316
           G+  Y+APE++    R  G  +D+WS+G     +  G+ PF++  E    +FK  + +  
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 230
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           P+       S+S  AK F+ K    DP  R  A   L
Sbjct: 231 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLL 263

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D+GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 76  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 135 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTA 191
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 251
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 252 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 140/312 (44%), Gaps = 46/312 (14%)
Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ + K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAF-------KNRELQ 65
Query: 149 ILQALAGHENVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           I++ L  H N+V+    FY++ E  + VY+ + L      + R+ A+  SR  +    + 
Sbjct: 66  IMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRV-ARHYSRAKQTLPVIY 123
Query: 205 VR----QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           V+    Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+    
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 261 IVGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIF-------- 309
            + S YY APE++   +   S  DVWS G +   LL G+  F  D   D +         
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 310 --KEVLRNK---------PDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             +E +R           P  +  PW     P     A     +LL   P ARLT  +A 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 354 SHPWVREGGDAS 365
           +H +  E  D +
Sbjct: 302 AHSFFDELRDPN 313

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 70  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 129 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 185
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 186 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 245
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 246 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 72
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 73  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 131
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 132 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 188
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 248
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 249 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 71  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 130 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 186
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 187 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 246
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 247 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 72
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 73  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 131
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 132 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 188
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 189 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 248
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 249 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 76  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 135 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 191
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 192 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 251
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 252 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 296

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 126/295 (42%), Gaps = 43/295 (14%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQALAGHENV 159
           L+G G +G      +K  G  VA+KK    + +KM+  IA+    RE+K+L+ L  HEN+
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLR-HENL 86
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V      +     Y+  E  +   L D  L      Y      +   Q++     CH H 
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFCHSHN 144
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--KRK 276
           ++HRD+KPEN L     +   +K  DFG +     PG+ + D V + +Y APE+L    K
Sbjct: 145 IIHRDIKPENIL---VSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 277 SGPESDVWSIGVITYILLCGRRPF-WDKTEDGIF-------------KEVLRNKPDF--- 319
            G   DVW+IG +   +  G   F  D   D ++             +E+    P F   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 320 ------RRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
                  R+P    +P +S    D  KK L  DP  R   A+ L H + +  G A
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 125/282 (44%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   + D +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 129/292 (44%), Gaps = 45/292 (15%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKI 149
           +RY     LG GQF   Y A DK     VA+KKI      E    I   A+    RE+K+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKL 65
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L+ H N++   +AF   + + +  +  E    L+ I+       T       +   L
Sbjct: 66  LQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +     H H ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYR 179
Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----GIFKEV--------- 312
           APE+L   R  G   D+W++G I   LL  R PF     D      IF+ +         
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 313 -LRNKPDFRR-KPWPSI---------SNSAKDFVKKLLVKDPRARLTAAQAL 353
            + + PD+   K +P I          +   D ++ L + +P AR+TA QAL
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 19  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 55
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 56  SVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 113
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 114 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 170 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQM 284
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 338

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 138/321 (42%), Gaps = 65/321 (20%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 77
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 78  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIHMELD----HERMSYLLY 131
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYVVTRY 188
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDK------TEDGIFKE 311
           Y APEV+      E+ D+WS+G I   L+ G   F        W+K      T    F  
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMA 248
Query: 312 VLRNKPDFR-----RKPWPSI---------------------SNSAKDFVKKLLVKDPRA 345
            L  +P  R     R  +P I                     ++ A+D + K+LV DP  
Sbjct: 249 AL--QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDK 306
Query: 346 RLTAAQALSHPWVREGGDASE 366
           R++  +AL HP++    D +E
Sbjct: 307 RISVDEALRHPYITVWYDPAE 327

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 20  QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 74
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 75  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 134
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 135 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 184
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 244
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 245 KQIRIPR----SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DF L+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 138/307 (44%), Gaps = 46/307 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    + D  +G ++AVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 109
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 165
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  DFGL+       +    V + +Y AP
Sbjct: 166 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAP 220
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           E++          D+WS+G I   LL GR  F         ++++R              
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP 280
Query: 315 ---------NKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                    + P   ++ +  +    +  A D ++K+LV D   R+TA++AL+HP+  + 
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340
Query: 362 GDASEIP 368
            D  + P
Sbjct: 341 HDPDDEP 347

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  + CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 5   QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 59
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 60  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 119
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 120 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 169
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 229
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 230 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+KKI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E  +  +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 72  DVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 131 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTA 187
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 188 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 247
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 248 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 292

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK   FGL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 22/286 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAV-KKIEKNKMILPIAVEDVKREVKILQALAG 155
           +Y +G LLG G +G      D     R AV    +K    +P    +VK+E+++L+ L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 156 HENVVKFYNAF--EDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H+NV++  +    E+   +Y+ ME C  G  E+LD +  K   R+    A     Q++  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDG 121
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQDIVGSAYYV 268
               H  G+VH+D+KP N L  +     +LK +  G+++ + P       +   GS  + 
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 269 APEV---LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            PE+   L   SG + D+WS GV  Y +  G  PF       +F+ + +          P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGP 238
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDI 371
            +S    D +K +L  +P  R +  Q   H W R+    +E P+ I
Sbjct: 239 PLS----DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPI 280

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+GVI   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 26/285 (9%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 24  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 77
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 78  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 135 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 187
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR---NKPDFRRK 322
           Y++PE L+      +SD+WS+G+    +  GR P    +      E+L    N+P   + 
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP-PKL 246
Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           P    S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 290

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 119/250 (47%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++          G+++
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  G  
Sbjct: 466 RDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 578
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 579 KHPGKRLGCG 588

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 19  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 55
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 56  SVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 113
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 114 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 169
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 170 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 224
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 225 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 284
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 285 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 338

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 145/354 (40%), Gaps = 69/354 (19%)
Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFG 110
           H  QER   Y+Q   K   +   R Q  + P G                       G +G
Sbjct: 20  HMSQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYG 56
Query: 111 YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF---- 166
               A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F    
Sbjct: 57  SVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 114
Query: 167 --EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
             E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD
Sbjct: 115 SLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRD 170
Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESD 282
           +KP N    +  ED  LK  DFGL+       +    V + +Y APE++          D
Sbjct: 171 LKPSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVD 225
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRK 322
           +WS+G I   LL GR  F         K +LR    P                     + 
Sbjct: 226 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 285
Query: 323 PWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 286 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 339

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I K++G G F    V   K  G   A+K + K  M+    V   + E  +L       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR 121
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + + AF+D+NY+Y+ ME   GG+LL  +L+K   R   + A   + +++      H 
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--VGSAYYVAPEVLK- 274
            G VHRD+KP+N L         ++  DFG    ++     + +  VG+  Y++PE+L+ 
Sbjct: 181 LGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 275 -------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW--P 325
                     GPE D W++GV  Y +  G+ PF+  +    + +++  K +    P    
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-EHLSLPLVDE 296
Query: 326 SISNSAKDFVKKLLVKDPRARL---TAAQALSHPW 357
            +   A+DF+++LL   P  RL    A    +HP+
Sbjct: 297 GVPEEARDFIQRLLCP-PETRLGRGGAGDFRTHPF 330

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 126
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEV 323

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
           F+  Y +G LLG G FG  +      +  +VA+K I +N+++    + D      EV +L
Sbjct: 29  FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 151 Q---ALAGHENVVKFYNAFEDDNYVYIAME-LCEGGELLDRILAKKDSRYTEKDAAVVVR 206
               A  GH  V++  + FE      + +E      +L D I  K      E  +     
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFG 146
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           Q++     CH  G+VHRD+K EN L    +     K  DFG    +   + + D  G+  
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRR--GCAKLIDFGSGALLH-DEPYTDFDGTRV 203
Query: 267 YVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           Y  PE + R       + VWS+G++ Y ++CG  PF     D   +E+L  +  F     
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF---ERD---QEILEAELHFPAH-- 255
Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
             +S      +++ L   P +R +  + L  PW++    A ++P++ S
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT--PAEDVPLNPS 299

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 119/250 (47%), Gaps = 11/250 (4%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++          G+++
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 144
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  G  
Sbjct: 145 RDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K L+ 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMT 257
Query: 341 KDPRARLTAA 350
           K P  RL   
Sbjct: 258 KHPGKRLGCG 267

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   K+ K +++     ++ V+ E  + 
Sbjct: 9   QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 64  EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 124 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSXFCGT 173
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 234 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 300
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 301 AKRISVDDALQHPYINVWYDPAEV 324

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 307
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 308 AKRISVDDALQHPYINVWYDPAEV 331

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 77
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 132
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 189
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 245
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 246 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 305
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 306 AKRISVDDALQHPYINVWYDPAEV 329

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 71
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 126
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 239
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEV 323

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 140/291 (48%), Gaps = 42/291 (14%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-VEDVKREVKIL 150
           +DFD    + +++G G +    +   K   DR+   ++ K +++     ++ V+ E  + 
Sbjct: 52  QDFD----LLRVIGRGSYAKVLLVRLKKT-DRIYAMRVVKKELVNDDEDIDWVQTEKHVF 106
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL-----DRILAKKDSRYTEKDAAVVV 205
           +  + H  +V  ++ F+ ++ ++  +E   GG+L+      R L ++ +R+   + ++ +
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGS 264
             +       H  G+++RD+K +N L  S   +  +K TD+G+  + ++PG       G+
Sbjct: 167 NYL-------HERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGT 216
Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF---------WDKTEDGIFKEVLR 314
             Y+APE+L+ +  G   D W++GV+ + ++ GR PF            TED +F+ +L 
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVR 359
            +    R    S+S  A   +K  L KDP+ RL        A    HP+ R
Sbjct: 277 KQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 116
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 171
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 284
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEV 368

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 300
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 301 AKRISVDDALQHPYINVWYDPAEV 324

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 307 AKRISVDDALQHPYINVWYDPAEV 330

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 307
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 308 AKRISVDDALQHPYINVWYDPAEV 331

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/324 (26%), Positives = 135/324 (41%), Gaps = 69/324 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 116
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 171
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 284
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 344 RARLTAAQALSHPWVREGGDASEI 367
             R++   AL HP++    D +E+
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEV 368

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+ KI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 128 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 184
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 185 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 244
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 245 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 34/285 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G  Y A +K  G+ VA+ KI  +     +    + RE+ +L+ L  H N+VK  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKEL-NHPNIVKLL 67
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
           +    +N +Y+  E     +L   + A   +          + Q+L+  A CH H ++HR
Sbjct: 68  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPE 280
           D+KP+N L  +   + ++K  DFGL+  F  P + +   V + +Y APE+L   +     
Sbjct: 127 DLKPQNLLINT---EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 281 SDVWSIGVITYILLCGRRPFWDKTE-DGIFK---------EV----LRNKPDFR------ 320
            D+WS+G I   ++  R  F   +E D +F+         EV    + + PD++      
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 321 -----RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                 K  P +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+GVI   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 46/308 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY     +G G +G    A D   G RVAVKK+ +    + I  +   RE+++L+ +  H
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-H 80
Query: 157 ENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           ENV+   + F      E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILR 136
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H   ++HRD+KP N    +  ED  LK  D GL+       +    V + +Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNL---AVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAP 191
Query: 271 EVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP--------- 317
           E++          D+WS+G I   LL GR  F         K +LR    P         
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 251
Query: 318 ---------DFRRKPWPSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                       + P  + +N        A D ++K+LV D   R+TAAQAL+H +  + 
Sbjct: 252 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 362 GDASEIPI 369
            D  + P+
Sbjct: 312 HDPDDEPV 319

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/320 (27%), Positives = 138/320 (43%), Gaps = 63/320 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVKREVKILQA 152
           +RY   K +G G  G    A D   G  VAVKK+ +   N+       +   RE+ +L+ 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKC 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 80  V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIHMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYVVTRY 190
Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDKTEDGI--------- 308
           Y APEV L        D+WS+G I   L+ G   F        W+K  + +         
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMA 250
Query: 309 -FKEVLRNKPDFRRKPWPSI---------------------SNSAKDFVKKLLVKDPRAR 346
             +  +RN  + R K +P I                     ++ A+D + K+LV DP  R
Sbjct: 251 ALQPTVRNYVENRPK-YPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKR 309
Query: 347 LTAAQALSHPWVREGGDASE 366
           ++  +AL HP++    D +E
Sbjct: 310 ISVDEALRHPYITVWYDPAE 329

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 39  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 92  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 262 VGSAYYVAPEVL----KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFKEVLR 314
            G++ + APE+L    KR+     D++S+G V  YIL  G+ PF DK   E  I + +  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF- 269
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 39  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 91
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 92  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 151 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 210
Query: 262 VGSAYYVAPEVL----KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFKEVLR 314
            G++ + APE+L    KR+     D++S+G V  YIL  G+ PF DK   E  I + +  
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF- 269
Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 270 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 18/270 (6%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV----KREV 147
           K  + RY I   LG G     Y+A D     +VA+K I     I P   E+     +REV
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI----FIPPREKEETLKRFEREV 62
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
                L+ H+N+V   +  E+D+  Y+ ME  EG  L + I  +     +   A     Q
Sbjct: 63  HNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQ 119
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSA 265
           +L      H   +VHRD+KP+N L  S K   +LK  DFG++  +      Q   ++G+ 
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNK---TLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 266 YYVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKP 323
            Y +PE  K ++  E +D++SIG++ Y +L G  PF  +T   I  K +  + P+     
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV 236
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
              I  S  + + +   KD   R    Q +
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYKTIQEM 266

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D   G +VA+KK+ +      +  +   RE+++L+ +  HENV+   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR-HENVIGLL 90
Query: 164 NAFEDDNYV------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F  D  +      Y+ M     G  L +++  K  +  E     +V QML+     H 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFM--GTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  ED  LK  DFGL+   +   +    V + +Y APEV+    
Sbjct: 147 AGIIHRDLKPGNL---AVNEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWM 201
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR--------------------- 314
           +     D+WS+G I   ++ G+  F         KE+++                     
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 315 --NKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
               P+  +K + SI  +A     + ++K+LV D   R+TA +AL+HP+     D  + P
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+         +  V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
            F +K  P++ N                                   A+D + K+LV D 
Sbjct: 247 AFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 137/284 (48%), Gaps = 28/284 (9%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 8   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 61
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 62  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 118
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +   +   + VG+  
Sbjct: 119 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRS 171
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK--EVLRNKPDFRRKP 323
           Y++PE L+      +SD+WS+G+    +  GR P   +    IF+  + + N+P   + P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVNEPP-PKLP 227
Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
               S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 228 SAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 270

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 137/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+         +  V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 72
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 127
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 185 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 240
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 241 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 300
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 301 SKRISVDEALQHPYINVWYDPSE 323

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 21  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 262 VGSAYYVAPEVL--------KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFK 310
            G++ + APE+L        KR+     D++S+G V  YIL  G+ PF DK   E  I +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            +  +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 253 GIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 83
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 138
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 195
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++C +  F        W+K    + +++    P
Sbjct: 196 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNK----VIEQLGTPCP 251
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 252 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 311
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 312 SKRISVDEALQHPYINVWYDPSE 334

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/337 (26%), Positives = 138/337 (40%), Gaps = 51/337 (15%)
Query: 74  RRQTGV---IPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE 130
           RR  GV   +P       G   D   RYT  + +G G +G    A D     RVA+KKI 
Sbjct: 18  RRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS 77
Query: 131 KNKMILPIAVEDVKREVKILQALAGHENVVKF-----YNAFEDDNYVYIAMELCEGGELL 185
             +       +   RE++IL     HENV+        +  E    VYI  +L E    L
Sbjct: 78  PFEH--QTYCQRTLREIQILLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMETD--L 132
Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
            ++L  K  + +       + Q+LR     H   ++HRD+KP N L  +      LK  D
Sbjct: 133 YKLL--KSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTT---CDLKICD 187
Query: 246 FGLSDFIKPGKK----FQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRP 299
           FGL+    P         + V + +Y APE++    G     D+WS+G I   +L  R  
Sbjct: 188 FGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247
Query: 300 FWDKTE-------DGIF----------------KEVLRNKPDFRRKPW----PSISNSAK 332
           F  K          GI                 +  L++ P   +  W    P   + A 
Sbjct: 248 FPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKAL 307
Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           D + ++L  +P  R+T  +AL+HP++ +  D ++ P+
Sbjct: 308 DLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPV 344

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 124/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N L  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANILISAT---NAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG+G  G T V      G  VAVK++  +     IA+     E+K+L     H NV++
Sbjct: 21  KILGYGSSG-TVVFQGSFQGRPVAVKRMLID--FCDIAL----MEIKLLTESDDHPNVIR 73
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT-----EKDAAVVVRQMLRVAAECH 216
           +Y +   D ++YIA+ELC    L D + +K  S        E +   ++RQ+    A  H
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 217 LHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKPGK-----KFQDI 261
              ++HRD+KP+N L  ++           E+  +  +DFGL   +  G+        + 
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 262 VGSAYYVAPEVL--------KRKSGPESDVWSIG-VITYILLCGRRPFWDK--TEDGIFK 310
            G++ + APE+L        KR+     D++S+G V  YIL  G+ PF DK   E  I +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
            +  +  + +     S+   A D + +++  DP  R TA + L HP
Sbjct: 253 GIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLARHT--ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 137/291 (47%), Gaps = 32/291 (10%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF--WDKTED-----GIFK--EVLRNK 316
           Y++PE L+      +SD+WS+G+    +  GR P    D  ED      IF+  + + N+
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE 228
Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           P   + P    S   +DFV K L+K+P  R    Q + H +++   DA E+
Sbjct: 229 PP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEV 277

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 23/267 (8%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LGHG  G T V     +   VAVK+I      LP       REV++L+    H NV+++
Sbjct: 31  VLGHGAEG-TIVYRGMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHPNVIRY 83
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           +   +D  + YIA+ELC     L   + +KD  +   +   +++Q     A  H   +VH
Sbjct: 84  FCTEKDRQFQYIAIELC--AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 223 RDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK----KFQDIVGSAYYVAPEVLKR- 275
           RD+KP N L         +KA  +DFGL   +  G+    +   + G+  ++APE+L   
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 276 -KSGP--ESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFR-RKPWPSISNS 330
            K  P    D++S G + Y ++  G  PF    +      +L          P       
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILLGACSLDCLHPEKHEDVI 259
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPW 357
           A++ ++K++  DP+ R +A   L HP+
Sbjct: 260 ARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +  H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 145/352 (41%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P                      +G G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSP----------------------IGSGAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 45
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 46  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 103
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 104 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 160 PSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 215 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 95/352 (26%), Positives = 144/352 (40%), Gaps = 69/352 (19%)
Query: 53  HQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT 112
            QER   Y+Q   K   +   R Q  + P G                       G +G  
Sbjct: 7   SQERPTFYRQELNKTIWEVPERYQ-NLSPVGS----------------------GAYGSV 43
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------ 166
             A D   G RVAVKK+ +    + I  +   RE+++L+ +  HENV+   + F      
Sbjct: 44  CAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 101
Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           E+ N VY+   L   G  L+ I+  K  + T+     ++ Q+LR     H   ++HRD+K
Sbjct: 102 EEFNDVYLVTHLM--GADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 157
Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVW 284
           P N    +  ED  LK  DFGL+       +    V + +Y APE++          D+W
Sbjct: 158 PSNL---AVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212
Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLR--NKP------------------DFRRKPW 324
           S+G I   LL GR  F         K +LR    P                     + P 
Sbjct: 213 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 272
Query: 325 PSISNS-------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            + +N        A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 273 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 324

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 128 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXX 181
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 182 XVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 240
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 241 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D  +   VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 127
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 128 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 181
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 240
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 241 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 137/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D++LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 131/315 (41%), Gaps = 69/315 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWV 358
             R++   AL HP++
Sbjct: 307 AKRISVDDALQHPYI 321

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 50  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 108
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 109 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 162
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 221
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 222 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 134/298 (44%), Gaps = 47/298 (15%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           YT  K++G+G FG  + A      D VA+KK+ ++K           RE++I++ +  H 
Sbjct: 42  YTNCKVIGNGSFGVVFQA-KLVESDEVAIKKVLQDKRF-------KNRELQIMR-IVKHP 92
Query: 158 NVVK----FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QML 209
           NVV     FY+  +  + V++ + L    E + R  ++  ++  +    ++++    Q+L
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA-SRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           R  A  H  G+ HRD+KP+N L         LK  DFG +  +  G+     + S YY A
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPP--SGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 270 PEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------------- 314
           PE++   +   +  D+WS G +   L+ G+  F  ++      E+++             
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 315 -------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                    P  R  P+     P     A D + +LL   P ARLTA +AL HP+  E
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 53  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 111
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 112 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 165
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 166 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 224
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 225 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 49  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 107
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 108 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 161
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 162 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 220
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 221 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 29/304 (9%)
Query: 70  KTNSRRQTGVIPC----GKRTDFGYDKD-FDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           K NS       PC      +   G +K+  + +Y +G LLG G  G  Y     ++   V
Sbjct: 20  KINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPV 79
Query: 125 AVKKIEKNKMI----LPIAVEDVKREVKILQALA-GHENVVKFYNAFE-DDNYVYIAMEL 178
           A+K +EK+++     LP     V  EV +L+ ++ G   V++  + FE  D++V I    
Sbjct: 80  AIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKED 238
               +L D I  +      E+ A     Q+L     CH  G++HRD+K EN L    +  
Sbjct: 139 EPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-- 194
Query: 239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG 296
             LK  DFG    +K    + D  G+  Y  PE ++  R  G  + VWS+G++ Y ++CG
Sbjct: 195 GELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253
Query: 297 RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
             PF         +E++R +  FR++    +S+  +  ++  L   P  R T  +  +HP
Sbjct: 254 DIPFEHD------EEIIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 303
Query: 357 WVRE 360
           W+++
Sbjct: 304 WMQD 307

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/322 (26%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VY+ MEL +   L   I  + D     +  + ++ 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LXQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVIT------YILLCGRRPF--WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I        IL  GR     W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSISN----------------------------------SAKDFVKKLLVKDP 343
           +F +K  P++ N                                   A+D + K+LV DP
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 344 RARLTAAQALSHPWVREGGDAS 365
             R++   AL HP++    D +
Sbjct: 307 AKRISVDDALQHPYINVWYDPA 328

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 136/323 (42%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +    L +++  +      +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQME---LDHERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPSP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 26/238 (10%)
Query: 139 AVEDVKREVKILQALAGHEN-VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK     
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155
Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
           E+ +    + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P   
Sbjct: 156 ERKS--YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTT 209
Query: 258 F---QDIVGSAYYVAPEVLK-----RKSGPES-------DVWSIGVITYILLCGRRPFWD 302
                  VG+  Y+ PE +K     R++G          DVWS+G I Y +  G+ PF  
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-Q 268
Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +  + I K      P+   + +P I     +D +K  L +DP+ R++  + L+HP+V+
Sbjct: 269 QIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 79
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 134
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 247
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 308 SKRISVDEALQHPYINVWYDPSE 330

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 80
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 135
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFVVTRY 192
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 248
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 249 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 308
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 309 SKRISVDEALQHPYINVWYDPSE 331

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  Y   D    + VA+K I+  +      +ED+++E+ +L        + +++
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQ-CDSPYITRYF 83
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            ++     ++I ME   GG  LD +   K     E   A ++R++L+     H    +HR
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSGP-ES 281
           D+K  N L     E   +K  DFG++  +   + K    VG+ +++APEV+K+ +   ++
Sbjct: 141 DIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----SNSAKDFVKK 337
           D+WS+G+    L  G  P  D     +   + +N P       P++    S   K+FV+ 
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PTLEGQHSKPFKEFVEA 250
Query: 338 LLVKDPRARLTAAQALSHPWV 358
            L KDPR R TA + L H ++
Sbjct: 251 CLNKDPRFRPTAKELLKHKFI 271

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/330 (25%), Positives = 141/330 (42%), Gaps = 56/330 (16%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-- 154
           R+ + ++ G G FG   +  +K+ G  VA+KK+ ++            RE++I+Q LA  
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVL 76
Query: 155 GHENVVK----FYNAFEDDN---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV--- 204
            H N+V+    FY   E D    Y+ + ME     + L R       R       ++   
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 205 VRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
           + Q++R     HL    + HRD+KP N L   A  D +LK  DFG +  + P +     +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----NK 316
            S YY APE++   +      D+WS+G I   ++ G   F      G   E++R      
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 317 PDFRRK----------------PWPSI--------SNSAKDFVKKLLVKDPRARLTAAQA 352
            +  RK                PW ++        +  A D +  LL   P  R+   +A
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 353 LSHPWVREGGD-ASEIPIDISVLNNMRQFV 381
           L HP+  E  D A+++P +  +  ++ +F+
Sbjct: 313 LCHPYFDELHDPATKLPNNKDLPEDLFRFL 342

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 69/323 (21%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-VKREVK--ILQA 152
           +RY   K +G G  G    A D      VA+KK+ +     P   +   KR  +  +L  
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-----PFQNQTHAKRAYRELVLMK 78
Query: 153 LAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              H+N++   N F      E+   VYI MEL +   L   I  + D     +  + ++ 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELD----HERMSYLLY 133
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           QML      H  G++HRD+KP N + KS   D +LK  DFGL+            V + Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEVVTRY 190
Query: 267 YVAPEVLKRKSGPES-DVWSIGVITYILLCGRRPF--------WDKTEDGIFKEVLRNKP 317
           Y APEV+      E+ D+WS+G I   ++ G   F        W+K    + +++    P
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK----VIEQLGTPCP 246
Query: 318 DFRRKPWPSI----------------------------------SNSAKDFVKKLLVKDP 343
           +F +K  P++                                  ++ A+D + K+LV D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDA 306
Query: 344 RARLTAAQALSHPWVREGGDASE 366
             R++  +AL HP++    D SE
Sbjct: 307 SKRISVDEALQHPYINVWYDPSE 329

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 11  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 65
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 66  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 123
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 124 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 181 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 237

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQ 76
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 77  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 132
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 133 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 246
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 24  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQ 81
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 82  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 137
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 138 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P      +   S  
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKP 251
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 252 LKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQ 61
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 62  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 117
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 118 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 174
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 231
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/349 (25%), Positives = 144/349 (41%), Gaps = 95/349 (27%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGH 156
           Y I  L+G G +GY Y+A DK     VA+KK+  N+M    I  + + RE+ IL  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS- 84
Query: 157 ENVVKFYNAFEDDNY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           + +++ Y+    D+      +YI +E+ +      + L K     TE+    ++  +L  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDL---KKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI----------------KPG 255
               H  G++HRD+KP N L     +D S+K  DFGL+  I                +PG
Sbjct: 142 ENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 256 -------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL----------CG 296
                  K+    V + +Y APE  +L+       D+WS G I   LL            
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 297 RRPFW----------DKTEDGIFKEVLR---------------------NKPDF------ 319
           R P +          D+    + ++  R                     NKP+       
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 320 --RRKP------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              RKP      +PSIS+   + ++ +L  +P  R+T  QAL HP++++
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 23  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR 78
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 79  -HVNILLFM-GYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 93
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  EDS L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNV---AVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 276 KSGPESDVWSIGVITYILLCGRRPF-----------------------WDKTEDGIFKEV 312
                 D+WS+G I   LL G+  F                         K      +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 313 LRNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           +++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 127/268 (47%), Gaps = 14/268 (5%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQ 61
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+  
Sbjct: 62  -CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGL 117
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 118 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 174
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+K+ +   ++D+WS+G+    L  G  P  +     +   + +N P        + S  
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKP 231
Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWV 358
            K+FV+  L K+P  R TA + L H ++
Sbjct: 232 LKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 17/291 (5%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           G++P G  +          RY +G++LG G     ++A D      VAVK +  +    P
Sbjct: 13  GLVPRG--SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP 70
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKD 193
                 +RE +   AL  H  +V  Y+  E +       YI ME  +G  L D  +   +
Sbjct: 71  SFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTE 127
Query: 194 SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
              T K A  V+    +     H +G++HRD+KP N +  +    +++K  DFG++  I 
Sbjct: 128 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIA 184
Query: 254 PG----KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
                  +   ++G+A Y++PE  +  S    SDV+S+G + Y +L G  PF   +   +
Sbjct: 185 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 244
Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
             + +R  P         +S      V K L K+P  R   A  +    VR
Sbjct: 245 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 295

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 23  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR 78
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L   + A  ++++  K    + RQ  R    
Sbjct: 79  -HVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDY 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++APE
Sbjct: 136 LHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN--KPDFRR 321
           V++ + S P   +SDV++ G++ Y L+ G+ P+ +    D I + V R    PD  +
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 16/282 (5%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 71
Query: 157 ENVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y   E +       YI ME  +G  L D  +   +   T K A  V+    +  
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG----KKFQDIVGSAYYV 268
              H +G++HRD+KP N +  +    +++K  DFG++  I        +   ++G+A Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           +PE  +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVR-EGGDASEIP 368
           S      V K L K+P  R   A  +    VR   G+  E P
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 93
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  EDS L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 150 AGIIHRDLKPSNV---AVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 276 KSGPESDVWSIGVITYILLCGRRPF-----------------------WDKTEDGIFKEV 312
                 D+WS+G I   LL G+  F                         K      +  
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 313 LRNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           +++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 324

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  + A ++   + VA+K++  + +   +P       RE+ +L+ L  H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELK-HKNIVR 65
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECHL 217
            ++    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+    CH 
Sbjct: 66  LHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--K 274
             ++HRD+KP+N L     E   LK  DFGL+  F  P + +   V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLR--------------NKPDF 319
           +      D+WS G I   L    RP +   + D   K + R                PD+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 320 RRKPW-----------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D +  +T  + +G G FG  +   D      VA+K I+  +      +ED+++E+ +L  
Sbjct: 20  DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQ 77
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
                 V K+Y ++   + ++I ME   GG  LD + A     + E   A +++++L+  
Sbjct: 78  -CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGL 133
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPE 271
              H    +HRD+K  N L     E   +K  DFG++  +   + K    VG+ +++APE
Sbjct: 134 DYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI--- 327
           V+++ +   ++D+WS+G+    L  G  P  D     +   + +N P       P++   
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------PTLVGD 243
Query: 328 -SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            + S K+F+   L KDP  R TA + L H ++
Sbjct: 244 FTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 80
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 81  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 134
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311
Query: 355 H 355
           H
Sbjct: 312 H 312

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKGS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 62/301 (20%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G FG  + A  +  G +VA+KK+  E  K   PI      RE+KILQ L  HENVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT---ALREIKILQLLK-HENVVN 81
Query: 162 F----------YNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQML 209
                      YN  +    +Y+  + CE     LL  +L K    +T  +   V++ +L
Sbjct: 82  LIEICRTKASPYNRCKAS--IYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLL 135
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGS 264
                 H + ++HRDMK  N L      D  LK  DFGL+      K     ++ + V +
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
            +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       +
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 323 PWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQALS 354
            WP++ N                             A D + KLLV DP  R+ +  AL+
Sbjct: 253 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 355 H 355
           H
Sbjct: 313 H 313

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 10/261 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K +    S
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 341 KDPRARL-----TAAQALSHP 356
           KDP  RL     +A +   HP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G    A D     +VAVKK+ +    L I      RE+++L+ L  HENV+   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHLK-HENVIGLL 85
Query: 164 NAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           + F      ED + VY+   L   G  L+ I+  K    +++    +V Q+LR     H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIV--KCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-- 275
            G++HRD+KP N    +  ED  L+  DFGL+   +  ++    V + +Y APE++    
Sbjct: 142 AGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 276 KSGPESDVWSIGVITYILLCGRRPF-----------------------WDKTEDGIFKEV 312
                 D+WS+G I   LL G+  F                         K      +  
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 313 LRNKPDFRRKPWPSISNSAK----DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           +++ P   +K   SI   A     D + ++LV D   R++AA+AL+H +  +  D  + P
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEP 316

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 10/261 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL+ +     VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPES 281
           +RD+KPEN L     +   ++ +D GL+  +  G+  +  VG+  Y+APEV+K +    S
Sbjct: 309 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 282 -DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 341 KDPRARL-----TAAQALSHP 356
           KDP  RL     +A +   HP
Sbjct: 426 KDPAERLGCRGGSAREVKEHP 446

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +G G +G  + A ++   + VA+K++  + +   +P       RE+ +L+ L  H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELK-HKNIVR 65
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVV---VRQMLRVAAECHL 217
            ++    D  + +  E C      D+ L K  DS   + D  +V   + Q+L+    CH 
Sbjct: 66  LHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL--K 274
             ++HRD+KP+N L     E   LK  +FGL+  F  P + +   V + +Y  P+VL   
Sbjct: 120 RNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLR--------------NKPDF 319
           +      D+WS G I   L    RP +   + D   K + R                PD+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 320 RRKPW-----------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 47/303 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 358 VRE 360
            ++
Sbjct: 300 FQD 302

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF- 162
           LG G FGY      +  G++VA+K+  +   + P   E    E++I++ L  H NVV   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAR 79
Query: 163 -----YNAFEDDNYVYIAMELCEGGELLDRI--------LAKKDSRYTEKDAAVVVRQML 209
                      ++   +AME CEGG+L   +        L +   R    D +  +R + 
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL- 138
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 139 ------HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 270 PEVLKRKSGPES-DVWSIGVITYILLCGRRPF 300
           PE+L++K    + D WS G + +  + G RPF
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF- 162
           LG G FGY      +  G++VA+K+  +   + P   E    E++I++ L  H NVV   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAR 78
Query: 163 -----YNAFEDDNYVYIAMELCEGGELLDRI--------LAKKDSRYTEKDAAVVVRQML 209
                      ++   +AME CEGG+L   +        L +   R    D +  +R + 
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL- 137
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 138 ------HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 270 PEVLKRKSGPES-DVWSIGVITYILLCGRRPF 300
           PE+L++K    + D WS G + +  + G RPF
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 47/303 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 358 VRE 360
            ++
Sbjct: 300 FQD 302

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/330 (23%), Positives = 142/330 (43%), Gaps = 80/330 (24%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           ++Y++GK LG G FG      D  +G R A+KK+ ++            RE+ I++ L  
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVL-D 58
Query: 156 HENVVKFYNAF--------------EDDN------------------------YVYIAME 177
           H N++K  + F              +D N                        Y+ + ME
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 178 LCEGGELLDRILAK--KDSRYTEKD-AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS 234
                + L ++L    +  R    +  ++ + Q+ R     H  G+ HRD+KP+N L  S
Sbjct: 119 YVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 235 AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYI 292
             +D++LK  DFG +  + P +     + S +Y APE++    +  P  D+WSIG +   
Sbjct: 177 --KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 293 LLCGRRPFWDKTE-DGIFK-----------EVLRNKPDFRRKPWPSI------------- 327
           L+ G+  F  +T  D + +           +++R  P +    +P++             
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            + A D ++++L  +P  R+   +A++HP+
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPF 324

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 47/300 (15%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKI--EKNKMILPIAVEDVKREVKILQ 151
           D++Y     +G G +G  + A D  NG R VA+K++  +  +  +P++     REV +L+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLR 66
Query: 152 ALAG--HENVVKFYNAF-----EDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAA 202
            L    H NVV+ ++       + +  + +  E  +      LD++        T KD  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V
Sbjct: 125 -MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEV--LRN 315
            + +Y APEVL + S     D+WS+G I +  +  R+P +  + D    G   +V  L  
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 316 KPDFRR------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R                  K    I    KD + K L  +P  R++A  ALSHP+
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLMGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 79  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 130
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 309 TALEAMTHPYFQQ 321

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 46/236 (19%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALAGHEN 158
           + LG G FG  + A +K +    A+K+I      LP   +A E V REVK L  L  H  
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIR-----LPNRELAREKVMREVKALAKLE-HPG 64
Query: 159 VVKFYNAFEDDN------------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +V+++NA+ + N            Y+YI M+LC    L D +  +      E++ +V + 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLH 122
Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-- 261
             L++A      H  GL+HRD+KP N  F     D  +K  DFGL   +   ++ Q +  
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 262 -----------VGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE 305
                      VG+  Y++PE +   S   + D++S+G+I + LL    PF  + E
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQME 232

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 80  ILQNLCGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 131
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 132 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 189
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 190 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 249
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 250 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 309
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 310 TALEAMTHPYFQQ 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 78  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 129
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 130 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 187
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 308 TALEAMTHPYFQQ 320

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 111/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 79  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 130
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 131 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 188
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--------- 310
           S Y+  PE+L   +      D+WS+G +   ++  + PF+      D + K         
Sbjct: 189 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 311 -EVLRNK------PDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
             V  NK      P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 309 TALEAMTHPYFQQ 321

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 41/291 (14%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L  H N+V 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK-HANIVT 64
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++    +  + +  E  +    L + L    +     +  + + Q+LR  A CH   ++
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS--G 278
           HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L   +   
Sbjct: 123 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----------------------NK 316
            + D+W +G I Y +  GR  F   T +     + R                      N 
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 317 PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
           P +R +      P + +   D + KLL  + R R++A  A+ HP+    G+
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
            G     +  + +  +LG G     +    K  GD  A+K       + P+ V+   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREF 58
Query: 148 KILQALAGHENVVKFYNAFEDDN---YVYIAMELCEGGELLDRILAKKDSRY--TEKDAA 202
           ++L+ L  H+N+VK + A E++    +  + ME C  G L   +L +  + Y   E +  
Sbjct: 59  EVLKKL-NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFL 115
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQDI 261
           +V+R ++        +G+VHR++KP N +    ++  S+ K TDFG +  ++  ++F  +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 262 VGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCGRRPF 300
            G+  Y+ P++ +R         K G   D+WSIGV  Y    G  PF
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +  +LG G     +    K  GD  A+K       + P+ V+   RE ++L+ L  H+
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NHK 67
Query: 158 NVVKFYNAFEDDN---YVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVA 212
           N+VK + A E++    +  + ME C  G L   +L +  + Y   E +  +V+R ++   
Sbjct: 68  NIVKLF-AIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
                +G+VHR++KP N +    ++  S+ K TDFG +  ++  ++F  + G+  Y+ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 272 VLKR---------KSGPESDVWSIGVITYILLCGRRPF 300
           + +R         K G   D+WSIGV  Y    G  PF
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 51/253 (20%)
Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAV 203
           ILQ L G  N+VK  +   D +         +   L+   +   D +      T+ D   
Sbjct: 99  ILQNLXGGPNIVKLLDIVRDQH--------SKTPSLIFEYVNNTDFKVLYPTLTDYDIRY 150
Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PGK++   V 
Sbjct: 151 YIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVA 208
Query: 264 SAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFW------------------DK 303
           S Y+  PE+L   +      D+WS+G +   ++  + PF+                  D 
Sbjct: 209 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 268
Query: 304 TEDGIFKEVLRNKPDFR-------RKPWPSISNS---------AKDFVKKLLVKDPRARL 347
               + K  +   P          RKPW    N+         A DF+ KLL  D + RL
Sbjct: 269 LNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 328
Query: 348 TAAQALSHPWVRE 360
           TA +A++HP+ ++
Sbjct: 329 TALEAMTHPYFQQ 341

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 190
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV------GSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P    +D++      G+  ++APE VL R 
Sbjct: 191 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS   +   +L G  P+       +  ++    P  R  P PS +      ++
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQAIQ 307
Query: 337 KLLVKDPRARLTAAQ 351
           + L K+P  R++AA+
Sbjct: 308 EGLRKEPIHRVSAAE 322

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 127/291 (43%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   + +V     +L A   H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-----MLLASLNHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I ME CE G L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HRD+KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D++S+G+I + ++    PF    E     + 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 21/255 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHG 209
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE VL R 
Sbjct: 210 DVKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
              + DVWS   +   +L G  P+       +  ++    P  R  P PS +      ++
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIP-PSCAPLTAQAIQ 326
Query: 337 KLLVKDPRARLTAAQ 351
           + L K+P  R++AA+
Sbjct: 327 EGLRKEPIHRVSAAE 341

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 129/307 (42%), Gaps = 61/307 (19%)
Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQ 151
            DR   I KL G G +G  Y A D    + VA+K+I  E  +  +P       REV +L+
Sbjct: 33  IDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----- 206
            L  H N+++  +    ++ +++  E  E              +Y +K+  V +R     
Sbjct: 89  ELQ-HRNIIELKSVIHHNHRLHLIFEYAE----------NDLKKYMDKNPDVSMRVIKSF 137
Query: 207 --QMLRVAAECHLHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKKFQDI 261
             Q++     CH    +HRD+KP+N L     A E   LK  DFGL+  F  P ++F   
Sbjct: 138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 262 VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFK--EVLRNK 316
           + + +Y  PE+L   R      D+WSI  I   +L     F   +E D +FK  EVL   
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GL 256
Query: 317 PDFRRKPWPSIS------NSAKDFVKK--------------------LLVKDPRARLTAA 350
           PD     WP ++       S   F  K                    +L  DP  R++A 
Sbjct: 257 PD--DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314
Query: 351 QALSHPW 357
            AL HP+
Sbjct: 315 NALEHPY 321

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N L     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 139/328 (42%), Gaps = 54/328 (16%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           K   F    D    Y I + +G+G +G    A  +  G +VA+KKI  N   +    +  
Sbjct: 42  KARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRT 100
Query: 144 KREVKILQALAGHENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
            RE+KIL+    H+N++           Y  F+    VY+ ++L E    L +I+     
Sbjct: 101 LRELKILKHFK-HDNIIAIKDILRPTVPYGEFKS---VYVVLDLMESD--LHQIIHSSQP 154
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-- 252
             T +     + Q+LR     H   ++HRD+KP N L     E+  LK  DFG++  +  
Sbjct: 155 -LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT 210
Query: 253 KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKT--- 304
            P +      + V + +Y APE++    +     D+WS+G I   +L  R+ F  K    
Sbjct: 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH 270
Query: 305 ------------EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLV 340
                          + + V        +++ P  +  PW    P     A   + ++L 
Sbjct: 271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLR 330
Query: 341 KDPRARLTAAQALSHPWVREGGDASEIP 368
            +P AR++AA AL HP++ +  D  + P
Sbjct: 331 FEPSARISAAAALRHPFLAKYHDPDDEP 358

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 10/251 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVK 336
             S D +++GV  Y ++  R PF  + E    KE L+ +   +   +P   S ++KDF +
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 337 KLLVKDPRARL 347
            LL KDP  RL
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPF---WDKTEDGIFKE-VLRNKPDFRRKPWPSISNSAKD 333
             S D +++GV  Y ++  R PF    +K E+   K+ VL     +  K     S ++KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPASKD 422
Query: 334 FVKKLLVKDPRARL 347
           F + LL KDP  RL
Sbjct: 423 FCEALLQKDPEKRL 436

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 136/306 (44%), Gaps = 40/306 (13%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-- 129
           +S +QTG +  G +    Y  + +    +G++ G G  G  +    +  G  +AVK++  
Sbjct: 5   SSGKQTGYLTIGGQR---YQAEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 130 ----EKNKMILPIAVEDVKREVKILQALAGHEN--VVKFYNAFEDDNYVYIAMEL---CE 180
               E+NK IL          + +   L  H+   +V+ +  F  +  V+IAMEL   C 
Sbjct: 61  SGNKEENKRIL----------MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC- 109
Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
             +L  R+      R   K    +V+ +  +  +   HG++HRD+KP N L     E   
Sbjct: 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILL---DERGQ 163
Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL------KRKSGPESDVWSIGVITYILL 294
           +K  DFG+S  +   K      G A Y+APE +      K      +DVWS+G+    L 
Sbjct: 164 IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 295 CGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            G+ P+ + KT+  +  +VL+ +P          S   + FVK  L KD R R    + L
Sbjct: 224 TGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM-GFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
Query: 354 SHPWVR 359
            H +++
Sbjct: 283 EHSFIK 288

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 10/251 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVK 336
             S D +++GV  Y ++  R PF  + E    KE L+ +   +   +P   S ++KDF +
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 337 KLLVKDPRARL 347
            LL KDP  RL
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 185
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 306 YDHQSRLTAREAMEHPY 322

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 122/251 (48%), Gaps = 10/251 (3%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
              AFE    + + M +  GG++   I  + + +  + E  A     Q++      H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKSG 278
           +++RD+KPEN L     +D +++ +D GL+  +K G+ K +   G+  ++APE+L  +  
Sbjct: 310 IIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 279 PES-DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVK 336
             S D +++GV  Y ++  R PF  + E    KE L+ +   +   +P   S ++KDF +
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-LKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 337 KLLVKDPRARL 347
            LL KDP  RL
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 184
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 305 YDHQSRLTAREAMEHPY 321

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 185
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 306 YDHQSRLTAREAMEHPY 322

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 134 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 191
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 192 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 251
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 252 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 311
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 312 YDHQSRLTAREAMEHPY 328

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/328 (25%), Positives = 139/328 (42%), Gaps = 54/328 (16%)
Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           K   F    D    Y I + +G+G +G    A  +  G +VA+KKI  N   +    +  
Sbjct: 43  KARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRT 101
Query: 144 KREVKILQALAGHENVVKF---------YNAFEDDNYVYIAMELCEGGELLDRILAKKDS 194
            RE+KIL+    H+N++           Y  F+    VY+ ++L E    L +I+     
Sbjct: 102 LRELKILKHFK-HDNIIAIKDILRPTVPYGEFKS---VYVVLDLMESD--LHQIIHSSQP 155
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-- 252
             T +     + Q+LR     H   ++HRD+KP N L     E+  LK  DFG++  +  
Sbjct: 156 -LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT 211
Query: 253 KPGKK---FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKT--- 304
            P +      + V + +Y APE++    +     D+WS+G I   +L  R+ F  K    
Sbjct: 212 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH 271
Query: 305 ------------EDGIFKEV--------LRNKPDFRRKPW----PSISNSAKDFVKKLLV 340
                          + + V        +++ P  +  PW    P     A   + ++L 
Sbjct: 272 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLR 331
Query: 341 KDPRARLTAAQALSHPWVREGGDASEIP 368
            +P AR++AA AL HP++ +  D  + P
Sbjct: 332 FEPSARISAAAALRHPFLAKYHDPDDEP 359

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 38/197 (19%)
Query: 197 TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
           T+ D    + ++L+    CH  G++HRD+KP N +     E   L+  D+GL++F  PG+
Sbjct: 129 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 186
Query: 257 KFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW------------- 301
           ++   V S Y+  PE+L   +      D+WS+G +   ++  + PF+             
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 302 -----DKTEDGIFKEVLRNKPDFR-------RKPWPS---------ISNSAKDFVKKLLV 340
                +   D I K  +   P F        RK W           +S  A DF+ KLL 
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 341 KDPRARLTAAQALSHPW 357
            D ++RLTA +A+ HP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 9   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 63
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 64  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 122 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 34  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 88
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 89  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 147 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 204 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 35  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 89
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 90  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 148 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 204
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 67  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 125 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 12  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 66
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 67  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 125 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF---IKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 112/285 (39%), Gaps = 32/285 (11%)
Query: 89  GYDKD-----FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           GYD       F + +     LGHG +G  +    K +G   AVK+     M      +D 
Sbjct: 45  GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDR 100
Query: 144 KR---EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
            R   EV   + +  H   V+   A+E+   +Y+  ELC  G  L +      +   E  
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQ 158
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
               +R  L   A  H  GLVH D+KP N            K  DFGL   +      + 
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP---RGRCKLGDFGLLVELGTAGAGEV 215
Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRR-----PFWDKTEDGIFKEVLRN 315
             G   Y+APE+L+   G  +DV+S+G+    + C          W +   G        
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL------ 269
Query: 316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            P+F       +S+  +  +  +L  DP+ R TA   L+ P +R+
Sbjct: 270 PPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 27  DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 81
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 82  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 140 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 197 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 34/283 (12%)
Query: 90  YDKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           + K+ D  Y  I +++G G+FG       KA G +   VA+K ++          E  +R
Sbjct: 7   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY------TERQRR 60
Query: 146 EVKILQALAG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           E     ++ G   H N+++      +   V I  E  E G L D  L   D ++T     
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLV 119
Query: 203 VVVRQM---LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-- 257
            ++R +   +R  AE      VHRD+   N L  S   +   K +DFGLS F++      
Sbjct: 120 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDP 173
Query: 258 -FQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
            +   +G      + APE +  RK    SD WS G++ + ++  G RP+WD +   +   
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINA 233
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +   + D+R  P P    S    +     KD  AR    Q +S
Sbjct: 234 I---EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 35  DGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 89
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 90  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 148 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 204
Query: 272 VLKRKS-GP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 205 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           D + T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+   
Sbjct: 7   DGQITVGQRIGSGSFGTVY--KGKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRK-T 61
Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N++ F   +     + I  + CEG  L    L   ++++       + RQ  +    
Sbjct: 62  RHVNILLFM-GYSTKPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYVAPE 271
            H   ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APE
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 272 VLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           V++ +   P   +SDV++ G++ Y L+ G+ P+
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   + +V     +L A   H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-----MLLASLNHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I ME CE   L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HRD+KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D++S+G+I + ++    PF    E     + 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 32  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 85
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 86  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 142
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 143 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 195
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP------------FWDKTED------- 306
           Y++PE L+      +SD+WS+G+    +  GR P            F  + E        
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 315 ERADLKQLMVHAFIKR-SDAEEV 336

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           DK F   +   +L+G G FG  + A  + +G    +K+++ N        E  +REVK L
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 151 QALAGHENVVKFYNAFEDDNY----------------VYIAMELCEGGELLDRILAKKDS 194
             L  H N+V +   ++  +Y                ++I ME C+ G L   I  ++  
Sbjct: 59  AKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           +  +  A  +  Q+ +     H   L++RD+KP N      K+   +K  DFGL   +K 
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKN 174
Query: 255 GKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILL--CG----RRPFWDKTEDG 307
             K     G+  Y++PE +  +  G E D++++G+I   LL  C        F+    DG
Sbjct: 175 DGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           I  ++   K               K  ++KLL K P  R   ++ L
Sbjct: 235 IISDIFDKKE--------------KTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP------------FWDKTED------- 306
           Y++PE L+      +SD+WS+G+    +  GR P            F  + E        
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP------------FWDKTED------- 306
           Y++PE L+      +SD+WS+G+    +  GR P            F  + E        
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP------------FWDKTED------- 306
           Y++PE L+      +SD+WS+G+    +  GR P            F  + E        
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 5   DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 58
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 59  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 115
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 116 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRS 168
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRP------------FWDKTED------- 306
           Y++PE L+      +SD+WS+G+    +  GR P            F  + E        
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 288 ERADLKQLMVHAFIKR-SDAEEV 309

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/323 (26%), Positives = 136/323 (42%), Gaps = 64/323 (19%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF++       LG G  G  +  + K +G  +A K I     I P     + RE+++L
Sbjct: 67  DDDFEKISE----LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVL 120
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTE----KDAAVVVR 206
                   +V FY AF  D  + I ME  +GG  LD++L KK  R  E    K +  V++
Sbjct: 121 HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KKAGRIPEQILGKVSIAVIK 177
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +  +  +   H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  
Sbjct: 178 GLTYLREK---HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRS 230
Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPF-----------------WDKTED-- 306
           Y++PE L+      +SD+WS+G+    +  GR P                   D  E   
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 290
Query: 307 --------------------GIFK--EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPR 344
                                IF+  + + N+P   + P    S   +DFV K L+K+P 
Sbjct: 291 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSAVFSLEFQDFVNKCLIKNPA 349
Query: 345 ARLTAAQALSHPWVREGGDASEI 367
            R    Q + H +++   DA E+
Sbjct: 350 ERADLKQLMVHAFIKR-SDAEEV 371

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 90  YDKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
           + K+ D  Y  I +++G G+FG       KA G +   VA+K ++          E  +R
Sbjct: 9   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY------TERQRR 62
Query: 146 EVKILQALAG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           E     ++ G   H N+++      +   V I  E  E G L D  L   D ++T     
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLV 121
Query: 203 VVVRQM---LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
            ++R +   +R  AE      VHRD+   N L  S   +   K +DFGLS F++      
Sbjct: 122 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEENSSDP 175
Query: 260 DIVGS------AYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKE 311
               S        + APE +  RK    SD WS G++ + ++  G RP+WD +   +   
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINA 235
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +   + D+R  P P    S    +     KD  AR    Q +S
Sbjct: 236 I---EQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 275

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D DF+R       LG G  G       + +G  +A K I     I P     + RE+++L
Sbjct: 15  DDDFERISE----LGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVL 68
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   +V FY AF  D  + I ME  +GG  LD++L K+  R  E+    V   +LR
Sbjct: 69  HE-CNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVL-KEAKRIPEEILGKVSIAVLR 125
Query: 211 VAAEC-HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
             A     H ++HRD+KP N L  S  E   +K  DFG+S  +         VG+  Y+A
Sbjct: 126 GLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMA-NSFVGTRSYMA 181
Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPF 300
           PE L+      +SD+WS+G+    L  GR P 
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 124/294 (42%), Gaps = 59/294 (20%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQ 151
           R  + ++L  G F + Y A D  +G   A+K++     EKN+ I+        +EV  ++
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII--------QEVCFMK 80
Query: 152 ALAGHENVVKFYNAF-----EDDN---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            L+GH N+V+F +A      E D       +  ELC+G   L   L K +SR       V
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ--LVEFLKKMESRGPLSCDTV 138
Query: 204 --VVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
             +  Q  R     H     ++HRD+K EN L  +     ++K  DFG +  I     + 
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTIS---HYP 192
Query: 260 DIVGSA----------------YYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRP 299
           D   SA                 Y  PE++   S    G + D+W++G I Y+L   + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           F    EDG    ++  K  +   P  +        ++ +L  +P  RL+ A+ +
Sbjct: 253 F----EDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 61/304 (20%)
Query: 86  TDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           T +  DK F   +   +L+G G FG  + A  + +G    +++++ N        E  +R
Sbjct: 2   TKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAER 54
Query: 146 EVKILQALAGHENVVKFYNAFEDDNY-----------------------------VYIAM 176
           EVK L  L  H N+V +   ++  +Y                             ++I M
Sbjct: 55  EVKALAKL-DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQM 113
Query: 177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
           E C+ G L   I  ++  +  +  A  +  Q+ +     H   L+HRD+KP N      K
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTK 173
Query: 237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILL- 294
           +   +K  DFGL   +K   K     G+  Y++PE +  +  G E D++++G+I   LL 
Sbjct: 174 Q---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 230
Query: 295 -CG----RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTA 349
            C        F+    DGI  ++   K               K  ++KLL K P  R   
Sbjct: 231 VCDTAFETSKFFTDLRDGIISDIFDKK--------------EKTLLQKLLSKKPEDRPNT 276
Query: 350 AQAL 353
           ++ L
Sbjct: 277 SEIL 280

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 119/272 (43%), Gaps = 51/272 (18%)
Query: 118 KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-----ENVVKFYNAFEDDNYV 172
           K+N D++++K             +D K E++I+  +        E ++  Y+       V
Sbjct: 75  KSNNDKISIKS----------KYDDFKNELQIITDIKNEYCLTCEGIITNYDE------V 118
Query: 173 YIAMELCEGGELL--DRILAKKDSRYTEKDAAVVVRQMLR--VAAECHLHG---LVHRDM 225
           YI  E  E   +L  D      D  YT      V++ +++  + +  ++H    + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 226 KPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS---GPESD 282
           KP N L     ++  +K +DFG S+++   KK +   G+  ++ PE    +S   G + D
Sbjct: 179 KPSNIL---MDKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVD 234
Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-------------PDFRRKPWPS--- 326
           +WS+G+  Y++     PF  K         +R K             P   +K   S   
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           +SN   DF+K  L K+P  R+T+  AL H W+
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAGHEN 158
           +G G +G       K +G  +AVK+I     EK +  L + ++ V R        +    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS-------SDCPY 82
Query: 159 VVKFYNAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +V+FY A   +   +I MEL      +    + +  D    E+    +   +  V A  H
Sbjct: 83  IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT--LATVKALNH 140
Query: 217 LH---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           L     ++HRD+KP N L   +    ++K  DFG+S   +    K +D  G   Y+APE 
Sbjct: 141 LKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 196
Query: 273 LKRKSGPE-----SDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +   +  +     SDVWS+G+  Y L  GR P+  W+   D + + V  + P        
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             S S  +FV   L KD   R    + L HP++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 94  FDRRYTIGKL--LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           F +RY + K+  LG G FG    Y Y  T+   G+ VAVK +++     P      +RE+
Sbjct: 6   FHKRY-LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREI 62
Query: 148 KILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           +IL+ L  HE++VK+    ED  +  V + ME    G L D +      R+    A +++
Sbjct: 63  EILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLL 116
Query: 206 --RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----Q 259
             +Q+    A  H    +HR +   N L  +   D  +K  DFGL+  +  G ++    +
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVRE 173
Query: 260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
           D     ++ APE LK  K    SDVWS GV  Y LL
Sbjct: 174 DGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 94  FDRRYTIGKL--LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           F +RY + K+  LG G FG    Y Y  T+   G+ VAVK +++     P      +RE+
Sbjct: 5   FHKRY-LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEG--CGPQLRSGWQREI 61
Query: 148 KILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           +IL+ L  HE++VK+    ED  +  V + ME    G L D +      R+    A +++
Sbjct: 62  EILRTLY-HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLL 115
Query: 206 --RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----Q 259
             +Q+    A  H    +HR +   N L  +   D  +K  DFGL+  +  G ++    +
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
           D     ++ APE LK  K    SDVWS GV  Y LL
Sbjct: 173 DGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 83/353 (23%), Positives = 139/353 (39%), Gaps = 100/353 (28%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-IAVEDVKREVKILQALAGH 156
           Y I  L+G G +GY Y+A DK     VA+KK+  N+M    I  + + RE+ IL  L   
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS- 86
Query: 157 ENVVKFYNAFEDDNY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           + +++ ++    ++      +YI +E+ +      + L K     TE+    ++  +L  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLEIADSDL---KKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK------------------ 253
               H  G++HRD+KP N L     +D S+K  DFGL+  I                   
Sbjct: 144 EKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 254 -PG-------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL--------- 294
            PG       K+    V + +Y APE  +L+       D+WS G I   LL         
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINN 260
Query: 295 -CGRRPFW---------------------DKTEDGIFKEVLRNKP--------------- 317
              R P +                     ++ +  I   V+   P               
Sbjct: 261 PTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKY 320
Query: 318 ----------DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                     D  +K + SIS    D ++ +L  + + R+T  +ALSHP++++
Sbjct: 321 IKLFPTRDGIDLSKK-YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKD 372

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 55/300 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N +RV VK ++  K       + +KREVKIL+ L G  
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKK------KKIKREVKILENLRGGT 93
Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++K  +  +D       +  E     +   L +IL   D R+        + ++L+   
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALD 146
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH  G++HRD+KP N +    ++   L+  D+GL++F  P +++   V S Y+  PE+L
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 204
Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------------GIFKEV-L 313
              +      D+WS+G +   ++  R PF+   ++                 G  K+  +
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 264
Query: 314 RNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              P F        RK W +         +S  A D + KLL  D + RLTA +A+ HP+
Sbjct: 265 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 135/300 (45%), Gaps = 55/300 (18%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y + + LG G++   + A +  N +RV VK ++          + +KREVKIL+ L G  
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPV------KKKKIKREVKILENLRGGT 98
Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++K  +  +D       +  E     +   L +IL   D R+        + ++L+   
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRF-------YMYELLKALD 151
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
            CH  G++HRD+KP N +    ++   L+  D+GL++F  P +++   V S Y+  PE+L
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL 209
Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-----------------GIFKEV-L 313
              +      D+WS+G +   ++  R PF+   ++                 G  K+  +
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI 269
Query: 314 RNKPDFR-------RKPWPS---------ISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
              P F        RK W +         +S  A D + KLL  D + RLTA +A+ HP+
Sbjct: 270 DLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G+R    Y +       +   +G G FG  Y    K +GD VAVK I K     P   
Sbjct: 21  PRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVY--KGKWHGD-VAVK-ILKVVDPTPEQF 76
Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
           +  + EV +L+    H N++ F      DN + I  + CEG  L    L  +++++    
Sbjct: 77  QAFRNEVAVLRK-TRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKH-LHVQETKFQMFQ 133
Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
              + RQ  +     H   ++HRDMK  N       E  ++K  DFGL+         Q 
Sbjct: 134 LIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 261 I---VGSAYYVAPEVLKRK-SGP---ESDVWSIGVITYILLCGRRPF 300
           +    GS  ++APEV++ + + P   +SDV+S G++ Y L+ G  P+
Sbjct: 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGY------TEKQRRDFLCEASIMGQ 100
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NVV           V I +E  E G L D  L K D ++T      ++R +     
Sbjct: 101 FDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                G VHRD+   N L  S   +   K +DFGLS  I+  P   +    G     + A
Sbjct: 160 YLADMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTA 216
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE ++ RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALA 154
           RY     +G G +G  Y A D  +G  VA+K  ++   +  LPI+     REV +L+ L 
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 155 G--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVV 205
              H NVV+  +            V +  E  +      LD+         T KD   ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD---LM 118
Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V + 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRNKPD 318
           +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  + D
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 319 FRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           + R              +P     P +  S    + ++L  +P  R++A +AL H ++
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE-----KNKMILPIAVEDVKREVKILQ 151
           RY     +G G +G  Y A D  +G  VA+K +           LPI+     REV +L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST---VREVALLR 66
Query: 152 ALAG--HENVVKFYNAFEDDNY-----VYIAMELCEGG--ELLDRILAKKDSRYTEKDAA 202
            L    H NVV+  +            V +  E  +      LD+         T KD  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD-- 124
Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +V
Sbjct: 125 -LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLARIYSYQMALTPVV 180
Query: 263 GSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEV-LRN 315
            + +Y APEVL + +     D+WS+G I +  +  R+P +    +      IF  + L  
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCI-FAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 316 KPDFRR--------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
           + D+ R              +P     P +  S    + ++L  +P  R++A +AL H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 358 V 358
           +
Sbjct: 300 L 300

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 81/352 (23%), Positives = 143/352 (40%), Gaps = 74/352 (21%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G    F  +   D RY + + LG G F   ++A D  N   VA+K +  +K    +  
Sbjct: 4   PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYT 59
Query: 141 EDVKREVKILQAL----------AGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRI 188
           E  + E+K+LQ +           G  +++K  + F  +  N V++ M     GE L  +
Sbjct: 60  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 189 LAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-- 241
           + K + R     Y ++ +  ++  +  +   C   G++H D+KPEN L +      +L  
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 242 -KATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRP 299
            K  D G + +    + + + + +  Y +PEV L    G  +D+WS   + + L+ G   
Sbjct: 177 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
Query: 300 F-------WDKTEDGIFK--EVLRNKPDF----------------------RRKPWP--- 325
           F       + K +D I +  E+L   P +                      + K WP   
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 326 ----------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                       +    DF+  +L  DPR R  A   ++HPW+++     EI
Sbjct: 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 346

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 27/238 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY------TEKQRRDFLSEASIMGQ 90
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NV+           V I  E  E G L D  L + D ++T      ++R +     
Sbjct: 91  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---PGKKFQDIVGSAY---Y 267
                  VHRD+   N L  S   +   K +DFGLS F++       +   +G      +
Sbjct: 150 YLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 206
Query: 268 VAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   +   + D+R  P
Sbjct: 207 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPP 261

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCY--EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 94  FDRRYTIGKL--LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           F +RY + K+  LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+
Sbjct: 11  FHKRY-LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEI 67
Query: 148 KILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
            IL+ L  HE+++K+    ED  +  + + ME    G L D +      R++   A +++
Sbjct: 68  DILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLL 121
Query: 206 --RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----Q 259
             +Q+    A  H    +HR++   N L  +   D  +K  DFGL+  +  G ++    +
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
           D     ++ APE LK  K    SDVWS GV  Y LL
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 72  NSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKAN 120
           N++++ G+   G   + GYD D              RY + K++G G FG    A D   
Sbjct: 64  NAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKV 121
Query: 121 GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYIA 175
              VA+K +   K     A E    E++IL+ L   +     NV+     F   N++ + 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177
Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
            EL     L + I   K   ++          +L+     H + ++H D+KPEN L K  
Sbjct: 178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ- 235
Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILL 294
           +  S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   LL
Sbjct: 236 QGRSGIKVIDFGSSCYEH--QRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 295 CG 296
            G
Sbjct: 294 TG 295

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 11/209 (5%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK-MILPIAVEDVKREVKILQALAGHE 157
           T+ +++G G FG  Y A     GD VAVK    +    +   +E+V++E K+  A+  H 
Sbjct: 10  TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLF-AMLKHP 66
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N++        +  + + ME   GG L   +  K+       + AV + + +    +  +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 218 HGLVHRDMKPENFLFKSAKEDSSL-----KATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
             ++HRD+K  N L     E+  L     K TDFGL+       K     G+  ++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEV 185
Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPF 300
           ++       SDVWS GV+ + LL G  PF
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 101 GKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQALAG 155
           G++LG G FG     T +  G+ + +K++     E  +  L        +EVK+++ L  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL--------KEVKVMRCLE- 65
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H NV+KF      D  +    E  +GG L   I+   DS+Y         + +    A  
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI--------------KPG-KKFQD 260
           H   ++HRD+   N L    +E+ ++   DFGL+  +              KP  KK   
Sbjct: 125 HSMNIIHRDLNSHNCL---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 261 IVGSAYYVAPEVLKRKSGPES-DVWSIGVI 289
           +VG+ Y++APE++  +S  E  DV+S G++
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 94  FDRRYTIGKL--LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           F +RY + K+  LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+
Sbjct: 11  FHKRY-LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEI 67
Query: 148 KILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
            IL+ L  HE+++K+    ED  +  + + ME    G L D +      R++   A +++
Sbjct: 68  DILRTLY-HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLL 121
Query: 206 --RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----Q 259
             +Q+    A  H    +HR++   N L  +   D  +K  DFGL+  +  G ++    +
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
           D     ++ APE LK  K    SDVWS GV  Y LL
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 81/352 (23%), Positives = 143/352 (40%), Gaps = 74/352 (21%)
Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
           P G    F  +   D RY + + LG G F   ++A D  N   VA+K +  +K    +  
Sbjct: 4   PGGFHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYT 59
Query: 141 EDVKREVKILQAL----------AGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRI 188
           E  + E+K+LQ +           G  +++K  + F  +  N V++ M     GE L  +
Sbjct: 60  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 119
Query: 189 LAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL-- 241
           + K + R     Y ++ +  ++  +  +   C   G++H D+KPEN L +      +L  
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 242 -KATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRP 299
            K  D G + +    + + + + +  Y +PEV L    G  +D+WS   + + L+ G   
Sbjct: 177 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
Query: 300 F-------WDKTEDGIFK--EVLRNKPDF----------------------RRKPWP--- 325
           F       + K +D I +  E+L   P +                      + K WP   
Sbjct: 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLED 294
Query: 326 ----------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                       +    DF+  +L  DPR R  A   ++HPW+++     EI
Sbjct: 295 VLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI 346

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P  + D  R  K+L    G  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAP-QLRDEYRTYKLLAGCTGIP 69
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NV  F    ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H 
Sbjct: 70  NVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYY 267
             LV+RD+KP+NFL    ++K  + +   DFG+  F +        P ++ +++ G+A Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           ++    L R+     D+ ++G +    L G  P+
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHE 157
           + +++G G FG   V   K     VA+K+IE         VE        L+ L+   H 
Sbjct: 12  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVE--------LRQLSRVNHP 61
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQMLRVAAECH 216
           N+VK Y A    N V + ME  EGG L + +  A+    YT   A     Q  +  A  H
Sbjct: 62  NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 217 ---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
                 L+HRD+KP N L  +    + LK  DFG +  I+      +  GSA ++APEV 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVF 175
Query: 274 KRKSGPE-SDVWSIGVITYILLCGRRPF 300
           +  +  E  DV+S G+I + ++  R+PF
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P  + D  R  K+L    G  
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAP-QLRDEYRTYKLLAGCTGIP 68
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           NV  F    ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H 
Sbjct: 69  NVYYF---GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYY 267
             LV+RD+KP+NFL    ++K  + +   DFG+  F +        P ++ +++ G+A Y
Sbjct: 124 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           ++    L R+     D+ ++G +    L G  P+
Sbjct: 184 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 51/291 (17%)
Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG    A +  +    A+KKI   +  L   +     EV +L +L  H+ VV++
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVXLLASL-NHQYVVRY 67
Query: 163 YNAF-EDDNYV------------YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           Y A+ E  N+V            +I  E CE   L D I ++  ++  + +   + RQ+L
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD-EYWRLFRQIL 126
Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIK------PGK 256
              +  H  G++HR++KP N       E  ++K  DFGL+       D +K      PG 
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 257 --KFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
                  +G+A YVA EVL        + D +S+G+I +  +    PF    E     + 
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILKK 240
Query: 313 LRN-----KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
           LR+      PDF            K  ++ L+  DP  R  A   L+  W+
Sbjct: 241 LRSVSIEFPPDFDDNK----XKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 46/237 (19%)
Query: 104 LGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           +G G F   Y+AT +      +++A+K +      + IA E     ++ L    G +NV+
Sbjct: 29  IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAE-----LQCLTVAGGQDNVM 83
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
                F  +++V IAM   E    LD +     +  + ++    +  + +     H  G+
Sbjct: 84  GVKYCFRKNDHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGI 138
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KF------------------ 258
           VHRD+KP NFL+    +  +L   DFGL+      K    KF                  
Sbjct: 139 VHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSIC 196
Query: 259 ----QDI---VGSAYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKTED 306
               Q +    G+  + APEVL +     +  D+WS GVI   LL GR PF+  ++D
Sbjct: 197 LSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           TI +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G
Sbjct: 25  TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGY------TEKQRRDFLGEASIMG 78
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N++           V I  E  E G L D  L K D ++T      ++R +    
Sbjct: 79  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 138 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           APE +  RK    SDVWS G++ + ++  G RP+W+ T   + K V
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ----ALAG 155
           + +++G G FG   V   K     VA+K+IE           + +R+  I++    +   
Sbjct: 13  VEEVVGRGAFGV--VCKAKWRAKDVAIKQIES----------ESERKAFIVELRQLSRVN 60
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL-AKKDSRYTEKDAAVVVRQMLRVAAE 214
           H N+VK Y A    N V + ME  EGG L + +  A+    YT   A     Q  +  A 
Sbjct: 61  HPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 215 CH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
            H      L+HRD+KP N L  +    + LK  DFG +  I+      +  GSA ++APE
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPE 174
Query: 272 VLKRKSGPE-SDVWSIGVITYILLCGRRPF 300
           V +  +  E  DV+S G+I + ++  R+PF
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI ME    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVMEYMSKGCLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 94  FDRRYTIGKL--LGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           F +RY + K+  LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+
Sbjct: 28  FHKRY-LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEI 84
Query: 148 KILQALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
            IL+ L  HE+++K+    ED     + + ME    G L D +      R++   A +++
Sbjct: 85  DILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLL 138
Query: 206 --RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF----Q 259
             +Q+    A  H    +HRD+   N L  +   D  +K  DFGL+  +  G +     +
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 260 DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL 294
           D     ++ APE LK  K    SDVWS GV  Y LL
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP----QLHIESKIYKMMQGG 64
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHP----QLHIESKIYKMMQGG 62
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI +E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVIEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI +E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVIEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 35/282 (12%)
Query: 89  GYDKDFD---RRYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDV 143
           G  +D++    R  +G+ +G GQFG  +  +     N       K  KN         D 
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDS 56
Query: 144 KREVKILQALA----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
            RE  + +AL      H ++VK       +N V+I MELC  GEL   +  +K   Y+  
Sbjct: 57  VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLD 112
Query: 200 DAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
            A++++       A  +L     VHRD+   N L  S   +  +K  DFGLS +++    
Sbjct: 113 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTY 169
Query: 258 FQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVL 313
           ++   G     ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   + 
Sbjct: 170 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 229
Query: 314 RNKPDFRRKPW-PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
             +    R P  P+   +    + K    DP  R R T  +A
Sbjct: 230 NGE----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 267

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 26  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 80
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 81  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQTVMXS 193
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 26  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 80
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 81  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQTVMXX 193
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 27/238 (11%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I +++G G+FG       K  G R   VA+K ++          E  +R+     ++ G 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY------TEKQRRDFLSEASIMGQ 64
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H NV+           V I  E  E G L D  L + D ++T      ++R +     
Sbjct: 65  FDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK---PGKKFQDIVGSAY---Y 267
                  VHR +   N L  S   +   K +DFGLS F++       +   +G      +
Sbjct: 124 YLADMNYVHRALAARNILVNS---NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 268 VAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   +   + D+R  P
Sbjct: 181 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPP 235

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVCEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G  +G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 20  NFDERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAA---MVDITTEELKQQFDQE 74
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K++ A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 75  IKVM-AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA 133
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 134 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQXVMXX 187
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y+APE L+ +  P+SD++S GV+   ++ G
Sbjct: 188 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 233
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 15  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 67
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 68  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 126 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 177
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 234
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 235 DLMCQCWRKDPEERPT 250

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 35/297 (11%)
Query: 67  QHQKTNSRRQTGVIPCGKRTDFGYDKDF----DRRYTIGKLLGHGQFGYTYVATDKANGD 122
           +H      R T V P  K    G  KD          +   LG G FG  ++ T   NG 
Sbjct: 152 KHADGLCHRLTNVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT--WNGT 209
Query: 123 -RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEG 181
            RVA+K ++   M    + E   +E ++++ L  HE +V+ Y    ++  +YI  E    
Sbjct: 210 TRVAIKTLKPGNM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSK 263
Query: 182 GELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
           G LLD  L  +  +Y      V +  Q+    A       VHRD++  N L     E+  
Sbjct: 264 GSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLV 319
Query: 241 LKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGV-ITY 291
            K  DFGL   I       + G KF        + APE  L  +   +SDVWS G+ +T 
Sbjct: 320 CKVADFGLGRLIEDNEYTARQGAKF-----PIKWTAPEAALYGRFTIKSDVWSFGILLTE 374
Query: 292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT 348
           +   GR P+       +  +V R    +R    P    S  D + +   KDP  R T
Sbjct: 375 LTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKDPEERPT 428

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 71
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 188
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 79
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 196
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 17  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 69
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 70  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 128 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 179
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 236
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 237 DLMCQCWRKDPEERPT 252

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 92
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 93  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 148
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 261
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 262 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 292

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 75
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 192
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 61
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 117
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 230
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 233
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 51/292 (17%)
Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           +H A     H    QH       +  + KQH   +S + T  +P         D     R
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQH---HSSKPTASMPRPHS-----DWQIPDR 54
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y I  L+G G +G+   A DK     VA+KKI +    L I  + + RE+ IL  L  H+
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRL-NHD 112
Query: 158 NVVKFYNA-----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +VVK  +       E  + +Y+ +E+ +      + L +     TE     ++  +L   
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDF---KKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPG-------------- 255
              H  G++HRD+KP N L     +D S+K  DFGL+   D+ + G              
Sbjct: 170 KYVHSAGILHRDLKPANCL---VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 256 -----------KKFQDIVGSAYYVAPE--VLKRKSGPESDVWSIGVITYILL 294
                      ++    V + +Y APE  +L+       DVWSIG I   LL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 78
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 195
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 66
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 67  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 122
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 235
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 236 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 266

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN------CTSDSVREKFLQEALT 69
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   Y+   A++++     
Sbjct: 70  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 125
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 238
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 109/249 (43%), Gaps = 24/249 (9%)
Query: 78  GVIPCGK-RTDFGYDKDFD-RRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKN 132
           G++P G  +T   + K+ D    +I K++G G+FG       K    +   VA+K ++  
Sbjct: 13  GLVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 72
Query: 133 KMILPIAVEDVKREVKILQALAG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
                   E  +R+     ++ G   H N+++          V I  E  E G L D  L
Sbjct: 73  Y------TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL 125
Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            K D+++T      ++R +          G VHRD+   N L  S   +   K +DFGLS
Sbjct: 126 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLS 182
Query: 250 DFIK--PGKKFQDIVG--SAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDK 303
             ++  P   +    G     + +PE +  RK    SDVWS G++ + ++  G RP+W+ 
Sbjct: 183 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 242
Query: 304 TEDGIFKEV 312
           +   + K V
Sbjct: 243 SNQDVIKAV 251

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ +  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKIR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 19  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 71
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 72  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 129
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 130 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 181
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 238
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 239 DLMCQCWRKEPEERPT 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 86
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 203
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 192 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 244
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 245 YAVVSEEP-IYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 303 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 354
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 411
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 412 DLMCQCWRKEPEERPT 427

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGCLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 192 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 244
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 245 YAVVSEEP-IYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 303 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 354
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 411
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 412 DLMCQCWRKEPEERPT 427

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 26  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 79  YAVVSEEP-IYIVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD+   N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 137 HRDLAAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 188
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 245
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   KDP  R T
Sbjct: 246 DLMCQCWRKDPEERPT 261

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVAT------DKANG-DRVAVKKIEKNKMILPIAVEDVKREVKI 149
           R  +GK LG G FG   +A       DK N   +VAVK ++ +     ++  D+  E+++
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 127
Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSR 195
           ++ +  H+N++    A   D  +Y+ +E    G L + + A++              + +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFI 252
            + KD      Q+ R          +HRD+   N L     ED+ +K  DFGL+     I
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLARDIHHI 244
Query: 253 KPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
              KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+     + +FK
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 21/251 (8%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  ++ T      RVA+K ++   M    + E   +E ++++ L  HE +V+ Y
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLY 328
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLVH 222
            A   +  +YI  E    G LLD  L  +  +Y      V +  Q+    A       VH
Sbjct: 329 -AVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV-LKRKSG 278
           RD++  N L     E+   K  DFGL+  I+   ++    G+ +   + APE  L  +  
Sbjct: 387 RDLRAANIL---VGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 279 PESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
            +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  D + +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQ 499
Query: 338 LLVKDPRARLT 348
              K+P  R T
Sbjct: 500 CWRKEPEERPT 510

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 23  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 76  YAVVSEEP-IYIVTEYMNKGSLLD-FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 134 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 185
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 242
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 243 DLMCQCWRKEPEERPT 258

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 31/245 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDR----VAVKKI-----EKNKMILPIAVEDVKREVKILQA 152
           K++G G+FG  Y    K +  +    VA+K +     EK ++       D   E  I+  
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-------DFLGEAGIMGQ 102
Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
            + H N+++          + I  E  E G L D+ L +KD  ++      ++R +    
Sbjct: 103 FS-HHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                   VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           APE +  RK    SDVWS G++ + ++  G RP+W+ +      EV++   D  R P P 
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAINDGFRLPTPM 273
Query: 327 ISNSA 331
              SA
Sbjct: 274 DCPSA 278

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 110
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K  S++K  DFG S   + G++    + S +Y
Sbjct: 170 LLFLATP--ELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS--CQLGQRIYQXIQSRFY 224
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 23  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 76  YAVVSEEP-IYIVTEYMNKGSLLD-FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 134 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEWTARQGAKF-----PIKWTAPEAAL 185
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 242
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 243 DLMCQCWRKEPEERPT 258

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 248
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 306
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 307 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 361
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF 300
           ++    +S  D +S+G + + LL G  PF
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI +E    G LLD +   ++    E +A V++    ++++     
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 133 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 188
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF 300
           ++    +S  D +S+G + + LL G  PF
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 91
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 92  DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K  S++K  DFG S   + G++    + S +Y
Sbjct: 151 LLFLATP--ELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS--CQLGQRIYQXIQSRFY 205
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 206 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 192 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 244
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  +YI  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 245 YAVVSEEP-IYIVGEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 303 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKWTAPEAAL 354
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 411
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 412 DLMCQCWRKEPEERPT 427

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 444
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++    ++   G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 613
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 420
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 17/257 (6%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +++ +++G G FG  Y       G   A+K ++K ++ +    E +    +I+ +L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTG 249
Query: 158 N---VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
            H   +V+RD+KP N L     E   ++ +D GL+ DF K  KK    VG+  Y+APEVL
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVL 362
Query: 274 KRKSGPES--DVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++    +S  D +S+G + + LL G  PF   KT+D    E+ R       +   S S  
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAVELPDSFSPE 420
Query: 331 AKDFVKKLLVKDPRARL 347
            +  ++ LL +D   RL
Sbjct: 421 LRSLLEGLLQRDVNRRL 437

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLSDFIKPGKKFQDIVGS---AYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+  I     +++         ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ+G  YV   K     VAVK ++++ M     VE+  +E  +++ +  H N+V+  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLL 94
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---HGL 220
                +   YI  E    G LLD +   ++    E  A V++    ++++          
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYL---RECNREEVTAVVLLYMATQISSAMEYLEKKNF 151
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLKRKS 277
           +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE L   +
Sbjct: 152 IHRDLAARNCL---VGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 278 -GPESDVWSIGVITY-ILLCGRRPF 300
              +SDVW+ GV+ + I   G  P+
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGFVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E  A V++    ++++     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  F    G+ +   + APE 
Sbjct: 126 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPES 181
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 133 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 188
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 130 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPES 185
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 33  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 90
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 91  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 148
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 149 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 207
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 208 --KICDFGLARHIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 295 C-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 265 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 87  DFGYDK-DFDRR-YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           D  YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  
Sbjct: 4   DPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFL 59
Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    E +A V+
Sbjct: 60  KEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVL 115
Query: 205 VRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +    ++++          +HRD+   N L     E+  +K  DFGLS  +  G  +   
Sbjct: 116 LYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAH 171
Query: 262 VGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 74
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 131
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 132 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 187
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 188
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 189 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 129 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPES 184
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  S   +  +K  DFGLS +++     +   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 84  KRTDFGYDKDFDRR------YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           K T +G   ++D+        T+   LG GQ+G  Y    K     VAVK ++++ M   
Sbjct: 241 KPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--- 297
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             VE+  +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    
Sbjct: 298 -EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ 352
Query: 198 EKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           E +A V++    ++++          +HR++   N L     E+  +K  DFGLS  +  
Sbjct: 353 EVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL---VGENHLVKVADFGLSRLMT- 408
Query: 255 GKKFQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           G  +    G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 409 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI +E    G LLD +   ++    E  A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 129
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 246
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 307 PGIPVEELFK 316

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY------ 266
                 G VHRD+   N L  S   +   K +DFGL      G+  +D   +AY      
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGL------GRVLEDDPEAAYTTRGGK 211
Query: 267 ----YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
               + +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI +E    G LLD +   ++    E  A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEED 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 130 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 185
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 46  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG------YTEKQRRDFLGEASIMG 99
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 100 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 159 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+ K LG GQFG   +   K   D VAVK I++  M    + ++  +E + +  L+ H  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHL 217
           +VKFY     +  +YI  E    G LL+ +  +   +  E    + +   +    A    
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK 274
           H  +HRD+   N L      D  +K +DFG++ ++    ++   VG+ +   + APEV  
Sbjct: 123 HQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFH 178
Query: 275 R-KSGPESDVWSIGVITY-ILLCGRRPF 300
             K   +SDVW+ G++ + +   G+ P+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 83
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 140
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 141 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 196
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 55/254 (21%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +   + P       +E +IL+  + H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPN 173
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----RQMLRVAAE 214
           +V+          +YI MEL +GG+ L   L  + +R   K    +V      M  + ++
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY-------- 266
           C     +HRD+   N L     E + LK +DFG+S      ++  D V +A         
Sbjct: 233 C----CIHRDLAARNCL---VTEKNVLKISDFGMS------REEADGVXAASGGLRQVPV 279
Query: 267 -YVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
            + APE L   +   ESDVWS G++           W+    G               P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGIL----------LWETFSLGA-------------SPY 316
Query: 325 PSISN-SAKDFVKK 337
           P++SN   ++FV+K
Sbjct: 317 PNLSNQQTREFVEK 330

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG------YTEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG------YTEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 161 KYLSDMGAVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 71
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 72  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 131 YLSDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 188 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 133 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 188
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 18  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 71
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 127
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 128 IHRDLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 93  DFDRR--YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----E 146
           +FD R     G   G G FG  Y      N   VAVKK+     ++ I  E++K+    E
Sbjct: 17  NFDERPISVGGNKXGEGGFGVVYKGY--VNNTTVAVKKL---AAMVDITTEELKQQFDQE 71
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           +K+  A   HEN+V+      D + + +       G LLDR+     +          + 
Sbjct: 72  IKV-XAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIA 130
Query: 207 QMLRVAAE-CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----- 260
           Q         H +  +HRD+K  N L   A    + K +DFGL+   +  +KF       
Sbjct: 131 QGAANGINFLHENHHIHRDIKSANILLDEA---FTAKISDFGLA---RASEKFAQXVXXS 184
Query: 261 -IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCG 296
            IVG+  Y APE L+ +  P+SD++S GV+   ++ G
Sbjct: 185 RIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 65
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 66  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 125 YLSDMSYVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 182 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 72
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 132 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 72
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     + 
Sbjct: 132 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 84  KRTDFGYDKDFDRR------YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
           K T +G   ++D+        T+   LG GQ+G  Y    K     VAVK ++++ M   
Sbjct: 202 KPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--- 258
Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             VE+  +E  +++ +  H N+V+       +   YI  E    G LLD +   ++    
Sbjct: 259 -EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQ 313
Query: 198 EKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           E  A V++    ++++          +HR++   N L     E+  +K  DFGLS  +  
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL---VGENHLVKVADFGLSRLMT- 369
Query: 255 GKKFQDIVGSAY---YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           G  +    G+ +   + APE L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG- 155
           I K++G G+FG       K  G R   VA+K ++          +  +R+     ++ G 
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG------YTDKQRRDFLSEASIMGQ 86
Query: 156 --HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N++           V I  E  E G L D  L K D R+T      ++R +     
Sbjct: 87  FDHPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYVA 269
                  VHRD+   N L  S   +   K +DFG+S  ++  P   +    G     + A
Sbjct: 146 YLSDMSAVHRDLAARNILVNS---NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           PE +  RK    SDVWS G++ + ++  G RP+WD +   + K +
Sbjct: 203 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 67
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 68  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 184
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 185 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 295 C-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 242 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 28  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 85
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 86  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 143
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 144 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 202
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 203 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 295 C-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 260 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 315

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 70
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 71  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 130
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 131 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVL---VTENNVMKIAD 187
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 188 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 248 PGIPVEELFK 257

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 444
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  +      +K  DFGLS +++    ++   G     
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           ++APE +  R+    SDVW  GV  + IL+ G +PF     + +   +   +    R P 
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----RLPM 613
Query: 325 -PSISNSAKDFVKKLLVKDP--RARLTAAQA 352
            P+   +    + K    DP  R R T  +A
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 97  RYTIGKLLGHGQFGYTY--VATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           R  +G+ +G GQFG  +  +     N       K  KN         D  RE  + +AL 
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN------CTSDSVREKFLQEALT 64
Query: 155 ----GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H ++VK       +N V+I MELC  GEL   +  +K   ++   A++++     
Sbjct: 65  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 211 VAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG--SAY 266
             A  +L     VHRD+   N L  +      +K  DFGLS +++    ++   G     
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSAT---DCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           ++APE +  R+    SDVW  GV  + IL+ G +PF
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 15  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 124
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 125 IHRDLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 13  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 66
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 122
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 123 IHRDLAARNCL---VGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E  A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 75
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 76  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 135
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 136 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 192
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 193 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 253 PGIPVEELFK 262

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I  L+G G FG    A D+   + VA+K I+  K  L       + EV++L+ +  H
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL----NQAQIEVRLLELMNKH 110
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDR----ILAKKDSR-----YTEKDAAVVVRQ 207
           +  +K+Y      ++++    LC   E+L      +L   + R      T K A  +   
Sbjct: 111 DTEMKYYIVHLKRHFMF-RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L +A       ++H D+KPEN L  + K   ++K  DFG S   + G++    + S +Y
Sbjct: 170 LLFLATP--ELSIIHCDLKPENILLCNPKR-XAIKIVDFGSS--CQLGQRIYQXIQSRFY 224
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTE 305
            +PEV L        D+WS+G I   +  G   F    E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 49/251 (19%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +   + P       +E +IL+  + H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPN 173
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----RQMLRVAAE 214
           +V+          +YI MEL +GG+ L   L  + +R   K    +V      M  + ++
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD------FIKPGKKFQDIVGSAYYV 268
           C     +HRD+   N L     E + LK +DFG+S       +   G   Q  V    + 
Sbjct: 233 C----CIHRDLAARNCL---VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK---WT 282
Query: 269 APEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           APE L   +   ESDVWS G++           W+    G               P+P++
Sbjct: 283 APEALNYGRYSSESDVWSFGIL----------LWETFSLGA-------------SPYPNL 319
Query: 328 SN-SAKDFVKK 337
           SN   ++FV+K
Sbjct: 320 SNQQTREFVEK 330

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 26  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 83
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 84  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 141
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 142 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 200
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 201 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 295 C-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 258 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 313

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E  A V++    ++++     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 133 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 188
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 72
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 73  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 132
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 133 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 189
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 250 PGIPVEELFK 259

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E  A V++    ++++     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G  +    G+ +   + APE 
Sbjct: 128 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFG-------YTYVATDKANGDRVAVKKIEKNKMI 135
           T   YD  ++    R + GK LG G FG       Y  + +D A    VAVK ++ +  +
Sbjct: 33  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM--TVAVKMLKPSAHL 90
Query: 136 LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR 195
                E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS 
Sbjct: 91  --TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 148
Query: 196 YTEKDAAVVVR----------------QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS 239
              K +  ++                 Q+ +  A       +HRD+   N L    +   
Sbjct: 149 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT- 207
Query: 240 SLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITYILL 294
             K  DFGL+  IK    +  + G+A     ++APE +       ESDVWS G+  + L 
Sbjct: 208 --KICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 295 C-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
             G  P+     D  F +++  K  FR            D +K     DP  R T  Q
Sbjct: 265 SLGSSPYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 320

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 16  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 69
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 125
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 126 IHRDLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDFIKPGKKFQDIV--GSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D     +     V  G + ++
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 195
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 196 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 249 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ ++  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMRIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDFIKPGKKFQDIV--GSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D     +     V  G + ++
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 197
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 198 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 250
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 251 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L   I  K+     E  A   + Q L      H   ++H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 190
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 191 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI +E    G LLD +   ++    E +A V++    ++++     
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 128
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE 
Sbjct: 129 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 184
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G++VAVK ++       IA  D+K+E++IL+ L  HEN+
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLY-HENI 73
Query: 160 VKFYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           VK+     +D  N + + ME    G L    L K  ++   K       Q+ +       
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV----GSAYYVAPEVL 273
              VHRD+   N L +S   +  +K  DFGL+  I+  K+   +        ++ APE L
Sbjct: 133 RQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 274 -KRKSGPESDVWSIGVITYILL 294
            + K    SDVWS GV  + LL
Sbjct: 190 MQSKFYIASDVWSFGVTLHELL 211

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G FG  +   DK  G + AVKK+          +E  + E  +  A      +V  Y
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            A  +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKP---GKKFQD---IVGSAYYVAPE-VLKRK 276
           D+K +N L  S    ++L   DFG +  ++P   GK       I G+  ++APE V+ + 
Sbjct: 175 DVKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 277 SGPESDVWSIGVITYILLCGRRPF 300
              + D+WS   +   +L G  P+
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G++VAVK ++       IA  D+K+E++IL+ L  HEN+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLY-HENI 85
Query: 160 VKFYNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           VK+     +D  N + + ME    G L    L K  ++   K       Q+ +       
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV----GSAYYVAPEVL 273
              VHRD+   N L +S   +  +K  DFGL+  I+  K+   +        ++ APE L
Sbjct: 145 RQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 274 -KRKSGPESDVWSIGVITYILL 294
            + K    SDVWS GV  + LL
Sbjct: 202 MQSKFYIASDVWSFGVTLHELL 223

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDFIKPGKKFQDIV--GSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D     +     V  G + ++
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 195
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 196 ANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 248
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 249 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +I K++G G+FG       K    +   VA+K ++          E  +R+     ++ G
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------TEKQRRDFLGEASIMG 101
Query: 156 ---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          V I  E  E G L D  L K D+++T      ++R +    
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAYYV 268
                 G VHRD+   N L  S   +   K +DFGL+  ++  P   +    G     + 
Sbjct: 161 KYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 269 APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           +PE +  RK    SDVWS G++ + ++  G RP+W+ +   + K V
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I++  M    + +D   E +++  L+ H  +V+ Y
Sbjct: 35  IGSGQFGLVHLGY-WLNKDKVAIKTIKEGSM----SEDDFIEEAEVMMKLS-HPKLVQLY 88
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV---VVRQMLRVAAECHLHGL 220
               +   + +  E  E G L D +  ++     E    +   V   M  +   C    +
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC----V 144
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RK 276
           +HRD+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +
Sbjct: 145 IHRDLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 277 SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
              +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQFG  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E  A V++    ++++     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE 
Sbjct: 126 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 181
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 121/275 (44%), Gaps = 36/275 (13%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG  +    + +G   A+K+  K  +   +  ++  REV     L  H +VV+++
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 73
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
           +A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R     H   LV
Sbjct: 74  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 133
Query: 222 HRDMKPEN-FLFKSAKEDSSLKATD----------FGLSDFIKPGKKFQDIV--GSAYYV 268
           H D+KP N F+ +++  +++ +  D          F + D     +     V  G + ++
Sbjct: 134 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 193
Query: 269 APEVLKRKSG--PESDVWSIGVITYILLCGRRPF------WDKTEDGIFKEVLRNKPDFR 320
           A EVL+      P++D++++  +T +   G  P       W +   G    + +      
Sbjct: 194 ANEVLQENYTHLPKADIFALA-LTVVXAAGAEPLPRNGDQWHEIRQGRLPRIPQ------ 246
Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                 +S    + +K ++  DP  R +A   + H
Sbjct: 247 -----VLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 34/266 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +Y +   + HG  G+ Y+A D+  NG  V +K +  +      A+   +R+     A   
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ---FLAEVV 137
Query: 156 HENVVKFYNAFE-----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           H ++V+ +N  E      D   YI ME   GG+ L R    K  +    +A   + ++L 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR---SKGQKLPVAEAIAYLLEILP 193
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
             +  H  GLV+ D+KPEN +      +  LK  D G    I     F  + G+  + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRI---NSFGYLYGTPGFQAP 246
Query: 271 EVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE--VLRNKPDFRRKPWPSIS 328
           E+++      +D++++G     L         +  DG+ ++  VL+    + R       
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR------- 299
Query: 329 NSAKDFVKKLLVKDPRARLTAAQALS 354
                 +++ +  DPR R T A+ +S
Sbjct: 300 -----LLRRAIDPDPRQRFTTAEEMS 320

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 17/224 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++ +G+ +G G FG  Y+ T+    + VA+K +E  K   P  + + K   +ILQ   G 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESK-IYRILQGGTGI 65
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            NV  F    E D Y  + M+L   G  L+ +      + + K   ++  QM+      H
Sbjct: 66  PNVRWF--GVEGD-YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    +  + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
           +    L  +     D+ S+G +    L G  P W   + G  K+
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQ 223

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQKRLLMDLDISMRTVDCPFTV 113
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I MEL      +D  L K   +  +K   +    + ++A        
Sbjct: 114 TFYGALFREGDVWICMEL------MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y+APE 
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDSVAKTIDAGCKPYMAPER 224
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 281
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  + + HP+
Sbjct: 282 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI  E    G LLD +   ++    E +A V++    ++++     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE 
Sbjct: 133 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 188
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 104 LGHGQFGYTYVATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG G FG  ++ T   NG  RVA+K ++   M    + E   +E ++++ L  HE +V+ 
Sbjct: 16  LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 68
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHLHGLV 221
           Y    ++  + I  E    G LLD  L  +  +Y      V +  Q+    A       V
Sbjct: 69  YAVVSEEP-IXIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEV-L 273
           HRD++  N L     E+   K  DFGL+  I       + G KF        + APE  L
Sbjct: 127 HRDLRAANIL---VGENLVCKVADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 178
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS G+ +T +   GR P+       +  +V R    +R    P    S  
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLH 235
Query: 333 DFVKKLLVKDPRARLT 348
           D + +   K+P  R T
Sbjct: 236 DLMCQCWRKEPEERPT 251

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E  +++ +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL- 217
           +V+       +   YI +E    G LLD +   ++    E  A V++    ++++     
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 218 --HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEV 272
                +HRD+   N L     E+  +K  DFGLS  +  G       G+ +   + APE 
Sbjct: 126 EKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPES 181
Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
           L   K   +SDVW+ GV+ + I   G  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y +G+ +G G FG  Y+  + A+G+ VA+K +E  K   P     +  E K  + + G 
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIK-LECVKTKHP----QLHIESKFYKMMQGG 64
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPSIKWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPF 300
           +    L  +     D+ S+G +      G  P+
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 80/329 (24%), Positives = 133/329 (40%), Gaps = 80/329 (24%)
Query: 97  RYTIGKLLGHGQFGYTYVATD-KANGDRVA---VKKIEKNKMILPIAVEDVKREVKILQA 152
           RY I   LG G FG      D +  G RVA   +K +EK K       E  + E+ +L+ 
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK-------EAARLEINVLEK 86
Query: 153 L----AGHENV-VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +      ++N+ V+ ++ F+   ++ I+ EL  G    D +       Y       +  Q
Sbjct: 87  INEKDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSA-----------KEDSSLKAT-----DFGLSDF 251
           + +     H + L H D+KPEN LF ++           +++ S+K+T     DFG + F
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF 205
Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG--- 307
               +    IV + +Y APEV L+       DVWSIG I +    G   F  +T D    
Sbjct: 206 --DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLF--QTHDNREH 261
Query: 308 --------------IFKEVLRNKPDFR-RKPWPSISNSAK-------------------- 332
                         + ++  + K  +R R  W   +++ +                    
Sbjct: 262 LAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEH 321
Query: 333 ----DFVKKLLVKDPRARLTAAQALSHPW 357
               D ++ +L  +P  RLT  +AL HP+
Sbjct: 322 HQLFDLIESMLEYEPAKRLTLGEALQHPF 350

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 22/228 (9%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  I K++G G  G       +  G R   VA+K ++          E  +R+     ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY------TERQRRDFLSEASI 103
Query: 154 AG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            G   H N+++            I  E  E G L D  L   D ++T      ++R +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--PGKKFQDIVG--SAY 266
                   G VHRD+   N L  S   +   K +DFGLS  ++  P   +    G     
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           + APE +  R     SDVWS GV+ + +L  G RP+W+ T   +   V
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 29/257 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG+GQFG  ++ T   N  +VA+K ++   M    + E    E +I++ L  H+ +V+
Sbjct: 15  KRLGNGQFGEVWMGTWNGN-TKVAIKTLKPGTM----SPESFLEEAQIMKKLK-HDKLVQ 68
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y A   +  +YI  E    G LLD +   +       +   +  Q+    A       +
Sbjct: 69  LY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 127
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPE-VL 273
           HRD++  N L  +       K  DFGL+  I       + G KF        + APE  L
Sbjct: 128 HRDLRSANILVGNG---LICKIADFGLARLIEDNEXTARQGAKF-----PIKWTAPEAAL 179
Query: 274 KRKSGPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSA 331
             +   +SDVWS G+ +T ++  GR P+       + ++V R      R P P     S 
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG----YRMPCPQDCPISL 235
Query: 332 KDFVKKLLVKDPRARLT 348
            + +     KDP  R T
Sbjct: 236 HELMIHCWKKDPEERPT 252

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  +V+ Y
Sbjct: 15  IGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLY 68
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
               +   + +  E  E G L D +  ++     E    + +  +    A      ++HR
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCEGMAYLEEASVIHR 127
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-RKSGP 279
           D+   N L     E+  +K +DFG++ F+    ++    G+ +   + +PEV    +   
Sbjct: 128 DLAARNCL---VGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 280 ESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV 312
           +SDVWS GV+ + +   G+ P+ +++   + +++
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +     G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G  +AVK+I        +  ++ KR   ++ I          V
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I MEL      +D  L K   +  +K   +    + ++A        
Sbjct: 70  TFYGALFREGDVWICMEL------MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y+APE 
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 237
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  + + HP+
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 42/250 (16%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVE---------- 141
           +F R + T+GK LG G FG   +A      + V + K +K K  + +AV+          
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMA------EAVGIDK-DKPKEAVTVAVKMLKDDATEKD 83
Query: 142 --DVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
             D+  E+++++ +  H+N++    A   D  +Y+ +     G L + + A++       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYS 143
Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + T KD      Q+ R          +HRD+   N L     E++ +K  D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIAD 200
Query: 246 FGLS---DFIKPGKKFQDIVGSAYYVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           FGL+   + I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 301 WDKTEDGIFK 310
                + +FK
Sbjct: 261 PGIPVEELFK 270

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 65
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMY 180
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 60
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 120 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 64
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 123
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 124 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 80
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV-------RQM 208
           HEN+V    A      V +  E C  G+LL+ +  ++ SR  E D A  +       R +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTRDL 166
Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           L  +++    G+        +HRD+   N L  +       K  DFGL+  I     +  
Sbjct: 167 LHFSSQV-AQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNY-I 221
Query: 261 IVGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 51/79 (64%), Gaps = 1/79 (1%)
Query: 378 RQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK 437
           +QF   ++ K+ ALR +A +L +EE+A L++ F+ ID DK+G I+ EE++  L K +   
Sbjct: 1   KQFSAXNKFKKXALRVIAESLSEEEIAGLKEXFNXIDADKSGQITFEELKAGL-KRVGAN 59
Query: 438 LKESRVLEILQAVNTPFLG 456
           LKES +L++ QA +    G
Sbjct: 60  LKESEILDLXQAADVDNSG 78

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV-------RQM 208
           HEN+V    A      V +  E C  G+LL+ +  ++ SR  E D A  +       R +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTLSTRDL 166
Query: 209 LRVAAECHLHGL--------VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           L  +++    G+        +HRD+   N L  +       K  DFGL+  I     +  
Sbjct: 167 LHFSSQV-AQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNY-I 221
Query: 261 IVGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 71
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 130
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++   VGS +   +  PEVL  
Sbjct: 131 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMY 186
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 19  KRLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 72
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 132
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 133 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 184
Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPFWDKT 304
                 +SDVWS G++ Y I+  G+ P+  +T
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRT 216

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 115/244 (47%), Gaps = 37/244 (15%)
Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREV 147
           +D  F++   IG+L+G G+FG  Y    + +G+ VA++   IE++       ++  KREV
Sbjct: 28  WDIPFEQ-LEIGELIGKGRFGQVY--HGRWHGE-VAIRLIDIERDN---EDQLKAFKREV 80
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK---DSRYTEKDAAVV 204
              +    HENVV F  A     ++ I   LC+G  L   +   K   D   T + A  +
Sbjct: 81  MAYRQ-TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL---SDFIKPGK---KF 258
           V+ M       H  G++H+D+K +N  + + K    +  TDFGL   S  ++ G+   K 
Sbjct: 140 VKGM----GYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKL 191
Query: 259 QDIVGSAYYVAPEVLKRKS----------GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
           +   G   ++APE++++ S             SDV+++G I Y L     PF  +  + I
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 309 FKEV 312
             ++
Sbjct: 252 IWQM 255

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 52/277 (18%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A     +   +   VAVK ++   +    A +D +RE ++L  L  HE+
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQ-HEH 78
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAVVVRQMLRV 211
           +VKFY    D + + +  E  + G+L   + A         D +  +    + + QML +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 212 AAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A++             VHRD+   N L  +   +  +K  DFG+S         +D+  +
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RDVYST 186
Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFK 310
            YY            + PE ++ RK   ESDVWS GVI + I   G++P++  +   + +
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
            + + +   R +  P       D +     ++P+ RL
Sbjct: 247 CITQGRVLERPRVCP---KEVYDVMLGCWQREPQQRL 280

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 188 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 241
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +     +  +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 242 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGP-E 280
           HRD++  N L  ++      K  DFGL+   + G KF        + APE +   S   +
Sbjct: 301 HRDLRAANILVSASL---VCKIADFGLA---RVGAKF-----PIKWTAPEAINFGSFTIK 349
Query: 281 SDVWSIGVITY-ILLCGRRPF 300
           SDVWS G++   I+  GR P+
Sbjct: 350 SDVWSFGILLMEIVTYGRIPY 370

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-------LAKKDSRYTE-KDAAVVVRQ 207
           HEN+V    A      V +  E C  G+LL+ +       L K+D R  E +D      Q
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY- 266
           + +  A       +HRD+   N L  +       K  DFGL+  I     +  + G+A  
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARL 224
Query: 267 ---YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
              ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 26/230 (11%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  I K++G G  G       +  G R   VA+K ++          E  +R+     ++
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY------TERQRRDFLSEASI 103
Query: 154 AG---HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            G   H N+++            I  E  E G L D  L   D ++T      ++R +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIK--PGKKFQDIVG--S 264
                   G VHRD+   N L      DS+L  K +DFGLS  ++  P        G   
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLV-----DSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 265 AYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
             + APE +  R     SDVWS GV+ + +L  G RP+W+ T   +   V
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRI-------LAKKDSRYTE-KDAAVVVRQ 207
           HEN+V    A      V +  E C  G+LL+ +       L K+D R  E +D      Q
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY- 266
           + +  A       +HRD+   N L  +       K  DFGL+  I     +  + G+A  
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNYI-VKGNARL 216
Query: 267 ---YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
              ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++     N  +VAVK ++   M    +V+    E  +++ L  H+ +V+
Sbjct: 18  KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 71
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            Y     +  +YI  E    G LLD + + +  +           Q+    A       +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 131
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L     E    K  DFGL+  I       + G KF        + APE + 
Sbjct: 132 HRDLRAANVL---VSESLMCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 183
Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPFWDKT 304
                 +S+VWS G++ Y I+  G+ P+  +T
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRT 215

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 119/323 (36%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D   G R    KI KN   +    E  + E+++L+ L   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTT 71
Query: 157 E-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +       V+    FE   ++ I  EL  G    D I       +       +  Q+ + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 212 AAECHLHGLVHRDMKPENFLF-----------KSAKEDSSL-----KATDFGLSDFIKPG 255
               H + L H D+KPEN LF           K  +++ +L     K  DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIG--VITYILLCGRRPFWDKTED-GIFKE 311
           +    +V + +Y APEV L        DVWSIG  +I Y L     P  D  E   + + 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 312 VLRNKPDFR-------------RKPWPSISNSAK------------------------DF 334
           +L   P                R  W   S++ +                        D 
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++K+L  DP  R+T  +AL HP+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPF 331

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 80
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++   ++    VGS +   +  PEVL  
Sbjct: 140 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSS-VGSKFPVRWSPPEVLMY 195
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQFG  ++     +  +VAVK +++  M    + +    E  +++ L  H+ +V+ Y
Sbjct: 29  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLY 82
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
                +  +YI  E  E G L+D +      + T      +  Q+    A       +HR
Sbjct: 83  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKRK 276
           D++  N L     +  S K  DFGL+  I       + G KF        + APE +   
Sbjct: 142 DLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINYG 193
Query: 277 S-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
           +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 241

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 27  LGAGQFGEVWMGY--YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 79
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 80  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 139 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 190
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 247
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            +     +  +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 248 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 307 HRDLRAANILVSASL---VCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 358
Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++   I+  GR P+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K LG GQFG  ++AT   +  +VAVK ++   M    +VE    E  +++ L  H+ +VK
Sbjct: 21  KKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVK 74
Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            + A      +YI  E    G LLD + + + S+           Q+    A       +
Sbjct: 75  LH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLK 274
           HRD++  N L  ++      K  DFGL+  I       + G KF        + APE + 
Sbjct: 134 HRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKF-----PIKWTAPEAIN 185
Query: 275 RKSGP-ESDVWSIGVITY-ILLCGRRPF 300
             S   +SDVWS G++   I+  GR P+
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQFG  ++     +  +VAVK +++  M    + +    E  +++ L  H+ +V+ Y
Sbjct: 31  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLY 84
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
                +  +YI  E  E G L+D +      + T      +  Q+    A       +HR
Sbjct: 85  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKRK 276
           D++  N L     +  S K  DFGL+  I       + G KF        + APE +   
Sbjct: 144 DLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINYG 195
Query: 277 SGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
           +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQFG  ++     +  +VAVK +++  M    + +    E  +++ L  H+ +V+ Y
Sbjct: 30  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLY 83
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
                +  +YI  E  E G L+D +      + T      +  Q+    A       +HR
Sbjct: 84  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKRK 276
           D++  N L     +  S K  DFGL+  I       + G KF        + APE +   
Sbjct: 143 DLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINYG 194
Query: 277 SGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
           +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 242

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 27  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 79
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 80  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 138
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 139 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 190
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 239

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMGY--YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 26  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 78
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 79  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 137
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 138 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 189
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 238

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 21  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 73
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 133 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 184
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 16  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 68
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 69  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 127
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 128 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINY 179
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 228

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 23  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 75
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 76  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 134
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 135 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 186
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)
Query: 104 LGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           LG GQFG  ++     NG  +VAVK +++  M    + +    E  +++ L  H+ +V+ 
Sbjct: 22  LGAGQFGEVWMG--YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRL 74
Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVH 222
           Y     +  +YI  E  E G L+D +      + T      +  Q+    A       +H
Sbjct: 75  YAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 133
Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKR 275
           RD++  N L     +  S K  DFGL+  I       + G KF        + APE +  
Sbjct: 134 RDLRAANIL---VSDTLSCKIADFGLARLIEDNEXTAREGAKF-----PIKWTAPEAINY 185
Query: 276 KSGP-ESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
            +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 234

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAG 155
           K +G G FG  +      +   VA+K +       + +MI     ++ +REV I+  L  
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREVFIMSNL-N 81
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGI 135
Query: 216 HLH-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYV 268
                    +VHRD++  N   +S  E++ +  K  DFGLS   +       ++G+  ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWM 193
Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           APE +   +     ++D +S  +I Y +L G  PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 85
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 142
Query: 207 QMLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           Q+L  AA+             +HRD+   N L     E+   K  DFGLS   +   K  
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKT 199
Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKP 317
                  ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +   
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 257
Query: 318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            +R +   +  +   D +++   + P  R + AQ L
Sbjct: 258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 75
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 132
Query: 207 QMLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           Q+L  AA+             +HRD+   N L     E+   K  DFGLS   +   K  
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLSRGQEVYVKKT 189
Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKP 317
                  ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +   
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 247
Query: 318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            +R +   +  +   D +++   + P  R + AQ L
Sbjct: 248 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K LG GQFG       +   D VA+K I++  M    + ++   E K++  L+ HE 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEK 65
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V+ Y        ++I  E    G LL+  L +   R+  +    + + +          
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLESK 124
Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK- 274
             +HRD+   N L     +   +K +DFGLS ++    ++    GS +   +  PEVL  
Sbjct: 125 QFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKFPVRWSPPEVLMY 180
Query: 275 RKSGPESDVWSIGVITY-ILLCGRRPF 300
            K   +SD+W+ GV+ + I   G+ P+
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L+  E
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAP----QLHLEYRFYKQLSATE 60
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V + Y       Y  + +EL   G  L+ +    D  +T K   ++  Q++      H 
Sbjct: 61  GVPQVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHT 118
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K   ++   DFGL+ ++I P  K        + + G+A Y
Sbjct: 119 KSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 178
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 179 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 232

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+F  +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 81/321 (25%), Positives = 128/321 (39%), Gaps = 68/321 (21%)
Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           G  +G G +G+ Y A  K   D    A+K+IE   + +        RE+ +L+ L  H N
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELK-HPN 79
Query: 159 VVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------VVRQML 209
           V+     F    D  V++  +  E  +L   I   + S+  +K   +       ++ Q+L
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 210 RVAAECHLHGLVHRDMKPENFL-FKSAKEDSSLKATDFGLSDF----IKPGKKFQDIVGS 264
                 H + ++HRD+KP N L      E   +K  D G +      +KP      +V +
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 265 AYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTED-------------GIF 309
            +Y APE+L   R      D+W+IG I   LL     F  + ED              IF
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258
Query: 310 K----------EVLRNKP-------DFRRKPWPSIS-------------NSAKDFVKKLL 339
                      E ++  P       DFRR  + + S             + A   ++KLL
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318
Query: 340 VKDPRARLTAAQALSHPWVRE 360
             DP  R+T+ QA+  P+  E
Sbjct: 319 TMDPIKRITSEQAMQDPYFLE 339

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 118/323 (36%), Gaps = 68/323 (21%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D   G R    KI KN   +    E  + E+++L+ L   
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTT 71
Query: 157 E-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +       V+    FE   ++ I  EL  G    D I       +       +  Q+ + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 212 AAECHLHGLVHRDMKPENFLF-----------KSAKEDSSL-----KATDFGLSDFIKPG 255
               H + L H D+KPEN LF           K  +++ +L     K  DFG + +    
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DD 188
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIG--VITYILLCGRRPFWDKTED-GIFKE 311
           +    +V   +Y APEV L        DVWSIG  +I Y L     P  D  E   + + 
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248
Query: 312 VLRNKPDFR-------------RKPWPSISNSAK------------------------DF 334
           +L   P                R  W   S++ +                        D 
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308
Query: 335 VKKLLVKDPRARLTAAQALSHPW 357
           ++K+L  DP  R+T  +AL HP+
Sbjct: 309 IQKMLEYDPAKRITLREALKHPF 331

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQFG  ++     +  +VAVK +++  M    + +    E  +++ L  H+ +V+ Y
Sbjct: 17  LGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLY 70
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
                +  +YI  E  E G L+D +      + T      +  Q+    A       +HR
Sbjct: 71  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKRK 276
           +++  N L     +  S K  DFGL+  I       + G KF        + APE +   
Sbjct: 130 NLRAANIL---VSDTLSCKIADFGLARLIEDNEYTAREGAKF-----PIKWTAPEAINYG 181
Query: 277 S-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
           +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 54/256 (21%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK ++        A +D  RE ++L  L  HE+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEH 76
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGEL--------LDRILAKKDSRYTEKDAAVVVRQMLR 210
           +VKFY    + + + +  E  + G+L         D +L  + +  TE   +    QML 
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS----QMLH 132
Query: 211 VAAECHL-------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           +A +             VHRD+   N L     E+  +K  DFG+S         +D+  
Sbjct: 133 IAQQIAAGMVYLASQHFVHRDLATRNCL---VGENLLVKIGDFGMS---------RDVYS 180
Query: 264 SAYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
           + YY            + PE ++ RK   ESDVWS+GV+ + I   G++P++  + + + 
Sbjct: 181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240
Query: 310 KEVLRNKPDFRRKPWP 325
           + + + +   R +  P
Sbjct: 241 ECITQGRVLQRPRTCP 256

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT----YVATDKANGDRVAVKKIEKNK 133
           G++P G      ++   +R     + LG G FG      Y       G+ VAVKK++ + 
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 69
Query: 134 MILPIAVEDVKREVKILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRIL 189
                 + D +RE++IL++L  H+N+VK+    Y+A   +  + + ME    G L D  L
Sbjct: 70  ---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YL 122
Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            K   R           Q+ +          +HRD+   N L ++   ++ +K  DFGL+
Sbjct: 123 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 179
Query: 250 DFIKPGKKFQDI----VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
             +   K+   +        ++ APE L + K    SDVWS GV+ Y L 
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 52/255 (20%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV------------EDVKREV 147
            GK+LG G FG    AT  A G       I K  + + +AV            E +  E+
Sbjct: 49  FGKVLGSGAFGKVMNAT--AYG-------ISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD-------------- 193
           K++  L  HEN+V    A      +Y+  E C  G+LL+ + +K++              
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 194 -------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF 246
                  +  T +D      Q+ +          VHRD+   N L    K    +K  DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK---VVKICDF 216
Query: 247 GLSDFIKPGKKFQDIVGSAY----YVAPEVL-KRKSGPESDVWSIGVITY-ILLCGRRPF 300
           GL+  I     +  + G+A     ++APE L +     +SDVWS G++ + I   G  P+
Sbjct: 217 GLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 301 WDKTEDGIFKEVLRN 315
                D  F ++++N
Sbjct: 276 PGIPVDANFYKLIQN 290

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 40/276 (14%)
Query: 103 LLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKR----EVKILQALAGH 156
           ++G G FG    A  K +G R+  A+K++++       A +D  R    E+++L  L  H
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE------YASKDDHRDFAGELEVLCKLGHH 82
Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV----------R 206
            N++    A E   Y+Y+A+E    G LLD +   + SR  E D A  +          +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQ 139
Query: 207 QMLRVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           Q+L  AA+             +HR++   N L     E+   K  DFGLS   +   K  
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNIL---VGENYVAKIADFGLSRGQEVYVKKT 196
Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKP 317
                  ++A E L        SDVWS GV+ + I+  G  P+   T   +++++ +   
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 254
Query: 318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            +R +   +  +   D +++   + P  R + AQ L
Sbjct: 255 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALAGHE 157
           K +G G FG  +      +   VA+K +     + +  +    ++ +REV I+  L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A     
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEY 137
Query: 218 H-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                  +VHRD++  N   +S  E++ +  K  DFG S   +       ++G+  ++AP
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAP 195
Query: 271 EVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           E +   +     ++D +S  +I Y +L G  PF
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYT----YVATDKANGDRVAVKKIEKNK 133
           G++P G      ++   +R     + LG G FG      Y       G+ VAVKK++ + 
Sbjct: 13  GLVPRGSHNMTQFE---ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 69
Query: 134 MILPIAVEDVKREVKILQALAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRIL 189
                 + D +RE++IL++L  H+N+VK+    Y+A   +  + + ME    G L D  L
Sbjct: 70  ---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YL 122
Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            K   R           Q+ +          +HRD+   N L ++   ++ +K  DFGL+
Sbjct: 123 QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---ENRVKIGDFGLT 179
Query: 250 DFIKPGKKFQDI----VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILL 294
             +   K+   +        ++ APE L + K    SDVWS GV+ Y L 
Sbjct: 180 KVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 229

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 76
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 193
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITY 291
           +    IV + +Y  PEV L+       DVWSIG I +
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 230

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 85
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 86  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 144
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 145 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 202
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITY 291
           +    IV + +Y  PEV L+       DVWSIG I +
Sbjct: 203 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 239

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            I + +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR-HPN 95
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V F  A      + I  E    G L  R+L K  +R    +     R+ L +A +    
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDE-----RRRLSMAYDVAKG 149
Query: 216 --HLHG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAY 266
             +LH     +VHRD+K  N L     +  ++K  DFGLS        F   +   G+  
Sbjct: 150 MNYLHNRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPE 204
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPF 300
           ++APEVL+   S  +SDV+S GVI + L   ++P+
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI------EKNKMILPIAVEDVKREVKILQALAG 155
           K +G G FG  +      +   VA+K +       + +MI     ++ +REV I+  L  
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE--KFQEFQREVFIMSNL-N 81
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H N+VK Y      N   + ME    G+L  R+L K          +V +R ML +A   
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGI 135
Query: 216 HLH-----GLVHRDMKPENFLFKSAKEDSSL--KATDFGLSDFIKPGKKFQDIVGSAYYV 268
                    +VHRD++  N   +S  E++ +  K  DF LS   +       ++G+  ++
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWM 193
Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPF 300
           APE +   +     ++D +S  +I Y +L G  PF
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 72
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 73  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 130 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELF 210

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY I   LG G FG      D A G      KI +N   +    E  + E+ +L+ +   
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEK 108
Query: 157 ENVVKFYNAFEDD-----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +   KF      D      ++ IA EL  G    + +       Y       +  Q+   
Sbjct: 109 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 167
Query: 212 AAECHLHGLVHRDMKPENFLF------------KSAKE----DSSLKATDFGLSDFIKPG 255
               H + L H D+KPEN LF            KS +E    ++S++  DFG + F    
Sbjct: 168 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DH 225
Query: 256 KKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITY 291
           +    IV + +Y  PEV L+       DVWSIG I +
Sbjct: 226 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILF 262

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 77
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 78  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 135 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELF 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 71
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 72  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 129 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELF 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 78
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 79  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 136 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELF 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 73
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 74  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 131 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 104
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 105 VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 162 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 80
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 81  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 138 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 79
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 80  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 137 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELF 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 74
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D  L K   R           Q+ +     
Sbjct: 75  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HR++   N L ++   ++ +K  DFGL+  +   K++  +        ++ APE
Sbjct: 132 GTKRYIHRNLATRNILVEN---ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELF 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           LG GQ G  ++     +  +VAVK +++  M    + +    E  +++ L  H+ +V+ Y
Sbjct: 21  LGAGQAGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLY 74
Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
                +  +YI  E  E G L+D +      + T      +  Q+    A       +HR
Sbjct: 75  AVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFI-------KPGKKFQDIVGSAYYVAPEVLKRK 276
           D++  N L     +  S K  DFGL+  I       + G KF        + APE +   
Sbjct: 134 DLRAANIL---VSDTLSCKIADFGLARLIEDAEXTAREGAKF-----PIKWTAPEAINYG 185
Query: 277 S-GPESDVWSIGV-ITYILLCGRRPFWDKTEDGIFKEVLRN----KPD 318
           +   +SDVWS G+ +T I+  GR P+   T   + + + R     +PD
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDA 201
           HEN+V    A      V +  E C  G+LL+ +  K+              + + + +D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
                Q+ +  A       +HRD+   N L  +       K  DFGL+  I     +  +
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMNDSNY-IV 224
Query: 262 VGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            I + +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLR-HPN 95
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V F  A      + I  E    G L  R+L K  +R    +     R+ L +A +    
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDE-----RRRLSMAYDVAKG 149
Query: 216 --HLHG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF---QDIVGSAY 266
             +LH     +VHR++K  N L     +  ++K  DFGLS        F   +   G+  
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLL---VDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPE 204
Query: 267 YVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPF 300
           ++APEVL+   S  +SDV+S GVI + L   ++P+
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDA-------AVV 204
           +  H NVV    A  +    + + +E C+ G L   + +K++     KD          +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 205 VRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFIKP 254
           +    +VA           +HRD+   N L     E + +K  DFGL+       D+++ 
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 255 GKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 G----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 40/232 (17%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLNLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD----------- 200
           +  H NVV    A  +    + + +E C+ G L   + +K++     KD           
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 201 ---AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              +  V + M  +A+       +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 ICYSFQVAKGMEFLASR----KXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 199
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           +++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 200 YVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L +  L K   R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEFLPYGSLRE-YLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYT----YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNI 76
Query: 160 VKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           VK+    Y+A   +  + + ME    G L D + A  + R           Q+ +     
Sbjct: 77  VKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYL 133
Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPE 271
                +HRD+   N L ++   ++ +K  DFGL+  +   K+   +        ++ APE
Sbjct: 134 GTKRYIHRDLATRNILVEN---ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 272 VL-KRKSGPESDVWSIGVITYILL 294
            L + K    SDVWS GV+ Y L 
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELF 214

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 104
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKF 258
           A++      +L GL  VHRD+   N L     +   +K  DFG+S      D+ + G + 
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 259 QDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
              +    ++ PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 221 MLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 81
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKF 258
           A++      +L GL  VHRD+   N L     +   +K  DFG+S      D+ + G + 
Sbjct: 141 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMSRDIYSTDYYRVGGR- 196
Query: 259 QDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
              +    ++ PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 197 --TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQALAG 155
            GK LG G FG    AT    G   AV K+   KM+   A  D K     E+KI+  L  
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--------------------LAKKDSR 195
           HEN+V    A      V +  E C  G+LL+ +                    L K+D R
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 196 YTE-KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
             E +D      Q+ +  A       +HRD+   N L  +       K  DFGL+  I  
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH---VAKIGDFGLARDIMN 210
Query: 255 GKKFQDIVGSAY----YVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
              +  + G+A     ++APE +       +SDVWS G++ + I   G  P+
Sbjct: 211 DSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 50/231 (21%)
Query: 104 LGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           LG G FG  ++A       + +   VAVK +++       A +D +RE ++L  L  H++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQ-HQH 75
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVV-----VRQMLRV 211
           +V+F+    +   + +  E    G+L +R L     D++       V      + Q+L V
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 212 AAEC-----HLHGL--VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           A++      +L GL  VHRD+   N L     +   +K  DFG+S         +DI  +
Sbjct: 135 ASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMS---------RDIYST 182
Query: 265 AYY------------VAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPFW 301
            YY            + PE +L RK   ESDVWS GV+ + I   G++P++
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 106/272 (38%), Gaps = 35/272 (12%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR---EVKILQALAGHENVV 160
           LG G +G         +G   AVK+I        +  ++ KR   ++ I          V
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRAT-----VNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC----- 215
            FY A   +  V+I  EL       D  L K   +  +K   +    + ++A        
Sbjct: 97  TFYGALFREGDVWICXEL------XDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 150
Query: 216 HLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           HLH    ++HRD+KP N L  +  +   +K  DFG+S ++          G   Y APE 
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINALGQ---VKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 273 L-----KRKSGPESDVWSIGVITYILLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWP 325
           +     ++    +SD+WS+G+    L   R P+  W      + + V    P     P  
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---PAD 264
Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
             S    DF  + L K+ + R T  +   HP+
Sbjct: 265 KFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI------------------ 188
             +L+ +  H +V+K Y A   D  + + +E  + G L   +                  
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 189 ---LAKKDSR-YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT 244
              L   D R  T  D      Q+ +         LVHRD+   N L     E   +K +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL---VAEGRKMKIS 192
Query: 245 DFGLSDFI----KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCGRRP 299
           DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G  P
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 300 F 300
           +
Sbjct: 253 Y 253

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 14  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 65
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 122
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 123 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 176
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 25  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 83
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K+A     
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLY 143
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 144 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 200
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 201 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 29  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 80
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 137
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 138 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 45/244 (18%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI------------------ 188
             +L+ +  H +V+K Y A   D  + + +E  + G L   +                  
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 189 ---LAKKDSR-YTEKDA---AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
              L   D R  T  D    A  + Q ++  AE     LVHRD+   N L     E   +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNIL---VAEGRKM 189
Query: 242 KATDFGLSDFI----KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCG 296
           K +DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 297 RRPF 300
             P+
Sbjct: 250 GNPY 253

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 85
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 145 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 72
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 132 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 252
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 309
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLK-RKS 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+ +K 
Sbjct: 310 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 363
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 73
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEV 272
               VHRD+   N L +S   ++ +K  DFGL+  +   K +  +        ++ APE 
Sbjct: 133 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 273 LKRKS-GPESDVWSIGVITYILL 294
           L       +SDVWS GV+ Y L 
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 100/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DFGL+ ++I P  K        + + G+A Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 237

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 45/244 (18%)
Query: 93  DFDRR-YTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKRE 146
           +F R+   +GK LG G+FG    AT      +A    VAVK +++N    P  + D+  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSE 76
Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI------------------ 188
             +L+ +  H +V+K Y A   D  + + +E  + G L   +                  
Sbjct: 77  FNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 189 ---LAKKDSR-YTEKDA---AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
              L   D R  T  D    A  + Q ++  AE     LVHRD+   N L     E   +
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNIL---VAEGRKM 189
Query: 242 KATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITY-ILLCG 296
           K +DFGLS  +       K+ Q  +   +     +       +SDVWS GV+ + I+  G
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 297 RRPF 300
             P+
Sbjct: 250 GNPY 253

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 20/234 (8%)
Query: 100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-AGHEN 158
           +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L +  E 
Sbjct: 4   VGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAP----QLHLEYRFYKQLGSAGEG 58
Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           + + Y       Y  + +EL   G  L+ +    D  +T K   ++  Q+L      H  
Sbjct: 59  LPQVYYFGPXGKYNAMVLELL--GPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSK 116
Query: 219 GLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYYV 268
            L++RD+KPENFL   +  K++  +   DFGL+ ++I P  K        + + G+A Y+
Sbjct: 117 NLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYM 176
Query: 269 APEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           +    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 177 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 229

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           LG G FG   +      GD     VAVK+++ +    P    D +RE++IL+AL  H + 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKAL--HSDF 69
Query: 160 VKFYNAFE---DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +  Y           + + ME    G L D  L +  +R       +   Q+ +      
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV-----GSAYYVAPE 271
               VHRD+   N L +S   ++ +K  DFGL+  + P  K   +V        ++ APE
Sbjct: 129 SRRCVHRDLAARNILVES---EAHVKIADFGLAKLL-PLDKDXXVVREPGQSPIFWYAPE 184
Query: 272 VLKRKS-GPESDVWSIGVITYILL 294
            L       +SDVWS GV+ Y L 
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  H N+V+  
Sbjct: 20  IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLL 71
Query: 164 NAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHLHG-- 219
               E+   +YI  E    G L+D + ++  S         +++  L V  A  +L G  
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL---GGDCLLKFSLDVCEAMEYLEGNN 128
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG-SAYYVAPEVLKRKS- 277
            VHRD+   N L     ED+  K +DFGL+   K     QD       + APE L+  + 
Sbjct: 129 FVHRDLAARNVL---VSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAAF 182
Query: 278 GPESDVWSIGVITY-ILLCGRRPF 300
             +SDVWS G++ + I   GR P+
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 41/234 (17%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 29  RLNLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +  H NVV    A  +    + + +E C+ G L   + +K++     K    + +  L +
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 212 AAECHL----------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------ 249
               HL                   +HRD+   N L     E + +K  DFGL+      
Sbjct: 148 E---HLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKD 201
Query: 250 -DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 202 PDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 81
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K A     
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 198
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 199 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 118
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K A     
Sbjct: 119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 235
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 236 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 74/320 (23%), Positives = 129/320 (40%), Gaps = 77/320 (24%)
Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED 142
           G    F   +   R+ T+ + +G G++G  +  +    G+ VAVK             + 
Sbjct: 24  GSGLPFLVQRTVARQITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KS 75
Query: 143 VKREVKILQA-LAGHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
             RE ++    +  HEN++ F      +      +++     E G L D +      + T
Sbjct: 76  WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLT 129
Query: 198 EKDAAVVVRQMLRVAAE-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDF 246
             D    +R +L +A+   HLH           + HRD+K +N L    K++      D 
Sbjct: 130 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADL 186
Query: 247 GLSDFIKPGKKFQDI-----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILL 294
           GL+          D+     VG+  Y+APEVL          S    D+W+ G++ + + 
Sbjct: 187 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV- 245
Query: 295 CGRRPFWDKTEDGI-------FKEVLRNKPDF----------RRKP-----W---PSISN 329
             RR       +GI       F +V+ N P F          +++P     W   P++++
Sbjct: 246 -ARR----MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS 300
Query: 330 SAKDFVKKLLVKDPRARLTA 349
            AK  +K+   ++P ARLTA
Sbjct: 301 LAK-LMKECWYQNPSARLTA 319

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 9/191 (4%)
Query: 113 YVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV 172
           Y A D      VA+K   +     P+     +RE +    L    +VV  ++  E D  +
Sbjct: 51  YEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109
Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF 232
           Y+   L  G +L   +  ++        A  +VRQ+       H  G  HRD+KPEN L 
Sbjct: 110 YVDXRLINGVDLAAXL--RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167
Query: 233 KSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPEVLKRKSGP-ESDVWSIGVI 289
            +   D      DFG++      K  Q  + VG+ YY APE          +D++++  +
Sbjct: 168 SA---DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCV 224
Query: 290 TYILLCGRRPF 300
            Y  L G  P+
Sbjct: 225 LYECLTGSPPY 235

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D+++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 YKDPDYVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/318 (21%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--------EKNKMILPIAVEDVKREVKI 149
           YT+ + +  G +G      D + G  VA+K++          N +      + V RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 150 LQALAGHENVVKF---YNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L     H N++     +  FE+   + +Y+  EL      L +++  +    + +     
Sbjct: 83  LNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYF 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +  +L      H  G+VHRD+ P N L     +++ +   DF L+            V  
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTH 196
Query: 265 AYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKT-----------------E 305
            +Y APE++ +  G     D+WS G +   +   +  F   T                 E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 306 DGIF------KEVLRNK-PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           D +       ++ LRN   +   + W    P+    A D + K+L  +P+ R++  QAL 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 355 HPWVREGGDASEIPIDIS 372
           HP+     D    P+D++
Sbjct: 317 HPYFESLFD----PLDLT 330

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/318 (21%), Positives = 127/318 (39%), Gaps = 54/318 (16%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--------EKNKMILPIAVEDVKREVKI 149
           YT+ + +  G +G      D + G  VA+K++          N +      + V RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 150 LQALAGHENVVKF---YNAFEDD--NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           L     H N++     +  FE+   + +Y+  EL      L +++  +    + +     
Sbjct: 83  LNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQYF 139
Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
           +  +L      H  G+VHRD+ P N L     +++ +   DF L+            V  
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLA---DNNDITICDFNLAREDTADANKTHYVTH 196
Query: 265 AYYVAPEVLKRKSGPES--DVWSIGVITYILLCGRRPFWDKT-----------------E 305
            +Y APE++ +  G     D+WS G +   +   +  F   T                 E
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 306 DGIF------KEVLRNK-PDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           D +       ++ LRN   +   + W    P+    A D + K+L  +P+ R++  QAL 
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316
Query: 355 HPWVREGGDASEIPIDIS 372
           HP+     D    P+D++
Sbjct: 317 HPYFESLFD----PLDLT 330

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 30  RLKLGKPLGRGAFGQV-IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K   +        
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 204 -VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------DFI 252
            ++    +VA           +HRD+   N L     E + +K  DFGL+       D +
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPDXV 205
Query: 253 KPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
           + G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 206 RKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y      +G+ V    A+K + +N    P A +++  E  ++  + G  
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGV-GSP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            V +          V +  +L   G LLD +   +  R   +D      Q+ +  +    
Sbjct: 80  YVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENR-GRLGSQDLLNWCMQIAKGMSYLED 137
Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEVL 273
             LVHRD+   N L KS      +K TDFGL+  +   +      G      +     +L
Sbjct: 138 VRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 274 KRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSIS 328
           +R+   +SDVWS GV  + L+  G +P+     DGI     R  PD      R P P I 
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMTFGAKPY-----DGIPA---REIPDLLEKGERLPQPPIC 246
Query: 329 N 329
Sbjct: 247 T 247

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 79
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LL+ +   KD+  ++      V Q+ +         
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 137
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 138 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 276 KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSISN 329
           K   +SDVWS GV  + L+  G +P+     DGI     R  PD      R P P I  
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPY-----DGI---PTREIPDLLEKGERLPQPPICT 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC---HLHGLVHRDMKP 227
           Y+YI M+LC    L D +   +     +++  V +   +++A      H  GL+HRD+KP
Sbjct: 135 YLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI-------------VGSAYYVAPEVLK 274
            N  F     D  +K  DFGL   +   ++ Q +             VG+  Y++PE + 
Sbjct: 193 SNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIH 249
Query: 275 RKS-GPESDVWSIGVITYILL 294
             +   + D++S+G+I + LL
Sbjct: 250 GNNYSHKVDIFSLGLILFELL 270

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 65
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DF L+ ++I P  K        + + G+A Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 237

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 23/238 (9%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G+ V +    K  N+   P A  +   E  I+ ++  H ++
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 102
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+          + +  +L   G LL+ +   KD+  ++      V Q+ +         
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERR 160
Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY---YVAPEVLK-R 275
           LVHRD+   N L KS    + +K TDFGL+  ++  +K  +  G      ++A E +  R
Sbjct: 161 LVHRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 276 KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF----RRKPWPSISN 329
           K   +SDVWS GV  + L+     F  K  DGI     R  PD      R P P I  
Sbjct: 218 KFTHQSDVWSYGVTIWELMT----FGGKPYDGIPT---REIPDLLEKGERLPQPPICT 268

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   +
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAP----QLHLEYRFYKQLGSGD 86
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H 
Sbjct: 87  GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 144
Query: 218 HGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKK-------FQDIVGSAYY 267
             L++RD+KPENFL      K    +   DF L+ ++I P  K        + + G+A Y
Sbjct: 145 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 204
Query: 268 VAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           ++    L ++     D+ ++G +    L G  P W   +    KE  +   D +R
Sbjct: 205 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP-WQGLKADTLKERYQKIGDTKR 258

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 XKDPDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K A          
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 203
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 XVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 36/232 (15%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EVKILQA 152
           R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+KIL  
Sbjct: 28  RLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 153 LAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-------- 203
           +  H NVV    A  +    + + +E C+ G L   + +K++     K A          
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 204 ---VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-------D 250
              ++    +VA           +HRD+   N L     E + +K  DFGL+       D
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 203
Query: 251 FIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
            ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 204 XVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR----EV 147
           +F R R  +GK LG G FG   +  D    D+ A  +    KM+   A     R    E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQV-IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 148 KILQALAGHENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV--- 203
           KIL  +  H NVV    A  +    + +  E C+ G L   + +K++     K A     
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 204 --------VVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAKEDSSLKATDFGLS--- 249
                   ++    +VA           +HRD+   N L     E + +K  DFGL+   
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDI 189
Query: 250 ----DFIKPGKKFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITY-ILLCGRRPF 300
               D ++ G    D      ++APE +  R    +SDVWS GV+ + I   G  P+
Sbjct: 190 XKDPDXVRKG----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 77/307 (25%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R  T+ + +G G++G  +  +    G+ VAVK             +   RE ++    + 
Sbjct: 8   RDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KSWFRETELYNTVML 59
Query: 155 GHENVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F      +      +++     E G L D +      + T  D    +R +L 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLS 113
Query: 211 VAAE-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           +A+   HLH           + HRD+K +N L    K++      D GL+          
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 260 DI-----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDG 307
           D+     VG+  Y+APEVL          S    D+W+ G++ + +   RR       +G
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARR----MVSNG 224
Query: 308 I-------FKEVLRNKPDF----------RRKP-----W---PSISNSAKDFVKKLLVKD 342
           I       F +V+ N P F          +++P     W   P++++ AK  +K+   ++
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQN 283
Query: 343 PRARLTA 349
           P ARLTA
Sbjct: 284 PSARLTA 290

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +   R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q
Sbjct: 25  RTIARTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQ 76
Query: 152 A-LAGHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVR 206
             +  HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++  
Sbjct: 77  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKL 131
Query: 207 QMLRVAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            +   +   HLH           + HRD+K +N L    K++ +    D GL+       
Sbjct: 132 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSAT 188
Query: 257 KFQDI-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
              DI     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 189 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +   R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE------RSWFREAEIYQ 89
Query: 152 A-LAGHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVR 206
             +  HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++  
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKL 144
Query: 207 QMLRVAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            +   +   HLH           + HRD+K +N L    K++ +    D GL+       
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSAT 201
Query: 257 KFQDI-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
              DI     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 3   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 54
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 109
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 166
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 4   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 55
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 56  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 110
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 167
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 79  HVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 136
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 137 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 224

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 9   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 60
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 61  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 115
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 172
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LAGHE 157
           T+ + +G G++G  +  +    G+ VAVK             +   RE ++    +  HE
Sbjct: 11  TLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHE 62
Query: 158 NVVKF----YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F      +      +++     E G L D +      + T  D    +R +L +A+
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIAS 116
Query: 214 E-CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI- 261
              HLH           + HRD+K +N L    K++      D GL+          D+ 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 262 ----VGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-- 308
               VG+  Y+APEVL          S    D+W+ G++ + +   RR       +GI  
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARR----MVSNGIVE 227
Query: 309 -----FKEVLRNKPDF----------RRKP-----W---PSISNSAKDFVKKLLVKDPRA 345
                F +V+ N P F          +++P     W   P++++ AK  +K+   ++P A
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMKECWYQNPSA 286
Query: 346 RLTA 349
           RLTA
Sbjct: 287 RLTA 290

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA-LA 154
           R   + + +G G+FG  +    K  G+ VAVK     +           RE +I Q  + 
Sbjct: 6   RTIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVML 57
Query: 155 GHENVVKFYNAFEDDNYVYIAMELC----EGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN  +  + L     E G L D +     +RYT     ++   +  
Sbjct: 58  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALST 112
Query: 211 VAAECHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
            +   HLH           + HRD+K +N L    K++ +    D GL+          D
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSATDTID 169
Query: 261 I-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
           I     VG+  Y+APEVL         +S   +D++++G++ +
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/291 (21%), Positives = 116/291 (39%), Gaps = 40/291 (13%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           ++ Y   + LG G F Y  +     +G   A+K+I  ++       E+ +RE   +  L 
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREAD-MHRLF 83
Query: 155 GHENVVKF--YNAFEDD--NYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQM 208
            H N+++   Y   E    +  ++ +   + G L + I  L  K +  TE     ++  +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVG- 263
            R     H  G  HRD+KP N L     +   +       +     G +     QD    
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 264 --SAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE------ 311
             +  Y APE+   +S       +DVWS+G + Y ++ G  P+     D +F++      
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-----DMVFQKGDSVAL 258
Query: 312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR------LTAAQALSHP 356
            ++N+    +   P  S++    +  ++  DP  R      L+  +AL  P
Sbjct: 259 AVQNQLSIPQS--PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 78
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 79  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 136
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 137 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 224

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 81
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 82  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 140 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 227

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 80  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 137
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 138 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G++V   V  +E  +   P A +++  E  ++ A   + +V
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM-ASVDNPHV 113
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECH 216
            +          V +  +L   G LLD +   KD   S+Y       + + M  +     
Sbjct: 114 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 169
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEV 272
              LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +     +
Sbjct: 170 -RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 273 LKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
           L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 257

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)
Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           ++++T+G++LG G+FG    A  K       +VAVK + K  +I    +E+  RE   ++
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMK 80
Query: 152 ALAGHENVVKFYNAFEDDN------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
               H +V K                  + +   + G+L   +LA   SR  E    + +
Sbjct: 81  EF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA---SRIGENPFNLPL 136
Query: 206 RQMLR--VAAECHLHGL-----VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           + ++R  V   C +  L     +HRD+   N +     ED ++   DFGLS  I  G  +
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYY 193
Query: 259 QDIVGSAY---YVAPEVLKRK-SGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVL 313
           +    S     ++A E L        SDVW+ GV  + I+  G+ P+       I+  ++
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
                 R K  P       D + +    DP+ R
Sbjct: 254 GGN---RLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 59/225 (26%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK--REVKILQA-LAGHEN 158
           K +G G++G  ++   K  G++VAVK             E+    RE +I Q  L  HEN
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVAVKVF--------FTTEEASWFRETEIYQTVLMRHEN 92
Query: 159 VVKFYNA----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           ++ F  A          +Y+  +  E G L D +          K   +  + ML++A  
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----------KSTTLDAKSMLKLAYS 142
Query: 215 -----CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKF 258
                CHLH           + HRD+K +N L    K++ +    D GL+  FI    + 
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDTNEV 199
Query: 259 QDI-----VGSAYYVAPEVLKR-------KSGPESDVWSIGVITY 291
            DI     VG+  Y+ PEVL         +S   +D++S G+I +
Sbjct: 200 -DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 110/266 (41%), Gaps = 20/266 (7%)
Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G F   Y   D      VA  +++  K+      +  K E + L+ L  H N+V+FY
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEXLKGLQ-HPNIVRFY 91
Query: 164 NAFEDD----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           +++E        + +  EL   G L  +   K+      K      RQ+L+     H   
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTL--KTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 220 --LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
             ++HRD+K +N          S+K  D GL+  +K     + ++G+  + APE  + K 
Sbjct: 150 PPIIHRDLKCDNIFITGPT--GSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKY 206
Query: 278 GPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRN-KP-DFRRKPWPSISNSAKDF 334
               DV++ G           P+ + +    I++ V    KP  F +   P +    K+ 
Sbjct: 207 DESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV----KEI 262
Query: 335 VKKLLVKDPRARLTAAQALSHPWVRE 360
           ++  + ++   R +    L+H + +E
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +FD ++    L+GHG FG  Y    + +G +VA+K+        P + + ++     ++ 
Sbjct: 40  NFDHKF----LIGHGVFGKVYKGVLR-DGAKVALKRRT------PESSQGIEEFETEIET 88
Query: 153 LA--GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVR 206
           L+   H ++V      ++ N + +  +  E G L  R L   D    S   E+   + + 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL-KRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD------ 260
              R     H   ++HRD+K  N L     E+   K TDFG+S   K G +         
Sbjct: 148 AA-RGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS---KKGTELDQTHLXXV 200
Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGR 297
           + G+  Y+ PE  +K +   +SDV+S GV+ + +LC R
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +FD ++    L+GHG FG  Y    + +G +VA+K+        P + + ++     ++ 
Sbjct: 40  NFDHKF----LIGHGVFGKVYKGVLR-DGAKVALKRRT------PESSQGIEEFETEIET 88
Query: 153 LA--GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVR 206
           L+   H ++V      ++ N + +  +  E G L  R L   D    S   E+   + + 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL-KRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD------ 260
              R     H   ++HRD+K  N L     E+   K TDFG+S   K G +         
Sbjct: 148 AA-RGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS---KKGTELGQTHLXXV 200
Query: 261 IVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGR 297
           + G+  Y+ PE  +K +   +SDV+S GV+ + +LC R
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 87
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 88  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 145
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 146 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 17/207 (8%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 74
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 75  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----YYVAPEVLK- 274
           +HRD+   N L  +      +K  DFGL   + P      ++         + APE LK 
Sbjct: 133 IHRDLAARNLLLATR---DLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 275 RKSGPESDVWSIGVITYILLC-GRRPF 300
           R     SD W  GV  + +   G+ P+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 83
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 84  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 141
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 142 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 45/285 (15%)
Query: 69  QKTNSRRQTGVIPCGKRTDFGYDKDF---------DRRYTIGKLLGHGQFGYTYVATDKA 119
           ++ NSR   GV+      ++    D            + T+ + LG G FG  Y    K 
Sbjct: 11  KRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKG 70
Query: 120 -----NGDRVAVKKI-EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
                   RVA+K + E   M   I   +   E  +++    H +VV+            
Sbjct: 71  VVKDEPETRVAIKTVNEAASMRERI---EFLNEASVMKEFNCH-HVVRLLGVVSQGQPTL 126
Query: 174 IAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQMLRVAAEC-------HLHGLVHRDM 225
           + MEL   G+L   + + + +       A   + +M+++A E        + +  VHRD+
Sbjct: 127 VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 186
Query: 226 KPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
              N +     ED ++K  DFG++      D+ + G K    +    +++PE LK     
Sbjct: 187 AARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGGKG---LLPVRWMSPESLKDGVFT 240
Query: 279 PESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV----LRNKPD 318
             SDVWS GV+ + I     +P+   + + + + V    L +KPD
Sbjct: 241 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 77
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 223

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 71
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 72  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 129
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 79
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 80  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 137
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 138 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 82
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 83  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 199 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 256 GGLLDKPD 263

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G++V +     E  +   P A +++  E  ++ A   + +V
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM-ASVDNPHV 104
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECH 216
            +          V +  +L   G LLD +   KD   S+Y       + + M  +     
Sbjct: 105 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 160
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEV 272
              LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +     +
Sbjct: 161 -RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 273 LKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
           L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 248

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 17/207 (8%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 84
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 85  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----YYVAPEVLK- 274
           +HRD+   N L  +      +K  DFGL   + P      ++         + APE LK 
Sbjct: 143 IHRDLAARNLLLATR---DLVKIGDFGLMRAL-PQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 275 RKSGPESDVWSIGVITYILLC-GRRPF 300
           R     SD W  GV  + +   G+ P+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPW 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 81
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 82  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 139
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFG +  +   +K     G      +    
Sbjct: 140 ---RRLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENV 159
           K+LG G FG  Y       G++V +     E  +   P A +++  E  ++ A   + +V
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM-ASVDNPHV 81
Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAECH 216
            +          V + M+L   G LLD +   KD   S+Y       + + M  +     
Sbjct: 82  CRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 137
Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAPEV 272
              LVHRD+   N L K+ +    +K TDFG +  +   +K     G      +     +
Sbjct: 138 -RRLVHRDLAARNVLVKTPQH---VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 273 LKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
           L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 82
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 83  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 199 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 256 GGLLDKPD 263

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+LG G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 80
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V +  +L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 81  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 138
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 139 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 17  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 73
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 74  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 190 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 246
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 247 GGLLDKPD 254

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 76  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 192 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 249 GGLLDKPD 256

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 74
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 75  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLK-R 275
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK R
Sbjct: 133 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 276 KSGPESDVWSIGVITYILLC-GRRPF 300
                SD W  GV  + +   G+ P+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 74
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 75  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLK-R 275
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK R
Sbjct: 133 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 276 KSGPESDVWSIGVITYILLC-GRRPF 300
                SD W  GV  + +   G+ P+
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPW 215

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 75
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 76  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 192 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 249 GGLLDKPD 256

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 13  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 69
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA-KKDSRYTEKDAAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 70  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 186 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 243 GGLLDKPD 250

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKI-EKNKMILPIAVEDVKREVKIL 150
           + T+ + LG G FG  Y    K         RVA+K + E   M   I   +   E  ++
Sbjct: 16  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI---EFLNEASVM 72
Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD-AAVVVRQML 209
           +    H +VV+            + MEL   G+L   + + + +       A   + +M+
Sbjct: 73  KEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 210 RVAAEC-------HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGK 256
           ++A E        + +  VHRD+   N +     ED ++K  DFG++      D+ + G 
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 257 KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV-- 312
           K    +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V  
Sbjct: 189 KG---LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 245
Query: 313 --LRNKPD 318
             L +KPD
Sbjct: 246 GGLLDKPD 253

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 104 LGHGQFGYTYVAT-DKANGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           LG G FG       D  +G    VAVK ++ + +  P A++D  REV  + +L  H N++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLI 78
Query: 161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGL 220
           + Y        + +  EL   G LLDR L K    +     +    Q+            
Sbjct: 79  RLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 136
Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAY-YVAPEVLK-R 275
           +HRD+   N L  +      +K  DFGL   +         Q+     + + APE LK R
Sbjct: 137 IHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 276 KSGPESDVWSIGVITYILLC-GRRPF 300
                SD W  GV  + +   G+ P+
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPW 219

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 102 KLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           K+L  G FG  Y       G++V    A+K++ +     P A +++  E  ++ A   + 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVM-ASVDNP 84
Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---SRYTEKDAAVVVRQMLRVAAE 214
           +V +          V + M+L   G LLD +   KD   S+Y       + + M  +   
Sbjct: 85  HVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 142
Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA----YYVAP 270
                LVHRD+   N L K+ +    +K TDFGL+  +   +K     G      +    
Sbjct: 143 ---RRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 271 EVLKRKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI 308
            +L R    +SDVWS GV  + L+  G +P+     DGI
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGI 230
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	487
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	0.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-179
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-179
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-178
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-166
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-165
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-165
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-157
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-157
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-155
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-155
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-154
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-153
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-151
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-150
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-149
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-147
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-147
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-145
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-144
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-141
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-140
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-140
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-139
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-138
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-138
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-137
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-136
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-136
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-133
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-132
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-128
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-123
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-106
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-105
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-86
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-85
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-84
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-84
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-83
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-82
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-82
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-82
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-79
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-78
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-78
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-77
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-77
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-77
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-77
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-77
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-76
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-76
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-76
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-75
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-75
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-74
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-73
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-72
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-72
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-71
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-71
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-71
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-70
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-70
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-68
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-66
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-61
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-61
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-59
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-56
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-55
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-54
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-53
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-50
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-49
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-48
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-48
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-47
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-46
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-46
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-46
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-46
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-45
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-45
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-44
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-44
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-44
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-44
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-43
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-43
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-41
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-41
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-41
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-40
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-40
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-40
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-39
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-39
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-39
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-39
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-39
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-39
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-39
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-39
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-38
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-38
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-38
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-38
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-38
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-38
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-38
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-38
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-38
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-37
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-37
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-37
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-37
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-37
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-36
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-36
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-36
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-36
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-35
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-34
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-34
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-34
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-34
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-32
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	3e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-31
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-30
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	8e-29
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-27
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-27
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-25
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-25
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-25
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-25
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-22
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	1e-21
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	6e-04
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-20
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	5e-20
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	9e-04
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-19
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	4e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-19
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	5e-19
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	5e-04
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-19
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-16
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	2e-14
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	9e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	1e-09
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	1e-06
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	1e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	4e-09
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	9e-09
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	2e-08
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	5e-08
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	2e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-08
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-07
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	1e-07
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	1e-07
3fwb_A	161	Cell division control protein 31; gene gating, com	3e-07
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	7e-07
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	1e-06
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	3e-06
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	3e-06
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	7e-04
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	4e-06
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	4e-06
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	7e-06
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	8e-06
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	1e-05
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	1e-05
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	1e-05
3li6_A	66	Calcium-binding protein; calcium signaling protein	1e-05
3li6_A	66	Calcium-binding protein; calcium signaling protein	2e-05
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	2e-05
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	2e-05
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	2e-05
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	3e-05
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	3e-05
2jnf_A	158	Troponin C; stretch activated muscle contraction,	3e-05
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	4e-05
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	4e-05
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	4e-05
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	4e-05
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	4e-05
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	6e-05
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	7e-05
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	8e-05
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	9e-05
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	9e-05
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	1e-04
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	1e-04
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	1e-04
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	8e-04
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	1e-04
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	2e-04
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	2e-04
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	2e-04
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	3e-04
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	3e-04
2hps_A	186	Coelenterazine-binding protein with bound coelent;	4e-04
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	4e-04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	4e-04
1y1x_A	191	Leishmania major homolog of programmed cell death	5e-04
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	6e-04
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	6e-04
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	7e-04
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	8e-04
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	9e-04

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  521 bits (1344), Expect = 0.0
 Identities = 134/390 (34%), Positives = 199/390 (51%), Gaps = 22/390 (5%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +   F  RY I  +LG G FG      D+      AVK I K         
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDT 65

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR----EGGDASEIPIDISVLNN 376
              W +IS+ AKD ++K+L   P  R+TA Q L HPW++    E    S++P   S + N
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTN 302

Query: 377 MRQFVKYSRLKQFALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP 435
           +RQF    +L Q AL  +AS L   +E   L + F  +D + +G +  +E+ +   + + 
Sbjct: 303 IRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMR 362

Query: 436 WK-------------LKESRVLEILQAVNT 452
            K               E ++  ++  ++ 
Sbjct: 363 LKGVDSNSLIQNEGSTIEDQIDSLMPLLDM 392

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  512 bits (1320), Expect = e-179
 Identities = 131/426 (30%), Positives = 207/426 (48%), Gaps = 38/426 (8%)

Query: 48  KHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
            H H H    +N        +     R++ G                   Y   + LG G
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEG--------------KIGESYFKVRKLGSG 47

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIA----------VEDVKREVKILQALAGHE 157
            +G   +  +K      A+K I+K++                 E++  E+ +L++L  H 
Sbjct: 48  AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHP 106

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
           N++K ++ FED  Y Y+  E  EGGEL ++I+ +   ++ E DAA +++Q+L      H 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK 164

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
           H +VHRD+KPEN L ++     ++K  DFGLS F     K +D +G+AYY+APEVLK+K 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY 224

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
             + DVWS GVI YILLCG  PF  + +  I K+V + K  F    W +IS+ AK+ +K 
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284

Query: 338 LLVKDPRARLTAAQALSHPWVREG---GDASEIPIDISVLNNMRQFVKYSRLKQFALRAL 394
           +L  D   R TA +AL+  W+++     + S+       L+NMR+F    +L Q A+  +
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFI 344

Query: 395 ASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAK-------DLPWKLKESRVLEI 446
            S L   EE  +L D F  +D + +G +  +E+ +               K  E  V  I
Sbjct: 345 GSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNI 404

Query: 447 LQAVNT 452
           L+ V+ 
Sbjct: 405 LKEVDF 410

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  510 bits (1314), Expect = e-179
 Identities = 133/375 (35%), Positives = 201/375 (53%), Gaps = 17/375 (4%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F  RY   ++LG G FG   +  DK  G   AVK I K ++      E + REV++L+
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N++K Y  FED  Y Y+  E+  GGEL D I+++K  R++E DAA ++RQ+L  
Sbjct: 82  QL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSG 138

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H + +VHRD+KPEN L +S  +D++++  DFGLS   +  KK +D +G+AYY+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 272 VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           VL      + DVWS GVI YILL G  PF    E  I K+V + K  F    W  +S SA
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR---EGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
           KD ++K+L   P  R++A  AL H W++   +   + ++P   + + N+RQF    +L Q
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQ 318

Query: 389 FALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW----------K 437
            AL  + S L   +E  +L   F  +D + +G +   E+ +   + +             
Sbjct: 319 AALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDAS 378

Query: 438 LKESRVLEILQAVNT 452
             E  V ++L AV+ 
Sbjct: 379 AVEHEVDQVLDAVDF 393

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  508 bits (1309), Expect = e-178
 Identities = 142/418 (33%), Positives = 211/418 (50%), Gaps = 30/418 (7%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGH 106
           H H H    R   Y Q   +         + G                   Y   K LG 
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKG--------------HLSEMYQRVKKLGS 47

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G +G   +  DK      A+K I K  +    +   +  EV +L+ L  H N++K Y+ F
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLL-DHPNIMKLYDFF 105

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           ED    Y+ ME  +GGEL D I+ +   ++ E DAAV+++Q+L      H H +VHRD+K
Sbjct: 106 EDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSI 286
           PEN L +S ++D+ +K  DFGLS   +  KK ++ +G+AYY+APEVL++K   + DVWSI
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSI 223

Query: 287 GVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
           GVI +ILL G  PF  +T+  I ++V + K  F    W ++S  AKD +K++L  D + R
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283

Query: 347 LTAAQALSHPWVREGGDASE----IPIDISVLNNMRQFVKYSRLKQFALRALASTL-DDE 401
           ++A QAL HPW++E     E    +P   + + NMR+F    +L Q AL  +AS L   E
Sbjct: 284 ISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQE 343

Query: 402 ELADLRDQFDAIDVDKNGSISLEEMRQALAK-------DLPWKLKESRVLEILQAVNT 452
           E  +L D F  ID + +G +  +E+    +K              ES V  IL A + 
Sbjct: 344 ETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADF 401

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  471 bits (1215), Expect = e-166
 Identities = 98/332 (29%), Positives = 171/332 (51%), Gaps = 8/332 (2%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVK 148
           D  F+  Y + +++G G F       ++  G + AVK ++  K      ++ ED+KRE  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS--RYTEKDAAVVVR 206
           I   L  H ++V+    +  D  +Y+  E  +G +L   I+ + D+   Y+E  A+  +R
Sbjct: 79  ICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSA 265
           Q+L     CH + ++HRD+KP   L  S +  + +K   FG++    + G      VG+ 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +++APEV+KR+  G   DVW  GVI +ILL G  PF+  T++ +F+ +++ K     + W
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQW 256

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYS 384
             IS SAKD V+++L+ DP  R+T  +AL+HPW++E    +        +  +R+F    
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316

Query: 385 RLKQFALRALASTLDDEELADLRDQFDAIDVD 416
           +LK   L A++S   +    D  ++      D
Sbjct: 317 KLKGAVLAAVSSHKFNSFYGDPPEELPDFSED 348

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  472 bits (1216), Expect = e-165
 Identities = 96/363 (26%), Positives = 179/363 (49%), Gaps = 11/363 (3%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F   Y + + LG G F           G   A   I   K+      + ++RE +I +
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICR 65

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N+V+ +++  ++ + Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L  
Sbjct: 66  LL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEA 122

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAP 270
              CH  G+VHR++KPEN L  S  + +++K  DFGL+  ++   + +    G+  Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           EVL++   G   D+W+ GVI YILL G  PFWD+ +  +++++     DF    W +++ 
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQF 389
            AKD + K+L  +P  R+TAA+AL HPW+      +        ++ +++F    +LK  
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302

Query: 390 ALRALAST--LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEIL 447
            L  + +T      +   ++     I+   NG    E   +     +    +   +  ++
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDF--ESYTKMCDPGMT-AFEPEALGNLV 359

Query: 448 QAV 450
           + +
Sbjct: 360 EGL 362

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  469 bits (1208), Expect = e-165
 Identities = 99/356 (27%), Positives = 178/356 (50%), Gaps = 10/356 (2%)

Query: 72  NSRRQTGVIPCGKRTDFGYDK--DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI 129
           +    TG    G+ ++F  +    F   Y + + LG G F        K  G   A K I
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
              K+      + ++RE +I + L  H N+V+ +++ +++++ Y+  +L  GGEL + I+
Sbjct: 63  NTKKLS-ARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
           A++   Y+E DA+  ++Q+L   A CH +G+VHR++KPEN L  S  + +++K  DFGL+
Sbjct: 121 ARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

Query: 250 DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
             +   + +    G+  Y++PEVLK+       D+W+ GVI YILL G  PFWD+ +  +
Sbjct: 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
           + ++     D+    W +++  AK  +  +L  +P+ R+TA QAL  PW+      +   
Sbjct: 239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298

Query: 369 IDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLE 424
                ++ +++F    +LK   L  + +T     L++L             S   E
Sbjct: 299 HRQDTVDCLKKFNARRKLKGAILTTMIAT---RNLSNLGRNLLNKKEQGPPSTIKE 351

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  447 bits (1151), Expect = e-157
 Identities = 111/280 (39%), Positives = 154/280 (55%), Gaps = 4/280 (1%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +   F  RY I  +LG G FG      D+      AVK I K         
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDT 65

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             + REV++L+ L  H N++K +   ED +  YI  EL  GGEL D I+ +K  R++E D
Sbjct: 66  STILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHD 122

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           AA +++Q+       H H +VHRD+KPEN L +S ++D  +K  DFGLS   +   K +D
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 261 IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
            +G+AYY+APEVL+     + DVWS GVI YILL G  PF+ K E  I K V   K  F 
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W +IS+ AKD ++K+L   P  R+TA Q L HPW+++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  447 bits (1152), Expect = e-157
 Identities = 83/319 (26%), Positives = 154/319 (48%), Gaps = 12/319 (3%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+   +Y I + LG G+FG  +   + ++      K ++            VK+E+ IL 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N++  + +FE    + +  E   G ++ +RI         E++    V Q+   
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H + H D++PEN ++++ +  S++K  +FG +  +KPG  F+ +  +  Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
           A DFV +LLVK+ ++R+TA++AL HPW+++  +     +   V+  ++    Y  L +  
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKD 289

Query: 391 LRALASTLDDEELADLRDQ 409
           L  + S         +R Q
Sbjct: 290 LNMVVSAARISCGGAIRSQ 308

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  442 bits (1140), Expect = e-155
 Identities = 92/283 (32%), Positives = 159/283 (56%), Gaps = 6/283 (2%)

Query: 81  PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
               R +  +    D  +   + LG G FG  ++  ++++G    +K I K++    + +
Sbjct: 7   HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPM 64

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTE 198
           E ++ E+++L++L  H N++K +  FED + +YI ME CEGGELL+RI++   +    +E
Sbjct: 65  EQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
              A +++QM+   A  H   +VH+D+KPEN LF+     S +K  DFGL++  K  +  
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 259 QDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            +  G+A Y+APEV KR    + D+WS GV+ Y LL G  PF   + + + ++    +P+
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
           +  +  P ++  A D +K++L KDP  R +AAQ L H W ++ 
Sbjct: 244 YAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  442 bits (1139), Expect = e-155
 Identities = 107/277 (38%), Positives = 163/277 (58%), Gaps = 6/277 (2%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D ++ YT+   +G G +G   +A  K    R A KKI K  +     V+  K+E++I+++
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKS 62

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H N+++ Y  FED+  +Y+ MELC GGEL +R++ K+   + E DAA +++ +L   
Sbjct: 63  L-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAV 119

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           A CH   + HRD+KPENFLF +   DS LK  DFGL+   KPGK  +  VG+ YYV+P+V
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179

Query: 273 LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           L+   GPE D WS GV+ Y+LLCG  PF   T+  +  ++      F  K W ++S  A+
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
             +++LL K P+ R+T+ QAL H W  +   +S   +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  441 bits (1136), Expect = e-154
 Identities = 116/355 (32%), Positives = 175/355 (49%), Gaps = 14/355 (3%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDK--DFDRRYTIGKLL 104
           H H H         + L  +      +    G                     + +   L
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61

Query: 105 GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN 164
           G G     Y    K      A+K ++K         + V+ E+ +L  L+ H N++K   
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKE 115

Query: 165 AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRD 224
            FE    + + +EL  GGEL DRI+ K    Y+E+DAA  V+Q+L   A  H +G+VHRD
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRD 173

Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDV 283
           +KPEN L+ +   D+ LK  DFGLS  ++     + + G+  Y APE+L+  + GPE D+
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 284 WSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
           WS+G+ITYILLCG  PF+D+  D  +F+ +L  +  F    W  +S +AKD V+KL+V D
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293

Query: 343 PRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAST 397
           P+ RLT  QAL HPWV   G A+      +    +++F    +LK      +AS+
Sbjct: 294 PKKRLTTFQALQHPWVT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASS 346

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  441 bits (1137), Expect = e-153
 Identities = 89/384 (23%), Positives = 160/384 (41%), Gaps = 18/384 (4%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRR 97
           N   ++            +                  +Q              +   D  
Sbjct: 4   NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
               ++LG G  G      +K   ++ A+K ++             +REV++    +   
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115

Query: 158 NVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++ +     
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL 273
             H   + HRD+KPEN L+ S + ++ LK TDFG +              + YYVAPEVL
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRKPWPSIS 328
             +      D+WS+GVI YILLCG  PF+         G+   +   + +F    W  +S
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
              K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S +    +  ++  +K+
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE-RWEDVKE 354

Query: 389 FALRALASTLDDEELADLRDQFDA 412
               ALA+   D E   ++   DA
Sbjct: 355 EMTSALATMRVDYEQIKIKKIEDA 378

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  435 bits (1121), Expect = e-151
 Identities = 99/365 (27%), Positives = 170/365 (46%), Gaps = 17/365 (4%)

Query: 6   STTKVSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKT 65
                SG ++  N       R         R    A   +      Q        ++L  
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 66  KQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVA 125
            Q + T +     + P  +  D+   K+F ++Y    ++G G          +A G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 126 VKKIEKNKMILPI-----AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCE 180
           VK +E     L         E  +RE  IL+ +AGH +++   +++E  +++++  +L  
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 181 GGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS 240
            GEL D +  K     +EK+   ++R +L   +  H + +VHRD+KPEN L     ++  
Sbjct: 184 KGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQ 238

Query: 241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYIL 293
           ++ +DFG S  ++PG+K +++ G+  Y+APE+LK          G E D+W+ GVI + L
Sbjct: 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298

Query: 294 LCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           L G  PFW + +  + + ++  +  F    W   S++ KD + +LL  DP ARLTA QAL
Sbjct: 299 LAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358

Query: 354 SHPWV 358
            HP+ 
Sbjct: 359 QHPFF 363

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  430 bits (1108), Expect = e-150
 Identities = 107/333 (32%), Positives = 171/333 (51%), Gaps = 18/333 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H NV+  +  +E+   V + +EL  GGEL D +  K+    TE++A   ++Q
Sbjct: 66  SILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQ 122

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I  G +F++I G+  
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE 182

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + 
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSR 385
           + S  AKDF+++LLVKDP+ R+T   +L HPW++              L+     V   +
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ-------QALSRKASAVNMEK 295

Query: 386 LKQFALRALASTLDDEELADLRDQFDAIDVDKN 418
            K+FA R  ++         L D F+A  ++ +
Sbjct: 296 FKKFAARKKSNNG---SGGGLNDIFEAQKIEWH 325

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  427 bits (1101), Expect = e-149
 Identities = 78/302 (25%), Positives = 145/302 (48%), Gaps = 4/302 (1%)

Query: 92  KDFDRRYTI-GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           ++F+  Y +  K LG G+F        K+ G   A K ++K +        ++  E+ +L
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVL 82

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           +       V+  +  +E+ + + + +E   GGE+    L +     +E D   +++Q+L 
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H + +VH D+KP+N L  S      +K  DFG+S  I    + ++I+G+  Y+AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 271 EVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
           E+L        +D+W+IG+I Y+LL    PF  +     +  + +   D+  + + S+S 
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI-PIDISVLNNMRQFVKYSRLKQ 388
            A DF++ LLVK+P  R TA   LSH W+++    +   P + S  +  +     S   +
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDK 322

Query: 389 FA 390
            +
Sbjct: 323 TS 324

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  421 bits (1086), Expect = e-147
 Identities = 90/284 (31%), Positives = 154/284 (54%), Gaps = 6/284 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
             F   Y + + LG G F        K  G   A K I   K+      + ++RE +I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICR 60

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H N+V+ +++ +++++ Y+  +L  GGEL + I+A++   Y+E DA+  ++Q+L  
Sbjct: 61  KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILES 117

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
            A CH +G+VHR++KPEN L  S  + +++K  DFGL+  +   + +    G+  Y++PE
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VLK+       D+W+ GVI YILL G  PFWD+ +  ++ ++     D+    W +++  
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGD-ASEIPIDISV 373
           AK  +  +L  +P+ R+TA QAL  PW+      AS I    +V
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  418 bits (1077), Expect = e-145
 Identities = 97/323 (30%), Positives = 154/323 (47%), Gaps = 23/323 (7%)

Query: 93  DFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
                Y + K +LG G  G       +  G + A+K +  +           ++EV    
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHW 76

Query: 152 ALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             +G  ++V   + +E+       + I ME  EGGEL  RI  + D  +TE++AA ++R 
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +       H H + HRD+KPEN L+ S ++D+ LK TDFG +         Q    + YY
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYY 195

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRK 322
           VAPEVL  +      D+WS+GVI YILLCG  PF+  T      G+ + +   +  F   
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQFV 381
            W  +S  AK  ++ LL  DP  RLT  Q ++HPW+ +     + P+  + VL   +   
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

Query: 382 KYSRLKQFALRALAS-TLDDEEL 403
               +K+    ALA+  +D +++
Sbjct: 316 D--EVKEEMTSALATMRVDYDQV 336

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  413 bits (1063), Expect = e-144
 Identities = 89/304 (29%), Positives = 145/304 (47%), Gaps = 23/304 (7%)

Query: 78  GVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP 137
             +P    T       F   Y   ++LG G          K      AVK I+       
Sbjct: 4   AALPGSHST-----HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58

Query: 138 IAV------EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK 191
            A       E   +EV IL+ ++GH N+++  + +E + + ++  +L + GEL D +  K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118

Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +EK+   ++R +L V    H   +VHRD+KPEN L     +D ++K TDFG S  
Sbjct: 119 V--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQ 173

Query: 252 IKPGKKFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCGRRPFWDKT 304
           + PG+K +++ G+  Y+APE+++          G E D+WS GVI Y LL G  PFW + 
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

Query: 305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA 364
           +  + + ++     F    W   S++ KD V + LV  P+ R TA +AL+HP+ ++    
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293

Query: 365 SEIP 368
               
Sbjct: 294 EVRH 297

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  418 bits (1075), Expect = e-141
 Identities = 102/406 (25%), Positives = 176/406 (43%), Gaps = 14/406 (3%)

Query: 42  RNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG 101
             D   + +    +      + K       ++           +            Y I 
Sbjct: 103 PGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIH 162

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           + LG G FG  +  T++A G+  A K +           E V++E++ +  L  H  +V 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR-HPTLVN 218

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
            ++AFEDDN + +  E   GGEL +++  + +   +E +A   +RQ+ +     H +  V
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYV 277

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           H D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV + K  G  
Sbjct: 278 HLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
           +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   KDF++KLL+
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

Query: 341 KDPRARLTAAQALSHPWVREG-GDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLD 399
            DP  R+T  QAL HPW+  G     +  I  S    +R  +K           L     
Sbjct: 397 ADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK--TKYDAWPEPLPPL-- 452

Query: 400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLE 445
              +++          + +   +  +  +A  + +  K   + V E
Sbjct: 453 -GRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIV-KPYGTEVGE 496

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  405 bits (1044), Expect = e-140
 Identities = 91/324 (28%), Positives = 152/324 (46%), Gaps = 30/324 (9%)

Query: 91  DKDFDRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           D  F + Y +    K LG G F        K +    AVK I K          + ++E+
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
             L+   GH N+VK +  F D  + ++ MEL  GGEL +RI  KK   ++E +A+ ++R+
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRK 114

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAY 266
           ++   +  H  G+VHRD+KPEN LF    ++  +K  DFG +    P  +  +    + +
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED-------GIFKEVLRNKPD 318
           Y APE+L +       D+WS+GVI Y +L G+ PF              I K++ +    
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI--------- 369
           F  + W ++S  AKD ++ LL  DP  RL  +    + W+++G   S  P+         
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSS 294

Query: 370 DISVLNNMR-QFVKYSRLKQFALR 392
             +V   ++  F  +++ K+    
Sbjct: 295 GAAVHTCVKATFHAFNKYKREGFC 318

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  405 bits (1044), Expect = e-140
 Identities = 106/354 (29%), Positives = 175/354 (49%), Gaps = 12/354 (3%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            +  +  Y IG+ LG GQF       +K+ G   A K I+K +       +  E+++REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H N++  ++ +E+   V + +EL  GGEL D +  K+    +E++A   ++Q
Sbjct: 67  SILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I+ G +F++I G+  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI--PIDISVLNNMRQFVKY 383
             S  AKDF++KLLVK+ R RLT  +AL HPW+        +     +  L N ++    
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVR 303

Query: 384 SRLKQ-FALRALASTLDDEELA-DLRDQFDAIDVDKNGSISLEEMRQALAKDLP 435
            R K  F++ +L + L    +        + +   ++ +      R+AL     
Sbjct: 304 RRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRR 357

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  400 bits (1031), Expect = e-139
 Identities = 96/283 (33%), Positives = 155/283 (54%), Gaps = 8/283 (2%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREVKI 149
             +  Y +G+ LG GQF        K  G   A K I+K ++      ++ E+++REV I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           L+ +  H N++  ++ FE+   V + +EL  GGEL D +  K+    TE +A   ++Q+L
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQIL 118

Query: 210 RVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                 H   + H D+KPEN +       +  +K  DFG++  I+ G +F++I G+  +V
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           APE++  +  G E+D+WSIGVITYILL G  PF  +T+      +     DF  + + + 
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
           S  AKDF+++LLVKDP+ R+T AQ+L H W++     +    D
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGED 281

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  399 bits (1028), Expect = e-138
 Identities = 78/314 (24%), Positives = 140/314 (44%), Gaps = 37/314 (11%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D      ++LG G  G      +K   ++ A+K ++             +REV++ 
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELH 64

Query: 151 QALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              +   ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +       H   + HRD+KPEN L+ S + ++ LK TDFG                   
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 166

Query: 267 YVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDK----TEDGIFKEVLRNKPDFRRK 322
             A E    K     D+WS+GVI YILLCG  PF+         G+   +   + +F   
Sbjct: 167 --AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
            W  +S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S +    +  +
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE-R 283

Query: 383 YSRLKQFALRALAS 396
           +  +K+    ALA+
Sbjct: 284 WEDVKEEMTSALAT 297

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  402 bits (1036), Expect = e-138
 Identities = 106/376 (28%), Positives = 167/376 (44%), Gaps = 12/376 (3%)

Query: 48  KHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIP-CGKRTDFGYDKDFDRRYTIGKLLGH 106
           +  H H       +            +    +      +            Y I + LG 
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61

Query: 107 GQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF 166
           G FG  +   +KA G     K I       P+    VK E+ I+  L  H  ++  ++AF
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAF 117

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
           ED   + + +E   GGEL DRI A+ D + +E +    +RQ        H H +VH D+K
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWS 285
           PEN + ++ K+ SS+K  DFGL+  + P +  +    +A + APE++ R+  G  +D+W+
Sbjct: 177 PENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 235

Query: 286 IGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRA 345
           IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+K LL K+PR 
Sbjct: 236 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 295

Query: 346 RLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQF----ALRALASTLDDE 401
           RLT   AL HPW++         I  S  N +RQ +K           A+  +A+     
Sbjct: 296 RLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 355

Query: 402 ELADLRDQFDAIDVDK 417
           +      Q      D+
Sbjct: 356 KHRPQEYQIYDSYFDR 371

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  397 bits (1023), Expect = e-137
 Identities = 102/314 (32%), Positives = 163/314 (51%), Gaps = 11/314 (3%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---LPIAVEDVKREV 147
            +  +  Y IG+ LG GQF       +K+ G   A K I+K +       ++ E+++REV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ +  H NV+  ++ +E+   V + +EL  GGEL D +  K+    +E++A   ++Q
Sbjct: 67  SILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDFIKPGKKFQDIVGSAY 266
           +L      H   + H D+KPEN +          +K  DFGL+  I+ G +F++I G+  
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           +VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      +     DF  + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI--PIDISVLNNMRQFVKY 383
             S  AKDF++KLLVK+ R RLT  +AL HPW+    +   +     +  L N R+    
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVR 303

Query: 384 SRLKQFALRALAST 397
            R K  +   ++  
Sbjct: 304 RRWKL-SFSIVSLC 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  397 bits (1023), Expect = e-136
 Identities = 102/376 (27%), Positives = 179/376 (47%), Gaps = 19/376 (5%)

Query: 20  NNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGV 79
           ++ +HH +      +  +    +N      +  H E  + +      +     S+R + +
Sbjct: 3   HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62

Query: 80  I--------PCGKRTDFGYDKDFDRRYTIGKL--LGHGQFGYTYVATDKANGDRVAVKKI 129
                    P   R         +  YT+ K   LG G+FG  +   + A G ++A K I
Sbjct: 63  AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122

Query: 130 EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRIL 189
           +   M      E+VK E+ ++  L  H N+++ Y+AFE  N + + ME  +GGEL DRI+
Sbjct: 123 KTRGMKD---KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178

Query: 190 AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS 249
            +     TE D  + ++Q+       H   ++H D+KPEN L  + ++   +K  DFGL+
Sbjct: 179 DE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLA 236

Query: 250 DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
              KP +K +   G+  ++APEV+        +D+WS+GVI Y+LL G  PF    +   
Sbjct: 237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
              +L  + D   + +  IS  AK+F+ KLL+K+   R++A++AL HPW+ +    S + 
Sbjct: 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356

Query: 369 IDI--SVLNNMRQFVK 382
                +  ++ + FV 
Sbjct: 357 AQKKKNRGSDAQDFVT 372

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  394 bits (1015), Expect = e-136
 Identities = 101/311 (32%), Positives = 147/311 (47%), Gaps = 37/311 (11%)

Query: 90  YDKDFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           +   F+  Y + + +LG G         +       AVK IEK           V REV+
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVE 62

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           +L    GH NV++    FE+++  Y+  E   GG +L  I  ++   + E +A+VVV+ +
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDV 120

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI------- 261
                  H  G+ HRD+KPEN L +   + S +K  DF L   IK       I       
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180

Query: 262 -VGSAYYVAPEVLKRKS------GPESDVWSIGVITYILLCGRRPFWDK----------- 303
             GSA Y+APEV++  S          D+WS+GVI YILL G  PF  +           
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240

Query: 304 ----TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                ++ +F+ +   K +F  K W  IS +AKD + KLLV+D + RL+AAQ L HPWV+
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

Query: 360 EGGDASEIPID 370
             G A E  + 
Sbjct: 301 --GCAPENTLP 309

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  388 bits (999), Expect = e-133
 Identities = 94/320 (29%), Positives = 154/320 (48%), Gaps = 21/320 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
              F   Y + + +G G +        KA     AVK I+K+K        D   E++IL
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEIL 69

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H N++   + ++D  YVY+  EL +GGELLD+IL +K   ++E++A+ V+  + +
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITK 127

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKED-SSLKATDFGLSDFIKP-GKKFQDIVGSAYYV 268
                H  G+VHRD+KP N L+     +  S++  DFG +  ++           +A +V
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFW---DKTEDGIFKEVLRNKPDFRRKPW 324
           APEVL+R+      D+WS+GV+ Y +L G  PF    D T + I   +   K       W
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ----- 379
            S+S++AKD V K+L  DP  RLTAA  L HPW+       +  ++     ++ +     
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307

Query: 380 -FVKYSRLKQFALRALASTL 398
            +   +R +   L  +  + 
Sbjct: 308 TYSALNRNQSPVLEPVGRST 327

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  385 bits (990), Expect = e-132
 Identities = 106/323 (32%), Positives = 162/323 (50%), Gaps = 20/323 (6%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-----VEDVK 144
           Y K     Y + K LG G  G   +A ++    +VA+K I K K  +  A       +V+
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 64  TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 119

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 265 AYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQ 379
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++        +     + + +
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE------DMKRKFQDLLSE 293

Query: 380 FVKYSRLKQFALRALASTLDDEE 402
             + + L Q   +   S     E
Sbjct: 294 ENESTALPQVLAQPSTSRKRPRE 316

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  374 bits (961), Expect = e-128
 Identities = 97/347 (27%), Positives = 148/347 (42%), Gaps = 56/347 (16%)

Query: 68  HQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVK 127
           H   +S R+      G         +  ++Y +   +G G +G   VA +       A+K
Sbjct: 4   HHHHSSGRENLYFQGGSL------LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 128 KIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELL 185
            + KNK+    P  VE +K EV++++ L  H N+ + Y  +ED+ Y+ + MELC GG LL
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLL 116

Query: 186 DRILAKK--------------------------------------DSRYTEKDAAVVVRQ 207
           D++                                          D    EK  + ++RQ
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIV 262
           +       H  G+ HRD+KPENFLF +  +   +K  DFGLS                  
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 263 GSAYYVAPEVLK---RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           G+ Y+VAPEVL       GP+ D WS GV+ ++LL G  PF    +     +VL  K  F
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
               +  +S  A+D +  LL ++   R  A +AL HPW+ +  D   
Sbjct: 296 ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  364 bits (937), Expect = e-123
 Identities = 100/288 (34%), Positives = 151/288 (52%), Gaps = 14/288 (4%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVK 144
           Y K     Y + K LG G  G   +A ++    +VA++ I K K  +          +V+
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E++IL+ L  H  ++K  N F+ ++Y YI +EL EGGEL D+++  K  R  E    + 
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK--RLKEATCKLY 244

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
             QML      H +G++HRD+KPEN L  S +ED  +K TDFG S  +      + + G+
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 265 AYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDF 319
             Y+APEVL            D WS+GVI +I L G  PF + +T+  +  ++   K +F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
             + W  +S  A D VKKLLV DP+AR T  +AL HPW+++     + 
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  320 bits (823), Expect = e-106
 Identities = 76/356 (21%), Positives = 139/356 (39%), Gaps = 27/356 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +    +LGHG  G T V     +   VAVK+I               REV++L+    H
Sbjct: 25  SFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            NV++++   +D  + YIA+ELC    L + +  +KD  +   +   +++Q     A  H
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK----KFQDIVGSAYYVAP 270
              +VHRD+KP N L         +KA  +DFGL   +  G+    +   + G+  ++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 271 EVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           E+L            D++S G + Y ++      + K+       +L         P   
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRL 386
               A++ ++K++  DP+ R +A   L HP+        +   D+S        ++   L
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVS------DRIEKESL 309

Query: 387 KQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESR 442
               ++ L          D R+                  +    +DL   ++  +
Sbjct: 310 DGPIVKQLERGGRAVVKMDWRENITVPLQTDLR--KFRTYKGGSVRDLLRAMRNKK 363

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  320 bits (822), Expect = e-105
 Identities = 80/314 (25%), Positives = 140/314 (44%), Gaps = 40/314 (12%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +++         K+LG+G  G T V      G  VAVK++  +        +    E+K+
Sbjct: 9   FEQSLKNLVVSEKILGYGSSG-TVVFQGSFQGRPVAVKRMLIDFC------DIALMEIKL 61

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS-----RYTEKDAAVV 204
           L     H NV+++Y +   D ++YIA+ELC    L D + +K  S        E +   +
Sbjct: 62  LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAK----------EDSSLKATDFGLSDFIKP 254
           +RQ+    A  H   ++HRD+KP+N L  ++           E+  +  +DFGL   +  
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 255 GK-----KFQDIVGSAYYVAPEVL--------KRKSGPESDVWSIGVITYILLC-GRRPF 300
           G+        +  G++ + APE+L        KR+     D++S+G + Y +L  G+ PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 301 WDK--TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            DK   E  I + +  +  + +     S+   A D + +++  DP  R TA + L HP  
Sbjct: 241 GDKYSRESNIIRGIF-SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 359 REGGDASEIPIDIS 372
                  E  + +S
Sbjct: 300 WPKSKKLEFLLKVS 313

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  266 bits (682), Expect = 8e-86
 Identities = 91/309 (29%), Positives = 150/309 (48%), Gaps = 14/309 (4%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDR 123
           K                P  +  +   D    RRY  G+ LG G F   +  +D    + 
Sbjct: 9   KAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEV 68

Query: 124 VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGE 183
            A K + K+ ++ P   E +  E+ I ++LA H++VV F+  FED+++V++ +ELC    
Sbjct: 69  FAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRS 127

Query: 184 LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA 243
           LL+    +K    TE +A   +RQ++      H + ++HRD+K  N       ED  +K 
Sbjct: 128 LLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKI 182

Query: 244 TDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
            DFGL+  ++  G++ + + G+  Y+APEVL +K    E DVWSIG I Y LL G+ PF 
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

Query: 302 DKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                  +  + +N  ++     P  I+  A   ++K+L  DP AR T  + L+  +   
Sbjct: 243 TSCLKETYLRIKKN--EYS---IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

Query: 361 GGDASEIPI 369
           G   + +PI
Sbjct: 298 GYIPARLPI 306

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  264 bits (677), Expect = 1e-85
 Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 14/283 (4%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
            D    RRY  G+ LG G F   +  +D    +  A K + K+ ++ P   E +  E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
            ++LA H++VV F+  FED+++V++ +ELC    LL+    +K    TE +A   +RQ++
Sbjct: 69  HRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIV 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYV 268
                 H + ++HRD+K  N       ED  +K  DFGL+  ++  G++ + + G+  Y+
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS- 326
           APEVL +K    E DVWSIG I Y LL G+ PF        +  + +N  ++     P  
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYS---IPKH 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           I+  A   ++K+L  DP AR T  + L+  +   G   + +PI
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  261 bits (670), Expect = 2e-84
 Identities = 75/306 (24%), Positives = 129/306 (42%), Gaps = 30/306 (9%)

Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK 131
           +    +GV    +   F       R Y+I K +G G     +   ++      A+K +  
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL 62

Query: 132 NKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA 190
            +      ++  + E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  
Sbjct: 63  EEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-- 118

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           KK       +     + ML      H HG+VH D+KP NFL      D  LK  DFG+++
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 174

Query: 251 FIKPGKKFQD---IVGSAYYVAPEVLKRKS------------GPESDVWSIGVITYILLC 295
            ++P          VG+  Y+ PE +K  S             P+SDVWS+G I Y +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 296 GRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           G+ PF         +   +    P+   +         +D +K  L +DP+ R++  + L
Sbjct: 235 GKTPFQQIINQISKLHAII---DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

Query: 354 SHPWVR 359
           +HP+V+
Sbjct: 292 AHPYVQ 297

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  262 bits (670), Expect = 3e-84
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              +  + +  +LG G     +    K  GD  A+K       + P  V+   RE ++L+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62

Query: 152 ALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQM 208
            L  H+N+VK +   E+    +  + ME C  G L   +          E +  +V+R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +        +G+VHR++KP N +    +   S  K TDFG +  ++  ++F  + G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 268 VAPEVLKRKS---------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--- 315
           + P++ +R           G   D+WSIGV  Y    G  PF         KEV+     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 316 ------------------KPDFRRKPWPSISNSAKD----FVKKLLVKDPRARLTAAQAL 353
                                       S+S   +      +  +L  D        Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 354 SHPW 357
           +   
Sbjct: 302 AETS 305

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  257 bits (659), Expect = 3e-83
 Identities = 91/267 (34%), Positives = 140/267 (52%), Gaps = 11/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + +G LLG G F   Y A     G  VA+K I+K  M     V+ V+ EVKI   L  H
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-H 70

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            ++++ YN FED NYVY+ +E+C  GE+    L  +   ++E +A   + Q++      H
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRY-LKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPEVLKR 275
            HG++HRD+   N L         +K  DFGL+  +K P +K   + G+  Y++PE+  R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
            + G ESDVWS+G + Y LL GR PF   T      +V+    D+    +  +S  AKD 
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDL 242

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREG 361
           + +LL ++P  RL+ +  L HP++   
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRN 269

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  258 bits (660), Expect = 2e-82
 Identities = 77/339 (22%), Positives = 135/339 (39%), Gaps = 37/339 (10%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            R Y+I K +G G     +   ++      A+K +   +      ++  + E+  L  L 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQ 65

Query: 155 GH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
            H + +++ Y+    D Y+Y+ ME C   +L   +  KK       +     + ML    
Sbjct: 66  QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVH 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD---IVGSAYYVAP 270
             H HG+VH D+KP NFL      D  LK  DFG+++ ++P          VG+  Y+ P
Sbjct: 123 TIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 271 EVLKRKS------------GPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNK 316
           E +K  S             P+SDVWS+G I Y +  G+ PF         +   +    
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---D 235

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS---- 372
           P+   +         +D +K  L +DP+ R++  + L+HP+V+            +    
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295

Query: 373 --VLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQ 409
             VL  +      + + + A + L       E  +    
Sbjct: 296 KYVLGQLVGLNSPNSILK-AAKTLYEHYSGGESHNSSSS 333

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  254 bits (652), Expect = 8e-82
 Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 43/299 (14%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           +   +    +LG G FG    A +  +    A+KKI   +      +  +  EV +L +L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASL 59

Query: 154 AGHENVVKFYNAFEDDN-------------YVYIAMELCEGGELLDRILAKKDSRYTEKD 200
             H+ VV++Y A+ +                ++I ME CE G L D I    ++   ++D
Sbjct: 60  N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRD 116

Query: 201 -AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---------- 249
               + RQ+L   +  H  G++HRD+KP N       E  ++K  DFGL+          
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDIL 173

Query: 250 -----DFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWD 302
                +           +G+A YVA EVL        + D++S+G+I + ++        
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG 231

Query: 303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                I K++     +F      +     K  ++ L+  DP  R  A   L+  W+   
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  257 bits (659), Expect = 9e-82
 Identities = 85/407 (20%), Positives = 146/407 (35%), Gaps = 49/407 (12%)

Query: 25  HRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGK 84
           H + +            +     K + QH +          K     N            
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVK------ 54

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
                      R Y+I K +G G     +   ++      A+K +   +      ++  +
Sbjct: 55  ----------GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYR 102

Query: 145 REVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            E+  L  L  H + +++ Y+    D Y+Y+ ME C   +L   +  KK       +   
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL--KKKKSIDPWERKS 159

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--- 260
             + ML      H HG+VH D+KP NFL      D  LK  DFG+++ ++P         
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDS 215

Query: 261 IVGSAYYVAPEVLKRKS------------GPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
            VG+  Y+ PE +K  S             P+SDVWS+G I Y +  G+ PF       I
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-I 274

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            K      P+   +         +D +K  L +DP+ R++  + L+HP+V+         
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334

Query: 369 IDIS------VLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQ 409
              +      VL  +      + + + A + L       E  +    
Sbjct: 335 AKGTTEEMKYVLGQLVGLNSPNSILK-AAKTLYEHYSGGESHNSSSS 380

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  248 bits (635), Expect = 1e-79
 Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 12/266 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I   L  H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 68

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 126

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L         LK  DFG S    P  +  D+ G+  Y+ PE+++ +
Sbjct: 127 SKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGR 182

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
               + D+WS+GV+ Y  L G+ PF   T    +K + R +  F   P   ++  A+D +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLI 238

Query: 336 KKLLVKDPRARLTAAQALSHPWVREG 361
            +LL  +P  R    + L HPW+   
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITAN 264

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  249 bits (636), Expect = 1e-78
 Identities = 53/363 (14%), Positives = 95/363 (26%), Gaps = 46/363 (12%)

Query: 38  NHHARNDTTHKHQHQHQERAKNYQQLK-TKQHQKTNSRRQTGVIPCGKRTDFGYD-KDFD 95
           +H    D+  +   + +E    Y + +  K+           V P    T         +
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL-- 153
           R+  + + L  G     ++  D    +  A+K            +E +         L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 154 ---------------------AGHENVVKFYNAFEDDNY--VYIAMELCEG-----GELL 185
                                       +     +D       + M             L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
           D +   +          ++  Q++R+AA     GLVH    P+N        D  L   D
Sbjct: 182 DFVYVFR-GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITYILLCGRRPFWD 302
                  K G +         Y   E L   +       + W +G+  Y + C   PF  
Sbjct: 238 VSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 303 KTEDGIFKEVL-----RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
            T                           + +  K  + + L  D R RL   +A+  P 
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355

Query: 358 VRE 360
             +
Sbjct: 356 FLQ 358

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  248 bits (636), Expect = 3e-78
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              +  + +  +LG G     +    K  GD  A+K       + P  V+   RE ++L+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLK 62

Query: 152 ALAGHENVVKFYNAFEDDN--YVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQM 208
            L  H+N+VK +   E+    +  + ME C  G L   +          E +  +V+R +
Sbjct: 63  KLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +        +G+VHR++KP N +    +   S  K TDFG +  ++  ++F  + G+  Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181

Query: 268 VAPEVLKRKS---------GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP- 317
           + P++ +R           G   D+WSIGV  Y    G  PF         KEV+     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 318 --------------------DFRRKPWPSISNSAKD----FVKKLLVKDPRARLTAAQAL 353
                                       S+S   +      +  +L  D        Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 354 SHPW 357
           +   
Sbjct: 302 AETS 305

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  242 bits (621), Expect = 1e-77
 Identities = 88/267 (32%), Positives = 130/267 (48%), Gaps = 12/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G  LG G FG   +   +  G +VAVK + + K+     V  +KRE++ L+    H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-H 70

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y         ++ ME   GGEL D I      R  E +A  + +Q+L     CH
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L        + K  DFGLS+ +  G+  +   GS  Y APEV+  +
Sbjct: 129 RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE D+WS GVI Y LLCG  PF D+    +FK++      F    +  ++ S    
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATL 241

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREG 361
           +  +L  DP  R T      H W ++ 
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQD 268

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  242 bits (620), Expect = 3e-77
 Identities = 82/271 (30%), Positives = 131/271 (48%), Gaps = 16/271 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G +G   +A ++   + VAVK ++  +       E++K+E+ I + L  H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-H 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           ENVVKFY    + N  Y+ +E C GGEL DRI         E DA     Q++      H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---VGSAYYVAPEVL 273
             G+ HRD+KPEN L     E  +LK +DFGL+   +   + + +    G+  YVAPE+L
Sbjct: 123 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRRKPWPSISNS 330
           KR+       DVWS G++   +L G  P+   ++    + +           PW  I ++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSA 237

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
               + K+LV++P AR+T        W  + 
Sbjct: 238 PLALLHKILVENPSARITIPDIKKDRWYNKP 268

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  244 bits (626), Expect = 3e-77
 Identities = 95/345 (27%), Positives = 152/345 (44%), Gaps = 28/345 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY   K +G G FG   +  DK   + VAVK IE+   I     E+V+RE+   ++L  H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLR-H 75

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V+F        ++ I ME   GGEL +RI      R++E +A    +Q+L   + CH
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH 133

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              + HRD+K EN L         LK  DFG S       + +  VG+  Y+APEVL R+
Sbjct: 134 SMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--KPDFRRKPWPSISNSAK 332
              G  +DVWS GV  Y++L G  PF D  E   +++ ++      +       IS    
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS----------------VLNN 376
             + ++ V DP  R++  +  +H W  +   A  +    +                ++  
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312

Query: 377 MRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSI 421
           + +    +   +     +   LD ++  D  D    ID+D +G I
Sbjct: 313 ISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEI 357

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  242 bits (619), Expect = 4e-77
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 12/278 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K N   +A+K + K+++        ++RE++I   L  H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-H 73

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ YN F D   +Y+ +E    GEL   +  +K  R+ E+ +A  + ++      CH
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 131

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L         LK  DFG S    P  + + + G+  Y+ PE+++ K
Sbjct: 132 ERKVIHRDIKPENLLM---GYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGK 187

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
           +   + D+W  GV+ Y  L G  PF   +     + ++    D +  P+  +S+ +KD +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLI 243

Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 373
            KLL   P  RL     + HPWV+        P+  S 
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  243 bits (621), Expect = 9e-77
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 24/288 (8%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED-----VKR 145
           + ++ ++Y+    LG G FG+ + A DK     V VK I+K K++    +ED     V  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMEL-CEGGELLDRILAKKDSRYTEKDAAVV 204
           E+ IL  +  H N++K  + FE+  +  + ME    G +L   I      R  E  A+ +
Sbjct: 79  EIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYI 135

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGS 264
            RQ++       L  ++HRD+K EN +     ED ++K  DFG + +++ GK F    G+
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGT 192

Query: 265 AYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK 322
             Y APEVL      GPE ++WS+GV  Y L+    PF +       +E +         
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAA--IHPP 244

Query: 323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
               +S      V  LL   P  R T  + ++ PWV +  + ++   +
Sbjct: 245 YL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWE 290

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  241 bits (617), Expect = 3e-76
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 22/295 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + K +G G F    +A     G  VA+K I+K + + P +++ + REV+I++ L  H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-H 73

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK +   E +  +Y+ ME   GGE+ D ++A    R  EK+A    RQ++     CH
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH 131

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              +VHRD+K EN L      D ++K  DFG S+    G K     G+  Y APE+ + K
Sbjct: 132 QKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGK 188

Query: 277 S--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
              GPE DVWS+GVI Y L+ G  PF  +    + + VLR    +R   +  +S   ++ 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY--MSTDCENL 244

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIP---------IDISVLNNMRQF 380
           +K+ LV +P  R T  Q +   W+  G +  E+           D   ++ M   
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  240 bits (614), Expect = 4e-76
 Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 28/313 (8%)

Query: 65  TKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
           TK  Q   +   T   P G +      + F+  Y +G LLG G FG  +      +  +V
Sbjct: 4   TKPLQGPPAPPGTPTPPPGGKDR----EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59

Query: 125 AVKKIEKNKMILPIAVED---VKREVKILQAL---AGHENVVKFYNAFEDDNYVYIAMEL 178
           A+K I +N+++    + D      EV +L  +    GH  V++  + FE      + +E 
Sbjct: 60  AIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLER 119

Query: 179 -CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE 237
                +L D I  K      E  +     Q++     CH  G+VHRD+K EN L      
Sbjct: 120 PLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--R 175

Query: 238 DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLC 295
               K  DFG    +     + D  G+  Y  PE + R       + VWS+G++ Y ++C
Sbjct: 176 RGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

Query: 296 GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
           G  PF         +E+L    +        +S      +++ L   P +R +  + L  
Sbjct: 235 GDIPFERD------QEILEA--ELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLD 284

Query: 356 PWVREGGDASEIP 368
           PW++   +   + 
Sbjct: 285 PWMQTPAEDVPLN 297

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  240 bits (615), Expect = 5e-76
 Identities = 87/318 (27%), Positives = 140/318 (44%), Gaps = 14/318 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G +G   +A ++   + VAVK ++  +       E++K+E+ I + L  H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-H 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           ENVVKFY    + N  Y+ +E C GGEL DRI         E DA     Q++      H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI---VGSAYYVAPEVL 273
             G+ HRD+KPEN L     E  +LK +DFGL+   +   + + +    G+  YVAPE+L
Sbjct: 123 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 274 KRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           KR+       DVWS G++   +L G  P+ D+  D   +     +      PW  I ++ 
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFAL 391
              + K+LV++P AR+T        W  +          ++          +S+  Q  L
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298

Query: 392 RALASTLDDEELADLRDQ 409
                            +
Sbjct: 299 DFSPVNSASRTPGSGWSK 316

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  242 bits (620), Expect = 6e-75
 Identities = 94/300 (31%), Positives = 141/300 (47%), Gaps = 21/300 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G  LG G FG   V   +  G +VAVK + + K+     V  ++RE++ L+    H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-H 75

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y      + +++ ME   GGEL D I      R  EK++  + +Q+L     CH
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH 133

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L        + K  DFGLS+ +  G+  +   GS  Y APEV+  +
Sbjct: 134 RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 190

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE D+WS GVI Y LLCG  PF D     +FK++      F    +  ++ S    
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--FYTPQY--LNPSVISL 246

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGG---------DASEIPIDISVLNNMRQFVKYSR 385
           +K +L  DP  R T      H W ++             S   ID   L  + +  + S 
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSE 306

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  237 bits (608), Expect = 9e-75
 Identities = 91/299 (30%), Positives = 148/299 (49%), Gaps = 21/299 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG   +AT      +VA+K I +  +        V+RE+  L+ L  H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-H 68

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            +++K Y+       + + +E   GGEL D I+ KK  R TE +     +Q++     CH
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH 125

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VHRD+KPEN L     ++ ++K  DFGLS+ +  G   +   GS  Y APEV+  K
Sbjct: 126 RHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182

Query: 277 --SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
             +GPE DVWS G++ Y++L GR PF D+    +FK+V      +    +  +S  A+  
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQSL 238

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIP--------IDISVLNNMRQFVKYSR 385
           +++++V DP  R+T  +    PW          P         D  +++ + + + +S 
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  235 bits (602), Expect = 3e-74
 Identities = 72/330 (21%), Positives = 119/330 (36%), Gaps = 27/330 (8%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
            H+HH+            Q   +   +  + + + + + +  G  P         +  F 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRP------ESFFQ 56

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           + +     LGHG +G  +    K +G   AVK+        P        EV   + +  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQ 115

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H   V+   A+E+   +Y+  ELC G  L         +   E      +R  L   A  
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
           H  GLVH D+KP N            K  DFGL   +      +   G   Y+APE+L+ 
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230

Query: 276 KSGPESDVWSIGVITYILLCGRRPF-----WDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             G  +DV+S+G+    + C          W +   G                   +S+ 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF----------TAGLSSE 280

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +  +  +L  DP+ R TA   L+ P +R+
Sbjct: 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  242 bits (619), Expect = 6e-73
 Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 32/316 (10%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + + LG G FGY      +  G++VA+K+  +     P   E    E++I++ L  H
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-H 71

Query: 157 ENVVKFYNAFEDDNYV------YIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQML 209
            NVV      +    +       +AME CEGG+L   +          E     ++  + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H + ++HRD+KPEN + +   +    K  D G +  +  G+   + VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191

Query: 270 PEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           PE+L++K      D WS G + +  + G RPF    +   +   +R K +     +  ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

Query: 329 NS--------------------AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA-SEI 367
            +                     + +++ +L+   R R T  Q  +    +      S  
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311

Query: 368 PIDISVLNNMRQFVKY 383
            + +  + + R     
Sbjct: 312 LLSVMNMVSGRVHTYP 327

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  228 bits (584), Expect = 6e-72
 Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 23/278 (8%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
             Y +   +G G +G       K++G  +  K+++   M      + +  EV +L+ L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK- 63

Query: 156 HENVVKFYNAFED--DNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRV 211
           H N+V++Y+   D  +  +YI ME CEGG+L   I    K+     E+    V+ Q+   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 212 AAECH-----LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGS 264
             ECH      H ++HRD+KP N FL        ++K  DFGL+  +     F +  VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDG----KQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
            YY++PE + R S   +SD+WS+G + Y L     PF   ++  +  ++   K       
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----R 235

Query: 324 WPSI-SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            P   S+   + + ++L      R +  + L +P + E
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  229 bits (586), Expect = 9e-72
 Identities = 76/327 (23%), Positives = 136/327 (41%), Gaps = 31/327 (9%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQ 108
           H H H       +          ++ +                +  + +Y +G LLG G 
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKE---------KEPLESQYQVGPLLGSGG 55

Query: 109 FGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKILQALA-GHENVVKFYN 164
           FG  Y     ++   VA+K +EK+++     + +   V  EV +L+ ++ G   V++  +
Sbjct: 56  FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 165 AFEDDNYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
            FE  +   + +E  E   +L D I  +      E+ A     Q+L     CH  G++HR
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHR 173

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPES 281
           D+K EN L         LK  DFG    +K    + D  G+  Y  PE ++     G  +
Sbjct: 174 DIKDENILIDL--NRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSA 230

Query: 282 DVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK 341
            VWS+G++ Y ++CG  PF         +E++R +     +    +S+  +  ++  L  
Sbjct: 231 AVWSLGILLYDMVCGDIPFEHD------EEIIRGQ--VFFRQR--VSSECQHLIRWCLAL 280

Query: 342 DPRARLTAAQALSHPWVREGGDASEIP 368
            P  R T  +  +HPW+++     E  
Sbjct: 281 RPSDRPTFEEIQNHPWMQDVLLPQETA 307

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  230 bits (587), Expect = 1e-71
 Identities = 65/324 (20%), Positives = 122/324 (37%), Gaps = 47/324 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK--------------NKMILPIAVED 142
            Y I + L  G+F    +          A+KK EK              +K+ +    +D
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 143 VKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------DSRY 196
            K E++I+  +  +E  +       + + VYI  E  E   +L                 
Sbjct: 90  FKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 197 TEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
             +    +++ +L   +  H    + HRD+KP N L     ++  +K +DFG S+     
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE-YMVD 204

Query: 256 KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKE 311
           KK +   G+  ++ PE    +   +G + D+WS+G+  Y++     PF  K +   +F  
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 312 VLRNKPDF---------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP 356
           +     ++                      +SN   DF+K  L K+P  R+T+  AL H 
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324

Query: 357 WVREGGDASEIPIDISVLNNMRQF 380
           W+ +            +    ++ 
Sbjct: 325 WLADTNIEDLREFSKELYKKRKKL 348

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  229 bits (586), Expect = 2e-71
 Identities = 73/300 (24%), Positives = 141/300 (47%), Gaps = 14/300 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G FG   +     +G +  +K+I  ++M      E+ +REV +L  +  H
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK-H 82

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+V++  +FE++  +YI M+ CEGG+L  RI A+K   + E        Q+       H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 217 LHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEVLK 274
              ++HRD+K +N FL K    D +++  DFG++  +    +  +  +G+ YY++PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTK----DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAK 332
            K    +SD+W++G + Y L   +  F   +   +  +++         P     S   +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
             V +L  ++PR R +    L   ++ +  +    P  I+    ++ F K+      A R
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  230 bits (588), Expect = 2e-71
 Identities = 54/388 (13%), Positives = 115/388 (29%), Gaps = 69/388 (17%)

Query: 37  HNHHARNDTTHKHQH----------QHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRT 86
           H+HH  +   + +             ++    N +          +S   T +   G+  
Sbjct: 3   HHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPF 62

Query: 87  DFG-YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
                  +  R    G +LG         ATD+  G+   V      +     A++ +K 
Sbjct: 63  RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 122

Query: 146 EVKILQALA------------------------GHENVVKFYNAFEDDN--YVYIAMELC 179
           EV  L+ L                           + +++      D      +      
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182

Query: 180 EG--GELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA 235
           +       + +   +             +  Q++R+ A  H +GLVH  ++P + +    
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-- 240

Query: 236 KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS------------GPESDV 283
            +   +  T F                 S  +  PE+  R++                D 
Sbjct: 241 -QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDP 343
           W++G++ Y + C   P       G  + + R+  +        I    +  ++  L    
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPK 348

Query: 344 RARLTAAQALSHPWVREGGD--ASEIPI 369
             RL   QA+  P   +     ++ +P+
Sbjct: 349 EDRLLPLQAMETPEYEQLRTELSAALPL 376

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  224 bits (574), Expect = 2e-70
 Identities = 68/288 (23%), Positives = 117/288 (40%), Gaps = 38/288 (13%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           DK F   +   +L+G G FG  + A  + +G    +K+++ N        E  +REVK L
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58

Query: 151 QALAGHENVVKFYNAFED----------------DNYVYIAMELCEGGELLDRILAKKDS 194
             L  H N+V +   ++                    ++I ME C+ G L   I  ++  
Sbjct: 59  AKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 195 RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIK 253
           +  +  A  +  Q+ +     H   L++RD+KP N FL         +K  DFGL   +K
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD----TKQVKIGDFGLVTSLK 173

Query: 254 PGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
              K     G+  Y++PE +  +  G E D++++G+I   LL      ++      F ++
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL 231

Query: 313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                              K  ++KLL K P  R   ++ L    V +
Sbjct: 232 RDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  224 bits (573), Expect = 6e-70
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 22/297 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAG 155
           +Y +G LLG G +G      D     R AVK ++K K+  +P    +VK+E+++L+ L  
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64

Query: 156 HENVVKFYN--AFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H+NV++  +    E+   +Y+ ME C  G  E+LD +  K   R+    A     Q++  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDG 121

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYV 268
               H  G+VH+D+KP N L        +LK +  G++            +   GS  + 
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 269 APEVL---KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            PE+       SG + D+WS GV  Y +  G  PF       +F+ + +    +      
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD- 235

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
                  D +K +L  +P  R +  Q   H W R+    +E P+ I    + +   +
Sbjct: 236 -CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWR 291

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  220 bits (562), Expect = 2e-68
 Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 39/293 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--------------------- 135
           +YT+   +G G +G   +A ++ +    A+K + K K+I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 136 --LPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAK 191
                 +E V +E+ IL+ L  H NVVK     +D  ++++Y+  EL   G +++     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--- 129

Query: 192 KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
                +E  A    + +++     H   ++HRD+KP N L     ED  +K  DFG+S+ 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE 186

Query: 252 IKPGKKF-QDIVGSAYYVAPEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTED 306
            K       + VG+  ++APE L    K  SG   DVW++GV  Y  + G+ PF D+   
Sbjct: 187 FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +  ++     +F     P I+   KD + ++L K+P +R+   +   HPWV 
Sbjct: 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  214 bits (547), Expect = 6e-66
 Identities = 59/315 (18%), Positives = 111/315 (35%), Gaps = 33/315 (10%)

Query: 63  LKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGD 122
           + +  H   +S  +  +   G           ++ Y   + LG G F Y  +     +G 
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGHMVIID-----NKHYLFIQKLGEGGFSYVDLVEGLHDGH 55

Query: 123 RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----NYVYIAMEL 178
             A+K+I  ++       E+ +RE  + +    H N+++       +    +  ++ +  
Sbjct: 56  FYALKRILCHEQ---QDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPF 111

Query: 179 CEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
            + G L + I  L  K +  TE     ++  + R     H  G  HRD+KP N L     
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-- 169

Query: 237 EDSSLKATDFGLSDFIKPGKKFQD----------IVGSAYYVAPEVLKRKS----GPESD 282
            +      D G  +      +                +  Y APE+   +S       +D
Sbjct: 170 -EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228

Query: 283 VWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKD 342
           VWS+G + Y ++ G  P+    + G     L  +        P  S++    +  ++  D
Sbjct: 229 VWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALAVQNQLSIPQSPRHSSALWQLLNSMMTVD 287

Query: 343 PRARLTAAQALSHPW 357
           P  R      LS   
Sbjct: 288 PHQRPHIPLLLSQLE 302

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  208 bits (532), Expect = 7e-64
 Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 14/279 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + I K +G GQF   Y A    +G  VA+KK++   ++   A  D  +E+ +L+ L  H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-H 91

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAE 214
            NV+K+Y +F +DN + I +EL + G+L   I    K+     E+       Q+      
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 215 CHLHGLVHRDMKPEN-FLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYYVAPEV 272
            H   ++HRD+KP N F+         +K  D GL  F          +VG+ YY++PE 
Sbjct: 152 MHSRRVMHRDIKPANVFITA----TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSISN 329
           +       +SD+WS+G + Y +   + PF+    +   + K++ +   D+   P    S 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 265

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             +  V   +  DP  R                 AS + 
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  205 bits (523), Expect = 2e-61
 Identities = 58/380 (15%), Positives = 117/380 (30%), Gaps = 55/380 (14%)

Query: 23  NHHRNANKEEAKRRHNHHARN-DTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIP 81
           +HH +++  E          +       +  ++    N +          +S   T +  
Sbjct: 3   HHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWN 62

Query: 82  CGKRTDFG-YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
            G+         +  R    G +LG         ATD+  G+   V      +     A+
Sbjct: 63  TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI 122

Query: 141 EDVKREVKILQALAG---------------------HENVVKFYNAFEDDNYVYIAMEL- 178
           + +K EV  L+ L G                          K      D+  +++     
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182

Query: 179 ------CEGGELLDRILAKKDSRYTEKDAAV--VVRQMLRVAAECHLHGLVHRDMKPENF 230
                        + +L+   +  +    A   +  Q++R+ A  H +GLVH  ++P + 
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY----YVAPEVL------KRKSGPE 280
           +     +   +  T F     ++ G      +G  +      A  +L             
Sbjct: 243 VLD---QRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G+  Y + C   P  D    G  + + R+  +        I    +  ++  L 
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLR 349

Query: 341 KDPRARLTAAQALSHPWVRE 360
                RL   QA+  P   +
Sbjct: 350 YPKEDRLLPLQAMETPEYEQ 369

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  201 bits (512), Expect = 4e-61
 Identities = 62/288 (21%), Positives = 122/288 (42%), Gaps = 32/288 (11%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            +   +   + +G G+FG  +    + +G   A+K+ +K      +  ++  REV     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAV 66

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLR 210
           L  H +VV++++A+ +D+++ I  E C GG L D I    +  S + E +   ++ Q+ R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 211 VAAECHLHGLVHRDMKPEN-FLFKS---------------AKEDSSLKATDFGLSDFIKP 254
                H   LVH D+KP N F+ ++               A      K  D G    I  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 255 GKKFQDIVGSAYYVAPEVLKRKSG--PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV 312
            +      G + ++A EVL+      P++D++++  +T +   G  P     +   + E+
Sbjct: 187 PQVE---EGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGDQ--WHEI 240

Query: 313 LRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            + +        P  +S    + +K ++  DP  R +A   + H  + 
Sbjct: 241 RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  198 bits (506), Expect = 4e-60
 Identities = 72/301 (23%), Positives = 119/301 (39%), Gaps = 40/301 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +   + LG G FG  + A +K +    A+K+I        +A E V REVK L  L  H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE-H 62

Query: 157 ENVVKFYNAFEDDN------------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAV- 203
             +V+++NA+ + N            Y+YI M+LC    L D +  +      E+   + 
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------------D 250
           +  Q+       H  GL+HRD+KP N  F     D  +K  DFGL               
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 251 FIKPGKKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE-DGI 308
            +    +    VG+  Y++PE +   S   + D++S+G+I + LL    PF  + E    
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236

Query: 309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
             +V   K       +          V+ +L   P  R  A   + +    +     +  
Sbjct: 237 LTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 369 I 369
           +
Sbjct: 294 L 294

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  197 bits (502), Expect = 3e-59
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 39/290 (13%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           + R  + ++L  G F + Y A D  +G   A+K++  N+         + +EV  ++ L+
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLS 83

Query: 155 GHENVVKFYNAF--------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           GH N+V+F +A                +  ELC+G  +      +     +      +  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 207 QMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI--- 261
           Q  R     H     ++HRD+K EN L  +     ++K  DFG +  I     +      
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 262 ----------VGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDG 307
                       +  Y  PE++   S    G + D+W++G I Y+L   + PF    EDG
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDG 256

Query: 308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
               ++  K  +   P  +        ++ +L  +P  RL+ A+ +    
Sbjct: 257 AKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  189 bits (483), Expect = 2e-56
 Identities = 76/322 (23%), Positives = 122/322 (37%), Gaps = 31/322 (9%)

Query: 51  HQHQERAKNYQQLKTKQHQ---KTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHG 107
           H     AK +     K  +   +T       +    K  D+ Y ++     T    +G G
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV-HWMTHQPRVGRG 69

Query: 108 QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK-REVKILQALAGHENVVKFYNAF 166
            FG  +   DK  G + AVKK+          +E  +  E+     L+    +V  Y A 
Sbjct: 70  SFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLS-SPRIVPLYGAV 119

Query: 167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMK 226
            +  +V I MEL EGG L    L K+     E  A   + Q L      H   ++H D+K
Sbjct: 120 REGPWVNIFMELLEGGSLGQ--LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177

Query: 227 PENFLFKSAKEDSSLKATDFGLSDFIKPGK------KFQDIVGSAYYVAPEVLKRKS-GP 279
            +N L   + + S     DFG +  ++P            I G+  ++APEV+  K    
Sbjct: 178 ADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 280 ESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           + D+WS      + +L G  P+          K +    P  R  P PS +      +++
Sbjct: 236 KVDIWSSC-CMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIP-PSCAPLTAQAIQE 292

Query: 338 LLVKDPRARLTAAQALSHPWVR 359
            L K+P  R +A +        
Sbjct: 293 GLRKEPVHRASAMELRRKVGKA 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  186 bits (474), Expect = 7e-55
 Identities = 56/285 (19%), Positives = 96/285 (33%), Gaps = 32/285 (11%)

Query: 95  DRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
            +   +  LLG G F   Y AT     D  N  +  +K  +      P       + ++ 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS---RYTEKDAAVVVR 206
           L+        +KFY+A    N   +  EL   G LL+ I   K++      +        
Sbjct: 121 LKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKS--------AKEDSSLKATDFGLSDFIK---PG 255
           +ML +  + H   ++H D+KP+NF+  +            + L   D G S  +K    G
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 256 KKFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR 314
             F     ++ +   E+L  K    + D + +    Y +L G        E G  K    
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN-EGGECKPEGL 298

Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
            +       W        +F   +L       L +   L     +
Sbjct: 299 FRRLPHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  183 bits (467), Expect = 2e-54
 Identities = 73/280 (26%), Positives = 128/280 (45%), Gaps = 22/280 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
                 +LG G +G  Y   D +N  R+A+K+I +         + +  E+ + + L  H
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-H 78

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--YTEKDAAVVVRQMLRVAAE 214
           +N+V++  +F ++ ++ I ME   GG L   +L  K       E+      +Q+L     
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL 273
            H + +VHRD+K +N L  +      LK +DFG S  +       +   G+  Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195

Query: 274 KRKS---GPESDVWSIGVITYI-LLCGRRPFWDKTEDG--IFK-EVLRNKPDFRRKPWPS 326
            +     G  +D+WS+G  T I +  G+ PF++  E    +FK  + +  P+    P  S
Sbjct: 196 DKGPRGYGKAADIWSLG-CTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI---P-ES 250

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
           +S  AK F+ K    DP  R  A   L   +++      +
Sbjct: 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  181 bits (462), Expect = 1e-53
 Identities = 90/280 (32%), Positives = 135/280 (48%), Gaps = 32/280 (11%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +DF      GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++ 
Sbjct: 30  EDFK----FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L  H   VK Y  F+DD  +Y  +   + GELL  I  +K   + E        ++  V
Sbjct: 86  RL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEI--V 140

Query: 212 AAECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS---DFIKPGKKFQDIVGS 264
           +A  +LH  G++HRD+KPEN L      +    ++ TDFG +          +    VG+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILL-----NEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           A YV+PE+L  KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF   P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P 252

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQA------LSHPW 357
                  A+D V+KLLV D   RL   +        +HP+
Sbjct: 253 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  174 bits (444), Expect = 7e-51
 Identities = 78/306 (25%), Positives = 144/306 (47%), Gaps = 32/306 (10%)

Query: 84  KRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDV 143
              D    +D    + + +L+G+G +G  Y       G   A+K ++    +     E++
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEI 67

Query: 144 KREVKILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
           K+E+ +L+  + H N+  +Y AF        D+ +++ ME C  G + D I   K +   
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127

Query: 198 EKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK- 256
           E+  A + R++LR  +  H H ++HRD+K +N L     E++ +K  DFG+S  +     
Sbjct: 128 EEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVG 184

Query: 257 KFQDIVGSAYYVAPEVLKRKSGPES------DVWSIGVITYI-LLCGRRPFWD----KTE 305
           +    +G+ Y++APEV+     P++      D+WS+G IT I +  G  P  D    +  
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRA- 242

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
             +F       P  + K W   S   + F++  LVK+   R    Q + HP++R+  +  
Sbjct: 243 --LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

Query: 366 EIPIDI 371
           ++ I +
Sbjct: 298 QVRIQL 303

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  172 bits (437), Expect = 4e-50
 Identities = 58/280 (20%), Positives = 111/280 (39%), Gaps = 21/280 (7%)

Query: 91  DKDFDRRYT-IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
               D R+      +G G F   Y   D      VA  +++  K +     +  K E ++
Sbjct: 20  GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEM 78

Query: 150 LQALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           L+ L  H N+V+FY+++E        + +  EL   G L      K+      K      
Sbjct: 79  LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWC 135

Query: 206 RQMLRVAAECHLHG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           RQ+L+      LH     ++HRD+K +N          S+K  D GL+  +K     + +
Sbjct: 136 RQILK--GLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT-LKRASFAKAV 190

Query: 262 VGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFR 320
           +G+  ++APE+ + K     DV++ G+    +     P+ +      I++ V        
Sbjct: 191 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P 248

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                      K+ ++  + ++   R +    L+H + +E
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  171 bits (436), Expect = 1e-49
 Identities = 83/320 (25%), Positives = 143/320 (44%), Gaps = 18/320 (5%)

Query: 52  QHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGY 111
            H     +   L T+     +            R       D          +G G  G 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVD-QGDPRLLLDSYVKIGEGSTGI 60

Query: 112 TYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY 171
             +A +K +G +VAVK ++  K       E +  EV I++    H NVV+ Y ++     
Sbjct: 61  VCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEE 116

Query: 172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFL 231
           +++ ME  +GG L D +      R  E+  A V   +L+  A  H  G++HRD+K ++ L
Sbjct: 117 LWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSIL 173

Query: 232 FKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS-GPESDVWSIGVI 289
                 D  +K +DFG    I     K + +VG+ Y++APEV+ R     E D+WS+G I
Sbjct: 174 L---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG-I 229

Query: 290 TYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
             I ++ G  P++  +    + +      P  +      +S   +DF++++LV+DP+ R 
Sbjct: 230 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS--HKVSPVLRDFLERMLVRDPQERA 287

Query: 348 TAAQALSHPWVREGGDASEI 367
           TA + L HP++ + G    +
Sbjct: 288 TAQELLDHPFLLQTGLPECL 307

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  169 bits (429), Expect = 2e-48
 Identities = 84/330 (25%), Positives = 142/330 (43%), Gaps = 20/330 (6%)

Query: 45  TTHKHQHQHQERAKNYQQLKTKQHQKTN-SRRQTGVIPCGKRTDFGYDKDFDRRYTIGKL 103
           + + H H H       + L  +       +  + G +      +  +  D ++ ++  + 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ LQ L  H N +++ 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYR 120

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR 223
             +  ++  ++ ME C G    D +L        E + A V    L+  A  H H ++HR
Sbjct: 121 GCYLREHTAWLVMEYCLGS-ASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178

Query: 224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS----GP 279
           D+K  N L     E   +K  DFG +  + P   F   VG+ Y++APEV+          
Sbjct: 179 DVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDG 232

Query: 280 ESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           + DVWS+G IT I L   + P ++      ++       P  +   W   S   ++FV  
Sbjct: 233 KVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDS 288

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEI 367
            L K P+ R T+   L H +V      + I
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  167 bits (425), Expect = 2e-48
 Identities = 75/281 (26%), Positives = 139/281 (49%), Gaps = 17/281 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             D  ++YT  + +G G  G  Y A D A G  VA++++   +       E +  E+ ++
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVM 71

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           +    + N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L+
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQ 127

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H + ++HRD+K +N L      D S+K TDFG    I P + K   +VG+ Y++A
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFRRKPWPS 326
           PEV+ RK+ GP+ D+WS+G I  I ++ G  P+ ++     ++       P+ +      
Sbjct: 185 PEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EK 241

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           +S   +DF+ + L  D   R +A + L H +++     S +
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  167 bits (426), Expect = 2e-48
 Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 28/290 (9%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D D +  + I   LG G FG  Y A +K  G   A K IE         +ED   E++IL
Sbjct: 14  DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEIL 70

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                H  +VK   A+  D  ++I +E C GG +   I+ + D   TE    VV RQML 
Sbjct: 71  ATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLE 128

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H   ++HRD+K  N L      +  ++  DFG+S        K    +G+ Y++A
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185

Query: 270 PEVLKRKSGPES------DVWSIGVITYI-LLCGRRPFWD----KTEDGIFKEVLRNKPD 318
           PEV+  ++  ++      D+WS+G IT I +     P  +    +    + K    + P 
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMRV---LLKIAKSDPPT 241

Query: 319 FRRKP-WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
                 W   S   +DF+K  L K+P  R +AAQ L HP+V        +
Sbjct: 242 LLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  165 bits (419), Expect = 3e-47
 Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 19/282 (6%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
            K  +  + + + LG G +G  Y A  K  G  VA+K++          ++++ +E+ I+
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIM 78

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           Q      +VVK+Y ++  +  ++I ME C  G + D I+  ++   TE + A +++  L+
Sbjct: 79  QQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLK 136

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVA 269
                H    +HRD+K  N L      +   K  DFG++  +     K   ++G+ +++A
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTE-DGIFKEVLRNKPDFR-RKPWP 325
           PEV++       +D+WS+G IT I +  G+ P+ D      IF       P FR  + W 
Sbjct: 194 PEVIQEIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW- 251

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
             S++  DFVK+ LVK P  R TA Q L HP+VR     S +
Sbjct: 252 --SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL 291

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  166 bits (421), Expect = 1e-46
 Identities = 80/317 (25%), Positives = 138/317 (43%), Gaps = 33/317 (10%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
              +L   ++     +    ++   K      D DF+      K++G G F    V   K
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRD-DFEIL----KVIGRGAFSEVAVVKMK 83

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
             G   A+K + K  M+    V   + E  +L        + + + AF+D+NY+Y+ ME 
Sbjct: 84  QTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-VNGDRRWITQLHFAFQDENYLYLVMEY 142

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+LL  +L+K   R   + A   + ++  V A   +H  G VHRD+KP+N L     
Sbjct: 143 YVGGDLL-TLLSKFGERIPAEMARFYLAEI--VMAIDSVHRLGYVHRDIKPDNILL---- 195

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKRKS--------GPESDVW 284
            D    ++  DFG    ++     +    VG+  Y++PE+L+           GPE D W
Sbjct: 196 -DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254

Query: 285 SIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKDP 343
           ++GV  Y +  G+ PF+  +    + +++  K           +   A+DF+++LL   P
Sbjct: 255 ALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPP 313

Query: 344 RARLTAAQAL---SHPW 357
             RL    A    +HP+
Sbjct: 314 ETRLGRGGAGDFRTHPF 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  165 bits (420), Expect = 2e-46
 Identities = 84/313 (26%), Positives = 136/313 (43%), Gaps = 31/313 (9%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           ++  L+  ++      R    I   +      + D++    + K++G G FG   +   K
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAE-DYE----VVKVIGRGAFGEVQLVRHK 91

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
           +     A+K + K +MI          E  I+ A A    VV+ + AF+DD Y+Y+ ME 
Sbjct: 92  STRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLFYAFQDDRYLYMVMEY 150

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+L+  +++       EK A     ++  V A   +H  G +HRD+KP+N L     
Sbjct: 151 MPGGDLV-NLMSNY--DVPEKWARFYTAEV--VLALDAIHSMGFIHRDVKPDNMLL---- 201

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQD--IVGSAYYVAPEVLKRKS-----GPESDVWSIG 287
            D S  LK  DFG    +      +    VG+  Y++PEVLK +      G E D WS+G
Sbjct: 202 -DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260

Query: 288 VITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARL 347
           V  Y +L G  PF+  +  G + +++ +K          IS  AK+ +   L  D   RL
Sbjct: 261 VFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRL 319

Query: 348 TAAQAL---SHPW 357
                     H +
Sbjct: 320 GRNGVEEIKRHLF 332

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  163 bits (414), Expect = 2e-46
 Identities = 73/304 (24%), Positives = 129/304 (42%), Gaps = 57/304 (18%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              Y + + LG G++   + A +  N ++V VK ++      P+  + +KRE+KIL+ L 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLR 88

Query: 155 GHENVVKFYNAFEDD---NYVYIAMELCEGGEL--LDRILAKKDSRYTEKDAAVVVRQML 209
           G  N++   +  +D        +   +    +   L + L   D R+        + ++L
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIRF-------YMYEIL 140

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +    CH  G++HRD+KP N +         L+  D+GL++F  PG+++   V S Y+  
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPF-------------------------WD 302
           PE+L   +      D+WS+G +   ++  + PF                          D
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258

Query: 303 KTEDGIFKEVLRNKPDFRRKPW---------PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
           K    +            RK W           +S  A DF+ KLL  D ++RLTA +A+
Sbjct: 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

Query: 354 SHPW 357
            HP+
Sbjct: 319 EHPY 322

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  162 bits (411), Expect = 3e-46
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 16/280 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             D +  +T  + +G G FG  +   D      VA+K I+  +    I  ED+++E+ +L
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVL 74

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
                   V K+Y ++  D  ++I ME   GG  LD +   +     E   A ++R++L+
Sbjct: 75  SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILK 130

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-GKKFQDIVGSAYYVA 269
                H    +HRD+K  N L     E   +K  DFG++  +     K    VG+ +++A
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 270 PEVLKRKS-GPESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PEV+K+ +   ++D+WS+G IT I L  G  P  +     +   + +N P      +   
Sbjct: 188 PEVIKQSAYDSKADIWSLG-ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY--- 243

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI 367
           S   K+FV+  L K+P  R TA + L H ++      +  
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  159 bits (405), Expect = 2e-45
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 28/290 (9%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + +++G G       A      ++VA+K+I   K     +++++ +E++ +     H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-H 72

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLD------RILAKKDSRYTEKDAAVVVRQMLR 210
            N+V +Y +F   + +++ M+L  GG +LD           K     E   A ++R++L 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI------KPGKKFQDIVGS 264
                H +G +HRD+K  N L     ED S++  DFG+S F+         K  +  VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 265 AYYVAPEVLKRKSG--PESDVWSIGVITYI-LLCGRRPFWDKTEDGIFKEVLRNKP---- 317
             ++APEV+++  G   ++D+WS G IT I L  G  P+       +    L+N P    
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248

Query: 318 --DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
                ++       S +  +   L KDP  R TAA+ L H + ++  +  
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  160 bits (408), Expect = 6e-45
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 30/280 (10%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
            F+    IGK    G FG   +          A+K + K K +    V +V +E++I+Q 
Sbjct: 16  HFEILRAIGK----GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           L  H  +V  + +F+D+  +++ ++L  GG+L  R   +++  + E+   + + ++  V 
Sbjct: 72  LE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICEL--VM 126

Query: 213 AECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIVGSAYYV 268
           A  +L    ++HRDMKP+N L      D    +  TDF ++  +    +   + G+  Y+
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILL-----DEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 269 APEVLKRKSGP----ESDVWSIGVITYILLCGRRPFWDKTEDG---IFKEVLRNKPDFRR 321
           APE+   + G       D WS+GV  Y LL GRRP+  ++      I          +  
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP- 240

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQAL-SHPWVRE 360
               + S      +KKLL  +P  R +    + + P++ +
Sbjct: 241 ---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  161 bits (410), Expect = 8e-45
 Identities = 81/318 (25%), Positives = 141/318 (44%), Gaps = 37/318 (11%)

Query: 59  NYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
           N   L+ +++               K+     + DF+    I K++G G FG   V   K
Sbjct: 42  NNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE-DFE----ILKVIGRGAFGEVAVVKLK 96

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
                 A+K + K +M+        + E  +L      + +   + AF+DDN +Y+ M+ 
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLHYAFQDDNNLYLVMDY 155

Query: 179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAK 236
             GG+LL   L+K + R  E+ A   + +M  V A   +H    VHRD+KP+N L     
Sbjct: 156 YVGGDLLTL-LSKFEDRLPEEMARFYLAEM--VIAIDSVHQLHYVHRDIKPDNILM---- 208

Query: 237 EDSS--LKATDFGLSDFIKPGKKFQDI-----VGSAYYVAPEVLKRKS------GPESDV 283
            D +  ++  DFG         +   +     VG+  Y++PE+L+         GPE D 
Sbjct: 209 -DMNGHIRLADFGSC---LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

Query: 284 WSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS-ISNSAKDFVKKLLVKD 342
           WS+GV  Y +L G  PF+ ++    + +++ +K  F+     + +S +AKD +++L+   
Sbjct: 265 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSR 324

Query: 343 PRARLTAAQAL---SHPW 357
              RL          HP+
Sbjct: 325 EH-RLGQNGIEDFKKHPF 341

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  157 bits (399), Expect = 2e-44
 Identities = 78/306 (25%), Positives = 124/306 (40%), Gaps = 45/306 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI---EKNKMILPIAVEDVKREVKILQAL 153
           +Y     +G G +G  +   ++  G  VA+KK    E + +I  IA+    RE+++L+ L
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQL 59

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V     F     +++  E C+    +   L +      E     +  Q L+   
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHT--VLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH H  +HRD+KPEN L       S +K  DFG +     P   + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK-------------EVLRN 315
           L    + GP  DVW+IG + +  L    P W      D ++              +V   
Sbjct: 174 LVGDTQYGPPVDVWAIGCV-FAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

Query: 316 KPDFR-------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG 362
              F                 +P+IS  A   +K  L  DP  RLT  Q L HP+     
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

Query: 363 DASEIP 368
           +  ++ 
Sbjct: 293 EIEDLA 298

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  158 bits (401), Expect = 3e-44
 Identities = 81/327 (24%), Positives = 140/327 (42%), Gaps = 44/327 (13%)

Query: 43  NDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGK 102
           N    K   + +   +   + K    +K  +  Q                 FD      K
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----------DQFD----RIK 47

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+     +VK 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKL 106

Query: 163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GL 220
             +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q+  V    +LH   L
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQI--VLTFEYLHSLDL 162

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV----GSAYYVAPEVLKRK 276
           ++RD+KPEN L         ++ TDFG +      K+ +       G+   +APE++  K
Sbjct: 163 IYRDLKPENLLIDQ---QGYIQVTDFGFA------KRVKGRTWTLCGTPEALAPEIILSK 213

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W++GV+ Y +  G  PF+      I+++++  K  F   P    S+  KD +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLL 269

Query: 336 KKLLVKDPRARLTAAQA-----LSHPW 357
           + LL  D   R    +       +H W
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  157 bits (399), Expect = 3e-44
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 26/283 (9%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +G       K +G  +AVK+I     +     + +  ++ ++   +    +V+FY
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 164 NAFEDDNYVYIAMELCEGG--ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--- 218
            A   +   +I MEL      +    + +  D    E+    +    ++  A  HL    
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK--ALNHLKENL 145

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS 277
            ++HRD+KP N L   +     +K  DFG+S   +    K +D  G   Y+APE +   +
Sbjct: 146 KIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSA 201

Query: 278 GPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
             +     SDVWS+G IT   L  GR P+  W+   D + + V  + P          S 
Sbjct: 202 SRQGYDVRSDVWSLG-ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSP 260

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
           S  +FV   L KD   R    + L HP++       E  ++++
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILM---YEERAVEVA 300

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  156 bits (397), Expect = 4e-44
 Identities = 75/327 (22%), Positives = 139/327 (42%), Gaps = 45/327 (13%)

Query: 72  NSRRQTGVI-PCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI- 129
           +S +QTG +   G+R     + D +    +G++ G G  G  +    +  G  +AVK++ 
Sbjct: 5   SSGKQTGYLTIGGQRYQAEIN-DLEN---LGEM-GSGTCGQVWKMRFRKTGHVIAVKQMR 59

Query: 130 -EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI 188
              NK       + +  ++ ++        +V+ +  F  +  V+IAMEL       +++
Sbjct: 60  RSGNKEEN----KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKL 113

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATD 245
             +      E+    +   +++  A  +L    G++HRD+KP N L     +   +K  D
Sbjct: 114 KKRMQGPIPERILGKMTVAIVK--ALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCD 168

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPE------SDVWSIGVITYI-LLCGRR 298
           FG+S  +   K      G A Y+APE +      +      +DVWS+G I+ + L  G+ 
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG-ISLVELATGQF 227

Query: 299 PFWDKTEDGIFK---EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
           P+  K     F+   +VL+ +P          S   + FVK  L KD R R    + L H
Sbjct: 228 PY--KNCKTDFEVLTKVLQEEPP-LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284

Query: 356 PWVREGGDASEIPIDISVLNNMRQFVK 382
            +++       + +D      +  + K
Sbjct: 285 SFIKR---YETLEVD------VASWFK 302

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  159 bits (403), Expect = 6e-44
 Identities = 89/360 (24%), Positives = 147/360 (40%), Gaps = 57/360 (15%)

Query: 39  HHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY 98
                 T+     +  ++   +  +K  +  K  S+  T V   G+  D       +  Y
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSR-DKDGSKVTTVVATPGQGPDR----PQEVSY 56

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++I++ L  H N
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKL-DHCN 108

Query: 159 VVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR----QM 208
           +V+    F      +D+ Y+ + ++     E + R+  +  SR  +    + V+    Q+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVA-RHYSRAKQTLPVIYVKLYMYQL 165

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
            R  A  H  G+ HRD+KP+N L         LK  DFG +  +  G+     + S YY 
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL--------- 313
           APE++          DVWS G +   LL   +P +  D   D + +  +VL         
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282

Query: 314 --------RNKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                      P  +  PW     P     A     +LL   P ARLT  +A +H +  E
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  155 bits (395), Expect = 1e-43
 Identities = 82/335 (24%), Positives = 133/335 (39%), Gaps = 49/335 (14%)

Query: 72  NSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-- 129
           +    +GV    +   F   +    +Y    L+G G +G      +K  G  VA+KK   
Sbjct: 5   HHHHSSGVDLGTENLYFQSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 130 -EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI 188
            + +KM+  IA+    RE+K+L+ L  HEN+V      +     Y+  E  +    +   
Sbjct: 61  SDDDKMVKKIAM----REIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHT--ILDD 113

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL 248
           L    +    +     + Q++     CH H ++HRD+KPEN L         +K  DFG 
Sbjct: 114 LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGF 170

Query: 249 S-DFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW--DK 303
           +     PG+ + D V + +Y APE+L    K G   DVW+IG +    +    P +  D 
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL-VTEMFMGEPLFPGDS 229

Query: 304 TEDGIFK-------------EVLRNKPDFR-------------RKPWPSISNSAKDFVKK 337
             D ++              E+    P F               + +P +S    D  KK
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289

Query: 338 LLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS 372
            L  DP  R   A+ L H + +  G A     ++ 
Sbjct: 290 CLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  153 bits (390), Expect = 5e-43
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 38/282 (13%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           DF     I + LG G FG  ++   + NG   A+K ++K  ++    VE    E  +L  
Sbjct: 7   DFQ----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +  H  +++ +  F+D   +++ M+  EGGEL   +  +K  R+    A     ++    
Sbjct: 63  VT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEV--CL 117

Query: 213 AECHLH--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLSDFIKPGKKFQDIV----GS 264
           A  +LH   +++RD+KPEN L      D +  +K TDFG +      K   D+     G+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILL-----DKNGHIKITDFGFA------KYVPDVTYTLCGT 166

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             Y+APEV+  K      D WS G++ Y +L G  PF+D      ++++L  +  F   P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P 223

Query: 324 WPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE 360
            P  +   KD + +L+ +D   RL           +HPW +E
Sbjct: 224 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  152 bits (386), Expect = 9e-43
 Identities = 74/296 (25%), Positives = 115/296 (38%), Gaps = 42/296 (14%)

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           LG G +G         +G  +AVK+I    N        + +  ++ I          V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTVT 70

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILA---KKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           FY A   +  V+I MEL +    LD+       K     E     +   +++  A  HLH
Sbjct: 71  FYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK--ALEHLH 126

Query: 219 G---LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
               ++HRD+KP N L  +  +   +K  DFG+S   +    K  D  G   Y+APE + 
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVDDVAKDID-AGCKPYMAPERIN 182

Query: 275 RKSGPE-----SDVWSIGVITYI-LLCGRRPF--WDKTEDGIFKEVLRNKPDFRRKPWPS 326
            +   +     SD+WS+G IT I L   R P+  W      + + V    P      +  
Sbjct: 183 PELNQKGYSVKSDIWSLG-ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-- 239

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
            S    DF  + L K+ + R T  + + HP+            D      +  FVK
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTD------VASFVK 285

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  151 bits (384), Expect = 2e-42
 Identities = 68/296 (22%), Positives = 134/296 (45%), Gaps = 42/296 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  + A ++   + VA+K++  + +   +P  A+    RE+ +L+ L
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 58

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H+N+V+ ++    D  + +  E C+    L +     +     +     + Q+L+   
Sbjct: 59  K-HKNIVRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH   ++HRD+KP+N L      +  LK  +FGL+  F  P + +   V + +Y  P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFW--DKTEDGIFK--EVL-----------RN 315
           L   +      D+WS G I   L    RP +  +  +D + +   +L             
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 316 KPDFRRKP-----------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            PD++  P            P ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  149 bits (379), Expect = 1e-41
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 10/264 (3%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
            + RY I   LG G     Y+A D     +VA+K I          ++  +REV     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           + H+N+V   +  E+D+  Y+ ME  EG  L + I  +     +   A     Q+L    
Sbjct: 69  S-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIK 125

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD--IVGSAYYVAPE 271
             H   +VHRD+KP+N L      + +LK  DFG++  +      Q   ++G+  Y +PE
Sbjct: 126 HAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 272 -VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSISN 329
                 +   +D++SIG++ Y +L G  PF  +T   I  K +  + P+        I  
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242

Query: 330 SAKDFVKKLLVKDPRARLTAAQAL 353
           S  + + +   KD   R    Q +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEM 266

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  150 bits (380), Expect = 6e-41
 Identities = 83/338 (24%), Positives = 136/338 (40%), Gaps = 54/338 (15%)

Query: 64  KTKQHQKTNSRRQTGVIPCGKR-----TDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDK 118
            T  +   N  +   +    K      +D    +  +  YT  K++G+G FG  + A   
Sbjct: 3   FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF------EDDNYV 172
            +   VA+KK+ ++K           RE++I++ +  H NVV     F      +D+ ++
Sbjct: 63  ESD-EVAIKKVLQDK-------RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVV---VRQMLRVAAECHLHGLVHRDMKPEN 229
            + +E     E + R               ++   + Q+LR  A  H  G+ HRD+KP+N
Sbjct: 114 NLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIG 287
            L         LK  DFG +  +  G+     + S YY APE++          D+WS G
Sbjct: 172 LLLDP--PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG 229

Query: 288 VITYILLCGRRPFWDKTE----DGIFK-------EVLRNK---------PDFRRKPW--- 324
            +   L+ G+  F  ++       I K       E ++           P  R  P+   
Sbjct: 230 CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289

Query: 325 --PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             P     A D + +LL   P ARLTA +AL HP+  E
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  148 bits (375), Expect = 7e-41
 Identities = 76/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           RY     LG G +G  Y A D    + VA+K+I  E  +  +P  A+    REV +L+ L
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKEL 90

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
             H N+++  +    ++ +++  E  E    + +D+         + +     + Q++  
Sbjct: 91  Q-HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-----PDVSMRVIKSFLYQLING 144

Query: 212 AAECHLHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
              CH    +HRD+KP+N L     A E   LK  DFGL+  F  P ++F   + + +Y 
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK------------ 310
            PE+L   R      D+WSI  I   +L     F   +E      IF+            
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 311 -----EVLRNKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                +  ++ P FR K         + +   D +  +L  DP  R++A  AL HP+   
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  147 bits (374), Expect = 2e-40
 Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 14/263 (5%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H  +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            +  F+    ++  ME   GG+L+  I  +   ++    A     +++ +  +  H  G+
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEII-LGLQFLHSKGI 139

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           V+RD+K +N L      D  +K  DFG+  + +    K     G+  Y+APE+L  +   
Sbjct: 140 VYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
              D WS GV+ Y +L G+ PF  + E+ +F  +  + P + R     +   AKD + KL
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLLVKL 252

Query: 339 LVKDPRARLTAAQAL-SHPWVRE 360
            V++P  RL     +  HP  RE
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFRE 275

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  147 bits (372), Expect = 4e-40
 Identities = 84/316 (26%), Positives = 135/316 (42%), Gaps = 59/316 (18%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            + Y     +G G +G    A DK +G++VA+KK+ +   +++         K   RE+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-------FAKRAYRELL 75

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +L+ +  HENV+   + F       +    Y+ M   +    L +I+     +++E+   
Sbjct: 76  LLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMG---LKFSEEKIQ 129

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            +V QML+     H  G+VHRD+KP N       ED  LK  DFGL+            V
Sbjct: 130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLA---VNEDCELKILDFGLARHADAEMT--GYV 184

Query: 263 GSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--------WDK--------T 304
            + +Y APEV+          D+WS+G I   +L G+  F          +         
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244

Query: 305 EDGIF-------KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQAL 353
            + +        K  +++ P   RK +    P  S  A D ++K+L  D   RLTAAQAL
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304

Query: 354 SHPWVREGGDASEIPI 369
           +HP+     D  E   
Sbjct: 305 THPFFEPFRDPEEETE 320

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  144 bits (366), Expect = 6e-40
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 42/295 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  Y A +   G+  A+KKI  EK    +P   +    RE+ IL+ L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTI----REISILKEL 57

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+VK Y+       + +  E  +    L ++L   +       A   + Q+L   A
Sbjct: 58  K-HSNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH   ++HRD+KP+N L     E   LK  DFGL+  F  P +K+   + + +Y AP+V
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK---------------- 310
           L   +K     D+WS+G I   ++ G   F   +E      IF+                
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 311 -EVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            +   N   +   PW      +  S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  145 bits (367), Expect = 1e-39
 Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 41/295 (13%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALA 154
            Y     LG G +   Y    K   + VA+K+I  E  +     A+    REV +L+ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H N+V  ++    +  + +  E  +    L + L    +     +  + + Q+LR  A 
Sbjct: 59  -HANIVTLHDIIHTEKSLTLVFEYLDKD--LKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
           CH   ++HRD+KP+N L     E   LK  DFGL+     P K + + V + +Y  P++L
Sbjct: 116 CHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172

Query: 274 --KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNKP 317
                   + D+W +G I Y +  GR  F   T       IF+ +          + +  
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232

Query: 318 DFR------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           +F+                P + +   D + KLL  + R R++A  A+ HP+   
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (381), Expect = 2e-39
 Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 40/271 (14%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMIL-----PIAVEDVKREVK 148
             +Y +   + HG  G+ Y+A D+  NG  V +K        L       A      E +
Sbjct: 79  AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-------GLVHSGDAEAQAMAMAERQ 131

Query: 149 ILQALAGHENVVKFYNAFEDDNY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
            L  +  H ++V+ +N  E  +       YI ME   G  L          +    +A  
Sbjct: 132 FLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIA 186

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
            + ++L   +  H  GLV+ D+KPEN +      +  LK  D G          F  + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAV---SRINSFGYLYG 239

Query: 264 SAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           +  + APE+++      +D++++G     L            +G + + L         P
Sbjct: 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTR-----NGRYVDGLPEDD-----P 289

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                +S    +++ +  DPR R T A+ +S
Sbjct: 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  150 bits (380), Expect = 2e-39
 Identities = 76/335 (22%), Positives = 142/335 (42%), Gaps = 25/335 (7%)

Query: 35  RRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDF 94
              N     + +  ++   Q+  +      TK  ++  +   +     G R       DF
Sbjct: 285 EYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLT-DF 343

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           +       +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L    
Sbjct: 344 N----FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               + + ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++      
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEI--AIGL 455

Query: 215 CHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPE 271
             L   G+++RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           ++  +  G   D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKE 568

Query: 331 AKDFVKKLLVKDPRARLTAAQA-----LSHPWVRE 360
           A    K L+ K P  RL            H + R 
Sbjct: 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  147 bits (372), Expect = 2e-39
 Identities = 85/329 (25%), Positives = 149/329 (45%), Gaps = 30/329 (9%)

Query: 42  RNDTTHKHQ---HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY 98
           R + T   Q      +++A      ++      +   +  V     +     + +F+   
Sbjct: 96  REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-EFE--- 151

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
              KLLG G FG   +  +KA G   A+K ++K  ++    V     E ++LQ  + H  
Sbjct: 152 -YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF 209

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +     +F+  + +   ME   GGEL   +   ++  ++E  A     ++  V+A  +LH
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEI--VSALDYLH 265

Query: 219 ---GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK 274
               +V+RD+K EN +      D  +K TDFGL  + IK G   +   G+  Y+APEVL+
Sbjct: 266 SEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 275 RKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
               G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++   AK 
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKS 378

Query: 334 FVKKLLVKDPRARLTAAQA-----LSHPW 357
            +  LL KDP+ RL          + H +
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  145 bits (367), Expect = 2e-39
 Identities = 83/299 (27%), Positives = 131/299 (43%), Gaps = 45/299 (15%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPI-AVEDVKREVKI 149
           +RY     LG GQF   Y A DK     VA+KKI      + K  +   A+    RE+K+
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKL 65

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L+ H N++   +AF   + + +  +  E    L+ I+       T       +   L
Sbjct: 66  LQELS-HPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYV 268
           +     H H ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y 
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR 179

Query: 269 APEVL--KRKSGPESDVWSIGVITYILLCGRRPFWD-KTE----DGIFKEV--------- 312
           APE+L   R  G   D+W++G I   LL  R PF    ++      IF+ +         
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238

Query: 313 -LRNKPDFRR-KPW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            + + PD+   K +          +  +   D ++ L + +P AR+TA QAL   +   
Sbjct: 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  143 bits (364), Expect = 3e-39
 Identities = 89/326 (27%), Positives = 132/326 (40%), Gaps = 66/326 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK---REVKILQ 151
             RY   K LG G  G  + A D     RVA+KKI             VK   RE+KI++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ------SVKHALREIKIIR 63

Query: 152 ALAGHENVVKFYNAF--------------EDDNYVYIAMELCEGGELLDRILAKKDSRYT 197
            L  H+N+VK +                  + N VYI  E  E    L  +L +      
Sbjct: 64  RL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGP--LL 118

Query: 198 EKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG 255
           E+ A + + Q+LR     ++H   ++HRD+KP N    +  ED  LK  DFGL+  + P 
Sbjct: 119 EEHARLFMYQLLR--GLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174

Query: 256 KKFQDI----VGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPF--------W 301
              +      + + +Y +P +L          D+W+ G I   +L G+  F         
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234

Query: 302 DK--------TEDGI------FKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDP 343
                      E+            +RN      KP     P IS  A DF++++L   P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294

Query: 344 RARLTAAQALSHPWVREGGDASEIPI 369
             RLTA +ALSHP++       + PI
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  144 bits (366), Expect = 3e-39
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 19/268 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG   +A  K  GD  AVK ++K+ ++    VE    E +IL     H  + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            +  F+  + ++  ME   GG+L+  I  +K  R+ E  A     +++  A    H  G+
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEII-SALMFLHDKGI 145

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N L      +   K  DFG+  + I  G       G+  Y+APE+L+    G
Sbjct: 146 IYRDLKLDNVLLDH---EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202

Query: 279 PESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL 338
           P  D W++GV+ Y +LCG  PF  + ED +F+ +L ++  +       +   A   +K  
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGILKSF 258

Query: 339 LVKDPRARL-----TAAQAL-SHPWVRE 360
           + K+P  RL         A+  HP+ +E
Sbjct: 259 MTKNPTMRLGSLTQGGEHAILRHPFFKE 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  145 bits (367), Expect = 4e-39
 Identities = 66/328 (20%), Positives = 120/328 (36%), Gaps = 74/328 (22%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREV 147
             ++    IGK  G        +A  K  G+ V V++I      N+M+       ++ E+
Sbjct: 25  GCYELLTVIGK--GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-----TFLQGEL 77

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            + +    H N+V +   F  DN +++       G   D I         E   A +++ 
Sbjct: 78  HVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136

Query: 208 MLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKK------- 257
           +L+  A  ++H  G VHR +K  + L      D  +  +    +   I  G++       
Sbjct: 137 VLK--ALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 258 FQDIVGSAYYVAPEVLKRKS---GPESDVWSIGVITYI-LLCGRRPFWD----------- 302
            +  V    +++PEVL++       +SD++S+G IT   L  G  PF D           
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKL 250

Query: 303 -------------------------KTEDGIFKEVLRNKPDFRRKPWPSI------SNSA 331
                                        G+   +  + P       PS       S   
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 332 KDFVKKLLVKDPRARLTAAQALSHPWVR 359
             FV++ L ++P AR +A+  L+H + +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFK 338

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  144 bits (365), Expect = 4e-39
 Identities = 86/349 (24%), Positives = 140/349 (40%), Gaps = 69/349 (19%)

Query: 66  KQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVA 125
             H    +     ++   +   F    D   RYT    +G G +G    A D  N  RVA
Sbjct: 4   HHHMAAAAAAGPEMV---RGQVF----DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVA 56

Query: 126 VKKIE--KNKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIA 175
           +KKI   +++          +   RE+KIL     HEN++   +       E    VYI 
Sbjct: 57  IKKISPFEHQT-------YCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIV 108

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFK 233
            +L E    L ++L  K    +       + Q+LR     ++H   ++HRD+KP N L  
Sbjct: 109 QDLMETD--LYKLL--KTQHLSNDHICYFLYQILR--GLKYIHSANVLHRDLKPSNLL-- 160

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEVL--KRKSGPESDVWSIG 287
                  LK  DFGL+    P           V + +Y APE++   +      D+WS+G
Sbjct: 161 -LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219

Query: 288 VITYILLCGRRPF--------WDK--------TEDGIF-------KEVLRNKPDFRRKPW 324
            I   +L  R  F         +         +++ +        +  L + P   + PW
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279

Query: 325 ----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
               P+  + A D + K+L  +P  R+   QAL+HP++ +  D S+ PI
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 328

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  146 bits (370), Expect = 4e-39
 Identities = 80/325 (24%), Positives = 136/325 (41%), Gaps = 67/325 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            +RY   K +G G  G    A D      VA+KK+ +   N+          K   RE+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-------HAKRAYRELV 113

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +++ +  H+N++   N F      E+   VY+ MEL +    L +++  +      +  +
Sbjct: 114 LMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME---LDHERMS 167

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ QML      H  G++HRD+KP N +    K D +LK  DFGL+            V
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 263 GSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDK--------TE 305
            + YY APEV L        D+WS+G I   ++  +  F        W+K          
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284

Query: 306 DGIFK------EVLRNKPDFRRKPWPSI----------------SNSAKDFVKKLLVKDP 343
           + + K        + N+P +    +P +                ++ A+D + K+LV DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344

Query: 344 RARLTAAQALSHPWVREGGDASEIP 368
             R++   AL HP++    D +E+ 
Sbjct: 345 AKRISVDDALQHPYINVWYDPAEVE 369

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  143 bits (362), Expect = 4e-39
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 43/296 (14%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y   + +G G +G  Y A D   G  VA+K+I  +     +P  A+    RE+ +L+ L
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI----REISLLKEL 76

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H N+V   +    +  + +  E  E    L ++L +  +   +    + + Q+LR  A
Sbjct: 77  H-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
            CH H ++HRD+KP+N L  S   D +LK  DFGL+  F  P + +   V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINS---DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 273 L--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV----------LRNK 316
           L   +K     D+WSIG I   ++ G+  F   T+      IF  +          ++  
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 317 PDFR------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P ++                P       D +  +L  DP  R++A  A++HP+ ++
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  143 bits (364), Expect = 5e-39
 Identities = 68/268 (25%), Positives = 123/268 (45%), Gaps = 20/268 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
            +LG G FG   ++  K   +  AVK ++K+ +I    VE    E ++L        + +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
            ++ F+  + +Y  ME   GG+L+  I  ++  R+ E  A     ++        L   G
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEI--AIGLFFLQSKG 141

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS- 277
           +++RD+K +N +  S   +  +K  DFG+  + I  G   +   G+  Y+APE++  +  
Sbjct: 142 IIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           G   D W+ GV+ Y +L G+ PF  + ED +F+ ++ +   + +    S+S  A    K 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKG 254

Query: 338 LLVKDPRARLTAAQA-----LSHPWVRE 360
           L+ K P  RL            H + R 
Sbjct: 255 LMTKHPGKRLGCGPEGERDIKEHAFFRY 282

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  143 bits (363), Expect = 7e-39
 Identities = 85/376 (22%), Positives = 144/376 (38%), Gaps = 83/376 (22%)

Query: 57  AKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVAT 116
            K  ++L+  + Q+   +R    +   ++     D DF++   I +L G G  G  +  +
Sbjct: 1   GKKLEELELDEQQR---KRLEAFLTQKQKVGELKDDDFEK---ISEL-GAGNGGVVFKVS 53

Query: 117 DKANGDRVAVKKI--EKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI 174
            K +G  +A K I  E    I       + RE+++L        +V FY AF  D  + I
Sbjct: 54  HKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 108

Query: 175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFL 231
            ME  +GG L    + KK  R  E+    V   +++     +L     ++HRD+KP N L
Sbjct: 109 CMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIK--GLTYLREKHKIMHRDVKPSNIL 164

Query: 232 FKSAKEDSSLKATDFGLSDFIKPGKKFQDI----VGSAYYVAPEVLKRKS-GPESDVWSI 286
             S  E   +K  DFG+S     G+    +    VG+  Y++PE L+      +SD+WS+
Sbjct: 165 VNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 287 GVITYILLCGRRPF--------------------WDKTEDGIFKEVLRNKPDFRRKPWPS 326
           G+    +  GR P                      +            NK     +P  +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 327 I--------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
           I                    S   +DFV K L+K+P  R    Q + H +++    +  
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDA 333

Query: 367 IPIDISVLNNMRQFVK 382
             +D         ++ 
Sbjct: 334 EEVD------FAGWLC 343

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  143 bits (362), Expect = 1e-38
 Identities = 59/323 (18%), Positives = 113/323 (34%), Gaps = 56/323 (17%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA-----VEDVK--- 144
                YT+ + +  G +G      D   G  VA+K++                   K   
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 145 REVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
           RE+++L     H N++   + F        + +Y+  EL      L +++  +    + +
Sbjct: 78  REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQ 134

Query: 200 DAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
                +  +L       LH  G+VHRD+ P N L     +++ +   DF L+        
Sbjct: 135 HIQYFMYHILL--GLHVLHEAGVVHRDLHPGNIL---LADNNDITICDFNLAREDTADAN 189

Query: 258 FQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFW-------------- 301
               V   +Y APE++   +      D+WS G +   +   R+  +              
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVE 248

Query: 302 ------DKTEDGIFKEVLRN-----KPDFRRKPW----PSISNSAKDFVKKLLVKDPRAR 346
                  +          R+       +   + W    P+    A D + K+L  +P+ R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308

Query: 347 LTAAQALSHPWVREGGDASEIPI 369
           ++  QAL HP+     D  ++  
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTE 331

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  142 bits (361), Expect = 1e-38
 Identities = 82/265 (30%), Positives = 131/265 (49%), Gaps = 21/265 (7%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H  +  
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 69

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
              AF+  + +   ME   GGEL   +   ++  +TE+ A     ++  V+A  +LH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEI--VSALEYLHSRD 125

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS- 277
           +V+RD+K EN +      D  +K TDFGL  + I  G   +   G+  Y+APEVL+    
Sbjct: 126 VVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 278 GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKK 337
           G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F R    ++S  AK  +  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG 238

Query: 338 LLVKDPRARLTAAQA-----LSHPW 357
           LL KDP+ RL    +     + H +
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  142 bits (361), Expect = 1e-38
 Identities = 90/340 (26%), Positives = 137/340 (40%), Gaps = 74/340 (21%)

Query: 83  GKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAV 140
            KR  +    +    + +  LLG G +G    AT K  G+ VA+KKIE     +      
Sbjct: 2   PKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------ 51

Query: 141 EDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKK 192
                  RE+KIL+    HEN++  +N       E+ N VYI  EL +    L R+++ +
Sbjct: 52  -FALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQ 107

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
               ++      + Q LR  A   LH   ++HRD+KP N L      +  LK  DFGL+ 
Sbjct: 108 M--LSDDHIQYFIYQTLR--AVKVLHGSNVIHRDLKPSNLL---INSNCDLKVCDFGLAR 160

Query: 251 FIKPGKKFQDIVGSA-----------YYVAPEVL--KRKSGPESDVWSIGVITYILLCGR 297
            I                        +Y APEV+    K     DVWS G I   L   R
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

Query: 298 --------------------RPFWDKTEDGIF----KEVLRNKPDFRRKPW----PSISN 329
                                P  D     I     +E +++ P +   P     P ++ 
Sbjct: 221 PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNP 280

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
              D ++++LV DP  R+TA +AL HP+++   D ++ P 
Sbjct: 281 KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  143 bits (362), Expect = 1e-38
 Identities = 85/346 (24%), Positives = 138/346 (39%), Gaps = 62/346 (17%)

Query: 65  TKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRV 124
              H   +  R T       +T +    +   RY     +G G +G    A D   G RV
Sbjct: 2   AHHHHHHSQERPTFYRQELNKTIW----EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 57

Query: 125 AVKKIEK---NKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF------EDDNYV 172
           AVKK+ +   + +         K   RE+++L+ +  HENV+   + F      E+ N V
Sbjct: 58  AVKKLSRPFQSII-------HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDV 109

Query: 173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF 232
           Y+   L      L+ I+  K  + T+     ++ Q+LR     H   ++HRD+KP N   
Sbjct: 110 YLVTHLMGAD--LNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA- 164

Query: 233 KSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVIT 290
               ED  LK  DFGL+       +    V + +Y APE++          D+WS+G I 
Sbjct: 165 --VNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220

Query: 291 YILLCGR-----------------------RPFWDKTEDGIFKEVLRNKPDFRRKPW--- 324
             LL GR                            K      +  +++     +  +   
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280

Query: 325 -PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
               +  A D ++K+LV D   R+TAAQAL+H +  +  D  + P+
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  142 bits (359), Expect = 2e-38
 Identities = 57/336 (16%), Positives = 106/336 (31%), Gaps = 79/336 (23%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAV------------KKIEKNKMIL----- 136
           +   +   + +G G FG  + A +K +    A+            +K+ +    L     
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63

Query: 137 --------------------------------------PIAVEDVKREVKILQALAGHEN 158
                                                 P  ++    +++ +   +  +N
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKN 122

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV-VVRQMLRVAAECHL 217
            V          Y+YI M+LC    L D +  +      E    + +  Q+       H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-------------DFIKPGKKFQDIVGS 264
            GL+HRD+KP N  F     D  +K  DFGL                +         VG+
Sbjct: 183 KGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 265 AYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
             Y++PE +   +   + D++S+G+I + LL       ++    I  +V   K       
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITDVRNLKFP---LL 294

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
           +          V+ +L   P  R  A   + +    
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  141 bits (357), Expect = 2e-38
 Identities = 72/279 (25%), Positives = 115/279 (41%), Gaps = 35/279 (12%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKRE 146
              RY +G++LG G     ++A D  +   VAVK       +L       P      +RE
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK-------VLRADLARDPSFYLRFRRE 62

Query: 147 VKILQALAG--HENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKD 200
               Q  A   H  +V  Y+  E +       YI ME  +G  L D +    +   T K 
Sbjct: 63  A---QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKR 117

Query: 201 AAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL----SDFIKPGK 256
           A  V+    +     H +G++HRD+KP N +       +++K  DFG+    +D      
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVT 174

Query: 257 KFQDIVGSAYYVAPE-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLR 314
           +   ++G+A Y++PE          SDV+S+G + Y +L G  PF   +   + ++ V R
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-R 233

Query: 315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
             P         +S      V K L K+P  R   A  +
Sbjct: 234 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  141 bits (357), Expect = 3e-38
 Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 52/305 (17%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI----LPI-AVEDVKREVKILQ 151
           ++   + LG+G +   Y   +K  G  VA+K++   K+      P  A+    RE+ +++
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI----REISLMK 58

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCE---GGELLDRILAKKDSRYTEKDAAVVVRQM 208
            L  HEN+V+ Y+    +N + +  E  +      +  R +                 Q+
Sbjct: 59  ELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYY 267
           L+  A CH + ++HRD+KP+N L     +   LK  DFGL+  F  P   F   V + +Y
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK----------- 310
            AP+VL   R      D+WS G I   ++ G+  F    +      IF            
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 311 --EVLRN-KPDFRRKP------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
               L    P+ +++P               +  +  DF+  LL  +P  RL+A QAL H
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294

Query: 356 PWVRE 360
           PW  E
Sbjct: 295 PWFAE 299

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (369), Expect = 3e-38
 Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 10/262 (3%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG       +A G   A KK+EK ++           E +IL        VV 
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVVS 248

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLV 221
              A+E  + + + + L  GG+L   I     + + E  A     ++     + H   +V
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308

Query: 222 HRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           +RD+KPEN L         ++ +D GL+  +  G+  +  VG+  Y+APEV+K +     
Sbjct: 309 YRDLKPENILLDD---HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 281 SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLV 340
            D W++G + Y ++ G+ PF  + +    +EV R   +   +     S  A+    +LL 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425

Query: 341 KDPRARL-----TAAQALSHPW 357
           KDP  RL     +A +   HP 
Sbjct: 426 KDPAERLGCRGGSAREVKEHPL 447

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  142 bits (359), Expect = 4e-38
 Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 23/266 (8%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           K++G G FG   +A  KA     AVK ++K  ++     + +  E  +L     H  +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--G 219
            + +F+  + +Y  ++   GGEL   +  +++  + E  A     ++   +A  +LH   
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEI--ASALGYLHSLN 159

Query: 220 LVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
           +V+RD+KPEN L      DS   +  TDFGL  + I+         G+  Y+APEVL ++
Sbjct: 160 IVYRDLKPENILL-----DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W +G + Y +L G  PF+ +    ++  +L      +    P+I+NSA+  +
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLL 270

Query: 336 KKLLVKDPRARL----TAAQALSHPW 357
           + LL KD   RL       +  SH +
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  141 bits (357), Expect = 6e-38
 Identities = 78/328 (23%), Positives = 138/328 (42%), Gaps = 66/328 (20%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVE 141
           +T +    +    Y   + +G G +G    A D   G +VA+KK+ +   +++       
Sbjct: 18  KTAW----EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL------- 66

Query: 142 DVK---REVKILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKK 192
             K   RE+++L+ +  HENV+   + F      +D    Y+ M        L +++  K
Sbjct: 67  FAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLM--K 121

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
             +  E     +V QML+     ++H  G++HRD+KP N       ED  LK  DFGL+ 
Sbjct: 122 HEKLGEDRIQFLVYQMLK--GLRYIHAAGIIHRDLKPGNLA---VNEDCELKILDFGLAR 176

Query: 251 FIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGR----------- 297
                      V + +Y APEV+    +     D+WS+G I   ++ G+           
Sbjct: 177 QADSEMT--GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234

Query: 298 ------------RPFWDKTEDGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVK 341
                         F  + +    K  ++  P+  +K +     + S  A + ++K+LV 
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294

Query: 342 DPRARLTAAQALSHPWVREGGDASEIPI 369
           D   R+TA +AL+HP+     D  + P 
Sbjct: 295 DAEQRVTAGEALAHPYFESLHDTEDEPQ 322

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  140 bits (356), Expect = 8e-38
 Identities = 75/320 (23%), Positives = 128/320 (40%), Gaps = 61/320 (19%)

Query: 88  FGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
               +    R+ + ++ G G FG   +  +K+ G  VA+KK+ ++            RE+
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-------FRNREL 67

Query: 148 KILQALA--GHENVVKFYNAF-------EDDNYVYIAMELCEGGELLDRILAKKDSRYTE 198
           +I+Q LA   H N+V+  + F         D Y+ + ME     + L R       R   
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCRNYYRRQVA 125

Query: 199 KDAAVV---VRQMLRVAAECHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
               ++   + Q++R     HL    + HRD+KP N L    + D +LK  DFG +  + 
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLS 183

Query: 254 PGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---- 307
           P +     + S YY APE++   +      D+WS+G I   ++ G   F  + ++     
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF--RGDNSAGQL 241

Query: 308 --IFKEVL-----------------RNKPDFRRKPW--------PSISNSAKDFVKKLLV 340
             I + VL                  +  + +  PW           +  A D +  LL 
Sbjct: 242 HEIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300

Query: 341 KDPRARLTAAQALSHPWVRE 360
             P  R+   +AL HP+  E
Sbjct: 301 YLPEERMKPYEALCHPYFDE 320

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  143 bits (361), Expect = 9e-38
 Identities = 84/424 (19%), Positives = 140/424 (33%), Gaps = 113/424 (26%)

Query: 45  TTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLL 104
           ++H+     Q  +     +   Q +    ++     P         D     RY I  L+
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61

Query: 105 GHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK------REVKILQALAGHEN 158
           G G +G+   A DK     VA+KKI +         ED+       RE+ IL  L  H++
Sbjct: 62  GTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRL-NHDH 113

Query: 159 VVKFYN-----AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           VVK  +       E  + +Y+ +E+ +      ++  +     TE     ++  +L    
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLF-RTPVYLTELHIKTLLYNLLVGVK 170

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-------- 265
             H  G++HRD+KP N L     +D S+K  DFGL+  +   +     +  +        
Sbjct: 171 YVHSAGILHRDLKPANCL---VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 266 --------------------YYVAPEVL--KRKSGPESDVWSIGVI----------TYIL 293
                               +Y APE++  +       DVWSIG I              
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 294 LCGRRPF--------------------------------------------WDKTEDGIF 309
              R P                                              +  E    
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347

Query: 310 KEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS 365
           K  +R  P           P+ S  A   +K++LV +P  R+T  + L+HP+ +E   A 
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

Query: 366 EIPI 369
               
Sbjct: 408 VETN 411

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  140 bits (355), Expect = 1e-37
 Identities = 81/326 (24%), Positives = 133/326 (40%), Gaps = 67/326 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVEDVK---REVK 148
            +RY   K +G G  G    A D      VA+KK+ +   N+          K   RE+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-------HAKRAYRELV 76

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
           +++ +  H+N++   N F      E+   VYI MEL +    L +++         +  +
Sbjct: 77  LMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ---MELDHERMS 130

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            ++ QML      H  G++HRD+KP N +    K D +LK  DFGL+            V
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 263 GSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPF--------WDK--------TE 305
            + YY APEV L        D+WS+G I   ++ G   F        W+K          
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247

Query: 306 DGIFK------EVLRNKPDFRRKPWPSI----------------SNSAKDFVKKLLVKDP 343
           + + K        + N+P +    +  +                ++ A+D + K+LV D 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307

Query: 344 RARLTAAQALSHPWVREGGDASEIPI 369
             R++  +AL HP++    D SE   
Sbjct: 308 SKRISVDEALQHPYINVWYDPSEAEA 333

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  140 bits (354), Expect = 3e-37
 Identities = 71/335 (21%), Positives = 147/335 (43%), Gaps = 38/335 (11%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG-----KL 103
           H H H +       + T ++        +G+    +  +            +      ++
Sbjct: 5   HHHHHHD-----YDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRV 59

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +G G +    +   K      A++ ++K  +     ++ V+ E  + +  + H  +V  +
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGLVH 222
           + F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++  +A    H  G+++
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEIS-LALNYLHERGIIY 176

Query: 223 RDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-GPE 280
           RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+ +  G  
Sbjct: 177 RDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233

Query: 281 SDVWSIGVITYILLCGRRPFW---------DKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
            D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S  A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 289

Query: 332 KDFVKKLLVKDPRARL-----TAAQAL-SHPWVRE 360
              +K  L KDP+ RL     T    +  HP+ R 
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  138 bits (349), Expect = 4e-37
 Identities = 76/274 (27%), Positives = 128/274 (46%), Gaps = 29/274 (10%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           ++LG G +G  +     T    G   A+K ++K  ++         K E  IL+    H 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-VKHP 81

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V    AF+    +Y+ +E   GGEL  ++  +++  + E  A   + ++    A  HL
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEI--SMALGHL 137

Query: 218 H--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEV 272
           H  G+++RD+KPEN +      +    +K TDFGL  + I  G       G+  Y+APE+
Sbjct: 138 HQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 273 LKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L R       D WS+G + Y +L G  PF  +       ++L+ K +    P P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEA 248

Query: 332 KDFVKKLLVKDPRARLTAAQA-----LSHPWVRE 360
           +D +KKLL ++  +RL A         +HP+ R 
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  137 bits (347), Expect = 5e-37
 Identities = 76/303 (25%), Positives = 121/303 (39%), Gaps = 49/303 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPI-AVEDVKREVKIL 150
           RY     +G G +G  Y A D  +G  VA+K +           LPI  V    REV +L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV----REVALL 65

Query: 151 QAL--AGHENVVKFY-----NAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDA 201
           + L    H NVV+       +  + +  V +  E  +      LD+           +  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETI 122

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
             ++RQ LR     H + +VHRD+KPEN L  S     ++K  DFGL+           +
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALTPV 179

Query: 262 VGSAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEV---- 312
           V + +Y APEVL +       D+WS+G I   +   +  F   +E      IF  +    
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239

Query: 313 ------LRNKPDFRRKPW---------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPW 357
                   + P     P          P +  S    + ++L  +P  R++A +AL H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

Query: 358 VRE 360
           + +
Sbjct: 300 LHK 302

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  138 bits (350), Expect = 5e-37
 Identities = 67/277 (24%), Positives = 133/277 (48%), Gaps = 28/277 (10%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           +++G G +    +   K      A+K ++K  +     ++ V+ E  + +  + H  +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HLHGL 220
            ++ F+ ++ ++  +E   GG+L+  +  ++  +  E+ A     ++  +A    H  G+
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEIS-LALNYLHERGI 131

Query: 221 VHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRKS-G 278
           ++RD+K +N L  S   +  +K TD+G+  + ++PG       G+  Y+APE+L+ +  G
Sbjct: 132 IYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188

Query: 279 PESDVWSIGVITYILLCGRRPFW---------DKTEDGIFKEVLRNKPDFRRKPWPSISN 329
              D W++GV+ + ++ GR PF            TED +F+ +L  +    R    S+S 
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 244

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQAL-SHPWVRE 360
            A   +K  L KDP+ RL     T    +  HP+ R 
Sbjct: 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  143 bits (362), Expect = 5e-37
 Identities = 71/333 (21%), Positives = 129/333 (38%), Gaps = 29/333 (8%)

Query: 44  DTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIG-- 101
           +    H  + Q     +Q    +  Q          I   K T F   K+ +    +   
Sbjct: 130 EHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN 189

Query: 102 -----KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
                +++G G FG  Y       G   A+K ++K ++ +         E  +L  ++  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249

Query: 157 EN--VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +   +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   +V+RD+KP N L     E   ++ +D GL+      KK    VG+  Y+APEVL+
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQ 363

Query: 275 RKSG--PESDVWSIGVITYILLCGRRPFWD---KTEDGIFKEVLRNKPDFRRKPWPSISN 329
           +       +D +S+G + + LL G  PF     K +  I +  L    +       S S 
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP 419

Query: 330 SAKDFVKKLLVKDPRARL-----TAAQALSHPW 357
             +  ++ LL +D   RL      A +    P+
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  141 bits (357), Expect = 8e-37
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 25/271 (9%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK 161
           ++LG G FG  +    KA G   A KK+ K ++      +    E KIL A      +V 
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVS 249

Query: 162 FYNAFEDDNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAAECHLH- 218
              AFE    + + M +  GG++   I  + + +  + E  A     Q+  V+   HLH 
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQ 307

Query: 219 -GLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKRK 276
             +++RD+KPEN L      D +++ +D GL+ +      K +   G+  ++APE+L  +
Sbjct: 308 RNIIYRDLKPENVLLDD---DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSISNSA 331
                 D +++GV  Y ++  R PF  + E      + + VL     +  K     S ++
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSPAS 420

Query: 332 KDFVKKLLVKDPRARL-----TAAQALSHPW 357
           KDF + LL KDP  RL     +     +HP 
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  136 bits (345), Expect = 1e-36
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 29/270 (10%)

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K+LG G FG  ++    +        A+K ++K   +        K E  IL     H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRTKMERDILVE-VNHPF 87

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +VK + AF+ +  +Y+ ++   GG+L  R+   K+  +TE+D    + ++    A  HLH
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAEL--ALALDHLH 143

Query: 219 --GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL 273
             G+++RD+KPEN L      D    +K TDFGLS + I   KK     G+  Y+APEV+
Sbjct: 144 SLGIIYRDLKPENILL-----DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
            R+     +D WS GV+ + +L G  PF  K        +L+ K          +S  A+
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ 254

Query: 333 DFVKKLLVKDPRARL-----TAAQALSHPW 357
             ++ L  ++P  RL        +   H +
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  137 bits (346), Expect = 2e-36
 Identities = 82/338 (24%), Positives = 155/338 (45%), Gaps = 44/338 (13%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDK-----DFDRRYTIG 101
           H H H+ +  +       +        +  T           G+ +     +F+    + 
Sbjct: 4   HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE----LL 59

Query: 102 KLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMILPI-AVEDVKREVKILQALAGHE 157
           K+LG G +G  ++    +    G   A+K ++K  ++      E  + E ++L+ +    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V  + AF+ +  +++ ++   GGEL   +   +  R+TE +  + V ++  V A  HL
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEI--VLALEHL 175

Query: 218 H--GLVHRDMKPENFLFKSAKEDSS--LKATDFGLS--DFIKPGKKFQDIVGSAYYVAPE 271
           H  G+++RD+K EN L      DS+  +  TDFGLS        ++  D  G+  Y+AP+
Sbjct: 176 HKLGIIYRDIKLENILL-----DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 272 VLKRKS---GPESDVWSIGVITYILLCGRRPFW----DKTEDGIFKEVLRNKPDFRRKPW 324
           +++          D WS+GV+ Y LL G  PF       ++  I + +L+++P +   P 
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P- 286

Query: 325 PSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPW 357
             +S  AKD +++LL+KDP+ RL      A +   H +
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (341), Expect = 3e-36
 Identities = 63/267 (23%), Positives = 106/267 (39%), Gaps = 24/267 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKREVKI 149
            Y + +L+G G  G  Y A D      VA+K       ++       P+    ++RE + 
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-------LMSETLSSDPVFRTRMQREART 87

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
              L    +VV  ++  E D  +Y+ M L  G +L   +  ++        A  +VRQ+ 
Sbjct: 88  AGRLQ-EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIG 144

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYY 267
                 H  G  HRD+KPEN L      D      DFG++      K  Q  + VG+ YY
Sbjct: 145 SALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 268 VAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           +APE      +   +D++++  + Y  L G  P+       +   + +  P       P 
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR-PG 260

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQAL 353
           I  +    + + + K+P  R      L
Sbjct: 261 IPVAFDAVIARGMAKNPEDRYVTCGDL 287

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  133 bits (338), Expect = 5e-36
 Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 31/275 (11%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKI----EKNKMILPIAVEDVKREVKILQALA 154
              K +G G FG  +      +   VA+K +     + +  +    ++ +REV I+  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-A 213
            H N+VK Y    +     + ME    G+L    L  K          V +R ML +A  
Sbjct: 82  -HPNIVKLYGLMHNP--PRMVMEFVPCGDLYH-RLLDKAHPIKWS---VKLRLMLDIALG 134

Query: 214 ECHLHG----LVHRDMKPENFLFKSAKEDS--SLKATDFGLSDFIKPGKKFQDIVGSAYY 267
             ++      +VHRD++  N   +S  E++    K  DFGLS           ++G+  +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQW 192

Query: 268 VAPEVLKRKSGP---ESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +APE +  +      ++D +S  +I Y +L G  PF + +   I    +  +   R    
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR---- 248

Query: 325 PSISNSAKDFVKKLLVK----DPRARLTAAQALSH 355
           P+I       ++ ++      DP+ R   +  +  
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (338), Expect = 6e-36
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 39/267 (14%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+G+ +G G FG  Y    K +GD VAVK +       P  ++  K EV +L+    H N
Sbjct: 27  TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-HVN 81

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           ++ F           I  + CEG  L    L   ++++         ++++ +A +    
Sbjct: 82  ILLFMGYSTAPQL-AIVTQWCEGSSLYH-HLHASETKFEM-------KKLIDIARQTARG 132

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS---DFIKPGKKFQDIVGSAYYV 268
               H   ++HRD+K  N       ED+++K  DFGL+          +F+ + GS  ++
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 269 APEVLKRKSGPE----SDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKP 323
           APEV++ +        SDV++ G++ Y L+ G+ P+ +    D I + V R         
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG---SLSPD 246

Query: 324 WPSISNSAKDFVKKLLVK----DPRAR 346
              + ++    +K+L+ +        R
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDER 273

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  136 bits (343), Expect = 8e-36
 Identities = 76/346 (21%), Positives = 138/346 (39%), Gaps = 86/346 (24%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
            ++Y++GK LG G FG      D  +G R A+KK+ ++            RE+ I++ L 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLD 58

Query: 155 GHENVVKFYNAF--------------------------------------EDDNYVYIAM 176
            H N++K  + F                                        + Y+ + M
Sbjct: 59  -HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 177 ELCEGGELLDRIL---AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK 233
           E     + L ++L    +          ++ + Q+ R     H  G+ HRD+KP+N L  
Sbjct: 118 EYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVL--KRKSGPESDVWSIGVITY 291
           S  +D++LK  DFG +  + P +     + S +Y APE++    +  P  D+WSIG +  
Sbjct: 176 S--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 292 ILLCGRRPFWDKTEDG------IFKEVL-----------------RNKPDFRRKPW---- 324
            L+ G+  F    E        I + ++                    P  + K W    
Sbjct: 234 ELILGKPLF--SGETSIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290

Query: 325 PSISNS-AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           P  + S A D ++++L  +P  R+   +A++HP+     ++ E  +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  133 bits (337), Expect = 8e-36
 Identities = 35/261 (13%), Positives = 68/261 (26%), Gaps = 36/261 (13%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA 154
           + RY +    G       + A D A   +VA+  ++   ++    +++       L  + 
Sbjct: 30  NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI- 88

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               V +  +         +  E   GG L +      D+  +   A   ++ +   A  
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADA 144

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H  G+      P          D  +                          +      
Sbjct: 145 AHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------------------TMPDA--- 179

Query: 275 RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW---PSISNSA 331
               P+ D+  IG   Y LL  R P  +           R+      +P      I    
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236

Query: 332 KDFVKKLLVKDPRARLTAAQA 352
                + +  D   R  +   
Sbjct: 237 SAVAARSVQGDGGIRSASTLL 257

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  133 bits (337), Expect = 1e-35
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 44/272 (16%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            IG+L+G G+FG  Y    + +G+ VA++ I+  +      ++  KREV   +    HEN
Sbjct: 36  EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HEN 90

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           VV F  A     ++ I   LC+G  L   ++                 +  ++A E    
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYS-VVRDAKIVLDV-------NKTRQIAQEIVKG 142

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS------DFIKPGKKFQDIVGSA 265
               H  G++H+D+K +N  +    ++  +  TDFGL          +   K +   G  
Sbjct: 143 MGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 266 YYVAPEVLKRKSGPE----------SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN 315
            ++APE++++ S             SDV+++G I Y L     PF  +  + I  ++   
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258

Query: 316 -KPDFRRKPWPSISNSAKDFVKKLLVKDPRAR 346
            KP+  +           D +      +   R
Sbjct: 259 MKPNLSQIGMGK---EISDILLFCWAFEQEER 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  132 bits (335), Expect = 4e-35
 Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 47/301 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQA 152
           +Y     +G G +G  + A D K  G  VA+K++  +  +  +P+  +    REV +L+ 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 67

Query: 153 L--AGHENVVKFY-----NAFEDDNYVYIAMELCEG--GELLDRILAKKDSRYTEKDAAV 203
           L    H NVV+ +     +  + +  + +  E  +      LD++    +     +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           ++ Q+LR     H H +VHRD+KP+N L  S+ +   +K  DFGL+           +V 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVV 181

Query: 264 SAYYVAPEVL-KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK-------- 310
           + +Y APEVL +       D+WS+G I   +   +  F   ++      I          
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 311 -----------EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
                                 K    I    KD + K L  +P  R++A  ALSHP+ +
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

Query: 360 E 360
           +
Sbjct: 302 D 302

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  131 bits (331), Expect = 7e-35
 Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 36/261 (13%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + +++G G FG    A  +     VA+K+IE          +    E++ L  +  H N
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER-----KAFIVELRQLSRVN-HPN 62

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHL 217
           +VK Y A  +   V + ME  EGG L   +L   +       AA  +   L+ +    +L
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYL 118

Query: 218 H-----GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV 272
           H      L+HRD+KP N L       + LK  DFG +  I+      +  GSA ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEV 174

Query: 273 LKRKSGPE-SDVWSIGVITYILLCGRRPFWD--KTEDGIFKEVLRNKPDFRRKPWPSISN 329
            +  +  E  DV+S G+I + ++  R+PF +       I   V       R    P +  
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---R----PPLIK 227

Query: 330 SAKDFVKKLLV----KDPRAR 346
           +    ++ L+     KDP  R
Sbjct: 228 NLPKPIESLMTRCWSKDPSQR 248

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  130 bits (329), Expect = 2e-34
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 26/259 (10%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            I + +G G FG  + A  + +G  VAVK + +        V +  REV I++ L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLR-HPN 95

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECHL 217
           +V F  A      + I  E    G L   +L K  +R  + D    +     VA    +L
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGARE-QLDERRRLSMAYDVAKGMNYL 153

Query: 218 HG----LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEV 272
           H     +VHR++K  N L     +  ++K  DFGLS          +   G+  ++APEV
Sbjct: 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 273 LKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
           L+ + S  +SDV+S GVI + L   ++P+ +     +   V       +R     I  + 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---KR---LEIPRNL 264

Query: 332 KDFVKKLLVK----DPRAR 346
              V  ++      +P  R
Sbjct: 265 NPQVAAIIEGCWTNEPWKR 283

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  133 bits (336), Expect = 2e-34
 Identities = 87/363 (23%), Positives = 130/363 (35%), Gaps = 82/363 (22%)

Query: 71  TNSRRQTGVIPCGKRTDFGYDKD-----------FDRRYTIGKLLGHGQFGYTYVATDKA 119
            N++++ G+   G   + GYD D              RY + K++G G FG    A D  
Sbjct: 63  LNAKKRQGMT--GGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHK 120

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----NVVKFYNAFEDDNYVYI 174
               VA+K +   K     A      E++IL+ L   +     NV+     F   N++ +
Sbjct: 121 VHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176

Query: 175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS 234
             EL     L + I   K   ++          +L+     H + ++H D+KPEN L K 
Sbjct: 177 TFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 235 AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYIL 293
               S +K  DFG S +    ++    + S +Y APEV L  + G   D+WS+G I   L
Sbjct: 236 QG-RSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292

Query: 294 LCGR-----------------------------------------RPFWDKTEDGIFKEV 312
           L G                                           P +          V
Sbjct: 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV 352

Query: 313 LRNKPDFRRKPWPSISNSA--------------KDFVKKLLVKDPRARLTAAQALSHPWV 358
           + N    RR        S                DF+K+ L  DP  R+T  QAL HPW+
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

Query: 359 REG 361
           R  
Sbjct: 413 RRR 415

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  132 bits (335), Expect = 2e-34
 Identities = 80/396 (20%), Positives = 138/396 (34%), Gaps = 114/396 (28%)

Query: 67  QHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAV 126
            H   +S  +  +   G   +          Y I  L+G G +GY Y+A DK     VA+
Sbjct: 2   HHHHHHSSGRENLYFQGI-KNV----HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAI 56

Query: 127 KKIEK---NKMILPIAVEDVK---REVKILQALAGHENVVKFYNAF-----EDDNYVYIA 175
           KK+ +   + +       D K   RE+ IL  L   + +++ Y+          + +YI 
Sbjct: 57  KKVNRMFEDLI-------DCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIV 108

Query: 176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFK 233
           +E+ +    L ++  K     TE+    ++  +L    E  +H  G++HRD+KP N L  
Sbjct: 109 LEIADSD--LKKLF-KTPIFLTEEHIKTILYNLLL--GENFIHESGIIHRDLKPANCL-- 161

Query: 234 SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA-----------------------YYVAP 270
              +D S+K  DFGL+  I   K    +                           +Y AP
Sbjct: 162 -LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220

Query: 271 EVL--KRKSGPESDVWSIGVI----------TYILLCGRRPF----------------WD 302
           E++  +       D+WS G I                 R P                   
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKV 280

Query: 303 KTEDG------IF-------------------KEVLRNKPDFRRKPW----PSISNSAKD 333
             +        IF                    + ++  P  +        PSIS+   +
Sbjct: 281 HEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340

Query: 334 FVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
            ++ +L  +P  R+T  QAL HP++++         
Sbjct: 341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  131 bits (332), Expect = 3e-34
 Identities = 85/363 (23%), Positives = 137/363 (37%), Gaps = 99/363 (27%)

Query: 85  RTDFGYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK---NKMILPIAVE 141
           R D        R+Y + K LG G +G  + + D+  G+ VAVKKI     N         
Sbjct: 2   RVDR----HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------- 50

Query: 142 DVK---REVKILQALAGHENVVKFYNAF--EDDNYVYIAMELCEGGELLDRILAKKDSRY 196
           D +   RE+ IL  L+GHEN+V   N    ++D  VY+  +  E    L  ++  + +  
Sbjct: 51  DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVI--RANIL 106

Query: 197 TEKDAAVVVRQMLRVAAECHLH--GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
                  VV Q+++     +LH  GL+HRDMKP N L      +  +K  DFGLS     
Sbjct: 107 EPVHKQYVVYQLIK--VIKYLHSGGLLHRDMKPSNIL---LNAECHVKVADFGLSRSFVN 161

Query: 255 GKKFQDIVGSA----------------------YYVAPEVL--KRKSGPESDVWSIGVIT 290
            ++  + +  +                      +Y APE+L    K     D+WS+G I 
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 291 YILLCGRRPFW------------------------DKTEDGIFKEVLRNKPDFRRKPW-- 324
             +L   +P +                        +  +    K ++ +  +        
Sbjct: 222 GEIL-CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSN 280

Query: 325 ------------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASE 366
                                +  A D + KLL  +P  R++A  AL HP+V    + +E
Sbjct: 281 KRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE 340

Query: 367 IPI 369
            P 
Sbjct: 341 EPN 343

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  128 bits (324), Expect = 3e-34
 Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 33/265 (12%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHE 157
           T+ +++G G FG  Y A     GD VAVK    +    +   +E+V++E K+   L  H 
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HP 66

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA-AECH 216
           N++        +  + + ME   GG L   +L+ K          ++V   +++A    +
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGK-----RIPPDILVNWAVQIARGMNY 120

Query: 217 LHG-----LVHRDMKPENFL-----FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
           LH      ++HRD+K  N L           +  LK TDFGL+       K     G+  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYA 179

Query: 267 YVAPEVLKRKSGPE-SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           ++APEV++     + SDVWS GV+ + LL G  PF       +   V  NK         
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK---LA---L 233

Query: 326 SISNSAKDFVKKLLVK----DPRAR 346
            I ++  +   KL+      DP +R
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSR 258

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  130 bits (329), Expect = 6e-34
 Identities = 73/345 (21%), Positives = 129/345 (37%), Gaps = 74/345 (21%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D RY + + LG G F   ++A D  N   VA+K +  +K+    A    + E+K+L
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLL 69

Query: 151 QAL----------AGHENVVKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRY 196
           Q +           G  +++K  + F     +  +V +  E+  G  LL  I   +    
Sbjct: 70  QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128

Query: 197 TEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAK---EDSSLKATDFGLSD 250
                  + +Q+L      ++H   G++H D+KPEN L +          +K  D G + 
Sbjct: 129 PLIYVKQISKQLLL--GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186

Query: 251 FIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIF 309
           +    + + + + +  Y +PEV L    G  +D+WS   + + L+ G   F         
Sbjct: 187 WY--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244

Query: 310 K---------EVL------------------------RNKPDFRRKPWPSISNSA----- 331
           K         E+L                        RN    +  P   +         
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304

Query: 332 ------KDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPID 370
                  DF+  +L  DPR R  A   ++HPW+++     EI + 
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 349

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  127 bits (321), Expect = 5e-33
 Identities = 85/327 (25%), Positives = 124/327 (37%), Gaps = 66/327 (20%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI--EKNKMILPI-AVEDVKREVKILQAL 153
           +Y     +G G FG  + A  +  G +VA+KK+  E  K   PI A+    RE+KILQ L
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLL 73

Query: 154 AGHENVVKFY--------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
             HENVV                   +Y+  + CE    L  +L+    ++T  +   V+
Sbjct: 74  K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSEIKRVM 130

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
           + +L      H + ++HRDMK  N L         LK  DFGL+      K  Q    + 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP---NR 184

Query: 266 Y--------YVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTE----DGIFK- 310
           Y        Y  PE+L  +R  GP  D+W  G I   +          TE      I + 
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

Query: 311 ------------------EVLRNKPDFRRK-----PWPSISNSAKDFVKKLLVKDPRARL 347
                             E L      +RK             A D + KLLV DP  R+
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304

Query: 348 TAAQALSHPWVREGGDASEIPIDISVL 374
            +  AL+H +         +P D+  +
Sbjct: 305 DSDDALNHDFFWS----DPMPSDLKGM 327

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  125 bits (315), Expect = 8e-32
 Identities = 80/326 (24%), Positives = 122/326 (37%), Gaps = 66/326 (20%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D     G  +G G +G+ Y A  K   +    A+K+IE    I   A     RE+ +L+ 
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSAC----REIALLRE 74

Query: 153 LAGHENVVKFYNAFED--DNYVYIAMELCEG--GELLDRILAKKDSRYTEK-DAAVV--- 204
           L  H NV+     F    D  V++  +  E     ++    A K ++   +    +V   
Sbjct: 75  LK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLS-DFIKPGKKFQDIV 262
           + Q+L      H + ++HRD+KP N L      +   +K  D G +  F  P K   D+ 
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 263 GSA---YYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG---------- 307
                 +Y APE+L   R      D+W+IG I   LL     F  + ED           
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253

Query: 308 ---IFK-----------------EVLRNKPDFRRKPW-------------PSISNSAKDF 334
              IF                  E      DFRR  +                 + A   
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313

Query: 335 VKKLLVKDPRARLTAAQALSHPWVRE 360
           ++KLL  DP  R+T+ QA+  P+  E
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLE 339

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197

 Score =  118 bits (298), Expect = 3e-31
 Identities = 28/103 (27%), Positives = 56/103 (54%), Gaps = 2/103 (1%)

Query: 351 QALSHPWVRE-GGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQ 409
               H   RE       + +  ++L N++ F K + LK+ AL  +A  L D E+ +LR+ 
Sbjct: 3   HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62

Query: 410 FDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           F A+DVD +G++S +E+   L K + ++     + ++L+ +++
Sbjct: 63  FIALDVDNSGTLSSQEILDGL-KKIGYQKIPPDIHQVLRDIDS 104

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  122 bits (308), Expect = 5e-31
 Identities = 78/385 (20%), Positives = 136/385 (35%), Gaps = 81/385 (21%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGY-----DKDFDRRYTIGKL 103
           H H H     +           ++ +++  V   G   D         + +  RY I  L
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSL 61

Query: 104 LGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-----N 158
           +G G FG    A D+   + VA+K I+  K  L  A    + EV++L+ +  H+      
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH 218
           +V     F   N++ +  E+     L D +        +        +QM          
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176

Query: 219 --GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LKR 275
              ++H D+KPEN L  + K  S++K  DFG S  +  G++    + S +Y +PEV L  
Sbjct: 177 ELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGM 233

Query: 276 KSGPESDVWSIGVITYILLCG---------------------------------RRPFWD 302
                 D+WS+G I   +  G                                  R F++
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFE 293

Query: 303 KTEDGIF--KEVLRNKPDFRRKPWPSISNSAK-------------------------DFV 335
           K  DG +  K+    K +++      + N                            D +
Sbjct: 294 KLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353

Query: 336 KKLLVKDPRARLTAAQALSHPWVRE 360
            ++L  DP+ R+    AL H + ++
Sbjct: 354 LRMLDYDPKTRIQPYYALQHSFFKK 378

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (304), Expect = 6e-31
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 32/247 (12%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
             G++LG G FG     T +  G+ + +K++ +             +EVK+++ L  H N
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA--EC- 215
           V+KF      D  +    E  +GG L   I+   DS+Y        V     +A+     
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWS---QRVSFAKDIASGMAYL 124

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI---------------KPGKKFQD 260
           H   ++HRD+   N L    +E+ ++   DFGL+  +                  KK   
Sbjct: 125 HSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 261 IVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF 319
           +VG+ Y++APE++  R    + DV+S G++   ++       D        +   N   F
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP--RTMDFGLNVRGF 239

Query: 320 RRKPWPS 326
             +  P 
Sbjct: 240 LDRYCPP 246

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (299), Expect = 1e-30
 Identities = 46/267 (17%), Positives = 89/267 (33%), Gaps = 43/267 (16%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
                L     G  +    +  G+ + VK ++           D   E   L+  + H N
Sbjct: 13  NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFS-HPN 68

Query: 159 VVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC- 215
           V+    A +     +  +       G L + +    +    +        Q ++ A +  
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ-------SQAVKFALDMA 121

Query: 216 ----HLHGL----VHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                LH L        +   + +     ED + + +   +    +   +    + +  +
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQSPGR----MYAPAW 174

Query: 268 VAPEVLKRKSGPE----SDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           VAPE L++K        +D+WS  V+ + L+    PF D +   I  +V        R  
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG---LR-- 229

Query: 324 WPSISNSAKDFVKKLL----VKDPRAR 346
            P+I       V KL+     +DP  R
Sbjct: 230 -PTIPPGISPHVSKLMKICMNEDPAKR 255

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191

 Score =  111 bits (280), Expect = 8e-29
 Identities = 18/80 (22%), Positives = 37/80 (46%)

Query: 353 LSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDA 412
           + H      G  +     I VL N + +    + ++ A+  +A   +D ++  L+  F  
Sbjct: 1   MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60

Query: 413 IDVDKNGSISLEEMRQALAK 432
           +D D  G I+ E++++ L K
Sbjct: 61  LDEDGKGYITKEQLKKGLEK 80

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  113 bits (285), Expect = 6e-28
 Identities = 60/334 (17%), Positives = 104/334 (31%), Gaps = 76/334 (22%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
            +  + + + +G G FG   +     N    AVK + +N           K E  IL+ +
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNI---KKYTRSAKIEADILKKI 88

Query: 154 AGHE----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
              +    N+VK++  F   +++ +  E   G  L + I     + +  +D  +   ++L
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAK----------------------EDSSLKATDFG 247
           +         L H D+KPEN L                           + + +K  DFG
Sbjct: 148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 248 LSDFIKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCG---------- 296
            + F         I+ +  Y APEV L       SD+WS G +   L  G          
Sbjct: 208 CATFK--SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 297 ------------------------RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI----- 327
                                       +   ++               K          
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 328 ---SNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                   DF+  +L  DP  R + A+ L H ++
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  112 bits (283), Expect = 9e-28
 Identities = 72/330 (21%), Positives = 114/330 (34%), Gaps = 70/330 (21%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
              RY I   LG G FG      D      +VA+K I +N        E  + E+ +L+ 
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNV---GKYREAARLEINVLKK 72

Query: 153 LAGHE-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +   +       V   + F    ++ IA EL  G    + +       Y       +  Q
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAK----------------EDSSLKATDFGLSDF 251
           +       H + L H D+KPEN LF +++                +++S++  DFG + F
Sbjct: 132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGR------------- 297
               +    IV + +Y  PEV L+       DVWSIG I +    G              
Sbjct: 192 D--HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249

Query: 298 --------------------------RPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA 331
                                        WD+            KP        S+ +  
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309

Query: 332 -KDFVKKLLVKDPRARLTAAQALSHPWVRE 360
             D ++++L  DP  R+T A+AL HP+   
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  111 bits (281), Expect = 1e-27
 Identities = 80/331 (24%), Positives = 117/331 (35%), Gaps = 74/331 (22%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
              RY I   LG G FG      D KA G  VAVK + KN        E  + E+++L+ 
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNV---DRYCEAARSEIQVLEH 67

Query: 153 LAGHE-----NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           L   +       V+    FE   ++ I  EL  G    D I       +       +  Q
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAK----------------EDSSLKATDFGLSDF 251
           + +     H + L H D+KPEN LF  +                  +  +K  DFG + +
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186

Query: 252 IKPGKKFQDIVGSAYYVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTED---- 306
               +    +V + +Y APEV L        DVWSIG I      G   F   T D    
Sbjct: 187 D--DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF--PTHDSKEH 242

Query: 307 --------GIF-KEVLRNKP-----DFRRKPWPSISNSAK-------------------- 332
                   G   K +++           R  W   S++ +                    
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302

Query: 333 ----DFVKKLLVKDPRARLTAAQALSHPWVR 359
               D ++K+L  DP  R+T  +AL HP+  
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFD 333

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score =  109 bits (274), Expect = 5e-27
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 19/225 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K +E  K   P     +  E KI + + G 
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQ----LHIESKIYKMMQGG 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL   G  L+ +      +++ K   ++  QM+      H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 269 APEVLKRKS-GPESDVWSIG-VITYILLCGRRPFWDKTEDGIFKE 311
           +             D+ S+G V+ Y    G  P W   +    ++
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMY-FNLGSLP-WQGLKAATKRQ 225

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  105 bits (263), Expect = 2e-25
 Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 71/306 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
           T+ + +G G++G  +  +    G+ VAVK             +   RE ++    +  HE
Sbjct: 11  TLLECVGKGRYGEVWRGS--WQGENVAVKIF------SSRDEKSWFRETELYNTVMLRHE 62

Query: 158 NVVKFYNA----FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  +          +++     E G L D +          +   +     LR+  
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----------QLTTLDTVSCLRIVL 112

Query: 214 EC-----HLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                  HLH           + HRD+K +N L    K++      D GL+         
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQ 169

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPE-------SDVWSIGVITYILLCGRRPFWDKTED 306
            D+     VG+  Y+APEVL      +        D+W+ G++ + +           + 
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLVK----DPRARLT 348
              F +V+ N P F           +R   P+   S+     + KL+ +    +P ARLT
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 349 AAQALS 354
           A +   
Sbjct: 290 ALRIKK 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  105 bits (265), Expect = 2e-25
 Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 71/306 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
            + K +G G++G  ++   K  G++VAVK                 RE +I Q  L  HE
Sbjct: 40  QMVKQIGKGRYGEVWMG--KWRGEKVAVKVF------FTTEEASWFRETEIYQTVLMRHE 91

Query: 158 NVVKFYNAFEDDNY----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  A          +Y+  +  E G L D +          K   +  + ML++A 
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----------KSTTLDAKSMLKLAY 141

Query: 214 E-----CHLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                 CHLH           + HRD+K +N L    K++ +    D GL+         
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNE 198

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPES-------DVWSIGVITYILLCGRRPFWDKTED 306
            DI     VG+  Y+ PEVL               D++S G+I + +           E 
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLVK----DPRARLT 348
            + + +++ + P +            R  +P+   S+     + KL+ +    +P +RLT
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318

Query: 349 AAQALS 354
           A +   
Sbjct: 319 ALRVKK 324

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score =  104 bits (261), Expect = 5e-25
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 21/227 (9%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + +GK +G G FG   +  +    + VA+K +E  K   P     +  E +  + L   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQLGSG 64

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           + + + Y       Y  + +EL   G  L+ +    D  ++ K   ++  Q++      H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFI-------KPGKKFQDIVGSAY 266
              L++RD+KPENFL      K    +   DF L+ ++I        P ++ + + G+A 
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 267 YVAPEVLKRKS-GPESDVWSIG-VITYILLCGRRPFWDKTEDGIFKE 311
           Y++      K      D+ ++G +  Y  L G  P W   +    KE
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMY-FLRGSLP-WQGLKADTLKE 227

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  104 bits (261), Expect = 5e-25
 Identities = 65/303 (21%), Positives = 114/303 (37%), Gaps = 71/303 (23%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAGHE 157
            + + +G G+FG  +    K  G+ VAVK                 RE +I Q  +  HE
Sbjct: 45  VLQESIGKGRFGEVWRG--KWRGEEVAVKIF------SSREERSWFREAEIYQTVMLRHE 96

Query: 158 NVVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
           N++ F  A   DN      ++  +  E G L D +              V V  M+++A 
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----------NRYTVTVEGMIKLAL 146

Query: 214 EC-----HLH----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
                  HLH           + HRD+K +N L    K++ +    D GL+         
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDT 203

Query: 259 QDI-----VGSAYYVAPEVLKRKSGPE-------SDVWSIGVITYILLCGRRPFWDKTED 306
            DI     VG+  Y+APEVL      +       +D++++G++ + +           + 
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263

Query: 307 GI-FKEVLRNKPDF-----------RRKPWPS--ISNSAKDFVKKLLV----KDPRARLT 348
            + + +++ + P              R   P+   S  A   + K++      +  ARLT
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 349 AAQ 351
           A +
Sbjct: 324 ALR 326

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  105 bits (263), Expect = 6e-25
 Identities = 66/369 (17%), Positives = 118/369 (31%), Gaps = 110/369 (29%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F+ RY + + LG G F   +++ D      VA+ K+ K+        E    E+++L+++
Sbjct: 35  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKS---AEHYTETALDEIRLLKSV 90

Query: 154 A-------GHENVVKFYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
                     E VV+  + F+    +  ++ +  E+  G  LL  I+             
Sbjct: 91  RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK 149

Query: 203 VVVRQMLRVAAECHLH-GLVHRDMKPENFLFK---------------------------- 233
            +++Q+L+     H    ++H D+KPEN L                              
Sbjct: 150 KIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 234 ------------------SAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-LK 274
                                E   +K  D G + +    K F + + +  Y + EV + 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIG 267

Query: 275 RKSGPESDVWSIGVITYILLCGRRPF-----------------------------WDK-- 303
                 +D+WS   + + L  G   F                                  
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327

Query: 304 ------TEDGIFKEVLRNKPDFRRKPWPSISN-------SAKDFVKKLLVKDPRARLTAA 350
                 T+ G  K + + KP    +                 DF+  +L   P  R TAA
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387

Query: 351 QALSHPWVR 359
           + L HPW+ 
Sbjct: 388 ECLRHPWLN 396

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score =  106 bits (265), Expect = 8e-25
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 17/214 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++ +G+ +G G FG  Y+ T+    + VA+K +E  K   P     +  E KI + L G 
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ----LLYESKIYRILQGG 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + M+L   G  L+ +      + + K   ++  QM+      H
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK--------PGKKFQDIVGSAYYV 268
               +HRD+KP+NFL    +  + +   DFGL+   +        P ++ +++ G+A Y 
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFW 301
           +             D+ S+G +    L G  P W
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score =  103 bits (258), Expect = 8e-25
 Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G+ +G G FG  +  T+  N  +VA+K  E  +   P     ++ E +  + LAG 
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQ----LRDEYRTYKLLAGC 65

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   Y   ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLS-DFI-------KPGKKFQDIVGSAY 266
              LV+RD+KP+NFL    ++K  + +   DFG+   +         P ++ +++ G+A 
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 267 YVAPEV-LKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE 311
           Y++    L R+     D+ ++G +    L G  P W   +    K+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-WQGLKAATNKQ 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (262), Expect = 9e-25
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 44/227 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            +G+ +G G FG  +    +A+   VAVK   +     P       +E +IL+    H N
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQY-SHPN 173

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           +V+          +YI MEL +GG+ L   L  + +R       + V+ +L++  +    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTF-LRTEGAR-------LRVKTLLQMVGDAAAG 225

Query: 216 ----HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
                    +HRD+   N L     E + LK +DFG+S         ++     Y     
Sbjct: 226 MEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMS---------REEADGVYAASGG 273

Query: 269 ---------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                    APE L   +   ESDVWS G++ +     G  P+ + +
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  102 bits (256), Expect = 4e-24
 Identities = 63/300 (21%), Positives = 107/300 (35%), Gaps = 45/300 (15%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD-- 93
            H+HH  +  T ++ +         Q  + K  +   S   T   P              
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDL 65

Query: 94  --FDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
               R+  T+ + LGHG FG  Y    +   N     +VAVK + +          D   
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLM 123

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  I+     H+N+V+           +I +EL  GG+L   +   +      + +++ +
Sbjct: 124 EALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR--PSQPSSLAM 180

Query: 206 RQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
             +L VA +      +L  +  +HRD+   N L          K  DFG++         
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 231

Query: 259 QDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           +DI  + YY              PE         ++D WS GV+ + I   G  P+  K+
Sbjct: 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =   99 bits (250), Expect = 9e-24
 Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 53/251 (21%)

Query: 81  PCGKRTD-----FGYDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK 133
           P G +        GY   + D +  T  K LG GQFG       +   D VA+K I++  
Sbjct: 2   PLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGS 60

Query: 134 MILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD 193
           M    + ++   E K++  L+ HE +V+ Y        ++I  E    G LL+  L +  
Sbjct: 61  M----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMR 114

Query: 194 SRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDF 246
            R+         +Q+L +  +      +L     +HRD+   N L     +   +K +DF
Sbjct: 115 HRFQ-------TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDF 164

Query: 247 GLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-IL 293
           GLS         + ++   Y              PEVL   K   +SD+W+ GV+ + I 
Sbjct: 165 GLS---------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215

Query: 294 LCGRRPFWDKT 304
             G+ P+   T
Sbjct: 216 SLGKMPYERFT 226

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 38/222 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T  + +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L+ H  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-- 216
           +V+ Y    +   + +  E  E G L D  L  +   +  +    +      V       
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGMCLD---VCEGMAYL 120

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
               ++HRD+   N L     E+  +K +DFG++         + ++   Y         
Sbjct: 121 EEACVIHRDLAARNCL---VGENQVIKVSDFGMT---------RFVLDDQYTSSTGTKFP 168

Query: 269 ----APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
               +PEV    +   +SDVWS GV+ + +   G+ P+ +++
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 69/302 (22%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + ++   G+FG  + A      + VAVK                + EV  L  +  HEN
Sbjct: 27  QLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDK----QSWQNEYEVYSLPGMK-HEN 79

Query: 159 VVKFYNAFEDDNYV----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           +++F  A +    V    ++     E G L D +          K   V   ++  +A  
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----------KANVVSWNELCHIAET 129

Query: 215 -----CHLH------------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK 257
                 +LH             + HRD+K +N L    K + +    DFGL+   + GK 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKS 186

Query: 258 FQDI---VGSAYYVAPEVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI 308
             D    VG+  Y+APEVL      +R +    D++++G++ + L           ++ +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 309 --FKEVLRNKPDF--------RRKPWPSISNS-AKDFVKKLLVK--------DPRARLTA 349
             F+E +   P           +K  P + +   K     +L +        D  ARL+A
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 350 AQ 351
             
Sbjct: 307 GC 308

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            + + LG G FG        A   +   VAVK ++ + +  P A++D  REV  + +L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H N+++ Y        + +  EL   G LLDR+   +           ++  + R A + 
Sbjct: 80  HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQV 130

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     +HRD+   N L  +      +K  DFGL   +             +YV
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQNDD--------HYV 179

Query: 269 ------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                       APE LK R     SD W  GV  + +   G+ P+    
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 8e-23
 Identities = 73/317 (23%), Positives = 118/317 (37%), Gaps = 62/317 (19%)

Query: 32  EAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSR--RQTGVIPCGKRT--- 86
           E +  H +     +  K     + R     +L    H  T +     T   P  KR    
Sbjct: 148 EGRVYH-YRINTASDGKLYVSSESRFNTLAELV--HHHSTVADGLITTLHYPAPKRNKPT 204

Query: 87  ----DFGYDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV 140
                  YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     V
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 260

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TE 198
           E+  +E  +++ +  H N+V+       +   YI  E    G LLD         Y    
Sbjct: 261 EEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLD---------YLREC 310

Query: 199 KDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
               V    +L +A +      +L     +HR++   N L     E+  +K  DFGLS  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS-- 365

Query: 252 IKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRR 298
                  + + G  Y             APE L   K   +SDVW+ GV+ + I   G  
Sbjct: 366 -------RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418

Query: 299 PFWDKTEDGIFKEVLRN 315
           P+       +++ + ++
Sbjct: 419 PYPGIDLSQVYELLEKD 435

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.1 bits (245), Expect = 9e-23
 Identities = 65/264 (24%), Positives = 101/264 (38%), Gaps = 51/264 (19%)

Query: 58  KNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHGQFGYTYV 114
           K   Q++ K  +       T + P    T   Y++   F R     GK LG G FG    
Sbjct: 9   KPKYQVRWKIIESYEGNSYTFIDP----TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64

Query: 115 AT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD 169
           AT     K +   +VAVK ++          E +  E+KI+  L  HEN+V    A    
Sbjct: 65  ATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122

Query: 170 NYVYIAMELCEGGELLD-----RILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL-- 217
             V +  E C  G+LL+       + + D  +   ++    R +L  +++       L  
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--------- 268
              +HRD+   N L          K  DFGL+         +DI+  + Y+         
Sbjct: 183 KNCIHRDVAARNVL---LTNGHVAKIGDFGLA---------RDIMNDSNYIVKGNARLPV 230

Query: 269 ---APEVLK-RKSGPESDVWSIGV 288
              APE +       +SDVWS G+
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGI 254

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 39/226 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVD 75

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            + +V +          V +  +L   G LLD  + +       +       Q   +A  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQ---IAKG 129

Query: 215 CH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
            +      LVHRD+   N L    K    +K TDFGL+  +              Y    
Sbjct: 130 MNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGA--------EEKEYHAEG 178

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   A E +  R    +SDVWS GV  + ++  G +P+    
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 62/290 (21%), Positives = 104/290 (35%), Gaps = 56/290 (19%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRY-TIGKLLGHG 107
           + H H                   S     V+         +  +      T  K++G G
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLK--------FTTEIHPSCVTRQKVIGAG 55

Query: 108 QFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY 163
           +FG  Y    K +  +    VA+K ++           D   E  I+   + H N+++  
Sbjct: 56  EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFS-HHNIIRLE 112

Query: 164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL- 217
                   + I  E  E G L    L +KD  ++       V Q++ +         +L 
Sbjct: 113 GVISKYKPMMIITEYMENGALDK-FLREKDGEFS-------VLQLVGMLRGIAAGMKYLA 164

Query: 218 -HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-------- 268
               VHRD+   N L      +   K +DFGLS  +      +D   + Y          
Sbjct: 165 NMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVL------EDDPEATYTTSGGKIPIR 215

Query: 269 --APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
             APE +  RK    SDVWS G++ + ++  G RP+W+ +      EV++
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMK 261

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 68/296 (22%), Positives = 103/296 (34%), Gaps = 60/296 (20%)

Query: 47  HKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGK----RTDFGYDKDFDRRY-TIG 101
           H H H    R   Y Q K           Q    P       R    + ++ +     I 
Sbjct: 2   HHHHHHSSGRENLYFQGKL-------PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIE 54

Query: 102 KLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           K++G G  G       +  G R   VA+K ++           D   E  I+     H N
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFD-HPN 111

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE---- 214
           +++            I  E  E G L    L   D ++T       + Q++ +       
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFT-------IMQLVGMLRGVGAG 163

Query: 215 -CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L   G VHRD+   N L      +   K +DFGLS  ++           A Y    
Sbjct: 164 MRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDP-------DAAYTTTG 213

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
                   APE +  R     SDVWS GV+ + +L  G RP+W+ T     ++V+ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVIS 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
           T+ K LG GQFG   +   K     VAVK I++  M    + ++  +E + +  L+ H  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPK 64

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLD--RILAKKDSRYTEKDAAVVVRQMLRVAAE-- 214
           +VKFY     +  +YI  E    G LL+  R               +   Q+L +  +  
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLR----------SHGKGLEPSQLLEMCYDVC 114

Query: 215 ---CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV- 268
                L  H  +HRD+   N L      D  +K +DFG++         + ++   Y   
Sbjct: 115 EGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMT---------RYVLDDQYVSS 162

Query: 269 ----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                     APEV    K   +SDVW+ G++ + +   G+ P+   T
Sbjct: 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 48/238 (20%)

Query: 87  DFGYDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVK 144
           +F       + +   + + +G G+FG   +      G++VAVK I+ +        +   
Sbjct: 10  EFYRSGWALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFL 62

Query: 145 REVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDA 201
            E  ++  L  H N+V+      E+   +YI  E    G L+D         Y  +   +
Sbjct: 63  AEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD---------YLRSRGRS 112

Query: 202 AVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-- 252
            +    +L+ + +      +L  +  VHRD+   N L     ED+  K +DFGL+     
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 169

Query: 253 -KPGKKFQDIVGSAYYV---APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
            +   K          V   APE L+ +K   +SDVWS G++ + I   GR P+    
Sbjct: 170 TQDTGKLP--------VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 43/236 (18%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+      LG G FG      Y       G  VAVK++   +   P    D +RE++
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQ 76

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+AL   + +VK+           + + ME    G L D  L +  +R       +   
Sbjct: 77  ILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF-LQRHRARLDASRLLLYSS 134

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            VHRD+   N L    + ++ +K  DFGL+  +   K       
Sbjct: 135 Q---ICKGMEYLGSRRCVHRDLAARNIL---VESEAHVKIADFGLAKLLPLDKD------ 182

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
             YYV            APE L       +SDVWS GV+ Y +     +      E
Sbjct: 183 --YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 46/247 (18%)

Query: 90  YDK-DFDRRY-TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEA 60

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            +++ +  H N+V+       +   YI  E    G LLD +        +          
Sbjct: 61  AVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVV 112

Query: 208 MLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           +L +A +      +L     +HRD+   N L     E+  +K  DFGLS  +        
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSRLMT------- 162

Query: 261 IVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDG 307
             G  Y             APE L   K   +SDVW+ GV+ + I   G  P+       
Sbjct: 163 --GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

Query: 308 IFKEVLR 314
           +++ + +
Sbjct: 221 VYELLEK 227

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 24/84 (28%), Positives = 45/84 (53%), Gaps = 5/84 (5%)

Query: 369 IDISVLNNMRQFVKYSRLKQFALRALASTLD--DEELADLRDQFDAIDVDKNGSISLEEM 426
           I  +VLNNM+ ++K+S ++   +  +A  L   +  +  + + F  +D + NGS+S  E+
Sbjct: 2   ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61

Query: 427 RQALAKDLPWKLKESRVLEILQAV 450
              LA      +K+  +  ILQA+
Sbjct: 62  YTVLAS---VGIKKWDINRILQAL 82

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180

 Score = 40.0 bits (94), Expect = 6e-04
 Identities = 11/61 (18%), Positives = 26/61 (42%), Gaps = 5/61 (8%)

Query: 394 LASTLDDEELAD--LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
           +A     + +    L+  F+ ID D++G IS  ++   +       L  + +     +V+
Sbjct: 96  MAGCYRWKNIESTFLKAAFNKIDKDEDGYISKSDIVSLVHDK---VLDNNDIDNFFLSVH 152

Query: 452 T 452
           +
Sbjct: 153 S 153

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 57/267 (21%)

Query: 67  QHQKTNSRR--QTGVIPCGKRTDFGYDKDFDR-----RYTIGKLLGHGQFGYTYVATDKA 119
            H K  +    Q   +PC         +            + K LG GQFG  ++AT   
Sbjct: 152 DHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK 211

Query: 120 NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC 179
           +   VAVK ++   M    +VE    E  +++ L  H+ +VK +     +  +YI  E  
Sbjct: 212 HTK-VAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVTKEP-IYIITEFM 264

Query: 180 EGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENF 230
             G LLD         +  +++ +   + +++  +A+       +     +HRD++  N 
Sbjct: 265 AKGSLLD---------FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKSG 278
           L          K  DFGL+         + I  + Y             APE +      
Sbjct: 316 LV---SASLVCKIADFGLA---------RVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363

Query: 279 PESDVWSIGVITY-ILLCGRRPFWDKT 304
            +SDVWS G++   I+  GR P+   +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMS 390

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 48/242 (19%)

Query: 94  FDRRY-TIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKIL 150
            D        ++G G FG    A  K +G R   A+K++++          D   E+++L
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVL 79

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKDAAV 203
             L  H N++    A E   Y+Y+A+E    G LLD              +      + +
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139

Query: 204 VVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
             +Q+L  AA+      +L     +HRD+   N L     E+   K  DFGLS       
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VGENYVAKIADFGLS------- 189

Query: 257 KFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWD 302
           + Q+      YV            A E L        SDVWS GV+ + I+  G  P+  
Sbjct: 190 RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

Query: 303 KT 304
            T
Sbjct: 245 MT 246

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 42/230 (18%), Positives = 77/230 (33%), Gaps = 41/230 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGD-------RVAVKKIEKNKMILPIAVEDVKREVKILQ 151
              + LG G F   +    +  GD        V +K ++K         E       ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMS 67

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            L+ H+++V  Y      +   +  E  + G L    L K  +         V +Q   +
Sbjct: 68  KLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDT-YLKKNKNCINILWKLEVAKQ---L 122

Query: 212 AAECH---LHGLVHRDMKPENFL-----FKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           AA  H    + L+H ++  +N L      +       +K +D G+S           ++ 
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLP 173

Query: 264 SAYY------VAPEVLK--RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                     V PE ++  +     +D WS G   + I   G +P     
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 68/317 (21%), Positives = 119/317 (37%), Gaps = 66/317 (20%)

Query: 36  RHNHHARNDTTHKHQHQHQERAKNYQQLKTK--------QHQKTNS----RRQTGVIPCG 83
               +A+      ++ +  +    Y   +T+         +   ++     R T V P  
Sbjct: 191 SDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTS 250

Query: 84  KRTDFGYDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIA 139
           K    G  KD     R    +   LG G FG  ++ T       VA+K ++   M    +
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----S 305

Query: 140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--T 197
            E   +E ++++ L  HE +V+ Y    ++  +YI  E    G LLD         +   
Sbjct: 306 PEAFLQEAQVMKKLR-HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLD---------FLKG 354

Query: 198 EKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD 250
           E    + + Q++ +AA+      ++     VHRD++  N L     E+   K  DFGL+ 
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLVCKVADFGLA- 410

Query: 251 FIKPGKKFQDIVGSAYYV-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGR 297
                   + I  + Y             APE     +   +SDVWS G++   +   GR
Sbjct: 411 --------RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 298 RPFWDKTEDGIFKEVLR 314
            P+       +  +V R
Sbjct: 463 VPYPGMVNREVLDQVER 479

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 41/240 (17%)

Query: 92  KDFDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
           K+  R+  T+ + LGHG FG  Y    +   N     +VAVK + +          D   
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLM 82

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  I+     H+N+V+           +I MEL  GG+L   +   +      + +++ +
Sbjct: 83  EALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR--PSQPSSLAM 139

Query: 206 RQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
             +L VA +      +L  +  +HRD+   N L          K  DFG++         
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 190

Query: 259 QDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           +DI  ++YY              PE         ++D WS GV+ + I   G  P+  K+
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 50/239 (20%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + + LG GQFG  ++     +  +VAVK +++  M    + +    E  +++ L  H+ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQR 69

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE-- 214
           +V+ Y     +  +YI  E  E G L+D         +  T     + + ++L +AA+  
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVD---------FLKTPSGIKLTINKLLDMAAQIA 119

Query: 215 ---CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV- 268
                +     +HRD++  N L     +  S K  DFGL+         + I  + Y   
Sbjct: 120 EGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA---------RLIEDNEYTAR 167

Query: 269 ----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRN 315
                     APE +       +SDVWS G++   I+  GR P+   T   + + + R 
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 48/225 (21%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            + + +G G+FG   +      G++VAVK I+ +        +    E  ++  L  H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLR-HSN 247

Query: 159 VVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE- 214
           +V+      E+   +YI  E    G L+D         Y  +   + +    +L+ + + 
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD---------YLRSRGRSVLGGDCLLKFSLDV 298

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L  +  VHRD+   N L     ED+  K +DFGL+         ++   +    
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---------KEASSTQDTG 346

Query: 269 -------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                  APE L+ +K   +SDVWS G++ + I   GR P+    
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 58/278 (20%)

Query: 67  QHQKTNS----RRQTGVIPCGKRTDFGYDKD---FDR-RYTIGKLLGHGQFGYTYVATDK 118
            +   ++     R T V P  K    G  KD     R    +   LG G FG  ++ T  
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206

Query: 119 ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL 178
               RVA+K ++   M    + E   +E ++++ L  HE +V+ Y    ++  +YI  E 
Sbjct: 207 GTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSEE-PIYIVTEY 259

Query: 179 CEGGELLDRILAKKDSRY--TEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPEN 229
              G LLD         +   E    + + Q++ +AA+      ++     VHRD++  N
Sbjct: 260 MSKGSLLD---------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN 310

Query: 230 FLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV-----------APEVLK-RKS 277
            L     E+   K  DFGL+         + I  + Y             APE     + 
Sbjct: 311 IL---VGENLVCKVADFGLA---------RLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 278 GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
             +SDVWS G++   +   GR P+       +  +V R
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 47/229 (20%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++    
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFD- 74

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H ++VK      ++  V+I MELC  GEL   +  +K S        + +  ++  A + 
Sbjct: 75  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQL 125

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     VHRD+   N L      +  +K  DFGLS         + +  S YY 
Sbjct: 126 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLS---------RYMEDSTYYK 173

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                      APE +  R+    SDVW  GV  + IL+ G +PF    
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 93.2 bits (232), Expect = 7e-21
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 47/246 (19%)

Query: 92  KDFDRRY-TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREV 147
           K+ D    +I K++G G+FG       K    +   VA+K ++           D   E 
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEA 97

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            I+     H N+++          V I  E  E G L    L K D+++T       V Q
Sbjct: 98  SIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFT-------VIQ 148

Query: 208 MLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
           ++ +         +L   G VHRD+   N L      +   K +DFGL   +      +D
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVL------ED 199

Query: 261 IVGSAYYV----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGI 308
              +AY            +PE +  RK    SDVWS G++ + ++  G RP+W+ +    
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--- 256

Query: 309 FKEVLR 314
            ++V++
Sbjct: 257 -QDVIK 261

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.9 bits (229), Expect = 8e-21
 Identities = 66/265 (24%), Positives = 98/265 (36%), Gaps = 59/265 (22%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANGD-------RVAVKKIEKNKMILPI 138
           YD     F R R  +GK LG G FG    A   A G         VAVK +++       
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKMLKEGAT--HS 72

Query: 139 AVEDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLD-------RILA 190
               +  E+KIL  +  H NVV    A  +    + + +E C+ G L           + 
Sbjct: 73  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

Query: 191 KKDSRYTEKDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKA 243
            K +        + +  ++  + +       L     +HRD+   N L     E + +K 
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL---LSEKNVVKI 189

Query: 244 TDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVIT 290
            DFGL+         +DI     YV            APE +  R    +SDVWS GV+ 
Sbjct: 190 CDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240

Query: 291 Y-ILLCGRRPFWDKTEDGIFKEVLR 314
           + I   G  P+     D   +E  R
Sbjct: 241 WEIFSLGASPYPGVKID---EEFCR 262

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 70/313 (22%), Positives = 104/313 (33%), Gaps = 77/313 (24%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD---FDRRY-TIGKLL 104
           + H H     +Y    T+            +   G       D+D   F+ R+    + L
Sbjct: 4   YHHHHHH---DYDIPTTE-----------NLYFQGAMGSAFEDRDPTQFEERHLKFLQQL 49

Query: 105 GHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV 160
           G G FG      Y       G+ VAVKK++ +       + D +RE++IL++L  H+N+V
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQ-HDNIV 105

Query: 161 KFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC--- 215
           K+           + + ME    G L D  L K   R           Q   +       
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTSQ---ICKGMEYL 161

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                +HRD+   N L    + ++ +K  DFGL+  +   K+        YY        
Sbjct: 162 GTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDKE--------YYKVKEPGES 210

Query: 269 -----APEVLK-RKSGPESDVWSIGV-----ITYILLCGRRPFWDKTEDGIFKEVLRNKP 317
                APE L   K    SDVWS GV      TYI      P       G          
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG---------- 260

Query: 318 DFRRKPWPSISNS 330
                    +   
Sbjct: 261 ---NDKQGQMIVF 270

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 61/265 (23%), Positives = 92/265 (34%), Gaps = 60/265 (22%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F+ R+    + LG G FG      Y       G+ VAVKK++ +       + D +RE++
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIE 63

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL++L  H+N+VK+           + + ME    G L D  L K   R           
Sbjct: 64  ILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY-LQKHKERIDHIKLLQYTS 121

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            +HRD+   N L    + ++ +K  DFGL+  +   K+      
Sbjct: 122 Q---ICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDKE------ 169

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGV-----ITYILLCGRRPFWDKTE 305
             ++             APE L   K    SDVWS GV      TYI      P      
Sbjct: 170 --FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

Query: 306 DGIFKEVLRNKPDFRRKPWPSISNS 330
            G                   +   
Sbjct: 228 IG-------------NDKQGQMIVF 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 63/252 (25%), Positives = 93/252 (36%), Gaps = 52/252 (20%)

Query: 86  TDFGYDKD--FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD-RVAVKKIEKNKMILP 137
           T   YD    F R R + GK LG G FG    AT     K++    VAVK ++ +     
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--L 67

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------RI 188
              E +  E+K+L  L  H N+V    A        +  E C  G+LL+           
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 189 LAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSL 241
                +   + + A+ +  +L  + +       L     +HRD+   N L          
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRIT 184

Query: 242 KATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV 288
           K  DFGL+         +DI   + YV            APE +       ESDVWS G+
Sbjct: 185 KICDFGLA---------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 289 ITY-ILLCGRRP 299
             + +   G  P
Sbjct: 236 FLWELFSLGSSP 247

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 56/225 (24%), Positives = 83/225 (36%), Gaps = 39/225 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            + ++LG G FG  Y      +      VAVK  +K+        E    E  I++ L  
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLD- 71

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           H ++VK     E++   +I MEL   GEL    L +  +        +   Q   +    
Sbjct: 72  HPHIVKLIGIIEEEP-TWIIMELYPYGELGHY-LERNKNSLKVLTLVLYSLQ---ICKAM 126

Query: 216 H---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---- 268
                   VHRD+   N L         +K  DFGLS         + I    YY     
Sbjct: 127 AYLESINCVHRDIAVRNIL---VASPECVKLGDFGLS---------RYIEDEDYYKASVT 174

Query: 269 -------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                  +PE +  R+    SDVW   V  + IL  G++PF+   
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 39/226 (17%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              K+LG G FG  Y       G++    VA+K++ +     P A +++  E  ++ ++ 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVD 75

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            + +V +          V +  +L   G LLD  + +       +       Q   +A  
Sbjct: 76  -NPHVCRLLGICLTST-VQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQ---IAKG 129

Query: 215 CH---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
            +      LVHRD+   N L    K    +K TDFGL+  +              Y    
Sbjct: 130 MNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGA--------EEKEYHAEG 178

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   A E +  R    +SDVWS GV  + ++  G +P+    
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.8 bits (233), Expect = 2e-20
 Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 47/237 (19%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++    
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQF-D 449

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE- 214
           H ++VK      ++  V+I MELC  GEL   +  +K S        + +  ++  A + 
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQL 500

Query: 215 ----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV 268
                +L     VHRD+   N L      +  +K  DFGLS +++          S YY 
Sbjct: 501 STALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYME---------DSTYYK 548

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
                      APE +  R+    SDVW  GV  + IL+ G +PF     + +   +
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 48/252 (19%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKI 149
               ++T+G++LG G+FG         +     +VAVK + K  +I    +E+  RE   
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAAC 78

Query: 150 LQALAGHENVVKFY------NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAV 203
           ++    H +V K         A        + +   + G+L   +     SR  E    +
Sbjct: 79  MKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL---LASRIGENPFNL 134

Query: 204 VVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK 256
            ++ ++R   +      +L     +HRD+   N +     ED ++   DFGLS       
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM---LAEDMTVCVADFGLS------- 184

Query: 257 KFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWD 302
             + I    YY             A E L        SDVW+ GV  + I+  G+ P+  
Sbjct: 185 --RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

Query: 303 KTEDGIFKEVLR 314
                I+  ++ 
Sbjct: 243 IENAEIYNYLIG 254

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 52/284 (18%)

Query: 63  LKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHGQFGYTYVATDKA 119
           + +  H   +S   +G++P G        +D   DR    +GK+LG G+FG       K 
Sbjct: 1   MGSSHHHHHHS---SGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57

Query: 120 NGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFY-----NAFEDDNY 171
                 +VAVK + K        +E+   E   ++    H NV++        + +    
Sbjct: 58  EDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPK 115

Query: 172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRD 224
             + +   + G+L   +     SR       + ++ +L+   +      +L     +HRD
Sbjct: 116 PMVILPFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172

Query: 225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEV 272
           +   N +    ++D ++   DFGLS         + I    YY             A E 
Sbjct: 173 LAARNCM---LRDDMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIES 220

Query: 273 LK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
           L  R    +SDVW+ GV  + I   G  P+       ++  +L 
Sbjct: 221 LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 42/236 (17%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F++R+    + LG G FG      Y       G++VAVK ++         + D+K+E++
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIE 75

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HEN+VK+     +D    + + ME    G L +  L K  ++   K       
Sbjct: 76  ILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY-LPKNKNKINLKQQLKYAV 133

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +            VHRD+   N L    + +  +K  DFGL+  I+  K+      
Sbjct: 134 Q---ICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKE------ 181

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
             YY             APE L   K    SDVWS GV  + +L            
Sbjct: 182 --YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 71/292 (24%), Positives = 110/292 (37%), Gaps = 61/292 (20%)

Query: 51  HQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKD--FDR-RYTIGKLLGHG 107
           H+++++ +   QL+  Q   ++      V       ++ YD    F R     GK+LG G
Sbjct: 1   HKYKKQFRYESQLQMVQVTGSSDNEYFYVDF----REYEYDLKWEFPRENLEFGKVLGSG 56

Query: 108 QFGYTYVAT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
            FG    AT     K     +VAVK +++         E +  E+K++  L  HEN+V  
Sbjct: 57  AFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL 114

Query: 163 YNAFEDDNYVYIAMELCEGGELLD--------------RILAKKDSRYTEKDAAVVVRQM 208
             A      +Y+  E C  G+LL+                  +K     E    +    +
Sbjct: 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174

Query: 209 LRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           L  A +       L     VHRD+   N L         +K  DFGL+         +DI
Sbjct: 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVL---VTHGKVVKICDFGLA---------RDI 222

Query: 262 VGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
           +  + YV            APE L       +SDVWS G++ + I   G  P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 50/257 (19%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD---RVAVKKIEKNKMILPIAVEDVKR 145
             R R  +GK LG G FG   +A     DK   +   +VAVK ++ +       + D+  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLIS 123

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTE 198
           E+++++ +  H+N++    A   D  +Y+ +E    G L +         L    +    
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 199 KDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
            +  +  + ++  A +      +L     +HRD+   N L     ED+ +K  DFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL---VTEDNVMKIADFGLA-- 238

Query: 252 IKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGR 297
                  +DI    YY             APE L  R    +SDVWS GV+ + I   G 
Sbjct: 239 -------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

Query: 298 RPFWDKTEDGIFKEVLR 314
            P+     + +FK +  
Sbjct: 292 SPYPGVPVEELFKLLKE 308

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 11/96 (11%)

Query: 368 PIDISVLNNMRQFVKYSRLKQFALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEM 426
                 L NM++F    +L Q A+  + S L   EE  +L   F  +D + +G +  +E+
Sbjct: 3   HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKEL 62

Query: 427 RQALAKDLPW----------KLKESRVLEILQAVNT 452
            +   K + W             E+ V  ILQ+V+ 
Sbjct: 63  IEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVDF 98

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191

 Score = 39.6 bits (93), Expect = 9e-04
 Identities = 12/53 (22%), Positives = 21/53 (39%), Gaps = 5/53 (9%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           L   E   L   F   D D +G I+ EE+ +        ++ +    ++LQ  
Sbjct: 119 LLSRE--RLLAAFQQFDSDGSGKITNEELGRLFGVT---EVDDETWHQVLQEC 166

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 64/261 (24%), Positives = 95/261 (36%), Gaps = 54/261 (20%)

Query: 94  FDRRY-TIGKLLGHGQFG----YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           F +RY    + LG G FG    Y Y  T+   G+ VAVK ++ +    P      K+E+ 
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEID 85

Query: 149 ILQALAGHENVVKFYNAFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
           IL+ L  HE+++K+    ED     + + ME    G L D +              +  +
Sbjct: 86  ILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQ 141

Query: 207 QMLRVAAEC---HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVG 263
           Q   +       H    +HRD+   N L      D  +K  DFGL+  +  G +      
Sbjct: 142 Q---ICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHE------ 189

Query: 264 SAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIF 309
             YY             APE LK  K    SDVWS GV  Y +L          T+    
Sbjct: 190 --YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247

Query: 310 KEVLRNKPDFRRKPWPSISNS 330
             +              ++  
Sbjct: 248 IGI----------AQGQMTVL 258

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 58/261 (22%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT-------DKANGDRVAVKKIEKNKMILPIAVEDVKR 145
           F R + T+GK LG G FG   +A               VAVK ++ +       + D+  
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVS 89

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTE 198
           E+++++ +  H+N++    A   D  +Y+ +E    G L +         +         
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 199 KDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF 251
            +  +  + ++    +      +L     +HRD+   N L     E++ +K  DFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTENNVMKIADFGLA-- 204

Query: 252 IKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV-----ITYIL 293
                  +DI    YY             APE L  R    +SDVWS GV      T   
Sbjct: 205 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL-- 255

Query: 294 LCGRRPFWDKTEDGIFKEVLR 314
             G  P+     + +FK +  
Sbjct: 256 --GGSPYPGIPVEELFKLLKE 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 70/329 (21%), Positives = 122/329 (37%), Gaps = 57/329 (17%)

Query: 24  HHRNANKEEAKR---RHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVI 80
           HH ++    A     +     R  T                ++ T+     ++    GV 
Sbjct: 7   HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66

Query: 81  PCGKRTDFGYDK-DFDR-RYTIGKLLGHGQFGYTYVAT----DKANGD---RVAVKKIEK 131
                 D    K +F R + T+GK LG G FG   +A     DK        VAVK ++ 
Sbjct: 67  EYELPED---PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123

Query: 132 NKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD----- 186
           +       + D+  E+++++ +  H+N++    A   D  +Y+ +E    G L +     
Sbjct: 124 DAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 181

Query: 187 --RILAKKDSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKE 237
               +          +  +  + ++    +      +L     +HRD+   N L     E
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL---VTE 238

Query: 238 DSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVW 284
           ++ +K  DFGL+         +DI    YY             APE L  R    +SDVW
Sbjct: 239 NNVMKIADFGLA---------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289

Query: 285 SIGVITY-ILLCGRRPFWDKTEDGIFKEV 312
           S GV+ + I   G  P+     + +FK +
Sbjct: 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLL 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 64/317 (20%), Positives = 107/317 (33%), Gaps = 90/317 (28%)

Query: 99  TIGKLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALAG 155
            + +L+G G++G  Y    K   +   VAVK             ++   E  I +  L  
Sbjct: 16  KLLELIGRGRYGAVY----KGSLDERPVAVKVFSFANR------QNFINEKNIYRVPLME 65

Query: 156 HENVVKFYNAFEDDNYV-----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
           H+N+ +F    E           + ME    G L   +                     R
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----------SLHTSDWVSSCR 115

Query: 211 VAAE-----CHLH-----------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
           +A        +LH            + HRD+   N L    K D +   +DFGLS  +  
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTG 172

Query: 255 GKKFQD---------IVGSAYYVAPEVLK--------RKSGPESDVWSIGVITYILLCG- 296
            +  +           VG+  Y+APEVL+          +  + D++++G+I + +    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 297 ------------RRPFWDK-----TEDGIFKEVLRNK--PDFRRKPWPSISNSAKDFVKK 337
                       +  F  +     T + +   V R K  P F    W   S + +   K+
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSL-KE 290

Query: 338 LLVK----DPRARLTAA 350
            +      D  ARLTA 
Sbjct: 291 TIEDCWDQDAEARLTAQ 307

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 43/239 (17%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
             R + T+ + LG G FG  Y  VA      +   RVA+K + +          +   E 
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEA 79

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVR 206
            +++      +VV+            + MEL   G+L   + + +         A   + 
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 207 QMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ 259
           +M+++A E      +L  +  VHRD+   N +     ED ++K  DFG++         +
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFTVKIGDFGMT---------R 186

Query: 260 DIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           DI  + YY             +PE LK       SDVWS GV+ + I     +P+   +
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166

 Score = 83.7 bits (208), Expect = 4e-19
 Identities = 30/75 (40%), Positives = 51/75 (68%), Gaps = 1/75 (1%)

Query: 378 RQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK 437
           +QF   ++ K+ ALR +A +L +EE+A L++ F+ ID DK+G I+ EE++  L K +   
Sbjct: 1   KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGL-KRVGAN 59

Query: 438 LKESRVLEILQAVNT 452
           LKES +L+++QA + 
Sbjct: 60  LKESEILDLMQAADV 74

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 51/223 (22%), Positives = 84/223 (37%), Gaps = 38/223 (17%)

Query: 101 GKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN 158
            K LG G FG       +       VAVK ++      P   +++  E  ++Q L  +  
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLD-NPY 79

Query: 159 VVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-- 216
           +V+      +     + ME+ E G L   +  +++    +K+   +V Q   V+      
Sbjct: 80  IVRMI-GICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ---VSMGMKYL 133

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------- 268
                VHRD+   N L          K +DFGLS  ++            YY        
Sbjct: 134 EESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALR--------ADENYYKAQTHGKW 182

Query: 269 -----APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                APE +   K   +SDVWS GV+ +     G++P+    
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 53/226 (23%), Positives = 83/226 (36%), Gaps = 39/226 (17%)

Query: 99  TIGKL-LGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            I  + LG G FG       +    +  VA+K +++         E++ RE +I+  L  
Sbjct: 12  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLD- 68

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           +  +V+          + + ME+  GG L    L  K       +   V   + +V+   
Sbjct: 69  NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKF-LVGKREEIPVSN---VAELLHQVSMGM 123

Query: 216 H---LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---- 268
                   VHRD+   N L          K +DFGLS  +            +YY     
Sbjct: 124 KYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKALG--------ADDSYYTARSA 172

Query: 269 --------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
                   APE +  RK    SDVWS GV  +  L  G++P+    
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 47/230 (20%)

Query: 99  TIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALA 154
              K+LG G FG  +       G+     V +K IE        + + V   +  + +L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            H ++V+        + + +  +    G LLD +   + +        +  + +L    +
Sbjct: 74  -HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQ 123

Query: 215 -----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
                 +L  HG+VHR++   N L    K  S ++  DFG++D + P             
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVL---LKSPSQVQVADFGVADLLPP--------DDKQL 172

Query: 268 V-----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKT 304
           +           A E +   K   +SDVWS GV  + ++  G  P+    
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 26/139 (18%), Positives = 50/139 (35%), Gaps = 14/139 (10%)

Query: 320 RRKPWPSISNSAKDFVKKLLVKDPR------ARLTAAQALSHPWVREGGDASEIPIDISV 373
           R +    I+   ++   KL   D +      AR  A +            A +  +   +
Sbjct: 39  RDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAAR--GDAAAEKQRLASLL 96

Query: 374 LNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD 433
            +       Y+RL+          L +E+   LR  F +  V  +G  S ++++Q LAK 
Sbjct: 97  KDLEDDASGYNRLRPSK-----PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAK- 150

Query: 434 LPWKLKESRVLEILQAVNT 452
               + E  + ++   V  
Sbjct: 151 YADTIPEGPLKKLFVMVEN 169

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 12/48 (25%), Positives = 20/48 (41%)

Query: 403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           L  LR  +   D DK+G +S EE+++ L      +    +       V
Sbjct: 252 LLVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 54/247 (21%), Positives = 91/247 (36%), Gaps = 43/247 (17%)

Query: 90  YDKDFDRRY-TIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKR 145
                        +++G G FG  Y  T   N  +    AVK + +        V     
Sbjct: 18  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLT 75

Query: 146 EVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
           E  I++    H NV+         +    + +   + G+L +  +  +    T KD   +
Sbjct: 76  EGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKD---L 130

Query: 205 VRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
           +   L+VA    +L     VHRD+   N +     E  ++K  DFGL+         +D+
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCM---LDEKFTVKVADFGLA---------RDM 178

Query: 262 VGSAYYV--------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTE 305
               YY               A E L+ +K   +SDVWS GV+ + ++  G  P+ D   
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238

Query: 306 DGIFKEV 312
             I   +
Sbjct: 239 FDITVYL 245

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 86.3 bits (214), Expect = 9e-19
 Identities = 60/288 (20%), Positives = 102/288 (35%), Gaps = 60/288 (20%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFDRRYTIGKLLGHGQ 108
           H H H     +            N   Q+   P GK  D         ++ +GK +G G 
Sbjct: 2   HHHHHHSSGVDLG--------TENLYFQSMPFPEGKVLDDM----EGNQWVLGKKIGSGG 49

Query: 109 FGYTYVATDKANGDRVAVK--KIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYN-- 164
           FG  Y+A      ++ A    K+E  +         +  E+K  Q +A  + + K+    
Sbjct: 50  FGLIYLAFPTNKPEKDARHVVKVEYQE------NGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 165 ----------------AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
                            F+  +Y ++ ME    G  L +I   ++  + +     +  +M
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI------- 261
           L V    H +  VH D+K  N L    K    +   D+GLS    P    +         
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 262 -VGSAYYVAPEVLKRKSGPE----SDVWSIG-VITYILLCGRRPFWDK 303
             G+  + + +  K   G      SDV  +G  +    LCG+ P W++
Sbjct: 220 HNGTIEFTSLDAHK---GVALSRRSDVEILGYCMLR-WLCGKLP-WEQ 262

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 48/245 (19%), Positives = 87/245 (35%), Gaps = 49/245 (20%)

Query: 94  FDRRY-TIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
                    + LG  +FG  Y       A G+    VA+K ++          E+ + E 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEA 63

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKD 200
            +   L  H NVV        D  + +    C  G+L +                     
Sbjct: 64  MLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 201 AAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
           +A+     + + A+      +L  H +VH+D+   N L     +  ++K +D GL     
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL---VYDKLNVKISDLGLF---- 175

Query: 254 PGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
                +++  + YY             APE +   K   +SD+WS GV+ + +   G +P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 300 FWDKT 304
           +   +
Sbjct: 231 YCGYS 235

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 57/326 (17%), Positives = 105/326 (32%), Gaps = 43/326 (13%)

Query: 11  SGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQERAKNYQQLKTKQHQK 70
                G ++++    R +              +      +       K   +    Q   
Sbjct: 3   PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62

Query: 71  TNSRRQTGVIPCGKRTDFGYDKDFDRRY-TIGKLLGHGQFGYTY--VATDKANGD-RVAV 126
           T     + + P   +                 +++G G FG  Y     D        AV
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 127 KKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELL 185
           K + +        V     E  I++  + H NV+         +    + +   + G+L 
Sbjct: 123 KSLNRITD--IGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 186 DRILAKKDSRYTEKDAAVVVRQMLRVAAEC-HL--HGLVHRDMKPENFLFKSAKEDSSLK 242
           +  +  +    T KD   ++   L+VA     L     VHRD+   N +     E  ++K
Sbjct: 180 N-FIRNETHNPTVKD---LIGFGLQVAKGMKFLASKKFVHRDLAARNCM---LDEKFTVK 232

Query: 243 ATDFGLSDFIKPGKKFQDIVGSAYYV--------------APEVLK-RKSGPESDVWSIG 287
             DFGL+         +D+    +                A E L+ +K   +SDVWS G
Sbjct: 233 VADFGLA---------RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283

Query: 288 VITY-ILLCGRRPFWDKTEDGIFKEV 312
           V+ + ++  G  P+ D     I   +
Sbjct: 284 VLLWELMTRGAPPYPDVNTFDITVYL 309

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 49/244 (20%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
             R    +   LG G FG  +     +         VAVK +   K     A +D +RE 
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREA 94

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD------RILAKKDSRYTEKDA 201
           ++L  L  H+++V+F+    +   + +  E    G+L                       
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 202 AVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP 254
            + + Q+L VA++      +L     VHRD+   N L     +   +K  DFG+S     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL---VGQGLVVKIGDFGMS----- 205

Query: 255 GKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPF 300
               +DI  + YY              PE +  RK   ESDVWS GV+ + I   G++P+
Sbjct: 206 ----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 301 WDKT 304
           +  +
Sbjct: 262 YQLS 265

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 42/239 (17%)

Query: 99  TIGKLLGHGQFGYTY--VATDKANGD-RVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
              +++G G FG  Y     D+A    + A+K + +        VE   RE  +++ L  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLN- 80

Query: 156 HENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           H NV+         +   ++ +     G+LL   +       T KD   ++   L+VA  
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKD---LISFGLQVARG 136

Query: 215 C-HL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV--- 268
             +L     VHRD+   N +     E  ++K  DFGL+         +DI+   YY    
Sbjct: 137 MEYLAEQKFVHRDLAARNCM---LDESFTVKVADFGLA---------RDILDREYYSVQQ 184

Query: 269 -----------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLR 314
                      A E L+  +   +SDVWS GV+ + +L  G  P+       +   + +
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 61/236 (25%), Positives = 90/236 (38%), Gaps = 56/236 (23%)

Query: 94  FDR-RYTIGKLLGHGQFGYTYVAT----DKANGD-RVAVKKIEKNKMILPIAVEDVKREV 147
           F R    +GK LG G+FG    AT        G   VAVK +++N    P  + D+  E 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEF 77

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------------RILAKK 192
            +L+ +  H +V+K Y A   D  + + +E  + G L                       
Sbjct: 78  NVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 193 DSRYTEKDAAVVVRQMLRVAAEC-----HL--HGLVHRDMKPENFLFKSAKEDSSLKATD 245
            S     + A+ +  ++  A +      +L    LVHRD+   N L     E   +K +D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL---VAEGRKMKISD 193

Query: 246 FGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGV 288
           FGLS         +D+     YV            A E L       +SDVWS GV
Sbjct: 194 FGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 50/245 (20%)

Query: 94  FDRRY-TIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
             RR   + + LG G FG  ++A         +   VAVK ++   +    A +D +RE 
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREA 68

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD-------RILAKKDSRYTEKD 200
           ++L  L  HE++VKFY    D + + +  E  + G+L           +   D +  +  
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 201 AAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK 253
             + + QML +A++      +L     VHRD+   N L      +  +K  DFG+S    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL---VGANLLVKIGDFGMS---- 180

Query: 254 PGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY-ILLCGRRP 299
                +D+  + YY              PE +  RK   ESDVWS GVI + I   G++P
Sbjct: 181 -----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

Query: 300 FWDKT 304
           ++  +
Sbjct: 236 WFQLS 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 84.2 bits (208), Expect = 2e-17
 Identities = 63/328 (19%), Positives = 100/328 (30%), Gaps = 52/328 (15%)

Query: 10  VSGSNSGSNNNNANHHRNANKEEAKRRHNHHARNDTTHKHQHQHQER--AKNYQQLKTKQ 67
           V      ++              A       A     H     H +R          T +
Sbjct: 236 VEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPE 295

Query: 68  HQKTNSRRQTGVIPCGKRTDFGYDKDF------------DRRYTIGKLLGHGQFGYTYVA 115
             +  S  +   +P           D             D        LG G FG     
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355

Query: 116 TDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY 173
             +    +  VA+K +++         E++ RE +I+  L  +  +V+          + 
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQL-DNPYIVRLI-GVCQAEALM 411

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH---LHGLVHRDMKPENF 230
           + ME+  GG L    L  K       + A ++ Q   V+           VHR++   N 
Sbjct: 412 LVMEMAGGGPLHKF-LVGKREEIPVSNVAELLHQ---VSMGMKYLEEKNFVHRNLAARNV 467

Query: 231 LFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKS 277
           L          K +DFGLS  +            +YY             APE +  RK 
Sbjct: 468 L---LVNRHYAKISDFGLSKALG--------ADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 278 GPESDVWSIGVITY-ILLCGRRPFWDKT 304
              SDVWS GV  +  L  G++P+    
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 51/253 (20%), Positives = 90/253 (35%), Gaps = 57/253 (22%)

Query: 94  FDR-RYTIGKLLGHGQFGYTY--VATDKANGD---RVAVKKIEKNKMILPIAVEDVKREV 147
           + R      + +G G FG  +   A      +    VAVK +++          D +RE 
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREA 101

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLD---------------RILAKK 192
            ++     + N+VK          + +  E    G+L +                 L+ +
Sbjct: 102 ALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160

Query: 193 DSRYTEKDAAVVVRQMLRVAAE-----CHL--HGLVHRDMKPENFLFKSAKEDSSLKATD 245
               +     +   + L +A +      +L     VHRD+   N L     E+  +K  D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL---VGENMVVKIAD 217

Query: 246 FGLSDFIKPGKKFQDIVGSAYYV------------APEVLK-RKSGPESDVWSIGVITY- 291
           FGLS         ++I  + YY              PE +   +   ESDVW+ GV+ + 
Sbjct: 218 FGLS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 292 ILLCGRRPFWDKT 304
           I   G +P++   
Sbjct: 269 IFSYGLQPYYGMA 281

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 34/230 (14%), Positives = 63/230 (27%), Gaps = 36/230 (15%)

Query: 49  HQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKR-TDFGYDKDFDRRYTIGKLLGHG 107
           H H H     +           T S      +P G   TD        R++ +       
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMTTSLEA---LPTGTVLTDK-----SGRQWKLKSFQTRD 53

Query: 108 QFGYTYVATDKANGD--------RVAVKKIEKNKMILPIAVEDVKREVKILQALA----- 154
             G  Y A   +           + ++K ++     L       +R  K LQ        
Sbjct: 54  NQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLY 112

Query: 155 --GHENVVKFY-NAFEDDNYVYIAMELCEGGELLDRILAKKDSR-YTEKDAAVVVRQMLR 210
                 +          D Y ++ +     G  L   L        +E+    V  ++L 
Sbjct: 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRLLD 170

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD 260
                H +  VH ++  EN       + S +    +G +       ++  
Sbjct: 171 ALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFA------FRYCP 213

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 44/239 (18%), Positives = 77/239 (32%), Gaps = 45/239 (18%)

Query: 96  RRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
             + +G  +G G FG  Y+A         +     VK    +   L         E+K  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL-------FTELKFY 87

Query: 151 QALAGHENVVKFYNA------------------FEDDNYVYIAMELCEGGELLDRILAKK 192
           Q  A  E + K+                         +Y ++ M+    G  L +I    
Sbjct: 88  QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN 145

Query: 193 DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI 252
             R++ K    +  ++L +    H H  VH D+K  N L  + K    +   D+GL+   
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRY 204

Query: 253 KPGKKFQDI--------VGSAYYVAPEV-LKRKSGPESDVWSIG-VITYILLCGRRPFW 301
            P    +           G+  + + +           D+  +G  +    L G  P W
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ-WLTGHLP-W 261

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87

 Score = 67.5 bits (166), Expect = 2e-14
 Identities = 18/63 (28%), Positives = 36/63 (57%), Gaps = 1/63 (1%)

Query: 388 QFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEIL 447
               + +A  L +EE+  L++ F  ID D +G+I+ +E++  L K +  +L ES + +++
Sbjct: 7   DDDDKHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGL-KRVGSELMESEIKDLM 65

Query: 448 QAV 450
            A 
Sbjct: 66  DAA 68

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220

 Score = 63.6 bits (155), Expect = 9e-12
 Identities = 15/98 (15%), Positives = 37/98 (37%), Gaps = 1/98 (1%)

Query: 355 HPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAID 414
            P V      +  PI  S +     +     ++      L +T+  ++   +   F  +D
Sbjct: 2   QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61

Query: 415 VDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
            D++G++ + E+          +L     L +++  +T
Sbjct: 62  RDRSGTLEINELMMGQFP-GGIRLSPQTALRMMRIFDT 98

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 2e-10
 Identities = 75/504 (14%), Positives = 139/504 (27%), Gaps = 138/504 (27%)

Query: 37  HNHHARNDT-THKHQHQHQERAKNYQQLKTKQHQKTNSRRQTGVIPCGKRTDFGYDKDFD 95
           H+HH   D  T +HQ+Q+++    ++                          F    +FD
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFED------------------------AF--VDNFD 34

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
            +                + + +       +  I    ++   AV    R    L  L+ 
Sbjct: 35  CKDVQDMPKS--------ILSKEE------IDHI----IMSKDAVSGTLRLFWTL--LSK 74

Query: 156 HENVVK-FYNAFEDDNYVYIAMEL---CEGGELL-DRILAKKDSRYTEKDAAV---VVR- 206
            E +V+ F       NY ++   +        ++    + ++D  Y +        V R 
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134

Query: 207 ----------QMLRVAAECHLHGL-----------VHRDMKPE-NFLFK--------SAK 236
                       LR A    + G+           V    K +    FK           
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194

Query: 237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEV-------LKRKSGPES-----DVW 284
            ++ L+     L           D   +       +       LK K          +V 
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 285 SIGVITY------ILLCGRRPFWDK--TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
           +            ILL  R     K  T+            D       +        +K
Sbjct: 255 NAKAWNAFNLSCKILLTTR----FKQVTDFLSAATTTHISLDHHSMTL-TPDEVKSLLLK 309

Query: 337 KLLVKD---PRARLTAAQALS-HPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALR 392
            L  +    PR      + L+ +P        S I   I          K+    +    
Sbjct: 310 YLDCRPQDLPR------EVLTTNPRR-----LSIIAESIRDGLATWDNWKHVNCDKLT-T 357

Query: 393 ALASTLDDEELADLRDQFDAIDV-DKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAV 450
            + S+L+  E A+ R  FD + V   +  I        L+  L W  + +S V+ ++  +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT----ILLS--LIWFDVIKSDVMVVVNKL 411

Query: 451 NTPFLGLFLPCHEKGEKFSYLLLF 474
           +   L   +    K    S   ++
Sbjct: 412 HKYSL---VEKQPKESTISIPSIY 432

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 44/194 (22%), Positives = 71/194 (36%), Gaps = 16/194 (8%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIA----V 140
           YD     F R R  +GK LG G FG    A   A G D+ A  +    KM+   A     
Sbjct: 12  YDASKWEFPRDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKMLKEGATHSEH 69

Query: 141 EDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEK 199
             +  E+KIL  +  H NVV    A  +    + + +E C+ G L   + +K++     K
Sbjct: 70  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129

Query: 200 DAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSDFIKPGKK 257
                 RQ         +      D    +    S+   E+ SL   +   +        
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189

Query: 258 F--QDIVGSAYYVA 269
              + ++  ++ VA
Sbjct: 190 LTLEHLICYSFQVA 203

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 34/120 (28%), Positives = 47/120 (39%), Gaps = 31/120 (25%)

Query: 219 GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYV---------- 268
             +HRD+   N L     E + +K  DFGL+         +DI     YV          
Sbjct: 213 KCIHRDLAARNILLS---EKNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLK 260

Query: 269 --APEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRN-----KPDF 319
             APE +  R    +SDVWS GV+ + I   G  P+     D  F   L+       PD+
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 12/77 (15%), Positives = 28/77 (36%), Gaps = 4/77 (5%)

Query: 378 RQFVKYSRLKQFALRALASTLDD----EELADLRDQFDAIDVDKNGSISLEEMRQALAKD 433
            +  K ++ ++ A   +   +      E      + F   D ++ G +  +E+     + 
Sbjct: 18  DKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEV 77

Query: 434 LPWKLKESRVLEILQAV 450
           L      SRV +I +  
Sbjct: 78  LKLDEFTSRVRDITKRA 94

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 14/63 (22%), Positives = 25/63 (39%), Gaps = 2/63 (3%)

Query: 390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA 449
             R +   + D    +L   FD ID   N  +  EE ++A+ K   W  K      + + 
Sbjct: 118 EFRLMLCYIYDFF--ELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKE 175

Query: 450 VNT 452
           ++ 
Sbjct: 176 LDK 178

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91

 Score = 54.3 bits (131), Expect = 1e-09
 Identities = 17/65 (26%), Positives = 29/65 (44%), Gaps = 3/65 (4%)

Query: 386 LKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLE 445
             +  L    +  D EELA LR  F A D +++G +  EE R    + L   ++ +    
Sbjct: 9   SGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTE-LR--VRPADAEA 65

Query: 446 ILQAV 450
           + Q +
Sbjct: 66  VFQRL 70

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 64/247 (25%)

Query: 92  KDFDRRYTIGK--LLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKR-- 145
            +FD R        +G G FG  Y    K   N   VAVKK+     ++ I  E++K+  
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY----KGYVNNTTVAVKKL---AAMVDITTEELKQQF 77

Query: 146 --EVKILQALAGHENVVKFYN-AFEDDNY--VYIAMELCEGGELLDRILAKKDSRYTEKD 200
             E+K++     HEN+V+    + + D+   VY        G LLDR+            
Sbjct: 78  DQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY---VYMPNGSLLDRLSCLDG------- 126

Query: 201 AAVVVRQML----RV-----AAE--CHLH--GLVHRDMKPENFLFKSAKEDSSLKA--TD 245
                   L    R      AA     LH    +HRD+K  N L      D +  A  +D
Sbjct: 127 -----TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL-----DEAFTAKISD 176

Query: 246 FGLSDFIKPGKKFQD------IVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRP 299
           FGL+   +  +KF        IVG+  Y+APE L+ +  P+SD++S GV+   ++ G   
Sbjct: 177 FGLA---RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPA 233

Query: 300 FWDKTED 306
             D+  +
Sbjct: 234 V-DEHRE 239

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.6 bits (138), Expect = 3e-09
 Identities = 30/182 (16%), Positives = 54/182 (29%), Gaps = 49/182 (26%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKI-----EKNKMILPIAVEDVKREVKILQ 151
           +    + +G G FG  +          VA+K I     +          E++  E+ I +
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 152 ALAG--------HENVVKFYNAF------------------------------EDDNYVY 173
            L+          E  +   +                                  D+ ++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDMKPENFLF 232
           I +E   GG  L+++  K  S      A  ++ Q+    A         HRD+   N L 
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 233 KS 234
           K 
Sbjct: 196 KK 197

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 11/68 (16%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 387 KQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD----LPWKLKESR 442
            ++A++      +   +   +  FD +D++ NG I+L+E+    + D    L    ++++
Sbjct: 3   SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62

Query: 443 VLEILQAV 450
             ++    
Sbjct: 63  RHQVCVEA 70

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188

 Score = 54.2 bits (131), Expect = 9e-09
 Identities = 17/56 (30%), Positives = 34/56 (60%), Gaps = 1/56 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           A  L +EE+  L++ F  ID D +G+I+ +E++  L + +  +L ES + +++ A 
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSELMESEIKDLMDAA 55

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108

 Score = 51.1 bits (123), Expect = 2e-08
 Identities = 15/58 (25%), Positives = 27/58 (46%), Gaps = 2/58 (3%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK--DLPWKLKESRVLEILQAV 450
            S L     + ++D F  ID D++G +  +E++  L K      +L ES    ++ A 
Sbjct: 32  TSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 9/89 (10%)

Query: 362 GDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSI 421
           G     P+  S ++ +   ++        LRA   +     +  L   F  +D D + S+
Sbjct: 3   GLVPRGPLG-SHMDAVDATME-------KLRAQCLSRGASGIQGLARFFRQLDRDGSRSL 54

Query: 422 SLEEMRQALAKDLPWKLKESRVLEILQAV 450
             +E RQ L   L   L ++    + +  
Sbjct: 55  DADEFRQGL-AKLGLVLDQAEAEGVCRKW 82

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 15/60 (25%), Positives = 24/60 (40%), Gaps = 7/60 (11%)

Query: 390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA 449
            L  L   LD  E   +       D + +G++ LEE  +AL       + ++R   I  A
Sbjct: 62  GLAKLGLVLDQAEAEGV---CRKWDRNGSGTLDLEEFLRALRP----PMSQAREAVIAAA 114

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.7 bits (130), Expect = 5e-08
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 41/219 (18%)

Query: 103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKF 162
           +LG G FG  Y     A+G  VAVK++++ +          + EV+++ ++A H N+++ 
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMI-SMAVHRNLLRL 92

Query: 163 YNAFEDDNY---VYIAMELCEGGELLDRILAKKDSRY-----TEKDAAVVVRQMLRVAA- 213
                       VY        G +   +  + +S+        +  A+        +A 
Sbjct: 93  RGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLDWPKRQRIALG-------SAR 142

Query: 214 -------ECHLHGLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGKK--FQDIV 262
                   C    ++HRD+K  N L      D   +A   DFGL+  +          + 
Sbjct: 143 GLAYLHDHCDPK-IIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPF 300
           G+  ++APE L   KS  ++DV+  GV+   L+ G+R F
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 64/237 (27%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
            +FD ++    L+GHG FG  Y    K    +G +VA+K+           +E+ + E++
Sbjct: 39  NNFDHKF----LIGHGVFGKVY----KGVLRDGAKVALKRRTPESSQ---GIEEFETEIE 87

Query: 149 ILQALAGHENVVKFYNAFEDDNY---VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
            L     H ++V      ++ N    +Y   +  E G L    L   D            
Sbjct: 88  TLSFCR-HPHLVSLIGFCDERNEMILIY---KYMENGNLKRH-LYGSDLPTMSMSW---- 138

Query: 206 RQMLRVAAE-----CHLH--GLVHRDMKPENFLFKSAKEDSSLKA--TDFGLSDFIKPGK 256
            Q L +         +LH   ++HRD+K  N L      D +     TDFG+S      K
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILL-----DENFVPKITDFGIS------K 187

Query: 257 KFQD---------IVGSAYYVAPEVLKR-----KSGPESDVWSIGVITYILLCGRRP 299
           K  +         + G+  Y+ PE   +     KS    DV+S GV+ + +LC R  
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS----DVYSFGVVLFEVLCARSA 240

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108

 Score = 48.8 bits (117), Expect = 1e-07
 Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 3/83 (3%)

Query: 370 DISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQA 429
              +   +R               ++  +  +  + L++ F  +D D++G I  +E++  
Sbjct: 8   PSDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDELKYF 66

Query: 430 LAK--DLPWKLKESRVLEILQAV 450
           L +       L  S     L A 
Sbjct: 67  LQRFESGARVLTASETKTFLAAA 89

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77

 Score = 47.9 bits (115), Expect = 1e-07
 Identities = 15/55 (27%), Positives = 32/55 (58%), Gaps = 1/55 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           L +E+  ++++ FD  D +K GSI   E++ A+   L + +K+  +LE++   + 
Sbjct: 1   LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRA-LGFDVKKPEILELMNEYDR 54

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 12/69 (17%), Positives = 33/69 (47%), Gaps = 1/69 (1%)

Query: 384 SRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRV 443
                     L S L +E+  ++ + F   D++ +G +   E++ A+   L ++L +  +
Sbjct: 3   KNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKA-LGFELPKREI 61

Query: 444 LEILQAVNT 452
           L+++   ++
Sbjct: 62  LDLIDEYDS 70

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109

 Score = 46.9 bits (112), Expect = 7e-07
 Identities = 13/90 (14%), Positives = 29/90 (32%), Gaps = 3/90 (3%)

Query: 365 SEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLE 424
           +++     +   +  F             +   L  +   D++  F  +D DK+G I  +
Sbjct: 3   TDLLSAEDIKKAIGAFTAADSFDHKKFFQMVG-LKKKSADDVKKVFHILDKDKSGFIEED 61

Query: 425 EMRQALAK--DLPWKLKESRVLEILQAVNT 452
           E+   L         L       ++ A + 
Sbjct: 62  ELGSILKGFSSDARDLSAKETKTLMAAGDK 91

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169

 Score = 47.2 bits (113), Expect = 1e-06
 Identities = 15/76 (19%), Positives = 37/76 (48%), Gaps = 1/76 (1%)

Query: 377 MRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW 436
           M    K     +   +     L +E+  ++R+ FD  D D +G+I  +E++ A+   L +
Sbjct: 1   MSYKAKTVVSARRDQKKGRVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRA-LGF 59

Query: 437 KLKESRVLEILQAVNT 452
           + K+  + +++  ++ 
Sbjct: 60  EPKKEEIKKMISEIDK 75

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 8/77 (10%)

Query: 382 KYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQAL--------AKD 433
           +Y R      +     L  + L+ L  +FD  D+D +G + ++E+            A D
Sbjct: 14  RYLRSVGNQWQFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATD 73

Query: 434 LPWKLKESRVLEILQAV 450
              +     V       
Sbjct: 74  EQVEKMRDAVRVFFLHK 90

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score = 46.0 bits (110), Expect = 3e-06
 Identities = 15/58 (25%), Positives = 31/58 (53%), Gaps = 1/58 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
             +L  EE+ +LR+ F   D DK+G I+  ++   + + + +   E  ++E+ Q +N 
Sbjct: 2   DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCM-RTMGYMPTEMELIELSQQINM 58

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153

 Score = 39.1 bits (92), Expect = 7e-04
 Identities = 16/54 (29%), Positives = 29/54 (53%)

Query: 399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           D   + +LRD F   D + +G IS  E+R+A+   L  ++    + EI++ V+ 
Sbjct: 83  DMIGVKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDL 136

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86

 Score = 44.2 bits (105), Expect = 4e-06
 Identities = 11/38 (28%), Positives = 18/38 (47%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           A+    +++AD    F   D + +G IS  E+  AL  
Sbjct: 2   AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKT 39

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156

 Score = 46.0 bits (110), Expect = 4e-06
 Identities = 16/74 (21%), Positives = 37/74 (50%), Gaps = 6/74 (8%)

Query: 390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA 449
           A   + + L  +++ ++++ F  IDVD++G +S E+++    + L     +  +  +L+ 
Sbjct: 4   AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQ-LGRAPDDKELTAMLKE 62

Query: 450 VNTP-----FLGLF 458
              P     FL +F
Sbjct: 63  APGPLNFTMFLSIF 76

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90

 Score = 43.4 bits (103), Expect = 7e-06
 Identities = 14/55 (25%), Positives = 27/55 (49%), Gaps = 1/55 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           L +E +A+ +  FD  D D  G IS +E+   + + L     +  +  I++ V+ 
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVM-RMLGQNPTKEELDAIIEEVDE 67

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147

 Score = 44.8 bits (107), Expect = 8e-06
 Identities = 14/58 (24%), Positives = 31/58 (53%), Gaps = 1/58 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           +  L +E++A+ ++ F   D D +GSIS  E+   + + L     E+ V +++  ++ 
Sbjct: 2   SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVM-RSLGLSPSEAEVADLMNEIDV 58

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162

 Score = 44.9 bits (107), Expect = 1e-05
 Identities = 14/53 (26%), Positives = 26/53 (49%), Gaps = 1/53 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           L +E +A+ +  FD  D D  G IS +E+   + + L     +  +  I++ V
Sbjct: 14  LSEEMIAEFKAAFDMFDADGGGDISTKELGTVM-RMLGQNPTKEELDAIIEEV 65

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107

 Score = 43.5 bits (103), Expect = 1e-05
 Identities = 9/59 (15%), Positives = 26/59 (44%), Gaps = 3/59 (5%)

Query: 377 MRQFVKYSRLKQFAL---RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
            +Q  +   + +  L   +  +      +L   ++++   D++ NG I +  +++ L K
Sbjct: 2   AQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92

 Score = 43.0 bits (102), Expect = 1e-05
 Identities = 15/55 (27%), Positives = 30/55 (54%), Gaps = 1/55 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           +D +   +L++ F   D D+NG IS  E+R  +  +L  KL +  V ++++  + 
Sbjct: 3   MDTDAEEELKEAFKVFDKDQNGYISASELRHVM-INLGEKLTDEEVEQMIKEADL 56

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 41.8 bits (99), Expect = 1e-05
 Identities = 10/45 (22%), Positives = 21/45 (46%), Gaps = 1/45 (2%)

Query: 406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
               F  IDV+ +G++S EE++  +         E  +  I +++
Sbjct: 2   AEALFKEIDVNGDGAVSYEEVKAFV-SKKRAIKNEQLLQLIFKSI 45

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66

 Score = 41.8 bits (99), Expect = 2e-05
 Identities = 9/42 (21%), Positives = 17/42 (40%), Gaps = 3/42 (7%)

Query: 390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALA 431
            +    +  +++ L  +   F +ID D NG I   E  +   
Sbjct: 25  FVSKKRAIKNEQLLQLI---FKSIDADGNGEIDQNEFAKFYG 63

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179

 Score = 44.4 bits (106), Expect = 2e-05
 Identities = 13/58 (22%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           A  L +E++A+ ++ F   D D +G+I+ +E+   + + L     E+ + +++  V+ 
Sbjct: 2   ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVM-RSLGQNPTEAELQDMINEVDA 58

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83

 Score = 41.8 bits (99), Expect = 2e-05
 Identities = 10/52 (19%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK-DLPWKLKESRVLEILQ 448
           +  +  A+L   F  +D + +G ++  E++  +   D    L + +V E   
Sbjct: 1   MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASA 52

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148

 Score = 43.6 bits (104), Expect = 2e-05
 Identities = 13/58 (22%), Positives = 32/58 (55%), Gaps = 1/58 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           A  L +E++A+ ++ F   D D +G+I+ +E+   + + L     E+ + +++  V+ 
Sbjct: 1   AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVM-RSLGQNPTEAELQDMINEVDA 57

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143

 Score = 42.8 bits (102), Expect = 3e-05
 Identities = 12/53 (22%), Positives = 32/53 (60%), Gaps = 1/53 (1%)

Query: 400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           +E+  ++R+ FD  D D  G+I ++E++ A+   L ++ K+  + +++  ++ 
Sbjct: 2   EEQKQEIREAFDLFDADGTGTIDVKELKVAMRA-LGFEPKKEEIKKMISEIDK 53

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67

 Score = 40.9 bits (97), Expect = 3e-05
 Identities = 8/49 (16%), Positives = 23/49 (46%), Gaps = 1/49 (2%)

Query: 404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           +  +  F+  D +K+G +SL+E R+           +  +++  + ++ 
Sbjct: 1   SSAKRVFEKFDKNKDGKLSLDEFREVA-LAFSPYFTQEDIVKFFEEIDV 48

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158

 Score = 42.9 bits (102), Expect = 3e-05
 Identities = 9/61 (14%), Positives = 26/61 (42%), Gaps = 2/61 (3%)

Query: 393 ALASTLDDEELADLRDQFDAID-VDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
              S L   ++  L   F   +  + +G +S +++   L + L  +  +S + +++   +
Sbjct: 2   GDVSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIIL-EVLGIQQTKSTIRQLIDEFD 60

Query: 452 T 452
            
Sbjct: 61  P 61

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 13/72 (18%), Positives = 26/72 (36%), Gaps = 2/72 (2%)

Query: 364 ASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISL 423
             E  ++ SV + +       R +   L    S    +EL  L   F       +G ++ 
Sbjct: 27  LIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNEC--PSGVVNE 84

Query: 424 EEMRQALAKDLP 435
           E  ++  ++  P
Sbjct: 85  ETFKEIYSQFFP 96

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161

 Score = 42.9 bits (102), Expect = 4e-05
 Identities = 13/60 (21%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 392 RALASTLDDEELADLRDQFDAIDVD-KNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
           +A    L +E+  + +  FD   +  ++GSIS +E+ + +   L        + E++  V
Sbjct: 6   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM-LGQNPTPEELQEMIDEV 64

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105

 Score = 41.7 bits (98), Expect = 4e-05
 Identities = 12/69 (17%), Positives = 23/69 (33%), Gaps = 4/69 (5%)

Query: 387 KQFALRALASTLDD---EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRV 443
              A R + + L          +  +F+  D  K  +IS EE R    +     L + + 
Sbjct: 4   MATADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNR-RVQILTDEQF 62

Query: 444 LEILQAVNT 452
             +   +  
Sbjct: 63  DRLWNEMPV 71

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142

 Score = 42.5 bits (101), Expect = 4e-05
 Identities = 8/53 (15%), Positives = 28/53 (52%), Gaps = 1/53 (1%)

Query: 400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           D+++++ ++ F+  D ++ G I+ E ++  L +    +++ +   E+    + 
Sbjct: 2   DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQ-FGVRVEPAAFNEMFNEADA 53

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109

 Score = 41.5 bits (98), Expect = 6e-05
 Identities = 14/60 (23%), Positives = 23/60 (38%), Gaps = 2/60 (3%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK--DLPWKLKESRVLEILQAVNT 452
              L  +    ++  F  +D DK+G I  EE++  L         L  +     L A +T
Sbjct: 33  TVGLSSKTPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDT 92

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147

 Score = 42.2 bits (99), Expect = 7e-05
 Identities = 9/53 (16%), Positives = 23/53 (43%), Gaps = 1/53 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
               +L   + ++   D++ NG I +  +++ L K L        +  +++ V
Sbjct: 42  DLPSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEK-LGVPKTHLELKRLIREV 93

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191

 Score = 42.5 bits (100), Expect = 8e-05
 Identities = 11/57 (19%), Positives = 25/57 (43%), Gaps = 4/57 (7%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKL----KESRVLEILQAV 450
            +   +   +  F+ +DV+ NG ISL+EM    +  +   L    ++++  +     
Sbjct: 10  DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEA 66

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 14/62 (22%), Positives = 23/62 (37%), Gaps = 3/62 (4%)

Query: 400 DEELADLRDQFDAIDVDKNGSIS---LEEMRQALAKDLPWKLKESRVLEILQAVNTPFLG 456
                 L+ +FD  D D NG++     E+  Q +A+        + V  +  A    F  
Sbjct: 3   AIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDY 62

Query: 457 LF 458
           L 
Sbjct: 63  LA 64

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71

 Score = 39.8 bits (94), Expect = 9e-05
 Identities = 14/50 (28%), Positives = 27/50 (54%), Gaps = 1/50 (2%)

Query: 401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
             L DL+  F A D D +G I+++E+R+A+   L   L +  +  +++  
Sbjct: 3   AGLEDLQVAFRAFDQDGDGHITVDELRRAM-AGLGQPLPQEELDAMIREA 51

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 13/50 (26%), Positives = 24/50 (48%)

Query: 382 KYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALA 431
           K  R        + S  D+ E+ D ++ F  ID + +G I  +++R+  A
Sbjct: 3   KAKRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFA 52

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109

 Score = 40.3 bits (95), Expect = 1e-04
 Identities = 14/60 (23%), Positives = 26/60 (43%), Gaps = 2/60 (3%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK--DLPWKLKESRVLEILQAVNT 452
              L  +   D++  F  ID DK+G I  +E++  L         L ++     L+A ++
Sbjct: 33  KVGLTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDS 92

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 15/49 (30%), Positives = 27/49 (55%), Gaps = 3/49 (6%)

Query: 400 DEELADLRDQFDAIDVDKNGSIS---LEEMRQALAKDLPWKLKESRVLE 445
           D  +  ++  F+ ID DK+G+I+    E M +  AK+   K + ++VL 
Sbjct: 2   DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLM 50

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174

 Score = 39.3 bits (92), Expect = 8e-04
 Identities = 9/52 (17%), Positives = 18/52 (34%), Gaps = 3/52 (5%)

Query: 399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
                  L   F A+D +++ +IS +E            L ++       A+
Sbjct: 89  KSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGM---LGLDKTMAPASFDAI 137

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109

 Score = 40.2 bits (95), Expect = 1e-04
 Identities = 11/64 (17%), Positives = 27/64 (42%), Gaps = 4/64 (6%)

Query: 391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW--KLKESRVLEILQ 448
              +      +    +++ F+ +D D++G I  EE++  L         L ++    +L 
Sbjct: 30  FHLVGLKGKTDA--QVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLA 87

Query: 449 AVNT 452
           A ++
Sbjct: 88  AGDS 91

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108

 Score = 39.9 bits (94), Expect = 2e-04
 Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 4/64 (6%)

Query: 391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW--KLKESRVLEILQ 448
              +       +  D++  F  ID DK+G I  +E++  L    P    L ++     L 
Sbjct: 30  FAKVGLASKSLD--DVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLA 87

Query: 449 AVNT 452
             + 
Sbjct: 88  DGDK 91

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 17/80 (21%), Positives = 32/80 (40%), Gaps = 6/80 (7%)

Query: 384 SRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRV 443
            R  Q +   + +     ++ + ++ F  ID DK+G IS  ++R      L     E  +
Sbjct: 37  KRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDS-LGRLCTEQEL 95

Query: 444 LEILQAVN-----TPFLGLF 458
             ++         T FL +F
Sbjct: 96  DSMVAEAPGPINFTMFLTIF 115

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110

 Score = 39.1 bits (92), Expect = 3e-04
 Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 4/64 (6%)

Query: 391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW--KLKESRVLEILQ 448
              +          D++  F AID D +G I  EE++  L         L ++     L+
Sbjct: 31  FALVGLKAMSAN--DVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLK 88

Query: 449 AVNT 452
           A + 
Sbjct: 89  AADK 92

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143

 Score = 39.8 bits (94), Expect = 3e-04
 Identities = 13/66 (19%), Positives = 30/66 (45%), Gaps = 6/66 (9%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP---- 453
            D  ++ + ++ F+ ID +++G I  E++   LA  +     +  +  ++     P    
Sbjct: 1   FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLAS-MGKNPTDEYLEGMMSEAPGPINFT 59

Query: 454 -FLGLF 458
            FL +F
Sbjct: 60  MFLTMF 65

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 7/42 (16%), Positives = 17/42 (40%)

Query: 391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           +  +  +     L  ++ +   +DV  +G IS E+      +
Sbjct: 1   MPEITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVR 42

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 7/35 (20%), Positives = 18/35 (51%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
              E+L   ++++   D++  G I L  +++ + K
Sbjct: 44  NLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEK 78

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} Length = 359

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 24/143 (16%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV- 160
           +    GQ   T+          V   K      +LP A   ++RE +++ ALAG +  V 
Sbjct: 44  EQFKGGQSNPTFKLVT-PGQTYVMRAKPGPKSKLLPSA-HAIEREYRVMDALAGTDVPVA 101

Query: 161 KFYNAFEDDN------YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           K Y   ED++      Y+   ME   G  L D+ L       +  +   +  +M RV A 
Sbjct: 102 KMYALCEDESVIGRAFYI---MEFVSGRVLWDQSLP----GMSPAERTAIYDEMNRVIAA 154

Query: 215 CHLHGLVHRDM------KPENFL 231
             +H + ++ +      KP N+ 
Sbjct: 155 --MHTVDYQAIGLGDYGKPGNYF 175

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV 450
            S     +  +L + F A+D D +G+IS+ E+  AL+         +   ++L   
Sbjct: 18  PSARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSS-AGVPFSLATTEKLLHMY 72

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134

 Score = 39.0 bits (92), Expect = 6e-04
 Identities = 10/37 (27%), Positives = 18/37 (48%), Gaps = 2/37 (5%)

Query: 396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
              DD+    L+  +  +DVD +G ++ EE+     K
Sbjct: 69  DLSDDKI--GLKVLYKLMDVDGDGKLTKEEVTSFFKK 103

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 11/58 (18%), Positives = 19/58 (32%), Gaps = 3/58 (5%)

Query: 376 NMRQFVK-YSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
            + +        + F L      L   E  +    +   D D +G I  EE++  L  
Sbjct: 76  GIVELAHVLPTEENFLLLFRCQQLKSCE--EFMKTWRKYDTDHSGFIETEELKNFLKD 131

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263

 Score = 40.2 bits (94), Expect = 7e-04
 Identities = 14/73 (19%), Positives = 27/73 (36%), Gaps = 3/73 (4%)

Query: 376 NMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP 435
            + +  +   +++  L          +  +    F+  D D NG I   E+   L KDL 
Sbjct: 165 ELTEMARLLPVQENFLLKFQGIKMCGK--EFNKAFELYDQDGNGYIDENELDALL-KDLC 221

Query: 436 WKLKESRVLEILQ 448
            K K+   +  + 
Sbjct: 222 EKNKQELDINNIS 234

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81

 Score = 37.5 bits (88), Expect = 8e-04
 Identities = 6/35 (17%), Positives = 16/35 (45%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           +  ++  ++   F   D + +G I  +E +  + K
Sbjct: 2   VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQK 36

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94

 Score = 37.6 bits (88), Expect = 9e-04
 Identities = 18/54 (33%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           D EE  ++R+ F   D D NG IS  E+R  +  +L  KL +  V E+++  + 
Sbjct: 26  DSEE--EIREAFRVEDKDGNGYISAAELRHVM-TNLGEKLTDEEVDEMIREADI 76

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	487
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	99.38
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	99.35
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
2ktg_A	85	Calmodulin, putative; ehcam, Ca-binding protein, p	99.12
1avs_A	90	Troponin C; muscle contraction, calcium-activated,	99.11
2opo_A	86	Polcalcin CHE A 3; calcium-binding protein, dimer,	99.1
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	99.08
1c07_A	95	Protein (epidermal growth factor receptor pathway	99.08
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	99.07
1j7q_A	86	CAVP, calcium vector protein; EF-hand family, calc	99.07
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	99.06
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	99.05
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	99.03
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	99.03
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	99.03
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	99.02
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	99.02
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	99.02
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	99.02
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	99.02
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	99.01
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	99.01
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	99.0
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	99.0
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	98.99
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	98.99
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	98.99
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	98.98
2kn2_A	92	Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco	98.98
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	98.97
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	98.96
2d58_A	107	Allograft inflammatory factor 1; EF-hand, metal bi	98.96
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	98.95
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	98.95
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	98.94
2y5i_A	99	S100Z, S100 calcium binding protein Z; metal-bindi	98.94
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	98.93
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	98.92
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	98.92
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	98.89
2jq6_A	139	EH domain-containing protein 1; metal binding prot	98.89
2wcb_A	95	Protein S100-A12; calcium signalling, HOST-parasit	98.89
3li6_A	66	Calcium-binding protein; calcium signaling protein	98.87
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	98.87
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	98.87
3fs7_A	109	Parvalbumin, thymic; calcium-binding protein, EF-h	98.87
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	98.87
5pal_A	109	Parvalbumin; calcium-binding protein; 1.54A {Triak	98.86
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	98.86
1xk4_C	113	Calgranulin B; S100 family, heterotetramer, metal	98.85
2pvb_A	108	Protein (parvalbumin); calcium binding protein, me	98.85
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	98.85
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	98.85
1xk4_A	93	Calgranulin A; S100 family, heterotetramer, metal	98.85
1pva_A	110	Parvalbumin; calcium binding; 1.65A {Esox lucius}	98.84
1k9u_A	78	Polcalcin PHL P 7; pollen allergen, calcium-bindin	98.84
1wlz_A	105	DJBP, CAP-binding protein complex interacting prot	98.84
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	98.83
1bu3_A	109	Calcium-binding protein; 1.65A {Merluccius bilinea	98.83
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	98.82
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	98.81
1rwy_A	109	Parvalbumin alpha; EF-hand, calcium-binding, calci	98.81
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	98.81
1qx2_A	76	Vitamin D-dependent calcium-binding protein, INTE;	98.81
3u0k_A	440	Rcamp; fluorescent protein, calcium binding, EF-ha	98.8
1wy9_A	147	Allograft inflammatory factor 1; EF-hand, calucium	98.8
1rro_A	108	RAT oncomodulin; calcium-binding protein; 1.30A {R	98.78
1psr_A	100	Psoriasin, S100A7; EF-hand protein, MAD phasing, p	98.77
2jjz_A	150	Ionized calcium-binding adapter molecule 2; EF-han	98.77
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	98.74
1exr_A	148	Calmodulin; high resolution, disorder, metal trans	98.74
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	98.74
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3a8r_A	179	Putative uncharacterized protein; EF-hand, membran	98.73
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	98.72
1k2h_A	93	S100A1, S-100 protein, alpha chain; non-covalent h	98.71
1a4p_A	96	S100A10; S100 family, EF-hand protein, ligand of a	98.71
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	98.7
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	98.7
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	98.69
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	98.69
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	98.69
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	98.68
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	98.68
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	98.66
1k8u_A	90	S100A6, calcyclin, CACY; calcium regulatory protei	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.66
3fwb_A	161	Cell division control protein 31; gene gating, com	98.66
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	98.65
2bl0_C	142	Myosin regulatory light chain; muscle protein, sli	98.65
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	98.65
3fia_A	121	Intersectin-1; EH 1 domain, NESG, structural genom	98.65
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	98.64
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	98.64
1qls_A	99	S100C protein, calgizzarin; metal-binding protein/	98.64
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	98.64
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	98.63
2jnf_A	158	Troponin C; stretch activated muscle contraction,	98.63
3fwb_A	161	Cell division control protein 31; gene gating, com	98.63
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	98.63
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	98.63
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	98.63
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	98.62
3qrx_A	169	Centrin; calcium-binding, EF-hand, cell division,	98.62
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	98.62
2kld_A	123	Polycystin-2; PC2, PKD2, calcium binding domain, E	98.61
4ds7_A	147	Calmodulin, CAM; protein binding, metal binding, s	98.61
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	98.61
2jnf_A	158	Troponin C; stretch activated muscle contraction,	98.61
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	98.59
1h8b_A	75	ACT-EF34, alpha-actinin 2, skeletal muscle isoform	98.59
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	98.59
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	98.59
3ox6_A	153	Calcium-binding protein 1; EF-hand, calcium-sensor	98.57
1top_A	162	Troponin C; contractIle system protein; 1.78A {Gal	98.56
2f2o_A	179	Calmodulin fused with calmodulin-binding domain of	98.56
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	98.56
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	98.54
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	98.54
1dtl_A	161	Cardiac troponin C; helix-turn-helix, structural p	98.53
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	98.51
2mys_C	149	Myosin; muscle protein, motor protein; HET: MLY; 2	98.51
1snl_A	103	Nucleobindin 1, calnuc; EF-hand, calcium-binding,	98.5
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	98.5
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	98.49
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	98.48
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	98.47
1qv0_A	195	Obelin, OBL; photoprotein, bioluminescence, atomic	98.47
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	98.47
1y1x_A	191	Leishmania major homolog of programmed cell death	98.46
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	98.45
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	98.44
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	98.43
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	98.43
1uhk_A	191	Aequorin 2, aequorin; EF-hand motif, complex, lumi	98.43
1wdc_C	156	Scallop myosin; calcium binding protein, muscle pr	98.42
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	98.42
3sjs_A	220	URE3-BP sequence specific DNA binding protein; EF-	98.41
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	98.41
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	98.41
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.41
2ccm_A	191	Calexcitin; EF hand, calcium, signaling protein; 1	98.41
1w7j_B	151	Myosin light chain 1; motor protein, unconventiona	98.4
1nya_A	176	Calerythrin; EF-hand, metal binding protein; NMR {	98.4
1m45_A	148	MLC1P, myosin light chain; protein-peptide complex	98.38
3e3r_A	204	Calcyphosin, calcyphosine; human calcyphosine, EF-	98.38
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	98.37
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	98.37
2hpk_A	208	Photoprotein berovin; structural genomics, PSI, pr	98.36
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	98.35
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	98.35
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	98.34
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	98.34
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	98.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	98.32
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	98.32
3j04_B	143	Myosin regulatory light chain 2, smooth muscle MA	98.32
2znd_A	172	Programmed cell death protein 6; penta-EF-hand pro	98.31
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	98.31
2ovk_C	159	Myosin catalytic light chain LC-1, mantle muscle,	98.3
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	98.3
2ovk_B	153	RLC, myosin regulatory light chain LC-2, mantle mu	98.29
1y1x_A	191	Leishmania major homolog of programmed cell death	98.28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	98.28
1alv_A	173	Calpain, S-camld; calcium binding, calmodulin like	98.28
2mys_B	166	Myosin; muscle protein, motor protein; HET: MLY; 2	98.27
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	98.27
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	98.27
3sg6_A	450	Gcamp2, myosin light chain kinase, green fluoresce	98.27
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	98.26
2aao_A	166	CDPK, calcium-dependent protein kinase, isoform AK	98.26
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	98.25
1jfj_A	134	Ehcabp, calcium-binding protein; EF-hand, helix-lo	98.24
1wdc_B	156	Scallop myosin; calcium binding protein, muscle pr	98.24
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	98.23
2hps_A	186	Coelenterazine-binding protein with bound coelent;	98.22
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	98.22
2sas_A	185	Sarcoplasmic calcium-binding protein; 2.40A {Branc	98.22
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	98.21
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	98.2
2jul_A	256	Calsenilin; EF-hand, calcium, LXXLL, DNA binding p	98.2
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	98.2
3akb_A	166	Putative calcium binding protein; EF-hand, metal b	98.2
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	98.18
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	98.18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	98.17
1jba_A	204	GCAP-2, protein (guanylate cyclase activating prot	98.16
2lvv_A	226	Flagellar calcium-binding protein TB-24; EF-hand,	98.16
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	98.16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	98.16
1juo_A	198	Sorcin; calcium-binding proteins, penta-EF-hand, P	98.15
3cs1_A	219	Flagellar calcium-binding protein; myristoylated,	98.15
1gjy_A	167	Sorcin, CP-22, V19; calcium binding, calcium-bindi	98.15
3dtp_E	196	RLC, myosin regulatory light chain; muscle protein	98.15
2bec_A	202	Calcineurin B homologous protein 2; calcineurin-ho	98.14
2bl0_B	145	Myosin regulatory light chain; muscle protein, sli	98.14
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	98.12
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	98.12
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	98.11
1ggw_A	140	Protein (CDC4P); light chain, cytokinesis, cell cy	98.11
1k94_A	165	Grancalcin; penta-EF-hand protein, calcium binding	98.1
2f33_A	263	Calbindin; EF-hand, Ca2+-binding, metal binding pr	98.09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	98.09
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.07
1q80_A	174	SCP, sarcoplasmic calcium-binding protein; all-alp	98.06
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	98.06
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	98.05
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	98.05
1djx_A	624	PLC-D1, phosphoinositide-specific phospholipase C,	98.02
1sjj_A	863	Actinin; 3-helix bundle, calponin homology domain,	98.02
2r2i_A	198	Guanylyl cyclase-activating protein 1; EF hand, GC	97.99
1fpw_A	190	Yeast frequenin, calcium-binding protein NCS-1; EF	97.95
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	97.94
2l2e_A	190	Calcium-binding protein NCS-1; NCS1P, myristoylate	97.94
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	97.93
2zfd_A	226	Calcineurin B-like protein 2; calcium binding prot	97.92
2be4_A	272	Hypothetical protein LOC449832; DR.36843, BC083168	97.91
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.9
2d8n_A	207	Recoverin; structural genomics, NPPSFA, national p	97.87
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.87
2qac_A	146	Myosin A tail domain interacting protein MTIP; mal	97.87
2hps_A	186	Coelenterazine-binding protein with bound coelent;	97.86
1s6c_A	183	KV4 potassium channel-interacting protein kchip1B;	97.85
2ggz_A	211	Guanylyl cyclase-activating protein 3; EF hand, gu	97.8
1bjf_A	193	Neurocalcin delta; calcium-binding, myristoylation	97.8
1s1e_A	224	KV channel interacting protein 1; kchip, calcium-b	97.79
2i7a_A	174	Calpain 13; calcium-dependent cytoplasmic cysteine	97.75
1dgu_A	183	Calcium-saturated CIB; helical, EF-hands, blood cl	97.75
2ct9_A	208	Calcium-binding protein P22; EF-hand, metal bindin	97.74
3bow_A	714	Calpain-2 catalytic subunit; cysteine protease, in	97.71
2zkm_X	799	1-phosphatidylinositol-4,5-bisphosphate phosphodie	97.7
1g8i_A	190	Frequenin, neuronal calcium sensor 1; calcium bind	97.69
1qxp_A	900	MU-like calpain; M-calpain, MU-calpain, catalytic	97.67
3dd4_A	229	KV channel-interacting protein 4; EF-hands protein	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.64

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-66  Score=542.08  Aligned_cols=374  Identities=34%  Similarity=0.572  Sum_probs=328.4

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh----------HhHHHHHHHHHHHHhccCCCCcc
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP----------IAVEDVKREVKILQALAGHENVV  160 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~~hpnIv  160 (487)
                      ...+.++|++++.||+|+||+||+|.++.+++.||+|++.+......          ...+.+.+|+.+++++. ||||+
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  109 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNII  109 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCC
Confidence            34577899999999999999999999999999999999976543211          24567899999999995 99999


Q ss_pred             EEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      ++++++.+...+|+|||||+||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+....
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999999988655  57999999999999999999999999999999999999986444457


Q ss_pred             EEEeecccccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       241 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      +||+|||++............+||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+.+..+..+...+.
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999988776666677899999999999998899999999999999999999999999999999999999888777


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCC---CcCHHHHHHHHHhhhhhHHHHHHHHHHhcc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI---PIDISVLNNMRQFVKYSRLKQFALRALAST  397 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~  397 (487)
                      ...|+.+|+++++||++||.+||.+|||+.|+|+||||+........   ......+.++++|...++++++.+.+++..
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~  347 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK  347 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            77788899999999999999999999999999999999886543221   112345777888998999999999988887


Q ss_pred             C-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC--------CCcccHHHHHHHHHhcCCCCCceeecCccccccc
Q 011380          398 L-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL--------PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       398 ~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~--------~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      + ++++..+++++|..+|.|+||.|+.+||..+|+. +        |...++++++.+|..+|.|+||.|        +|
T Consensus       348 ~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I--------~~  418 (504)
T 3q5i_A          348 LTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNV-LRNFKNELGELKNVEEEVDNILKEVDFDKNGYI--------EY  418 (504)
T ss_dssp             TSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSE--------EH
T ss_pred             CCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHH-hhhcccccccccccHHHHHHHHHHhCCCCCCcE--------eH
Confidence            7 8888999999999999999999999999999987 5        556788999999999999999999        99


Q ss_pred             hhhhcccc
Q 011380          469 SYLLLFPV  476 (487)
Q Consensus       469 ~~f~~~~~  476 (487)
                      +||+.+..
T Consensus       419 ~EF~~~~~  426 (504)
T 3q5i_A          419 SEFISVCM  426 (504)
T ss_dssp             HHHHHHHS
T ss_pred             HHHHHHHH
Confidence            99987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.2e-67  Score=540.39  Aligned_cols=374  Identities=35%  Similarity=0.595  Sum_probs=327.3

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+.++|++.+.||+|+||+||+|.++.+|+.||||++.+.... ......+.+|+.+++++. ||||+++++++.+.+
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSS   94 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCC
Confidence            345678899999999999999999999999999999998654321 123567889999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+|||||+||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999999988655  579999999999999999999999999999999999999865567889999999998


Q ss_pred             ccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....+.+..+..+...+..+.|+.+|++
T Consensus       173 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             TBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             ECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            87766666778899999999999999999999999999999999999999999999999999999888888888899999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCCCCCC----CcCHHHHHHHHHhhhhhHHHHHHHHHHhccC-ChHHHHH
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI----PIDISVLNNMRQFVKYSRLKQFALRALASTL-DDEELAD  405 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~-~~~~~~~  405 (487)
                      +++||.+||+.||.+|||+.++|+||||+........    +.....+.++++|....+++++.+.+++..+ +.++..+
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~  332 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQ  332 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHH
Confidence            9999999999999999999999999999976543322    2223456778899999999999999888877 7788899


Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhh---CCCccc----------HHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKD---LPWKLK----------ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~~~~~----------~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ++++|..+|.|+||.|+.+||..++...   +|...+          +++++.+|..+|.|+||.|        +|+||+
T Consensus       333 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I--------~~~Ef~  404 (486)
T 3mwu_A          333 LTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSI--------EYSEFI  404 (486)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSB--------CHHHHH
T ss_pred             HHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcC--------cHHHHH
Confidence            9999999999999999999996555431   465555          8899999999999999999        999998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      ....
T Consensus       405 ~~~~  408 (486)
T 3mwu_A          405 ASAI  408 (486)
T ss_dssp             HHHS
T ss_pred             HHHH
Confidence            7653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.7e-67  Score=540.53  Aligned_cols=373  Identities=36%  Similarity=0.604  Sum_probs=331.1

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence            346678999999999999999999999999999999997765444446678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+|||||.||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999988543  6799999999999999999999999999999999999997655678999999999988


Q ss_pred             cCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....+.+..+..+...+..+.|+.+|+++
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            77666667788999999999999999999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCCC---CCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccC-ChHHHHHHH
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDA---SEIPIDISVLNNMRQFVKYSRLKQFALRALASTL-DDEELADLR  407 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~-~~~~~~~l~  407 (487)
                      ++||.+||+.||.+|||+.++|+||||+.....   ...+.....+.++++|.....++++++.+++..+ ++++..+++
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~  338 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT  338 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence            999999999999999999999999999875431   2344456678889999999999999999998776 778889999


Q ss_pred             HhhcccCCCCCCCCCHHHHH----HHHHhhCCCccc-------HHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          408 DQFDAIDVDKNGSISLEEMR----QALAKDLPWKLK-------ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       408 ~~F~~~D~d~~G~i~~~el~----~~l~~~~~~~~~-------~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++|..+|.|+||.|+.+||.    .+++. +|...+       +++++++|+.+|.|++|.|        +|+||+.+..
T Consensus       339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~-~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i--------~~~Ef~~~~~  409 (484)
T 3nyv_A          339 AIFHKMDKNGDGQLDRAELIEGYKELMRM-KGQDASMLDASAVEHEVDQVLDAVDFDKNGYI--------EYSEFVTVAM  409 (484)
T ss_dssp             HHHHHHCTTCSSEEEHHHHHHHHHHHHC-----CGGGCSHHHHHHHHHHHHHHHTCCTTSEE--------EHHHHHHHHH
T ss_pred             HHHHHhCcCCCceEeHHHHHHHHHHHhhh-cccccccccccccHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            99999999999999999994    45555 677777       8899999999999999999        9999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-66  Score=539.78  Aligned_cols=372  Identities=37%  Similarity=0.613  Sum_probs=327.6

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.++|++++.||+|+||+||+|+++.++..||+|++.+.... ......+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  110 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKRN  110 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence            44667899999999999999999999999999999999765432 223467889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+|||||+||+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++..
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999999988655  5799999999999999999999999999999999999998655667899999999988


Q ss_pred             cCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..........+||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....+.+..+..+...+....|+.+|+++
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence            77666667788999999999999889999999999999999999999999999999999999998888888889999999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCCC----CCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccC-ChHHHHHH
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGDA----SEIPIDISVLNNMRQFVKYSRLKQFALRALASTL-DDEELADL  406 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~-~~~~~~~l  406 (487)
                      ++||++||+.||.+|||+.++|+||||+.....    ...+.....+.++++|.....++++++.+++..+ ++++..++
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l  348 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKEL  348 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHH
Confidence            999999999999999999999999999864321    2234444678889999999999999999998877 78889999


Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCC--------cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPW--------KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~--------~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++|..+|.|+||.|+.+||..+|+. +|.        ..++++++.+|+.+|.|++|.|        +|+||+.+..
T Consensus       349 ~~~F~~~D~d~dG~I~~~El~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I--------~~~EF~~~~~  417 (494)
T 3lij_A          349 TDIFRHIDKNGDGQLDRQELIDGYSK-LSGEEVAVFDLPQIESEVDAILGAADFDRNGYI--------DYSEFVTVAM  417 (494)
T ss_dssp             HHHHHHHCTTCSSEECHHHHHHTTHH-HHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHS
T ss_pred             HHHHHHhCcCCCCeEcHHHHHHHHHH-hcccccccccccccHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            99999999999999999999999988 543        5668999999999999999999        9999988754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.4e-65  Score=497.14  Aligned_cols=257  Identities=33%  Similarity=0.577  Sum_probs=229.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|+.|. |||||+++++|.+++.+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            45799999999999999999999999999999999765432   3356789999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||||+||+|.+++..   ..+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+.+..
T Consensus       149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCceecCC
Confidence            9999999999998743   4699999999999999999999999999999999999998   578899999999987654


Q ss_pred             C-CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 G-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      . ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+..+.+..+....+ .....++.+|++++
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~  301 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK  301 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHH
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHH
Confidence            3 34567899999999999975 479999999999999999999999999988888888876543 23344678999999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +||.+||+.||++|||+.|+|+||||++..
T Consensus       302 dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          302 GFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999998764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-65  Score=493.34  Aligned_cols=257  Identities=33%  Similarity=0.576  Sum_probs=231.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++|. |||||+++++|++++.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999998654433345678999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.+...
T Consensus       111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCceecCCC
Confidence            9999999999999654  6799999999999999999999999999999999999998   5789999999999876533


Q ss_pred             ---CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 ---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                         ....+.+||+.|||||++.+. |+.++|||||||++|+|++|++||.+.+..+++.++......++    ..+|+++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~  261 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKA  261 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHH
Confidence               234578999999999999764 68999999999999999999999999999999999999877654    4689999


Q ss_pred             HHHHHHccccCccCCcCHHH------HhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQ------ALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e------~L~h~~~~~~~  362 (487)
                      ++||.+||++||++|||+.|      +++||||+...
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            99999999999999999987      68999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-65  Score=483.74  Aligned_cols=255  Identities=33%  Similarity=0.633  Sum_probs=213.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+++. |||||++++++.+++.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            47999999999999999999999999999999998766555556678999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||| +|+|++++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC------
T ss_pred             EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCeecCCC
Confidence            9999 68999988554  6799999999999999999999999999999999999998   5788999999999887666


Q ss_pred             CccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      ....+.+||+.|||||++.+. + +.++|||||||++|+|++|+.||.+.+...++..+..+.+.++    ..+|+++++
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  241 (275)
T 3hyh_A          166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAG  241 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred             CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            666778999999999999865 3 6799999999999999999999999999899999988876553    468999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ||.+||+.||++|||+.|+|+||||+..
T Consensus       242 li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          242 LIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHHcCcccccC
Confidence            9999999999999999999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-65  Score=498.38  Aligned_cols=258  Identities=24%  Similarity=0.498  Sum_probs=227.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+ |||||++++++++.+.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999987654 3445678999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++...+...+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccceeecCC
Confidence            9999999999999877767789999999999999999999999999999999999998   5788999999999876543


Q ss_pred             C-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      . ...+.+||+.|||||++.+. |+.++|||||||++|||++|+.||.+.+..+++..+..+...   ..+..+|+++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence            2 23457899999999999764 789999999999999999999999999999999999887643   234578999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ||.+||+.||++|||+.|+|+||||++.
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            9999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-63  Score=475.35  Aligned_cols=254  Identities=21%  Similarity=0.355  Sum_probs=218.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNYVY  173 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----~~~~~  173 (487)
                      |++.++||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++|++|+ |||||+++++|.+    ++.+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence            4788899999999999999999999999999976543 3445678999999999995 9999999999875    45689


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ||||||+||+|.+++...  ..+++..++.++.||+.||.|||++|  ||||||||+||||+.  .++.+||+|||+|+.
T Consensus       106 lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGGG
T ss_pred             EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCCEe
Confidence            999999999999998654  67999999999999999999999998  999999999999973  467899999999986


Q ss_pred             cCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCCHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ... ....+.+||+.|||||++.+.|+.++|||||||++|||+||+.||.+..... ++..+..+..  +....+..+++
T Consensus       182 ~~~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~  258 (290)
T 3fpq_A          182 KRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPE  258 (290)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHH
T ss_pred             CCC-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHH
Confidence            543 3456789999999999999999999999999999999999999998765544 4444444322  11223457899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +++||.+||..||++|||+.|+|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-64  Score=502.01  Aligned_cols=259  Identities=33%  Similarity=0.574  Sum_probs=231.1

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +..++|++.+.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|+.|. |||||+++++|.+.+.+
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEE
Confidence            3456799999999999999999999999999999999765432   3456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.+++..   ..+++..++.++.||+.||.|||++|||||||||+||||+   .++.+||+|||+|+.+
T Consensus       224 ~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla~~~  297 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV  297 (423)
T ss_dssp             EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccceEC
Confidence            999999999999998743   4699999999999999999999999999999999999998   5788999999999876


Q ss_pred             CCC-CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPG-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+..+.+..+....+ .....+..+|++
T Consensus       298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~  376 (423)
T 4fie_A          298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPS  376 (423)
T ss_dssp             CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHH
T ss_pred             CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHH
Confidence            543 34567899999999999975 479999999999999999999999999998888888877643 233456789999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +++||.+||+.||++|||+.|+|+||||++..
T Consensus       377 ~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          377 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            99999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-63  Score=475.52  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=219.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+..... .....+.+|+++|++|. |||||++++++.+++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            47999999999999999999874   468899999997654322 12346788999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus       102 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSEEEEC-
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccccceec
Confidence            9999999999999999654  6799999999999999999999999999999999999998   5788999999999865


Q ss_pred             CC-CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KP-GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .. .....+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..+....+.++    +.+|++
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~  252 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPE  252 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHH
Confidence            43 334567899999999999975 479999999999999999999999999999999999998876553    468999


Q ss_pred             HHHHHHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          331 AKDFVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +++||.+||++||++|||     ++|+++||||+..
T Consensus       253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            999999999999999998     5899999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.1e-62  Score=473.14  Aligned_cols=253  Identities=27%  Similarity=0.366  Sum_probs=221.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +.|++.++||+|+||+||+|+++.+|+.||||++......        .+|+.+|+.|+ |||||++++++.+.+.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLS-SPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999999865431        46999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC-cEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~~~~~  254 (487)
                      ||||+||+|.+++...  +.+++..++.++.||+.||.|||++|||||||||+||||+.   ++ .+||+|||+|+.+..
T Consensus       129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS---DGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT---TSCCEEECCCTTCEEC--
T ss_pred             EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC---CCCEEEEeeCCCCeEccC
Confidence            9999999999998654  57999999999999999999999999999999999999984   44 699999999987654


Q ss_pred             CCc------cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          255 GKK------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       255 ~~~------~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ...      ....+||+.|||||++.+. |+.++|||||||++|||++|++||.+.....++..+....+.+. ..++.+
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  282 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSC  282 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTS
T ss_pred             CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccC
Confidence            321      2346899999999999765 79999999999999999999999998888888888888765433 234689


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHH-------------hcCccccccCC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQA-------------LSHPWVREGGD  363 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~-------------L~h~~~~~~~~  363 (487)
                      |+++++||.+||++||++|||+.|+             |+|||+.+...
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            9999999999999999999999997             67999987643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-60  Score=475.07  Aligned_cols=263  Identities=27%  Similarity=0.424  Sum_probs=224.2

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----  168 (487)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.|+ |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            455789999999999999999999999999999999976542 3345567889999999995 9999999998764    


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                        .+.+|||||||+ |+|++++.  ....+++..++.+++||+.||.|||++|||||||||+|||++   .++.+||+||
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~DF  202 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDF  202 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEeec
Confidence              467999999996 67999884  346899999999999999999999999999999999999998   5789999999


Q ss_pred             ccccccCCC-----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          247 GLSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       247 G~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |+|+.+...     ....+.+||+.|||||++.+  .++.++||||+|||+|||++|++||.+.+..+.+..|......+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999865332     23456899999999999865  35899999999999999999999999999888888776532222


Q ss_pred             CC-----------------------C----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          320 RR-----------------------K----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       320 ~~-----------------------~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ..                       .    .++.+|+++++||.+||.+||++|||+.|+|+||||++...
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            11                       1    13567999999999999999999999999999999998654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-59  Score=466.28  Aligned_cols=256  Identities=27%  Similarity=0.494  Sum_probs=211.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +.++|++++.||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+++|+.+.+|||||+++++|.+.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4568999999999999999999875   467899999986543     23567899999999977999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ++|||||||+||+|.+.+     ..+++..++.+++||+.||+|||++||+||||||+|||++.  +.+.+||+|||+|+
T Consensus        94 ~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~  166 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred             EEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence            999999999999999987     35999999999999999999999999999999999999984  34789999999997


Q ss_pred             ccCCCC-----------------------------ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCC
Q 011380          251 FIKPGK-----------------------------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRP  299 (487)
Q Consensus       251 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~p  299 (487)
                      ......                             ...+.+||+.|||||++.+  .|+.++||||+|||+|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            543221                             2345689999999999865  378999999999999999999999


Q ss_pred             CCCCCh-hHHHHHHHhc-----------------------------------------C---------CCCCCCCCCCCC
Q 011380          300 FWDKTE-DGIFKEVLRN-----------------------------------------K---------PDFRRKPWPSIS  328 (487)
Q Consensus       300 f~~~~~-~~~~~~i~~~-----------------------------------------~---------~~~~~~~~~~~s  328 (487)
                      |..... .+.+..+...                                         .         .......|+.+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            976543 3333333210                                         0         001123467799


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++++|||++||++||++|||+.|+|+||||++.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-58  Score=485.18  Aligned_cols=265  Identities=34%  Similarity=0.620  Sum_probs=241.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+-++|++++.||+|+||+||+|.++.+|+.||+|++.+..   ....+.+.+|+.+|+.|+ |||||+++++|.+.+.+
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            34468999999999999999999999999999999997653   345677899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|++++... ...+++..++.+++||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+.+
T Consensus       230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEEC
T ss_pred             EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEc
Confidence            9999999999999988543 3579999999999999999999999999999999999999842 3578999999999988


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .........+||+.|||||++.+. |+.++|||||||++|+|++|++||.+.+..+.+..+......+....|+.+|+++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            777777788999999999999765 6889999999999999999999999999999999999988888888888999999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ++||.+||+.||.+|||+.|+|+||||+....
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999999999999999999999999997543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.4e-59  Score=447.45  Aligned_cols=255  Identities=28%  Similarity=0.468  Sum_probs=199.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----  170 (487)
                      .+|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+++|++|. |||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            46999999999999999999999999999999997653  3445678899999999995 999999999987544     


Q ss_pred             -------EEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          171 -------YVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 -------~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                             .+|||||||+||+|.+++..... ...++..++.++.||+.||+|||++||+||||||+|||++   .++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCCcEE
Confidence                   47999999999999999854321 2245677899999999999999999999999999999998   477899


Q ss_pred             EeecccccccCCCC-------------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-H
Q 011380          243 ATDFGLSDFIKPGK-------------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-G  307 (487)
Q Consensus       243 l~DfG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  307 (487)
                      |+|||+|+......             ...+.+||+.|||||++.+ .|+.++|||||||++|||++   ||.+.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            99999998765332             1234689999999999976 47999999999999999996   77654322 2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+..+....  ++ +.++..++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          236 TLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            223333222  11 12334567789999999999999999999999999998753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-57  Score=473.12  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=218.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHH---HHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE---VKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +.+++.+ +|||||+++++|.+.+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence            469999999999999999999999999999999976543222233344444   4555566 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.++|...  +.+++..++.++.||+.||+|||++|||||||||+||||+   .++.+||+|||+|+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---CCCCEEecccceeeec
Confidence            9999999999999999654  6799999999999999999999999999999999999998   5789999999999877


Q ss_pred             CCCCccccccCCccccchhhhc-c-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCCC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLK-R-KSGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ... ...+.+||+.|||||++. + .|+.++||||||||+|||++|++||.+..   ...+...+......++    ..+
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~  417 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSF  417 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccC
Confidence            544 345679999999999995 3 47999999999999999999999997643   3345566666655443    568


Q ss_pred             CHHHHHHHHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      |+++++||.+||+.||.+|++     +.|+++||||+..
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            999999999999999999998     7999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-58  Score=440.76  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=216.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+.+.||+|+||+||+|++.     .+|+.||||++....   ....+.+.+|+++|++|+ |||||++++++.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            57999999999999999999875     357889999997542   456678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          171 YVYIAMELCEGGELLDRILAK-----------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~-----------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      .+|||||||+||+|.+++...           ....+++..+..++.||+.||.|||+++|+||||||+|||++   .++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~---~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC---CCC
Confidence            999999999999999998653           235699999999999999999999999999999999999998   478


Q ss_pred             cEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 011380          240 SLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  314 (487)
                      .+||+|||+|+.......   ....+||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..+++..+..
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            899999999986643322   223579999999999864 57999999999999999998 9999999999999988888


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +....   ..+.+|+++.+||.+||+.||++|||+.++  ++|++.
T Consensus       246 ~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          246 GRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            75322   224689999999999999999999999999  557654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-57  Score=435.75  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      +++.+++.||+|+||+||+|+++   ..||||+++... ......+.+.+|+.+|++|+ |||||++++++.. +.+|||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            56899999999999999999754   369999986543 23456788999999999995 9999999998764 568999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++... ...+++..+..++.||+.||.|||+++||||||||+||||+   .++.+||+|||+|+.....
T Consensus       110 mEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC----
T ss_pred             EEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccC
Confidence            9999999999988543 35799999999999999999999999999999999999998   5789999999999865432


Q ss_pred             ---CccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--CCCCCC
Q 011380          256 ---KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--RKPWPS  326 (487)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~  326 (487)
                         ......+||+.|||||++.+    .|+.++|||||||++|||+||+.||.+.+....+..+.......+  ...++.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence               23456789999999999853    368899999999999999999999988776655555544332222  223467


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +|+++.+||.+||+.||++|||+.|++++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-56  Score=436.41  Aligned_cols=250  Identities=21%  Similarity=0.316  Sum_probs=209.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|.+.++||+|+||+||+|+++     .+++.||||++...   .....+.+.+|+++|++|+ |||||++++++.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            46889999999999999999865     36889999999754   3456678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK-------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      .+|||||||++|+|.+++....             ..++++..+..++.||+.||.|||+++||||||||+||||+   .
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence            9999999999999999986532             24689999999999999999999999999999999999998   5


Q ss_pred             CCcEEEeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 011380          238 DSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  312 (487)
                      ++.+||+|||+|+......   .....+||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            7899999999998764332   2245689999999999875 57999999999999999999 99999999988888888


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..+...   ...+.+|+++.+||.+||+.||++|||+.|++++
T Consensus       274 ~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            876532   1224689999999999999999999999999763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-55  Score=438.78  Aligned_cols=300  Identities=30%  Similarity=0.611  Sum_probs=263.6

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF  102 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence            3456789999999999999999999999999999999976543 3345677899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||++||+|.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus       103 ~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999999998843  36799999999999999999999999999999999999998655567899999999988


Q ss_pred             cCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+..+...++...|+.++++
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             CTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             ecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            776666667899999999999876 4789999999999999999999999999998999999999888888888899999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHh
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALA  395 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~  395 (487)
                      +++||.+||..||.+|||+.++|+||||...............+..+++|....+++..++..+.
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  325 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI  325 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998643333333445667788888888888887776553

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.2e-56  Score=430.92  Aligned_cols=251  Identities=19%  Similarity=0.272  Sum_probs=214.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++++.+.||+|+||+||+|...     .+++.||||++....  .....+.+.+|+.+|++|+ |||||++++++.+.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            45889999999999999999863     467899999996543  2335678999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      .++||||||++|+|.++|....              ...+++..+..++.||+.||.|||+++||||||||+||||+   
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~---  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC---
Confidence            9999999999999999996532              24589999999999999999999999999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCC---ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKE  311 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~  311 (487)
                      +++.+||+|||+|+......   .....+||+.|||||++. +.++.++|||||||++|||+| |..||.+.+..+++..
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            47889999999998664322   234568999999999886 467999999999999999998 8999999998888888


Q ss_pred             HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          312 VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       312 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +..+...   +..+.+|+++.+|+.+||+.||++|||+.|++++
T Consensus       260 i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8766432   2234689999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.7e-56  Score=454.70  Aligned_cols=299  Identities=30%  Similarity=0.606  Sum_probs=262.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCEE
Confidence            456789999999999999999999999999999999987553 2334567899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||||+||+|.+.+...  ..+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++...
T Consensus        86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999988654  67999999999999999999999999999999999999986556788999999999776


Q ss_pred             CCCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+..+...++...|+.+|++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            5433 3456789999999999876 4799999999999999999999999999999999999999999888889999999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHh
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALA  395 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~  395 (487)
                      +++||.+||+.||++|||+.|+|+||||+..............+..+++|....+++.+++..+.
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~  308 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML  308 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEEC
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998754333334445678889999988888887776654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-55  Score=431.96  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=212.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC-----CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  168 (487)
                      .++|++++.||+|+||+||+|.+..+     ++.||||++....  .....+.+.+|+++|.++.+|||||+++++|.. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            46899999999999999999998654     3679999987543  234567789999999999756999999999865 


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      .+.+|||||||++|+|.++|....              ...+++..+..++.||+.||.|||+++||||||||+|||++ 
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-  219 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  219 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC-
Confidence            457899999999999999996542              24589999999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        .++.+||+|||+|+.+.....   ....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+....+.+
T Consensus       220 --~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             --CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              477899999999987654332   235679999999999865 57999999999999999998 99999887655544


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..++.......  ..+.+|+++.++|.+||+.||++|||+.++++|
T Consensus       298 ~~~i~~g~~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            44443332222  224588999999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-55  Score=434.34  Aligned_cols=267  Identities=36%  Similarity=0.613  Sum_probs=238.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh---HhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||+|++.+......   ...+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence            4566789999999999999999999999999999999976543211   23577899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC-CCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-DSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG  247 (487)
                      .+.+|+||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999998843  467999999999999999999999999999999999999984221 2279999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....|+.
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            9988776666677899999999999876 578999999999999999999999999999999999998887777666788


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|+++++||.+||..||.+|||+.|+|+||||+..
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999999999999999999999854

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-53  Score=422.28  Aligned_cols=295  Identities=37%  Similarity=0.636  Sum_probs=236.0

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.++|++.+.||+|+||+||+|.++.+++.||||++....     ..+.+.+|+.+++++. ||||+++++++...+.
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCCe
Confidence            456678999999999999999999999999999999987543     3356789999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++||||++||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus       123 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            9999999999999998843  35699999999999999999999999999999999999998545578999999999987


Q ss_pred             cCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCCH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ..........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+..+......+....++.++.
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  280 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL  280 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence            665555566789999999999876 46899999999999999999999998766554 6677777776666667788999


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAS  396 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~  396 (487)
                      ++.+||.+||..||++|||+.++|+||||+.......  ........+++|....++++.+...++.
T Consensus       281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (349)
T 2w4o_A          281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV--HMDTAQKKLQEFNARRKLKAAVKAVVAS  345 (349)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS--CCHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh--hhcchHHHHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543222  2234566788888888888877766543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-54  Score=428.07  Aligned_cols=302  Identities=30%  Similarity=0.568  Sum_probs=243.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++......  .....+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            3567899999999999999999999999999999998653211  1123577899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      .+|+|||||+||+|.+.+...  ....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998887654  234689999999999999999999999999999999999998655566799999999


Q ss_pred             ccccCCCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          249 SDFIKPGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       249 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      +........ ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+. ....+..+..+...+....|+.
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence            987654332 3457899999999998764 689999999999999999999999775 4567777777776666556678


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALAS  396 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~  396 (487)
                      +|+++++||.+||..||++|||+.++|+||||+..............+..++.|....+++..++..++.
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  328 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSS  328 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-----------
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999987533222222334567778887777777776665543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-53  Score=416.94  Aligned_cols=257  Identities=35%  Similarity=0.630  Sum_probs=232.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      -++|++.+.||+|+||.||+|.+..+|+.||||++.+... .+...+.+.+|+++++.+. ||||+++++++...+.+|+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            3579999999999999999999999999999999976543 3445677889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCGGGSS
T ss_pred             EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCceecCC
Confidence            99999999999998655  5799999999999999999999999999999999999998   578899999999988776


Q ss_pred             CCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .......+||+.|+|||++.+..  +.++|||||||++|+|++|+.||.+.........+..+...++    ..+|+++.
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  242 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCE  242 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence            66677889999999999987653  4789999999999999999999999999889988988866544    25789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +||++||..||.+|||+.|+|+||||+...
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-54  Score=421.75  Aligned_cols=263  Identities=29%  Similarity=0.549  Sum_probs=238.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++.++|++.+.||+|+||+||+|.++.+|+.||+|++....    .....+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            46678999999999999999999999999999999986542    34567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||||+||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           77 VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeEC
Confidence            999999999999998843 23469999999999999999999999999999999999999842 2678999999999888


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......+....|+.+|+++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence            766666677899999999998776 5889999999999999999999999999999999999988887777778899999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+||.+||..||.+|||+.|+|+||||++..
T Consensus       235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            9999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=420.89  Aligned_cols=257  Identities=28%  Similarity=0.534  Sum_probs=225.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..+++.+.+||||+++++++.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997654333345567889999999986799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-C
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~  254 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++... .
T Consensus       103 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCC-
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccceeecccC
Confidence            9999999999988654  5799999999999999999999999999999999999998   57889999999997643 2


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+......++    ..+++++.+
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  253 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATG  253 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            334456789999999999865 479999999999999999999999999999999999998876654    348899999


Q ss_pred             HHHHccccCccCCcCH------HHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTA------AQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~------~e~L~h~~~~~~  361 (487)
                      ||++||+.||.+||++      .++++||||+..
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            9999999999999999      999999999874

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.9e-53  Score=422.29  Aligned_cols=257  Identities=33%  Similarity=0.527  Sum_probs=206.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.....    ..+.+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEE
Confidence            4689999999999999999999999999999999976543    2356789999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++....
T Consensus        94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC-----
T ss_pred             EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccccc
Confidence            99999999999988554  579999999999999999999999999999999999999842 234599999999976544


Q ss_pred             CCccccccCCccccchhhhccC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCh----hHHHHHHHhcCCCCCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SG-PESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .......+||+.|+|||++.+. ++ .++|||||||++|+|++|+.||.+...    ...+..+......+  +....++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s  248 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--PDDIRIS  248 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--CTTSCCC
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--CCcCCCC
Confidence            4445567899999999998654 44 448999999999999999999987544    33444454444333  2334689


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +++.+||.+||..||.+|||+.|+++||||...
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999999764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3e-52  Score=417.89  Aligned_cols=265  Identities=35%  Similarity=0.595  Sum_probs=236.7

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++....   ......+.+|+.+|+.+. ||||+++++++.+...+
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence            45578999999999999999999999999999999987543   334567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++...
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceec
Confidence            9999999999999987432 3469999999999999999999999999999999999999742 3578999999999887


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+..+......+....+..+|+++
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            665555667899999999998764 6889999999999999999999999998888888888888777777788899999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .+||.+||..||.+|||+.++|+||||+....
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            99999999999999999999999999987543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-52  Score=419.89  Aligned_cols=257  Identities=25%  Similarity=0.479  Sum_probs=222.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..++.++.+||||+++++++.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57999999999999999999999999999999998765544445566889999999886799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc-cCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF-IKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~-~~~  254 (487)
                      |||++||+|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++. ...
T Consensus       132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecceeeecccC
Confidence            9999999999988654  5799999999999999999999999999999999999998   578899999999976 334


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHHHHhcCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDK---------TEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...         ........+......++    
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  282 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  282 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----
Confidence            4456678999999999998764 689999999999999999999999642         23345666666655544    


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCH------HHHhcCcccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVREG  361 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~------~e~L~h~~~~~~  361 (487)
                      +.+|+++++||++||+.||.+||++      .|+++||||+..
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            3589999999999999999999985      899999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-52  Score=411.36  Aligned_cols=256  Identities=30%  Similarity=0.526  Sum_probs=227.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            47999999999999999999999999999999997643222234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-C
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~  254 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .
T Consensus        84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccchhhcccC
Confidence            9999999999988654  5799999999999999999999999999999999999998   47889999999997643 3


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+......++    ..+|+++++
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  234 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS  234 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHH
Confidence            3445678899999999998654 68999999999999999999999999988888888888765544    358999999


Q ss_pred             HHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ||.+||+.||++||     ++.++++||||+..
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999     99999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=412.21  Aligned_cols=267  Identities=36%  Similarity=0.631  Sum_probs=235.4

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---hHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+.....   ....+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            345678999999999999999999999999999999997654321   123577899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG  247 (487)
                      .+.+|+||||++||+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+ ....+||+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999999884  346799999999999999999999999999999999999998532 22379999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......+....++.
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            9988765555667789999999999875 468999999999999999999999999988888888888776666555678


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|+.+.+||.+||..||.+|||+.++|+||||+..
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            89999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-52  Score=401.89  Aligned_cols=268  Identities=34%  Similarity=0.657  Sum_probs=229.3

Q ss_pred             CcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      .....+.++|.+.+.||+|+||+||+|.++.+|+.+|+|++.....  ....+.+.+|+++++++. ||||+++++++.+
T Consensus        15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   91 (285)
T 3is5_A           15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD-HPNIIKIFEVFED   91 (285)
T ss_dssp             EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred             CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCC-CchHHhHHHheec
Confidence            3445677889999999999999999999999999999999876542  234577899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          169 DNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ...+|+||||++||+|.+.+...  ....+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999999999988543  3467999999999999999999999999999999999999976556788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      |++.............||+.|+|||++.+.++.++|||||||++|+|++|+.||.+.........+....+.+... ...
T Consensus       172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  250 (285)
T 3is5_A          172 GLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRP  250 (285)
T ss_dssp             CCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CC
T ss_pred             ecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCc
Confidence            9998776655556778999999999998888999999999999999999999999988888777777666554433 245


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            7899999999999999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-51  Score=396.77  Aligned_cols=267  Identities=32%  Similarity=0.669  Sum_probs=241.9

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++...+..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            467889999999999999999999999999999999976543 3345677889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||++|++|.+.+...  ..+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++...
T Consensus        81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999999988655  56999999999999999999999999999999999999986555677999999999877


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..........||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.........+..+...++...+..+++++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            766666678899999999998765 6899999999999999999999999999999999999888888887788999999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .+||.+||+.||++|||+.|+|+||||+....
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999999999987544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-52  Score=413.77  Aligned_cols=261  Identities=34%  Similarity=0.621  Sum_probs=228.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++.+...       ...+|++++.++.+||||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            355689999999999999999999999999999999976542       2357888998886699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeecccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSDF  251 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a~~  251 (487)
                      |+|||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++..
T Consensus        92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999988543  6799999999999999999999999999999999999986432 234699999999987


Q ss_pred             cCCC-CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCC---CChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWD---KTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .... ......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+   ....+++..+..+...+....|+.
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 334567899999999998764 78899999999999999999999976   355677888888888887778889


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|+++++||++||..||++|||+.++|+||||....
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            999999999999999999999999999999997643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-52  Score=399.42  Aligned_cols=264  Identities=40%  Similarity=0.761  Sum_probs=239.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+.+++++. ||||+++++++.+.+.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCeE
Confidence            456789999999999999999999999999999999976532   23567889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999999988654  56899999999999999999999999999999999999954446789999999999887


Q ss_pred             CCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..........||+.|+|||++.+.++.++||||||+++|+|++|+.||......+....+..+...++...+..+++++.
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             cCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            76666677889999999999998899999999999999999999999999998888889988877776666678999999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +||.+||+.||.+|||+.++|+||||++..
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-52  Score=411.00  Aligned_cols=258  Identities=27%  Similarity=0.490  Sum_probs=227.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997643222234567788999999875699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-  254 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.... 
T Consensus        97 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChhhhhcccC
Confidence            9999999999988654  5799999999999999999999999999999999999998   477899999999976432 


Q ss_pred             CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+....+.++    ..+|+++++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  247 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  247 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHH
Confidence            2345667999999999998764 68999999999999999999999999999889999988776554    358999999


Q ss_pred             HHHHccccCccCCcCHH-HHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAA-QALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~-e~L~h~~~~~~~  362 (487)
                      ||.+||..||++||++. ++++||||+...
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            99999999999999998 999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.6e-53  Score=425.11  Aligned_cols=260  Identities=28%  Similarity=0.471  Sum_probs=226.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999987532211112345778999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       148 ~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             ECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccceeEeeccC
Confidence            999999999998743   4689999999999999999999999999999999999998   5788999999999876544


Q ss_pred             C--ccccccCCccccchhhhccC-----CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 K--KFQDIVGSAYYVAPEVLKRK-----SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .  .....+||+.|+|||++.+.     ++.++|||||||++|+|++|+.||.+.+....+..++.....+..+.++.+|
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            3  23467899999999998653     5789999999999999999999999999999999988765444444456799


Q ss_pred             HHHHHHHHHccccCccC--CcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~~  362 (487)
                      +++++||++||+.+|.+  ||++.|+++||||+...
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            99999999999999999  99999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.9e-52  Score=408.82  Aligned_cols=279  Identities=27%  Similarity=0.496  Sum_probs=241.5

Q ss_pred             CCCCCCCcccccCCCeeEe-eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccE
Q 011380           83 GKRTDFGYDKDFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK  161 (487)
Q Consensus        83 ~~~~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~  161 (487)
                      .....|...+.+.++|.+. +.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.+++.+.+||||++
T Consensus        15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEE
Confidence            3445566677888999998 899999999999999999999999999976542 22345778899999999987899999


Q ss_pred             EEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcE
Q 011380          162 FYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL  241 (487)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~v  241 (487)
                      +++++.+.+.+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.....+.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence            99999999999999999999999998855555779999999999999999999999999999999999999854446889


Q ss_pred             EEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          242 KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       242 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus       174 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS  253 (327)
T ss_dssp             EECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence            9999999988766555566789999999999875 468999999999999999999999999998888888888888888


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ...++.+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            777888999999999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-51  Score=405.92  Aligned_cols=257  Identities=25%  Similarity=0.472  Sum_probs=224.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++++.+||||+++++++.+.+.+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999998776555566778899999999885699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-CC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~~  254 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.. ..
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEeccccccccCC
Confidence            9999999999988654  5799999999999999999999999999999999999998   4788999999999763 23


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCC---------CChhHHHHHHHhcCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWD---------KTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||..         .........+......++    
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  239 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  239 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----
Confidence            344566799999999999876 468999999999999999999999965         233445566666655443    


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCH------HHHhcCcccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTA------AQALSHPWVREG  361 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~------~e~L~h~~~~~~  361 (487)
                      +.+|.++++||.+||+.||.+||++      .++++||||+..
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            3689999999999999999999995      899999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.8e-52  Score=417.05  Aligned_cols=264  Identities=30%  Similarity=0.572  Sum_probs=219.3

Q ss_pred             cCCCeeEe-eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 011380           94 FDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (487)
Q Consensus        94 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----  168 (487)
                      +.++|.+. +.||+|+||+||+|.++.+|+.||||++...        ..+.+|+.++.++.+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            34567776 7899999999999999999999999998642        3567899988766679999999999876    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ...+|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            66799999999999999999765455799999999999999999999999999999999999999654478999999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh----HHHHHHHhcCCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----GIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~  323 (487)
                      +............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....    .....+..+...++...
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            987765555667899999999999865 5789999999999999999999999776432    35666777777777777


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                      |..+|+++.+||++||..||.+|||+.++|+||||.......
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  332 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  332 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence            889999999999999999999999999999999998754433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-52  Score=406.14  Aligned_cols=247  Identities=23%  Similarity=0.286  Sum_probs=189.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~----  170 (487)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++....    ........|+..+.+++ |||||++++++.+++    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            35799999999999999999986  58999999986542    12223345666667785 999999999997653    


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCceEeccCCCCCcEE
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--------~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      .+|||||||+||+|.+++..   ..+++..+..++.|++.||.|||++        +|+||||||+|||++   .++.+|
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---~~~~~K  148 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCC  148 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC---TTSCEE
T ss_pred             EEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC---CCCCEE
Confidence            68999999999999999854   4689999999999999999999987        999999999999998   578999


Q ss_pred             EeecccccccCCCCc-----cccccCCccccchhhhccC-------CCCcchHHHHHHHHHHHHhCCCCCCCCC------
Q 011380          243 ATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKT------  304 (487)
Q Consensus       243 l~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~ell~g~~pf~~~~------  304 (487)
                      |+|||+|+.......     ....+||+.|||||++.+.       ++.++|||||||++|||+||.+||....      
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            999999987654332     2346899999999998653       4678999999999999999987653211      


Q ss_pred             ---------hhHHHHHHHhcCCCCCCCC-CC--CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          305 ---------EDGIFKEVLRNKPDFRRKP-WP--SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       305 ---------~~~~~~~i~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                               .......+.........+. ++  ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                     1222233333222111110 11  12346889999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-52  Score=403.95  Aligned_cols=254  Identities=27%  Similarity=0.553  Sum_probs=226.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence            46999999999999999999999999999999997643222234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSS-
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcceecCC-
Confidence            9999999999988543  5799999999999999999999999999999999999998   578999999999987543 


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+......++    +.+++++.++
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  233 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDL  233 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence             23467899999999998764 68999999999999999999999999988889999988765544    4688999999


Q ss_pred             HHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      |.+||..||++||     ++.++++||||+..
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            9999999999999     99999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.8e-52  Score=409.58  Aligned_cols=257  Identities=25%  Similarity=0.439  Sum_probs=227.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..++..+.+||||+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999997653322234567889999999886699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC-C
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-P  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~-~  254 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.... .
T Consensus       100 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcccccccC
Confidence            9999999999988654  5699999999999999999999999999999999999998   47889999999997643 2


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++..+......++    +.+|+++.+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  250 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVA  250 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence            334566789999999999865 468999999999999999999999999999999999998876654    368999999


Q ss_pred             HHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ||.+||..||.+||     ++.++++||||+..
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999999999     47999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.6e-53  Score=413.98  Aligned_cols=257  Identities=34%  Similarity=0.590  Sum_probs=220.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      .-++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+|
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            3467999999999999999999999999999999987543222223457889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+ +|+|++++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        86 lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTBTTT
T ss_pred             EEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccceecc
Confidence            999999 78999988665  5799999999999999999999999999999999999998   57789999999998877


Q ss_pred             CCCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ........+||+.|+|||++.+..  ++++|||||||++|+|++|+.||.+.........+......    ....+|+++
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~  235 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV----MPDFLSPGA  235 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCC----CCTTSCHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC----CcccCCHHH
Confidence            666667789999999999997653  68999999999999999999999876554433333222211    123588999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+||++||..||.+|||+.|+++||||+..
T Consensus       236 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          236 QSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.6e-52  Score=406.68  Aligned_cols=266  Identities=32%  Similarity=0.607  Sum_probs=210.1

Q ss_pred             CCCeeEe---eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIG---KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++|++.   +.||+|+||+||+|.++.+|+.||||++.+.      ....+.+|+.+++.+.+||||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            3567775   7899999999999999999999999999654      346678999999999779999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999988543  6799999999999999999999999999999999999998644455899999999986


Q ss_pred             cCCC-CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-------hhHHHHHHHhcCCCCCCC
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT-------EDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~  322 (487)
                      .... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..       ..+.+..+..+...+...
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            5433 33456789999999999865 46889999999999999999999997643       245667777777666666


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCC
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~  368 (487)
                      .|+.+|+++++||.+||..||.+|||+.++++||||+........+
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~  284 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP  284 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCC
Confidence            6778999999999999999999999999999999999865544443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.1e-51  Score=396.88  Aligned_cols=258  Identities=28%  Similarity=0.481  Sum_probs=223.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+|++.+.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++.+. ||||+++++++...+.+|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   93 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEEE
Confidence            446899999999999999999999999999999998755422   3467889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++||+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCceecC
Confidence            99999999999998854   3689999999999999999999999999999999999998   47789999999987765


Q ss_pred             CCC-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ... .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+....... ....+.+++.+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  246 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIF  246 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHH
Confidence            432 34557899999999998654 6899999999999999999999998887776666655443221 12235689999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+||.+||+.||++|||+.|+|+||||+...
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            9999999999999999999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-51  Score=402.59  Aligned_cols=267  Identities=36%  Similarity=0.599  Sum_probs=222.3

Q ss_pred             ccccCCCeeEe-eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           91 DKDFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        91 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ...+.++|++. +.||+|+||+||+|.+..+|+.||||++....   ......+.+|+.++.++.+||||+++++++.+.
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            45677889995 78999999999999999999999999997653   234567889999999965799999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999999998654  57899999999999999999999999999999999999986444456999999998


Q ss_pred             cccCCC--------CccccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh----------
Q 011380          250 DFIKPG--------KKFQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTE----------  305 (487)
Q Consensus       250 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~----------  305 (487)
                      ......        ......+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            765321        11234579999999999863      468999999999999999999999977542          


Q ss_pred             -----hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          306 -----DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       306 -----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                           ......+..+...++...++.+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence                 345666777766665555567899999999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=409.65  Aligned_cols=256  Identities=24%  Similarity=0.484  Sum_probs=224.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEE
Confidence            57999999999999999999999999999999997654333334577889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.||+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEeccceeeeccCC
Confidence            999999999998854  46799999999999999999999999999999999999998   5789999999999887766


Q ss_pred             CccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          256 KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      ......+||+.|+|||++.+    .++.++|||||||++|+|++|+.||....   .......+......++    ..+|
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s  244 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWS  244 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCC
Confidence            66778899999999999853    36889999999999999999999997543   3445555555544433    3588


Q ss_pred             HHHHHHHHHccccCccCCcC-HHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLT-AAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt-~~e~L~h~~~~~~  361 (487)
                      +++.+||.+||+.||.+||+ +.++++||||+..
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999999998 9999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3e-51  Score=405.62  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=227.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999999765432233457788999999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccceeccCC
Confidence            9999999999998654  5699999999999999999999999999999999999998   4788999999999876432


Q ss_pred             CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                        ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+..+...++    +.+++++.+|
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  268 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL  268 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence              346789999999999865 468999999999999999999999999998899999988876554    3589999999


Q ss_pred             HHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      |.+||+.||.+||+     +.++++||||+..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            99999999999998     9999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7e-52  Score=420.75  Aligned_cols=262  Identities=26%  Similarity=0.455  Sum_probs=224.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+|
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999997533211122334788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       153 ~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             ECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhhhhhcccC
Confidence            9999999999988542 36799999999999999999999999999999999999998   5789999999999766543


Q ss_pred             Cc--cccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CCCC
Q 011380          256 KK--FQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PWPS  326 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~  326 (487)
                      ..  ....+||+.|+|||++.      +.++.++|||||||++|||++|+.||.+.+..+.+..++.....+..+ .++.
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            32  23468999999999985      347899999999999999999999999999888888887643222222 2356


Q ss_pred             CCHHHHHHHHHccccCccC--CcCHHHHhcCccccccC
Q 011380          327 ISNSAKDFVKKLLVKDPRA--RLTAAQALSHPWVREGG  362 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~--Rpt~~e~L~h~~~~~~~  362 (487)
                      +|+++++||++||+.+|++  ||++.|+++||||+...
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            8999999999999999998  99999999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.7e-51  Score=397.62  Aligned_cols=263  Identities=27%  Similarity=0.484  Sum_probs=217.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+.++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.+.
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERC   93 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSC
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCE
Confidence            456788999999999999999999985 589999999975432 2234567889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARA  168 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCcee
Confidence            9999999975 888877543 35699999999999999999999999999999999999998   467899999999987


Q ss_pred             cCCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC-----
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP-----  323 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-----  323 (487)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+...........     
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            6432 33455689999999999865  468999999999999999999999988877776666654211111111     


Q ss_pred             ---------------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          324 ---------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       324 ---------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                           .+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                                 235788999999999999999999999999999998753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-51  Score=408.46  Aligned_cols=262  Identities=34%  Similarity=0.626  Sum_probs=228.0

Q ss_pred             cCCCeeE--eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           94 FDRRYTI--GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        94 ~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +...|.+  .+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND  160 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            4445666  678999999999999999999999999997653   245578899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. ..++.+||+|||++..
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~  238 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARR  238 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCcee
Confidence            99999999999999988643 346899999999999999999999999999999999999953 1467899999999988


Q ss_pred             cCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ..........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......+....++.++++
T Consensus       239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  318 (373)
T 2x4f_A          239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE  318 (373)
T ss_dssp             CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred             cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence            7766666677899999999998754 688999999999999999999999999998899999988777776677889999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +++||.+||+.||.+|||+.|+|+||||+..
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-51  Score=396.81  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=218.9

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALA--GHENVVKFYNAFED  168 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~  168 (487)
                      .+.++|++.+.||+|+||+||+|++..+|+.||+|++......  .......+.+|+.+++.+.  +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3457899999999999999999999999999999998643311  1111245667888777764  49999999999987


Q ss_pred             CC-----EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEE
Q 011380          169 DN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       169 ~~-----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                      ..     .+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence            65     5899999996 5999998766555699999999999999999999999999999999999998   4778999


Q ss_pred             eecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011380          244 TDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       244 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  322 (487)
                      +|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+..........
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99999987766666677899999999999854 57999999999999999999999999998888877776532222222


Q ss_pred             C-----------------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          323 P-----------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       323 ~-----------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .                       .+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            2                       245789999999999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.5e-51  Score=406.19  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=218.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHH-HhccCCCCccEEEEEEEeCCEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL-QALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l-~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.+|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEE
Confidence            35799999999999999999999999999999999876554444556677787774 556 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCBCGGGB
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCccccccc
Confidence            999999999999988654  5789999999999999999999999999999999999998   47899999999997633


Q ss_pred             -CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 -PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 -~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                       ........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..++.....++    +.++.++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  266 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSA  266 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHH
Confidence             33445678999999999998764 68999999999999999999999999999999999988765543    4689999


Q ss_pred             HHHHHHccccCccCCcCH----HHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTA----AQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~----~e~L~h~~~~~~  361 (487)
                      ++||.+||+.||.+||++    .++++||||+..
T Consensus       267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999999986    699999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-50  Score=391.26  Aligned_cols=259  Identities=24%  Similarity=0.433  Sum_probs=216.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            479999999999999999999999999999999976543 2334577889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCSC
T ss_pred             EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceecCCc
Confidence            999975 666666443 46799999999999999999999999999999999999998   4778999999999876433


Q ss_pred             -CccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHhcCCCCCCC---------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPF-WDKTEDGIFKEVLRNKPDFRRK---------  322 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~---------  322 (487)
                       ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..|| .+......+..+..........         
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             334556899999999998653  689999999999999999988775 4555556666655422111111         


Q ss_pred             ----------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          323 ----------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       323 ----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                      ..+.+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                            124578999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-51  Score=413.59  Aligned_cols=261  Identities=27%  Similarity=0.470  Sum_probs=222.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|..++..+. ||||+++++++.+.+.+|+|
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999997643222223345788999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus       140 mE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             ECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechhheeccCC
Confidence            9999999999988654 34799999999999999999999999999999999999998   5789999999999876543


Q ss_pred             Cc--cccccCCccccchhhhc--------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CC
Q 011380          256 KK--FQDIVGSAYYVAPEVLK--------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK-PW  324 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~  324 (487)
                      ..  ....+||+.|+|||++.        +.++.++|||||||++|||++|+.||.+.+..+.+.++......+..+ ..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            32  23468999999999986        346899999999999999999999999999888888887643222211 12


Q ss_pred             CCCCHHHHHHHHHccccCccCC---cCHHHHhcCccccccC
Q 011380          325 PSISNSAKDFVKKLLVKDPRAR---LTAAQALSHPWVREGG  362 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~R---pt~~e~L~h~~~~~~~  362 (487)
                      ..+|+++++||++||+ +|.+|   |++.|+++||||+...
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~  335 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD  335 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence            4689999999999999 99998   5999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7e-51  Score=398.81  Aligned_cols=267  Identities=36%  Similarity=0.616  Sum_probs=233.3

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh---HhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++++. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            3456789999999999999999999999999999999976543221   13577899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC-CCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-DSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~vkl~DfG  247 (487)
                      .+.+|+||||++|++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++..+. ...+||+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999998854  467899999999999999999999999999999999999984211 1279999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++...++.
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            9988766655667789999999999875 468999999999999999999999999988888888887766555444567


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +++.+.+||.+||..||++|||+.++|+||||+..
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            89999999999999999999999999999999764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.8e-51  Score=406.41  Aligned_cols=264  Identities=33%  Similarity=0.660  Sum_probs=234.0

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-----hHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||||++.......     ....+.+.+|+.+++++.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            345578999999999999999999999999999999987543211     123467789999999995699999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ...+..|+||||++|++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++   .++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEEec
Confidence            9999999999999999999988654  5799999999999999999999999999999999999998   5788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |++............+||+.|+|||++.+       .++.++|||||||++|+|++|..||.+......+..+..+...+
T Consensus       245 G~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF  324 (365)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             CcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            99988776666677899999999999853       36789999999999999999999999988888888888887776


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ....|+.++..+.+||.+||..||++|||+.++|+||||++
T Consensus       325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            66667789999999999999999999999999999999973

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-50  Score=390.74  Aligned_cols=264  Identities=41%  Similarity=0.727  Sum_probs=236.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++++. ||||+++++++...+.+|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCeEE
Confidence            445799999999999999999999999999999998764432 234577889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++....
T Consensus        98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999999988654  468999999999999999999999999999999999999865556789999999998776


Q ss_pred             CCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..+...+....+..+|+++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55555566799999999999988999999999999999999999999998888888888888777666667789999999


Q ss_pred             HHHHccccCccCCcCHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|.+||..||.+|||+.++|+||||++.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-51  Score=396.94  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=212.7

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.++||+|+||+||+|.++.+|+.||||++..... ..........|+..+.++.+||||+++++++.+.+.+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            345789999999999999999999999999999999865432 2334455667777777765699999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++...
T Consensus       133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCEEC
T ss_pred             EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeeeec
Confidence            9999999 67998887654 35799999999999999999999999999999999999998   4678999999999877


Q ss_pred             CCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..........||+.|+|||++.+.++.++|||||||++|+|++|..||.+..   ....+..+..  .....+.+++++.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSELR  282 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHHHH
T ss_pred             ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHHHH
Confidence            6555556678999999999999989999999999999999999977775532   2333332221  1112346889999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +||.+||+.||++|||+.++|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-51  Score=418.75  Aligned_cols=257  Identities=35%  Similarity=0.612  Sum_probs=229.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|.+++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            357999999999999999999999999999999997653322234567899999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        94 v~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           94 VMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSCEECCT
T ss_pred             EEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccchhhccc
Confidence            999999999999884  346799999999999999999999999999999999999998   477899999999988776


Q ss_pred             CCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .......+||+.|+|||++.+..  +.++|||||||++|+|++|+.||.+......+..+..+....+    ..+++++.
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  244 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVI  244 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHH
Confidence            66667789999999999997753  6789999999999999999999999888888888887754332    35789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +||.+||..||.+|||+.++++||||+..
T Consensus       245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          245 SLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-50  Score=392.90  Aligned_cols=263  Identities=40%  Similarity=0.735  Sum_probs=231.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHY   81 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEE
Confidence            456789999999999999999999999999999999976432   23356889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999999988654  56899999999999999999999999999999999999954446789999999998765


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ... .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+..+...+....++.+++++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            432 23456799999999998654 6889999999999999999999999998888888998888777777778899999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+||.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.4e-50  Score=388.66  Aligned_cols=266  Identities=32%  Similarity=0.619  Sum_probs=235.6

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC------ChHhHHHHHHHHHHHHhccCCCCccEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI------LPIAVEDVKREVKILQALAGHENVVKFYNA  165 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  165 (487)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++......      .....+.+.+|+.+++++.+||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34567899999999999999999999999999999999754311      112346778999999999669999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          166 FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       166 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                      +...+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~d  167 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTD  167 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEEEec
Confidence            99999999999999999999988654  5799999999999999999999999999999999999998   477899999


Q ss_pred             cccccccCCCCccccccCCccccchhhhc-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLK-------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                      ||++.............||+.|+|||++.       ..++.++||||||+++|+|++|..||...........+..+...
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            99998876666666778999999999874       23578999999999999999999999998888888888888877


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +....++.++..+.++|.+||..||.+|||+.++|+||||+...
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            77777778999999999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-50  Score=396.76  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=207.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.++.+|+.||+|++.....  ......+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence            579999999999999999999999999999999975432  223466789999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          176 MELCEGGELLDRILAKK----DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      |||++ |+|.+++....    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcccee
Confidence            99997 59998886543    24589999999999999999999999999999999999998   477899999999987


Q ss_pred             cCCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC------
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK------  322 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  322 (487)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+..........      
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6432 33456689999999999865  46899999999999999999999999988877777665421111100      


Q ss_pred             ------------------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          323 ------------------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       323 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                              ....++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    11257889999999999999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-50  Score=391.03  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=212.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ......+.+|+.+++++. ||||+++++++...+.+|+|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            4799999999999999999998 67999999999654321 223466789999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        79 ~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIP  153 (288)
T ss_dssp             EECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC-
T ss_pred             EEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccccCcc
Confidence            999975 888877543 36799999999999999999999999999999999999998   4778999999999766432


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (487)
                       .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.........           
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             23345689999999999865  4689999999999999999999999988877776666542111100           


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                    ...+.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          0123578999999999999999999999999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-51  Score=393.45  Aligned_cols=256  Identities=29%  Similarity=0.568  Sum_probs=216.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-----------------------hHhHHHHHHHHHHHHh
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----------------------PIAVEDVKREVKILQA  152 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----------------------~~~~~~~~~E~~~l~~  152 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++.......                       ....+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57999999999999999999999999999999997654211                       1123568899999999


Q ss_pred             ccCCCCccEEEEEEEe--CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCce
Q 011380          153 LAGHENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (487)
Q Consensus       153 l~~hpnIv~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NI  230 (487)
                      +. ||||+++++++.+  .+.+|+||||+++++|.+.+   ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus        93 l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            95 9999999999986  67899999999999987743   335799999999999999999999999999999999999


Q ss_pred             EeccCCCCCcEEEeecccccccCCCC-ccccccCCccccchhhhccCC----CCcchHHHHHHHHHHHHhCCCCCCCCCh
Q 011380          231 LFKSAKEDSSLKATDFGLSDFIKPGK-KFQDIVGSAYYVAPEVLKRKS----GPESDVWSIGVITYILLCGRRPFWDKTE  305 (487)
Q Consensus       231 ll~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~DiwSlG~il~ell~g~~pf~~~~~  305 (487)
                      |++   .++.+||+|||++....... ......||+.|+|||++.+..    +.++|||||||++|+|++|+.||.+...
T Consensus       169 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          169 LVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            998   47789999999998765432 335578999999999987643    6789999999999999999999998887


Q ss_pred             hHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          306 DGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       306 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ......+......++.  .+.+++++.+||.+||..||++|||+.|+|+||||++
T Consensus       246 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            7777777766554432  3578999999999999999999999999999999963

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-51  Score=410.31  Aligned_cols=262  Identities=33%  Similarity=0.501  Sum_probs=210.3

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+++.+.+||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            45578999999999999999999999999999999986542 234456778899999999977999999999997544  


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+|||||+ ++|.+.+..   ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCcccc
Confidence            7999999997 588887744   4789999999999999999999999999999999999998   47889999999997


Q ss_pred             ccCC----------------------CCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          251 FIKP----------------------GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       251 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                      ....                      .......+||++|+|||++.+  .++.++|||||||++|+|++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            6532                      112345689999999999865  5789999999999999999999999998887


Q ss_pred             HHHHHHHhcCCCCC------------------------------C-------------CCCCCCCHHHHHHHHHccccCc
Q 011380          307 GIFKEVLRNKPDFR------------------------------R-------------KPWPSISNSAKDFVKKLLVKDP  343 (487)
Q Consensus       307 ~~~~~i~~~~~~~~------------------------------~-------------~~~~~~s~~~~~li~~~L~~dp  343 (487)
                      ..+..+........                              .             .....+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            77766653211100                              0             0122678999999999999999


Q ss_pred             cCCcCHHHHhcCccccccC
Q 011380          344 RARLTAAQALSHPWVREGG  362 (487)
Q Consensus       344 ~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++|||+.|+|+||||+...
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTC
T ss_pred             ccCCCHHHHhCCHHHHHhc
Confidence            9999999999999998654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-50  Score=405.21  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=218.5

Q ss_pred             CCeeEeeeeeec--CceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           96 RRYTIGKLLGHG--QFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++|++++.||+|  +||+||+|+++.+|+.||||++..... .....+.+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEE
Confidence            579999999999  999999999999999999999976543 3445678889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +|||||++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccccceeec
Confidence            999999999999999776667799999999999999999999999999999999999998   57799999999875432


Q ss_pred             CC--------CccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC---
Q 011380          254 PG--------KKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF---  319 (487)
Q Consensus       254 ~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---  319 (487)
                      ..        ......+||+.|+|||++.+   .++.++|||||||++|+|++|+.||.+......+..+..+....   
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            11        11233589999999999876   46899999999999999999999998876655554433322110   


Q ss_pred             ---------------------------------------CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          320 ---------------------------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       320 ---------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                                             ....+..+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                                   01123457899999999999999999999999999999987


Q ss_pred             cCC
Q 011380          361 GGD  363 (487)
Q Consensus       361 ~~~  363 (487)
                      ...
T Consensus       340 ~~~  342 (389)
T 3gni_B          340 IKR  342 (389)
T ss_dssp             C--
T ss_pred             Hhh
Confidence            643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4e-51  Score=425.14  Aligned_cols=259  Identities=26%  Similarity=0.459  Sum_probs=226.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEEE
Confidence            357999999999999999999999999999999997653322334567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecccceeccc
Confidence            99999999999988765555699999999999999999999999999999999999998   578999999999988766


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..    ...+...+......++    ..+|+
T Consensus       339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~  414 (576)
T 2acx_A          339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSP  414 (576)
T ss_dssp             TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCH
Confidence            666667799999999999876 47999999999999999999999998753    2445555555444332    46899


Q ss_pred             HHHHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          330 SAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ++++||.+||+.||.+||     ++.|+++||||+..
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999999999     89999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-50  Score=397.28  Aligned_cols=259  Identities=33%  Similarity=0.590  Sum_probs=217.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++++.||+|+||+||+|.++.+|+.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            55789999999999999999999999999999999875432  223466789999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++||+|.+++  .....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           82 LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEECE
T ss_pred             EEEEcCCCCcHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccceec
Confidence            999999999999887  3345799999999999999999999999999999999999998   47789999999997653


Q ss_pred             CC---CccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHhcCCCCCCCCCCCC
Q 011380          254 PG---KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGI-FKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       254 ~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..   ......+||+.|+|||++.+.  ++.++|||||||++|+|++|+.||........ +.......  .....+..+
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~  234 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKI  234 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--TTSTTGGGS
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--ccCCccccC
Confidence            22   223467899999999998654  36789999999999999999999987655433 33333322  222345678


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++.+.+||.+||..||++|||+.|+++||||+...
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            99999999999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.4e-51  Score=417.76  Aligned_cols=262  Identities=29%  Similarity=0.433  Sum_probs=199.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----  168 (487)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++..    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence            35578999999999999999999999999999999996542 23445678899999999995 9999999999843    


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                       ...+|+||||+ +++|.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~DFG  201 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCDFG  201 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeecccc
Confidence             36799999998 5689888743  46799999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCC----------------------------CccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHh--
Q 011380          248 LSDFIKPG----------------------------KKFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLC--  295 (487)
Q Consensus       248 ~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~--  295 (487)
                      +++.....                            ......+||++|+|||++.  ..++.++||||||||+|||++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            99865422                            1234568999999999863  357999999999999999999  


Q ss_pred             ---------CCCCCCCCCh--------------------hHHHHHHHh-----------------------cCCCC----
Q 011380          296 ---------GRRPFWDKTE--------------------DGIFKEVLR-----------------------NKPDF----  319 (487)
Q Consensus       296 ---------g~~pf~~~~~--------------------~~~~~~i~~-----------------------~~~~~----  319 (487)
                               |++||.+...                    ...+..+..                       ..+..    
T Consensus       282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (458)
T 3rp9_A          282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD  361 (458)
T ss_dssp             TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred             cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence                     6777755431                    111221111                       11100    


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ....++.+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus       362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            1122467799999999999999999999999999999999764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.3e-50  Score=399.18  Aligned_cols=260  Identities=28%  Similarity=0.448  Sum_probs=224.8

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .....+|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+++++++. ||||+++++++...+.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  128 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT  128 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCe
Confidence            445567999999999999999999999999999999997654444445677899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||+. |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred             EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCcee
Confidence            999999997 5888877543 36799999999999999999999999999999999999998   578999999999976


Q ss_pred             cCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ...   ....+||+.|+|||++.    +.++.++|||||||++|+|++|+.||.+......+..+........  ....+
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  278 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW  278 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTS
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCC
Confidence            543   24568999999999984    4568899999999999999999999998887777777766543222  22467


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++.+.+||.+||+.||++|||+.++|+||||....
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            89999999999999999999999999999997643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.8e-51  Score=415.06  Aligned_cols=266  Identities=36%  Similarity=0.633  Sum_probs=217.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-----hHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-----PIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..+.++|.+.+.||+|+||+||+|.++.+++.||+|++.+.....     ......+.+|+.+|+++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            445678999999999999999999999999999999997654221     112235789999999995 99999999998


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      .. +.+|+||||+++|+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+||
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             ec-CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence            64 45899999999999998774  3467999999999999999999999999999999999999986555678999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRR  321 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~  321 (487)
                      |++............+||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+..
T Consensus       287 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          287 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             STTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             ccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            9998876655566788999999999985    34577999999999999999999999765443 445556666555555


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ..|+.+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            5567899999999999999999999999999999999763

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-50  Score=414.35  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=217.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence            357999999999999999999999999999999997653333344567788999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||++....
T Consensus       226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCCCCCTTC
T ss_pred             EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCCCceecc
Confidence            99999999999988554  579999999999999999999998 9999999999999998   47789999999997643


Q ss_pred             -CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 -PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 -~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                       ........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+......++    +.+++++
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~  376 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEA  376 (446)
T ss_dssp             C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHH
Confidence             2334566889999999999865 579999999999999999999999999988888888888766544    3588999


Q ss_pred             HHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      .+||.+||..||.+||     |+.|+|+||||+..
T Consensus       377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            9999999999999999     99999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.2e-50  Score=392.18  Aligned_cols=257  Identities=27%  Similarity=0.511  Sum_probs=214.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++|++.+.||+|+||.||+|++.   .+|+.||+|++.+.... .......+.+|+.+++.+. ||||+++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            357999999999999999999985   68999999999765322 1223456788999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCK  169 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECCCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEeCCccc
Confidence            999999999999999988654  5689999999999999999999999999999999999998   47889999999987


Q ss_pred             ccCC-CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          251 FIKP-GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       251 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+......++    +.++
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~  245 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT  245 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence            5432 233456789999999999865 468999999999999999999999999988888888888765543    4688


Q ss_pred             HHHHHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      +++.+||.+||..||.+||     ++.++++||||+..
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999999999     89999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.2e-50  Score=395.50  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=212.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++++. ||||+++++++.+.+.+|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence            34579999999999999999999999999999999975532 2233456779999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC--CCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DfG~a~~  251 (487)
                      +||||++| +|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++..  ...+.+||+|||++..
T Consensus       110 lv~e~~~~-~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEECCSE-EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEecCCC-CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99999974 999988543  569999999999999999999999999999999999999642  1355699999999977


Q ss_pred             cCCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC---
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP---  325 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---  325 (487)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+...........|+   
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            6432 33455688999999999865  36899999999999999999999999988877777766532222221111   


Q ss_pred             -----------------------CCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          326 -----------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       326 -----------------------~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                             .+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                   1678999999999999999999999999999998753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-51  Score=402.02  Aligned_cols=269  Identities=35%  Similarity=0.629  Sum_probs=228.1

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+.++|++.+.||+|+||+||+|.+..+++.||+|++.+....  .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  101 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccCC
Confidence            4567899999999999999999999999999999998654321  2335678899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhh--------------------------------------cCCCCCHHHHHHHHHHHHHHH
Q 011380          171 YVYIAMELCEGGELLDRILAK--------------------------------------KDSRYTEKDAAVVVRQMLRVA  212 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--------------------------------------~~~~l~~~~~~~~~~qil~~l  212 (487)
                      .+++||||++||+|.+++...                                      ....+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999877310                                      011246788999999999999


Q ss_pred             HHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-----ccccccCCccccchhhhcc---CCCCcchHH
Q 011380          213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKR---KSGPESDVW  284 (487)
Q Consensus       213 ~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~Diw  284 (487)
                      .|||++||+||||||+|||++.+ ....+||+|||++.......     ......||+.|+|||++.+   .++.++|||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            99999999999999999999842 23489999999997653211     2345689999999999863   568899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          285 SIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       285 SlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ||||++|+|++|+.||.+....+....+......+....++.+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            9999999999999999999999999999988877777777779999999999999999999999999999999987643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=398.18  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=212.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|++.....  ......+.+|+.+++.+. ||||+++++++.+.+.+++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            479999999999999999999999999999999865431  111123457999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC---
T ss_pred             ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCcccccccCC
Confidence            99997 5888887544 45699999999999999999999999999999999999998   4678999999999765432


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC---------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP---------  323 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  323 (487)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+...........         
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             23445688999999999865  468999999999999999999999999888877777655322222222         


Q ss_pred             -----------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          324 -----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       324 -----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                                       ++.+++++.+||.+||+.||++|||+.|+|+||||......
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                             23578899999999999999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.4e-50  Score=384.11  Aligned_cols=265  Identities=36%  Similarity=0.651  Sum_probs=226.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.......   ....+.+.+|+.+++++. ||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCCe
Confidence            457999999999999999999999999999999987654321   123578899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeeccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFGLSD  250 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG~a~  250 (487)
                      .++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++..+ ....+||+|||++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999988554  5799999999999999999999999999999999999998532 23379999999998


Q ss_pred             ccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+......+....++.+++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            7765555566789999999999875 468899999999999999999999999888888888877766555444567899


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+.+||.+||..||++|||+.++|+||||+...
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            999999999999999999999999999998653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=387.92  Aligned_cols=261  Identities=28%  Similarity=0.477  Sum_probs=214.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence            57999999999999999999999999999999986654 23445677889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+.+.  ....+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        81 ~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           81 FEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             EECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCchhccCc
Confidence            99999988877663  336799999999999999999999999999999999999998   4788999999999876532


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  318 (487)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+......              
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             23456689999999999865  4689999999999999999999999888776665544331100              


Q ss_pred             -----CCCC--------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          319 -----FRRK--------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       319 -----~~~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                           .+..        .++.+++++.+||.+||..||.+|||+.|+|+||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence                 0000        13568899999999999999999999999999999997643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.7e-50  Score=382.99  Aligned_cols=257  Identities=29%  Similarity=0.579  Sum_probs=222.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEE
Confidence            57999999999999999999999999999999986543322233567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccccccCCcc
Confidence            9999999999988654  5699999999999999999999999999999999999998   4778999999998655432


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......++    ..+++.+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence             23456899999999998765 58899999999999999999999998888888888877655443    3578999999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccCC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      |.+||..||.+|||+.|+|+||||+....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999999987543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-49  Score=396.87  Aligned_cols=263  Identities=23%  Similarity=0.349  Sum_probs=221.8

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc----CCCCccEEEEE
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----GHENVVKFYNA  165 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~  165 (487)
                      ....+.++|++.+.||+|+||+||+|.+..+|+.||||++...    ......+..|+.+++.+.    +||||++++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            3445678999999999999999999999999999999998643    234567788999999985    49999999999


Q ss_pred             EEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC----------
Q 011380          166 FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----------  235 (487)
Q Consensus       166 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~----------  235 (487)
                      +...+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..          
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            99999999999999 8999999977766679999999999999999999999999999999999999731          


Q ss_pred             ------------CCCCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 011380          236 ------------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWD  302 (487)
Q Consensus       236 ------------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~  302 (487)
                                  ...+.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        1367899999999986543  2346789999999999865 579999999999999999999999998


Q ss_pred             CChhHHHHHHHhcCCCCCC---------------------CCCC---------------------CCCHHHHHHHHHccc
Q 011380          303 KTEDGIFKEVLRNKPDFRR---------------------KPWP---------------------SISNSAKDFVKKLLV  340 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~---------------------~~~~---------------------~~s~~~~~li~~~L~  340 (487)
                      ....+.+..+......++.                     ..|+                     ..++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            8877766665543322211                     0011                     123678899999999


Q ss_pred             cCccCCcCHHHHhcCcccc
Q 011380          341 KDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       341 ~dp~~Rpt~~e~L~h~~~~  359 (487)
                      .||++|||+.|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.6e-50  Score=413.63  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=210.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+|+.+. ||||+++++++...    
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccc
Confidence            4578999999999999999999999999999999997642 23445677889999999995 99999999999654    


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|+||||+++ +|.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~DFG  209 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  209 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCC
T ss_pred             cCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEEEE
Confidence              468999999976 5666552    3589999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  316 (487)
                      +++...........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+....          
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9988776656677899999999999865 57899999999999999999999999888777666665421          


Q ss_pred             ------------CCCCCCCCCC----------------CCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 ------------PDFRRKPWPS----------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 ------------~~~~~~~~~~----------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                  +.+....++.                .++++++||.+||..||++|||+.|+|+||||+...
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                        1111111110                156799999999999999999999999999998643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-50  Score=394.91  Aligned_cols=266  Identities=36%  Similarity=0.635  Sum_probs=220.5

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-----ChHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++......     .......+.+|+.+++++. ||||+++++++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence            34567899999999999999999999999999999998764321     1122345789999999995 99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      .... +|+||||+++++|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+||
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             cCCc-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            8766 899999999999999884  3467999999999999999999999999999999999999986555567999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKPDFRR  321 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~  321 (487)
                      |++.............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+..
T Consensus       162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            9998765544445567999999999973    35688999999999999999999999765443 344555555554444


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ..++.+++++.+||.+||..||++|||+.++|+||||+..
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            4456789999999999999999999999999999999763

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.4e-49  Score=412.65  Aligned_cols=258  Identities=27%  Similarity=0.449  Sum_probs=224.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|.+.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999997654322234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||++||+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEeecceeeecc
Confidence            99999999999886543  35699999999999999999999999999999999999998   57889999999998765


Q ss_pred             CCCc-cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhcCCCCCCCCCCCC
Q 011380          254 PGKK-FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       254 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      .... ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..    ...+...+......++    +.+
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~  416 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF  416 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----ccc
Confidence            4433 3456999999999998764 7999999999999999999999998753    3556667776655443    468


Q ss_pred             CHHHHHHHHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      |+++++||.+||+.||.+||+     +.++++||||+..
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            999999999999999999995     5899999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-49  Score=393.04  Aligned_cols=262  Identities=27%  Similarity=0.435  Sum_probs=220.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe------
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------  168 (487)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            36899999999999999999999999999999998665432 223456779999999995 9999999999987      


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                        .+.+|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~kl~Df  168 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADF  168 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEEEccc
Confidence              4578999999975 777777543 35699999999999999999999999999999999999998   4778999999


Q ss_pred             ccccccCC-----CCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          247 GLSDFIKP-----GKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       247 G~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      |++.....     .......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+......+
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99976542     223345689999999999865  36899999999999999999999999988888777776644444


Q ss_pred             CCCCCCCC----------------------------CHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          320 RRKPWPSI----------------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       320 ~~~~~~~~----------------------------s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ....|+..                            ++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            44444432                            678999999999999999999999999999987543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.3e-51  Score=410.23  Aligned_cols=259  Identities=29%  Similarity=0.451  Sum_probs=212.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      ....+|++.+.||+|+||+||+|++..+++ +|+|++......       ..+|+.+++.+. ||||+++++++...+  
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~-h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVK-HPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCC-CTTBCCEEEEEEEESSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCC-CCCcceEEEEEEecCCC
Confidence            345679999999999999999999887765 888887654321       237999999995 999999999985433  


Q ss_pred             ----EEEEEEeccCCCCHHHHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          171 ----YVYIAMELCEGGELLDRIL--AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       171 ----~~~lv~e~~~gg~L~~~l~--~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                          .+++||||++++ +...+.  ......+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEEC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCcEEEe
Confidence                488999999764 444432  223467999999999999999999999999999999999999983  46789999


Q ss_pred             ecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC------
Q 011380          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK------  316 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------  316 (487)
                      |||+++...........+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+....      
T Consensus       185 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9999988766666667889999999999865  47999999999999999999999999988777766665421      


Q ss_pred             ------C-----CCC---CC-----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          317 ------P-----DFR---RK-----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       317 ------~-----~~~---~~-----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                            +     .++   ..     ..+.+++++.+||.+||..||.+|||+.|+|+||||++...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                  0     011   00     12348899999999999999999999999999999997644

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-49  Score=398.53  Aligned_cols=257  Identities=27%  Similarity=0.496  Sum_probs=214.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccC-CCCccEEEEEEEeCCEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~~~~~~  173 (487)
                      ..+|++++.||+|+||+||+|.+.. |+.||||++..... .....+.+.+|+.+|++|.. ||||+++++++...+.+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3569999999999999999999765 89999999976543 34566788999999999963 699999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||| +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++....
T Consensus       133 lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC-
T ss_pred             EEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccccc
Confidence            9999 5688999988554  5789999999999999999999999999999999999996    4689999999998765


Q ss_pred             CCC---ccccccCCccccchhhhcc------------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhcCC
Q 011380          254 PGK---KFQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEVLRNKP  317 (487)
Q Consensus       254 ~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~  317 (487)
                      ...   .....+||+.|+|||++.+            .++.++|||||||++|+|++|+.||..... ...+..+.....
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  285 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  285 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence            332   2345689999999999864            578899999999999999999999987543 345555655443


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+..+  ...+.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       286 ~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          286 EIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            33322  23578999999999999999999999999999998643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.8e-49  Score=385.13  Aligned_cols=255  Identities=31%  Similarity=0.537  Sum_probs=221.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|...+.||+|+||.||+|+++.+|+.||||++.....   ...+.+.+|+.+++++. ||||+++++++...+..|+||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            48888899999999999999999999999999875432   34567889999999995 999999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-  255 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-  255 (487)
                      ||++|++|.+++.   ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... 
T Consensus       122 e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          122 EFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             CCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSSS
T ss_pred             ecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeecccCc
Confidence            9999999998773   24699999999999999999999999999999999999998   4678999999998776433 


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                      ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||...........+....... ......+++++.++
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  274 (321)
T 2c30_A          196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDF  274 (321)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHH
T ss_pred             cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHH
Confidence            234567899999999998654 6899999999999999999999999888877777776654322 22234688999999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      |.+||..||++|||+.++|+||||....
T Consensus       275 i~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          275 LERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHccCChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-49  Score=400.56  Aligned_cols=263  Identities=29%  Similarity=0.489  Sum_probs=209.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~---  169 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++.... ........+.+|+.+|+.+. ||||+++++++...   
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCC
Confidence            45678999999999999999999999999999999997542 23445678899999999995 99999999999766   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ..+|+||||+. |+|.+.+..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~DFG  174 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVCDFG  174 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             cCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEccCC
Confidence              67999999996 599988843  46799999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCC-----------------------ccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhC------
Q 011380          248 LSDFIKPGK-----------------------KFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCG------  296 (487)
Q Consensus       248 ~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g------  296 (487)
                      +++......                       .....+||++|+|||++.  ..++.++|||||||++|+|++|      
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            998764321                       235678999999999863  3479999999999999999984      


Q ss_pred             -----CCCCCCCCh-----------------hHHHHHHH-----------------------hcCCCCCCC----CCCCC
Q 011380          297 -----RRPFWDKTE-----------------DGIFKEVL-----------------------RNKPDFRRK----PWPSI  327 (487)
Q Consensus       297 -----~~pf~~~~~-----------------~~~~~~i~-----------------------~~~~~~~~~----~~~~~  327 (487)
                           +++|.+...                 ...+..+.                       ...+.....    .++.+
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                 344433320                 11111111                       111111111    13678


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ++++.+||.+||..||++|||+.|+|+||||+....
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.1e-50  Score=426.77  Aligned_cols=258  Identities=25%  Similarity=0.431  Sum_probs=230.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+..|..++..+.+||+|+++++++.+.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            35799999999999999999999999999999999764332233456778999999988779999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc-C
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-K  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~-~  253 (487)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++.. .
T Consensus       420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecceeecccc
Confidence            99999999999988654  5799999999999999999999999999999999999998   5788999999999863 3


Q ss_pred             CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ........+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+++..++.....++    ..+|++++
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  570 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAV  570 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence            3344567899999999999875 579999999999999999999999999999999999998876655    36899999


Q ss_pred             HHHHHccccCccCCcCH-----HHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLTA-----AQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~-----~e~L~h~~~~~~  361 (487)
                      +||++||+.||++||++     .|+++||||+..
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999999997     999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-49  Score=394.35  Aligned_cols=260  Identities=29%  Similarity=0.488  Sum_probs=214.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~---  169 (487)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   99 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence            45678999999999999999999999999999999986543 23445677889999999995 99999999999765   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                         ..+|+||||+ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Df  172 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDF  172 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEEee
Confidence               3569999999 8899888744   4689999999999999999999999999999999999998   4788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--------  316 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  316 (487)
                      |+++....  .....+||++|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+....        
T Consensus       173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99987543  3456789999999999865  57999999999999999999999999888776666654321        


Q ss_pred             ---------------CCCCC----CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          317 ---------------PDFRR----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       317 ---------------~~~~~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                     +....    ..++.+++++.+||.+||..||.+|||+.++|+||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                           11111    123567999999999999999999999999999999987543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.5e-49  Score=386.00  Aligned_cols=263  Identities=32%  Similarity=0.542  Sum_probs=231.6

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      +....++|.+++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  114 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDND  114 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            3445678999999999999999999999999999999998765555567788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLAT  189 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCEEEeeccCce
Confidence            999999999999999987554  5799999999999999999999999999999999999998   47789999999998


Q ss_pred             ccCC-CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          251 FIKP-GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       251 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .... ........||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+.+..+......++    ..++
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~  265 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHIN  265 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred             ecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCC
Confidence            7643 2334556899999999998764 58899999999999999999999998888777777777654433    3578


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +++.+||.+||..||++|||+.++|+||||+....
T Consensus       266 ~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            99999999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-48  Score=377.95  Aligned_cols=262  Identities=32%  Similarity=0.539  Sum_probs=230.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEE
Confidence            45568999999999999999999999999999999998765555566788899999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCEEEEeccCceec
Confidence            9999999999999987554  5799999999999999999999999999999999999998   4778999999999776


Q ss_pred             CC-CCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KP-GKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      .. ........||+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+......++    ..+++.
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  241 (294)
T 2rku_A          166 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPV  241 (294)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHH
T ss_pred             ccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHH
Confidence            43 2334456899999999998764 58899999999999999999999998888777777776654332    357899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCccccccCCC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDA  364 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~  364 (487)
                      +.++|.+||+.||++|||+.++++||||+.....
T Consensus       242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            9999999999999999999999999999876443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-49  Score=377.85  Aligned_cols=257  Identities=34%  Similarity=0.602  Sum_probs=216.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+. ||||+++++++...+.+|+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEEE
Confidence            367999999999999999999999999999999986543222234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccccccCC
Confidence            99999999999988654  5689999999999999999999999999999999999998   467899999999987765


Q ss_pred             CCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ........||+.|+|||++.+..  +.++||||||+++|+|++|..||...........+......++    ..++.++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  239 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVA  239 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHH
Confidence            55455678999999999987653  5789999999999999999999988888777777776654332    35789999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++|.+||+.||.+|||+.++++||||+..
T Consensus       240 ~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          240 TLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            99999999999999999999999999865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.2e-49  Score=378.60  Aligned_cols=257  Identities=30%  Similarity=0.582  Sum_probs=225.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence            57999999999999999999999999999999986543222223467889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccccccCccc
Confidence            9999999999988654  5689999999999999999999999999999999999998   4678999999998765432


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+......++    +.++.++.++
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l  242 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDL  242 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHH
Confidence             23456899999999998764 68899999999999999999999998888887777777654433    4688999999


Q ss_pred             HHHccccCccCCcCHHHHhcCccccccCC
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      |.+||..||.+|||+.++++||||+....
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999999987543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-48  Score=376.68  Aligned_cols=258  Identities=20%  Similarity=0.330  Sum_probs=217.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----~~~  171 (487)
                      ..|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+++++. ||||+++++++..    ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCce
Confidence            468999999999999999999999999999999876543 3445678899999999995 9999999999875    467


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|  |+||||||+|||++.  .++.+||+|||++
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGG
T ss_pred             EEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCc
Confidence            89999999999999998554  56899999999999999999999999  999999999999973  4678999999999


Q ss_pred             cccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          250 DFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       250 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...... ......||+.|+|||++.+.++.++|||||||++|+|++|+.||.................. ........++
T Consensus       180 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  257 (290)
T 1t4h_A          180 TLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIP  257 (290)
T ss_dssp             GGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGGGGGCCCH
T ss_pred             cccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccccCCCCCH
Confidence            765433 34456899999999999988999999999999999999999999876554444333332221 1112235678


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++.+||.+||..||.+|||+.++|+||||++.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-49  Score=401.99  Aligned_cols=263  Identities=28%  Similarity=0.397  Sum_probs=218.3

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-----CCCCccEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-----GHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~~~~~  166 (487)
                      ..+..+|++++.||+|+||+||+|.+..+++.||||++....    .....+.+|+.+++.+.     +||||+++++++
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            446678999999999999999999999999999999997542    34567788999998884     478999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ...+.+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vkL~DF  246 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIKVIDF  246 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEEECCC
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceEEeec
Confidence            99999999999995 6999998777666799999999999999999999999999999999999998421 233999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----  320 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  320 (487)
                      |++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+.+..+........     
T Consensus       247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            99976542  3456789999999999865 579999999999999999999999999888777666543210000     


Q ss_pred             ---------------------------------------------CCC-----CCCCCHHHHHHHHHccccCccCCcCHH
Q 011380          321 ---------------------------------------------RKP-----WPSISNSAKDFVKKLLVKDPRARLTAA  350 (487)
Q Consensus       321 ---------------------------------------------~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~  350 (487)
                                                                   ...     ....++++.+||.+||++||++|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                         000     012377899999999999999999999


Q ss_pred             HHhcCccccccC
Q 011380          351 QALSHPWVREGG  362 (487)
Q Consensus       351 e~L~h~~~~~~~  362 (487)
                      |+|+||||+...
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.6e-50  Score=391.26  Aligned_cols=265  Identities=27%  Similarity=0.428  Sum_probs=223.3

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence            3456789999999999999999999999999999999998765555566678899999999995 999999999987543


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          171 ----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       171 ----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                          .+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Df  160 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDF  160 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeec
Confidence                459999999999999988654  5799999999999999999999999999999999999998   4778999999


Q ss_pred             ccccccCCCC----ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 011380          247 GLSDFIKPGK----KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR  321 (487)
Q Consensus       247 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  321 (487)
                      |++.......    .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+...................
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  240 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence            9997654322    22346799999999998764 688999999999999999999999998888887777776655444


Q ss_pred             CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       322 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ..++.+|+++.++|.+||..||.+||++.++|.|+|++..
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            4456789999999999999999999999999999999854

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-49  Score=398.66  Aligned_cols=257  Identities=27%  Similarity=0.489  Sum_probs=214.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-----  168 (487)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++.....       ...+|+.+++.+. ||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            34689999999999999999999999999999999865432       1247999999995 9999999999843     


Q ss_pred             ---------------------------------CCEEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHH
Q 011380          169 ---------------------------------DNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAA  213 (487)
Q Consensus       169 ---------------------------------~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~  213 (487)
                                                       ...+++||||++ |+|.+.+..  .....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             345899999997 487776643  34567999999999999999999


Q ss_pred             HHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHH
Q 011380          214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITY  291 (487)
Q Consensus       214 ~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~  291 (487)
                      |||++||+||||||+|||++.  .++.+||+|||++.............||+.|+|||++.+  .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            999999999999999999974  467899999999988766666667889999999998865  3799999999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHhc------------CCCCCC--------CC-----CCCCCHHHHHHHHHccccCccCC
Q 011380          292 ILLCGRRPFWDKTEDGIFKEVLRN------------KPDFRR--------KP-----WPSISNSAKDFVKKLLVKDPRAR  346 (487)
Q Consensus       292 ell~g~~pf~~~~~~~~~~~i~~~------------~~~~~~--------~~-----~~~~s~~~~~li~~~L~~dp~~R  346 (487)
                      +|++|+.||.+....+.+..+...            .+.+..        ..     .+.+|+++.+||.+||..||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999998887777666541            111111        11     12478899999999999999999


Q ss_pred             cCHHHHhcCcccccc
Q 011380          347 LTAAQALSHPWVREG  361 (487)
Q Consensus       347 pt~~e~L~h~~~~~~  361 (487)
                      ||+.|+|+||||+..
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5e-49  Score=388.09  Aligned_cols=266  Identities=34%  Similarity=0.601  Sum_probs=194.2

Q ss_pred             ccCCCeeEee-eeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 011380           93 DFDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED---  168 (487)
Q Consensus        93 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~---  168 (487)
                      .+.++|.+.+ .||+|+||+||+|.++.+|+.||||++....        ...+|+..+.++.+||||+++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            3557899965 6999999999999999999999999986531        223444443333369999999999976   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                       ...+++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             5568999999999999999976655679999999999999999999999999999999999999865567789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHH----HHHHHhcCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGI----FKEVLRNKPDFRRK  322 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~  322 (487)
                      ++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........    ...+......++..
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99765432 3455689999999999854 458899999999999999999999977655433    33344444555566


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCC
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEI  367 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~  367 (487)
                      .+..+++++.+||.+||..||.+|||+.++|+||||+........
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  300 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT  300 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence            677899999999999999999999999999999999876544333

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-48  Score=384.50  Aligned_cols=255  Identities=26%  Similarity=0.492  Sum_probs=213.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYV  172 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~  172 (487)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++...      ....+.+|+.+++++.+||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            36799999999999999999999999999999998643      246788999999999779999999999987  6789


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++++|.+.+     ..+++..++.++.||+.||.|||++||+||||||+|||++.  +...+||+|||++...
T Consensus       109 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEEECCCCCCHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEEC
T ss_pred             EEEEeccCchhHHHHH-----HhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEc
Confidence            9999999999998876     34899999999999999999999999999999999999984  3348999999999887


Q ss_pred             CCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-hHHHHHH-------------HhcC
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTE-DGIFKEV-------------LRNK  316 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i-------------~~~~  316 (487)
                      ..........||+.|+|||++.+  .++.++|||||||++|+|++|+.||..... ...+..+             ....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            76666677889999999999865  468999999999999999999999965432 2222211             1111


Q ss_pred             CCCC--------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 PDFR--------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 ~~~~--------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ....                    ......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            1110                    111123789999999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=392.38  Aligned_cols=254  Identities=31%  Similarity=0.557  Sum_probs=216.5

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh-----HhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP-----IAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||||++........     .....+.+|+.+++++. ||||+++++++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~   99 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE   99 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            456789999999999999999999999999999999976543211     12345678999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCC-CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          168 DDNYVYIAMELCEGG-ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg-~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +.+.+++||||+.+| +|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Df  174 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDF  174 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCC
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEeec
Confidence            999999999999766 99888743  45799999999999999999999999999999999999998   4788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |++............+||+.|+|||++.+. + +.++|||||||++|+|++|..||.....      ....    .....
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----~~~~~  244 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA----AIHPP  244 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT----CCCCS
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh----ccCCC
Confidence            999887766666678899999999998764 3 6789999999999999999999965322      1111    11222


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus       245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            35899999999999999999999999999999998743

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.6e-49  Score=399.90  Aligned_cols=258  Identities=28%  Similarity=0.443  Sum_probs=213.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-----  168 (487)
                      ...+|++.+.||+|+||+||+|++..+|+.||||++.....       ...+|+++|+.+. ||||+++++++..     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCC
Confidence            34579999999999999999999999999999999865432       2247999999995 9999999998853     


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          169 -DNYVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                       ..++++||||+++ +|.+.+..  .....+++..++.++.||+.||.|||++||+||||||+|||++.  +.+.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEecc
Confidence             2247799999975 66665532  33567999999999999999999999999999999999999984  346789999


Q ss_pred             cccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--------
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN--------  315 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--------  315 (487)
                      ||+++...........+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+.+++..        
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987765555567789999999999865  5799999999999999999999999988877666665541        


Q ss_pred             ----CCCCCCC--------C-----CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          316 ----KPDFRRK--------P-----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       316 ----~~~~~~~--------~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                          .+.+...        .     .+.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                1111111        1     135689999999999999999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-49  Score=390.21  Aligned_cols=262  Identities=27%  Similarity=0.396  Sum_probs=214.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC--hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCce
Confidence            467999999999999999999999999999999987543211  111246789999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecccceec
Confidence            999999976 78777643 345689999999999999999999999999999999999998   4778999999999876


Q ss_pred             CCC-CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC------
Q 011380          253 KPG-KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP------  323 (487)
Q Consensus       253 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  323 (487)
                      ... ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+..+...........      
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            432 33456789999999999864  368899999999999999999999999888877777765322211111      


Q ss_pred             ------------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          324 ------------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       324 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                        ++.+++++.+||.+||..||.+|||+.|+|+||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                              145678999999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=378.44  Aligned_cols=258  Identities=34%  Similarity=0.609  Sum_probs=196.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++. ||||+++++++.+.+..|+|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEE
Confidence            46999999999999999999999999999999996543222233567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecceeeccCC
Confidence            9999999999887543 35799999999999999999999999999999999999998   4778999999999775432


Q ss_pred             -CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 -KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                       .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+......    ....++.++.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  241 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKD  241 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHH
T ss_pred             CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHH
Confidence             223456799999999998654 588999999999999999999999877665554443332221    12357899999


Q ss_pred             HHHHccccCccCCcCHHHHhcCccccccC
Q 011380          334 FVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +|.+||..||++|||+.++|+||||....
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999998653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.3e-48  Score=373.05  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=216.0

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.++..+.+||||+++++++.+.+
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            345667899999999999999999999999999999998765432 3345678899999999955999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC------------
Q 011380          171 YVYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK------------  236 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~------------  236 (487)
                      .+++||||++|++|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++..+            
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            9999999999999999886542  25689999999999999999999999999999999999998533            


Q ss_pred             ----CCCcEEEeecccccccCCCCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 011380          237 ----EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFK  310 (487)
Q Consensus       237 ----~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  310 (487)
                          ....+||+|||++......   ....||+.|+|||++.+..  +.++|||||||++|+|++|.+|+...   ....
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred             cccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence                4557999999999876543   2346999999999997653  57899999999999999999887543   2344


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .+..+...   ...+.+++++.++|.+||..||++|||+.++|+||||+..
T Consensus       239 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 EIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            44444322   1224689999999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-48  Score=377.46  Aligned_cols=264  Identities=26%  Similarity=0.394  Sum_probs=221.1

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++. ||||+++++++...+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence            3456789999999999999999999999999999999997665555566788999999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSSST
T ss_pred             eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCCcc
Confidence            999999999999999988654  5799999999999999999999999999999999999998   47789999999997


Q ss_pred             ccCCCC--ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC-CCCCCCCC
Q 011380          251 FIKPGK--KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD-FRRKPWPS  326 (487)
Q Consensus       251 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~  326 (487)
                      ......  .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+................ ......+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence            664332  23346799999999998765 588999999999999999999999988877666555554322 21223467


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +|+.+.++|.+||..||.+||+..+.+.++|..-
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            8999999999999999999997777777777654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=379.92  Aligned_cols=262  Identities=27%  Similarity=0.506  Sum_probs=218.4

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--  168 (487)
                      -....++|++.+.||+|+||.||+|.+..+|+.||+|++.....    ..+.+.+|+.+++++.+||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            34566789999999999999999999999999999999875432    346788999999999669999999999986  


Q ss_pred             ----CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          169 ----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       169 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                          .+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEEe
Confidence                56899999999999999998766556799999999999999999999999999999999999998   47789999


Q ss_pred             ecccccccCCC-CccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 011380          245 DFGLSDFIKPG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       245 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |||++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  251 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA  251 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            99998765432 2234567999999999985      3468899999999999999999999988877666666655432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .  ......++..+.+||.+||..||.+|||+.++++||||+..
T Consensus       252 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            2  22235688999999999999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-48  Score=390.62  Aligned_cols=264  Identities=24%  Similarity=0.359  Sum_probs=218.9

Q ss_pred             cccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC-----ccEEEE
Q 011380           90 YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN-----VVKFYN  164 (487)
Q Consensus        90 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-----Iv~~~~  164 (487)
                      ....+.++|++.+.||+|+||+||+|.++.+|+.||||++...    ......+.+|+.+++.+..|++     |+++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3455678999999999999999999999999999999999753    2345677889999998864664     999999


Q ss_pred             EEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeecCCCCceEeccCCCCCcEE
Q 011380          165 AFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       165 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH--~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      ++...+.+|+||||+. |+|.+++.......+++..++.++.||+.||.|||  ..||+||||||+|||++. +.++.+|
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~k  201 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIK  201 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEE
Confidence            9999999999999996 59999987766567999999999999999999999  579999999999999963 2467899


Q ss_pred             EeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-
Q 011380          243 ATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-  320 (487)
Q Consensus       243 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-  320 (487)
                      |+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+.+..+.......+ 
T Consensus       202 L~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          202 IVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             ECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999999987643  3456789999999999876 478999999999999999999999998888777766654211100 


Q ss_pred             -----------------CCCC-----------------CC-------------------------CCHHHHHHHHHcccc
Q 011380          321 -----------------RKPW-----------------PS-------------------------ISNSAKDFVKKLLVK  341 (487)
Q Consensus       321 -----------------~~~~-----------------~~-------------------------~s~~~~~li~~~L~~  341 (487)
                                       ...|                 ..                         .++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                             0000                 00                         013689999999999


Q ss_pred             CccCCcCHHHHhcCcccccc
Q 011380          342 DPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       342 dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ||++|||+.|+|+||||+..
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-49  Score=384.64  Aligned_cols=262  Identities=23%  Similarity=0.391  Sum_probs=217.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++......  ...+.+.+|+.+++++. ||||+++++++....  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence            4567899999999999999999999999999999999754422  23567789999999995 999999999998755  


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc-CCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~-~~~~~~vkl~DfG~  248 (487)
                      .+++||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+.. .+..+.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            88999999999999998865432 33999999999999999999999999999999999999822 12466799999999


Q ss_pred             ccccCCCCccccccCCccccchhhhc---------cCCCCcchHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhc
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLK---------RKSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRN  315 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~  315 (487)
                      +.............||+.|+|||++.         ..++.++|||||||++|+|++|+.||....    ..+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            98877666666788999999999985         456889999999999999999999996433    34556666665


Q ss_pred             CCCCC-------------------C--CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          316 KPDFR-------------------R--KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       316 ~~~~~-------------------~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      .+...                   .  .....++..+.++|.+||+.||++|||+.|+|+||=
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            54211                   0  001124557899999999999999999999999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.1e-49  Score=386.23  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=214.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++++. ||||+++++++.+.+.+|+|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEEE
Confidence            57999999999999999999999999999999986554 23345567789999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++.  ....+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++......
T Consensus       103 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCceeecCC
Confidence            99999888777653  335799999999999999999999999999999999999998   4778999999999765432


Q ss_pred             -CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------------  318 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  318 (487)
                       .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+......              
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             33455689999999999876  4689999999999999999999999988776665554421100              


Q ss_pred             CCC-------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 FRR-------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 ~~~-------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +..             ..++.+++++.+||.+||..||.+|||+.|+|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            000             0134678999999999999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-49  Score=392.17  Aligned_cols=260  Identities=31%  Similarity=0.490  Sum_probs=202.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~---  169 (487)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...   
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  103 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL  103 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCcc
Confidence            34578999999999999999999999999999999986543 23445677889999999995 99999999998754   


Q ss_pred             ---CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          170 ---NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       170 ---~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                         ..+|+|+|++ +++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+||
T Consensus       104 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~DF  176 (367)
T 2fst_X          104 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDF  176 (367)
T ss_dssp             GGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC-
T ss_pred             ccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEeec
Confidence               5689999999 7888887733   5799999999999999999999999999999999999998   4788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC--------
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--------  316 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  316 (487)
                      |+++....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+....        
T Consensus       177 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          177 GLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99976543  2456789999999999865  57899999999999999999999999888776666654321        


Q ss_pred             ---------------CCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          317 ---------------PDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       317 ---------------~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                     +..+..    .++..++++.+||.+||..||.+|||+.++|+||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                           111111    13457889999999999999999999999999999997644

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-48  Score=390.46  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=205.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+   
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccc
Confidence            4468999999999999999999999999999999997643 23445677889999999995 999999999997665   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                         .+|+||||+++ +|.+.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg  172 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFG  172 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCCC
T ss_pred             cccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEEee
Confidence               78999999975 7887773    3589999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC--------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD--------  318 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  318 (487)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+......        
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9987665544566789999999999876 4689999999999999999999999988877777666543211        


Q ss_pred             --------------CCCCC---------CCC-------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          319 --------------FRRKP---------WPS-------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       319 --------------~~~~~---------~~~-------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                    +....         ++.       .+.++++||.+||..||++|||+.|+|+||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                          11100         000       14678999999999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-48  Score=389.15  Aligned_cols=260  Identities=29%  Similarity=0.455  Sum_probs=218.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +..+|++++.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++++. ||||+++++++...    
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccc
Confidence            4468999999999999999999999999999999997532  3445577889999999995 99999999999754    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+|+||||+. |+|.+.+..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~  174 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGL  174 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCcc
Confidence             47899999996 589888743   4699999999999999999999999999999999999998   477899999999


Q ss_pred             ccccCCCC----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC----
Q 011380          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD----  318 (487)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----  318 (487)
                      +.......    .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+......    
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            97654322    1345689999999998743  3689999999999999999999999988877766665431111    


Q ss_pred             -------------------CCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          319 -------------------FRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       319 -------------------~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                         ....    .++.+++++.+||.+||..||++|||+.|+|+||||+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                               0111    12567899999999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.4e-49  Score=386.08  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +.++|++.+.||+|+||.||+|+++.+|+.||||++....  .....+.+.+|+.+++++. ||||+++++++.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            3457999999999999999999999999999999997543  2345678899999999995 999999999986543   


Q ss_pred             ------------------------------------------------------EEEEEEeccCCCCHHHHHHhhcC-CC
Q 011380          171 ------------------------------------------------------YVYIAMELCEGGELLDRILAKKD-SR  195 (487)
Q Consensus       171 ------------------------------------------------------~~~lv~e~~~gg~L~~~l~~~~~-~~  195 (487)
                                                                            .+++|||||+||+|.+++..... ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999998865422 23


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC-------------cccccc
Q 011380          196 YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK-------------KFQDIV  262 (487)
Q Consensus       196 l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~  262 (487)
                      .++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......             .....+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            56667899999999999999999999999999999998   47789999999998765432             224467


Q ss_pred             CCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHcccc
Q 011380          263 GSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVK  341 (487)
Q Consensus       263 gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  341 (487)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|..|+..  .......+....   ....++..++++.+||.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC---CCcccccCChhHHHHHHHHccC
Confidence            9999999999876 468999999999999999998777521  112222232221   1111234567889999999999


Q ss_pred             CccCCcCHHHHhcCccccc
Q 011380          342 DPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       342 dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ||++|||+.|+|+||||++
T Consensus       313 ~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCC
T ss_pred             CCCcCCCHHHHhhchhhhc
Confidence            9999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=398.98  Aligned_cols=262  Identities=26%  Similarity=0.421  Sum_probs=197.9

Q ss_pred             cCCCeeE-eeeeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 011380           94 FDRRYTI-GKLLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (487)
Q Consensus        94 ~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--  168 (487)
                      +.+.|.+ +++||+|+||+||+|+++  .+++.||||++.....     ...+.+|+.+|++|. ||||+++++++..  
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEETT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEecCC
Confidence            4456877 568999999999999976  5788999999976542     246789999999995 9999999999954  


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC-CCCCc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK-------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA-KEDSS  240 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~-------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~  240 (487)
                      ...+|+||||+. |+|.+.+....       ...+++..++.++.||+.||.|||++||+||||||+|||+... ..++.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence            778999999996 58888775321       2249999999999999999999999999999999999999532 25689


Q ss_pred             EEEeecccccccCCC----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh--------
Q 011380          241 LKATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED--------  306 (487)
Q Consensus       241 vkl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--------  306 (487)
                      +||+|||++......    ......+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....        
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876432    23345789999999999875  3788999999999999999999999765542        


Q ss_pred             -HHHHHHHhcCCCCCCCCCCC----------------------------------CCHHHHHHHHHccccCccCCcCHHH
Q 011380          307 -GIFKEVLRNKPDFRRKPWPS----------------------------------ISNSAKDFVKKLLVKDPRARLTAAQ  351 (487)
Q Consensus       307 -~~~~~i~~~~~~~~~~~~~~----------------------------------~s~~~~~li~~~L~~dp~~Rpt~~e  351 (487)
                       +.+..+...........|+.                                  .++.+.+||.+||..||.+|||+.|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             34444443222222222222                                  2678999999999999999999999


Q ss_pred             HhcCccccccC
Q 011380          352 ALSHPWVREGG  362 (487)
Q Consensus       352 ~L~h~~~~~~~  362 (487)
                      +|+||||++..
T Consensus       331 ~L~hp~f~~~~  341 (405)
T 3rgf_A          331 AMQDPYFLEDP  341 (405)
T ss_dssp             HHTSGGGTSSS
T ss_pred             HhcChhhccCC
Confidence            99999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-47  Score=371.42  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=224.9

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ....+.|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.....
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred             CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCe
Confidence            3455789999999999999999999999999999999976542  234678899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||++|++|.+++.   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        95 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ  168 (303)
T ss_dssp             EEEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeeccccee
Confidence            999999999999999873   35799999999999999999999999999999999999998   467899999999977


Q ss_pred             cCCCC-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          252 IKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ..... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+....+..   ....++.
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  245 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSK  245 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCH
T ss_pred             cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCH
Confidence            65432 23456899999999998654 6889999999999999999999998887777766666554322   2346889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+.+||.+||..||.+|||+.++++||||....
T Consensus       246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-48  Score=382.53  Aligned_cols=257  Identities=27%  Similarity=0.507  Sum_probs=209.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~~~~~~~  173 (487)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+|+.+..| |||+++++++...+.+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            46799999999999999999987 4689999999976542 344567889999999999622 99999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||| +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++....
T Consensus        86 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred             EEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence            9999 4588999988553  6799999999999999999999999999999999999997    4679999999998764


Q ss_pred             CCCc---cccccCCccccchhhhc------------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCC
Q 011380          254 PGKK---FQDIVGSAYYVAPEVLK------------RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNKP  317 (487)
Q Consensus       254 ~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~  317 (487)
                      ....   ....+||+.|+|||++.            ..++.++|||||||++|+|++|+.||...... ..+..+.....
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  238 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  238 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence            3322   23568999999999985            34678999999999999999999999765443 33444443332


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ...  .....+.++.+||.+||..||.+|||+.++|+||||+...
T Consensus       239 ~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          239 EIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             CCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            222  1234578899999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-48  Score=371.47  Aligned_cols=258  Identities=33%  Similarity=0.586  Sum_probs=218.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....  ....+.+.+|+.+++.+. ||||+++++++.+.+..|+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEEE
Confidence            4579999999999999999999999999999999875442  234577889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++  .....+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           83 FLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEECEE
T ss_pred             EEEecCCCcHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCccccCC
Confidence            99999999999877  3345799999999999999999999999999999999999998   467899999999976532


Q ss_pred             C---CccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCC
Q 011380          255 G---KKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       255 ~---~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      .   .......||+.|+|||++.+..  +.++||||||+++|+|++|..||....... .+..+.....  ....++.++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKID  235 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSC
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcC
Confidence            2   2234568999999999987642  678999999999999999999998765542 3333333322  223356789


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +.+.+||.+||..||.+|||+.++++||||+...
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-49  Score=390.22  Aligned_cols=257  Identities=27%  Similarity=0.522  Sum_probs=215.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ++|++.+.||+|+||+||+|++.   .+|+.||||++.+.... .....+.+.+|+.+++.+.+||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57999999999999999999984   58999999998653211 111234567899999999679999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEeeCCCCee
Confidence            99999999999999998654  5799999999999999999999999999999999999998   477899999999976


Q ss_pred             cCCC--CccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCC----hhHHHHHHHhcCCCCCCC
Q 011380          252 IKPG--KKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKT----EDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~  322 (487)
                      ....  ......+||+.|+|||++.+   .++.++|||||||++|+|++|+.||....    ...+...+....+.++  
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  286 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--  286 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--
Confidence            5322  22345689999999999875   35789999999999999999999997543    2344455555544332  


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                        +.++..+.+||.+||..||.+||     |+.++++||||+..
T Consensus       287 --~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 --QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             --cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence              46889999999999999999999     99999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.2e-48  Score=378.03  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=213.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+|++.+.||+|+||+||+|.+..+|+   .||||++....  .....+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            35689999999999999999999986665   49999997542  3445678899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSR  199 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCSSCE
T ss_pred             ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCCccc
Confidence            999999999999999988543 35799999999999999999999999999999999999998   57889999999998


Q ss_pred             ccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          251 FIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       251 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .......    .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+...   ...
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~  276 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---PAP  276 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---CCC
Confidence            7643321    223456889999999875 46889999999999999999 99999998888888877765322   223


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+++.+.+||.+||..||.+|||+.++++
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            468899999999999999999999999886

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.8e-48  Score=370.87  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+..+...++.+ +||||+++++++.+.+..|+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEE
Confidence            3679999999999999999999999999999999875432 122223333444446666 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          175 AMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ||||++| +|.+++..  .....+++..++.++.||+.||.|||++ ||+||||||+|||++   .++.+||+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCCccc
Confidence            9999974 88776643  2456799999999999999999999998 999999999999998   467899999999987


Q ss_pred             cCCCCccccccCCccccchhhhc-----cCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLK-----RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ...........||+.|+|||++.     ..++.++|||||||++|+|++|+.||... .....+.........  .....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  237 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLPAD  237 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCCTT
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Ccccc
Confidence            76555555568999999999963     24678999999999999999999999763 334444444443322  22234


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+++++.++|.+||+.||++|||+.++++||||+...
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            6899999999999999999999999999999998653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.4e-48  Score=377.89  Aligned_cols=265  Identities=26%  Similarity=0.374  Sum_probs=219.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEc-CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEE---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDK-ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFE---  167 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~---  167 (487)
                      ..++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+.  +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4468999999999999999999995 678999999986543211 11234567888877763  5999999999987   


Q ss_pred             --eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEee
Q 011380          168 --DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD  245 (487)
Q Consensus       168 --~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~D  245 (487)
                        ....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEEec
Confidence              5678999999997 5999988766556699999999999999999999999999999999999998   477899999


Q ss_pred             cccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC----
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR----  320 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  320 (487)
                      ||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+........    
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999987654444556789999999999865 468999999999999999999999998888777777664211100    


Q ss_pred             -------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          321 -------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       321 -------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                         ...++.++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                               0123568899999999999999999999999999999987543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.8e-48  Score=373.98  Aligned_cols=262  Identities=30%  Similarity=0.454  Sum_probs=218.3

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++.++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.+. ||||+++++++...+.
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence            346678999999999999999999999999999999986543   234577889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAK  166 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCcc
Confidence            99999999999998877543 35699999999999999999999999999999999999998   467899999998754


Q ss_pred             cCC-CCccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          252 IKP-GKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       252 ~~~-~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      ... ........||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+........ ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  245 (302)
T 2j7t_A          167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTP  245 (302)
T ss_dssp             HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSG
T ss_pred             ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCc
Confidence            321 11223457999999999873      3468899999999999999999999998888777777766654322 122


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..++.++.++|.+||..||.+|||+.++++||||+...
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            45789999999999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=374.99  Aligned_cols=261  Identities=26%  Similarity=0.475  Sum_probs=220.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~  170 (487)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+++++. ||||+++++++.  ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            346899999999999999999999999999999998754321 1234577899999999995 999999999984  456


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|+||||++++ |.+.+.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeecccccc
Confidence            899999999876 77777666667899999999999999999999999999999999999998   47889999999997


Q ss_pred             ccCCC---CccccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          251 FIKPG---KKFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       251 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .....   .......||+.|+|||++.+.   ++.++||||||+++|+|++|..||.+.........+......++    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            75432   223456799999999998753   26789999999999999999999998888888888877654432    


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      ..+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            467899999999999999999999999999999987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.4e-49  Score=398.29  Aligned_cols=252  Identities=19%  Similarity=0.226  Sum_probs=203.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEE-------EE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFY-------NA  165 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~-------~~  165 (487)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.+++.+.  +||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999998654444556788899995544443  599999998       77


Q ss_pred             EEeCCE-----------------EEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 011380          166 FEDDNY-----------------VYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHR  223 (487)
Q Consensus       166 ~~~~~~-----------------~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~iiHr  223 (487)
                      +.+.+.                 .|+||||+ +|+|.+++.....     ..+++..++.++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776643                 89999999 6799999865421     112347888899999999999999999999


Q ss_pred             cCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhccC------------CCCcchHHHHHHHHH
Q 011380          224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK------------SGPESDVWSIGVITY  291 (487)
Q Consensus       224 Dlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------~~~~~DiwSlG~il~  291 (487)
                      ||||+|||++   .++.+||+|||++....  ......+| +.|+|||++.+.            ++.++|||||||++|
T Consensus       231 Dikp~NIll~---~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLD---QRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEEC---TTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEc---CCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999998   46789999999998643  34456778 999999998654            789999999999999


Q ss_pred             HHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       292 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|++|+.||.+.........+.        ..++.+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            9999999997655433322222        1235789999999999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=377.25  Aligned_cols=262  Identities=32%  Similarity=0.499  Sum_probs=214.1

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE----
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----  167 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~----  167 (487)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++++. ||||+++++++.    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGS   82 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSC
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccc
Confidence            346678999999999999999999999999999999986542   456678899999999995 999999999873    


Q ss_pred             ----------eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          168 ----------DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       168 ----------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                                ....+|+||||++ |+|.+++.   ...+++..++.++.||+.||.|||++||+||||||+|||++.  .
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~  156 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--E  156 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--T
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--C
Confidence                      4478999999997 58988773   357999999999999999999999999999999999999974  4


Q ss_pred             CCcEEEeecccccccCCC----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 011380          238 DSSLKATDFGLSDFIKPG----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE  311 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  311 (487)
                      ++.+||+|||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            578999999999865432    12344578999999998753  568899999999999999999999998887777766


Q ss_pred             HHhcCCCCC----------------------C----CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          312 VLRNKPDFR----------------------R----KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       312 i~~~~~~~~----------------------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +....+...                      .    ..++.++.++.+||.+||+.||.+|||+.++|+||||+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            665432211                      0    012468999999999999999999999999999999987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.8e-49  Score=392.54  Aligned_cols=259  Identities=17%  Similarity=0.183  Sum_probs=198.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-CCCCccEEE-------EEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-GHENVVKFY-------NAFE  167 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~-------~~~~  167 (487)
                      ..|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.|. +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999999999999999998865444556677888866666654 499988865       5554


Q ss_pred             eC-----------------CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCceeec
Q 011380          168 DD-----------------NYVYIAMELCEGGELLDRILAKKDSRYTEKDA------AVVVRQMLRVAAECHLHGLVHRD  224 (487)
Q Consensus       168 ~~-----------------~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~------~~~~~qil~~l~~lH~~~iiHrD  224 (487)
                      ..                 ..+|+||||++ |+|.+++.... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            33                 34899999998 89999986542 23445555      67779999999999999999999


Q ss_pred             CCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCC
Q 011380          225 MKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFW  301 (487)
Q Consensus       225 lkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~  301 (487)
                      |||+|||++   .++.+||+|||++.....  ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll~---~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIM---PDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEEC---TTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEEC---CCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999998   477899999999987643  2224567899999999864   57899999999999999999999997


Q ss_pred             CCChhHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          302 DKTEDGI--FKE---VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       302 ~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +......  +..   .......+....++.+|+.+.+||.+||+.||++|||+.++|+||||++.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            7643210  000   11112233333456889999999999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=371.52  Aligned_cols=260  Identities=28%  Similarity=0.511  Sum_probs=216.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +...++|++.+.||+|+||.||+|.+..+|+.||+|++....     ..+.+.+|+.+++.+. ||||+++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCE
Confidence            445678999999999999999999999999999999997643     2366889999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+||||||+||+++   .++.+||+|||++..
T Consensus        99 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~  174 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred             EEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchh
Confidence            9999999999999998753 346799999999999999999999999999999999999998   467899999999976


Q ss_pred             cCCC-CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          252 IKPG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       252 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .... .......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+...... .......++.
T Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSD  253 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCH
T ss_pred             hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCH
Confidence            5433 223456899999999998764 689999999999999999999999887766655555544322 1122245789


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .+.+||.+||..||.+|||+.++|+||||+...
T Consensus       254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999999999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.7e-47  Score=375.48  Aligned_cols=264  Identities=27%  Similarity=0.386  Sum_probs=218.1

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEE-cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCC------CccEEE
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATD-KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE------NVVKFY  163 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hp------nIv~~~  163 (487)
                      ...+.++|++.+.||+|+||+||+|.+ ..+|+.||+|++...    ....+.+.+|+.+++.+. |+      +|++++
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~   83 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQML   83 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEeee
Confidence            345677999999999999999999998 568899999998643    235577889999999985 55      499999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC------
Q 011380          164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE------  237 (487)
Q Consensus       164 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~------  237 (487)
                      +++...+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+.      
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 889999997766567999999999999999999999999999999999999984221      


Q ss_pred             ----------CCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          238 ----------DSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       238 ----------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                                ++.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                      56799999999976543  2345689999999999876 5699999999999999999999999888776


Q ss_pred             HHHHHHHhcCCCCCC----------------CCC------------------------CCCCHHHHHHHHHccccCccCC
Q 011380          307 GIFKEVLRNKPDFRR----------------KPW------------------------PSISNSAKDFVKKLLVKDPRAR  346 (487)
Q Consensus       307 ~~~~~i~~~~~~~~~----------------~~~------------------------~~~s~~~~~li~~~L~~dp~~R  346 (487)
                      +....+.......+.                ..|                        ...++++.+||.+||..||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            655444322111110                001                        1124678899999999999999


Q ss_pred             cCHHHHhcCccccccC
Q 011380          347 LTAAQALSHPWVREGG  362 (487)
Q Consensus       347 pt~~e~L~h~~~~~~~  362 (487)
                      ||+.|+|+||||+...
T Consensus       321 pt~~ell~hp~f~~~~  336 (339)
T 1z57_A          321 ITLREALKHPFFDLLK  336 (339)
T ss_dssp             CCHHHHTTSGGGGGGG
T ss_pred             cCHHHHhcCHHHHHHh
Confidence            9999999999998753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.4e-48  Score=388.60  Aligned_cols=264  Identities=23%  Similarity=0.393  Sum_probs=213.1

Q ss_pred             CcccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-------CCCCccE
Q 011380           89 GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-------GHENVVK  161 (487)
Q Consensus        89 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-------~hpnIv~  161 (487)
                      .....+.++|++.+.||+|+||+||+|++..+|+.||||++...    ....+.+.+|+.+++.+.       +||||++
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            34455678999999999999999999999999999999999653    345677889999999985       2788999


Q ss_pred             EEEEEE----eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCC
Q 011380          162 FYNAFE----DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       162 ~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~  236 (487)
                      +++++.    ....+|+||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|||++..+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999987    566899999999 77888888776667799999999999999999999998 999999999999998421


Q ss_pred             ----------------------------------------------CCCcEEEeecccccccCCCCccccccCCccccch
Q 011380          237 ----------------------------------------------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP  270 (487)
Q Consensus       237 ----------------------------------------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aP  270 (487)
                                                                    ....+||+|||++.....  .....+||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCC
Confidence                                                          113799999999987643  24556899999999


Q ss_pred             hhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHhcCCCCC-----------------------
Q 011380          271 EVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE------DGIFKEVLRNKPDFR-----------------------  320 (487)
Q Consensus       271 E~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~-----------------------  320 (487)
                      |++.+. ++.++|||||||++|+|++|+.||.+...      ...+..+.......+                       
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            998764 78999999999999999999999976542      222222211000000                       


Q ss_pred             --CCC-------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          321 --RKP-------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       321 --~~~-------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                        ..+             ....++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence              000             012345688999999999999999999999999996

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.1e-48  Score=384.30  Aligned_cols=257  Identities=32%  Similarity=0.508  Sum_probs=213.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE-
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV-  172 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~-  172 (487)
                      +.++|.+.+.||+|+||+||+|.++.+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+.. 
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSST
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcc
Confidence            5578999999999999999999999999999999997643 23445678889999999995 99999999999877654 


Q ss_pred             -----EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          173 -----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       173 -----~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                           |+||||+. ++|.+.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg  189 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFG  189 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECSTT
T ss_pred             cceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEEecC
Confidence                 99999997 5777765    24599999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP--------  317 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------  317 (487)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.....        
T Consensus       190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            9976543  3456789999999999865  568999999999999999999999998887766666543111        


Q ss_pred             ---------------CCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 ---------------DFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 ---------------~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                     .....    .++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                           11111    1346789999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-47  Score=381.90  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=215.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+.+++.+. ||||+++++++...+.+|
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEE
Confidence            3467999999999999999999999999999999987653  3455678899999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +||||++|++|.+++...  ..+++..+..++.||+.||.|||+. ||+||||||+|||++   .++.+||+|||++...
T Consensus       108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHH
T ss_pred             EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCccc
Confidence            999999999999988654  5689999999999999999999996 999999999999998   4678999999998655


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHH---------------------
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK---------------------  310 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---------------------  310 (487)
                      ... ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||..........                     
T Consensus       183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            322 23456899999999998764 6889999999999999999999997765543321                     


Q ss_pred             ---------------------HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          311 ---------------------EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       311 ---------------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                           .+.....  .......++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                 1222211  111223578899999999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.4e-48  Score=374.12  Aligned_cols=262  Identities=27%  Similarity=0.484  Sum_probs=199.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.+++++. ||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEE
Confidence            3579999999999999999999988999999998865432  234567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          175 AMELCEGGELLDRILAK------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ||||++|++|.+++...      ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEEeccc
Confidence            99999999999988542      245689999999999999999999999999999999999998   477899999999


Q ss_pred             ccccCCCC------ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          249 SDFIKPGK------KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       249 a~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      +.......      ......||+.|+|||++.+  .++.++|||||||++|+|++|..||....................
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            87654321      1234679999999999864  578999999999999999999999988877766665555443221


Q ss_pred             C------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 R------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 ~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .      ..++.++.++.++|.+||..||.+|||+.++++||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            1      12356889999999999999999999999999999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.6e-47  Score=375.88  Aligned_cols=261  Identities=32%  Similarity=0.519  Sum_probs=216.1

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD---  169 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~---  169 (487)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++++. ||||+++++++...   
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCST
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccC
Confidence            45678999999999999999999999999999999996432  3445667889999999995 99999999988654   


Q ss_pred             --CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          170 --NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                        ...|+||||+. ++|.+.+..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg  157 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFG  157 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCT
T ss_pred             ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEecc
Confidence              67999999996 588887744   4699999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCC-----------ccccccCCccccchhhhc--cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 011380          248 LSDFIKPGK-----------KFQDIVGSAYYVAPEVLK--RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       248 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  314 (487)
                      ++.......           .....+||+.|+|||++.  ..++.++|||||||++|+|++|+.||.+......+..+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            997654321           123457999999999875  3568899999999999999999999988876655544432


Q ss_pred             c------------------------CCCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          315 N------------------------KPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       315 ~------------------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      .                        .+.+...    .++.+++++.+||.+||..||++|||+.++|+||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence            1                        1111111    13568999999999999999999999999999999987654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-48  Score=386.74  Aligned_cols=261  Identities=24%  Similarity=0.424  Sum_probs=221.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH--------------hHHHHHHHHHHHHhccCCCCc
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI--------------AVEDVKREVKILQALAGHENV  159 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~--------------~~~~~~~E~~~l~~l~~hpnI  159 (487)
                      +.++|++.+.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.+++++. ||||
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i  105 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYC  105 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTB
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCc
Confidence            456899999999999999999998  8999999998754322111              1277899999999995 9999


Q ss_pred             cEEEEEEEeCCEEEEEEeccCCCCHHHH------HHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEe
Q 011380          160 VKFYNAFEDDNYVYIAMELCEGGELLDR------ILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLF  232 (487)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~gg~L~~~------l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll  232 (487)
                      +++++++.+.+.+|+||||+++|+|.++      +.......+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999887      543335789999999999999999999999 999999999999999


Q ss_pred             ccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhccC--CCC-cchHHHHHHHHHHHHhCCCCCCCCCh-hHH
Q 011380          233 KSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK--SGP-ESDVWSIGVITYILLCGRRPFWDKTE-DGI  308 (487)
Q Consensus       233 ~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwSlG~il~ell~g~~pf~~~~~-~~~  308 (487)
                      +   .++.+||+|||++...... ......||+.|+|||++.+.  ++. ++|||||||++|+|++|..||..... .+.
T Consensus       186 ~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 D---KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             C---TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             c---CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            8   4778999999999876543 44567899999999998765  344 89999999999999999999988776 667


Q ss_pred             HHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          309 FKEVLRNKPDFRRKP---------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ...+......++...               .+.+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            777766655444211               15688999999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.4e-47  Score=378.33  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=215.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-------CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      .++|++++.||+|+||+||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+.+||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            468999999999999999999875       345679999997543  34456789999999999955999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      ..+.+|+||||++||+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            9999999999999999999986543              23589999999999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  308 (487)
                         .++.+||+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.
T Consensus       238 ---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          238 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence               57889999999998664332   2234567899999998865 46889999999999999999 9999998888887


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +..+..+...   .....+++++.++|.+||..||.+|||+.+++++
T Consensus       315 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7777665422   1224688999999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.9e-47  Score=377.78  Aligned_cols=262  Identities=22%  Similarity=0.363  Sum_probs=207.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC--------ChHhHHHHHHHHHHHHhccCCCCccEEEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI--------LPIAVEDVKREVKILQALAGHENVVKFYNA  165 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  165 (487)
                      +.++|++.+.||+|+||.||+|.+.. |+.||||++......        .....+.+.+|+.+++++. ||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeee
Confidence            45689999999999999999999754 999999998653221        2233478899999999995 9999999999


Q ss_pred             EEe-----CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          166 FED-----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       166 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      +..     ...+|+||||++ |+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~  172 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA---DNND  172 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---CCCC
Confidence            843     347899999997 5888887543 35799999999999999999999999999999999999998   4778


Q ss_pred             EEEeecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-
Q 011380          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKP-  317 (487)
Q Consensus       241 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-  317 (487)
                      +||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+..... 
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999986655555566789999999999865  468999999999999999999999998887766666543111 


Q ss_pred             -----------------------CCCCCC----CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          318 -----------------------DFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       318 -----------------------~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                             ..+...    .+.+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                   111111    245788999999999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-47  Score=379.39  Aligned_cols=260  Identities=26%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-----  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-----  170 (487)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++.....    ......+|+..+..+. ||||+++++++...+     
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTT
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccccc
Confidence            579999999999999999999999999999999865432    2234567888888885 999999999986533     


Q ss_pred             --EEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHH--HcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          171 --YVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECH--LHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH--~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                        .+++||||+++ +|...+..  .....+++..++.++.||+.||.|||  ++||+||||||+|||++.  .++.+||+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~kl~  174 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLKLC  174 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEEEEC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcEEEe
Confidence              38899999976 55554432  34567899999999999999999999  999999999999999983  36789999


Q ss_pred             ecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC--
Q 011380          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR--  320 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--  320 (487)
                      |||++.............||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+......+..+........  
T Consensus       175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            9999988776666667789999999999854  369999999999999999999999999888777776654211100  


Q ss_pred             ------------------C--------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          321 ------------------R--------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       321 ------------------~--------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                        .        ......++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence                              0        011225678999999999999999999999999999998654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=380.10  Aligned_cols=262  Identities=21%  Similarity=0.250  Sum_probs=221.1

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEE-----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      ...++|++++.||+|+||+||+|.     +..+++.||||++....  .......+.+|+.+++++. ||||+++++++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            345789999999999999999999     44577899999986432  3445567889999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      .....|+||||++||+|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            99999999999999999999876532     4589999999999999999999999999999999999998655566799


Q ss_pred             EeecccccccCC---CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          243 ATDFGLSDFIKP---GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |+|||+++....   ........||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999975422   122344678999999998854 57899999999999999998 9999999888888887776653


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ..   ....++..+.+||.+||+.||.+|||+.+++++.|+-.
T Consensus       305 ~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22   22468899999999999999999999999999988653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.2e-47  Score=363.47  Aligned_cols=259  Identities=25%  Similarity=0.458  Sum_probs=220.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~~~~  173 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.  ..+.+|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEE
Confidence            579999999999999999999999999999999976543 3445678899999999995 999999999875  467899


Q ss_pred             EEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeecCCCCceEeccCCCCCcEEEeec
Q 011380          174 IAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHG-----LVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~-----iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      +||||++|++|.+++....  ...+++..++.++.||+.||.|||+.|     |+||||||+|||++   .++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCCEEEecC
Confidence            9999999999999886532  345999999999999999999999999     99999999999998   4778999999


Q ss_pred             ccccccCCCCc-cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          247 GLSDFIKPGKK-FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       247 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+....   ..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~  237 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP  237 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CC
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CC
Confidence            99977654322 234579999999999866 46889999999999999999999999888877777777765422   12


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ..+++++.++|.+||..||.+|||+.++|+|+|+.+..
T Consensus       238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            36889999999999999999999999999999998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-47  Score=367.92  Aligned_cols=256  Identities=27%  Similarity=0.480  Sum_probs=209.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-----  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-----  168 (487)
                      +.++|++++.||+|+||.||+|++..+|+.||+|++...    ....+.+.+|+.+++++. ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            446799999999999999999999999999999998643    245677889999999995 9999999998865     


Q ss_pred             --------CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          169 --------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       169 --------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                              .+.+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~  154 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRN  154 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSC
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCC
Confidence                    45789999999999999988643 35688999999999999999999999999999999999998   4778


Q ss_pred             EEEeecccccccCCC---------------CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 011380          241 LKATDFGLSDFIKPG---------------KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDK  303 (487)
Q Consensus       241 vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~  303 (487)
                      +||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            999999998765421               12345679999999999875  47899999999999999998   55433


Q ss_pred             -ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          304 -TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       304 -~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                       ........+......++.......+..+.++|.+||+.||.+|||+.++++||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence             2334455555555555554455678889999999999999999999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-46  Score=373.68  Aligned_cols=264  Identities=26%  Similarity=0.372  Sum_probs=217.7

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCC-CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC------ccEEE
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANG-DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN------VVKFY  163 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn------Iv~~~  163 (487)
                      ...+.++|++.+.||+|+||+||+|.+..++ +.||+|++...    ....+.+.+|+.+++.+. |++      |+.++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFLCVLMS   88 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCceeEEEee
Confidence            4456789999999999999999999998877 68999998653    235577889999999996 655      99999


Q ss_pred             EEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC--------
Q 011380          164 NAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--------  235 (487)
Q Consensus       164 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~--------  235 (487)
                      +++...+.+++||||+ +++|.+.+.......+++..++.++.||+.||.|||++||+||||||+|||+...        
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 6788888877665679999999999999999999999999999999999999532        


Q ss_pred             --------CCCCcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          236 --------KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       236 --------~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                              ..++.+||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    2468899999999976543  3345689999999999865 5689999999999999999999999888776


Q ss_pred             HHHHHHHhcCCCCCC----------------CCCC------------------------CCCHHHHHHHHHccccCccCC
Q 011380          307 GIFKEVLRNKPDFRR----------------KPWP------------------------SISNSAKDFVKKLLVKDPRAR  346 (487)
Q Consensus       307 ~~~~~i~~~~~~~~~----------------~~~~------------------------~~s~~~~~li~~~L~~dp~~R  346 (487)
                      ..+..+.......+.                ..|+                        ..+.++.+||.+||..||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            655444332111110                0011                        123478899999999999999


Q ss_pred             cCHHHHhcCccccccC
Q 011380          347 LTAAQALSHPWVREGG  362 (487)
Q Consensus       347 pt~~e~L~h~~~~~~~  362 (487)
                      ||+.|+|+||||+...
T Consensus       326 pt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CCHHHHTTSGGGGGCC
T ss_pred             cCHHHHhcChhhcCCC
Confidence            9999999999998753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=375.27  Aligned_cols=257  Identities=31%  Similarity=0.509  Sum_probs=212.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE--
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY--  171 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~--  171 (487)
                      +.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.+. ||||+++++++.....  
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccc
Confidence            4568999999999999999999999999999999997643 23445677889999999995 9999999999987654  


Q ss_pred             ----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          172 ----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       172 ----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                          +|+||||+. ++|.+.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~Dfg  171 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFG  171 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECSTT
T ss_pred             cceeEEEEecccc-CCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEeecc
Confidence                599999997 5877655    24599999999999999999999999999999999999998   47789999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC---------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK---------  316 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------  316 (487)
                      ++.....  .....+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+....         
T Consensus       172 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          172 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             CTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             cccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9976543  2345689999999999865  46899999999999999999999998887766665554311         


Q ss_pred             --------------CCC----CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 --------------PDF----RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 --------------~~~----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                    +..    ....++.+++++.+||.+||..||++|||+.++|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                          110    1122356899999999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-46  Score=365.84  Aligned_cols=257  Identities=24%  Similarity=0.338  Sum_probs=208.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..+|++.+.||+|+||+||+|.+  +|+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.+.+.+++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEE
Confidence            45799999999999999999976  588999999876543 3445677899999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          175 AMELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ||||++||+|.+++..... ..+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.+||+|||++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCCCCCcc
Confidence            9999999999998854321 23899999999999999999999999  99999999999998   578899999999976


Q ss_pred             cCCCC-ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          252 IKPGK-KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ..... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.........+........  ....+++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~  266 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNP  266 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCCH
Confidence            54322 23456899999999998765 68999999999999999999999998888777776654443322  2246899


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc--Cccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~--h~~~~~  360 (487)
                      ++.+||.+||..||.+|||+.++++  .+|++.
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999987  566654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=363.49  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=208.4

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      |.....||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.+. ||||+++++++...+.+++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            334458999999999999999999999999987643   234577889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC
Q 011380          178 LCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~  256 (487)
                      |+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence            999999999886543 235679999999999999999999999999999999999984  36789999999997764322


Q ss_pred             -ccccccCCccccchhhhccC---CCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          257 -KFQDIVGSAYYVAPEVLKRK---SGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       257 -~~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                       ......||+.|+|||++.+.   ++.++||||||+++|+|++|+.||....... .........  ........+++++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccCCHHH
Confidence             23456899999999998653   6889999999999999999999997643322 221211111  1112234688999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      .++|.+||..||++|||+.++|+||||+...
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=366.28  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=197.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++..... .....+.+..+..+++.+ +||||+++++++...+.+|+|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Confidence            579999999999999999999999999999999976542 122223344444566666 599999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||+ ++.+ ..+.......+++..++.++.||+.||.|||+. ||+||||||+|||++   .++.+||+|||++.....
T Consensus       103 ~e~~-~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          103 MELM-GTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             ECCC-SEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC-----
T ss_pred             Eecc-CCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCchhccC
Confidence            9999 4444 444444457799999999999999999999995 999999999999998   477899999999977655


Q ss_pred             CCccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          255 GKKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ........||+.|+|||++.      ..++.++|||||||++|+|++|+.||... .....+..+........ .....+
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  256 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMGF  256 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSCC
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCCC
Confidence            55555678999999999984      34688999999999999999999999874 44556666666544322 223468


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ++++.+||.+||..||.+|||+.++++||||+...
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            99999999999999999999999999999998653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-46  Score=355.84  Aligned_cols=247  Identities=21%  Similarity=0.373  Sum_probs=213.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEE
Confidence            57999999999999999999986 577899999976542    3467889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccccc
Confidence            9999999999988543 35689999999999999999999999999999999999998   4678999999999765432


Q ss_pred             C--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .  ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+........   ...+++.+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHH
Confidence            2  2234567889999999874 56889999999999999999 9999999888888888776643322   24578999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++|.+||+.||.+|||+.++++|
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.7e-46  Score=363.11  Aligned_cols=258  Identities=27%  Similarity=0.494  Sum_probs=209.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccC-CCCccEEEEEEEeCCEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDDNYV  172 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~~~~~  172 (487)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+.+++++.. ||||+++++++...+.+
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            4567999999999999999999975 589999999976542 34456788999999999963 59999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||| +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++...
T Consensus       104 ~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC-
T ss_pred             EEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccc
Confidence            99999 5588999988543  5789999999999999999999999999999999999996    478999999999776


Q ss_pred             CCCCc---cccccCCccccchhhhcc------------CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcC
Q 011380          253 KPGKK---FQDIVGSAYYVAPEVLKR------------KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNK  316 (487)
Q Consensus       253 ~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~  316 (487)
                      .....   .....||+.|+|||++.+            .++.++|||||||++|+|++|..||...... ..+..+....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  256 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  256 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence            43321   234579999999999864            4678999999999999999999999765433 3344444333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      ....  .....+.++.++|.+||..||.+|||+.++|+||||+...
T Consensus       257 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          257 HEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             SCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             cccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            2221  1234578999999999999999999999999999998753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-46  Score=366.32  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=199.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ..++|++++.||+|+||+||+|.+..++.   .||+|++..... .....+.+.+|+.+++++. ||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence            34679999999999999999999877765   899999876532 2345678899999999995 999999999998776


Q ss_pred             EE------EEEEeccCCCCHHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          171 YV------YIAMELCEGGELLDRILAKKD----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       171 ~~------~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      ..      ++||||+++|+|.+++.....    ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCC
Confidence            55      999999999999998865432    2589999999999999999999999999999999999998   4688


Q ss_pred             EEEeecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 011380          241 LKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRN  315 (487)
Q Consensus       241 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~  315 (487)
                      +||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+.........+..+
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999977644322   2234578899999998664 6889999999999999999 99999988888888877765


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHccccCccCCcC-------HHHHhcCcccccc
Q 011380          316 KPDFRRKPWPSISNSAKDFVKKLLVKDPRARLT-------AAQALSHPWVREG  361 (487)
Q Consensus       316 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt-------~~e~L~h~~~~~~  361 (487)
                      ....   ..+.+++++.+||.+||+.||.+|||       +.+++.|||+...
T Consensus       256 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 NRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            5322   23568899999999999999999999       7888999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-46  Score=373.69  Aligned_cols=255  Identities=25%  Similarity=0.319  Sum_probs=211.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEE-----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ..++|++++.||+|+||.||+|.     +..+++.||||++....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            34689999999999999999998     45677899999997543  234557789999999999769999999999987


Q ss_pred             CC-EEEEEEeccCCCCHHHHHHhhcC------------------------------------------------------
Q 011380          169 DN-YVYIAMELCEGGELLDRILAKKD------------------------------------------------------  193 (487)
Q Consensus       169 ~~-~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------------  193 (487)
                      .+ .+++|||||+||+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 48999999999999999865432                                                      


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCC---cccc
Q 011380          194 ----------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQD  260 (487)
Q Consensus       194 ----------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~  260 (487)
                                ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.......   ....
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchhccc
Confidence                      1289999999999999999999999999999999999998   46789999999998654332   2334


Q ss_pred             ccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHc
Q 011380          261 IVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKL  338 (487)
Q Consensus       261 ~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  338 (487)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+............  ...+++++.++|.+|
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~  332 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC  332 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC--CCCCCHHHHHHHHHH
Confidence            678999999998865 56889999999999999998 99999887765555444443322222  245889999999999


Q ss_pred             cccCccCCcCHHHHhcC
Q 011380          339 LVKDPRARLTAAQALSH  355 (487)
Q Consensus       339 L~~dp~~Rpt~~e~L~h  355 (487)
                      |..||.+|||+.++++|
T Consensus       333 l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          333 WHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCCCHHHHHHH
Confidence            99999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.9e-46  Score=353.24  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=213.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++. ||||+++++++.+.+.+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEE
Confidence            457999999999999999999875 567899999976543    3466889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEECCT
T ss_pred             EEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceecch
Confidence            99999999999988654 34699999999999999999999999999999999999998   478899999999987654


Q ss_pred             CCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+.........   ...++.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  233 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDT  233 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHH
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHH
Confidence            332  233456788999999876 46899999999999999999 99999988888877777766543332   357899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +.++|.+||+.||.+|||+.+++++
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-46  Score=368.42  Aligned_cols=255  Identities=29%  Similarity=0.526  Sum_probs=214.5

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh---HhHHHHHHHHHHHHhcc-CCCCccEEEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA-GHENVVKFYNAFE  167 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~  167 (487)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++........   .....+.+|+.+++++. +||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            4567789999999999999999999999999999999976543211   12244568999999996 3699999999999


Q ss_pred             eCCEEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          168 DDNYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       168 ~~~~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ..+.+++|||++.+ ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.  +++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEeeC
Confidence            99999999999976 8999988654  57899999999999999999999999999999999999973  4678999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |++...... ......||+.|+|||++.+. + +.++|||||||++|+|++|+.||....      .+......+    .
T Consensus       195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~----~  263 (320)
T 3a99_A          195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----R  263 (320)
T ss_dssp             TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----S
T ss_pred             ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc----c
Confidence            999876543 34556899999999998654 3 678999999999999999999996432      233333222    2


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +.+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            4688999999999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-46  Score=376.04  Aligned_cols=262  Identities=26%  Similarity=0.445  Sum_probs=210.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc----------CCCCccEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----------GHENVVKFYN  164 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------~hpnIv~~~~  164 (487)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++....    ...+.+.+|+.+++++.          +||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            468999999999999999999999999999999987532    34567889999999885          2789999999


Q ss_pred             EEEeCC----EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccC---C
Q 011380          165 AFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSA---K  236 (487)
Q Consensus       165 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~---~  236 (487)
                      ++...+    .+++|||++ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++..   .
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            988654    789999999 89999998776667799999999999999999999998 99999999999999642   1


Q ss_pred             CCCcEEEeecccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC------hhHHH
Q 011380          237 EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT------EDGIF  309 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~~~  309 (487)
                      ..+.+||+|||++.....  .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+..      ....+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            345799999999977643  23456899999999998764 6899999999999999999999997654      22222


Q ss_pred             HHHHhcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHccccCccCCcCHHH
Q 011380          310 KEVLRNKPDFRR--------------------------------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQ  351 (487)
Q Consensus       310 ~~i~~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e  351 (487)
                      ..+.......+.                                      ...+.++.++.+||.+||+.||.+|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            222221000000                                      000134567899999999999999999999


Q ss_pred             HhcCccccccCC
Q 011380          352 ALSHPWVREGGD  363 (487)
Q Consensus       352 ~L~h~~~~~~~~  363 (487)
                      +|+||||+....
T Consensus       331 ll~hp~f~~~~~  342 (373)
T 1q8y_A          331 LVNHPWLKDTLG  342 (373)
T ss_dssp             HHTCGGGTTCTT
T ss_pred             HhhChhhhcccC
Confidence            999999997543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=360.66  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=206.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++...   .....+.+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEE
Confidence            5799999999999999999999999999999988543   3456778999999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceecccc
Confidence            9999999999988543 46799999999999999999999999999999999999998   5788999999999765432


Q ss_pred             Ccc---------------ccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhH-----HHHHHHh
Q 011380          256 KKF---------------QDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDG-----IFKEVLR  314 (487)
Q Consensus       256 ~~~---------------~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~~~~i~~  314 (487)
                      ...               ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.......     .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            211               156899999999998764 6899999999999999999999986543211     1111211


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..      ..+.+++.+.++|.+||+.||++|||+.++++
T Consensus       242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11      12457788999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=370.62  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=217.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCC-------CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKAN-------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..++|.+++.||+|+||+||+|.+..+       +..||+|++....  .......+.+|+++++++.+||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            346899999999999999999997543       3579999987653  3445678899999999995699999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEe
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLF  232 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll  232 (487)
                      ...+.+++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999987653              2459999999999999999999999999999999999999


Q ss_pred             ccCCCCCcEEEeecccccccCCCC---ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhH
Q 011380          233 KSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDG  307 (487)
Q Consensus       233 ~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  307 (487)
                      +   .++.+||+|||++.......   ......||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+....+
T Consensus       225 ~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 T---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             C---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             c---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            8   46789999999998664332   23345678999999998654 6889999999999999999 999999888887


Q ss_pred             HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          308 IFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       308 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ....+..+....   ....+++++.+||.+||+.||++|||+.+++++
T Consensus       302 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            777776654322   225688999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-46  Score=370.54  Aligned_cols=253  Identities=18%  Similarity=0.255  Sum_probs=206.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++.+.||+|+||+||+|.+..+|+.||||++.....     ...+.+|+.++++|.+||||+++++++...+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            45689999999999999999999999999999999875432     2357789999999956999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC--CCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE--DSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~--~~~vkl~DfG~a~~  251 (487)
                      +||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+.  ...+||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999999 99999988653 467999999999999999999999999999999999999984221  12399999999987


Q ss_pred             cCCCCc--------cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcCCCC
Q 011380          252 IKPGKK--------FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDF  319 (487)
Q Consensus       252 ~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~  319 (487)
                      ......        ....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+...   .+.+..+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            543321        2467899999999998764 68899999999999999999999987543   33344443332222


Q ss_pred             CCCC-CCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          320 RRKP-WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       320 ~~~~-~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +... ...+| ++.++|.+||..||.+||++.++++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111 12244 8999999999999999999998875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.3e-46  Score=358.71  Aligned_cols=249  Identities=29%  Similarity=0.563  Sum_probs=200.4

Q ss_pred             ccCCCeeEe-eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 011380           93 DFDRRYTIG-KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED---  168 (487)
Q Consensus        93 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~---  168 (487)
                      .+.++|.+. +.||+|+||.||+|.++.+|+.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345668777 7899999999999999999999999998643        4567899998666579999999999987   


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                       ...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             7789999999999999999977665679999999999999999999999999999999999999965447889999999


Q ss_pred             cccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH----hcCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL----RNKPDFRRKP  323 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~  323 (487)
                      ++.....                    ..++.++|||||||++|+|++|+.||.+...........    .....++...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9865431                    234678999999999999999999997665433221111    1111111112


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI  369 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~  369 (487)
                      +..+++++.+||.+||+.||.+|||+.|+|+||||+........+.
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~  271 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  271 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence            2468999999999999999999999999999999988655444443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.5e-46  Score=356.31  Aligned_cols=253  Identities=22%  Similarity=0.319  Sum_probs=207.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhH----HHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAV----EDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~----~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...........    +.+.+|+.+++++. ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            34689999999999999999999999999999999866443222211    67889999999995 99999999999776


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCC--CCCcEEEee
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAK--EDSSLKATD  245 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~--~~~~vkl~D  245 (487)
                      .  ++||||+++|+|.+.+... ...+++..++.++.||+.||.|||++|  |+||||||+|||++..+  ....+||+|
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            6  6899999999999888654 457999999999999999999999999  99999999999998422  122499999


Q ss_pred             cccccccCCCCccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHH--HHHHHhcCCCCC
Q 011380          246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGI--FKEVLRNKPDFR  320 (487)
Q Consensus       246 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~  320 (487)
                      ||++.....  ......||+.|+|||++.+   .++.++|||||||++|+|++|+.||........  ...+.....  .
T Consensus       173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~  248 (287)
T 4f0f_A          173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--R  248 (287)
T ss_dssp             CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--C
T ss_pred             CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--C
Confidence            999975432  3456789999999999843   357899999999999999999999987654433  333333332  2


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            2233578999999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-46  Score=368.01  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=191.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK-ILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++....  .......+..|+. +++.+ +||||+++++++...+..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceEE
Confidence            57999999999999999999999999999999997643  2334455667776 55555 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          175 AMELCEGGELLDRILA---KKDSRYTEKDAAVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~---~~~~~l~~~~~~~~~~qil~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ||||+++ +|.+.+..   .....+++..+..++.|++.||.|||+. ||+||||||+|||++   .++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCce
Confidence            9999975 77766642   2356799999999999999999999999 999999999999998   57889999999998


Q ss_pred             ccCCCCccccccCCccccchhhhc-----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcC-CCCCCCC
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLK-----RKSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLRNK-PDFRRKP  323 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~~  323 (487)
                      ............||+.|+|||++.     ..++.++|||||||++|+|++|..||.+.... +.+..+..+. +.+....
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            765544445568999999999983     34688999999999999999999999764321 2222222221 2222233


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +..+++.+.+||.+||..||.+|||+.++++||||....
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            456899999999999999999999999999999998654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-45  Score=359.59  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|++.......+...+.+.+|+.+++++. ||||+++++++...+.+|+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence            357999999999999999999999999999999997665444556688999999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCccccc
Confidence            99999999999988654  5799999999999999999999999999999999999998   467899999999876543


Q ss_pred             CC--ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          255 GK--KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       255 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+..... +...............+.+|+++
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l  265 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAF  265 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCCGGGTSTTCCTHH
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCCccccCCCCCHHH
Confidence            32  23456799999999998654 6889999999999999999999998766553 33444443333333456789999


Q ss_pred             HHHHHHccccCccCCc-CHHHHhc
Q 011380          332 KDFVKKLLVKDPRARL-TAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rp-t~~e~L~  354 (487)
                      .++|.+||..||++|| ++.++++
T Consensus       266 ~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          266 DAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHhccCCHHHHHHhHHHHHH
Confidence            9999999999999999 7777664

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-45  Score=352.39  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ++|++.+.||+|+||.||+|.+.  |+.||+|++....... ....+.+.+|+.+++.+. ||||+++++++.+.+.+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEE
Confidence            57999999999999999999874  8899999986543221 234577889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---ceeecCCCCceEeccCC-----CCCcEEEeec
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG---LVHRDMKPENFLFKSAK-----EDSSLKATDF  246 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---iiHrDlkp~NIll~~~~-----~~~~vkl~Df  246 (487)
                      ||||++|++|.+++.   ...+++..++.++.||+.||.|||++|   |+||||||+|||++...     .++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999988772   357999999999999999999999999   99999999999998422     2678999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      |++....... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.........+.........  ..
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  237 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PS  237 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CT
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Cc
Confidence            9997665433 2356899999999998664 688999999999999999999999988877777776665543332  24


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+++.+.++|.+||..||.+|||+.+++++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            688999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-45  Score=353.97  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=210.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++++. ||||+++++++.+.+.+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEE
Confidence            468999999999999999999876 677899999976543    3366889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEccccccccccc
Confidence            99999999999988553 35699999999999999999999999999999999999998   577899999999976543


Q ss_pred             CC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|+|++ |+.||...........+........   ....++.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  249 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEK  249 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHH
Confidence            21  1233457889999999864 57889999999999999998 9999998888888777776643322   2457899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcC
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +.++|.+||+.||.+|||+.++++|
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-46  Score=358.62  Aligned_cols=251  Identities=26%  Similarity=0.454  Sum_probs=214.7

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--  168 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--  168 (487)
                      +..+..+|++.+.||+|+||.||+|.+..+|+.||+|++....       +.+.+|+.+++++. ||||+++++++..  
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEE
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEeccc
Confidence            4456678999999999999999999999999999999997543       34578999999995 9999999998864  


Q ss_pred             --------------CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          169 --------------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       169 --------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                                    ...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-  156 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-  156 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-
Confidence                          45689999999999999999776667899999999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL  313 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  313 (487)
                        .++.+||+|||++.............||+.|+|||++.+. ++.++||||||+++|+|++|..||...  ......+.
T Consensus       157 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~  232 (284)
T 2a19_B          157 --DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR  232 (284)
T ss_dssp             --ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred             --CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence              4678999999999887665555667899999999998754 689999999999999999999987432  22333333


Q ss_pred             hcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          314 RNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       314 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ....      .+.++..+.++|.+||..||.+|||+.+++++.|.-.
T Consensus       233 ~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          233 DGII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TTCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            3221      1457899999999999999999999999999988654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.5e-46  Score=377.84  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=202.0

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ...+.+.|.+.+.||+|+||+||.+ ...+|+.||||++...      ..+.+.+|+.+++++.+||||+++++++.+.+
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3456677888999999999999875 4568999999998653      23567899999998756999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC----------
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSR-----YTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA----------  235 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~-----l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~----------  235 (487)
                      .+|+|||||. |+|.+++.......     .++..++.++.||+.||.|||++||+||||||+|||++..          
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence            9999999995 69999885432111     1233467899999999999999999999999999999742          


Q ss_pred             CCCCcEEEeecccccccCCCCc-----cccccCCccccchhhhcc--------CCCCcchHHHHHHHHHHHHh-CCCCCC
Q 011380          236 KEDSSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLC-GRRPFW  301 (487)
Q Consensus       236 ~~~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ell~-g~~pf~  301 (487)
                      ..+..+||+|||++........     ....+||+.|+|||++.+        .++.++|||||||++|+|++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence            2356899999999987654321     234689999999999854        46889999999999999999 999997


Q ss_pred             CCChhHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          302 DKTEDGIFKEVLRNKPDFRRKP---WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       302 ~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      +.....  ..+..+........   .+.+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            654433  34555443333221   1235678999999999999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=377.87  Aligned_cols=259  Identities=24%  Similarity=0.398  Sum_probs=212.7

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||||++.....  ....+.+.+|+++++++. ||||+++++++...+  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence            456789999999999999999999999999999999975432  223567789999999995 999999999998755  


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc-CCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS-AKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~-~~~~~~vkl~DfG~  248 (487)
                      ..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+.. .+..+.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999885432 233999999999999999999999999999999999999832 12466799999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc---------CCCCcchHHHHHHHHHHHHhCCCCCCC----CChhHHHHHHHhc
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR---------KSGPESDVWSIGVITYILLCGRRPFWD----KTEDGIFKEVLRN  315 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwSlG~il~ell~g~~pf~~----~~~~~~~~~i~~~  315 (487)
                      +............+||+.|+|||++.+         .++.++|||||||++|+|++|+.||..    ....+.+..+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            988766655667789999999999853         457889999999999999999999964    3345566677766


Q ss_pred             CCCCCC-----------------CC----CCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          316 KPDFRR-----------------KP----WPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       316 ~~~~~~-----------------~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+....                 ..    ...++..+.++|.+||..||++|||+.++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            543111                 00    0124457889999999999999999999854

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-45  Score=355.98  Aligned_cols=255  Identities=26%  Similarity=0.449  Sum_probs=202.5

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++. ||||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence            3357999999999999999999999999999999998655445566788899999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +||||+++++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEeccceee
Confidence            999999999999988542  346699999999999999999999999999999999999998   477899999999876


Q ss_pred             cCCCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE--DGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...  ......+....  ++......+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCccccc
Confidence            54332 2344679999999999865 468899999999999999999999976533  23344443332  233334568


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++++.++|.+||..||.+|||+.++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-45  Score=359.79  Aligned_cols=254  Identities=26%  Similarity=0.325  Sum_probs=214.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEE-----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++++.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            36899999999999999999985     4577899999997543  2345678899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          170 NYVYIAMELCEGGELLDRILAKKD----------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~----------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      +..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            999999999999999999865532                2489999999999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  308 (487)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......
T Consensus       180 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          180 ---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             ---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence               478899999999987654332   234567889999998755 56889999999999999999 9999988776655


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ............  ..+.+++++.++|.+||..||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            555554433222  235688999999999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-45  Score=360.22  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=215.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|.+.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecC
Confidence            467999999999999999999983     456899999987543  3455678899999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 011380          170 NYVYIAMELCEGGELLDRILAKKD----------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP  227 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp  227 (487)
                      +.+++||||++||+|.+++.....                      ..+++..++.++.||+.||.|||++||+||||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp  178 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA  178 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence            999999999999999999865432                      3489999999999999999999999999999999


Q ss_pred             CceEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCC
Q 011380          228 ENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWD  302 (487)
Q Consensus       228 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~  302 (487)
                      +|||++   .++.+||+|||++........   .....||+.|+|||++.+. ++.++|||||||++|+|++ |..||.+
T Consensus       179 ~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          179 RNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             heEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998   477899999999976643322   2345678899999988654 6889999999999999999 9999998


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .........+..+...   .....+++++.++|.+||..||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8887777766655422   2235689999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-45  Score=355.09  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=217.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    ...+.+.+|+.+++++. ||||+++++++.+.+.+|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEE
Confidence            4467999999999999999999999999999999997543    24577889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceecc
Confidence            999999999999999776667799999999999999999999999999999999999998   46789999999998765


Q ss_pred             CCC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...  ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+.....   ....+.+++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  239 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPE  239 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCCCH
Confidence            432  2234567889999999864 56889999999999999999 9999988887777766655432   222356889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+.+||.+||..||.+|||+.++++
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.2e-46  Score=359.40  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=210.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.+.+||||+++++++......
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            356789999999999999999999999999999999865432     245678999999997799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--CCCcEEEeeccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSD  250 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a~  250 (487)
                      ++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999999 99999988543 35699999999999999999999999999999999999998531  23459999999998


Q ss_pred             ccCCCC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCC
Q 011380          251 FIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPD  318 (487)
Q Consensus       251 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~  318 (487)
                      ......        ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+..   ....+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            765432        23456799999999998764 6889999999999999999999998743   33444444332211


Q ss_pred             CC-CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          319 FR-RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       319 ~~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .. ....+.+|+++.++|.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            11 1123468899999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.1e-46  Score=363.41  Aligned_cols=262  Identities=21%  Similarity=0.261  Sum_probs=216.9

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEE-----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVAT-----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      ...++|++++.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.+++++. ||||+++++++.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  103 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL  103 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEc
Confidence            345689999999999999999998     55678899999986432  3445667889999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKD-----SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      .....|+||||++||+|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999999866432     3589999999999999999999999999999999999998655567899


Q ss_pred             EeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          243 ATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||...........+..+..
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            99999987543222   2234578999999998854 56889999999999999998 9999988888777777766543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      .   ...+.++..+.++|.+||..||.+|||+.+++++.|+-.
T Consensus       264 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            2   223568899999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=365.19  Aligned_cols=251  Identities=20%  Similarity=0.260  Sum_probs=214.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++++. ||||+++++++.+.
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  122 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG  122 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccC
Confidence            467999999999999999999987     355899999997543  3445678899999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 011380          170 NYVYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP  227 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp  227 (487)
                      +.+|+||||+++|+|.+++....                      ...+++..++.++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            99999999999999999986532                      15689999999999999999999999999999999


Q ss_pred             CceEeccCCCCCcEEEeecccccccCCC---CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 011380          228 ENFLFKSAKEDSSLKATDFGLSDFIKPG---KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWD  302 (487)
Q Consensus       228 ~NIll~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~  302 (487)
                      +|||++   .++.+||+|||++......   .......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+
T Consensus       203 ~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          203 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999998   4678999999999765322   12234578999999998864 57889999999999999999 9999999


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ....+....+..+....   ....+++++.++|.+||..||.+|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            88888887777665322   22468899999999999999999999999976

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=365.53  Aligned_cols=256  Identities=25%  Similarity=0.326  Sum_probs=212.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++++.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            468999999999999999999973     456789999997542  2234577899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCC
Q 011380          170 NYVYIAMELCEGGELLDRILAKKD---------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPE  228 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~  228 (487)
                      +.+|+||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            999999999999999999865432                     23799999999999999999999999999999999


Q ss_pred             ceEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 011380          229 NFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDK  303 (487)
Q Consensus       229 NIll~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~  303 (487)
                      |||++   .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.
T Consensus       202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99998   478899999999976643322   234567889999998854 56889999999999999998 99999888


Q ss_pred             ChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       304 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      .....+..+........  ....+++++.+||.+||..||.+|||+.+++++..
T Consensus       279 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            76666666665543322  22457899999999999999999999999998654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.8e-46  Score=370.67  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=211.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|.+.+.||+|+||.||+|.++.+|+.||||++....  .....+.+.+|+++++++. ||||+++++++...+.+|+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEE
Confidence            357999999999999999999999999999999986542  2344567889999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       190 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCEECTT
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCceecCC
Confidence            99999999999988644 34689999999999999999999999999999999999998   477899999999976543


Q ss_pred             CCcc---ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          255 GKKF---QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       255 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ....   ....+++.|+|||++.+ .++.++|||||||++|||++ |..||.+.........+..+...   .....+++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---PCPELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            2111   11235778999999864 56889999999999999998 99999888877776666554321   12245789


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+||.+||+.||++|||+.++++
T Consensus       343 ~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.2e-45  Score=352.77  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=201.9

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.+++++. ||||+++++++. ++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cC
Confidence            346899999999999999999998654   4569999886542  3445678899999999995 999999999985 56


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR  164 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccc
Confidence            689999999999999988543 35699999999999999999999999999999999999998   46789999999998


Q ss_pred             ccCCCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          251 FIKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       251 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .......  .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+...   ...+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~  241 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN  241 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence            7654322  233457889999999864 56889999999999999996 99999988888888777765432   22357


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +++++.++|.+||..||.+|||+.+++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            89999999999999999999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-45  Score=362.05  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=210.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEE--EEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRV--AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++|++.+.||+|+||.||+|.++.+|..+  |+|.+....  .....+.+.+|+.+++++.+||||+++++++.+.+.+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            57999999999999999999999888865  999886432  23345678899999999955999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          174 IAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      +||||+++|+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---CCC
Confidence            9999999999999886532              24699999999999999999999999999999999999998   467


Q ss_pred             cEEEeecccccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      .+||+|||++.............+++.|+|||++.+. ++.++|||||||++|+|++ |..||.+.........+..+..
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            8999999998754433333445678899999998754 5889999999999999998 9999998888777776655432


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                         ......+++++.+||.+||..||.+|||+.+++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               12234688999999999999999999999999885

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-45  Score=356.07  Aligned_cols=250  Identities=15%  Similarity=0.210  Sum_probs=206.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCC-------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANG-------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..++|++.+.||+|+||+||+|.+..++       ..||+|++....   ....+.+.+|+.+++++. ||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~   81 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLS-HKHLVLNYGVC   81 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence            4568999999999999999999998877       479999986543   335578899999999995 99999999999


Q ss_pred             EeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC-----CCcE
Q 011380          167 EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE-----DSSL  241 (487)
Q Consensus       167 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~-----~~~v  241 (487)
                      .+.+..++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+.     .+.+
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999988654 244899999999999999999999999999999999999985221     1129


Q ss_pred             EEeecccccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 011380          242 KATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDF  319 (487)
Q Consensus       242 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  319 (487)
                      ||+|||++.....   .....||+.|+|||++.+  .++.++|||||||++|+|++|..|+...................
T Consensus       161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL  237 (289)
T ss_dssp             EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence            9999999865532   234568999999999874  47899999999999999999665555554444444444443333


Q ss_pred             CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          320 RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       320 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +    +..++++.+||.+||+.||.+|||+.+++++
T Consensus       238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          238 P----APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2    3457789999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=378.24  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=198.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .+|.+.+.||+|+||+||. ....+|+.||||++.....      ..+.+|+.+|+.+.+||||+++++++.+...+|+|
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            3699999999999999764 3457899999999865432      23468999999995699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC--CCCcEEEeecccccccC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK--EDSSLKATDFGLSDFIK  253 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~vkl~DfG~a~~~~  253 (487)
                      ||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||++....
T Consensus        97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            99996 59999886543 3456667789999999999999999999999999999996422  23468899999998765


Q ss_pred             CC----CccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC-CC
Q 011380          254 PG----KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR-KP  323 (487)
Q Consensus       254 ~~----~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~-~~  323 (487)
                      ..    ......+||+.|+|||++.+    .++.++|||||||++|+|++ |..||........ .. ......... ..
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~  252 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NI-LLGACSLDCLHP  252 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HH-HTTCCCCTTSCT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HH-HhccCCccccCc
Confidence            33    22345789999999999863    45779999999999999999 8999865544332 22 222222211 11


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ....+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            22345668999999999999999999999999999763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.9e-45  Score=358.72  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=213.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc-------CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK-------ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      .++|++++.||+|+||.||+|.+.       .+++.||+|++....  .......+.+|+.+++++.+||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            468999999999999999999975       467789999987543  34456788999999999955999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEec
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFK  233 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~  233 (487)
                      ..+.+|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence            99999999999999999999865431              3489999999999999999999999999999999999998


Q ss_pred             cCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHH
Q 011380          234 SAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGI  308 (487)
Q Consensus       234 ~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  308 (487)
                         .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+.
T Consensus       192 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          192 ---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             ---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence               478899999999987654322   233467889999998865 46889999999999999999 9999998888877


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...+..+....   ....++.++.++|.+||..||.+|||+.+++++
T Consensus       269 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          269 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77776654221   224688999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=360.88  Aligned_cols=257  Identities=27%  Similarity=0.517  Sum_probs=204.3

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh---HhHHHHHHHHHHHHhcc---CCCCccEEEEE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---IAVEDVKREVKILQALA---GHENVVKFYNA  165 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~~~~~E~~~l~~l~---~hpnIv~~~~~  165 (487)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........   .....+.+|+.+++++.   +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4567789999999999999999999999999999999976543211   12234567999999983   49999999999


Q ss_pred             EEeCCEEEEEEec-cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          166 FEDDNYVYIAMEL-CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       166 ~~~~~~~~lv~e~-~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                      +...+..++|||+ +.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.  .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEE
Confidence            9999999999999 7899999998654  56999999999999999999999999999999999999983  46789999


Q ss_pred             ecccccccCCCCccccccCCccccchhhhccCC--CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC
Q 011380          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK  322 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  322 (487)
                      |||++...... ......||+.|+|||++.+..  +.++|||||||++|+|++|+.||...      ..+......+   
T Consensus       183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~---  252 (312)
T 2iwi_A          183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHF---  252 (312)
T ss_dssp             CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCC---
T ss_pred             EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCC---
Confidence            99999876543 345678999999999986543  45899999999999999999999643      1233333322   


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                       ...++.++.++|.+||..||++|||+.++++||||+....
T Consensus       253 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          253 -PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             2468899999999999999999999999999999987543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.8e-45  Score=359.00  Aligned_cols=250  Identities=22%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEE----EEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++|++.+.||+|+||+||+|++..+|+.+    |+|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            357999999999999999999998887765    777665332  2335578899999999995 999999999998765


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                       .++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence             78899999999999988654 35799999999999999999999999999999999999998   46789999999998


Q ss_pred             ccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+.........+..+....   ..+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  242 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPP  242 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCc
Confidence            7654332   223457889999998865 46899999999999999999 999998887777666665543221   224


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++.++.+++.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            678999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=366.89  Aligned_cols=247  Identities=16%  Similarity=0.228  Sum_probs=201.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC--------CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccE-----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN--------GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK-----  161 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~-----  161 (487)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...        ..+.+|+.+++++. ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            46899999999999999999999874        889999998754        35678999999995 999887     


Q ss_pred             ----------EEEEEEe-CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCce
Q 011380          162 ----------FYNAFED-DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENF  230 (487)
Q Consensus       162 ----------~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NI  230 (487)
                                +++++.. .+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777765 78899999999 99999999765456799999999999999999999999999999999999


Q ss_pred             EeccCCCCC--cEEEeecccccccCCCC--------ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCC
Q 011380          231 LFKSAKEDS--SLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP  299 (487)
Q Consensus       231 ll~~~~~~~--~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~p  299 (487)
                      |++.   ++  .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus       191 l~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FVDP---EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EEET---TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EEcC---CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9983   44  89999999997654321        1234589999999999876 568899999999999999999999


Q ss_pred             CCCCC--hhHHHHH---HHhcCCCCCC--CCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          300 FWDKT--EDGIFKE---VLRNKPDFRR--KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       300 f~~~~--~~~~~~~---i~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      |....  .......   +......+..  ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            97754  2222222   2222222211  123467999999999999999999999999876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.8e-45  Score=347.93  Aligned_cols=246  Identities=18%  Similarity=0.203  Sum_probs=211.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD--NYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~~~  173 (487)
                      ++|++.+.||+|+||+||+|++.  |+.||+|++..... .....+.+.+|+.+++++. ||||+++++++.+.  +.++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSCE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCeE
Confidence            57999999999999999999874  88999999976542 3445677899999999995 99999999999877  7899


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +||||++||+|.+++.......+++..++.++.||+.||.|||++|  |+||||||+|||++   .++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEeccceee
Confidence            9999999999999997655556999999999999999999999999  99999999999998   477899999998754


Q ss_pred             cCCCCccccccCCccccchhhhccC-C---CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRK-S---GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ..    .....||+.|+|||++.+. +   +.++|||||||++|+|++|..||.+.........+........  ..+.+
T Consensus       163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  236 (271)
T 3kmu_A          163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGI  236 (271)
T ss_dssp             TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTTC
T ss_pred             ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCCC
Confidence            33    2345789999999998754 2   3379999999999999999999998888877777766543322  23568


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++++.++|.+||+.||++|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-45  Score=354.11  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=201.0

Q ss_pred             cCCCeeEeeeeeecCceEEEEEE----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-  168 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  168 (487)
                      ..++|++.+.||+|+||+||+|+    +..+|+.||+|++....   ....+.+.+|+.+++++. ||||+++++++.. 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            34689999999999999999998    56789999999987542   445678899999999995 9999999999854 


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                       ...+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFG  159 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCc
Confidence             45689999999999999988654 24599999999999999999999999999999999999998   46789999999


Q ss_pred             cccccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh----------------
Q 011380          248 LSDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED----------------  306 (487)
Q Consensus       248 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----------------  306 (487)
                      ++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            9987643321    233457888999999865 4688999999999999999999998543211                


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       307 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .....+... ..  ......+++++.++|.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELLKNN-GR--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHTT-CC--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcc-Cc--CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            111122222 11  2223568899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.4e-45  Score=359.38  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=213.1

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCC-----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+.+||||+++++++...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            4689999999999999999999977664     79999987543  2345678899999999995599999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCC
Q 011380          170 NYVYIAMELCEGGELLDRILAKK------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~  237 (487)
                      +.+|+||||+++|+|.+++....            ...+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence            99999999999999999886542            34689999999999999999999999999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 011380          238 DSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i  312 (487)
                      ++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+..+
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            67899999999976543322   234567889999998865 56889999999999999998 99999887766666666


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .........  ....++.+.++|.+||+.||.+|||+.++++
T Consensus       280 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          280 VKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            554433222  2457899999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.1e-45  Score=378.36  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=215.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      ..+|++.+.||+|+||.||+|.++.++..||||++.....    ..+.+.+|+.+|+++. ||||+++++++.....+||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEE
Confidence            4579999999999999999999999999999999976532    3577899999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceeccC
Confidence            99999999999999766566799999999999999999999999999999999999998   467899999999987643


Q ss_pred             CCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+..   ......++++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  447 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEK  447 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence            321  223456789999999864 46889999999999999999 9999988887777766655432   2223568899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +.+||.+||+.||.+|||+.++++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999976

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.4e-45  Score=345.39  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEE
Confidence            57999999999999999999986 678899999976542    3367889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++   .++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             ECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccccc
Confidence            9999999999988543 35689999999999999999999999999999999999998   4678999999999765432


Q ss_pred             C--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .  ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+.....   ...++..+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence            1  1234567889999999874 56889999999999999999 8999998888888877776643222   24578999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++|.+||..||.+|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.4e-45  Score=355.99  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=215.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      ...++|++.+.||+|+||.||+|.++     .+++.||+|++....  .......+.+|+.+++.+. ||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   98 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   98 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence            34578999999999999999999876     467889999987543  2345567889999999995 999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      +.+..++||||+++|+|.+++....        ...+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCC
Confidence            9999999999999999999886532        14578999999999999999999999999999999999998   477


Q ss_pred             cEEEeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 011380          240 SLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLR  314 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~  314 (487)
                      .+||+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            89999999997654322   1233467899999999865 46889999999999999999 8999988888877777766


Q ss_pred             cCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          315 NKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       315 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +....   ....+++.+.++|.+||..||.+|||+.+++++
T Consensus       256 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          256 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            54321   224688999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.2e-45  Score=350.66  Aligned_cols=253  Identities=26%  Similarity=0.435  Sum_probs=197.8

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +-..++|++.+.||+|+||+||+|.+.   ..||+|++.... ......+.+.+|+.+++++. ||||++++++. ....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~   93 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQ   93 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSS
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCc
Confidence            445678999999999999999999753   359999987554 23456678899999999995 99999999954 5566


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATE  169 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC----
T ss_pred             cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccc
Confidence            89999999999999887433 45699999999999999999999999999999999999998   467899999999976


Q ss_pred             cCC---CCccccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH-hcCCCCC-CC
Q 011380          252 IKP---GKKFQDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL-RNKPDFR-RK  322 (487)
Q Consensus       252 ~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~-~~  322 (487)
                      ...   ........||+.|+|||++.    ..++.++||||||+++|+|++|+.||.+......+.... .+..... ..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            532   22334567999999999985    345779999999999999999999998866555444443 3332222 22


Q ss_pred             CCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          323 PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       323 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ....+|+.+.+||.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23568899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-45  Score=360.06  Aligned_cols=246  Identities=23%  Similarity=0.297  Sum_probs=196.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----E
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----Y  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~----~  171 (487)
                      .+|++.+.||+|+||+||+|++.  ++.||||++....    .......+|+.+++++. ||||+++++++....    .
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCce
Confidence            47999999999999999999865  7899999986542    23455667999999995 999999999998743    5


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CceeecCCCCceEeccCCCCCcE
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH----------GLVHRDMKPENFLFKSAKEDSSL  241 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~----------~iiHrDlkp~NIll~~~~~~~~v  241 (487)
                      +++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.          ||+||||||+|||++   .++.+
T Consensus        97 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~~~  170 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTA  170 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTCCE
T ss_pred             EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCCeE
Confidence            7999999999999998854   3589999999999999999999999          999999999999998   57889


Q ss_pred             EEeecccccccCCCCc---cccccCCccccchhhhcc------CCCCcchHHHHHHHHHHHHhCCCCCCCCCh-------
Q 011380          242 KATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR------KSGPESDVWSIGVITYILLCGRRPFWDKTE-------  305 (487)
Q Consensus       242 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------  305 (487)
                      ||+|||++........   ....+||+.|+|||++.+      .++.++|||||||++|+|++|+.||.+...       
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999977654322   334689999999999875      335678999999999999999999965432       


Q ss_pred             ---------hHHHHHHHhcCCCCCCC-CCC--CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          306 ---------DGIFKEVLRNKPDFRRK-PWP--SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       306 ---------~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                               ......+.......... .|+  ..++++.+||.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                     11222222222111110 011  12345999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-44  Score=369.80  Aligned_cols=244  Identities=23%  Similarity=0.335  Sum_probs=208.6

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-EEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-YVY  173 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-~~~  173 (487)
                      .++|++.+.||+|+||.||+|.+.  |+.||||++....     ..+.+.+|+.+|+++. ||||+++++++.... .+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceE
Confidence            357999999999999999999875  7899999997643     3467889999999995 999999999987655 799


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCccccc
Confidence            999999999999999776555689999999999999999999999999999999999998   47889999999998653


Q ss_pred             CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..   ....+.+|+++
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l  415 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV  415 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHHH
T ss_pred             cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHH
Confidence            32  233467899999999865 56899999999999999998 9999998888777777766532   22235689999


Q ss_pred             HHHHHHccccCccCCcCHHHHhc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+||.+||..||.+|||+.++++
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-45  Score=356.34  Aligned_cols=254  Identities=25%  Similarity=0.322  Sum_probs=209.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEE-----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++++.||+|+||+||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++.+||||+++++++...
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            46899999999999999999985     3567899999997643  2345567899999999996699999999998765


Q ss_pred             C-EEEEEEeccCCCCHHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          170 N-YVYIAMELCEGGELLDRILAKKD--------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       170 ~-~~~lv~e~~~gg~L~~~l~~~~~--------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      + .+++||||++||+|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+|||++ 
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-  182 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-  182 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC-
Confidence            4 59999999999999999865432              1288999999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        .++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+
T Consensus       183 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             --GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             --CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence              467899999999976643322   234568899999998865 46889999999999999998 99999877654444


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...........  ....+++++.++|.+||..||.+|||+.++++|
T Consensus       261 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCccCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44333322222  124578999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.2e-45  Score=352.03  Aligned_cols=254  Identities=20%  Similarity=0.290  Sum_probs=205.2

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCcc-EEEEEEEeCCE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVV-KFYNAFEDDNY  171 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv-~~~~~~~~~~~  171 (487)
                      .+.++|++.+.||+|+||.||+|++..+|+.||+|++.....     ...+.+|+.+++.+. |++++ .+..++...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence            356789999999999999999999999999999999876442     245789999999997 66654 45455577889


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            99999999 89999988533 35799999999999999999999999999999999999995333578899999999987


Q ss_pred             cCCCCc--------cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhcCCCC
Q 011380          252 IKPGKK--------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKT---EDGIFKEVLRNKPDF  319 (487)
Q Consensus       252 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~  319 (487)
                      ......        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..   ....+..+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            654322        245689999999999876 46889999999999999999999997643   223333333322111


Q ss_pred             C-CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          320 R-RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       320 ~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      + ....+.+|+++.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1 1112467899999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=347.65  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=211.2

Q ss_pred             CCeeEee-eeeecCceEEEEEEEc--CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGK-LLGHGQFGYTYVATDK--ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++++. ||||+++++++. .+.+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-AEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE-SSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEec-CCCc
Confidence            4577766 9999999999999864  467889999997643  3456678899999999995 999999999994 5568


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence            999999999999998743 345699999999999999999999999999999999999998   4678999999999876


Q ss_pred             CCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....    .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||......+....+..+...   ...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~  237 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  237 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCC
Confidence            43322    223457899999999864 46889999999999999998 99999888887777777665422   12257


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      +++++.++|.+||..||.+|||+.+++++.+
T Consensus       238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8999999999999999999999999998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.9e-45  Score=360.86  Aligned_cols=250  Identities=20%  Similarity=0.273  Sum_probs=205.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCE----EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++|++.+.||+|+||+||+|.+..+|+.    ||+|.+.....  ......+.+|+.+++++. ||||+++++++.+ +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD-HAHIVRLLGLCPG-S   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCC-CTTBCCEEEEECB-S
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-C
Confidence            35799999999999999999999888876    67776643321  122345678999999995 9999999998864 5


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD  163 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSCSGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCCCccc
Confidence            688999999999999988543 35789999999999999999999999999999999999998   47789999999998


Q ss_pred             ccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          251 FIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       251 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+.....   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQ  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CT
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CC
Confidence            764432   2345678889999999874 57889999999999999999 9999998887777776665542222   13


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++.++.++|.+||..||.+|||+.+++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            467789999999999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.4e-45  Score=372.36  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=212.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||+||+|.+. ++..||||++.....    ..+.+.+|+.+|+++. ||||+++++++. ...+|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccE
Confidence            3468999999999999999999975 467899999976432    4578899999999995 999999999986 56789


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEcC
Confidence            999999999999999765445789999999999999999999999999999999999998   47889999999998764


Q ss_pred             CCC--ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGK--KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...  ......+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+..+...   .....+++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  412 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  412 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSCH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            321  122345678999999986 457899999999999999999 99999998888888877765322   22346889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+||.+||..||++|||+.++++
T Consensus       413 ~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          413 ELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHH
Confidence            9999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-45  Score=366.03  Aligned_cols=258  Identities=18%  Similarity=0.234  Sum_probs=195.2

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCC-----CCEEEEEEecccCcCChH--------hHHHHHHHHHHHHhccCCCCc
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKAN-----GDRVAVKKIEKNKMILPI--------AVEDVKREVKILQALAGHENV  159 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~--------~~~~~~~E~~~l~~l~~hpnI  159 (487)
                      ...++|++++.||+|+||+||+|.+..+     ++.||+|++.........        .......|+..+..+ +||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCC
Confidence            3456899999999999999999998765     588999998754310000        001122344445555 39999


Q ss_pred             cEEEEEEEeC----CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC
Q 011380          160 VKFYNAFEDD----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (487)
Q Consensus       160 v~~~~~~~~~----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~  235 (487)
                      +++++++...    ...||||||+ |++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. 
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-  187 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-  187 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-
Confidence            9999998764    5689999999 9999998854 3467999999999999999999999999999999999999983 


Q ss_pred             CCCCcEEEeecccccccCCCC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          236 KEDSSLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       236 ~~~~~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                      ..++.+||+|||+++......        .....+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            236789999999997654321        12345699999999998765 689999999999999999999999864332


Q ss_pred             HHHHHHHh-c---C-CCCCC--CCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          307 GIFKEVLR-N---K-PDFRR--KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       307 ~~~~~i~~-~---~-~~~~~--~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ........ .   . .....  .....+++++.++|..||..||.+||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22211111 0   0 00000  001457899999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-44  Score=349.29  Aligned_cols=251  Identities=26%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEE----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-
Q 011380           95 DRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-  169 (487)
                      .++|++.+.||+|+||.||+|.    +..+|+.||+|++....  .....+.+.+|+.+++.+. ||||+++++++... 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            4569999999999999999998    56789999999987543  2234577899999999995 99999999999876 


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ..+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~  172 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIGDFGL  172 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC---CCCEEECcccc
Confidence             6789999999999999988554 356999999999999999999999999999999999999984   67899999999


Q ss_pred             ccccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCC--------------ChhHHH
Q 011380          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDK--------------TEDGIF  309 (487)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~--------------~~~~~~  309 (487)
                      +........    .....||+.|+|||++.+ .++.++|||||||++|+|++|..|+...              .....+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987654432    234678899999998865 4688999999999999999999886321              111122


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ........  .....+.+++++.+||.+||..||.+|||+.++++
T Consensus       253 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22222222  22223578999999999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.7e-45  Score=363.98  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=201.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEc---CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDK---ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ..+|.+.+.||+|+||.||+|+++   .++..||||++....  .....+.+.+|+.+++++. ||||+++++++...+.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            357999999999999999999876   467789999987542  3445678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRV  196 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-----
T ss_pred             eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCccccc
Confidence            99999999999999988543 45799999999999999999999999999999999999998   478899999999987


Q ss_pred             cCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          252 IKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       252 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ......    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |+.||...........+..+..   .....
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~  273 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPPM  273 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCCT
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCc
Confidence            643321    122345778999999865 57889999999999999998 9999998888877777765432   12224


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .++..+.++|.+||+.||.+||++.++++
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            67899999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-44  Score=345.11  Aligned_cols=250  Identities=22%  Similarity=0.282  Sum_probs=207.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++|.+.+.||+|+||+||+|.+..   ++..||+|++....  .....+.+.+|+.+++.+. ||||+++++++.+. .
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-S
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-C
Confidence            3579999999999999999998754   34469999987653  2445678899999999995 99999999998754 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY  162 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred             CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence            68999999999999988654 35689999999999999999999999999999999999998   467899999999987


Q ss_pred             cCCCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++ |+.||...........+.......   ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCC
Confidence            644321  234567889999999864 56889999999999999998 999998887777777666654321   22457


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ++.+.++|.+||..||.+|||+.+++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            8999999999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-44  Score=350.47  Aligned_cols=253  Identities=19%  Similarity=0.280  Sum_probs=203.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN-  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~-  170 (487)
                      .++|.+++.||+|+||.||+|.+..   +++.||+|++..... .....+.+.+|+.+++++. ||||+++++++.... 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence            3579999999999999999998765   556899999875532 3345677899999999995 999999999998654 


Q ss_pred             ----EEEEEEeccCCCCHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          171 ----YVYIAMELCEGGELLDRILAK----KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ----~~~lv~e~~~gg~L~~~l~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                          ..++||||+++|+|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEE
Confidence                359999999999999988542    335699999999999999999999999999999999999998   467899


Q ss_pred             EeecccccccCCCC---ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCC
Q 011380          243 ATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |+|||++.......   ......|++.|+|||++.+. ++.++||||||+++|+|++ |..||.+.........+..+..
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999997664332   12334678899999998654 6889999999999999999 9999988888888877776543


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .   ...+.+++++.++|.+||..||.+|||+.+++++
T Consensus       268 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 L---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             C---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   2235688999999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=356.22  Aligned_cols=252  Identities=21%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE----eCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE----DDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~----~~~  170 (487)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.+++.+. ||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCc
Confidence            357999999999999999999999999999999986532   345678899999999995 999999999986    345


Q ss_pred             EEEEEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ..|+||||+++|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEecCc
Confidence            789999999999999988653  346799999999999999999999999999999999999998   477899999998


Q ss_pred             ccccCCCC----------ccccccCCccccchhhhccC----CCCcchHHHHHHHHHHHHhCCCCCCCCC--hhHHHHHH
Q 011380          249 SDFIKPGK----------KFQDIVGSAYYVAPEVLKRK----SGPESDVWSIGVITYILLCGRRPFWDKT--EDGIFKEV  312 (487)
Q Consensus       249 a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i  312 (487)
                      +.......          ......||+.|+|||++.+.    ++.++|||||||++|+|++|+.||....  ...... .
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~  259 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-A  259 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-H
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-H
Confidence            86543211          11234679999999998643    4889999999999999999999995321  111222 2


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCc
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHP  356 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~  356 (487)
                      .....  .....+.+++++.++|.+||+.||.+|||+.+++++-
T Consensus       260 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          260 VQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            22222  2223357899999999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=365.51  Aligned_cols=258  Identities=21%  Similarity=0.229  Sum_probs=196.5

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcC---CCCEEEEEEecccCcCCh--------HhHHHHHHHHHHHHhccCCCCcc
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKA---NGDRVAVKKIEKNKMILP--------IAVEDVKREVKILQALAGHENVV  160 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~--------~~~~~~~~E~~~l~~l~~hpnIv  160 (487)
                      ....++|++++.||+|+||+||+|.+..   ++..+|+|++........        .....+.+|+.+++.+. ||||+
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~  111 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIP  111 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCcc
Confidence            3345789999999999999999999987   788999999876432100        01123567888888885 99999


Q ss_pred             EEEEEEEe----CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC
Q 011380          161 KFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       161 ~~~~~~~~----~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~  236 (487)
                      ++++++..    ...+|+||||+ |++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.. 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-  187 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-  187 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-
Confidence            99999987    78899999999 99999987443  379999999999999999999999999999999999999842 


Q ss_pred             CCCcEEEeecccccccCCCC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh-
Q 011380          237 EDSSLKATDFGLSDFIKPGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED-  306 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~-  306 (487)
                      ..+.+||+|||+++......        ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.... 
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            22489999999997653221        12456899999999998765 689999999999999999999999653222 


Q ss_pred             HHHHH----HHhcCCCCCCC--CCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          307 GIFKE----VLRNKPDFRRK--PWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       307 ~~~~~----i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .....    .....+.....  ....+++++.++|.+||..||++|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            11111    11111110000  01268899999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=353.73  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=203.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEE----EEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRV----AVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++|++.+.||+|+||+||+|.+..+|+.+    |+|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            467999999999999999999998888765    666554322  2335678899999999995 999999999998765


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                       .++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred             -ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence             78899999999999988654 35799999999999999999999999999999999999998   46789999999998


Q ss_pred             ccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          251 FIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       251 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+.......   ..+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  242 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPP  242 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCc
Confidence            7643322   233457889999999865 46889999999999999999 999998888877776666554222   224


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .++.++.++|.+||..||.+|||+.++++
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68899999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.2e-44  Score=343.31  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=210.1

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.....    ..+.+.+|+.+++++. ||||+++++++.. +..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCcE
Confidence            3468999999999999999999975 567899999876432    3467889999999995 9999999998874 4589


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCccccccc
Confidence            999999999999988544334699999999999999999999999999999999999998   57889999999998765


Q ss_pred             CCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ....  .....||+.|+|||++.+ .++.++||||||+++|+|++ |+.||.+....+....+..+...   .....+++
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  237 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPE  237 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccccH
Confidence            4322  234467889999999874 46889999999999999999 99999988887777777665322   22246889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.++|.+||..||++|||+.++++
T Consensus       238 ~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          238 ELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-44  Score=346.61  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=206.6

Q ss_pred             CCeeEee-eeeecCceEEEEEEE--cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGK-LLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+|.+.+ .||+|+||+||+|.+  ..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++ ..+.+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCCc
Confidence            5799988 999999999999954  56778999999876532 2344678899999999995 99999999999 56678


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+++++|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC---CCcEEEccCCcceee
Confidence            999999999999998854  356999999999999999999999999999999999999984   678999999999876


Q ss_pred             CCCCcc----ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKKF----QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ......    ....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+...   ...+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  244 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAG  244 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence            543321    22456789999999865 45889999999999999999 99999988887777766655422   12246


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +++++.++|.+||+.||.+|||+.++++
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-44  Score=351.12  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHh--ccCCCCccEEEEEEEe-
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFED-  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~hpnIv~~~~~~~~-  168 (487)
                      ..+.++|++.+.||+|+||+||+|.+  +|+.||||++...      ....+.+|.+++..  + +||||+++++++.. 
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS   74 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence            34667899999999999999999986  6899999998654      23556677777776  6 59999999998654 


Q ss_pred             ---CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeecCCCCceEeccCCC
Q 011380          169 ---DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--------LHGLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       169 ---~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH--------~~~iiHrDlkp~NIll~~~~~  237 (487)
                         ...+++||||+++|+|.+++.   ...+++..++.++.||+.||.|||        ++||+||||||+|||++   .
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~  148 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---K  148 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---T
T ss_pred             cCCCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---C
Confidence               356899999999999999882   357999999999999999999999        99999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCCc-----cccccCCccccchhhhccC-------CCCcchHHHHHHHHHHHHhC---------
Q 011380          238 DSSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCG---------  296 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~ell~g---------  296 (487)
                      ++.+||+|||++........     ....+||+.|+|||++.+.       ++.++|||||||++|+|++|         
T Consensus       149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~  228 (301)
T 3q4u_A          149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED  228 (301)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence            77899999999976544322     2345899999999998764       23689999999999999999         


Q ss_pred             -CCCCCCCCh----hHHHHHHHhcCCCCCCCCC----CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          297 -RRPFWDKTE----DGIFKEVLRNKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       297 -~~pf~~~~~----~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                       ..||.....    .................+.    ...++++.+||.+||+.||++|||+.++++
T Consensus       229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence             888865322    2333333322221111110    124567999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.3e-44  Score=349.60  Aligned_cols=254  Identities=20%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccE-EEEEEEeCCE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVK-FYNAFEDDNY  171 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~-~~~~~~~~~~  171 (487)
                      .+.++|++.+.||+|+||+||+|.+..+|+.||+|++.....     ...+.+|+.+++.+. |++++. +..++...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhc-CCCCCCeeeeecCCCCc
Confidence            456789999999999999999999999999999998765432     234678999999997 655554 5555578889


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            99999999 99999987543 45799999999999999999999999999999999999994333578899999999987


Q ss_pred             cCCCCc--------cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCC
Q 011380          252 IKPGKK--------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDF  319 (487)
Q Consensus       252 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~  319 (487)
                      ......        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   ..+..+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            654322        235689999999999876 4688999999999999999999999764332   2333332222111


Q ss_pred             C-CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          320 R-RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       320 ~-~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      + ....+.+|+++.++|.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            1 1112457899999999999999999999999876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-45  Score=360.41  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ....++|++.+.||+|+||+||+|.+ .+|+.||+|++....   ....+.+.+|+.+++.+. ||||+++++++...+.
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTC
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCe
Confidence            34557899999999999999999996 468999999886543   235678899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          172 VYIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +++||||+++|+|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence            999999999999998874432  23589999999999999999999999999999999999998   5789999999999


Q ss_pred             cccCCC---CccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHH-----HHhcCCCCC
Q 011380          250 DFIKPG---KKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE-----VLRNKPDFR  320 (487)
Q Consensus       250 ~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~~~  320 (487)
                      ......   .......||+.|+|||++. +.++.++|||||||++|+|++|+.||...........     .......+.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            764322   1223456899999999885 4579999999999999999999999976543221100     001111111


Q ss_pred             --------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          321 --------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       321 --------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                              ....+..+..+.+++.+||+.||++|||+.+++++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                    1111234567899999999999999999999997653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=351.83  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCC----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ...+|.+.+.||+|+||+||+|.+..++    ..||+|++....  .......+.+|+.+++++. ||||+++++++...
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            3467999999999999999999987653    359999987543  2345567889999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS  194 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC-
T ss_pred             CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECCCCcc
Confidence            9999999999999999988543 46799999999999999999999999999999999999998   4788999999999


Q ss_pred             cccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          250 DFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       250 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      ........    .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+....+..+...   ..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~  271 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PT  271 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CC
Confidence            77643221    123456889999999865 46889999999999999998 99999988888777777665321   22


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ...++..+.++|.+||+.||.+||++.+++++
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34688999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-44  Score=352.96  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=205.7

Q ss_pred             CCeeEeeeeeecCceEEEEEE----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE--eC
Q 011380           96 RRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE--DD  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~  169 (487)
                      ++|++.+.||+|+||.||+|.    +..+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++.  +.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCC
Confidence            579999999999999999998    46789999999987643   345677899999999995 999999999886  56


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccc
Q 011380          170 NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS  249 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a  249 (487)
                      +.+|+||||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA  174 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence            77999999999999999886543 4699999999999999999999999999999999999998   4778999999999


Q ss_pred             cccCCCCc----cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh--------------HHHH
Q 011380          250 DFIKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED--------------GIFK  310 (487)
Q Consensus       250 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~--------------~~~~  310 (487)
                      ........    .....||+.|+|||++.+. ++.++|||||||++|+|++|..||......              ....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87654332    2345688999999998664 588999999999999999999998544321              1112


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .......  .....+.+++++.+||.+||..||.+|||+.++++
T Consensus       255 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          255 ELLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2222222  12223578999999999999999999999999964

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=356.21  Aligned_cols=250  Identities=24%  Similarity=0.444  Sum_probs=188.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE-------
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-------  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-------  167 (487)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.+++++.+||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            347999999999999999999999999999999986543   3456778899999999967999999999984       


Q ss_pred             -eCCEEEEEEeccCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEE
Q 011380          168 -DDNYVYIAMELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKA  243 (487)
Q Consensus       168 -~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl  243 (487)
                       ....+++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.|  |+||||||+|||++   .++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEEE
Confidence             4456899999995 6898888542 3456999999999999999999999999  99999999999998   4678999


Q ss_pred             eecccccccCCCCcc-------------ccccCCccccchhhhc----cCCCCcchHHHHHHHHHHHHhCCCCCCCCChh
Q 011380          244 TDFGLSDFIKPGKKF-------------QDIVGSAYYVAPEVLK----RKSGPESDVWSIGVITYILLCGRRPFWDKTED  306 (487)
Q Consensus       244 ~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  306 (487)
                      +|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876533221             1456999999999983    23578999999999999999999999765443


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          307 GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       307 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                      ...    ....  ........+..+.+||.+||+.||.+|||+.+++++-+
T Consensus       260 ~~~----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 RIV----NGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Hhh----cCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            322    2221  12223456788999999999999999999999998765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-44  Score=352.46  Aligned_cols=252  Identities=26%  Similarity=0.345  Sum_probs=203.7

Q ss_pred             cccCCCe-eEeeeeeecCceEEEEEEE----cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 011380           92 KDFDRRY-TIGKLLGHGQFGYTYVATD----KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF  166 (487)
Q Consensus        92 ~~~~~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  166 (487)
                      ..+..+| ++++.||+|+||+||++..    ..+|+.||+|++....  .....+.+.+|+.+++++. ||||+++++++
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~  102 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCC  102 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEE
Confidence            3455566 9999999999999988754    4578899999997653  3455678899999999996 99999999999


Q ss_pred             Ee--CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          167 ED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       167 ~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                      .+  ...+++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.||+||||||+|||++   .++.+||+
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~  176 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIG  176 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEEC
Confidence            87  4689999999999999998843   3599999999999999999999999999999999999998   47889999


Q ss_pred             ecccccccCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-------------
Q 011380          245 DFGLSDFIKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED-------------  306 (487)
Q Consensus       245 DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------------  306 (487)
                      |||++........    .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......             
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  256 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT  256 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence            9999987654432    234568899999999876 4688999999999999999999998653221             


Q ss_pred             -HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          307 -GIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       307 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                       ............  ......+++++.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          257 VLRLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             011222222221  2223568899999999999999999999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-44  Score=347.60  Aligned_cols=252  Identities=22%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-CCC--EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-NGD--RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++|++.+.||+|+||+||+|.+.. +++  .||+|++...........+.+.+|+.+++++. ||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            3579999999999999999998643 333  68999987654444456788999999999995 999999999998765 


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA  170 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred             ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence            889999999999999886543 5689999999999999999999999999999999999998   467899999999987


Q ss_pred             cCCCCc----cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          252 IKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       252 ~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ......    .....||+.|+|||++.+. ++.++||||||+++|+|++ |..||.+.........+........  ...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  248 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPE  248 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCc
Confidence            654332    2235678899999998654 5889999999999999999 9999999888888888776654333  235


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .++.++.++|.+||..||.+|||+.++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            68999999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.5e-44  Score=344.76  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-CEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD-NYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~l  174 (487)
                      ++|++.+.||+|+||+||+|.+  +|+.||+|++....     ..+.+.+|+.+++++. ||||+++++++... +.+|+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceEE
Confidence            5799999999999999999986  48899999987543     3467889999999995 99999999987544 57899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccccccc
Confidence            99999999999998665434489999999999999999999999999999999999998   477899999999876543


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .  .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+..   ......+++.+.
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  244 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVY  244 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHH
Confidence            2  234468899999999865 46889999999999999998 9999988877777766655432   223356899999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++|.+||..||.+|||+.++++
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-44  Score=367.91  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=209.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.+|+++. ||||+++++++.+ +.+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence            34679999999999999999999864 46799999976542    3467899999999995 9999999999876 6789


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceecC
Confidence            999999999999998655456799999999999999999999999999999999999998   46789999999998764


Q ss_pred             CCC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...  ......+++.|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+....+..+...   ...+.+|+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  408 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPE  408 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            322  1233457889999998864 57899999999999999999 99999988888888777665322   22246889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc--Cccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~--h~~~~~  360 (487)
                      .+.+||.+||..||++|||+.++++  ..++..
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999999999999999987  455543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-43  Score=343.94  Aligned_cols=249  Identities=22%  Similarity=0.267  Sum_probs=205.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC---CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEE-EeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAF-EDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~~~~~  171 (487)
                      .+|++.+.||+|+||+||+|.+..++   ..+|+|.+....  .....+.+.+|+.+++++. ||||+++++++ ..++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCc
Confidence            46999999999999999999975433   358999887532  3445678899999999995 99999999985 45678


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       102 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD  177 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCGGGCC
T ss_pred             eEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccccccc
Confidence            8999999999999998854 345689999999999999999999999999999999999998   577899999999976


Q ss_pred             cCCCC-----ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          252 IKPGK-----KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       252 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .....     ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.........+..+......   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence            54322     2234567889999999865 46889999999999999999 66777777766677667665543322   


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+++.+.++|.+||..||.+|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            457899999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-44  Score=349.33  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=204.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCc-CChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-ILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .|..++.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence            355678999999999999975  688999999865432 22345678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          176 MELCEGGELLDRILAK-KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGLARASEK  185 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeeccccccccc
Confidence            9999999999988643 235699999999999999999999999999999999999998   577999999999876543


Q ss_pred             CCc---cccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHH----HHHHHhcCCCC-------C
Q 011380          255 GKK---FQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGI----FKEVLRNKPDF-------R  320 (487)
Q Consensus       255 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~-------~  320 (487)
                      ...   .....||+.|+|||++.+.++.++||||||+++|+|++|..||........    ...+......+       .
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            221   234679999999999988889999999999999999999999976544322    22222211110       0


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ....+..+..+.+++.+||..||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11112345678999999999999999999999863

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=340.58  Aligned_cols=248  Identities=22%  Similarity=0.263  Sum_probs=204.5

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE-
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV-  172 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~-  172 (487)
                      .|.+.+.||+|+||+||+|.+..+++   .||+|++....  .....+.+.+|+.+++.+. ||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCc
Confidence            57888999999999999999766555   79999987532  3445678899999999995 99999999999866554 


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTTSSCTT
T ss_pred             EEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCCCcccc
Confidence            999999999999998854 346789999999999999999999999999999999999998   5778999999999755


Q ss_pred             CCC-----CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          253 KPG-----KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP-FWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       253 ~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ...     .......||+.|+|||.+.+ .++.++|||||||++|+|++|..| |...........+.......   ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~  251 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPE  251 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCc
Confidence            332     22334578999999999876 468899999999999999995555 55555555555555543221   224


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++.+.++|.+||..||.+|||+.++++
T Consensus       252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            57899999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-45  Score=387.85  Aligned_cols=263  Identities=24%  Similarity=0.386  Sum_probs=211.4

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe------
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------  168 (487)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....  .....+.+.+|+.+++++. ||||+++++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccC
Confidence            367999999999999999999999999999999986542  3456678899999999995 9999999998765      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK-DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      .+..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++..+....+||+|||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            677899999999999999886532 2368999999999999999999999999999999999999965445569999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHH--------------H
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE--------------V  312 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--------------i  312 (487)
                      ++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..              .
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            9988776666667889999999999875 568999999999999999999999976533221100              0


Q ss_pred             HhcCCCCCC------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          313 LRNKPDFRR------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       313 ~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                      ..+...+..      ...+.+++.+.+||.+||..||++|||+.++|+||||+.
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            111111111      112236788999999999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=344.16  Aligned_cols=241  Identities=27%  Similarity=0.418  Sum_probs=193.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++...     ...+.+.+|+.+++++. ||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEE
Confidence            47999999999999999999864  789999998643     24577899999999995 9999999998774  47899


Q ss_pred             EeccCCCCHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCceeecCCCCceEeccCCCCC-cEEEeeccccc
Q 011380          176 MELCEGGELLDRILAKKD-SRYTEKDAAVVVRQMLRVAAECHL---HGLVHRDMKPENFLFKSAKEDS-SLKATDFGLSD  250 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~iiHrDlkp~NIll~~~~~~~-~vkl~DfG~a~  250 (487)
                      |||++||+|.+++..... ..+++..++.++.||+.||.|||+   +||+||||||+|||++.   ++ .+||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA---GGTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET---TTTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC---CCCEEEEccccccc
Confidence            999999999998854422 247899999999999999999999   89999999999999984   44 48999999997


Q ss_pred             ccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCCC
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED--GIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......  .....+..+..   ....+.+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence            65432  334579999999999876 4689999999999999999999999754332  23333333321   2223568


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3e-44  Score=352.36  Aligned_cols=260  Identities=19%  Similarity=0.251  Sum_probs=204.4

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ...++|++.+.||+|+||+||+|.+ .+|+.||+|++......  .....+.+|+.+++.+. ||||+++++++...+..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhcc-CCCccceEEEEecCCce
Confidence            3456899999999999999999975 46899999998764321  12236789999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          173 YIAMELCEGGELLDRILAKK--DSRYTEKDAAVVVRQMLRVAAECHLH---GLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      ++||||+++|+|.+++....  ...+++..+..++.||+.||.|||++   ||+||||||+|||++   .++.+||+|||
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg  179 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFG  179 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECCCS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEeccCc
Confidence            99999999999999886543  23499999999999999999999999   999999999999998   57789999999


Q ss_pred             cccccCCCC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCC----CChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWD----KTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~----~~~~~~~~~i~~~~~~~~  320 (487)
                      ++.......  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..    ..................
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK  259 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred             cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence            998764322  2344669999999999854 468899999999999999999999952    111111222222111000


Q ss_pred             -----------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          321 -----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       321 -----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                                 ....+..+..+.+++.+||+.||.+|||+.++++|-+-.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                       000112336789999999999999999999999987643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.8e-44  Score=366.35  Aligned_cols=255  Identities=18%  Similarity=0.281  Sum_probs=207.8

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++......     ..+.+|+++++.|..|++|+.+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4567899999999999999999999999999999988654422     34678999999997567788888888889999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      +|||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.....+.+||+|||++...
T Consensus        79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999999 89999988543 457999999999999999999999999999999999999953335789999999999876


Q ss_pred             CCCCc--------cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhcCCCCC
Q 011380          253 KPGKK--------FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTE---DGIFKEVLRNKPDFR  320 (487)
Q Consensus       253 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~  320 (487)
                      .....        ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+...   ...+..+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            54322        225789999999999876 468899999999999999999999977543   233333332211111


Q ss_pred             -CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          321 -RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       321 -~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                       ......++.++.+||.+||..||.+||++.++++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             1112457899999999999999999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=356.38  Aligned_cols=250  Identities=22%  Similarity=0.256  Sum_probs=198.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC---CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEE-eCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFE-DDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~~  171 (487)
                      ..|++.+.||+|+||+||+|.+..++   ..||+|.+....  .....+.+.+|+.+++++. ||||+++++++. ..+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence            35889999999999999999876433   468999886432  3446678999999999995 999999999864 4568


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       166 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARD  241 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-----
T ss_pred             eEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeecccccc
Confidence            8999999999999998854 345689999999999999999999999999999999999998   477899999999976


Q ss_pred             cCCCC-----ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          252 IKPGK-----KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       252 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      .....     ......||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+....+..+.....   .
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p  318 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P  318 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---C
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            54322     1233567889999999865 46889999999999999999 7888877776666666666543222   2


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +.+++.+.++|.+||..||++|||+.+++++
T Consensus       319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4578999999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=355.97  Aligned_cols=249  Identities=21%  Similarity=0.267  Sum_probs=198.7

Q ss_pred             CCCeeEeeeeeecCceEEEEE-----EEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccC--CCCccEEEEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVA-----TDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG--HENVVKFYNAFE  167 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~--hpnIv~~~~~~~  167 (487)
                      .++|.+.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|+.+++.+..  ||||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            467999999999999999999     467789999999987542      3567788888888742  899999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc--------CC
Q 011380          168 DDNYVYIAMELCEGGELLDRILAK---KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS--------AK  236 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~--------~~  236 (487)
                      ..+..|+|||||+||+|.+++...   ....+++..++.++.||+.||.|||++||+||||||+|||++.        ..
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            999999999999999999998643   3457999999999999999999999999999999999999984        12


Q ss_pred             CCCcEEEeecccccccC---CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 011380          237 EDSSLKATDFGLSDFIK---PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV  312 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  312 (487)
                      .++.+||+|||++....   ........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence            26899999999996543   33345667899999999998765 69999999999999999999999965432110    


Q ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcc
Q 011380          313 LRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPW  357 (487)
Q Consensus       313 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~  357 (487)
                       .....+..   ...++.+.+++.+||+.+|.+|++..+.|.+.+
T Consensus       294 -~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          294 -KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             -EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             -eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence             00111111   124677999999999999999976665555443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=370.09  Aligned_cols=254  Identities=25%  Similarity=0.354  Sum_probs=213.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.+|++|. ||||+++++++.+ +.+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccce
Confidence            34679999999999999999999864 46799999976542    3467899999999995 9999999999876 6789


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceecC
Confidence            999999999999998655456799999999999999999999999999999999999998   46789999999997654


Q ss_pred             CCC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          254 PGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       254 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      ...  ......++..|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+.+..+..+..   ....+.++.
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~  491 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPE  491 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence            321  1223457789999998864 57899999999999999999 9999998888888877766532   122346889


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc--Cccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS--HPWVRE  360 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~--h~~~~~  360 (487)
                      ++.+||.+||..||++|||+.++++  ..+|..
T Consensus       492 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999999999999999987  345543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.7e-45  Score=359.74  Aligned_cols=250  Identities=17%  Similarity=0.217  Sum_probs=198.4

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-----ChHhHHHHHHHHHHHHhcc--------CCCCccEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----LPIAVEDVKREVKILQALA--------GHENVVKF  162 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~hpnIv~~  162 (487)
                      ++|++++.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+++.+.        +||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999987  6899999999765421     2234577889999999985        48888888


Q ss_pred             EEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 011380          163 YNAFE------------------------------DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA  212 (487)
Q Consensus       163 ~~~~~------------------------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l  212 (487)
                      .+++.                              +.+.+|||||||++|++++.+..   ..+++..++.++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            88753                              26789999999999988777632   5689999999999999999


Q ss_pred             HHHH-HcCceeecCCCCceEeccCC-----------------CCCcEEEeecccccccCCCCccccccCCccccchhhhc
Q 011380          213 AECH-LHGLVHRDMKPENFLFKSAK-----------------EDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK  274 (487)
Q Consensus       213 ~~lH-~~~iiHrDlkp~NIll~~~~-----------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  274 (487)
                      .||| ++||+||||||+|||++..+                 ....+||+|||+|+.....    ..+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999532                 1128999999999876532    458999999999998


Q ss_pred             cCCCCcchHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHHHHhcCCC---CCCCCCCCCCHHHHHHHHHccccCccCCcCH
Q 011380          275 RKSGPESDVWSIGVI-TYILLCGRRPFWDKTE-DGIFKEVLRNKPD---FRRKPWPSISNSAKDFVKKLLVKDPRARLTA  349 (487)
Q Consensus       275 ~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~  349 (487)
                      +..+.++||||||++ .+++++|..||.+... ......+......   .....++.+|+++++||++||++|     |+
T Consensus       251 g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa  325 (336)
T 2vuw_A          251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SA  325 (336)
T ss_dssp             CCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SH
T ss_pred             CCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CH
Confidence            888889999998777 7788899999843211 1122333322111   111113357889999999999976     99


Q ss_pred             HHHh-cCcccc
Q 011380          350 AQAL-SHPWVR  359 (487)
Q Consensus       350 ~e~L-~h~~~~  359 (487)
                      .|+| +||||+
T Consensus       326 ~e~l~~Hp~f~  336 (336)
T 2vuw_A          326 TDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHCGGGC
T ss_pred             HHHHhcCCCcC
Confidence            9999 999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-43  Score=372.15  Aligned_cols=243  Identities=22%  Similarity=0.278  Sum_probs=202.8

Q ss_pred             eeeeeecCceEEEEEEE--cCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEec
Q 011380          101 GKLLGHGQFGYTYVATD--KANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      .+.||+|+||+||+|.+  +.+++.||||++.... ......+.+.+|+.+|+++. |||||++++++..+ .+++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-CEEEEEEc
Confidence            34899999999999955  4567899999987643 23345678999999999995 99999999999754 58899999


Q ss_pred             cCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc-
Q 011380          179 CEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-  257 (487)
Q Consensus       179 ~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~-  257 (487)
                      +++|+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++....... 
T Consensus       451 ~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          451 AELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC----
T ss_pred             cCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCccc
Confidence            999999999854  46799999999999999999999999999999999999998   467899999999987654322 


Q ss_pred             ---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          258 ---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       258 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                         .....||+.|+|||++.+ .++.++|||||||++|+|++ |+.||.+....+....+..+....   ....+++++.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  602 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMY  602 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHH
Confidence               223457889999999875 57899999999999999998 999999988888887777664322   2246889999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +||.+||..||++|||+.++++
T Consensus       603 ~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          603 DLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-43  Score=344.28  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=194.9

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc-CCCCccEEEEEEEeC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-GHENVVKFYNAFEDD  169 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~~~  169 (487)
                      ...+.++|++.+.||+|+||.||+|++.  |+.||||++....      .....+|.+++..+. +||||+++++++...
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3456678999999999999999999875  8999999986432      234455666655441 599999999999887


Q ss_pred             ----CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CceeecCCCCceEeccCCC
Q 011380          170 ----NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------GLVHRDMKPENFLFKSAKE  237 (487)
Q Consensus       170 ----~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--------~iiHrDlkp~NIll~~~~~  237 (487)
                          ..+|+||||+++|+|.+++..   ..+++..++.++.|++.||.|||++        ||+||||||+|||++   .
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~  177 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---K  177 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---T
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---C
Confidence                789999999999999998843   3689999999999999999999999        999999999999998   4


Q ss_pred             CCcEEEeecccccccCCCCc-----cccccCCccccchhhhccCC-CC------cchHHHHHHHHHHHHhC---------
Q 011380          238 DSSLKATDFGLSDFIKPGKK-----FQDIVGSAYYVAPEVLKRKS-GP------ESDVWSIGVITYILLCG---------  296 (487)
Q Consensus       238 ~~~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~------~~DiwSlG~il~ell~g---------  296 (487)
                      ++.+||+|||++........     ....+||+.|+|||++.+.. +.      ++|||||||++|+|++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            77899999999976543322     13468999999999987653 33      38999999999999999         


Q ss_pred             -CCCCCCCCh----hHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          297 -RRPFWDKTE----DGIFKEVLRNKPDFRRKP----WPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       297 -~~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                       ..||.....    .................+    ...+++++.+||.+||+.||.+|||+.+++++
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence             777754321    222333332211111111    01355679999999999999999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-44  Score=363.47  Aligned_cols=250  Identities=20%  Similarity=0.208  Sum_probs=194.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCc---------------
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENV---------------  159 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnI---------------  159 (487)
                      ..|.+++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +|+               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            35888999999999999999999999999999987544333344677899999999885 5 321               


Q ss_pred             ------cEEEEEEEe-----CCEEEEEEeccCCCCHHHHHH-----hhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceee
Q 011380          160 ------VKFYNAFED-----DNYVYIAMELCEGGELLDRIL-----AKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHR  223 (487)
Q Consensus       160 ------v~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~-----~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHr  223 (487)
                            ..+..++..     ...++++|+++ +++|.+++.     ......+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  111122221     22467788876 679988774     2223457788999999999999999999999999


Q ss_pred             cCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccccchhhhc----------c-CCCCcchHHHHHHHHHH
Q 011380          224 DMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK----------R-KSGPESDVWSIGVITYI  292 (487)
Q Consensus       224 Dlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~----------~-~~~~~~DiwSlG~il~e  292 (487)
                      ||||+|||++   .++.+||+|||+++.....  ....+| +.|+|||++.          + .++.++|||||||++|+
T Consensus       236 DiKp~NILl~---~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLD---QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEEC---TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEe---cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999998   4677999999998765432  456688 9999999983          2 25779999999999999


Q ss_pred             HHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          293 LLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       293 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |++|+.||...........++.        .++.+|+++.+||.+||..||++|||+.++++||||+..
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999999987665443333322        234688999999999999999999999999999999763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=369.84  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=206.8

Q ss_pred             CCeeEee-eeeecCceEEEEEEEcC--CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGK-LLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~-~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      +.+.+.+ .||+|+||.||+|.++.  ++..||||++....  .....+.+.+|+++|+++. |||||++++++.. +.+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCe
Confidence            3455655 89999999999998763  55679999997643  2335678999999999995 9999999999986 458


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||||++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence            999999999999998843 345699999999999999999999999999999999999998   4778999999999876


Q ss_pred             CCCCc----cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKK----FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....    .....+|+.|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+..+...   ...+.
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence            43322    12234568999999986 457899999999999999998 99999998888888877766432   22246


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHh---cCcccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQAL---SHPWVR  359 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L---~h~~~~  359 (487)
                      +++++.+||.+||..||.+|||+.+++   ++.|+.
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            889999999999999999999999975   454443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-43  Score=342.85  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEE----EcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVAT----DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .++|++++.||+|+||.||+|.    +..+|+.||+|++....   ....+.+.+|+.+++++. ||||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence            4579999999999999999998    45689999999987642   345678899999999995 999999999987544


Q ss_pred             --EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 --YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                        .+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence              789999999999999988654 35699999999999999999999999999999999999998   467899999999


Q ss_pred             ccccCCCCc----cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCCh------------hH---H
Q 011380          249 SDFIKPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTE------------DG---I  308 (487)
Q Consensus       249 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~------------~~---~  308 (487)
                      +........    .....|++.|+|||++.+. ++.++|||||||++|+|++|..||.....            ..   .
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            987654332    2234678889999998654 68899999999999999999999853211            00   1


Q ss_pred             HHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          309 FKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       309 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +...+......  ...+.+++++.++|.+||..||.+|||+.++++
T Consensus       272 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          272 LIELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhcCCCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11222222211  223568899999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=347.05  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=189.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHH--HHhccCCCCccEEEEEEEe-----
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI--LQALAGHENVVKFYNAFED-----  168 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~--l~~l~~hpnIv~~~~~~~~-----  168 (487)
                      ++|++++.||+|+||.||+|++  +|+.||||++....      ...+..|.++  +..+ +||||+++++.+..     
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccCC
Confidence            5799999999999999999975  68999999986542      2334444444  4446 59999999986542     


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CceeecCCCCceEeccCCCCC
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---------GLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---------~iiHrDlkp~NIll~~~~~~~  239 (487)
                      ...+|+||||+++|+|.+++...   ..++..++.++.||+.||.|||+.         ||+||||||+|||++   .++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~~  157 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---NDG  157 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TTS
T ss_pred             CceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CCC
Confidence            34689999999999999988543   458999999999999999999999         999999999999998   467


Q ss_pred             cEEEeecccccccCCCC---------ccccccCCccccchhhhcc--------CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 011380          240 SLKATDFGLSDFIKPGK---------KFQDIVGSAYYVAPEVLKR--------KSGPESDVWSIGVITYILLCGRRPFWD  302 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlG~il~ell~g~~pf~~  302 (487)
                      .+||+|||++.......         .....+||+.|+|||++.+        .++.++|||||||++|+|++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            89999999997654321         2234579999999999875        345789999999999999999777643


Q ss_pred             CCh-----------------hHHHHHHHhcC---CCCCCCCCC---CCCHHHHHHHHHccccCccCCcCHHHH------h
Q 011380          303 KTE-----------------DGIFKEVLRNK---PDFRRKPWP---SISNSAKDFVKKLLVKDPRARLTAAQA------L  353 (487)
Q Consensus       303 ~~~-----------------~~~~~~i~~~~---~~~~~~~~~---~~s~~~~~li~~~L~~dp~~Rpt~~e~------L  353 (487)
                      ...                 ...........   +.++ ..|+   ..++++.+||.+||..||++|||+.|+      +
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC-cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            321                 11111112111   1111 1111   244579999999999999999999999      4


Q ss_pred             cCccccccC
Q 011380          354 SHPWVREGG  362 (487)
Q Consensus       354 ~h~~~~~~~  362 (487)
                      -++|-++..
T Consensus       317 l~~~~~~~~  325 (336)
T 3g2f_A          317 MMIWERNKS  325 (336)
T ss_dssp             HHCCCC---
T ss_pred             HHHHHhccc
Confidence            477766543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.7e-43  Score=343.77  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=201.2

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHh--ccCCCCccEEEEEEEe
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA--LAGHENVVKFYNAFED  168 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~hpnIv~~~~~~~~  168 (487)
                      ...+.++|++.+.||+|+||.||+|.+  +|+.||||++...      ....+.+|++++..  + +||||+++++++..
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEEC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeecc
Confidence            344567899999999999999999987  5899999998643      33567789999988  5 59999999999987


Q ss_pred             CC----EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCceeecCCCCceEeccCC
Q 011380          169 DN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH--------LHGLVHRDMKPENFLFKSAK  236 (487)
Q Consensus       169 ~~----~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH--------~~~iiHrDlkp~NIll~~~~  236 (487)
                      ..    .+|+||||+++|+|.+++..   ..+++..++.++.||+.||.|||        +.||+||||||+|||++   
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---  181 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---  181 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---
Confidence            76    89999999999999998854   36899999999999999999999        89999999999999998   


Q ss_pred             CCCcEEEeecccccccCCCC-----ccccccCCccccchhhhccCC-------CCcchHHHHHHHHHHHHhC--------
Q 011380          237 EDSSLKATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRKS-------GPESDVWSIGVITYILLCG--------  296 (487)
Q Consensus       237 ~~~~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~DiwSlG~il~ell~g--------  296 (487)
                      .++.+||+|||++.......     ......||+.|+|||++.+..       +.++|||||||++|+|++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            46789999999997765433     234568999999999987643       2579999999999999999        


Q ss_pred             --CCCCCCCCh-----hHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          297 --RRPFWDKTE-----DGIFKEVLRNKPDFRRK-PW--PSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       297 --~~pf~~~~~-----~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                        ..||.....     ......+.......... .+  ...++.+.+||.+||+.||++|||+.++++|
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence              789866432     22333332222111111 01  1233578999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=345.09  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=204.5

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||.||+|.+..   .+|+|++...... ....+.+.+|+.+++++. ||||+++++++.+.+.+++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence            4679999999999999999998753   4999998754321 223345678999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||++|++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             ECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----
T ss_pred             EeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccccc
Confidence            9999999999988743 234699999999999999999999999999999999999997    46899999999865431


Q ss_pred             ------CCccccccCCccccchhhhcc----------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 011380          255 ------GKKFQDIVGSAYYVAPEVLKR----------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPD  318 (487)
Q Consensus       255 ------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  318 (487)
                            ........||+.|+|||++.+          .++.++|||||||++|+|++|..||...........+..+...
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence                  122334569999999999864          3577899999999999999999999988888777777665432


Q ss_pred             CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       319 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..  ....++.++.++|.+||..||.+|||+.++++
T Consensus       262 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          262 NL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22  22357889999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.4e-42  Score=364.10  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=208.2

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC---CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN---GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .++|++++.||+|+||+||+|.+..+   +..||+|++....  .....+.+.+|+.+++++. ||||+++++++. ++.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cCc
Confidence            46799999999999999999998654   4579999886532  3445678899999999995 999999999985 456


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY  540 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCS
T ss_pred             eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCee
Confidence            89999999999999988543 35689999999999999999999999999999999999998   467899999999987


Q ss_pred             cCCCCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+....   ..+.+
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~  617 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC  617 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence            654332  223457889999999865 46889999999999999997 999999988888888877764322   23568


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.+.++|.+||..||.+|||+.++++
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            899999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-42  Score=333.13  Aligned_cols=228  Identities=15%  Similarity=0.134  Sum_probs=189.5

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++.++. ||||+++++++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            46678999999999999999999999999999999998765555566688999999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+||||++|++|.+++..    ......+..++.||+.||.|||++||+||||||+|||++   .++.+||+++|     
T Consensus       107 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~-----  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA-----  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC-----
T ss_pred             EEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc-----
Confidence            999999999999998722    246667899999999999999999999999999999998   47789998544     


Q ss_pred             CCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHH---HHHhcCCCCCCCCCCCCCH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFK---EVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~  329 (487)
                                    |++|      ++.++|||||||++|+|++|+.||.+......+.   ..............+.+++
T Consensus       175 --------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T 3uqc_A          175 --------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF  234 (286)
T ss_dssp             --------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred             --------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence                          3333      5789999999999999999999998765432110   1111111111122356899


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ++.++|.+||+.||.+| |+.++++
T Consensus       235 ~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          235 QISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHHHHHcccCCccC-CHHHHHH
Confidence            99999999999999999 9999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-43  Score=376.94  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=204.0

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcC-CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKA-NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      ...+.++|++.+.||+|+||+||+|.+.. +|+.||||++....  .......+.+|+.+++++. ||||+++++++...
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            34566899999999999999999999976 78999999886532  3445677889999999995 99999999999876


Q ss_pred             CE-----EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEe
Q 011380          170 NY-----VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT  244 (487)
Q Consensus       170 ~~-----~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~  244 (487)
                      +.     .||||||++|++|.+++.    ..+++..++.++.||+.||.|||++||+||||||+|||++.    +.+||+
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~  223 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLI  223 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEEC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEE
Confidence            55     799999999999988662    26999999999999999999999999999999999999983    379999


Q ss_pred             ecccccccCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          245 DFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       245 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |||++......   ...+||+.|+|||++.+.++.++|||||||++|+|++|..||.+......        +  .....
T Consensus       224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~--~~~~~  290 (681)
T 2pzi_A          224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------P--EDDPV  290 (681)
T ss_dssp             CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------C--TTCHH
T ss_pred             ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc--------c--ccccc
Confidence            99999876543   45689999999999988888999999999999999999999865321100        0  01111


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ...++.+.++|.+||..||.+||++.+++.|+|+.
T Consensus       291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            12467899999999999999999999999999875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.6e-36  Score=317.65  Aligned_cols=232  Identities=15%  Similarity=0.086  Sum_probs=159.7

Q ss_pred             eeeecCceEEEEEEEcCCCCEEEEEEecccCcCC-------hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380          103 LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL-------PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus       103 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      .++.|++|.+..++....|+.||+|++.+.....       ....+.+.+|+++|+++..|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3567777877777777789999999997653221       234567999999999997799999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||++|++|.+.|..  .+.+++.   .|+.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccCeeCCCC
Confidence            999999999999954  3567664   4789999999999999999999999999998   5788999999999876543


Q ss_pred             -CccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 -KKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..|+        ...+. ..+.        ....+..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~-~~~~--------~~~~~~~l  455 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVW-QEPV--------ERWNFVLL  455 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHH-TSCG--------GGCSHHHH
T ss_pred             CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhh-cCCC--------CCCcHHHH
Confidence             334567899999999999999989999999999998887664443        11111 1111        01125667


Q ss_pred             HHHccccCccCCcCHHHHhcCcccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ...++..+|..||.......++|..
T Consensus       456 ~~~l~~~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          456 LALFEKKAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             HHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCChhhhccchhHH
Confidence            7777778888888776666666654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.9e-29  Score=262.75  Aligned_cols=184  Identities=18%  Similarity=0.162  Sum_probs=143.2

Q ss_pred             eEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH-----hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           99 TIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI-----AVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        99 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ...+.||+|+||+||+|  ...++.+++|+........+.     ..+.+.+|+++++++. ||||+++..++...+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            44678999999999999  456889999987554332221     2455799999999995 999995555555667779


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||||++|++|.+++..          +..++.||+.||.|||++||+||||||+|||++.     .+||+|||+++...
T Consensus       416 lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~  480 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECC
Confidence            99999999999998732          6689999999999999999999999999999982     89999999998875


Q ss_pred             CCCc--------cccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCC
Q 011380          254 PGKK--------FQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPF  300 (487)
Q Consensus       254 ~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf  300 (487)
                      ....        ....+||+.|||||++..   .|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            4322        135789999999999864   4677889999998888888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=5.8e-26  Score=217.13  Aligned_cols=159  Identities=25%  Similarity=0.280  Sum_probs=122.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh---------------HhHHHHHHHHHHHHhccCCCCcc
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP---------------IAVEDVKREVKILQALAGHENVV  160 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~---------------~~~~~~~~E~~~l~~l~~hpnIv  160 (487)
                      ..|.+++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++++. |++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~  167 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP  167 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC
Confidence            3466779999999999999999 8899999999864321110               23567889999999996 55555


Q ss_pred             EEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCc
Q 011380          161 KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSS  240 (487)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  240 (487)
                      .++   .. +..|+||||++||+|.+ +  .      ......++.||+.||.|||++||+||||||+|||++    ++.
T Consensus       168 ~~~---~~-~~~~lvmE~~~g~~L~~-l--~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~  230 (282)
T 1zar_A          168 KVY---AW-EGNAVLMELIDAKELYR-V--R------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEG  230 (282)
T ss_dssp             CEE---EE-ETTEEEEECCCCEEGGG-C--C------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTE
T ss_pred             eEE---ec-cceEEEEEecCCCcHHH-c--c------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCc
Confidence            543   33 44699999999999977 3  1      123557999999999999999999999999999998    578


Q ss_pred             EEEeecccccccCCCCccccccCCccccchhhhcc-----------CCCCcchHHH
Q 011380          241 LKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-----------KSGPESDVWS  285 (487)
Q Consensus       241 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~DiwS  285 (487)
                      +||+|||++..            +..|+|||.+.+           .++..+|+|.
T Consensus       231 vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          231 IWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999999853            445789998742           3455566665

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=5.7e-22  Score=187.11  Aligned_cols=141  Identities=16%  Similarity=0.176  Sum_probs=108.4

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCE--EEEEEecccCcCC---------------------hHhHHHHHHHHHHHHhc
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMIL---------------------PIAVEDVKREVKILQAL  153 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~---------------------~~~~~~~~~E~~~l~~l  153 (487)
                      .|.+.+.||+|+||.||+|.+..+|+.  ||||++.......                     ......+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378999999999999999998778999  9999875432110                     01224678999999999


Q ss_pred             cCCCCc--cEEEEEEEeCCEEEEEEeccCC-C----CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCceeecC
Q 011380          154 AGHENV--VKFYNAFEDDNYVYIAMELCEG-G----ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH-LHGLVHRDM  225 (487)
Q Consensus       154 ~~hpnI--v~~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH-~~~iiHrDl  225 (487)
                      . |++|  +.+++.    +..+|||||+.+ |    +|.+....     .++..+..++.||+.+|.||| ++||+||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl  197 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADL  197 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence            6 7754  445543    246899999942 3    56554321     235578899999999999999 999999999


Q ss_pred             CCCceEeccCCCCCcEEEeeccccccc
Q 011380          226 KPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       226 kp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ||+|||++   .  .++|+|||+|...
T Consensus       198 kp~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEES---S--SEEECCCTTCEET
T ss_pred             CHHHEEEc---C--cEEEEECcccccC
Confidence            99999998   2  7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=1.2e-18  Score=170.94  Aligned_cols=141  Identities=18%  Similarity=0.239  Sum_probs=100.6

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC-----------Ch--------HhHHHHHHHHHHHHhccCCC
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI-----------LP--------IAVEDVKREVKILQALAGHE  157 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-----------~~--------~~~~~~~~E~~~l~~l~~hp  157 (487)
                      -|.++..||+|+||.||+|.+. +|+.||||++......           ..        .......+|...|.++. ++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            4999999999999999999874 6999999987532110           00        01112346788888884 44


Q ss_pred             Ccc--EEEEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC
Q 011380          158 NVV--KFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (487)
Q Consensus       158 nIv--~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~  235 (487)
                      ++.  ..+++  ..  .+|||||++|++|....        ....+..++.||+.+|.+||++|||||||||.|||++.+
T Consensus       174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             TCSCCCEEEE--ET--TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred             CCCCCeeeec--cC--ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence            443  23322  22  37999999998875421        123456789999999999999999999999999999853


Q ss_pred             CCC-------CcEEEeecccccc
Q 011380          236 KED-------SSLKATDFGLSDF  251 (487)
Q Consensus       236 ~~~-------~~vkl~DfG~a~~  251 (487)
                      ++.       ..+.|+||+-+..
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcccccccccceEEEEeCCccc
Confidence            211       1389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=4.4e-13  Score=126.30  Aligned_cols=139  Identities=17%  Similarity=0.159  Sum_probs=110.7

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|.+...+|.|+++.||++..  .|+.+++|+.......   ....+.+|+.+++.|..+..++++++++.+.+..|+||
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            488888899999999999964  3689999988643111   12357899999999976788999999999999999999


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---------------------------------------  217 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~---------------------------------------  217 (487)
                      |+++|.+|.+.+       .+......++.++..+|..||+                                       
T Consensus        90 e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           90 SEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999887642       1122345788899999999998                                       


Q ss_pred             --------------------cCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          218 --------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       218 --------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                                          ..++|+|++|.|||++   ++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence                                4589999999999997   34456799999764

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=99.38  E-value=3.9e-13  Score=120.94  Aligned_cols=113  Identities=25%  Similarity=0.399  Sum_probs=86.4

Q ss_pred             cCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 011380          354 SHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD  433 (487)
Q Consensus       354 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~  433 (487)
                      .|||.+... ....+....++.++++|...+.+++..+..++..++.++...++++|..+|.|++|.|+.+||+.+|.. 
T Consensus         8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~-   85 (197)
T 3pm8_A            8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKK-   85 (197)
T ss_dssp             ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-
T ss_pred             cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-
Confidence            589998754 345677788999999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          434 LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       434 ~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +|..++..++..++..+|.|++|.|        +|+||+....
T Consensus        86 ~g~~~~~~~~~~l~~~~D~d~~g~I--------~~~EF~~~~~  120 (197)
T 3pm8_A           86 IGYQKIPPDIHQVLRDIDSNASGQI--------HYTDFLAATI  120 (197)
T ss_dssp             HC----CHHHHHHHHC-------CE--------EHHHHHHTTC
T ss_pred             hCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHHH
Confidence            8998999999999999999999999        9999988654

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=99.35  E-value=7.4e-13  Score=118.53  Aligned_cols=112  Identities=20%  Similarity=0.312  Sum_probs=94.2

Q ss_pred             cCccccccCCCCCCCcCHHHHHHHHHhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh
Q 011380          354 SHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD  433 (487)
Q Consensus       354 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~  433 (487)
                      .|||+-... ....+.+..++.++++|...+.+++.++..++..++.++..+++++|..+|.|++|.|+.+||+.+|+. 
T Consensus         3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~-   80 (191)
T 3k21_A            3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEK-   80 (191)
T ss_dssp             ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-
T ss_pred             CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH-
Confidence            477776543 344566778899999999999999999999999999999999999999999999999999999999999 


Q ss_pred             CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          434 LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       434 ~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +|...+ .++..++..+|.|++|.|        +|+||+.+..
T Consensus        81 ~g~~~~-~~~~~l~~~~D~d~~g~i--------~~~EF~~~~~  114 (191)
T 3k21_A           81 DGLKLP-YNFDLLLDQIDSDGSGKI--------DYTEFIAAAL  114 (191)
T ss_dssp             TTCCCC-TTHHHHHHHHCTTCSSSE--------EHHHHHHHHS
T ss_pred             cCCCcH-HHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            998888 899999999999999999        9999988654

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=99.35  E-value=4.4e-13  Score=106.15  Aligned_cols=70  Identities=26%  Similarity=0.404  Sum_probs=65.6

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++++..+++++|+.||.|++|+|+.+||+.+|+. +|..+++++++++++.+|.|+||.|        +|+||+.++
T Consensus        29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~-lg~~~~~~ei~~l~~~~D~d~dG~I--------~~~EF~~~m   98 (100)
T 2lv7_A           29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRS-LGYMPNEVELEVIIQRLDMDGDGQV--------DFEEFVTLL   98 (100)
T ss_dssp             CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHH-HTCCCCTTTHHHHHHHHCSSCSSSB--------CHHHHHHHT
T ss_pred             cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHHCCCCCCeE--------eHHHHHHHh
Confidence            456778899999999999999999999999999999 9999999999999999999999999        999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=1.4e-11  Score=115.51  Aligned_cols=135  Identities=14%  Similarity=0.099  Sum_probs=97.8

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCC-CccEEEEEEEeCCEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE-NVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hp-nIv~~~~~~~~~~~~~lv  175 (487)
                      .|.+....+.|..+.||++.. .+|+.+++|+.....      ...+.+|+.+++.+..+. .+++++.+....+..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            456554444666799999963 567889999875431      145678999999997442 266789988888889999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG------------------------------------  219 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~------------------------------------  219 (487)
                      |||++|.+|.  .  .   ...   ...++.++...|..||+..                                    
T Consensus        94 ~e~i~G~~l~--~--~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           94 LGEVPGQDLL--S--S---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EECCSSEETT--T--S---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEecCCcccC--c--C---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            9999998773  1  1   111   2356677777777777643                                    


Q ss_pred             ----------------------ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          220 ----------------------LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       220 ----------------------iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                                            ++|+|++|.|||++   ++..+.|+|||.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence                                  99999999999997   344567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.16  E-value=1.1e-10  Score=115.03  Aligned_cols=142  Identities=25%  Similarity=0.406  Sum_probs=104.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEec--ccCcCChHhHHHHHHHHHHHHhccC-CCCccEEEEEEEeC---CEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIE--KNKMILPIAVEDVKREVKILQALAG-HENVVKFYNAFEDD---NYVYI  174 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~~---~~~~l  174 (487)
                      ++.|+.|.++.||++..  .+..+++|+..  ....  ......+.+|..+++.|.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            56789999999999974  35688898765  3221  1123567889999999963 35688899888776   45899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-------------------------------------  217 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-------------------------------------  217 (487)
                      ||||++|..+.+.    ....+++.....++.++...|..||+                                     
T Consensus       119 vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999998876431    12347788889999999999999997                                     


Q ss_pred             ---------------------cCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          218 ---------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       218 ---------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                                           .+++|+|++|.|||++.++ ...+.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence                                 3689999999999998421 13469999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=7e-11  Score=113.74  Aligned_cols=181  Identities=17%  Similarity=0.246  Sum_probs=124.1

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCC--ccEEEEEEEeCC---EEEEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHEN--VVKFYNAFEDDN---YVYIAM  176 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpn--Iv~~~~~~~~~~---~~~lv~  176 (487)
                      +.++.|....||++.     ..+++|+....     .....+.+|.++|+.+..+..  +++++.......   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999873     46889975432     345678899999998853433  455555443333   358899


Q ss_pred             eccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011380          177 ELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL---------------------------------------  217 (487)
Q Consensus       177 e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~---------------------------------------  217 (487)
                      ++++|.+|.+...    ..++......++.++...|..||+                                       
T Consensus        96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999988765432    246788888888999998888886                                       


Q ss_pred             -------------------cCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCccccccCCccc---cchhhhc-
Q 011380          218 -------------------HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY---VAPEVLK-  274 (487)
Q Consensus       218 -------------------~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y---~aPE~~~-  274 (487)
                                         ..++|+|++|.||+++.. ....+.|+||+.+.........   .....+   ..|+... 
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl---~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDF---ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHH---HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHH---HHHHhhccccCHHHHHH
Confidence                               136999999999999841 1456789999988654322111   111111   3343221 


Q ss_pred             --cCCC------------CcchHHHHHHHHHHHHhCCCCC
Q 011380          275 --RKSG------------PESDVWSIGVITYILLCGRRPF  300 (487)
Q Consensus       275 --~~~~------------~~~DiwSlG~il~ell~g~~pf  300 (487)
                        ..|+            ...+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              1121            1258999999999999998886

>1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A

Probab=99.11  E-value=6.4e-11  Score=91.79  Aligned_cols=75  Identities=24%  Similarity=0.373  Sum_probs=68.2

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ++..++.++...++.+|..+|.|++|+|+.+||+.+|+. +|..++..++..++..+|.|++|.|        +|++|+.
T Consensus        10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~D~~~dg~i--------~~~eF~~   80 (90)
T 1avs_A           10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRM-LGQNPTKEELDAIIEEVDEDGSGTI--------DFEEFLV   80 (90)
T ss_dssp             HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTCCSSE--------EHHHHHH
T ss_pred             HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHH
Confidence            344567778889999999999999999999999999999 9999999999999999999999999        9999988


Q ss_pred             cccc
Q 011380          474 FPVD  477 (487)
Q Consensus       474 ~~~~  477 (487)
                      +...
T Consensus        81 ~~~~   84 (90)
T 1avs_A           81 MMVR   84 (90)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A

Probab=99.10  E-value=6.7e-11  Score=90.77  Aligned_cols=72  Identities=24%  Similarity=0.345  Sum_probs=64.1

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +..+++++...++.+|..+|.|++|+|+.+|++.+|+. +| .++.+++..++..+|.|++|.|        +|++|+.+
T Consensus         2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g-~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~   71 (86)
T 2opo_A            2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKT-LG-SVTPDEVRRMMAEIDTDGDGFI--------SFDEFTDF   71 (86)
T ss_dssp             ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHT-TT-TCCHHHHHHHHHHHCTTCSSEE--------CHHHHHHH
T ss_pred             CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHH-cC-CCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHH
Confidence            45567778899999999999999999999999999999 99 9999999999999999999999        99999886


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        72 ~~   73 (86)
T 2opo_A           72 AR   73 (86)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=99.08  E-value=4.7e-11  Score=94.14  Aligned_cols=68  Identities=15%  Similarity=0.165  Sum_probs=59.8

Q ss_pred             HHHHHHHHhhcccC-CCCC-CCCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKN-GSISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~-G~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      .....++++|..|| +|++ |+|+.+||+.+|+..+    |..+++++++++|+.+|.|+||.|        +|+||+.+
T Consensus         7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~I--------df~EF~~~   78 (101)
T 3nso_A            7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEV--------DFVEYVRS   78 (101)
T ss_dssp             HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCE--------EHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCC--------cHHHHHHH
Confidence            34578999999997 8998 9999999999998524    577889999999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        79 ~~   80 (101)
T 3nso_A           79 LA   80 (101)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=99.08  E-value=1.1e-10  Score=91.34  Aligned_cols=67  Identities=22%  Similarity=0.180  Sum_probs=61.0

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++..+++++|..||+|++|+|+.+|++.+|+. +|  ++++++.+++..+|.|+||.|        +|+||+.++
T Consensus         4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~-~g--~~~~~~~~i~~~~D~d~dG~i--------~~~EF~~~~   70 (95)
T 1c07_A            4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK-TG--LPSTLLAHIWSLCDTKDCGKL--------SKDQFALAF   70 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHT-TT--CCHHHHHHHHHHHCTTCSSSE--------ETTTHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH-cC--CCHHHHHHHHHHHCCCCCCcC--------CHHHHHHHH
Confidence            45667889999999999999999999999999998 77  678999999999999999999        899998765

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=99.07  E-value=1e-10  Score=90.99  Aligned_cols=67  Identities=19%  Similarity=0.156  Sum_probs=61.1

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++..+++++|+.||.|++|+|+.+|++.+|+. +|  ++++++.+++..+|.|+||.|        +|+||+.++
T Consensus         3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~-~g--~~~~~~~~i~~~~D~d~dG~i--------~~~EF~~~~   69 (92)
T 1fi6_A            3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK-SK--LPILELSHIWELSDFDKDGAL--------TLDEFCAAF   69 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHH-HS--SCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cC--CCHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence            45677889999999999999999999999999998 76  678899999999999999999        999998765

>1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A

Probab=99.07  E-value=9.7e-11  Score=89.88  Aligned_cols=73  Identities=15%  Similarity=0.114  Sum_probs=66.3

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHH---HHHHHHhcCCCCCceeecCccccccchhh
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESR---VLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e---~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      +..+++++..+++++|..||.|++|+|+.+||+.+|+. +|..++..+   +..++..+|.|++|.|        +| +|
T Consensus         5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~~~~d~~~~g~i--------~~-eF   74 (86)
T 1j7q_A            5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTK-LGQTYTKRETEAIMKEARGPKGDKKNIG--------PE-EW   74 (86)
T ss_dssp             CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHH-TSCCCSHHHHHHHHHHHHCSSCSSCCBC--------TT-HH
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-HcCCCCHHHHHHHHHHHHHhCCCCCCcC--------CH-HH
Confidence            34556778889999999999999999999999999999 999999999   9999999999999999        99 99


Q ss_pred             hccccc
Q 011380          472 LLFPVD  477 (487)
Q Consensus       472 ~~~~~~  477 (487)
                      +.+...
T Consensus        75 ~~~~~~   80 (86)
T 1j7q_A           75 LTLCSK   80 (86)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            876643

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=99.06  E-value=2.5e-10  Score=100.82  Aligned_cols=96  Identities=25%  Similarity=0.380  Sum_probs=87.4

Q ss_pred             CHHHHHHHHHhhhhhHHHHHHHHHHhccCC--hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHH
Q 011380          370 DISVLNNMRQFVKYSRLKQFALRALASTLD--DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEIL  447 (487)
Q Consensus       370 ~~~~~~~~~~~~~~~~~k~~~l~~m~~~~~--~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~  447 (487)
                      ...++.+++.|...+.+++.++..++..+.  +++...++++|..+|.|++|.|+.+|++.+|+. +|..  ..++..++
T Consensus         3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~-~g~~--~~~~~~~~   79 (180)
T 3mse_B            3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLAS-VGIK--KWDINRIL   79 (180)
T ss_dssp             CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH-TTCC--HHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-cCCC--HHHHHHHH
Confidence            457889999999999999999999998886  788899999999999999999999999999999 8854  68899999


Q ss_pred             HhcCCCCCceeecCccccccchhhhcccc
Q 011380          448 QAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       448 ~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+|.|++|.|        +|+||+....
T Consensus        80 ~~~D~d~~g~i--------~~~Ef~~~~~  100 (180)
T 3mse_B           80 QALDINDRGNI--------TYTEFMAGCY  100 (180)
T ss_dssp             HHHCTTCCSEE--------CHHHHHHHHS
T ss_pred             HHhCCCCCCcC--------cHHHHHHHHH
Confidence            99999999999        9999987554

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=99.05  E-value=7.4e-11  Score=88.36  Aligned_cols=70  Identities=24%  Similarity=0.485  Sum_probs=64.6

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ++++...++.+|..+|.|++|.|+.+|++.+|+. +|..++..++..++..+|.|++|.|        +|++|+.+...
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~~~~g~i--------~~~eF~~~~~~   71 (77)
T 2joj_A            2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRA-LGFDVKKPEILELMNEYDREGNGYI--------GFDDFLDIMTE   71 (77)
T ss_dssp             CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHH-HTCCCHHHHHHHHHHHHCCSSSSEE--------EHHHHHHHHTH
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHH-hCCCCCHHHHHHHHHHHCCCCCCcC--------cHHHHHHHHHH
Confidence            4567788999999999999999999999999999 8999999999999999999999999        99999887654

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=99.03  E-value=1.4e-10  Score=99.49  Aligned_cols=77  Identities=13%  Similarity=0.227  Sum_probs=65.1

Q ss_pred             HHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccc
Q 011380          390 ALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       390 ~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      |+..+.... ..+..+.++.+|+.||.|++|+|+.+||+.+|.. +|..+++++++.|++.+|.| ||.|        +|
T Consensus        70 f~~~~~~~~~~~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~-~g~~ls~~ei~~~~~~~D~~-dG~I--------~y  139 (153)
T 3i5g_B           70 FLTLFGEKVSGTDPEDALRNAFSMFDEDGQGFIPEDYLKDLLEN-MGDNFSKEEIKNVWKDAPLK-NKQF--------NY  139 (153)
T ss_dssp             HHHTTTTTTTTCCCHHHHHHHHHTTCSSCSSCCCHHHHHHHHHS-SSSCCCHHHHHHHHTTCCEE-TTEE--------CH
T ss_pred             HHHHHHhhhcccccHHHHHHHHhccccCCCCeEeHHHHHHHHHH-cCCcCCHHHHHHHHHHhCCC-cCEE--------cH
Confidence            344444333 2223467999999999999999999999999999 99999999999999999988 9999        99


Q ss_pred             hhhhcccc
Q 011380          469 SYLLLFPV  476 (487)
Q Consensus       469 ~~f~~~~~  476 (487)
                      +||+.++.
T Consensus       140 ~EF~~~m~  147 (153)
T 3i5g_B          140 NKMVDIKG  147 (153)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            99998764

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=99.03  E-value=1.9e-10  Score=92.55  Aligned_cols=69  Identities=12%  Similarity=0.241  Sum_probs=60.0

Q ss_pred             hHHHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          400 DEELADLRDQFDAID-VDKNG-SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      .++..+++++|..|| .|++| +|+.+||+.+|+..    +|..+++++++++++.+|.|+||.|        +|+||+.
T Consensus        18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~I--------df~EF~~   89 (113)
T 2lnk_A           18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEV--------DFQEYCV   89 (113)
T ss_dssp             HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCB--------CHHHHHH
T ss_pred             hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHH
Confidence            345678999999999 89997 99999999999752    4456788999999999999999999        9999987


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      ++.
T Consensus        90 ~m~   92 (113)
T 2lnk_A           90 FLS   92 (113)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A

Probab=99.02  E-value=3.7e-10  Score=89.97  Aligned_cols=66  Identities=15%  Similarity=0.186  Sum_probs=60.7

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++..+++++|+.||+ ++|+|+.+|++.+|+. +|  ++++++.+|+..+|.|+||.|        +|+||+.++
T Consensus         9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~-~g--l~~~el~~i~~~~D~d~dG~i--------d~~EF~~~m   74 (106)
T 1eh2_A            9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLN-SK--LPVDILGRVWELSDIDHDGML--------DRDEFAVAM   74 (106)
T ss_dssp             SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHT-TT--CCHHHHHHHHHHHCSSCSSBC--------CHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHH-cC--CCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHH
Confidence            466778899999999999 9999999999999998 77  678999999999999999999        999998765

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=99.02  E-value=1.2e-10  Score=103.70  Aligned_cols=99  Identities=26%  Similarity=0.327  Sum_probs=90.1

Q ss_pred             cCHHHHHHHHHhhhhhHHHHHHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC-----------CC
Q 011380          369 IDISVLNNMRQFVKYSRLKQFALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL-----------PW  436 (487)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~k~~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~-----------~~  436 (487)
                      ....++.++++|...+.+++.++..++..+ ++++...++++|..+|.|++|.|+.+|+..+|.. +           |.
T Consensus         4 ~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~   82 (191)
T 3khe_A            4 ALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRK-LMQWKGDTVSDLDS   82 (191)
T ss_dssp             HHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HHC-----CCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH-HHhhcccccccccc
Confidence            445778899999999999999999999888 7888899999999999999999999999999997 6           67


Q ss_pred             cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          437 KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       437 ~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..++..++..+|.|++|.|        +|+||+.+..
T Consensus        83 ~~~~~~~~~~~~~~D~d~~g~i--------~~~ef~~~~~  114 (191)
T 3khe_A           83 SQIEAEVDHILQSVDFDRNGYI--------EYSEFVTVCM  114 (191)
T ss_dssp             HHHHHHHHHHHHHTCTTCSSSE--------EHHHHHHHHS
T ss_pred             hhhHHHHHHHHHHhCCCCCCcC--------CHHHHHHHHH
Confidence            7888999999999999999999        8999988653

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=99.02  E-value=1.2e-10  Score=90.97  Aligned_cols=67  Identities=24%  Similarity=0.369  Sum_probs=61.5

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +..++++++|..+|.|++|+|+.+||+.+|+. +|..+++++++.+++.+|.|++|.|        +|+||+.++.
T Consensus        26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~e~~~l~~~~D~d~dG~I--------~~~EF~~~~~   92 (94)
T 2kz2_A           26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTN-LGEKLTDEEVDEMIREADIDGDGQV--------NYEEFVQMMT   92 (94)
T ss_dssp             SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHh
Confidence            34567899999999999999999999999999 8999999999999999999999999        9999987653

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=99.02  E-value=2.3e-10  Score=90.81  Aligned_cols=68  Identities=13%  Similarity=0.256  Sum_probs=58.3

Q ss_pred             HHHHHHHHhhcccC-CCCC-CCCCHHHHHHHHHhhCC----CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKN-GSISLEEMRQALAKDLP----WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~-G~i~~~el~~~l~~~~~----~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ....+++++|..|| .|++ |+|+.+||+.+|+..+|    ..+++++++++|+.+|.|+||.|        +|+||+.+
T Consensus        10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~I--------df~EF~~~   81 (104)
T 3zwh_A           10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEV--------DFQEYCVF   81 (104)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCC--------cHHHHHHH
Confidence            35678999999997 7886 89999999999984355    44679999999999999999999        99999886


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        82 m~   83 (104)
T 3zwh_A           82 LS   83 (104)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=99.02  E-value=2.2e-10  Score=89.11  Aligned_cols=68  Identities=13%  Similarity=0.256  Sum_probs=57.2

Q ss_pred             HHHHHHHHhhcccC-CCCC-CCCCHHHHHHHHHhhCC----CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKN-GSISLEEMRQALAKDLP----WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~-G~i~~~el~~~l~~~~~----~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      .....++++|+.|| .|++ |+|+.+||+.+|+..+|    ...++++++++++.+|.|+||.|        +|+||+.+
T Consensus         7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~I--------df~EF~~~   78 (93)
T 4eto_A            7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEV--------DFQEYCVF   78 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCC--------cHHHHHHH
Confidence            34678999999997 6885 89999999999984365    34578999999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        79 ~~   80 (93)
T 4eto_A           79 LS   80 (93)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=99.01  E-value=9.2e-11  Score=90.17  Aligned_cols=74  Identities=26%  Similarity=0.529  Sum_probs=65.9

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ++..++.++...++++|..+|.|++|+|+.+||+.+|+. +|..++.+++..+++.+|.|++|.|        +|++|+.
T Consensus        13 ~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~   83 (87)
T 1s6j_A           13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSELMESEIKDLMDAADIDKSGTI--------DYGEFIA   83 (87)
T ss_dssp             SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHT-TTSSCCHHHHHHHHHHHCTTCSSEE--------CHHHHTT
T ss_pred             HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHH
Confidence            444555555667899999999999999999999999999 9999999999999999999999999        9999988


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      +.+
T Consensus        84 ~~~   86 (87)
T 1s6j_A           84 ATV   86 (87)
T ss_dssp             CCC
T ss_pred             HHh
Confidence            654

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A

Probab=99.01  E-value=5.1e-10  Score=88.25  Aligned_cols=68  Identities=18%  Similarity=0.198  Sum_probs=57.5

Q ss_pred             HHHHHHHHhhcccCCCC---CCCCCHHHHHHHHHhhCCCcc----cHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          401 EELADLRDQFDAIDVDK---NGSISLEEMRQALAKDLPWKL----KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~---~G~i~~~el~~~l~~~~~~~~----~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ....+++++|..||.++   +|+|+.+||+.+|+..++..+    ++++++++++.+|.|+||.|        +|+||+.
T Consensus         8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~I--------df~EF~~   79 (100)
T 3nxa_A            8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRI--------SFDEYWT   79 (100)
T ss_dssp             HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCB--------CHHHHHH
T ss_pred             HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCC--------cHHHHHH
Confidence            34578999999999964   799999999999986344333    47899999999999999999        9999988


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      ++.
T Consensus        80 ~m~   82 (100)
T 3nxa_A           80 LIG   82 (100)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            664

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=99.00  E-value=2.5e-10  Score=97.41  Aligned_cols=65  Identities=20%  Similarity=0.341  Sum_probs=61.0

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+.++.+|+.||.|++|+|+.+||+.+|.. +|..++..+++.+++.+|.|+||.|        +|+||+.++.
T Consensus        82 ~~~l~~aF~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~e~~~l~~~~D~d~dG~I--------~~~EF~~~m~  146 (148)
T 2lmt_A           82 EEEMREAFKIFDRDGDGFISPAELRFVMIN-LGEKVTDEEIDEMIREADFDGDGMI--------NYEEFVWMIS  146 (148)
T ss_dssp             HHHHHHHHHHHHSSCSSEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCCSCCSSE--------EHHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCcCcCcHHHHHHHHHH-cCccccHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHh
Confidence            457899999999999999999999999999 9999999999999999999999999        9999998653

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=99.00  E-value=3.1e-10  Score=83.39  Aligned_cols=65  Identities=25%  Similarity=0.386  Sum_probs=60.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++++|..+|.|++|+|+.+||+.+++. +|..++..++..++..+|.|++|.|        +|++|+.+.
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~eF~~~~   68 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAG-LGQPLPQEELDAMIREADVDQDGRV--------NYEEFARML   68 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGG-TTCSSCHHHHHHHHHHCCSSSSSEE--------ETTHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            3467899999999999999999999999999 9999999999999999999999999        899998764

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=98.99  E-value=5.6e-10  Score=96.79  Aligned_cols=88  Identities=34%  Similarity=0.623  Sum_probs=79.4

Q ss_pred             HhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          379 QFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       379 ~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      .|...+.+++..+..++..+++++...++++|..+|.|++|.|+.+|++.++.. +|..++..++..++..+|.|++|.|
T Consensus         2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i   80 (166)
T 2aao_A            2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKR-VGANLKESEILDLMQAADVDNSGTI   80 (166)
T ss_dssp             ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGG-GTCCCCHHHHHHHHHHHCTTCCSSB
T ss_pred             chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE
Confidence            566778899999999999999999999999999999999999999999999999 8999999999999999999999999


Q ss_pred             ecCccccccchhhhccc
Q 011380          459 LPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       459 ~~~~~~~~~f~~f~~~~  475 (487)
                              +|+||+...
T Consensus        81 --------~~~ef~~~~   89 (166)
T 2aao_A           81 --------DYKEFIAAT   89 (166)
T ss_dssp             --------CHHHHHHHH
T ss_pred             --------cHHHHHHHH
Confidence                    899998754

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=98.99  E-value=3.1e-10  Score=82.31  Aligned_cols=63  Identities=14%  Similarity=0.266  Sum_probs=59.0

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++++|..+|.|++|.|+.+|++.++.. +|..++.+++..++..+|.|++|.|        +|+||+.+..
T Consensus         2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~D~~~dg~i--------~~~ef~~~~~   64 (67)
T 1tiz_A            2 SAKRVFEKFDKNKDGKLSLDEFREVALA-FSPYFTQEDIVKFFEEIDVDGNGEL--------NADEFTSCIE   64 (67)
T ss_dssp             THHHHHHHHCTTSSSCEEHHHHHHHHHH-TCTTSCHHHHHHHHHHHCCSSSSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHHCCCCCCcC--------cHHHHHHHHH
Confidence            4678999999999999999999999999 9999999999999999999999999        9999987654

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=98.99  E-value=5e-10  Score=98.54  Aligned_cols=67  Identities=21%  Similarity=0.334  Sum_probs=61.9

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+..+.++.+|+.||.|++|+|+.+||+.+|.. +|..+++++++++++.+| |+||.|        +|+||+.++.
T Consensus        80 ~~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~-~g~~~~~~ei~~l~~~~d-d~dG~I--------~~~EF~~~m~  146 (176)
T 2lhi_A           80 NDSEQELLEAFKVFDKNGDGLISAAELKHVLTS-IGEKLTDAEVDDMLREVS-DGSGEI--------NIQQFAALLS  146 (176)
T ss_dssp             SHHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHT-TTCCCCHHHHHHHHHHHH-TTSSCB--------CTTHHHHHHT
T ss_pred             CCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCcccchHHHHHHHHhhc-CCCCeE--------eHHHHHHHHH
Confidence            344568999999999999999999999999999 999999999999999999 999999        9999998764

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=98.98  E-value=2.2e-10  Score=90.35  Aligned_cols=63  Identities=11%  Similarity=0.087  Sum_probs=57.6

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +..+++++|..||+|++|+|+.+|++.+|+. +|  ++++++.+|++.+|.|+||.|        +|+||+.++
T Consensus         9 ~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~-~~--l~~~~l~~i~~~~D~d~dG~i--------~~~EF~~~~   71 (99)
T 1qjt_A            9 GNPVYEKYYRQVEAGNTGRVLALDAAAFLKK-SG--LPDLILGKIWDLADTDGKGVL--------SKQEFFVAL   71 (99)
T ss_dssp             TCTHHHHHHHHHCCTTSSCCCSHHHHHHHHT-SS--SCHHHHHHHHHHHCCSSSSSC--------CSHHHHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-cC--CCHHHHHHHHHHHCCCCCCcC--------CHHHHHHHH
Confidence            3467899999999999999999999999998 77  678999999999999999999        999998765

>2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max}

Probab=98.98  E-value=5e-10  Score=87.01  Aligned_cols=69  Identities=23%  Similarity=0.403  Sum_probs=63.8

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++...++.+|..+|.|++|+|+.+||+.+|+. +|..++.+++..++..+|.|++|.|        +|++|+.++.
T Consensus         4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~d~~~dg~i--------~~~eF~~~~~   72 (92)
T 2kn2_A            4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMIN-LGEKLTDEEVEQMIKEADLDGDGQV--------NYEEFVKMMM   72 (92)
T ss_dssp             CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSCCSSE--------EHHHHHHHHH
T ss_pred             CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            4556788999999999999999999999999999 9999999999999999999999999        8999987654

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens}

Probab=98.97  E-value=3.7e-10  Score=87.67  Aligned_cols=69  Identities=26%  Similarity=0.345  Sum_probs=62.2

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++.++...++.+|..+|.|++|+|+.+||+.+|+. +|  ++..+++.++..+|.|++|.|        +|+||+.+..
T Consensus        20 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~g--~~~~~~~~~~~~~D~d~dg~I--------~~~EF~~~~~   88 (91)
T 2pmy_A           20 DGDGEELARLRSVFAACDANRSGRLEREEFRALCTE-LR--VRPADAEAVFQRLDADRDGAI--------TFQEFARGFL   88 (91)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH-TT--CCHHHHHHHHHHHCTTCSSEE--------CHHHHTHHHH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH-cC--cCHHHHHHHHHHhCCCCCCCE--------eHHHHHHHHH
Confidence            345567788999999999999999999999999999 88  688999999999999999999        9999987653

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=98.96  E-value=5.5e-10  Score=96.49  Aligned_cols=66  Identities=21%  Similarity=0.318  Sum_probs=60.7

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCC--CCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT--PFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~--~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++++++|+.||.|++|+|+.+||+.+|+. +|..+++++++.+++.+|.  |+||.|        +|++|+.++.
T Consensus        83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~-~g~~ls~~e~~~l~~~~D~~~d~dG~I--------~~~EF~~~m~  150 (159)
T 3i5g_C           83 AADEFMEAFKTFDREGQGLISSAEIRNVLKM-LGERITEDQCNDIFTFCDIREDIDGNI--------KYEDLMKKVM  150 (159)
T ss_dssp             CHHHHHHHHHHHCTTSSSEECHHHHHHHHHH-SSSCCCHHHHHHHHHHTTCCCCSSCCE--------EHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCcCCCCCCeE--------eHHHHHHHHH
Confidence            3467899999999999999999999999999 9999999999999999995  889999        9999987654

>2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens}

Probab=98.96  E-value=5e-10  Score=89.78  Aligned_cols=74  Identities=15%  Similarity=0.283  Sum_probs=66.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccccce
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMV  479 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~~~  479 (487)
                      .++...++.+|..+|.|++|+|+.+|++.+|+. +|..++..++..++..+|.|++|.|        +|++|+.+.....
T Consensus        28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~l~~~~D~d~dg~i--------~~~eF~~~~~~~~   98 (107)
T 2d58_A           28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK-LGVPKTHLELKKLIGEVSSGSGETF--------SYPDFLRMMLGKR   98 (107)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSSSSEE--------CHHHHHHHHSSSS
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHHHHcc
Confidence            466788999999999999999999999999999 9999999999999999999999999        9999998776544


Q ss_pred             eee
Q 011380          480 YNL  482 (487)
Q Consensus       480 ~~~  482 (487)
                      .++
T Consensus        99 ~~~  101 (107)
T 2d58_A           99 SAI  101 (107)
T ss_dssp             CCH
T ss_pred             cHH
Confidence            433

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=98.95  E-value=4e-10  Score=91.65  Aligned_cols=67  Identities=16%  Similarity=0.228  Sum_probs=59.2

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...+.++.+|+.||.| +|+|+.+||+.+|++.    +|...++++++++|+.+|.|+||.|        +|+||+.++.
T Consensus        12 ~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~I--------dF~EF~~lm~   82 (121)
T 4drw_A           12 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKV--------GFQSFFSLIA   82 (121)
T ss_dssp             HHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCC--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHH
Confidence            3467899999999988 8999999999999752    4777889999999999999999999        9999988653

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=98.95  E-value=4.2e-10  Score=88.06  Aligned_cols=68  Identities=15%  Similarity=0.239  Sum_probs=54.8

Q ss_pred             HHHHHHHHhhcccC-CCC-CCCCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDK-NGSISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~-~G~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++..+++++|+.|| .|+ +|+|+.+||+.+|+..    +|..+++++++++++.+|.|+||.|        +|+||+.+
T Consensus         6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I--------~f~EF~~~   77 (95)
T 1j55_A            6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQV--------DFSEFIVF   77 (95)
T ss_dssp             HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSE--------EHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcC--------CHHHHHHH
Confidence            35678999999999 798 5899999999999863    3556788899999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        78 ~~   79 (95)
T 1j55_A           78 VA   79 (95)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=98.94  E-value=1.1e-10  Score=93.99  Aligned_cols=68  Identities=15%  Similarity=0.111  Sum_probs=60.6

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++.++..+++++|+.||+|++|+|+.+|++.+|+. +|  ++++++.+|++.+|.|++|.|        +|+||+.++.
T Consensus        16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~-~g--l~~~el~~i~~~~D~d~dG~I--------~~~EF~~~m~   83 (110)
T 1iq3_A           16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK-SK--LSIPELSYIWELSDADCDGAL--------TLPEFCAAFH   83 (110)
T ss_dssp             CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCS-SS--CSSCCHHHHHHHHCSSSCSEE--------EHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-cC--CCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHH
Confidence            34566788999999999999999999999999998 77  567889999999999999999        9999987653

>2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio}

Probab=98.94  E-value=5.6e-10  Score=87.98  Aligned_cols=68  Identities=13%  Similarity=0.186  Sum_probs=59.4

Q ss_pred             HHHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKNG-SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++..+++++|..|| .|++| +|+.+||+.+|+..    +|..+++.+++++++.+|.|+||.|        +|+||+.+
T Consensus         7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I--------~f~EF~~~   78 (99)
T 2y5i_A            7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEV--------DFNEFVVL   78 (99)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcC--------cHHHHHHH
Confidence            35678999999997 89998 99999999999852    3566789999999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        79 ~~   80 (99)
T 2y5i_A           79 VA   80 (99)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=98.93  E-value=9e-10  Score=88.82  Aligned_cols=67  Identities=15%  Similarity=0.185  Sum_probs=60.3

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++..+++++|..||.|++|+|+.+||+.+|+.   ..++++++.+++..+|.|+||.|        +|+||+.++
T Consensus         8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~---~~~~~~~~~~i~~~~D~d~dG~I--------~~~EF~~~~   74 (111)
T 2kgr_A            8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ---SSLPQAQLASIWNLSDIDQDGKL--------TAEEFILAM   74 (111)
T ss_dssp             SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHHT---TCCCHHHHHHHHHHHCSSCCSEE--------EHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHh---CCCCHHHHHHHHHHHCCCCCCCC--------cHHHHHHHH
Confidence            45677889999999999999999999999999984   45788999999999999999999        899998765

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=98.92  E-value=1.1e-09  Score=92.61  Aligned_cols=64  Identities=17%  Similarity=0.258  Sum_probs=60.1

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|+.||.|++|+|+.+||+.+|.. +|..+++++++++++.+|.|+||.|        +|+||+.++
T Consensus        78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~D~d~dG~I--------~~~eF~~~~  141 (143)
T 2obh_A           78 KEEILKAFKLFDDDETGKISFKNLKRVAKE-LGENLTDEELQEMIDEADRDGDGEV--------SEQEFLRIM  141 (143)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            467889999999999999999999999999 9999999999999999999999999        999998754

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A

Probab=98.92  E-value=3.5e-10  Score=90.13  Aligned_cols=68  Identities=18%  Similarity=0.249  Sum_probs=58.2

Q ss_pred             HHHHHHHHhhcccC-CCCC-CCCCHHHHHHHHHhhCCCccc-HHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAID-VDKN-GSISLEEMRQALAKDLPWKLK-ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~-G~i~~~el~~~l~~~~~~~~~-~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++..+++++|..|| .|++ |+|+.+||+.+|+..+|...+ .++++++++.+|.|+||.|        +|+||+.++.
T Consensus        19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~I--------df~EF~~~~~   89 (106)
T 2h2k_A           19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSEL--------KFNEYWRLIG   89 (106)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCC--------cHHHHHHHHH
Confidence            45678999999999 7997 799999999999853675543 4789999999999999999        9999988654

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=98.89  E-value=9.4e-11  Score=113.56  Aligned_cols=136  Identities=19%  Similarity=0.265  Sum_probs=95.9

Q ss_pred             CCCHHHHHHHHHcc---ccCccCCcCHHHHhcC------ccccccCCCCC-----------------------CCcCHHH
Q 011380          326 SISNSAKDFVKKLL---VKDPRARLTAAQALSH------PWVREGGDASE-----------------------IPIDISV  373 (487)
Q Consensus       326 ~~s~~~~~li~~~L---~~dp~~Rpt~~e~L~h------~~~~~~~~~~~-----------------------~~~~~~~  373 (487)
                      .++.++.+|.++++   ..+|.+|.+..+.+.|      +|+.++.+...                       .+.-..+
T Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v   95 (323)
T 1ij5_A           16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL   95 (323)
T ss_dssp             HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence            34567889999888   8899999999999998      99887632110                       0011123


Q ss_pred             HHHHH-HhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCC
Q 011380          374 LNNMR-QFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT  452 (487)
Q Consensus       374 ~~~~~-~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~  452 (487)
                      +.+++ +|...+.+++     ++..++.++...++.+|..+|.|++|.|+.+||+.+|.. +|..++..++..++..+|.
T Consensus        96 l~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~-lg~~~~~~~i~~l~~~~D~  169 (323)
T 1ij5_A           96 LKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAK-YADTIPEGPLKKLFVMVEN  169 (323)
T ss_dssp             HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHH-HHTTSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhcC
Confidence            33344 4444444444     345678888999999999999999999999999999999 8988999999999999999


Q ss_pred             CCCceeecCccccccchhhhccc
Q 011380          453 PFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       453 ~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      |++|.|        +|.+|+.+.
T Consensus       170 d~~G~I--------~f~ef~~l~  184 (323)
T 1ij5_A          170 DTKGRM--------SYITLVAVA  184 (323)
T ss_dssp             CCSSTH--------HHHHHTTSH
T ss_pred             CCCCcC--------cHHHHHhhh
Confidence            999999        898887653

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A

Probab=98.89  E-value=1.1e-09  Score=91.16  Aligned_cols=63  Identities=16%  Similarity=0.191  Sum_probs=58.0

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++..+++++|+.|| |++|+|+.+|++.+|+. +|  ++++++.+|+..+|.|+||.|        +|+||+.++
T Consensus        48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~-~g--l~~~el~~I~~~~D~d~dG~L--------d~~EF~~am  110 (139)
T 2jq6_A           48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVK-SK--LPNTVLGKIWKLADVDKDGLL--------DDEEFALAN  110 (139)
T ss_dssp             GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHH-TT--CCHHHHHHHHHHHCSSCCSEE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHH-hC--cCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            45678999999999 99999999999999998 77  678999999999999999999        999998765

>2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A

Probab=98.89  E-value=3.9e-10  Score=88.27  Aligned_cols=68  Identities=19%  Similarity=0.224  Sum_probs=59.2

Q ss_pred             HHHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKNG-SISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++..+++++|+.|| .|++| +|+.+||+.+|+..+    |..+++.+++++++.+|.|+||.|        +|+||+.+
T Consensus         9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I--------~f~EF~~~   80 (95)
T 2wcb_A            9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQV--------DFQEFISL   80 (95)
T ss_dssp             HHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEE--------EHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcC--------cHHHHHHH
Confidence            45678999999999 89998 999999999998523    455788999999999999999999        99999886


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        81 ~~   82 (95)
T 2wcb_A           81 VA   82 (95)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica}

Probab=98.87  E-value=3.9e-10  Score=81.55  Aligned_cols=62  Identities=21%  Similarity=0.233  Sum_probs=57.1

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++|..+|.|++|.|+.+|++.+++. +|..++++++..++..+|.|++|.|        +|+||+.+..
T Consensus         2 l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~D~~~~g~i--------~~~ef~~~~~   63 (66)
T 3li6_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSK-KRAIKNEQLLQLIFKSIDADGNGEI--------DQNEFAKFYG   63 (66)
T ss_dssp             CCHHHHHHCTTCSSSCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHCTTCSSSC--------CHHHHHHHHT
T ss_pred             HHHHHHHHCCCCCCcccHHHHHHHHHH-ccCCCcHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHH
Confidence            357899999999999999999999999 8888999999999999999999999        9999987653

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=98.87  E-value=1.8e-09  Score=83.84  Aligned_cols=66  Identities=15%  Similarity=0.292  Sum_probs=58.4

Q ss_pred             HHHHHHHhhcccCCCCCC---CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          402 ELADLRDQFDAIDVDKNG---SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G---~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ....++++|..|| +++|   +|+.+||+.+|+..    +|..+++.+++++++.+|.|+||.|        +|+||+.+
T Consensus         7 ~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I--------~f~EF~~~   77 (92)
T 3rm1_A            7 AVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGEC--------DFQEFMAF   77 (92)
T ss_dssp             HHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCC--------cHHHHHHH
Confidence            4578999999999 7777   99999999999862    5778889999999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        78 ~~   79 (92)
T 3rm1_A           78 VA   79 (92)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=98.87  E-value=1.6e-09  Score=105.67  Aligned_cols=72  Identities=21%  Similarity=0.429  Sum_probs=67.6

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++++|+++++++|..||.|++|.|+.+||+.+|+. +|..+++++++++|+.+|.|++|.|        +|+||+.+..
T Consensus       295 ~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrs-LG~~~TeeEI~~Lf~~~D~DgDG~I--------dFeEFl~lms  365 (440)
T 3u0k_A          295 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGDGTI--------DFPEFLIMMA  365 (440)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSCSSSE--------EHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            457899999999999999999999999999999999 9999999999999999999999999        9999987654


Q ss_pred             c
Q 011380          477 D  477 (487)
Q Consensus       477 ~  477 (487)
                      .
T Consensus       366 ~  366 (440)
T 3u0k_A          366 R  366 (440)
T ss_dssp             T
T ss_pred             H
Confidence            3

>3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A

Probab=98.87  E-value=1.5e-09  Score=87.09  Aligned_cols=65  Identities=22%  Similarity=0.222  Sum_probs=60.2

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|+|+.+||+.+++. +   |..+++++++.+++.+|.|++|.|        +|+||+.++
T Consensus        40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~~~~D~~~dg~i--------~~~EF~~~~  107 (109)
T 3fs7_A           40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKN-FSSSARVLTSAETKAFLAAGDTDGDGKI--------GVEEFQSLV  107 (109)
T ss_dssp             CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGG-TCTTSCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHH-HhcccccCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            4567899999999999999999999999998 8   889999999999999999999999        999998754

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=98.87  E-value=1.2e-09  Score=91.49  Aligned_cols=67  Identities=12%  Similarity=0.106  Sum_probs=61.8

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC-CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP-WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..||.|++|+|+.+||+.+|.. +| ..+++++++.+++.+|.|+||.|        +|+||+.++..
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~e~~~~~~~~D~d~dG~I--------~~~EF~~~~~~  105 (135)
T 3h4s_E           38 FVSELCKGFSLLADPERHLITAESLRRNSGI-LGIEGMSKEDAQGMVREGDLDGDGAL--------NQTEFCVLMVR  105 (135)
T ss_dssp             HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGG-GTCCCCCHHHHHHHHHHHCSSCSSSB--------CHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-hCCCCCCHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHHH
Confidence            4568899999999999999999999999999 99 49999999999999999999999        99999887653

>5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4

Probab=98.86  E-value=1.5e-09  Score=87.10  Aligned_cols=65  Identities=20%  Similarity=0.288  Sum_probs=60.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|+.+|.|++|+|+.+|++.+|+. +   |..+++++++.+++.+|.|++|.|        +|+||+.++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~  106 (109)
T 5pal_A           39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKG-FSAHGRDLNDTETKALLAAGDSDHDGKI--------GADEFAKMV  106 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHTHHHH-HCTTCCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-HHHcCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            4567899999999999999999999999998 7   899999999999999999999999        899998765

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=98.86  E-value=6e-10  Score=84.29  Aligned_cols=66  Identities=20%  Similarity=0.313  Sum_probs=60.6

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC-CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP-WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +....++ +|..+|.|++|+|+.+||+.+|+. +| ..++.+++..++..+|.|++|.|        +|++|+.+..
T Consensus         6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~   72 (81)
T 1c7v_A            6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQK-VGEEPLTDAEVEEAMKEADEDGNGVI--------DIPEFMDLIK   72 (81)
T ss_dssp             -CHHHHH-HHHHHSCSGGGEECHHHHHHHSST-TTTCCCCHHHHHHHHHHHCSSGGGSE--------EHHHHHHHHH
T ss_pred             cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHH-hCCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            3456789 999999999999999999999999 99 99999999999999999999999        8999988664

>1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A*

Probab=98.85  E-value=2.3e-09  Score=86.74  Aligned_cols=67  Identities=12%  Similarity=0.207  Sum_probs=59.3

Q ss_pred             HHHHHHHHhhcccCC-CCCC-CCCHHHHHHHHH-hhCCCc-----ccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          401 EELADLRDQFDAIDV-DKNG-SISLEEMRQALA-KDLPWK-----LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~-d~~G-~i~~~el~~~l~-~~~~~~-----~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ++...++++|..||. |++| +|+.+||+.+|+ . +|..     +++.+++.+|+.+|.|+||.|        +|+||+
T Consensus         9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~-lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I--------~f~EF~   79 (113)
T 1xk4_C            9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKD-LQNFLKKENKNEKVIEHIMEDLDTNADKQL--------SFEEFI   79 (113)
T ss_dssp             HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHH-TTTTTTTGGGCHHHHHHHHHHHCTTCSSSB--------CHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHH-hhhhhcccccCHHHHHHHHHHhCCCCCCCE--------eHHHHH
Confidence            346789999999995 9999 999999999999 6 7753     688999999999999999999        999998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .++.
T Consensus        80 ~~~~   83 (113)
T 1xk4_C           80 MLMA   83 (113)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A

Probab=98.85  E-value=2.2e-09  Score=85.98  Aligned_cols=65  Identities=22%  Similarity=0.295  Sum_probs=60.1

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|+.+|.|++|+|+.+||+.+|+. +   |..+++++++.++..+|.|++|.|        +|+||+.++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~  106 (108)
T 2pvb_A           39 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQN-FSPSARALTDAETKAFLADGDKDGDGMI--------GVDEFAAMI  106 (108)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGG-TCTTSCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-HhccCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            4567899999999999999999999999998 8   888999999999999999999999        999998753

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A

Probab=98.85  E-value=3.2e-10  Score=86.21  Aligned_cols=66  Identities=18%  Similarity=0.257  Sum_probs=59.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC--CcccHHHHHH----HHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP--WKLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~--~~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +...++.+|..+|.|++|+|+.+|++.++.. +|  ..++.+++..    ++..+|.|++|.|        +|+||+...
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I--------~~~eF~~~~   75 (83)
T 1yx7_A            5 VKAELEAAFKKLDANGDGYVTALELQTFMVT-LDAYKALSKDKVKEASAKLIKMADKNSDGKI--------SKEEFLNAN   75 (83)
T ss_dssp             SCTHHHHHHHHHSSSCSSSCSHHHHHHHHHH-HTTCTTTTTTTTHHHHHHHHTTTCSSSCSCC--------SHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-HccccCCCHHHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHhh
Confidence            3457889999999999999999999999998 88  7888889999    9999999999999        999998654


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        76 ~   76 (83)
T 1yx7_A           76 A   76 (83)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=98.85  E-value=1.5e-09  Score=95.51  Aligned_cols=72  Identities=26%  Similarity=0.415  Sum_probs=67.2

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++++.+++++|..||.|++|.|+.+||+.+|+. +|..+++.++..++..+|.|++|.|        +|.+|+...
T Consensus         3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~-lg~~~~~~~~~~~~~~~d~d~~~~i--------~~~ef~~~~   73 (176)
T 2lhi_A            3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRS-LGLSPSEAEVNDLMNEIDVDGNHQI--------EFSEFLALM   73 (176)
T ss_dssp             CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHH-HTCCCCHHHHHHHHTTTCSSCSSSB--------CTTHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-cCCChhHHHHHHHHHHhCcCCCccc--------hHHHHHHHH
Confidence            4567888999999999999999999999999999999 9999999999999999999999999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        74 ~   74 (176)
T 2lhi_A           74 S   74 (176)
T ss_dssp             T
T ss_pred             H
Confidence            4

>1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A

Probab=98.85  E-value=8.6e-10  Score=85.95  Aligned_cols=67  Identities=12%  Similarity=0.262  Sum_probs=60.1

Q ss_pred             HHHHHHHHhhcccCC-CCCC-CCCHHHHHHHH-HhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDV-DKNG-SISLEEMRQAL-AKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~-d~~G-~i~~~el~~~l-~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +....++.+|..||. |++| +|+.+||+.+| +. +|..++..++..+++.+|.|+||.|        +|+||+.+..
T Consensus         7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~-~g~~~~~~~~~~l~~~~D~d~dG~I--------~~~EF~~~~~   76 (93)
T 1xk4_A            7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETE-SPQYIRKKGADVWFKELDINTDGAV--------NFQEFLILVI   76 (93)
T ss_dssp             HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHH-SCHHHHTTCHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHH-CcccCCHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHH
Confidence            345689999999999 9999 99999999999 67 8887777889999999999999999        9999987653

>1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A

Probab=98.84  E-value=2.5e-09  Score=85.92  Aligned_cols=66  Identities=23%  Similarity=0.285  Sum_probs=60.8

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .....++.+|..+|.|++|+|+.+||+.+|.. +   |..++.++++.+++.+|.|++|.|        +|+||+.++
T Consensus        39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~  107 (110)
T 1pva_A           39 MSANDVKKVFKAIDADASGFIEEEELKFVLKS-FAADGRDLTDAETKAFLKAADKDGDGKI--------GIDEFETLV  107 (110)
T ss_dssp             SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGG-TCTTCCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-HhhcCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHH
Confidence            44578899999999999999999999999998 7   788999999999999999999999        999998764

>1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10

Probab=98.84  E-value=1.4e-09  Score=81.60  Aligned_cols=63  Identities=25%  Similarity=0.416  Sum_probs=58.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++.+|..+|.|++|+|+.+|++.+|+. +| .++.+++..++..+|.|++|.|        +|++|+.+..
T Consensus         3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~-~g-~~~~~~~~~~~~~~D~~~dg~i--------~~~ef~~~~~   65 (78)
T 1k9u_A            3 DDMERIFKRFDTNGDGKISLSELTDALRT-LG-STSADEVQRMMAEIDTDGDGFI--------DFNEFISFCN   65 (78)
T ss_dssp             CHHHHHHHHHCTTCSSEECHHHHHHHHHH-HH-TCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hC-CCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHHH
Confidence            35788999999999999999999999999 88 8999999999999999999999        8999987654

>1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7

Probab=98.84  E-value=2e-09  Score=85.80  Aligned_cols=66  Identities=18%  Similarity=0.215  Sum_probs=61.4

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..||.|++|+|+.+||+.+|+. +|..+++.++..++..+|.|++|.|        +|++|+.++.
T Consensus        22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~e~~~l~~~~d~~~~g~i--------~~~eF~~~~~   87 (105)
T 1wlz_A           22 HYHAITQEFENFDTMKTNTISREEFRAICNR-RVQILTDEQFDRLWNEMPVNAKGRL--------KYPDFLSRFS   87 (105)
T ss_dssp             THHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-HTCCCCHHHHHHHHTTSCBCTTSCB--------CHHHHHHHHC
T ss_pred             hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHcCCCCCCCC--------cHHHHHHHHh
Confidence            3467889999999999999999999999999 8999999999999999999999999        9999988665

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A

Probab=98.83  E-value=1e-09  Score=85.30  Aligned_cols=67  Identities=16%  Similarity=0.287  Sum_probs=58.8

Q ss_pred             HHHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhhCC--CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAID-VDKNG-SISLEEMRQALAKDLP--WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~~~--~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++..+++++|..|| +|++| +|+.+||+.+|+..++  . +++.+++.+++.+|.|++|.|        +|+||+.++.
T Consensus         7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I--------~f~EF~~~~~   77 (92)
T 2kax_A            7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEI--------DFKEYSVFLT   77 (92)
T ss_dssp             HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            35678999999999 99999 9999999999986333  4 778899999999999999999        9999987653

>1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4

Probab=98.83  E-value=2.9e-09  Score=85.50  Aligned_cols=65  Identities=22%  Similarity=0.254  Sum_probs=60.0

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|+|+.+||+.+++. +   |..++++++..+++.+|.|++|.|        +|+||+.++
T Consensus        40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~  107 (109)
T 1bu3_A           40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQV-FSAGARALTDAETKAFLKAGDSDGDGAI--------GVDEWAALV  107 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHH-HSTTCCCCCHHHHHHHHHHHCTTCSSEE--------CHHHHHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-HcccCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            4567899999999999999999999999998 7   788999999999999999999999        999998754

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=98.82  E-value=4.2e-09  Score=89.50  Aligned_cols=66  Identities=26%  Similarity=0.370  Sum_probs=61.1

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|.. +|..++++++..++..+|.|++|.|        +|+||+.++.
T Consensus        81 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~d~dg~i--------~~~eF~~~~~  146 (148)
T 1exr_A           81 SEEELIEAFKVFDRDGNGLISAAELRHVMTN-LGEKLTDDEVDEMIREADIDGDGHI--------NYEEFVRMMV  146 (148)
T ss_dssp             HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSSSSSB--------CHHHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHc
Confidence            3467889999999999999999999999999 9999999999999999999999999        9999987653

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=98.81  E-value=2.5e-09  Score=90.40  Aligned_cols=68  Identities=22%  Similarity=0.472  Sum_probs=63.2

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++..+++++|..||.|++|.|+.+||+.+|+. +|..++..++..++..+|.|++|.|        +|++|+.++.
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~~~~g~i--------~~~eF~~~~~   69 (143)
T 2obh_A            2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRA-LGFEPKKEEIKKMISEIDKEGTGKM--------NFGDFLTVMT   69 (143)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHHHTTTCCSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCee--------eHHHHHHHHH
Confidence            456788999999999999999999999999999 9999999999999999999999999        9999987653

>1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A

Probab=98.81  E-value=3.1e-09  Score=85.25  Aligned_cols=66  Identities=18%  Similarity=0.233  Sum_probs=60.5

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .....++.+|+.+|.|++|+|+.+||+.+|+. +   |..+++++++.+++.+|.|++|.|        +|+||+.++
T Consensus        38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~  106 (109)
T 1rwy_A           38 KSADDVKKVFHILDKDKSGFIEEDELGSILKG-FSSDARDLSAKETKTLMAAGDKDGDGKI--------GVEEFSTLV  106 (109)
T ss_dssp             SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHH-HCTTCCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHH
T ss_pred             chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-HhccCCCCCHHHHHHHHHHHCCCCCCcC--------CHHHHHHHH
Confidence            34567899999999999999999999999998 7   788999999999999999999999        899998754

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=98.81  E-value=4.4e-09  Score=88.61  Aligned_cols=65  Identities=17%  Similarity=0.259  Sum_probs=61.0

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|..+++++++.++..+|.|++|.|        +|+||+.++.
T Consensus        75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~  139 (143)
T 3j04_B           75 EDVIRNAFACFDEEASGFIHEDHLRELLTT-MGDRFTDEEVDEMYREAPIDKKGNF--------NYVEFTRILK  139 (143)
T ss_dssp             HHHHHHHHTTSCSSSCCCCCTTTHHHHHHT-SSSCCCHHHHHHHHHHTTCCSSSCC--------CSTHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-cCCCCCHHHHHHHHHHcCCCCCCcC--------cHHHHHHHHh
Confidence            457889999999999999999999999999 9999999999999999999999999        9999988764

>1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A

Probab=98.81  E-value=9.2e-10  Score=82.01  Aligned_cols=65  Identities=20%  Similarity=0.285  Sum_probs=59.9

Q ss_pred             HHHHHHhhccc-CCCCC-CCCCHHHHHHHHHhhCCCcc--cHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAI-DVDKN-GSISLEEMRQALAKDLPWKL--KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~-D~d~~-G~i~~~el~~~l~~~~~~~~--~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+ |.|++ |+|+.+||+.+|+. +|..+  +.+++..++..+|.|++|.|        +|++|+.+..
T Consensus         4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~eF~~~~~   72 (76)
T 1qx2_A            4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQT-LGPSLLKGMSTLDEMIEEVDKNGDGEV--------SFEEFLVMMK   72 (76)
T ss_dssp             HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHH-HGGGSCTTSCSHHHHHHHHCTTCSSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCcCeECHHHHHHHHHH-hCCCcCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            45788999999 99999 99999999999999 89888  88999999999999999999        9999987654

>3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor}

Probab=98.80  E-value=2.9e-09  Score=103.80  Aligned_cols=78  Identities=23%  Similarity=0.346  Sum_probs=65.0

Q ss_pred             HHHHHHhccCC-hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCcccccc
Q 011380          389 FALRALASTLD-DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEK  467 (487)
Q Consensus       389 ~~l~~m~~~~~-~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~  467 (487)
                      .|+.++...+. .+..++++++|+.||.|++|+|+.+||+.+|.. +|..+++++++++|+.+|.|+||.|        +
T Consensus       359 EFl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~-lGe~LSdeEIdeLfke~D~DgDGkI--------s  429 (440)
T 3u0k_A          359 EFLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTN-LGEKLTDEEVDEMIREADIDGDGQV--------N  429 (440)
T ss_dssp             HHHHHHHTC------CHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSSE--------E
T ss_pred             HHHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------e
Confidence            44555554442 233467899999999999999999999999999 9999999999999999999999999        9


Q ss_pred             chhhhccc
Q 011380          468 FSYLLLFP  475 (487)
Q Consensus       468 f~~f~~~~  475 (487)
                      |+||+.++
T Consensus       430 yeEFvkmM  437 (440)
T 3u0k_A          430 YEEFVQMM  437 (440)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99998765

>1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A

Probab=98.80  E-value=8.5e-09  Score=87.69  Aligned_cols=68  Identities=18%  Similarity=0.317  Sum_probs=63.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++..+++.+|..||.|++|+|+.+||+.+|+. +|..+++.++..++..+|.|++|.|        +|++|+.+..
T Consensus        44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~-~g~~~~~~~~~~l~~~~D~d~dg~I--------~~~eF~~~~~  111 (147)
T 1wy9_A           44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEK-LGVPKTHLELKRLIREVSSGSEETF--------SYSDFLRMML  111 (147)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSCTTEE--------CHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            467788999999999999999999999999999 9999999999999999999999999        9999987664

>1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A

Probab=98.78  E-value=3e-09  Score=85.24  Aligned_cols=65  Identities=22%  Similarity=0.279  Sum_probs=59.7

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +...++.+|+.+|.|++|+|+.+||+.+|+. +   |..++++++..+++.+|.|++|.|        +|+||+.++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~  106 (108)
T 1rro_A           39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQK-FQSDARELTESETKSLMDAADNDGDGKI--------GADEFQEMV  106 (108)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECTHHHHTGGGG-TCTTSCCCCHHHHHHHHHHHCCSSSSSE--------EHHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-HhhccCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            4567889999999999999999999999998 7   678999999999999999999999        899998754

>1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A

Probab=98.77  E-value=1.2e-09  Score=86.40  Aligned_cols=67  Identities=12%  Similarity=0.138  Sum_probs=57.4

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh----CCC--cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKD----LPW--KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~----~~~--~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++..+++++|+.||.+ +|+|+.+||+.+|+..    +|.  .+++.+++++++.+|.|+||.|        +|+||+.+
T Consensus         7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I--------~f~EF~~~   77 (100)
T 1psr_A            7 RSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKI--------DFSEFLSL   77 (100)
T ss_dssp             HHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcC--------cHHHHHHH
Confidence            4567899999999976 8999999999999862    233  5677889999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus        78 ~~   79 (100)
T 1psr_A           78 LG   79 (100)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A

Probab=98.77  E-value=7e-09  Score=88.56  Aligned_cols=69  Identities=13%  Similarity=0.300  Sum_probs=63.6

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      .++..+++.+|..||.|++|+|+.+||+.+|+. +|..+++++++.++..+|.|++|.|        +|++|+.++..
T Consensus        46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~e~~~l~~~~D~d~dg~I--------~~~eF~~~~~~  114 (150)
T 2jjz_A           46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEK-LGVPKTHLEMKKMISEVTGGVSDTI--------SYRDFVNMMLG  114 (150)
T ss_dssp             HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHHTTSCSSB--------CHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHHCCCCCCcE--------eHHHHHHHHHH
Confidence            356788999999999999999999999999999 9999999999999999999999999        99999886643

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=98.74  E-value=1.1e-08  Score=88.55  Aligned_cols=67  Identities=13%  Similarity=0.167  Sum_probs=61.7

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|.. +|..+++++++.+|..+|.|+||.|        +|+||+.++..
T Consensus        93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~I--------~~~eF~~~~~~  159 (166)
T 2mys_B           93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTT-GGGRFTPEEIKNMWAAFPPDVAGNV--------DYKNICYVITH  159 (166)
T ss_pred             cHHHHHHHHHHhCCCCCcceeHHHHHHHHHH-cCCCCCHHHHHHHHHhcCCCCCCeE--------eHHHHHHHHHh
Confidence            3467889999999999999999999999999 9999999999999999999999999        89999887653

>1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ...

Probab=98.74  E-value=7.2e-09  Score=88.00  Aligned_cols=71  Identities=21%  Similarity=0.416  Sum_probs=65.5

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++..+++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++..+|.|++|.|        +|+||+.+..
T Consensus         3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~~~~   73 (148)
T 1exr_A            3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLSLMA   73 (148)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHHCCCCCCcC--------cHHHHHHHHH
Confidence            456778889999999999999999999999999999 8999999999999999999999999        8999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.6e-07  Score=90.10  Aligned_cols=137  Identities=17%  Similarity=0.291  Sum_probs=95.7

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCC--CccEEEEEEE-eCCEEEEEEe
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE--NVVKFYNAFE-DDNYVYIAME  177 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hp--nIv~~~~~~~-~~~~~~lv~e  177 (487)
                      ++.++.|....||++     |..+++|+-..     ......+.+|..+|+.|..+-  .+++++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            345888998999988     56788887422     234567899999999997432  3567777664 4566789999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH---------------------------------------  218 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---------------------------------------  218 (487)
                      +++|.++.+...    ..++......++.++...|..||+.                                       
T Consensus        94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999988765321    2245555555666666666655532                                       


Q ss_pred             ---------------------CceeecCCCCceEeccCCCCCc-EEEeecccccc
Q 011380          219 ---------------------GLVHRDMKPENFLFKSAKEDSS-LKATDFGLSDF  251 (487)
Q Consensus       219 ---------------------~iiHrDlkp~NIll~~~~~~~~-vkl~DfG~a~~  251 (487)
                                           .++|+|++|.|||++....++. +.|+||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 3599999999999984222344 48999998754

>3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group}

Probab=98.73  E-value=6.7e-09  Score=91.51  Aligned_cols=68  Identities=21%  Similarity=0.325  Sum_probs=60.1

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHH-hhCCCc-c------cHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALA-KDLPWK-L------KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~-~~~~~~-~------~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      .....++.+|+.||.|++|+|+.+||+.+|+ . +|.. +      ++++++.+|..+|.|+||.|        +|+||+
T Consensus        95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~-~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I--------~~~EF~  165 (179)
T 3a8r_A           95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALS-ASANKLSKIKERADEYTALIMEELDPTNLGYI--------EMEDLE  165 (179)
T ss_dssp             CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHH-HHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEE--------CHHHHH
T ss_pred             CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH-hccccccccccchHHHHHHHHHHhCCCCCCcC--------cHHHHH
Confidence            3456899999999999999999999999998 7 7765 5      78899999999999999999        999998


Q ss_pred             ccccc
Q 011380          473 LFPVD  477 (487)
Q Consensus       473 ~~~~~  477 (487)
                      .++..
T Consensus       166 ~~~~~  170 (179)
T 3a8r_A          166 ALLLQ  170 (179)
T ss_dssp             HHHC-
T ss_pred             HHHHh
Confidence            76653

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=98.72  E-value=7.1e-09  Score=87.86  Aligned_cols=65  Identities=23%  Similarity=0.352  Sum_probs=60.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|..++++++..++..+|.|++|.|        +|++|+.++.
T Consensus        82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~d~dg~i--------~~~eF~~~~~  146 (148)
T 1m45_A           82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTG-LGEKLTDAEVDELLKGVEVDSNGEI--------DYKKFIEDVL  146 (148)
T ss_dssp             THHHHHHHHTTCSSSSSEEEHHHHHHHHHH-STTCCCHHHHHHHHTTCCCCTTSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHh
Confidence            356889999999999999999999999999 9999999999999999999999999        9999987653

>1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A

Probab=98.71  E-value=4.6e-09  Score=81.63  Aligned_cols=68  Identities=16%  Similarity=0.255  Sum_probs=60.2

Q ss_pred             HHHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAID-VDKNG-SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      .+...++.+|..+| .|++| +|+.+||+.+|+..    +|..+++++++.++..+|.|++|.|        +|+||+.+
T Consensus         6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~   77 (93)
T 1k2h_A            6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEV--------DFQEFVVL   77 (93)
T ss_dssp             HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCC--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHH
Confidence            34578999999999 79999 99999999999852    4677899999999999999999999        99999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        78 ~~   79 (93)
T 1k2h_A           78 VA   79 (93)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A

Probab=98.71  E-value=3.2e-09  Score=83.13  Aligned_cols=67  Identities=13%  Similarity=0.197  Sum_probs=56.8

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++..+++++|..||. ++|+|+.+||+.+|+..+    |..+++.+++++++.+|.|+||.|        +|+||+.++.
T Consensus         6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I--------~f~EF~~~~~   76 (96)
T 1a4p_A            6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKV--------GFQSFFSLIA   76 (96)
T ss_dssp             HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            356789999999994 567999999999997533    345688899999999999999999        9999987654

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=98.70  E-value=1.2e-08  Score=85.97  Aligned_cols=69  Identities=29%  Similarity=0.372  Sum_probs=63.2

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDM  478 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~~  478 (487)
                      .....++.+|..+|.|++|+|+.+|++.+|.. +|..+++++++.++..+|.|++|.|        +|++|+.++...
T Consensus        73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~g~~~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~~~~  141 (145)
T 2bl0_B           73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLN-LGDALTSSEVEELMKEVSVSGDGAI--------NYESFVDMLVTG  141 (145)
T ss_dssp             GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHTTCCCCTTSEE--------EHHHHHHHHHHS
T ss_pred             ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH-cCCCCCHHHHHHHHHHcCCCCCCcE--------eHHHHHHHHHhc
Confidence            34567899999999999999999999999999 9999999999999999999999999        999999876643

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=98.70  E-value=1.3e-08  Score=85.99  Aligned_cols=74  Identities=23%  Similarity=0.414  Sum_probs=66.5

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      |+..+++++...++++|..+|.|++|.|+.+|++.++.. +|..++..++..++..+|.+++|.|        +|++|+.
T Consensus         1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i--------~~~ef~~   71 (147)
T 4ds7_A            1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRS-LGLSPSEAEVADLMNEIDVDGNHAI--------EFSEFLA   71 (147)
T ss_dssp             ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSEE--------EHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHH-hCCCCCHHHHHHHHHHhccCCCCcC--------cHHHHHH
Confidence            456678888999999999999999999999999999999 9999999999999999999999999        8999987


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      +..
T Consensus        72 ~~~   74 (147)
T 4ds7_A           72 LMS   74 (147)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1

Probab=98.69  E-value=2e-09  Score=80.62  Aligned_cols=67  Identities=18%  Similarity=0.293  Sum_probs=59.3

Q ss_pred             HHHHHHHhhcccCC-CCCC-CCCHHHHHHHHHhhCCCcc-cHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDV-DKNG-SISLEEMRQALAKDLPWKL-KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~-d~~G-~i~~~el~~~l~~~~~~~~-~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +...++.+|..+|. |++| .|+.+||+.+|+..+|..+ +..+++.++..+|.|++|.|        +|+||+.+..
T Consensus         5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~   74 (78)
T 1cb1_A            5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEV--------SFEEFQVLVK   74 (78)
T ss_dssp             CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCC--------cHHHHHHHHH
Confidence            45678999999999 9999 9999999999984378766 88889999999999999999        8999987653

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=98.69  E-value=1.7e-08  Score=86.32  Aligned_cols=67  Identities=25%  Similarity=0.359  Sum_probs=61.9

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHh--cCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA--VNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~--~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|.. +|..++++++..++..  +|.|++|.|        +|++|+.++..
T Consensus        82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~~  150 (156)
T 1wdc_C           82 TFADYMEAFKTFDREGQGFISGAELRHVLTA-LGERLSDEDVDEIIKLTDLQEDLEGNV--------KYEDFVKKVMA  150 (156)
T ss_dssp             CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHHHHTCCCCTTSEE--------EHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCCCcE--------eHHHHHHHHhc
Confidence            3467889999999999999999999999999 9999999999999999  999999999        99999887653

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=98.69  E-value=1.6e-08  Score=88.71  Aligned_cols=73  Identities=22%  Similarity=0.423  Sum_probs=64.4

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +..+++++...++++|..+|.|++|.|+.+|++.+|.. +|..++..++..++..+|.|++|.|        +|+||+.+
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~EF~~~   72 (179)
T 2f2o_A            2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLTM   72 (179)
T ss_dssp             ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhccCCCCCC--------cHHHHHHH
Confidence            34566778889999999999999999999999999999 9999999999999999999999999        89999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        73 ~~   74 (179)
T 2f2o_A           73 MA   74 (179)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=98.68  E-value=2.1e-08  Score=84.28  Aligned_cols=64  Identities=22%  Similarity=0.271  Sum_probs=59.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|.|+.+|++.+|.. +|..+++++++.++..+| |++|.|        +|+||+.++
T Consensus        77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~d-~~dg~i--------~~~eF~~~~  140 (142)
T 2bl0_C           77 SEDILRQAFRTFDPEGTGYIPKAALQDALLN-LGDRLKPHEFAEFLGITE-TEKGQI--------RYDNFINTM  140 (142)
T ss_dssp             CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHH-SSSCCCHHHHHHHHHHHC-CSSSEE--------CSHHHHTTT
T ss_pred             hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhC-CCCCcE--------eHHHHHHHH
Confidence            3457889999999999999999999999999 999999999999999999 999999        999998764

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=98.68  E-value=2.1e-08  Score=86.21  Aligned_cols=74  Identities=22%  Similarity=0.353  Sum_probs=67.4

Q ss_pred             HhccCChHHHHHHHHhhcccCCCC-CCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDK-NGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~-~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      +...+++++..+++++|..+|.|+ +|.|+.+|++.+|.. +|..++..++..++..+|.|++|.|        +|+||+
T Consensus         8 ~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~D~~~~g~i--------~~~eF~   78 (161)
T 1dtl_A            8 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM-LGQNPTPEELQEMIDEVDEDGSGTV--------DFDEFL   78 (161)
T ss_dssp             GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSSB--------CHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHH
Confidence            345667888899999999999999 999999999999999 9999999999999999999999999        899998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .+..
T Consensus        79 ~~~~   82 (161)
T 1dtl_A           79 VMMV   82 (161)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=98.66  E-value=2.5e-08  Score=86.52  Aligned_cols=66  Identities=15%  Similarity=0.237  Sum_probs=61.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+||+.++.. +|..+++++++.++..+|.|+||.|        +|+||+.++.
T Consensus        99 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~  164 (169)
T 3qrx_A           99 SREEILKAFRLFDDDNSGTITIKDLRRVAKE-LGENLTEEELQEMIAEADRNDDNEI--------DEDEFIRIMK  164 (169)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCCSSSSCB--------CHHHHHHHHC
T ss_pred             cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCCE--------eHHHHHHHHH
Confidence            3457888999999999999999999999999 9999999999999999999999999        9999988764

>1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A

Probab=98.66  E-value=5.6e-09  Score=80.49  Aligned_cols=67  Identities=13%  Similarity=0.248  Sum_probs=59.6

Q ss_pred             HHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhh--CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAID-VDKNG-SISLEEMRQALAKD--LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~--~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+| +|++| .|+.+||+.+++..  +|..++..+++.+++.+|.|++|.|        +|+||+.+..
T Consensus         8 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~   78 (90)
T 1k8u_A            8 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEV--------NFQEYVTFLG   78 (90)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHH
Confidence            4568899999999 69999 99999999999853  5778888999999999999999999        8999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.66  E-value=3.7e-07  Score=85.79  Aligned_cols=133  Identities=17%  Similarity=0.192  Sum_probs=96.7

Q ss_pred             eeecCce-EEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEeccCCC
Q 011380          104 LGHGQFG-YTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGG  182 (487)
Q Consensus       104 lG~G~~g-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~gg  182 (487)
                      +..|..| .||+......+..+++|+-...      ....+.+|..+|+.|..+-.+.+++.++.+.+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445444 6999887777788999976432      34678899999999976656888999999999999999999998


Q ss_pred             CHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------------
Q 011380          183 ELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLH--------------------------------------------  218 (487)
Q Consensus       183 ~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~--------------------------------------------  218 (487)
                      ++.+.....      ......+..++...|.-||..                                            
T Consensus       106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            876654221      122334555566666666621                                            


Q ss_pred             --------------CceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          219 --------------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       219 --------------~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                                    .++|+|+.|.|||++   +.+.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence                          268999999999998   345567999998753

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=98.66  E-value=2e-08  Score=86.25  Aligned_cols=66  Identities=17%  Similarity=0.291  Sum_probs=61.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|.. +|..+++++++.++..+|.|++|.|        +|+||+.++.
T Consensus        94 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~eF~~~~~  159 (161)
T 3fwb_A           94 PLDEIKRAFQLFDDDHTGKISIKNLRRVAKE-LGETLTDEELRAMIEEFDLDGDGEI--------NENEFIAICT  159 (161)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHTTCSSSSSSE--------EHHHHHHHHH
T ss_pred             cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHh
Confidence            4567889999999999999999999999999 9999999999999999999999999        8999987653

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=98.65  E-value=1e-08  Score=87.15  Aligned_cols=72  Identities=24%  Similarity=0.439  Sum_probs=67.1

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +..+++++...++++|..+|.|++|.|+.+|++.+|.. +|..++..++..++..+|.+++|.|        +|++|+.+
T Consensus         2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~~   72 (153)
T 3ox6_A            2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRT-MGYMPTEMELIELSQQINMNLGGHV--------DFDDFVEL   72 (153)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHH-TTCCCCHHHHHHHHHHHHTTSTTCC--------CHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCccC--------cHHHHHHH
Confidence            45677888999999999999999999999999999999 9999999999999999999999999        89999876


Q ss_pred             c
Q 011380          475 P  475 (487)
Q Consensus       475 ~  475 (487)
                      .
T Consensus        73 ~   73 (153)
T 3ox6_A           73 M   73 (153)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=98.65  E-value=1.5e-08  Score=85.09  Aligned_cols=68  Identities=16%  Similarity=0.375  Sum_probs=62.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++..+++++|..+|.|++|.|+.+|++.+|+. +|..++..++..++..+|.|++|.|        +|++|+.+..
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~~~~   69 (142)
T 2bl0_C            2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQ-FGVRVEPAAFNEMFNEADATGNGKI--------QFPEFLSMMG   69 (142)
T ss_dssp             CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCcCCCCee--------eHHHHHHHHH
Confidence            456788999999999999999999999999999 8999999999999999999999999        8999987654

>3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A

Probab=98.65  E-value=2.4e-08  Score=80.36  Aligned_cols=66  Identities=17%  Similarity=0.137  Sum_probs=59.7

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.++..+++++|+.+|. ++|+|+.+|++.+|.+ .|  ++.+++.+|+..+|.|+||.|        +|+||+..+
T Consensus        27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~-sg--Lp~~~L~~Iw~laD~d~dG~L--------d~~EF~~aM   92 (121)
T 3fia_A           27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQ-SG--LPQPVLAQIWALADMNNDGRM--------DQVEFSIAM   92 (121)
T ss_dssp             CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGG-GC--CCHHHHHHHHHHHCTTCSSEE--------CHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHH-cC--CCHHHHHHHHHHHcCCCCCcC--------CHHHHHHHH
Confidence            467788999999999998 8999999999999998 65  578999999999999999999        999998744

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=98.64  E-value=1.6e-08  Score=90.36  Aligned_cols=66  Identities=14%  Similarity=0.056  Sum_probs=61.0

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..||.|++|+|+.+||+.+| . +|..++++++..+|..+|.|+||.|        +|++|+.++..
T Consensus       124 ~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~-~g~~~~~~~~~~l~~~~D~d~dG~I--------~~~EF~~~l~~  189 (196)
T 3dtp_E          124 EEDVIVNAFNLFDEGDGKCKEETLKRSLT-T-WGEKFSQDEVDQALSEAPIDGNGLI--------DIKKFAQILTK  189 (196)
T ss_dssp             CHHHHHHHHHTTCSSSSCCBHHHHHHHHH-H-SSSCCCHHHHHHHHHSSCEETTEEC--------HHHHHHHHHSS
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHH-H-cCCCCCHHHHHHHHHHcCCCCCCEE--------eHHHHHHHHHc
Confidence            34578899999999999999999999999 8 9999999999999999999999999        99999987653

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=98.64  E-value=6.6e-09  Score=88.43  Aligned_cols=71  Identities=18%  Similarity=0.335  Sum_probs=65.9

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++++++++++++|..+|.|++|.|+.+||+.+++. +|..+++.++..++..+|.+++|.|        +|.+|+....
T Consensus         3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~~   73 (148)
T 2lmt_A            3 ELTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRT-LGQNPTEAELQDLIAEAENNNNGQL--------NFTEFCGIMA   73 (148)
T ss_dssp             SCCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHH-HTCCCCHHHHHHHHHHHHTTSTTEE--------EHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHh-cCCCchHHHHHHHHHhcccCCCCcc--------cHHHHHHHHH
Confidence            467888999999999999999999999999999999 9999999999999999999999999        8999987543

>1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A

Probab=98.64  E-value=1.3e-08  Score=80.05  Aligned_cols=67  Identities=16%  Similarity=0.142  Sum_probs=58.4

Q ss_pred             HHHHHHHhhcccC-CCCCC-CCCHHHHHHHHHhhCC----CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAID-VDKNG-SISLEEMRQALAKDLP----WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D-~d~~G-~i~~~el~~~l~~~~~----~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+| .|++| +|+.+||+.+|+..+|    ..++..+++.+++.+|.|++|.|        +|+||+.+.
T Consensus        11 ~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I--------~~~EF~~~~   82 (99)
T 1qls_A           11 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQL--------DFQEFLNLI   82 (99)
T ss_dssp             HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            4568999999998 99999 9999999999983154    56788999999999999999999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        83 ~   83 (99)
T 1qls_A           83 G   83 (99)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=98.64  E-value=1.6e-08  Score=92.22  Aligned_cols=89  Identities=15%  Similarity=0.227  Sum_probs=76.4

Q ss_pred             HhhhhhHHHHHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          379 QFVKYSRLKQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       379 ~~~~~~~~k~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      .+.....+++.....+...++.++..+++++|..+|.|++|.|+.+|++.+|+. +|..++.++++.+++.+|.|++|.|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~~~~~l~~~~D~d~dg~I  104 (220)
T 3sjs_A           26 IYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFP-GGIRLSPQTALRMMRIFDTDFNGHI  104 (220)
T ss_dssp             HHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBG-GGBCCCHHHHHHHHHHHCTTCSSCB
T ss_pred             ccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcC
Confidence            333344455555555667788999999999999999999999999999999999 8999999999999999999999999


Q ss_pred             ecCccccccchhhhcccc
Q 011380          459 LPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       459 ~~~~~~~~~f~~f~~~~~  476 (487)
                              +|+||+.+..
T Consensus       105 --------~~~EF~~~~~  114 (220)
T 3sjs_A          105 --------SFYEFMAMYK  114 (220)
T ss_dssp             --------CHHHHHHHHH
T ss_pred             --------CHHHHHHHHH
Confidence                    9999987653

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=98.63  E-value=2.5e-08  Score=85.36  Aligned_cols=65  Identities=11%  Similarity=0.219  Sum_probs=60.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|..+++++++.+++.+|.| +|.|        +|++|+.++..
T Consensus        86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~~-dg~i--------~~~eF~~~~~~  150 (156)
T 1wdc_B           86 EETIRNAFAMFDEQETKKLNIEYIKDLLEN-MGDNFNKDEMRMTFKEAPVE-GGKF--------DYVKFTAMIKG  150 (156)
T ss_dssp             HHHHHHHHHTTCTTCCSCEEHHHHHHHHHH-SSSCCCHHHHHHHHHHCCEE-TTEE--------CHHHHHHHHHT
T ss_pred             HHHHHHHHHHHCcCCCCccCHHHHHHHHHH-hCCCCCHHHHHHHHHhcCCC-CCEE--------eHHHHHHHHhc
Confidence            457889999999999999999999999999 99999999999999999999 9999        99999887653

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=98.63  E-value=3.3e-08  Score=84.69  Aligned_cols=71  Identities=14%  Similarity=0.242  Sum_probs=65.9

Q ss_pred             cCChHHHHHHHHhhcccC-CCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAID-VDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D-~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++++..+++++|..+| .|++|.|+.+|++.+|+. +|..++..++..++..+|.|++|.|        +|++|+.+.
T Consensus         6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~eF~~~~   76 (158)
T 2jnf_A            6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEV-LGIQQTKSTIRQLIDEFDPFGNGDI--------DFDSFKIIG   76 (158)
T ss_dssp             TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHH-TTCSCSHHHHHHHHHHHCTTCCSEE--------CHHHHHHHH
T ss_pred             hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            456778889999999999 999999999999999999 9999999999999999999999999        999998866


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        77 ~   77 (158)
T 2jnf_A           77 A   77 (158)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A

Probab=98.63  E-value=3e-08  Score=85.16  Aligned_cols=72  Identities=18%  Similarity=0.393  Sum_probs=66.6

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+++++...++++|..+|.|++|.|+.+||..+|+. +|..++..++..++..+|.+++|.|        +|++|+.+.
T Consensus        15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~l~~~~d~~~~g~i--------~~~eF~~~~   85 (161)
T 3fwb_A           15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKA-LGFELPKREILDLIDEYDSEGRHLM--------KYDDFYIVM   85 (161)
T ss_dssp             TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSCE--------EHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCcCCCCeE--------eHHHHHHHH
Confidence            4467788899999999999999999999999999999 9999999999999999999999999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        86 ~   86 (161)
T 3fwb_A           86 G   86 (161)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=98.63  E-value=4.3e-08  Score=82.90  Aligned_cols=66  Identities=21%  Similarity=0.344  Sum_probs=60.8

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .....++.+|..+|.|++|+|+.+|++.+|.. +|..++++++..++.. |.|++|.|        +|++|+.++.
T Consensus        82 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~-d~~~dg~i--------~~~eF~~~~~  147 (149)
T 2mys_C           82 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLAT-LGEKMTEEEVEELMKG-QEDSNGCI--------NYEAFVKHIM  147 (149)
T ss_pred             chHHHHHHHHHHhCCCCCceEcHHHHHHHHHH-hCCCCCHHHHHHHHhh-CCCCCCcE--------eHHHHHHHHh
Confidence            34567889999999999999999999999999 8999999999999999 99999999        9999988654

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=98.63  E-value=3.1e-08  Score=83.03  Aligned_cols=65  Identities=23%  Similarity=0.369  Sum_probs=60.0

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|+. +|..+++++++.++..+|. ++|.|        +|+||+.++.
T Consensus        74 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~-~dg~i--------~~~eF~~~~~  138 (140)
T 1ggw_A           74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTS-LGEKLSNEEMDELLKGVPV-KDGMV--------NYHDFVQMIL  138 (140)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHH-HHSCSCHHHHHHHHHHTTC-SSCCS--------TTTHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH-cCCCCCHHHHHHHHHhccC-CCCcE--------eHHHHHHHHh
Confidence            3467889999999999999999999999999 8999999999999999999 99999        9999987654

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=98.63  E-value=4.7e-08  Score=87.65  Aligned_cols=69  Identities=22%  Similarity=0.238  Sum_probs=62.6

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC-CCcccHHHHHHHHHh----cCCCCCceeecCccccccchhhhcc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL-PWKLKESRVLEILQA----VNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~-~~~~~~~e~~~~~~~----~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ......++.+|..+|.|++|+|+.+||+.++.. + |..+++++++.++..    +|.|+||.|        +|+||+.+
T Consensus       110 ~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~-~~g~~~~~~~~~~~~~~~~~~~D~d~dG~I--------s~~EF~~~  180 (202)
T 2bec_A          110 NSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRL-MVGVQVTEEQLENIADRTVQEADEDGDGAV--------SFVEFTKS  180 (202)
T ss_dssp             TSHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-SCCSCCCHHHHHHHHHHHHHHHCSSCSSSE--------EHHHHHHT
T ss_pred             ccHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHcCCCCCCcC--------cHHHHHHH
Confidence            345578999999999999999999999999999 7 999999999999999    999999999        99999987


Q ss_pred             ccc
Q 011380          475 PVD  477 (487)
Q Consensus       475 ~~~  477 (487)
                      +..
T Consensus       181 ~~~  183 (202)
T 2bec_A          181 LEK  183 (202)
T ss_dssp             TTT
T ss_pred             HHH
Confidence            653

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A

Probab=98.62  E-value=2.3e-09  Score=85.88  Aligned_cols=64  Identities=20%  Similarity=0.236  Sum_probs=58.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|+.+|.|++|+|+.+||+.+|.. +   |..++++++..+++.+|.|++|.|        +|+||+.++
T Consensus        40 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~~~~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~  106 (108)
T 2kyc_A           40 SSQLKEIFRILDNDQSGFIEEDELKYFLQR-FESGARVLTASETKTFLAAADHDGDGKI--------GAEEFQEMV  106 (108)
T ss_dssp             SSSHHHHCSSSCSCCSSCCCGGGTTTSHHH-HSSSCCCCCTTTTHHHHTTTCCSSSSCC--------CSSHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCeEcHHHHHHHHHH-HhhccCCCCHHHHHHHHHHhCCCCCCcC--------CHHHHHHHH
Confidence            356888999999999999999999999998 7   788899999999999999999999        999998754

>3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A

Probab=98.62  E-value=3.4e-08  Score=85.64  Aligned_cols=71  Identities=23%  Similarity=0.455  Sum_probs=65.9

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++..+++++|..+|.|++|.|+.+||..+|+. +|..++..++..++..+|.|++|.|        +|+||+.+..
T Consensus        21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~eF~~~~~   91 (169)
T 3qrx_A           21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRA-LGFEPKKEEIKKMISEIDKDGSGTI--------DFEEFLTMMT   91 (169)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHH-TSCCCCHHHHHHHHHHHCSSSSSSE--------EHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhcCCCCCcC--------CHHHHHHHHH
Confidence            457788899999999999999999999999999999 9999999999999999999999999        8999987654

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=98.62  E-value=1.9e-08  Score=85.55  Aligned_cols=64  Identities=23%  Similarity=0.331  Sum_probs=58.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|..++++++..++..+| |++|.|        +|+||+.++.
T Consensus        86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d-~~dg~i--------~~~eF~~~~~  149 (151)
T 1w7j_B           86 YEDYLEGFRVFDKEGNGKVMGAELRHVLTT-LGEKMTEEEVETVLAGHE-DSNGCI--------NYEAFLKHIL  149 (151)
T ss_dssp             --CCHHHHHTTCTTSSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHTTCC-CTTSEE--------EHHHHHHHTC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHhcc-CCCCeE--------eHHHHHHHHh
Confidence            456788999999999999999999999999 999999999999999999 999999        9999988654

>2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A

Probab=98.61  E-value=6.9e-09  Score=85.25  Aligned_cols=71  Identities=13%  Similarity=0.110  Sum_probs=59.1

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccccce
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMV  479 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~~~  479 (487)
                      .++..+++++|+.||    |+|+.+||+.+|+. +|.  ++++++++++.+|.|++|.|        +|+||+.++.+..
T Consensus        46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~-lG~--t~~ei~~~~~~~D~d~dG~I--------~~~EF~~~~~~~~  110 (123)
T 2kld_A           46 KNTVDDISESLRQGG----GKLNFDELRQDLKG-KGH--TDAEIEAIFTKYDQDGDQEL--------TEHEHQQMRDDLE  110 (123)
T ss_dssp             -----CCSCSSTTTT----TCEEHHHHHHHTTT-CCS--SHHHHHHHHHHHSSSSCCEE--------CSHHHHHCSCTTT
T ss_pred             hhHHHHHHHHHHHhC----CCCCHHHHHHHHHH-hCC--CHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHHHHH
Confidence            344567889999999    99999999999999 997  89999999999999999999        9999999887665


Q ss_pred             eeeeee
Q 011380          480 YNLLYL  485 (487)
Q Consensus       480 ~~~~~~  485 (487)
                      .+.-|+
T Consensus       111 ~~~~~~  116 (123)
T 2kld_A          111 KEREDL  116 (123)
T ss_dssp             CCCSCC
T ss_pred             HhHHHH
Confidence            555443

>4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A

Probab=98.61  E-value=4.5e-08  Score=82.53  Aligned_cols=64  Identities=23%  Similarity=0.333  Sum_probs=59.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|.|+.+|++.++.. +|..++++++..++..+| |++|.|        +|++|+.++
T Consensus        82 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d-~~dg~i--------~~~eF~~~l  145 (147)
T 4ds7_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVLTS-IGEKLTDAEVDEMLREVS-DGSGEI--------NIKQFAALL  145 (147)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHS-SSCSSE--------EHHHHHHHT
T ss_pred             cHHHHHHHHHHhCCCCCCeECHHHHHHHHHH-cCCCCCHHHHHHHHHHhc-CCCCcC--------cHHHHHHHH
Confidence            3467889999999999999999999999998 999999999999999999 999999        899998764

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=98.61  E-value=6.5e-09  Score=89.69  Aligned_cols=70  Identities=19%  Similarity=0.265  Sum_probs=62.5

Q ss_pred             cCChHHHHHHHHhhcccCC--CCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          397 TLDDEELADLRDQFDAIDV--DKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~--d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      .++++++++++++|..||.  |++|+|+.+||+.+|+. +|..+++.++..++. .|.+++|.|        +|++|+.+
T Consensus         2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~-lG~~~t~~el~~~~~-~d~~~~g~i--------~f~eFl~~   71 (159)
T 3i5g_C            2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRC-LGMNPTEAQVHQHGG-TKKMGEKAY--------KLEEILPI   71 (159)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHH-TTCCCCHHHHHTTTC-CSSTTSCEE--------CHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHH-cCCCCCHHHHHHHHc-ccccCCCcc--------cHHHHHHH
Confidence            4678899999999999995  89999999999999999 999999999999865 577899999        99999875


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        72 ~~   73 (159)
T 3i5g_C           72 YE   73 (159)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A

Probab=98.61  E-value=2e-08  Score=86.12  Aligned_cols=65  Identities=25%  Similarity=0.344  Sum_probs=60.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|..++++++..++..+|.|++|.|        +|+||+.++.
T Consensus        90 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~  154 (158)
T 2jnf_A           90 QQELREAFRLYDKEGNGYISTDVMREILAE-LDETLSSEDLDAMIDEIDADGSGTV--------DFEEFMGVMT  154 (158)
T ss_dssp             SSTHHHHHHHHCSSSSSSEEHHHHHHHHHH-HCTTCCHHHHHHHHHHHCSSCCSEE--------CSHHHHHHTS
T ss_pred             HHHHHHHHHHhCCCCCCeEcHHHHHHHHHH-hCCcCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHh
Confidence            356888999999999999999999999999 8999999999999999999999999        9999987654

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=98.59  E-value=4.3e-08  Score=84.24  Aligned_cols=75  Identities=24%  Similarity=0.374  Sum_probs=68.7

Q ss_pred             HHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          393 ALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       393 ~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      .++..+++++...++++|..+|.|++|.|+.+|++.++.. +|..++..++..++..+|.|++|.|        +|++|+
T Consensus         9 ~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~   79 (162)
T 1top_A            9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRM-LGQNPTKEELDAIIEEVDEDGSGTI--------DFEEFL   79 (162)
T ss_dssp             HHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHHHCTTSCCEE--------EHHHHH
T ss_pred             HhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHHcCCCCCcE--------eHHHHH
Confidence            3555678889999999999999999999999999999999 9999999999999999999999999        899998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .+..
T Consensus        80 ~~~~   83 (162)
T 1top_A           80 VMMV   83 (162)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=98.59  E-value=1.8e-08  Score=89.44  Aligned_cols=71  Identities=25%  Similarity=0.526  Sum_probs=64.3

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++..+++++|..+|.|++|.|+.+||+.+|.. +|..+++.++..++..+|.|++|.|        +|+||+....
T Consensus         3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~-~g~~~~~~~~~~l~~~~D~d~dG~I--------~~~EF~~~~~   73 (188)
T 1s6i_A            3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSELMESEIKDLMDAADIDKSGTI--------DYGEFIAATV   73 (188)
T ss_dssp             SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTT-TTCCCCHHHHHHHHHHTCTTCSSEE--------CHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHcCCCCCCeE--------eHHHHHHHHH
Confidence            455666778999999999999999999999999999 9999999999999999999999999        8999987653

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=98.59  E-value=4.9e-08  Score=82.48  Aligned_cols=63  Identities=14%  Similarity=0.197  Sum_probs=58.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|+|+.+||+.++.. +|..+++++++.++..+  |++|.|        +|++|+.++
T Consensus        82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~--d~dg~i--------~~~eF~~~l  144 (146)
T 2qac_A           82 NVEELIKMFAHFDNNCTGYLTKSQMKNILTT-WGDALTDQEAIDALNAF--SSEDNI--------DYKLFCEDI  144 (146)
T ss_dssp             CHHHHHHHHHTTCTTCSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHHHH--CSSSEE--------EHHHHHHHH
T ss_pred             hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hCCCCCHHHHHHHHHHc--CCCCcC--------cHHHHHHHH
Confidence            3567889999999999999999999999999 99999999999999999  999999        999998765

>3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A

Probab=98.57  E-value=5e-08  Score=82.78  Aligned_cols=65  Identities=26%  Similarity=0.401  Sum_probs=59.8

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|...+|..+++++++.++..+|.|++|.|        +|+||+.++
T Consensus        87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~  151 (153)
T 3ox6_A           87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRV--------DFEEFVRMM  151 (153)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSB--------CHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHH
Confidence            46788999999999999999999999998746888999999999999999999999        999998754

>1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ...

Probab=98.56  E-value=9.2e-08  Score=82.11  Aligned_cols=66  Identities=18%  Similarity=0.279  Sum_probs=60.8

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|.|+.+|++.++.. +|..++++++..++..+|.|++|.|        +|+||+.++.
T Consensus        94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~-~g~~~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~~  159 (162)
T 1top_A           94 SEEELANCFRIFDKNADGFIDIEELGEILRA-TGEHVTEEDIEDLMKDSDKNNDGRI--------DFDEFLKMME  159 (162)
T ss_dssp             HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHT-TTCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHh
Confidence            3467889999999999999999999999999 9999999999999999999999999        8999987653

>2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A

Probab=98.56  E-value=5.7e-08  Score=85.13  Aligned_cols=67  Identities=24%  Similarity=0.372  Sum_probs=59.7

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..+|.|++|+|+.+|++.++.. +|..++++++..+|..+|.|++|.|        +|+||+.++..
T Consensus        82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~-~g~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~~  148 (179)
T 2f2o_A           82 SEEEIREAFRVFDKDGNGYISAAELRHVMTN-LGEKLTDEEVDEMIREADIDGDGQV--------NYEEFVQMMTA  148 (179)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-C--CCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHSCC
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHcCCCCCCcC--------cHHHHHHHHHH
Confidence            3457889999999999999999999999999 9999999999999999999999999        89999887653

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=98.56  E-value=1.9e-08  Score=90.10  Aligned_cols=65  Identities=25%  Similarity=0.293  Sum_probs=58.2

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC--CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL--PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~--~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|+.+|.|++|+|+.+||+.+|.. +  |..+++++++.++..+|.|+||.|        +|+||+.++.
T Consensus       128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~-~~~~~~~~~~~~~~l~~~~D~d~dG~I--------s~~EF~~~l~  194 (197)
T 3pm8_A          128 KEVCLIPFKFFDIDGNGKISVEELKRIFGR-DDIENPLIDKAIDSLLQEVDLNGDGEI--------DFHEFMLMMS  194 (197)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHHC-----CCHHHHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-cccCCCCCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHH
Confidence            357889999999999999999999999998 7  778999999999999999999999        8999988654

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=98.54  E-value=3.3e-08  Score=86.58  Aligned_cols=62  Identities=11%  Similarity=0.197  Sum_probs=57.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++++|+.|| |++|+|+.+||+.+|+. +    |..+++++++.++..+| |++|.|        +|+||+.++.
T Consensus        76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~-l~~~~G~~~~~~~~~~l~~~~d-d~dG~I--------~~~EF~~~~~  141 (174)
T 2i7a_A           76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIEN-TDFLRGIFISRELLHLVTLRYS-DSVGRV--------SFPSLVCFLM  141 (174)
T ss_dssp             HHHHHHHHHHC-SBTTBEEGGGHHHHHHT-CGGGTTCCCCHHHHHHHHHHHS-CTTSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhc-CCCCcCCHHHHHHHHHH-hHhccCCCCCHHHHHHHHHHHc-CCCCeE--------cHHHHHHHHH
Confidence            46889999999 99999999999999999 8    99999999999999999 999999        9999987654

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=98.54  E-value=7.6e-08  Score=86.79  Aligned_cols=67  Identities=19%  Similarity=0.209  Sum_probs=60.6

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHH----HHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEI----LQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~----~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+||+.+|...+|..+++++++.+    ++.+|.|+||.|        +|+||+.++.
T Consensus       111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~I--------s~~EF~~~~~  181 (208)
T 2ct9_A          111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAI--------SFTEFVKVLE  181 (208)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSE--------EHHHHHHTTT
T ss_pred             HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHh
Confidence            456889999999999999999999999999833999999999888    999999999999        8999988664

>1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ...

Probab=98.53  E-value=3.3e-08  Score=84.89  Aligned_cols=66  Identities=23%  Similarity=0.324  Sum_probs=58.9

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|..+|.|++|+|+.+|++.++.. +|..++++++..++..+|.|++|.|        +|+||+.++.
T Consensus        93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~  158 (161)
T 1dtl_A           93 SEEELSDLFRMFDKNADGYIDLEELKIMLQA-TGETITEDDIEELMKDGDKNNDGRI--------DYDEFLEFMK  158 (161)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTT-C--CCCHHHHHHHHHHHCTTSSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            4467889999999999999999999999998 9999999999999999999999999        8999987653

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=98.51  E-value=1.3e-07  Score=80.49  Aligned_cols=80  Identities=21%  Similarity=0.216  Sum_probs=66.2

Q ss_pred             HHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHh----cCCCCCceeecCcc
Q 011380          389 FALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA----VNTPFLGLFLPCHE  463 (487)
Q Consensus       389 ~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~----~d~~~~g~i~~~~~  463 (487)
                      .|+..+.... .......++.+|..+|.|++|+|+.+|++.++...+|..++..++..++..    +|.|++|.|     
T Consensus        59 ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i-----  133 (155)
T 3ll8_B           59 EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRI-----  133 (155)
T ss_dssp             HHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSB-----
T ss_pred             HHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcC-----
Confidence            4455554433 334557889999999999999999999999998834888999999999999    999999999     


Q ss_pred             ccccchhhhcccc
Q 011380          464 KGEKFSYLLLFPV  476 (487)
Q Consensus       464 ~~~~f~~f~~~~~  476 (487)
                         +|+||+.++.
T Consensus       134 ---~~~eF~~~~~  143 (155)
T 3ll8_B          134 ---SFEEFCAVVG  143 (155)
T ss_dssp             ---CHHHHHHHHG
T ss_pred             ---cHHHHHHHHh
Confidence               8999988664

>2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C*

Probab=98.51  E-value=1.2e-07  Score=80.09  Aligned_cols=69  Identities=13%  Similarity=0.174  Sum_probs=63.5

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhc---CCCCCceeecCccccccchhhhcc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV---NTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~---d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +++++..+++++|..+|.|++|.|+.+|++.+|.. +|..++..++..++..+   |.++ |.|        +|++|+.+
T Consensus         2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-~~~~~~~~~~~~l~~~~~~~d~~~-g~i--------~~~eF~~~   71 (149)
T 2mys_C            2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARA-LGQNPTNAEINKILGNPSKEEMNA-AAI--------TFEEFLPM   71 (149)
T ss_pred             CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhhhccccC-CcC--------cHHHHHHH
Confidence            45677889999999999999999999999999999 99999999999999999   9999 999        89999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        72 ~~   73 (149)
T 2mys_C           72 LQ   73 (149)
T ss_pred             HH
Confidence            54

>1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7

Probab=98.50  E-value=6e-08  Score=76.92  Aligned_cols=64  Identities=17%  Similarity=0.170  Sum_probs=53.7

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh----hCCCcccH-----------HHHHHHHHhcCCCCCceeecCccccccch
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK----DLPWKLKE-----------SRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~----~~~~~~~~-----------~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      .++.+|..||.|++|+|+.+||+.++..    .+|...+.           ..+..+|..+|.|+||.|        +|+
T Consensus        21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~I--------s~~   92 (103)
T 1snl_A           21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLV--------TLE   92 (103)
T ss_dssp             CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEE--------EHH
T ss_pred             CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcC--------CHH
Confidence            4678999999999999999999999984    35654432           348899999999999999        999


Q ss_pred             hhhcccc
Q 011380          470 YLLLFPV  476 (487)
Q Consensus       470 ~f~~~~~  476 (487)
                      ||+.++.
T Consensus        93 EF~~~~~   99 (103)
T 1snl_A           93 EFLASTQ   99 (103)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9987653

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=98.50  E-value=1.7e-07  Score=80.14  Aligned_cols=69  Identities=20%  Similarity=0.437  Sum_probs=59.4

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++++.+++++|..||.|++|.|+.+||+.+|+. +|..+++.++..++..    .+|.|        +|.+|+.++
T Consensus         8 ~~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~-lg~~~~~~~~~~~~~~----~~~~i--------~f~ef~~~~   74 (153)
T 3i5g_B            8 VKLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSS-LGRVPPDDELNAMLKE----CPGQL--------NFTAFLTLF   74 (153)
T ss_dssp             TTCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHH-TTSCCCHHHHHHHHHT----SSSCC--------CSHHHHHTT
T ss_pred             cCCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-cCCCccHHHHHHHHHh----ccCCc--------cHHHHHHHH
Confidence            3468899999999999999999999999999999999 9999999888887764    45678        888888765


Q ss_pred             cc
Q 011380          476 VD  477 (487)
Q Consensus       476 ~~  477 (487)
                      ..
T Consensus        75 ~~   76 (153)
T 3i5g_B           75 GE   76 (153)
T ss_dssp             TT
T ss_pred             Hh
Confidence            43

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=98.49  E-value=6.3e-08  Score=81.83  Aligned_cols=64  Identities=14%  Similarity=0.129  Sum_probs=51.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC--------CCcccHHHHHHHH----HhcCCCCCceeecCccccccchh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL--------PWKLKESRVLEIL----QAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~--------~~~~~~~e~~~~~----~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      .+.++.+|+.||.|++|+|+.+||+.++.. +        |..++.+++..++    +.+|.|+||.|        +|+|
T Consensus        67 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~-~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d~dG~I--------s~~E  137 (143)
T 3a4u_B           67 QELQLHYFKMHDYDGNNLLDGLELSTAITH-VHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYI--------DYAE  137 (143)
T ss_dssp             HHHHHHHHHHTCTTCSSCEEHHHHHHTCC--------------CCHHHHHHHHHHHHHHHCTTCSSEE--------CHHH
T ss_pred             HHHHHHHHHHhCCCCCCccCHHHHHHHHHH-HHhhhccccCCCCCHHHHHHHHHHHHHHcCCCCCCcE--------eHHH
Confidence            356788999999999999999999999987 6        3568888886666    99999999999        9999


Q ss_pred             hhccc
Q 011380          471 LLLFP  475 (487)
Q Consensus       471 f~~~~  475 (487)
                      |+.++
T Consensus       138 F~~~~  142 (143)
T 3a4u_B          138 FAKSL  142 (143)
T ss_dssp             HHC--
T ss_pred             HHHHH
Confidence            98753

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=98.48  E-value=6e-08  Score=86.21  Aligned_cols=71  Identities=20%  Similarity=0.218  Sum_probs=63.3

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHH-----HHHHhhCCCcccHH-----HHHHHHHhcCCCCCceeecCcccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMR-----QALAKDLPWKLKES-----RVLEILQAVNTPFLGLFLPCHEKG  465 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~-----~~l~~~~~~~~~~~-----e~~~~~~~~d~~~~g~i~~~~~~~  465 (487)
                      ..+++++..+++++|..+|.|++|.|+.+||+     .+++. +|..++..     ++..++..+|.|++|.|       
T Consensus        12 ~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~-~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i-------   83 (195)
T 1qv0_A           12 DFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAK-LEATPEQTKRHQVCVEAFFRGCGMEYGKEI-------   83 (195)
T ss_dssp             CTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHH-TTCCHHHHHHHHHHHHHHHHHTTCCTTCCB-------
T ss_pred             ccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHH-cCCCccHHHHHHHHHHHHHHHcCCCCCceE-------
Confidence            33477888999999999999999999999999     78888 89888776     68999999999999999       


Q ss_pred             ccchhhhccc
Q 011380          466 EKFSYLLLFP  475 (487)
Q Consensus       466 ~~f~~f~~~~  475 (487)
                       +|+||+.+.
T Consensus        84 -~~~EF~~~~   92 (195)
T 1qv0_A           84 -AFPQFLDGW   92 (195)
T ss_dssp             -CHHHHHHHH
T ss_pred             -cHHHHHHHH
Confidence             999998754

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=98.47  E-value=1.1e-07  Score=82.75  Aligned_cols=69  Identities=13%  Similarity=0.146  Sum_probs=61.7

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHH----HHHhhCCCcccHHHHH-----------HHHHhcCCCCCceeecCcc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQ----ALAKDLPWKLKESRVL-----------EILQAVNTPFLGLFLPCHE  463 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~----~l~~~~~~~~~~~e~~-----------~~~~~~d~~~~g~i~~~~~  463 (487)
                      ++++..+++++|..+|.|++|.|+.+|++.    +++. +|..++..++.           .++..+|.|++|.|     
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~-~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i-----   75 (176)
T 1nya_A            2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEA-FGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSL-----   75 (176)
T ss_dssp             CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHH-TSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCB-----
T ss_pred             cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHH-cCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeE-----
Confidence            456788999999999999999999999999    6787 89998888887           89999999999999     


Q ss_pred             ccccchhhhcccc
Q 011380          464 KGEKFSYLLLFPV  476 (487)
Q Consensus       464 ~~~~f~~f~~~~~  476 (487)
                         +|+||+.+..
T Consensus        76 ---~~~Ef~~~~~   85 (176)
T 1nya_A           76 ---TEEQFIRVTE   85 (176)
T ss_dssp             ---CHHHHHHHHH
T ss_pred             ---cHHHHHHHHH
Confidence               8999987654

>1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A*

Probab=98.47  E-value=7.1e-08  Score=85.75  Aligned_cols=62  Identities=15%  Similarity=0.127  Sum_probs=53.8

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ..+|+.+|.|++|+|+.+||+.++.. +|..+++++++.++..+|.|++|.|        +|+||+..+..
T Consensus       116 ~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~~  177 (195)
T 1qv0_A          116 DAVFDIFDKDGSGTITLDEWKAYGKI-SGISPSQEDCEATFRHCDLDNAGDL--------DVDEMTRQHLG  177 (195)
T ss_dssp             HHHHHHTC----CEECHHHHHHHHHH-HSSCCCHHHHHHHHHHSCCCTTSCE--------EHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------CHHHHHHHHHH
Confidence            38999999999999999999999999 8999999999999999999999999        89999876653

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=98.47  E-value=7.8e-08  Score=85.11  Aligned_cols=63  Identities=17%  Similarity=0.185  Sum_probs=58.3

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ++.+|..+|.|++|+|+.+||+.++.. +|..++++++..++..+|.|++|.|        +|+||+.++..
T Consensus       111 ~~~~F~~~D~d~~G~Is~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dG~i--------~~~eF~~~~~~  173 (191)
T 1uhk_A          111 GDALFDIVDKDQNGAITLDEWKAYTKA-AGIIQSSEDCEETFRVCDIDESGQL--------DVDEMTRQHLG  173 (191)
T ss_dssp             HHHHHHHHCTTCSSEECHHHHHHHHHH-HTSCCSHHHHHHHHHHSCCCTTSCE--------EHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHHH
Confidence            348999999999999999999999999 8999999999999999999999999        89999887653

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=98.46  E-value=1.4e-07  Score=83.85  Aligned_cols=64  Identities=17%  Similarity=0.339  Sum_probs=59.5

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+|++.++.. +|..+++++++.+++.+|.|++|.|        +|+||+.+..
T Consensus        93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~-~g~~~~~~~~~~~~~~~D~d~dg~i--------~~~eF~~~~~  156 (191)
T 1y1x_A           93 LSMREGFRKRDSSGDGRLDSNEVRAALLS-SGYQVSEQTFQALMRKFDRQRRGSL--------GFDDYVELSI  156 (191)
T ss_dssp             HHHHHHHHHHCTTSSSCBCHHHHHHHHHT-TSCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            46788999999999999999999999999 9999999999999999999999999        8999987654

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=98.45  E-value=1.2e-07  Score=82.44  Aligned_cols=64  Identities=22%  Similarity=0.267  Sum_probs=57.9

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...++.+|+.+|.|++|+|+.+|++.++.. +|  +++++++.++..+|.|++|.|        +|+||+.++..
T Consensus        93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~-~g--~~~~~~~~~~~~~D~d~dg~i--------~~~ef~~~~~~  156 (174)
T 1q80_A           93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGM-LG--LDKTMAPASFDAIDTNNDGLL--------SLEEFVIAGSD  156 (174)
T ss_dssp             HTHHHHHHHHHCTTSSSSBCHHHHHHHHHH-HT--CCGGGHHHHHHHHCTTCSSSB--------CHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcccHHHHHHHHHH-cC--CCHHHHHHHHHHhCCCCCceE--------eHHHHHHHHHH
Confidence            467889999999999999999999999998 66  678899999999999999999        89999887643

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=98.44  E-value=1.2e-07  Score=85.01  Aligned_cols=68  Identities=22%  Similarity=0.247  Sum_probs=57.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+...++++|..+|.|++|.|+.+|++.+|+. +|..++..++..++..+|.|++|.|        +|+||+.+..
T Consensus        33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~D~d~dg~i--------~~~ef~~~~~  100 (204)
T 3e3r_A           33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAK-LGLVLDQAEAEGVCRKWDRNGSGTL--------DLEEFLRALR  100 (204)
T ss_dssp             -------CHHHHHHCTTCCSSBCHHHHHHHHHT-TTCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHTS
T ss_pred             chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHH-cCCCCCHHHHHHHHHHhccCCCCcC--------cHHHHHHHHH
Confidence            345678899999999999999999999999999 9999999999999999999999999        8999987664

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=98.43  E-value=1.9e-07  Score=80.41  Aligned_cols=63  Identities=16%  Similarity=0.160  Sum_probs=58.0

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ..++.+|..+|.|++|+|+.+|++.++.. +|  ++++++..++..+|.|+||.|        +|+||+.++..
T Consensus        98 ~~~~~~F~~~D~d~~G~i~~~E~~~~l~~-~~--~~~~~~~~~~~~~D~d~dg~i--------~~~ef~~~~~~  160 (166)
T 3akb_A           98 PFLHAALGVADTDGDGAVTVADTARALTA-FG--VPEDLARQAAAALDTDGDGKV--------GETEIVPAFAR  160 (166)
T ss_dssp             HHHHHHHHHHCSSSSSCCBHHHHHHHHHH-TT--CCHHHHHHHHHHHCTTCSSBC--------CHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHH-hC--CCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHHH
Confidence            45889999999999999999999999999 88  889999999999999999999        99999876643

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=98.43  E-value=1.2e-07  Score=86.11  Aligned_cols=66  Identities=18%  Similarity=0.224  Sum_probs=57.2

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-----cccHHHHHH----HHHhcCCCCCceeecCccccccchhhh
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-----KLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-----~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ....++.+|+.||.|++|+|+.+||+.++.. ++.     .+++++++.    +|..+|.|+||.|        +|+||+
T Consensus       127 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~-~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~I--------s~~EF~  197 (214)
T 2l4h_A          127 PDIKSHYAFRIFDFDDDGTLNREDLSRLVNC-LTGEGEDTRLSASEMKQLIDNILEESDIDRDGTI--------NLSEFQ  197 (214)
T ss_dssp             HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-HHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSB--------CSHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-HhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcC--------CHHHHH
Confidence            3457899999999999999999999999988 654     677777664    9999999999999        999998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .++.
T Consensus       198 ~~~~  201 (214)
T 2l4h_A          198 HVIS  201 (214)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A

Probab=98.43  E-value=1.7e-07  Score=82.94  Aligned_cols=69  Identities=17%  Similarity=0.183  Sum_probs=62.4

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHH-----HHHHhhCCCcccHH-----HHHHHHHhcCCCCCceeecCccccccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMR-----QALAKDLPWKLKES-----RVLEILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~-----~~l~~~~~~~~~~~-----e~~~~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      ++++..+++++|..+|.|++|.|+.+||+     .+++. +|..++..     ++..+++.+|.|++|.|        +|
T Consensus        11 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~-~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i--------~~   81 (191)
T 1uhk_A           11 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINN-LGATPEQAKRHKDAVEAFFGGAGMKYGVET--------DW   81 (191)
T ss_dssp             CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHTTCCTTCEE--------EH
T ss_pred             CHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHH-cCCCchhHHHHHHHHHHHHHHhCcCCCCcC--------cH
Confidence            56778899999999999999999999999     88888 99888877     68999999999999999        89


Q ss_pred             hhhhcccc
Q 011380          469 SYLLLFPV  476 (487)
Q Consensus       469 ~~f~~~~~  476 (487)
                      +||+.+..
T Consensus        82 ~EF~~~~~   89 (191)
T 1uhk_A           82 PAYIEGWK   89 (191)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987543

>1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ...

Probab=98.42  E-value=5.9e-08  Score=82.95  Aligned_cols=69  Identities=17%  Similarity=0.262  Sum_probs=61.6

Q ss_pred             CChHHHHHHHHhhcccCC--CCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDV--DKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~--d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +++++..+++++|..+|.  |++|.|+.+||+.+|+. +|..++..++..+ ..+|.|++|.|        +|++|+.+.
T Consensus         3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l-~~~D~~~~g~i--------~~~eF~~~~   72 (156)
T 1wdc_C            3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRC-LGINPRNEDVFAV-GGTHKMGEKSL--------PFEEFLPAY   72 (156)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHH-TTCCCCHHHHHHT-TCCSSTTSCEE--------CHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH-cCCCCCHHHHHHH-HhhCCCCCCee--------eHHHHHHHH
Confidence            466778889999999999  99999999999999998 8999999999999 99999999999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        73 ~   73 (156)
T 1wdc_C           73 E   73 (156)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=98.42  E-value=3.2e-07  Score=81.20  Aligned_cols=66  Identities=9%  Similarity=-0.007  Sum_probs=59.1

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      .....++.+|..+|.|++|+|+.+|++.++.. +|  ++++++..+|+.+|.|+||.|        +|+||+.++..
T Consensus       106 ~~~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~-~g--~~~~~~~~~~~~~D~d~dG~i--------~~~Ef~~~~~~  171 (191)
T 2ccm_A          106 WLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMS-YG--IPKSDCDAAFDTLSDGGKTMV--------TREIFARLWTE  171 (191)
T ss_dssp             HHHHHHHHHHHHHCTTCSSBCCHHHHHHHHHT-TT--CCHHHHHHHHHHHTTTTTSCC--------BHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-hC--CCHHHHHHHHHHhCCCCCCCc--------CHHHHHHHHHH
Confidence            33467889999999999999999999999998 88  788999999999999999999        89999876543

>3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A

Probab=98.41  E-value=1.1e-07  Score=86.55  Aligned_cols=63  Identities=11%  Similarity=0.140  Sum_probs=57.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+||+.+|.. +|..+++++++.+++.+| |+||.|        +|+||+.++.
T Consensus       117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~~~~~l~~~~d-d~dg~I--------~~~eF~~~~~  179 (220)
T 3sjs_A          117 ELAYNLFVMNARARSGTLEPHEILPALQQ-LGFYINQRTSLLLHRLFA-RGMAFC--------DLNCWIAICA  179 (220)
T ss_dssp             HHHHHHHHHHCCSSTTEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHC---CCSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhc-CCCCcC--------cHHHHHHHHH
Confidence            56889999999999999999999999999 999999999999999999 999999        8999987654

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=98.41  E-value=1.2e-07  Score=83.42  Aligned_cols=66  Identities=18%  Similarity=0.225  Sum_probs=58.9

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-----cccHHHHHH----HHHhcCCCCCceeecCccccccchhhhc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-----KLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-----~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ...++.+|..+|.|++|+|+.+||+.+|.. +|.     .++++++..    ++..+|.|++|.|        +|+||+.
T Consensus        97 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I--------~~~EF~~  167 (183)
T 1dgu_A           97 DIKSHYAFRIFDFDDDGTLNREDLSRLVNC-LTGEGEDTRLSASEMKQLIDNILEESDIDRDGTI--------NLSEFQH  167 (183)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHH-HHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEE--------EHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-HhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeE--------cHHHHHH
Confidence            357899999999999999999999999998 765     788888876    9999999999999        8999988


Q ss_pred             cccc
Q 011380          474 FPVD  477 (487)
Q Consensus       474 ~~~~  477 (487)
                      ++..
T Consensus       168 ~~~~  171 (183)
T 1dgu_A          168 VISR  171 (183)
T ss_dssp             HHCS
T ss_pred             HHHh
Confidence            7653

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=98.41  E-value=1.9e-07  Score=81.33  Aligned_cols=64  Identities=20%  Similarity=0.319  Sum_probs=59.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+|++.+|.. +|..++++++..++..+|.|++|.|        +|+||+.+..
T Consensus        74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~~  137 (172)
T 2znd_A           74 TDWQNVFRTYDRDNSGMIDKNELKQALSG-FGYRLSDQFHDILIRKFDRQGRGQI--------AFDDFIQGCI  137 (172)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCccCHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            56888999999999999999999999999 9999999999999999999999999        8999987653

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=98.41  E-value=4.8e-08  Score=88.95  Aligned_cols=65  Identities=22%  Similarity=0.272  Sum_probs=59.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..||.|++|+|+.+||+.+|.. +|. .++.++++.+|..+|.|+||.|        +|+||+.++.
T Consensus       129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~-~g~~~~~~~e~~~l~~~~D~d~dG~I--------~~~EF~~~~~  194 (219)
T 3cs1_A          129 FFELTVMFDEIDASGNMLVDEEEFKRAVPK-LEAWGAKVEDPAALFKELDKNGTGSV--------TFDEFAAWAS  194 (219)
T ss_dssp             HHHHHHHHHTTCSSSSSEEEHHHHHHHHHH-HHHHTCCCSCHHHHHHHHCTTSSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hcccCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            457889999999999999999999999998 786 6888899999999999999999        8999988764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.41  E-value=8.2e-07  Score=88.46  Aligned_cols=80  Identities=16%  Similarity=0.263  Sum_probs=50.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCc-CC---hHhHHHHHHHHHHHHhccCC-C-CccEEEEEEEeCCEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM-IL---PIAVEDVKREVKILQALAGH-E-NVVKFYNAFEDDNYVYI  174 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-p-nIv~~~~~~~~~~~~~l  174 (487)
                      .+.||.|..+.||++....+++.+++|....... ..   +...+.+..|.++++.+..+ | .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4679999999999997655678999997653211 00   11234567899999887533 3 34466643  3444689


Q ss_pred             EEeccCCC
Q 011380          175 AMELCEGG  182 (487)
Q Consensus       175 v~e~~~gg  182 (487)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii}

Probab=98.41  E-value=1.4e-07  Score=83.62  Aligned_cols=72  Identities=15%  Similarity=0.202  Sum_probs=64.1

Q ss_pred             ccCChHHHHHHHHhhccc-CCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHHHH-----------HhcCCCCCceee
Q 011380          396 STLDDEELADLRDQFDAI-DVDKNGSISLEEMRQALAKDL----PWKLKESRVLEIL-----------QAVNTPFLGLFL  459 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~-D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~~~-----------~~~d~~~~g~i~  459 (487)
                      ..++..+..+++++|..+ |.|++|.|+.+|+..++.. +    |...+..++..++           ..+|.|++|.| 
T Consensus         4 ~~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~-~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i-   81 (191)
T 2ccm_A            4 HQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKK-ICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQV-   81 (191)
T ss_dssp             CCCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHH-HHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCE-
T ss_pred             hhccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeE-
Confidence            345677788999999999 9999999999999999998 7    8888888999998           99999999999 


Q ss_pred             cCccccccchhhhcccc
Q 011380          460 PCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       460 ~~~~~~~~f~~f~~~~~  476 (487)
                             +|+||+.+..
T Consensus        82 -------~~~Ef~~~~~   91 (191)
T 2ccm_A           82 -------TKEEWLKMWA   91 (191)
T ss_dssp             -------EHHHHHHHHH
T ss_pred             -------CHHHHHHHHH
Confidence                   8999987543

>1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C

Probab=98.40  E-value=2.6e-08  Score=84.67  Aligned_cols=70  Identities=16%  Similarity=0.280  Sum_probs=59.7

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCC--CCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP--FLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~--~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +++++..+++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++..+|.|  ++|.|        +|+||+.+.
T Consensus         4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~d~~~~~~g~i--------~~~eF~~~~   74 (151)
T 1w7j_B            4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRA-LGQNPTNAEVLKVLGNPKSDELKSRRV--------DFETFLPML   74 (151)
T ss_dssp             -------CHHHHHHHHCCSSSSEEESTTHHHHHHH-TTCCCCHHHHHHHTTCCCHHHHTTCEE--------EHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCcCcCCCCcC--------cHHHHHHHH
Confidence            45667788999999999999999999999999999 99999999999999999999  99999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        75 ~   75 (151)
T 1w7j_B           75 Q   75 (151)
T ss_dssp             H
T ss_pred             H
Confidence            4

>1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5

Probab=98.40  E-value=2.1e-07  Score=80.98  Aligned_cols=63  Identities=21%  Similarity=0.245  Sum_probs=58.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ..++.+|..+|.|++|+|+.+|++.++.. +|  ++++++..+|+.+|.|++|.|        +|+||+.++..
T Consensus       102 ~~~~~~F~~~D~d~~G~I~~~e~~~~l~~-~g--~~~~~~~~~~~~~D~d~dg~i--------~~~ef~~~~~~  164 (176)
T 1nya_A          102 PVVKGIVGMCDKNADGQINADEFAAWLTA-LG--MSKAEAAEAFNQVDTNGNGEL--------SLDELLTAVRD  164 (176)
T ss_dssp             HHHHHHHHHTCSSCCSEEEHHHHHHHHHH-TT--CCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHSC
T ss_pred             HHHHHHHHHhcCCCCCCCCHHHHHHHHHH-hC--CCHHHHHHHHHHhCCCCCCCC--------cHHHHHHHHHH
Confidence            56889999999999999999999999999 88  889999999999999999999        89999887654

>1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A

Probab=98.38  E-value=2.8e-08  Score=84.15  Aligned_cols=64  Identities=14%  Similarity=0.167  Sum_probs=56.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhc-CCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV-NTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~-d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++..+ |.|++|.|        +|++|+.+..
T Consensus         4 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~~D~~~~g~i--------~~~eF~~~~~   68 (148)
T 1m45_A            4 RANKDIFTLFDKKGQGAIAKDSLGDYLRA-IGYNPTNQLVQDIINADSSLRDASSL--------TLDQITGLIE   68 (148)
T ss_dssp             CCCTTCHHHHCTTCCSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHC--CC--CCEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHH-hCCCCCHHHHHHHHHHhhCCCCCCeE--------cHHHHHHHHH
Confidence            45678999999999999999999999999 99999999999999999 99999999        8999987654

>3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens}

Probab=98.38  E-value=2.5e-07  Score=82.80  Aligned_cols=81  Identities=14%  Similarity=0.179  Sum_probs=66.5

Q ss_pred             HHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh------hCCCcccHHHHHHHHHhcCC-CCCceeecC
Q 011380          389 FALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK------DLPWKLKESRVLEILQAVNT-PFLGLFLPC  461 (487)
Q Consensus       389 ~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~------~~~~~~~~~e~~~~~~~~d~-~~~g~i~~~  461 (487)
                      .|+..+...........++.+|..+|.|++|+|+.+||+.++..      ..|...++++++.+|+.+|. |+||.|   
T Consensus        94 ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~I---  170 (204)
T 3e3r_A           94 EFLRALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQV---  170 (204)
T ss_dssp             HHHHHTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCE---
T ss_pred             HHHHHHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcC---
Confidence            45555555555555678999999999999999999999999984      15677888899999999998 999999   


Q ss_pred             ccccccchhhhccccc
Q 011380          462 HEKGEKFSYLLLFPVD  477 (487)
Q Consensus       462 ~~~~~~f~~f~~~~~~  477 (487)
                           +|+||+.+...
T Consensus       171 -----s~~EF~~~~~~  181 (204)
T 3e3r_A          171 -----TLAEFQDYYSG  181 (204)
T ss_dssp             -----EHHHHHHHHHH
T ss_pred             -----cHHHHHHHHHH
Confidence                 89999886543

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=98.37  E-value=2.6e-07  Score=92.23  Aligned_cols=66  Identities=24%  Similarity=0.379  Sum_probs=61.1

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+.++.+|+.+|.|++|+|+.+||+.+|+. +|..+++++++.++..+|.|+||.|        +|+||+.++.
T Consensus       383 ~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~-lG~~ls~eei~~Lf~~~D~D~DG~I--------sfdEFv~~L~  448 (450)
T 3sg6_A          383 SEEEIREAFRVFDKDGNGYISAAELRHVMTN-LGEKLTDEEVDEMIREADIDGDGQV--------NYEEFVQMMT  448 (450)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTSSSSE--------EHHHHHHHHC
T ss_pred             hhhHHHHHHHHhCCCCCCeEeHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHh
Confidence            3457889999999999999999999999999 8999999999999999999999999        9999987654

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=98.37  E-value=1.9e-07  Score=84.13  Aligned_cols=62  Identities=13%  Similarity=0.304  Sum_probs=57.4

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDM  478 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~~  478 (487)
                      ++.+|..+|.|++|+|+.+||+.++.. +|  +++++++.+|..+|.|+||.|        +|+||+.++...
T Consensus       130 ~~~~F~~~D~d~~G~Is~~El~~~l~~-~g--~~~~~~~~~~~~~D~d~dG~I--------~~~EF~~~~~~~  191 (208)
T 2hpk_A          130 SNSYYDVLDDDGDGTVDVDELKTMMKA-FD--VPQEAAYTFFEKADTDKSGKL--------ERTELVHLFRKF  191 (208)
T ss_dssp             HHHHHHHHCTTCSSSBCHHHHHHHHHH-TT--SCTTHHHHHHHHHCTTCCSSB--------CHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCcCCHHHHHHHHHH-hC--cCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHHHH
Confidence            788999999999999999999999998 88  788999999999999999999        999998876543

>2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola}

Probab=98.36  E-value=1e-07  Score=85.81  Aligned_cols=71  Identities=14%  Similarity=0.161  Sum_probs=59.5

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC--cccHHHHHHHH-------HhcCCCCCceeecCcccccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW--KLKESRVLEIL-------QAVNTPFLGLFLPCHEKGEK  467 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~--~~~~~e~~~~~-------~~~d~~~~g~i~~~~~~~~~  467 (487)
                      .+++++..+++++|..+|.|++|.|+.+||+.+|.. +|.  .++.+++..++       ..+|.|++|.|        +
T Consensus        29 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~-~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i--------~   99 (208)
T 2hpk_A           29 DLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDR-MRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGL--------L   99 (208)
T ss_dssp             -------CHHHHHHHHHCTTCSSEECHHHHTHHHHH-HHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBE--------E
T ss_pred             HcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeE--------c
Confidence            345667788999999999999999999999999998 787  78899999999       99999999999        8


Q ss_pred             chhhhcccc
Q 011380          468 FSYLLLFPV  476 (487)
Q Consensus       468 f~~f~~~~~  476 (487)
                      |+||+.+..
T Consensus       100 ~~EF~~~~~  108 (208)
T 2hpk_A          100 REDWVEANR  108 (208)
T ss_dssp             GGGHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999987653

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=98.35  E-value=1.7e-07  Score=85.87  Aligned_cols=65  Identities=18%  Similarity=0.214  Sum_probs=55.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC------------CCcccHHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL------------PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~------------~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      ...++.+|+.+|.|++|+|+.+|++.++.. +            +...++++++.+|+.+|.|+||.|        +|+|
T Consensus       137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------s~~E  207 (229)
T 3dd4_A          137 QEKLNWAFNLYDINKDGYITKEEMLDIMKA-IYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVV--------TIDE  207 (229)
T ss_dssp             HHHHHHHHHHHCTTCSSCCBHHHHHHHHHH-HHHHCC-----------CCTHHHHHHHHHCSSCSSBC--------CHHH
T ss_pred             HHHHHHHHHHhCCCCCCeECHHHHHHHHHH-HHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcE--------eHHH
Confidence            357888999999999999999999999987 4            556778899999999999999999        8999


Q ss_pred             hhcccc
Q 011380          471 LLLFPV  476 (487)
Q Consensus       471 f~~~~~  476 (487)
                      |+....
T Consensus       208 F~~~~~  213 (229)
T 3dd4_A          208 FIESCQ  213 (229)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988665

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=98.35  E-value=2.5e-07  Score=76.35  Aligned_cols=61  Identities=21%  Similarity=0.255  Sum_probs=38.3

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++|..+|.|++|.|+.+|+..++.. +|..++.+++..+++.+|.|++|.|        +|+||+.+.
T Consensus         2 l~~~F~~~D~~~~g~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~D~~~~g~i--------~~~ef~~~~   62 (134)
T 1jfj_A            2 AEALFKEIDVNGDGAVSYEEVKAFVSK-KRAIKNEQLLQLIFKSIDADGNGEI--------DQNEFAKFY   62 (134)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHT-TCCSSHHHHHHHHHHHHCSSCCSEE--------EHHHHHHHT
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHHcCCCCCeE--------cHHHHHHHH
Confidence            445666666666666666666666666 6666666666666666666666666        566665543

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=98.34  E-value=5.3e-07  Score=80.06  Aligned_cols=65  Identities=20%  Similarity=0.264  Sum_probs=55.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh-CCCcccH---HHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD-LPWKLKE---SRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~-~~~~~~~---~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|..+|.|++|+|+.+||+.++... .|..+++   +++..+|..+|.|+||.|        +|+||+.++
T Consensus       121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~I--------s~~EF~~~~  189 (191)
T 3k21_A          121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKI--------DFHEFSEMM  189 (191)
T ss_dssp             HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeE--------CHHHHHHHH
Confidence            4578889999999999999999999999872 3455665   468999999999999999        899998754

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=98.34  E-value=7.9e-08  Score=85.29  Aligned_cols=62  Identities=19%  Similarity=0.351  Sum_probs=56.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+||+.+|.. +|  +++++++.+|..+|.|++|.|        +|+||+.++.
T Consensus        82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~-~g--~~~~~~~~~~~~~D~d~dG~I--------s~~EF~~~~~  143 (188)
T 1s6i_A           82 ENLVSAFSYFDKDGSGYITLDEIQQACKD-FG--LDDIHIDDMIKEIDQDNDGQI--------DYGEFAAMMR  143 (188)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTT-TT--CCTTHHHHHHHHHCSSSSSEE--------ETTHHHHTTS
T ss_pred             HHHHHHHHHHCCCCCCcCcHHHHHHHHHH-cC--CCHHHHHHHHHHHCCCCCCcE--------eHHHHHHHHH
Confidence            35778999999999999999999999998 77  677889999999999999999        8999988765

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=98.34  E-value=2.1e-07  Score=82.30  Aligned_cols=63  Identities=19%  Similarity=0.262  Sum_probs=57.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ..++.+|..+|.|++|.|+.+|++.++.   |..++++++..++..+|.|++|.|        +|+||+.++..
T Consensus       123 ~~~~~~F~~~D~d~~G~I~~~E~~~~l~---~~~~~~~~~~~~~~~~D~~~dg~i--------~~~eF~~~~~~  185 (191)
T 3khe_A          123 ERLLAAFQQFDSDGSGKITNEELGRLFG---VTEVDDETWHQVLQECDKNNDGEV--------DFEEFVEMMQK  185 (191)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHTT---SSCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCcCcCCHHHHHHHHc---cCCCCHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHH
Confidence            5688999999999999999999999887   667889999999999999999999        89999887653

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=98.32  E-value=1.7e-07  Score=81.72  Aligned_cols=64  Identities=14%  Similarity=0.203  Sum_probs=58.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC-C-------CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL-P-------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~-~-------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      +..+++++|..+| |++|.|+.+||+.+|+. + |       ..++..++..++..+|.|++|.|        +|+||+.
T Consensus         2 ~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~-~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~eF~~   71 (173)
T 1alv_A            2 EVRQFRRLFAQLA-GDDMEVSATELMNILNK-VVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKL--------GFEEFKY   71 (173)
T ss_dssp             HHHHHHHHHHHHH-GGGTSBCHHHHHHHHHH-HHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHH
T ss_pred             chhHHHHHHHHHh-CCCCCcCHHHHHHHHHH-hhhcccccccCCCCHHHHHHHHHHHcCCCCCcc--------CHHHHHH
Confidence            5678999999999 99999999999999998 5 5       67889999999999999999999        9999987


Q ss_pred             cc
Q 011380          474 FP  475 (487)
Q Consensus       474 ~~  475 (487)
                      +.
T Consensus        72 ~~   73 (173)
T 1alv_A           72 LW   73 (173)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=98.32  E-value=6e-07  Score=81.03  Aligned_cols=66  Identities=17%  Similarity=0.152  Sum_probs=56.7

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC-----CcccH-HHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP-----WKLKE-SRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-----~~~~~-~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|..+|.|++|+|+.+||+.++.. ++     ...+. +.+..+|+.+|.|+||.|        +|+||+.++
T Consensus        91 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~-~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef~~~~  161 (211)
T 2ggz_A           91 MEQKLKWYFKLYDADGNGSIDKNELLDMFMA-VQALNGQQTLSPEEFINLVFHKIDINNDGEL--------TLEEFINGM  161 (211)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-HTTSSCCCSCTHHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             hHHHHHHHHHHhcCCCCCcCcHHHHHHHHHH-HHhhcCCccccHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHH
Confidence            3457889999999999999999999999988 54     45555 458999999999999999        899998766


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus       162 ~  162 (211)
T 2ggz_A          162 A  162 (211)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus}

Probab=98.32  E-value=4e-07  Score=76.38  Aligned_cols=65  Identities=18%  Similarity=0.388  Sum_probs=55.4

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++..+++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++..    ++|.|        +|++|+.+..
T Consensus         2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~----~~g~i--------~~~eF~~~~~   66 (143)
T 3j04_B            2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLAS-MGKNPTDEYLEGMMSE----APGPI--------NFTMFLTMFG   66 (143)
T ss_dssp             CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHH-TSCCCCHHHHHTTTTT----SSSCC--------CHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHH-hCCCCCHHHHHHHHHh----CCCCc--------CHHHHHHHHH
Confidence            5677889999999999999999999999999999 9988888888777665    67888        7888876544

>2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A

Probab=98.31  E-value=2.3e-07  Score=80.80  Aligned_cols=65  Identities=23%  Similarity=0.211  Sum_probs=58.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC-CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP-WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~-~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +..+++++|..+|.|++|.|+.+|++.+|+. +| ..++..++..++..+|.|++|.|        +|+||+.+.
T Consensus         5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~ef~~~~   70 (172)
T 2znd_A            5 DQSFLWNVFQRVDKDRSGVISDTELQQALSN-GTWTPFNPVTVRSIISMFDRENKAGV--------NFSEFTGVW   70 (172)
T ss_dssp             -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCC-SSSSCCCHHHHHHHHHHHCSSSSSEE--------CHHHHHHHH
T ss_pred             chhHHHHHHHHhCCCCCCcCcHHHHHHHHHh-cCCCCCCHHHHHHHHHHhCCCCCCcC--------CHHHHHHHH
Confidence            3467889999999999999999999999998 88 77899999999999999999999        899998754

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=98.31  E-value=7.8e-07  Score=79.30  Aligned_cols=65  Identities=17%  Similarity=0.129  Sum_probs=56.2

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC------CcccHH-HHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLP------WKLKES-RVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~------~~~~~~-e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|..+|.|++|+|+.+||+.++.. ++      ...+.+ .+..+|+.+|.|++|.|        +|+||+.++
T Consensus        87 ~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~-~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef~~~~  157 (198)
T 2r2i_A           87 DQKLRWYFKLYDVDGNGCIDRGELLNIIKA-IRAINRCNEAMTAEEFTNMVFDKIDINGDGEL--------SLEEFMEGV  157 (198)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHH-TTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEE--------CHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHHH-HHhhcCCCchhhHHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            457888999999999999999999999998 65      445554 48999999999999999        899998766


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus       158 ~  158 (198)
T 2r2i_A          158 Q  158 (198)
T ss_dssp             T
T ss_pred             H
Confidence            4

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=98.30  E-value=3.9e-07  Score=79.94  Aligned_cols=69  Identities=13%  Similarity=0.193  Sum_probs=60.9

Q ss_pred             ChHHHHHHHHhhccc-CCCCCCCCCHHHHHHHHHhhCC----CcccHHHHHHH-----------HHhcCCCCCceeecCc
Q 011380          399 DDEELADLRDQFDAI-DVDKNGSISLEEMRQALAKDLP----WKLKESRVLEI-----------LQAVNTPFLGLFLPCH  462 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~-D~d~~G~i~~~el~~~l~~~~~----~~~~~~e~~~~-----------~~~~d~~~~g~i~~~~  462 (487)
                      ++.+..+++.+|..+ |.|++|.|+.+|+..++.. ++    ..++..++..+           ++.+|.|++|.|    
T Consensus         3 s~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I----   77 (185)
T 2sas_A            3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTR-YKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVV----   77 (185)
T ss_dssp             CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHH-HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCE----
T ss_pred             CHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHH-HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeE----
Confidence            456778899999999 9999999999999999988 77    77888888765           999999999999    


Q ss_pred             cccccchhhhcccc
Q 011380          463 EKGEKFSYLLLFPV  476 (487)
Q Consensus       463 ~~~~~f~~f~~~~~  476 (487)
                          +|+||+.+..
T Consensus        78 ----~~~Ef~~~~~   87 (185)
T 2sas_A           78 ----SWEEYLAMWE   87 (185)
T ss_dssp             ----EHHHHHHHHH
T ss_pred             ----cHHHHHHHHH
Confidence                8999987654

>1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8

Probab=98.28  E-value=4.9e-07  Score=80.27  Aligned_cols=63  Identities=22%  Similarity=0.319  Sum_probs=52.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++++|..+|.|++|.|+.+||+.+|.. +|..++++++..+++.+|.|++|.|        +|+||+...
T Consensus        27 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~-~~~~~~~~~~~~l~~~~D~d~dG~I--------~~~EF~~~~   89 (191)
T 1y1x_A           27 QELMEWFRAVDTDGSGAISVPELNAALSS-AGVPFSLATTEKLLHMYDKNHSGEI--------TFDEFKDLH   89 (191)
T ss_dssp             SCHHHHHHHHCTTCSSSBCHHHHHHHHCB-TTBCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------cHHHHHHHH
Confidence            45778888888888999999998888876 7778888888888888888888888        888887654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=98.28  E-value=8.7e-08  Score=98.29  Aligned_cols=80  Identities=14%  Similarity=0.166  Sum_probs=47.1

Q ss_pred             HHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccch
Q 011380          390 ALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       390 ~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      |+..+.........+.++.+|+.||.|++|+|+.+||+.+|.. +|..+++++++++|+.+|.|+||.|        +|+
T Consensus       403 f~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dG~I--------~~~  473 (486)
T 3mwu_A          403 FIASAIDRTILLSRERMERAFKMFDKDGSGKISTKELFKLFSQ-ADSSIQMEELESIIEQVDNNKDGEV--------DFN  473 (486)
T ss_dssp             HHHHHSCTTTTCCHHHHHHHHHHHCSSCSSSBCSSCC---------------------CCCCSSCSSSB--------CHH
T ss_pred             HHHHHHhhhccchHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcE--------eHH
Confidence            3444433332223457889999999999999999999999999 9999999999999999999999999        999


Q ss_pred             hhhcccccc
Q 011380          470 YLLLFPVDM  478 (487)
Q Consensus       470 ~f~~~~~~~  478 (487)
                      ||+.++...
T Consensus       474 EF~~~~~~~  482 (486)
T 3mwu_A          474 EFVEMLQNF  482 (486)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHh
Confidence            998876543

>1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A

Probab=98.28  E-value=3.3e-07  Score=79.85  Aligned_cols=63  Identities=21%  Similarity=0.298  Sum_probs=58.5

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+|++.+|+. +|..+++++++.++..+| |++|.|        +|+||+.+..
T Consensus        77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~d-d~dg~i--------~~~eF~~~~~  139 (173)
T 1alv_A           77 KKWQAIYKQFDVDRSGTIGSSELPGAFEA-AGFHLNEHLYSMIIRRYS-DEGGNM--------DFDNFISCLV  139 (173)
T ss_dssp             HHHHHHHHHHCTTCCSSBCTTTHHHHHHH-HTCCCCHHHHHHHHHHHT-CSSSCB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHH-cCCCCCHHHHHHHHHHhc-CCCCcC--------cHHHHHHHHH
Confidence            57888999999999999999999999999 899999999999999999 999999        9999987653

>2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B

Probab=98.27  E-value=6.8e-07  Score=77.14  Aligned_cols=67  Identities=21%  Similarity=0.468  Sum_probs=57.7

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++++...++.+|..+|.|++|.|+.+||+.+|+. +|. .++..++..++...    +|.|        +|++|+.+.
T Consensus        18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~l~~~~----dg~i--------~~~eF~~~~   84 (166)
T 2mys_B           18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAA-MGRLNVKNEELDAMIKEA----SGPI--------NFTVFLTMF   84 (166)
T ss_pred             hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-hCCCCCCHHHHHHHHHHC----CCCc--------CHHHHHHHH
Confidence            557788899999999999999999999999999999 898 88888888888764    6888        788887654


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        85 ~   85 (166)
T 2mys_B           85 G   85 (166)
T ss_pred             H
Confidence            3

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=98.27  E-value=4.5e-07  Score=79.62  Aligned_cols=62  Identities=18%  Similarity=0.235  Sum_probs=54.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCC--------ceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFL--------GLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~--------g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++.+|..+|.|++|+|+.+||+.++.   +..+++++++.++..+|.|+|        |.|        +|+||+.++
T Consensus       108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~---~~~~~~~~~~~~~~~~d~~~d~~~~~~~~G~i--------~~~eF~~~l  176 (180)
T 3mse_B          108 TFLKAAFNKIDKDEDGYISKSDIVSLVH---DKVLDNNDIDNFFLSVHSIKKGIPREHIINKI--------SFQEFKDYM  176 (180)
T ss_dssp             CHHHHHHHHHCTTCSSCBCHHHHHHHTT---TSSCCHHHHHHHHHHHHTC---------CCCB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHc---CCCCCHHHHHHHHHHhhhccCcccccccCCee--------eHHHHHHHH
Confidence            5788999999999999999999999987   456889999999999999999        999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus       177 ~  177 (180)
T 3mse_B          177 L  177 (180)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=98.27  E-value=1e-06  Score=80.45  Aligned_cols=66  Identities=17%  Similarity=0.217  Sum_probs=57.1

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHH----hhCCCcccHHHHHHHH----HhcCCCCCceeecCccccccchhhhc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALA----KDLPWKLKESRVLEIL----QAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~----~~~~~~~~~~e~~~~~----~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ....++.+|..+|.|++|+|+.+||+.++.    . .|..+++++++.++    +.+|.|+||.|        +|+||+.
T Consensus       120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~-~g~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~EF~~  190 (226)
T 2zfd_A          120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAE-SGMNLKDTVIEDIIDKTFEEADTKHDGKI--------DKEEWRS  190 (226)
T ss_dssp             HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHCSSCSSEE--------CHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHH-cCCCCCHHHHHHHHHHHHHHhCCCCCCcC--------cHHHHHH
Confidence            456789999999999999999999999995    4 78888888876655    59999999999        8999988


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      ++.
T Consensus       191 ~~~  193 (226)
T 2zfd_A          191 LVL  193 (226)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            665

>3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A

Probab=98.27  E-value=7e-07  Score=89.06  Aligned_cols=72  Identities=21%  Similarity=0.415  Sum_probs=65.4

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+..++..+++++|..+|.|++|.|+.+||+.+|+. +|..++.+++..+++.+|.|++|.|        +|+||+.+..
T Consensus       305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~-lg~~~s~eel~~Lf~~~D~DgdG~I--------sfeEFl~ll~  375 (450)
T 3sg6_A          305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLTMMA  375 (450)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHTTCTTSSSSE--------EHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHHHhccCCCCcc--------cHHHHHHHHH
Confidence            456677889999999999999999999999999999 9999999999999999999999999        8999987664


Q ss_pred             c
Q 011380          477 D  477 (487)
Q Consensus       477 ~  477 (487)
                      .
T Consensus       376 ~  376 (450)
T 3sg6_A          376 R  376 (450)
T ss_dssp             C
T ss_pred             h
Confidence            3

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=98.26  E-value=5.3e-07  Score=79.20  Aligned_cols=66  Identities=24%  Similarity=0.294  Sum_probs=55.1

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCc----cc----HHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWK----LK----ESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~----~~----~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      ...++.+|+.+|.|++|+|+.+|++.++.. +    |..    ++    .+++..+|+.+|.|++|.|        +|+|
T Consensus        91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~-~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i--------~~~E  161 (183)
T 1s6c_A           91 HEKLRWTFNLYDINKDGYINKEEMMDIVKA-IYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIV--------TLDE  161 (183)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHH-HHHHTC-----------CHHHHHHHHHHHCTTCSSEE--------CHHH
T ss_pred             HHHHHHHHHHhCCCCCCeEcHHHHHHHHHH-HHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcE--------eHHH
Confidence            357889999999999999999999999987 4    532    33    3889999999999999999        9999


Q ss_pred             hhccccc
Q 011380          471 LLLFPVD  477 (487)
Q Consensus       471 f~~~~~~  477 (487)
                      |+.++..
T Consensus       162 f~~~~~~  168 (183)
T 1s6c_A          162 FLESXQE  168 (183)
T ss_dssp             HHHHTTS
T ss_pred             HHHHHhc
Confidence            9887653

>2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana}

Probab=98.26  E-value=2.1e-07  Score=80.33  Aligned_cols=63  Identities=21%  Similarity=0.329  Sum_probs=50.8

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|.|+.+|++.++.. +|  +++++++.++..+|.|++|.|        +|+||+.+..
T Consensus        98 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~-~~--~~~~~~~~~~~~~d~~~dg~i--------~~~eF~~~~~  160 (166)
T 2aao_A           98 EDHLFAAFTYFDKDGSGYITPDELQQACEE-FG--VEDVRIEELMRDVDQDNDGRI--------DYNEFVAMMQ  160 (166)
T ss_dssp             THHHHHHHHHHCTTCSSSBCHHHHHHHTCC-----------CCHHHHHCTTCSSSB--------CHHHHHHHHC
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cC--CCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            356889999999999999999999999998 77  568889999999999999999        9999988764

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=98.25  E-value=8.6e-07  Score=76.46  Aligned_cols=62  Identities=21%  Similarity=0.357  Sum_probs=57.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+|++.+|.. +|..+++++++.++..+  |++|.|        +|+||+.++.
T Consensus        70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~--d~dg~i--------~~~eF~~~~~  131 (165)
T 1k94_A           70 NAWKENFMTVDQDGSGTVEHHELRQAIGL-MGYRLSPQTLTTIVKRY--SKNGRI--------FFDDYVACCV  131 (165)
T ss_dssp             HHHHHHHHHHCTTCCSBCCHHHHHHHHHH-TTCCCCHHHHHHHHHHH--CBTTBC--------BHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCceECHHHHHHHHHH-hCCCCCHHHHHHHHHHh--CCCCeE--------cHHHHHHHHH
Confidence            56888999999999999999999999999 99999999999999999  899999        8999987654

>1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A

Probab=98.24  E-value=6.8e-07  Score=73.68  Aligned_cols=59  Identities=22%  Similarity=0.291  Sum_probs=53.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+++.+|..+|.|++|.|+.+|++.++.. +|...    +..+|..+|.|++|.|        +|+||+.++
T Consensus        75 ~~~~~~f~~~D~d~~G~i~~~e~~~~l~~-~~~~~----~~~~~~~~D~~~dg~i--------~~~ef~~~l  133 (134)
T 1jfj_A           75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKK-HGIEK----VAEQVMKADANGDGYI--------TLEEFLEFS  133 (134)
T ss_dssp             HHHHHHHHHHCCSSSSEEEHHHHHHHHTT-TTCHH----HHHHHHHHHCSSSSEE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCccCHHHHHHHHHH-hCHHH----HHHHHHHhCCCCCCcE--------eHHHHHHHh
Confidence            45889999999999999999999999998 88654    8999999999999999        899998754

>1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ...

Probab=98.24  E-value=8.7e-07  Score=75.55  Aligned_cols=69  Identities=20%  Similarity=0.421  Sum_probs=57.6

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ...+++++...++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++.    +++|.|        +|++|+.+
T Consensus         9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~----~~~g~i--------~~~eF~~~   75 (156)
T 1wdc_B            9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQ-LGRAPDDKELTAMLK----EAPGPL--------NFTMFLSI   75 (156)
T ss_dssp             ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHH-HSSCCCHHHHHHHHT----TSSSCC--------CHHHHHHH
T ss_pred             hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHH-hCCCCCHHHHHHHHH----hCCCcC--------cHHHHHHH
Confidence            34567778889999999999999999999999999999 898899888888885    467888        88888775


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus        76 ~~   77 (156)
T 1wdc_B           76 FS   77 (156)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=98.23  E-value=7.5e-07  Score=79.84  Aligned_cols=53  Identities=17%  Similarity=0.156  Sum_probs=27.6

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      .+..+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|
T Consensus        60 ~~~~~f~~~D~d~~G~i~~~Ef~~~~~~-~~~~~~~~~~~~~F~~~D~d~~G~I  112 (204)
T 1jba_A           60 YVEAMFRAFDTNGDNTIDFLEYVAALNL-VLRGTLEHKLKWTFKIYDKDRNGCI  112 (204)
T ss_dssp             HHHHHHHHHCCSSSSEECHHHHHHHHHH-HSSCCCTHHHHHHHHHHCSSCSSCB
T ss_pred             HHHHHHHHHcCCCCCeEeHHHHHHHHHH-HccCCHHHHHHHHHHHhCCCCCCcC
Confidence            3444555555555555555555555554 3444444455555555555555555

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=98.22  E-value=5.3e-07  Score=79.39  Aligned_cols=65  Identities=23%  Similarity=0.321  Sum_probs=57.4

Q ss_pred             HHHHHhh--cccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          404 ADLRDQF--DAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       404 ~~l~~~F--~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      .++..+|  ..||.|++|+|+.+||+.++.. +|..++++++..+|+.+|.|++|.|        +|+||+.++..
T Consensus       100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~-~g~~~~~~~~~~~~~~~D~d~dG~i--------~~~ef~~~~~~  166 (186)
T 2hps_A          100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQA-VGPDLTDDKAITCFNTLDFNKNGQI--------SRDEFLVTVND  166 (186)
T ss_dssp             TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHH-HCTTCCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHHH
Confidence            3455555  7779999999999999999999 8988999999999999999999999        89999887654

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=98.22  E-value=4.3e-07  Score=83.02  Aligned_cols=62  Identities=24%  Similarity=0.380  Sum_probs=55.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|+|+.+||+.+|.. +   |...+  ++..+|..+|.|+||.|        +|+||+.++.
T Consensus       133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~-~~~~g~~~~--e~~~~~~~~D~d~dG~I--------s~~EF~~~~~  197 (226)
T 2lvv_A          133 FELTVMFDTMDKDGSLLLELQEFKEALPK-LKEWGVDIT--DATTVFNEIDTNGSGVV--------TFDEFSCWAV  197 (226)
T ss_dssp             HHHHHHHHHHSCSSCCEECHHHHHHHHHH-HHHHTCCCC--SCHHHHHHHCCSCSSCE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeEcHHHHHHHHHH-HhhcCCCHH--HHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            57889999999999999999999999987 5   55443  59999999999999999        8999988764

>2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5

Probab=98.22  E-value=3.3e-07  Score=80.42  Aligned_cols=65  Identities=15%  Similarity=0.168  Sum_probs=58.2

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|..+|.|++|.|+.+|++.+++. +|  ++++++..+|+.+|.|+||.|        +|+||+.++..
T Consensus       103 ~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~-~g--~~~~~~~~~~~~~D~d~dG~i--------~~~ef~~~~~~  167 (185)
T 2sas_A          103 CQNRIPFLFKGMDVSGDGIVDLEEFQNYCKN-FQ--LQCADVPAVYNVITDGGKVTF--------DLNRYKELYYR  167 (185)
T ss_dssp             HHHHHHHHHHHHCTTSSSCCCHHHHHHHTTS-SC--CCCSSHHHHHHHHHTTTTSCC--------SHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCeEcHHHHHHHHHH-hC--CCHHHHHHHHHHhcCCCCCcC--------cHHHHHHHHHH
Confidence            3467889999999999999999999999988 87  567889999999999999999        89999886654

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=98.21  E-value=1.4e-06  Score=76.91  Aligned_cols=67  Identities=22%  Similarity=0.173  Sum_probs=56.9

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---C--------CCcccHHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKD---L--------PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~--------~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      ....++.+|..+|.|++|+|+.+|++.++...   +        +...+.+++..+|+.+|.|++|.|        +|+|
T Consensus        97 ~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~E  168 (190)
T 2l2e_A           97 LNDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQL--------TLEE  168 (190)
T ss_dssp             SHHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCB--------CHHH
T ss_pred             HHHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcC--------cHHH
Confidence            34578889999999999999999999988761   1        234678899999999999999999        8999


Q ss_pred             hhcccc
Q 011380          471 LLLFPV  476 (487)
Q Consensus       471 f~~~~~  476 (487)
                      |+.+..
T Consensus       169 f~~~~~  174 (190)
T 2l2e_A          169 FCEGSK  174 (190)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988664

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=98.20  E-value=5e-07  Score=87.29  Aligned_cols=66  Identities=18%  Similarity=0.203  Sum_probs=60.7

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHH-HhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccccce
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQAL-AKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVDMV  479 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l-~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~~~  479 (487)
                      .+..+|..+|.|++|+|+.+||+.+| .. +|..+++.++..+|..+|.|+||.|        +|++|+.++....
T Consensus       254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~-~g~~ls~~e~~~l~~~~D~d~dG~I--------s~~EF~~~~~~~~  320 (323)
T 1ij5_A          254 VLRILYAFADFDKSGQLSKEEVQKVLEDA-HIPESARKKFEHQFSVVDVDDSKSL--------SYQEFVMLVLLMF  320 (323)
T ss_dssp             HHHHHHHHTCSSSCSSEEHHHHHHHHHHT-TCCGGGCSTHHHHHHHHTTTTCSEE--------CHHHHHHHHHHHC
T ss_pred             HHHHHHHHhCCCCCCCccHHHHHHHHHHH-cCCCCCHHHHHHHHHHHCCCCCCcE--------eHHHHHHHHHHhc
Confidence            67889999999999999999999999 88 9999999999999999999999999        9999998765443

>2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus}

Probab=98.20  E-value=1.3e-06  Score=81.47  Aligned_cols=65  Identities=20%  Similarity=0.224  Sum_probs=57.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----C--------CcccHHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL----P--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      ...++.+|..+|.|++|+|+.+||+.++.. +    |        ...+++++..+|+.+|.|+||.|        +|+|
T Consensus       164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~-~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------s~~E  234 (256)
T 2jul_A          164 HEKLKWAFNLYDINKDGCITKEEMLAIMKS-IYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVV--------TIDE  234 (256)
T ss_dssp             HHHHHHHHHHTCCSSSSCBCHHHHHHHHHH-HHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSB--------CHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-HHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcE--------eHHH
Confidence            457889999999999999999999999987 4    4        34578899999999999999999        8999


Q ss_pred             hhcccc
Q 011380          471 LLLFPV  476 (487)
Q Consensus       471 f~~~~~  476 (487)
                      |+.+..
T Consensus       235 f~~~~~  240 (256)
T 2jul_A          235 FLETCQ  240 (256)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988765

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=98.20  E-value=1e-06  Score=76.15  Aligned_cols=62  Identities=23%  Similarity=0.395  Sum_probs=57.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|.|+.+|++.+|.. +|..+++++++.++..+  |++|.|        +|+||+.+..
T Consensus        72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~~~--d~dg~i--------~~~eF~~~~~  133 (167)
T 1gjy_A           72 NGWRQHFISFDSDRSGTVDPQELQKALTT-MGFRLNPQTVNSIAKRY--STSGKI--------TFDDYIACCV  133 (167)
T ss_dssp             HHHHHHHHHHCTTCCSEECHHHHHHHHHT-TTCCCCHHHHHHHHHHT--CBTTBE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHHHh--CcCCcC--------cHHHHHHHHH
Confidence            56888999999999999999999999999 99999999999999999  899999        8999987553

>3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A

Probab=98.20  E-value=8.2e-07  Score=76.33  Aligned_cols=66  Identities=15%  Similarity=0.091  Sum_probs=56.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHH----HhhCCCcccHHHHHHH-----------HHhcCCCCCceeecCccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQAL----AKDLPWKLKESRVLEI-----------LQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l----~~~~~~~~~~~e~~~~-----------~~~~d~~~~g~i~~~~~~~~  466 (487)
                      +..+++++|..+|.|++|.|+.+|++.++    +. +|..++..++..+           +..+|.|++|.|        
T Consensus         2 ~~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~-~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i--------   72 (166)
T 3akb_A            2 YERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAE-FGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRI--------   72 (166)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHH-HTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCE--------
T ss_pred             HHHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcC--------
Confidence            35678999999999999999999999975    44 6888888877755           699999999999        


Q ss_pred             cchhhhcccc
Q 011380          467 KFSYLLLFPV  476 (487)
Q Consensus       467 ~f~~f~~~~~  476 (487)
                      +|+||+.+..
T Consensus        73 ~~~ef~~~~~   82 (166)
T 3akb_A           73 TREEFVTGAV   82 (166)
T ss_dssp             EHHHHHHTHH
T ss_pred             cHHHHHHHHH
Confidence            8999987654

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=98.19  E-value=1.7e-06  Score=77.56  Aligned_cols=67  Identities=15%  Similarity=0.167  Sum_probs=56.6

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHh---hCCCcccHHHHHHHH----HhcCCCCCceeecCccccccchhhhcc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAK---DLPWKLKESRVLEIL----QAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~---~~~~~~~~~e~~~~~----~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ....++.+|..+|.|++|+|+.+|++.++..   ..|..+++++++.++    +.+|.|+||.|        +|+||+.+
T Consensus       109 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef~~~  180 (207)
T 2ehb_A          109 VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKI--------DIDEWKDF  180 (207)
T ss_dssp             HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEE--------CHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcC--------cHHHHHHH
Confidence            4467889999999999999999999999862   158888888876555    69999999999        89999886


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus       181 ~~  182 (207)
T 2ehb_A          181 VS  182 (207)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=1.3e-06  Score=85.72  Aligned_cols=85  Identities=8%  Similarity=0.079  Sum_probs=56.5

Q ss_pred             Eeeee-eecCceEEEEEEEc--C----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC--CCccEEEEEEEeC-
Q 011380          100 IGKLL-GHGQFGYTYVATDK--A----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDD-  169 (487)
Q Consensus       100 ~~~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--pnIv~~~~~~~~~-  169 (487)
                      ..+.| +.|....+|++...  .    ++..+++|+..............+.+|+.+++.|..+  ..+++++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35678 88888999988643  0    2567899976543200000113567899999888654  3577888877655 


Q ss_pred             --CEEEEEEeccCCCCH
Q 011380          170 --NYVYIAMELCEGGEL  184 (487)
Q Consensus       170 --~~~~lv~e~~~gg~L  184 (487)
                        +..|+|||+++|..+
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              357899999988654

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=98.18  E-value=1e-06  Score=80.32  Aligned_cols=65  Identities=22%  Similarity=0.229  Sum_probs=55.8

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CC--------cccHHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PW--------KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~--------~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      ...++.+|+.+|.|++|+|+.+|++.++.. +    |.        ..+.+++..+|+.+|.|+||.|        +|+|
T Consensus       124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~-~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------s~~E  194 (224)
T 1s1e_A          124 HEKLRWTFNLYDINKDGYINKEEMMDIVKA-IYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIV--------TLDE  194 (224)
T ss_dssp             HHHHHHHHHHHCTTCCSEECHHHHHHHHHH-HHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCE--------EHHH
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHH-HHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcE--------eHHH
Confidence            457889999999999999999999999987 4    42        2235889999999999999999        8999


Q ss_pred             hhcccc
Q 011380          471 LLLFPV  476 (487)
Q Consensus       471 f~~~~~  476 (487)
                      |+.+..
T Consensus       195 F~~~~~  200 (224)
T 1s1e_A          195 FLESCQ  200 (224)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            988765

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=98.18  E-value=1.4e-06  Score=77.80  Aligned_cols=62  Identities=23%  Similarity=0.390  Sum_probs=57.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.|++|.|+.+||+.+|+. +|..+++++++.++..+  |++|.|        +|+||+.+..
T Consensus       103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~l~~~~--d~dg~i--------~~~eF~~~~~  164 (198)
T 1juo_A          103 NGWRQHFISFDTDRSGTVDPQELQKALTT-MGFRLSPQAVNSIAKRY--STNGKI--------TFDDYIACCV  164 (198)
T ss_dssp             HHHHHHHHTTCTTCCSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHT--CSSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHh--CCCCeE--------cHHHHHHHHH
Confidence            57889999999999999999999999999 99999999999999999  899999        8999987653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=98.17  E-value=1.1e-06  Score=90.03  Aligned_cols=65  Identities=18%  Similarity=0.233  Sum_probs=57.9

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ..+.++.+|+.||.|+||+|+.+||+.+|..   ..+++++++++|+.+|.|+||.|        +|+||+.++..
T Consensus       416 ~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~---~~~~~~~~~~~~~~~D~d~dG~i--------~~~Ef~~~~~~  480 (484)
T 3nyv_A          416 SRERLERAFRMFDSDNSGKISSTELATIFGV---SDVDSETWKSVLSEVDKNNDGEV--------DFDEFQQMLLK  480 (484)
T ss_dssp             HHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH---TTCCHHHHHHHHHHHCTTCCSEE--------EHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh---cCCCHHHHHHHHHHhcCCCCCcC--------CHHHHHHHHHh
Confidence            3467889999999999999999999999987   34678999999999999999999        89999887654

>1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5

Probab=98.16  E-value=1.4e-06  Score=78.06  Aligned_cols=64  Identities=20%  Similarity=0.197  Sum_probs=55.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----C-------------CcccHHHHHHHHHhcCCCCCceeecCccccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDL----P-------------WKLKESRVLEILQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~-------------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~  466 (487)
                      ..++.+|..+|.|++|+|+.+||+.++.. +    |             ...+++++..+|+.+|.|+||.|        
T Consensus        95 ~~~~~~F~~~D~d~~G~I~~~E~~~~l~~-~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~I--------  165 (204)
T 1jba_A           95 HKLKWTFKIYDKDRNGCIDRQELLDIVES-IYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQL--------  165 (204)
T ss_dssp             HHHHHHHHHHCSSCSSCBCHHHHHHHHHH-HHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCB--------
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHH-HHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeE--------
Confidence            46788999999999999999999999987 4    2             11556789999999999999999        


Q ss_pred             cchhhhcccc
Q 011380          467 KFSYLLLFPV  476 (487)
Q Consensus       467 ~f~~f~~~~~  476 (487)
                      +|+||+.+..
T Consensus       166 s~~Ef~~~~~  175 (204)
T 1jba_A          166 SLNEFVEGAR  175 (204)
T ss_dssp             CHHHHHHHHT
T ss_pred             cHHHHHHHHH
Confidence            8999987664

>2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei}

Probab=98.16  E-value=4.4e-07  Score=82.98  Aligned_cols=75  Identities=17%  Similarity=0.189  Sum_probs=63.1

Q ss_pred             HHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhc---------CCCCCceeecCc
Q 011380          392 RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV---------NTPFLGLFLPCH  462 (487)
Q Consensus       392 ~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~---------d~~~~g~i~~~~  462 (487)
                      ..+...++.++..+++++|..+|.|++|.|+.+||+.++...+|...+..++..++..+         |.|++|.|    
T Consensus        39 ~~l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I----  114 (226)
T 2lvv_A           39 CAIPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEE----  114 (226)
T ss_dssp             HHSCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCC----
T ss_pred             HHhchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcC----
Confidence            33455678888999999999999999999999999984443388888877888888877         99999999    


Q ss_pred             cccccchhhhcc
Q 011380          463 EKGEKFSYLLLF  474 (487)
Q Consensus       463 ~~~~~f~~f~~~  474 (487)
                          +|+||+.+
T Consensus       115 ----~~~EF~~~  122 (226)
T 2lvv_A          115 ----DLVEFLEF  122 (226)
T ss_dssp             ----SCBCHHHH
T ss_pred             ----CHHHHHHH
Confidence                89999874

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=98.16  E-value=2.1e-06  Score=79.91  Aligned_cols=65  Identities=17%  Similarity=0.302  Sum_probs=58.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHH----HHHhcCCCCCceeecCccccccchhhhcc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+++.+|..+|.|++|+|+.+||+.+|.. +    |..++..++..    ++..+|.|++|.|        +|++|+.+
T Consensus       102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i--------~~~ef~~~  172 (263)
T 2f33_A          102 CEEFMKTWRKYDTDHSGFIETEELKNFLKD-LLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKL--------ELTEMARL  172 (263)
T ss_dssp             HHHHHHHHTTSSTTTCSSBCHHHHHHHHHH-HHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcCHHHHHHHHHH-HHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeE--------cHHHHHHH
Confidence            456889999999999999999999999998 6    88889888877    9999999999999        89999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus       173 ~~  174 (263)
T 2f33_A          173 LP  174 (263)
T ss_dssp             SC
T ss_pred             HH
Confidence            53

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=98.16  E-value=8e-07  Score=91.52  Aligned_cols=64  Identities=20%  Similarity=0.307  Sum_probs=57.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      .+.++.+|+.||.|++|+|+.+||+.+|.. .+  +++++++++|+.+|.|+||.|        +|+||+.++..
T Consensus       434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~-~~--~~~~~~~~~~~~~D~d~dG~I--------~~~EF~~~~~~  497 (504)
T 3q5i_A          434 EERLRRAFNLFDTDKSGKITKEELANLFGL-TS--ISEKTWNDVLGEADQNKDNMI--------DFDEFVSMMHK  497 (504)
T ss_dssp             HHHHHHHHHHHCTTCCSEECHHHHHHHTTC-SC--CCHHHHHHHHHTTCSSCSSSE--------EHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh-CC--CCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHHH
Confidence            357889999999999999999999999876 44  789999999999999999999        89999887654

>1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A

Probab=98.15  E-value=2.7e-07  Score=82.40  Aligned_cols=66  Identities=12%  Similarity=0.173  Sum_probs=59.0

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-----cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-----KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-----~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+..++++ |..+|.|++|.|+.+||+.+|+. +|.     .++..++..+++.+|.|++|.|        +|+||+.+
T Consensus        29 ~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~-lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i--------~~~eF~~~   98 (198)
T 1juo_A           29 GQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQ-SGIAGGYKPFNLETCRLMVSMLDRDMSGTM--------GFNEFKEL   98 (198)
T ss_dssp             TCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHH-HTTTCSSCCCCHHHHHHHHHHHCTTCSSCE--------EHHHHHHH
T ss_pred             ccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHH-hcccCCCCCCCHHHHHHHHHHhCCCCCCeE--------CHHHHHHH
Confidence            345567888 99999999999999999999999 776     5789999999999999999999        89999875


Q ss_pred             c
Q 011380          475 P  475 (487)
Q Consensus       475 ~  475 (487)
                      .
T Consensus        99 ~   99 (198)
T 1juo_A           99 W   99 (198)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi}

Probab=98.15  E-value=7.2e-07  Score=81.05  Aligned_cols=77  Identities=19%  Similarity=0.199  Sum_probs=61.8

Q ss_pred             HHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhc---------CCCCCceeecC
Q 011380          391 LRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAV---------NTPFLGLFLPC  461 (487)
Q Consensus       391 l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~---------d~~~~g~i~~~  461 (487)
                      ...+...++.++...++++|..+|.|++|.|+.+||+.+|...+|..++..++..++..+         |.|++|.|   
T Consensus        35 ~~~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I---  111 (219)
T 3cs1_A           35 RQAIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSE---  111 (219)
T ss_dssp             HHHSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCC---
T ss_pred             HHHhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcC---
Confidence            334555677888999999999999999999999999999986468877777777666543         44889999   


Q ss_pred             ccccccchhhhccc
Q 011380          462 HEKGEKFSYLLLFP  475 (487)
Q Consensus       462 ~~~~~~f~~f~~~~  475 (487)
                           +|.||+.+.
T Consensus       112 -----~~~EF~~~~  120 (219)
T 3cs1_A          112 -----DFVEFLEFR  120 (219)
T ss_dssp             -----SSBCHHHHH
T ss_pred             -----CHHHHHHHH
Confidence                 888888653

>1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8

Probab=98.15  E-value=1e-06  Score=76.23  Aligned_cols=59  Identities=12%  Similarity=0.158  Sum_probs=54.1

Q ss_pred             HhhcccCCCCCCCCCHHHHHHHHHhhCCC-----cccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          408 DQFDAIDVDKNGSISLEEMRQALAKDLPW-----KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       408 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~-----~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +.|..+|.|++|.|+.+|++.+|+. +|.     .++..++..++..+|.|++|.|        +|+||+.+.
T Consensus         5 ~~F~~~D~d~~G~i~~~el~~~l~~-lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~eF~~~~   68 (167)
T 1gjy_A            5 YGYFASVAGQDGQIDADELQRCLTQ-SGIAGGYKPFNLETCRLMVSMLDRDMSGTM--------GFNEFKELW   68 (167)
T ss_dssp             HHHHHHHCCTTSCBCHHHHHHHHHH-HTCSTTSCCCCHHHHHHHHHHHCTTCCSCB--------CHHHHHHHH
T ss_pred             HHHHHHHcCCCCcCCHHHHHHHHHh-hcccCCCCCcCHHHHHHHHHHHCCCCCCcC--------CHHHHHHHH
Confidence            3699999999999999999999999 786     6789999999999999999999        999998754

>3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia}

Probab=98.15  E-value=1.5e-06  Score=77.44  Aligned_cols=67  Identities=21%  Similarity=0.375  Sum_probs=58.6

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++.++...++++|..+|.|++|.|+.+||+.+|.. +|..++..++..++..+    +|.|        +|.+|+.+..
T Consensus        50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~-lg~~~~~~~~~~l~~~~----~g~i--------~~~eF~~~~~  116 (196)
T 3dtp_E           50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDS-LGRLCTEQELDSMVAEA----PGPI--------NFTMFLTIFG  116 (196)
T ss_dssp             SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHT-TSCCCCHHHHHHHHTTS----SSCC--------BHHHHHHHHH
T ss_pred             hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHc----cCCC--------cHHHHHHHHH
Confidence            356677889999999999999999999999999999 99999999999888877    7888        8888887654

>2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens}

Probab=98.14  E-value=7.8e-07  Score=79.57  Aligned_cols=67  Identities=18%  Similarity=0.186  Sum_probs=59.1

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++.++...++++|..+|.|++|.|+.+||+.+ .. +|...+   +..++..+|.|++|.|        +|+||+.+..
T Consensus        22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~-lg~~~~---~~~l~~~~D~d~dg~i--------~~~EF~~~~~   88 (202)
T 2bec_A           22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GA-LAVNPL---GDRIIESFFPDGSQRV--------DFPGFVRVLA   88 (202)
T ss_dssp             CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HH-HHHSTT---HHHHHHTTSCSSCCCC--------CHHHHHHHHG
T ss_pred             CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-Hh-cCCCcc---HHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            457778899999999999999999999999998 66 776554   8999999999999999        9999988654

>2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum}

Probab=98.14  E-value=1.1e-06  Score=73.77  Aligned_cols=59  Identities=20%  Similarity=0.253  Sum_probs=53.9

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++|..+|.|++|.|+.+|++.+|+. +|..++..++..++..   +++|.|        +|++|+.+..
T Consensus         7 l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~---~~~g~i--------~~~eF~~~~~   65 (145)
T 2bl0_B            7 IQECFQIFDKDNDGKVSIEELGSALRS-LGKNPTNAELNTIKGQ---LNAKEF--------DLATFKTVYR   65 (145)
T ss_dssp             HHHHHHHHCTTCSSCEEGGGHHHHHHH-TTCCCCHHHHHHHHHH---HTSSEE--------CHHHHHHHHT
T ss_pred             HHHHHHHhCCCCcCccCHHHHHHHHHH-hCCCCCHHHHHHHHHh---cCCCeE--------cHHHHHHHHH
Confidence            889999999999999999999999999 8999999999999988   889999        8999987654

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=98.12  E-value=8.6e-07  Score=79.61  Aligned_cols=64  Identities=22%  Similarity=0.168  Sum_probs=55.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----C----Cccc------HHHHHHHHHhcCCCCCceeecCccccccch
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDL----P----WKLK------ESRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~----~~~~------~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      ..++.+|..+|.|++|+|+.+||+.++.. +    |    ..++      ++++..+|..+|.|++|.|        +|+
T Consensus       107 ~~~~~~f~~~D~d~~G~I~~~E~~~~l~~-~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~  177 (207)
T 2d8n_A          107 QKLEWAFSLYDVDGNGTISKNEVLEIVMA-IFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKL--------TEK  177 (207)
T ss_dssp             TTHHHHHHHHCTTCSSEECHHHHHHHHHH-HHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCE--------EHH
T ss_pred             HHHHHHHHHhcCCCCCeEcHHHHHHHHHH-HHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcC--------cHH
Confidence            35778999999999999999999999987 4    6    4443      4679999999999999999        899


Q ss_pred             hhhcccc
Q 011380          470 YLLLFPV  476 (487)
Q Consensus       470 ~f~~~~~  476 (487)
                      ||+.++.
T Consensus       178 Ef~~~~~  184 (207)
T 2d8n_A          178 EFIEGTL  184 (207)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9988765

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=98.12  E-value=1e-06  Score=74.81  Aligned_cols=52  Identities=29%  Similarity=0.443  Sum_probs=24.6

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      +..+++++|..+|.|++|.|+.+|+ ..+.. ++...   ++..++..+|.|++|.|
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~-~~~~~---~~~~~~~~~D~~~~g~i   55 (155)
T 3ll8_B            4 EIKRLGKRFKKLDLDNSGSLSVEEF-MSLPE-LQQNP---LVQRVIDIFDTDGNGEV   55 (155)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHH-TTSGG-GTTCT---THHHHHHHHCTTCSSSB
T ss_pred             HHHHHHHHHHHhCcCCCCeEcHHHH-HHhhc-cccch---HHHHHHHHHCCCCCCcC
Confidence            3444555555555555555555555 33333 33221   34455555555555555

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=98.11  E-value=1.3e-06  Score=77.07  Aligned_cols=66  Identities=21%  Similarity=0.172  Sum_probs=56.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CC--------CcccHHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LP--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      ...++.+|..+|.|++|.|+.+|++.++...   +|        ...+++++..+|+.+|.|++|.|        +|+||
T Consensus        98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i--------~~~ef  169 (190)
T 1g8i_A           98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKL--------TLQEF  169 (190)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEE--------EHHHH
T ss_pred             HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcE--------eHHHH
Confidence            4578889999999999999999999998762   23        34678899999999999999999        89999


Q ss_pred             hcccc
Q 011380          472 LLFPV  476 (487)
Q Consensus       472 ~~~~~  476 (487)
                      +.++.
T Consensus       170 ~~~~~  174 (190)
T 1g8i_A          170 QEGSK  174 (190)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88764

>1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5

Probab=98.11  E-value=7.4e-07  Score=74.42  Aligned_cols=60  Identities=13%  Similarity=0.130  Sum_probs=53.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++|..+|.|++|.|+.+||+.+|+. +|..++..++..++.    +++|.|        +|+||+.+..
T Consensus         5 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~-~g~~~~~~~~~~~~~----~~~g~i--------~~~eF~~~~~   64 (140)
T 1ggw_A            5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRA-CGQNPTLAEITEIES----TLPAEV--------DMEQFLQVLN   64 (140)
T ss_dssp             TTTHHHHHHTCSSSSSEECHHHHHHHHHH-TSCCCCHHHHHHHHT----TSCSSE--------EHHHHHHHHC
T ss_pred             HHHHHHHHHHCCCCCCcCCHHHHHHHHHH-cCCCCCHHHHHHHHh----CCCCcC--------cHHHHHHHHH
Confidence            45788999999999999999999999999 899999999988887    889999        8999987654

>1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A

Probab=98.10  E-value=8.5e-07  Score=76.49  Aligned_cols=59  Identities=10%  Similarity=0.155  Sum_probs=54.1

Q ss_pred             HhhcccCCCCCCCCCHHHHHHHHHhhCCC-----cccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          408 DQFDAIDVDKNGSISLEEMRQALAKDLPW-----KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       408 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~-----~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..|..+|.|++|.|+.+|++.+|+. +|.     .++..++..++..+|.|++|.|        +|+||+.+.
T Consensus         3 ~~F~~~D~d~~G~i~~~el~~~l~~-lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~eF~~~~   66 (165)
T 1k94_A            3 YTYFSAVAGQDGEVDAEELQRCLTQ-SGINGTYSPFSLETCRIMIAMLDRDHTGKM--------GFNAFKELW   66 (165)
T ss_dssp             HHHHHHHHGGGTSBCHHHHHHHHHH-HTTTTTSCCCCHHHHHHHHHHHCTTCSSCB--------CHHHHHHHH
T ss_pred             HHHHHHhCCCCCcCCHHHHHHHHHH-hccccCCCCCCHHHHHHHHHHhCCCCCCcC--------CHHHHHHHH
Confidence            3699999999999999999999999 886     6789999999999999999999        999998754

>2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A

Probab=98.09  E-value=6.7e-07  Score=83.35  Aligned_cols=70  Identities=11%  Similarity=0.058  Sum_probs=61.5

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccH------HHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKE------SRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~------~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      .+++.+..+++++|..+|.|++|.|+.+||+.+|+. +|..++.      .++..++..+|.|++|.|        +|+|
T Consensus         9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~-l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i--------~~~E   79 (263)
T 2f33_A            9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQE-LLQARKKAGLELSPEMKTFVDQYGQRDDGKI--------GIVE   79 (263)
T ss_dssp             TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHH-HHHHHHHHTCCCCHHHHHHHHHHTTGGGCCB--------CHHH
T ss_pred             hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHH-HHhhcCCCccchHHHHHHHHHHhCCCCCCcC--------cHHH
Confidence            345556778999999999999999999999999998 7766665      788999999999999999        8999


Q ss_pred             hhccc
Q 011380          471 LLLFP  475 (487)
Q Consensus       471 f~~~~  475 (487)
                      |+.+.
T Consensus        80 f~~~~   84 (263)
T 2f33_A           80 LAHVL   84 (263)
T ss_dssp             HHHHT
T ss_pred             HHHHH
Confidence            98765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=98.09  E-value=9.6e-07  Score=90.68  Aligned_cols=63  Identities=21%  Similarity=0.286  Sum_probs=55.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+.++.+|+.||.|++|+|+.+||+.+|..   ..+++++++++|+.+|.|+||.|        +|+||+.++.
T Consensus       425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~---~~~~~~~~~~~~~~~D~d~dG~I--------~~~EF~~~~~  487 (494)
T 3lij_A          425 KDKLESAFQKFDQDGNGKISVDELASVFGL---DHLESKTWKEMISGIDSNNDGDV--------DFEEFCKMIQ  487 (494)
T ss_dssp             HHHHHHHHHHHCTTCSSEECHHHHHHHC-C---CSCCCHHHHHHHHTTCSSSSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh---cCCCHHHHHHHHHHhCCCCCCcC--------CHHHHHHHHH
Confidence            457889999999999999999999998875   45678899999999999999999        8999988764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.07  E-value=2.6e-05  Score=75.57  Aligned_cols=74  Identities=14%  Similarity=0.235  Sum_probs=42.7

Q ss_pred             eeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEE------EEEeCCEEEE
Q 011380          102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYN------AFEDDNYVYI  174 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~------~~~~~~~~~l  174 (487)
                      +.|+.|..+.||++...  +..+++|+....       ...+..|..+++.|..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            45677788999999753  335899988642       13344566666655411 12333332      1234678899


Q ss_pred             EEeccCCCCH
Q 011380          175 AMELCEGGEL  184 (487)
Q Consensus       175 v~e~~~gg~L  184 (487)
                      +|+|++|.++
T Consensus       109 l~~~i~G~~~  118 (346)
T 2q83_A          109 VYDWIEGRPF  118 (346)
T ss_dssp             EEECCCCBCC
T ss_pred             EEEeecCccC
Confidence            9999998643

>1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A

Probab=98.06  E-value=1.4e-06  Score=75.63  Aligned_cols=66  Identities=18%  Similarity=0.207  Sum_probs=57.1

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC----CcccHHH-H--------HHHHHhcCCCCCceeecCccccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLP----WKLKESR-V--------LEILQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~----~~~~~~e-~--------~~~~~~~d~~~~g~i~~~~~~~~  466 (487)
                      +++..+++++|..+|.|++|.|+.+||+.+|+. ++    ..++..+ +        +.+++.+|  ++|.|        
T Consensus         2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~-~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D--~~g~i--------   70 (174)
T 1q80_A            2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAER-FAKESEMKAEHAKVLMDSLTGVWDNFLTAVA--GGKGI--------   70 (174)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHH-HHHHSSCCTTHHHHHHHHHHHHHHHTGGGTT--TTSCE--------
T ss_pred             HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHH-HHHHhCCCCCcHHHHHHHHHHHHHHHHHhcC--CCCeE--------
Confidence            456788999999999999999999999999998 67    7888777 6        46788999  99999        


Q ss_pred             cchhhhcccc
Q 011380          467 KFSYLLLFPV  476 (487)
Q Consensus       467 ~f~~f~~~~~  476 (487)
                      +|+||+.+..
T Consensus        71 ~~~EF~~~~~   80 (174)
T 1q80_A           71 DETTFINSMK   80 (174)
T ss_dssp             EHHHHHHHHH
T ss_pred             cHHHHHHHHH
Confidence            8999987654

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=98.06  E-value=2.8e-06  Score=74.96  Aligned_cols=65  Identities=20%  Similarity=0.221  Sum_probs=56.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CC--------CcccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKD---LP--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ..++.+|..+|.|++|.|+.+|++.++...   +|        ...+.+++..+|+.+|.|++|.|        +|+||+
T Consensus        99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef~  170 (190)
T 1fpw_A           99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYI--------TLDEFR  170 (190)
T ss_dssp             HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEE--------EHHHHH
T ss_pred             HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcC--------cHHHHH
Confidence            467889999999999999999999998762   23        23678899999999999999999        899998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .+..
T Consensus       171 ~~~~  174 (190)
T 1fpw_A          171 EGSK  174 (190)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8665

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=98.05  E-value=2.9e-06  Score=75.04  Aligned_cols=66  Identities=24%  Similarity=0.267  Sum_probs=54.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CC--Cccc------HHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LP--WKLK------ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~--~~~~------~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      ...++.+|..+|.|++|.|+.+|++.++...   +|  ..++      ..++..+|+.+|.|++|.|        +|+||
T Consensus        98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef  169 (193)
T 1bjf_A           98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKL--------SLEEF  169 (193)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEE--------CHHHH
T ss_pred             HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeE--------eHHHH
Confidence            4578889999999999999999999998752   24  2232      4569999999999999999        89999


Q ss_pred             hcccc
Q 011380          472 LLFPV  476 (487)
Q Consensus       472 ~~~~~  476 (487)
                      +.+..
T Consensus       170 ~~~~~  174 (193)
T 1bjf_A          170 IRGAK  174 (193)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            88664

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=98.05  E-value=1.5e-06  Score=81.30  Aligned_cols=65  Identities=17%  Similarity=0.154  Sum_probs=57.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC----cccHHHHHH----HHHhcCCCCCceeecCccccccchhhhcc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW----KLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~----~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ...++.+|..+|.|++|+|+.+||+.+++. ++.    .+++++++.    +|..+|.|+||.|        +|+||+.+
T Consensus       195 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~-~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~i--------s~~EF~~~  265 (272)
T 2be4_A          195 KRDFEKIFAHYDVSRTGALEGPEVDGFVKD-MMELVRPSISGGDLDKFRECLLTHCDMNKDGKI--------QKSELALC  265 (272)
T ss_dssp             HHHHHHHHHHHCTTCCSEEETHHHHHHHHH-HHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEE--------EHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCeecHHHHHHHHHH-HHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcC--------cHHHHHHH
Confidence            356888999999999999999999999987 665    788888877    9999999999999        89999876


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus       266 ~~  267 (272)
T 2be4_A          266 LG  267 (272)
T ss_dssp             TT
T ss_pred             Hc
Confidence            54

>1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A

Probab=98.02  E-value=6.3e-07  Score=93.84  Aligned_cols=64  Identities=11%  Similarity=0.172  Sum_probs=4.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++|..||.|++|.|+.+||+.+|+. +|..++++++.++|+.+|.|++|.|        +|+||+.+..
T Consensus        11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~-lg~~~s~~el~~lf~~~D~d~~G~I--------~f~EF~~~~~   74 (624)
T 1djx_A           11 HWIHSCLRKADKNKDNKMNFKELKDFLKE-LNIQVDDGYARKIFRECDHSQTDSL--------EDEEIETFYK   74 (624)
T ss_dssp             ------------------------------------------------------------------CTTHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            46899999999999999999999999999 9999999999999999999999999        8888887654

>1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1

Probab=98.02  E-value=2.2e-06  Score=94.29  Aligned_cols=72  Identities=21%  Similarity=0.465  Sum_probs=66.0

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++.++...++.+|..||.|++|.|+.+||+.+|+. +|..+++.+++.+|..+|.|+||.|        +|+||+.++
T Consensus       717 ~~l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-~g~~~~~~~~~~~~~~~D~d~dG~I--------~~~EF~~~~  787 (863)
T 1sjj_A          717 KGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLIS-MGYNMGEAEFARIMSIVDPNRMGVV--------TFQAFIDFM  787 (863)
T ss_dssp             CCSSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHH-HTCCCCTHHHHHHHHHHCTTSCSEE--------ETTHHHHTH
T ss_pred             cCCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            4456777889999999999999999999999999999 8999999999999999999999999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus       788 ~  788 (863)
T 1sjj_A          788 S  788 (863)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus}

Probab=97.99  E-value=7.6e-06  Score=72.77  Aligned_cols=68  Identities=16%  Similarity=0.117  Sum_probs=59.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ......++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        48 ~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~-~~~~~~~~~~~~~F~~~D~d~~G~I--------~~~Ef~~~~~  115 (198)
T 2r2i_A           48 PSANKYVEQMFETFDFNKDGYIDFMEYVAALSL-VLKGKVDQKLRWYFKLYDVDGNGCI--------DRGELLNIIK  115 (198)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH-HSSCCHHHHHHHHHHHHCTTCSSCE--------EHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHH-HccCchHHHHHHHHHHhcCCCCCcC--------cHHHHHHHHH
Confidence            344456889999999999999999999999998 7777788999999999999999999        8888876553

>1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A

Probab=97.95  E-value=5.1e-06  Score=73.20  Aligned_cols=63  Identities=21%  Similarity=0.234  Sum_probs=57.2

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~i--------~~~ef~~~~~  126 (190)
T 1fpw_A           64 FANHLFTVFDKDNNGFIHFEEFITVLST-TSRGTLEEKLSWAFELYDLNHDGYI--------TFDEMLTIVA  126 (190)
T ss_dssp             HHHHHHHTCCSSCSSEECHHHHHHHHHH-HSCCCSTHHHHHHHHHHCSSCSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcEeHHHHHHHHHH-HccCCcHHHHHHHHHHhcCCCCCcC--------cHHHHHHHHH
Confidence            5788999999999999999999999998 7777888999999999999999999        8888877653

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=97.94  E-value=7.3e-06  Score=73.40  Aligned_cols=70  Identities=19%  Similarity=0.227  Sum_probs=49.9

Q ss_pred             cCChHHHHHHHHhhcccCCC--CCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          397 TLDDEELADLRDQFDAIDVD--KNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d--~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      .++.++...++++|..+|.|  ++|.|+.+|++.+|..  .....+..+.++|..+|.|++|.|        +|+||+..
T Consensus        30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~--~~~~~~~~~~~~f~~~D~d~~g~i--------~~~Ef~~~   99 (207)
T 2ehb_A           30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR--NRNRRNLFADRIFDVFDVKRNGVI--------EFGEFVRS   99 (207)
T ss_dssp             SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS--CTTCCCHHHHHHHHHHCTTCSSEE--------CHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc--cccccHHHHHHHHHHhcCCCCCeE--------eHHHHHHH
Confidence            35666777788888888877  8888888888887765  222334456778888888888888        77777665


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      ..
T Consensus       100 ~~  101 (207)
T 2ehb_A          100 LG  101 (207)
T ss_dssp             HG
T ss_pred             HH
Confidence            43

>2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe}

Probab=97.94  E-value=1e-05  Score=71.30  Aligned_cols=65  Identities=23%  Similarity=0.223  Sum_probs=58.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        62 ~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~i--------~~~e~~~~~~  126 (190)
T 2l2e_A           62 SAFAEYVFNVFDADKNGYIDFKEFICALSV-TSRGELNDKLIWAFQLYDLDNNGLI--------SYDEMLRIVD  126 (190)
T ss_dssp             HHHHHHHHHHHCSSSTTCEEHHHHHHHHTT-SSCSCSHHHHHHHHHHHCTTSCSCB--------CHHHHHHHHH
T ss_pred             cHHHHHHHHHhcCCCCCeEeHHHHHHHHHH-HcCCCHHHHHHHHHhHccCCCCCcC--------cHHHHHHHHH
Confidence            346788999999999999999999999998 8888889999999999999999999        8888877553

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=97.93  E-value=7e-06  Score=87.79  Aligned_cols=63  Identities=24%  Similarity=0.296  Sum_probs=59.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|+.+|.|++|+|+.+||+.+|+. +|..+++++++.++..+| |+||.|        +|+||+.++.
T Consensus       605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~-~G~~ls~~~~~~l~~~~D-d~dG~I--------sf~EF~~~l~  667 (714)
T 3bow_A          605 QKYQKIYREIDVDRSGTMNSYEMRKALEE-AGFKLPCQLHQVIVARFA-DDELII--------DFDNFVRCLV  667 (714)
T ss_dssp             HHHHHHHHHHCTTCCSSEEHHHHHHHHHH-TTEECCHHHHHHHHHHHS-CTTCEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeECHHHHHHHHHH-cCCCCCHHHHHHHHHHhC-CCCCeE--------cHHHHHHHHH
Confidence            57889999999999999999999999999 999999999999999999 999999        9999987654

>2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A

Probab=97.92  E-value=7.1e-06  Score=74.79  Aligned_cols=67  Identities=22%  Similarity=0.264  Sum_probs=35.9

Q ss_pred             CChHHHHHHHHhhcccCCC--CCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          398 LDDEELADLRDQFDAIDVD--KNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d--~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++.++..+++++|..+|.|  ++|.|+.+||+.+|..  +....+..+.++|..+|.|++|.|        +|+||+.+
T Consensus        42 ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~--~~~~~~~~~~~~f~~~D~d~dG~I--------~~~Ef~~~  110 (226)
T 2zfd_A           42 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK--TNKKESLFADRVFDLFDTKHNGIL--------GFEEFARA  110 (226)
T ss_dssp             CCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS--CSSCCCHHHHHHHHHHCSSCSSSB--------CHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc--cCcccHHHHHHHHHHHcCCCCCcC--------cHHHHHHH
Confidence            3455555555666666655  6666666666655554  112222344555666666666666        55555543

>2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A

Probab=97.91  E-value=5.8e-06  Score=77.31  Aligned_cols=65  Identities=18%  Similarity=0.258  Sum_probs=57.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHH----HHHhcCCCCCceeecCccccccchhhhcc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESRVLE----ILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~----~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+++.+|..+|.|++|.|+.+|++.++.. +    |..++..++..    ++..+|.|++|.|        +|+||+.+
T Consensus       103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i--------~~~ef~~~  173 (272)
T 2be4_A          103 SVEFMKIWRKYDADSSGYISAAELKNFLKD-LFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRL--------DLNDLARI  173 (272)
T ss_dssp             HHHHHHHHHHHCTTCCSEEEGGGHHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEE--------EHHHHGGG
T ss_pred             HHHHHHHHHHhCCCCCCccCHHHHHHHHHH-HHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcC--------cHHHHHHH
Confidence            456889999999999999999999999988 6    88888888754    9999999999999        89999886


Q ss_pred             cc
Q 011380          475 PV  476 (487)
Q Consensus       475 ~~  476 (487)
                      +.
T Consensus       174 ~~  175 (272)
T 2be4_A          174 LA  175 (272)
T ss_dssp             SC
T ss_pred             Hh
Confidence            53

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.90  E-value=8.7e-05  Score=70.94  Aligned_cols=76  Identities=20%  Similarity=0.176  Sum_probs=60.9

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC--CCccEEEEEEEeCCEEEEEEec
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYIAMEL  178 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--pnIv~~~~~~~~~~~~~lv~e~  178 (487)
                      .+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.|..+  ..+++++.+....+..++|||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            46789999999999963  5678999976542      246678999999988643  5688899988888899999999


Q ss_pred             cCCCCH
Q 011380          179 CEGGEL  184 (487)
Q Consensus       179 ~~gg~L  184 (487)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A

Probab=97.87  E-value=6.4e-06  Score=73.80  Aligned_cols=64  Identities=14%  Similarity=0.106  Sum_probs=57.4

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~I--------~~~E~~~~l~  134 (207)
T 2d8n_A           71 AYAQHVFRSFDSNLDGTLDFKEYVIALHM-TTAGKTNQKLEWAFSLYDVDGNGTI--------SKNEVLEIVM  134 (207)
T ss_dssp             HHHHHHHHHHCTTCCSEEEHHHHHHHHHH-HSCSSSSTTHHHHHHHHCTTCSSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCeEeHHHHHHHHHH-HcCCCHHHHHHHHHHHhcCCCCCeE--------cHHHHHHHHH
Confidence            56888999999999999999999999998 7777788899999999999999999        8888877553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.87  E-value=7e-05  Score=75.02  Aligned_cols=77  Identities=10%  Similarity=0.094  Sum_probs=45.5

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCc--CC----hHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM--IL----PIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~----~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .+.||.|..+.||++.  .+++.++||.......  ..    ......+..|+..+..-.....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            4678999999999995  3567899994322110  00    012223333433322211234677777665  456789


Q ss_pred             EEecc-CC
Q 011380          175 AMELC-EG  181 (487)
Q Consensus       175 v~e~~-~g  181 (487)
                      |||++ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A

Probab=97.87  E-value=2.8e-06  Score=71.49  Aligned_cols=62  Identities=18%  Similarity=0.141  Sum_probs=50.0

Q ss_pred             HHHHHHHHhhcccCCCC-CCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          401 EELADLRDQFDAIDVDK-NGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~-~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++..+++++|..+|.|+ +|.|+.+|++.+|+. +|..++..++..++..+|.+    |        +|++|+.+.
T Consensus        11 ~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~-~g~~~~~~~~~~l~~~~d~~----i--------~~~eF~~~~   73 (146)
T 2qac_A           11 EEKVDESDVRIYFNEKSSGGKISIDNASYNARK-LGLAPSSIDEKKIKELYGDN----L--------TYEQYLEYL   73 (146)
T ss_dssp             HHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSE----E--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCccCCCCcccHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCC----C--------CHHHHHHHH
Confidence            34556888999999999 999999999999998 88888888888887777765    6        677776544

>2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A

Probab=97.86  E-value=7.6e-07  Score=78.36  Aligned_cols=65  Identities=18%  Similarity=0.148  Sum_probs=56.6

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh-----CCCcccHHHHHHHH---------HhcCCCCCceeecCcc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD-----LPWKLKESRVLEIL---------QAVNTPFLGLFLPCHE  463 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~-----~~~~~~~~e~~~~~---------~~~d~~~~g~i~~~~~  463 (487)
                      +++++..+++++|..+|.|++|.|+.+||+.+|+..     +|..++..++..++         +.+|.|++|.|     
T Consensus         8 l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I-----   82 (186)
T 2hps_A            8 ERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAA-----   82 (186)
T ss_dssp             HHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHH-----
T ss_pred             ccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcc-----
Confidence            345677899999999999999999999999999761     38888899999885         99999999999     


Q ss_pred             ccccchh
Q 011380          464 KGEKFSY  470 (487)
Q Consensus       464 ~~~~f~~  470 (487)
                         +|+|
T Consensus        83 ---~~~E   86 (186)
T 2hps_A           83 ---VNAT   86 (186)
T ss_dssp             ---HHHH
T ss_pred             ---cHHH
Confidence               7777

>1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E

Probab=97.85  E-value=1.4e-05  Score=69.82  Aligned_cols=66  Identities=15%  Similarity=0.126  Sum_probs=56.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+...
T Consensus        55 ~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~i--------~~~e~~~~~~~  120 (183)
T 1s6c_A           55 STYAHYLFNAFDTTQTGSVKFEDFVTALSI-LLRGTVHEKLRWTFNLYDINKDGYI--------NKEEMMDIVKA  120 (183)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHH-HHHCCHHHHHHHHHHHHCTTCSSCE--------EHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcEeHHHHHHHHHH-HcCCCHHHHHHHHHHHhCCCCCCeE--------cHHHHHHHHHH
Confidence            356778899999999999999999999987 6666778889999999999999999        88888876653

>2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens}

Probab=97.80  E-value=1.8e-05  Score=71.12  Aligned_cols=67  Identities=13%  Similarity=0.139  Sum_probs=58.5

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ......++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+.
T Consensus        53 ~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~-~~~~~~~~~l~~~F~~~D~d~~G~I--------~~~E~~~~l  119 (211)
T 2ggz_A           53 QKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNL-IMQEKMEQKLKWYFKLYDADGNGSI--------DKNELLDMF  119 (211)
T ss_dssp             HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHH-HSCSSHHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             cchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHH-hccCchHHHHHHHHHHhcCCCCCcC--------cHHHHHHHH
Confidence            344456889999999999999999999999988 6767778899999999999999999        888887654

>1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5

Probab=97.80  E-value=1.1e-05  Score=71.35  Aligned_cols=63  Identities=16%  Similarity=0.124  Sum_probs=56.6

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+..+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+.
T Consensus        63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~I--------~~~E~~~~~  125 (193)
T 1bjf_A           63 KFAEHVFRTFDANGDGTIDFREFIIALSV-TSRGKLEQKLKWAFSMYDLDGNGYI--------SKAEMLEIV  125 (193)
T ss_dssp             HHHHHHHHHHCSSCSSEEEHHHHHHHHHH-HTSSCHHHHHHHHHHHHCTTCSSCE--------EHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHH-HcCCCHHHHHHHHHhhcCCCCCCeE--------CHHHHHHHH
Confidence            45778999999999999999999999998 7777788999999999999999999        888887654

>1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5

Probab=97.79  E-value=1.8e-05  Score=72.07  Aligned_cols=65  Identities=15%  Similarity=0.129  Sum_probs=56.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        88 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~-~~~~~~~~~l~~~F~~~D~d~dG~I--------s~~E~~~~l~  152 (224)
T 1s1e_A           88 STYAHYLFNAFDTTQTGSVKFEDFVTALSI-LLRGTVHEKLRWTFNLYDINKDGYI--------NKEEMMDIVK  152 (224)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-HHHCCHHHHHHHHHHHHCTTCCSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcEeHHHHHHHHHH-HccCCHHHHHHHHHHHHcCCCCCeE--------CHHHHHHHHH
Confidence            346778999999999999999999999987 6666678899999999999999999        8888876543

>2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens}

Probab=97.75  E-value=1.5e-05  Score=69.54  Aligned_cols=55  Identities=7%  Similarity=-0.016  Sum_probs=47.9

Q ss_pred             ccCCCCCCCCCHHHHHHHHHhhC------CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          412 AIDVDKNGSISLEEMRQALAKDL------PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       412 ~~D~d~~G~i~~~el~~~l~~~~------~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .-+.|++|.|+.+||+.+|+. +      |..++.+++..++..+|.|++|.|        +|+||+.+.
T Consensus        12 ~~~~~~dG~I~~~EL~~~l~~-l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I--------~f~EF~~~~   72 (174)
T 2i7a_A           12 SGLVPRGSDIDATQLQGLLNQ-ELLTGPPGDMFSLDECRSLVALMELKVNGRL--------DQEEFARLW   72 (174)
T ss_dssp             CCSCC-CCCEEHHHHHHHHHH-HHC-----CCCCHHHHHHHHHHHCSSCSSEE--------CHHHHHHHH
T ss_pred             cccCCCCCcCCHHHHHHHHHH-HHhccCCCCCCCHHHHHHHHHHHCCCCCCcC--------CHHHHHHHH
Confidence            347899999999999999998 6      667889999999999999999999        999998754

>1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A*

Probab=97.75  E-value=1.8e-05  Score=69.31  Aligned_cols=55  Identities=13%  Similarity=0.112  Sum_probs=26.2

Q ss_pred             ChHHHHHHHHhhcccCC-----CC-C--CCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCce-e
Q 011380          399 DDEELADLRDQFDAIDV-----DK-N--GSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGL-F  458 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~-----d~-~--G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~-i  458 (487)
                      +.+++..++++|..+|.     |+ +  |.|+.+||+. |.. +|..++..   +++..+|.|++|. |
T Consensus        15 s~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~-~g~~~~~~---~l~~~~D~d~~G~~I   78 (183)
T 1dgu_A           15 TKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPE-LKANPFKE---RICRVFSTSPAKDSL   78 (183)
T ss_dssp             CHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STT-SSSCTTHH---HHHHHHSCSSSSCCC
T ss_pred             CHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHh-hhcCcHHH---HHHHHhCCCCCCCEe
Confidence            33444445555555555     34 4  5555555555 444 44444332   3344445555555 5

>2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A

Probab=97.74  E-value=4.6e-06  Score=74.90  Aligned_cols=68  Identities=16%  Similarity=0.228  Sum_probs=57.1

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+++++...++++|..+|.|++|.|+.+||+.++ . +|...+.   ++++..+|.+++|.|        +|+||+.+.
T Consensus        21 ~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~-lg~~~~~---~~l~~~~d~~~~g~i--------~~~EF~~~~   87 (208)
T 2ct9_A           21 TGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-E-LAINPLG---DRIINAFFSEGEDQV--------NFRGFMRTL   87 (208)
T ss_dssp             HCCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-H-HHTSTTH---HHHHHTTSCTTCSCE--------EHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-H-cCCCCcH---HHHHHHHcCCCCCcC--------cHHHHHHHH
Confidence            34678888999999999999999999999999865 4 5655543   568899999999999        899998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        88 ~   88 (208)
T 2ct9_A           88 A   88 (208)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L

Probab=97.71  E-value=1.2e-05  Score=85.99  Aligned_cols=69  Identities=12%  Similarity=0.172  Sum_probs=62.2

Q ss_pred             CChHH-HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC--------CCcccHHHHHHHHHhcCCCCCceeecCccccccc
Q 011380          398 LDDEE-LADLRDQFDAIDVDKNGSISLEEMRQALAKDL--------PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       398 ~~~~~-~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~--------~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      +++++ ..+++++|..+| |++|.|+.+||+.+|+. +        |..++.+++..++..+|.|++|.|        +|
T Consensus       525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~-l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I--------~f  594 (714)
T 3bow_A          525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRR-VLAKREDIKSDGFSIETCKIMVDMLDEDGSGKL--------GL  594 (714)
T ss_dssp             CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHH-HHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSB--------CH
T ss_pred             CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHH-HhhhcccccCCCCCHHHHHHHHHHhCCCCCCcC--------cH
Confidence            45566 789999999999 99999999999999998 5        778999999999999999999999        99


Q ss_pred             hhhhcccc
Q 011380          469 SYLLLFPV  476 (487)
Q Consensus       469 ~~f~~~~~  476 (487)
                      +||+.+..
T Consensus       595 ~EF~~l~~  602 (714)
T 3bow_A          595 KEFYILWT  602 (714)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987653

>2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B

Probab=97.70  E-value=1.8e-05  Score=84.96  Aligned_cols=65  Identities=8%  Similarity=0.151  Sum_probs=42.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhC-CCc---------ccHHHHHHHHHhcCCC----CCceeecCccccccch
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDL-PWK---------LKESRVLEILQAVNTP----FLGLFLPCHEKGEKFS  469 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~-~~~---------~~~~e~~~~~~~~d~~----~~g~i~~~~~~~~~f~  469 (487)
                      .+++++|..||.|++|+|+.+||+.+|+. + |..         ++++++++||+++|.|    ++|.|        +|+
T Consensus       219 ~el~~aF~~fD~d~~g~Is~~eL~~fL~~-~Qge~~~~~~~~~~~t~ee~~~iI~~~d~d~~~~~dg~i--------s~e  289 (799)
T 2zkm_X          219 PEIDEIFTSYHAKAKPYMTKEHLTKFINQ-KQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQL--------SPE  289 (799)
T ss_dssp             HHHHTTCC--------CCCHHHHHHHHHH-TCC---------------CHHHHHHHHCCC--------C--------CHH
T ss_pred             HHHHHHHHHhccCCCCeEcHHHHHHHHHH-hcCCcccccccccCCCHHHHHHHHHHhhcccccccCCcc--------chh
Confidence            46899999999999999999999999998 6 665         7889999999999999    89999        899


Q ss_pred             hhhccccc
Q 011380          470 YLLLFPVD  477 (487)
Q Consensus       470 ~f~~~~~~  477 (487)
                      +|+.++..
T Consensus       290 eF~~~L~S  297 (799)
T 2zkm_X          290 GMVWFLCG  297 (799)
T ss_dssp             HHHHHHHS
T ss_pred             hhhhcccC
Confidence            99887753

>1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A

Probab=97.69  E-value=1.3e-05  Score=70.49  Aligned_cols=64  Identities=17%  Similarity=0.115  Sum_probs=56.5

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..+|..+|.|++|.|+.+|+..++.. ++...+.+++..+|+.+|.|++|.|        +++||..+..
T Consensus        63 ~~~~~~f~~~D~d~~g~i~~~ef~~~~~~-~~~~~~~~~~~~~f~~~D~d~~G~i--------~~~e~~~~l~  126 (190)
T 1g8i_A           63 KFATFVFNVFDENKDGRIEFSEFIQALSV-TSRGTLDEKLRWAFKLYDLDNDGYI--------TRNEMLDIVD  126 (190)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHHH-HHHCCHHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCeEeHHHHHHHHHH-hcCCCHHHHHHHHHHhhcCCCCCeE--------CHHHHHHHHH
Confidence            35788999999999999999999999988 6666778899999999999999999        8888877553

>1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3

Probab=97.67  E-value=3.4e-05  Score=84.99  Aligned_cols=64  Identities=25%  Similarity=0.265  Sum_probs=59.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|+.+|.|++|+|+.+||+.+|+. +|..+++++++.++..+| |++|.|        +|+||+.++.
T Consensus       606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~-~g~~l~~~~~~~l~~~~d-d~dg~I--------~~~eF~~~~~  669 (900)
T 1qxp_A          606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEA-AGFKLPCQLHQVIVARFA-DDELII--------DFDNFVRCLV  669 (900)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHH-TTEECCHHHHHHHHHHTS-CSSSBC--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhhCCCCCCeECHHHHHHHHHH-hCCCCCHHHHHHHHHHhC-CCCCeE--------cHHHHHHHHH
Confidence            367899999999999999999999999999 999999999999999999 999999        8999987654

>3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A

Probab=97.66  E-value=5.3e-05  Score=69.09  Aligned_cols=64  Identities=19%  Similarity=0.172  Sum_probs=54.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..+|..+|.|++|.|+.+|+..++.. +....+++++..+|+.+|.|++|.|        +++||..+..
T Consensus       102 ~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~-~~~~~~~~~l~~~F~~~D~d~dG~I--------s~~E~~~~l~  165 (229)
T 3dd4_A          102 TYAHFLFNAFDTDHNGAVSFEDFIKGLSI-LLRGTVQEKLNWAFNLYDINKDGYI--------TKEEMLDIMK  165 (229)
T ss_dssp             HHHHHHHHTTCSSCCSSCCHHHHHHHHHH-HHHSCHHHHHHHHHHHHCTTCSSCC--------BHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCeEeHHHHHHHHHH-HcCCChHHHHHHHHHHhCCCCCCeE--------CHHHHHHHHH
Confidence            34567899999999999999999999887 5555667889999999999999999        8888877665

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.64  E-value=0.00014  Score=69.21  Aligned_cols=72  Identities=7%  Similarity=-0.081  Sum_probs=45.4

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc-
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC-  179 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~-  179 (487)
                      .+.|+.|....+|++      ..+++|+......    ......+|+.+++.+..+.-.++++...  ...-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            577989999999999      4688897754311    0112346888888776443235666543  33346899999 


Q ss_pred             CCCCH
Q 011380          180 EGGEL  184 (487)
Q Consensus       180 ~gg~L  184 (487)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	487
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-85
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-83
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-81
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-81
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-81
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-81
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-77
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-76
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-74
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-74
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-71
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-70
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-63
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-63
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-63
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-61
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-61
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-60
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-59
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-57
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-57
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-56
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-54
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-53
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-53
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-53
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-17
d1ij5a_	321	a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind	2e-07
d1s6ia_	182	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	7e-07
d1s6ja_	87	a.39.1.5 (A:) Calcium-dependent protein kinase sk5	8e-07
d1f54a_	77	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	1e-06
d1lkja_	146	a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom	4e-05
d2opoa1	81	a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che	5e-05
d1y1xa_	182	a.39.1.8 (A:) Programmed cell death 6 protein-like	5e-05
d2pq3a1	73	a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T	6e-05
d1qv0a_	189	a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr	9e-05
d1c7va_	68	a.39.1.5 (A:) Calcium vector protein {Amphioxus (B	9e-05
d1avsa_	81	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	9e-05
d1uhka1	187	a.39.1.5 (A:3-189) Calcium-regulated photoprotein	1e-04
d1wrka1	82	a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens)	2e-04
d1auib_	165	a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch	4e-04
d1wdcb_	142	a.39.1.5 (B:) Myosin Essential Chain {Bay scallop	5e-04
d1oqpa_	77	a.39.1.5 (A:) Caltractin (centrin 2) {Green algae	5e-04
d1topa_	162	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	7e-04
d1rroa_	108	a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus)	8e-04
d1wdcc_	152	a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop	0.002
d2scpa_	174	a.39.1.5 (A:) Sarcoplasmic calcium-binding protein	0.003
d1j7la_	263	d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos	0.003
d1tiza_	67	a.39.1.5 (A:) Calmodulin-related protein T21P5.17	0.003
d1dtla_	156	a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus)	0.004
d1w7jb1	139	a.39.1.5 (B:11-149) Myosin Essential Chain {Human	0.004
d1exra_	146	a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr	0.004

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  262 bits (671), Expect = 3e-85
 Identities = 115/298 (38%), Positives = 165/298 (55%), Gaps = 7/298 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           +D    Y    +LG G F    +A DK     VA+K I K  +        ++ E+ +L 
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
            +  H N+V   + +E   ++Y+ M+L  GGEL DRI   +   YTE+DA+ ++ Q+L  
Sbjct: 63  KIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA 119

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H  G+VHRD+KPEN L+ S  EDS +  +DFGLS    PG       G+  YVAPE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           VL +K      D WSIGVI YILLCG  PF+D+ +  +F+++L+ + +F    W  IS+S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQ 388
           AKDF++ L+ KDP  R T  QAL HPW+  G  A +  I  SV   +++    S+ KQ
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIA-GDTALDKNIHQSVSEQIKKNFAKSKWKQ 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  259 bits (663), Expect = 2e-83
 Identities = 99/287 (34%), Positives = 148/287 (51%), Gaps = 7/287 (2%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG  +   +KA G     K I       P+    VK E+ I+  L  H
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-H 85

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             ++  ++AFED   + + +E   GGEL DRI   +D + +E +    +RQ        H
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            H +VH D+KPEN +    K+ SS+K  DFGL+  + P +  +    +A + APE++ R+
Sbjct: 145 EHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 203

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G  +D+W+IGV+ Y+LL G  PF  + +    + V R   +F    + S+S  AKDF+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 336 KKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVK 382
           K LL K+PR RLT   AL HPW++         I  S  N +RQ +K
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 310

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  255 bits (651), Expect = 1e-81
 Identities = 96/276 (34%), Positives = 151/276 (54%), Gaps = 10/276 (3%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y I + LG G FG  +  T++A G+  A K +           E V++E++ +  L  H
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLR-H 82

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V  ++AFEDDN + +  E   GGEL +++ A + ++ +E +A   +RQ+ +     H
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
            +  VH D+KPEN +F + K  + LK  DFGL+  + P +  +   G+A + APEV + K
Sbjct: 142 ENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G  +D+WS+GV++YILL G  PF  + +D   + V     +     +  IS   KDF+
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 336 KKLLVKDPRARLTAAQALSHPWVREG---GDASEIP 368
           +KLL+ DP  R+T  QAL HPW+  G   G  S+IP
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 5e-81
 Identities = 81/307 (26%), Positives = 149/307 (48%), Gaps = 12/307 (3%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           K+   +Y I + LG G+FG  +   + ++      K ++            VK+E+ IL 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILN 56

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
               H N++  + +FE    + +  E   G ++ +RI         E++    V Q+   
Sbjct: 57  IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEA 114

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPE 271
               H H + H D++PEN ++   +  S++K  +FG +  +KPG  F+ +  +  Y APE
Sbjct: 115 LQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V +       +D+WS+G + Y+LL G  PF  +T   I + ++  +  F  + +  IS  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFVKYSRLKQFA 390
           A DFV +LLVK+ ++R+TA++AL HPW+++  +     +   V+  ++    Y  L +  
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKD 289

Query: 391 LRALAST 397
           L  + S 
Sbjct: 290 LNMVVSA 296

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  252 bits (645), Expect = 6e-81
 Identities = 87/333 (26%), Positives = 155/333 (46%), Gaps = 18/333 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           +   D      ++LG G  G      +K   ++ A+K ++             +REV++ 
Sbjct: 7   NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELH 58

Query: 151 QALAGHENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVR 206
              +   ++V+  + +E+       + I ME  +GGEL  RI  + D  +TE++A+ +++
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118

Query: 207 QMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAY 266
            +       H   + HRD+KPEN L+ S + ++ LK TDFG +              + Y
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTE----DGIFKEVLRNKPDFRR 321
           YVAPEVL  +      D+WS+GVI YILLCG  PF+         G+   +   + +F  
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMRQFV 381
             W  +S   K  ++ LL  +P  R+T  + ++HPW+ +     + P+  S +    +  
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE- 297

Query: 382 KYSRLKQFALRALASTLDDEELADLRDQFDAID 414
           ++  +K+    ALA+   D E   ++   DA +
Sbjct: 298 RWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  250 bits (639), Expect = 7e-81
 Identities = 85/280 (30%), Positives = 141/280 (50%), Gaps = 18/280 (6%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM------ILPIAVEDVKREV 147
           F   Y   ++LG G          K      AVK I+           +    E   +EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            IL+ ++GH N+++  + +E + + ++  +L + GEL D +   +    +EK+   ++R 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRA 118

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +L V    H   +VHRD+KPEN L     +D ++K TDFG S  + PG+K +++ G+  Y
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 268 VAPEVL-------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR 320
           +APE++           G E D+WS GVI Y LL G  PFW + +  + + ++     F 
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235

Query: 321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
              W   S++ KD V + LV  P+ R TA +AL+HP+ ++
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 1e-77
 Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 12/265 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + IG+ LG G+FG  Y+A +K +   +A+K + K ++        ++REV+I   L  H
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 65

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+++ Y  F D   VY+ +E    G +   +  +K S++ E+  A  + ++    + CH
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 123

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              ++HRD+KPEN L  S      LK  DFG S    P  +   + G+  Y+ PE+++ +
Sbjct: 124 SKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGR 179

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
               + D+WS+GV+ Y  L G+ PF   T    +K + R +  F       ++  A+D +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLI 235

Query: 336 KKLLVKDPRARLTAAQALSHPWVRE 360
            +LL  +P  R    + L HPW+  
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITA 260

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 2e-76
 Identities = 97/274 (35%), Positives = 152/274 (55%), Gaps = 8/274 (2%)

Query: 92  KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVK 148
           ++ D  Y  G+ LG GQF       +K+ G + A K I+K +       ++ ED++REV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 149 ILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           IL+ +  H NV+  +  +E+   V + +EL  GGEL D +  K+    TE++A   ++Q+
Sbjct: 66  ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSA-KEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           L      H   + H D+KPEN +          +K  DFGL+  I  G +F++I G+  +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           VAPE++  +  G E+D+WSIGVITYILL G  PF   T+      V     +F  + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
            S  AKDF+++LLVKDP+ R+T   +L HPW++ 
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 3e-76
 Identities = 72/278 (25%), Positives = 135/278 (48%), Gaps = 13/278 (4%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D  ++YT  + +G G  G  Y A D A G  VA++++   +       E +  E+ +++ 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRE 73

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              + N+V + +++   + +++ ME   GG L D +    ++   E   A V R+ L+  
Sbjct: 74  N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQAL 129

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK-PGKKFQDIVGSAYYVAPE 271
              H + ++HRD+K +N L      D S+K TDFG    I     K   +VG+ Y++APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           V+ RK+ GP+ D+WS+G++   ++ G  P+ ++        +  N      +    +S  
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAI 245

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP 368
            +DF+ + L  D   R +A + L H +++     S + 
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (610), Expect = 5e-76
 Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 18/307 (5%)

Query: 90  YDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKI 149
           +  D ++ ++  + +GHG FG  Y A D  N + VA+KK+  +        +D+ +EV+ 
Sbjct: 9   FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 68

Query: 150 LQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           LQ L  H N +++   +  ++  ++ ME C G       + KK     E + A V    L
Sbjct: 69  LQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGAL 125

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
           +  A  H H ++HRD+K  N L     E   +K  DFG +  + P   F   VG+ Y++A
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANSF---VGTPYWMA 179

Query: 270 PEVL----KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
           PEV+    + +   + DVWS+G+    L   + P ++         + +N+         
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSG 237

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDIS-VLNNMRQF--VK 382
             S   ++FV   L K P+ R T+   L H +V      + I   I    + +R+   ++
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297

Query: 383 YSRLKQF 389
           Y ++K+ 
Sbjct: 298 YRKMKKI 304

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 8e-75
 Identities = 82/280 (29%), Positives = 136/280 (48%), Gaps = 16/280 (5%)

Query: 91  DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKIL 150
           D + +  + I   LG G FG  Y A +K      A K I+         +ED   E+ IL
Sbjct: 7   DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDIL 63

Query: 151 QALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            +   H N+VK  +AF  +N ++I +E C GG  +D ++ + +   TE    VV +Q L 
Sbjct: 64  ASCD-HPNIVKLLDAFYYENNLWILIEFCAGG-AVDAVMLELERPLTESQIQVVCKQTLD 121

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVA 269
                H + ++HRD+K  N LF     D  +K  DFG+S    +  ++    +G+ Y++A
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 270 PEVL------KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP 323
           PEV+       R    ++DVWS+G+    +     P  +     +  ++ +++P    +P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD 363
               S++ KDF+KK L K+  AR T +Q L HP+V    +
Sbjct: 239 -SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 2e-74
 Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 14/273 (5%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           F   + + + LG G +G   +A ++   + VAVK ++  + +     E++K+E+ I + L
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML 60

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             HENVVKFY    + N  Y+ +E C GGEL DRI  + D    E DA     Q++    
Sbjct: 61  -NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 117

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG---KKFQDIVGSAYYVAP 270
             H  G+ HRD+KPEN L        +LK +DFGL+   +     +    + G+  YVAP
Sbjct: 118 YLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 271 EVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS 328
           E+LKR+       DVWS G++   +L G  P+   ++        + K  +   PW  I 
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKID 233

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
           ++    + K+LV++P AR+T        W  + 
Sbjct: 234 SAPLALLHKILVENPSARITIPDIKKDRWYNKP 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 5e-74
 Identities = 86/268 (32%), Positives = 130/268 (48%), Gaps = 14/268 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +  GK+LG G F    +A + A     A+K +EK  +I    V  V RE  ++  L  H
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
              VK Y  F+DD  +Y  +   + GELL  I  +K   + E        +++      H
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLH 125

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVL 273
             G++HRD+KPEN L     ED  ++ TDFG +  + P  K       VG+A YV+PE+L
Sbjct: 126 GKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 274 KRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             KS    SD+W++G I Y L+ G  PF    E  IF+++++ + DF           A+
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKAR 238

Query: 333 DFVKKLLVKDPRARLTAAQALSHPWVRE 360
           D V+KLLV D   RL   +   +  ++ 
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 3e-71
 Identities = 70/267 (26%), Positives = 123/267 (46%), Gaps = 12/267 (4%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            + + K+LG G FG  ++A  K      A+K ++K+ +++   VE    E ++L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   +  F+    ++  ME   GG+L+  I  +   ++    A     +++      H
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLKR 275
             G+V+RD+K +N L     +D  +K  DFG+  + +    K     G+  Y+APE+L  
Sbjct: 121 SKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 177

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF 334
           +      D WS GV+ Y +L G+ PF  + E+ +F  +  + P +       +   AKD 
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDL 233

Query: 335 VKKLLVKDPRARLTAAQA-LSHPWVRE 360
           + KL V++P  RL        HP  RE
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  221 bits (565), Expect = 9e-70
 Identities = 69/269 (25%), Positives = 113/269 (42%), Gaps = 9/269 (3%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G++LG G     ++A D      VAVK +  +    P      +RE +   AL  H
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NH 66

Query: 157 ENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
             +V  Y+  E +       YI ME  +G  L D +    +   T K A  V+    +  
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQAL 124

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG-LSDFIKPGKKFQDIVGSAYYVAPE 271
              H +G++HRD+KP N +  +      +       ++D      +   ++G+A Y++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 272 VLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
             +  S    SDV+S+G + Y +L G  PF   +   +  + +R  P         +S  
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 331 AKDFVKKLLVKDPRARLTAAQALSHPWVR 359
               V K L K+P  R   A  +    VR
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 2e-69
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 19/272 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           Y +   +G G +G       K++G  +  K+++   M      + +  EV +L+ L  H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK-HP 63

Query: 158 NVVKFYNAFED--DNYVYIAMELCEGGELLDRI--LAKKDSRYTEKDAAVVVRQMLRVAA 213
           N+V++Y+   D  +  +YI ME CEGG+L   I    K+     E+    V+ Q+     
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 214 ECHL-----HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF-QDIVGSAYY 267
           ECH      H ++HRD+KP N          ++K  DFGL+  +     F +  VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           ++PE + R S   +SD+WS+G + Y L     PF   ++  +  ++   K    R+    
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYR 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
            S+   + + ++L      R +  + L +P +
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 8e-69
 Identities = 55/271 (20%), Positives = 107/271 (39%), Gaps = 16/271 (5%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           R       +G G F   Y   D      VA  +++  K+      +  K E ++L+ L  
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQ- 66

Query: 156 HENVVKFYNAFED----DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           H N+V+FY+++E        + +  EL   G L   +  K+      K      RQ+L+ 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKG 124

Query: 212 AAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
               H     ++HRD+K +N          S+K  D GL+   K     + ++G+  ++A
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMA 181

Query: 270 PEVLKRKSGPESDVWSIGVITYILLCGRRPFWDK-TEDGIFKEVLRNKPDFRRKPWPSIS 328
           PE+ + K     DV++ G+    +     P+ +      I++ V                
Sbjct: 182 PEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAI 239

Query: 329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVR 359
              K+ ++  + ++   R +    L+H + +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 2e-68
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 20/273 (7%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVED---VKREVKIL 150
            + +Y +G LLG G FG  Y     ++   VA+K +EK+++     + +   V  EV +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 151 QAL-AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           + + +G   V++  + FE  +   + +E  E  + L   +  +     E+ A     Q+L
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVL 120

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                CH  G++HRD+K EN L         LK  DFG    +K    + D  G+  Y  
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 177

Query: 270 PEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PE +   R  G  + VWS+G++ Y ++CG  PF          E++R +  FR      +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRV 227

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           S+  +  ++  L   P  R T  +  +HPW+++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 7e-67
 Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 51/306 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +     LG G  G  +  + K +G  +A K I       P     + RE+++L      
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECN-S 63

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V FY AF  D  + I ME  +GG L   +  KK  R  E+    V   +++      
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 217 -LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR 275
             H ++HRD+KP N L  S      +K  DFG+S  +         VG+  Y++PE L+ 
Sbjct: 122 EKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQG 177

Query: 276 KS-GPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDF------------ 319
                +SD+WS+G+    +  GR P           +F   +                  
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 320 -------------------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                                     + P    S   +DFV K L+K+P  R    Q + 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 355 HPWVRE 360
           H +++ 
Sbjct: 298 HAFIKR 303

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  207 bits (528), Expect = 3e-63
 Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 16/273 (5%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA-- 154
            +++ +++G G FG  Y       G   A+K ++K ++ +         E  +L  ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 155 GHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
               +V    AF   + +   ++L  GG+L   +   +   ++E D      +++     
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 122

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
            H   +V+RD+KP N L     E   ++ +D GL+      K     VG+  Y+APEVL+
Sbjct: 123 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ 178

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
           +       +D +S+G + + LL G  PF          E+ R       +   S S   +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237

Query: 333 DFVKKLLVKDPRARLT-----AAQALSHPWVRE 360
             ++ LL +D   RL      A +    P+ R 
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-63
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 17/270 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           +   KLLG G FG   +  +KA G   A+K + K  +I    V     E ++LQ    H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHP 65

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +     AF+  + +   ME   GGEL   +   ++  +TE+ A     +++      H 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVLKRK 276
             +V+RD+K EN +     +D  +K TDFGL       G   +   G+  Y+APEVL+  
Sbjct: 124 RDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
             G   D W +GV+ Y ++CGR PF+++  + +F+ +L  +  F      ++S  AK  +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236

Query: 336 KKLLVKDPRARL-----TAAQALSHPWVRE 360
             LL KDP+ RL      A + + H +   
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  206 bits (524), Expect = 3e-63
 Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 18/269 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
           + I + LG G FG  ++   + NG   A+K ++K  ++    VE    E  +L  +  H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +++ +  F+D   +++ M+  EGGEL    L +K  R+    A     ++       H 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFS--LLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RK 276
             +++RD+KPEN L     ++  +K TDFG + ++        + G+  Y+APEV+  + 
Sbjct: 123 KDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVK 336
                D WS G++ Y +L G  PF+D      ++++L  +  F     P  +   KD + 
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233

Query: 337 KLLVKDPRARL-----TAAQALSHPWVRE 360
           +L+ +D   RL           +HPW +E
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 8e-63
 Identities = 62/268 (23%), Positives = 112/268 (41%), Gaps = 19/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           + T+G+ +G G FG  Y          VAVK +       P  ++  K EV +L+    H
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR-H 63

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N++ F   +     + I  + CEG  L    L   ++++       + RQ  +     H
Sbjct: 64  VNILLFM-GYSTAPQLAIVTQWCEGSSLYHH-LHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVL 273
              ++HRD+K  N       ED ++K  DFGL+          +F+ + GS  ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 274 KRKS----GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK--PDFRRKPWPSI 327
           + +       +SDV++ G++ Y L+ G+ P+ +         ++          K   + 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 328 SNSAKDFVKKLLVKDPRARLTAAQALSH 355
             + K  + + L K    R    Q L+ 
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-61
 Identities = 82/315 (26%), Positives = 123/315 (39%), Gaps = 48/315 (15%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D   RYT    +G G +G    A D  N  RVA+KKI   +       +   RE+KIL  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLR 62

Query: 153 LAGHENVVKFYNAFEDDN-----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
              HEN++   +            VY+   L  G +L   +   K    +       + Q
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLL---KTQHLSNDHICYFLYQ 117

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK----KFQDIVG 263
           +LR     H   ++HRD+KP N L         LK  DFGL+    P         + V 
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 264 SAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR------- 314
           + +Y APE++          D+WS+G I   +L  R  F  K        +L        
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 315 ----------------NKPDFRRKPW----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                           + P   + PW    P+  + A D + K+L  +P  R+   QAL+
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 355 HPWVREGGDASEIPI 369
           HP++ +  D S+ PI
Sbjct: 295 HPYLEQYYDPSDEPI 309

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-61
 Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 44/306 (14%)

Query: 89  GYDKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVK 148
           G D+  +  YT  K++G+G FG  Y A    +G+ VA+KK+ ++K           RE++
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQ 65

Query: 149 ILQALAGHENVVKFYNAF------EDDNYVYIAMELCEGGELLD-RILAKKDSRYTEKDA 201
           I++ L  H N+V+    F      +D+ Y+ + ++          R  ++          
Sbjct: 66  IMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 202 AVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDI 261
            + + Q+ R  A  H  G+ HRD+KP+N L     + + LK  DFG +  +  G+     
Sbjct: 125 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSY 182

Query: 262 VGSAYYVAPEVLKRKS--GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR----- 314
           + S YY APE++   +      DVWS G +   LL G+  F   +      E+++     
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 315 ---------------NKPDFRRKPW-----PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                            P  +  PW     P     A     +LL   P ARLT  +A +
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

Query: 355 HPWVRE 360
           H +  E
Sbjct: 303 HSFFDE 308

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  198 bits (504), Expect = 3e-60
 Identities = 73/302 (24%), Positives = 127/302 (42%), Gaps = 51/302 (16%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y + + LG G++   + A +  N ++V VK ++  K       + +KRE+KIL+ L G 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 157 ENVVKFYNAFED--DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
            N++   +  +D       +  E     +             T+ D    + ++L+    
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
           CH  G++HRD+KP N +     E   L+  D+GL++F  PG+++   V S Y+  PE+L 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202

Query: 275 RKS--GPESDVWSIGVITYILLCGRRPFWDKT------------------EDGIFKEVLR 314
                    D+WS+G +   ++  + PF+                      D I K  + 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262

Query: 315 NKPDF----------------RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
             P F                  +    +S  A DF+ KLL  D ++RLTA +A+ HP+ 
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

Query: 359 RE 360
             
Sbjct: 323 YT 324

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-59
 Identities = 72/288 (25%), Positives = 111/288 (38%), Gaps = 35/288 (12%)

Query: 102 KLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL--PIAVEDVKREVKILQALAGHENV 159
             LG GQF   Y A DK     VA+KKI+                RE+K+LQ L  H N+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           +   +AF   + + +  +  E       I+       T       +   L+     H H 
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVLK--RK 276
           ++HRD+KP N L     E+  LK  DFGL+  F  P + +   V + +Y APE+L   R 
Sbjct: 121 ILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 277 SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWP----------- 325
            G   D+W++G I   LL         ++      +         + WP           
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 326 -------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                        +  +   D ++ L + +P AR+TA QAL   +   
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-59
 Identities = 69/278 (24%), Positives = 130/278 (46%), Gaps = 19/278 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVA---TDKANGDRVAVKKIEKNKMIL-PIAVEDVKREVKILQA 152
            + + K+LG G +G  ++    +    G   A+K ++K  ++      E  + E ++L+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
           +     +V  + AF+ +  +++ ++   GGEL   +   +  R+TE +  + V +++   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLAL 142

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP--GKKFQDIVGSAYYVAP 270
              H  G+++RD+K EN L      +  +  TDFGLS        ++  D  G+  Y+AP
Sbjct: 143 EHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 271 EVLKRKS---GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           ++++          D WS+GV+ Y LL G  PF    E     E+ R            +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259

Query: 328 SNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVRE 360
           S  AKD +++LL+KDP+ RL      A +   H + ++
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-58
 Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 37/299 (12%)

Query: 94  FDRRYTIGKLLGHGQFGYTYVATDKANGDR-VAVKKIEKNKMILPIAVEDVKREVKILQA 152
            D++Y     +G G +G  + A D  NG R VA+K++               REV +L+ 
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRH 63

Query: 153 LAG--HENVVKFYNAF-----EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           L    H NVV+ ++       + +  + +  E  +       +    +     +    ++
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMM 122

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSA 265
            Q+LR     H H +VHRD+KP+N L  S      +K  DFGL+           +V + 
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTL 179

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
           +Y APEVL + S     D+WS+G I   +   +  F   ++     ++L        + W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 325 P-----------------------SISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
           P                        I    KD + K L  +P  R++A  ALSHP+ ++
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  192 bits (487), Expect = 3e-58
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 36/292 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G +G  Y A +   G+  A+KKI   K           RE+ IL+ L  H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELK-H 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK Y+       + +  E  +    L ++L   +       A   + Q+L   A CH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL-- 273
              ++HRD+KP+N L      +  LK  DFGL+     P +K+   + + +Y AP+VL  
Sbjct: 118 DRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI------ 327
            +K     D+WS+G I   ++ G   F   +E      + R       K WP++      
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 328 -------------------SNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                                S  D + K+L  DP  R+TA QAL H + +E
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-57
 Identities = 75/314 (23%), Positives = 116/314 (36%), Gaps = 50/314 (15%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y     +G G FG  + A  +  G +VA+KK+               RE+KILQ L  H
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-H 68

Query: 157 ENVVKFYNAFED--------DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQM 208
           ENVV                   +Y+  + CE              ++T  +   V++ +
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQML 126

Query: 209 LRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK-----FQDIVG 263
           L      H + ++HRDMK  N L      D  LK  DFGL+      K      + + V 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 264 SAYYVAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR 321
           + +Y  PE+L  +R  GP  D+W  G I   +          TE      + +       
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 322 KPWPSISN----------------------------SAKDFVKKLLVKDPRARLTAAQAL 353
           + WP++ N                             A D + KLLV DP  R+ +  AL
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 354 SHPWVREGGDASEI 367
           +H +       S++
Sbjct: 304 NHDFFWSDPMPSDL 317

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 5e-57
 Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 19/263 (7%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +   + + +G G+FG   +   +  G++VAVK I+ +        +    E  ++  L  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLR- 58

Query: 156 HENVVKFYNAF-EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAE 214
           H N+V+      E+   +YI  E    G L+D + ++  S             +      
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 215 CHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLK 274
              +  VHRD+   N L     ED+  K +DFGL+      +          + APE L+
Sbjct: 119 LEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALR 173

Query: 275 RKS-GPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
            K    +SDVWS G++ + +   GR P+       +   V +    ++         +  
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230

Query: 333 DFVKKLLVKDPRARLTAAQALSH 355
           + +K     D   R +  Q    
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQ 253

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 6e-57
 Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 38/308 (12%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +    Y   + +G G +G    A D   G +VA+KK+ +      +  +   RE+++L+ 
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKH 73

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLR 210
           +  HENV+   + F  D  +    +       +   L K  K  +  E     +V QML+
Sbjct: 74  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 132

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAP 270
                H  G++HRD+KP N       ED  LK  DFGL+       +    V + +Y AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAP 187

Query: 271 EVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           EV+    +     D+WS+G I   ++ G+  F         KE+++              
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 315 ---------NKPDFRRKPWPSI----SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG 361
                      P+  +K + SI    S  A + ++K+LV D   R+TA +AL+HP+    
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

Query: 362 GDASEIPI 369
            D  + P 
Sbjct: 308 HDTEDEPQ 315

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (479), Expect = 7e-57
 Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 24/296 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           RY +G+ +G G FG  Y+ TD A G+ VA+K               +  E KI + + G 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGG 62

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +        + +Y  + MEL             +  +++ K   ++  QM+      H
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH 120

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--------DIVGSAYYV 268
               +HRD+KP+NFL    K+ + +   DFGL+   +  +  Q        ++ G+A Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 269 APEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP---- 323
           +             D+ S+G +      G  P+         ++  R        P    
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREGGDASEIPIDISVLNN 376
                +    ++          +   +   Q   + + R+G    +   D ++L  
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS-YDYVFDWNMLKF 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 6e-56
 Identities = 69/304 (22%), Positives = 114/304 (37%), Gaps = 41/304 (13%)

Query: 86  TDFGYDK--DFDR-RYTIGKLLGHGQFGYTYVATDKANGDR-----VAVKKIEKNKMILP 137
            ++ YD   +F R     GK+LG G FG    AT            VAVK +++      
Sbjct: 24  REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--S 81

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKD---- 193
              E +  E+K++  L  HEN+V    A      +Y+  E C  G+LL+ + +K++    
Sbjct: 82  SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141

Query: 194 -----------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK 236
                            +  T +D      Q+ +          VHRD+   N L     
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---T 198

Query: 237 EDSSLKATDFGLSDFIKPGKKF---QDIVGSAYYVAPEVLKRKS-GPESDVWSIGVITY- 291
               +K  DFGL+  I     +    +      ++APE L       +SDVWS G++ + 
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258

Query: 292 ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQ 351
           I   G  P+     D  F ++++N   F+       +      ++     D R R +   
Sbjct: 259 IFSLGVNPYPGIPVDANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 352 ALSH 355
             S 
Sbjct: 317 LTSF 320

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 7e-56
 Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 34/292 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            +   + +G G +G  Y A +K  G+ VA+KKI  +            RE+ +L+ L  H
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NH 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
            N+VK  +    +N +Y+  E      L   + A   +          + Q+L+  A CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI-KPGKKFQDIVGSAYYVAPEVL-- 273
            H ++HRD+KP+N L      + ++K  DFGL+     P + +   V + +Y APE+L  
Sbjct: 120 SHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS------- 326
            +      D+WS+G I   ++  R  F   +E      + R         WP        
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 327 ------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                             +    +  + ++L  DP  R++A  AL+HP+ ++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 6e-55
 Identities = 66/278 (23%), Positives = 106/278 (38%), Gaps = 21/278 (7%)

Query: 88  FGYDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
              D  +  R    +   LG G FG  ++ T      RVA+K ++   M    + E   +
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQ 61

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E ++++ L  HE +V+ Y    ++   YI  E    G LLD +  +            + 
Sbjct: 62  EAQVMKKL-RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVG 263
            Q+    A       VHRD++  N L     E+   K  DFGL+  I+  +    Q    
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKF 176

Query: 264 SAYYVAPEVLKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR 321
              + APE         +SDVWS G++   L   GR P+       +  +V R    +R 
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRM 233

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS--HPW 357
              P    S  D + +   K+P  R T     +    +
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 9e-55
 Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 23/279 (8%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           D++       ++G G FG    A  K +G R+        +        D   E+++L  
Sbjct: 8   DWND-IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRI--------------LAKKDSRYTE 198
           L  H N++    A E   Y+Y+A+E    G LLD +                   S  + 
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 199 KDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF 258
           +        + R          +HRD+   N L     E+   K  DFGLS   +   K 
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKK 183

Query: 259 QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILL-CGRRPFWDKTEDGIFKEVLRNK 316
                   ++A E L        SDVWS GV+ + ++  G  P+   T   +++++ +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
             +R +   +  +   D +++   + P  R + AQ L  
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-54
 Identities = 57/262 (21%), Positives = 101/262 (38%), Gaps = 17/262 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHE 157
            T  K LG GQFG       +     VA+K I++  M    + ++   E K++  L+ HE
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HE 59

Query: 158 NVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL 217
            +V+ Y        ++I  E    G LL+  L +   R+  +    + + +         
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLN-YLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLKR 275
              +HRD+   N L     +   +K +DFGLS ++   +            +  PEVL  
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 276 KS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
                +SD+W+ GV+ + I   G+ P+   T     + + +    +R       S     
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYT 232

Query: 334 FVKKLLVKDPRARLTAAQALSH 355
            +     +    R T    LS+
Sbjct: 233 IMYSCWHEKADERPTFKILLSN 254

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 4e-54
 Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 15/270 (5%)

Query: 90  YDK-DFDR-RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREV 147
           YDK + +R   T+   LG GQ+G  Y    K     VAVK ++++ M     VE+  +E 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEA 64

Query: 148 KILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
            +++ +  H N+V+       +   YI  E    G LLD +        +      +  Q
Sbjct: 65  AVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSA 265
           +            +HRD+   N L     E+  +K  DFGLS  +               
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 266 YYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW 324
            + APE L       +SDVW+ GV+ + +       +   +     E+L  + D+R +  
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--EKDYRMERP 238

Query: 325 PSISNSAKDFVKKLLVKDPRARLTAAQALS 354
                   + ++     +P  R + A+   
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (464), Expect = 5e-54
 Identities = 71/270 (26%), Positives = 127/270 (47%), Gaps = 18/270 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           ++   K LG G FG   +   K +G+  A+K ++K K++    +E    E +ILQA+   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NF 100

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +VK   +F+D++ +Y+ ME   GGE+   +  ++  R++E  A     Q++      H
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKRK 276
              L++RD+KPEN L     +   ++ TDFG +  +K   +   + G+   +APE++  K
Sbjct: 159 SLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK 213

Query: 277 S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFV 335
                 D W++GV+ Y +  G  PF+      I+++++  K  F        S+  KD +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLL 269

Query: 336 KKLLVKDPRARL-----TAAQALSHPWVRE 360
           + LL  D   R            +H W   
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (459), Expect = 6e-54
 Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 22/279 (7%)

Query: 89  GYDKDFDR-RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVK 144
            + K+ D     I +++G G+FG       K  G R   VA+K ++           D  
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFL 75

Query: 145 REVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVV 204
            E  I+     H NV+           V I  E  E G L D  L + D ++T      +
Sbjct: 76  SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGM 133

Query: 205 VRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD---- 260
           +R +            VHRD+   N L      +   K +DFGLS F++           
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190

Query: 261 --IVGSAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNK 316
                   + APE ++ RK    SDVWS G++ + ++  G RP+WD T   +   + +  
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-- 248

Query: 317 PDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
            D+R  P     ++    +     KD   R    Q ++ 
Sbjct: 249 -DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-53
 Identities = 56/270 (20%), Positives = 94/270 (34%), Gaps = 17/270 (6%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQ 151
           ++   + + LG G FG        A   +   VAVK ++ + +  P A++D  REV  + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRV 211
           +L  H N+++ Y          +  EL   G LLDR+  K    +     +    Q+   
Sbjct: 67  SL-DHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEG 123

Query: 212 AAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ----DIVGSAYY 267
                    +HRD+   N L         +K  DFGL   +                  +
Sbjct: 124 MGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 268 VAPEVLKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWP 325
            APE LK ++    SD W  GV  + +   G+ P+       I  ++ +      R    
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PE 238

Query: 326 SISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                  + + +     P  R T       
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-53
 Identities = 75/319 (23%), Positives = 129/319 (40%), Gaps = 55/319 (17%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAG 155
           +RY   K +G G  G    A D      VA+KK+ +         +   RE+ +++ +  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCV-N 74

Query: 156 HENVVKFYNAF------EDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQML 209
           H+N++   N F      E+   VY+ MEL +       +          +  + ++ QML
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQML 129

Query: 210 RVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYYVA 269
                 H  G++HRD+KP N + KS   D +LK  DFGL+            V + YY A
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 270 PE-VLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------- 314
           PE +L        D+WS+G I   ++  +  F  +     + +V+               
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 315 --------NKPDFRRKPWPSI----------------SNSAKDFVKKLLVKDPRARLTAA 350
                   N+P +    +P +                ++ A+D + K+LV DP  R++  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 351 QALSHPWVREGGDASEIPI 369
            AL HP++    D +E+  
Sbjct: 307 DALQHPYINVWYDPAEVEA 325

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 1e-53
 Identities = 65/293 (22%), Positives = 121/293 (41%), Gaps = 36/293 (12%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
           +Y   + +G G +G  + A ++   + VA+K++  +            RE+ +L+ L  H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELK-H 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
           +N+V+ ++    D  + +  E C+                  +     + Q+L+    CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLS-DFIKPGKKFQDIVGSAYYVAPEVL-- 273
              ++HRD+KP+N L      +  LK  +FGL+  F  P + +   V + +Y  P+VL  
Sbjct: 119 SRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 274 KRKSGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFRRKPWPS------ 326
            +      D+WS G I   L    RP +     D   K + R       + WPS      
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 327 -------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE 360
                              ++ + +D ++ LL  +P  R++A +AL HP+  +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 56/273 (20%), Positives = 107/273 (39%), Gaps = 20/273 (7%)

Query: 89  GYDKDFD---RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKR 145
            ++ +++       + + LG GQFG  ++        +VAVK +++  M    + +    
Sbjct: 3   WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLA 57

Query: 146 EVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVV 205
           E  +++ L  H+ +V+ Y     +  +YI  E  E G L+D +      + T      + 
Sbjct: 58  EANLMKQLQ-HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 206 RQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKF--QDIVG 263
            Q+    A       +HRD++  N L          K  DFGL+  I+  +    +    
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKF 172

Query: 264 SAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRR 321
              + APE +       +SDVWS G++   ++  GR P+   T   + + + R    +R 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRM 229

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
               +        ++    + P  R T     S
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-53
 Identities = 53/263 (20%), Positives = 105/263 (39%), Gaps = 17/263 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
             T  + +G GQFG  ++     N D+VA+K I +  M    + ED   E +++  L  H
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SH 59

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +V+ Y    +   + +  E  E G L D +   +   +  +    +   +    A   
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 217 LHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGK--KFQDIVGSAYYVAPEVLK 274
              ++HRD+   N L     E+  +K +DFG++ F+   +            + +PEV  
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 275 -RKSGPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKPWPSISNSAK 332
             +   +SDVWS GV+ + +    +  + +++   + +++      FR       S    
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 232

Query: 333 DFVKKLLVKDPRARLTAAQALSH 355
             +     + P  R   ++ L  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-52
 Identities = 79/311 (25%), Positives = 125/311 (40%), Gaps = 44/311 (14%)

Query: 93  DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQA 152
           +   RY     +G G +G    A D   G RVAVKK+ +      I  +   RE+++L+ 
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKH 73

Query: 153 LAGHENVVKFYNAFEDDNYV-----YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQ 207
           +  HENV+   + F     +        +    G +L + +   K  + T+     ++ Q
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQ 129

Query: 208 MLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIVGSAYY 267
           +LR     H   ++HRD+KP N       ED  LK  DFGL+       +    V + +Y
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVATRWY 184

Query: 268 VAPEVL--KRKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR----- 320
            APE++          D+WS+G I   LL GR  F         K +LR           
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 321 ----------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV 358
                                    +   +  A D ++K+LV D   R+TAAQAL+H + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

Query: 359 REGGDASEIPI 369
            +  D  + P+
Sbjct: 305 AQYHDPDDEPV 315

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-51
 Identities = 71/297 (23%), Positives = 106/297 (35%), Gaps = 36/297 (12%)

Query: 86  TDFGYDKDFD---RRYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILP 137
           T   YD  ++    R + GK LG G FG    AT            VAVK ++ +     
Sbjct: 10  TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--L 67

Query: 138 IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDS--- 194
              E +  E+K+L  L  H N+V    A        +  E C  G+LL+ +  K+DS   
Sbjct: 68  TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 195 -------------RYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSL 241
                            +D      Q+ +  A       +HRD+   N L          
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRIT 184

Query: 242 KATDFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGR 297
           K  DFGL+  IK    +    +      ++APE +       ESDVWS G+  + L    
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244

Query: 298 RP-FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL 353
              +     D  F ++++    FR            D +K     DP  R T  Q +
Sbjct: 245 SSPYPGMPVDSKFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-51
 Identities = 58/267 (21%), Positives = 103/267 (38%), Gaps = 22/267 (8%)

Query: 102 KLLGHGQFGYTYVAT--DKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV 159
           K LG G FG         K     VAVK + KN+   P   +++  E  ++Q L  +  +
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70

Query: 160 VKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG 219
           V+     E +++  + ME+ E G L   +  +++    +K+   +V Q+           
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN 127

Query: 220 LVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYVAPEVLK- 274
            VHRD+   N L  +       K +DFGLS  ++  + +            + APE +  
Sbjct: 128 FVHRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 275 RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD 333
            K   +SDVWS GV+ +     G++P+       +   + + +   R            D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYD 241

Query: 334 FVKKLLVKDPRARLTAAQ---ALSHPW 357
            +      D   R   A     L + +
Sbjct: 242 LMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 5e-51
 Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 23/274 (8%)

Query: 97  RYTIGKL-LGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
              I  + LG G FG       +    +  VA+K +++         E++ RE +I+  L
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQL 66

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             +  +V+     + +    + ME+  GG L   ++ K++      + A ++ Q+     
Sbjct: 67  -DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMK 123

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD----IVGSAYYVA 269
                  VHRD+   N L          K +DFGLS  +     +            + A
Sbjct: 124 YLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 270 PEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI 327
           PE +  RK    SDVWS GV  +  L  G++P+       +   + + K   R +  P  
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 237

Query: 328 SNSAKDFVKKLLVKDPRARLTAA---QALSHPWV 358
                  +    +     R       Q +   + 
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 8e-51
 Identities = 62/266 (23%), Positives = 104/266 (39%), Gaps = 18/266 (6%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQAL 153
           R  +G+ +G GQFG  +     +  +    VA+K  +          E   +E   ++  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQF 65

Query: 154 AGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAA 213
             H ++VK       +N V+I MELC  GEL    L  +          +   Q+    A
Sbjct: 66  -DHPHIVKLIGVIT-ENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALA 122

Query: 214 ECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQ--DIVGSAYYVAPE 271
                  VHRD+   N L  S   +  +K  DFGLS +++    ++         ++APE
Sbjct: 123 YLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 272 VLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN 329
            +  R+    SDVW  GV  + IL+ G +PF     + +   +   +   R    P+   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPP 236

Query: 330 SAKDFVKKLLVKDPRARLTAAQALSH 355
           +    + K    DP  R    +  + 
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 31/292 (10%)

Query: 90  YDKDFD---RRYTIGKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIA 139
            D  ++    R  +GK LG G FG   +A              +VAVK ++ +       
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKD 61

Query: 140 VEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKK------- 192
           + D+  E+++++ +  H+N++    A   D  +Y+ +E    G L + + A++       
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 193 -------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                  + + + KD      Q+ R          +HRD+   N L              
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 246 FGLSDFIKPGKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITY-ILLCGRRPFWDK 303
                 I   KK  +      ++APE L  R    +SDVWS GV+ + I   G  P+   
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 304 TEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
             + +FK +       R     + +N     ++      P  R T  Q +  
Sbjct: 242 PVEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 50/273 (18%), Positives = 105/273 (38%), Gaps = 22/273 (8%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH 156
            Y +G+ +G G FG  +  T+  N  +VA+K   +           ++ E +  + LAG 
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGC 60

Query: 157 ENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECH 216
             +   Y   ++  +  + ++L   G  L+ +L     +++ K  A+  +QML      H
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 217 LHGLVHRDMKPENFLF--KSAKEDSSLKATDFGLSDFIKPG--------KKFQDIVGSAY 266
              LV+RD+KP+NFL    ++K  + +   DFG+  F +          ++ +++ G+A 
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 267 YVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDG----IFKEVLRNKPDFRR 321
           Y++      +      D+ ++G +    L G  P+             +   + +    R
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 322 KPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           +           ++         A         
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 7e-47
 Identities = 56/265 (21%), Positives = 101/265 (38%), Gaps = 16/265 (6%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEK--NKMILPIAVEDVKREVKILQALAG 155
           +   K+LG G FG  Y       G++V +    K   +   P A +++  E  ++ ++  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 156 HENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAEC 215
           + +V +            I  +L   G LLD +   KD     +       Q+ +     
Sbjct: 70  NPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL 127

Query: 216 HLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEV 272
               LVHRD+   N L    K    +K TDFGL+  +   +K    +       ++A E 
Sbjct: 128 EDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 273 LKRKS-GPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS 330
           +  +    +SDVWS GV  + L+  G +P+       I   + + +   R    P  +  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTID 241

Query: 331 AKDFVKKLLVKDPRARLTAAQALSH 355
               + K  + D  +R    + +  
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 20/268 (7%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKANGDR----VAVKKIEKNKMILPIAVEDVKREVKILQA 152
             T  K++G G+FG  Y    K +  +    VA+K ++           D   E  I+  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQ 65

Query: 153 LAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVA 212
              H N+++          + I  E  E G L   +  +KD  ++      ++R +    
Sbjct: 66  F-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 123

Query: 213 AECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK----FQDIVGSAYYV 268
                   VHRD+   N L      +   K +DFGLS  ++   +             + 
Sbjct: 124 KYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 269 APEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS 326
           APE +  RK    SDVWS G++ + ++  G RP+W+ +   + K +      FR      
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMD 237

Query: 327 ISNSAKDFVKKLLVKDPRARLTAAQALS 354
             ++    + +   ++   R   A  +S
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 4e-45
 Identities = 50/295 (16%), Positives = 96/295 (32%), Gaps = 42/295 (14%)

Query: 93  DFDR-RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKRE 146
           ++ R      + +G G FG  + A             VAVK +++          D +RE
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQRE 66

Query: 147 VKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRY---------- 196
             ++     + N+VK          + +  E    G+L + + +                
Sbjct: 67  AALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 197 ------------TEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKAT 244
                       +  +   + RQ+    A       VHRD+   N L     E+  +K  
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIA 182

Query: 245 DFGLSDFIKPGKKFQ---DIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRR-P 299
           DFGLS  I     ++   +      ++ PE +   +   ESDVW+ GV+ + +      P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 300 FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS 354
           ++    + +   V             +      + ++    K P  R +      
Sbjct: 243 YYGMAHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-44
 Identities = 53/272 (19%), Positives = 99/272 (36%), Gaps = 21/272 (7%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDR---VAVKKIEKNKMILPIAVEDVKREVKILQ 151
                  +++G G FG  Y  T   N  +    AVK + +        V     E  I++
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMK 83

Query: 152 ALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
             + H NV+         +    + +   + G+L +  +  +    T KD      Q+ +
Sbjct: 84  DFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 141

Query: 211 VAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-----IVGSA 265
                     VHRD+   N +     E  ++K  DFGL+  +   +              
Sbjct: 142 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 266 YYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFW-DKTEDGIFKEVLRNKPDFRRKP 323
            ++A E L+ +K   +SDVWS GV+ + L+    P + D     I   +L+ +   R   
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQ 255

Query: 324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                +   + + K        R + ++ +S 
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (392), Expect = 1e-43
 Identities = 69/335 (20%), Positives = 122/335 (36%), Gaps = 64/335 (19%)

Query: 95  DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQAL- 153
           D RY + + LG G F   ++A D  N   VA+K +  +K+      E  + E+K+LQ + 
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVN 67

Query: 154 ---------AGHENVVKFYNAFED---DNYVYIAMELCEGGELLDRILAKKDSRYTEKDA 201
                     G  +++K  + F     +    + +    G  LL  I   +         
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 202 AVVVRQMLRVAAECHLH-GLVHRDMKPENFLFKSAKEDSSL-KATDFGLSDFIKPGKKFQ 259
             + +Q+L      H   G++H D+KPEN L +      +L +     L +     + + 
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 260 DIVGSAYYVAPEVLKRKS-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEV------ 312
           + + +  Y +PEVL     G  +D+WS   + + L+ G   F         K+       
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 313 ---------------------------LRNKPDFRRKPWPSI-----------SNSAKDF 334
                                      LRN    +  P   +           +    DF
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 335 VKKLLVKDPRARLTAAQALSHPWVREGGDASEIPI 369
           +  +L  DPR R  A   ++HPW+++     EI +
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 54/288 (18%), Positives = 108/288 (37%), Gaps = 33/288 (11%)

Query: 97  RYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQ 151
           + T+ + LG G FG  Y    K         RVA+K + +          +   E  +++
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMK 78

Query: 152 ALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSR--------YTEKDAAV 203
                 +VV+            + MEL   G+L   + + + +          +      
Sbjct: 79  EF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 204 VVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG---KKFQD 260
           +  ++    A  + +  VHRD+   N +     ED ++K  DFG++  I      +K   
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 261 IVGSAYYVAPEVLKRKS-GPESDVWSIGVITY-ILLCGRRPFWDKTEDGIFKEVLRNKPD 318
            +    +++PE LK       SDVWS GV+ + I     +P+   + + + + V+     
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-- 252

Query: 319 FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVRE 360
                  +  +   + ++     +P+ R +  + +S       P  RE
Sbjct: 253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-41
 Identities = 60/301 (19%), Positives = 107/301 (35%), Gaps = 57/301 (18%)

Query: 96  RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQ-ALA 154
           R   + + +G G+FG  +    +  G+ VAVK     +           RE +I Q  + 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVML 54

Query: 155 GHENVVKFYNAFEDDN----YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLR 210
            HEN++ F  A   DN     +++  +  E G L D +        T +    +      
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTAS 111

Query: 211 VAAECHLH--------GLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQD-- 260
             A  H+          + HRD+K +N L    K++ +    D GL+          D  
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 261 ---IVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPF---------- 300
               VG+  Y+APEVL         +S   +D++++G++ + +                 
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 301 -----WDKTEDGIFKEVLRNKPDFR---RKPWPSISNSAKDFVKKLLVKDPRARLTAAQA 352
                 D + + + K V   K       R             +++    +  ARLTA + 
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 353 L 353
            
Sbjct: 289 K 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-41
 Identities = 67/295 (22%), Positives = 108/295 (36%), Gaps = 36/295 (12%)

Query: 90  YDKD---FDR-RYTIGKLLGHGQFGYTYVATD-----KANGDRVAVKKIEKNKMILPIAV 140
           YD     F R R  +GK LG G FG    A        A    VAVK +++         
Sbjct: 3   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEH 60

Query: 141 EDVKREVKILQALAGHENVVKFYNA-FEDDNYVYIAMELCEGGELLDRILAKKD------ 193
             +  E+KIL  +  H NVV    A  +    + + +E C+ G L   + +K++      
Sbjct: 61  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 194 --------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATD 245
                      T +       Q+ +          +HRD+   N L     E + +K  D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICD 177

Query: 246 FGLSDFIKPGKKFQ---DIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRR-PF 300
           FGL+  I     +    D      ++APE +  R    +SDVWS GV+ + +      P+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237

Query: 301 WDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH 355
                D  F   L+     R   +   +      +      +P  R T ++ + H
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.5 bits (190), Expect = 3e-17
 Identities = 37/205 (18%), Positives = 67/205 (32%), Gaps = 35/205 (17%)

Query: 98  YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKM---------------ILPIAVED 142
             IGKL+G G+    +    +       VK  +                      +A+  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 143 VKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAA 202
            + E + LQ L     V K Y    +     + MEL +           +  R   ++  
Sbjct: 61  ARNEFRALQKLQ-GLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPD 106

Query: 203 VVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKKFQDIV 262
            V+  +L   A+ +  G+VH D+   N L      +  +   DF  S  +   + +++I+
Sbjct: 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGE-EGWREIL 161

Query: 263 GSAYYVAPEVLKRKSGPESDVWSIG 287
                       R    E D+ S  
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAI 186

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

 Score = 50.0 bits (118), Expect = 2e-07
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 1/67 (1%)

Query: 387 KQFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEI 446
               LR     L +E+   LR  F +  V  +G  S ++++Q L       + E  + ++
Sbjct: 105 GYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVL-AKYADTIPEGPLKKL 163

Query: 447 LQAVNTP 453
              V   
Sbjct: 164 FVMVEND 170

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 47.3 bits (111), Expect = 7e-07
 Identities = 13/38 (34%), Positives = 24/38 (63%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           A  L +EE+  L++ F  ID D +G+I+ +E++  L +
Sbjct: 1   AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR 38

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 44.6 bits (105), Expect = 8e-07
 Identities = 18/61 (29%), Positives = 37/61 (60%), Gaps = 1/61 (1%)

Query: 392 RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
           + +A  L +EE+  L++ F  ID D +G+I+ +E++  L K +  +L ES + +++ A +
Sbjct: 11  KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGL-KRVGSELMESEIKDLMDAAD 69

Query: 452 T 452
            
Sbjct: 70  I 70

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.8 bits (103), Expect = 1e-06
 Identities = 16/62 (25%), Positives = 31/62 (50%), Gaps = 1/62 (1%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPF 454
           +S L +E++A+ ++ F   D D NGSIS  E+     + L     E+ V +++  ++   
Sbjct: 1   SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATV-MRSLGLSPSEAEVNDLMNEIDVDG 59

Query: 455 LG 456
             
Sbjct: 60  NH 61

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.8 bits (97), Expect = 4e-05
 Identities = 13/35 (37%), Positives = 21/35 (60%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQA 429
           +S L +E++A+ ++ F   D D NGSIS  E+   
Sbjct: 1   SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATV 35

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

 Score = 39.5 bits (92), Expect = 5e-05
 Identities = 12/45 (26%), Positives = 19/45 (42%)

Query: 400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVL 444
            +++AD    F   D + +G IS  E+  AL         E R +
Sbjct: 2   PQDIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRM 46

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

 Score = 41.6 bits (96), Expect = 5e-05
 Identities = 13/38 (34%), Positives = 24/38 (63%), Gaps = 2/38 (5%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           A  ++D +  +L + F A+D D +G+IS+ E+  AL+ 
Sbjct: 11  ARHMNDNQ--ELMEWFRAVDTDGSGAISVPELNAALSS 46

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

 Score = 39.2 bits (91), Expect = 6e-05
 Identities = 13/59 (22%), Positives = 31/59 (52%), Gaps = 1/59 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLG 456
           L +E++A+ ++ F   D D +G+I+ +E+   +   L     E+ + +++  V+    G
Sbjct: 2   LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNG 59

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

 Score = 41.2 bits (95), Expect = 9e-05
 Identities = 11/41 (26%), Positives = 22/41 (53%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKL 438
            +   +   +  FD +D++ NG I+L+E+    + D+  KL
Sbjct: 8   DNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKL 48

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

 Score = 38.3 bits (89), Expect = 9e-05
 Identities = 9/48 (18%), Positives = 21/48 (43%)

Query: 405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           ++   F   D + +G I  +E +  + K     L ++ V E ++  + 
Sbjct: 3   EILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADE 50

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 38.8 bits (90), Expect = 9e-05
 Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 1/55 (1%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           L +E +A+ +  FD  D D  G IS +E+   +         +  +  I++ V+ 
Sbjct: 8   LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRML-GQNPTKEELDAIIEEVDE 61

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

 Score = 40.3 bits (93), Expect = 1e-04
 Identities = 11/41 (26%), Positives = 20/41 (48%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKL 438
            +   +   +  F+ +DV+ NG ISL+EM    +  +   L
Sbjct: 6   DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNL 46

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

 Score = 37.6 bits (87), Expect = 2e-04
 Identities = 10/40 (25%), Positives = 22/40 (55%), Gaps = 1/40 (2%)

Query: 392 RALASTLDDEELADLRDQFDAIDVD-KNGSISLEEMRQAL 430
           +A    L +E+  + +  FD   +  ++GSIS +E+ + +
Sbjct: 3   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVM 42

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 4e-04
 Identities = 12/47 (25%), Positives = 23/47 (48%)

Query: 394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKE 440
           + S  D +E+  L  +F  +D+D +GS+S+EE            ++ 
Sbjct: 6   MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQR 52

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 38.1 bits (87), Expect = 5e-04
 Identities = 9/39 (23%), Positives = 23/39 (58%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW 436
           L  +++ ++++ F  IDVD++G +S E+++    +    
Sbjct: 1   LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRA 39

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 36.4 bits (84), Expect = 5e-04
 Identities = 11/54 (20%), Positives = 28/54 (51%), Gaps = 1/54 (1%)

Query: 399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT 452
           + +   ++   F   D D +G+I+++++R+   K+L   L E  + E++   + 
Sbjct: 4   ERDSREEILKAFRLFDDDNSGTITIKDLRRVA-KELGENLTEEELQEMIAEADR 56

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 38.0 bits (87), Expect = 7e-04
 Identities = 11/34 (32%), Positives = 18/34 (52%)

Query: 396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQA 429
           + L +E +A+ +  FD  D D  G IS +E+   
Sbjct: 12  AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTV 45

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.9 bits (85), Expect = 8e-04
 Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK--DLPWKLKESRVLEILQAVNT 452
            S L     + ++D F  ID D++G +  +E++  L K      +L ES    ++ A + 
Sbjct: 32  TSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADN 91

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

 Score = 36.6 bits (83), Expect = 0.002
 Identities = 10/51 (19%), Positives = 21/51 (41%), Gaps = 3/51 (5%)

Query: 398 LDDEELADLRDQFDAIDVDKN--GSISLEEMRQALAKDLPWKLKESRVLEI 446
           L  +E+ DL+D F+  D      G++   ++     + L    +   V  +
Sbjct: 1   LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVC-RCLGINPRNEDVFAV 50

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

 Score = 36.6 bits (83), Expect = 0.003
 Identities = 8/33 (24%), Positives = 17/33 (51%)

Query: 400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           D  +  ++  F+ ID DK+G+I+  +      +
Sbjct: 2   DLWVQKMKTYFNRIDFDKDGAITRMDFESMAER 34

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 1/93 (1%)

Query: 141 EDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKD 200
            DV+RE  ++  L G   V K  +    D +  + M   +G    +    ++      + 
Sbjct: 54  YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIEL 113

Query: 201 AAVVVRQMLRV-AAECHLHGLVHRDMKPENFLF 232
            A  +R    +  ++C     +   +   ++L 
Sbjct: 114 YAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

 Score = 34.1 bits (78), Expect = 0.003
 Identities = 8/29 (27%), Positives = 16/29 (55%)

Query: 404 ADLRDQFDAIDVDKNGSISLEEMRQALAK 432
           +  +  F+  D +K+G +SL+E R+    
Sbjct: 1   SSAKRVFEKFDKNKDGKLSLDEFREVALA 29

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 36.1 bits (82), Expect = 0.004
 Identities = 10/42 (23%), Positives = 22/42 (52%), Gaps = 1/42 (2%)

Query: 392 RALASTLDDEELADLRDQFDAIDVD-KNGSISLEEMRQALAK 432
           +A    L +E+  + +  FD   +  ++GSIS +E+ + +  
Sbjct: 2   KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM 43

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.7 bits (81), Expect = 0.004
 Identities = 8/47 (17%), Positives = 19/47 (40%), Gaps = 1/47 (2%)

Query: 405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVN 451
           + ++ F+  D   +G I   +    + + L      + VL++L    
Sbjct: 1   EFKEAFELFDRVGDGKILYSQCGDVM-RALGQNPTNAEVLKVLGNPK 46

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

 Score = 35.6 bits (81), Expect = 0.004
 Identities = 9/32 (28%), Positives = 20/32 (62%)

Query: 398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQA 429
           L +E++A+ ++ F   D D +G+I+ +E+   
Sbjct: 3   LTEEQIAEFKEAFALFDKDGDGTITTKELGTV 34

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	487
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	99.41
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	99.4
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	99.38
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.37
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	99.36
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.31
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	99.31
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	99.29
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	99.29
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	99.25
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	99.25
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	99.24
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	99.23
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	99.17
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.13
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	99.05
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	99.0
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	98.97
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	98.96
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.94
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	98.91
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	98.91
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	98.9
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	98.9
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	98.85
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	98.83
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.82
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	98.78
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	98.78
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	98.78
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	98.77
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	98.77
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.77
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	98.76
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	98.75
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	98.72
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	98.71
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	98.7
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	98.7
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.69
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	98.68
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	98.65
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	98.64
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	98.62
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	98.6
d1exra_	146	Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI	98.6
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	98.58
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	98.56
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	98.54
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	98.53
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	98.52
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	98.5
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	98.47
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	98.47
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	98.45
d2obha1	141	Calmodulin {Human (Homo sapiens) [TaxId: 9606]}	98.45
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	98.44
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	98.44
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	98.44
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	98.43
d1topa_	162	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.42
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	98.38
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	98.36
d1y1xa_	182	Programmed cell death 6 protein-like protein {Leis	98.35
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	98.34
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	98.34
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	98.31
d1lkja_	146	Calmodulin {Baker's yeast (Saccharomyces cerevisia	98.31
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	98.26
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	98.26
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	98.23
d1jfja_	134	EHCABP {Entamoeba (Entamoeba histolytica) [TaxId:	98.21
d1dtla_	156	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	98.21
d1s6ia_	182	Calcium-dependent protein kinase sk5 CLD {Soybean	98.21
d2mysb_	145	Myosin Essential Chain {Chicken (Gallus gallus) [T	98.2
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.2
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	98.18
d1auib_	165	Calcineurin regulatory subunit (B-chain) {Human (H	98.18
d1hqva_	181	Apoptosis-linked protein alg-2 {Mouse (Mus musculu	98.17
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	98.14
d1ggwa_	140	Cdc4p {Fission yeast (Schizosaccharomyces pombe) [	98.12
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	98.12
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	98.1
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	98.08
d1w7jb1	139	Myosin Essential Chain {Human (Homo sapiens) [TaxI	98.07
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	98.03
d1ij5a_	321	Cbp40 (plasmodial specific CaII-binding protein LA	98.02
d1m45a_	146	Myosin Light Chain Mlc1p {Baker's yeast (Saccharom	98.0
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	97.99
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	97.98
d1jbaa_	189	Guanylate cyclase activating protein 2, GCAP-2 {Co	97.98
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	97.97
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	97.87
d1juoa_	172	Sorcin {Human (Homo sapiens) [TaxId: 9606]}	97.85
d1qlsa_	95	Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1	97.84
d1alva_	173	Calpain small (regulatory) subunit (domain VI) {Pi	97.81
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	97.81
d1xk4c1	83	Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr	97.78
d1omra_	201	Recoverin {Cow (Bos taurus) [TaxId: 9913]}	97.76
d2zfda1	183	Calcineurin B-like protein 2 {Thale cress (Arabido	97.72
d1j55a_	94	Calcyclin (S100) {Human (Homo sapiens), s100p [Tax	97.68
d1df0a1	186	Calpain large subunit, C-terminal domain (domain I	97.61
d1fpwa_	190	Frequenin (neuronal calcium sensor 1) {Baker's yea	97.57
d1qxpa2	188	Calpain large subunit, C-terminal domain (domain I	97.53
d1k94a_	165	Grancalcin {Human (Homo sapiens) [TaxId: 9606]}	97.53
d1bjfa_	181	Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}	97.52
d1s6ca_	178	Kchip1, Kv4 potassium channel-interacting protein	97.38
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.27
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	97.1
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	96.93
d1uhka1	187	Calcium-regulated photoprotein {Jellyfish (Aequore	96.86
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	96.83
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.76
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	96.65
d2zkmx1	170	Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI	96.52
d2scpa_	174	Sarcoplasmic calcium-binding protein {Sandworm (Ne	96.51
d1qv0a_	189	Calcium-regulated photoprotein {Hydrozoa (Obelia l	96.43
d1tuza_	118	Diacylglycerol kinase alpha, N-terminal domain {Hu	96.33
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	96.15
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	95.94
d1nyaa_	176	Calerythrin {Saccharopolyspora erythraea [TaxId: 1	95.93
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	95.92
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.78
d1j7qa_	86	Calcium vector protein {Amphioxus (Branchiostoma l	95.65
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	94.5
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	94.28
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	94.26
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	94.25
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	93.98
d3c1va1	93	Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta	92.68
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	92.43
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	92.03
d1sraa_	151	C-terminal (EC) domain of BM-40/SPARC/osteonectin	91.16
d1zfsa1	93	Calcyclin (S100) {Rat (Rattus norvegicus), s100a1	91.05
d1snla_	99	Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax	90.93
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	90.85
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	90.25
d1ksoa_	93	Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta	90.23
d1e8aa_	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	89.75
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	89.69
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	89.57
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	89.23
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	89.0
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	88.32
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	87.74
d1xk4a1	87	Calcyclin (S100) {Human (Homo sapiens), calgranuli	86.75
d1qjta_	99	Eps15 {Mouse (Mus musculus) [TaxId: 10090]}	86.2
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	85.85
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	85.67
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	85.16
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	85.09
d1fi6a_	92	Reps1 {Mouse (Mus musculus) [TaxId: 10090]}	84.68
d3cr5x1	90	Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId:	84.5
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	83.69
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	81.75
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	81.38
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	81.33
d1psra_	100	Calcyclin (S100) {Human (Homo sapiens), psoriasin	81.0
d1k8ua_	89	Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta	80.55
d2jxca1	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	80.09

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-64  Score=486.01  Aligned_cols=266  Identities=40%  Similarity=0.721  Sum_probs=223.1

Q ss_pred             ccccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           91 DKDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        91 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      .+++.++|++++.||+|+||+||+|+++.+|+.||||++.+....  .....+.+|+.+|+++. |||||++++++.+++
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            356778899999999999999999999999999999999865432  23456789999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .+|||||||+||+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||+....+++.+||+|||+|+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999999854  4679999999999999999999999999999999999999865567899999999998


Q ss_pred             ccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCH
Q 011380          251 FIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISN  329 (487)
Q Consensus       251 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  329 (487)
                      .........+.+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+....+....+......+....++.+|+
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  238 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD  238 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence            87766666778999999999998764 79999999999999999999999999999999999999988888878889999


Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++++||.+||++||++|||+.|+|+||||+..
T Consensus       239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-63  Score=465.37  Aligned_cols=255  Identities=29%  Similarity=0.577  Sum_probs=229.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++++++. |||||++++++.+++.+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999997654333345677899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|......
T Consensus        85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSCSCCCCC
T ss_pred             EeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeecccceeeecCCC
Confidence            9999999999988654  5799999999999999999999999999999999999998   4678999999999876543


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++    +.+|+++++|
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  234 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL  234 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHH
T ss_pred             -cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence             34567899999999999875 68999999999999999999999999999889988888765543    3589999999


Q ss_pred             HHHccccCccCCcCHHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |.+||+.||++|||+.|+|+||||+..
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-63  Score=467.33  Aligned_cols=259  Identities=33%  Similarity=0.574  Sum_probs=219.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++.+...  ....+.+.+|+++|++++ |||||++++++.+++.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            34679999999999999999999999999999999976542  223467889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+||+|.+++.  ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+...
T Consensus        80 ivmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          80 LFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECE
T ss_pred             EEEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheeec
Confidence            9999999999999883  446799999999999999999999999999999999999998   46789999999998764


Q ss_pred             CCC---ccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          254 PGK---KFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       254 ~~~---~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      ...   .....+||+.|||||++.+. + +.++|||||||++|+|++|++||.................. ....++.+|
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s  233 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKID  233 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSC
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCC
Confidence            332   24567899999999998764 3 57899999999999999999999876654444333333332 334467899


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       234 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         234 SAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-61  Score=474.51  Aligned_cols=264  Identities=35%  Similarity=0.596  Sum_probs=239.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+..   ......+.+|+.+|++|. |||||+++++|.+++.+|
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4467999999999999999999999999999999997653   334567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+||+|.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||+|....
T Consensus       103 ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         103 LILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred             EEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecC
Confidence            99999999999987643 34579999999999999999999999999999999999999742 46789999999999887


Q ss_pred             CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ........+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++...++.+|++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            77667778999999999998765 68999999999999999999999999999999999999988888888889999999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                      +||.+||++||.+|||+.|+|+||||+....
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            9999999999999999999999999987543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-61  Score=465.78  Aligned_cols=267  Identities=36%  Similarity=0.635  Sum_probs=239.6

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC---hHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL---PIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      .++.++|++++.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+|++|+ |||||++++++.+
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~   84 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   84 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence            456788999999999999999999999999999999997654322   224678899999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCC-CCCcEEEeecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAK-EDSSLKATDFG  247 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~vkl~DfG  247 (487)
                      .+.+|||||||+||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++..+ ....+||+|||
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999999988654  5799999999999999999999999999999999999998532 23469999999


Q ss_pred             cccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      +|.............||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......+....++.
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            99988776667778999999999999765 69999999999999999999999999999999999998887776666678


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|+++++||++||+.||++|||+.|+|+||||+..
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.1e-61  Score=456.49  Aligned_cols=263  Identities=33%  Similarity=0.623  Sum_probs=238.4

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCC------hHhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMIL------PIAVEDVKREVKILQALAGHENVVKFYNAFE  167 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  167 (487)
                      |.++|++.+.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+.+|+.+++++..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            4578999999999999999999999999999999997754332      1234568899999999977999999999999


Q ss_pred             eCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          168 DDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       168 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                      +.+.+|||||||+||+|.+++..+  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl~DFG  155 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFG  155 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred             cCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEEccch
Confidence            999999999999999999998654  5799999999999999999999999999999999999998   57899999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc-------CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR-------KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      +++.+.........+||+.|+|||.+.+       .++.++||||+||++|+|++|+.||.+.+.......+..+...+.
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9998876666677899999999998853       357899999999999999999999999999999999999888877


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ...++.+|+++++||.+||++||++|||+.|+|+||||+++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            77778999999999999999999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-61  Score=462.22  Aligned_cols=257  Identities=28%  Similarity=0.487  Sum_probs=225.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++.+.||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.+|+++. |||||++++++.+.+.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            345799999999999999999999999999999999765432   3467899999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+||+|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.+.
T Consensus        94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheeec
Confidence            99999999999987643   4699999999999999999999999999999999999998   46789999999998765


Q ss_pred             CC-CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .. ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+...... ....++.+|+++
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~  246 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHH
T ss_pred             cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHH
Confidence            43 344567899999999999765 689999999999999999999999988887777776655432 222346789999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++||.+||+.||++|||+.|+|+||||+..
T Consensus       247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-61  Score=473.24  Aligned_cols=263  Identities=34%  Similarity=0.625  Sum_probs=238.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|++|+ |||||++++++.+++.+|
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            4468999999999999999999999999999999997653   345677899999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.. .++.+||+|||+|+.+.
T Consensus       100 ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence            999999999999987433 3569999999999999999999999999999999999999742 35789999999999887


Q ss_pred             CCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ........+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......+....++.+|++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            76666778999999999999765 68899999999999999999999999999999999999888777777788999999


Q ss_pred             HHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          333 DFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                      +||.+||+.||++|||+.|+|+||||+...
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-61  Score=461.64  Aligned_cols=259  Identities=31%  Similarity=0.471  Sum_probs=226.8

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ..+.|++++.||+|+||+||+|+++.+|+.||+|++.+..   ....+.+.+|+++|+++. |||||++++++.+++.+|
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEE
Confidence            3457999999999999999999999999999999997653   234567889999999995 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      ||||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccC
Confidence            999999999999887544 45799999999999999999999999999999999999998   47789999999997643


Q ss_pred             CC-CccccccCCccccchhhhc------cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 PG-KKFQDIVGSAYYVAPEVLK------RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .. ......+||+.|+|||++.      ..++.++|||||||++|+|++|+.||.+.+..+.+..+..+.+.... ..+.
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~  240 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSR  240 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGG
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-cccc
Confidence            22 2234678999999999983      23688999999999999999999999999988888888887654322 2357


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|+++++||.+||+.||++|||+.|+|+||||+..
T Consensus       241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            89999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=452.09  Aligned_cols=253  Identities=21%  Similarity=0.352  Sum_probs=217.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----DNYVY  173 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----~~~~~  173 (487)
                      |++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++++ |||||++++++.+    ...+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence            4788899999999999999999999999999976543 3345678899999999995 9999999999875    45789


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHG--LVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ||||||+||+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.  +++.+||+|||+|+.
T Consensus        89 ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGG
T ss_pred             EEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCccee
Confidence            999999999999988654  57999999999999999999999998  999999999999973  467899999999986


Q ss_pred             cCCCCccccccCCccccchhhhccCCCCcchHHHHHHHHHHHHhCCCCCCCCChhH-HHHHHHhcCCCCCCCCCCCCCHH
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKRKSGPESDVWSIGVITYILLCGRRPFWDKTEDG-IFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ... ......+||+.|||||++.+.++.++|||||||++|+|++|+.||.+..... +...+..+...  .......+++
T Consensus       165 ~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~  241 (270)
T d1t4ha_         165 KRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPE  241 (270)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHH
T ss_pred             ccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCHH
Confidence            543 3345679999999999999999999999999999999999999997765444 44445443321  1223457899


Q ss_pred             HHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      +++||.+||++||++|||+.|+|+||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-61  Score=461.81  Aligned_cols=256  Identities=33%  Similarity=0.578  Sum_probs=225.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+++. ||||+++++++.+++.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999997654333345678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.+...
T Consensus        87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECC--
T ss_pred             EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccceecccC
Confidence            9999999999988554  6799999999999999999999999999999999999998   5788999999999876432


Q ss_pred             ---CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 ---KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                         ......+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+++.++......++    ..+|+++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~  237 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA  237 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHH
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHH
Confidence               233457899999999999764 68999999999999999999999999999999999988876554    3689999


Q ss_pred             HHHHHHccccCccCCcCHHH------HhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQ------ALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e------~L~h~~~~~~  361 (487)
                      ++||.+||+.||++|||++|      +++||||+..
T Consensus       238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            99999999999999999987      6889999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-61  Score=462.79  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=228.2

Q ss_pred             cccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           92 KDFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        92 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +++.+.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++|+ |||||++++++.+.+.
T Consensus        11 ~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHT   89 (309)
T ss_dssp             SCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             cCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCE
Confidence            345567999999999999999999999999999999998766555556678999999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +|||||||+||+|..++..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccc
Confidence            9999999999988655533  36799999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCCCccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCC
Q 011380          252 IKPGKKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSI  327 (487)
Q Consensus       252 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  327 (487)
                      ...   ....+||+.|||||++.+    .|+.++|||||||++|+|++|..||.+....+.+..+..+.....  ....+
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  239 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW  239 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTS
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCC
Confidence            543   345689999999999853    468899999999999999999999999888888888877654332  23468


Q ss_pred             CHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          328 SNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       328 s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      |+++++||.+||+.||++|||+.|+|+||||...
T Consensus       240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=462.84  Aligned_cols=256  Identities=30%  Similarity=0.527  Sum_probs=230.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+++. ||||+++++++.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            46999999999999999999999999999999998654333345677889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC-
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP-  254 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~-  254 (487)
                      ||||+||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.... 
T Consensus        84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccccccccC
Confidence            9999999999988654  6799999999999999999999999999999999999998   478999999999987543 


Q ss_pred             CCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                      .......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+++..+....+.++    ..+|+++++
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  234 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKS  234 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence            344567899999999999875 479999999999999999999999999999999999998876654    468999999


Q ss_pred             HHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          334 FVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      ||.+||++||++||     ++.|+++||||+..
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999999999     49999999999763

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-60  Score=463.23  Aligned_cols=262  Identities=29%  Similarity=0.556  Sum_probs=237.7

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      .+-++|++++.||+|+||+||+|.++.+|+.||||++.+..    .....+.+|+++|+.++ |||||+++++|++.+.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            45678999999999999999999999999999999997653    23456889999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.. +...+||+|||++...
T Consensus        77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhcc
Confidence            9999999999999988433 3479999999999999999999999999999999999999842 3568999999999887


Q ss_pred             CCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .........+||+.|+|||.+.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...|+.+|+++
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            766666778899999999998654 6889999999999999999999999999999999999998888777778899999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ++||.+||..||++|||+.|+|+||||++.
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=450.57  Aligned_cols=255  Identities=26%  Similarity=0.470  Sum_probs=213.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~  173 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++|+++. |||||++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            579999999999999999999999999999999987654 3445677899999999995 9999999999865  46689


Q ss_pred             EEEeccCCCCHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ceeecCCCCceEeccCCCCCcEEEeec
Q 011380          174 IAMELCEGGELLDRILAK--KDSRYTEKDAAVVVRQMLRVAAECHLHG-----LVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~~~~qil~~l~~lH~~~-----iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                      ||||||+||+|.+++...  ....+++..++.++.||+.||.|||+.|     |+||||||+|||++   .++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcEEEeec
Confidence            999999999999988542  3567999999999999999999999976     99999999999998   4788999999


Q ss_pred             ccccccCCCC-ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          247 GLSDFIKPGK-KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       247 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      |+|+...... .....+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+.+..++...+..+....   ..
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            9998765443 3456789999999999966 47899999999999999999999999998888888888775432   22


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcCccc
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWV  358 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~  358 (487)
                      ..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999996

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-60  Score=464.22  Aligned_cols=267  Identities=29%  Similarity=0.563  Sum_probs=225.2

Q ss_pred             cCCCeeEee-eeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 011380           94 FDRRYTIGK-LLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED----  168 (487)
Q Consensus        94 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~----  168 (487)
                      +-++|++.. .||+|+||+||+|+++.+|+.||||++...        ..+.+|+.++.++.+|||||+++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            345798864 699999999999999999999999998653        4567899998776579999999999976    


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ...+|||||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..++.+.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46799999999999999999765556799999999999999999999999999999999999999766678899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH----hcCCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL----RNKPDFRRKP  323 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~  323 (487)
                      |+...........+||+.|+|||++.+. |+.++|||||||++|+|+||++||.+.........+.    .....++...
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            9887776667788999999999998764 7899999999999999999999998776555444433    3334444444


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCC
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIP  368 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~  368 (487)
                      ++.+|+++++||++||+.||++|||+.|+|+||||++.......+
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence            567899999999999999999999999999999998765444433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-59  Score=455.95  Aligned_cols=254  Identities=27%  Similarity=0.553  Sum_probs=228.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ |||||++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            36999999999999999999999999999999997654333345678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|...+..  ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.... 
T Consensus        83 mE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a~~~~~-  156 (316)
T d1fota_          83 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPD-  156 (316)
T ss_dssp             ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSCEECSS-
T ss_pred             eeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccceEecc-
Confidence            999999999887754  36789999999999999999999999999999999999998   478899999999987653 


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+..+...++    +.+|++++++
T Consensus       157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  231 (316)
T d1fota_         157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDL  231 (316)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred             -ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence             34567999999999999775 79999999999999999999999999999999999998875543    4689999999


Q ss_pred             HHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      |.+||..||.+|+     |++++|+||||++.
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            9999999999996     99999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-60  Score=458.95  Aligned_cols=256  Identities=27%  Similarity=0.406  Sum_probs=215.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....  .+...+.+.+|+.+|++++ |||||+++++|.+++.+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            468999999999999999999999999999999997643  2345678899999999995 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      |||||+||+|.+++.+.  ..+++..++.++.||+.||.|||+ +||+||||||+|||++   .++.+||+|||+|....
T Consensus        82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHHH
T ss_pred             EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCccccC
Confidence            99999999999988654  579999999999999999999997 5999999999999998   47889999999998764


Q ss_pred             CCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHH---------------------
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKE---------------------  311 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---------------------  311 (487)
                      .. ...+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+.......                     
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            32 2346799999999999876 579999999999999999999999977654321110                     


Q ss_pred             ---------------------HHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          312 ---------------------VLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       312 ---------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                                           +....  .+..+...+|.++++||.+||+.||.+|||+.|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                 01000  0111112368899999999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.1e-59  Score=455.81  Aligned_cols=254  Identities=28%  Similarity=0.504  Sum_probs=228.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.+. |||||++++++.+...+|+|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            47999999999999999999999999999999997654333345677899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.||+|..++...  ..+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.... 
T Consensus       120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a~~~~~-  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECSS-
T ss_pred             cccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceeeeeccc-
Confidence            9999999999988655  5799999999999999999999999999999999999998   478899999999987753 


Q ss_pred             CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Q 011380          256 KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKDF  334 (487)
Q Consensus       256 ~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  334 (487)
                       .....+||+.|||||++.+. ++.++|||||||++|+|++|+.||.+.+....+..+..+.+.++    +.+|+++.+|
T Consensus       194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  268 (350)
T d1rdqe_         194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL  268 (350)
T ss_dssp             -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred             -ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHH
Confidence             23567899999999998765 68999999999999999999999999999899999988876543    4689999999


Q ss_pred             HHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          335 VKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       335 i~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      |++||..||.+|+     |++++++||||+..
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            9999999999995     99999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=447.86  Aligned_cols=257  Identities=28%  Similarity=0.502  Sum_probs=225.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.++.+..+|||||++++++.+.+.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999997644322334566778888776433699999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchhhhcccc
Confidence            9999999999988554  5799999999999999999999999999999999999998   5789999999999865433


Q ss_pred             -CccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          256 -KKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                       ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+...++..+..+.+.++    +.+|+++++
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d  232 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKD  232 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence             33455789999999999876 568999999999999999999999999999999999988876554    358999999


Q ss_pred             HHHHccccCccCCcCHH-HHhcCcccccc
Q 011380          334 FVKKLLVKDPRARLTAA-QALSHPWVREG  361 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~-e~L~h~~~~~~  361 (487)
                      ||++||+.||++|||+. ++++||||+..
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            99999999999999995 89999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-58  Score=453.18  Aligned_cols=258  Identities=23%  Similarity=0.372  Sum_probs=216.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHH---HHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKRE---VKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E---~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +++++.+ +|||||++++++.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence            469999999999999999999999999999999976443222223334444   5566666 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeeceeeec
Confidence            9999999999999998654  6789999999999999999999999999999999999998   5788999999999876


Q ss_pred             CCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          253 KPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       253 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ... .....+||+.|+|||++..  .++.++|||||||++|+|++|+.||.+........ +...........++.+|++
T Consensus       158 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         158 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             SSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHH
T ss_pred             CCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHH
Confidence            544 3456789999999999853  36899999999999999999999998765543332 2233333333344679999


Q ss_pred             HHHHHHHccccCccCCcC-----HHHHhcCcccccc
Q 011380          331 AKDFVKKLLVKDPRARLT-----AAQALSHPWVREG  361 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt-----~~e~L~h~~~~~~  361 (487)
                      +++||.+||++||++|||     |+|+++||||+..
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            999999999999999999     8999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-58  Score=441.00  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=212.8

Q ss_pred             EeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCCh--HhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEe
Q 011380          100 IGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILP--IAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAME  177 (487)
Q Consensus       100 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e  177 (487)
                      .+++||+|+||+||+|+++.+|+.||||++........  ...+.+.+|+.+|+++. |||||++++++.+++.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            45789999999999999999999999999976543211  12346889999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC-C
Q 011380          178 LCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG-K  256 (487)
Q Consensus       178 ~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~-~  256 (487)
                      ||.|+++....  .....+++..++.+++||+.||+|||++||+||||||+|||++   .++.+||+|||++...... .
T Consensus        81 ~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          81 FMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTTTSCCC
T ss_pred             hhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCccccccCCCcc
Confidence            99887665443  4456799999999999999999999999999999999999998   5789999999999776443 3


Q ss_pred             ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC------------
Q 011380          257 KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRK------------  322 (487)
Q Consensus       257 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------  322 (487)
                      .....+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..........            
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            3456789999999999854  36889999999999999999999999998888887776531111111            


Q ss_pred             ------------CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          323 ------------PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       323 ------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                  .++.+++++++||.+||+.||++||||.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                        0235788999999999999999999999999999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-57  Score=435.66  Aligned_cols=262  Identities=26%  Similarity=0.437  Sum_probs=219.7

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|+++. |||||++++++.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            479999999999999999999999999999999965432 2234567889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+.+ .+.+.+.......+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCcceeccCC
Confidence            999965 566666666667899999999999999999999999999999999999998   4778999999999876543


Q ss_pred             -CccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC---------
Q 011380          256 -KKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP---------  323 (487)
Q Consensus       256 -~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  323 (487)
                       ......+||+.|+|||++...  ++.++|||||||++|+|++|+.||.+.+..+.+..+...........         
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             334567899999999987543  47899999999999999999999998887777766654322211111         


Q ss_pred             ----------------CCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          324 ----------------WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       324 ----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                      ++.+|+++++||++||..||++|||+.|+|+||||++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                            2357889999999999999999999999999999987543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=431.17  Aligned_cols=253  Identities=29%  Similarity=0.539  Sum_probs=214.7

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChH---hHHHHHHHHHHHHhcc-CCCCccEEEEEEEeC
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPI---AVEDVKREVKILQALA-GHENVVKFYNAFEDD  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~E~~~l~~l~-~hpnIv~~~~~~~~~  169 (487)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+.......   ....+.+|+.+|+++. +|||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            457899999999999999999999999999999999765432211   1233568999999985 389999999999999


Q ss_pred             CEEEEEEeccCC-CCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 NYVYIAMELCEG-GELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 ~~~~lv~e~~~g-g~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      +.+|+||||+.+ +++.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.  +++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~  157 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGS  157 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTT
T ss_pred             CeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECcccc
Confidence            999999999976 5777777544  67999999999999999999999999999999999999984  457899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhccC-C-CCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-S-GPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      |..... ....+.+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+.      ..+..+...++    +.
T Consensus       158 a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~  226 (273)
T d1xwsa_         158 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QR  226 (273)
T ss_dssp             CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SC
T ss_pred             ceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CC
Confidence            986543 345678899999999998754 3 57799999999999999999999653      23555544433    46


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      +|+++++||.+||+.||++|||+.|+|+||||++.
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            89999999999999999999999999999999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.3e-57  Score=429.28  Aligned_cols=261  Identities=28%  Similarity=0.435  Sum_probs=223.0

Q ss_pred             ccCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 011380           93 DFDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN--  170 (487)
Q Consensus        93 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--  170 (487)
                      .+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.....+.....+.+|+.+|+.+. ||||+++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            45678999999999999999999999999999999998776656666778999999999995 999999999997643  


Q ss_pred             --EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 --YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                        .+|||||||+||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++   .++.++|+|||+
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~  157 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI  157 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTT
T ss_pred             CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhh
Confidence              489999999999999888554  5799999999999999999999999999999999999998   478899999999


Q ss_pred             ccccCCC----CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 011380          249 SDFIKPG----KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKP  323 (487)
Q Consensus       249 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  323 (487)
                      +......    ......+||+.|+|||++.+. ++.++|||||||++|+|+||++||.+.+..+.+..++...+.++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  237 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence            8654332    234457899999999998765 68999999999999999999999999998888888888887777667


Q ss_pred             CCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccc
Q 011380          324 WPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVR  359 (487)
Q Consensus       324 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~  359 (487)
                      ++.+|+++.+||.+||++||.+||+..+.|.|+|.+
T Consensus       238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            788999999999999999999999655566677764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=430.53  Aligned_cols=263  Identities=26%  Similarity=0.367  Sum_probs=216.9

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCC-CCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe---
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKAN-GDRVAVKKIEKNKMILPIAVEDVKREVKILQALA--GHENVVKFYNAFED---  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~hpnIv~~~~~~~~---  168 (487)
                      .++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.|.  +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999999765 6679999987543221 12234567888887763  59999999999853   


Q ss_pred             --CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeec
Q 011380          169 --DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDF  246 (487)
Q Consensus       169 --~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~Df  246 (487)
                        ...+|++|||+.++.+. .........+++..++.++.||+.||+|||++||+||||||+|||++   ..+.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecch
Confidence              35789999999876554 34445567799999999999999999999999999999999999998   4788999999


Q ss_pred             ccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC-----
Q 011380          247 GLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR-----  320 (487)
Q Consensus       247 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----  320 (487)
                      |++............+||+.|+|||++.+ .++.++||||+||++|||++|++||.+.+..+.+..+........     
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99987665556677899999999998865 579999999999999999999999999988887777654211100     


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 ------------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 ------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                        ...++.+|+++++||.+||++||++|||+.|+|+||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                              012345789999999999999999999999999999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-55  Score=421.74  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=213.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++ |||||++++++.+.+..|++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            58999999999999999999985 789999999976543 2233577889999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||++.++.+....  .....+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        79 ~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          79 FEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIP  153 (286)
T ss_dssp             EECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHHHCC-
T ss_pred             EEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEecccccceecccC
Confidence            9999776554433  3457899999999999999999999999999999999999998   4788999999999876543


Q ss_pred             C-ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC-----------
Q 011380          256 K-KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRR-----------  321 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  321 (487)
                      . ......|++.|+|||.+.+  .++.++|||||||++|+|++|+.||.+.+..+.+..+.........           
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            2 2345679999999999864  3589999999999999999999999988887777766542111111           


Q ss_pred             --------------CCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccc
Q 011380          322 --------------KPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVRE  360 (487)
Q Consensus       322 --------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~  360 (487)
                                    ...+.+|+++.+||++||++||++|||+.|+|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                          112457889999999999999999999999999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-55  Score=420.55  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=213.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.....    ..+.+.+|+++|++++ |||||++++++.+.+.+|||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEE
Confidence            579999999999999999999999999999999876542    4567899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeecCCC
Confidence            9999999999999777677899999999999999999999999999999999999998   4678999999999876543


Q ss_pred             Cc--cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      ..  .....||+.|+|||++. +.++.++|||||||++|||++|..||........+.+++.....  ....+.+|+++.
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~  246 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPEKVY  246 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC--CCCCccchHHHH
Confidence            32  23456899999999876 45799999999999999999977766555444444444443322  223356899999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +||.+||+.||++|||+.++++
T Consensus       247 ~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         247 ELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=430.75  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=214.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe------CC
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------DN  170 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------~~  170 (487)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.+...       ...+|+++|++++ ||||++++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            69999999999999999999999999999999976542       2247999999995 9999999999853      34


Q ss_pred             EEEEEEeccCCCCHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 YVYIAMELCEGGELLDRILA--KKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      ++|||||||+++ +.+.+..  .....+++..++.+++||+.||+|||++||+||||||+|||++.  +...+||+|||+
T Consensus        93 ~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~  169 (350)
T d1q5ka_          93 YLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTT
T ss_pred             EEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccc
Confidence            689999999765 4443322  34567999999999999999999999999999999999999984  345899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC----------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK----------  316 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  316 (487)
                      +..........+.+||+.|+|||++.+  .++.++||||+||++|||++|+.||...+..+.+..+....          
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            988776666777899999999998754  47999999999999999999999999888777776664310          


Q ss_pred             -------CCCC--------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          317 -------PDFR--------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       317 -------~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                             ..+.        ....+.+++++.+||.+||.+||++|||+.|+|+||||++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                   0011        112345789999999999999999999999999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.4e-55  Score=426.80  Aligned_cols=253  Identities=27%  Similarity=0.513  Sum_probs=213.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED--DNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~~  173 (487)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+..      .+.+.+|+.+|+.+.+||||++++++|..  ...++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            57999999999999999999999999999999997543      46788999999999779999999999984  45799


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +|||||.+++|....     ..+++..++.+++||+.||.|||++||+||||||+|||++.  +++.+||+|||+|....
T Consensus       109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECC
T ss_pred             EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceecc
Confidence            999999999986543     56999999999999999999999999999999999999984  34579999999999887


Q ss_pred             CCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHh-------------cCC
Q 011380          254 PGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTED-GIFKEVLR-------------NKP  317 (487)
Q Consensus       254 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~-------------~~~  317 (487)
                      ........+||+.|+|||++.+  .++.++||||+||++|+|++|+.||...... .....+..             ...
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            7767778899999999999765  3689999999999999999999999765432 22211110             000


Q ss_pred             C--------------------CCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          318 D--------------------FRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       318 ~--------------------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      .                    +....+..+|+++++||++||.+||++|||++|+|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            0                    0111223478999999999999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-55  Score=425.40  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=213.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC-----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD-----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++++.||+|+||+||+|+++.+++     .||+|++....  .......+.+|+.+|.++.+|||||++++++.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            579999999999999999999876654     69999886543  22345678899999999966999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCc
Q 011380          171 YVYIAMELCEGGELLDRILAKKD---------------------SRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPEN  229 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~N  229 (487)
                      .+|+|||||+||+|.+++.....                     ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            99999999999999999865432                     358999999999999999999999999999999999


Q ss_pred             eEeccCCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 011380          230 FLFKSAKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKT  304 (487)
Q Consensus       230 Ill~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  304 (487)
                      ||++   .++.+||+|||+|+.......   .....||+.|||||++. +.++.++|||||||++|||++ |+.||.+..
T Consensus       195 ill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9998   578999999999987654332   23567899999999886 457999999999999999997 899999887


Q ss_pred             hhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          305 EDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       305 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ....+.+++.....++.  .+.+|+++++||.+||+.||++|||++|+++|
T Consensus       272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77777777766543332  35689999999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=421.06  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=212.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-------
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-------  168 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-------  168 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|++++ ||||+++++++..       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccc
Confidence            6899999999999999999999999999999998765432 234467789999999995 9999999998854       


Q ss_pred             -CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          169 -DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       169 -~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                       .+.+|+|||||.++.+...  ......+++..++.+++||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~--~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~kl~dfg  162 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLL--SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFG  162 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHH--TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCT
T ss_pred             cCceEEEEEeccCCCccchh--hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEEeeecc
Confidence             4568999999987654432  34456799999999999999999999999999999999999998   47889999999


Q ss_pred             cccccCCC-----CccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 011380          248 LSDFIKPG-----KKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR  320 (487)
Q Consensus       248 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  320 (487)
                      ++......     ......+||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+.........+......+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99765432     22345689999999999864  468999999999999999999999998888777766655333333


Q ss_pred             CCCCCC----------------------------CCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          321 RKPWPS----------------------------ISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       321 ~~~~~~----------------------------~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                      ...+..                            .++++++||.+||++||++|||+.|+|+||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            222211                            26778999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=415.41  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=205.8

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++++.||+|+||+||+|+.+   ..||||++..... .+...+.+.+|+.+|++++ |||||++++++. .+.++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEE
Confidence            357999999999999999999743   4699999976543 3446678999999999995 999999999865 456899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+....
T Consensus        81 v~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC---
T ss_pred             EEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeeccc
Confidence            99999999999988543 35699999999999999999999999999999999999998   578999999999977643


Q ss_pred             C---CccccccCCccccchhhhcc----CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC-CCCC-CCCCC
Q 011380          255 G---KKFQDIVGSAYYVAPEVLKR----KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNK-PDFR-RKPWP  325 (487)
Q Consensus       255 ~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~  325 (487)
                      .   .......||+.|||||++.+    .++.++|||||||++|||+||+.||.+......+..+.... .... ....+
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence            2   23456789999999999853    36889999999999999999999998877665555544433 2211 22345


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+|+++.+||.+||..||++|||+.+++++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            789999999999999999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-55  Score=413.14  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=214.0

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEE
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  174 (487)
                      .++|++.+.||+|+||+||+|.++ +++.||||++.....    ..+.+.+|+.+|++++ |||||++++++.+ +.+|+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            357999999999999999999975 578899999976542    3467899999999995 9999999998755 55799


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      |||||++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+||||+   +++.+||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEccC
Confidence            99999999999987655555799999999999999999999999999999999999998   578999999999988754


Q ss_pred             CCc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHH
Q 011380          255 GKK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNS  330 (487)
Q Consensus       255 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  330 (487)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|||+|| .+||......+.+..+..+....   ....+|++
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHH
Confidence            432  345679999999999874 578999999999999999995 55566666667777776654322   22468999


Q ss_pred             HHHHHHHccccCccCCcCHHHHhc--Ccccc
Q 011380          331 AKDFVKKLLVKDPRARLTAAQALS--HPWVR  359 (487)
Q Consensus       331 ~~~li~~~L~~dp~~Rpt~~e~L~--h~~~~  359 (487)
                      +.+||.+||+.||++|||+.++++  |+||.
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999999999999998  78885

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=425.00  Aligned_cols=258  Identities=29%  Similarity=0.487  Sum_probs=212.2

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++.+... .....+.+.+|+.+|+.+. |||||+++++|...+   
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            66799999999999999999999999999999999976432 3445678899999999995 999999999997654   


Q ss_pred             ---EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecc
Q 011380          171 ---YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFG  247 (487)
Q Consensus       171 ---~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG  247 (487)
                         .+|+||||| |++|...+. .  ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~-~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~Dfg  166 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMK-H--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG  166 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHH-H--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred             ccceEEEEEecc-cccHHHHHH-h--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---ccccccccccc
Confidence               579999999 566666552 2  5799999999999999999999999999999999999998   57889999999


Q ss_pred             cccccCCCCccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc----------
Q 011380          248 LSDFIKPGKKFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN----------  315 (487)
Q Consensus       248 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------  315 (487)
                      +|.....  .....+||+.|+|||++.+  .++.++||||+||++|+|++|++||.+.+....+..+...          
T Consensus       167 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         167 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            9987643  3466789999999999865  3589999999999999999999999888776655444321          


Q ss_pred             -------------CCCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          316 -------------KPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       316 -------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                   .+.....    ..+.+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                         1111211    2356789999999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-54  Score=414.85  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC---EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD---RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++.+.||+|+||+||+|.++.+|+   .||||.+....  .....+.+.+|+.+|++++ |||||++++++...+.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence            469999999999999999999987765   58888876543  3445678999999999995 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC------
T ss_pred             EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCcccceEc
Confidence            9999999999999877543 45799999999999999999999999999999999999998   5789999999999876


Q ss_pred             CCCCcc------ccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCC
Q 011380          253 KPGKKF------QDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPW  324 (487)
Q Consensus       253 ~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  324 (487)
                      ......      ....||+.|||||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+..   .+..
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~~  255 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LPPP  255 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence            543221      22467999999999865 57889999999999999998 8999999988888888776542   2233


Q ss_pred             CCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          325 PSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       325 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      ..+|+++.+||.+||+.||++|||+.|++++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            5689999999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=407.86  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=203.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|.++ +++.||||++.....    ..+.+.+|++++++++ |||||++++++...+.+|+|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            46999999999999999999976 577899999976442    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++   .++.+||+|||+++.....
T Consensus        79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheeccCC
Confidence            9999999999987543 35689999999999999999999999999999999999998   4778999999999876543


Q ss_pred             Cc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||+| |.+||...+..+.+..+..+.....   ....++++
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l  231 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  231 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHH
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHH
Confidence            22  234679999999999875 57899999999999999999 5667777777777787777643322   24578999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+||.+||+.||++|||++++++|
T Consensus       232 ~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=409.59  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=213.5

Q ss_pred             CCeeEeee-eeecCceEEEEEEEcCC--CCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKL-LGHGQFGYTYVATDKAN--GDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~-lG~G~~g~V~~~~~~~~--~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|.+.+. ||+|+||+||+|.++.+  +..||||++....  .....+.+.+|+++|++++ |||||++++++.++ .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-AL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-eE
Confidence            45788874 99999999999987644  4579999997543  3455678999999999995 99999999998764 58


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |||||||+||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus        84 ~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence            999999999999987643 345799999999999999999999999999999999999998   4778999999999876


Q ss_pred             CCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....    ....+||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+...   ...+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence            54322    234578999999999864 57899999999999999998 99999988888888877766432   22357


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHH---hcCccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQA---LSHPWVRE  360 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~---L~h~~~~~  360 (487)
                      +|+++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            89999999999999999999999887   67888753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=403.39  Aligned_cols=247  Identities=22%  Similarity=0.347  Sum_probs=215.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++ +++.||||++.+...    ..+.+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            46889999999999999999985 788999999987543    3467899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      |||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.....
T Consensus        78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCSSS
T ss_pred             EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheeccCC
Confidence            99999999988875543 5689999999999999999999999999999999999998   5789999999999866543


Q ss_pred             Cc--cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 KK--FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||.+.+..++...+..+....   .....++++
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l  230 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKV  230 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHH
Confidence            22  234679999999999864 57899999999999999998 899999999888888887754322   224678999


Q ss_pred             HHHHHHccccCccCCcCHHHHhcC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .+||.+||+.||++|||+.++|+|
T Consensus       231 ~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         231 YTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=408.13  Aligned_cols=260  Identities=23%  Similarity=0.407  Sum_probs=217.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++ ||||+++++++.+....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            479999999999999999999999999999999976543 3445678899999999995 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ++++.|++|...+  .....+++..++.++.|++.||+|||++||+||||||+|||++   .++.+||+|||.+......
T Consensus        80 ~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          80 FEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             EECCSEEHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSC
T ss_pred             eeecccccccccc--ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhcccCC
Confidence            9999988877665  3457889999999999999999999999999999999999998   4678999999999876543


Q ss_pred             C-ccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCCC-----------
Q 011380          256 K-KFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWD-KTEDGIFKEVLRNKPDFR-----------  320 (487)
Q Consensus       256 ~-~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~-----------  320 (487)
                      . ......+++.|+|||++.+.  ++.++|||||||++|+|++|+.||.. .+..+.+..+........           
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            3 33445678999999988653  58999999999999999999998654 444555555433111110           


Q ss_pred             --------------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccC
Q 011380          321 --------------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGG  362 (487)
Q Consensus       321 --------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~  362 (487)
                                    ....+.+++.+.+||++||+.||++||||+|+|+||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                          112345788999999999999999999999999999998753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=421.06  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=211.6

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN---  170 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~---  170 (487)
                      +..+|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|++|. ||||+++++++....   
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTT
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeeccccc
Confidence            4568999999999999999999999999999999997543  3445678899999999995 999999999987543   


Q ss_pred             --EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          171 --YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       171 --~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                        .+|++ +++.||+|.+++..   ..+++..++.++.||+.||+|||++|||||||||+|||++   .++.+||+|||+
T Consensus        83 ~~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~DfG~  155 (345)
T d1pmea_          83 MKDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGL  155 (345)
T ss_dssp             CCCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTT
T ss_pred             cceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEcccCc
Confidence              35555 55668999998853   3699999999999999999999999999999999999998   478899999999


Q ss_pred             ccccCCCC----ccccccCCccccchhhhcc--CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc-------
Q 011380          249 SDFIKPGK----KFQDIVGSAYYVAPEVLKR--KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRN-------  315 (487)
Q Consensus       249 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-------  315 (487)
                      +.......    .....+||+.|+|||++..  .++.++||||+||++|+|++|+.||.+.............       
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            97654322    2355789999999998743  3588999999999999999999999887765554443221       


Q ss_pred             ----------------CCCCCCC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCC
Q 011380          316 ----------------KPDFRRK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGD  363 (487)
Q Consensus       316 ----------------~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~  363 (487)
                                      .+.....    .++.+|+++++||.+||+.||++|||+.|+|+||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                            1111111    24578899999999999999999999999999999996544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=408.48  Aligned_cols=246  Identities=22%  Similarity=0.292  Sum_probs=204.6

Q ss_pred             eeeeecCceEEEEEEEcC--CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEEecc
Q 011380          102 KLLGHGQFGYTYVATDKA--NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAMELC  179 (487)
Q Consensus       102 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~  179 (487)
                      ++||+|+||+||+|.++.  +++.||||++..... .+...+.+.+|+++|++++ |||||++++++.++ ..|||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            479999999999998653  567899999975432 3445678999999999995 99999999999765 578999999


Q ss_pred             CCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCCCc--
Q 011380          180 EGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPGKK--  257 (487)
Q Consensus       180 ~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~~~--  257 (487)
                      ++|+|.+++..  ...+++..+..++.||+.||+|||+++|+||||||+|||++   .++.+||+|||+++.......  
T Consensus        90 ~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          90 ELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc
Confidence            99999998854  36799999999999999999999999999999999999998   478999999999987654332  


Q ss_pred             --cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011380          258 --FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAKD  333 (487)
Q Consensus       258 --~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  333 (487)
                        .....||+.|+|||++.+ .++.++|||||||++|||++ |+.||.+.+..++...+..+...   ...+.+|+++.+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~  241 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYD  241 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHH
Confidence              223578999999999865 46889999999999999998 89999998888888777765422   222468999999


Q ss_pred             HHHHccccCccCCcCHHHH---hcCccc
Q 011380          334 FVKKLLVKDPRARLTAAQA---LSHPWV  358 (487)
Q Consensus       334 li~~~L~~dp~~Rpt~~e~---L~h~~~  358 (487)
                      ||.+||+.||++|||+.++   |+|+|+
T Consensus       242 li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         242 LMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999999999998   456665

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=420.41  Aligned_cols=261  Identities=26%  Similarity=0.474  Sum_probs=217.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEE---cCCCCEEEEEEecccCcC-ChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATD---KANGDRVAVKKIEKNKMI-LPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++.+.... .....+.+.+|+++|+++++||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   447899999998754321 112345678999999999745899999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      ++++|||+.||+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEeeccchhh
Confidence            99999999999999988555  5688999999999999999999999999999999999998   467899999999976


Q ss_pred             cCCC--CccccccCCccccchhhhcc---CCCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPG--KKFQDIVGSAYYVAPEVLKR---KSGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ....  .......||+.|+|||.+.+   .++.++|||||||+||+|++|+.||.+.........+............+.
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            5432  23345789999999999864   357899999999999999999999988765555444444332222222346


Q ss_pred             CCHHHHHHHHHccccCccCCc-----CHHHHhcCcccccc
Q 011380          327 ISNSAKDFVKKLLVKDPRARL-----TAAQALSHPWVREG  361 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rp-----t~~e~L~h~~~~~~  361 (487)
                      +|+++.+||.+||.+||.+||     |++|+|+||||+..
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            899999999999999999999     58999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=402.35  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=208.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIA  175 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  175 (487)
                      ++|++++.||+|+||+||+|+++.+ +.||||++.....    ..+.+.+|+.++++++ |||||++++++.+ +.+|+|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEE
Confidence            5799999999999999999998655 5799999976542    3467899999999995 9999999999855 557899


Q ss_pred             EeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCCC
Q 011380          176 MELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKPG  255 (487)
Q Consensus       176 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~~  255 (487)
                      ||||++|+|...+.......+++..++.++.||+.||.|||++||+||||||+||||+   .++.+||+|||+++.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhccCC
Confidence            9999999999888666556799999999999999999999999999999999999998   4688999999999876443


Q ss_pred             C--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHhcCCCCCCCCCCCCCHHH
Q 011380          256 K--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP-FWDKTEDGIFKEVLRNKPDFRRKPWPSISNSA  331 (487)
Q Consensus       256 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  331 (487)
                      .  ......||+.|+|||++.. .++.++|||||||++|||++|..| +.+....+.+..+..+..   .+..+.+|+++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l  243 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESL  243 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHHH
Confidence            3  2234679999999999864 578999999999999999996554 555566667776665532   22345789999


Q ss_pred             HHHHHHccccCccCCcCHHHHhc--CccccccC
Q 011380          332 KDFVKKLLVKDPRARLTAAQALS--HPWVREGG  362 (487)
Q Consensus       332 ~~li~~~L~~dp~~Rpt~~e~L~--h~~~~~~~  362 (487)
                      ++||.+||+.||++|||+++++.  ++||....
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999999999999998  88997653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=418.79  Aligned_cols=262  Identities=29%  Similarity=0.427  Sum_probs=215.2

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD----  169 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~----  169 (487)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|. |||||++++++...    
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence            45789999999999999999999999999999999986543 3345567889999999995 99999999998633    


Q ss_pred             -CEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          170 -NYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       170 -~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                       ...+++++++.||+|.+++.   ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|++|||+
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~dfg~  167 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGL  167 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCC--
T ss_pred             cCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---ccccccccccch
Confidence             33456667778999998773   35799999999999999999999999999999999999998   478899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhccC--CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK--SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLRNKPDFR------  320 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------  320 (487)
                      +....  ....+..||+.|+|||++.+.  ++.++|||||||++|+|++|++||.+.+.......+........      
T Consensus       168 a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            97643  334567899999999987553  58899999999999999999999998887776666654322111      


Q ss_pred             -----------------CC----CCCCCCHHHHHHHHHccccCccCCcCHHHHhcCccccccCCCC
Q 011380          321 -----------------RK----PWPSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDAS  365 (487)
Q Consensus       321 -----------------~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~  365 (487)
                                       ..    .++.+|+++++||++||+.||++|||+.|+|+||||++.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                             11    1346889999999999999999999999999999999765433

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=400.75  Aligned_cols=249  Identities=23%  Similarity=0.342  Sum_probs=203.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC---CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++++.||+|+||+||+|++..++   ..||||++....  .....+.+.+|+.+|++++ |||||++++++. ++.+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCeE
Confidence            57999999999999999999987543   468899886433  3455678999999999995 999999999986 4678


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      |+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            9999999999999876543 46799999999999999999999999999999999999998   4778999999999876


Q ss_pred             CCCC--ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCC
Q 011380          253 KPGK--KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSIS  328 (487)
Q Consensus       253 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  328 (487)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++ |.+||.+.+..+++..+..+...   +.++.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            5332  2344678999999999864 57889999999999999998 89999999998888888776532   2346789


Q ss_pred             HHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          329 NSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       329 ~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +++.+||.+||+.||++|||+.|+++|
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999865

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-53  Score=415.79  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=202.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe------
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED------  168 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~------  168 (487)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+++. |||||+++++|..      
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccccc
Confidence            3689999999999999999999999999999999976543 3445667899999999995 9999999999963      


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGL  248 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~  248 (487)
                      .+++|+|||||.|+ +++.+    ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+|++|||+
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~---~~~~~kl~df~~  165 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGL  165 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC
T ss_pred             CceeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc---cccceeeechhh
Confidence            47899999999664 55544    25689999999999999999999999999999999999998   477899999999


Q ss_pred             ccccCCCCccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-------------
Q 011380          249 SDFIKPGKKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVLR-------------  314 (487)
Q Consensus       249 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-------------  314 (487)
                      +............+||+.|+|||++.+. +++++||||+||++|+|++|++||.+.+.......+..             
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            9887766666778999999999998764 68999999999999999999999988876665555432             


Q ss_pred             ---------cCCCCCCCCC----------------CCCCHHHHHHHHHccccCccCCcCHHHHhcCcccccc
Q 011380          315 ---------NKPDFRRKPW----------------PSISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREG  361 (487)
Q Consensus       315 ---------~~~~~~~~~~----------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~  361 (487)
                               ..+......+                ...|+++++||++||..||++||||+|+|+||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                     2211111111                1135678999999999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=395.91  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=201.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC----CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG----DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      +.|.+.+.||+|+||+||+|.++.++    ..||||++....  .......+.+|+++|++++ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            46999999999999999999987655    469999986543  2345567899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      +++|||||.+|++.+.+.. ....+++..+..++.||+.||.|||+++|+||||||+||||+   .++.+||+|||+++.
T Consensus        84 ~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          84 MMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCCC---
T ss_pred             eEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccchhhc
Confidence            9999999999999887654 346799999999999999999999999999999999999998   578999999999987


Q ss_pred             cCCCCc----cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCC-CCCCChhHHHHHHHhcCCCCCCCCCC
Q 011380          252 IKPGKK----FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRP-FWDKTEDGIFKEVLRNKPDFRRKPWP  325 (487)
Q Consensus       252 ~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~  325 (487)
                      ......    .....||+.|+|||++.+ .++.++|||||||++|||++|..| |......+++..+..+...   +...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~  236 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPM  236 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCch
Confidence            644321    234568999999998865 578899999999999999996555 5555666666666554321   2234


Q ss_pred             CCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          326 SISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       326 ~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .++.++.+||.+||..||++|||+.++++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            68899999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=402.18  Aligned_cols=250  Identities=22%  Similarity=0.273  Sum_probs=206.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCC----EEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGD----RVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNY  171 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  171 (487)
                      .+|++++.||+|+||+||+|.+..+|+    .||+|++....  .....+.+.+|+.++++++ |||||++++++.+++ 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-
Confidence            369999999999999999999988886    57888775432  2335678999999999995 999999999998754 


Q ss_pred             EEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccc
Q 011380          172 VYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDF  251 (487)
Q Consensus       172 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~  251 (487)
                      .++++|++.+|+|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+.
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~  160 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHH
T ss_pred             eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeecccccee
Confidence            67888999999999887654 46799999999999999999999999999999999999998   477899999999987


Q ss_pred             cCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          252 IKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       252 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ......   .....||+.|+|||++.+ .++.++|||||||++|||+| |.+||.+.+..++...+..+...   ...+.
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~  237 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPI  237 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTT
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            654332   234568999999998765 57899999999999999998 89999888888777777665422   22256


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcCc
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSHP  356 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h~  356 (487)
                      +|+++.+||.+||..||++|||+.|+++|.
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            889999999999999999999999999873

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=395.55  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-CC--CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-NG--DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYV  172 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  172 (487)
                      ++|++.+.||+|+||+||+|+... ++  ..||||++.+.........+.+.+|+.+|++++ ||||+++++++.++ .+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~~-~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTP-PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS-SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeec-ch
Confidence            469999999999999999998653 33  368999998766555666788999999999995 99999999999764 67


Q ss_pred             EEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeeccccccc
Q 011380          173 YIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFI  252 (487)
Q Consensus       173 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~  252 (487)
                      ++|||||++|++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhc
Confidence            89999999999998876543 56999999999999999999999999999999999999994   678999999999876


Q ss_pred             CCCCc----cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCC
Q 011380          253 KPGKK----FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       253 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      .....    .....|++.|+|||++.+. ++.++|||||||++|||+| |..||.+.+..+....+......++  ..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~  239 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPED  239 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Cccc
Confidence            54332    2345688899999998764 5888999999999999998 8999999999999888887654432  3357


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      +|+++.+||.+||..||++|||+.+++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            899999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=403.59  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=210.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCE--EEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDR--VAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||++....  .....+.+.+|+++|+++.+|||||++++++.+.+.+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            5799999999999999999999988875  6777765432  23345678999999999956999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCC
Q 011380          174 IAMELCEGGELLDRILAK--------------KDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDS  239 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~--------------~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  239 (487)
                      +||||++||+|.+++...              ....+++..+..++.||+.||.|||+++|+||||||+|||++   .++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~---~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc---CCC
Confidence            999999999999988543              246799999999999999999999999999999999999998   467


Q ss_pred             cEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHhcCC
Q 011380          240 SLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGR-RPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       240 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~  317 (487)
                      .+||+|||+++............||+.|+|||.+.+ .++.++|||||||++|||++|. +||.+.+..+++..+..+..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            899999999987655444456679999999999864 5789999999999999999965 57878888888777766532


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                         ...+..+|+++++||.+||+.||++|||+.+++++
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence               22345789999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=398.58  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=201.1

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-C
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-D  169 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~  169 (487)
                      ++|++++.||+|+||+||+|.+..     +++.||||++....  .....+.+.+|..++.++.+||||+.+++++.. .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            579999999999999999999764     44689999987543  234556788899999888779999999998765 4


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC
Q 011380          170 NYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA  235 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~  235 (487)
                      ..+++|||||++|+|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~--  168 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--  168 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--
Confidence            56899999999999999986542              23588999999999999999999999999999999999998  


Q ss_pred             CCCCcEEEeecccccccCCCC---ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChhHHHH
Q 011380          236 KEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFK  310 (487)
Q Consensus       236 ~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~  310 (487)
                       .++.+||+|||+|+......   .....+||+.|+|||++.+. ++.++|||||||++|||++| .+||.+......+.
T Consensus       169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             47789999999997654332   23456899999999998654 68999999999999999986 56787766555555


Q ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          311 EVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       311 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      .++.....+.  ..+.+|+++.+||.+||+.||++|||+.|+++|
T Consensus       248 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5544433222  234689999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=391.69  Aligned_cols=243  Identities=22%  Similarity=0.329  Sum_probs=201.6

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVYI  174 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~l  174 (487)
                      ++|++++.||+|+||.||+|.+  +|+.||||++++..     ..+.+.+|++++++++ ||||+++++++.+ .+.+|+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            4699999999999999999987  47899999997643     3477899999999995 9999999998854 566899


Q ss_pred             EEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccCC
Q 011380          175 AMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIKP  254 (487)
Q Consensus       175 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~~  254 (487)
                      ||||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++   .++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccceecCC
Confidence            99999999999998765545689999999999999999999999999999999999998   578899999999987543


Q ss_pred             CCccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCCCCHHHH
Q 011380          255 GKKFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIFKEVLRNKPDFRRKPWPSISNSAK  332 (487)
Q Consensus       255 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  332 (487)
                      .  .....+|+.|+|||++. +.+++++|||||||++|||+| |++||......++...+..+...   ...+.+++++.
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHH
Confidence            2  34567899999999885 457899999999999999998 79999888888888887654322   22346889999


Q ss_pred             HHHHHccccCccCCcCHHHHhc
Q 011380          333 DFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       333 ~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      +||.+||..||.+|||+.++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~  252 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLRE  252 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHH
Confidence            9999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=393.32  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=209.8

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCC-------CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANG-------DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED  168 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  168 (487)
                      ++|++++.||+|+||.||+|++..++       ..||||++.+..  .......+.+|...+.++.+|||||++++++.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            58999999999999999999976554       379999987643  234567788999999999669999999999999


Q ss_pred             CCEEEEEEeccCCCCHHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          169 DNYVYIAMELCEGGELLDRILAKK--------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       169 ~~~~~lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      ++.+++|||||++|+|.+++....              ...+++..++.++.||+.||+|||+++|+||||||+|||++ 
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~-  169 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-  169 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec-
Confidence            999999999999999999986543              24589999999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCC---ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        .++.+||+|||++.......   ......||+.|+|||++. +.++.++|||||||++|||++ |.+||.+......+
T Consensus       170 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         170 --EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             --TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             --CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence              57889999999998764432   234468999999999885 467999999999999999998 79999888888777


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ..+..+.. +  ...+.+|+++.+||.+||+.||++|||+.|+++
T Consensus       248 ~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHTTCC-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCC-C--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            77665432 2  223568999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-51  Score=393.13  Aligned_cols=251  Identities=20%  Similarity=0.248  Sum_probs=212.7

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDD  169 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  169 (487)
                      .++|++++.||+|+||+||+|+++.     +++.||||++....  .....+.+.+|+.+|++++ ||||+++++++...
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            3579999999999999999999753     56789999987543  2445678999999999995 99999999999999


Q ss_pred             CEEEEEEeccCCCCHHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCC
Q 011380          170 NYVYIAMELCEGGELLDRILAKK----------------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKP  227 (487)
Q Consensus       170 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp  227 (487)
                      +..+++|||+++|+|.+++....                      ...+++..+..++.||+.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999885432                      23488999999999999999999999999999999


Q ss_pred             CceEeccCCCCCcEEEeecccccccCCCC---ccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCC-CCCCC
Q 011380          228 ENFLFKSAKEDSSLKATDFGLSDFIKPGK---KFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGR-RPFWD  302 (487)
Q Consensus       228 ~NIll~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~-~pf~~  302 (487)
                      +|||++   .++.+||+|||+|+......   .....+||+.|+|||++.+ .++.++|||||||++|||++|. +||.+
T Consensus       169 ~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999998   46789999999997654322   2345679999999999876 5789999999999999999985 68888


Q ss_pred             CChhHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          303 KTEDGIFKEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       303 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      ....+....+..+...   .....+|+++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888888888776532   223468999999999999999999999999854

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=389.62  Aligned_cols=252  Identities=26%  Similarity=0.324  Sum_probs=213.3

Q ss_pred             CCeeEeeeeeecCceEEEEEEEc-----CCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDK-----ANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++++.||+|+||.||+|+++     .+++.||||++....  .......+.+|+.+++++.+|||||++++++.+.+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            68999999999999999999863     466789999997654  24456678999999999977999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEecc
Q 011380          171 YVYIAMELCEGGELLDRILAKK----------------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKS  234 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~----------------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~  234 (487)
                      .+|+|||||++|+|.+++....                ...+++..+..++.||+.||+|||++||+||||||+|||++ 
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-  179 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-  179 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence            9999999999999999886543                23589999999999999999999999999999999999998 


Q ss_pred             CCCCCcEEEeecccccccCCCCc---cccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 011380          235 AKEDSSLKATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLC-GRRPFWDKTEDGIF  309 (487)
Q Consensus       235 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  309 (487)
                        ..+.+||+|||+++.......   ....+||+.|+|||++.+ .++.++|||||||++|||+| |.+||......+.+
T Consensus       180 --~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         180 --HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             --TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             --ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              478999999999987654332   234678999999998864 56899999999999999998 66667666666666


Q ss_pred             HHHHhcCCCCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          310 KEVLRNKPDFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       310 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                      .+++........  ...+|+++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         258 YKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666655433222  2467899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-50  Score=390.60  Aligned_cols=261  Identities=21%  Similarity=0.301  Sum_probs=207.2

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+..|+++++.+.+|++|+.+..++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45689999999999999999999999999999998876432     2346789999999974555667777788899999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|+...
T Consensus        80 ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            999999 5566665543 44679999999999999999999999999999999999998765567789999999998765


Q ss_pred             CCC--------ccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChhHHHHHHH---hcCCCC-C
Q 011380          254 PGK--------KFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTEDGIFKEVL---RNKPDF-R  320 (487)
Q Consensus       254 ~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~-~  320 (487)
                      ...        .....+||+.|+|||++.+. ++.++|||||||++|||++|..||...........+.   ...... .
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            432        23456899999999998775 7899999999999999999999998765543332221   111111 1


Q ss_pred             CCCCCCCCHHHHHHHHHccccCccCCcCHH---HHhcCcccccc
Q 011380          321 RKPWPSISNSAKDFVKKLLVKDPRARLTAA---QALSHPWVREG  361 (487)
Q Consensus       321 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~---e~L~h~~~~~~  361 (487)
                      ...++.+|+++.+||.+||+.||++||++.   ++|+|+|.+..
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            112356889999999999999999999987   55778876543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=387.24  Aligned_cols=256  Identities=20%  Similarity=0.295  Sum_probs=216.9

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcC-----CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKA-----NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN  170 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  170 (487)
                      ++|++++.||+|+||+||+|.++.     +++.||||++....  .......+.+|+.+++++. |||||++++++..++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCC
Confidence            689999999999999999998753     35789999997543  3445567899999999995 999999999999999


Q ss_pred             EEEEEEeccCCCCHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          171 YVYIAMELCEGGELLDRILAKK--------DSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~--------~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      ..++|||||++|+|.+++....        ...+++..+..++.|++.||.|||+++|+||||||+|||++   .++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec---CCceEE
Confidence            9999999999999999885432        13478899999999999999999999999999999999998   578999


Q ss_pred             EeecccccccCCCCc---cccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCC
Q 011380          243 ATDFGLSDFIKPGKK---FQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCG-RRPFWDKTEDGIFKEVLRNKP  317 (487)
Q Consensus       243 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~  317 (487)
                      |+|||+++.......   .....||+.|+|||.+.+. ++.++|||||||++|||+|| .+||.+.+..+.+..+..+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            999999986643322   2345789999999998654 68899999999999999998 588888888888888877653


Q ss_pred             CCCCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc------Cccccc
Q 011380          318 DFRRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS------HPWVRE  360 (487)
Q Consensus       318 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~------h~~~~~  360 (487)
                      ..   ..+.+|+.+.++|.+||+.||++|||+.++++      +|+|++
T Consensus       254 ~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         254 LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            21   22568899999999999999999999999997      666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-49  Score=378.94  Aligned_cols=248  Identities=21%  Similarity=0.249  Sum_probs=201.5

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCC---CEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCEEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANG---DRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFED-DNYVY  173 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-~~~~~  173 (487)
                      +.+.++||+|+||+||+|++..++   ..||||++++.  ......+.+.+|+++|++++ ||||+++++++.. ++.++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceE
Confidence            344678999999999999986643   36899998643  24556788999999999995 9999999999765 57899


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEEEeecccccccC
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLKATDFGLSDFIK  253 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~~~~  253 (487)
                      +|||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+|||++   +++.+||+|||+++...
T Consensus       106 lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGGCCTT
T ss_pred             EEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccchhhcc
Confidence            99999999999987743 345678899999999999999999999999999999999998   57889999999998764


Q ss_pred             CCC-----ccccccCCccccchhhhc-cCCCCcchHHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCC
Q 011380          254 PGK-----KFQDIVGSAYYVAPEVLK-RKSGPESDVWSIGVITYILLCGRRPFWDKT-EDGIFKEVLRNKPDFRRKPWPS  326 (487)
Q Consensus       254 ~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  326 (487)
                      ...     ......||+.|+|||.+. +.++.++||||||+++|||++|..||.... ..+....+..+.....   .+.
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~  258 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEY  258 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTT
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---ccc
Confidence            332     123357899999999876 467999999999999999999877776543 3345555555543221   246


Q ss_pred             CCHHHHHHHHHccccCccCCcCHHHHhcC
Q 011380          327 ISNSAKDFVKKLLVKDPRARLTAAQALSH  355 (487)
Q Consensus       327 ~s~~~~~li~~~L~~dp~~Rpt~~e~L~h  355 (487)
                      +++++.+||.+||..||++|||+.|+++|
T Consensus       259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         259 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            78999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-48  Score=374.61  Aligned_cols=254  Identities=20%  Similarity=0.316  Sum_probs=207.3

Q ss_pred             cCCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380           94 FDRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus        94 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.....     ...+.+|+++++.|.+|+||+.+++++......|
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            35689999999999999999999999999999998865432     2346789999999986799999999999999999


Q ss_pred             EEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccC--CCCCcEEEeecccccc
Q 011380          174 IAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSA--KEDSSLKATDFGLSDF  251 (487)
Q Consensus       174 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~vkl~DfG~a~~  251 (487)
                      +||||+ |++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++..  ...+.+||+|||+|+.
T Consensus        78 ~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999 7899887643 44679999999999999999999999999999999999999742  2357899999999987


Q ss_pred             cCCC--------CccccccCCccccchhhhccC-CCCcchHHHHHHHHHHHHhCCCCCCCCChh---HHHHHHHhcCCCC
Q 011380          252 IKPG--------KKFQDIVGSAYYVAPEVLKRK-SGPESDVWSIGVITYILLCGRRPFWDKTED---GIFKEVLRNKPDF  319 (487)
Q Consensus       252 ~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~  319 (487)
                      ....        ......+||+.|||||++.+. ++.++|||||||++|+|++|..||.+....   ..+..+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6432        123456899999999998775 789999999999999999999999765432   2333333221111


Q ss_pred             -CCCCCCCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          320 -RRKPWPSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       320 -~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                       .....+.+|+++.+++..|+..+|++||++..+.+
T Consensus       236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             11123568899999999999999999999876643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=372.49  Aligned_cols=247  Identities=22%  Similarity=0.280  Sum_probs=188.3

Q ss_pred             CCCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 011380           95 DRRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDN----  170 (487)
Q Consensus        95 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~----  170 (487)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++....    ........|+..+..+ +|||||++++++.+.+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcce
Confidence            46799999999999999999985  68999999986542    1122233445555567 4999999999997643    


Q ss_pred             EEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCceeecCCCCceEeccCCCCCcEE
Q 011380          171 YVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL--------HGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       171 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~--------~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      .+|+|||||++|+|.+++..   ..+++..+..++.|++.||.|||+        +||+||||||+||||+   .++.+|
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~~K  148 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCC  148 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSCEE
T ss_pred             EEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCCeE
Confidence            68999999999999999854   368999999999999999999996        5999999999999998   578999


Q ss_pred             EeecccccccCCCC-----ccccccCCccccchhhhccC-------CCCcchHHHHHHHHHHHHhCCCCCCCCC------
Q 011380          243 ATDFGLSDFIKPGK-----KFQDIVGSAYYVAPEVLKRK-------SGPESDVWSIGVITYILLCGRRPFWDKT------  304 (487)
Q Consensus       243 l~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DiwSlG~il~ell~g~~pf~~~~------  304 (487)
                      |+|||++.......     .....+||+.|+|||++.+.       ++.++|||||||++|||+||..||....      
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765432     23457899999999998753       3568999999999999999988773211      


Q ss_pred             --------hhHHHHHHHh-cCCCCCC-CCC--CCCCHHHHHHHHHccccCccCCcCHHHHhc
Q 011380          305 --------EDGIFKEVLR-NKPDFRR-KPW--PSISNSAKDFVKKLLVKDPRARLTAAQALS  354 (487)
Q Consensus       305 --------~~~~~~~i~~-~~~~~~~-~~~--~~~s~~~~~li~~~L~~dp~~Rpt~~e~L~  354 (487)
                              .......... ....... ..+  ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                    1122222222 2211110 011  112245889999999999999999999876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-46  Score=372.50  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=200.0

Q ss_pred             CCeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhcc----------CCCCccEEEEE
Q 011380           96 RRYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALA----------GHENVVKFYNA  165 (487)
Q Consensus        96 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------~hpnIv~~~~~  165 (487)
                      .+|+++++||+|+||+||+|+++.+|+.||||++.+..    ...+.+.+|+.+++.+.          +||||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            47999999999999999999999999999999997653    34467788999998874          25889999988


Q ss_pred             EE--eCCEEEEEEeccCCCC-HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCceeecCCCCceEeccCCCC---
Q 011380          166 FE--DDNYVYIAMELCEGGE-LLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHL-HGLVHRDMKPENFLFKSAKED---  238 (487)
Q Consensus       166 ~~--~~~~~~lv~e~~~gg~-L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~iiHrDlkp~NIll~~~~~~---  238 (487)
                      +.  .....+++++++..+. ............+++..++.++.||+.||.|||+ .||+||||||+|||++..+..   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            75  4466777777765544 3344444556789999999999999999999998 899999999999999853221   


Q ss_pred             CcEEEeecccccccCCCCccccccCCccccchhhhcc-CCCCcchHHHHHHHHHHHHhCCCCCCCCChh------HHHHH
Q 011380          239 SSLKATDFGLSDFIKPGKKFQDIVGSAYYVAPEVLKR-KSGPESDVWSIGVITYILLCGRRPFWDKTED------GIFKE  311 (487)
Q Consensus       239 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~  311 (487)
                      ..+||+|||.+.....  .....+||+.|+|||++.+ .++.++||||+||++++|++|+.||......      ..+..
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            2599999999976543  3356789999999998764 5789999999999999999999999654321      11111


Q ss_pred             HHh--cC-------------------------CCCC-----------CCCCCCCCHHHHHHHHHccccCccCCcCHHHHh
Q 011380          312 VLR--NK-------------------------PDFR-----------RKPWPSISNSAKDFVKKLLVKDPRARLTAAQAL  353 (487)
Q Consensus       312 i~~--~~-------------------------~~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~L  353 (487)
                      ...  +.                         ....           ...++..++++++||.+||.+||.+||||+|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            110  00                         0000           001122457799999999999999999999999


Q ss_pred             cCccccccCC
Q 011380          354 SHPWVREGGD  363 (487)
Q Consensus       354 ~h~~~~~~~~  363 (487)
                      +||||++...
T Consensus       327 ~Hp~f~~~~~  336 (362)
T d1q8ya_         327 NHPWLKDTLG  336 (362)
T ss_dssp             TCGGGTTCTT
T ss_pred             cCcccCCCCC
Confidence            9999996543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=8.5e-27  Score=207.83  Aligned_cols=165  Identities=23%  Similarity=0.226  Sum_probs=122.8

Q ss_pred             eeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcC---------------ChHhHHHHHHHHHHHHhccCCCCccEE
Q 011380           98 YTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMI---------------LPIAVEDVKREVKILQALAGHENVVKF  162 (487)
Q Consensus        98 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~~l~~l~~hpnIv~~  162 (487)
                      |.++++||+|+||+||+|.+. +|+.||||++......               .........+|...+.++. |++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            568899999999999999984 7899999987532110               0112344567889999995 9999998


Q ss_pred             EEEEEeCCEEEEEEeccCCCCHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHcCceeecCCCCceEeccCCCCCcEE
Q 011380          163 YNAFEDDNYVYIAMELCEGGELLDRILAKKDSRYTEKDAAVVVRQMLRVAAECHLHGLVHRDMKPENFLFKSAKEDSSLK  242 (487)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~vk  242 (487)
                      +++..    .+++|||++++.+.         .+++..+..++.||+.+|.|||++||+||||||+|||++    +..++
T Consensus        80 ~~~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~  142 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW  142 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred             EEecC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEE
Confidence            86532    26999999876542         245566788999999999999999999999999999998    34599


Q ss_pred             EeecccccccCCCCccccccCCccccc------hhhhccCCCCcchHHHHHH
Q 011380          243 ATDFGLSDFIKPGKKFQDIVGSAYYVA------PEVLKRKSGPESDVWSIGV  288 (487)
Q Consensus       243 l~DfG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwSlG~  288 (487)
                      |+|||+|.....+..       ..|..      .+.+...|+.++|+||+.-
T Consensus       143 liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         143 IIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             ECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             EEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence            999999876542221       11222      2334567889999999754

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=99.41  E-value=2.8e-14  Score=107.81  Aligned_cols=77  Identities=25%  Similarity=0.519  Sum_probs=71.3

Q ss_pred             HHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          392 RALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       392 ~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      ..|+..++++++..++++|..||.|++|.|+.+||+.+|+. +|..+++.+++++++.+|.|++|.|        +|+||
T Consensus        11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~-lg~~~s~~e~~~l~~~~D~d~~g~I--------~~~EF   81 (87)
T d1s6ja_          11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSELMESEIKDLMDAADIDKSGTI--------DYGEF   81 (87)
T ss_dssp             HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHT-TTSSCCHHHHHHHHHHHCTTCSSEE--------CHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH-cCCCCCHHHHHHHHHHcCCCCCCeE--------eHHHH
Confidence            45667788888888999999999999999999999999999 9999999999999999999999999        99999


Q ss_pred             hccccc
Q 011380          472 LLFPVD  477 (487)
Q Consensus       472 ~~~~~~  477 (487)
                      +.++++
T Consensus        82 l~am~h   87 (87)
T d1s6ja_          82 IAATVH   87 (87)
T ss_dssp             TTCCCC
T ss_pred             HHHHcC
Confidence            987764

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=99.40  E-value=2e-13  Score=101.69  Aligned_cols=74  Identities=22%  Similarity=0.353  Sum_probs=68.5

Q ss_pred             HhccCChHHHHHHHHhhcccCCCC-CCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDK-NGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~-~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ....+++++..+++++|..||.|+ +|.|+..||+.+|+. +|..+++.+++++++.+|.|++|.|        +|+||+
T Consensus         5 ~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~-lg~~~t~~el~~~i~~~D~d~~G~I--------~f~eFl   75 (82)
T d1wrka1           5 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM-LGQNPTPEELQEMIDEVDEDGSGTV--------DFDEFL   75 (82)
T ss_dssp             HHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHH-TTCCCCHHHHHHHHHTTCTTCCSSB--------CHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHH
Confidence            345678899999999999999995 799999999999999 9999999999999999999999999        999998


Q ss_pred             cccc
Q 011380          473 LFPV  476 (487)
Q Consensus       473 ~~~~  476 (487)
                      .++.
T Consensus        76 ~im~   79 (82)
T d1wrka1          76 VMMV   79 (82)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8754

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.38  E-value=1.3e-13  Score=101.89  Aligned_cols=73  Identities=26%  Similarity=0.408  Sum_probs=68.3

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++++.+++++|..||.|++|+|+.+||+.+|+. +|..+++.++..++..+|.+++|.|        +|+||+.++
T Consensus         2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~t~~e~~~~~~~~D~~~~g~I--------~~~eF~~~m   72 (77)
T d1f54a_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRS-LGLSPSEAEVNDLMNEIDVDGNHQI--------EFSEFLALM   72 (77)
T ss_dssp             CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHH-HTCCCCHHHHHHHHHTTCCSSCCEE--------EHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHH
Confidence            4567889999999999999999999999999999999 9999999999999999999999999        999999876


Q ss_pred             cc
Q 011380          476 VD  477 (487)
Q Consensus       476 ~~  477 (487)
                      ..
T Consensus        73 ~~   74 (77)
T d1f54a_          73 SR   74 (77)
T ss_dssp             TT
T ss_pred             HH
Confidence            43

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.37  E-value=1.9e-13  Score=101.73  Aligned_cols=72  Identities=25%  Similarity=0.391  Sum_probs=67.6

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++++++.+++++|..||.|++|+|+..||+.+|+. +|..+++.++.+++..+|.|++|.|        +|++|+.++.
T Consensus         7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~s~~e~~~~~~~~D~d~~g~I--------~~~eF~~~m~   77 (81)
T d1avsa_           7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRM-LGQNPTKEELDAIIEEVDEDGSGTI--------DFEEFLVMMV   77 (81)
T ss_dssp             HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTCCSSE--------EHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            357888899999999999999999999999999999 9999999999999999999999999        9999998765


Q ss_pred             c
Q 011380          477 D  477 (487)
Q Consensus       477 ~  477 (487)
                      .
T Consensus        78 ~   78 (81)
T d1avsa_          78 R   78 (81)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=99.36  E-value=1.9e-13  Score=99.66  Aligned_cols=69  Identities=22%  Similarity=0.433  Sum_probs=65.8

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++++.+++++|..||.|++|+|+.+||+.+|+. +|..++++++..+++.+|.|++|.|        +|+||+.++
T Consensus         2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~s~~~~~~~~~~~D~d~~g~I--------~f~eF~~~m   70 (73)
T d2pq3a1           2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLTMM   70 (73)
T ss_dssp             CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHH
Confidence            56788999999999999999999999999999999 9999999999999999999999999        999998764

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.31  E-value=7.1e-13  Score=94.13  Aligned_cols=63  Identities=25%  Similarity=0.411  Sum_probs=59.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++++|+.||.|++|+|+.+||+.+++. +|..+++.++..+++.+|.|++|.|        +|++|+.++
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~-lg~~~~~~e~~~l~~~~D~d~~g~I--------~~~eF~~~m   65 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTN-LGEKLTDEEVDEMIREADIDGDGQV--------NYEEFVQMM   65 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHH-TTCCCCHHHHHHHHHTTCTTCSSSE--------EHHHHHHHC
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHH-hCCCCCHHHHHHHHHHcCCCCCCcE--------eHHHHHHHC
Confidence            46899999999999999999999999999 9999999999999999999999999        999998753

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=99.31  E-value=7.6e-13  Score=98.43  Aligned_cols=68  Identities=24%  Similarity=0.368  Sum_probs=63.0

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++++.+++++|+.+|.|++|.|+.+||+.+|+. +| .++..++..+|..+|.|++|.|        +|+||+.++.
T Consensus         1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~-lg-~~~~~ei~~~~~~~D~d~~G~I--------~~~EF~~~~~   68 (81)
T d2opoa1           1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKT-LG-SVTPDEVRRMMAEIDTDGDGFI--------SFDEFTDFAR   68 (81)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHT-TT-TCCHHHHHHHHHHHCTTCSSEE--------CHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH-hh-cCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            3577899999999999999999999999999999 88 5799999999999999999999        9999998654

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.29  E-value=1e-12  Score=96.13  Aligned_cols=63  Identities=19%  Similarity=0.305  Sum_probs=60.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++++|+.||.|++|+|+.+||+.+|+. +|..+++++++.+++.+|.|++|.|        +|+||+.++
T Consensus         9 eel~~~F~~fD~~~~G~I~~~el~~~l~~-lg~~~~~~e~~~~~~~~D~d~dg~I--------~~~EF~~~m   71 (75)
T d1jc2a_           9 EELANCFRIFDKNADGFIDIEELGEILRA-TGEHVIEEDIEDLMKDSDKNNDGRI--------DFDEFLKMM   71 (75)
T ss_dssp             HHHHHHHHHHCCSTTSSEEHHHHHHHHHH-SSSCCCHHHHHHHHHHHCSSSCSEE--------CHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHh-cCCCccHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            57899999999999999999999999999 9999999999999999999999999        999998765

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.29  E-value=1.1e-12  Score=91.75  Aligned_cols=60  Identities=25%  Similarity=0.429  Sum_probs=57.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      ++++++|..||++++|+|+.+||+.+|+. +|..+++.+++.+++.+|.|++|.|        +|++|+
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~-~g~~~~~~ei~~l~~~~D~d~dg~I--------~~~eFl   60 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTG-LGEKLTDAEVDELLKGVEVDSNGEI--------DYKKFI   60 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHH-TTCCCCHHHHHHHHTTCCCCTTSEE--------CHHHHH
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHH-cCCCCCHHHHHHHHHHcCCCCCCcE--------eHHHhc
Confidence            36889999999999999999999999999 9999999999999999999999999        999997

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=99.25  E-value=1.5e-12  Score=96.78  Aligned_cols=65  Identities=23%  Similarity=0.328  Sum_probs=61.0

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++|+++|..||.|++|+|+.+||+.+|+. +|..++..+++.++..+|.|+||.|        +|+||+.++.
T Consensus        14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~ev~~~~~~~D~d~dg~I--------~~~EF~~~m~   78 (81)
T d1fi5a_          14 EEELSDLFRMFDKNADGYIDLEELKIMLQA-TGETITEDDIEELMKDGDKNNDGRI--------DYDEFLEFMK   78 (81)
T ss_dssp             HHHHHHHHHHHCSSCSSEECHHHHHHHHHT-SSSCCCHHHHHHHHHHHCSSSSSSE--------EHHHHHHHHS
T ss_pred             HHHHHHHHHHHcCCCCCcccHHHHHHHHHh-cCCCCCHHHHHHHHHHHCCCCCCcE--------eHHHHHHHHH
Confidence            357899999999999999999999999999 9999999999999999999999999        9999988653

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=99.25  E-value=2.3e-12  Score=92.07  Aligned_cols=62  Identities=15%  Similarity=0.268  Sum_probs=58.9

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++|..+|.|++|+|+.+||+.+|+. +|..+++++++.+|..+|.|++|.|        +|+||+.++.
T Consensus         3 ~r~~F~~~D~d~~G~I~~~El~~~l~~-lg~~~~~~~i~~~~~~~D~d~dg~I--------~~~EF~~~m~   64 (67)
T d1tiza_           3 AKRVFEKFDKNKDGKLSLDEFREVALA-FSPYFTQEDIVKFFEEIDVDGNGEL--------NADEFTSCIE   64 (67)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHHHHH-TCTTSCHHHHHHHHHHHCCSSSSEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHCCCCcCcCcHHHHHHHHHH-hccccchHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            678999999999999999999999999 9999999999999999999999999        9999987654

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.24  E-value=2.1e-12  Score=95.15  Aligned_cols=67  Identities=15%  Similarity=0.247  Sum_probs=62.5

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +..++++++|+.||.|++|+|+.+||+.+|+. +|..++..++..+++.+|.|++|.|        +|+||+.++.
T Consensus         6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~e~~~~~~~~D~d~~G~I--------~~~EF~~~m~   72 (77)
T d1oqpa_           6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKE-LGENLTEEELQEMIAEADRNDDNEI--------DEDEFIRIMK   72 (77)
T ss_dssp             SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHCCSSSSEE--------CHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHcCCCCCEechHHHHHHHHH-hCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            44568999999999999999999999999999 9999999999999999999999999        9999998654

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=99.23  E-value=1e-12  Score=94.10  Aligned_cols=64  Identities=16%  Similarity=0.304  Sum_probs=59.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc-ccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK-LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~-~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ++++++|..||.|++|+|+.+||+.+|+. +|.. ++.++++.+++.+|.|+||.|        +|+||+.++.
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~-~g~~~~s~~e~~~~~~~~D~d~dG~i--------~~~EF~~~m~   66 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQK-VGEEPLTDAEVEEAMKEADEDGNGVI--------DIPEFMDLIK   66 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSST-TTTCCCCHHHHHHHHHHHCSSGGGSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHH-hCCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            46889999999999999999999999999 8875 799999999999999999999        9999987653

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=99.17  E-value=8.2e-12  Score=98.17  Aligned_cols=78  Identities=17%  Similarity=0.172  Sum_probs=64.1

Q ss_pred             HHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh--CCCcccHHHHHHHHHhcCCCCCceeecCccccc
Q 011380          389 FALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKD--LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGE  466 (487)
Q Consensus       389 ~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~--~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~  466 (487)
                      .|+.++.....  ..++++++|..||+|++|+|+.+||+.+|+..  .|..+++++++++++.+|.|+||.|        
T Consensus        28 eF~~~~~~~~~--~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I--------   97 (109)
T d5pala_          28 RFFHLVGLKGK--TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKI--------   97 (109)
T ss_dssp             HHHHHHTCTTC--CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSE--------
T ss_pred             HHHHHHHhcCC--CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCE--------
Confidence            34455543322  23578999999999999999999999999761  3778999999999999999999999        


Q ss_pred             cchhhhcccc
Q 011380          467 KFSYLLLFPV  476 (487)
Q Consensus       467 ~f~~f~~~~~  476 (487)
                      +|+||+.++.
T Consensus        98 ~~~EF~~~m~  107 (109)
T d5pala_          98 GADEFAKMVA  107 (109)
T ss_dssp             EHHHHHHHHH
T ss_pred             eHHHHHHHHH
Confidence            9999988654

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.13  E-value=2e-11  Score=95.88  Aligned_cols=78  Identities=19%  Similarity=0.208  Sum_probs=64.5

Q ss_pred             HHHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccc
Q 011380          388 QFALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEK  464 (487)
Q Consensus       388 ~~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~  464 (487)
                      ..|+.+++....  ....++++|+.+|.|++|+|+.+||+.+|+. +   |..+++++++.+++.+|.|+||.|      
T Consensus        27 ~EF~~~~~~~~~--~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-l~~~g~~ls~~ev~~~~~~~D~d~dG~I------   97 (109)
T d1pvaa_          27 KKFFALVGLKAM--SANDVKKVFKAIDADASGFIEEEELKFVLKS-FAADGRDLTDAETKAFLKAADKDGDGKI------   97 (109)
T ss_dssp             HHHHHHHTCTTS--CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGG-TCTTCCCCCHHHHHHHHHHHCTTCSSSB------
T ss_pred             HHHHHHHHHccC--CHHHHHHHhhCccCCCcCeEcHHHHHHHHHH-hhhcCCCCCHHHHHHHHHHHCCCCcCcE------
Confidence            345555544332  2356889999999999999999999999987 6   678999999999999999999999      


Q ss_pred             cccchhhhcccc
Q 011380          465 GEKFSYLLLFPV  476 (487)
Q Consensus       465 ~~~f~~f~~~~~  476 (487)
                        +|+||+.++.
T Consensus        98 --~~~EF~~~m~  107 (109)
T d1pvaa_          98 --GIDEFETLVH  107 (109)
T ss_dssp             --CHHHHHHHHH
T ss_pred             --eHHHHHHHHH
Confidence              9999987653

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=99.05  E-value=6.2e-11  Score=92.76  Aligned_cols=65  Identities=22%  Similarity=0.295  Sum_probs=58.8

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++.+|+.+|.|++|+|+.+|++.+|+. +   +..+++++++.+|+.+|.|+||.|        +|+||+.++
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~-l~~~~~~~~~~~~~~l~~~~D~d~dG~I--------~~~EF~~~m  105 (107)
T d2pvba_          38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQN-FSPSARALTDAETKAFLADGDKDGDGMI--------GVDEFAAMI  105 (107)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGG-TCTTSCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             CHHHHHHHHHhhccCCCCcCcHHHHHHHHHH-hhcccccCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHH
Confidence            3457899999999999999999999999988 6   456899999999999999999999        999998654

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=99.00  E-value=1e-10  Score=91.92  Aligned_cols=65  Identities=18%  Similarity=0.230  Sum_probs=58.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|..||+|++|+|+.+||+.+|+. +   +..+++.+++.+++.+|.|+||.|        +|+||+.++.
T Consensus        40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~-l~~~~~~~~~~e~~~~~~~~D~d~dG~i--------~~~EF~~~m~  107 (109)
T d1rwya_          40 ADDVKKVFHILDKDKSGFIEEDELGSILKG-FSSDARDLSAKETKTLMAAGDKDGDGKI--------GVEEFSTLVA  107 (109)
T ss_dssp             HHHHHHHHHHHSTTCSSEECHHHHHTHHHH-HCTTCCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHhhcccCCCCCcCcHHHHHHHHHH-hccccccCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHHH
Confidence            457889999999999999999999999987 4   356889999999999999999999        9999987654

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=2e-10  Score=85.60  Aligned_cols=63  Identities=19%  Similarity=0.248  Sum_probs=59.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ...++++|..+|.+++|+|+.+||+.+|.. +|..++++++..++..+|.|++|.|        +|.+|+..
T Consensus        19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~-~~~~l~~~e~~~l~~~~d~~~~g~I--------~y~eFl~~   81 (83)
T d1wlza1          19 YHAITQEFENFDTMKTNTISREEFRAICNR-RVQILTDEQFDRLWNEMPVNAKGRL--------KYPDFLSR   81 (83)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHH-HTCCCCHHHHHHHHTTSCBCTTSCB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCceEChhHHHHHHHH-hCCCCChhHHHHHhhccccCCCCcE--------eHHHHHHH
Confidence            457889999999999999999999999999 9999999999999999999999999        99999864

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.96  E-value=1e-10  Score=91.67  Aligned_cols=65  Identities=22%  Similarity=0.279  Sum_probs=58.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL---PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+.++++|+.||.|++|+|+.+||+.+|+. +   |..+++++++.+++.+|.|+||.|        +|+||+.++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~-l~~~~~~l~~~~~~~~~~~~D~d~dG~I--------~~~EF~~~m  106 (108)
T d1rroa_          39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQK-FQSDARELTESETKSLMDAADNDGDGKI--------GADEFQEMV  106 (108)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECTHHHHTGGGG-TCTTSCCCCHHHHHHHHHHHCCSSSSSE--------EHHHHHHHH
T ss_pred             CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHH-HHhccCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHH
Confidence            3457889999999999999999999999987 5   456899999999999999999999        899998754

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.94  E-value=4e-10  Score=86.06  Aligned_cols=66  Identities=23%  Similarity=0.202  Sum_probs=59.8

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++.++...++++|+.+|+|++|+|+.+|++.+|.+ .|  ++.+++.++++.+|.|+||.|        +|+||+.+
T Consensus         4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~-~~--l~~~~l~~i~~~~D~d~dG~l--------~~~EF~~a   69 (95)
T d1c07a_           4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK-TG--LPSTLLAHIWSLCDTKDCGKL--------SKDQFALA   69 (95)
T ss_dssp             SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHT-TT--CCHHHHHHHHHHHCTTCSSSE--------ETTTHHHH
T ss_pred             CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-cC--CCHHHHHHHHHHhCCCCCCeE--------cHHHHHHH
Confidence            46677888999999999999999999999999998 76  578899999999999999999        89999753

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.91  E-value=1.8e-10  Score=84.15  Aligned_cols=64  Identities=20%  Similarity=0.283  Sum_probs=54.9

Q ss_pred             HHHHHHhhcccCCC--CCCCCCHHHHHHHHHhhCCCccc--HHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVD--KNGSISLEEMRQALAKDLPWKLK--ESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d--~~G~i~~~el~~~l~~~~~~~~~--~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .++++++|+.||.+  ++|+|+.+||+.+|+. +|..++  ..+++++++.+|.|+||.|        +|+||+.++
T Consensus         4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~-lg~~~~~~~~ei~~~~~~~D~d~dG~I--------~f~EF~~~m   71 (76)
T d1qx2a_           4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQT-LGPSLLKGMSTLDEMIEEVDKNGDGEV--------SFEEFLVMM   71 (76)
T ss_dssp             HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHH-HGGGSCTTSCSHHHHHHHHCTTCSSEE--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCCCEECHHHHHHHHHH-hCCcCCCCHHHHHHHHHHhhcCCCCcC--------cHHHHHHHH
Confidence            35688999999654  4799999999999999 887665  4579999999999999999        999998764

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.91  E-value=4.8e-10  Score=92.87  Aligned_cols=64  Identities=11%  Similarity=0.222  Sum_probs=59.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+.++++|+.||.|++|+|+.+||+.+|.. +|..+++++++++++.+|.| +|.|        +|.+|+.++.
T Consensus        75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-~g~~lt~~e~~~l~~~~d~~-~G~I--------~y~eF~~~l~  138 (142)
T d1wdcb_          75 EETIRNAFAMFDEQETKKLNIEYIKDLLEN-MGDNFNKDEMRMTFKEAPVE-GGKF--------DYVKFTAMIK  138 (142)
T ss_dssp             HHHHHHHHHTTCTTCCSCEEHHHHHHHHHH-SSSCCCHHHHHHHHHHCCEE-TTEE--------CHHHHHHHHH
T ss_pred             hhhHHHhhhhhcccCCCcccHHHHHHHHHH-ccccCCHHHHHHHHHHhCCC-CCEE--------cHHHHHHHHh
Confidence            467899999999999999999999999999 99999999999999999998 6999        9999987764

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.90  E-value=5.9e-10  Score=84.59  Aligned_cols=65  Identities=20%  Similarity=0.192  Sum_probs=59.8

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      +++++...++++|+.+|.|++|+|+.+|++.+|.+ .|  ++..++.+|++.+|.|++|.|        +|+||+.
T Consensus         3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~-~~--l~~~~l~~i~~~~D~d~dG~l--------~~~EF~~   67 (92)
T d1fi6a_           3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK-SK--LPILELSHIWELSDFDKDGAL--------TLDEFCA   67 (92)
T ss_dssp             CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHH-HS--SCHHHHHHHHHHHCTTCSSEE--------EHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHH-cc--CCHHHHHHHHHHhCCCCCCee--------cHHHHHH
Confidence            56778889999999999999999999999999998 66  578899999999999999999        9999974

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.90  E-value=6.3e-10  Score=91.89  Aligned_cols=65  Identities=23%  Similarity=0.383  Sum_probs=60.4

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++++|+.+|.|++|+|+.+||+.+|.. +|..+++++++.+++.+|.+ ||.|        +|++|+.+++
T Consensus        74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-~g~~lt~~e~~~l~~~~d~~-dG~I--------~y~eF~~~m~  138 (140)
T d1ggwa_          74 DPEEFVKGFQVFDKDATGMIGVGELRYVLTS-LGEKLSNEEMDELLKGVPVK-DGMV--------NYHDFVQMIL  138 (140)
T ss_dssp             CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHH-HHSCSCHHHHHHHHHHTTCS-SCCS--------TTTHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCcchHHHHHHHHHH-cCCCCCHHHHHHHHHhhCCC-CCEE--------eHHHHHHHHh
Confidence            3467899999999999999999999999999 99999999999999999988 9999        9999998764

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.85  E-value=1.2e-09  Score=90.66  Aligned_cols=67  Identities=13%  Similarity=0.167  Sum_probs=62.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ....++.+|+.||.+++|+|+.+|++.+|+. +|..+++++++.+++.+|.|++|.|        +|.+|+.++.+
T Consensus        75 ~~~~l~~aF~~fD~~~~g~I~~~el~~~l~~-~g~~ls~~e~~~~~~~~d~d~dg~I--------~y~eF~~~l~~  141 (145)
T d2mysb_          75 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTT-GGGRFTPEEIKNMWAAFPPDVAGNV--------DYKNICYVITH  141 (145)
T ss_pred             hHHHHHHHHHhhhhcccchhhHHHHHHHHHH-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHhcc
Confidence            3457889999999999999999999999999 9999999999999999999999999        99999988754

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=98.83  E-value=1.1e-09  Score=83.11  Aligned_cols=67  Identities=16%  Similarity=0.243  Sum_probs=56.8

Q ss_pred             HHHHHHHhhccc-CCCCC-CCCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAI-DVDKN-GSISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~-G~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .++.+.++|..+ |.||+ |+|+.+||+.+|+...    ....+++++.++|+.+|.|+||.|        +|+||+.++
T Consensus         7 ~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I--------df~EF~~lm   78 (93)
T d1zfsa1           7 AMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEV--------DFQEFVVLV   78 (93)
T ss_dssp             HHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEE--------CSHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCC--------cHHHHHHHH
Confidence            356888999988 88875 9999999999998722    245678999999999999999999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        79 ~   79 (93)
T d1zfsa1          79 A   79 (93)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=98.82  E-value=8.3e-10  Score=82.33  Aligned_cols=67  Identities=12%  Similarity=0.220  Sum_probs=59.0

Q ss_pred             HHHHHHHhhccc-CCCCCCCC-CHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAI-DVDKNGSI-SLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~G~i-~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+..+..+|..+ |+||+|.+ +.+||+.+|...+|..++.++++++++++|.|+||.|        +|+||+.++.
T Consensus         8 ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~I--------dF~EF~~l~~   76 (87)
T d1xk4a1           8 ALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAV--------NFQEFLILVI   76 (87)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            446788889888 99999975 8999999998658888888999999999999999999        9999998764

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=98.78  E-value=2.6e-10  Score=83.48  Aligned_cols=67  Identities=15%  Similarity=0.242  Sum_probs=55.7

Q ss_pred             HHHHHHHhhcccCC-C-CCCCCCHHHHHHHHHhhC-CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDV-D-KNGSISLEEMRQALAKDL-PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~-d-~~G~i~~~el~~~l~~~~-~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++|+.+|..||. + +.|+|+.+||+.+|+..+ +...+.+++++++..+|.|+||.|        +|.||+.++.
T Consensus         5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~I--------df~EF~~l~~   74 (78)
T d1cb1a_           5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEV--------SFEEFQVLVK   74 (78)
T ss_dssp             CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSE--------EHHHHHHHHH
T ss_pred             hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcC--------cHHHHHHHHH
Confidence            45789999999964 3 458999999999999833 445566789999999999999999        9999987653

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=98.78  E-value=1.2e-09  Score=83.53  Aligned_cols=68  Identities=15%  Similarity=0.206  Sum_probs=56.5

Q ss_pred             HHHHHHHHhhccc-CCCCC-CCCCHHHHHHHHHhhCC-CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAI-DVDKN-GSISLEEMRQALAKDLP-WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~-D~d~~-G~i~~~el~~~l~~~~~-~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..+.++|..| |.||+ |+|+..||+.+|+...+ ...+..++++++..+|.|+||.|        +|.||+.++.
T Consensus        11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~I--------dF~EF~~l~~   81 (98)
T d1yuta1          11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSEL--------KFNEYWRLIG   81 (98)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcC--------CHHHHHHHHH
Confidence            3457888999988 78875 99999999999987333 33456679999999999999999        9999998764

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.78  E-value=2.6e-09  Score=88.69  Aligned_cols=63  Identities=22%  Similarity=0.333  Sum_probs=59.1

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+.++.+|+.+|+|++|+|+.+||+.+|.. +|..+++++++++++.+| |++|+|        +|+||+.++
T Consensus        82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~~~~~~~~~~d-d~dG~I--------~~~eF~~~m  144 (146)
T d1lkja_          82 EQELLEAFKVFDKNGDGLISAAELKHVLTS-IGEKLTDAEVDDMLREVS-DGSGEI--------NIQQFAALL  144 (146)
T ss_dssp             HHHHHHHHHHHCSSSSCEEEHHHHHHHHHH-HTCSCCHHHHHHHHHHHC-CSSSEE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cCCcccHHHHHHHHHhcc-CCCCeE--------eHHHHHHHh
Confidence            467889999999999999999999999999 999999999999999999 999999        899998654

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=98.77  E-value=3.4e-09  Score=87.96  Aligned_cols=66  Identities=26%  Similarity=0.370  Sum_probs=61.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++.+|+.+|.|++|+|+.+|++.++.. +|..+++++++.+++.+|.|+||.|        +|++|+.+++
T Consensus        80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~-~~~~~~~~~~~~i~~~~D~d~dG~i--------~~~eF~~~l~  145 (146)
T d1exra_          80 SEEELIEAFKVFDRDGNGLISAAELRHVMTN-LGEKLTDDEVDEMIREADIDGDGHI--------NYEEFVRMMV  145 (146)
T ss_dssp             HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCSSSSSSB--------CHHHHHHHHH
T ss_pred             hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHH-HhhcCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHhc
Confidence            3467889999999999999999999999999 9999999999999999999999999        9999988654

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.77  E-value=3e-09  Score=89.04  Aligned_cols=66  Identities=26%  Similarity=0.361  Sum_probs=59.4

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCC--CCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP--FLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~--~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...+++++|+.||.+++|+|+.+||+.+|.. +|..+++++++.+++.+|.+  ++|.|        +|++|+..++
T Consensus        80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~-~g~~ls~~e~~~l~~~~d~~~d~~G~I--------~y~eF~~~~~  147 (152)
T d1wdcc_          80 TFADYMEAFKTFDREGQGFISGAELRHVLTA-LGERLSDEDVDEIIKLTDLQEDLEGNV--------KYEDFVKKVM  147 (152)
T ss_dssp             CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHHHHTCCCCTTSEE--------EHHHHHHHHH
T ss_pred             HHHhhhhhhhccccccCccchHHHHHHHHHH-cCCCCCHHHHHHHHHHhccCCCCCCEE--------EHHHHHHHHh
Confidence            3457889999999999999999999999999 99999999999999999865  46899        9999987654

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.77  E-value=1.6e-09  Score=91.06  Aligned_cols=65  Identities=23%  Similarity=0.338  Sum_probs=58.6

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+.++.+|+.+|.|++|+|+.+|++.++.. +|..+++++++.+++.+|.|+||.|        +|+||+.++
T Consensus        89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~-~~~~ls~~e~~~i~~~~D~d~dG~I--------~~~eF~~~l  153 (156)
T d1dtla_          89 SEEELSDLFRMFDKNADGYIDLEELKIMLQA-TGETITEDDIEELMKDGDKNNDGRI--------DYDEFLEFM  153 (156)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTT-C--CCCHHHHHHHHHHHCTTSSSEE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhh-cCCCCCHHHHHHHHHHhCCCCCCeE--------eHHHHHHHH
Confidence            3467899999999999999999999999998 9999999999999999999999999        899998754

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.76  E-value=3.8e-09  Score=87.60  Aligned_cols=65  Identities=22%  Similarity=0.354  Sum_probs=59.2

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....++++|+.+|.|++|+|+.+||+.+|.. +|..+++++++.+++. |.|++|.|        +|+||+..++
T Consensus        79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~e~~~l~~~-~~d~dG~I--------~y~eF~~~ll  143 (145)
T d2mysc_          79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLAT-LGEKMTEEEVEELMKG-QEDSNGCI--------NYEAFVKHIM  143 (145)
T ss_pred             hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHH-hCCCCCHHHHHHHHhh-cCCCCCeE--------EHHHHHHHHh
Confidence            3457889999999999999999999999999 9999999999999985 78999999        9999987654

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.75  E-value=2.4e-09  Score=88.99  Aligned_cols=64  Identities=23%  Similarity=0.364  Sum_probs=60.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +.++++|..+|.+++|+|+.+||+.+|.. +|..++++++..++..+|.|++|.|        +|+||+..++
T Consensus        81 ~~l~~~F~~~D~~~~G~I~~~el~~~l~~-~g~~l~~~ei~~l~~~~D~d~dG~I--------~y~eF~~~i~  144 (146)
T d1m45a_          81 EDFVKAFQVFDKESTGKVSVGDLRYMLTG-LGEKLTDAEVDELLKGVEVDSNGEI--------DYKKFIEDVL  144 (146)
T ss_dssp             HHHHHHHHTTCSSSSSEEEHHHHHHHHHH-STTCCCHHHHHHHHTTCCCCTTSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHhhccccccccchhhhhhhhcc-cCCcchHHHHHHHHHHhCCCCCCcE--------EHHHHHHHHH
Confidence            46888999999999999999999999999 9999999999999999999999999        9999987654

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.72  E-value=4.6e-09  Score=79.87  Aligned_cols=64  Identities=16%  Similarity=0.222  Sum_probs=58.3

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      ++.++...++++|..+| +++|+|+.+|++.+|.+ .|  ++.+++..|+..+|.|++|.|        +|+||+.
T Consensus         4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~-~g--l~~~~L~~Iw~~~D~~~dG~l--------~~~EF~~   67 (95)
T d2jxca1           4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLN-SK--LPVDILGRVWELSDIDHDGML--------DRDEFAV   67 (95)
T ss_dssp             SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTT-SS--CCHHHHHHHHHHHCTTCSSEE--------EHHHHHH
T ss_pred             CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHH-cC--CCHHHHHHHHHHhcCCCCCeE--------cHHHHHH
Confidence            56778889999999999 89999999999999998 77  567899999999999999999        8999964

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=98.71  E-value=4.2e-09  Score=79.39  Aligned_cols=67  Identities=13%  Similarity=0.149  Sum_probs=57.1

Q ss_pred             HHHHHHHhhccc-CCCCCC-CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAI-DVDKNG-SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~G-~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+..+..+|..+ |+||+| +|+.+||+.+|+..    ++...+..++.++++.+|.|+||.|        +|+||+.++
T Consensus         7 ~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~I--------dF~EF~~l~   78 (93)
T d1ksoa_           7 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEV--------DFVEYVRSL   78 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEE--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCC--------cHHHHHHHH
Confidence            456788899987 999999 59999999999863    2345678899999999999999999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        79 ~   79 (93)
T d1ksoa_          79 A   79 (93)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=98.70  E-value=1.8e-09  Score=81.49  Aligned_cols=66  Identities=15%  Similarity=0.219  Sum_probs=55.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+.+..+|..+|.| +|+|+.+||+.+|....    +...+...++++|+.+|.|+||.|        +|+||+.++.
T Consensus         7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I--------~F~EF~~li~   76 (92)
T d1a4pa_           7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKV--------GFQSFFSLIA   76 (92)
T ss_dssp             HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCC--------cHHHHHHHHH
Confidence            457899999999987 89999999999998622    223356789999999999999999        9999987653

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=98.70  E-value=7.3e-09  Score=78.24  Aligned_cols=67  Identities=12%  Similarity=0.227  Sum_probs=56.3

Q ss_pred             HHHHHHHhhccc-CCCCCC-CCCHHHHHHHHHhh----CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAI-DVDKNG-SISLEEMRQALAKD----LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~G-~i~~~el~~~l~~~----~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+.+.++|..| |.|++| +|+.+||+++|+..    ++...+++++.++|+.+|.|+||.|        +|+||+.++
T Consensus         7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I--------~F~EF~~lm   78 (93)
T d3c1va1           7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEV--------DFQEYCVFL   78 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCC--------CHHHHHHHH
Confidence            456788999998 777765 69999999999862    2456788999999999999999999        999998865


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        79 ~   79 (93)
T d3c1va1          79 S   79 (93)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.69  E-value=1.1e-08  Score=86.35  Aligned_cols=64  Identities=19%  Similarity=0.297  Sum_probs=59.5

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|+.+|.|++|+|+.+|++.+|.. .|...+.+++..+|+.+|.|+||.|        +|+||+.++
T Consensus        95 ~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~-~~~~~~~~~~~~l~~~~D~d~dG~I--------s~~EF~~~l  158 (162)
T d1topa_          95 EEELANCFRIFDKNADGFIDIEELGEILRA-TGEHVTEEDIEDLMKDSDKNNDGRI--------DFDEFLKMM  158 (162)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHT-TTCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-hCCCCCHHHHHHHHHHhCCCCCCcE--------EHHHHHHHH
Confidence            356788999999999999999999999999 8999999999999999999999999        899998764

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.68  E-value=1.1e-08  Score=84.10  Aligned_cols=64  Identities=17%  Similarity=0.270  Sum_probs=60.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ....++.+|..+|.+++|.|+..+|+.++.. +|..++++++..+|+.+|.|+||.|        +|+||+.+
T Consensus        77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~-~g~~l~~~e~~~l~~~~D~d~dG~i--------~~~EF~~~  140 (141)
T d2obha1          77 TKEEILKAFKLFDDDETGKISFKNLKRVAKE-LGENLTDEELQEMIDEADRDGDGEV--------SEQEFLRI  140 (141)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSSB--------CHHHHHHH
T ss_pred             cHHHHHHHHHHhcccCCCCccHHHHHHHHHH-hCCCCCHHHHHHHHHHHCCCCCCCE--------eHHHHHHh
Confidence            3467899999999999999999999999999 9999999999999999999999999        99999875

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=6.5e-09  Score=85.41  Aligned_cols=64  Identities=23%  Similarity=0.332  Sum_probs=56.8

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...+++++|+.+|.+++|+|+.+||+.+|.. +|..+++++++.++.. |.|++|.|        +|.+|+.++
T Consensus        75 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~-~g~~~~~~e~~~l~~~-~~d~dg~I--------~~~eF~~~l  138 (139)
T d1w7jb1          75 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTT-LGEKMTEEEVETVLAG-HEDSNGCI--------NYEAFLKHI  138 (139)
T ss_dssp             ---CCHHHHHTTCTTSSSEEEHHHHHHHHHH-SSSCCCHHHHHHHHTT-CCCTTSEE--------EHHHHHHHT
T ss_pred             HHHHHHHhhhhccCCCCCeEeHHHHHHHHHH-hCCCCCHHHHHHHHhh-CCCCCCeE--------eHHHHHHHh
Confidence            3456888999999999999999999999999 9999999999999975 88999999        999998754

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=98.64  E-value=1.8e-08  Score=87.19  Aligned_cols=67  Identities=16%  Similarity=0.106  Sum_probs=61.2

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .....++.+|..+|.|++|+|+.+||+.+|+. +|..+++++++.+|+.+|.|+||.|        +|+||+.+..
T Consensus       102 ~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~-~g~~~~~~~~~~lf~~~D~d~dG~I--------s~~EF~~~~~  168 (187)
T d1uhka1         102 LIRIWGDALFDIVDKDQNGAITLDEWKAYTKA-AGIIQSSEDCEETFRVCDIDESGQL--------DVDEMTRQHL  168 (187)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HTSCCSHHHHHHHHHHSCCCTTSCE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHccCCCcccchHHHHHHHHH-hCCCccHHHHHHHHHHhCCCCCCCE--------eHHHHHHHHH
Confidence            34456889999999999999999999999999 9999999999999999999999999        8999987553

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=98.62  E-value=2.1e-08  Score=86.94  Aligned_cols=65  Identities=14%  Similarity=0.061  Sum_probs=56.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...+..+|..+|.|++|+|+.+|++.++.. +|..++++++..+|+.+|.|+||.|        +|+||+.++.
T Consensus       106 ~~~~~~~F~~~D~d~~G~is~~E~~~~l~~-~g~~~~~~~~~~lf~~~D~d~dG~I--------s~~EF~~~~~  170 (189)
T d1qv0a_         106 REWGDAVFDIFDKDGSGTITLDEWKAYGKI-SGISPSQEDCEATFRHCDLDNAGDL--------DVDEMTRQHL  170 (189)
T ss_dssp             HHHHHHHHHHTC----CEECHHHHHHHHHH-HSSCCCHHHHHHHHHHSCCCTTSCE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCCCcccchhhHHHHHh-cCCCCCHHHHHHHHHHhCCCCCCcE--------eHHHHHHHHH
Confidence            456778999999999999999999999999 9999999999999999999999999        9999987654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=1.3e-07  Score=86.13  Aligned_cols=85  Identities=18%  Similarity=0.142  Sum_probs=63.0

Q ss_pred             CeeEeeeeeecCceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEEEEE
Q 011380           97 RYTIGKLLGHGQFGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVYIAM  176 (487)
Q Consensus        97 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~  176 (487)
                      .|+..+..+.++.+.||++.  ..++.+++|+.......   ....+.+|..+++.|..+--+++++.+..+++..|+||
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            46666665555567899885  46777889987654321   22346789999988876656788888888999999999


Q ss_pred             eccCCCCHHH
Q 011380          177 ELCEGGELLD  186 (487)
Q Consensus       177 e~~~gg~L~~  186 (487)
                      ++++|.++.+
T Consensus        90 ~~l~G~~~~~   99 (263)
T d1j7la_          90 SEADGVLCSE   99 (263)
T ss_dssp             ECCSSEEHHH
T ss_pred             Eecccccccc
Confidence            9999887654

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=98.60  E-value=6.7e-09  Score=77.51  Aligned_cols=67  Identities=13%  Similarity=0.246  Sum_probs=57.7

Q ss_pred             HHHHHHHhhccc-CCCCCC-CCCHHHHHHHHHhh--CCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAI-DVDKNG-SISLEEMRQALAKD--LPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~G-~i~~~el~~~l~~~--~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....+.++|..+ |+||+| +|+..||+.+++..  .+...++++++++++.+|.|+||.|        +|.||+.++.
T Consensus         7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~I--------dF~EF~~l~~   77 (89)
T d1k8ua_           7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEV--------NFQEYVTFLG   77 (89)
T ss_dssp             HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCC--------cHHHHHHHHH
Confidence            456788899888 999999 59999999999863  3556677889999999999999999        9999998654

>d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]

Probab=98.60  E-value=1.6e-08  Score=83.72  Aligned_cols=71  Identities=21%  Similarity=0.416  Sum_probs=65.8

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++..+++++|..+|.|++|.|+.+|++.++.. .|..+++..+..++..+|.+++|.|        +|++|+....
T Consensus         2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~~   72 (146)
T d1exra_           2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRS-LGQNPTEAELQDMINEVDADGNGTI--------DFPEFLSLMA   72 (146)
T ss_dssp             CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHH-HTCCCCHHHHHHHHHHHCTTCSSSE--------EHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHh-cCCCCCHHHHHHHHHhcCCCCCCcc--------cHHHHHHHHH
Confidence            357788899999999999999999999999999999 8999999999999999999999999        8999987654

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=98.58  E-value=1.2e-08  Score=59.49  Aligned_cols=31  Identities=35%  Similarity=0.641  Sum_probs=28.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCC
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLP  435 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~  435 (487)
                      ++++++|+.||+|++|+|+.+||+.+|+. +|
T Consensus         3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~-lG   33 (33)
T d2hf5a1           3 EEIREAFRVFDKDGNGYISAAELRHVMTN-LG   33 (33)
T ss_dssp             HHHHHHHHHHSSSCCSCBCHHHHHHHTTS-CC
T ss_pred             HHHHHHHHHhCCCCCCcCcHHHHHHHHHH-cC
Confidence            47899999999999999999999999988 76

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=98.56  E-value=7.6e-09  Score=79.45  Aligned_cols=68  Identities=13%  Similarity=0.208  Sum_probs=54.6

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC------cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW------KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~------~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+..+.++|..+| +++|.|+.+||+.+|+..++.      ..+..+++++|+.+|.|+||.|        +|+||+.+
T Consensus         7 ~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I--------~F~EF~~l   77 (100)
T d1psra_           7 RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKI--------DFSEFLSL   77 (100)
T ss_dssp             HHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCB--------CHHHHHHH
T ss_pred             HHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcC--------cHHHHHHH
Confidence            34567788888887 789999999999999983221      2234568999999999999999        99999987


Q ss_pred             ccc
Q 011380          475 PVD  477 (487)
Q Consensus       475 ~~~  477 (487)
                      +..
T Consensus        78 i~~   80 (100)
T d1psra_          78 LGD   80 (100)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=4.9e-09  Score=81.97  Aligned_cols=66  Identities=15%  Similarity=0.144  Sum_probs=58.7

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++.++...++++|..+|+|++|+|+.+|++.+|.+ .|  ++.+++.+|++.+|.|++|.|        +|+||+.+
T Consensus        16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~-s~--L~~~~L~~Iw~l~D~d~dG~l--------~~~EF~~a   81 (110)
T d1iq3a_          16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK-SK--LSIPELSYIWELSDADCDGAL--------TLPEFCAA   81 (110)
T ss_dssp             CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCS-SS--CSSCCHHHHHHHHCSSSCSEE--------EHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHh-hc--cchHHHHHHHHHhccCCCCeE--------CHHHHHHH
Confidence            45667788999999999999999999999999987 66  566789999999999999999        99999753

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.53  E-value=1.1e-08  Score=78.68  Aligned_cols=61  Identities=15%  Similarity=0.133  Sum_probs=50.5

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCC----------------cccHHHHHHHHHhcCCCCCceeecCccccccch
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPW----------------KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~----------------~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      ++.+|..+|.|++|+|+.+||..+|+. ++.                ......+..+|+.+|.|+||.|        +|+
T Consensus        18 ~r~~F~~~D~DgdG~i~~~El~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~I--------s~~   88 (99)
T d1snla_          18 PKTFFILHDINSDGVLDEQELEALFTK-ELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLV--------TLE   88 (99)
T ss_dssp             HHHHHHHHCSSCCSEEEHHHHHHHHHH-HHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEE--------EHH
T ss_pred             HHHHHHHHCCCCCCcCCHHHHHHHHHH-HHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcC--------cHH
Confidence            678999999999999999999999975 221                1123457889999999999999        999


Q ss_pred             hhhccc
Q 011380          470 YLLLFP  475 (487)
Q Consensus       470 ~f~~~~  475 (487)
                      ||+..+
T Consensus        89 EF~~~~   94 (99)
T d1snla_          89 EFLAST   94 (99)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998764

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=98.52  E-value=1.7e-08  Score=86.97  Aligned_cols=72  Identities=25%  Similarity=0.520  Sum_probs=65.9

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++++.+|+++|+.+|.|++|+|+.+||+.+|+. ++..++..+++.++..+|.+++|.|        +|++|+...
T Consensus         2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~-l~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~   72 (182)
T d1s6ia_           2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKR-VGSELMESEIKDLMDAADIDKSGTI--------DYGEFIAAT   72 (182)
T ss_dssp             CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTT-TTCCCCHHHHHHHHHHTCTTCSSEE--------CHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHH-cCCccccccchhhhhhhhccccccc--------hHHHHHHHH
Confidence            4566777889999999999999999999999999999 9999999999999999999999999        899998754


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        73 ~   73 (182)
T d1s6ia_          73 V   73 (182)
T ss_dssp             T
T ss_pred             H
Confidence            3

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=98.50  E-value=8e-08  Score=71.00  Aligned_cols=67  Identities=18%  Similarity=0.197  Sum_probs=54.8

Q ss_pred             HHHHHHHhhccc-CCCCCC-CCCHHHHHHHHHhhCC----CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAI-DVDKNG-SISLEEMRQALAKDLP----WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~-D~d~~G-~i~~~el~~~l~~~~~----~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+..+..+|..+ +.++++ +|+.+||+.+|++.++    ...+.+.++++|+.+|.|+||.|        +|.||+.++
T Consensus         6 ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~i--------dF~EF~~li   77 (87)
T d1e8aa_           6 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQV--------DFQEFISLV   77 (87)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcC--------CHHHHHHHH
Confidence            456788899988 667665 5999999999987333    34467889999999999999999        999998865


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        78 ~   78 (87)
T d1e8aa_          78 A   78 (87)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=6.5e-08  Score=81.60  Aligned_cols=63  Identities=22%  Similarity=0.393  Sum_probs=56.9

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|+.||+|++|+|+.+||+.+|+. +|..++.++++.+++.+|.  +|.|        +|++|+..++
T Consensus        69 ~~~~~~~F~~fD~d~sG~I~~~El~~~l~~-~G~~l~~~~~~~l~~~~d~--~g~i--------~~~eFi~~~~  131 (165)
T d1k94a_          69 LNAWKENFMTVDQDGSGTVEHHELRQAIGL-MGYRLSPQTLTTIVKRYSK--NGRI--------FFDDYVACCV  131 (165)
T ss_dssp             HHHHHHHHHHHCTTCCSBCCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCB--TTBC--------BHHHHHHHHH
T ss_pred             cchhHHHHHHhCCCCCCeEcHHHHHHHHHH-hhhcCCHHHHHHHHHHcCC--CCcC--------cHHHHHHHHH
Confidence            356788999999999999999999999999 9999999999999999975  6899        8999987554

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=98.47  E-value=4e-08  Score=79.78  Aligned_cols=61  Identities=21%  Similarity=0.244  Sum_probs=56.6

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+|..+|.|++|.|+.+||+.++.. ++...+++++..++..+|.+++|.|        +|+||+.+..
T Consensus         3 e~~F~~~D~d~dG~is~~E~~~~l~~-~~~~~~~~~~~~~~~~~D~~~~g~i--------~~~Ef~~~~~   63 (134)
T d1jfja_           3 EALFKEIDVNGDGAVSYEEVKAFVSK-KRAIKNEQLLQLIFKSIDADGNGEI--------DQNEFAKFYG   63 (134)
T ss_dssp             HHHHHHHCTTCSSEEEHHHHHHHHHT-TCCSSHHHHHHHHHHHHCSSCCSEE--------EHHHHHHHTT
T ss_pred             HHHHHHHcCCCcCCCcHHHHHHHHHH-cCCCCCHHHHHHHHHHhhhcccccc--------cccccccccc
Confidence            46899999999999999999999999 9999999999999999999999999        8999987553

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.45  E-value=6.4e-08  Score=73.95  Aligned_cols=59  Identities=12%  Similarity=0.125  Sum_probs=53.4

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+++|+.+|.|++|+|+.+|++.+|+. .|  ++..++..|+..+|.|++|.|        +|+||+..
T Consensus        12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~-s~--L~~~~L~~i~~~~D~d~dG~L--------~~~EF~~a   70 (99)
T d1qjta_          12 VYEKYYRQVEAGNTGRVLALDAAAFLKK-SG--LPDLILGKIWDLADTDGKGVL--------SKQEFFVA   70 (99)
T ss_dssp             HHHHHHHHHCCTTSSCCCSHHHHHHHHT-SS--SCHHHHHHHHHHHCCSSSSSC--------CSHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcccHHHHHHHHHH-cC--CcHHHHHHHHHHHcCCCCCcc--------CHHHHHHH
Confidence            4557899999999999999999999998 76  578999999999999999999        89999753

>d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=5.7e-08  Score=79.67  Aligned_cols=68  Identities=22%  Similarity=0.472  Sum_probs=63.3

Q ss_pred             hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          400 DEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       400 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++..+++++|..+|.|++|.|+.+||+.+++. .|..++..++..++..+|.+++|.|        +|.+|+....
T Consensus         2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~~   69 (141)
T d2obha1           2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRA-LGFEPKKEEIKKMISEIDKEGTGKM--------NFGDFLTVMT   69 (141)
T ss_dssp             HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHHHTTTCCSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHh-cCCchhHHHHHHHHHhhccCCCCee--------chHHHHHHHH
Confidence            567789999999999999999999999999999 9999999999999999999999999        8999987653

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.44  E-value=3.9e-08  Score=81.22  Aligned_cols=65  Identities=14%  Similarity=0.165  Sum_probs=58.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCC--CCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP--FLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~--~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .++++++|..||.|++|.|+.+||+.+|+. +|..++..++..++..++.+  ++|.|        +|++|+.+..
T Consensus         3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~-lg~~~~~~e~~~~~~~~~~d~~~~g~i--------~~~eF~~~~~   69 (145)
T d2mysc_           3 ADDFKEAFLLFDRTGDAKITASQVGDIARA-LGQNPTNAEINKILGNPSKEEMNAAAI--------TFEEFLPMLQ   69 (145)
T ss_pred             HHHHHHHHHHHcCCCCCeECHHHHHHHHHH-hhhcchhhhhHHHHHHHhhcccccCcc--------chhHHHHHHh
Confidence            467899999999999999999999999999 99999999999999988766  58899        8999987654

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.44  E-value=7.3e-08  Score=79.28  Aligned_cols=67  Identities=22%  Similarity=0.455  Sum_probs=59.5

Q ss_pred             CChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          398 LDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ++++++++++++|..+|.|++|.|+.+||+.+|+. +|..+++.++..++.    +++|.|        +|.+|+.+...
T Consensus         1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~-lg~~~~~~el~~~~~----~~~~~i--------~~~eF~~~~~~   67 (142)
T d1wdcb_           1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQ-LGRAPDDKELTAMLK----EAPGPL--------NFTMFLSIFSD   67 (142)
T ss_dssp             CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHH-HSSCCCHHHHHHHHT----TSSSCC--------CHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHH-hhcCCCHHHHHHHHH----hccCcc--------ccccccccccc
Confidence            35788999999999999999999999999999999 999999999998885    567899        89999886643

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=98.44  E-value=8e-08  Score=81.78  Aligned_cols=64  Identities=20%  Similarity=0.218  Sum_probs=58.0

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...++.+|..+|.|++|+|+.+|++.+++. +|  +++++++.+|..+|.|+||.|        +++||+.+..+
T Consensus       101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~-~~--~~~~~~~~~f~~~D~d~dG~i--------~~~Ef~~~~~~  164 (176)
T d1nyaa_         101 GPVVKGIVGMCDKNADGQINADEFAAWLTA-LG--MSKAEAAEAFNQVDTNGNGEL--------SLDELLTAVRD  164 (176)
T ss_dssp             HHHHHHHHHHTCSSCCSEEEHHHHHHHHHH-TT--CCHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHSC
T ss_pred             HHHHHHHHHHHccCCChhhhHHHHHHHHHh-cC--CcHHHHHHHHHHHCCCCCCcE--------eHHHHHHHHHH
Confidence            356788999999999999999999999998 77  578999999999999999999        99999987665

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=98.43  E-value=1e-07  Score=81.95  Aligned_cols=64  Identities=17%  Similarity=0.339  Sum_probs=59.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++++|..+|.+++|.|+.+||+.+|.. +|..+++++++.+++.+|.|++|.|        +|+||+.+.+
T Consensus        84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~-~g~~ls~~e~~~i~~~~d~~~dg~I--------~~~eF~~~~~  147 (182)
T d1y1xa_          84 LSMREGFRKRDSSGDGRLDSNEVRAALLS-SGYQVSEQTFQALMRKFDRQRRGSL--------GFDDYVELSI  147 (182)
T ss_dssp             HHHHHHHHHHCTTSSSCBCHHHHHHHHHT-TSCCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             cccccchhccccccchhhhhHHHHHHHHH-hCCchhHHHHHHHHhhcccCCCCCc--------CHHHHHHHHH
Confidence            45778899999999999999999999999 9999999999999999999999999        8999987653

>d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.42  E-value=6.6e-08  Score=81.44  Aligned_cols=72  Identities=25%  Similarity=0.398  Sum_probs=65.8

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++.+++.+++++|..+|+|++|+|+.+||+.+|.. ++..+++.++..++..+|.+++|.+        +|.+|+...
T Consensus        12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~-~~~~~~~~~~~~~~~~~d~~~~~~~--------~~~e~~~~~   82 (162)
T d1topa_          12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRM-LGQNPTKEELDAIIEEVDEDGSGTI--------DFEEFLVMM   82 (162)
T ss_dssp             HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHHHCTTSCCEE--------EHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhc-cCCchhHHHHHhhhheeccCCCCCe--------eeehhhhhh
Confidence            3457788899999999999999999999999999999 9999999999999999999999999        888887755


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        83 ~   83 (162)
T d1topa_          83 V   83 (162)
T ss_dssp             H
T ss_pred             h
Confidence            4

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=98.38  E-value=2e-07  Score=80.39  Aligned_cols=64  Identities=25%  Similarity=0.253  Sum_probs=55.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|+.+|+|++|.|+..||+.+|.. +|..++.+.++.++.. |.|++|.|        +|++|+..++
T Consensus        92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~-~g~~~~~~~~~~l~~~-~~~~dg~i--------~f~eFi~~~~  155 (188)
T d1qxpa2          92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEA-AGFKLPCQLHQVIVAR-FADDELII--------DFDNFVRCLV  155 (188)
T ss_dssp             HHHHHHHHGGGCTTCCSCCBHHHHHHHHHH-TTEECCHHHHHHHHHH-TSCSSSBC--------CHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCEECHHHHHHHHHH-hhhcCCHHHHHHHHHH-hcCCCCcC--------CHHHHHHHHH
Confidence            356788999999999999999999999999 9999988766666665 67999999        9999988654

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=98.36  E-value=6.2e-08  Score=80.73  Aligned_cols=69  Identities=17%  Similarity=0.246  Sum_probs=60.4

Q ss_pred             CChHHHHHHHHhhcccCC--CCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          398 LDDEELADLRDQFDAIDV--DKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D~--d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++++++++++|..||.  |++|.|+.+||+.+|+. +|..++++++..++ ..|.+++|.|        +|++|+.+.
T Consensus         1 Ls~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~-lG~~~t~~e~~~~~-~~~~~~~~~i--------~~~eFl~~~   70 (152)
T d1wdcc_           1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRC-LGINPRNEDVFAVG-GTHKMGEKSL--------PFEEFLPAY   70 (152)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHH-TTCCCCHHHHHHTT-CCSSTTSCEE--------CHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHH-hccCccHhhhhhhh-hhhccccccc--------ccccccccc
Confidence            356788999999999994  89999999999999999 99999999998764 5688899999        999998765


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        71 ~   71 (152)
T d1wdcc_          71 E   71 (152)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Programmed cell death 6 protein-like protein
species: Leishmania major [TaxId: 5664]

Probab=98.35  E-value=7.6e-08  Score=82.78  Aligned_cols=63  Identities=22%  Similarity=0.319  Sum_probs=58.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++++|..+|.|++|+|+.+||+.+|+. +|..+++.++..++..+|.|++|.|        +|++|+...
T Consensus        18 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~-l~~~~s~~~~~~l~~~~d~d~~~~i--------~~~ef~~~~   80 (182)
T d1y1xa_          18 QELMEWFRAVDTDGSGAISVPELNAALSS-AGVPFSLATTEKLLHMYDKNHSGEI--------TFDEFKDLH   80 (182)
T ss_dssp             SCHHHHHHHHCTTCSSSBCHHHHHHHHCB-TTBCCCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCcCCCCHHHHHHHHHH-hcccCchhhhhhhhccccccccccc--------ccccccccc
Confidence            47899999999999999999999999999 9999999999999999999999999        888887643

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.34  E-value=1.7e-07  Score=80.32  Aligned_cols=81  Identities=22%  Similarity=0.163  Sum_probs=63.6

Q ss_pred             HHHHHHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC-----------CCcccHHHHHHHHHhcCCCCCce
Q 011380          389 FALRALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL-----------PWKLKESRVLEILQAVNTPFLGL  457 (487)
Q Consensus       389 ~~l~~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~-----------~~~~~~~e~~~~~~~~d~~~~g~  457 (487)
                      .|+..+.........+.++.+|..+|.|++|+|+.+|+..++....           +....++.++.+|+++|.|+||.
T Consensus        80 eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~  159 (181)
T d1bjfa_          80 EFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGK  159 (181)
T ss_dssp             HHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSE
T ss_pred             HHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCc
Confidence            3445554444444556788999999999999999999999887521           22456678999999999999999


Q ss_pred             eecCccccccchhhhccccc
Q 011380          458 FLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       458 i~~~~~~~~~f~~f~~~~~~  477 (487)
                      |        +|+||......
T Consensus       160 I--------s~~EF~~~~~~  171 (181)
T d1bjfa_         160 L--------SLEEFIRGAKS  171 (181)
T ss_dssp             E--------CHHHHHHHHHH
T ss_pred             E--------eHHHHHHHHHh
Confidence            9        99999987653

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=1.3e-07  Score=81.10  Aligned_cols=80  Identities=16%  Similarity=0.120  Sum_probs=58.5

Q ss_pred             HHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC----CCcccHHH----HHHHHHhcCCCCCceee
Q 011380          389 FALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDL----PWKLKESR----VLEILQAVNTPFLGLFL  459 (487)
Q Consensus       389 ~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~----~~~~~~~e----~~~~~~~~d~~~~g~i~  459 (487)
                      .|+..++... .....+.++.+|+.+|.|++|+|+.+|+..+++..+    +..+++++    ++.+++.+|.|+||.| 
T Consensus        79 EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~I-  157 (180)
T d1xo5a_          79 DFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTI-  157 (180)
T ss_dssp             HHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSB-
T ss_pred             HHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcC-
Confidence            3444444333 223345788899999999999999999999988732    23344433    5668999999999999 


Q ss_pred             cCccccccchhhhcccc
Q 011380          460 PCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       460 ~~~~~~~~f~~f~~~~~  476 (487)
                             +|+||..++.
T Consensus       158 -------s~~EF~~~~~  167 (180)
T d1xo5a_         158 -------NLSEFQHVIS  167 (180)
T ss_dssp             -------CHHHHHHHHH
T ss_pred             -------cHHHHHHHHH
Confidence                   8999988665

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=98.31  E-value=2.4e-07  Score=78.81  Aligned_cols=64  Identities=20%  Similarity=0.242  Sum_probs=56.8

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      ...+..+|..+|.|++|+|+.+|++.+++. +|.  +.+++..+|+.+|.|+||.|        +|+||+.+..+
T Consensus        93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~-~~~--~~~~~~~~f~~~D~d~dG~I--------s~~Ef~~~~~~  156 (174)
T d2scpa_          93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGM-LGL--DKTMAPASFDAIDTNNDGLL--------SLEEFVIAGSD  156 (174)
T ss_dssp             HTHHHHHHHHHCTTCSSSEEHHHHHHHHHH-TTC--CGGGHHHHHHHHCTTCSSEE--------CHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCccccCCHHHHHHHHHH-Hhh--hhHHHHHHHhhcCCCCCCcE--------eHHHHHHHHHH
Confidence            456788999999999999999999999998 774  56789999999999999999        99999887654

>d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.31  E-value=1.9e-07  Score=77.07  Aligned_cols=72  Identities=26%  Similarity=0.415  Sum_probs=65.7

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++++++.+++++|+.+|.|++|+|+.+||+.++.. .|..+++.++..++...+.++++.+        +|++|+...
T Consensus         2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~-~g~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~   72 (146)
T d1lkja_           2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRS-LGLSPSEAEVNDLMNEIDVDGNHQI--------EFSEFLALM   72 (146)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHCSSSCCEE--------EHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHh-cCCCCCHHHHHHHHHHhccCCcccc--------cHHHHHHHH
Confidence            4567889999999999999999999999999999999 8999999999999999999999999        888887755


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus        73 ~   73 (146)
T d1lkja_          73 S   73 (146)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.26  E-value=2.2e-07  Score=79.73  Aligned_cols=66  Identities=24%  Similarity=0.293  Sum_probs=58.8

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +.++|.++|..+|.|++|+|+.+||+.+|+. ++. ..+.+++..+++.+|.|++|.|        +|+||+.+..
T Consensus        17 ~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~-~~~~~~~~~~~~~l~~~~D~d~~g~i--------~~~EFl~~~~   83 (181)
T d1hqva_          17 DQSFLWNVFQRVDKDRSGVISDNELQQALSN-GTWTPFNPVTVRSIISMFDRENKAGV--------NFSEFTGVWK   83 (181)
T ss_dssp             CHHHHHHHHHHHCTTCCSSBCHHHHHHHCCC-SSSSCCCHHHHHHHHHHHCCSSSSSB--------CHHHHHHHHH
T ss_pred             cHHHHHHHHHHHcCCCCCcCcHHHHHHHHHH-cCCCcccHHHHHHHhhccccccccch--------hhhHHHhhhh
Confidence            3467999999999999999999999999998 664 4788999999999999999999        9999987654

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.26  E-value=1.7e-07  Score=80.83  Aligned_cols=66  Identities=21%  Similarity=0.172  Sum_probs=54.0

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CC--------CcccHHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LP--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      .+.++.+|+.+|.|++|+|+.+|+..+++..   .+        ....++.++.+|+++|.|+||.|        +|+||
T Consensus        95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~I--------s~~EF  166 (187)
T d1g8ia_          95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKL--------TLQEF  166 (187)
T ss_dssp             HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEE--------EHHHH
T ss_pred             hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcE--------eHHHH
Confidence            4578889999999999999999999888641   11        22335678999999999999999        89999


Q ss_pred             hcccc
Q 011380          472 LLFPV  476 (487)
Q Consensus       472 ~~~~~  476 (487)
                      .....
T Consensus       167 ~~~~~  171 (187)
T d1g8ia_         167 QEGSK  171 (187)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88665

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=98.23  E-value=1.7e-07  Score=80.51  Aligned_cols=64  Identities=16%  Similarity=0.172  Sum_probs=56.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ....+..+|+.+|.|++|+|+.+|++.+|+. +|  ++.++++.+|..+|.|++|.|        +|+||..+..
T Consensus       103 ~~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~-~~--l~~~~~~~~f~~~D~d~dG~i--------~~~EF~~~~~  166 (185)
T d2sasa_         103 CQNRIPFLFKGMDVSGDGIVDLEEFQNYCKN-FQ--LQCADVPAVYNVITDGGKVTF--------DLNRYKELYY  166 (185)
T ss_dssp             HHHHHHHHHHHHCTTSSSCCCHHHHHHHTTS-SC--CCCSSHHHHHHHHHTTTTSCC--------SHHHHHHHHH
T ss_pred             HHHHHHHHHHHHccCCCccCCHHHHHHHHHH-cC--CCHHHHHHHHHHcCCCCCCCC--------cHHHHHHHHH
Confidence            3456888999999999999999999999988 77  467889999999999999999        8888876543

>d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: EHCABP
species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]

Probab=98.21  E-value=4.9e-07  Score=73.04  Aligned_cols=61  Identities=21%  Similarity=0.305  Sum_probs=53.4

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ....++.+|+.+|.+++|+|+.+|++.++.. ++.    +++.++|..+|.|+||.|        +|+||+.++
T Consensus        73 ~~~~~~~~F~~~D~~~~g~i~~~el~~~~~~-~~~----~~~~~~~~~~D~d~dG~i--------s~~EF~~~~  133 (134)
T d1jfja_          73 DKIGLKVLYKLMDVDGDGKLTKEEVTSFFKK-HGI----EKVAEQVMKADANGDGYI--------TLEEFLEFS  133 (134)
T ss_dssp             HHHHHHHHHHHHCCSSSSEEEHHHHHHHHTT-TTC----HHHHHHHHHHHCSSSSEE--------EHHHHHHHH
T ss_pred             ccccccccccccccccCCcccHHHHHHHHHh-cCc----HHHHHHHHHHCCCCCCCC--------CHHHHHHHh
Confidence            3456788999999999999999999999988 664    578889999999999999        899998764

>d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.21  E-value=8.2e-07  Score=73.94  Aligned_cols=70  Identities=21%  Similarity=0.373  Sum_probs=63.4

Q ss_pred             ccCChHHHHHHHHhhcccCCCC-CCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          396 STLDDEELADLRDQFDAIDVDK-NGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~-~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ..+++++.++++++|..||.|+ +|.|+.+|++.+|+. +|..++..++..++..++.+++|.+        .+.+|...
T Consensus         6 ~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~-lg~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~   76 (156)
T d1dtla_           6 EQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRM-LGQNPTPEELQEMIDEVDEDGSGTV--------DFDEFLVM   76 (156)
T ss_dssp             GGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHH-TTCCCCHHHHHHHHHHHCTTSSSSB--------CHHHHHHH
T ss_pred             HHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHH-cCCCCCHHHHHHHHHHhhccCCCcc--------chhhhhhh
Confidence            4668888999999999999995 899999999999999 9999999999999999999999999        77777653

>d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=98.21  E-value=1.1e-07  Score=81.64  Aligned_cols=63  Identities=19%  Similarity=0.348  Sum_probs=56.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      +.++.+|..+|.+++|+|+.++|+.+++. +|  ++++++..+|+.+|.|+||.|        +|+||+.++..
T Consensus        82 e~l~~aF~~~D~d~~G~i~~~el~~~l~~-~g--l~~~ev~~~f~~~D~d~DG~I--------s~~EF~~~m~~  144 (182)
T d1s6ia_          82 ENLVSAFSYFDKDGSGYITLDEIQQACKD-FG--LDDIHIDDMIKEIDQDNDGQI--------DYGEFAAMMRK  144 (182)
T ss_dssp             CSTHHHHHHTTTTCSSEEEHHHHHHTTTT-TT--CCTTHHHHHHHHHCSSSSSEE--------ETTHHHHTTSC
T ss_pred             HHHHHHHHHHhhcCCCccchhhhhhhhhh-cC--ccHHHHHHHHHHhhcCCCCeE--------eHHHHHHHHHh
Confidence            35678999999999999999999999998 77  678999999999999999999        89999887764

>d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.20  E-value=6.1e-07  Score=73.79  Aligned_cols=67  Identities=22%  Similarity=0.401  Sum_probs=55.6

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      +++++.+++++|..+|.+++|.|+.+||+.+|+. +|...+..++   +..++.+.+|.|        +|.+|+.....
T Consensus         2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~-lg~~~~~~~~---~~~~~~~~~g~i--------~~~eF~~~~~~   68 (145)
T d2mysb_           2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAA-MGRLNVKNEE---LDAMIKEASGPI--------NFTVFLTMFGE   68 (145)
T ss_pred             CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-hCCCcchHHH---HHHHHHhccCce--------eechhhhhhhh
Confidence            5678899999999999999999999999999999 9976655433   444556788999        89999986654

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=98.20  E-value=2.7e-07  Score=79.54  Aligned_cols=64  Identities=23%  Similarity=0.320  Sum_probs=55.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...++.+|+.+|+|++|+|+.+||+.+|+. +|..++.+. .+++...|.|++|.|        +|++|+.+++
T Consensus        90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~-~g~~~~~~~-~~~~~~~d~d~dg~I--------~f~eFi~~~~  153 (186)
T d1df0a1          90 IQKYQKIYREIDVDRSGTMNSYEMRKALEE-AGFKLPCQL-HQVIVARFADDELII--------DFDNFVRCLV  153 (186)
T ss_dssp             HHHHHHHHHHHCTTCCSCEEGGGHHHHHHH-TTEECCHHH-HHHHHHHHCCSTTEE--------CHHHHHHHHH
T ss_pred             HHHHHHHHHhhCCCCCCcccHHHHHHHHHH-HHhcccHHH-HHHHHHHHcCCCCeE--------eHHHHHHHHH
Confidence            356788999999999999999999999999 999988664 456667899999999        9999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.20  E-value=1.5e-06  Score=84.00  Aligned_cols=82  Identities=16%  Similarity=0.270  Sum_probs=51.8

Q ss_pred             eeeeeecCceEEEEEEEcCCCCEEEEEEecccC----cCChHhHHHHHHHHHHHHhccCC--CCccEEEEEEEeCCEEEE
Q 011380          101 GKLLGHGQFGYTYVATDKANGDRVAVKKIEKNK----MILPIAVEDVKREVKILQALAGH--ENVVKFYNAFEDDNYVYI  174 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~~~~~E~~~l~~l~~h--pnIv~~~~~~~~~~~~~l  174 (487)
                      .+.||.|....||++.+..+|+.+++|.-....    -..+........|.+.|+.+..+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            456899999999999887778899999643210    00112234556788888877544  345666654  3444578


Q ss_pred             EEeccCCCCH
Q 011380          175 AMELCEGGEL  184 (487)
Q Consensus       175 v~e~~~gg~L  184 (487)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.18  E-value=1.8e-07  Score=78.89  Aligned_cols=70  Identities=23%  Similarity=0.310  Sum_probs=57.4

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      |...++++++.+|+++|..+|.|++|.|+.+||+.++.. ...    +.+++++..+|.+++|.|        +|+||+.
T Consensus         6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~-~~~----~~~~~l~~~~d~~~~g~i--------~~~EFl~   72 (165)
T d1auib_           6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPEL-QQN----PLVQRVIDIFDTDGNGEV--------DFKEFIE   72 (165)
T ss_dssp             CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHH-HTC----TTHHHHHHHHCTTCSSSE--------EHHHHHH
T ss_pred             HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhc-cCC----HHHHHHHHHHccccchhh--------hhhhhhh
Confidence            445678899999999999999999999999999876654 222    346789999999999999        8999987


Q ss_pred             ccc
Q 011380          474 FPV  476 (487)
Q Consensus       474 ~~~  476 (487)
                      ...
T Consensus        73 ~~~   75 (165)
T d1auib_          73 GVS   75 (165)
T ss_dssp             HHG
T ss_pred             hcc
Confidence            554

>d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin regulatory subunit (B-chain)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.18  E-value=8.9e-07  Score=74.52  Aligned_cols=80  Identities=19%  Similarity=0.114  Sum_probs=62.9

Q ss_pred             HHHHHHhccC-ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc----ccHHHHHHHHHhcCCCCCceeecCcc
Q 011380          389 FALRALASTL-DDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK----LKESRVLEILQAVNTPFLGLFLPCHE  463 (487)
Q Consensus       389 ~~l~~m~~~~-~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~----~~~~e~~~~~~~~d~~~~g~i~~~~~  463 (487)
                      .|+..+.... .......++.+|..+|.|++|+|+.+|++.+++...+..    ..+..+..++..+|.|+||.|     
T Consensus        69 EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~I-----  143 (165)
T d1auib_          69 EFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRI-----  143 (165)
T ss_dssp             HHHHHHGGGCTTCCHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSE-----
T ss_pred             hhhhhccccccchhhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcE-----
Confidence            4555555543 334566789999999999999999999999987644443    345667889999999999999     


Q ss_pred             ccccchhhhcccc
Q 011380          464 KGEKFSYLLLFPV  476 (487)
Q Consensus       464 ~~~~f~~f~~~~~  476 (487)
                         +|+||+.++.
T Consensus       144 ---s~~EF~~i~~  153 (165)
T d1auib_         144 ---SFEEFCAVVG  153 (165)
T ss_dssp             ---EHHHHHHHHG
T ss_pred             ---eHHHHHHHHh
Confidence               8999987654

>d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Apoptosis-linked protein alg-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.17  E-value=6.8e-07  Score=76.52  Aligned_cols=64  Identities=20%  Similarity=0.319  Sum_probs=58.6

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|..+|.+++|.|+.+||+.+|.. .|..+++++++.+++.+|.+++|.|        +|++|+..++
T Consensus        86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~-~~~~l~~e~~~~~~~~~d~~~dg~I--------s~~eF~~~~~  149 (181)
T d1hqva_          86 TDWQNVFRTYDRDNSGMIDKNELKQALSG-FGYRLSDQFHDILIRKFDRQGRGQI--------AFDDFIQGCI  149 (181)
T ss_dssp             HHHHHHHHHHCTTCCSSBCHHHHHHHHHH-HTBCCCHHHHHHHHHHHCSSCSSCB--------CHHHHHHHHH
T ss_pred             cccccccccccccccchhhhHHHHHHHHH-cCCcchhHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            45778999999999999999999999998 8999999999999999999999999        8999986553

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=98.14  E-value=4.6e-07  Score=84.98  Aligned_cols=71  Identities=23%  Similarity=0.340  Sum_probs=64.9

Q ss_pred             ccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          396 STLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       396 ~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..++.++...++++|..+|.|++|.|+.+||+.+|.. +|..+++.++..++..+|.|++|.|        +|.+|+...
T Consensus       114 ~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~-~~~~~~~~~~~~~~~~~d~~~~g~i--------~~~ef~~~~  184 (321)
T d1ij5a_         114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAK-YADTIPEGPLKKLFVMVENDTKGRM--------SYITLVAVA  184 (321)
T ss_dssp             CCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHH-HHTTSCSSHHHHHHHHHHHCCSSTH--------HHHHHTTSH
T ss_pred             ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHH-cCCcccHHHHHHHHHHHhhcCCccc--------cchhhhhhh
Confidence            3456677889999999999999999999999999999 8999999999999999999999999        999998754

>d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Cdc4p
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.12  E-value=2.4e-07  Score=75.85  Aligned_cols=60  Identities=13%  Similarity=0.158  Sum_probs=52.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      .+++++|..||.|++|.|+.+||+.+|+. +|..++.+++..+    +.+.+|.|        +|++|+.+..
T Consensus         5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~-lg~~~t~~ei~~~----~~~~~~~i--------~~~eF~~~~~   64 (140)
T d1ggwa_           5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRA-CGQNPTLAEITEI----ESTLPAEV--------DMEQFLQVLN   64 (140)
T ss_dssp             TTTHHHHHHTCSSSSSEECHHHHHHHHHH-TSCCCCHHHHHHH----HTTSCSSE--------EHHHHHHHHC
T ss_pred             HHHHHHHHHHCCCCCCeECHHHHHHHHHH-HHhhhHHHhhhhh----hccccccc--------cchhhhhhhh
Confidence            46789999999999999999999999999 9999999887665    56788999        8999987654

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=98.12  E-value=2.1e-06  Score=63.41  Aligned_cols=66  Identities=14%  Similarity=0.246  Sum_probs=52.7

Q ss_pred             HHHHHHhhccc-CCCCC-CCCCHHHHHHHHHhhCC----CcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAI-DVDKN-GSISLEEMRQALAKDLP----WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~-D~d~~-G~i~~~el~~~l~~~~~----~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +..+..+|..+ ..+|+ ++++..||+.+|++-++    ...+...++++|+.+|.|+||.|        +|.||+.++.
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~v--------dF~EF~~li~   79 (90)
T d3cr5x1           8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGEC--------DFQEFMAFVA   79 (90)
T ss_dssp             HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcC--------CHHHHHHHHH
Confidence            45677889887 45655 57999999999987443    33346679999999999999999        9999987653

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.10  E-value=8.1e-07  Score=76.60  Aligned_cols=134  Identities=17%  Similarity=0.106  Sum_probs=80.6

Q ss_pred             HHHHHHHHccccCccCCcCHHHHhcCccccccCCCCCCCcCHHHHHHHH-Hhhhh--hHH-HHHHHHHHhccCChHHHHH
Q 011380          330 SAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISVLNNMR-QFVKY--SRL-KQFALRALASTLDDEELAD  405 (487)
Q Consensus       330 ~~~~li~~~L~~dp~~Rpt~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~-k~~~l~~m~~~~~~~~~~~  405 (487)
                      +++.+.++-....|+=+++..|..+-  |+...    .+.....+..+- .+...  +.+ -..|+..+...........
T Consensus        22 ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~~----~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~   95 (189)
T d1jbaa_          22 QLQEWYKKFLEECPSGTLFMHEFKRF--FKVPD----NEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHK   95 (189)
T ss_dssp             HHHHHHHHHHSSSTTCCEEHHHHHHH--HHCCS----SSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHH
T ss_pred             HHHHHHHHhcccCCCCeeeHHHHHHH--HHHcC----CCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHH
Confidence            45666666666678888888775432  22211    111222233222 22111  111 1233333333332222356


Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhh---------------C-CCcccHHHHHHHHHhcCCCCCceeecCccccccch
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKD---------------L-PWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~---------------~-~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      ++.+|+.+|.|++|.|+.+|+..++...               . ....+++.++.+|+.+|.|+||.|        +|+
T Consensus        96 ~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~I--------s~~  167 (189)
T d1jbaa_          96 LKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQL--------SLN  167 (189)
T ss_dssp             HHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCB--------CHH
T ss_pred             HHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcE--------eHH
Confidence            7889999999999999999998877541               0 111224567899999999999999        999


Q ss_pred             hhhccccc
Q 011380          470 YLLLFPVD  477 (487)
Q Consensus       470 ~f~~~~~~  477 (487)
                      ||+..+..
T Consensus       168 EF~~~~~~  175 (189)
T d1jbaa_         168 EFVEGARR  175 (189)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHh
Confidence            99887653

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.08  E-value=6.7e-07  Score=77.21  Aligned_cols=66  Identities=20%  Similarity=0.190  Sum_probs=53.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhC---C--------CcccHHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDL---P--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~---~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      .+.++.+|+.+|.|++|.|+.+|+..+++...   +        ....+..++++|+.+|.|+||.|        +|+||
T Consensus        98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~I--------s~~EF  169 (190)
T d1fpwa_          98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYI--------TLDEF  169 (190)
T ss_dssp             THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEE--------EHHHH
T ss_pred             HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcC--------cHHHH
Confidence            35678899999999999999999999886521   1        11235678999999999999999        89999


Q ss_pred             hcccc
Q 011380          472 LLFPV  476 (487)
Q Consensus       472 ~~~~~  476 (487)
                      .....
T Consensus       170 ~~~~~  174 (190)
T d1fpwa_         170 REGSK  174 (190)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87654

>d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.07  E-value=1.8e-07  Score=76.49  Aligned_cols=63  Identities=16%  Similarity=0.233  Sum_probs=56.7

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCC--CCCceeecCccccccchhhhcccc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNT--PFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~--~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +++++|..||.|++|.|+.+||+.+|+. +|..+++.++..++..++.  +++|.|        +|.+|..+..
T Consensus         1 e~ke~F~~~D~d~~G~I~~~el~~~l~~-lg~~~t~~e~~~~~~~~~~~~~~~~~i--------~~~ef~~~~~   65 (139)
T d1w7jb1           1 EFKEAFELFDRVGDGKILYSQCGDVMRA-LGQNPTNAEVLKVLGNPKSDELKSRRV--------DFETFLPMLQ   65 (139)
T ss_dssp             CHHHHHHHHCCSSSSEEESTTHHHHHHH-TTCCCCHHHHHHHTTCCCHHHHTTCEE--------EHHHHHHHHH
T ss_pred             CHHHHHHHHhCCCCCeECHHHHHHHHHH-hccCCCHHHHHHHHHHHhcccccCCce--------eeeccchhhH
Confidence            3688999999999999999999999999 9999999999999988874  578999        8999977654

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=98.03  E-value=1.1e-06  Score=74.52  Aligned_cols=63  Identities=21%  Similarity=0.293  Sum_probs=51.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..++.+|+.+|.|++|.|+..|++.+|+. .|..+++++++.++. +|.|++|.|        +|+||+.+++
T Consensus        77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~-~g~~~~~~~~~~~~~-~d~d~~G~i--------~~~EF~~~~~  139 (173)
T d1alva_          77 KKWQAIYKQFDVDRSGTIGSSELPGAFEA-AGFHLNEHLYSMIIR-RYSDEGGNM--------DFDNFISCLV  139 (173)
T ss_dssp             HHHHHHHHHHCTTCCSSBCTTTHHHHHHH-HTCCCCHHHHHHHHH-HHTCSSSCB--------CHHHHHHHHH
T ss_pred             hHHHHHHHHhccCCCCeecHHHHHHHHHH-HHHhhHHHHHHHhhc-cccCCCCeE--------eHHHHHHHHH
Confidence            45677899999999999999999999998 888888877766664 455999999        8999988653

>d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2)
species: Physarum polycephalum [TaxId: 5791]

Probab=98.02  E-value=1.1e-06  Score=82.36  Aligned_cols=64  Identities=17%  Similarity=0.236  Sum_probs=57.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ..+..+|..+|.|++|+|+.+||+.+|.. +|. .+++.++..+|..+|.|+||.|        +|+||+.+++
T Consensus       253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~-~~~~~~~~~~~~~l~~~~D~d~dG~I--------s~~EF~~~ml  317 (321)
T d1ij5a_         253 LVLRILYAFADFDKSGQLSKEEVQKVLED-AHIPESARKKFEHQFSVVDVDDSKSL--------SYQEFVMLVL  317 (321)
T ss_dssp             HHHHHHHHHTCSSSCSSEEHHHHHHHHHH-TTCCGGGCSTHHHHHHHHTTTTCSEE--------CHHHHHHHHH
T ss_pred             hHHHHHHHHHhcCCCCCCcHHHHHHHHHH-cCCCcCcHHHHHHHHHHhCCCCCCcC--------cHHHHHHHHH
Confidence            35667899999999999999999999999 886 5888999999999999999999        8999987653

>d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Light Chain Mlc1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=98.00  E-value=5.4e-07  Score=74.23  Aligned_cols=61  Identities=15%  Similarity=0.201  Sum_probs=52.2

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHh-cCCCCCceeecCccccccchhhhccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQA-VNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~-~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++++|..+|.|++|+|+.+||+.+|+. +|..++.++++.++.. .+.+.+|.|        +|.+|..++
T Consensus         4 ~k~~F~~~D~d~~G~I~~~el~~~l~~-lg~~~s~~ei~~l~~~~~~~~~~~~i--------~~~ef~~~~   65 (146)
T d1m45a_           4 NKDIFTLFDKKGQGAIAKDSLGDYLRA-IGYNPTNQLVQDIINADSSLRDASSL--------TLDQITGLI   65 (146)
T ss_dssp             CTTCHHHHCTTCCSEEEGGGHHHHHHH-TTCCCCHHHHHHHHHC--CC--CCEE--------EHHHHHHHH
T ss_pred             HHHHHHHHcCCCcCCCCHHHHHHHHHH-cCCchhHHHHhhhhcccccccccccc--------ccchhhhhh
Confidence            578999999999999999999999999 9999999999999974 555667899        888888764

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.99  E-value=2.4e-06  Score=47.28  Aligned_cols=29  Identities=28%  Similarity=0.540  Sum_probs=26.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ++|.++|..||+|.||+|+.+||..+++.
T Consensus         4 eELae~FRifDkNaDGyiD~eEl~~ilr~   32 (34)
T d1ctda_           4 EELANAFRIFDKNADGYIDIEELGEILRA   32 (34)
T ss_dssp             HHHHHHHHTTCCSSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccccHHHHHHHHHh
Confidence            57888999999999999999999999886

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=97.98  E-value=2.8e-06  Score=72.71  Aligned_cols=66  Identities=15%  Similarity=0.182  Sum_probs=53.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CCCcccHHH----HHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LPWKLKESR----VLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~~~~~~~e----~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ...++.+|+.+|.|++|.|+.+|++.++...   .|..+++.+    +..+|+.+|.|+||.|        +|+||...+
T Consensus        90 ~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~I--------s~~EF~~~~  161 (183)
T d2zfda1          90 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKI--------DKEEWRSLV  161 (183)
T ss_dssp             HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEE--------CHHHHHHHH
T ss_pred             HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeE--------cHHHHHHHH
Confidence            4568889999999999999999999876541   455555544    5668899999999999        899998866


Q ss_pred             c
Q 011380          476 V  476 (487)
Q Consensus       476 ~  476 (487)
                      .
T Consensus       162 ~  162 (183)
T d2zfda1         162 L  162 (183)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Guanylate cyclase activating protein 2, GCAP-2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.98  E-value=2.8e-06  Score=73.11  Aligned_cols=53  Identities=11%  Similarity=0.137  Sum_probs=26.2

Q ss_pred             HHHHhhcccCCC-CCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          405 DLRDQFDAIDVD-KNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       405 ~l~~~F~~~D~d-~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      +++++|+.|+.+ ++|.|+.+||+++|.. .+...+...++.+|+.+|.|++|.|
T Consensus        22 ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~-~~~~~~~~~~~~lf~~~D~d~dG~I   75 (189)
T d1jbaa_          22 QLQEWYKKFLEECPSGTLFMHEFKRFFKV-PDNEEATQYVEAMFRAFDTNGDNTI   75 (189)
T ss_dssp             HHHHHHHHHHSSSTTCCEEHHHHHHHHHC-CSSSTTHHHHHHHHHHHCCSSSSEE
T ss_pred             HHHHHHHHhcccCCCCeeeHHHHHHHHHH-cCCCccHHHHHHHHHHhccCCCCeE
Confidence            344444444322 3455555555555554 4444455555555555555555555

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.97  E-value=1.5e-06  Score=75.61  Aligned_cols=64  Identities=20%  Similarity=0.118  Sum_probs=51.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc--------------ccHHHHHHHHHhcCCCCCceeecCccccccch
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK--------------LKESRVLEILQAVNTPFLGLFLPCHEKGEKFS  469 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~--------------~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~  469 (487)
                      ..++.+|+.+|.|++|.|+.+|+..+++. +...              ..+..++.+|+.+|.|+||.|        +|+
T Consensus        99 ~~l~~~F~~~D~d~~G~is~~E~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~I--------s~~  169 (201)
T d1omra_          99 QKLEWAFSLYDVDGNGTISKNEVLEIVTA-IFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKL--------TEK  169 (201)
T ss_dssp             GSHHHHHHHHCTTCSSSBCHHHHHHHHHH-HHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCB--------CHH
T ss_pred             HHHHHHHHHHccCCCCccCHHHHHHHHHH-HHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCC--------cHH
Confidence            45788999999999999999999988865 2111              123457889999999999999        999


Q ss_pred             hhhcccc
Q 011380          470 YLLLFPV  476 (487)
Q Consensus       470 ~f~~~~~  476 (487)
                      ||+....
T Consensus       170 EF~~~~~  176 (201)
T d1omra_         170 EFIEGTL  176 (201)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9987654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=1.5e-05  Score=71.64  Aligned_cols=75  Identities=12%  Similarity=0.090  Sum_probs=52.6

Q ss_pred             eeeecC-ceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCEEEEEEeccC
Q 011380          103 LLGHGQ-FGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGH-ENVVKFYNAFEDDNYVYIAMELCE  180 (487)
Q Consensus       103 ~lG~G~-~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~~~~~~~~lv~e~~~  180 (487)
                      .+..|. -+.||++.. ..|..+++|......      ...+..|...++.|..+ -.+++++.+..+.+..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            344444 368898874 456678889765432      13467788888877633 236778888888889999999998


Q ss_pred             CCCH
Q 011380          181 GGEL  184 (487)
Q Consensus       181 gg~L  184 (487)
                      |.++
T Consensus        90 G~~~   93 (255)
T d1nd4a_          90 GQDL   93 (255)
T ss_dssp             SEET
T ss_pred             cccc
Confidence            8654

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.87  E-value=6.9e-06  Score=69.38  Aligned_cols=61  Identities=23%  Similarity=0.406  Sum_probs=51.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ..+..+|+.+|.|++|+|+.+|++.+|.. +|..++.++++.+++.+|.  +|.|        +|++|+.++
T Consensus        77 ~~~~~~f~~~D~d~sG~i~~~El~~~l~~-~g~~ls~~~~~~l~~~~d~--~g~i--------~~~eF~~~~  137 (172)
T d1juoa_          77 NGWRQHFISFDTDRSGTVDPQELQKALTT-MGFRLSPQAVNSIAKRYST--NGKI--------TFDDYIACC  137 (172)
T ss_dssp             HHHHHHHHTTCTTCCSEECHHHHHHHHHH-TTCCCCHHHHHHHHHHTCS--SSSE--------EHHHHHHHH
T ss_pred             hhhhHHHHHhCcCCCCcCCHHHHHHHHHH-HHHhhhHHHHHHHHHHHHh--cCCc--------CHHHHHHHH
Confidence            34667899999999999999999999999 9999999999888888754  5667        777776644

>d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Sorcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.85  E-value=1.4e-06  Score=73.84  Aligned_cols=63  Identities=14%  Similarity=0.230  Sum_probs=54.4

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc-----ccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK-----LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~-----~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+.+++.|..++ ++||.|+.+||+.+|++ +|..     ++.+++..++..+|.|++|.|        +|+||+.+.
T Consensus         6 ~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~-~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I--------~f~EF~~~~   73 (172)
T d1juoa_           6 QDPLYGYFAAVA-GQDGQIDADELQRCLTQ-SGIAGGYKPFNLETCRLMVSMLDRDMSGTM--------GFNEFKELW   73 (172)
T ss_dssp             CCTTHHHHHHHH-TTTTEECHHHHHHHHHH-HTTTCSSCCCCHHHHHHHHHHHCTTCSSCE--------EHHHHHHHH
T ss_pred             HHHHHHHHHHhC-CCCCCCCHHHHHHHHHH-cCCCCCcccCCHHHHHHHHHHHCCCCCCce--------ehHHHHHHH
Confidence            346788999886 78999999999999998 6654     457889999999999999999        899998654

>d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]

Probab=97.84  E-value=4.5e-06  Score=62.12  Aligned_cols=66  Identities=17%  Similarity=0.154  Sum_probs=51.5

Q ss_pred             HHHHHHhhccc-CCCCC-CCCCHHHHHHHHHhhCCC----cccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAI-DVDKN-GSISLEEMRQALAKDLPW----KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~-D~d~~-G~i~~~el~~~l~~~~~~----~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +..+..+|..+ ..+|+ ++++..||+.+|++.++.    .-+...++++|+.+|.|+||.|        +|.||+.++.
T Consensus         8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~v--------dF~EF~~li~   79 (95)
T d1qlsa_           8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQL--------DFQEFLNLIG   79 (95)
T ss_dssp             HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSB--------CHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcC--------cHHHHHHHHH
Confidence            45677788876 45565 679999999999763332    2345679999999999999999        9999988654

>d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain small (regulatory) subunit (domain VI)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=97.81  E-value=2.9e-06  Score=71.88  Aligned_cols=65  Identities=15%  Similarity=0.220  Sum_probs=55.4

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc--------ccHHHHHHHHHhcCCCCCceeecCccccccchhhh
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK--------LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLL  472 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~--------~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~  472 (487)
                      +++.+++++|..+|. +||.|+..||+.+|.. +|..        .+.+.+..++..+|.|++|.|        +|++|+
T Consensus         1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~-~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i--------~~~ef~   70 (173)
T d1alva_           1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNK-VVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKL--------GFEEFK   70 (173)
T ss_dssp             CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHH-HHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSB--------CHHHHH
T ss_pred             ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHH-hCCCcchhhhccCCHHHHHHHHHHhccCCCCcc--------cchhhh
Confidence            367889999999994 5899999999999987 5432        456889999999999999999        999997


Q ss_pred             ccc
Q 011380          473 LFP  475 (487)
Q Consensus       473 ~~~  475 (487)
                      .+.
T Consensus        71 ~~~   73 (173)
T d1alva_          71 YLW   73 (173)
T ss_dssp             HHH
T ss_pred             hhh
Confidence            754

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.81  E-value=8.1e-06  Score=69.29  Aligned_cols=67  Identities=21%  Similarity=0.213  Sum_probs=52.3

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CC--------CcccHHHHHHHHHhcCCCCCceeecCccccccchhh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LP--------WKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYL  471 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~--------~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f  471 (487)
                      ...++.+|+.+|.|++|.|+.+|+...+...   .+        ....+..++.+|+.+|.|+||.|        +|+||
T Consensus        86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~I--------s~~EF  157 (178)
T d1s6ca_          86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIV--------TLDEF  157 (178)
T ss_dssp             HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEE--------CHHHH
T ss_pred             HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcE--------eHHHH
Confidence            4567889999999999999999998766531   11        12234557899999999999999        89999


Q ss_pred             hccccc
Q 011380          472 LLFPVD  477 (487)
Q Consensus       472 ~~~~~~  477 (487)
                      .....+
T Consensus       158 ~~~i~~  163 (178)
T d1s6ca_         158 LESCQE  163 (178)
T ss_dssp             HHHTTS
T ss_pred             HHHHHH
Confidence            986654

>d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]

Probab=97.78  E-value=2e-05  Score=56.88  Aligned_cols=65  Identities=15%  Similarity=0.247  Sum_probs=50.6

Q ss_pred             HHHHHHhhcccC-CCC-CCCCCHHHHHHHHHhhCCCcc-----cHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          403 LADLRDQFDAID-VDK-NGSISLEEMRQALAKDLPWKL-----KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       403 ~~~l~~~F~~~D-~d~-~G~i~~~el~~~l~~~~~~~~-----~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +..+..+|..+. .+| .+.++..||+.+|++-++.-+     +...++++|+.+|.|+||.|        +|.||+.++
T Consensus         9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~v--------dF~EF~~li   80 (83)
T d1xk4c1           9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQL--------SFEEFIMLM   80 (83)
T ss_dssp             HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcC--------cHHHHHHHH
Confidence            456777888884 343 368999999999987555322     34558999999999999999        999999765

>d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Recoverin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.76  E-value=1.3e-05  Score=69.44  Aligned_cols=51  Identities=14%  Similarity=0.175  Sum_probs=27.4

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      ..+|..+|.|++|.|+..|+..++.. +.....++.+..+|+.+|.|++|.|
T Consensus        66 ~~if~~~D~~~~G~I~f~EF~~~~~~-~~~~~~~~~l~~~F~~~D~d~~G~i  116 (201)
T d1omra_          66 QHVFRSFDANSDGTLDFKEYVIALHM-TSAGKTNQKLEWAFSLYDVDGNGTI  116 (201)
T ss_dssp             HHHHHTTTSCSSSEEEHHHHHHHHHH-HHSSCGGGSHHHHHHHHCTTCSSSB
T ss_pred             HHHHHHhccCCCCeEeehhHHHHHHh-hcccchHHHHHHHHHHHccCCCCcc
Confidence            34555555555555555555555544 3333334445555555555555555

>d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcineurin B-like protein 2
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=97.72  E-value=1.6e-05  Score=67.79  Aligned_cols=51  Identities=22%  Similarity=0.296  Sum_probs=25.3

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCC-cccHHHHHHHHHhcCCCCCcee
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPW-KLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~-~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      ..+|..+|.|++|.|+..|+..++.. +.. ...++.+..+|+.+|.|++|.|
T Consensus        57 ~~lf~~~d~~~dg~I~f~EFl~~l~~-~~~~~~~~~~~~~~F~~~D~d~~G~I  108 (183)
T d2zfda1          57 DRVFDLFDTKHNGILGFEEFARALSV-FHPNAPIDDKIHFSFQLYDLKQQGFI  108 (183)
T ss_dssp             HHHHHHHCSSCSSSBCHHHHHHHHHH-TSTTSCHHHHHHHHHHHHCTTSSSSE
T ss_pred             HHHHHHHccCCCCcCcHHHHHHHHHh-hhccCcHHHHHHHhhcccccCCCCCc
Confidence            34555555555555555555555443 221 1223345555555555555555

>d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100p [TaxId: 9606]

Probab=97.68  E-value=1.6e-05  Score=58.95  Aligned_cols=66  Identities=17%  Similarity=0.274  Sum_probs=50.4

Q ss_pred             HHHHHHhhcccC-CCCC-CCCCHHHHHHHHHhhCCCc----ccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          403 LADLRDQFDAID-VDKN-GSISLEEMRQALAKDLPWK----LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       403 ~~~l~~~F~~~D-~d~~-G~i~~~el~~~l~~~~~~~----~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      +..+..+|..+. .+|+ ++++.+||+.+|++-++.-    .+...++++++.+|.|+||.|        +|.||+.++.
T Consensus         8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~v--------dF~EF~~li~   79 (94)
T d1j55a_           8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQV--------DFSEFIVFVA   79 (94)
T ss_dssp             HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSE--------EHHHHHHHHH
T ss_pred             HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcC--------CHHHHHHHHH
Confidence            456778888873 4444 5799999999998645432    334569999999999999999        9999988653

>d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), M-type [TaxId: 10116]

Probab=97.61  E-value=7.2e-06  Score=70.21  Aligned_cols=62  Identities=11%  Similarity=0.155  Sum_probs=53.7

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC--------cccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPW--------KLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~--------~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +.++++|..+| |++|.|+..||..+|.. +|.        ..+.+++..++..+|.|++|.|        +|+||+.+.
T Consensus        18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~-~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I--------~~~EF~~~~   87 (186)
T d1df0a1          18 DGFRRLFAQLA-GEDAEISAFELQTILRR-VLAKREDIKSDGFSIETCKIMVDMLDEDGSGKL--------GLKEFYILW   87 (186)
T ss_dssp             HHHHHHHHHHH-GGGTCEEHHHHHHHHHH-HHHC----CCCCCCHHHHHHHHHHHCCSSSSEE--------CHHHHHHHH
T ss_pred             HHHHHHHHHHc-CCCCeEcHHHHHHHHHH-hcccccccccccCCHHHHHHHHHHHcCCCCCcc--------cHHHHHHHH
Confidence            56899999998 99999999999999987 443        3467889999999999999999        999997654

>d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.57  E-value=2.4e-05  Score=67.03  Aligned_cols=61  Identities=21%  Similarity=0.265  Sum_probs=54.0

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +..+|..+|.+++|.|+..|+..++.. ++....++.+..+|+.+|.|++|.|        +++||..+.
T Consensus        65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~-~~~~~~~e~~~~~F~~~D~d~dG~i--------s~~E~~~~~  125 (190)
T d1fpwa_          65 ANHLFTVFDKDNNGFIHFEEFITVLST-TSRGTLEEKLSWAFELYDLNHDGYI--------TFDEMLTIV  125 (190)
T ss_dssp             HHHHHHTCCSSCSSEECHHHHHHHHHH-HSCCCSTHHHHHHHHHHCSSCSSEE--------EHHHHHHHH
T ss_pred             HHHHHHHhCcCCCCcccHHHHHHHHHH-HccCchHHHHHHHHHHhccCCCCcC--------cHHHHHHHH
Confidence            456899999999999999999999988 7766778999999999999999999        788876654

>d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Calpain large subunit, C-terminal domain (domain IV)
species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]

Probab=97.53  E-value=4.4e-06  Score=71.61  Aligned_cols=66  Identities=14%  Similarity=0.244  Sum_probs=42.4

Q ss_pred             hHHH-HHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCc--------ccHHHHHHHHHhcCCCCCceeecCccccccchh
Q 011380          400 DEEL-ADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWK--------LKESRVLEILQAVNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       400 ~~~~-~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~--------~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      +++. +.++++|..+| +++|.|+..||..+|.+ .+..        .+.+.++.++..+|.|++|.|        +|+|
T Consensus        15 ~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~-~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i--------~~~E   84 (188)
T d1qxpa2          15 EEEIDDNFKTLFSKLA-GDDMEISVKELQTILNR-IISKHKDLRTNGFSLESCRSMVNLMDRDGNGKL--------GLVE   84 (188)
T ss_dssp             ------------CCCC-CSSSSCCCSCTTTTTCC----------CCCCCHHHHHHHHHHHCC--CCCC--------CSSS
T ss_pred             HHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHH-hCccccccccccCCHHHHHHHHHHhcCCCCCcc--------cHHH
Confidence            3443 45899999999 55899999999998876 4433        345789999999999999999        8999


Q ss_pred             hhccc
Q 011380          471 LLLFP  475 (487)
Q Consensus       471 f~~~~  475 (487)
                      |..+.
T Consensus        85 F~~l~   89 (188)
T d1qxpa2          85 FNILW   89 (188)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            97654

>d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Penta-EF-hand proteins
domain: Grancalcin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.53  E-value=1.9e-05  Score=66.01  Aligned_cols=59  Identities=14%  Similarity=0.207  Sum_probs=49.2

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcc-----cHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKL-----KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~-----~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .+.|..+ .+.+|.|+.+||+.+|+. +|...     +.+.+..++..+|.|++|.|        +|+||+.+.
T Consensus         3 ~~~F~~~-a~~dG~I~~~EL~~~L~~-~g~~~~~~~~s~~~~~~li~~~D~~~~G~i--------~~~EF~~l~   66 (165)
T d1k94a_           3 YTYFSAV-AGQDGEVDAEELQRCLTQ-SGINGTYSPFSLETCRIMIAMLDRDHTGKM--------GFNAFKELW   66 (165)
T ss_dssp             HHHHHHH-HGGGTSBCHHHHHHHHHH-HTTTTTSCCCCHHHHHHHHHHHCTTCSSCB--------CHHHHHHHH
T ss_pred             HHHHHHh-cCCCCCCCHHHHHHHHHH-cCCCCCcccCCHHHHHHHHHHhCCCCCCcC--------cHHHHHHHh
Confidence            4456666 578999999999999998 66543     56789999999999999999        999998754

>d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Neurocalcin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.52  E-value=2.4e-05  Score=66.41  Aligned_cols=51  Identities=18%  Similarity=0.203  Sum_probs=29.5

Q ss_pred             HHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          407 RDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       407 ~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      .++|..+|.+++|.|+.+|+..++.. +-....++.+..+|+.+|.|++|.|
T Consensus        62 ~~lf~~~d~~~~g~i~~~eFl~~~~~-~~~~~~~~~~~~~f~~~D~d~dg~i  112 (181)
T d1bjfa_          62 EHVFRTFDANGDGTIDFREFIIALSV-TSRGKLEQKLKWAFSMYDLDGNGYI  112 (181)
T ss_dssp             HHHHHHHCSSCSSEEEHHHHHHHHHH-HTSSCHHHHHHHHHHHHCTTCSSCE
T ss_pred             HHHHHhcCCCCCCcEeHHHHHHHHHH-HhhhchHHHHHHHHHHhccCCCCee
Confidence            44566666666666666666655554 3333334555666666666666666

>d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Kchip1, Kv4 potassium channel-interacting protein
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.38  E-value=6.8e-05  Score=63.30  Aligned_cols=61  Identities=16%  Similarity=0.170  Sum_probs=46.8

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +..+|..+|.|++|.|+.+|+..++.. +.....++.+..+++.+|.|++|.|        +.+++..+.
T Consensus        53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~-~~~~~~~~~~~~~f~~~D~~~~g~i--------~~~e~~~~~  113 (178)
T d1s6ca_          53 AHYLFNAFDTTQTGSVKFEDFVTALSI-LLRGTVHEKLRWTFNLYDINKDGYI--------NKEEMMDIV  113 (178)
T ss_dssp             HHHHHHHHCTTCSSCEEHHHHHHHHHH-HHHCCHHHHHHHHHHHHCTTCSSCE--------EHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcccHHHHHHHHHH-HhccchHHHHHHHHHhhccCCCCee--------cHHHHHHHH
Confidence            456788888999999999998877765 4444556778888889999999998        677765543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.27  E-value=0.00045  Score=66.05  Aligned_cols=75  Identities=13%  Similarity=0.097  Sum_probs=52.1

Q ss_pred             eeeeeecCceEEEEEEEcC-------CCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCEEE
Q 011380          101 GKLLGHGQFGYTYVATDKA-------NGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENVVKFYNAFEDDNYVY  173 (487)
Q Consensus       101 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  173 (487)
                      ++.|+.|---.+|++....       ..+.|.+++.-...     ......+|..+++.+..+.-.+++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-----~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-----hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4568888888999998653       34567777764321     223456899999998766555688877653    5


Q ss_pred             EEEeccCCCCH
Q 011380          174 IAMELCEGGEL  184 (487)
Q Consensus       174 lv~e~~~gg~L  184 (487)
                      +|+||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987543

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.10  E-value=0.00023  Score=60.40  Aligned_cols=62  Identities=18%  Similarity=0.145  Sum_probs=51.6

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPV  476 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~  476 (487)
                      ...+|+.+|.+++|.|+.+|+..++.. +.....++.+..+|+.+|.|++|.|        +.+||..++.
T Consensus        62 ~~~if~~~d~~~dg~I~~~EF~~~l~~-~~~~~~~e~l~~~F~~~D~d~dG~i--------~~~El~~~~~  123 (187)
T d1g8ia_          62 ATFVFNVFDENKDGRIEFSEFIQALSV-TSRGTLDEKLRWAFKLYDLDNDGYI--------TRNEMLDIVD  123 (187)
T ss_dssp             HHHHHHHHCTTCSSEEEHHHHHHHHHH-HHHCCHHHHHHHHHHHHCTTCSSEE--------EHHHHHHHHH
T ss_pred             HHHHHHHhCcCCCCCCcHHHHHHHHHH-hccCchhhhHHHHHHHHhcCCCCeE--------cHHHHHHHHH
Confidence            356899999999999999999998887 4444456779999999999999999        7888766554

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=96.93  E-value=0.00021  Score=60.32  Aligned_cols=69  Identities=16%  Similarity=0.239  Sum_probs=51.9

Q ss_pred             CChHHHHHHHHhhcc-cCCCCCCCCCHHHHHHHHHhhCCC----ccc-----------HHHHHHHHHhcCCCCCceeecC
Q 011380          398 LDDEELADLRDQFDA-IDVDKNGSISLEEMRQALAKDLPW----KLK-----------ESRVLEILQAVNTPFLGLFLPC  461 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~-~D~d~~G~i~~~el~~~l~~~~~~----~~~-----------~~e~~~~~~~~d~~~~g~i~~~  461 (487)
                      +++.+..+++.+|.. +|.|++|.|+.+|++.+|.. ++.    ...           ......++...|.+++|.|   
T Consensus         2 lt~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i---   77 (185)
T d2sasa_           2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTR-YKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVV---   77 (185)
T ss_dssp             CCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHH-HHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCE---
T ss_pred             cCHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHH-hccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcE---
Confidence            355677889999997 59999999999999998875 321    111           1223556788899999999   


Q ss_pred             ccccccchhhhccc
Q 011380          462 HEKGEKFSYLLLFP  475 (487)
Q Consensus       462 ~~~~~~f~~f~~~~  475 (487)
                           +|++|+...
T Consensus        78 -----~~~~~~~~~   86 (185)
T d2sasa_          78 -----SWEEYLAMW   86 (185)
T ss_dssp             -----EHHHHHHHH
T ss_pred             -----eeeHhhHHH
Confidence                 888887654

>d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]

Probab=96.86  E-value=0.00043  Score=58.44  Aligned_cols=32  Identities=31%  Similarity=0.495  Sum_probs=26.7

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQAL  430 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l  430 (487)
                      ++....+++++|..+|.|++|.|+.+||+.++
T Consensus         7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~   38 (187)
T d1uhka1           7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKA   38 (187)
T ss_dssp             CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence            34556789999999999999999999996544

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.83  E-value=0.00026  Score=59.17  Aligned_cols=71  Identities=8%  Similarity=0.159  Sum_probs=42.1

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCC----------cccHHHHHHHHHhcCCCCC----ceeecCccccccchh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPW----------KLKESRVLEILQAVNTPFL----GLFLPCHEKGEKFSY  470 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~----------~~~~~e~~~~~~~~d~~~~----g~i~~~~~~~~~f~~  470 (487)
                      ++..+|..+|.|++|+|+.+||+..|.. ...          ..+.+.+..++..++.+.+    |.|        ++++
T Consensus        79 ei~~~F~~~d~d~~~~it~~el~~fL~~-~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l--------s~d~  149 (170)
T d2zkmx1          79 EIDEIFTSYHAKAKPYMTKEHLTKFINQ-KQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQL--------SPEG  149 (170)
T ss_dssp             HHHTTCC--------CCCHHHHHHHHHH-TCC---------------CHHHHHHHHCCC--------C--------CHHH
T ss_pred             HHHHHHHHHcCCCCCcccHHHHHHHHHH-HhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeE--------CHHH
Confidence            5778999999999999999999999987 332          3466778999999887755    789        8999


Q ss_pred             hhcccccceeeeee
Q 011380          471 LLLFPVDMVYNLLY  484 (487)
Q Consensus       471 f~~~~~~~~~~~~~  484 (487)
                      |+.++...=++|+.
T Consensus       150 F~~fL~S~en~i~~  163 (170)
T d2zkmx1         150 MVWFLCGPENSVLA  163 (170)
T ss_dssp             HHHHHHSTTSCSBC
T ss_pred             HHHHHcCccCCCCC
Confidence            98866422255554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.76  E-value=0.0026  Score=58.74  Aligned_cols=68  Identities=13%  Similarity=0.203  Sum_probs=45.3

Q ss_pred             ceEEEEEEEcCCCCEEEEEEecccCcCChHhHHHHHHHHHHHHhccCCCCc--cEEE-----EEEEeCCEEEEEEeccCC
Q 011380          109 FGYTYVATDKANGDRVAVKKIEKNKMILPIAVEDVKREVKILQALAGHENV--VKFY-----NAFEDDNYVYIAMELCEG  181 (487)
Q Consensus       109 ~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI--v~~~-----~~~~~~~~~~lv~e~~~g  181 (487)
                      --.||++.. .+|+.|++|+......    ..+.+..|...+..|..+ .|  +..+     ..+...+..+.++++++|
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            358999974 5788999998765432    346678899988888622 22  1111     123456778899999976


Q ss_pred             C
Q 011380          182 G  182 (487)
Q Consensus       182 g  182 (487)
                      .
T Consensus       109 ~  109 (325)
T d1zyla1         109 R  109 (325)
T ss_dssp             E
T ss_pred             c
Confidence            4

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.65  E-value=0.00066  Score=57.10  Aligned_cols=61  Identities=10%  Similarity=-0.011  Sum_probs=49.1

Q ss_pred             HHhhcccCCC-CCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          407 RDQFDAIDVD-KNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       407 ~~~F~~~D~d-~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .++|+.||.+ ++|.|+.+|+..+|.........++.+..+|+.+|.|++|.|        +.+|+..+.
T Consensus        60 ~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I--------~~~el~~~l  121 (180)
T d1xo5a_          60 ERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTL--------NREDLSRLV  121 (180)
T ss_dssp             HHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSB--------CHHHHHHHH
T ss_pred             HHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCee--------eHHHHHHHH
Confidence            4588889987 699999999999987623344456789999999999999999        677776544

>d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Phospholipase C-beta-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.52  E-value=4.7e-05  Score=63.86  Aligned_cols=50  Identities=10%  Similarity=-0.025  Sum_probs=24.9

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCcee
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLF  458 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i  458 (487)
                      .+...|...|.+++|.|+.+|+...+.. +.   +..++..+|..+|.|++|.|
T Consensus        46 ~~~~~~~~~D~~~~~~i~F~eF~~~~~~-l~---~r~ei~~~F~~~d~d~~~~i   95 (170)
T d2zkmx1          46 ACHLPKGKNDAINPEDFPEPVYKSFLMS-LC---PRPEIDEIFTSYHAKAKPYM   95 (170)
T ss_dssp             HTTCCCCTTCEECGGGCCHHHHHHHHHH-HS---CCHHHHTTCC--------CC
T ss_pred             HHhhhhccccccCCCccCHHHHHHHHhc-cC---CHHHHHHHHHHHcCCCCCcc
Confidence            4444566666666666666666666665 32   23556666666666666666

>d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Sandworm (Nereis diversicolor) [TaxId: 126592]

Probab=96.51  E-value=0.00047  Score=57.46  Aligned_cols=68  Identities=12%  Similarity=0.072  Sum_probs=47.0

Q ss_pred             HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CCCcccH-HH----HHHHHHh--cCCCCCceeecCccccccchh
Q 011380          401 EELADLRDQFDAIDVDKNGSISLEEMRQALAKD---LPWKLKE-SR----VLEILQA--VNTPFLGLFLPCHEKGEKFSY  470 (487)
Q Consensus       401 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~~~~~~-~e----~~~~~~~--~d~~~~g~i~~~~~~~~~f~~  470 (487)
                      -...+++.+|+.+|.|++|.|+.+||..++...   .+..... ..    ...++..  .+.+++|.|        ++++
T Consensus         3 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i--------~~~e   74 (174)
T d2scpa_           3 LWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGI--------DETT   74 (174)
T ss_dssp             HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCE--------EHHH
T ss_pred             HHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcC--------cHHH
Confidence            356789999999999999999999999887651   1211111 11    1222332  377889999        8999


Q ss_pred             hhcccc
Q 011380          471 LLLFPV  476 (487)
Q Consensus       471 f~~~~~  476 (487)
                      |+....
T Consensus        75 f~~~~~   80 (174)
T d2scpa_          75 FINSMK   80 (174)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887654

>d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-regulated photoprotein
species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]

Probab=96.43  E-value=0.002  Score=54.19  Aligned_cols=69  Identities=19%  Similarity=0.253  Sum_probs=52.0

Q ss_pred             ChHHHHHHHHhhcccCCCCCCCCCHHHHHHHH-----HhhCCCcccHHHHHH-----HHHhcCCCCCceeecCccccccc
Q 011380          399 DDEELADLRDQFDAIDVDKNGSISLEEMRQAL-----AKDLPWKLKESRVLE-----ILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       399 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l-----~~~~~~~~~~~e~~~-----~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      +++.+..++.+|..+|.|++|.|+.+||+..+     +. +|...+..++.+     .+...+.+.++.|        +|
T Consensus         9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i--------~~   79 (189)
T d1qv0a_           9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAK-LEATPEQTKRHQVCVEAFFRGCGMEYGKEI--------AF   79 (189)
T ss_dssp             CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHH-TTCCHHHHHHHHHHHHHHHHHTTCCTTCCB--------CH
T ss_pred             CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHH-cCCCchhHHHHHHHHHHHhhhccccCCCce--------eh
Confidence            45677889999999999999999999998754     44 677777666544     3455667777888        78


Q ss_pred             hhhhcccc
Q 011380          469 SYLLLFPV  476 (487)
Q Consensus       469 ~~f~~~~~  476 (487)
                      ++|+....
T Consensus        80 ~e~~~~~~   87 (189)
T d1qv0a_          80 PQFLDGWK   87 (189)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88776543

>d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Diacylglycerol kinase alpha, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.33  E-value=0.0011  Score=51.37  Aligned_cols=70  Identities=14%  Similarity=0.175  Sum_probs=54.0

Q ss_pred             CChHHHHHHHHhhcccC---CCCCCCCCHHHHHHHHHhhCCCc-ccHHHHHHHHHhcCCCCC--------ceeecCcccc
Q 011380          398 LDDEELADLRDQFDAID---VDKNGSISLEEMRQALAKDLPWK-LKESRVLEILQAVNTPFL--------GLFLPCHEKG  465 (487)
Q Consensus       398 ~~~~~~~~l~~~F~~~D---~d~~G~i~~~el~~~l~~~~~~~-~~~~e~~~~~~~~d~~~~--------g~i~~~~~~~  465 (487)
                      ++..++..+.+.|+...   .+.+|.|+.++++.++...++.. .++.-++.+|+.+|.|++        |.|       
T Consensus        22 fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I-------   94 (118)
T d1tuza_          22 YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVV-------   94 (118)
T ss_dssp             HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCE-------
T ss_pred             CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCcee-------
Confidence            45667777888886542   25689999999999998745543 356778999999999987        889       


Q ss_pred             ccchhhhccc
Q 011380          466 EKFSYLLLFP  475 (487)
Q Consensus       466 ~~f~~f~~~~  475 (487)
                       +|.||+..+
T Consensus        95 -~f~efv~~L  103 (118)
T d1tuza_          95 -CLNDVSCYF  103 (118)
T ss_dssp             -EHHHHHHHH
T ss_pred             -eHHHHHHHH
Confidence             899998743

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=96.15  E-value=0.0069  Score=45.88  Aligned_cols=56  Identities=11%  Similarity=0.177  Sum_probs=42.1

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +.+++..+|  .+|.|+.+|+..++.. .+  .+++++.++|+.+|.|++|.|        +.+|+..+
T Consensus        11 i~~~~~~~~--~~G~idf~eF~~~~~~-~~--~~~~~l~~~F~~~D~d~~G~I--------~~~El~~~   66 (109)
T d5pala_          11 INKAISAFK--DPGTFDYKRFFHLVGL-KG--KTDAQVKEVFEILDKDQSGFI--------EEEELKGV   66 (109)
T ss_dssp             HHHHHHHTC--STTCCCHHHHHHHHTC-TT--CCHHHHHHHHHHHCTTCSSEE--------CHHHHHTH
T ss_pred             HHHHHHhcC--CCCcCcHHHHHHHHHh-cC--CCHHHHHHHHhhhcCCCCCeE--------cHHHHHHH
Confidence            445555555  4588999999876643 22  356889999999999999999        77776543

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=95.94  E-value=0.008  Score=45.53  Aligned_cols=58  Identities=12%  Similarity=0.129  Sum_probs=44.0

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      ++.+++..++.  +|.|+.+|+..++.. .+  .++.++..+|+.+|.|++|.|        +++||..++
T Consensus        10 ~i~~~~~~~~~--~~~i~f~eF~~~~~~-~~--~~~~~~~~~F~~~D~d~~G~I--------~~~El~~~l   67 (109)
T d1rwya_          10 DIKKAIGAFTA--ADSFDHKKFFQMVGL-KK--KSADDVKKVFHILDKDKSGFI--------EEDELGSIL   67 (109)
T ss_dssp             HHHHHHHTTCS--TTCCCHHHHHHHHTG-GG--SCHHHHHHHHHHHSTTCSSEE--------CHHHHHTHH
T ss_pred             HHHHHHHhccc--CCCcCHHHHHHHHcc-cc--CCHHHHHHHhhcccCCCCCcC--------cHHHHHHHH
Confidence            34445555544  578999999887754 22  357789999999999999999        888887655

>d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calerythrin
species: Saccharopolyspora erythraea [TaxId: 1836]

Probab=95.93  E-value=0.002  Score=53.29  Aligned_cols=65  Identities=12%  Similarity=0.140  Sum_probs=48.6

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHhh---CCCcccHHH-----------HHHHHHhcCCCCCceeecCccccccc
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAKD---LPWKLKESR-----------VLEILQAVNTPFLGLFLPCHEKGEKF  468 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~---~~~~~~~~e-----------~~~~~~~~d~~~~g~i~~~~~~~~~f  468 (487)
                      .++|+++|+.+|.|++|.|+.+||+.++.+.   ++......+           ...++...|.+++|.|        ++
T Consensus         6 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i--------~~   77 (176)
T d1nyaa_           6 SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSL--------TE   77 (176)
T ss_dssp             HHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCB--------CH
T ss_pred             HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc--------cH
Confidence            4678999999999999999999999988651   233332222           2556778899999999        77


Q ss_pred             hhhhccc
Q 011380          469 SYLLLFP  475 (487)
Q Consensus       469 ~~f~~~~  475 (487)
                      .+++...
T Consensus        78 ~~~~~~~   84 (176)
T d1nyaa_          78 EQFIRVT   84 (176)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            7776543

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=95.92  E-value=0.0068  Score=45.94  Aligned_cols=57  Identities=16%  Similarity=0.320  Sum_probs=42.2

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      ++.+++..+|  ++|.|+.+|+..++.. .+  .+..++..+|+.+|.|++|.|        +.+|+..+
T Consensus        10 eI~~~~~~~d--~dG~idf~EF~~~~~~-~~--~~~~~~~~~F~~~D~d~~G~I--------~~~El~~~   66 (109)
T d1pvaa_          10 DIKKALDAVK--AEGSFNHKKFFALVGL-KA--MSANDVKKVFKAIDADASGFI--------EEEELKFV   66 (109)
T ss_dssp             HHHHHHHHTC--STTCCCHHHHHHHHTC-TT--SCHHHHHHHHHHHCTTCSSSB--------CHHHHHTG
T ss_pred             HHHHHHHhcC--CCCCCcHHHHHHHHHH-cc--CCHHHHHHHhhCccCCCcCeE--------cHHHHHHH
Confidence            3444555454  5688999999887754 22  356789999999999999999        77776544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.78  E-value=0.01  Score=54.14  Aligned_cols=30  Identities=27%  Similarity=0.439  Sum_probs=25.0

Q ss_pred             cCceeecCCCCceEeccCCCCCcEEEeeccccc
Q 011380          218 HGLVHRDMKPENFLFKSAKEDSSLKATDFGLSD  250 (487)
Q Consensus       218 ~~iiHrDlkp~NIll~~~~~~~~vkl~DfG~a~  250 (487)
                      .|+||+|+.++||+++.   +...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~---~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLG---DELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEET---TEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhccc---ccceeEecccccc
Confidence            47999999999999983   4456799999874

>d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=95.65  E-value=0.012  Score=38.44  Aligned_cols=56  Identities=20%  Similarity=0.278  Sum_probs=49.6

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCC
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTP  453 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~  453 (487)
                      .+..++.++...+|+.||.|........+-..+|.+ +|...+..|.+.+++++...
T Consensus         7 algpeekdecmkifdifdrnaeniapvsdtmdmltk-lgqtytkreteaimkeargp   62 (86)
T d1j7qa_           7 ALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTK-LGQTYTKRETEAIMKEARGP   62 (86)
T ss_dssp             CCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHH-TSCCCSHHHHHHHHHHHHCS
T ss_pred             ccCchhHHHHHHHHHHHhccccccCCcchHHHHHHH-hhhHHhHHHHHHHHHHhcCC
Confidence            345667788889999999999999999999999999 99999999999999987644

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=94.50  E-value=0.037  Score=41.46  Aligned_cols=59  Identities=14%  Similarity=0.116  Sum_probs=44.3

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccccc
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFPVD  477 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~~~  477 (487)
                      +..++...|.+  |.|+..|+...+.- .+  .+.+++..+|+.+|.|++|.|        +..||..++..
T Consensus        10 i~~~~~~~~~~--gsi~~~eF~~~~~l-~~--~~~~~l~~~F~~~D~d~~G~I--------~~~el~~~l~~   68 (107)
T d2pvba_          10 VAAALAACSAA--DSFKHKEFFAKVGL-AS--KSLDDVKKAFYVIDQDKSGFI--------EEDELKLFLQN   68 (107)
T ss_dssp             HHHHHHHTCST--TCCCHHHHHHHHTG-GG--SCHHHHHHHHHHHCTTCSSSB--------CHHHHHTGGGG
T ss_pred             HHHHHHhccCC--CCcCHHHHHHHHhc-cc--CCHHHHHHHHHhhccCCCCcC--------cHHHHHHHHHH
Confidence            44556666554  67999999887654 22  356789999999999999999        78888765443

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=94.28  E-value=0.01  Score=32.53  Aligned_cols=28  Identities=11%  Similarity=0.089  Sum_probs=23.6

Q ss_pred             cHHHHHHHHHhcCCCCCceeecCccccccchhhhcc
Q 011380          439 KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLF  474 (487)
Q Consensus       439 ~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~  474 (487)
                      +++|+.+.|+.+|.|.||.|        +-+||..+
T Consensus         2 sEeELae~FRifDkNaDGyi--------D~eEl~~i   29 (34)
T d1ctda_           2 SEEELANAFRIFDKNADGYI--------DIEELGEI   29 (34)
T ss_dssp             HHHHHHHHHHTTCCSSSSCB--------CHHHHHHH
T ss_pred             CHHHHHHHHHHHccCCcccc--------cHHHHHHH
Confidence            46889999999999999999        77777543

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=94.26  E-value=0.018  Score=39.07  Aligned_cols=36  Identities=28%  Similarity=0.564  Sum_probs=28.9

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      +...++.   +++..+|..+|.|++|.|+.+|+..+|.+
T Consensus        30 lg~~~~~---~~i~~~~~~~D~d~dg~I~~~EF~~~m~~   65 (67)
T d1tiza_          30 FSPYFTQ---EDIVKFFEEIDVDGNGELNADEFTSCIEK   65 (67)
T ss_dssp             TCTTSCH---HHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred             hccccch---HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            3444444   35677899999999999999999999876

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=94.25  E-value=0.076  Score=39.71  Aligned_cols=63  Identities=17%  Similarity=0.234  Sum_probs=43.4

Q ss_pred             cCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          397 TLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       397 ~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      .++.+++..   +....  +.+|.++.+++...+.- .  ..+.+++.++|+.+|.|++|.|        +++||..++
T Consensus         5 ~ls~~dI~~---~l~~~--~~~~s~~~~~F~~~~~~-~--~~~~~~l~~~F~~~D~d~~G~I--------~~~El~~~l   67 (108)
T d1rroa_           5 ILSAEDIAA---ALQEC--QDPDTFEPQKFFQTSGL-S--KMSASQVKDIFRFIDNDQSGYL--------DGDELKYFL   67 (108)
T ss_dssp             TSCHHHHHH---HHHHT--CSTTCCCHHHHHHHHSG-G--GSCHHHHHHHHHHHCTTCSSEE--------CTHHHHTGG
T ss_pred             hCCHHHHHH---HHHhc--ccCCCccHHHHHHHHcc-C--cCCHHHHHHHHhhhcCCCCCeE--------cHHHHHHHH
Confidence            344444443   33434  35578999999765432 1  2456889999999999999999        788876554

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=93.98  E-value=0.015  Score=33.09  Aligned_cols=29  Identities=14%  Similarity=0.077  Sum_probs=24.1

Q ss_pred             cHHHHHHHHHhcCCCCCceeecCccccccchhhhccc
Q 011380          439 KESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLLFP  475 (487)
Q Consensus       439 ~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~~~  475 (487)
                      +++++.+.|+.+|.|++|.|        +-.|+-.++
T Consensus         1 seeel~eAF~~FDkDg~G~I--------s~~EL~~vm   29 (33)
T d2hf5a1           1 SEEEIREAFRVFDKDGNGYI--------SAAELRHVM   29 (33)
T ss_dssp             CHHHHHHHHHHHSSSCCSCB--------CHHHHHHHT
T ss_pred             CHHHHHHHHHHhCCCCCCcC--------cHHHHHHHH
Confidence            46789999999999999999        777766544

>d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a4 [TaxId: 9606]

Probab=92.68  E-value=0.032  Score=40.62  Aligned_cols=30  Identities=13%  Similarity=0.276  Sum_probs=26.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ...+.++|..+|.|+||.|+.+|+..+|..
T Consensus        51 ~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~   80 (93)
T d3c1va1          51 EAAFQKLMSNLDSNRDNEVDFQEYCVFLSC   80 (93)
T ss_dssp             HHHHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCCCHHHHHHHHHH
Confidence            356788999999999999999999998877

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=92.43  E-value=0.043  Score=38.69  Aligned_cols=29  Identities=28%  Similarity=0.455  Sum_probs=26.3

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .++.++|..+|.|++|.|+.+|+..+++.
T Consensus        41 ~ei~~~~~~~D~d~~G~I~~~EF~~~~~~   69 (81)
T d2opoa1          41 DEVRRMMAEIDTDGDGFISFDEFTDFARA   69 (81)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            35778999999999999999999999887

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=92.03  E-value=0.051  Score=37.81  Aligned_cols=29  Identities=17%  Similarity=0.363  Sum_probs=25.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .++.++|..+|.|++|.|+.+|+..+|++
T Consensus        45 ~e~~~~~~~~D~d~~G~I~~~EF~~~m~k   73 (77)
T d1oqpa_          45 EELQEMIAEADRNDDNEIDEDEFIRIMKK   73 (77)
T ss_dssp             HHHHHHHHHHCCSSSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCcEeHHHHHHHHHc
Confidence            35667899999999999999999999987

>d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Osteonectin
domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.16  E-value=0.017  Score=45.82  Aligned_cols=58  Identities=16%  Similarity=0.084  Sum_probs=45.5

Q ss_pred             HHHHhhcccCCC-CCCCCCHHHHHHHHHhhCCCcccHHHHHHHHHhcCCCCCceeecCccccccchhhhc
Q 011380          405 DLRDQFDAIDVD-KNGSISLEEMRQALAKDLPWKLKESRVLEILQAVNTPFLGLFLPCHEKGEKFSYLLL  473 (487)
Q Consensus       405 ~l~~~F~~~D~d-~~G~i~~~el~~~l~~~~~~~~~~~e~~~~~~~~d~~~~g~i~~~~~~~~~f~~f~~  473 (487)
                      .+.-.|..+|.| .||.++..||+.+... +  ...+.=+..+++..|.|+||.|        ++.|+..
T Consensus        78 ~v~W~F~~LD~n~~D~~L~~~EL~~l~~~-L--~~~e~C~~~F~~~CD~n~D~~I--------s~~EW~~  136 (151)
T d1sraa_          78 PVHWQFGQLDQHPIDGYLSHTELAPLRAP-L--IPMEHCTTRFFETCDLDNDKYI--------ALDEWAG  136 (151)
T ss_dssp             HHHHHHHHHCCTTCSSEECTTTTGGGGST-T--STTGGGHHHHHHHHCTTCSSSE--------EHHHHHH
T ss_pred             cceeehhhcCCCCCCCccCHHHHHHHHHh-h--cCCchHHHHHHHHhcCCCCCcC--------CHHHHHH
Confidence            455679999999 5999999999885433 2  1223347899999999999999        8888876

>d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]

Probab=91.05  E-value=0.064  Score=38.91  Aligned_cols=30  Identities=13%  Similarity=0.309  Sum_probs=26.7

Q ss_pred             HHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          403 LADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       403 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ...+.++|+.+|.|+||.|+.+|+..+|..
T Consensus        51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~   80 (93)
T d1zfsa1          51 ADAVDKIMKELDENGDGEVDFQEFVVLVAA   80 (93)
T ss_dssp             HHHHHHHHHHHTTTCCSEECSHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence            456788999999999999999999998876

>d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: Nucleobindin 1 (CALNUC)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.93  E-value=0.058  Score=39.63  Aligned_cols=29  Identities=14%  Similarity=0.268  Sum_probs=26.0

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ..+..+|..+|.|+||.|+.+|+..++++
T Consensus        68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~   96 (99)
T d1snla_          68 RMREHVMKNVDTNQDRLVTLEEFLASTQR   96 (99)
T ss_dssp             HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence            45778999999999999999999998875

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=90.85  E-value=0.036  Score=37.66  Aligned_cols=29  Identities=28%  Similarity=0.490  Sum_probs=25.6

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .++..+|..+|.|++|.|+.+|+..+|.+
T Consensus        39 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~r   67 (68)
T d1c7va_          39 AEVEEAMKEADEDGNGVIDIPEFMDLIKK   67 (68)
T ss_dssp             HHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            46677899999999999999999998865

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=90.25  E-value=0.046  Score=39.61  Aligned_cols=28  Identities=11%  Similarity=0.298  Sum_probs=25.0

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+.++|..+|.|+||.|+.+|+..++..
T Consensus        50 ~v~~~~~~~D~n~DG~I~F~EF~~li~~   77 (92)
T d1a4pa_          50 AVDKIMKDLDQCRDGKVGFQSFFSLIAG   77 (92)
T ss_dssp             HHHHHHHHHCTTSSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcHHHHHHHHHH
Confidence            5677899999999999999999988766

>d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a3 [TaxId: 9606]

Probab=90.23  E-value=0.079  Score=38.38  Aligned_cols=31  Identities=19%  Similarity=0.301  Sum_probs=27.3

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ....+.+++..+|.|+||.|+.+|+..+|..
T Consensus        50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~   80 (93)
T d1ksoa_          50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLAC   80 (93)
T ss_dssp             CHHHHHHHHHHHHHTTTCEECHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHH
Confidence            3457888999999999999999999988876

>d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]

Probab=89.75  E-value=0.15  Score=36.28  Aligned_cols=31  Identities=16%  Similarity=0.387  Sum_probs=27.0

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ....+.++|+.+|.|+||.|+.+|+..++..
T Consensus        49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~   79 (87)
T d1e8aa_          49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAI   79 (87)
T ss_dssp             SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHH
Confidence            3457888999999999999999999887765

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=89.69  E-value=0.1  Score=34.82  Aligned_cols=35  Identities=29%  Similarity=0.559  Sum_probs=26.6

Q ss_pred             HHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 011380          393 ALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQAL  430 (487)
Q Consensus       393 ~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l  430 (487)
                      .+...++..   ++..+|..+|.|++|.|+.+|+..+|
T Consensus        31 ~lg~~~~~~---e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_          31 NLGEKLTDE---EVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             HTTCCCCHH---HHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HhCCCCCHH---HHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            334444443   56778999999999999999998754

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=89.57  E-value=0.1  Score=36.59  Aligned_cols=29  Identities=17%  Similarity=0.363  Sum_probs=25.2

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .++..+|..+|.|++|.|+.+|+..+|+.
T Consensus        51 ~ev~~~~~~~D~d~dg~I~~~EF~~~m~~   79 (81)
T d1fi5a_          51 DDIEELMKDGDKNNDGRIDYDEFLEFMKG   79 (81)
T ss_dssp             HHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred             HHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence            34667899999999999999999998865

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=89.23  E-value=0.16  Score=35.66  Aligned_cols=36  Identities=19%  Similarity=0.473  Sum_probs=28.7

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      +....+.   .+++++|..+|.|++|.|+.+|+..+|.+
T Consensus        45 lg~~~t~---~el~~~i~~~D~d~~G~I~f~eFl~im~~   80 (82)
T d1wrka1          45 LGQNPTP---EELQEMIDEVDEDGSGTVDFDEFLVMMVR   80 (82)
T ss_dssp             TTCCCCH---HHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred             cCCCCCH---HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence            4444443   45777899999999999999999998875

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=89.00  E-value=0.16  Score=34.92  Aligned_cols=36  Identities=19%  Similarity=0.406  Sum_probs=28.5

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      +...++.+   ++.++|..+|.|++|.|+.+|+..+|..
T Consensus        38 lg~~~~~~---e~~~~~~~~D~d~dg~I~~~EF~~~m~~   73 (75)
T d1jc2a_          38 TGEHVIEE---DIEDLMKDSDKNNDGRIDFDEFLKMMEG   73 (75)
T ss_dssp             SSSCCCHH---HHHHHHHHHCSSSCSEECHHHHHHHHHT
T ss_pred             cCCCccHH---HHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence            44444444   4677889999999999999999998875

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=88.32  E-value=0.1  Score=36.12  Aligned_cols=28  Identities=25%  Similarity=0.508  Sum_probs=24.9

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ++.++|..+|.|++|.|+.+|+..+|.+
T Consensus        46 ei~~~~~~~D~d~dG~I~f~EF~~~m~~   73 (76)
T d1qx2a_          46 TLDEMIEEVDKNGDGEVSFEEFLVMMKK   73 (76)
T ss_dssp             SHHHHHHHHCTTCSSEECHHHHHHHHHH
T ss_pred             HHHHHHHHhhcCCCCcCcHHHHHHHHHH
Confidence            3667899999999999999999998876

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=87.74  E-value=0.2  Score=34.95  Aligned_cols=37  Identities=24%  Similarity=0.444  Sum_probs=29.0

Q ss_pred             HHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          393 ALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       393 ~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+...++..   ++.++|..+|.|++|.|+.+|+..+|.+
T Consensus        42 ~~g~~~s~~---e~~~~~~~~D~d~~g~I~~~eF~~~m~~   78 (81)
T d1avsa_          42 MLGQNPTKE---ELDAIIEEVDEDGSGTIDFEEFLVMMVR   78 (81)
T ss_dssp             HTTCCCCHH---HHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred             HcCCCCCHH---HHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            344445544   4677899999999999999999998865

>d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]

Probab=86.75  E-value=0.18  Score=35.87  Aligned_cols=28  Identities=18%  Similarity=0.419  Sum_probs=24.9

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+.+++..+|.|+||.|+.+|+..++..
T Consensus        50 ~v~~i~~~~D~n~DG~IdF~EF~~l~~~   77 (87)
T d1xk4a1          50 GADVWFKELDINTDGAVNFQEFLILVIK   77 (87)
T ss_dssp             CHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence            4667889999999999999999998876

>d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=86.20  E-value=0.18  Score=36.82  Aligned_cols=28  Identities=32%  Similarity=0.341  Sum_probs=24.6

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALA  431 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~  431 (487)
                      ..+.++++..|.|++|.|+.+|+..+|+
T Consensus        45 ~~L~~i~~~~D~d~dG~L~~~EF~~am~   72 (99)
T d1qjta_          45 LILGKIWDLADTDGKGVLSKQEFFVALR   72 (99)
T ss_dssp             HHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence            3577788999999999999999998876

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=85.85  E-value=0.32  Score=31.68  Aligned_cols=32  Identities=25%  Similarity=0.565  Sum_probs=24.2

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQ  428 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~  428 (487)
                      +...++..   ++..+|+.+|.|++|.|+.+|+.+
T Consensus        30 ~g~~~~~~---ei~~l~~~~D~d~dg~I~~~eFl~   61 (61)
T d2fcea1          30 LGEKLTDA---EVDELLKGVEVDSNGEIDYKKFIE   61 (61)
T ss_dssp             TTCCCCHH---HHHHHHTTCCCCTTSEECHHHHHH
T ss_pred             cCCCCCHH---HHHHHHHHcCCCCCCcEeHHHhcC
Confidence            33444443   566789999999999999999853

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=85.67  E-value=0.16  Score=34.66  Aligned_cols=36  Identities=28%  Similarity=0.559  Sum_probs=28.2

Q ss_pred             HhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          394 LASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       394 m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      +...++.+   .+..+|..+|.|++|.|+.+|+..+|..
T Consensus        37 ~g~~~s~~---~~~~~~~~~D~d~~g~I~f~eF~~~m~~   72 (73)
T d2pq3a1          37 LGQNPTEA---ELQDMINEVDADGNGTIDFPEFLTMMAR   72 (73)
T ss_dssp             TTCCCCHH---HHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred             hCCCCCHH---HHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence            44444443   5677889999999999999999988864

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.16  E-value=0.11  Score=37.81  Aligned_cols=28  Identities=18%  Similarity=0.254  Sum_probs=24.1

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALA  431 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~  431 (487)
                      ..+.++|..+|.|++|+|+.+|+..+|.
T Consensus        44 ~~l~~i~~~~D~d~dG~l~~~EF~~am~   71 (95)
T d1c07a_          44 TLLAHIWSLCDTKDCGKLSKDQFALAFH   71 (95)
T ss_dssp             HHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence            3567889999999999999999987764

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=85.09  E-value=0.27  Score=33.81  Aligned_cols=37  Identities=27%  Similarity=0.478  Sum_probs=28.9

Q ss_pred             HHhccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          393 ALASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       393 ~m~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+...++.   .++.++|..+|.+++|.|+.+|+..+|.+
T Consensus        38 ~~g~~~t~---~e~~~~~~~~D~~~~g~I~~~eF~~~m~~   74 (77)
T d1f54a_          38 SLGLSPSE---AEVNDLMNEIDVDGNHQIEFSEFLALMSR   74 (77)
T ss_dssp             HHTCCCCH---HHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred             HhCCCCCH---HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence            34444444   35677899999999999999999998865

>d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Reps1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=84.68  E-value=0.18  Score=36.24  Aligned_cols=28  Identities=29%  Similarity=0.561  Sum_probs=24.0

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALA  431 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~  431 (487)
                      ..+.++++.+|.|++|+|+.+|+..+|.
T Consensus        43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~   70 (92)
T d1fi6a_          43 LELSHIWELSDFDKDGALTLDEFCAAFH   70 (92)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence            3577788899999999999999987664

>d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Cow (Bos taurus), s100b [TaxId: 9913]

Probab=84.50  E-value=0.53  Score=33.49  Aligned_cols=31  Identities=19%  Similarity=0.329  Sum_probs=26.5

Q ss_pred             HHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          402 ELADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       402 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ....+.++|+.+|.|+||.|+.+|+..++..
T Consensus        50 d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~   80 (90)
T d3cr5x1          50 EQEVVDKVMETLDSDGDGECDFQEFMAFVAM   80 (90)
T ss_dssp             SHHHHHHHHHHHCTTSSSSBCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            3456788999999999999999999887765

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.69  E-value=0.6  Score=32.41  Aligned_cols=33  Identities=15%  Similarity=0.393  Sum_probs=25.8

Q ss_pred             hccCChHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 011380          395 ASTLDDEELADLRDQFDAIDVDKNGSISLEEMRQAL  430 (487)
Q Consensus       395 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l  430 (487)
                      ...++++   ++..+|..+|.|++|.|+..|+...+
T Consensus        50 ~~~l~~~---e~~~l~~~~d~~~~g~I~y~eFl~~f   82 (83)
T d1wlza1          50 VQILTDE---QFDRLWNEMPVNAKGRLKYPDFLSRF   82 (83)
T ss_dssp             TCCCCHH---HHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred             CCCCChh---HHHHHhhccccCCCCcEeHHHHHHHh
Confidence            3344444   46678999999999999999998765

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=81.75  E-value=0.19  Score=34.87  Aligned_cols=27  Identities=33%  Similarity=0.619  Sum_probs=24.2

Q ss_pred             HHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          406 LRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       406 l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      +.++|..+|.|+||.|+.+|+..+|.+
T Consensus        49 v~~~~~~~D~d~dG~Idf~EF~~l~~~   75 (78)
T d1cb1a_          49 LDDLFQELDKNGDGEVSFEEFQVLVKK   75 (78)
T ss_dssp             SSHHHHHTCCCSSSSEEHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCcCcHHHHHHHHHH
Confidence            556889999999999999999998876

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=81.38  E-value=0.18  Score=35.87  Aligned_cols=27  Identities=37%  Similarity=0.647  Sum_probs=22.8

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHH
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQAL  430 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l  430 (487)
                      .++.++|..+|.|++|.|+.+|+..+|
T Consensus        59 ~e~~~l~~~~D~d~~g~I~~~EFl~am   85 (87)
T d1s6ja_          59 SEIKDLMDAADIDKSGTIDYGEFIAAT   85 (87)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred             HHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence            356788999999999999999997543

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=81.33  E-value=0.45  Score=34.52  Aligned_cols=28  Identities=14%  Similarity=0.494  Sum_probs=24.9

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+.++|..+|.|+||.|+.+|+..++..
T Consensus        55 ~v~~l~~~~D~d~DG~IdF~EF~~l~~~   82 (98)
T d1yuta1          55 SLDEKMKSLDVNQDSELKFNEYWRLIGE   82 (98)
T ss_dssp             CHHHHHHHHCTTCCSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence            4667899999999999999999988866

>d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]

Probab=81.00  E-value=0.28  Score=35.77  Aligned_cols=28  Identities=25%  Similarity=0.386  Sum_probs=25.0

Q ss_pred             HHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          405 DLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       405 ~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      .+.++|+.+|.|+||.|+.+|+..++..
T Consensus        53 ~v~~~~~~~D~n~DG~I~F~EF~~li~~   80 (100)
T d1psra_          53 YLADVFEKKDKNEDKKIDFSEFLSLLGD   80 (100)
T ss_dssp             GGGTHHHHHCTTCSSCBCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCcCcHHHHHHHHHH
Confidence            4667899999999999999999998876

>d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a6 [TaxId: 9606]

Probab=80.55  E-value=0.25  Score=35.20  Aligned_cols=29  Identities=17%  Similarity=0.376  Sum_probs=25.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALAK  432 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~  432 (487)
                      ..+.+.++.+|.|+||.|+.+|+..++..
T Consensus        50 ~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~   78 (89)
T d1k8ua_          50 AEIARLMEDLDRNKDQEVNFQEYVTFLGA   78 (89)
T ss_dssp             HHHHHHHHHHHHTTTCEEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCcHHHHHHHHHH
Confidence            46788999999999999999999988876

>d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.09  E-value=0.34  Score=34.94  Aligned_cols=28  Identities=21%  Similarity=0.367  Sum_probs=23.9

Q ss_pred             HHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 011380          404 ADLRDQFDAIDVDKNGSISLEEMRQALA  431 (487)
Q Consensus       404 ~~l~~~F~~~D~d~~G~i~~~el~~~l~  431 (487)
                      ..|..++...|.|++|+|+.+|+..+|.
T Consensus        43 ~~L~~Iw~~~D~~~dG~l~~~EF~~a~~   70 (95)
T d2jxca1          43 DILGRVWELSDIDHDGMLDRDEFAVAMF   70 (95)
T ss_dssp             HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence            3577889999999999999999976654